PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jers, C; Kobir, A; Sondergaard, EO; Jensen, PR; Mijakovic, I				Jers, Carsten; Kobir, Ahasanul; Sondergaard, Elsebeth Oline; Jensen, Peter Ruhdal; Mijakovic, Ivan			Bacillus subtilis Two-Component System Sensory Kinase DegS Is Regulated by Serine Phosphorylation in Its Input Domain	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; TYROSINE KINASE; PROTEIN-KINASES; SER/THR KINASE; DNA; COMPETENCE; BACTERIA; TRANSFORMATION	Bacillus subtilis two-component system DegS/U is well known for the complexity of its regulation. The cytosolic sensory kinase DegS does not receive a single predominant input signal like most two-component kinases, instead it integrates a wide array of metabolic inputs that modulate its activity. The phosphorylation state of the response regulator DegU also does not confer a straightforward "on/off" response; it is fine-tuned and at different levels triggers different sub-regulons. Here we describe serine phosphorylation of the DegS sensing domain, which stimulates its kinase activity. We demonstrate that DegS phosphorylation can be carried out by at least two B. subtilis Hanks-type kinases in vitro, and this stimulates the phosphate transfer towards DegU. The consequences of this process were studied in vivo, using phosphomimetic (Ser76Asp) and non-phosphorylatable (Ser76Ala) mutants of DegS. In a number of physiological assays focused on different processes regulated by DegU, DegS S76D phosphomimetic mutant behaved like a strain with intermediate levels of DegU phosphorylation, whereas DegS S76A behaved like a strain with lower levels of DegU phophorylation. These findings suggest a link between DegS phosphorylation at serine 76 and the level of DegU phosphorylation, establishing this post-translational modification as an additional trigger for this two-component system.	[Jers, Carsten; Sondergaard, Elsebeth Oline; Jensen, Peter Ruhdal] Tech Univ Denmark, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark; [Kobir, Ahasanul; Mijakovic, Ivan] AgroParisTech Inst Natl Rech Agron, Micalis, Jouy En Josas, France	Technical University of Denmark; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Jers, C (corresponding author), Tech Univ Denmark, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark.	Ivan.Mijakovic@grignon.inra.fr	Mijakovic, Ivan/Q-5583-2016; jensen, Peter Ruhdal/AAC-4891-2019	Mijakovic, Ivan/0000-0002-8860-6853; Jensen, Peter Ruhdal/0000-0003-2080-2070	Danish National Research Council (FNU) [272-07-0129]; Lundbeckfonden [R17-A1535]; Institut National de Recherche Agronomique (INRA); Technical University of Denmark (DTU)	Danish National Research Council (FNU)(Danmarks GrundforskningsfondDanish Natural Science Research Council); Lundbeckfonden(Lundbeckfonden); Institut National de Recherche Agronomique (INRA); Technical University of Denmark (DTU)	This work was supported by grants from the Danish National Research Council (FNU) 272-07-0129, the Lundbeckfonden R17-A1535 and the Institut National de Recherche Agronomique (INRA) installation package to IM and a PhD stipend from the Technical University of Denmark (DTU) to CJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati G, 2004, J BACTERIOL, V186, P6003, DOI 10.1128/jb.186.18.6003-6014.2004; AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; Christiansen LC, 1997, J BACTERIOL, V179, P2540, DOI 10.1128/jb.179.8.2540-2550.1997; Dervyn E, 2004, MOL MICROBIOL, V51, P1629, DOI 10.1111/j.1365-2958.2003.03951.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Madec E, 2003, J MOL BIOL, V330, P459, DOI 10.1016/S0022-2836(03)00579-5; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; MUKAI K, 1992, J BACTERIOL, V174, P7954, DOI 10.1128/JB.174.24.7954-7962.1992; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ogura M, 2003, MOL MICROBIOL, V49, P1685, DOI 10.1046/j.1365-2958.2003.03665.x; Ogura M, 1997, MOL GEN GENET, V254, P157, DOI 10.1007/s004380050403; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Ogura M, 2010, MOL MICROBIOL, V75, P1244, DOI 10.1111/j.1365-2958.2010.07047.x; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Phalip V, 2001, BIOCHEM J, V360, P639, DOI 10.1042/0264-6021:3600639; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Steil L, 2005, MICROBIOL-SGM, V151, P399, DOI 10.1099/mic.0.27493-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WITTEKIND M, 1989, BIOCHEMISTRY-US, V28, P9908, DOI 10.1021/bi00452a005; YASBIN RE, 1975, J BACTERIOL, V121, P296, DOI 10.1128/JB.121.1.296-304.1975; Yasumura A, 2008, J BACTERIOL, V190, P5162, DOI 10.1128/JB.00368-08	45	38	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14653	10.1371/journal.pone.0014653	http://dx.doi.org/10.1371/journal.pone.0014653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304896	Green Published, Green Submitted, gold			2022-12-27	WOS:000287036600005
J	D'Ostilio, K; Garraux, G				D'Ostilio, Kevin; Garraux, Gaetan			Automatic Stimulus-Induced Medial Premotor Cortex Activation without Perception or Action	PLOS ONE			English	Article							DETECTING AWARENESS; MOTOR ACTIVATION; VEGETATIVE STATE; INHIBITION; GOALS; WILL	Who has ever been surprised to return to the bowl of salted peanuts without realizing it, even after having eating a moderate number and deciding to stop? Using rapid event-related functional magnetic resonance imaging (fMRI) in healthy volunteers, we investigated the neural correlates of automatic processes induced by subliminal stimuli. We demonstrated that the automatic activation of motor programs elicited unconsciously in the medial premotor cortex was normally restricted to specific contexts set by the environment, but can occur below the threshold of awareness even when no movement was executed. This novel finding expands our view on brain mechanisms underlying unconscious motor control and provides new evidence that activation of the motor preparation system and consciousness are not obligatory linked.	[D'Ostilio, Kevin; Garraux, Gaetan] Univ Liege, Cyclotron Res Ctr, Liege, Belgium	University of Liege	D'Ostilio, K (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	kevin.dostilio@ulg.ac.be	Garraux, Gaëtan/G-9050-2011	Garraux, Gaetan/0000-0001-7829-2806	FRS-FNRS [1.5.047.06]	FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	KD and GG are Doctoral Fellow and Senior Research Associate at the Fonds National de la Recherche Scientifique de Belgique (FRS-FNRS), respectively. This work was supported by FRS-FNRS (Grant 1.5.047.06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccardi E, 2002, CORTEX, V38, P289, DOI 10.1016/S0010-9452(08)70661-0; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dijksterhuis A, 2010, ANNU REV PSYCHOL, V61, P467, DOI 10.1146/annurev.psych.093008.100445; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; Eimer M, 2003, BIOL PSYCHOL, V64, P7, DOI 10.1016/S0301-0511(03)00100-5; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; Nachev P, 2007, SCIENCE, V315, DOI 10.1126/science.1135096; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Praamstra P, 2005, J COGNITIVE NEUROSCI, V17, P483, DOI 10.1162/0898929053279513; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435	15	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16613	10.1371/journal.pone.0016613	http://dx.doi.org/10.1371/journal.pone.0016613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	717IF	21311759	Green Published, Green Submitted, gold			2022-12-27	WOS:000287036200024
J	Corbett, JE; Fischer, J; Whitney, D				Corbett, Jennifer E.; Fischer, Jason; Whitney, David			Facilitating Stable Representations: Serial Dependence in Vision	PLOS ONE			English	Article							MEMORY; PERCEPTION; NUMBER	We tested whether the intervening time between multiple glances influences the independence of the resulting visual percepts. Observers estimated how many dots were present in brief displays that repeated one, two, three, four, or a random number of trials later. Estimates made farther apart in time were more independent, and thus carried more information about the stimulus when combined. In addition, estimates from different visual field locations were more independent than estimates from the same location. Our results reveal a retinotopic serial dependence in visual numerosity estimates, which may be a mechanism for maintaining the continuity of visual perception in a noisy environment.	[Corbett, Jennifer E.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Fischer, Jason; Whitney, David] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	Brown University; University of California System; University of California Berkeley	Corbett, JE (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	jennifer.e.corbett@gmail.com			National Science Foundation [0748689]; National Institutes of Health [EY018216]; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by the National Science Foundation (0748689) and the National Institutes of Health (EY018216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADSHAW JL, 1978, TRENDS NEUROSCI, V1, P113, DOI 10.1016/0166-2236(78)90080-2; Brascamp JW, 2007, J VISION, V7, DOI 10.1167/7.12.12; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Butterworth B, 2008, CURR BIOL, V18, pR388, DOI 10.1016/j.cub.2008.03.014; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rensink RA, 2000, VIS COGN, V7, P127, DOI 10.1080/135062800394720; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Vul E, 2008, PSYCHOL SCI, V19, P645, DOI 10.1111/j.1467-9280.2008.02136.x; WAGENAAR WA, 1972, PSYCHOL BULL, V77, P65, DOI 10.1037/h0032060; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	18	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16701	10.1371/journal.pone.0016701	http://dx.doi.org/10.1371/journal.pone.0016701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21304953	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300124
J	Cutfield, WS; Derraik, JGB; Gunn, AJ; Reid, K; Delany, T; Robinson, E; Hofman, PL				Cutfield, Wayne S.; Derraik, Jose G. B.; Gunn, Alistair J.; Reid, Kyle; Delany, Theresa; Robinson, Elizabeth; Hofman, Paul L.			Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth	PLOS ONE			English	Article							PATIENT COMPLIANCE; THERAPY	Background: GH therapy requires daily injections over many years and compliance can be difficult to sustain. As growth hormone (GH) is expensive, non-compliance is likely to lead to suboptimal growth, at considerable cost. Thus, we aimed to assess the compliance rate of children and adolescents with GH treatment in New Zealand. Methods: This was a national survey of GH compliance, in which all children receiving government-funded GH for a four-month interval were included. Compliance was defined as >= 85% adherence (no more than one missed dose a week on average) to prescribed treatment. Compliance was determined based on two parameters: either the number of GH vials requested (GHreq) by the family or the number of empty GH vials returned (GHret). Data are presented as mean +/- SEM. Findings: 177 patients were receiving GH in the study period, aged 12.1 +/- 0.6 years. The rate of returned vials, but not number of vials requested, was positively associated with HVSDS (p<0.05), such that patients with good compliance had significantly greater linear growth over the study period (p<0.05). GHret was therefore used for subsequent analyses. 66% of patients were non-compliant, and this outcome was not affected by sex, age or clinical diagnosis. However, Maori ethnicity was associated with a lower rate of compliance. Interpretation: An objective assessment of compliance such as returned vials is much more reliable than compliance based on parental or patient based information. Non-compliance with GH treatment is common, and associated with reduced linear growth. Non-compliance should be considered in all patients with apparently suboptimal response to GH treatment.	[Cutfield, Wayne S.; Derraik, Jose G. B.; Delany, Theresa; Hofman, Paul L.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Cutfield, Wayne S.; Hofman, Paul L.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; [Gunn, Alistair J.] Univ Auckland, Dept Physiol, Auckland 1, New Zealand; [Gunn, Alistair J.] Univ Auckland, Dept Paediat, Auckland 1, New Zealand; [Reid, Kyle] Pharmaceut Management Agcy New Zealand PHARMAC, Wellington, New Zealand; [Robinson, Elizabeth] Univ Auckland, Dept Epidemiol & Biostat, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Gunn, Alistair/0000-0003-0656-7035	PHARMAC (the pharmaceutical purchasing division of New Zealand's Ministry of Health)	PHARMAC (the pharmaceutical purchasing division of New Zealand's Ministry of Health)	This study was funded by PHARMAC (the pharmaceutical purchasing division of New Zealand's Ministry of Health) who assisted with data collection. However, PHARMAC had no role on the analysis, decision to publish, or preparation of the manuscript. Note that, as a government agency, PHARMAC is completely independent of the pharmaceutical industry.	Allen DB, 2006, PEDIATRICS, V118, P343, DOI 10.1542/peds.2006-0329; Barclay E, 2009, LANCET, V373, P15, DOI 10.1016/S0140-6736(08)61938-8; Carter PJ, 2008, DIABETOLOGIA, V51, P1835, DOI 10.1007/s00125-008-1106-9; CHRISTENSEN DB, 1978, HEALTH SERV RES, V13, P171; CROMER BA, 1989, J DEV BEHAV PEDIATR, V10, P207; Desrosiers Paul, 2005, Pediatr Endocrinol Rev, V2 Suppl 3, P327; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; GABRIEL M, 1977, AM J PUBLIC HEALTH, V67, P968, DOI 10.2105/AJPH.67.10.968; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Haverkamp F, 2008, CLIN THER, V30, P307, DOI 10.1016/j.clinthera.2008.02.017; Hunter I, 2000, ARCH DIS CHILDHOOD, V82, pA8, DOI [10.1136/adc.47.255.839-c, DOI 10.1136/ADC.47.255.839-C]; Kapoor RR, 2008, ARCH DIS CHILD, V93, P147, DOI 10.1136/adc.2006.114249; Kardas P, 2002, J ANTIMICROB CHEMOTH, V49, P897, DOI 10.1093/jac/dkf046; MAIN KM, 1995, ACTA PAEDIATR, V84, P331, DOI 10.1111/j.1651-2227.1995.tb13638.x; Marcus S F, 2001, Hum Fertil (Camb), V4, P85, DOI 10.1080/1464727012000199351; McCreanor Timothy, 2002, N Z Med J, V115, pU272; Oyarzabal M, 1998, ACTA PAEDIATR, V87, P387, DOI 10.1080/08035259850156959; Rosenfeld Ron G, 2008, Endocr Pract, V14, P143; SMITH SL, 1993, ARCH DIS CHILD, V68, P91, DOI 10.1136/adc.68.1.91; SMYTH AR, 1993, ARCH DIS CHILD, V68, P235, DOI 10.1136/adc.68.2.235; *US OFF INSP GEN, 1990, OEI048989121 US OFF	21	150	168	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16223	10.1371/journal.pone.0016223	http://dx.doi.org/10.1371/journal.pone.0016223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305004	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300042
J	Jain, S; Moscicka, KB; Bos, MP; Pachulec, E; Stuart, MCA; Keegstra, W; Boekema, EJ; van der Does, C				Jain, Samta; Moscicka, Katarzyna B.; Bos, Martine P.; Pachulec, Emilia; Stuart, Marc C. A.; Keegstra, Wilko; Boekema, Egbert J.; van der Does, Chris			Structural Characterization of Outer Membrane Components of the Type IV Pili System in Pathogenic Neisseria	PLOS ONE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; SECRETIN PULD; CRYOELECTRON MICROSCOPY; TWITCHING MOTILITY; BIOFILM FORMATION; PHASE VARIATION; DNA TRANSFER; GONORRHOEAE	Structures of the type IV pili secretin complexes from Neisseria gonorrhoeae and Neisseria meningitidis, embedded in outer membranes were investigated by transmission electron microscopy. Single particle averaging revealed additional domains not observed previously. Secretin complexes of N. gonorrhoeae showed a double ring structure with a 14-15-fold symmetry in the central ring, and a 14-fold symmetry of the peripheral ring with 7 spikes protruding. In secretin complexes of N. meningitidis, the spikes were absent and the peripheral ring was partly or completely lacking. When present, it had a 19-fold symmetry. The structures of the complexes in several pil mutants were determined. Structures obtained from the pilC1/C2 adhesin and the pilW minor pilin deletion strains were similar to wild-type, whereas deletion of the homologue of N. meningitidis PilW resulted in the absence of secretin structures. Remarkably, the pilE pilin subunit and pilP lipoprotein deletion mutants showed a change in the symmetry of the peripheral ring from 14 to 19 and loss of spikes. The pilF ATPase mutant also lost the spikes, but maintained 14-fold symmetry. These results show that secretin complexes contain previously unidentified large and flexible extra domains with a probable role in stabilization or assembly of type IV pili.	[Jain, Samta; Pachulec, Emilia; van der Does, Chris] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands; [Jain, Samta; Pachulec, Emilia; van der Does, Chris] Univ Groningen, Zernike Inst Adv Mat, Haren, Netherlands; [Moscicka, Katarzyna B.; Stuart, Marc C. A.; Keegstra, Wilko; Boekema, Egbert J.] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Bos, Martine P.] Univ Utrecht, Dept Mol Microbiol, Fac Sci, Utrecht, Netherlands; [Jain, Samta; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Max Planck Society	Jain, S (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands.	does@mpi-marburg.mpg.de	Institute, Zernike/W-7033-2019; Stuart, Marc/B-6274-2008	Stuart, Marc/0000-0003-0667-6338				Aho EL, 1997, INFECT IMMUN, V65, P2613, DOI 10.1128/IAI.65.7.2613-2620.1997; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; BLACK WJ, 1984, INFECT IMMUN, V45, P453, DOI 10.1128/IAI.45.2.453-457.1984; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2003, FRONT BIOSCI, V8, pS544; Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x; Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; FROHOLM LO, 1973, ACTA PATH MICRO IM B, VB 81, P525; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; Greiner LL, 2005, INFECT IMMUN, V73, P1964, DOI 10.1128/IAI.73.4.1964-1970.2005; Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; Hazes B, 2008, BBA-BIOMEMBRANES, V1778, P1839, DOI 10.1016/j.bbamem.2008.03.011; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kereiche S, 2008, FEBS LETT, V582, P3650, DOI 10.1016/j.febslet.2008.09.050; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; NEWHALL WJ, 1980, INFECT IMMUN, V27, P475, DOI 10.1128/IAI.27.2.475-482.1980; NICOLSON IJ, 1987, J GEN MICROBIOL, V133, P553; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; REICHOW SL, 2010, NAT STRUCT MOL BIOL; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; Tonjum T, 1998, MOL MICROBIOL, V29, P111, DOI 10.1046/j.1365-2958.1998.00910.x; Trindade MB, 2008, J MOL BIOL, V378, P1031, DOI 10.1016/j.jmb.2008.03.028; TSAI CM, 1980, J BACTERIOL, V141, P169, DOI 10.1128/JB.141.1.169-176.1980; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l	69	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16624	10.1371/journal.pone.0016624	http://dx.doi.org/10.1371/journal.pone.0016624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304951	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300101
J	Richter, SH; Garner, JP; Zipser, B; Lewejohann, L; Sachser, N; Touma, C; Schindler, B; Chourbaji, S; Brandwein, C; Gass, P; van Stipdonk, N; van der Harst, J; Spruijt, B; Voikar, V; Wolfer, DP; Wurbel, H				Richter, S. Helene; Garner, Joseph P.; Zipser, Benjamin; Lewejohann, Lars; Sachser, Norbert; Touma, Chadi; Schindler, Britta; Chourbaji, Sabine; Brandwein, Christiane; Gass, Peter; van Stipdonk, Niek; van der Harst, Johanneke; Spruijt, Berry; Voikar, Vootele; Wolfer, David P.; Wuerbel, Hanno			Effect of Population Heterogenization on the Reproducibility of Mouse Behavior: A Multi-Laboratory Study	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; ENVIRONMENTAL ENRICHMENT; LABORATORY ENVIRONMENT; EMOTIONAL BEHAVIOR; HOUSING CONDITIONS; INBRED STRAINS; MICE; STANDARDIZATION; RESPONSES; ANXIETY	In animal experiments, animals, husbandry and test procedures are traditionally standardized to maximize test sensitivity and minimize animal use, assuming that this will also guarantee reproducibility. However, by reducing within-experiment variation, standardization may limit inference to the specific experimental conditions. Indeed, we have recently shown in mice that standardization may generate spurious results in behavioral tests, accounting for poor reproducibility, and that this can be avoided by population heterogenization through systematic variation of experimental conditions. Here, we examined whether a simple form of heterogenization effectively improves reproducibility of test results in a multi-laboratory situation. Each of six laboratories independently ordered 64 female mice of two inbred strains (C57BL/6NCrl, DBA/2NCrl) and examined them for strain differences in five commonly used behavioral tests under two different experimental designs. In the standardized design, experimental conditions were standardized as much as possible in each laboratory, while they were systematically varied with respect to the animals' test age and cage enrichment in the heterogenized design. Although heterogenization tended to improve reproducibility by increasing within-experiment variation relative to between-experiment variation, the effect was too weak to account for the large variation between laboratories. However, our findings confirm the potential of systematic heterogenization for improving reproducibility of animal experiments and highlight the need for effective and practicable heterogenization strategies.	[Richter, S. Helene; Chourbaji, Sabine; Brandwein, Christiane; Gass, Peter] Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Richter, S. Helene; Wuerbel, Hanno] Univ Giessen, Giessen, Germany; [Richter, S. Helene; Zipser, Benjamin; Lewejohann, Lars; Sachser, Norbert] Univ Munster, Munster, Germany; [Garner, Joseph P.] Purdue Univ, W Lafayette, IN 47907 USA; [Touma, Chadi; Chourbaji, Sabine] Max Planck Inst Psychiat, D-80804 Munich, Germany; [van Stipdonk, Niek; van der Harst, Johanneke; Spruijt, Berry] Delta Phen BV, Utrecht, Netherlands; [Voikar, Vootele] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Voikar, Vootele; Wolfer, David P.] Univ Zurich, Inst Anat, Zurich, Switzerland	Central Institute of Mental Health; Justus Liebig University Giessen; University of Munster; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Max Planck Society; University of Helsinki; University of Zurich	Richter, SH (corresponding author), Cent Inst Mental Hlth, D-6800 Mannheim, Germany.	hanno.wuerbel@vetmed.uni-giessen.de	Voikar, Vootele/V-4542-2019; Würbel, Hanno/D-6281-2012; Touma, Chadi/G-4677-2011; Garner, Joseph P/C-8422-2009; Wolfer, David P/B-3293-2016; Lewejohann, Lars/H-3717-2013	Voikar, Vootele/0000-0003-4201-8666; Würbel, Hanno/0000-0002-2934-3010; Wolfer, David P/0000-0002-5957-1401; Lewejohann, Lars/0000-0002-0202-4351	German Research Foundation (DFG) [WU 494/2-1, SFB636]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by a grant (WU 494/2-1) from the German Research Foundation (DFG; www.dfg.de/index.jsp). P.G. was supported by a grant from the DFG within SFB636. Three authors are employed by a commercial company (Delta Phenomics BV; www.deltaphenomics.com/), and part of the study was conducted in a lab of this company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 1999, CURR DIR PSYCHOL SCI, V8, P3, DOI 10.1111/1467-8721.00002; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; [Anonymous], 1986, OFFICIAL J EUROPEAN, VL358, P1; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Beynen A. C., 2003, PRINCIPLES LAB ANIMA, P103; Beynen AC, 2003, PRINCIPLES LAB ANIMA, P219; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Cabib S, 2002, BEHAV BRAIN RES, V130, P103, DOI 10.1016/S0166-4328(01)00422-3; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Chourbaji S, 2008, BEHAV BRAIN RES, V192, P254, DOI 10.1016/j.bbr.2008.04.015; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Crestani F, 2000, NAT NEUROSCI, V3, P1059, DOI 10.1038/80553; Dahlborn K, 1996, SCAND J LAB ANIM SCI, V23, P97; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Festing MFW, 2004, ATLA-ALTERN LAB ANIM, V32, P133, DOI 10.1177/026119290403201s20; Festing MFW, 2004, ATLA-ALTERN LAB ANIM, V32, P259, DOI 10.1177/026119290403201s43; Galsworthy MJ, 2005, BEHAV BRAIN RES, V157, P211, DOI 10.1016/j.bbr.2004.06.021; Garcia AMB, 2005, PHYSIOL BEHAV, V85, P265, DOI 10.1016/j.physbeh.2005.04.007; GREENMAN DL, 1993, FUND APPL TOXICOL, V20, P383, DOI 10.1006/faat.1993.1049; Hall CS, 1936, J COMP PSYCHOL, V22, P345, DOI 10.1037/h0059253; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hascoet M, 1999, PHYSIOL BEHAV, V66, P567, DOI 10.1016/S0031-9384(98)00333-3; HERZBERG AM, 1991, ENVIRON HEALTH PERSP, V96, P199, DOI 10.2307/3431232; Hossain SM, 2004, GENES BRAIN BEHAV, V3, P167, DOI 10.1111/j.1601-183x.2004.00069.x; IMHOF JT, 1993, BEHAV BRAIN RES, V56, P177, DOI 10.1016/0166-4328(93)90036-P; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kafkafi N, 2005, P NATL ACAD SCI USA, V102, P4619, DOI 10.1073/pnas.0409554102; Kafkafi N, 2003, BEHAV NEUROSCI, V117, P464, DOI 10.1037/0735-7044.117.3.464; Lad HV, 2010, PHYSIOL BEHAV, V99, P301, DOI 10.1016/j.physbeh.2009.11.007; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; MARTIN P, 2002, MEASURING BEHAV INTR; MILLIGAN SR, 1993, PHYSIOL BEHAV, V53, P1067, DOI 10.1016/0031-9384(93)90361-I; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Obrink KJ, 2000, LAB ANIM, V34, P121, DOI 10.1258/002367700780457608; Paylor R, 2009, NAT METHODS, V6, P253, DOI 10.1038/nmeth0409-253; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Prior H, 1995, J EXP ANIM SCI, V37, P57; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P262; Richter SH, 2010, NAT METHODS, V7, P167, DOI 10.1038/nmeth0310-167; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; SALES GD, 1988, LAB ANIM, V22, P369, DOI 10.1258/002367788780746188; SCHARMANN W, 1993, P 5 FELASA S BRIGHT, P335; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Tachibana T, 1996, PHYSIOL BEHAV, V60, P941; Tautz D, 2000, TRENDS GENET, V16, P475, DOI 10.1016/S0168-9525(00)02118-1; Tucci V, 2006, MAMM GENOME, V17, P1113, DOI 10.1007/s00335-006-0075-x; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; van der Staay FJ, 2002, GENES BRAIN BEHAV, V1, P9, DOI 10.1046/j.1601-1848.2001.00007.x; van der Staay FJ, 2001, BEHAV BRAIN RES, V125, P3, DOI 10.1016/S0166-4328(01)00278-9; VANDEWEERD HA, 1994, J EXP ANIM SCI, V36, P117; Vissers G, 2001, QUAL QUANT, V35, P129, DOI 10.1023/A:1010319117701; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; WEIL CS, 1971, TOXICOL APPL PHARM, V19, P276, DOI 10.1016/0041-008X(71)90112-8; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Wotjak CT, 2004, BIF FUTURA, V19, P158; Wurbel H, 2002, GENES BRAIN BEHAV, V1, P3, DOI 10.1046/j.1601-1848.2001.00006.x; Wurbel H., 2007, NC3RS, V9, P1, DOI DOI 10.1016/S1353-8020(08)70759-4; Yang HN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003724	72	97	99	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16461	10.1371/journal.pone.0016461	http://dx.doi.org/10.1371/journal.pone.0016461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305027	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000286834300066
J	Sela, I; Krentsis, IM; Shlomai, Z; Sadeh, M; Dabby, R; Argov, Z; Ben-Bassat, H; Mitrani-Rosenbaum, S				Sela, Ilan; Krentsis, Irit Milman; Shlomai, Zipora; Sadeh, Menachem; Dabby, Ron; Argov, Zohar; Ben-Bassat, Hannah; Mitrani-Rosenbaum, Stella			The Proteomic Profile of Hereditary Inclusion Body Myopathy	PLOS ONE			English	Article							DISTAL MYOPATHY; SIALIC ACIDS; MUSCLE; PROTEINS; MUTATION; GENE; QUADRICEPS; EXPRESSION; MYOBLASTS; MYOSITIS	Hereditary inclusion body myopathy (HIBM) is an adult onset, slowly progressive distal and proximal myopathy. Although the causing gene, GNE, encodes for a key enzyme in the biosynthesis of sialic acid, its primary function in HIBM remains unknown. The goal of this study was to unravel new clues on the biological pathways leading to HIBM by proteomic comparison. Muscle cultures and biopsies were analyzed by two dimensional gel electrophoresis (2-DE) and the same biopsy extracts by isobaric tag for relative and absolute quantitation (iTRAQ). Proteins that were differentially expressed in all HIBM specimens versus all controls in each analysis were identified by mass spectrometry. The muscle cultures 2-DE analysis yielded 41 such proteins, while the biopsies 2-DE analysis showed 26 differentially expressed proteins. Out of the 400 proteins identified in biopsies by iTRAQ, 41 showed altered expression. In spite of the different nature of specimens (muscle primary cultures versus muscle biopsies) and of the different methods applied (2D gels versus iTRAQ) the differentially expressed proteins identified in each of the three analyses where related mainly to the same pathways, ubiquitination, stress response and mitochondrial processes, but the most robust cluster (30%) was assigned to cytoskeleton and sarcomere organization. Taken together, these findings indicate a possible novel function of GNE in the muscle filamentous apparatus that could be involved in the pathogenesis of HIBM.	[Sela, Ilan; Krentsis, Irit Milman; Mitrani-Rosenbaum, Stella] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Shlomai, Zipora; Ben-Bassat, Hannah] Hadassah Hebrew Univ Med Ctr, Expt Surg Lab, Jerusalem, Israel; [Sadeh, Menachem; Dabby, Ron] Wolfson Med Ctr, Dept Neurol, Holon, Israel; [Argov, Zohar] Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Sela, I (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	stella@cc.huji.ac.il		Mitrani-Rosenbaum, Stella/0000-0001-5335-8709	German Israeli Foundation [I-9191-142.3/2006]; Israel Science Foundation [671/07]; Neuromuscular Disease Foundation	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Neuromuscular Disease Foundation	The work was supported in part by the German Israeli Foundation (www.gif.org.il) (I-9191-142.3/2006), by the Israel Science Foundation (www.isf.org.il) (671/07) and by the Neuromuscular Disease Foundation (www.neuromuscdisease.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Arnardottir S, 2004, J NEUROL NEUROSUR PS, V75, P917, DOI 10.1136/jnnp.2003.018994; Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; ASKANAS V, 1998, INCLUSION BODY MYOSI, P3; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; De Palma S, 2006, PROTEOMICS, V6, P379, DOI 10.1002/pmic.200500098; Doran P, 2004, EUR J BIOCHEM, V271, P3943, DOI 10.1111/j.1432-1033.2004.04332.x; Doran P, 2009, PROTEOMICS, V9, P989, DOI 10.1002/pmic.200800365; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gelfi C, 2006, J PROTEOME RES, V5, P1344, DOI 10.1021/pr050414x; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Krause S, 2003, NEUROMUSCULAR DISORD, V13, P830, DOI 10.1016/S0960-8966(03)00140-8; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Li J, 2006, J NEUROPATH EXP NEUR, V65, P826, DOI 10.1097/01.jnen.0000228204.19915.69; LINDBERG C, 1991, J NEUROL SCI, V103, P76, DOI 10.1016/0022-510X(91)90287-H; Mahjneh I, 2003, NEUROLOGY, V61, P87, DOI 10.1212/01.WNL.0000073618.91577.E8; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Nonaka Ikuya, 2005, Curr Neurol Neurosci Rep, V5, P61, DOI 10.1007/s11910-005-0025-0; O'Connell K, 2009, PROTEOMICS, V9, P5509, DOI 10.1002/pmic.200900472; Ohlendieck K, 2010, EXPERT REV PROTEOMIC, V7, P283, DOI 10.1586/EPR.10.2; Parker KC, 2009, MUSCLE NERVE, V39, P739, DOI 10.1002/mus.21230; Reuter G, 1996, BIOL CHEM H-S, V377, P325; Rosen R, 2004, PROTEOMICS, V4, P1061, DOI 10.1002/pmic.200300640; Rosen R, 2001, FEMS MICROBIOL ECOL, V35, P277, DOI 10.1111/j.1574-6941.2001.tb00813.x; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; WHEELER SD, 1982, PHYS THER, V62, P1809, DOI 10.1093/ptj/62.12.1809	39	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16334	10.1371/journal.pone.0016334	http://dx.doi.org/10.1371/journal.pone.0016334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305017	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300051
J	Soonawala, D; Rimmelzwaan, GF; Gelinck, LBS; Visser, LG; Kroon, FP				Soonawala, Darius; Rimmelzwaan, Guus F.; Gelinck, Luc B. S.; Visser, Leo G.; Kroon, Frank P.			Response to 2009 Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Patients and the Influence of Prior Seasonal Influenza Vaccination	PLOS ONE			English	Article							SWINE-ORIGIN 2009; IMMUNOGENICITY; VIRUSES; ADULTS; PROTECTION; IMMUNITY	Background: The immunogenicity of 2009 pandemic influenza A(H1N1) (pH1N1) vaccines and the effect of previous influenza vaccination is a matter of current interest and debate. We measured the immune response to pH1N1 vaccine in HIV-infected patients and in healthy controls. In addition we tested whether recent vaccination with seasonal trivalent inactivated vaccine (TIV) induced cross-reactive antibodies to pH1N1. (clinicaltrials.gov Identifier:NCT01066169) Methods and Findings: In this single-center prospective cohort study MF59-adjuvanted pH1N1 vaccine (Focetria (R), Novartis) was administered twice to 58 adult HIV-infected patients and 44 healthy controls in November 2009 (day 0 and day 21). Antibody responses were measured at baseline, day 21 and day 56 with hemagglutination-inhibition (HI) assay. The seroprotection rate (defined as HI titers >= :40) for HIV-infected patients was 88% after the first and 91% after the second vaccination. These rates were comparable to those in healthy controls. Post-vaccination GMT, a sensitive marker of the immune competence of a group, was lower in HIV-infected patients. We found a high seroprotection rate at baseline (31%). Seroprotective titers at baseline were much more common in those who had received 2009-2010 seasonal TIV three weeks prior to the first dose of pH1N1 vaccine. Using stored serum samples of 51 HIV-infected participants we measured the pH1N1 specific response to 2009-2010 seasonal TIV. The seroprotection rate to pH1N1 increased from 22% to 49% after vaccination with 2009-2010 seasonal TIV. Seasonal TIV induced higher levels of antibodies to pH1N1 in older than in younger subjects. Conclusion: In HIV-infected patients on combination antiretroviral therapy, with a median CD4+ T-lymphocyte count above 500 cells/mm(3), one dose of MF59-adjuvanted pH1N1 vaccine induced a high seroprotection rate comparable to that in healthy controls. A second dose had a modest additional effect. Furthermore, seasonal TIV induced cross-reactive antibodies to pH1N1 and this effect was more pronounced in older subjects.	[Soonawala, Darius; Visser, Leo G.; Kroon, Frank P.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Rimmelzwaan, Guus F.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Gelinck, Luc B. S.] MC Haaglanden, Dept Internal Med, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Soonawala, D (corresponding author), Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands.	d.soonawala@lumc.nl	Visser, Leo/AAH-5755-2021	Visser, Leo/0000-0002-3600-9782	charitable organization Stichting MOBO Foundation, Noordwijk, The Netherlands [70228-8215]	charitable organization Stichting MOBO Foundation, Noordwijk, The Netherlands(Netherlands Government)	This study was funded by a restricted grant from the charitable organization Stichting MOBO Foundation, Noordwijk, The Netherlands (project code 70228-8215). The grant was used to purchase materials for the study, to pay an incentive to the volunteers and to compensate their travel costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anema A, 2008, HIV MED, V9, P57, DOI 10.1111/j.1468-1293.2008.00515.x; Atashili J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-138; Bickel M, 2010, AIDS, V24, pF31, DOI 10.1097/QAD.0b013e3283398da1; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Center for Biologics Evaluation and Research, 2007, GUID IND CLIN DAT NE; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; European Committee for Proprietary Medial Products, 1997, CPMPBWP21496 EUR COM; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gasparini R, 2010, INT J CLIN PRACT, V64, P432, DOI 10.1111/j.1742-1241.2009.02309.x; Gelinck LBS, 2009, VACCINE, V27, P2469, DOI 10.1016/j.vaccine.2009.02.053; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ikonen N, 2010, EURO SURVEILL, V15; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; KAPLAN JE, 2009, SOCIETY, V58, P1; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; LAUNAY O, 2010, SAN FRANC US 17 C RE; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; LIU LJ, 2010, J CLIN VIRO IN PRESS; *NAT I PUBL HLTH E, PAND INFL A HINI HOS; Neuzil KM, 2003, JAIDS-J ACQ IMM DEF, V34, P304, DOI 10.1097/00126334-200311010-00008; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Orlando G, 2010, AIDS, V24, P2142, DOI 10.1097/QAD.0b013e32833cfcb0; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Roman F, 2010, CLIN INFECT DIS, V51, P668, DOI 10.1086/655830; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Vajo Z, 2010, LANCET, V375, P49, DOI 10.1016/S0140-6736(09)62039-0; Viboud C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000259; Vogtlander NPJ, 2004, VACCINE, V22, P2199, DOI 10.1016/j.vaccine.2003.11.046; *WHO, HUM INF PAND HINI 20; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	39	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16496	10.1371/journal.pone.0016496	http://dx.doi.org/10.1371/journal.pone.0016496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304982	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300072
J	Van den Eede, P; Soto-Calle, VE; Delgado, C; Gamboa, D; Grande, T; Rodriguez, H; Llanos-Cuentas, A; Anne, J; D'Alessandro, U; Erhart, A				Van den Eede, Peter; Soto-Calle, Veronica E.; Delgado, Christopher; Gamboa, Dionicia; Grande, Tanilu; Rodriguez, Hugo; Llanos-Cuentas, Alejandro; Anne, Jozef; D'Alessandro, Umberto; Erhart, Annette			Plasmodium vivax Sub-Patent Infections after Radical Treatment Are Common in Peruvian Patients: Results of a 1-Year Prospective Cohort Study	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; MALARIA CONTROL; AMAZON REGION; PRIMAQUINE; CHLOROQUINE; PREVALENCE; FALCIPARUM; EPIDEMIOLOGY; RESISTANCE; DIVERSITY	Background: There is an increasing body of literature reporting treatment failure of the currently recommended radical treatment of Plasmodium vivax infections. As P. vivax is the main malaria species outside the African continent, emerging tolerance to its radical treatment regime could have major consequences in countries like Peru, where 80% of malaria cases are due to P. vivax. Here we describe the results of a 1-year longitudinal follow up of 51 confirmed P. vivax patients living around Iquitos, Peruvian Amazon, and treated according to the Peruvian national guidelines. Methodology: Each month a blood sample for microscopy and later genotyping was systematically collected. Recent exposure to infection was estimated by detecting antibodies against the P. vivax circumsporozoite protein (CSP) and all PCR confirmed P. vivax infections were genotyped with 16 polymorphic microsatellites. Results: During a 1-year period, 84 recurrent infections, 22 positive also by microscopy, were identified, with a median survival time to first recurrent infection of 203 days. Most of them (71%) were asymptomatic; in 13 patients the infection persisted undetected by microscopy for several consecutive months. The genotype of mostly recurrent infections differed from that at day 0 while fewer differences were seen between the recurrent infections. The average expected heterozygosity was 0.56. There was strong linkage disequilibrium (I-A(s) = 0.29, p<1.10(-4)) that remained also when analyzing only the unique haplotypes, suggesting common inbreeding. Conclusion: In Peru, the P. vivax recurrent infections were common and displayed a high turnover of parasite genotypes compared to day 0. Plasmodium vivax patients, even when treated according to the national guidelines, may still represent an important parasite reservoir that can maintain transmission. Any elimination effort should consider such a hidden reservoir.	[Van den Eede, Peter; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Soto-Calle, Veronica E.; Delgado, Christopher; Gamboa, Dionicia; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Bioquim Biol Mol & Farmacol, Lima, Peru; [Grande, Tanilu; Rodriguez, Hugo] Organismo Andinode Salud Convenio Hipolito Unanue, Multicountry Malaria Project Malaria Control Cros, Lima, Peru; [Anne, Jozef] Catholic Univ Louvain, Dept Microbiol & Immunol, B-3000 Louvain, Belgium	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universite Catholique Louvain	Van den Eede, P (corresponding author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	pvandeneede@itg.be	ANNE, Jozef/H-7983-2019; Delgado Ratto, Christopher/D-3838-2013; Gamboa, Dionicia/CAF-2097-2022; D'Alessandro, Umberto/D-3457-2015	ANNE, Jozef/0000-0002-0493-2644; Gamboa, Dionicia/0000-0002-1420-7729; D'Alessandro, Umberto/0000-0001-6341-5009; Delgado-Ratto, Christopher/0000-0003-2300-5181; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Soto-Calle, Veronica Elena/0000-0003-0257-7869	"Fonds voor Wetenschappelijk Onderzoek" (FWO); "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT); Directorate General for Development Cooperation (DGCD) of the Belgian Government [95501, 95502]	"Fonds voor Wetenschappelijk Onderzoek" (FWO)(FWO); "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Directorate General for Development Cooperation (DGCD) of the Belgian Government	This study was funded by the Flemish government funds: "Fonds voor Wetenschappelijk Onderzoek" (FWO), and the "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT, PhD grant). The sample collection was funded by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 2 and 3; project 95501 and 95502 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez G, 2006, AM J TROP MED HYG, V75, P605, DOI 10.4269/ajtmh.2006.75.605; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Arevalo-Herrera M, 1998, ANN TROP MED PARASIT, V92, P539, DOI 10.1080/00034989859230; Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arruda ME, 2007, MEM I OSWALDO CRUZ, V102, P367, DOI 10.1590/S0074-02762007005000041; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; BROWN AE, 1991, AM J TROP MED HYG, V44, P21, DOI 10.4269/ajtmh.1991.44.21; CONTACOS PG, 1972, AM J TROP MED HYG, V21, P707, DOI 10.4269/ajtmh.1972.21.707; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; EEDE PV, 2010, AM J TROP MED HYG, V82, P223; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; FRANKE ED, 1992, AM J TROP MED HYG, V46, P708, DOI 10.4269/ajtmh.1992.46.708; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Hanf M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-278; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Havryliuk T, 2008, EXP PARASITOL, V120, P330, DOI 10.1016/j.exppara.2008.08.012; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; JELINEK T, 1995, AM J TROP MED HYG, V52, P322, DOI 10.4269/ajtmh.1995.52.322; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Leslie T, 2004, T ROY SOC TROP MED H, V98, P168, DOI 10.1016/S0035-9203(03)00041-5; Lim CS, 2005, MICROBIOL IMMUNOL, V49, P521, DOI 10.1111/j.1348-0421.2005.tb03757.x; *MIN HLTH PER, NAT GUID MAL TREATM; *MIN SAL PER DIR G, SIT MAL PER 2009; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Razakandrainibe R, 2009, ACTA TROP, V111, P160, DOI 10.1016/j.actatropica.2009.04.007; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Suphavilai C, 2004, AM J TROP MED HYG, V71, P29, DOI 10.4269/ajtmh.2004.71.29; Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Villalobos-Salcedo JM, 2000, ANN TROP MED PARASIT, V94, P749, DOI 10.1080/00034980020027960	43	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16257	10.1371/journal.pone.0016257	http://dx.doi.org/10.1371/journal.pone.0016257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297986	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100016
J	Bichsel, C; Neeld, DK; Hamazaki, T; Wu, DH; Chang, LJ; Yang, LJ; Terada, N; Jin, SG				Bichsel, Candace; Neeld, Dennis K.; Hamazaki, Takashi; Wu, Donghai; Chang, Lung-Ji; Yang, Lijun; Terada, Naohiro; Jin, Shouguang			Bacterial Delivery of Nuclear Proteins into Pluripotent and Differentiated Cells	PLOS ONE			English	Article							III SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; LENTIVIRAL VECTOR; CRE RECOMBINASE; STEM-CELLS; INDUCTION; FIBROBLASTS; EXCISION	Numerous Gram negative pathogens possess a type III secretion system (T3SS) which allows them to inject virulent proteins directly into the eukaryotic cell cytoplasm. Injection of these proteins is dependent on a variable secretion signal sequence. In this study, we utilized the N-terminal secretion signal sequence of Pseudomonas aeruginosa exotoxin ExoS to translocate Cre recombinase containing a nuclear localization sequence (Cre-NLS). Transient exposure of human sarcoma cell line, containing Cre-dependent lacZ reporter, resulted in efficient recombination in the host chromosome, indicating that the bacterially delivered protein was not only efficiently localized to the nucleus but also retained its biological function. Using this system, we also illustrate the ability of P. aeruginosa to infect mouse embryonic stem cells (mESC) and the susceptibility of these cells to bacterially delivered Cre-NLS. A single two-hour infection caused as high as 30% of the mESC reporter cells to undergo loxP mediated chromosomal DNA recombination. A simple antibiotic treatment completely eliminated the bacterial cells following the delivery, while the use of an engineered mutant strain greatly reduced cytotoxicity. Utility of the system was demonstrated by delivery of the Cre-NLS to induced pluripotent stem cells to excise the floxed oncogenic nuclear reprogramming cassette. These results validate the use of T3SS for the delivery of transcription factors for the purpose of cellular reprogramming.	[Bichsel, Candace; Neeld, Dennis K.; Chang, Lung-Ji; Jin, Shouguang] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Hamazaki, Takashi; Yang, Lijun; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Bichsel, C (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	sjin@mgm.ufl.edu	Jin, Shouguang/N-5548-2016		National Institutes of Health [RC1GM091238]; UF Opportunity Fund [UF-RGP80830]; Bankhead-Coley Cancer Research Program [FLDH 09BW-12]; National Basic Research Program of China (973 Program) [2011CB504004, 2010CB945500]; National Natural Science Foundation of China [90813033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UF Opportunity Fund; Bankhead-Coley Cancer Research Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (RC1GM091238), UF Opportunity Fund (UF-RGP80830), Bankhead-Coley Cancer Research Program (FLDH 09BW-12), National Basic Research Program of China (973 Program) (2011CB504004 and 2010CB945500) and the National Natural Science Foundation of China (90813033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dasgupta N, 2006, INFECT IMMUN, V74, P3334, DOI 10.1128/IAI.00090-06; Epaulard O, 2006, MOL THER, V14, P656, DOI 10.1016/j.ymthe.2006.06.011; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ha U, 2001, INFECT IMMUN, V69, P4398, DOI 10.1128/IAI.69.7.4398-4406.2001; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2005, MICROBIOL-SGM, V151, P3575, DOI 10.1099/mic.0.28277-0; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Oka Masahiro, 2006, V329, P273; Polack B, 2000, BIOCHEM BIOPH RES CO, V275, P854, DOI 10.1006/bbrc.2000.3399; Rabin SDP, 2005, INFECT IMMUN, V73, P573, DOI 10.1128/IAI.73.1.573-582.2005; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yu J, 2009, INFECT IMMUN, V77, P585, DOI 10.1128/IAI.01003-08; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaiss AK, 2002, J VIROL, V76, P7209, DOI 10.1128/JVI.76.14.7209-7219.2002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	35	29	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16465	10.1371/journal.pone.0016465	http://dx.doi.org/10.1371/journal.pone.0016465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304583	gold, Green Published			2022-12-27	WOS:000286663900053
J	Kawanishi, T; Shiraishi, T; Okano, Y; Sugawara, K; Hashimoto, M; Maejima, K; Komatsu, K; Kakizawa, S; Yamaji, Y; Hamamoto, H; Oshima, K; Namba, S				Kawanishi, Takeshi; Shiraishi, Takuya; Okano, Yukari; Sugawara, Kyoko; Hashimoto, Masayoshi; Maejima, Kensaku; Komatsu, Ken; Kakizawa, Shigeyuki; Yamaji, Yasuyuki; Hamamoto, Hiroshi; Oshima, Kenro; Namba, Shigetou			New Detection Systems of Bacteria Using Highly Selective Media Designed by SMART: Selective Medium-Design Algorithm Restricted by Two Constraints	PLOS ONE			English	Article							OCEAN SAMPLING EXPEDITION; CAMPESTRIS PV. MUSACEARUM; SEQUENCING TECHNOLOGIES; SEMISELECTIVE MEDIUM; SOIL; MICROORGANISMS; DIVERSITY; GENOMES; GENES; ELISA	Culturing is an indispensable technique in microbiological research, and culturing with selective media has played a crucial role in the detection of pathogenic microorganisms and the isolation of commercially useful microorganisms from environmental samples. Although numerous selective media have been developed in empirical studies, unintended microorganisms often grow on such media probably due to the enormous numbers of microorganisms in the environment. Here, we present a novel strategy for designing highly selective media based on two selective agents, a carbon source and antimicrobials. We named our strategy SMART for highly Selective Medium-design Algorithm Restricted by Two constraints. To test whether the SMART method is applicable to a wide range of microorganisms, we developed selective media for Burkholderia glumae, Acidovorax avenae, Pectobacterium carotovorum, Ralstonia solanacearum, and Xanthomonas campestris. The series of media developed by SMART specifically allowed growth of the targeted bacteria. Because these selective media exhibited high specificity for growth of the target bacteria compared to established selective media, we applied three notable detection technologies: paper-based, flow cytometry-based, and color change-based detection systems for target bacteria species. SMART facilitates not only the development of novel techniques for detecting specific bacteria, but also our understanding of the ecology and epidemiology of the targeted bacteria.	[Kawanishi, Takeshi; Shiraishi, Takuya; Okano, Yukari; Sugawara, Kyoko; Hashimoto, Masayoshi; Maejima, Kensaku; Komatsu, Ken; Kakizawa, Shigeyuki; Yamaji, Yasuyuki; Hamamoto, Hiroshi; Oshima, Kenro; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan	University of Tokyo	Kawanishi, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Komatsu, Ken/B-3244-2015; kakizawa, shigeyuki/L-8901-2018; Yamazaki, Kyoko/O-4931-2014	Komatsu, Ken/0000-0003-3323-7314; kakizawa, shigeyuki/0000-0003-3885-4434; Oshima, Kenro/0000-0001-7327-4481	Grants-in-Aid for Scientific Research [21248004] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; CHUN WWC, 1983, PLANT DIS, V67, P632; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Cordwell SJ, 1999, ARCH MICROBIOL, V172, P269, DOI 10.1007/s002030050780; Courvalin P, 2001, CLIN INFECT DIS, V33, pS138, DOI 10.1086/321840; CUPPELS D, 1974, PHYTOPATHOLOGY, V64, P468, DOI 10.1094/Phyto-64-468; Fournier PE, 2007, LANCET INFECT DIS, V7, P711, DOI 10.1016/S1473-3099(07)70260-8; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Giovannoni S, 2007, NAT REV MICROBIOL, V5, P820, DOI 10.1038/nrmicro1752; GRANADA GA, 1983, CAN J MICROBIOL, V29, P433, DOI 10.1139/m83-070; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Jin M, 2005, APPL MICROBIOL BIOT, V69, P229, DOI 10.1007/s00253-005-0108-5; Jones JB, 1997, J APPL MICROBIOL, V83, P397, DOI 10.1046/j.1365-2672.1997.00251.x; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kawaradani Mitsuo, 2000, Journal of General Plant Pathology, V66, P234, DOI 10.1007/PL00012951; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Mwangi M, 2007, PLANT PATHOL, V56, P383, DOI 10.1111/j.1365-3059.2007.01564.x; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Roy D, 2001, INT J FOOD MICROBIOL, V69, P167, DOI 10.1016/S0168-1605(01)00496-2; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; SCHLEGEL HG, 1967, ANNU REV MICROBIOL, V21, P49, DOI 10.1146/annurev.mi.21.100167.000405; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; SHIRAKAWA T, 2000, ANN PHYTOPATHOL SOC, V66, P132; Sundsfjord A, 2004, APMIS, V112, P815, DOI 10.1111/j.1600-0463.2004.apm11211-1208.x; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tripathi L, 2007, EUR J PLANT PATHOL, V117, P177, DOI 10.1007/s10658-006-9083-7; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang ZK, 1999, PLANT PATHOL, V48, P245, DOI 10.1046/j.1365-3059.1999.00332.x; Williams P. H., 1980, Plant Disease, V64, P736, DOI 10.1094/PD-64-736; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999	44	25	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16512	10.1371/journal.pone.0016512	http://dx.doi.org/10.1371/journal.pone.0016512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304596	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900059
J	Lofmark, S; de Klerk, N; Aro, H				Lofmark, Sonja; de Klerk, Nele; Aro, Helena			Neisseria gonorrhoeae Infection Induces Altered Amphiregulin Processing and Release	PLOS ONE			English	Article							GROWTH-FACTOR; EPITHELIAL-CELLS; IV PILI; PATHOGENIC NEISSERIAE; UP-REGULATION; EXPRESSION; CANCER; RECEPTOR; GENE; APOPTOSIS	Adhesion of the human pathogen Neisseria gonorrhoeae has established effects on the host cell and evokes a variety of cellular events including growth factor activation. In the present study we report that infection with N. gonorrhoeae causes altered amphiregulin processing and release in human epithelial cells. Amphiregulin is a well-studied growth factor with functions in various cell processes and is upregulated in different forms cancer and proliferative diseases. The protein is prototypically cleaved on the cell surface in response to external stimuli. We demonstrate that upon infection, a massive upregulation of amphiregulin mRNA is seen. The protein changes its subcellular distribution and is also alternatively cleaved at the plasma membrane, which results in augmented release of an infection-specific 36 kDa amphiregulin product from the surface of human cervical epithelial cells. Further, using antibodies directed against different domains of the protein we could determine the impact of infection on pro-peptide processing. In summary, we present data showing that the infection of N. gonorrhoeae causes an alternative amphiregulin processing, subcellular distribution and release in human epithelial cervical cells that likely contribute to the predisposition cellular abnormalities and anti-apoptotic features of N. gonorrhoeae infections.	[Lofmark, Sonja; de Klerk, Nele; Aro, Helena] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Lofmark, S (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	Helena.Aro@gmt.su.se						Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Binnicker MJ, 2003, CELL MICROBIOL, V5, P549, DOI 10.1046/j.1462-5822.2003.00300.x; Bostwick DG, 2004, PROSTATE, V58, P164, DOI 10.1002/pros.10322; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Busiello I, 2004, CELL MICROBIOL, V6, P255, DOI 10.1046/j.1462-5822.2004.00366.x; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; EBERT M, 1994, CANCER RES, V54, P3959; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Follows SA, 2009, INFECT IMMUN, V77, P3602, DOI 10.1128/IAI.01366-08; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Hurbin A, 2002, J BIOL CHEM, V277, P49127, DOI 10.1074/jbc.M207584200; Isokane M, 2008, J CELL SCI, V121, P3608, DOI 10.1242/jcs.031443; Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kallstrom H, 2000, CELL MICROBIOL, V2, P341, DOI 10.1046/j.1462-5822.2000.00063.x; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kim Y, 2009, INT J FOOD MICROBIOL, V131, P224, DOI 10.1016/j.ijfoodmicro.2009.03.002; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Merz AJ, 1996, MOL MED, V2, P745, DOI 10.1007/BF03401658; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; PIEPKORN M, 1995, J INVEST DERMATOL, V105, P802, DOI 10.1111/1523-1747.ep12326567; Plant L, 2004, CELL MICROBIOL, V6, P663, DOI 10.1111/j.1462-5822.2004.00393.x; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Sutcliffe S, 2006, J UROLOGY, V175, P1937, DOI 10.1016/S0022-5347(05)00892-X; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P2160, DOI 10.1158/1055-9965.EPI-05-0913; SWANSON J, 1986, CELL, V47, P267, DOI 10.1016/0092-8674(86)90449-6; SWANSON J, 1973, J EXP MED, V137, P571, DOI 10.1084/jem.137.3.571; THORNE BA, 1994, MOL CELL BIOL, V14, P1635, DOI 10.1128/MCB.14.3.1635	38	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16369	10.1371/journal.pone.0016369	http://dx.doi.org/10.1371/journal.pone.0016369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298020	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900042
J	Sato, F; Hatano, E; Kitamura, K; Myomoto, A; Fujiwara, T; Takizawa, S; Tsuchiya, S; Tsujimoto, G; Uemoto, S; Shimizu, K				Sato, Fumiaki; Hatano, Etsuro; Kitamura, Koji; Myomoto, Akira; Fujiwara, Takeshi; Takizawa, Satoko; Tsuchiya, Soken; Tsujimoto, Gozoh; Uemoto, Shinji; Shimizu, Kazuharu			MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; LIVER-TRANSPLANTATION; SUPPRESSOR GENE; CANCER; CIRRHOSIS; OUTCOMES; CLASSIFICATION; IDENTIFICATION; GENOMICS; TUMORS	Objective: Hepatocellular carcinoma (HCC) is difficult to manage due to the high frequency of post-surgical recurrence. Early detection of the HCC recurrence after liver resection is important in making further therapeutic options, such as salvage liver transplantation. In this study, we utilized microRNA expression profiling to assess the risk of HCC recurrence after liver resection. Methods: We examined microRNA expression profiling in paired tumor and non-tumor liver tissues from 73 HCC patients who satisfied the Milan Criteria. We constructed prediction models of recurrence-free survival using the Cox proportional hazard model and principal component analysis. The prediction efficiency was assessed by the leave-one-out cross-validation method, and the time-averaged area under the ROC curve (ta-AUROC). Results: The univariate Cox analysis identified 13 and 56 recurrence-related microRNAs in the tumor and non-tumor tissues, such as miR-96. The number of recurrence-related microRNAs was significantly larger in the non-tumor-derived microRNAs (N-miRs) than in the tumor-derived microRNAs (T-miRs, P < 0.0001). The best ta-AUROC using the whole dataset, T-miRs, N-miRs, and clinicopathological dataset were 0.8281, 0.7530, 0.7152, and 0.6835, respectively. The recurrence-free survival curve of the low-risk group stratified by the best model was significantly better than that of the high-risk group (Log-rank: P = 0.00029). The T-miRs tend to predict early recurrence better than late recurrence, whereas N-miRs tend to predict late recurrence better (P, 0.0001). This finding supports the concept of early recurrence by the dissemination of primary tumor cells and multicentric late recurrence by the 'field effect'. Conclusion: microRNA profiling can predict HCC recurrence in Milan criteria cases.	[Sato, Fumiaki; Fujiwara, Takeshi; Tsuchiya, Soken; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan; [Hatano, Etsuro; Kitamura, Koji; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Myomoto, Akira; Takizawa, Satoko] Toray Industries Ltd, New Frontiers Res Labs, Kanagawa, Japan; [Myomoto, Akira; Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacogenom, Kyoto, Japan	Kyoto University; Kyoto University; Toray Industries, Inc.; Kyoto University	Hatano, E (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan.	fsato@pharm.kyoto-u.ac.jp	Hatano, Etsuro/AAX-2407-2020	Hatano, Etsuro/0000-0003-3407-1918	Japanese federal organization; New Energy and Industrial Technology Development Organization (NEDO), Japan	Japanese federal organization; New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a Japanese federal fund promoting academia-industry collaboration, "Grant for Practical Application of University R&D Results under the Matching Fund Method, from a Japanese federal organization, the New Energy and Industrial Technology Development Organization ( NEDO), Japan''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Toray Industries, Inc. is a funder due to employment of Arira Myomoto and Satoko Takizawa, who provided technical support to conduct this project, but did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akriviadis EA, 1998, BRIT J SURG, V85, P1319; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Centeno BA, 2005, CANCER CYTOPATHOL, V105, P101, DOI 10.1002/cncr.20737; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; F Simon, 2010, LANGENBECKS ARCH SUR; Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Iizuka N, 2004, LANCET, V364, P1837, DOI 10.1016/S0140-6736(04)17455-2; Ito T, 2007, LIVER TRANSPLANT, V13, P1637, DOI 10.1002/lt.21281; Ito T, 2007, ONCOLOGY-BASEL, V73, P366, DOI 10.1159/000136156; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Liver Cancer Study Group of Japan, 2000, GEN RUL CLIN PATH ST; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michel J, 1997, J HEPATOL, V26, P1274, DOI 10.1016/S0168-8278(97)80462-X; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Stewart B.W., 2003, WORLD CANC REPORT; Taura K, 2007, SURGERY, V142, P685, DOI 10.1016/j.surg.2007.05.009; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Utsunomiya T, 2010, J GASTROENTEROL, V45, P146, DOI 10.1007/s00535-009-0164-1; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	34	98	107	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16435	10.1371/journal.pone.0016435	http://dx.doi.org/10.1371/journal.pone.0016435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298008	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900048
J	Lin, RY; Lu, GD; Wang, JH; Zhang, CS; Xie, WJ; Lu, XM; Mantion, G; Martin, H; Richert, L; Vuitton, DA; Wen, H				Lin, Renyong; Lue, Guodong; Wang, Junhua; Zhang, Chuanshan; Xie, Wenjuan; Lu, Xiaomei; Mantion, Georges; Martin, Helene; Richert, Lysiane; Vuitton, Dominique A.; Wen, Hao			Time Course of Gene Expression Profiling in the Liver of Experimental Mice Infected with Echinococcus multilocularis	PLOS ONE			English	Article							SERUM AMYLOID-A; EXPERIMENTAL ALVEOLAR ECHINOCOCCOSIS; DOWN-REGULATION; MESSENGER-RNA; CELL-SURVIVAL; HEPATITIS-B; APOPTOSIS; PROTEIN; CYTOCHROME-P450; IDENTIFICATION	Background: Alveolar echinococcosis (AE) is a severe chronic parasitic disease which behaves like a slow-growing liver cancer. Clinical observations suggest that the parasite, Echinococcus multilocularis (E. multilocularis) influences liver homeostasis and hepatic cell metabolism. However, this has never been analyzed during the time course of infection in the common model of secondary echinococcosis in experimental mice. Methodology/Principal Findings: Gene expression profiles were assessed using DNA microarray analysis, 1, 2, 3 and 6 months after injection of E. multilocularis metacestode in the liver of susceptible mice. Data were collected at different time points to monitor the dynamic behavior of gene expression. 557 differentially expressed genes were identified at one or more time points, including 351 up-regulated and 228 down-regulated genes. Time-course analysis indicated, at the initial stage of E. multilocularis infection (month 1-2), that most of up-regulated pathways were related to immune processes and cell trafficking such as chemokine-, mitogen-activated protein kinase (MAPK) signaling, and down-regulated pathways were related to xenobiotic metabolism; at the middle stage (month 3), MAPK signaling pathway was maintained and peroxisome proliferator-activated receptor (PPAR) signaling pathway emerged; at the late stage (month 6), most of up-regulated pathways were related to PPAR signaling pathway, complement and coagulation cascades, while down-regulated pathways were related to metabolism of xenobiotics by cytochrome P450. Quantitative RT-PCR analysis of a random selection of 19 genes confirmed the reliability of the microarray data. Immunohistochemistry analysis showed that proliferating cell nuclear antigen (PCNA) was increased in the liver of E. multilocularis infected mice from 2 months to 6 months. Conclusions: E. multilocularis metacestode definitely exerts a deep influence on liver homeostasis, by modifying a number of gene expression and metabolic pathways. It especially promotes hepatic cell proliferation, as evidenced by the increased PCNA constantly found in all the experimental time-points we studied and by an increased gene expression of key metabolic pathways.	[Lin, Renyong; Lue, Guodong; Wang, Junhua; Zhang, Chuanshan; Xie, Wenjuan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Echinococcosis, Urumqi, Peoples R China; [Lin, Renyong; Lue, Guodong; Wang, Junhua; Zhang, Chuanshan; Xie, Wenjuan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, Med Res Ctr, Urumqi, Peoples R China; [Lin, Renyong; Mantion, Georges; Martin, Helene; Richert, Lysiane] Univ Franche Comte, Lab Toxicol Cellulaire, Fac Med & Pharm, EA 4267, F-25030 Besancon, France; [Mantion, Georges; Vuitton, Dominique A.] Univ Franche Comte, Jean Minjoz Hosp, Dept Digest Surg, World Hlth Org Collaborating Ctr Prevent & Treatm, F-25030 Besancon, France; [Mantion, Georges; Vuitton, Dominique A.] Univ Hosp, Besancon, France	Xinjiang Medical University; Xinjiang Medical University; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; World Health Organization; Universite de Franche-Comte; CHU Besancon	Lin, RY (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Echinococcosis, Urumqi, Peoples R China.	dominique.vuitton@univ-fcomte.fr; Dr.wenhao@163.com	Wang, Junhua/ABB-6324-2021	MARTIN, helene/0000-0001-8318-3858; Wang, Junhua/0000-0002-6110-3711	National Science Foundation of China [30860253]; Technology Foundation for Xinjiang Uygur Autonomous Region of China [200891126]; French Ministry of Foreign Affairs for LRY (French Embassy in Beijing)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Foundation for Xinjiang Uygur Autonomous Region of China; French Ministry of Foreign Affairs for LRY (French Embassy in Beijing)	This work was supported by grants from the National Science Foundation of China (30860253), the Technology Foundation for Xinjiang Uygur Autonomous Region of China (200891126), and a PhD grant (theses en alternance) from the French Ministry of Foreign Affairs for LRY (French Embassy in Beijing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIKHAN Z, 1988, EXP PARASITOL, V67, P334, DOI 10.1016/0014-4894(88)90080-X; ARMSTRONG SG, 1994, INT J IMMUNOPHARMACO, V16, P747, DOI 10.1016/0192-0561(94)90094-9; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bell AW, 1996, SCAND J IMMUNOL, V43, P173, DOI 10.1046/j.1365-3083.1996.d01-26.x; BONDY SC, 1994, BIOCHEM PHARMACOL, V48, P155, DOI 10.1016/0006-2952(94)90235-6; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; BRESSONHADNI S, 1994, EUR CYTOKINE NETW, V5, P461; BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x; BRESSONHADNI S, 2007, TXB HEPATOLOGY BASIC, V1, P1047; CELIS JE, 1987, FEBS LETT, V220, P1, DOI 10.1016/0014-5793(87)80865-7; Chawla M, 2003, J LIPID RES, V44, P594, DOI 10.1194/jlr.M200296-JLR200; Chen L, 2002, J BIOL CHEM, V277, P34329, DOI 10.1074/jbc.M201344200; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Craig P, 2003, CURR OPIN INFECT DIS, V16, P437, DOI 10.1097/00001432-200310000-00010; De-Oliveira ACAX, 2006, EXP PARASITOL, V113, P256, DOI 10.1016/j.exppara.2006.01.013; Deplazes P, 2005, VET PARASITOL, V130, P213, DOI 10.1016/j.vetpar.2005.03.034; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; DU T, 1990, J EXP PATHOL, V71, P313; El-Kowrany Samy I., 2001, Journal of the Egyptian Society of Parasitology, V31, P245; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; GABRION C, 1995, INT J PARASITOL, V25, P127, DOI 10.1016/0020-7519(94)00086-4; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Gottstein B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009779; Gressner OA, 2008, J GASTROEN HEPATOL, V23, P1024, DOI 10.1111/j.1440-1746.2008.05345.x; Guerret S, 1998, PARASITOL RES, V84, P657, DOI 10.1007/s004360050466; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; Hauet-Broere F, 2006, ANN RHEUM DIS, V65, P65, DOI 10.1136/ard.2006.058495; Hill EW, 2005, VET IMMUNOL IMMUNOP, V105, P247, DOI 10.1016/j.vetimm.2005.02.004; Honda M, 2001, GASTROENTEROLOGY, V120, P955, DOI 10.1053/gast.2001.22468; Horton J, 2003, FUND CLIN PHARMACOL, V17, P205; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kepron C, 2002, J HELMINTHOL, V76, P31, DOI 10.1079/JOH200188; Leu JI, 2003, J CLIN INVEST, V111, P129, DOI 10.1172/JCI200316712; LIANCE M, 1984, EXPERIENTIA, V40, P1436, DOI 10.1007/BF01951932; Lin RY, 2009, WORLD J GASTROENTERO, V15, P2116, DOI 10.3748/wjg.15.2116; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ortona E, 2003, PARASITE IMMUNOL, V25, P119, DOI 10.1046/j.1365-3024.2003.00617.x; Pahlavan PS, 2006, J SURG RES, V134, P238, DOI 10.1016/j.jss.2005.12.011; Prosser CC, 2006, WORLD J GASTROENTERO, V12, P509, DOI 10.3748/wjg.v12.i4.509; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Richardson TA, 2006, DRUG METAB DISPOS, V34, P354, DOI 10.1124/dmd.105.007393; Rodriguez EVA, 2003, J LEUKOCYTE BIOL, V73, P127, DOI 10.1189/jlb.0702353; Roudkenar MH, 2008, J RADIAT RES, V49, P29, DOI 10.1269/jrr.07078; Roudkenar MH, 2007, J RADIAT RES, V48, P39, DOI 10.1269/jrr.06057; Samanta TB, 2003, BIOCHEM BIOPH RES CO, V312, P75, DOI 10.1016/j.bbrc.2003.09.227; Sharma MR, 2008, EXP MOL PATHOL, V84, P46, DOI 10.1016/j.yexmp.2007.10.001; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Stiles JK, 2001, ANN TROP MED PARASIT, V95, P797, DOI 10.1080/00034980120111145; Tangkijvanich P, 2002, EUR J SURG, V168, P100; Tannapfel A, 2002, VIRCHOWS ARCH, V440, P345, DOI 10.1007/s00428-002-0617-x; Volkmann X, 2008, HEPATOLOGY, V47, P1624, DOI 10.1002/hep.22237; VUITTON D, 1999, HEPATOLOGY; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wiese L, 2006, EXP NEUROL, V200, P216, DOI 10.1016/j.expneurol.2006.02.011; Wu Jian, 1999, Frontiers in Bioscience, V4, pd520; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhang S, 2008, J INFECT DIS, V197, P1341, DOI 10.1086/586709; Zhang WY, 2009, ACTA PHARMACOL SIN, V30, P424, DOI 10.1038/aps.2009.22; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	69	88	96	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14557	10.1371/journal.pone.0014557	http://dx.doi.org/10.1371/journal.pone.0014557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283804	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600004
J	Young, RP; Hopkins, RJ; Whittington, CF; Hay, BA; Epton, MJ; Gamble, GD				Young, Robert P.; Hopkins, Raewyn J.; Whittington, Chris F.; Hay, Bryan A.; Epton, Michael J.; Gamble, Gregory D.			Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; NUTRITION EXAMINATION SURVEY; GLYCATION END-PRODUCTS; FLOATING ABSOLUTE RISK; AIR-FLOW OBSTRUCTION; GENETIC SUSCEPTIBILITY; NICOTINE DEPENDENCE	Epidemiological studies show that approximately 20-30% of chronic smokers develop chronic obstructive pulmonary disease (COPD) while 10-15% develop lung cancer. COPD pre-exists lung cancer in 50-90% of cases and has a heritability of 40-77%, much greater than for lung cancer with heritability of 15-25%. These data suggest that smokers susceptible to COPD may also be susceptible to lung cancer. This study examines the association of several overlapping chromosomal loci, recently implicated by GWA studies in COPD, lung function and lung cancer, in (n = 1400) subjects sub-phenotyped for the presence of COPD and matched for smoking exposure. Using this approach we show; the 15q25 locus confers susceptibility to lung cancer and COPD, the 4q31 and 4q22 loci both confer a reduced risk to both COPD and lung cancer, the 6p21 locus confers susceptibility to lung cancer in smokers with pre-existing COPD, the 5p15 and 1q23 loci both confer susceptibility to lung cancer in those with no pre-existing COPD. We also show the 5q33 locus, previously associated with reduced FEV1, appears to confer susceptibility to both COPD and lung cancer. The 6p21 locus previously linked to reduced FEV1 is associated with COPD only. Larger studies will be needed to distinguish whether these COPD-related effects may reflect, in part, associations specific to different lung cancer histology. We demonstrate that when the "risk genotypes" derived from the univariate analysis are incorporated into an algorithm with clinical variables, independently associated with lung cancer in multivariate analysis, modest discrimination is possible on receiver operator curve analysis (AUC = 0.70). We suggest that genetic susceptibility to lung cancer includes genes conferring susceptibility to COPD and that sub-phenotyping with spirometry is critical to identifying genes underlying the development of lung cancer.	[Young, Robert P.; Hopkins, Raewyn J.; Whittington, Chris F.; Hay, Bryan A.; Gamble, Gregory D.] Auckland Hosp, Dept Med, Auckland, New Zealand; [Epton, Michael J.] Univ Otago, Dept Med, Christchurch, New Zealand; [Young, Robert P.] Synergenz Biosci Ltd, Auckland, New Zealand	Auckland City Hospital; University of Otago	Young, RP (corresponding author), Auckland Hosp, Dept Med, Auckland, New Zealand.	roberty@adhb.govt.nz		Gamble, Greg/0000-0003-0412-3203; Hopkins, Raewyn/0000-0003-2168-6235; Epton, Michael/0000-0003-4644-366X	HRC grant; Synergenz BioScience Ltd.	HRC grant; Synergenz BioScience Ltd.	This project was jointly funded by an HRC grant and Synergenz BioScience Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Bartling B, 2005, CARCINOGENESIS, V26, P293, DOI 10.1093/carcin/bgh333; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Brown V, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-24; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Dasari V, 2006, AM J RESP CELL MOL, V35, P3, DOI 10.1165/rcmb.2006-0051SF; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; DOCKERY DW, 1988, AM REV RESPIR DIS, V137, P286, DOI 10.1164/ajrccm/137.2.286; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gwilt CR, 2007, PHARMACOL THERAPEUT, V115, P208, DOI 10.1016/j.pharmthera.2007.05.007; Hancock DB, 2009, NAT GENET, V42, P45; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Jin GF, 2009, CARCINOGENESIS, V30, P987, DOI 10.1093/carcin/bgp090; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; Minetti M, 2008, ANTIOXID REDOX SIGN, V10, P829, DOI 10.1089/ars.2007.1864; Molfino NA, 2004, CHEST, V125, P1929, DOI 10.1378/chest.125.5.1929; Mortensen EM, 2010, AM J MED, V123, P66, DOI 10.1016/j.amjmed.2009.08.009; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Petty TL, 2005, CHEST, V128, P1895, DOI 10.1378/chest.128.4.1895; Piitulainen E, 1999, EUR RESPIR J, V13, P247, DOI 10.1183/09031936.99.13224799; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Pritchard JK, 2000, GENETICS, V155, P945; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Qi B, 2009, CURR PHARM DESIGN, V15, P2336, DOI 10.2174/138161209788682352; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; REDLINE S, 1989, AM J EPIDEMIOL, V129, P827, DOI 10.1093/oxfordjournals.aje.a115197; Repapi E, 2009, NAT GENET, V42, P36; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Schwartz AG, 2006, AM J RESP CRIT CARE, V173, P16, DOI 10.1164/rccm.200502-235PP; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Sohal SS, 2009, SMOKING HAS POTENTIA; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Stav D, 2007, ISR MED ASSOC J, V9, P800; Thakkinstian A, 2009, J APPL STAT, V36, P633, DOI 10.1080/02664760802484990; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Wright CF, 2010, HUM GENET, V127, P125, DOI 10.1007/s00439-009-0767-x; Xu HY, 2005, HUM GENET, V116, P121, DOI 10.1007/s00439-004-1212-9; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Yang P, 2010, CANCER EPIDEM BIOMAR, V19, P240, DOI 10.1158/1055-9965.EPI-09-0710; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Young RP, 2010, EUR RESPIR J, V36, P1375, DOI 10.1183/09031936.00033310; Young RP, 2009, EUR RESPIR REV, V18, P222, DOI 10.1183/09059180.00005309; Young RP, 2009, POSTGRAD MED J, V85, P515, DOI 10.1136/pgmj.2008.077107; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Young RP, 2011, APPL CLIN GENET, V4, P1, DOI 10.2147/TACG.S15758; Young RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005302; Young RP, 2008, EUR RESPIR J, V32, P1; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	84	82	84	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16476	10.1371/journal.pone.0016476	http://dx.doi.org/10.1371/journal.pone.0016476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304900	gold, Green Submitted, Green Published			2022-12-27	WOS:000287036600008
J	Biedasek, K; Andres, J; Mai, K; Adams, S; Spuler, S; Fielitz, J; Spranger, J				Biedasek, Katrin; Andres, Janin; Mai, Knut; Adams, Stephanie; Spuler, Simone; Fielitz, Jens; Spranger, Joachim			Skeletal Muscle 11beta-HSD1 Controls Glucocorticoid-Induced Proteolysis and Expression of E3 Ubiquitin Ligases Atrogin-1 and MuRF-1	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; FOXO TRANSCRIPTION FACTORS; C2C12 MYOTUBES; ADIPOSE-TISSUE; PROTEIN BREAKDOWN; ATROPHY; OBESITY; RESPONSES; PATHWAY; L6	Recent studies demonstrated expression and activity of the intracellular cortisone-cortisol shuttle 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in skeletal muscle and inhibition of 11beta-HSD1 in muscle cells improved insulin sensitivity. Glucocorticoids induce muscle atrophy via increased expression of the E3 ubiquitin ligases Atrogin-1 (Muscle Atrophy F-box (MAFbx)) and MuRF-1 (Muscle RING-Finger-1). We hypothesized that 11beta-HSD1 controls glucocorticoid-induced expression of atrophy E3 ubiquitin ligases in skeletal muscle. Primary human myoblasts were generated from healthy volunteers. 11beta-HSD1-dependent protein degradation was analyzed by [H-3]-tyrosine release assay. RT-PCR was used to determine mRNA expression of E3 ubiquitin ligases and 11beta-HSD1 activity was measured by conversion of radioactively labeled [H-3]-cortisone to [H-3]-cortisol separated by thin-layer chromatography. We here demonstrate that 11beta-HSD1 is expressed and biologically active in interconverting cortisone to active cortisol in murine skeletal muscle cells (C2C12) as well as in primary human myotubes. 11beta-HSD1 expression increased during differentiation from myoblasts to mature myotubes (p<0.01), suggesting a role of 11beta-HSD1 in skeletal muscle growth and differentiation. Treatment with cortisone increased protein degradation by about 20% (p<0.001), which was paralleled by an elevation of Atrogin-1 and MuRF-1 mRNA expression (p<0.01, respectively). Notably, pre-treatment with the 11beta-HSD1 inhibitor carbenoxolone (Cbx) completely abolished the effect of cortisone on protein degradation as well as on Atrogin-1 and MuRF-1 expression. In summary, our data suggest that 11beta-HSD1 controls glucocorticoid-induced protein degradation in human and murine skeletal muscle via regulation of the E3 ubiquitin ligases Atrogin-1 and MuRF-1.	[Biedasek, Katrin; Andres, Janin; Mai, Knut; Spranger, Joachim] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany; [Adams, Stephanie; Spuler, Simone] Charite, Muscle Res Unit, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Fielitz, Jens] Charite, Dept Cardiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Biedasek, K (corresponding author), Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany.	joachim.spranger@charite.de	Mai, Knut/W-9904-2019; Fielitz, Jens/AAF-4178-2020	Mai, Knut/0000-0003-0126-3155; Fielitz, Jens/0000-0001-8522-1045; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Spuler, Simone/0000-0002-0155-1117	German Research Foundation (DFG) [DFG GK 1208, GK 1631, KFO218/1, FI 965/2-1]; research group (Molecular Nutrition) of the Bundesministerium fur Bildung und Forschung (BMBF); Deutsche Forschungsgemeinschaft [DFG SP716/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); research group (Molecular Nutrition) of the Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG GK 1208, GK 1631, KFO218/1 and FI 965/2-1). JS was supported by a research group (Molecular Nutrition) of the Bundesministerium fur Bildung und Forschung (BMBF) and a Heisenberg-Professorship of the Deutsche Forschungsgemeinschaft (DFG SP716/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2005, EUR J CLIN INVEST, V35, P627, DOI 10.1111/j.1365-2362.2005.01552.x; Aubry EM, 2009, ENDOCRINOLOGY, V150, P2700, DOI 10.1210/en.2008-1618; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CHO YS, 2009, ANAL BIOCH; Engeli S, 2004, OBES RES, V12, P9, DOI 10.1038/oby.2004.3; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Jang C, 2007, J CLIN ENDOCR METAB, V92, P3314, DOI 10.1210/jc.2006-2729; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; Mai K, 2007, CLIN ENDOCRINOL, V67, P419, DOI 10.1111/j.1365-2265.2007.02903.x; Mariniello B, 2006, EUR J ENDOCRINOL, V155, P435, DOI 10.1530/eje.1.02228; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sultan KR, 2006, AM J PHYSIOL-CELL PH, V290, pC650, DOI 10.1152/ajpcell.00163.2005; TOMAS FM, 1979, BIOCHEM J, V178, P139, DOI 10.1042/bj1780139; Zhang M, 2009, MOL CELL BIOCHEM, V324, P147, DOI 10.1007/s11010-008-9993-0	23	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16674	10.1371/journal.pone.0016674	http://dx.doi.org/10.1371/journal.pone.0016674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304964	Green Accepted, gold, Green Published			2022-12-27	WOS:000286834300118
J	Chakraborty, C; Roy, SS; Hsu, MJ; Agoramoorthy, G				Chakraborty, Chiranjib; Roy, Sanjiban S.; Hsu, Minna J.; Agoramoorthy, Govindasamy			Landscape Mapping of Functional Proteins in Insulin Signal Transduction and Insulin Resistance: A Network-Based Protein-Protein Interaction Analysis	PLOS ONE			English	Article							DATABASE; 3-KINASE; MATRIX	The type 2 diabetes has increased rapidly in recent years throughout the world. The insulin signal transduction mechanism gets disrupted sometimes and it's known as insulin-resistance. It is one of the primary causes associated with type-2 diabetes. The signaling mechanisms involved several proteins that include 7 major functional proteins such as INS, INSR, IRS1, IRS2, PIK3CA, Akt2, and GLUT4. Using these 7 principal proteins, multiple sequences alignment has been created. The scores between sequences also have been developed. We have constructed a phylogenetic tree and modified it with node and distance. Besides, we have generated sequence logos and ultimately developed the protein-protein interaction network. The small insulin signal transduction protein arrangement shows complex network between the functional proteins.	[Hsu, Minna J.] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chakraborty, Chiranjib] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India; [Roy, Sanjiban S.] VIT Univ, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India; [Agoramoorthy, Govindasamy] Tajen Univ, Coll Environm & Hlth Sci, Yanpu, Taiwan	National Sun Yat Sen University; Vellore Institute of Technology; Vellore Institute of Technology	Hsu, MJ (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	hsumin@mail.nsysu.edu.tw; agoram@mail.tajen.edu.tw	Roy, Sanjiban Sekhar/T-4266-2019; Chakraborty, Chiranjib/J-4847-2013	Roy, Sanjiban Sekhar/0000-0003-2003-7882; Chakraborty, Chiranjib/0000-0002-3958-239X; Hsu, Minna J/0000-0001-7681-3532; Agoramoorthy, Govindasamy/0000-0002-8936-6978				Chakraborty C, 2006, CURR PROTEIN PEPT SC, V7, P113, DOI 10.2174/138920306776359759; Cho I, 2007, ACTA APPL MATH, V95, P95, DOI 10.1007/s10440-006-9081-y; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Del Aguila LF, 2000, AM J PHYSIOL-ENDOC M, V279, pE206, DOI 10.1152/ajpendo.2000.279.1.E206; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Ginter E, 2010, BRATISL MED J, V111, P134; Hu ZJ, 2005, NUCLEIC ACIDS RES, V33, pW352, DOI 10.1093/nar/gki431; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufman FR, 2002, J PEDIATR ENDOCR MET, V15, P737; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Liu Y, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-158; NEOGI S, 2007, HINDUSTAN TIMES 0903; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taylor Simeon I., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P419; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	23	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16388	10.1371/journal.pone.0016388	http://dx.doi.org/10.1371/journal.pone.0016388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305025	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300059
J	Franck, N; Montembault, E; Rome, P; Pascal, A; Cremet, JY; Giet, R				Franck, Nathalie; Montembault, Emilie; Rome, Pierre; Pascal, Aude; Cremet, Jean-Yves; Giet, Regis			CDK11(p58) Is Required for Centriole Duplication and Plk4 Recruitment to Mitotic Centrosomes	PLOS ONE			English	Article							HUMAN-CELLS; PROTEIN SPD-2; POLO KINASE; C-ELEGANS; CYTOKINESIS; ABERRATIONS; BIOGENESIS; MATURATION; NUMBER; CYCLE	Background: CDK11(p58) is a mitotic protein kinase, which has been shown to be required for different mitotic events such as centrosome maturation, chromatid cohesion and cytokinesis. Methodology/Principal Findings: In addition to these previously described roles, our study shows that CDK11(p58) inhibition induces a failure in the centriole duplication process in different human cell lines. We propose that this effect is mediated by the defective centrosomal recruitment of proteins at the onset of mitosis. Indeed, Plk4 protein kinase and the centrosomal protein Cep192, which are key components of the centriole duplication machinery, showed reduced levels at centrosomes of mitotic CDK11-depleted cells. CDK11(p58), which accumulates only in the vicinity of mitotic centrosomes, directly interacts with the centriole-associated protein kinase Plk4 that regulates centriole number in cells. In addition, we show that centriole from CDK11 defective cells are not able to be over duplicated following Plk4 overexpression. Conclusion/Significance: We thus propose that CDK11 is required for centriole duplication by two non-mutually-exclusive mechanisms. On one hand, the observed duplication defect could be caused indirectly by a failure of the centrosome to fully maturate during mitosis. On the other hand, CDK11(p58) could also directly regulate key centriole components such as Plk4 during mitosis to trigger essential mitotic centriole modifications, required for centriole duplication during subsequent interphase.	[Franck, Nathalie; Montembault, Emilie; Rome, Pierre; Pascal, Aude; Cremet, Jean-Yves; Giet, Regis] Univ Rennes 1, CNRS, UMR6061, Inst Genet & Dev Rennes, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Franck, N (corresponding author), Univ Rennes 1, CNRS, UMR6061, Inst Genet & Dev Rennes, Rennes, France.	regis.giet@univ-rennes1.fr		Rome, Pierre/0000-0001-5611-5323; MONTEMBAULT-SEVIN, Emilie/0000-0002-4191-9094	Agence Nationale de la Recherche (programme Jeune Chercheur); Ligue Nationale Contre le Cancer (Equipe Labellise)	Agence Nationale de la Recherche (programme Jeune Chercheur)(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer (Equipe Labellise)	RG and NF are funded by the Agence Nationale de la Recherche (programme Jeune Chercheur) and the Ligue Nationale Contre le Cancer (Equipe Labellise). EM and PR are doctoral fellows of the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bonni S, 2008, CELL CYCLE, V7, P545, DOI 10.4161/cc.7.4.5387; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; DZHINDZHEV NS, NATURE; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Palazzo RE, 1999, J CELL SCI, V112, P1291; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Petrinac S, 2009, CELL CYCLE, V8, P327, DOI 10.4161/cc.8.2.7355; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Tanenbaum ME, 2007, NAT CELL BIOL, V9, P1127, DOI 10.1038/ncb1007-1127; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	35	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14600	10.1371/journal.pone.0014600	http://dx.doi.org/10.1371/journal.pone.0014600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297952	Green Published, gold			2022-12-27	WOS:000286834300003
J	Guerra, F; Mancinelli, L; Angelini, L; Fortunati, M; Rappelli, A; Dessi-Fulgheri, P; Sarzani, R				Guerra, Federico; Mancinelli, Lucia; Angelini, Luca; Fortunati, Marco; Rappelli, Alessandro; Dessi-Fulgheri, Paolo; Sarzani, Riccardo			The Association of Left Ventricular Hypertrophy with Metabolic Syndrome is Dependent on Body Mass Index in Hypertensive Overweight or Obese Patients	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GENDER-DIFFERENCES; RISK-FACTOR; MORTALITY; GEOMETRY; IMPACT; ADULTS; POPULATION; PREVALENCE; NUTRITION	Background: Overweight (Ow) and obesity (Ob) influence blood pressure (BP) and left ventricular hypertrophy (LVH). It is unclear whether the presence of metabolic syndrome (MetS) independently affects echocardiographic parameters in hypertension. Methods: 380 Ow/Ob essential hypertensive patients (age <= 65 years) presenting for referred BP control-related problems. MetS was defined according to NCEP III/ATP with AHA modifications and LVH as LVM/h(2.7) >= 49.2 g/m(2.7) in males and >= 46.7 g/m(2.7) in females. Treatment intensity score (TIS) was used to control for BP treatment as previously reported. Results: Hypertensive patients with MetS had significantly higher BMI, systolic and mean BP, interventricular septum and relative wall thickness and lower ejection fraction than those without MetS. LVM/h(2.7) was significantly higher in MetS patients (59.14 +/- 14.97 vs. 55.33 +/- 14.69 g/m(2.7); p = 0.022). Hypertensive patients with MetS had a 2.3-fold higher risk to have LVH/h(2.7) after adjustment for age, SBP and TIS (OR 2.34; 95% CI 1.40-3.92; p = 0.001), but MetS lost its independent relationship with LVH when BMI was included in the model. Conclusions: In Ow/Ob hypertensive patients MetS maintains its role of risk factor for LVH independently of age, SBP, and TIS, resulting in a useful predictor of target organ damage in clinical practice. However, MetS loses its independent relationship when BMI is taken into account, suggesting that the effects on MetS on LV parameters are mainly driven by the degree of adiposity.	[Guerra, Federico; Mancinelli, Lucia; Angelini, Luca; Fortunati, Marco; Rappelli, Alessandro; Dessi-Fulgheri, Paolo; Sarzani, Riccardo] Univ Politecn Marche, Univ Hosp Osped Riuniti, Dept Internal Med & Cardiovasc Dis, Hypertens Excellence Ctr,European Soc Hypertens, Ancona, Italy	Marche Polytechnic University	Guerra, F (corresponding author), Univ Politecn Marche, Univ Hosp Osped Riuniti, Dept Internal Med & Cardiovasc Dis, Hypertens Excellence Ctr,European Soc Hypertens, Ancona, Italy.	r.sarzani@univpm.it	Guerra, Federico/P-6635-2017; Sarzani, Riccardo/AAB-3110-2021; Mancinelli, Lucia LM/K-4136-2018	Guerra, Federico/0000-0001-5394-1312; Sarzani, Riccardo/0000-0002-5159-0181; Mancinelli, Lucia LM/0000-0003-3783-4482				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Bailey KR, 2008, HYPERTENSION, V51, P841, DOI 10.1161/HYPERTENSIONAHA.107.101659; Chumlea WC, 2009, J NUTR HEALTH AGING, V13, P821, DOI 10.1007/s12603-009-0219-2; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DEVEREUX RB, 1984, J AM COLL CARDIOL, V4, P1222, DOI 10.1016/S0735-1097(84)80141-2; Foppa Murilo, 2005, Cardiovasc Ultrasound, V3, P17, DOI 10.1186/1476-7120-3-17; Gerdts E, 2008, HYPERTENSION, V51, P1109, DOI 10.1161/HYPERTENSIONAHA.107.107474; Hallan S, 2004, AM J KIDNEY DIS, V44, P84, DOI 10.1053/j.ajkd.2004.03.027; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Krauser DG, 2006, HERZ, V31, P305, DOI 10.1007/s00059-006-2819-5; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; MacMahon S, 2008, LANCET, V371, P1480, DOI 10.1016/S0140-6736(08)60632-7; Mancia G, 2005, J HYPERTENS, V23, pS17; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; MULE G, 1987, INT J CARDIOL, V121, P267; Mule G, 2008, AM J HYPERTENS, V21, P1055, DOI 10.1038/ajh.2008.225; Papademetriou V, 2001, AM J HYPERTENS, V14, P768, DOI 10.1016/S0895-7061(01)01292-4; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Patel DA, 2009, AM J CARDIOL, V104, P69, DOI 10.1016/j.amjcard.2009.02.063; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Reaven GM, 2005, CLIN CHEM, V51, P931, DOI 10.1373/clinchem.2005.048611; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sarzani R, 2008, J HYPERTENS, V26, P831, DOI 10.1097/HJH.0b013e3282f624a0; SAVAGE DD, 1987, CIRCULATION, V75, P26; Schillaci G, 2006, HYPERTENSION, V47, P881, DOI 10.1161/01.HYP.0000216778.83626.39; Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580; Schmieder RE, 2005, NEPHROL DIAL TRANSPL, V20, P2610, DOI 10.1093/ndt/gfi190; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tsioufis C, 2008, J HYPERTENS, V26, P773, DOI 10.1097/HJH.0b013e3282f430b0	37	37	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16630	10.1371/journal.pone.0016630	http://dx.doi.org/10.1371/journal.pone.0016630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304952	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300102
J	Hunt, PW; Landay, AL; Sinclair, E; Martinson, JA; Hatano, H; Emu, B; Norris, PJ; Busch, MP; Martin, JN; Brooks, C; McCune, JM; Deeks, SG				Hunt, Peter W.; Landay, Alan L.; Sinclair, Elizabeth; Martinson, Jeffrey A.; Hatano, Hiroyu; Emu, Brinda; Norris, Philip J.; Busch, Michael P.; Martin, Jeffrey N.; Brooks, Cicely; McCune, Joseph M.; Deeks, Steven G.			A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-LEVEL VIREMIA; HLA-B-ASTERISK-57(+) ELITE SUPPRESSORS; BLOOD-BANK COHORT; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; LYMPHOCYTE ACTIVATION; INFECTED INDIVIDUALS; PERIPHERAL-BLOOD; TYPE-1 INFECTION	HIV-infected individuals maintaining undetectable viremia in the absence of therapy (HIV controllers) often maintain high HIV-specific T cell responses, which has spurred the development of vaccines eliciting HIV-specific T cell responses. However, controllers also often have abnormally high T cell activation levels, potentially contributing to T cell dysfunction, CD4+ T cell depletion, and non-AIDS morbidity. We hypothesized that a weak T regulatory cell (Treg) response might contribute to the control of viral replication in HIV controllers, but might also contribute to generalized immune activation, contributing to CD4+ T cell loss. To address these hypotheses, we measured frequencies of activated (CD38+ HLA-DR+), regulatory (CD4+CD25+CD127(dim)), HIV-specific, and CMV-specific T cells among HIV controllers and 3 control populations: HIV-infected individuals with treatment-mediated viral suppression (ART-suppressed), untreated HIV-infected "non-controllers'' with high levels of viremia, and HIV-uninfected individuals. Despite abnormally high T cell activation levels, controllers had lower Treg frequencies than HIV-uninfected controls (P = 0.014). Supporting the propensity for an unusually low Treg response to viral infection in HIV controllers, we observed unusually high CMV-specific CD4+ T cell frequencies and a strong correlation between HIV-specific CD4+ T cell responses and generalized CD8+ T cell activation levels in HIV controllers (P <= 0.001). These data support a model in which low frequencies of Tregs in HIV controllers may contribute to an effective adaptive immune response, but may also contribute to generalized immune activation, potentially contributing to CD4 depletion.	[Hunt, Peter W.; Sinclair, Elizabeth; Hatano, Hiroyu; Emu, Brinda; Norris, Philip J.; Busch, Michael P.; Martin, Jeffrey N.; McCune, Joseph M.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Hunt, Peter W.; Sinclair, Elizabeth; Hatano, Hiroyu; Emu, Brinda; Norris, Philip J.; Busch, Michael P.; Martin, Jeffrey N.; McCune, Joseph M.; Deeks, Steven G.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Landay, Alan L.; Martinson, Jeffrey A.; Brooks, Cicely] Rush Univ, Med Ctr, Dept Microbiol Immunol, Chicago, IL 60612 USA; [Norris, Philip J.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rush University; Vitalant; Vitalant Research Institute	Hunt, PW (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	phunt@php.ucsf.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870	UCSF/Gladstone Center for AIDS Research [P30 AI27763, P30 MH59037]; NIAID [AI065244, AI055273, AI44595, AI067854, AI076981, AI-76174]; Center for AIDS Prevention Studies [P30 MH62246]; UCSF Clinical and Translational Science Institute [UL1 RR024131-01]; CFAR Network of Integrated Clinical Sciences [5R24AI067039]; Ragon Institute of MGH; American Foundation for AIDS Research [106710-40-RGRL]; NIH Roadmap for Medical Research [DPI OD00329]; Ragon Institute of MIT; Ragon Institute of Harvard; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, R01AI044595, U19AI076981, U19AI067854, P01AI076174, P30AI027763, K23AI065244, R24AI067039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037, P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	UCSF/Gladstone Center for AIDS Research; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Prevention Studies; UCSF Clinical and Translational Science Institute; CFAR Network of Integrated Clinical Sciences; Ragon Institute of MGH; American Foundation for AIDS Research; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MIT; Ragon Institute of Harvard; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the UCSF/Gladstone Center for AIDS Research (P30 AI27763, P30 MH59037); NIAID (AI065244, AI055273, AI44595, AI067854, AI076981, and AI-76174); the Center for AIDS Prevention Studies (P30 MH62246); the UCSF Clinical and Translational Science Institute (UL1 RR024131-01); the CFAR Network of Integrated Clinical Sciences (5R24AI067039); the Ragon Institute of MGH, MIT, and Harvard; and American Foundation for AIDS Research (106710-40-RGRL). JMM is a recipient of a grant (DPI OD00329) from the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Davidson R, 1993, ESTIMATION INFERENCE; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dyer WB, 1999, J VIROL, V73, P436, DOI 10.1128/JVI.73.1.436-443.1999; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goudsmit J, 2002, AIDS, V16, P791, DOI 10.1097/00002030-200203290-00016; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; HO HN, 1993, J IMMUNOL, V150, P3070; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; JAGANNATHAN P, 2009, J VIROL; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; MDEL MD, J INFECT DIS, V201, P331; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; NAEGER DM, PLOS ONE, V5, pE8886; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Para MF, 2001, J ACQ IMMUN DEF SYND, V26, P320, DOI 10.1097/00126334-200104010-00004; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sajadi MM, 2010, AIDS, V24, P1689, DOI 10.1097/QAD.0b013e32833a2a32; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Zaunders JJ, 1999, J INFECT DIS, V180, P320, DOI 10.1086/314880; Zaunders JJ, 2004, BLOOD, V103, P2238, DOI 10.1182/blood-2003-08-2765	86	108	112	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15924	10.1371/journal.pone.0015924	http://dx.doi.org/10.1371/journal.pone.0015924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305005	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300029
J	Makarova, AV; Grabow, C; Gening, LV; Tarantul, VZ; Tahirov, TH; Bessho, T; Pavlov, YI				Makarova, Alena V.; Grabow, Corinn; Gening, Leonid V.; Tarantul, Vyacheslav Z.; Tahirov, Tahir H.; Bessho, Tadayoshi; Pavlov, Youri I.			Inaccurate DNA Synthesis in Cell Extracts of Yeast Producing Active Human DNA Polymerase Iota	PLOS ONE			English	Article							SEQUENTIAL ACTION; REPLICATION; FIDELITY; VARIANT; ETA; EXPRESSION; BYPASS; BASE; OVEREXPRESSION; INVOLVEMENT	Mammalian Pol i has an unusual combination of properties: it is stimulated by Mn2+ ions, can bypass some DNA lesions and misincorporates "G" opposite template "T" more frequently than incorporates the correct "A." We recently proposed a method of detection of Pol i activity in animal cell extracts, based on primer extension opposite the template T with a high concentration of only two nucleotides, dGTP and dATP (incorporation of "G" versus "A" method of Gening, abbreviated as "misGvA"). We provide unambiguous proof of the "misGvA" approach concept and extend the applicability of the method for the studies of variants of Pol i in the yeast model system with different cation cofactors. We produced human Pol i in baker's yeast, which do not have a POLI ortholog. The "misGvA" activity is absent in cell extracts containing an empty vector, or producing catalytically dead Pol i, or Pol i lacking exon 2, but is robust in the strain producing wild-type Pol i or its catalytic core, or protein with the active center L62I mutant. The signature pattern of primer extension products resulting from inaccurate DNA synthesis by extracts of cells producing either Pol i or human Pol g is different. The DNA sequence of the template is critical for the detection of the infidelity of DNA synthesis attributed to DNA Pol i. The primer/template and composition of the exogenous DNA precursor pool can be adapted to monitor replication fidelity in cell extracts expressing various error-prone Pols or mutator variants of accurate Pols. Finally, we demonstrate that the mutation rates in yeast strains producing human DNA Pols i and g are not elevated over the control strain, despite highly inaccurate DNA synthesis by their extracts.	[Makarova, Alena V.; Gening, Leonid V.; Tarantul, Vyacheslav Z.] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Makarova, Alena V.; Grabow, Corinn; Tahirov, Tahir H.; Bessho, Tadayoshi; Pavlov, Youri I.] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE USA	Russian Academy of Sciences; University of Nebraska System; University of Nebraska Medical Center	Makarova, AV (corresponding author), Russian Acad Sci, Inst Mol Genet, Moscow, Russia.	ypavlov@unmc.edu	Makarova, Alena Vladimirovna/I-1338-2014; Pavlov, Youri/T-7532-2017	Tahirov, Tahir/0000-0002-1238-0069; Pavlov, Youri/0000-0003-1179-5796	Nebraska Department of Health and Human Services [2011-27]; National Cancer Institute [CA129925]; RFFI [10-04-01434-a]; National Institute of General Medical Sciences [R01GM082923]; NATIONAL CANCER INSTITUTE [R01CA129925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082923] Funding Source: NIH RePORTER	Nebraska Department of Health and Human Services; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RFFI(Russian Foundation for Basic Research (RFBR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work has been supported by Nebraska Department of Health and Human Services grant 2011-27 to YIP and, in part, by National Cancer Institute grant CA129925 to YIP; by RFFI grant 10-04-01434-a to LVG and LVZ; and by National Institute of General Medical Sciences grant R01GM082923 to THT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Bebenek K, 2000, COLD SPRING HARB SYM, V65, P81, DOI 10.1101/sqb.2000.65.81; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Dumstorf CA, 2006, P NATL ACAD SCI USA, V103, P18083, DOI 10.1073/pnas.0605247103; Faili A, 2002, NATURE, V419, P944, DOI 10.1038/nature01117; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gening LV, 2006, IMMUNOL LETT, V106, P198, DOI 10.1016/j.imlet.2006.05.002; Gening LV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P155, DOI 10.1134/S0006297906020064; Gening LV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P435, DOI 10.1023/B:BIRY.0000026201.71587.a2; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Ito A, 2006, BIOCHEM BIOPH RES CO, V351, P306, DOI 10.1016/j.bbrc.2006.10.048; Jain R, 2009, STRUCTURE, V17, P974, DOI 10.1016/j.str.2009.04.011; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; [Казаков А.А. Kazakov A.A.], 2008, [Медицинская генетика, Meditsinskaya genetika], V7, P32; Kazakov AA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P905, DOI 10.1134/S0006297910070138; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Lee GH, 2005, CANCER SCI, V96, P256, DOI 10.1111/j.1349-7006.2005.00042.x; Makarova AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P346, DOI 10.1134/S0006297908030176; Makarova A V, 2008, Ontogenez, V39, P367; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; McDonald JP, 2001, PHILOS T R SOC B, V356, P53, DOI 10.1098/rstb.2000.0748; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Pavlov YI, 2001, MUTAT RES-FUND MOL M, V478, P129, DOI 10.1016/S0027-5107(01)00131-2; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Poltoratsky V, 2000, J EXP MED, V192, pF27, DOI 10.1084/jem.192.10.F27; Prasad R, 2003, J BIOL CHEM, V278, P29649, DOI 10.1074/jbc.M305399200; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Stallons LJ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/643857; Tissier A, 2000, GENE DEV, V14, P1642; Vaisman A, 2006, DNA REPAIR, V5, P210, DOI 10.1016/j.dnarep.2005.09.011; Vidal AE, 2009, DNA REPAIR, V8, P420, DOI 10.1016/j.dnarep.2008.12.007; Wang HB, 2010, NEURO-ONCOLOGY, V12, P679, DOI 10.1093/neuonc/nop074; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wolfle WT, 2006, MOL CELL BIOL, V26, P381, DOI 10.1128/MCB.26.1.381-386.2006; Yagi Y, 2005, DNA REPAIR, V4, P1252, DOI 10.1016/j.dnarep.2005.06.010; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	52	22	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16612	10.1371/journal.pone.0016612	http://dx.doi.org/10.1371/journal.pone.0016612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304950	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300099
J	Pacifici, PG; Peter, C; Yampolsky, P; Koenen, M; McArdle, JJ; Witzemann, V				Pacifici, Pier Giorgio; Peter, Christoph; Yampolsky, Pessah; Koenen, Michael; McArdle, Joseph J.; Witzemann, Veit			Novel Mouse Model Reveals Distinct Activity-Dependent and -Independent Contributions to Synapse Development	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; CONGENITAL MYASTHENIC SYNDROME; MUSCLE ACETYLCHOLINE-RECEPTOR; IN-VIVO; CHOLINE-ACETYLTRANSFERASE; SKELETAL-MUSCLE; EPSILON-SUBUNIT; DEFICIENT MICE; GAMMA-SUBUNIT; AGRIN	The balanced action of both pre- and postsynaptic organizers regulates the formation of neuromuscular junctions (NMJ). The precise mechanisms that control the regional specialization of acetylcholine receptor (AChR) aggregation, guide ingrowing axons and contribute to correct synaptic patterning are unknown. Synaptic activity is of central importance and to understand synaptogenesis, it is necessary to distinguish between activity-dependent and activity-independent processes. By engineering a mutated fetal AChR subunit, we used homologous recombination to develop a mouse line that expresses AChR with massively reduced open probability during embryonic development. Through histological and immunochemical methods as well as electrophysiological techniques, we observed that endplate anatomy and distribution are severely aberrant and innervation patterns are completely disrupted. Nonetheless, in the absence of activity AChRs form postsynaptic specializations attracting motor axons and permitting generation of multiple nerve/muscle contacts on individual fibers. This process is not restricted to a specialized central zone of the diaphragm and proceeds throughout embryonic development. Phenotypes can be attributed to separate activity-dependent and -independent pathways. The correct patterning of synaptic connections, prevention of multiple contacts and control of nerve growth require AChR-mediated activity. In contrast, myotube survival and acetylcholine-mediated dispersal of AChRs are maintained even in the absence of AChR-mediated activity. Because mouse models in which acetylcholine is entirely absent do not display similar effects, we conclude that acetylcholine binding to the AChR initiates activity-dependent and activity-independent pathways whereby the AChR modulates formation of the NMJ.	[Pacifici, Pier Giorgio; Peter, Christoph; Yampolsky, Pessah; Koenen, Michael; Witzemann, Veit] Max Planck Inst Med Res, Dept Mol Neurobiol, Heidelberg, Germany; [McArdle, Joseph J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Max Planck Society; Rutgers State University New Brunswick; Rutgers State University Medical Center	Pacifici, PG (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Heidelberg, Germany.	Veit.Witzemann@mpimf-heidelberg.mpg.de			Deutsche Forschungsgemeinschaft [SFB 488]; Ruprecht-Karls Universitat Heidelberg [Graduiertenkolleg 791/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls Universitat Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft SFB 488 and by the Graduiertenkolleg 791/2 of the Ruprecht-Karls Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Christoph P, 2005, PFLUG ARCH EUR J PHY, V450, P178, DOI 10.1007/s00424-005-1387-5; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2003, J NEUROCYTOL, V32, P1017, DOI 10.1023/B:NEUR.0000020639.22895.28; ENTWISTLE A, 1988, J CELL BIOL, V106, P1703, DOI 10.1083/jcb.106.5.1703; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Herlitze S, 1996, J PHYSIOL-LONDON, V492, P775, DOI 10.1113/jphysiol.1996.sp021345; Jing LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008843; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; Krause RM, 1995, J PHYSIOL-LONDON, V489, P779, DOI 10.1113/jphysiol.1995.sp021091; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Liu Y, 2008, DEVELOPMENT, V135, P1957, DOI 10.1242/dev.018119; Lomo T, 2003, J NEUROCYTOL, V32, P835, DOI 10.1023/B:NEUR.0000020627.18156.b1; LOMO T, 1972, J PHYSIOL-LONDON, V221, P493, DOI 10.1113/jphysiol.1972.sp009764; McArdle JJ, 2005, NEUROPHARMACOLOGY, V49, P1132, DOI 10.1016/j.neuropharm.2005.06.011; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Muller JS, 2006, BRAIN, V129, P2784, DOI 10.1093/brain/awl188; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Vock VM, 2008, J NEUROSCI, V28, P3123, DOI 10.1523/JNEUROSCI.5080-07.2008; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16469	10.1371/journal.pone.0016469	http://dx.doi.org/10.1371/journal.pone.0016469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305030	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300067
J	Sautya, S; Ingole, B; Ray, D; Stohr, S; Samudrala, K; Raju, KAK; Mudholkar, A				Sautya, Sabyasachi; Ingole, Baban; Ray, Durbar; Stohr, Sabine; Samudrala, Kiranmai; Raju, K. A. Kamesh; Mudholkar, Abhay			Megafaunal Community Structure of Andaman Seamounts Including the Back-Arc Basin - A Quantitative Exploration from the Indian Ocean	PLOS ONE			English	Article							HEXACTINELLID SPONGE; PHERONEMA-CARPENTERI; SPECIES RICHNESS; ENDEMISM	Species rich benthic communities have been reported from some seamounts, predominantly from the Atlantic and Pacific Oceans, but the fauna and habitats on Indian Ocean seamounts are still poorly known. This study focuses on two seamounts, a submarine volcano (cratered seamount - CSM) and a non-volcano (SM2) in the Andaman Back-arc Basin (ABB), and the basin itself. The main purpose was to explore and generate regional biodiversity data from summit and flank (upper slope) of the Andaman seamounts for comparison with other seamounts worldwide. We also investigated how substratum types affect the megafaunal community structure along the ABB. Underwater video recordings from TeleVision guided Gripper (TVG) lowerings were used to describe the benthic community structure along the ABB and both seamounts. We found 13 varieties of substratum in the study area. The CSM has hard substratum, such as boulders and cobbles, whereas the SM2 was dominated by cobbles and fine sediment. The highest abundance of megabenthic communities was recorded on the flank of the CSM. Species richness and diversity were higher at the flank of the CSM than other are of ABB. Non-metric multi-dimensional scaling (nMDS) analysis of substratum types showed 50% similarity between the flanks of both seamounts, because both sites have a component of cobbles mixed with fine sediments in their substratum. Further, nMDS of faunal abundance revealed two groups, each restricted to one of the seamounts, suggesting faunal distinctness between them. The sessile fauna corals and poriferans showed a significant positive relation with cobbles and fine sediments substratum, while the mobile categories echinoderms and arthropods showed a significant positive relation with fine sediments only.	[Sautya, Sabyasachi; Ingole, Baban; Ray, Durbar; Samudrala, Kiranmai; Raju, K. A. Kamesh; Mudholkar, Abhay] Natl Inst Oceanog CSIR, Panaji, Goa, India; [Stohr, Sabine] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Swedish Museum of Natural History	Sautya, S (corresponding author), Natl Inst Oceanog CSIR, Panaji, Goa, India.	sabya_aqua@rediffmail.com	Stöhr, Sabine/B-8629-2011; Ingole, Baban Shravan/GLR-9722-2022	Stöhr, Sabine/0000-0002-2586-7239; Sautya, Sabyasachi/0000-0003-2229-5834; Ingole, Baban/0000-0001-6096-6980	CenSeam (Global Census of Marine Life on Seamount)	CenSeam (Global Census of Marine Life on Seamount)	The CenSeam (Global Census of Marine Life on Seamount) provided the financial support to identify the benthic invertebrates and publish the data. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Barthel D, 1996, MAR ECOL-P S Z N I, V17, P603, DOI 10.1111/j.1439-0485.1996.tb00420.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clarke K.R., 2006, PRIMER; Clarke KR, 1994, CHANGE MARINE COMMUN; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; GRANGE K, 1994, P 2 INT TEMP REEF S, P169; Grigg R.W., 1974, Proceedings int Coral Reef Symp, V2, P235; GRIGG RICHARD W., 1965, PACIFIC SCI, V19, P244; GRIGG RW, 1984, PSZNI MAR ECOL, V5, P57, DOI 10.1111/j.1439-0485.1984.tb00307.x; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hoff Gerald R., 2005, Alaska Fishery Research Bulletin, V11, P27; Holme N. A., 1984, METHODS STUDY MARINE; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; INGOLE B, 2009, JMBA 2 BIODIVERSITY, P1; KAMESHRAJU KA, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2006GL028730; KATTOJU KR, 2010, EOS T AGU S, V89; Margalef R., 1968, PERSPECTIVES ECOLOGI; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; O'Hara TD, 2010, MAR ECOL-EVOL PERSP, V31, P26, DOI 10.1111/j.1439-0485.2010.00373.x; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Raju KAK, 2004, EARTH PLANET SC LETT, V221, P145, DOI 10.1016/S0012-821X(04)00075-5; RAYMORE PA, 1982, PAC SCI, V36, P15; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Sautya S, 2010, ZOOTAXA, P64; Shannon C.E., 1963, MATH THEORY COMMUNIC; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STOCKS K, SEAMOUNTS ONLINE ONL; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; WRIGHT IC, 1994, MAR GEOL, V118, P217, DOI 10.1016/0025-3227(94)90085-X	35	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16162	10.1371/journal.pone.0016162	http://dx.doi.org/10.1371/journal.pone.0016162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297959	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300037
J	Voisin, SN; Krakovska, O; Matta, A; DeSouza, LV; Romaschin, AD; Colgan, TJ; Siu, KWM				Voisin, Sebastien N.; Krakovska, Olga; Matta, Ajay; DeSouza, Leroi V.; Romaschin, Alexander D.; Colgan, Terence J.; Siu, K. W. Michael			Identification of Novel Molecular Targets for Endometrial Cancer Using a Drill-Down LC-MS/MS Approach with iTRAQ	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; PYRUVATE-KINASE M2; MASS-SPECTROMETRY; BIOMARKER DISCOVERY; OXIDATIVE STRESS; S100 PROTEINS; CATHEPSIN-B; PROTEOMICS; SURVIVAL; ROLES	Background: The number of patients with endometrial carcinoma (EmCa) with advanced stage or high histological grade is increasing and prognosis has not improved for over the last decade. There is an urgent need for the discovery of novel molecular targets for diagnosis, prognosis and treatment of EmCa, which will have the potential to improve the clinical strategy and outcome of this disease. Methodology and Results: We used a "drill-down'' proteomics approach to facilitate the identification of novel molecular targets for diagnosis, prognosis and/or therapeutic intervention for EmCa. Based on peptide ions identified and their retention times in the first LC-MS/MS analysis, an exclusion list was generated for subsequent iterations. A total of 1529 proteins have been identified below the Proteinpilot (R) 5% error threshold from the seven sets of iTRAQ experiments performed. On average, the second iteration added 78% new peptides to those identified after the first run, while the third iteration added 36% additional peptides. Of the 1529 proteins identified, only 40 satisfied our criteria for significant differential expression in EmCa in comparison to normal proliferative tissues. These proteins included metabolic enzymes (pyruvate kinase M2 and lactate dehydrogenase A); calcium binding proteins (S100A6, calcyphosine and calumenin), and proteins involved in regulating inflammation, proliferation and invasion (annexin A1, interleukin enhancer-binding factor 3, alpha-1-antitrypsin, macrophage capping protein and cathepsin B). Network analyses revealed regulation of these molecular targets by c-myc, Her2/neu and TNF alpha, suggesting intervention with these pathways may be a promising strategy for the development of novel molecular targeted therapies for EmCa. Conclusions: Our analyses revealed the significance of drill-down proteomics approach in combination with iTRAQ to overcome some of the limitations of current proteomics strategies. This study led to the identification of a number of novel molecular targets having therapeutic potential for targeted molecular therapies for endometrial carcinoma.	[Voisin, Sebastien N.; Krakovska, Olga; Matta, Ajay; DeSouza, Leroi V.; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Voisin, Sebastien N.; Krakovska, Olga; Matta, Ajay; DeSouza, Leroi V.] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Romaschin, Alexander D.] St Michaels Hosp, Div Clin Biochem, Toronto, ON M5B 1W8, Canada; [Romaschin, Alexander D.; Colgan, Terence J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Colgan, Terence J.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	York University - Canada; York University - Canada; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Voisin, SN (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada.	kwmsiu@yorku.ca	Colgan, Terence J/J-2339-2016; MATTA, AJAY/AFT-2977-2022; DeSouza, Leroi V/H-3831-2013	Voisin, Sebastien/0000-0001-5897-333X	Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada); MITACS, Ontario, Canada	Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada); MITACS, Ontario, Canada	The support of the Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada) is gratefully acknowledged. AB SCIEX provided infrastructural and reagent support of this research; Ajay Matta is the recipient of a MITACS Accelerate Fellowship, Ontario, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chen HS, 2005, ANAL CHEM, V77, P7816, DOI 10.1021/ac050956y; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clarke BA, 2010, J CLIN PATHOL, V63, P410, DOI 10.1136/jcp.2009.071225; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; De Petris L, 2009, LUNG CANCER, V63, P410, DOI 10.1016/j.lungcan.2008.06.003; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; DeSouza LV, 2007, MOL CELL PROTEOMICS, V6, P1170, DOI 10.1074/mcp.M600378-MCP200; DeSouza LV, 2009, ANAL CHEM, V81, P3462, DOI 10.1021/ac802726a; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Diamandis EP, 2004, MOL CELL PROTEOMICS, V3, P367, DOI 10.1074/mcp.R400007-MCP200; Dizon DS, 2010, GYNECOL ONCOL, V117, P373, DOI 10.1016/j.ygyno.2010.02.007; Dube V, 2007, J PROTEOME RES, V6, P2648, DOI 10.1021/pr070087o; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Fais S, 2004, TRENDS MOL MED, V10, P249, DOI 10.1016/j.molmed.2004.04.005; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Guo WH, 2011, J CANCER RES CLIN, V137, P65, DOI 10.1007/s00432-010-0860-5; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hung KE, 2010, GASTROENTEROLOGY, V138, P46, DOI 10.1053/j.gastro.2009.11.020; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kaiserman Dion, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000184; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Li ZY, 2008, INT J CANCER, V123, P2377, DOI 10.1002/ijc.23808; Li ZY, 2010, INT J GYNECOL CANCER, V20, P9, DOI 10.1111/IGC.0b013e3181a9026d; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Makawita S, 2010, CLIN CHEM, V56, P212, DOI 10.1373/clinchem.2009.127019; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Negishi A, 2009, CANCER SCI, V100, P514, DOI 10.1111/j.1349-7006.2008.01055.x; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Scherl A, 2004, PROTEOMICS, V4, P917, DOI 10.1002/pmic.200300673; Shi HS, 2010, CANCER SCI, V101, P1447, DOI 10.1111/j.1349-7006.2010.01562.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simpson RJ, 2008, CURR OPIN CHEM BIOL, V12, P72, DOI 10.1016/j.cbpa.2008.02.010; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Street JM, 2010, BRIT J CLIN PHARMACO, V69, P367, DOI 10.1111/j.1365-2125.2009.03610.x; Tomoo K, 2010, CURR TOP MED CHEM, V10, P696, DOI 10.2174/156802610791113441; van der Merwe DE, 2007, ADV CANCER RES, V96, P23, DOI 10.1016/S0065-230X(06)96002-3; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wang N, 2008, ANAL CHEM, V80, P4696, DOI 10.1021/ac800260w; Wang XH, 2010, AM J PATHOL, V177, P586, DOI 10.2353/ajpath.2010.091217	50	37	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16352	10.1371/journal.pone.0016352	http://dx.doi.org/10.1371/journal.pone.0016352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305022	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300054
J	Whittington, RA; Virag, L; Marcouiller, F; Papon, MA; El Khoury, NB; Julien, C; Morin, F; Emala, CW; Planel, E				Whittington, Robert A.; Virag, Laszlo; Marcouiller, Francois; Papon, Marie-Amelie; El Khoury, Noura B.; Julien, Carl; Morin, Francoise; Emala, Charles W.; Planel, Emmanuel			Propofol Directly Increases Tau Phosphorylation	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN PHOSPHATASE 2A; ALZHEIMERS-DISEASE; IN-VIVO; KINASE; HYPERPHOSPHORYLATION; ANESTHESIA; INHIBITION; PATHOLOGY; HYPOTHERMIA	In Alzheimer's disease (AD) and other tauopathies, the microtubule-associated protein tau can undergo aberrant hyperphosphorylation potentially leading to the development of neurofibrillary pathology. Anesthetics have been previously shown to induce tau hyperphosphorylation through a mechanism involving hypothermia-induced inhibition of protein phosphatase 2A (PP2A) activity. However, the effects of propofol, a common clinically used intravenous anesthetic, on tau phosphorylation under normothermic conditions are unknown. We investigated the effects of a general anesthetic dose of propofol on levels of phosphorylated tau in the mouse hippocampus and cortex under normothermic conditions. Thirty min following the administration of propofol 250 mg/kg i.p., significant increases in tau phosphorylation were observed at the AT8, CP13, and PHF-1 phosphoepitopes in the hippocampus, as well as at AT8, PHF-1, MC6, pS262, and pS422 epitopes in the cortex. However, we did not detect somatodendritic relocalization of tau. In both brain regions, tau hyperphosphorylation persisted at the AT8 epitope 2 h following propofol, although the sedative effects of the drug were no longer evident at this time point. By 6 h following propofol, levels of phosphorylated tau at AT8 returned to control levels. An initial decrease in the activity and expression of PP2A were observed, suggesting that PP2A inhibition is at least partly responsible for the hyperphosphorylation of tau at multiple sites following 30 min of propofol exposure. We also examined tau phosphorylation in SH-SY5Y cells transfected to overexpress human tau. A 1 h exposure to a clinically relevant concentration of propofol in vitro was also associated with tau hyperphosphorylation. These findings suggest that propofol increases tau phosphorylation both in vivo and in vitro under normothermic conditions, and further studies are warranted to determine the impact of this anesthetic on the acceleration of neurofibrillary pathology.	[Whittington, Robert A.; Virag, Laszlo; Emala, Charles W.] Columbia Univ, Dept Anesthesiol, Coll Phys & Surg, New York, NY 10027 USA; [Marcouiller, Francois; Papon, Marie-Amelie; El Khoury, Noura B.; Julien, Carl; Morin, Francoise; Planel, Emmanuel] CHU Laval, Quebec City, PQ G1V 4G2, Canada	Columbia University; Laval University	Whittington, RA (corresponding author), Columbia Univ, Dept Anesthesiol, Coll Phys & Surg, New York, NY 10027 USA.	raw9@columbia.edu; emmanuel@planel.org	Julien, Carl/AAU-5309-2021	Planel, Emmanuel/0000-0001-5128-0565	Columbia University Department of Anesthesiology; CIHR [MOP-106423, PCN-102993]; NSERC [354722]; FRSQ [16205, 20048]	Columbia University Department of Anesthesiology; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Columbia University Department of Anesthesiology Research Allocation Panel Fund to RAW, and from the CIHR (MOP-106423, PCN-102993), the NSERC (354722), and the FRSQ (16205, 20048) to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DEGARCINI EM, 1986, BIOCHEM BIOPH RES CO, V141, P790, DOI 10.1016/S0006-291X(86)80242-X; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; ECKENHOFF RG, 2007, CELLSCIENCE REV, P78; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Engdahl O, 1998, BRIT J ANAESTH, V81, P957, DOI 10.1093/bja/81.6.957; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Mailliot C, 2000, ANN NY ACAD SCI, V920, P107; Oscarsson A, 2007, ACTA ANAESTH SCAND, V51, P1184, DOI 10.1111/j.1399-6576.2007.01388.x; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PAPON MA, 2011, FRONTIERS N IN PRESS; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Planel E, 2002, DRUG DEVELOP RES, V56, P491, DOI 10.1002/ddr.10100; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; RUN X, 2010, J ALZHEIMERS DIS; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; SINGH TJ, 1994, MOL CELL BIOCHEM, V131, P181; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wunsch H, 2009, CRIT CARE MED, V37, P3031, DOI 10.1097/CCM.0b013e3181b02eff; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	48	105	109	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16648	10.1371/journal.pone.0016648	http://dx.doi.org/10.1371/journal.pone.0016648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304998	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300108
J	Biber, U; Ilg, UJ				Biber, Ulrich; Ilg, Uwe J.			Visual Stability and the Motion Aftereffect: A Psychophysical Study Revealing Spatial Updating	PLOS ONE			English	Article							FRONTAL EYE FIELD; MONKEY SUPERIOR COLLICULUS; BRAIN-STEM TELLS; CORTICAL AREA MT; COROLLARY DISCHARGE; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; TRANSSACCADIC INTEGRATION; FUNCTIONAL-PROPERTIES; TEMPORAL INTEGRATION	Eye movements create an ever-changing image of the world on the retina. In particular, frequent saccades call for a compensatory mechanism to transform the changing visual information into a stable percept. To this end, the brain presumably uses internal copies of motor commands. Electrophysiological recordings of visual neurons in the primate lateral intraparietal cortex, the frontal eye fields, and the superior colliculus suggest that the receptive fields (RFs) of special neurons shift towards their post-saccadic positions before the onset of a saccade. However, the perceptual consequences of these shifts remain controversial. We wanted to test in humans whether a remapping of motion adaptation occurs in visual perception. The motion aftereffect (MAE) occurs after viewing of a moving stimulus as an apparent movement to the opposite direction. We designed a saccade paradigm suitable for revealing pre-saccadic remapping of the MAE. Indeed, a transfer of motion adaptation from pre-saccadic to post-saccadic position could be observed when subjects prepared saccades. In the remapping condition, the strength of the MAE was comparable to the effect measured in a control condition (33 +/- 7% vs. 27 +/- 4%). Contrary, after a saccade or without saccade planning, the MAE was weak or absent when adaptation and test stimulus were located at different retinal locations, i.e. the effect was clearly retinotopic. Regarding visual cognition, our study reveals for the first time predictive remapping of the MAE but no spatiotopic transfer across saccades. Since the cortical sites involved in motion adaptation in primates are most likely the primary visual cortex and the middle temporal area (MT/V5) corresponding to human MT, our results suggest that pre-saccadic remapping extends to these areas, which have been associated with strict retinotopy and therefore with classical RF organization. The pre-saccadic transfer of visual features demonstrated here may be a crucial determinant for a stable percept despite saccades.	[Biber, Ulrich; Ilg, Uwe J.] Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Biber, U (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	ulrich.biber@student.uni-tuebingen.de		Ilg, Uwe/0000-0003-2623-1627; Biber, Ulrich/0000-0001-9788-1761	Deutsche Forschungsgemeinschaft (DFG IL) [34/6-1]	Deutsche Forschungsgemeinschaft (DFG IL)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG IL) 34/6-1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Andersen R A, 1992, Curr Opin Neurobiol, V2, P840, DOI 10.1016/0959-4388(92)90143-9; ANGEL RW, 1980, ANN NEUROL, V7, P73, DOI 10.1002/ana.410070113; Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; BAIZER JS, 1982, INVEST OPHTH VIS SCI, V23, P87; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; Bakola S, 2007, J NEUROSCI, V27, P2224, DOI 10.1523/JNEUROSCI.4224-06.2007; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Bisley James W, 2003, Adv Neurol, V93, P141; BLATT GJ, 1990, J COMP NEUROL, V300, P1; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; CHAPMAN J, 1966, BRIT J PSYCHIAT, V112, P225, DOI 10.1192/bjp.112.484.225; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Ezzati A, 2008, J VISION, V8, DOI 10.1167/8.14.23; Feinberg I, 1999, BRIT J PSYCHIAT, V174, P196, DOI 10.1192/bjp.174.3.196; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Filehne W., 1922, Z SINNESPHYSIOL, V53, P134; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; GAYMARD B, 1994, EXP BRAIN RES, V102, P1; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Gysen V, 2002, VISION RES, V42, P1785, DOI 10.1016/S0042-6989(02)00105-0; Gysen V, 2002, VISION RES, V42, P379, DOI 10.1016/S0042-6989(01)00296-6; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; HEIDE W, 1995, ANN NEUROL, V38, P739, DOI 10.1002/ana.410380508; Heiser LM, 2006, J NEUROPHYSIOL, V95, P2751, DOI 10.1152/jn.00054.2005; Helmholtz Hermann von, 1962, PHYSL OPTICS; HIRIS E, 1992, P NATL ACAD SCI USA, V89, P9025, DOI 10.1073/pnas.89.19.9025; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Knapen T, 2009, J VISION, V9, DOI [10.1167/9.13.16, 10.1167/9.5.16]; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; KORNMULLER AE, 1931, PSYCHOLOGIE, V41, P354; LEICHNETZ GR, 1989, VISUAL NEUROSCI, V3, P171, DOI 10.1017/S0952523800004478; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; MAIOLI MG, 1983, BRAIN RES, V265, P294, DOI 10.1016/0006-8993(83)90345-1; MASLAND RH, 1969, SCIENCE, V165, P819, DOI 10.1126/science.165.3895.819; Mather G., 1998, MOTION AFTEREFFECT M; Mather G, 2008, TRENDS COGN SCI, V12, P481, DOI 10.1016/j.tics.2008.09.002; MATIN L, 1982, SCIENCE, V216, P198, DOI 10.1126/science.7063881; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Meng X, 2006, VISION RES, V46, P3681, DOI 10.1016/j.visres.2006.05.012; Merriam EP, 2007, J NEUROPHYSIOL, V97, P1738, DOI 10.1152/jn.00189.2006; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1990, COLD SPRING HARB SYM, V55, P697; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Parks NA, 2008, PSYCHOPHYSIOLOGY, V45, P776, DOI 10.1111/j.1469-8986.2008.00669.x; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Pollatsek A, 2002, PERCEPT PSYCHOPHYS, V64, P1120, DOI 10.3758/BF03194761; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; RAFAL RD, 1994, CURR OPIN NEUROBIOL, V4, P231, DOI 10.1016/0959-4388(94)90078-7; RODMAN HR, 1990, J NEUROSCI, V10, P1154; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1362, DOI 10.1152/jn.1976.39.6.1362; SCHILLER PH, 1998, COGNITIVE NEUROSCIEN, V464, P463; Shepherd AJ, 2006, BRAIN, V129, P1833, DOI 10.1093/brain/awl124; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Snowden RJ, 1997, CURR BIOL, V7, P717, DOI 10.1016/S0960-9822(06)00329-0; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sommer MA, 2008, PERCEPTION, V37, P408, DOI 10.1068/p5873; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SPERRY RW, 1950, J COMP PHYSL, V43, P483; STANDAGE GP, 1983, BRAIN RES, V262, P288, DOI 10.1016/0006-8993(83)91020-X; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STEVENS JK, 1976, VISION RES, V16, P93, DOI 10.1016/0042-6989(76)90082-1; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; THOMPSON P, 1994, PERCEPTION, V23, P1233, DOI 10.1068/p231233; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VERFAILLIE K, 1994, J EXP PSYCHOL LEARN, V20, P649, DOI 10.1037/0278-7393.20.3.649; Versino M, 2000, J NEUROL NEUROSUR PS, V68, P234, DOI 10.1136/jnnp.68.2.234; Verstraten FAJ, 1998, PERCEPTION, V27, P1055, DOI 10.1068/p271055; VONDERHEYDT R, 1978, ARCH ITAL BIOL, V116, P248; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; WEISSTEIN N, 1977, SCIENCE, V198, P955, DOI 10.1126/science.929181; Wenderoth P, 2008, VISION RES, V48, P1949, DOI 10.1016/j.visres.2008.06.013; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	104	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16265	10.1371/journal.pone.0016265	http://dx.doi.org/10.1371/journal.pone.0016265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298104	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800021
J	de Groot, GA; During, HJ; Maas, JW; Schneider, H; Vogel, JC; Erkens, RHJ				de Groot, G. Arjen; During, Heinjo J.; Maas, Jan W.; Schneider, Harald; Vogel, Johannes C.; Erkens, Roy H. J.			Use of rbcL and trnL-F as a Two-Locus DNA Barcode for Identification of NW-European Ferns: An Ecological Perspective	PLOS ONE			English	Article							NONCODING REGIONS; LAND PLANTS; CHLOROPLAST; PHYLOGENY; SEQUENCES; PCR; AMPLIFICATION; POLYPODIIDAE; CONSERVATION; POPULATIONS	Although consensus has now been reached on a general two-locus DNA barcode for land plants, the selected combination of markers (rbcL + matK) is not applicable for ferns at the moment. Yet especially for ferns, DNA barcoding is potentially of great value since fern gametophytes-while playing an essential role in fern colonization and reproduction-generally lack the morphological complexity for morphology-based identification and have therefore been underappreciated in ecological studies. We evaluated the potential of a combination of rbcL with a noncoding plastid marker, trnL-F, to obtain DNA-identifications for fern species. A regional approach was adopted, by creating a reference database of trusted rbcL and trnL-F sequences for the wild-occurring homosporous ferns of NW-Europe. A combination of parsimony analyses and distance-based analyses was performed to evaluate the discriminatory power of the two-region barcode. DNA was successfully extracted from 86 tiny fern gametophytes and was used as a test case for the performance of DNA-based identification. Primer universality proved high for both markers. Based on the combined rbcL + trnL-F dataset, all genera as well as all species with non-equal chloroplast genomes formed their own well supported monophyletic clade, indicating a high discriminatory power. Interspecific distances were larger than intraspecific distances for all tested taxa. Identification tests on gametophytes showed a comparable result. All test samples could be identified to genus level, species identification was well possible unless they belonged to a pair of Dryopteris species with completely identical chloroplast genomes. Our results suggest a high potential of the combined use of rbcL and trnL-F as a two-locus cpDNA barcode for identification of fern species. A regional approach may be preferred for ecological tests. We here offer such a ready-to-use barcoding approach for ferns, which opens the way for answering a whole range of questions previously unaddressed in fern gametophyte ecology.	[de Groot, G. Arjen; During, Heinjo J.; Maas, Jan W.; Erkens, Roy H. J.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [Schneider, Harald; Vogel, Johannes C.] Nat Hist Museum, Dept Bot, London SW7 5BD, England	Utrecht University; Natural History Museum London	de Groot, GA (corresponding author), Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands.	G.A.deGroot@uu.nl	Schneider, Harald/B-6681-2008; Erkens, Roy H.J./B-9961-2008	Schneider, Harald/0000-0002-4548-7268; Erkens, Roy H.J./0000-0002-1093-0370	Schure-Beijerink-Popping Fund (KNAW) [SBP/JK/2009-21]; Miquel Fund	Schure-Beijerink-Popping Fund (KNAW); Miquel Fund	This work was supported by grants from the Schure-Beijerink-Popping Fund (KNAW, SBP/JK/2009-21) and Miquel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BARRINGTON DS, 1989, AM FERN J, V79, P55, DOI 10.2307/1547160; Bremer P, 2010, GORTERIA, V34, P146; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; *CONS BARC LIF, 2007, NONCOI BARC REG GUID; COUSENS MI, 1981, BOT GAZ, V142, P251, DOI 10.1086/337220; de Groot GA, 2008, GORTERIA, V33, P59; DEOLIVIERA SM, 2010, THESIS UTRECHT U UTR; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Duffy AM, 2009, GENE, V438, P17, DOI 10.1016/j.gene.2009.02.006; DYER AF, 1994, BIODIVERS CONSERV, V3, P160, DOI 10.1007/BF02291886; Ekrt L, 2009, PRESLIA, V81, P261; Erkens RHJ, 2009, J BIOGEOGR, V36, P2338, DOI 10.1111/j.1365-2699.2009.02162.x; Farrar DR, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P222, DOI 10.1017/CBO9780511541827.010; Fazekas AJ, 2010, TAXON, V59, P694, DOI 10.1002/tax.593002; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fraser-Jenkins C. R., 2007, Fern Gazette, V18, P1; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Geiger JMO, 2005, MOL PHYLOGENET EVOL, V34, P392, DOI 10.1016/j.ympev.2004.11.001; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; Janssen T, 2005, PLANT SYST EVOL, V252, P175, DOI 10.1007/s00606-004-0264-6; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lambinon J., 1998, FLORA BELGIE GROOTHE; Landergott U, 2001, HEREDITY, V87, P344, DOI 10.1046/j.1365-2540.2001.00912.x; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Li FW, 2009, PLANT SYST EVOL, V281, P77, DOI 10.1007/s00606-009-0188-2; Little DP, 2003, AM J BOT, V90, P508, DOI 10.3732/ajb.90.3.508; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Ovcharenko Ivan, 2003, Current Genomics, V4, P557, DOI 10.2174/1389202033490169; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Ptacek Travis, 2005, Briefings in Functional Genomics & Proteomics, V4, P178, DOI 10.1093/bfgp/4.2.178; Quintanilla LG, 2006, ANN BOT-LONDON, V98, P609, DOI 10.1093/aob/mcl137; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Schneider H, 2005, P ROY SOC B-BIOL SCI, V272, P455, DOI 10.1098/rspb.2004.2965; Schneider H, 2004, SYST BOT, V29, P260, DOI 10.1600/036364404774195476; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; SCHNELLER J J, 1975, Bulletin de la Societe Botanique Suisse, V85, P110; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SLEEP A, 1971, British Fern Gazette, V10, P208; SLEEP A, 1983, ACTA BOT MALACITANA, V8, P11; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Stace C., 1997, NEW FLORA BRIT ISLES; Stein DB, 2010, AM J BOT, V97, P998, DOI 10.3732/ajb.0900355; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; Vogel JC, 1999, SYST ASSOC SPEC VOL, V57, P101; Watkins JE, 2007, AM J BOT, V94, P701, DOI 10.3732/ajb.94.4.701; WERTH C R, 1989, American Journal of Botany, V76, P208; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044	72	68	74	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16371	10.1371/journal.pone.0016371	http://dx.doi.org/10.1371/journal.pone.0016371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298108	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800032
J	Alverson, AJ; Zhuo, S; Rice, DW; Sloan, DB; Palmer, JD				Alverson, Andrew J.; Zhuo, Shi; Rice, Danny W.; Sloan, Daniel B.; Palmer, Jeffrey D.			The Mitochondrial Genome of the Legume Vigna radiata and the Analysis of Recombination across Short Mitochondrial Repeats	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INTRACELLULAR GENE-TRANSFER; BETA-VULGARIS L.; HOMOLOGOUS RECOMBINATION; EXTENSIVE LOSS; DNA; NUCLEUS; EVOLUTION; SUBUNIT-2; ORGANIZATION	The mitochondrial genomes of seed plants are exceptionally fluid in size, structure, and sequence content, with the accumulation and activity of repetitive sequences underlying much of this variation. We report the first fully sequenced mitochondrial genome of a legume, Vigna radiata (mung bean), and show that despite its unexceptional size (401,262 nt), the genome is unusually depauperate in repetitive DNA and "promiscuous" sequences from the chloroplast and nuclear genomes. Although Vigna lacks the large, recombinationally active repeats typical of most other seed plants, a PCR survey of its modest repertoire of short (38-297 nt) repeats nevertheless revealed evidence for recombination across all of them. A set of novel control assays showed, however, that these results could instead reflect, in part or entirely, artifacts of PCR-mediated recombination. Consequently, we recommend that other methods, especially high-depth genome sequencing, be used instead of PCR to infer patterns of plant mitochondrial recombination. The average-sized but repeat-and feature-poor mitochondrial genome of Vigna makes it ever more difficult to generalize about the factors shaping the size and sequence content of plant mitochondrial genomes.	[Alverson, Andrew J.; Zhuo, Shi; Rice, Danny W.; Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Sloan, Daniel B.] Univ Virginia, Dept Biol, Charlottesville, VA USA	Indiana University System; Indiana University Bloomington; University of Virginia	Alverson, AJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	andy.alverson@gmail.com	Palmer, Jeffrey/P-6747-2014; Sloan, Daniel/D-4152-2011	Palmer, Jeffrey/0000-0002-4626-2220; Alverson, Andrew/0000-0003-1241-2654; Rice, Danny/0000-0002-1123-4617; Sloan, Daniel/0000-0002-3618-0897	National Institutes of Health [1F32GM080079-01A1, RO1-GM-70612]; METACyt Initiative of Indiana University; Lilly Endowment, Inc.; U.S. Department of Energy's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM070612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); METACyt Initiative of Indiana University; Lilly Endowment, Inc.; U.S. Department of Energy's Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Ruth L. Kirschstein NRSA Postdoctoral Fellowship (1F32GM080079-01A1) to AJA, NIH research grant RO1-GM-70612 to JDP, and the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. to JDP. This work was performed under the auspices of the U.S. Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Adams KL, 2001, GENETICS, V158, P1289; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Arrieta-Montiel MP, 2009, GENETICS, V183, P1261, DOI 10.1534/genetics.109.108514; COVELLO PS, 1992, EMBO J, V11, P3815, DOI 10.1002/j.1460-2075.1992.tb05473.x; Daley DO, 2002, P NATL ACAD SCI USA, V99, P10510, DOI 10.1073/pnas.122354399; Daley DO, 2002, PLANT J, V30, P11, DOI 10.1046/j.1365-313X.2002.01263.x; FALCONET D, 1984, EMBO J, V3, P297, DOI 10.1002/j.1460-2075.1984.tb01799.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2002, MOL GENET GENOMICS, V267, P797, DOI 10.1007/s00438-002-0711-4; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Knoop V, 1996, GENETICS, V142, P579; KOLODNER R, 1972, P NATL ACAD SCI USA, V69, P1830, DOI 10.1073/pnas.69.7.1830; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lilly JW, 2001, CURR GENET, V40, P144, DOI 10.1007/s002940100238; LONSDALE DM, 1988, PHILOS T ROY SOC B, V319, P149, DOI 10.1098/rstb.1988.0039; LONSDALE DM, 1984, NUCLEIC ACIDS RES, V12, P9249, DOI 10.1093/nar/12.24.9249; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; McDermott P, 2008, THEOR APPL GENET, V117, P459, DOI 10.1007/s00122-008-0790-7; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; NUGENT JM, 1991, CELL, V66, P473, DOI 10.1016/0092-8674(81)90011-8; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; PALMER JD, 1982, NUCLEIC ACIDS RES, V10, P1593, DOI 10.1093/nar/10.5.1593; PALMER JD, 1980, CARNEGIE I WASH YB, V79, P120; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Qualmann SR, 2003, PLANT BIOLOGY, V5, P481, DOI 10.1055/s-2003-44781; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Satoh M, 2006, THEOR APPL GENET, V113, P477, DOI 10.1007/s00122-006-0312-4; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Woloszynska M, 2001, MOL GENET GENOMICS, V265, P865, DOI 10.1007/s004380100481; Woloszynska M, 2009, PLANT MOL BIOL, V70, P511, DOI 10.1007/s11103-009-9488-8; Yamato KT, 1999, J HERED, V90, P369, DOI 10.1093/jhered/90.3.369	49	117	120	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16404	10.1371/journal.pone.0016404	http://dx.doi.org/10.1371/journal.pone.0016404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283772	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522200062
J	Sianglum, W; Srimanote, P; Wonglumsom, W; Kittiniyom, K; Voravuthikunchai, SP				Sianglum, Wipawadee; Srimanote, Potjanee; Wonglumsom, Wijit; Kittiniyom, Kanokwan; Voravuthikunchai, Supayang P.			Proteome Analyses of Cellular Proteins in Methicillin-Resistant Staphylococcus aureus Treated with Rhodomyrtone, a Novel Antibiotic Candidate	PLOS ONE			English	Article							ESCHERICHIA-COLI; WALL; PEPTIDOGLYCAN; INFECTIONS; MORPHOGENESIS; PROTEOLYSIS; ADAPTATION; EXPRESSION; COMMUNITY; LOCUS	The ethanolic extract from Rhodomyrtus tomentosa leaf exhibited good antibacterial activities against both methicillin-resistant Staphylococcus aureus (MRSA) and S. aureus ATCC 29213. Its minimal inhibitory concentration (MIC) values ranged from 31.25-62.5 mu g/ml, and the minimal bactericidal concentration (MBC) was 250 mu g/ml. Rhodomyrtone, an acylphloroglucinol derivative, was 62.5-125 times more potent at inhibiting the bacteria than the ethanolic extract, the MIC and MBC values were 0.5 mu g/ml and 2 mu g/ml, respectively. To provide insights into antibacterial mechanisms involved, the effects of rhodomyrtone on cellular protein expression of MRSA have been investigated using proteomic approaches. Proteome analyses revealed that rhodomyrtone at subinhibitory concentration (0.174 mu g/ml) affected the expression of several major functional classes of whole cell proteins in MRSA. The identified proteins involve in cell wall biosynthesis and cell division, protein degradation, stress response and oxidative stress, cell surface antigen and virulence factor, and various metabolic pathways such as amino acid, carbohydrate, energy, lipid, and nucleotide metabolism. Transmission electron micrographs confirmed the effects of rhodomyrtone on morphological and ultrastructural alterations in the treated bacterial cells. Biological processes in cell wall biosynthesis and cell division were interrupted. Prominent changes including alterations in cell wall, abnormal septum formation, cellular disintegration, and cell lysis were observed. Unusual size and shape of staphylococcal cells were obviously noted in the treated MRSA. These pioneer findings on proteomic profiling and phenotypic features of rhodomyrtone-treated MRSA may resolve its antimicrobial mechanisms which could lead to the development of a new effective regimen for the treatment of MRSA infections.	[Sianglum, Wipawadee; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand; [Sianglum, Wipawadee; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Nat Prod Res Ctr, Fac Sci, Hat Yai, Thailand; [Srimanote, Potjanee] Thammasat Univ, Fac Allied Hlth Sci, Grad Study, Pathumtanee, Thailand; [Wonglumsom, Wijit; Kittiniyom, Kanokwan] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol, Nakhon Pathom, Thailand	Prince of Songkla University; Prince of Songkla University; Thammasat University; Mahidol University	Sianglum, W (corresponding author), Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand.	supayang.v@psu.ac.th	Srimanote, Potjanee/W-2221-2019		Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program [PHD/0053/2550, DBG: 5180021]	Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program	This work was supported by the Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program (http://rgj.trf.or.th/eng/rgje11.asp), Grant number PHD/0053/2550 and DBG: 5180021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2007, INT J MED MICROBIOL, V297, P483, DOI 10.1016/j.ijmm.2007.04.004; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P800, DOI 10.1128/AAC.00603-08; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; Brunskill EW, 1997, MICROBIOL-UK, V143, P2877, DOI 10.1099/00221287-143-9-2877; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chusri S, 2009, J APPL MICROBIOL, V106, P89, DOI 10.1111/j.1365-2672.2008.03979.x; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI; Cookson BD, 2000, INFECT CONT HOSP EP, V21, P398, DOI 10.1086/501781; Cordwell SJ, 2002, MICROBIOL-SGM, V148, P2765, DOI 10.1099/00221287-148-9-2765; Dachriyanus, 2002, AUST J CHEM, V55, P229, DOI 10.1071/CH01194; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Doyle M, 2009, J ANTIMICROB CHEMOTH, V64, P949, DOI 10.1093/jac/dkp325; Eliopoulos GM, 2009, J INFECTION, V59, pS17, DOI 10.1016/S0163-4453(09)60004-9; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; GIESBRECHT P, 1976, INT REV CYTOL, V44, P225, DOI 10.1016/S0074-7696(08)61651-4; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; GUSTAFSON JE, 1992, ANTIMICROB AGENTS CH, V36, P566, DOI 10.1128/AAC.36.3.566; Hadjivassileva T, 2005, J ANTIMICROB CHEMOTH, V56, P513, DOI 10.1093/jac/dki256; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiranrat A, 2008, TETRAHEDRON, V64, P11193, DOI 10.1016/j.tet.2008.09.054; Jarrige AC, 2001, EMBO J, V20, P6845, DOI 10.1093/emboj/20.23.6845; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; Limsuwan S, 2008, FEMS IMMUNOL MED MIC, V53, P429, DOI 10.1111/j.1574-695X.2008.00445.x; Limsuwan S, 2009, PHYTOMEDICINE, V16, P645, DOI 10.1016/j.phymed.2009.01.010; Livermore DM, 2000, INT J ANTIMICROB AG, V16, pS3; Lorenz U, 2000, FEMS IMMUNOL MED MIC, V29, P145, DOI 10.1111/j.1574-695X.2000.tb01517.x; Ly A, 2004, J BACTERIOL, V186, P296, DOI 10.1128/JB.186.2.296-306.2004; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Manfredi R, 2010, BRAZ J INFECT DIS, V14, P96, DOI 10.1590/S1413-86702010000100020; Martin KW, 2003, J ANTIMICROB CHEMOTH, V51, P241, DOI 10.1093/jac/dkg087; Nguyen HM, 2010, J ANTIMICROB CHEMOTH, V65, P24, DOI 10.1093/jac/dkp377; NISHINO T, 1975, JPN J MICROBIOL, V19, P53, DOI 10.1111/j.1348-0421.1975.tb00847.x; Saising J, 2008, J HEALTH SCI, V54, P589, DOI 10.1248/jhs.54.589; SAMY RP, 2008, THERAPEUTIC POTENTIA, P283; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Scherl A, 2005, J MICROBIOL METH, V60, P247, DOI 10.1016/j.mimet.2004.09.017; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Singh VK, 2007, MICROBIOL-SGM, V153, P3162, DOI 10.1099/mic.0.2007/009506-0; Sohlberg B, 2003, J BACTERIOL, V185, P7273, DOI 10.1128/JB.185.24.7273-7278.2003; SQUIRES C, 1992, J BACTERIOL, V174, P1081, DOI 10.1128/jb.174.4.1081-1085.1992; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Sugai M, 1997, J BACTERIOL, V179, P2958, DOI 10.1128/jb.179.9.2958-2962.1997; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; Tomczykowa M, 2008, FOLIA HISTOCHEM CYTO, V46, P389, DOI 10.2478/v10042-008-0082-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turgay K, 1998, EMBO J, V17, P6730; van den Ent F, 2001, CURR OPIN MICROBIOL, V4, P634, DOI 10.1016/S1369-5274(01)00262-4; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; Yu L, 2008, J BIOTECHNOL, V135, P304, DOI 10.1016/j.jbiotec.2008.04.010; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	54	71	73	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16628	10.1371/journal.pone.0016628	http://dx.doi.org/10.1371/journal.pone.0016628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326597	Green Submitted, gold, Green Published			2022-12-27	WOS:000287037000014
J	Kostic, C; Crippa, SV; Pignat, V; Bemelmans, AP; Samardzija, M; Grimm, C; Wenzel, A; Arsenijevic, Y				Kostic, Corinne; Crippa, Sylvain Vincent; Pignat, Verene; Bemelmans, Alexis-Pierre; Samardzija, Marijana; Grimm, Christian; Wenzel, Andreas; Arsenijevic, Yvan			Gene Therapy Regenerates Protein Expression in Cone Photoreceptors in Rpe65R91W1aR91W Mice	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; PUPILLARY LIGHT REFLEX; RPE65 MUTATIONS; RETINAL DYSTROPHY; RESTORES VISION; VISUAL FUNCTION; CANINE MODEL; MOUSE MODEL; TRANSLOCATION; DEGENERATION	Cone photoreceptors mediate visual acuity under daylight conditions, so loss of cone-mediated central vision of course dramatically affects the quality of life of patients suffering from retinal degeneration. Therefore, promoting cone survival has become the goal of many ocular therapies and defining the stage of degeneration that still allows cell rescue is of prime importance. Using the Rpe65(R91W/R91W) mouse, which carries a mutation in the Rpe65 gene leading to progressive photoreceptor degeneration in both patients and mice, we defined stages of retinal degeneration that still allow cone rescue. We evaluated the therapeutic window within which cones can be rescued, using a subretinal injection of a lentiviral vector driving expression of RPE65 in the Rpe65(R91W/R91W) mice. Surprisingly, when applied to adult mice (1 month) this treatment not only stalls or slows cone degeneration but, actually, induces cone-specific protein expression that was previously absent. Before the intervention only part of the cones (40% of the number found in wild-type animals) in the Rpe65(R91W/R91W) mice expressed cone transducin (GNAT2); this fraction increased to 64% after treatment. Correct S-opsin localization is also recovered in the transduced region. In consequence these results represent an extended therapeutic window compared to the Rpe65(-/-) mice, implying that patients suffering from missense mutations might also benefit from a prolonged therapeutic window. Moreover, cones are not only rescued during the course of the degeneration, but can actually recover their initial status, meaning that a proportion of altered cones in chromophore deficiency-related disease can be rehabilitated even though they are severely affected.	[Kostic, Corinne; Crippa, Sylvain Vincent; Pignat, Verene; Bemelmans, Alexis-Pierre; Arsenijevic, Yvan] Univ Lausanne, Unit Gene Therapy & Stem Cell Biol, Jules Gonin Eye Hosp, Lausanne, Switzerland; [Samardzija, Marijana; Grimm, Christian; Wenzel, Andreas] Univ Zurich, Lab Retinal Cell Biol, Dept Ophthalmol, Zurich, Switzerland	University of Lausanne; University of Zurich	Kostic, C (corresponding author), Univ Lausanne, Unit Gene Therapy & Stem Cell Biol, Jules Gonin Eye Hosp, Lausanne, Switzerland.	corinne.kostic@fa2.ch	Bemelmans, Alexis-Pierre/H-4476-2019; Samardzija, Marijana/B-9245-2008	Bemelmans, Alexis-Pierre/0000-0001-7605-5225; Samardzija, Marijana/0000-0003-0991-4653; Kostic, Corinne/0000-0003-1006-9733; Grimm, Christian/0000-0001-9318-4352; Crippa, Sylvain Vincent/0000-0002-4677-2642; Arsenijevic, Yvan/0000-0001-6960-1291	Provisu foundation; Novartis foundation	Provisu foundation; Novartis foundation(Novartis)	This work was supported by the Provisu foundation (www.provisu.ch) and the Novartis foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Aleman TS, 2004, INVEST OPHTH VIS SCI, V45, P1259, DOI 10.1167/iovs.03-1230; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bemelmans AP, 2006, PLOS MED, V3, P1892, DOI 10.1371/journal.pmed.0030347; Cachafeiro M, 2010, INVEST OPHTHALMOL VI; Caruso RC, 2010, INVEST OPHTHALMOL VI; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coleman JE, 2005, INVEST OPHTH VIS SCI, V46, P12, DOI 10.1167/iovs.04-0691; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; El Matri L, 2006, GRAEF ARCH CLIN EXP, V244, P1104, DOI 10.1007/s00417-005-0096-2; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Lai Chooi-May, 2004, Genet Vaccines Ther, V2, P3, DOI 10.1186/1479-0556-2-3; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Lorenz B, 2008, INVEST OPHTH VIS SCI, V49, P5235, DOI 10.1167/iovs.07-1671; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mendez A, 2003, J NEUROSCI, V23, P3124; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Narfstrom K, 2003, INVEST OPHTH VIS SCI, V44, P1663, DOI 10.1167/iovs.02-0595; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Nusinowitz S, 2006, VISION RES, V46, P3926, DOI 10.1016/j.visres.2006.05.010; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Paunescu K, 2005, GRAEF ARCH CLIN EXP, V243, P417, DOI 10.1007/s00417-004-1020-x; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Samardzija M, 2008, HUM MOL GENET, V17, P281, DOI 10.1093/hmg/ddm304; Samardzija M, 2009, HUM MOL GENET, V18, P1266, DOI 10.1093/hmg/ddp026; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111; Zhang HB, 2003, MOL VIS, V9, P231; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	58	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16588	10.1371/journal.pone.0016588	http://dx.doi.org/10.1371/journal.pone.0016588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304899	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600010
J	Karathia, H; Vilaprinyo, E; Sorribas, A; Alves, R				Karathia, Hiren; Vilaprinyo, Ester; Sorribas, Albert; Alves, Rui			Saccharomyces cerevisiae as a Model Organism: A Comparative Study	PLOS ONE			English	Article							COMPARATIVE GENOMICS; DATABASE; SGD; EVOLUTION; YEAST; SPACE	Background: Model organisms are used for research because they provide a framework on which to develop and optimize methods that facilitate and standardize analysis. Such organisms should be representative of the living beings for which they are to serve as proxy. However, in practice, a model organism is often selected ad hoc, and without considering its representativeness, because a systematic and rational method to include this consideration in the selection process is still lacking. Methodology/Principal Findings: In this work we propose such a method and apply it in a pilot study of strengths and limitations of Saccharomyces cerevisiae as a model organism. The method relies on the functional classification of proteins into different biological pathways and processes and on full proteome comparisons between the putative model organism and other organisms for which we would like to extrapolate results. Here we compare S. cerevisiae to 704 other organisms from various phyla. For each organism, our results identify the pathways and processes for which S. cerevisiae is predicted to be a good model to extrapolate from. We find that animals in general and Homo sapiens in particular are some of the non-fungal organisms for which S. cerevisiae is likely to be a good model in which to study a significant fraction of common biological processes. We validate our approach by correctly predicting which organisms are phenotypically more distant from S. cerevisiae with respect to several different biological processes. Conclusions/Significance: The method we propose could be used to choose appropriate substitute model organisms for the study of biological processes in other species that are harder to study. For example, one could identify appropriate models to study either pathologies in humans or specific biological processes in species with a long development time, such as plants.	[Karathia, Hiren; Sorribas, Albert; Alves, Rui] Univ Lleida, Dept Ciencies Med Basiques, Lleida, Spain; [Vilaprinyo, Ester] Hosp del Mar IMIM, Evaluat & Clin Epidemiol Dept, Barcelona, Spain; [Karathia, Hiren; Sorribas, Albert; Alves, Rui] IRBLleida, Lleida, Spain	Universitat de Lleida; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Karathia, H (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Lleida, Spain.	ralves@cmb.udl.es	Sorribas, Albert/A-2181-2009; Vilaprinyo, Ester/A-6702-2010; Alves, Rui/C-5920-2009; Karathia, Hiren/AAD-2361-2021	Sorribas, Albert/0000-0002-7407-4075; Vilaprinyo, Ester/0000-0002-5787-5890; Alves, Rui/0000-0002-8112-5184; Karathia, Hiren/0000-0003-3607-6552	Beatriu dePinos; Generalitat de Catalunya; Ministerio de Ciencia e Innovacion (MICINN, Spain) [BFU2007-62772/BMC, BFU2010-17704, BFU2008-0196]; FLAD foundation;  [AP2002-2772]	Beatriu dePinos; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FLAD foundation; 	This work was partially financed by fellowships AP2002-2772 and Beatriu dePinos to EV. HK is funded by a Generalitat de Catalunya Ph. D. fellowship. RA was partially supported by the Ministerio de Ciencia e Innovacion (MICINN, Spain through the Ramon y Cajal program and grants BFU2007-62772/BMC and BFU2010-17704) and by the FLAD foundation during a short stay. AS acknowledges financial support from grant BFU2008-0196 from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2002, BIOINFORMATICS, V18, P908, DOI 10.1093/bioinformatics/18.7.908; Altmann Katrin, 2007, Methods Mol Biol, V372, P81, DOI 10.1007/978-1-59745-365-3_6; Alves R, 2008, CURR BIOINFORM, V3, P98, DOI 10.2174/157489308784340694; Arakawa Kazuharu, 2005, In Silico Biology, V5, P419; Beck H, 2008, FEMS YEAST RES, V8, P1209, DOI 10.1111/j.1567-1364.2008.00442.x; Biddick R, 2009, YEAST, V26, P205, DOI 10.1002/yea.1660; Brocard-Masson Corinne, 2006, Biotechnol Genet Eng Rev, V22, P213; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Caspi RR, 2008, BLOOD, V112, P3003, DOI 10.1182/blood-2008-08-173609; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cogburn LA, 2007, POULTRY SCI, V86, P2059, DOI 10.1093/ps/86.10.2059; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Ellegren H, 2008, MOL ECOL, V17, P4586, DOI 10.1111/j.1365-294X.2008.03954.x; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hu JC, 2009, TRENDS MICROBIOL, V17, P269, DOI 10.1016/j.tim.2009.04.004; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Jin T, 2009, IMMUNOL RES, V43, P118, DOI 10.1007/s12026-008-8056-7; Jonsson KI, 2007, ASTROBIOLOGY, V7, P757, DOI 10.1089/ast.2006.0088; Lee I, 2010, GENOME RES; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Meyer Markus, 2009, Briefings in Functional Genomics & Proteomics, V8, P60, DOI 10.1093/bfgp/elp002; Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217; Murakami C, 2009, J VIS EXP; Nasheuer HP, 2002, PROG NUCLEIC ACID RE, V72, P41, DOI 10.1016/S0079-6603(02)72067-9; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Owsianowski E, 2008, BBA-MOL CELL RES, V1783, P1303, DOI 10.1016/j.bbamcr.2008.03.006; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Scheer M, 2006, NUCLEIC ACIDS RES, V34, pW510, DOI 10.1093/nar/gkl329; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Tyson JJ, 2008, CURR BIOL, V18, pR759, DOI 10.1016/j.cub.2008.07.001; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Wolfram S., 2003, MATH BOOK	39	95	98	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16015	10.1371/journal.pone.0016015	http://dx.doi.org/10.1371/journal.pone.0016015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311596	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200007
J	Chiu, WC; Lai, YP; Chou, MY				Chiu, Wei-Chun; Lai, Ya-Ping; Chou, Min-Yuan			Humanization and Characterization of an Anti-Human TNF-alpha Murine Monoclonal Antibody	PLOS ONE			English	Article							FRAMEWORK RESIDUES; VARIABLE DOMAINS; ARTHRITIS; THERAPY; IMMUNOGENICITY; MECHANISMS; CELLS; BINDS	A murine monoclonal antibody, m357, showing the highly neutralizing activities for human tumor necrosis factor (TNF-alpha) was chosen to be humanized by a variable domain resurfacing approach. The non-conserved surface residues in the framework regions of both the heavy and light chain variable regions were identified via a molecular modeling of m357 built by computer-assisted homology modeling. By replacing these critical surface residues with the human counterparts, a humanized version, h357, was generated. The humanized h357 IgG(1) was then stably expressed in a mammalian cell line and the purified antibody maintained the high antigen binding affinity as compared with the parental m357 based on a soluble TNF-alpha neutralization bioassay. Furthermore, h357 IgG(1) possesses the ability to mediate antibody-dependent cell-mediated cytotoxicity and complement dependent cytotoxicity upon binding to cells bearing the transmembrane form of TNF-alpha. In a mouse model of collagen antibody-induced arthritis, h357 IgG significantly inhibited disease progression by intra-peritoneal injection of 50 mu g/mouse once-daily for 9 consecutive days. These results provided a basis for the development of h357 IgG as therapeutic use.	[Chiu, Wei-Chun; Lai, Ya-Ping; Chou, Min-Yuan] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan	Industrial Technology Research Institute - Taiwan	Chiu, WC (corresponding author), Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan.	minyuanc@itri.org.tw			Ministry of Economic Affairs [9356E71100]	Ministry of Economic Affairs	This work was funded by the Ministry of Economic Affairs, grant number 9356E71100 (http://www.moeaidb.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aringer M, 2008, EXPERT OPIN DRUG SAF, V7, P411, DOI [10.1517/14740338.7.4.411, 10.1517/14740338.7.4.411 ]; Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Beenhouwer D, 2004, J RHEUMATOL, V31, P1888; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUGGEMANN M, 1989, J EXP MED, V170, P2153, DOI 10.1084/jem.170.6.2153; Caron G, 1999, EUR J IMMUNOL, V29, P3588, DOI 10.1002/(SICI)1521-4141(199911)29:11<3588::AID-IMMU3588>3.0.CO;2-O; Dokurno P, 1998, J MOL BIOL, V284, P713, DOI 10.1006/jmbi.1998.2209; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2001, NAT IMMUNOL, V2, P771, DOI 10.1038/ni0901-771; Fontayne A, 2006, THROMB HAEMOSTASIS, V96, P671, DOI 10.1160/TH06-06-0297; Kabat E.A., 1991, SEQUENCES IMMUNOLOGI; Khachigian LM, 2006, NAT PROTOC, V1, P2512, DOI 10.1038/nprot.2006.393; MATTHEWS N, 1987, LYMPHOKINES INTERFER, P221; MEAGER A, 1987, HYBRIDOMA, V6, P305, DOI 10.1089/hyb.1987.6.305; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Murali R, 1998, PROTEIN ENG, V11, P79, DOI 10.1093/protein/11.2.79; O'Connor SJ, 1998, PROTEIN ENG, V11, P321, DOI 10.1093/protein/11.4.321; OWENS RJ, 1994, J IMMUNOL METHODS, V168, P149, DOI 10.1016/0022-1759(94)90051-5; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; SANDHU JS, 1992, CRIT REV BIOTECHNOL, V12, P437, DOI 10.3109/07388559209114235; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; SCHROFF RW, 1985, CANCER RES, V45, P879; Staelens S, 2006, MOL IMMUNOL, V43, P1243, DOI 10.1016/j.molimm.2005.07.018; Taylor PC, 2010, CURR OPIN PHARMACOL, V10, P1; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Zhang W, 2005, MOL IMMUNOL, V42, P1445, DOI 10.1016/j.molimm.2005.01.015	33	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16373	10.1371/journal.pone.0016373	http://dx.doi.org/10.1371/journal.pone.0016373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305012	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300056
J	Jones, PB; Adams, KW; Rozkalne, A; Spires-Jones, TL; Hshieh, TT; Hashimoto, T; von Armin, CAF; Mielke, M; Bacskai, BJ; Hyman, BT				Jones, Phillip B.; Adams, Kenneth W.; Rozkalne, Anete; Spires-Jones, Tara L.; Hshieh, Tammy T.; Hashimoto, Tadafumi; von Armin, Christine A. F.; Mielke, Mathew; Bacskai, Brian J.; Hyman, Bradley T.			Apolipoprotein E: Isoform Specific Differences in Tertiary Structure and Interaction with Amyloid-beta in Human Alzheimer Brain	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; DOMAIN INTERACTION; A-BETA; TRANSGENIC MICE; TYPE-4 ALLELE; E GENOTYPE; DISEASE; APOE; BINDING; PROTEIN	We applied a novel application of FLIM-FRET to in situ measurement and quantification of protein interactions to explore isoform specific differences in A beta-ApoE interaction and ApoE tertiary conformation in senile plaques in human Alzheimer brain. ApoE3 interacts more closely with A beta than ApoE4, but a greater proportion of A beta molecules within plaques are decorated with ApoE4 than ApoE3, lending strong support to the hypothesis that isoform specific differences in ApoE are linked with A beta deposition. We found an increased number of ApoE N-terminal fragments in ApoE4 plaques, consistent with the observation that ApoE4 is more easily cleaved than ApoE3. In addition, we measured a small but significant isoform specific difference in ApoE domain interaction. Based on our in situ data, supported by traditional biochemical data, we propose a pathway by which isoform specific conformational differences increase the level of cleavage at the hinge region of ApoE4, leading to a loss of ApoE function to mediate clearance of A beta and thereby increase the risk of AD for carriers of the APOE epsilon 4 allele.	[Jones, Phillip B.; Adams, Kenneth W.; Rozkalne, Anete; Spires-Jones, Tara L.; Hshieh, Tammy T.; Hashimoto, Tadafumi; Mielke, Mathew; Bacskai, Brian J.; Hyman, Bradley T.] Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Charlestown, MA USA; [von Armin, Christine A. F.] Univ Ulm Klinikum, Neurol Klin, Ulm, Germany	Harvard University; Massachusetts General Hospital; Ulm University	Jones, PB (corresponding author), Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Charlestown, MA USA.	bhyman@partners.org	Spires-Jones, Tara/AAR-7697-2020; Bacskai, Brian/AAE-9583-2021; Hashimoto, Tadafumi/A-7723-2013	Spires-Jones, Tara/0000-0003-2530-0598; Jones, Phill/0000-0003-0525-6323; Hashimoto, Tadafumi/0000-0001-5442-4800	National Institutes of Health (NIH) [AG026240, AG005134, K99 AG033670-01A1, DK048549]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG033670, P50AG005134, R01AG026240] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants AG026240, AG005134, K99 AG033670-01A1, and DK048549 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Cho HS, 2001, J NEUROPATH EXP NEUR, V60, P342, DOI 10.1093/jnen/60.4.342; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; ELLIOTT DA, 2009, NEUROBIOLOGY AGING; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; HYMAN BT, 1994, J NEUROPATH EXP NEUR, V53, P427, DOI 10.1097/00005072-199409000-00001; Jones PB, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363367; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2837169; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Luo JH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000663; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Masi A, 2010, ADV EXP MED BIOL, V674, P33; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Phu MJ, 2005, J NEUROSCI RES, V80, P877, DOI 10.1002/jnr.20503; Rebeck GW, 1998, EXP NEUROL, V149, P175, DOI 10.1006/exnr.1997.6710; REBECK GW, 1993, NEURON, V11, P575; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tamamizu-Kato S, 2008, BIOCHEMISTRY-US, V47, P5225, DOI 10.1021/bi702097s; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Weisgraber K H, 1986, Methods Enzymol, V129, P145; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WISNIEWSKI T, 1995, LANCET, V345, P956, DOI 10.1016/S0140-6736(95)90701-7; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Zhao LZ, 2009, J NEUROSCI, V29, P3603, DOI 10.1523/JNEUROSCI.5302-08.2009	43	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14586	10.1371/journal.pone.0014586	http://dx.doi.org/10.1371/journal.pone.0014586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297948	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300002
J	Ribeiro, CMS; Bird, S; Raes, G; Ghassabeh, GH; Schijns, VEJC; Pontes, MJSL; Savelkoul, HFJ; Wiegertjes, GF				Ribeiro, Carla M. S.; Bird, Steve; Raes, Geert; Ghassabeh, Gholamreza H.; Schijns, Virgil E. J. C.; Pontes, Maria J. S. L.; Savelkoul, Huub F. J.; Wiegertjes, Geert F.			A Novel Soluble Immune-Type Receptor (SITR) in Teleost Fish: Carp SITR Is Involved in the Nitric Oxide-Mediated Response to a Protozoan Parasite	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE TRANSCRIPTS; IG-LIKE DOMAINS; TRYPANOPLASMA-BORRELI; GENE-CLUSTER; EVOLUTION; MOLECULES; RECOGNITION; FAMILY; MEMBER; CELLS	Background: The innate immune system relies upon a wide range of germ-line encoded receptors including a large number of immunoglobulin superfamily (IgSF) receptors. Different Ig-like immune receptor families have been reported in mammals, birds, amphibians and fish. Most innate immune receptors of the IgSF are type I transmembrane proteins containing one or more extracellular Ig-like domains and their regulation of effector functions is mediated intracellularly by distinct stimulatory or inhibitory pathways. Methodology/Principal Findings: Carp SITR was found in a substracted cDNA repertoire from carp macrophages, enriched for genes up-regulated in response to the protozoan parasite Trypanoplasma borreli. Carp SITR is a type I protein with two extracellular Ig domains in a unique organisation of a N-proximal V/C2 (or I-) type and a C-proximal V-type Ig domain, devoid of a transmembrane domain or any intracytoplasmic signalling motif. The carp SITR C-proximal V-type Ig domain, in particular, has a close sequence similarity and conserved structural characteristics to the mammalian CD300 molecules. By generating an anti-SITR antibody we could show that SITR protein expression was restricted to cells of the myeloid lineage. Carp SITR is abundantly expressed in macrophages and is secreted upon in vitro stimulation with the protozoan parasite T. borreli. Secretion of SITR protein during in vivo T. borreli infection suggests a role for this IgSF receptor in the host response to this protozoan parasite. Overexpression of carp SITR in mouse macrophages and knock-down of SITR protein expression in carp macrophages, using morpholino antisense technology, provided evidence for the involvement of carp SITR in the parasite-induced NO production. Conclusion/Significance: We report the structural and functional characterization of a novel soluble immune-type receptor (SITR) in a teleost fish and propose a role for carp SITR in the NO-mediated response to a protozoan parasite.	[Ribeiro, Carla M. S.; Schijns, Virgil E. J. C.; Pontes, Maria J. S. L.; Savelkoul, Huub F. J.; Wiegertjes, Geert F.] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Bird, Steve] Univ Aberdeen, Scottish Fish Immunol Res Ctr, Sch Biol Sci, Aberdeen, Scotland; [Raes, Geert; Ghassabeh, Gholamreza H.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, Brussels, Belgium; [Raes, Geert; Ghassabeh, Gholamreza H.] Vrije Univ Brussel, Dept Mol & Cellular Interact, Brussels, Belgium	Wageningen University & Research; University of Aberdeen; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Ribeiro, CMS (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	geert.wiegertjes@wur.nl	Bird, Steve/K-4822-2014; Raes, Geert M/H-5185-2013; Wiegertjes, Geert F/E-3330-2012; Savelkoul, Huub FJ/F-6026-2012; Pontes, Maria Jose/GQB-0171-2022	Bird, Steve/0000-0003-2937-8579; Raes, Geert M/0000-0002-9065-1549; wiegertjes, geert/0000-0001-9265-3436; Ribeiro, Carla/0000-0002-5682-4143	Portuguese foundation Fundacao para a Ciencia e Tecnologia [SFRH/BD/21522/2005]	Portuguese foundation Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This study was supported by the Portuguese foundation Fundacao para a Ciencia e Tecnologia under grant agreement number SFRH/BD/21522/2005 (http://alfa.fct.mctes.pt/contactos.phtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barclay AN, 1999, P NATL ACAD SCI USA, V96, P14672, DOI 10.1073/pnas.96.26.14672; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cannon JP, 2006, IMMUNOGENETICS, V58, P362, DOI 10.1007/s00251-006-0112-7; Cannon JP, 2010, SEMIN IMMUNOL, V22, P17, DOI 10.1016/j.smim.2009.11.006; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Clark GJ, 2001, TISSUE ANTIGENS, V57, P415, DOI 10.1034/j.1399-0039.2001.057005415.x; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Du Pasquier L, 2004, IMMUNOL LETT, V92, P3, DOI 10.1016/j.imlet.2003.10.012; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Forlenza M, 2008, MOL IMMUNOL, V45, P3178, DOI 10.1016/j.molimm.2008.02.025; GAMULIN V, 1994, BIOL CHEM H-S, V375, P583; Gattis JL, 2006, J BIOL CHEM, V281, P13396, DOI 10.1074/jbc.M600489200; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; IRNAZAROW I, 1995, AQUACULTURE, V129, P215, DOI 10.1016/0044-8486(95)91961-T; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joerink M, 2006, J IMMUNOL, V177, P61, DOI 10.4049/jimmunol.177.1.61; Joerink M, 2006, FISH SHELLFISH IMMUN, V21, P561, DOI 10.1016/j.fsi.2006.03.006; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; KOUMANSVANDIEPEN JCE, 1995, DEV COMP IMMUNOL, V19, P97, DOI 10.1016/0145-305X(94)00061-J; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Litman GW, 2001, IMMUNOL REV, V181, P250, DOI 10.1034/j.1600-065X.2001.1810121.x; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nakayasu C, 1998, FISH SHELLFISH IMMUN, V8, P91, DOI 10.1006/fsim.1997.0125; Nikolaidis N, 2005, IMMUNOGENETICS, V57, P151, DOI 10.1007/s00251-004-0764-0; Ostergaard AE, 2009, DEV COMP IMMUNOL, V33, P525, DOI 10.1016/j.dci.2008.10.002; Overath P, 1998, PARASITOL RES, V84, P343, DOI 10.1007/s004360050408; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Ribeiro CMS, 2010, J IMMUNOL, V184, P2355, DOI 10.4049/jimmunol.0900990; RIBEIRO CM, 2002, J IMMUNOL, V184, P2355; Rombout JHWM, 1996, J FISH BIOL, V49, P521, DOI 10.1111/j.1095-8649.1996.tb00047.x; Saeij JPJ, 2003, DEV COMP IMMUNOL, V27, P859, DOI 10.1016/S0145-305X(03)00083-1; Saeij JPJ, 2002, PARASITOLOGY, V124, P77, DOI 10.1017/S0031182001008915; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; SECOMBES CJ, 1983, IMMUNOLOGY, V48, P165; STEINHAGEN D, 1989, J PARASITOL, V75, P685, DOI 10.2307/3283050; Steinhagen D, 2000, DIS AQUAT ORGAN, V41, P195, DOI 10.3354/dao041195; Stet RJM, 2005, IMMUNOGENETICS, V57, P77, DOI 10.1007/s00251-005-0771-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Volz A, 2001, IMMUNOL REV, V181, P39, DOI 10.1034/j.1600-065X.2001.1810103.x; Weyts FAA, 1997, FISH SHELLFISH IMMUN, V7, P123, DOI 10.1006/fsim.1996.0069; Wines BD, 1999, J IMMUNOL, V162, P2146; Yoder JA, 2004, P NATL ACAD SCI USA, V101, P15706, DOI 10.1073/pnas.0405242101; Yoder JA, 2009, DEV COMP IMMUNOL, V33, P135, DOI 10.1016/j.dci.2008.09.004	73	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15986	10.1371/journal.pone.0015986	http://dx.doi.org/10.1371/journal.pone.0015986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305002	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300031
J	Mangin, L; Leseche, G; Duprey, A; Clerici, C				Mangin, Laurence; Leseche, Guy; Duprey, Alain; Clerici, Christine			Ventilatory Chaos Is Impaired in Carotid Atherosclerosis	PLOS ONE			English	Article							LIPID-RICH; VARIABILITY; FREQUENCY; DYNAMICS; NUCLEUS; NEURONS; PLAQUES	Ventilatory chaos is strongly linked to the activity of central pattern generators, alone or influenced by respiratory or cardiovascular afferents. We hypothesized that carotid atherosclerosis should alter ventilatory chaos through baroreflex and autonomic nervous system dysfunctions. Chaotic dynamics of inspiratory flow was prospectively evaluated in 75 subjects undergoing carotid ultrasonography: 27 with severe carotid stenosis (>70%), 23 with moderate stenosis (<70%), and 25 controls. Chaos was characterized by the noise titration method, the correlation dimension and the largest Lyapunov exponent. Baroreflex sensitivity was estimated in the frequency domain. In the control group, 92% of the time series exhibit nonlinear deterministic chaos with positive noise limit, whereas only 68% had a positive noise limit value in the stenoses groups. Ventilatory chaos was impaired in the groups with carotid stenoses, with significant parallel decrease in the noise limit value, correlation dimension and largest Lyapunov exponent, as compared to controls. In multiple regression models, the percentage of carotid stenosis was the best in predicting the correlation dimension (p<0.001, adjusted R-2 : 0.35) and largest Lyapunov exponent (p<0.001, adjusted R-2 : 0.6). Baroreflex sensitivity also predicted the correlation dimension values (p = 0.05), and the LLE (p = 0.08). Plaque removal after carotid surgery reversed the loss of ventilatory complexity. To conclude, ventilatory chaos is impaired in carotid atherosclerosis. These findings depend on the severity of the stenosis, its localization, plaque surface and morphology features, and is independently associated with baroreflex sensitivity reduction. These findings should help to understand the determinants of ventilatory complexity and breathing control in pathological conditions.	[Mangin, Laurence; Clerici, Christine] Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75877 Paris 18, France; [Mangin, Laurence; Leseche, Guy; Clerici, Christine] Univ Paris 07, Paris, France; [Mangin, Laurence] CNRS, UMR 7057, Lab Matieres & Syst Complexes MSC, Paris, France; [Leseche, Guy; Duprey, Alain] Hop Bichat Claude Bernard, AP HP, Serv Chirurg Thorac Vasc & Transplantat Pulm, F-75877 Paris 18, France; [Clerici, Christine] INSERM, U773, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mangin, L (corresponding author), Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75877 Paris 18, France.	laurence.mangin@bch.aphp.fr		Breakspear, Michael/0000-0003-4943-3969	ANTADIR/SPLF	ANTADIR/SPLF	This work was supported by a grant from the ANTADIR/SPLF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELLJAMES JE, 1989, CARDIOVASC RES, V23, P541, DOI 10.1093/cvr/23.6.541; ANGELLJAMES JE, 1974, CIRC RES, V34, P27, DOI 10.1161/01.RES.34.1.27; Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; BENCHETRIT G, 1975, RESP PHYSIOL, V23, P147, DOI 10.1016/0034-5687(75)90056-0; Brack T, 2002, AM J RESP CRIT CARE, V165, P1260, DOI 10.1164/rccm.2201018; BRUNNER MJ, 1982, CIRC RES, V51, P624, DOI 10.1161/01.RES.51.5.624; Del Negro CA, 2002, BIOPHYS J, V82, P206, DOI 10.1016/S0006-3495(02)75387-3; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Gianaros PJ, 2002, AM J HYPERTENS, V15, P486, DOI 10.1016/S0895-7061(02)02923-0; Good DC, 1996, STROKE, V27, P252, DOI 10.1161/01.STR.27.2.252; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Gronholdt MLM, 1999, ARTERIOSCL THROM VAS, V19, P2, DOI 10.1161/01.ATV.19.1.2; Gronholdt MLM, 2002, J VASC SURG, V35, P137, DOI 10.1067/mva.2002.119042; GRUNSTEIN MM, 1975, J APPL PHYSIOL, V39, P395, DOI 10.1152/jappl.1975.39.3.395; HEATH D, 1973, J PATHOL, V110, P49, DOI 10.1002/path.1711100106; Kantz H., 2004, NONLINEAR TIME SERIE; Li Z, 1996, CIRC RES, V79, P802, DOI 10.1161/01.RES.79.4.802; LIEBERT W, 1991, EUROPHYS LETT, V14, P521, DOI 10.1209/0295-5075/14/6/004; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mangin L, 2008, RESP PHYSIOL NEUROBI, V161, P189, DOI 10.1016/j.resp.2008.02.006; Mangin L, 2009, AM J PHYSIOL-REG I, V296, pR1088, DOI 10.1152/ajpregu.90862.2008; Mathiesen EB, 2001, CEREBROVASC DIS, V12, P44, DOI 10.1159/000047680; McMullan S, 2009, RESP PHYSIOL NEUROBI, V166, P80, DOI 10.1016/j.resp.2009.02.006; Nasr N, 2005, STROKE, V36, P1891, DOI 10.1161/01.STR.0000177890.30065.cb; PANNETON WM, 1980, BRAIN RES, V191, P239, DOI 10.1016/0006-8993(80)90326-1; PEREZ W, 1985, J APPL PHYSIOL, V59, P1515, DOI 10.1152/jappl.1985.59.5.1515; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; REILLY LM, 1983, AM J SURG, V146, P188, DOI 10.1016/0002-9610(83)90370-7; RICHTER DW, 1975, BRAIN RES, V86, P168, DOI 10.1016/0006-8993(75)90651-4; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; SAMMON M, 1993, J APPL PHYSIOL, V75, P887, DOI 10.1152/jappl.1993.75.2.887; SAMMON MP, 1991, J APPL PHYSIOL, V70, P1748, DOI 10.1152/jappl.1991.70.4.1748; SEAGARD JL, 1995, NEUROSCI LETT, V191, P13, DOI 10.1016/0304-3940(95)11545-1; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; TOBIN MJ, 1988, J APPL PHYSIOL, V65, P309, DOI 10.1152/jappl.1988.65.1.309; Zureik M, 2001, AM J RESP CRIT CARE, V164, P2181, DOI 10.1164/ajrccm.164.12.2107137; Zureik M, 2001, ARCH INTERN MED, V161, P1669, DOI 10.1001/archinte.161.13.1669	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16297	10.1371/journal.pone.0016297	http://dx.doi.org/10.1371/journal.pone.0016297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297985	gold, Green Submitted, Green Published			2022-12-27	WOS:000286664100020
J	Kuespert, K; Roth, A; Hauck, CR				Kuespert, Katharina; Roth, Alexandra; Hauck, Christof R.			Neisseria meningitidis Has Two Independent Modes of Recognizing Its Human Receptor CEACAM1	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CARCINOEMBRYONIC ANTIGEN FAMILY; NONTYPABLE HAEMOPHILUS-INFLUENZAE; IMMUNOGENIC AUTOTRANSPORTER PROTEIN; GONOCOCCAL OPACITY PROTEINS; EPITHELIAL-CELLS; ESCHERICHIA-COLI; OPA PROTEINS; PATHOGENIC NEISSERIAE; N-DOMAIN	Background: Several human-restricted Gram-negative bacteria exploit carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) for host colonization. For example, Neisseria meningitidis engages these human receptors via outer membrane proteins of the colony opacity-associated (Opa) protein family triggering internalization into non-phagocytic cells. Principal Findings: We report that a non-opaque strain of N. meningitidis selectively interacts with CEACAM1, but not other CEACAM family members. Using functional assays of bacterial adhesion and internalisation, microscopic analysis, and a panel of CEACAM1 deletion mutants we demonstrate that the engagement of CEACAM1 by non-opaque meningococci occurs in a manner distinct from Opa protein-mediated association. In particular, the amino-terminal domain of CEACAM1 is necessary, but not sufficient for Opa protein-independent binding, which requires multiple extracellular domains of the human receptor in a cellular context. Knock-down of CEACAM1 interferes with binding to lung epithelial cells, whereas chemical or pharmacological disruption of host protein glycosylation does not abrogate CEACAM1 recognition by nonopaque meningococci. The previously characterized meningococcal invasins NadA or Opc do not operate in a CEACAM1dependent manner. Conclusions: The results demonstrate a mechanistically distinct, Opa protein-independent interaction between N. meningitidis and human CEACAM1. Our functional investigations suggest the presence of a second CEACAM1-binding invasin on the meningococcal surface that associates with the protein backbone and not the carbohydrate structures of CEACAM1. The redundancy in meningococcal CEACAM1-binding factors further highlights the important role of CEACAM recognition in the biology of this human-adapted pathogen.	[Kuespert, Katharina; Roth, Alexandra; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany	University of Konstanz	Kuespert, K (corresponding author), Hain Lifesci GmbH, Nehren, Germany.	christof.hauck@uni-konstanz.de			Deutsche Forschungsgemeinschaft (DFG) [Ha2568/3-3]; GRK [1331]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); GRK(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) Ha2568/3-3 to CRH. AR was supported by a fellowship of the GRK 1331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella MA, 2010, MANDELL DOUGLAS BENN, V7, P2737; Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Bos MP, 1999, J EXP MED, V190, P331, DOI 10.1084/jem.190.3.331; Bos MP, 2002, INFECT IMMUN, V70, P1715, DOI 10.1128/IAI.70.4.1715-1723.2002; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hadi HA, 2001, MOL MICROBIOL, V41, P611, DOI 10.1046/j.1365-2958.2001.02516.x; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Korotkova N, 2006, J BIOL CHEM, V281, P29120, DOI 10.1074/jbc.M605681200; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; LEUSCH HG, 1991, INFECT IMMUN, V59, P2051, DOI 10.1128/IAI.59.6.2051-2057.1991; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; Marrazzo J, 2010, PRINCIPLES PRACTICE, P2753; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; MEYER TF, 1990, ANNU REV MICROBIOL, V44, P451; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; OLYHOEK AJM, 1991, MICROB PATHOGENESIS, V11, P249, DOI 10.1016/0882-4010(91)90029-A; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; SAUTER SL, 1993, J BIOL CHEM, V268, P15510; Schmitt C, 2007, J BACTERIOL, V189, P7968, DOI 10.1128/JB.00851-07; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; Serruto D, 2003, MOL MICROBIOL, V48, P323, DOI 10.1046/j.1365-2958.2003.03420.x; Singer BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008747; Slanina H, 2010, INFECT IMMUN, V78, P1905, DOI 10.1128/IAI.01267-09; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Webb DC, 1998, J MED MICROBIOL, V47, P1059, DOI 10.1099/00222615-47-12-1059; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	70	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14609	10.1371/journal.pone.0014609	http://dx.doi.org/10.1371/journal.pone.0014609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298042	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900012
J	Ma, N; Liu, Y; Fu, XM; Li, N; Wang, CX; Zhang, H; Qian, RB; Xu, HS; Hu, XP; Zhang, DR				Ma, Ning; Liu, Ying; Fu, Xian-Ming; Li, Nan; Wang, Chang-Xin; Zhang, Hao; Qian, Ruo-Bing; Xu, Hu-Sheng; Hu, Xiaoping; Zhang, Da-Ren			Abnormal Brain Default-Mode Network Functional Connectivity in Drug Addicts	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DETOXIFIED ALCOHOLIC PATIENTS; STRUCTURAL CONNECTIVITY; RECEPTOR AVAILABILITY; COCAINE ADDICTION; FLUCTUATIONS; DYSFUNCTION; ATTENTION; MEMORY; DISORDERS	Background: The default mode network (DMN) is a set of brain regions that exhibit synchronized low frequency oscillations at resting-state, and is believed to be relevant to attention and self-monitoring. As the anterior cingulate cortex and hippocampus are impaired in drug addiction and meanwhile are parts of the DMN, the present study examined addiction-related alteration of functional connectivity of the DMN. Methodology: Resting-state functional magnetic resonance imaging data of chronic heroin users (14 males, age: 30.1+/-5.3 years, range from 22 to 39 years) and non-addicted controls (13 males, age: 29.8+/-7.2 years, range from 20 to 39 years) were investigated with independent component analysis to address their functional connectivity of the DMN. Principal Findings: Compared with controls, heroin users showed increased functional connectivity in right hippocampus and decreased functional connectivity in right dorsal anterior cingulate cortex and left caudate in the DMN. Conclusions: These findings suggest drug addicts' abnormal functional organization of the DMN, and are discussed as addiction-related abnormally increased memory processing but diminished cognitive control related to attention and self-monitoring, which may underlie the hypersensitivity toward drug related cues but weakened strength of cognitive control in the state of addiction.	[Ma, Ning; Li, Nan; Xu, Hu-Sheng; Zhang, Da-Ren] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China; [Ma, Ning; Li, Nan; Xu, Hu-Sheng; Zhang, Da-Ren] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Liu, Ying; Wang, Chang-Xin] Anhui Med Univ, Dept MRI, Prov Hosp, Hefei, Peoples R China; [Fu, Xian-Ming; Qian, Ruo-Bing] Anhui Med Univ, Dept Neurosurg, Prov Hosp, Hefei, Peoples R China; [Fu, Xian-Ming; Qian, Ruo-Bing] Anhui Prov Inst Stereotact Neurosurg, Hefei, Peoples R China; [Zhang, Hao] Anhui Detoxificat & Rehabil Ctr, Hefei, Peoples R China; [Hu, Xiaoping] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Hu, Xiaoping] Emory Univ, Atlanta, GA 30322 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University; University System of Georgia; Georgia Institute of Technology; Emory University	Ma, N (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China.	man@ustc.edu.cn		Hu, Xiaoping/0000-0001-7014-5983; Qian, Ruobing/0000-0002-9559-1952	National Nature Science Foundation of China [31000458, 30770713, 30870764, 30973084]; Ministry of Science and Technology of China [2006CB500705]; Academic Exchange Fund of International Medical MR [N7014]; US National Institutes of Health [RO1EB002009, RO1DA17795]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017795] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Academic Exchange Fund of International Medical MR; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is supported by the National Nature Science Foundation of China (31000458, 30770713, 30870764, and 30973084), Ministry of Science and Technology of China (2006CB500705), Academic Exchange Fund of International Medical MR, (N7014), and the US National Institutes of Health (RO1EB002009 and RO1DA17795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Heinz A, 2005, AM J PSYCHIAT, V162, P1515, DOI 10.1176/appi.ajp.162.8.1515; Heinz A, 2005, ARCH GEN PSYCHIAT, V62, P57, DOI 10.1001/archpsyc.62.1.57; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Heinz A, 2003, PHARMACOPSYCHIATRY, V36, pS149; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Lundqvist T, 2005, PHARMACOL BIOCHEM BE, V81, P319, DOI 10.1016/j.pbb.2005.02.017; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Talairach J, 1992, Adv Neurol, V57, P651; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zhao XH, 2007, EUR J RADIOL, V63, P373, DOI 10.1016/j.ejrad.2007.02.006; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	44	107	113	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16560	10.1371/journal.pone.0016560	http://dx.doi.org/10.1371/journal.pone.0016560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298074	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800055
J	Levesque, S; Michaud, S; Arbeit, RD; Frost, EH				Levesque, Simon; Michaud, Sophie; Arbeit, Robert D.; Frost, Eric H.			High-Resolution Melting System to Perform Multilocus Sequence Typing of Campylobacter jejuni	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; CLONAL COMPLEXES; GENE; ELECTROPHORESIS; IDENTIFICATION; DIVERSITY; STRAINS; QUEBEC; CANADA; COLI	Multi-locus sequence typing (MLST) has emerged as the state-of-the-art method for resolving bacterial population genetics but it is expensive and time consuming. We evaluated the potential of high resolution melting (HRM) to identify known MLST alleles of Campylobacter jejuni at reduced cost and time. Each MLST locus was amplified in two or three sub fragments, which were analyzed by HRM. The approach was investigated using 47 C. jejuni isolates, previously characterized by classical MLST, representing isolates from diverse environmental, animal and clinical sources and including the six most prevalent sequence types (ST) and the most frequent alleles. HRM was then applied to a validation set of 84 additional C. jejuni isolates from chickens; 92% of the alleles were resolved in 35 hours of laboratory time and the cost of reagents per isolate was $20 compared with $100 for sequence-based typing. HRM has the potential to complement sequence-based methods for resolving SNPs and to facilitate a wide range of genotyping studies.	[Levesque, Simon; Michaud, Sophie; Frost, Eric H.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada; [Arbeit, Robert D.] Tufts Univ, Sch Med, Infect Dis Sect, Boston, MA 02111 USA	University of Sherbrooke; Tufts University	Levesque, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada.	Eric.Frost@USherbrooke.ca		Frost, Eric/0000-0001-8958-4388; Levesque, Simon/0000-0002-4356-9702	Canadian Institutes of Health Research [313026-2005]; Natural Sciences and Engineering Research Council of Canada; Centre de Recherche Clinique Etienne Le-Bel of the Centre Hospitalier Universitaire de Sherbrooke	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Centre de Recherche Clinique Etienne Le-Bel of the Centre Hospitalier Universitaire de Sherbrooke	Financial support (grant number 313026-2005) was received jointly from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). Funding was also obtained from the Centre de Recherche Clinique Etienne Le-Bel of the Centre Hospitalier Universitaire de Sherbrooke (http://www.crc.chus.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, decision to publish or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Best EL, 2005, J MED MICROBIOL, V54, P919, DOI 10.1099/jmm.0.45971-0; Best EL, 2004, J CLIN MICROBIOL, V42, P2836, DOI 10.1128/JCM.42.6.2836-2839.2004; Clark CG, 2005, J CLIN MICROBIOL, V43, P2080, DOI 10.1128/JCM.43.5.2080-2091.2005; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Djordjevic SP, 2007, J CLIN MICROBIOL, V45, P102, DOI 10.1128/JCM.01012-06; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; Merchant-Patel S, 2010, APPL ENVIRON MICROB, V76, P493, DOI 10.1128/AEM.01164-09; Michaud S, 2004, EMERG INFECT DIS, V10, P1844, DOI 10.3201/eid1010.040228; Millat G, 2009, CLIN BIOCHEM, V42, P892, DOI 10.1016/j.clinbiochem.2009.01.016; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; *ROCH DIAGN GMBH, 2008, 1 ROCH DIAGN GMBH; Sails AD, 2003, J CLIN MICROBIOL, V41, P4733, DOI 10.1128/JCM.41.10.4733-4739.2003; Sails AD, 2003, J CLIN MICROBIOL, V41, P4058, DOI 10.1128/JCM.41.9.4058-4067.2003; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433	24	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16167	10.1371/journal.pone.0016167	http://dx.doi.org/10.1371/journal.pone.0016167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21297862	Green Published, gold, Green Submitted			2022-12-27	WOS:000286523400025
J	Singh, V; Jain, S; Gowthaman, U; Parihar, P; Gupta, P; Gupta, UD; Agrewala, JN				Singh, Vijender; Jain, Shweta; Gowthaman, Uthaman; Parihar, Pankaj; Gupta, Pushpa; Gupta, Umesh D.; Agrewala, Javed N.			Co-Administration of IL-1+IL-6+TNF-alpha with Mycobacterium tuberculosis Infected Macrophages Vaccine Induces Better Protective T Cell Memory than BCG	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VIVO; ANTIGEN; CYTOKINES; DIFFERENTIATION; SUBSETS; CHALLENGE; EXPANSION; APOPTOSIS; RESPONSES	BCG has been administered globally for more than 75 years, yet tuberculosis (TB) continues to kill more than 2 million people annually. Further, BCG protects childhood TB but is quite inefficient in adults. This indicates that BCG fails to induce long-term protection. Hence there is a need to explore alternative vaccination strategies that can stimulate enduring T cell memory response. Dendritic cell based vaccination has attained extensive popularity following their success in various malignancies. In our previous study, we have established a novel and unique vaccination strategy against Mycobacterium tuberculosis (M. tb) and Salmonella typhimurium by utilizing infected macrophages (IM). In short-term experiments (30 days), substantial degree of protection was observed. However, remarkable difference was not observed in long-term studies (240 days) due to failure of the vaccine to generate long-lasting memory T cells. Hence, in the present study we employed T cell memory augmenting cytokines IL-1+IL-6+TNF-alpha and IL-7+IL-15 for the induction of the enhancement of long-term protection by the vaccine. We co-administered the M. tb infected macrophages vaccine with IL-1+IL-6+TNF-alpha (IM-1.6.alpha) and IL-7+IL-15 (IM-7.15). The mice were then rested for a reasonably large period (240 days) to study the bona fide T cell memory response before exposing them to aerosolized M. tb. IM-1.6.alpha but not IM-7.15 significantly improved memory T cell response against M. tb, as evidenced by recall responses of memory T cells, expansion of both central as well as effector memory CD4 and CD8 T cell pools, elicitation of mainly Th1 memory response, reduction in the mycobacterial load and alleviated lung pathology. Importantly, the protection induced by IM-1.6.alpha was significantly better than BCG. Thus, this study demonstrates that not only antigen-pulsed DCs can be successfully employed as vaccines against cancer and infectious diseases but also macrophages infected with M. tb can be utilized with great efficacy especially in protection against TB.	[Singh, Vijender; Jain, Shweta; Gowthaman, Uthaman; Parihar, Pankaj; Agrewala, Javed N.] Inst Microbial Technol, Immunol Lab, Chandigarh, India; [Gupta, Pushpa; Gupta, Umesh D.] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra	Singh, V (corresponding author), Inst Microbial Technol, Immunol Lab, Chandigarh, India.	javed@imtech.res.in	Agrewala, Javed Naim/AAS-8449-2021		Indian Council of Medical Research [5/8/5/6/2005-ECD-I]; Department of Biotechnology, New Delhi, India [BT/PR6219/Med/14/762/2005]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This study is supported by the Indian Council of Medical Research (Grant Reference No. 5/8/5/6/2005-ECD-I) and Department of Biotechnology (Grant Reference No. BT/PR6219/Med/14/762/2005), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrewala JN, 2007, J BIOL CHEM, V282, P6106, DOI 10.1074/jbc.M608266200; Agrewala JN, 2003, CLIN EXP IMMUNOL, V134, P13, DOI 10.1046/j.1365-2249.2003.02254.x; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Fine PEM, 2001, SCAND J INFECT DIS, V33, P243, DOI 10.1080/003655401300077144; Haynes L, 2004, J IMMUNOL, V172, P5194, DOI 10.4049/jimmunol.172.9.5194; Hernandez-Flores G, 2005, ANTICANCER RES, V25, P4091; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Kaufmann SHE, 2006, INT J TUBERC LUNG D, V10, P1068; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Moll H, 2003, IMMUNOL LETT, V85, P153, DOI 10.1016/S0165-2478(02)00222-5; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; Orme IM, 2005, VACCINE, V23, P2105, DOI 10.1016/j.vaccine.2005.01.062; Orme IM, 2001, TRENDS MICROBIOL, V9, P115, DOI 10.1016/S0966-842X(00)01949-1; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Pape KA, 1997, J IMMUNOL, V159, P591; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sharma N, 2004, J INFECT DIS, V190, P107, DOI 10.1086/421116; Singh V, 2010, J INFECT DIS, V202, P480, DOI 10.1086/653827; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; *WHO, 1998, GLOB TUB CONTR; *WHO, 1992, EXP PROGR IMM PROGR; *WHO, 2009, 104 WHO; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367	36	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16097	10.1371/journal.pone.0016097	http://dx.doi.org/10.1371/journal.pone.0016097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283805	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600022
J	Grantham, HS; Game, ET; Lombard, AT; Hobday, AJ; Richardson, AJ; Beckley, LE; Pressey, RL; Huggett, JA; Coetzee, JC; van der Lingen, CD; Petersen, SL; Merkle, D; Possingham, HP				Grantham, Hedley S.; Game, Edward T.; Lombard, Amanda T.; Hobday, Alistair J.; Richardson, Anthony J.; Beckley, Lynnath E.; Pressey, Robert L.; Huggett, Jenny A.; Coetzee, Janet C.; van der Lingen, Carl D.; Petersen, Samantha L.; Merkle, Dagmar; Possingham, Hugh P.			Accommodating Dynamic Oceanographic Processes and Pelagic Biodiversity in Marine Conservation Planning	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; SEA-SURFACE TEMPERATURE; GANNETS MORUS-CAPENSIS; FOOD AVAILABILITY; SOUTH-AFRICA; POSSIBLE MECHANISMS; ECOSYSTEM APPROACH; TROPHIC CASCADES; PROTECTED AREAS; REGIME SHIFTS	Pelagic ecosystems support a significant and vital component of the ocean's productivity and biodiversity. They are also heavily exploited and, as a result, are the focus of numerous spatial planning initiatives. Over the past decade, there has been increasing enthusiasm for protected areas as a tool for pelagic conservation, however, few have been implemented. Here we demonstrate an approach to plan protected areas that address the physical and biological dynamics typical of the pelagic realm. Specifically, we provide an example of an approach to planning protected areas that integrates pelagic and benthic conservation in the southern Benguela and Agulhas Bank ecosystems off South Africa. Our aim was to represent species of importance to fisheries and species of conservation concern within protected areas. In addition to representation, we ensured that protected areas were designed to consider pelagic dynamics, characterized from time-series data on key oceanographic processes, together with data on the abundance of small pelagic fishes. We found that, to have the highest likelihood of reaching conservation targets, protected area selection should be based on time-specific data rather than data averaged across time. More generally, we argue that innovative methods are needed to conserve ephemeral and dynamic pelagic biodiversity.	[Grantham, Hedley S.; Richardson, Anthony J.; Pressey, Robert L.; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia; [Lombard, Amanda T.] Nelson Mandela Metropolitan Univ, Dept Bot, George, South Africa; [Hobday, Alistair J.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Richardson, Anthony J.] CSIRO Marine & Atmospher Res, Cleveland, Qld, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math CARM, Sch Math & Phys, St Lucia, Qld, Australia; [Beckley, Lynnath E.] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia; [Huggett, Jenny A.; Coetzee, Janet C.; van der Lingen, Carl D.; Merkle, Dagmar] Dept Environm Affairs & Tourism, Cape Town, South Africa; [Huggett, Jenny A.; van der Lingen, Carl D.] Univ Cape Town, Marine Res Inst, ZA-7700 Rondebosch, South Africa; [Petersen, Samantha L.] WWF S Africa, WWF Responsible Fisheries Programme, Cape Town, South Africa; [Grantham, Hedley S.; Richardson, Anthony J.; Pressey, Robert L.; Possingham, Hugh P.] Univ Queensland, Ctr Appl Environm Decis Anal, St Lucia, Qld, Australia	University of Queensland; Nelson Mandela University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Murdoch University; University of Cape Town; World Wildlife Fund; University of Queensland	Grantham, HS (corresponding author), Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia.	h.grantham@uq.edu.au	Pressey, Bob/C-8370-2013; Possingham, Hugh/B-1337-2008; Richardson, Anthony J/B-3649-2010; Game, Edward/AAD-2289-2020; Lombard, Mandy/AAE-4649-2019; POSSINGHAM, HUGH/R-8310-2019; Hobday, Alistair/A-1460-2012	Pressey, Bob/0000-0003-2740-0330; Possingham, Hugh/0000-0001-7755-996X; Richardson, Anthony J/0000-0002-9289-7366; Game, Edward/0000-0003-4707-9281; Lombard, Mandy/0000-0002-4323-1170; POSSINGHAM, HUGH/0000-0001-7755-996X; Hobday, Alistair/0000-0002-3194-8326; Huggett, Jenny/0000-0001-9315-8672; Coetzee, Janet/0000-0002-2382-7815	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative; African Coelacanth Ecosystem Programme; National Research Foundation of South African; Australian Research Council	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative(Australian Government); African Coelacanth Ecosystem Programme; National Research Foundation of South African; Australian Research Council(Australian Research Council)	This work was supported by the Applied Environmental Decision Analysis research hub funded by the Commonwealth Environment Research Facilities (CERF) program, an Australian Government initiative, African Coelacanth Ecosystem Programme, National Research Foundation of South African, Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbag JJ, 2003, PROG OCEANOGR, V59, P275, DOI 10.1016/j.pocean.2003.07.004; Airame S, 2003, ECOL APPL, V13, pS170; Alpine JE, 2007, MAR FRESHWATER RES, V58, P558, DOI 10.1071/MF06214; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Ardron J, 2008, MAR POLICY, V32, P832, DOI 10.1016/j.marpol.2008.03.018; Bakun A., 1996, OCEAN PROCESSES MARI; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Barange M, 1999, S AFR J MARINE SCI, V21, P367; Beckley LE, 1999, MAR FRESHWATER RES, V50, P955, DOI 10.1071/MF99068; BECKLEY LE, 1994, S AFR J MARINE SCI, V14, P205; BECKLEY LE, 1986, S AFR J ZOOL, V21, P244; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Campbell RA, 2003, SWORDFISH ENV SEAMOU; Camphuysen KCJ, 2007, J ORNITHOL, V148, P333, DOI 10.1007/s10336-007-0135-3; Coetzee J, 2010, BIOL LETT; Coetzee JC, 2008, AFR J MAR SCI, V30, P205, DOI 10.2989/AJMS.2008.30.2.1.551; Coetzee JC, 2008, ICES J MAR SCI, V65, P1676, DOI 10.1093/icesjms/fsn184; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; CRAWFORD RJM, 1987, OCEANOGR MAR BIOL, V25, P353; Crawford RJM, 2007, FINAL REPORT BCLME P; Crawford RJM, 2007, J ORNITHOL, V148, pS253, DOI 10.1007/s10336-007-0228-z; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Cury PM, 2005, ICES J MAR SCI, V62, P430, DOI 10.1016/j.icesjms.2004.12.006; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Dingle RV, 1987, ANN S AFRICAN MUSEUM, P98; Dreyfus-Leon M, 2001, ECOL MODEL, V146, P47, DOI 10.1016/S0304-3800(01)00295-2; Driver A., 2005, NATL SPATIAL BIODIVE; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Etnoyer Peter, 2004, Oceanography, V17, P90; Field JC, 2006, FISH FISH, V7, P284, DOI 10.1111/j.1467-2979.2006.00226.x; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Game ET, 2010, TRENDS ECOL EVOL, V25, P63, DOI 10.1016/j.tree.2009.09.002; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Game ET, 2008, MARXAN USER MANUAL M; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Grantham Hedley S., 2008, Endangered Species Research, V5, P291, DOI 10.3354/esr00159; Gremillet D., 2008, P ROY SOC LOND B BIO, V18, P1; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Griffiths CL, 1997, T ROY SOC S AFR, V52, P121, DOI 10.1080/00359199709520619; Hall SJ, 2004, FISH FISH, V5, P1, DOI 10.1111/j.1467-2960.2004.00133.x; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hobday AJ, 2006, FISHERIES MANAG ECOL, V13, P365, DOI 10.1111/j.1365-2400.2006.00515.x; Hobday AJ, INFLUENCE TOPOGRAPHY; Howell Evan A., 2008, Endangered Species Research, V5, P267, DOI 10.3354/esr00096; Huggett J, 2009, PROG OCEANOGR, V83, P197, DOI 10.1016/j.pocean.2009.07.048; Hunt BPV, 2003, J PLANKTON RES, V25, P885, DOI 10.1093/plankt/25.8.885; Hutchings L, 2002, MAR FRESHWATER RES, V53, P307, DOI 10.1071/MF01147; Hutchings L, 2006, BENGUELA PREDICTING; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jonker FC, 1998, ANTARCT SCI, V10, P21, DOI 10.1017/S0954102098000042; Kemper J, 2007, FINAL REPORT BCLME P; Keough HL, 2006, CONSERV BIOL, V20, P1373, DOI 10.1111/j.1523-1739.2006.00445.x; Klages NTW, 1998, MAR BIOL, V131, P559, DOI 10.1007/s002270050348; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Leslie HM, 2005, CONSERV BIOL, V19, P1701, DOI 10.1111/j.1523-1739.2005.00268.x; Lett C, 2006, FISH OCEANOGR, V15, P363, DOI 10.1111/j.1365-2419.2005.00392.x; Lombard AT, 2007, ANTARCT SCI, V19, P39, DOI 10.1017/S0954102007000077; Lombard AT, 2005, NATL SPATIAL BIODIVE, VVol 4; Lundquist CJ, 2005, CONSERV BIOL, V19, P1771, DOI 10.1111/j.1523-1739.2005.00279.x; Martell SJD, 2005, CAN J FISH AQUAT SCI, V62, P1320, DOI 10.1139/F05-114; Moilanen A., 2009, SPATIAL CONSERVATION; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Nielsen KN, 2007, MAR POLICY, V31, P669, DOI 10.1016/j.marpol.2007.03.014; Omardien A., 2007, WWF REPORT SERIES; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Pakhomov EA, 2000, POLAR BIOL, V23, P410, DOI 10.1007/s003000050462; Paterson HL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004707; Pecquerie L, 2004, AFR J MAR SCI, V26, P115, DOI 10.2989/18142320409504053; Penven P, 2001, S AFR J SCI, V97, P472; Petersen S., 2008, WWF S AFRICA REPORT; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher GC, 1996, J PLANKTON RES, V18, P643, DOI 10.1093/plankt/18.5.643; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Richardson AJ, 2003, MAR ECOL PROG SER, V254, P239, DOI 10.3354/meps254239; Richardson AJ, 1998, S AFR J MARINE SCI, V19, P275; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Roughan M, 2002, CONTINENTAL SHELF RE, P22; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shannon LJ, 2006, AFR J MAR SCI, V28, P115, DOI 10.2989/18142320609504139; Sink E, 2007, DRAFT GUIDELINES EST; Thibault-Botha D, 2004, J PLANKTON RES, V26, P1115, DOI 10.1093/plankt/fbh104; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; van der Lingen CD, 2006, LAR MAR ECOSYST, V14, P309; van der Lingen D, 2006, LAR MAR ECOSYST, V14, P147; Verity PG, 2002, ENVIRON CONSERV, V29, P207, DOI 10.1017/S0376892902000139; Walmsley SA, 2007, ICES J MAR SCI, V64, P405, DOI 10.1093/icesjms/fsl022; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2	98	56	56	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16552	10.1371/journal.pone.0016552	http://dx.doi.org/10.1371/journal.pone.0016552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311757	gold, Green Published, Green Accepted			2022-12-27	WOS:000287036200020
J	Robert, EMR; Schmitz, N; Boeren, I; Driessens, T; Herremans, K; De Mey, J; Van de Casteele, E; Beeckman, H; Koedam, N				Robert, Elisabeth M. R.; Schmitz, Nele; Boeren, Ilse; Driessens, Tess; Herremans, Kristof; De Mey, Johan; Van de Casteele, Elke; Beeckman, Hans; Koedam, Nico			Successive Cambia: A Developmental Oddity or an Adaptive Structure?	PLOS ONE			English	Article							SECONDARY GROWTH; FUNCTIONAL-SIGNIFICANCE; AVICENNIA-MARINA; STEM; PHLOEM; WOOD; TISSUES; VARIANT; XYLEM; DIFFERENTIATION	Background: Secondary growth by successive cambia is a rare phenomenon in woody plant species. Only few plant species, within different phylogenetic clades, have secondary growth by more than one vascular cambium. Often, these successive cambia are organised concentrically. In the mangrove genus Avicennia however, the successive cambia seem to have a more complex organisation. This study aimed (i) at understanding the development of successive cambia by giving a three-dimensional description of the hydraulic architecture of Avicennia and (ii) at unveiling the possible adaptive nature of growth by successive cambia through a study of the ecological distribution of plant species with concentric internal phloem. Results: Avicennia had a complex network of non-cylindrical wood patches, the complexity of which increased with more stressful ecological conditions. As internal phloem has been suggested to play a role in water storage and embolism repair, the spatial organisation of Avicennia wood could provide advantages in the ecologically stressful conditions species of this mangrove genus are growing in. Furthermore, we could observe that 84.9% of the woody shrub and tree species with concentric internal phloem occurred in either dry or saline environments strengthening the hypothesis that successive cambia provide the necessary advantages for survival in harsh environmental conditions. Conclusions: Successive cambia are an ecologically important characteristic, which seems strongly related with water-limited environments.	[Robert, Elisabeth M. R.; Schmitz, Nele; Driessens, Tess; Herremans, Kristof; Koedam, Nico] Vrije Univ Brussel VUB, Lab Plant Biol & Nat Management APNA, Brussels, Belgium; [Robert, Elisabeth M. R.; Schmitz, Nele; Boeren, Ilse; Beeckman, Hans] Royal Museum Cent Africa RMCA, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Boeren, Ilse] Univ Stuttgart Hohenheim, Inst Bot 210, D-70599 Stuttgart, Germany; [De Mey, Johan] Univ Ziekenhuis Brussel, Brussels, Belgium; [Van de Casteele, Elke] SkyScan NV, Kontich, Belgium; [Van de Casteele, Elke] Univ Antwerpen UA, Vis Lab, Antwerp, Belgium	Vrije Universiteit Brussel; Royal Museum for Central Africa; University Hohenheim; University Hospital Brussels; Vrije Universiteit Brussel; University of Antwerp	Robert, EMR (corresponding author), Vrije Univ Brussel VUB, Lab Plant Biol & Nat Management APNA, Brussels, Belgium.	erobert@vub.ac.be	Robert, Elisabeth/A-8524-2018; Beeckman, Hans/I-7653-2019; de Mey, Johan/AAL-9312-2021; Robert, Elisabeth/AAJ-4984-2021; de Mey, Johan/F-3602-2011	Robert, Elisabeth/0000-0002-3611-7265; Beeckman, Hans/0000-0001-8954-6277; Robert, Elisabeth/0000-0002-3611-7265; Van de Casteele, Elke/0000-0003-0395-3002; de Mey, Johan/0000-0002-3601-3212	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); National Fund for Scientific Research (FWO, Belgium); King Leopold III Fund for Nature Exploration and Conservation, Belgium; Royal Museum for Central Africa (RMCA), Tervuren	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); National Fund for Scientific Research (FWO, Belgium)(FWO); King Leopold III Fund for Nature Exploration and Conservation, Belgium; Royal Museum for Central Africa (RMCA), Tervuren	The study was financially supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen), the National Fund for Scientific Research (FWO, Belgium), the King Leopold III Fund for Nature Exploration and Conservation, Belgium, and the AFRODENDRO project of the Royal Museum for Central Africa (RMCA), Tervuren. The funders had no role in study design, content of the study, decision to publish or determination of the conclusions.	Araujo GUC, 2006, IAWA J, V27, P269, DOI 10.1163/22941932-90000154; BAKER RT, 1915, J P ROY SOC NS WALES, V49, P257; BHAMBIE S, 1985, P INDIAN AS-PLANT SC, V95, P295; BHAMBIE S, 1972, P INDIAN ACAD SCI B, V75, P246; Breckle S.W, 2002, WALTERS VEGETATION E; Carlquist S., 2001, COMP WOOD ANATOMY; Carlquist S, 2007, J TORREY BOT SOC, V134, P301, DOI 10.3159/1095-5674(2007)134[301:SCROHD]2.0.CO;2; Carlquist S, 2007, BOT J LINN SOC, V153, P141, DOI 10.1111/j.1095-8339.2007.00593.x; Chapman V. J., 1947, Proc. Linn. Soc. Lond. 1945-46, V158, P2; DENOUTER RW, 1995, IAWA J, V16, P151, DOI 10.1163/22941932-90001401; DOBBINS DR, 1986, BOT GAZ, V147, P278, DOI 10.1086/337595; Dunisch O, 2003, HOLZFORSCHUNG, V57, P196, DOI 10.1515/HF.2003.029; FAHN A, 1967, PHYTOMORPHOLOGY, V17, P147; FAHN A, 1982, BOT GAZ, V143, P353, DOI 10.1086/337309; FELDKAMP LA, 1997, J MICROSC-OXFORD, V185, P67; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; GILL AM, 1971, FOREST SCI, V17, P462; KITIN P, 2007, INT C PLANT VASC BIO; Kitin P, 2009, ANN BOT-LONDON, V103, P1145, DOI 10.1093/aob/mcp050; KRISHNAMURTHY K V, 1984, Indian Journal of Botany, V7, P183; Mauseth JD, 1997, AM J BOT, V84, P815, DOI 10.2307/2445817; MCDONALD JA, 1992, B TORREY BOT CLUB, V119, P262, DOI 10.2307/2996757; Murakami Y, 1999, ANN BOT-LONDON, V84, P429, DOI 10.1006/anbo.1999.0931; NAIR MNB, 1993, IAWA J, V14, P191, DOI 10.1163/22941932-90001317; NAIR MNB, 1990, IAWA BULL, V11, P379, DOI 10.1163/22941932-90000526; PHILIPSON WR, 1971, VASCULAR CAMBIUM DEV; Rajput KS, 2006, FLORA, V201, P65, DOI 10.1016/j.flora.2005.04.004; Rajput KS, 2000, IAWA J, V21, P417, DOI 10.1163/22941932-90000257; Robert EMR, 2009, FUNCT ECOL, V23, P649, DOI 10.1111/j.1365-2435.2009.01551.x; Salleo S, 2004, PLANT CELL ENVIRON, V27, P1065, DOI 10.1111/j.1365-3040.2004.01211.x; Salleo S, 2006, FUNCT PLANT BIOL, V33, P1063, DOI 10.1071/FP06149; Salleo S, 2009, FUNCT PLANT BIOL, V36, P815, DOI 10.1071/FP09103; Schmitz Nele, 2007, Dendrochronologia, V25, P87, DOI 10.1016/j.dendro.2006.08.001; Schmitz N, 2008, ANN BOT-LONDON, V101, P49, DOI 10.1093/aob/mcm280; Scholz FG, 2007, PLANT CELL ENVIRON, V30, P236, DOI 10.1111/j.1365-3040.2006.01623.x; STUDHOLME W. P., 1966, N Z J BOT, V4, P355; TERRAZAS T, 1991, AM J BOT, V78, P1335, DOI 10.2307/2445272; Tomlinson PB, 1994, BOT MANGROVES; WHEAT D, 1977, AM J BOT, V64, P1209, DOI 10.2307/2442483; ZAMSKI E, 1981, ISRAEL J BOT, V30, P57; ZAMSKI E, 1980, ANN BOT-LONDON, V45, P561, DOI 10.1093/oxfordjournals.aob.a085861; ZAMSKI E, 1979, BOT GAZ, V140, P67, DOI 10.1086/337058; Zwieniecki MA, 2009, TRENDS PLANT SCI, V14, P530, DOI 10.1016/j.tplants.2009.07.002	43	52	56	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16558	10.1371/journal.pone.0016558	http://dx.doi.org/10.1371/journal.pone.0016558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304983	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300086
J	Sariyer, IK; Khalili, K				Sariyer, Ilker Kudret; Khalili, Kamel			Regulation of Human Neurotropic JC Virus Replication by Alternative Splicing Factor SF2/ASF in Glial Cells	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SR PROTEINS; MESSENGER-RNA; NATALIZUMAB; IDENTIFICATION; AGNOPROTEIN; INHIBITION; GENERATION; INFECTION; ELEMENTS	Background: The human neurotropic virus, JC virus (JCV), is the etiologic agent of the fatal demyelinating disease of the central nervous system, Progressive Multifocal Leukoencephlopathy (PML) that is seen primarily in immunodeficient individuals. Productive infection of JCV occurs only in glial cells, and this restriction is, to a great extent, due to the activation of the viral promoter that has cell type-specific characteristics. Earlier studies led to the hypothesis that glial-specific activation of the JCV promoter is mediated through positive and negative transcription factors that control reactivation of the JCV genome under normal physiological conditions and suppress its activation in non-glial cells. Methodololgy/Principal Findings: Using a variety of virological and molecular biological approaches, we demonstrate that the alternative splicing factor SF2/ASF has the capacity to exert a negative effect on transcription of the JCV promoter in glial cells through direct association with a specific DNA sequence within the viral enhancer/promoter region. Our results show that down-regulation of SF2/ASF in fetal and adult glial cells increases the level of JCV gene expression and its replication indicating that negative regulation of the JCV promoter by SF2/ASF may control reactivation of JCV replication in brain. Conclusions/Significance: Our results establish a new regulatory role for SF2/ASF in controlling gene expression at the transcriptional level.	[Sariyer, Ilker Kudret] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sariyer, IK (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institutes of Health (NIH) [R01 NS350000, R01 MH086358]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086358] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) grant R01 NS350000 (Proteins mediating interaction of HIV-1 and JCV in glial cells) and NIH grant R01 MH086358 (BAG3 mediates interplay of HIV-1 and JCV in brain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; BERGER JR, 1995, J NEUROVIROL, V1, P5, DOI 10.3109/13550289509111006; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Eng PM, 2006, NEUROLOGY, V67, P884, DOI 10.1212/01.wnl.0000233918.21986.9c; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Imperiale M.J., 2007, FIELDS VIROLOGY, V2, P2263; Kinoshita Y, 2004, J BIOL CHEM, V279, P35879, DOI 10.1074/jbc.M401640200; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MILLER JR, 1982, NEW ENGL J MED, V307, P1436, DOI 10.1056/NEJM198212023072307; Radhakrishnan S, 2003, J VIROL, V77, P10638, DOI 10.1128/JVI.77.19.10638-10644.2003; Romagnoli L, 2008, VIROLOGY, V375, P331, DOI 10.1016/j.virol.2008.02.021; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Safak M., 2005, The neurology of AIDS, P461; Sandborn WJ, 2005, NEW ENGL J MED, V353, P375; SANFORD SR, 2005, PNAS, V102, P15042; Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Sariyer IK, 2009, J VIROL METHODS, V159, P122, DOI 10.1016/j.jviromet.2009.02.023; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; TROWBRIDGE PW, 1995, J NEUROVIROL, V1, P195, DOI 10.3109/13550289509113966; WANG J, 1995, RNA, V1, P335; Weber T, 2008, NEUROL CLIN, V26, P833, DOI 10.1016/j.ncl.2008.03.007; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618; White MK, 2009, J VIROL, V83, P10846, DOI 10.1128/JVI.00542-09; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	34	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14630	10.1371/journal.pone.0014630	http://dx.doi.org/10.1371/journal.pone.0014630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297941	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300012
J	Sheppard, JP; Wang, JP; Wong, PCM				Sheppard, John P.; Wang, Ji-Ping; Wong, Patrick C. M.			Large-Scale Cortical Functional Organization and Speech Perception across the Lifespan	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; SMALL-WORLD; PREFRONTAL CORTEX; BRAIN NETWORKS; INDIVIDUAL-DIFFERENCES; LOW-FREQUENCY; DEFAULT MODE; CONNECTIVITY	Aging is accompanied by substantial changes in brain function, including functional reorganization of large-scale brain networks. Such differences in network architecture have been reported both at rest and during cognitive task performance, but an open question is whether these age-related differences show task-dependent effects or represent only task-independent changes attributable to a common factor (i.e., underlying physiological decline). To address this question, we used graph theoretic analysis to construct weighted cortical functional networks from hemodynamic (functional MRI) responses in 12 younger and 12 older adults during a speech perception task performed in both quiet and noisy listening conditions. Functional networks were constructed for each subject and listening condition based on inter-regional correlations of the fMRI signal among 66 cortical regions, and network measures of global and local efficiency were computed. Across listening conditions, older adult networks showed significantly decreased global (but not local) efficiency relative to younger adults after normalizing measures to surrogate random networks. Although listening condition produced no main effects on whole-cortex network organization, a significant age group x listening condition interaction was observed. Additionally, an exploratory analysis of regional effects uncovered age-related declines in both global and local efficiency concentrated exclusively in auditory areas (bilateral superior and middle temporal cortex), further suggestive of specificity to the speech perception tasks. Global efficiency also correlated positively with mean cortical thickness across all subjects, establishing gross cortical atrophy as a task-independent contributor to age-related differences in functional organization. Together, our findings provide evidence of age-related disruptions in cortical functional network organization during speech perception tasks, and suggest that although task-independent effects such as cortical atrophy clearly underlie age-related changes in cortical functional organization, age-related differences also demonstrate sensitivity to task domains.	[Sheppard, John P.; Wong, Patrick C. M.] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL USA; [Sheppard, John P.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Wong, Patrick C. M.] Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Sheppard, JP (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	pwong@northwestern.edu	Wong, Patrick/A-8102-2012	Wong, Patrick/0000-0002-6105-5027; Sheppard, John/0000-0002-8040-8481	National Science Foundation [BCS-0719666]; National Institutes of Health [R01DC008333, R21DC009652]; Northwestern University Office of the Provost; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009652, R01DC008333] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Office of the Provost; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Science Foundation (grants BCS-0719666 to P. W.), the National Institutes of Health (grants R01DC008333 and R21DC009652 to P.W.) and grants administered through the Northwestern University Office of the Provost to J.S. The funders' websites are available at www.nsf.gov, www.nih.gov, and www.northwestern.edu/provost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Christensen H, 2001, PSYCHOL AGING, V16, P588, DOI 10.1037//0882-7974.16.4.588; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; FRISINA DR, 2001, FUNCTIONAL NEUROBIOL, P565; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; GordonSalant S, 2010, SPRINGER HANDB AUDIT, V34, P1; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Grady CL, 2003, HIPPOCAMPUS, V13, P572, DOI 10.1002/hipo.10114; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gunning-Dixon FM, 2003, NEUROBIOL AGING, V24, P285, DOI 10.1016/S0197-4580(02)00099-4; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; HUMES LE, 1991, J SPEECH HEAR RES, V34, P686, DOI 10.1044/jshr.3403.686; HUMES LE, 1994, J SPEECH HEAR RES, V37, P465, DOI 10.1044/jshr.3702.465; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAYMER AM, 1990, FLORIDA SEMATI UNPUB; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Saad ZS, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1510; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Schneider B.A., 2000, HDB AGING COGNITION, P155; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stelmach G., 1993, SENSORIMOTOR IMPAIRM, DOI [10.1007/978-94-011-1976-4, DOI 10.1007/978-94-011-1976-4]; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Wong PCM, 2010, EAR HEARING, V31, P471, DOI 10.1097/AUD.0b013e3181d709c2; Wong PCM, 2009, NEUROPSYCHOLOGIA, V47, P693, DOI 10.1016/j.neuropsychologia.2008.11.032; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	83	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16510	10.1371/journal.pone.0016510	http://dx.doi.org/10.1371/journal.pone.0016510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304991	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000286834300073
J	Simo, L; Koci, J; Zitnan, D; Park, Y				Simo, Ladislav; Koci, Juraj; Zitnan, Dusan; Park, Yoonseong			Evidence for D1 Dopamine Receptor Activation by a Paracrine Signal of Dopamine in Tick Salivary Glands	PLOS ONE			English	Article							IXODID TICKS; FLUID SECRETION; MECHANISM; QUANTIFICATION; PHYSIOLOGY; CALCIUM	Ticks that feed on vertebrate hosts use their salivary secretion, which contains various bioactive components, to manipulate the host's responses. The mechanisms controlling the tick salivary gland in this dynamic process are not well understood. We identified the tick D1 receptor activated by dopamine, a potent inducer of the salivary secretion of ticks. Temporal and spatial expression patterns examined by immunohistochemistry and reverse transcription polymerase chain reaction suggest that the dopamine produced in the basal cells of salivary gland acini is secreted into the lumen and activates the D1 receptors on the luminal surface of the cells lining the acini. Therefore, we propose a paracrine function of dopamine that is mediated by the D1 receptor in the salivary gland at an early phase of feeding. The molecular and pharmacological characterization of the D1 receptor in this study provides the foundation for understanding the functions of dopamine in the blood-feeding of ticks.	[Simo, Ladislav; Koci, Juraj; Park, Yoonseong] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Zitnan, Dusan] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia	Kansas State University; Slovak Academy of Sciences	Simo, L (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	ypark@ksu.edu	Koči, Juraj/C-3754-2014; Park, Yoonseong/J-5861-2013	Koči, Juraj/0000-0002-5560-806X; Simo, Ladislav/0000-0002-4472-1016; Park, Yoonseong/0000-0003-1191-7335	National Institutes of Health (NIH) [R01AI090062-01, 1R21AI081136-01]; National Center for Research Resources [NIH P20 RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081136, R01AI090062] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This paper is contribution no. 11-168-J from the Kansas Agricultural Experiment Station. The project described was supported by National Institutes of Health (NIH) Grant Numbers R01AI090062-01 and 1R21AI081136-01. The confocal facility in the K-state is supported by NIH P20 RR017686 from the IDEA Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINNINGTON KC, 1978, INT J PARASITOL, V8, P97, DOI 10.1016/0020-7519(78)90004-8; Bowman AS, 2004, PARASITOLOGY, V129, pS67, DOI 10.1017/S0031182004006468; COONS LB, 1973, J PARASITOL, V59, P900, DOI 10.2307/3278433; Gaede K, 1997, J EXP BIOL, V200, P1491; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Grigorieva LA, 2008, J EVOL BIOCHEM PHYS+, V44, P735, DOI 10.1134/S0022093008060100; KAUFMAN W, 1976, J EXP BIOL, V64, P727; Kaufman WR, 1999, EXP APPL ACAROL, V23, P251, DOI 10.1023/A:1006071031547; KAUFMAN WR, 1983, EUR J PHARMACOL, V87, P43, DOI 10.1016/0014-2999(83)90048-1; KAUFMAN WR, 1980, AM J PHYSIOL, V238, pR102, DOI 10.1152/ajpregu.1980.238.1.R102; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; NEEDHAM GR, 1979, J PARASITOL, V65, P531, DOI 10.2307/3280316; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RUDOLPH D, 1974, NATURE, V249, P84, DOI 10.1038/249084a0; Sauer JR, 2000, J INSECT PHYSIOL, V46, P1069, DOI 10.1016/S0022-1910(99)00210-3; SAUER JR, 1995, ANNU REV ENTOMOL, V40, P245, DOI 10.1146/annurev.en.40.010195.001333; Scheckelhoff MR, 2007, P NATL ACAD SCI USA, V104, P7247, DOI 10.1073/pnas.0607263104; SCHMIDT SP, 1981, J CYCLIC NUCL PROT, V7, P375; Simo L, 2009, CELL TISSUE RES, V335, P639, DOI 10.1007/s00441-008-0731-4; Simo L, 2009, J COMP NEUROL, V517, P551, DOI 10.1002/cne.22182; Vernon WI, 2002, BIOTECHNIQUES, V33, P730, DOI 10.2144/02334bm02	24	33	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16158	10.1371/journal.pone.0016158	http://dx.doi.org/10.1371/journal.pone.0016158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297964	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300036
J	Frydman-Marom, A; Levin, A; Farfara, D; Benromano, T; Scherzer-Attali, R; Peled, S; Vassar, R; Segal, D; Gazit, E; Frenkel, D; Ovadia, M				Frydman-Marom, Anat; Levin, Aviad; Farfara, Dorit; Benromano, Tali; Scherzer-Attali, Roni; Peled, Sivan; Vassar, Robert; Segal, Daniel; Gazit, Ehud; Frenkel, Dan; Ovadia, Michael			Orally Administrated Cinnamon Extract Reduces beta-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models	PLOS ONE			English	Article							A-BETA; TRANSGENIC MICE; PROTEIN; POLYPHENOLS; NEURODEGENERATION; AGGREGATION; INHIBITORS; GLUCOSE; COMMON; BRAIN	An increasing body of evidence indicates that accumulation of soluble oligomeric assemblies of beta-amyloid polypeptide (A beta) play a key role in Alzheimer's disease (AD) pathology. Specifically, 56 kDa oligomeric species were shown to be correlated with impaired cognitive function in AD model mice. Several reports have documented the inhibition of A beta plaque formation by compounds from natural sources. Yet, evidence for the ability of common edible elements to modulate A beta oligomerization remains an unmet challenge. Here we identify a natural substance, based on cinnamon extract (CEppt), which markedly inhibits the formation of toxic A beta oligomers and prevents the toxicity of A beta on neuronal PC12 cells. When administered to an AD fly model, CEppt rectified their reduced longevity, fully recovered their locomotion defects and totally abolished tetrameric species of A beta in their brain. Furthermore, oral administration of CEppt to an aggressive AD transgenic mice model led to marked decrease in 56 kDa A beta oligomers, reduction of plaques and improvement in cognitive behavior. Our results present a novel prophylactic approach for inhibition of toxic oligomeric A beta species formation in AD through the utilization of a compound that is currently in use in human diet.	[Frydman-Marom, Anat; Scherzer-Attali, Roni; Peled, Sivan; Segal, Daniel; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Levin, Aviad; Ovadia, Michael] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Farfara, Dorit; Benromano, Tali; Frenkel, Dan] Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Vassar, Robert] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Tel Aviv University; Tel Aviv University; Tel Aviv University; Northwestern University	Frydman-Marom, A (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ehudg@post.tau.ac.il; dfrenkel@post.tau.ac.il; MichaelO@tauex.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Farfara, Dorit/0000-0001-7515-5769; Segal, Daniel/0000-0002-6777-505X				Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Chauhan NB, 2007, PHYTOTHER RES, V21, P629, DOI 10.1002/ptr.2122; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Dugoua JJ, 2007, CAN J PHYSIOL PHARM, V85, P837, DOI 10.1139/Y07-080; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Frenkel D, 2008, ANN NEUROL, V63, P591, DOI 10.1002/ana.21340; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Gazit E, 2004, DRUG FUTURE, V29, P613, DOI 10.1358/dof.2004.029.06.853453; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAMAGUCHI T, 2010, CNS NEUROSCI THER; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; JARRETT JT, 1993, ANN NY ACAD SCI, V24, P144; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Kim DSHL, 2007, J ALTERN COMPLEM MED, V13, P333, DOI 10.1089/acm.2006.6107; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Paiva SAR, 1999, J AM COLL NUTR, V18, P426, DOI 10.1080/07315724.1999.10718880; Panickar KS, 2009, EXP NEUROL, V216, P420, DOI 10.1016/j.expneurol.2008.12.024; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Prins ND, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt28; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; SEVILLIA G, 2007, CINNAMON EXTRACT INH, P467; Shoval H, 2008, BBA-PROTEINS PROTEOM, V1784, P1570, DOI 10.1016/j.bbapap.2008.08.007; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; YOUNG HM, 2008, J NUTR BIOCH, V19, P448	43	137	141	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16564	10.1371/journal.pone.0016564	http://dx.doi.org/10.1371/journal.pone.0016564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305046	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100044
J	Matsumoto, T; Yun, CS; Yoshikawa, H; Nishida, H				Matsumoto, Takashi; Yun, Choong-Soo; Yoshikawa, Hirofumi; Nishida, Hiromi			Comparative Studies of Genome-Wide Maps of Nucleosomes between Deletion Mutants of elp3 and hos2 Genes of Saccharomyces cerevisiae	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE; IN-VIVO; YEAST; DEACETYLASES; ACETYLATION; CHROMATIN; TRANSCRIPTION; RESOLUTION; ELONGATOR; FAMILY	In order to elucidate the influence of histone acetylation upon nucleosomal DNA length and nucleosome position, we compared nucleosome maps of the following three yeast strains; strain BY4741 (control), the elp3 (one of histone acetyltransferase genes) deletion mutant, and the hos2 (one of histone deactylase genes) deletion mutant of Saccharomyces cerevisiae. We sequenced mononucleosomal DNA fragments after treatment with micrococcal nuclease. After mapping the DNA fragments to the genome, we identified the nucleosome positions. We showed that the distributions of the nucleosomal DNA lengths of the control and the hos2 disruptant were similar. On the other hand, the distribution of the nucleosomal DNA lengths of the elp3 disruptant shifted toward shorter than that of the control. It strongly suggests that inhibition of Elp3-induced histone acetylation causes the nucleosomal DNA length reduction. Next, we compared the profiles of nucleosome mapping numbers in gene promoter regions between the control and the disruptant. We detected 24 genes with low conservation level of nucleosome positions in promoters between the control and the elp3 disruptant as well as between the control and the hos2 disruptant. It indicates that both Elp3-induced acetylation and Hos2-induced deacetylation influence the nucleosome positions in the promoters of those 24 genes. Interestingly, in 19 of the 24 genes, the profiles of nucleosome mapping numbers were similar between the two disruptants.	[Matsumoto, Takashi; Yoshikawa, Hirofumi] Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Tokyo, Japan; [Yun, Choong-Soo; Nishida, Hiromi] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan; [Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan	Tokyo University of Agriculture; University of Tokyo; Tokyo University of Agriculture	Matsumoto, T (corresponding author), Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Tokyo, Japan.	hnishida@iu.a.u-tokyo.ac.jp	Nishida, Hiromi/B-1635-2008; YUN, Choong-Soo/C-7453-2017	YUN, Choong-Soo/0000-0001-7128-2584	Institute for Fermentation, Osaka (IFO), Japan; Ministry of Education, Culture, Sports, Science and Technology [S0801025]	Institute for Fermentation, Osaka (IFO), Japan(Institute for Fermentation (IFO)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a grant from the Institute for Fermentation, Osaka (IFO), Japan, to HN, and by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (S0801025) to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Nishida H., 2009, OPEN ACCESS BIOINFOR, V1, P1; Nishida H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009916; Nishida H, 2009, BIOINFORMATICS, V25, P2295, DOI 10.1093/bioinformatics/btp413; Nishida H, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/379317; Nishida H, 2008, MAMM GENOME, V19, P667, DOI 10.1007/s00335-008-9146-5; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16372	10.1371/journal.pone.0016372	http://dx.doi.org/10.1371/journal.pone.0016372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297980	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100025
J	Zhang, LH; Wang, MN; Bisogno, T; Di Marzo, V; Alger, BE				Zhang, Longhua; Wang, Meina; Bisogno, Tiziana; Di Marzo, Vincenzo; Alger, Bradley E.			Endocannabinoids Generated by Ca2+ or by Metabotropic Glutamate Receptors Appear to Arise from Different Pools of Diacylglycerol Lipase	PLOS ONE			English	Article							ENDOGENOUS CANNABINOIDS; RETROGRADE; INHIBITION; SUPPRESSION; SYNAPSES; BLOCKADE; SYSTEM; ALPHA; BINDS	The identity and subcellular sources of endocannabinoids (eCBs) will shape their ability to affect synaptic transmission and, ultimately, behavior. Recent discoveries support the conclusion that 2-arachidonoyl glycerol, 2-AG, is the major signaling eCB, however, some important issues remain open. 2-AG can be synthesized by a mechanism that is strictly Ca2+-dependent, and another that is initiated by G-protein coupled receptors (GPCRs) and facilitated by Ca2+. An important question is whether or not the 2-AG in these cases is synthesized by the same pool of diacylglycerol lipase alpha (DAGL alpha). Using whole-cell voltage-clamp techniques in CA1 pyramidal cells in acute in vitro rat hippocampal slices, we investigated two mechanistically distinct eCB-mediated responses to address this issue. We now report that pharmacological inhibitors of DGL alpha have quantitatively different effects on eCB-mediated responses triggered by different stimuli, suggesting that functional, and perhaps physical, distinctions among pools of DAGL alpha exist.	[Zhang, Longhua; Wang, Meina; Alger, Bradley E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Alger, Bradley E.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Alger, Bradley E.] Univ Maryland, Sch Med, Neurosci Program, Baltimore, MD 21201 USA; [Bisogno, Tiziana; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, ECB Res Grp, Pozzuoli, Italy	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Consiglio Nazionale delle Ricerche (CNR)	Zhang, LH (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	balgerlab@gmail.com	Bisogno, Tiziana/B-7891-2015; Di Marzo, Vincenzo/AAD-7742-2019; Zhang, Longhua/P-1417-2014	Di Marzo, Vincenzo/0000-0002-1490-3070; 	NIH [RO1 MH077277, RO1 DA014625]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH RO1 MH077277 and RO1 DA014625 to B. E. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermark L, 2007, P NATL ACAD SCI USA, V104, P20564, DOI 10.1073/pnas.0706873104; ALGER BE, 2010, TRENDS NEUR IN PRESS; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Min R, 2010, NEUROSCIENTIST, V16, P608, DOI 10.1177/1073858410373281; Min R, 2010, J NEUROSCI, V30, P2710, DOI 10.1523/JNEUROSCI.BC-3622-09.2010; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	32	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16305	10.1371/journal.pone.0016305	http://dx.doi.org/10.1371/journal.pone.0016305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305054	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100021
J	Wang, X; Shi, Q; Xu, K; Gao, C; Chen, C; Li, XL; Wang, GR; Tian, C; Han, J; Dong, XP				Wang, Xin; Shi, Qi; Xu, Kun; Gao, Chen; Chen, Cao; Li, Xiao-Li; Wang, Gui-Rong; Tian, Chan; Han, Jun; Dong, Xiao-Ping			Familial CJD Associated PrP Mutants within Transmembrane Region Induced Ctm-PrP Retention in ER and Triggered Apoptosis by ER Stress in SH-SY5Y Cells	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; ENDOPLASMIC-RETICULUM; PRION PROTEIN; MEMBRANE-PROTEIN; GENE; TRANSMISSION; DETERMINANT; ORIENTATION; BIOGENESIS; INDUCTION	Background: Genetic prion diseases are linked to point and inserted mutations in the prion protein (PrP) gene that are presumed to favor conversion of the cellular isoform of PrP (PrPC) to the pathogenic one (PrPSc). The pathogenic mechanisms and the subcellular sites of the conversion are not completely understood. Here we introduce several PRNP gene mutations (such as, PrP-KDEL, PrP-3AV, PrP-A117V, PrP-G114V, PrP-P102L and PrP-E200K) into the cultured cells in order to explore the pathogenic mechanism of familial prion disease. Methodology/Principal Findings: To address the roles of aberrant retention of PrP in endoplasmic reticulum (ER), the recombinant plasmids expressing full-length human PrP tailed with an ER signal peptide at the COOH-terminal (PrP-KDEL) and PrP with three amino acids exchange in transmembrane region (PrP-3AV) were constructed. In the preparations of transient transfections, 18-kD COOH-terminal proteolytic resistant fragments (Ctm-PrP) were detected in the cells expressing PrP-KDEL and PrP-3AV. Analyses of the cell viabilities in the presences of tunicamycin and brefeldin A revealed that expressions of PrP-KDEL and PrP-3AV sensitized the transfected cells to ER stress stimuli. Western blots and RT-PCR identified the clear alternations of ER stress associated events in the cells expressing PrP-KDEL and PrP-3AV that induced ER mediated apoptosis by CHOP and capase-12 apoptosis pathway. Moreover, several familial CJD related PrP mutants were transiently introduced into the cultured cells. Only the mutants within the transmembrane region (G114V and A117V) induced the formation of Ctm-PrP and caused the ER stress, while the mutants outside the transmembrane region (P102L and E200K) failed. Conclusions/Significance: The data indicate that the retention of PrP in ER through formation of Ctm-PrP results in ER stress and cell apoptosis. The cytopathic activities caused by different familial CJD associated PrP mutants may vary, among them the mutants within the transmembrane region undergo an ER-stress mediated cell apoptosis.	[Wang, Xin; Shi, Qi; Xu, Kun; Gao, Chen; Chen, Cao; Li, Xiao-Li; Wang, Gui-Rong; Tian, Chan; Han, Jun; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xu, Kun] Xi An Jiao Tong Univ, Sch Med, Xian 710049, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Xi'an Jiaotong University	Wang, X (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	Chinese National Natural Science Foundation [30771914, 30800975]; National Science and Technology Task Force Project [2006BAD06A13-2]; Institution Technique RD Grant [2008EG150300]; National Basic Research Program of China [2007CB310505]; China Mega-Project for Infectious Disease [2009ZX10004-101]; SKLID development Grant [2008SKLID102, 2008SKLID202]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Task Force Project; Institution Technique RD Grant; National Basic Research Program of China(National Basic Research Program of China); China Mega-Project for Infectious Disease; SKLID development Grant	This work was supported by Chinese National Natural Science Foundation Grants 30771914 and 30800975, National Science and Technology Task Force Project (2006BAD06A13-2), Institution Technique R&D Grant (2008EG150300), National Basic Research Program of China (973 Program) (2007CB310505), China Mega-Project for Infectious Disease (2009ZX10004-101) and the SKLID development Grant (2008SKLID102 and 2008SKLID202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; An R, 2008, SCI CHINA SER C, V51, P630, DOI 10.1007/s11427-008-0062-4; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Chen L, 2007, J BIOCHEM MOL BIOL, V40, P662; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Dimcheff DE, 2003, J VIROL, V77, P12617, DOI 10.1128/JVI.77.23.12617-12629.2003; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hegde RS, 1999, TRENDS CELL BIOL, V9, P132, DOI 10.1016/S0962-8924(99)01504-4; HITT AL, 1994, J CELL BIOL, V126, P1421, DOI 10.1083/jcb.126.6.1421; HOWELL S, 1994, J BIOL CHEM, V269, P16993; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; Ozols J, 1998, BIOCHEMISTRY-US, V37, P10336, DOI 10.1021/bi9807916; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rodriguez MM, 2005, NEUROLOGY, V64, P1455, DOI 10.1212/01.WNL.0000158618.39527.93; Shi Q, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-360; TATEISHI J, 1995, NATURE, V376, P434, DOI 10.1038/376434a0; Tranchant C, 1999, NEUROLOGY, V52, P1244, DOI 10.1212/WNL.52.6.1244; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Winklhofer KF, 2006, HANDB EXP PHARM, V172, P221; Ye Jing, 2008, J Med Case Rep, V2, P331, DOI 10.1186/1752-1947-2-331; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0	32	39	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14602	10.1371/journal.pone.0014602	http://dx.doi.org/10.1371/journal.pone.0014602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298055	Green Submitted, gold, Green Published			2022-12-27	WOS:000286663900006
J	Dechanet, C; Fort, A; Barbero-Camps, E; Dechaud, H; Richard, S; Virsolvy, A				Dechanet, Clotilde; Fort, Aurelie; Barbero-Camps, Elisabet; Dechaud, Herve; Richard, Sylvain; Virsolvy, Anne			Endothelin-Dependent Vasoconstriction in Human Uterine Artery: Application to Preeclampsia	PLOS ONE			English	Article							NORMOTENSIVE PREGNANT-WOMEN; RESISTANCE ARTERIES; PLACENTAL ISCHEMIA; ET(A) RECEPTOR; BLOOD-VESSELS; HYPERTENSION; CALCIUM; EXPRESSION; PATHOPHYSIOLOGY; MYOMETRIAL	Background: Reduced uteroplacental perfusion, the initiating event in preeclampsia, is associated with enhanced endothelin-1 (ET-1) production which feeds the vasoconstriction of uterine artery. Whether the treatments of preeclampsia were effective on ET-1 induced contraction and could reverse placental ischemia is the question addressed in this study. We investigated the effect of antihypertensive drugs used in preeclampsia and of ET receptor antagonists on the contractile response to ET-1 on human uterine arteries. Methodology/Principal Findings: Experiments were performed, ex vivo, on human uterine artery samples obtained after hysterectomy. We studied variations in isometric tension of arterial rings in response to the vasoconstrictor ET-1 and evaluated the effects of various vasodilators and ET-receptor antagonists on this response. Among antihypertensive drugs, only dihydropyridines were effective in blocking and reversing the ET-1 contractile response. Their efficiency, independent of the concentration of ET-1, was only partial. Hydralazine, alpha-methyldopa and labetalol had no effect on ET-1 induced contraction which is mediated by both ETA and ETB receptors in uterine artery. ET receptors antagonists, BQ-123 and BQ-788, slightly reduced the amplitude of the response to ET-1. Combination of both antagonists was more efficient, but it was not possible to reverse the maximal ET-1-induced contraction with antagonists used alone or in combination. Conclusion: Pharmacological drugs currently used in the context of preeclampsia, do not reverse ET-1 induced contraction. Only dihydropyridines, which partially relax uterine artery previously contracted with ET-1, might offer interesting perspectives to improve placental perfusion.	[Dechanet, Clotilde; Fort, Aurelie; Barbero-Camps, Elisabet; Dechaud, Herve; Richard, Sylvain; Virsolvy, Anne] Univ Montpellier 1 & 2, INSERM, U637, Montpellier, France; [Dechanet, Clotilde; Dechaud, Herve] CHU Villeneuve, Serv Gynecol Obstet, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Dechanet, C (corresponding author), Univ Montpellier 1 & 2, INSERM, U637, Montpellier, France.	anne.virsolvy@inserm.fr	VIRSOLVY, Anne/E-4964-2016; Richard, Sylvain/C-9695-2016; Petit, Aurelie/O-1731-2018	VIRSOLVY, Anne/0000-0002-5819-3306; Petit, Aurelie/0000-0002-9069-9868; Richard, Sylvain/0000-0001-9460-6705	INSERM (Institut National de la Sante et de la Recherche Medical); University of Montpellier 1	INSERM (Institut National de la Sante et de la Recherche Medical)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier 1	This research was funded by INSERM (Institut National de la Sante et de la Recherche Medical; http://inserm.fr) and University of Montpellier 1 (http://univ-montp1.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajne G, 2005, AM J OBSTET GYNECOL, V193, P234, DOI 10.1016/j.ajog.2004.11.023; BENIGNI A, 1992, BRIT J OBSTET GYNAEC, V99, P798, DOI 10.1111/j.1471-0528.1992.tb14409.x; BODELSSON G, 1992, AM J OBSTET GYNECOL, V167, P745, DOI 10.1016/S0002-9378(11)91582-8; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; CHUN MY, 1995, J BIOL CHEM, V270, P10855, DOI 10.1074/jbc.270.18.10855; CLARK BA, 1992, AM J OBSTET GYNECOL, V166, P962, DOI 10.1016/0002-9378(92)91372-H; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Faxen M, 2000, ARCH GYNECOL OBSTET, V264, P143, DOI 10.1007/s004040000111; FENAKEL K, 1991, OBSTET GYNECOL, V77, P331; Fort A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007360; FRIED G, 1994, ACTA PHYSIOL SCAND, V151, P477, DOI 10.1111/j.1748-1716.1994.tb09770.x; FRIED G, 1991, AM J OBSTET GYNECOL, V164, P1330, DOI 10.1016/0002-9378(91)90709-Z; Goldman-Wohl D, 2002, MOL CELL ENDOCRINOL, V187, P233, DOI 10.1016/S0303-7207(01)00687-6; Gomez O, 2006, ULTRASOUND OBST GYN, V28, P802, DOI 10.1002/uog.2814; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Hawfield Amret, 2009, Ther Adv Cardiovasc Dis, V3, P65, DOI 10.1177/1753944708097114; Higgins JR, 2001, LANCET, V357, P131, DOI 10.1016/S0140-6736(00)03552-2; KUBLICKIENE KR, 1994, AM J HYPERTENS, V7, pS50, DOI 10.1093/ajh/7.7.50S; LaMarca BD, 2008, GENDER MED, V5, pS133, DOI 10.1016/j.genm.2008.03.013; LUNNELL NO, 1982, BRIT J OBSTET GYNAEC, V89, P640, DOI 10.1111/j.1471-0528.1982.tb04719.x; Lyall F, 2002, PLACENTA, V23, pS142, DOI 10.1053/plac.2002.0803; Mccoy S, 2009, AM J HEALTH-SYST PH, V66, P337, DOI 10.2146/ajhp080104; MCMAHON LP, 1993, CLIN SCI, V85, P417, DOI 10.1042/cs0850417; Miwa Soichi, 2005, Journal of Smooth Muscle Research, V41, P61, DOI 10.1540/jsmr.41.61; MONTAN S, 1993, AM J OBSTET GYNECOL, V168, P152, DOI 10.1016/S0002-9378(12)90905-9; Murphy SR, 2010, HYPERTENSION, V55, P394, DOI 10.1161/HYPERTENSIONAHA.109.141473; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; NISELL H, 1991, J HYPERTENS, V9, pS168; NOVA A, 1991, AM J OBSTET GYNECOL, V165, P724, DOI 10.1016/0002-9378(91)90317-K; NYLUND L, 1984, ACTA OBSTET GYN SCAN, P71; POLLOCK DM, 1995, FASEB J, V9, P1196, DOI 10.1096/fasebj.9.12.7672512; Richard S, 2005, DRUGS, V65, P1; Sand AE, 1998, ACTA PHYSIOL SCAND, V163, P227, DOI 10.1046/j.1365-201x.1998.00368.x; SEO B, 1994, CIRCULATION, V89, P1203, DOI 10.1161/01.CIR.89.3.1203; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Singh HJ, 2001, ACTA OBSTET GYN SCAN, V80, P99, DOI 10.1034/j.1600-0412.2001.080002099.x; Spence S, 1999, REPROD TOXICOL, V13, P15, DOI 10.1016/S0890-6238(98)00064-1; Steiner MK, 2008, VASC HEALTH RISK MAN, V4, P943; TAYLOR RN, 1990, J CLIN ENDOCR METAB, V71, P1675, DOI 10.1210/jcem-71-6-1675; Thaete LG, 2007, BIOL REPROD, V77, P526, DOI 10.1095/biolreprod.107.061820; Wimalasundera RC, 2005, AM J OBSTET GYNECOL, V192, P625, DOI 10.1016/j.ajog.2004.07.040; Wimalasundera RC, 2010, J HYPERTENS, V28, P568, DOI 10.1097/HJH.0b013e328334f20b; Wolff K, 1996, REGUL PEPTIDES, V67, P211, DOI 10.1016/S0167-0115(96)00122-X; Wolff K, 1996, ACTA OBSTET GYN SCAN, V75, P432, DOI 10.3109/00016349609033349	45	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16540	10.1371/journal.pone.0016540	http://dx.doi.org/10.1371/journal.pone.0016540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298073	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800054
J	Sanchez-Villegas, A; Verberne, L; De Irala, J; Ruiz-Canela, M; Toledo, E; Serra-Majem, L; Martinez-Gonzalez, MA				Sanchez-Villegas, Almudena; Verberne, Lisa; De Irala, Jokin; Ruiz-Canela, Miguel; Toledo, Estefania; Serra-Majem, Lluis; Angel Martinez-Gonzalez, Miguel			Dietary Fat Intake and the Risk of Depression: The SUN Project	PLOS ONE			English	Article							OLIVE OIL CONSUMPTION; MEDITERRANEAN DIET; FOLLOW-UP; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; ENDOTHELIAL-CELLS; MAJOR DEPRESSION; NERVOUS-SYSTEM; ACIDS; MOOD	Emerging evidence relates some nutritional factors to depression risk. However, there is a scarcity of longitudinal assessments on this relationship. Objective: To evaluate the association between fatty acid intake or the use of culinary fats and depression incidence in a Mediterranean population. Material and Methods: Prospective cohort study (1999-2010) of 12,059 Spanish university graduates (mean age: 37.5 years) initially free of depression with permanently open enrolment. At baseline, a 136-item validated food frequency questionnaire was used to estimate the intake of fatty acids (saturated fatty acids (SFA), polyunsaturated fatty acids (PUFA), trans unsaturated fatty acids (TFA) and monounsaturated fatty acids (MUFA) and culinary fats (olive oil, seed oils, butter and margarine) During follow-up participants were classified as incident cases of depression if they reported a new clinical diagnosis of depression by a physician and/or initiated the use of antidepressant drugs. Cox regression models were used to calculate Hazard Ratios (HR) of incident depression and their 95% confidence intervals (CI) for successive quintiles of fats. Results: During follow-up (median: 6.1 years), 657 new cases of depression were identified. Multivariable-adjusted HR (95% CI) for depression incidence across successive quintiles of TFA intake were: 1 (ref), 1.08 (0.82-1.43), 1.17 (0.88-1.53), 1.28 (0.97-1.68), 1.42 (1.09-1.84) with a significant dose-response relationship (p for trend = 0.003). Results did not substantially change after adjusting for potential lifestyle or dietary confounders, including adherence to a Mediterranean Dietary Pattern. On the other hand, an inverse and significant dose-response relationship was obtained for MUFA (p for trend = 0.05) and PUFA (p for trend = 0.03) intake. Conclusions: A detrimental relationship was found between TFA intake and depression risk, whereas weak inverse associations were found for MUFA, PUFA and olive oil. These findings suggest that cardiovascular disease and depression may share some common nutritional determinants related to subtypes of fat intake.	[Sanchez-Villegas, Almudena; Verberne, Lisa; Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Sanchez-Villegas, Almudena; De Irala, Jokin; Ruiz-Canela, Miguel; Toledo, Estefania; Angel Martinez-Gonzalez, Miguel] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Verberne, Lisa] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Universidad de Las Palmas de Gran Canaria; University of Navarra; Wageningen University & Research	Sanchez-Villegas, A (corresponding author), Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain.	asanchez@dcc.ulpgc.es	Sanchez-Villegas, Almudena/T-6733-2019; Toledo, Estefania/H-6211-2014; Serra-Majem, Lluis/I-6708-2019; de Irala, Jokin/H-2936-2017; Ruiz-Canela, Miguel/I-7738-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019	Sanchez-Villegas, Almudena/0000-0001-7733-9238; Toledo, Estefania/0000-0002-6263-4434; Serra-Majem, Lluis/0000-0002-9658-9061; de Irala, Jokin/0000-0002-7249-6581; Ruiz-Canela, Miguel/0000-0002-7684-2787; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Spanish Government Instituto de Salud Carlos III; Fondo de Investigaciones Sanitarias [PI042241, PI040233, PI050976, PI070240, PI0801943, RD 06/0045]; Navarra Regional Government [PI41/2005]	Spanish Government Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Navarra Regional Government	The Spanish Government Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, projects PI042241, PI040233, PI050976, PI070240, PI0801943, and RD 06/0045 and the Navarra Regional Government project PI41/2005 have supported the SUN Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4; Appleton KM, 2008, PROSTAG LEUKOTR ESS, V78, P337, DOI 10.1016/j.plefa.2008.04.009; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Assies J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010635; Barzi F, 2003, EUR J CLIN NUTR, V57, P604, DOI 10.1038/sj.ejcn.1601575; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bilici M, 2001, J AFFECT DISORDERS, V64, P43, DOI 10.1016/S0165-0327(00)00199-3; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P386; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377; Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002; Chishti P, 2003, EUR J PUBLIC HEALTH, V13, P108, DOI 10.1093/eurpub/13.2.108; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fernandez-Jarne E, 2002, INT J EPIDEMIOL, V31, P474, DOI 10.1093/ije/31.2.474; Freeman MP, 2010, AM J PSYCHIAT, V167, P244, DOI 10.1176/appi.ajp.2009.09121746; Gilbody S, 2007, J EPIDEMIOL COMMUN H, V61, P631, DOI 10.1136/jech.2006.050385; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Glassman Alexander H, 2007, Dialogues Clin Neurosci, V9, P9; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Greenland S, 2008, MODERN EPIDEMIOLOGY, V3rd; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kiecolt-Glaser JK, 2007, PSYCHOSOM MED, V69, P217, DOI 10.1097/PSY.0b013e3180313a45; Kontogianni MD, 2007, CLIN CARDIOL, V30, P125, DOI 10.1002/clc.20043; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kovess-Masfety V, 2007, PSYCHIAT SERV, V58, P213, DOI 10.1176/appi.ps.58.2.213; Kyrozis A, 2009, J PSYCHIATR RES, V43, P763, DOI 10.1016/j.jpsychires.2008.09.003; Logan AC, 2005, PROSTAG LEUKOTR ESS, V72, P441, DOI 10.1016/j.plefa.2005.02.006; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; Mena MP, 2009, AM J CLIN NUTR, V89, P248, DOI 10.3945/ajcn.2008.26094; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Naska A, 2006, EUR J CLIN NUTR, V60, P181, DOI 10.1038/sj.ejcn.1602284; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P446, DOI 10.1358/dnp.2008.21.8.1272136; Payne Martha E, 2010, Aging health, V6, P133, DOI 10.2217/ahe.09.90; Puri BK, 2000, ARCH GEN PSYCHIAT, V57, P715, DOI 10.1001/archpsyc.57.7.715; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S0007114507801097; Salas-Salvado J, 2008, EUR J CLIN NUTR, V62, P651, DOI 10.1038/sj.ejcn.1602762; Sanchez-Villegas A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-43; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Sarris J, 2009, NUTR REV, V67, P125, DOI 10.1111/j.1753-4887.2009.00180.x; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Silvers KM, 2005, PROSTAG LEUKOTR ESS, V72, P211, DOI 10.1016/j.plefa.2004.11.004; Skarupski KA, 2010, AM J CLIN NUTR, V92, P330, DOI 10.3945/ajcn.2010.29413; Soh NL, 2009, ACTA NEUROPSYCHIATR, V21, P214, DOI 10.1111/j.1601-5215.2009.00413.x; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Uauy R, 2009, EUR J CLIN NUTR, V63, pS68, DOI 10.1038/ejcn.2009.15; Vaccarino V, 2007, J AM COLL CARDIOL, V50, P2044, DOI 10.1016/j.jacc.2007.07.069; Wagner JA, 2006, PSYCHOSOM MED, V68, P80, DOI 10.1097/01.psy.0000195868.68122.9e; Waterman E, 2007, ALTERN MED REV, V12, P331; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wolfe AR, 2009, PROG NEURO-PSYCHOPH, V33, P972, DOI 10.1016/j.pnpbp.2009.05.002; World Health Organization, 2008, GLOB BURD DIS 2004 U	65	145	150	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16268	10.1371/journal.pone.0016268	http://dx.doi.org/10.1371/journal.pone.0016268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298116	Green Published, gold			2022-12-27	WOS:000286662800023
J	Thelin, J; Jorntell, H; Psouni, E; Garwicz, M; Schouenborg, J; Danielsen, N; Linsmeier, CE				Thelin, Jonas; Jorntell, Henrik; Psouni, Elia; Garwicz, Martin; Schouenborg, Jens; Danielsen, Nils; Linsmeier, Cecilia Eriksson			Implant Size and Fixation Mode Strongly Influence Tissue Reactions in the CNS	PLOS ONE			English	Article							INTRACORTICAL ELECTRODE ARRAY; SILICON MICROELECTRODE ARRAYS; RODENT SOMATOSENSORY CORTEX; DEEP BRAIN-STIMULATION; RAT; BIOCOMPATIBILITY; CAPABILITY; INTERFACES; MULTISITE; TITANIUM	The function of chronic brain machine interfaces depends on stable electrical contact between neurons and electrodes. A key step in the development of interfaces is therefore to identify implant configurations that minimize adverse long-term tissue reactions. To this end, we here characterized the separate and combined effects of implant size and fixation mode at 6 and 12 weeks post implantation in rat (n = 24) cerebral cortex. Neurons and activated microglia and astrocytes were visualized using NeuN, ED1 and GFAP immunofluorescence microscopy, respectively. The contributions of individual experimental variables to the tissue response were quantified. Implants tethered to the skull caused larger tissue reactions than un-tethered implants. Small diameter (50 mu m) implants elicited smaller tissue reactions and resulted in the survival of larger numbers of neurons than did large diameter (200 mu m) implants. In addition, tethering resulted in an oval-shaped cavity, with a cross-section area larger than that of the implant itself, and in marked changes in morphology and organization of neurons in the region closest to the tissue interface. Most importantly, for implants that were both large diameter and tethered, glia activation was still ongoing 12 weeks after implantation, as indicated by an increase in GFAP staining between week 6 and 12, while this pattern was not observed for un-tethered, small diameter implants. Our findings therefore clearly indicate that the combined small diameter, un-tethered implants cause the smallest tissue reactions.	[Thelin, Jonas; Jorntell, Henrik; Garwicz, Martin; Schouenborg, Jens; Danielsen, Nils; Linsmeier, Cecilia Eriksson] Lund Univ, Neuronano Res Ctr, Lund, Sweden; [Psouni, Elia] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden; [Psouni, Elia] Lund Univ, Dept Psychol, Lund, Sweden	Lund University; Kristianstad University; Lund University	Thelin, J (corresponding author), Lund Univ, Neuronano Res Ctr, Lund, Sweden.	Jonas.Thelin@med.lu.se	LInsmeier, Cecilia Eriksson/N-2212-2015	Danielsen, Nils/0000-0002-4917-8294; Schouenborg, Jens/0000-0002-2815-6918; Thelin, Jonas/0000-0002-6452-1476; Garwicz-Psouni, Elia/0000-0003-2758-5785	Knut and Alice Wallenberg foundation [KAW 2004-0119]; Swedish Research Council [60012701, 600012701]; Medical Faculty at Lund University; Royal Physiographic Society in Lund; Magnus Bergvall Foundation	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty at Lund University; Royal Physiographic Society in Lund; Magnus Bergvall Foundation	This work was funded by the Knut and Alice Wallenberg foundation and by Linne grants (project number 60012701) from the Swedish Research Council and the Medical Faculty at Lund University. The project was sponsored by The Royal Physiographic Society in Lund, The Magnus Bergvall Foundation, The Knut and Alice Wallenberg Foundation (project number: KAW 2004-0119), and a Linne grant (project number: 600012701) from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benabid AL, 2007, EXPERT REV MED DEVIC, V4, P895, DOI 10.1586/17434440.4.6.895; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kipke DR, 2004, P ANN INT IEEE EMBS, V26, P5344; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028; Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x; Lundgren D, 1992, Clin Oral Implants Res, V3, P136, DOI 10.1034/j.1600-0501.1992.030306.x; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055005; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003; Mushahwar VK, 2007, J NEURAL ENG, V4, pS181, DOI 10.1088/1741-2560/4/3/S05; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Otto KJ, 2005, J NEURAL ENG, V2, P42, DOI 10.1088/1741-2560/2/2/005; Otto KJ, 2005, HEARING RES, V210, P112, DOI 10.1016/j.heares.2005.08.004; Purcell EK, 2009, J NEUROSCI METH, V183, P149, DOI 10.1016/j.jneumeth.2009.06.026; ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Song YK, 2007, P ANN INT IEEE EMBS, P445, DOI 10.1109/IEMBS.2007.4352319; Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; Westby GWM, 1997, J NEUROSCI METH, V76, P123, DOI 10.1016/S0165-0270(97)00088-5; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192	37	121	127	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16267	10.1371/journal.pone.0016267	http://dx.doi.org/10.1371/journal.pone.0016267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298109	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800022
J	Wood, LM; Sankar, S; Reed, RE; Haas, AL; Liu, LF; McKinnon, P; Desai, SD				Wood, Laurence M.; Sankar, Surendran; Reed, Ryan E.; Haas, Arthur L.; Liu, Leroy F.; McKinnon, Peter; Desai, Shyamal D.			A Novel Role for ATM in Regulating Proteasome-Mediated Protein Degradation through Suppression of the ISG15 Conjugation Pathway	PLOS ONE			English	Article							INNATE ANTIVIRAL RESPONSE; UBIQUITIN-LIKE PROTEIN; ATAXIA-TELANGIECTASIA; PARKINSONS-DISEASE; TUMOR-CELLS; DNA-REPAIR; HELA-CELLS; E2 ENZYME; SYSTEM; LIGASE	Ataxia Telangiectasia (A-T) is an inherited immunodeficiency disorder wherein mutation of the ATM kinase is responsible for the A-T pathogenesis. Although the precise role of ATM in A-T pathogenesis is still unclear, its function in responding to DNA damage has been well established. Here we demonstrate that in addition to its role in DNA repair, ATM also regulates proteasome-mediated protein turnover through suppression of the ISG15 pathway. This conclusion is based on three major pieces of evidence: First, we demonstrate that proteasome-mediated protein degradation is impaired in A-T cells. Second, we show that the reduced protein turnover is causally linked to the elevated expression of the ubiquitin-like protein ISG15 in A-T cells. Third, we show that expression of the ISG15 is elevated in A-T cells derived from various A-T patients, as well as in brain tissues derived from the ATM knockout mice and A-T patients, suggesting that ATM negatively regulates the ISG15 pathway. Our current findings suggest for the first time that proteasome-mediated protein degradation is impaired in A-T cells due to elevated expression of the ISG15 conjugation pathway, which could contribute to progressive neurodegeneration in A-T patients.	[Wood, Laurence M.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Sankar, Surendran; Reed, Ryan E.; Haas, Arthur L.; Desai, Shyamal D.] Louisiana State Univ, Sch Med, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA; [Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [McKinnon, Peter] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	University of Pennsylvania; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Rutgers State University New Brunswick; Rutgers State University Medical Center; St Jude Children's Research Hospital	Wood, LM (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	sdesai@lsuhsc.edu		Liu, Leroy/0000-0001-9396-763X; surendran, Sankar/0000-0003-1430-5393	LSU-Health Science Center School of Medicine; NIH/NINDS [1R21NS060960]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060960, R01NS037956] Funding Source: NIH RePORTER	LSU-Health Science Center School of Medicine; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by funds from the LSU-Health Science Center School of Medicine and NIH/NINDS grant 1R21NS060960 to S.D. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMANOLIS DP, 1979, J NEUROPATH EXP NEUR, V38, P475, DOI 10.1097/00005072-197909000-00003; Ardley HC, 2005, FEBS LETT, V579, P571, DOI 10.1016/j.febslet.2004.12.058; Ashburner BP, 1999, CANCER RES, V59, P5456; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; BODER E, 1985, ATAXIA TELANGIECTASI, V19, P1; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Chen SJ, 2004, BIOCHEM BIOPH RES CO, V317, P1037, DOI 10.1016/j.bbrc.2004.03.149; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2001, CANCER RES, V61, P5926; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Eilam R, 2003, NEUROSCIENCE, V121, P83, DOI 10.1016/S0306-4522(03)00322-1; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Haas AL, 2006, PROTEIN DEGRADATION, V5, P103; Hamerman JA, 2002, J IMMUNOL, V168, P2415, DOI 10.4049/jimmunol.168.5.2415; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Lavin MF, 2004, DNA REPAIR, V3, P1197, DOI 10.1016/j.dnarep.2004.03.011; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lim KL, 2007, EXPERT REV PROTEOMIC, V4, P769, DOI 10.1586/14789450.4.6.769; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Padovan E, 2002, CANCER RES, V62, P3453; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Pitha-Rowe I, 2004, J BIOL CHEM, V279, P18178, DOI 10.1074/jbc.M309259200; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; SiddooAtwal C, 1996, CANCER RES, V56, P443; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; TSCHERNE JS, 1975, ANTIMICROB AGENTS CH, V8, P479, DOI 10.1128/AAC.8.4.479; Ulane CM, 2005, J VIROL, V79, P10180, DOI 10.1128/JVI.79.16.10180-10189.2005; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	60	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16422	10.1371/journal.pone.0016422	http://dx.doi.org/10.1371/journal.pone.0016422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298066	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800039
J	Steinmetz, R; Garshelis, DL; Chutipong, W; Seuaturien, N				Steinmetz, Robert; Garshelis, David L.; Chutipong, Wanlop; Seuaturien, Naret			The Shared Preference Niche of Sympatric Asiatic Black Bears and Sun Bears in a Tropical Forest Mosaic	PLOS ONE			English	Article							HABITAT SELECTION; HELARCTOS-MALAYANUS; COMMUNITY STRUCTURE; FEEDING ECOLOGY; COMPETITION; POPULATION; FRUGIVORY; PHENOLOGY; OVERLAP; TAIWAN	Background: Ecologically similar species often coexist by partitioning use of habitats or resources. Such partitioning can occur through divergent or shared niches. We investigated overlap in habitat use and spatial co-occurrence by sympatric Asiatic black bears and sun bears in three habitats in Thailand, and thereby assessed which niche model best accounts for their coexistence. Methods/Principal Findings: We used density of species-specific signs to assess habitat use. Signs of both bear species occurred in all three habitats, and on >60% of sampling transects. Both species fed mostly on fruit; insect feeding signs were uncommon, and were mostly from sun bears. Significant differences in habitat use occurred only in montane forest, the habitat in which fruit was most abundant; incidence of black bear sign there was six times higher than that of sun bears. Habitat use was similar between the two species in the other habitats, which comprised 85% of the area. Of 10 habitat attributes examined, fruiting tree density was the best predictor of occurrence for both species. Models that included interspecific competition (fresh foraging activity of the other species) were less supported than the top models without competition. Conclusions/Significance: Bear species co-occurrence at both coarse and fine spatial scales and use of the same resources (fruit trees) indicated common niche preferences. However, their habitat use differed in ways expected from their physical differences: larger black bears dominated in the most fruit-rich habitat, and smaller sun bears used less-preferred insects. These results indicate broadly overlapping fundamental niches combined with asymmetric competition-features consistent with the concept of shared preference niches. This model of the niche has received little attention in ecology, but appears to be relatively common in nature.	[Steinmetz, Robert; Seuaturien, Naret] World Wide Fund Nat Thailand, Conservat Biol Unit, Bangkok, Thailand; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MI USA; [Chutipong, Wanlop] King Mongkuts Univ Technol Thonburi, Conservat Ecol Program, Bangkok, Thailand	King Mongkuts University of Technology Thonburi	Steinmetz, R (corresponding author), World Wide Fund Nat Thailand, Conservat Biol Unit, Bangkok, Thailand.	robtyn@hotmail.com			World Wildlife Fund United Kingdom; World Wildlife Fund Netherlands; University of Minnesota	World Wildlife Fund United Kingdom; World Wildlife Fund Netherlands; University of Minnesota(University of Minnesota System)	This study was funded through grants from World Wildlife Fund United Kingdom (http://www.panda.org/united_kingdom/) and World Wildlife Fund Netherlands (http://www.panda.org/netherlands/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Department of National Parks, Wildlife, and Plant Conservation, and the National Research Council of Thailand, for granting permission for this research. We are grateful to Kietiphum Kaewplang for assistance in the field; to Chris Bingham, Sandy Weisberg, and Nicholas Gotelli for statistical advice; and to Surasak Srirattanaporn for GIS help. RS was supported by a Doctoral Dissertation Fellowship from the Graduate School, and by the Conservation Biology Program, University of Minnesota. We thank Dave Smith, Todd Arnold, Peter Jordan, Edward Cushing, and two anonymous reviewers for insights that helped us improve the paper. We thank Paiboon Sawetmelanon and Erb Chirng-saard, previous Superintendents of Thung Yai, for their assistance.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Apps CD, 2006, ECOGRAPHY, V29, P561, DOI 10.1111/j.0906-7590.2006.04564.x; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Buskirk SW, 2006, J WILDLIFE MANAGE, V70, P358, DOI 10.2193/0022-541X(2006)70[358:MFSORS]2.0.CO;2; Christiansen P, 2007, J ZOOL, V272, P423, DOI 10.1111/j.1469-7998.2006.00286.x; Christiansen P, 2008, J MORPHOL, V269, P896, DOI 10.1002/jmor.10643; CLARK JD, 1994, INT C BEAR RES MANAG, V9, P309; COLLINS NM, 1980, OECOLOGIA, V44, P263, DOI 10.1007/BF00572689; COSTELLO CM, 1994, INT C BEAR RES MAN, V9, P375; Creel S, 2001, CONSERV BIOL SER, V5, P35; CROME FHJ, 1988, ECOLOGY, V69, P1960, DOI 10.2307/1941173; Davis H, 2006, URSUS, V17, P41, DOI 10.2192/1537-6176(2006)17[41:IOPOSS]2.0.CO;2; DICKMAN CR, 1988, ECOLOGY, V69, P569, DOI 10.2307/1941006; Erdbrink DP., 1953, REV FOSSIL RECENT BE; Field A, 2013, DISCOVERING STAT USI; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; Garneau DE, 2008, MAMM BIOL, V73, P48, DOI 10.1016/j.mambio.2006.11.004; Garshelis David L., 2004, P53; Garshelis DL, 2008, FRONTIERS WILDLIFE S, P139; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Gotelli N., 2001, ECOSIM NULL MODELS S, V78, DOI 10.5281/zenodo.16504; Hara Masatoshi, 2002, Natural History Research (Chiba), V7, P1; HERRERO S, 1978, CARNIVORE, V1, P7; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Holm Greg W., 1999, Ursus, V11, P99; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; HTUN S, 2006, JAPAN BEAR NETWORK C, P45; Huygens OC, 2001, URSUS-SERIES, V12, P47; Huygens Oscar C., 2003, Ursus, V14, P236; Hwang MH, 2010, URSUS, V21, P81, DOI 10.2192/09GR024.1; Hwang MH, 2002, URSUS, V13, P111; IUCN, 2014, IUCN RED LIST THREAT; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; KOTLER BP, 1984, ECOLOGY, V65, P689, DOI 10.2307/1938041; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Lekagul B., 1988, MAMMALS THAILAND; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; MANJREKAR N, 1989, THESIS SAURASHTRA U; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; MATTSON DJ, 1991, CAN J ZOOL, V69, P2430, DOI 10.1139/z91-341; Maxwell J. F., 1995, Natural History Bulletin of the Siam Society, V43, P131; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McLoughlin PD, 2002, OECOLOGIA, V132, P102, DOI 10.1007/s00442-002-0941-5; Nakhasathien S., 1990, NOMINATION THUNG YAI; Neale JCC, 2001, OIKOS, V94, P236, DOI 10.1034/j.1600-0706.2001.940204.x; PHOONJAMPA R, 2002, THESIS KASETSART U B; PIMM SL, 1985, ECOLOGY, V66, P798, DOI 10.2307/1940541; REID D, 1991, MAMMALIA, V55, P221, DOI 10.1515/mamm.1991.55.2.221; Ritchie M, 2002, ECOL STU AN, V161, P109; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Schaller G.B., 1989, P212; SCHOEN JW, 1990, INT C BEAR, V8, P143; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; STEINMETZ R, DRY FORESTS IN PRESS; STEINMETZ R, ESTIMATING IN PRESS; STEINMETZ R, 2009, THESIS U MINNESOTA; Steinmetz R, 2008, J WILDLIFE MANAGE, V72, P814, DOI 10.2193/2007-098; Steinmetz R, 2006, CONSERV BIOL, V20, P1391, DOI 10.1111/j.1523-1739.2006.00505.x; Stewart KM, 2002, J MAMMAL, V83, P229, DOI 10.1644/1545-1542(2002)083&lt;0229:TDOEMD&gt;2.0.CO;2; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; THEBERGE JB, 1989, CAN J ZOOL, V67, P1285, DOI 10.1139/z89-183; Tougard C, 2001, PALAEOGEOGR PALAEOCL, V168, P337, DOI 10.1016/S0031-0182(00)00243-1; TUMBELAKA L, 2006, JAPAN BEAR NETWORK C, P73; VINITPORNSAWAN S, 2006, JAPAN BEAR NETWORK C, P50; WEBB EL, 2007, BOTANICAL EXPLORATIO; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Wisheu IC, 1998, OIKOS, V83, P246, DOI 10.2307/3546836; Wong ST, 2005, J TROP ECOL, V21, P627, DOI 10.1017/S0266467405002622; Wong ST, 2004, BIOL CONSERV, V119, P169, DOI 10.1016/j.biocon.2003.10.029; Wong ST, 2002, URSUS, V13, P127; Young KA, 2004, ECOLOGY, V85, P134, DOI 10.1890/02-0402; [No title captured]	75	27	30	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14509	10.1371/journal.pone.0014509	http://dx.doi.org/10.1371/journal.pone.0014509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283792	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200001
J	Raybuck, JD; Lattal, KM				Raybuck, Jonathan D.; Lattal, K. Matthew			Double Dissociation of Amygdala and Hippocampal Contributions to Trace and Delay Fear Conditioning	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; REVERSIBLE INACTIVATION; DORSAL HIPPOCAMPUS; ENTORHINAL CORTEX; PERIRHINAL CORTEX; C57BL/6 MICE; EXPRESSION; MEMORY; RAT	A key finding in studies of the neurobiology of learning memory is that the amygdala is critically involved in Pavlovian fear conditioning. This is well established in delay-cued and contextual fear conditioning; however, surprisingly little is known of the role of the amygdala in trace conditioning. Trace fear conditioning, in which the CS and US are separated in time by a trace interval, requires the hippocampus and prefrontal cortex. It is possible that recruitment of cortical structures by trace conditioning alters the role of the amygdala compared to delay fear conditioning, where the CS and US overlap. To investigate this, we inactivated the amygdala of male C57BL/6 mice with GABA (A) agonist muscimol prior to 2-pairing trace or delay fear conditioning. Amygdala inactivation produced deficits in contextual and delay conditioning, but had no effect on trace conditioning. As controls, we demonstrate that dorsal hippocampal inactivation produced deficits in trace and contextual, but not delay fear conditioning. Further, pre- and post-training amygdala inactivation disrupted the contextual but the not cued component of trace conditioning, as did muscimol infusion prior to 1- or 4-pairing trace conditioning. These findings demonstrate that insertion of a temporal gap between the CS and US can generate amygdala-independent fear conditioning. We discuss the implications of this surprising finding for current models of the neural circuitry involved in fear conditioning.	[Raybuck, Jonathan D.; Lattal, K. Matthew] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	Oregon Health & Science University	Raybuck, JD (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	raybuck@ohsu.edu	Lattal, K/W-8386-2019		National Institutes of Health-NIMH/NIDA [RO1MH077111, RO1DA025922];  [T32DA007262]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262, R01DA025922] Funding Source: NIH RePORTER	National Institutes of Health-NIMH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute on Drug Abuse (NIDA)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank grant support from National Institutes of Health-NIMH/NIDA (RO1MH077111 & RO1DA025922, KML) and JD Raybuck was supported by (T32DA007262, KA Neve). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier T, 2007, COMPUTATION STAT, V22, P91, DOI 10.1007/s00180-007-0023-6; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Blum S, 2006, NEUROREPORT, V17, P341, DOI 10.1097/01.wnr.0000201509.53750.bc; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410; Gilmartin MR, 2005, BEHAV NEUROSCI, V119, P1496, DOI 10.1037/0735-7044.119.6.1496; Gould TJ, 1999, BEHAV BRAIN RES, V102, P31, DOI 10.1016/S0166-4328(98)00157-0; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Hui IR, 2006, NEUROBIOL LEARN MEM, V86, P160, DOI 10.1016/j.nlm.2006.02.002; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Kholodar-Smith DB, 2008, NEUROBIOL LEARN MEM, V90, P537, DOI 10.1016/j.nlm.2008.06.006; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Lewis MC, 2007, HIPPOCAMPUS, V17, P462, DOI 10.1002/hipo.20284; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 1999, BEHAV NEUROSCI, V113, P283, DOI 10.1037/0735-7044.113.2.283; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ponnusamy R, 2007, NEUROSCIENCE, V147, P919, DOI 10.1016/j.neuroscience.2007.04.026; Quinn JJ, 2008, LEARN MEMORY, V15, P368, DOI 10.1101/lm.813608; Radulovic J, 2010, REV NEUROSCIENCE, V21, P1; Raybuck JD, 2010, NEUROBIOL LEARN MEM, V94, P353, DOI 10.1016/j.nlm.2010.08.001; Raybuck JD, 2009, EUR J NEUROSCI, V29, P377, DOI 10.1111/j.1460-9568.2008.06580.x; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Stafford JM, 2009, LEARN MEMORY, V16, P494, DOI 10.1101/lm.1452209; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906	42	75	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15982	10.1371/journal.pone.0015982	http://dx.doi.org/10.1371/journal.pone.0015982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OH	21283812	gold, Green Submitted, Green Published			2022-12-27	WOS:000286520600017
J	Girard, P; Koenig-Robert, R				Girard, Pascal; Koenig-Robert, Roger			Ultra-Rapid Categorization of Fourier-Spectrum Equalized Natural Images: Macaques and Humans Perform Similarly	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; TOP-DOWN FACILITATION; VISUAL OBJECT RECOGNITION; FRONTAL EYE FIELD; NONHUMAN-PRIMATES; PROCESSING SPEED; FACE PERCEPTION; MONKEYS; REPRESENTATIONS; INFORMATION	Background: Comparative studies of cognitive processes find similarities between humans and apes but also monkeys. Even high-level processes, like the ability to categorize classes of object from any natural scene under ultra-rapid time constraints, seem to be present in rhesus macaque monkeys (despite a smaller brain and the lack of language and a cultural background). An interesting and still open question concerns the degree to which the same images are treated with the same efficacy by humans and monkeys when a low level cue, the spatial frequency content, is controlled. Methodology/Principal Findings: We used a set of natural images equalized in Fourier spectrum and asked whether it is still possible to categorize them as containing an animal and at what speed. One rhesus macaque monkey performed a forced-choice saccadic task with a good accuracy (67.5% and 76% for new and familiar images respectively) although performance was lower than with non-equalized images. Importantly, the minimum reaction time was still very fast (100 ms). We compared the performances of human subjects with the same setup and the same set of (new) images. Overall mean performance of humans was also lower than with original images (64% correct) but the minimum reaction time was still short (140 ms). Conclusion: Performances on individual images (% correct but not reaction times) for both humans and the monkey were significantly correlated suggesting that both species use similar features to perform the task. A similar advantage for full-face images was seen for both species. The results also suggest that local low spatial frequency information could be important, a finding that fits the theory that fast categorization relies on a rapid feedforward magnocellular signal.	[Girard, Pascal; Koenig-Robert, Roger] Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit CerCo, Toulouse, France; [Girard, Pascal; Koenig-Robert, Roger] CerCo, Ctr Natl Rech Sci CNRS, Toulouse, France; [Girard, Pascal] Inst Natl Sante & Rech Med INSERM, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Girard, P (corresponding author), Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit CerCo, Toulouse, France.	pascal.girard@cerco.ups-tlse.fr	Girard, Pascal/C-6427-2009		Centre National de la Recherche Scientifique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	The work was funded by Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BIEDERMAN I, 1991, COGNITIVE PSYCHOL, V23, P393, DOI 10.1016/0010-0285(91)90014-F; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Blanke O, 1999, NEUROREPORT, V10, P925, DOI 10.1097/00001756-199904060-00006; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Cook R, 2009, P NATL ACAD SCI USA, V106, P9530, DOI 10.1073/pnas.0903378106; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; DAMATO MR, 1988, J EXP PSYCHOL ANIM B, V14, P43, DOI 10.1037/0097-7403.14.1.43; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Deregowski J B, 1972, Perception, V1, P417, DOI 10.1068/p010417; DIXON D, 1981, MAN ZOOLOGY FUTURE, P124; Dufour V, 2006, BEHAV PROCESS, V73, P107, DOI 10.1016/j.beproc.2006.04.006; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Fabre-Thorpe M, 2003, PHILOS T R SOC B, V358, P1215, DOI 10.1098/rstb.2003.1310; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Gaspar CM, 2009, VISION RES, V49, P3001, DOI 10.1016/j.visres.2009.09.021; Gilchrist ID, 2006, EXP BRAIN RES, V173, P708, DOI 10.1007/s00221-006-0455-1; Girard P, 2008, ANIM COGN, V11, P485, DOI 10.1007/s10071-008-0139-2; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Honey C, 2008, J VISION, V8, DOI 10.1167/8.12.9; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Joubert OR, 2009, J VISION, V9, DOI 10.1167/9.1.2; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kirchner H, 2009, J NEUROSCI, V29, P7599, DOI 10.1523/JNEUROSCI.1233-09.2009; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Lloyd-Jones TJ, 2010, EXP PSYCHOL, V57, P117, DOI 10.1027/1618-3169/a000015; Mace MJM, 2010, ANIM COGN, V13, P405, DOI 10.1007/s10071-009-0290-4; Mace MJM, 2005, NEUROREPORT, V16, P349; NOWAK LG, 1997, EXTRASTRIATE VISUAL, P205; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Pascalis O, 1999, CAH PSYCHOL COGN, V18, P889; Passingham R, 2009, CURR OPIN NEUROBIOL, V19, P6, DOI 10.1016/j.conb.2009.01.002; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; Tompa T, 2010, BRAIN RES REV, V62, P165, DOI 10.1016/j.brainresrev.2009.10.001; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Wichmann FA, 2010, J VISION, V10, DOI 10.1167/10.4.6	46	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16453	10.1371/journal.pone.0016453	http://dx.doi.org/10.1371/journal.pone.0016453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326600	Green Published, gold, Green Submitted			2022-12-27	WOS:000287037000011
J	Lemmens, SG; Born, JM; Martens, EA; Martens, MJ; Westerterp-Plantenga, MS				Lemmens, Sofie G.; Born, Jurriaan M.; Martens, Eveline A.; Martens, Mieke J.; Westerterp-Plantenga, Margriet S.			Influence of Consumption of a High-Protein vs. High-Carbohydrate Meal on the Physiological Cortisol and Psychological Mood Response in Men and Women	PLOS ONE			English	Article							PITUITARY-ADRENAL-AXIS; EATING BEHAVIOR; ACUTE STRESS; FOOD; OBESITY; RICH; QUESTIONNAIRE; APPETITE; GLUCOSE; EVENTS	Consumption of meals with different macronutrient contents, especially high in carbohydrates, may influence the stress-induced physiological and psychological response. The objective of this study was to investigate effects of consumption of a high-protein vs. high-carbohydrate meal on the physiological cortisol response and psychological mood response. Subjects (n = 38, 19m/19f, age = 25 +/- 69 yrs, BMI = 25.0 +/- 63.3 kg/m(2)) came to the university four times, fasted, for either condition: rest-protein, stress-protein, rest-carbohydrate, stress-carbohydrate (randomized cross-over design). Stress was induced by means of a psychological computer-test. The test-meal was either a high-protein meal (En% P/C/F 65/5/30) or a high-carbohydrate meal (En% P/C/F 6/64/30), both meals were matched for energy density (4 kJ/g) and daily energy requirements (30%). Per test-session salivary cortisol levels, appetite profile, mood state and level of anxiety were measured. High hunger, low satiety (81 +/- 16, 12 +/- 15 mmVAS) confirmed the fasted state. The stress condition was confirmed by increased feelings of depression, tension, anger, anxiety (AUC stress vs. rest p<0.02). Consumption of the high-protein vs. high-carbohydrate meal did not affect feelings of depression, tension, anger, anxiety. Cortisol levels did not differ between the four test-sessions in men and women (AUC nmol.min/L p>0.1). Consumption of the test-meals increased cortisol levels in men in all conditions (p<0.01), and in women in the rest-protein and stress-protein condition (p<0.03). Men showed higher cortisol levels than women (AUC nmol.min/L p<0.0001). Consumption of meals with different macronutrient contents, i.e. high-protein vs. high-carbohydrate, does not influence the physiological and psychological response differentially. Men show a higher meal-induced salivary cortisol response compared with women.	[Lemmens, Sofie G.; Born, Jurriaan M.; Martens, Eveline A.; Martens, Mieke J.; Westerterp-Plantenga, Margriet S.] Top Inst Food & Nutr, Wageningen, Netherlands; [Lemmens, Sofie G.; Born, Jurriaan M.; Martens, Eveline A.; Martens, Mieke J.; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands	Top Institute Food & Nutrition; Maastricht University	Lemmens, SG (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	s.lemmens@hb.unimaas.nl						Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; ALBRECHT RR, 1989, J PERS ASSESS, V53, P31, DOI 10.1207/s15327752jpa5301_4; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; BORN JM, 2009, INT J OBES; Bourrilhon C, 2010, HORM METAB RES, V42, P31, DOI 10.1055/s-0029-1237727; Bray GA, 2007, ANN NUTR METAB, V51, P163, DOI 10.1159/000103277; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002; Gibson EL, 1999, PSYCHOSOM MED, V61, P214, DOI 10.1097/00006842-199903000-00014; Gonzalez-Bono E, 2002, HORM BEHAV, V41, P328, DOI 10.1006/hbeh.2002.1766; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hemmink GJM, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01327.x; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kyrou I, 2006, ANN NY ACAD SCI, V1083, P77, DOI 10.1196/annals.1367.008; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001; Lovallo WR, 2006, PHARMACOL BIOCHEM BE, V83, P441, DOI 10.1016/j.pbb.2006.03.005; Markus CR, 1998, APPETITE, V31, P49, DOI 10.1006/appe.1997.0155; Markus R, 2000, PHYSIOL BEHAV, V70, P333, DOI 10.1016/S0031-9384(00)00265-1; MARTENS MJ, 2010, PHYSL BEHAV; MCARDLE WD, 1996, EXERCISE PHYSL; Michaud K, 2008, STRESS, V11, P177, DOI 10.1080/10253890701727874; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Peeters F, 2003, PSYCHOSOM MED, V65, P836, DOI 10.1097/01.PSY.0000088594.17747.2E; Peters ML, 1998, PSYCHONEUROENDOCRINO, V23, P1, DOI 10.1016/S0306-4530(97)00082-6; Rutters F, 2009, OBESITY, V17, P72, DOI 10.1038/oby.2008.493; Rutters F, 2010, CLIN ENDOCRINOL, V72, P738, DOI 10.1111/j.1365-2265.2009.03712.x; SLAG MF, 1981, METABOLISM, V30, P1104, DOI 10.1016/0026-0495(81)90055-X; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Svec F, 1997, PSYCHONEUROENDOCRINO, V22, pS115, DOI 10.1016/S0306-4530(97)00022-X; Takeda Eiji, 2004, J Med Invest, V51, P139, DOI 10.2152/jmi.51.139; TENENBAUM G, 1985, J CLIN PSYCHOL, V41, P239, DOI 10.1002/1097-4679(198503)41:2<239::AID-JCLP2270410218>3.0.CO;2-5; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; VANCAUTER E, 1992, AM J PHYSIOL, V262, pE467, DOI 10.1152/ajpendo.1992.262.4.E467; Vicennati V, 2002, J CLIN ENDOCR METAB, V87, P3984, DOI 10.1210/jc.87.8.3984; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Zellner DA, 2006, PHYSIOL BEHAV, V87, P789, DOI 10.1016/j.physbeh.2006.01.014	42	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16826	10.1371/journal.pone.0016826	http://dx.doi.org/10.1371/journal.pone.0016826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	717IJ	21304815	Green Submitted, Green Published, gold			2022-12-27	WOS:000287036600030
J	Locey, KJ; White, EP				Locey, Kenneth J.; White, Ethan P.			Simple Structural Differences between Coding and Noncoding DNA	PLOS ONE			English	Article							SEQUENCES; PATTERN	Background: The study of large-scale genome structure has revealed patterns suggesting the influence of evolutionary constraints on genome evolution. However, the results of these studies can be difficult to interpret due to the conceptual complexity of the analyses. This makes it difficult to understand how observed statistical patterns relate to the physical distribution of genomic elements. We use a simpler and more intuitive approach to evaluate patterns of genome structure. Methodology/Principal Findings: We used randomization tests based on Morisita's Index of aggregation to examine average differences in the distribution of purines and pyrimidines among coding and noncoding regions of 261 chromosomes from 223 microbial genomes representing 21 phylum level groups. Purines and pyrimidines were aggregated in the noncoding DNA of 86% of genomes, but were only aggregated in the coding regions of 52% of genomes. Coding and noncoding DNA differed in aggregation in 94% of genomes. Noncoding regions were more aggregated than coding regions in 91% of these genomes. Genome length appears to limit aggregation, but chromosome length does not. Chromosomes from the same species are similarly aggregated despite substantial differences in length. Aggregation differed among taxonomic groups, revealing support for a previously reported pattern relating genome structure to environmental conditions. Conclusions/Significance: Our approach revealed several patterns of genome structure among different types of DNA, different chromosomes of the same genome, and among different taxonomic groups. Similarity in aggregation among chromosomes of varying length from the same genome suggests that individual chromosome structure has not evolved independently of the general constraints on genome structure as a whole. These patterns were detected using simple and readily interpretable methods commonly used in other areas of biology.	[Locey, Kenneth J.; White, Ethan P.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [White, Ethan P.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Locey, KJ (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	locey@biology.usu.edu		White, Ethan/0000-0001-6728-7745				Allen TE, 2006, PLOS COMPUT BIOL, V2, P13, DOI 10.1371/journal.pcbi.0020002; Almeida JS, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-6; Almirantis Y, 1997, CLUSTERED STRUCTURE; Bohlin J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-346; Cristea PD, 2002, J CELL MOL MED, V6, P279, DOI 10.1111/j.1582-4934.2002.tb00196.x; DEWEY SE, 1988, EVOLUTION, V42, P834, DOI 10.1111/j.1558-5646.1988.tb02504.x; Garte S, 2004, J THEOR BIOL, V230, P251, DOI 10.1016/j.jtbi.2004.05.015; HURLBERT SH, 1990, OIKOS, V58, P257, DOI 10.2307/3545216; Li M, 2001, BIOINFORMATICS, V17, P149, DOI 10.1093/bioinformatics/17.2.149; Marenduzzo D, 2006, BIOPHYS J, V90, P3712, DOI 10.1529/biophysj.105.077685; Mitra A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007978; Morisita M., 1971, Researches Popul Ecol Kyoto Univ, V13, P1, DOI 10.1007/BF02522010; Morisita M., 1959, MEMOIRS FS KYUSHU U, V2, P215; Morisita M., 1962, RES POPUL ECOL, V4, P1, DOI [10.1007/BF02533903, DOI 10.1007/BF02533903]; Nandy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006829; Oliver JL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-107; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; RICKLEFS RE, 1980, ECOLOGY, V61, P1019, DOI 10.2307/1936817; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P4264, DOI 10.1093/nar/gkf549; SAKAI AK, 1983, AM NAT, V122, P489, DOI 10.1086/284151; Wang YW, 2005, GENE, V346, P173, DOI 10.1016/j.gene.2004.10.021; WILLIAMSON GB, 1975, ECOLOGY, V56, P727, DOI 10.2307/1935509; Zhou LQ, 2005, J THEOR BIOL, V232, P559, DOI 10.1016/j.jtbi.2004.09.002	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14651	10.1371/journal.pone.0014651	http://dx.doi.org/10.1371/journal.pone.0014651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304908	gold, Green Published			2022-12-27	WOS:000287036600004
J	el Barzouhi, A; Elias-Smale, S; Dehghan, A; Vliegenthart-Proenca, R; Oudkerk, M; Hofman, A; Witteman, JCM				el Barzouhi, Abdelilah; Elias-Smale, Suzette; Dehghan, Abbas; Vliegenthart-Proenca, Rozemarijn; Oudkerk, Matthijs; Hofman, Albert; Witteman, Jacqueline C. M.			Renal Function Is Related to Severity of Coronary Artery Calcification in Elderly Persons: The Rotterdam Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; BEAM COMPUTED-TOMOGRAPHY; CARDIOVASCULAR-DISEASE; SERUM CREATININE; RISK-FACTOR; CLINICAL EPIDEMIOLOGY; YOUNG-ADULTS; PREDICTION; EVENTS	Background: Coronary artery calcification (CAC) has been proposed to be the underlying mechanism of the increased risk of coronary heart disease with reductions in glomerular filtration rate (GFR). Since renal function diminishes with aging we examined the association between GFR and CAC in the Rotterdam Study, a population-based study of elderly individuals. Methods: The study was performed in 1703 subjects without a history of coronary heart disease. GFR was estimated using the modification of diet in renal disease equation. We used analysis of covariance to test for mean differences in CAC between GFR tertiles. Results: The mean CAC scores in the middle and lowest GFR tertile did not significantly differ from the mean CAC score in the highest GFR tertile (geometric mean CAC score 4.1 and 4.3 vs 4.2). In a multivariable model the mean CAC score did also not differ between the GFR tertiles. As the interaction term between age and GFR was significant (P = 0.037), we divided the population in two age categories based on median age of 70 years. Below 70 years, the mean CAC scores did not differ between the GFR tertiles. Above median age, mean CAC score in the lowest GFR tertile was significantly higher than the mean CAC score in the highest tertile in a multivariable model (CAC 4.9 vs 4.5, p = 0.010). Conclusion: In this population-based study we observed that the association between CAC and GFR is modified by age. In participants at least 70 years of age, a decrease in GFR was associated with increased CAC.	[el Barzouhi, Abdelilah; Elias-Smale, Suzette; Dehghan, Abbas; Hofman, Albert; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Vliegenthart-Proenca, Rozemarijn; Oudkerk, Matthijs] Univ Groningen, Dept Radiobiol, Univ Med Ctr Groningen, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen	el Barzouhi, A (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	a.barzouhiel@erasmusmc.nl	Elias-Smale, Suzette/F-2410-2014; Dehghan, Abbas/ABE-7377-2020; Dehghan, Abbas/B-9896-2008	Dehghan, Abbas/0000-0001-6403-016X; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Heart Foundation [2003B179]; Netherlands Organization for Scientific Research, Health Research and Development Council [28-2975, 97-1-364]; Municipality of Rotterdam	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research, Health Research and Development Council(Netherlands Organization for Scientific Research (NWO)); Municipality of Rotterdam	This study is supported by grants from the Netherlands Heart Foundation (2003B179), Netherlands Organization for Scientific Research, Health Research and Development Council (28-2975 and 97-1-364), and the Municipality of Rotterdam. None of the funders had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abaci A, 2007, CORONARY ARTERY DIS, V18, P463, DOI 10.1097/MCA.0b013e3282c1fd86; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; APPEL G, 1991, KIDNEY INT, V39, P169, DOI 10.1038/ki.1991.22; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2004, CURR OPIN NEPHROL HY, V13, P73, DOI 10.1097/00041552-200401000-00011; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Douville P, 2009, NEPHROL DIAL TRANSPL, V24, P97, DOI 10.1093/ndt/gfn473; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fox CS, 2004, KIDNEY INT, V66, P2017, DOI 10.1111/j.1523-1755.2004.00973.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Ix JH, 2008, J AM SOC NEPHROL, V19, P579, DOI 10.1681/ASN.2007070765; KAUFMANN RB, 1994, RADIOLOGY, V190, P347, DOI 10.1148/radiology.190.2.8284380; KEANE WF, 1993, AM J KIDNEY DIS, V21, P43, DOI 10.1016/0272-6386(93)70094-F; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Kramer H, 2005, J AM SOC NEPHROL, V16, P507, DOI 10.1681/ASN.2004070610; Kundhal K, 2005, NEPHRON CLIN PRACT, V101, pC47, DOI 10.1159/000086221; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Pajunen P, 2002, EUR J CLIN INVEST, V32, P472, DOI 10.1046/j.1365-2362.2002.01019.x; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schrier RW, 2006, J AM COLL CARDIOL, V47, P1, DOI 10.1016/j.jacc.2005.07.067; Seyahi N, 2007, AM J KIDNEY DIS, V49, P143, DOI 10.1053/j.ajkd.2006.10.016; Shields J P, 1996, Am J Card Imaging, V10, P91; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Tuttle KR, 2009, CLIN J AM SOC NEPHRO, V4, P1968, DOI 10.2215/CJN.01250209; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	44	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16738	10.1371/journal.pone.0016738	http://dx.doi.org/10.1371/journal.pone.0016738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311747	gold, Green Submitted, Green Published			2022-12-27	WOS:000287036200037
J	Zubko, E; Kunova, A; Meyer, P				Zubko, Elena; Kunova, Andrea; Meyer, Peter			Sense and Antisense Transcripts of Convergent Gene Pairs in Arabidopsis thaliana Can Share a Common Polyadenylation Region	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; POSTTRANSCRIPTIONAL REGULATION; MOUSE GENES; EXPRESSION; RECEPTOR; OVERLAP; DEPENDS; SIGNALS; ELEMENT; GENOME	The Arabidopsis genome contains a large number of gene pairs that encode sense and antisense transcripts with overlapping 39 regions, indicative for a potential role of natural antisense transcription in regulating sense gene expression or transcript processing. When we mapped poly(A) transcripts of three plant gene pairs with long overlapping antisense transcripts, we identified an unusual transcript composition for two of the three gene pairs. Both genes pairs encoded a class of long sense transcripts and a class of short sense transcripts that terminate within the same polyadenylation region as the antisense transcripts encoded by the opposite strand. We find that the presence of the short sense transcript was not dependent on the expression of an antisense transcript. This argues against the assumption that the common termination region for sense and antisense poly(A) transcripts is the result of antisense-specific regulation. We speculate that for some genes evolution may have especially favoured alternative polyadenylation events that shorten transcript length for gene pairs with overlapping sense/antisense transcription, if this reduces the likelihood for dsRNA formation and transcript degradation.	[Zubko, Elena; Kunova, Andrea; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Zubko, E (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk	Kunova, Andrea/F-3769-2016; Kunova, Andrea/AAB-8717-2022	Kunova, Andrea/0000-0002-9210-4792; Kunova, Andrea/0000-0002-9210-4792	BBSRC; Epigenome Network of Excellence; BBSRC [BB/D015774/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015774/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Epigenome Network of Excellence; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	E.Z. and A.K. were supported by BBSRC (http://www.bbsrc.ac.uk/) and by the Epigenome Network of Excellence (http://www.epigenome-noe.net/WWW/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batshake B, 1996, BIOCHEM BIOPH RES CO, V227, P70, DOI 10.1006/bbrc.1996.1469; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Carlile M, 2008, PHYSIOL GENOMICS, V34, P95, DOI 10.1152/physiolgenomics.00004.2008; Dahary D, 2005, GENOME RES, V15, P364, DOI 10.1101/gr.3308405; Danckwardt S, 2007, EMBO J, V26, P2658, DOI 10.1038/sj.emboj.7601699; de Jong M, 2006, PLANT J, V46, P708, DOI 10.1111/j.1365-313X.2006.02724.x; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; FEHER A, 1991, PLANT CELL TISS ORG, V27, P105, DOI 10.1007/BF00048214; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Hedtke B, 2009, NUCLEIC ACIDS RES, V37, P3739, DOI 10.1093/nar/gkp241; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; KOES RE, 1989, PLANT MOL BIOL, V12, P213, DOI 10.1007/BF00020506; Li VY, 2003, DEV DYNAM, V228, P606; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; MANEN JF, 1993, PLANTA, V191, P289, DOI 10.1007/BF00199763; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Schwartz AM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1377, DOI 10.1134/S0006297906120145; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vejlupkova Z, 2003, MAIZE GENETICS COOPE, V7, P24; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zubko E, 2007, PLANT J, V52, P1131, DOI 10.1111/j.1365-313X.2007.03309.x	41	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16769	10.1371/journal.pone.0016769	http://dx.doi.org/10.1371/journal.pone.0016769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311762	Green Published, Green Submitted, gold			2022-12-27	WOS:000287036200039
J	Colak, G; Keillor, JW; Johnson, GVW				Colak, Gozde; Keillor, Jeffrey W.; Johnson, Gail V. W.			Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation	PLOS ONE			English	Article							ERYTHROCYTE BAND 4.2; TISSUE TRANSGLUTAMINASE; CYTOPLASMIC DOMAIN; GTP; FIBRONECTIN; EXPRESSION; INTERACTS; ADHESION; MUTATION; CALCIUM	Transglutaminase 2 (TG2) is a hypoxia-responsive protein that is a calcium-activated transamidating enzyme, a GTPase and a scaffolding/linker protein. Upon activation TG2 undergoes a large conformational change, which likely affects not only its enzymatic activities but its non-catalytic functions as well. The focus of this study was on the role of transamidating activity, conformation and localization of TG2 in ischemic cell death. Cells expressing a GTP binding deficient form of TG2 (TG2-R580A) with high basal transamidation activity and a more extended conformation showed significantly increased cell death in response to oxygen-glucose deprivation; however, targeting TG2-R580A to the nucleus abrogated its detrimental role in oxygen-glucose deprivation. Treatment of cells expressing wild type TG2, TG2-C277S (a transamidating inactive mutant) and TG2-R580A with Cp4d, a reversible TG2 inhibitor, did not affect cell death in response to oxygen-glucose deprivation. These findings indicate that the pro-cell death effects of TG2 are dependent on its localization to the cytosol and independent of its transamidation activity. Further, the conformational state of TG2 is likely an important determinant in cell survival and the prominent function of TG2 in ischemic cell death is as a scaffold to modulate cellular processes.	[Colak, Gozde; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA; [Keillor, Jeffrey W.] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Johnson, Gail V. W.] Univ Rochester, Dept Anesthesiol, Rochester, NY USA	University of Rochester; Universite de Montreal; University of Rochester	Colak, G (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health [NS041744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant NS041744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Ahn JS, 2008, BIOCHEM BIOPH RES CO, V376, P743, DOI 10.1016/j.bbrc.2008.09.048; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Fesus L, 2005, FEBS LETT, V579, P3297, DOI 10.1016/j.febslet.2005.03.063; FILIANO AJ, 2010, NEUROBIOL DIS; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Ientile R, 2004, NEUROSCI LETT, V363, P173, DOI 10.1016/j.neulet.2004.04.003; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; KORSGREN C, 1988, J BIOL CHEM, V263, P10212; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; LORAND LG, 2003, NAT REV MOL CELL BIO; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Pardin C, 2008, CHEM BIOL DRUG DES, V72, P189, DOI 10.1111/j.1747-0285.2008.00696.x; Peng XJ, 1999, FEBS LETT, V446, P35, DOI 10.1016/S0014-5793(99)00018-6; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Ruan QM, 2007, J NEUROCHEM, V102, P25, DOI 10.1111/j.1471-4159.2007.04491.x; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; THORPE GHG, 1986, METHOD ENZYMOL, V133, P331; Tolentino PJ, 2004, J NEUROCHEM, V89, P1301, DOI 10.1111/j.1471-4159.2004.02436.x; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tucholski J, 2002, J NEUROCHEM, V81, P780, DOI 10.1046/j.1471-4159.2002.00859.x; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang JW, 1998, J NEUROCHEM, V71, P240	39	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16665	10.1371/journal.pone.0016665	http://dx.doi.org/10.1371/journal.pone.0016665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304968	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300111
J	Villard, PH; Barlesi, F; Armand, M; Dao, TMA; Pascussi, JM; Fouchier, F; Champion, S; Dufour, C; Ginies, C; Khalil, A; Amiot, MJ; Barra, Y; Seree, E				Villard, Pierre-Henri; Barlesi, Fabrice; Armand, Martine; Dao, Thi-Mai-Anh; Pascussi, Jean-Marc; Fouchier, Francis; Champion, Serge; Dufour, Claire; Ginies, Christian; Khalil, Ayman; Amiot, Marie-Josephe; Barra, Yves; Seree, Eric			CYP1A1 Induction in the Colon by Serum: Involvement of the PPAR alpha Pathway and Evidence for a New Specific Human PPRE alpha Site	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; LIPID-PEROXIDATION PRODUCTS; AH RECEPTOR; FATTY-ACIDS; VOLATILE BIOMARKERS; CYTOCHROME P4501A1; FOOD SOURCES; CANCER; DIETARY; WOMEN	Background: We previously showed that blood serum induced cytochrome P450 1A1 (CYP1A1) monooxygenase expression in vitro. Objective: Our purpose was (i) to identify the molecular mechanism involved and (ii) to characterize the inducer compound(s) in serum involved at least in part. Methods: Serum was fractionated on hydrophobic columns. PPAR alpha involvement was demonstrated by gene reporter assays, DNA mutagenesis and EMSA. Gene expression was evaluated by qRT-PCR. Serum samples were analyzed using HS-SPME-GC-MS. Results: The inductive effect of serum did not depend on the AhR pathway and was enhanced by cotransfection of PPAR alpha cDNA. Mutations in the PPAR response elements of the CYP1A1 gene promoter suppressed this effect. One of the PPRE sites appeared highly specific for human PPAR alpha, an unreported PPRE property. A link was found between CYP1A1 inducibility and serum hydrophobic compounds. Characterization of sera showed that hexanal, a metabolite produced by peroxidation of linoleic acid, was involved in CYP1A1 induction by serum, possibly along with other serum entities. Conclusion: We demonstrate that serum induces CYP1A1 via the PPAR alpha pathway and that hexanal is one of the serum inducers. The two PPRE sites within the CYP1A1 promoter are functional and one of them is specific for PPAR alpha.	[Villard, Pierre-Henri; Armand, Martine; Dao, Thi-Mai-Anh; Fouchier, Francis; Champion, Serge; Khalil, Ayman; Amiot, Marie-Josephe; Barra, Yves; Seree, Eric] INRA, UMR1260, Marseille, France; [Villard, Pierre-Henri; Armand, Martine; Dao, Thi-Mai-Anh; Fouchier, Francis; Champion, Serge; Khalil, Ayman; Amiot, Marie-Josephe; Barra, Yves; Seree, Eric] Univ Aix Marseille 2, Fac Med, IPHM IFR 125, Marseille, France; [Barlesi, Fabrice] Univ Aix Marseille 2, Assistance Publ Hop Marseille, Marseille, France; [Pascussi, Jean-Marc] Univ Perpignan, CNRS, UMR 5096, IRD, Montpellier, France; [Dufour, Claire; Ginies, Christian] Univ Avignon, INRA, UMR Safety & Qual Plant Prod 408, Avignon, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Avignon Universite; INRAE	Villard, PH (corresponding author), INRA, UMR1260, Marseille, France.	pierre-henri.villard@pharmacie.univ-mrs.fr; eric.seree@pharmacie.univ-mrs.fr	Amiot, Marie Josephe/C-4457-2015; Khalil, Ayman/F-4834-2019; ARMAND, Martine/O-5780-2016; pascussi, jean marc/F-9311-2013; AMIOT, MARIE JOSEPHE/N-8894-2019; Amiot, Marie Josephe/M-1203-2017	Khalil, Ayman/0000-0001-5054-7408; ARMAND, Martine/0000-0002-8712-6620; pascussi, jean marc/0000-0002-5168-5383; AMIOT, MARIE JOSEPHE/0000-0003-4563-4587; Amiot, Marie Josephe/0000-0003-4563-4587; Dufour, Claire/0000-0002-1745-7053	Assistance Publique - Ho'pitaux de Marseille [AP-HM 2001]	Assistance Publique - Ho'pitaux de Marseille	This study was promoted by the Assistance Publique - Ho'pitaux de Marseille (Promotion AP-HM 2001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; Bakewell L, 2006, BRIT J NUTR, V96, P93, DOI 10.1079/BJN20061801; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Coste TC, 2008, CLIN CHEM, V54, P388, DOI 10.1373/clinchem.2007.094623; Deng CH, 2004, J CHROMATOGR B, V808, P269, DOI 10.1016/j.jchromb.2004.05.015; ESTERBAUER H, 1989, FREE RADICAL BIO MED, V7, P197, DOI 10.1016/0891-5849(89)90015-4; Eubank DW, 2001, J BIOL CHEM, V276, P30561, DOI 10.1074/jbc.M103019200; Fallone F, 2004, BIOCHEM BIOPH RES CO, V322, P551, DOI 10.1016/j.bbrc.2004.07.153; Folch J., 1957, J BIOL CHEM, V226, P498; Goode EL, 2007, CARCINOGENESIS, V28, P328, DOI 10.1093/carcin/bgl135; Guengerich FP, 2000, CARCINOGENESIS, V21, P345, DOI 10.1093/carcin/21.3.345; Guigal N, 2000, BIOCHEM BIOPH RES CO, V267, P572, DOI 10.1006/bbrc.1999.1959; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Morita M, 2008, LIPIDS, V43, P589, DOI 10.1007/s11745-008-3170-9; Murtaugh MA, 2005, J NUTR, V135, P179, DOI 10.1093/jn/135.2.179; N'Guyen QB, 2002, BIOCHEM BIOPH RES CO, V297, P249, DOI 10.1016/S0006-291X(02)02177-0; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; OHTA A, 1990, LIPIDS, V25, P742, DOI 10.1007/BF02544044; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; POELLINGER L, 1983, J BIOL CHEM, V258, P3535; ROY D, 1992, ARCH BIOCHEM BIOPHYS, V296, P450, DOI 10.1016/0003-9861(92)90596-O; Savouret JF, 2001, J BIOL CHEM, V276, P3054, DOI 10.1074/jbc.M005988200; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Seree E, 2004, GASTROENTEROLOGY, V127, P1436, DOI 10.1053/j.gastro.2004.08.023; Spiteller P, 2001, BBA-MOL CELL BIOL L, V1531, P188, DOI 10.1016/S1388-1981(01)00100-7; Stoll BA, 2002, EUR J CANCER PREV, V11, P319, DOI 10.1097/00008469-200208000-00002; VECCHINI F, 1994, BIOCHEM BIOPH RES CO, V201, P1205, DOI 10.1006/bbrc.1994.1833; Villard PH, 2007, BIOCHEM BIOPH RES CO, V364, P896, DOI 10.1016/j.bbrc.2007.10.084; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Widerak M, 2006, BIOCHIMIE, V88, P387, DOI 10.1016/j.biochi.2005.11.007; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466; Zock PL, 2001, CURR OPIN LIPIDOL, V12, P5, DOI 10.1097/00041433-200102000-00002	36	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14629	10.1371/journal.pone.0014629	http://dx.doi.org/10.1371/journal.pone.0014629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304969	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300011
J	An, JH; Wan, HL; Zhou, XT; Hu, DN; Wang, LD; Hao, LL; Yan, DS; Shi, FJ; Zhou, ZL; Wang, JA; Hu, SN; Yu, J; Qu, J				An, Jianhong; Wan, Haolei; Zhou, Xiangtian; Hu, Dan-Ning; Wang, Ledan; Hao, Lili; Yan, Dongsheng; Shi, Fanjun; Zhou, Zhonglou; Wang, Jiao; Hu, Songnian; Yu, Jun; Qu, Jia			A Comparative Transcriptomic Analysis of Uveal Melanoma and Normal Uveal Melanocyte	PLOS ONE			English	Article							S-PHASE FRACTION; CELL-CYCLE; SIGNALING PATHWAY; GENE-EXPRESSION; DNA-PLOIDY; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; FLOW-CYTOMETRY; UNITED-STATES; APOPTOSIS	Background: Uveal melanoma is the most common primary intraocular tumor in adults in western countries. It is associated with very severe visual morbidity and may lead to distant metastases even after successful treatment of the primary tumor. In order to gain better insight into molecular mechanisms related to tumorigenesis and metastasis of uveal melanoma, we used next-generation sequencing technology (SOLiD, Life Technologies) to acquire global transcriptome alteration between posterior uveal melanoma cells and normal uveal melanocyte. Results: From mRNAs of the cultured uveal melanoma cells and normal uveal melanocytes, we annotated more than 3.7x10(7) and 2.7x10(7) sequencing tags based on human Ensembl databases, respectively. For detailed analysis, we chose 5155 well-annotated genes mainly involved in the MAPK signaling pathway, cell cycle, cell adhesion junction, apoptosis, and P53 signaling pathways as well as melanogenesis. In an effort to confirm the authenticity of our sequencing results, we validated twenty-one identically differentially expressed genes by using quantitative real time PCR from cultured cell lines of other posterior uveal melanoma cells and normal uveal melanocytes. Conclusion: We have identified a large number of potentially interesting genes for biological investigation of uveal melanoma. The expression profiling also provides useful resources for other functional genomic and transcriptome studies. These 21 potential genes could discriminate between uveal melanoma cells and normal uveal melanocyte, which may be indicative of tumorigenesis process. Our results further suggest that high-throughput sequencing technology provides a powerful tool to study mechanisms of tumogenesis in the molecular level.	[An, Jianhong; Zhou, Xiangtian; Hu, Dan-Ning; Wang, Ledan; Yan, Dongsheng; Shi, Fanjun; Zhou, Zhonglou; Wang, Jiao; Qu, Jia] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China; [An, Jianhong; Zhou, Xiangtian; Hu, Dan-Ning; Wang, Ledan; Yan, Dongsheng; Shi, Fanjun; Zhou, Zhonglou; Wang, Jiao; Qu, Jia] Wenzhou Med Coll, Hosp Eye, Wenzhou, Peoples R China; [An, Jianhong; Zhou, Xiangtian; Wang, Ledan; Yan, Dongsheng; Shi, Fanjun; Zhou, Zhonglou; Wang, Jiao; Qu, Jia] Minist Hlth, State Key Lab Cultivat Base, Wenzhou, Peoples R China; [An, Jianhong; Zhou, Xiangtian; Wang, Ledan; Yan, Dongsheng; Shi, Fanjun; Zhou, Zhonglou; Wang, Jiao; Qu, Jia] Minist Hlth, Key Lab Vis Sci, Wenzhou, Peoples R China; [An, Jianhong; Zhou, Xiangtian; Wang, Ledan; Yan, Dongsheng; Shi, Fanjun; Zhou, Zhonglou; Wang, Jiao; Qu, Jia] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Peoples R China; [Wan, Haolei; Hao, Lili; Hu, Songnian; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Hu, Dan-Ning] New York Med Coll, Tissue Culture Ctr, New York Eye & Ear Infirm, New York, NY USA; [Hao, Lili] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; New York Eye & Ear Infirmary of Mount Sinai; New York Medical College; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	An, JH (corresponding author), Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China.	junyu@big.ac.cn; jqu@wz.zj.cn	zhou, xt/GWZ-9212-2022; Yan, Dongsheng/B-1861-2018; 郑, 征/C-8514-2011; Hu, Songnian/C-6509-2013	Yan, Dongsheng/0000-0003-0551-2219; Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [30772385]; Zhejiang Provincial Natural Science Foundation of China [Y2080853]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported in part by the National Natural Science Foundation of China Grant 30772385 and Zhejiang Provincial Natural Science Foundation of China Grant Y2080853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto Y, 2001, INVEST OPHTH VIS SCI, V42, P313; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; Bouali S, 2008, EJC SUPPL, V6, P146, DOI 10.1016/S1359-6349(08)71736-1; Brantley MA, 2000, INVEST OPHTH VIS SCI, V41, pS382; Cantorias MV, 2009, NUCL MED BIOL, V36, P505, DOI 10.1016/j.nucmedbio.2009.01.017; Capeans C, 2001, INVEST OPHTH VIS SCI, V42, pS216; Cerbone L, 2009, EJC SUPPL, V7, P585, DOI 10.1016/S1359-6349(09)71970-6; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chowers I, 2002, CURR EYE RES, V24, P105, DOI 10.1076/ceyr.24.2.105.8166; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; COLEMAN K, 1995, HUM PATHOL, V26, P99, DOI 10.1016/0046-8177(95)90121-3; Davies L, 2009, J CELL MOL MED, V13, P1995, DOI 10.1111/j.1582-4934.2008.00590.x; DRATVIMANSTOROB.YC, 2010, INVESTIGATI IN PRESS; Ehlers JP, 2008, CLIN CANCER RES, V14, P115, DOI 10.1158/1078-0432.CCR-07-1825; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Honda S, 2004, RETINA-J RET VIT DIS, V24, P646, DOI 10.1097/00006982-200408000-00030; HU DN, 1993, INVEST OPHTH VIS SCI, V34, P2210; Jung IL, 2010, INT J MOL MED, V25, P517, DOI 10.3892/ijmm_00000372; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson M, 1996, EUR J CANCER, V32A, P357, DOI 10.1016/0959-8049(95)00562-5; KARLSSON M, 1995, BRIT J CANCER, V71, P177, DOI 10.1038/bjc.1995.36; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Landreville S, 2008, FUTURE ONCOL, V4, P629, DOI 10.2217/14796694.4.5.629; Lederman M, 2008, CURR EYE RES, V33, P876, DOI 10.1080/02713680802382989; Loercher AE, 2004, INVEST OPHTH VIS SCI, V45, pU513; Loercher AE, 2003, CURR EYE RES, V27, P69, DOI 10.1076/ceyr.27.2.69.15952; Lopez MN, 2007, INVEST OPHTH VIS SCI, V48, P1219, DOI 10.1167/iovs.06-0090; MOOY C, 1995, BRIT J OPHTHALMOL, V79, P174, DOI 10.1136/bjo.79.2.174; Mooy CM, 1996, SURV OPHTHALMOL, V41, P215, DOI 10.1016/S0039-6257(96)80024-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Pardo M, 2004, J CELL BIOCHEM, V93, P708, DOI 10.1002/jcb.20230; PETER H, 2005, SEMINARS OPHTHALMOLO, V20, P231; Popov SG, 2002, BIOCHEM BIOPH RES CO, V293, P349, DOI 10.1016/S0006-291X(02)00227-9; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Seo JH, 2008, EUR J PHARM BIOPHARM, V70, P621, DOI 10.1016/j.ejpb.2008.05.009; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Singh AD, 2003, OPHTHALMOLOGY, V110, P956, DOI 10.1016/S0161-6420(03)00078-2; Singh AD, 2003, OPHTHALMOLOGY, V110, P962, DOI 10.1016/S0161-6420(03)00077-0; SOULIERES D, 1991, INT J CANCER, V49, P498, DOI 10.1002/ijc.2910490404; Stitt AW, 1998, J PATHOL, V186, P306, DOI 10.1002/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; White VA, 1998, CANCER, V83, P354, DOI 10.1002/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.3.CO;2-C; Xiao Y, 2007, CANCER BIOL THER, V6, P1044, DOI 10.4161/cbt.6.7.4317; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192; Zuidervaart W, 2003, BRIT J CANCER, V89, P1914, DOI 10.1038/sj.bjc.6601374	54	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16516	10.1371/journal.pone.0016516	http://dx.doi.org/10.1371/journal.pone.0016516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305041	Green Submitted, gold, Green Published			2022-12-27	WOS:000286664100041
J	Famulski, JK; Vos, LJ; Rattner, JB; Chan, GK				Famulski, Jakub K.; Vos, Larissa J.; Rattner, Jerome B.; Chan, Gordon K.			Dynein/Dynactin-Mediated Transport of Kinetochore Components off Kinetochores and onto Spindle Poles Induced by Nordihydroguaiaretic Acid	PLOS ONE			English	Article							MITOTIC CHECKPOINT PROTEINS; ROUGH-DEAL; CYTOPLASMIC DYNEIN; AURORA-B; CENP-E; MICROTUBULE ATTACHMENT; HELA-CELLS; DYNAMICS; COMPLEX; ZW10	The mitotic checkpoint functions to ensure accurate chromosome segregation by regulating the progression from metaphase to anaphase. Once the checkpoint has been satisfied, it is inactivated in order to allow the cell to proceed into anaphase and complete the cell cycle. The minus end-directed microtubule motor dynein/dynactin has been implicated in the silencing of the mitotic checkpoint by "stripping'' checkpoint proteins off kinetochores. A recent study suggested that Nordihydroguaiaretic acid (NDGA) stimulates dynein/dynactin-mediated transport of its cargo including ZW10 (Zeste White 10). We analyzed the effects of NDGA on dynein/dynactin dependent transport of the RZZ (Zeste White 10, Roughdeal, Zwilch) complex as well as other kinetochore components from kinetochores to spindle poles. Through this approach we have catalogued several kinetochore and centromere components as dynein/dynactin cargo. These include hZW10, hZwilch, hROD, hSpindly, hMad1, hMad2, hCENP-E, hCdc27, cyclin-B and hMps1. Furthermore, we found that treatment with NDGA induced a robust accumulation and complete stabilization of hZW10 at spindle poles. This finding suggests that NDGA may not induce dynein/dynactin transport but rather interfere with cargo release. Lastly, we determined that NDGA induced accumulation of checkpoint proteins at the poles requires dynein/dynactin-mediated transport, hZW10 kinetochore localization and kinetochore-microtubule attachments but not tension or Aurora B kinase activity.	[Famulski, Jakub K.; Vos, Larissa J.; Chan, Gordon K.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Rattner, Jerome B.] Univ Calgary, Dept Anat & Cell Biol, Calgary, AB, Canada; [Chan, Gordon K.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Chan, Gordon K.] Univ Alberta, Sch Canc Engn & Imaging Sci, Edmonton, AB, Canada	University of Alberta; University of Calgary; University of Alberta; University of Alberta	Famulski, JK (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	gordonch@cancerboard.ab.ca	Chan, Gordon/AAN-7784-2020	Chan, Gordon/0000-0003-0497-9407	Canadian Institute of Health Research (CIHR); Alberta Cancer Research Institute (ACRI); NSERC; Canadian Foundation for Innovation; Alberta Heritage Foundation for Medical Research; Natural Sciences and Engineering Research Council of Canada; Alberta Science and Research Authority	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute (ACRI); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Science and Research Authority	J.K. Famulski is funded by a Canadian Graduate Scholarship Award from the Canadian Institute of Health Research (CIHR) and a graduate studentship from the Alberta Cancer Research Institute (ACRI). L.J. Vos is funded by a PGS-A graduate studentship from NSERC and a graduate studentship from ACRI. J.B. Rattner is funded by NSERC. G. K. Chan is funded by a CIHR New Investigator Award. This research is funded by grants from CIHR, ACRI, the Canadian Foundation for Innovation, the Alberta Heritage Foundation for Medical Research, Natural Sciences and Engineering Research Council of Canada and the Alberta Science and Research Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasaki K, 2007, MOL PHARMACOL, V71, P454, DOI 10.1124/mol.106.029611; Ban KH, 2007, DEV CELL, V13, P29, DOI 10.1016/j.devcel.2007.04.017; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Delacour-Larose M, 2004, CELL CYCLE, V3, P1418, DOI 10.4161/cc.3.11.1203; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Famulski JK, 2007, CURR BIOL, V17, P2143, DOI 10.1016/j.cub.2007.11.037; Fujiwara T, 1998, J BIOL CHEM, V273, P3068, DOI 10.1074/jbc.273.5.3068; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Li DY, 2010, MOL CELL BIOL, V30, P3384, DOI 10.1128/MCB.00258-10; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakamura M, 2003, BIOSCI BIOTECH BIOCH, V67, P151, DOI 10.1271/bbb.67.151; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Scaerou F, 2001, J CELL SCI, V114, P3103; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Starr DA, 2000, J CELL SCI, V113, P1939; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; WENDELL KL, 1993, J CELL SCI, V104, P261; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624; WILLIAMS BC, 1992, J CELL BIOL, V118, P759, DOI 10.1083/jcb.118.4.759; WILLIAMS BC, 1994, J CELL SCI, V107, P785; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003; Yang ZY, 2003, CELL RES, V13, P275, DOI 10.1038/sj.cr.7290172	53	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16494	10.1371/journal.pone.0016494	http://dx.doi.org/10.1371/journal.pone.0016494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305043	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100038
J	Gamell, C; Susperregui, AG; Bernard, O; Rosa, JL; Ventura, F				Gamell, Cristina; Susperregui, Antonio G.; Bernard, Ora; Luis Rosa, Jose; Ventura, Francesc			The p38/MK2/Hsp25 Pathway Is Required for BMP-2-Induced Cell Migration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEIN-2; TGF-BETA; SIGNAL-TRANSDUCTION; NEUTROPHIL CHEMOTAXIS; ACTIN DYNAMICS; NUCLEAR EXPORT; AXON GUIDANCE; BMP RECEPTOR; MAP KINASE	Background: Bone morphogenetic proteins (BMPs) have been shown to participate in the patterning and specification of several tissues and organs during development and to regulate cell growth, differentiation and migration in different cell types. BMP-mediated cell migration requires activation of the small GTPase Cdc42 and LIMK1 activities. In our earlier report we showed that activation of LIMK1 also requires the activation of PAKs through Cdc42 and PI3K. However, the requirement of additional signaling is not clearly known. Methodology/Principal Findings: Activation of p38 MAPK has been shown to be relevant for a number of BMP-29s physiological effects. We report here that BMP-2 regulation of cell migration and actin cytoskeleton remodelling are dependent on p38 activity. BMP-2 treatment of mesenchymal cells results in activation of the p38/MK2/Hsp25 signaling pathway downstream from the BMP receptors. Moreover, chemical inhibition of p38 signaling or genetic ablation of either p38 alpha or MK2 blocks the ability to activate the downstream effectors of the pathway and abolishes BMP-2-induction of cell migration. These signaling effects on p38/MK2/Hsp25 do not require the activity of either Cdc42 or PAK, whereas p38/MK2 activities do not significantly modify the BMP-2-dependent activation of LIMK1, measured by either kinase activity or with an antibody raised against phospho-threonine 508 at its activation loop. Finally, phosphorylated Hsp25 colocalizes with the BMP receptor complexes in lamellipodia and overexpression of a phosphorylation mutant form of Hsp25 is able to abolish the migration of cells in response to BMP-2. Conclusions: These results indicate that Cdc42/PAK/LIMK1 and p38/MK2/Hsp25 pathways, acting in parallel and modulating specific actin regulatory proteins, play a critical role in integrating responses during BMP-induced actin reorganization and cell migration.	[Gamell, Cristina; Susperregui, Antonio G.; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, Dept Ciencies Fisiol 2, IDIBELL, Lhospitalet De Llobregat, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Gamell, C (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, IDIBELL, Lhospitalet De Llobregat, Spain.	fventura@ub.edu	Ventura, Francesc/K-9700-2014; Ventura, Francesc/ABG-2285-2020; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Gamell, Cristina/0000-0003-0720-2652	MICINN (Ministerio De Ciencia E Innovacion) [BFU2008-02010]; ISCIII (Instituto ce Salud Carlos III) [RETIC RD06/0020]; M.E.C.	MICINN (Ministerio De Ciencia E Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII (Instituto ce Salud Carlos III)(Instituto de Salud Carlos III); M.E.C.(European Commission)	This research was supported by public grants from the MICINN (Ministerio De Ciencia E Innovacion) (BFU2008-02010) and ISCIII (Instituto ce Salud Carlos III) (RETIC RD06/0020). http://www.micinn.es; http://www.isciii.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wyeth for providing BMP-2. We also thank Drs. G. Bokoch, X. Bustelo, M. Gaestel, K. Kim and A. Nebreda for reagents and E. Adanero, E. Castano and especially B. Torrejon for technical assistance. C. Gamell is recipient of a fellowship from the M.E.C.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BERNSTEIN BW, TRENDS CELL BIOL, V20, P187; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; CHEN HF, 1927, MOL CELL BIOCHEM, V333, P49; Damarla M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004600; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Edlund S, 2004, J CELL SCI, V117, P1835, DOI 10.1242/jcs.01036; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Eyers CE, 2005, BIOCHEM J, V389, P127, DOI 10.1042/BJ20050387; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Hannigan MO, 2001, J IMMUNOL, V167, P3953, DOI 10.4049/jimmunol.167.7.3953; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Huang CK, 1997, J BIOL CHEM, V272, P17, DOI 10.1074/jbc.272.1.17; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jog NR, 2007, J IMMUNOL, V178, P2421, DOI 10.4049/jimmunol.178.4.2421; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee SJ, 2001, INVEST OPHTH VIS SCI, V42, pS455; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nomura N, 2007, MOL VIS, V13, P2320; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Philip A, 2000, J BIOL CHEM, V275, P5911, DOI 10.1074/jbc.275.8.5911; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Singh S, 2003, J BIOL CHEM, V278, P36410, DOI 10.1074/jbc.M306428200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Wu Y, 2004, BIOCHEM BIOPH RES CO, V316, P666, DOI 10.1016/j.bbrc.2004.02.107; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	65	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16477	10.1371/journal.pone.0016477	http://dx.doi.org/10.1371/journal.pone.0016477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297993	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100037
J	Rohenkohl, G; Coull, JT; Nobre, AC				Rohenkohl, Gustavo; Coull, Jennifer T.; Nobre, Anna C.			Behavioural Dissociation between Exogenous and Endogenous Temporal Orienting of Attention	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; SIMPLE REACTION-TIME; MODULATION; EXPECTATION; CEREBELLUM; RESPONSES; SHIFTS; FMRI; V1	Background: In the current study we compared the effects of temporal orienting of attention based on predictions carried by the intrinsic temporal structure of events (rhythm) and by instructive symbolic cues; and tested the degree of cognitive, strategic control that could be exerted over each type of temporal expectation. The experiments tested whether the distinction between exogenous and endogenous orienting made in spatial attention may extend to the temporal domain. Task Design and Main Results: In this task, a ball moved across the screen in discrete steps and disappeared temporarily under an occluding band. Participants were required to make a perceptual discrimination on the target upon its reappearance. The regularity of the speed (rhythmic cue) or colour (symbolic cue) of the moving stimulus could predict the exact time at which a target would reappear after a brief occlusion (valid trials) or provide no temporal information (neutral trials). The predictive nature of rhythmic and symbolic cues was manipulated factorially in a symmetrical and orthogonal fashion. To test for the effects of strategic control over temporal orienting based on rhythmic or symbolic cues, participants were instructed either to "attend-to-speed" (rhythm) or "attend-to-colour". Our results indicated that both rhythmic and symbolic (colour) cues speeded reaction times in an independent fashion. However, whilst the rhythmic cueing effects were impervious to instruction, the effects of symbolic cues were contingent on the instruction to attend to colour. Final Conclusions: Taken together, our results provide evidence for the existence of qualitatively separable types of temporal orienting of attention, akin to exogenous and endogenous mechanisms.	[Rohenkohl, Gustavo; Nobre, Anna C.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Rohenkohl, Gustavo; Nobre, Anna C.] Univ Oxford, Oxford Ctr Human Brain Act OHBA, Dept Psychiat, Oxford OX1 3UD, England; [Coull, Jennifer T.] Univ Aix Marseille 1, Lab Neurobiol Cognit, Marseille, France; [Coull, Jennifer T.] CNRS, Marseille, France	University of Oxford; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Rohenkohl, G (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	gustavo.rohenkohl@psy.ox.ac.uk	Coull, Jennifer T/M-4243-2015; Rohenkohl, Gustavo/I-5854-2014	Coull, Jennifer T/0000-0002-8790-5835; Rohenkohl, Gustavo/0000-0002-6841-5240; Nobre, Anna Christina/0000-0001-5762-2802	Wellcome Trust; European Union [E07D403637BR]; Oxford University	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Oxford University	This work was supported by Wellcome Trust ACN, Programme Alban (the European Union Programme of High Level Scholarship for Latin America - no. E07D403637BR) and Oxford University Overseas Research Student Award Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2005, J EXP PSYCHOL GEN, V134, P207, DOI 10.1037/0096-3445.134.2.207; Busse L, 2008, P NATL ACAD SCI USA, V105, P16380, DOI 10.1073/pnas.0707369105; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Correa A, 2008, J NEUROPHYSIOL, V100, P1649, DOI 10.1152/jn.90656.2008; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Giordano AM, 2009, J VISION, V9, DOI 10.1167/9.3.30; Griffin IC, 2001, FRONT BIOSCI-LANDMRK, V6, pD660, DOI 10.2741/Griffin; Griffin Ivan C., 2005, P257, DOI 10.1016/B978-012375731-9/50046-X; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jones M., 2010, ATTENTION TIME, P137; Jones MR, 2006, COGNITIVE PSYCHOL, V53, P59, DOI 10.1016/j.cogpsych.2006.01.003; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lupianez J., 2010, ATTENTION TIME, P17; Martin T, 2005, PERCEPT PSYCHOPHYS, V67, P168, DOI 10.3758/BF03195020; Martin T, 2006, HUM BRAIN MAPP, V27, P552, DOI 10.1002/hbm.20200; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; Mayer AR, 2004, NEUROIMAGE, V23, P534, DOI 10.1016/j.neuroimage.2004.06.027; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Nobre AC., 2010, ATTENTION TIME, V2010, P371, DOI [10.1093/acprof:oso/9780199563456.003.0027, DOI 10.1093/ACPROF:0S0/9780199563456.003.0027]; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; O'Reilly JX, 2008, J NEUROPHYSIOL, V99, P2731, DOI 10.1152/jn.01141.2007; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283	38	93	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14620	10.1371/journal.pone.0014620	http://dx.doi.org/10.1371/journal.pone.0014620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JX	21297968	Green Submitted, Green Published, gold			2022-12-27	WOS:000286664100005
J	Marquet, F; Bonneau, M; Pascale, F; Urien, C; Kang, C; Schwartz-Cornil, I; Bertho, N				Marquet, Florian; Bonneau, Michel; Pascale, Florentina; Urien, Celine; Kang, Chantal; Schwartz-Cornil, Isabelle; Bertho, Nicolas			Characterization of Dendritic Cells Subpopulations in Skin and Afferent Lymph in the Swine Model	PLOS ONE			English	Article							EPIDERMAL LANGERHANS CELLS; TRANSCUTANEOUS IMMUNIZATION; DISTINCT POPULATIONS; PORCINE SKIN; IN-VIVO; ANTIGEN; SUBSET; MACROPHAGES; RESPONSES; IMMUNITY	Transcutaneous delivery of vaccines to specific skin dendritic cells (DC) subsets is foreseen as a promising strategy to induce strong and specific types of immune responses such as tolerance, cytotoxicity or humoral immunity. Because of striking histological similarities between human and pig skin, pig is recognized as the most suitable model to study the cutaneous delivery of medicine. Therefore improving the knowledge on swine skin DC subsets would be highly valuable to the skin vaccine field. In this study, we showed that pig skin DC comprise the classical epidermal langerhans cells (LC) and dermal DC (DDC) that could be divided in 3 subsets according to their phenotypes: (1) the CD163(neg)/CD172a(neg), (2) the CD163(high)CD172a(pos) and (3) the CD163(low)CD172a(pos) DDC. These subtypes have the capacity to migrate from skin to lymph node since we detected them in pseudo-afferent lymph. Extensive phenotyping with a set of markers suggested that the CD163(high) DDC resemble the antibody response-inducing human skin DC/macrophages whereas the CD163(neg)CD172(low) DDC share properties with the CD8(+) T cell response-inducing murine skin CD103(pos) DC. This work, by showing similarities between human, mouse and swine skin DC, establishes pig as a model of choice for the development of transcutaneous immunisation strategies targeting DC.	[Marquet, Florian; Pascale, Florentina; Urien, Celine; Schwartz-Cornil, Isabelle; Bertho, Nicolas] INRA, Virol & Immunol Mol UR892, Jouy En Josas, France; [Bonneau, Michel; Pascale, Florentina; Kang, Chantal] INRA, Ctr Rech Imagerie Intervent, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Marquet, F (corresponding author), INRA, Virol & Immunol Mol UR892, Jouy En Josas, France.	isabelle.schwartz@jouy.inra.fr; nicolas.bertho@jouy.inra.fr	BERTHO, Nicolas/B-8167-2019; schwartz-cornil, isabelle/D-8547-2011	BERTHO, Nicolas/0000-0002-6732-3483; 	Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was funded by the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista EM, 2002, VET IMMUNOL IMMUNOP, V88, P131, DOI 10.1016/S0165-2427(02)00152-6; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Bullido R, 1996, J IMMUNOL METHODS, V195, P125, DOI 10.1016/0022-1759(96)00095-6; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Caminschi I, 2009, EUR J IMMUNOL, V39, P931, DOI 10.1002/eji.200839035; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Corbett AJ, 2005, EUR J IMMUNOL, V35, P2815, DOI 10.1002/eji.200526100; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Etchart N, 2007, VACCINE, V25, P6891, DOI 10.1016/j.vaccine.2007.07.014; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Grabbe S, 1994, Exp Dermatol, V3, P276, DOI 10.1111/j.1600-0625.1994.tb00289.x; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Hammond SA, 2000, ADV DRUG DELIVER REV, V43, P45, DOI 10.1016/S0169-409X(00)00076-4; Henri S, 2009, J EXP MED, p[189, S181]; Huang YW, 2009, DEV COMP IMMUNOL, V33, P464, DOI 10.1016/j.dci.2008.09.010; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nfon CK, 2008, VET IMMUNOL IMMUNOP, V126, P236, DOI 10.1016/j.vetimm.2008.07.012; Ochoa MT, 2008, J INVEST DERMATOL, V128, pS180; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Takeuchi A, 2009, J IMMUNOL, V183, P4220, DOI 10.4049/jimmunol.0901248; Turnbull E, 2001, IMMUNOL REV, V184, P58, DOI 10.1034/j.1600-065x.2001.1840106.x; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282	32	66	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16320	10.1371/journal.pone.0016320	http://dx.doi.org/10.1371/journal.pone.0016320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298011	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900034
J	Matrisciano, F; Busceti, CL; Bucci, D; Orlando, R; Caruso, A; Molinaro, G; Cappuccio, I; Riozzi, B; Gradini, R; Motolese, M; Caraci, F; Copani, A; Scaccianoce, S; Melchiorri, D; Bruno, V; Battaglia, G; Nicoletti, F				Matrisciano, Francesco; Busceti, Carla L.; Bucci, Domenico; Orlando, Rosamaria; Caruso, Alessandra; Molinaro, Gemma; Cappuccio, Irene; Riozzi, Barbara; Gradini, Roberto; Motolese, Marta; Caraci, Filippo; Copani, Agata; Scaccianoce, Sergio; Melchiorri, Daniela; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando			Induction of the Wnt Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage	PLOS ONE			English	Article							CA3 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; OPTICAL FRACTIONATOR; TAU-PHOSPHORYLATION; NEGATIVE MODULATOR; SIGNALING PATHWAY; LITHIUM TREATMENT; MAJOR DEPRESSION; APICAL DENDRITES; INDUCED ATROPHY	The identification of mechanisms that mediate stress-induced hippocampal damage may shed new light into the pathophysiology of depressive disorders and provide new targets for therapeutic intervention. We focused on the secreted glycoprotein Dickkopf-1 (Dkk-1), an inhibitor of the canonical Wnt pathway, involved in neurodegeneration. Mice exposed to mild restraint stress showed increased hippocampal levels of Dkk-1 and reduced expression of beta-catenin, an intracellular protein positively regulated by the canonical Wnt signalling pathway. In adrenalectomized mice, Dkk-1 was induced by corticosterone injection, but not by exposure to stress. Corticosterone also induced Dkk-1 in mouse organotypic hippocampal cultures and primary cultures of hippocampal neurons and, at least in the latter model, the action of corticosterone was reversed by the type-2 glucocorticoid receptor antagonist mifepristone. To examine whether induction of Dkk-1 was causally related to stress-induced hippocampal damage, we used doubleridge mice, which are characterized by a defective induction of Dkk-1. As compared to control mice, doubleridge mice showed a paradoxical increase in basal hippocampal Dkk-1 levels, but no Dkk-1 induction in response to stress. In contrast, stress reduced Dkk-1 levels in doubleridge mice. In control mice, chronic stress induced a reduction in hippocampal volume associated with neuronal loss and dendritic atrophy in the CA1 region, and a reduced neurogenesis in the dentate gyrus. Doubleridge mice were resistant to the detrimental effect of chronic stress and, instead, responded to stress with increases in dendritic arborisation and neurogenesis. Thus, the outcome of chronic stress was tightly related to changes in Dkk-1 expression in the hippocampus. These data indicate that induction of Dkk-1 is causally related to stress-induced hippocampal damage and provide the first evidence that Dkk-1 expression is regulated by corticosteroids in the central nervous system. Drugs that rescue the canonical Wnt pathway may attenuate hippocampal damage in major depression and other stress-related disorders.	[Matrisciano, Francesco; Orlando, Rosamaria; Caruso, Alessandra; Scaccianoce, Sergio; Melchiorri, Daniela; Bruno, Valeria; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Busceti, Carla L.; Bucci, Domenico; Molinaro, Gemma; Riozzi, Barbara; Motolese, Marta; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy; [Cappuccio, Irene] Ist Casimiro Mondino, Pavia, Italy; [Gradini, Roberto] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Caraci, Filippo; Copani, Agata] Univ Catania, Dept Pharmaceut Sci, Catania, Italy; [Melchiorri, Daniela] Ist San Raffaele Pisana, Rome, Italy	Sapienza University Rome; IRCCS Neuromed; Sapienza University Rome; University of Catania; IRCCS San Raffaele Pisana	Matrisciano, F (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	ferdinandonicoletti@hotmail.com	motolese, marta/G-8274-2011; Orlando, Rosamaria/AAA-4139-2021; Molinaro, Gemma/G-8822-2011; Nicoletti, Ferdinando/T-4898-2019; Busceti, Carla Letizia/F-9941-2011; Busceti, Carla Letizia/K-6485-2016; Battaglia, Giuseppe/A-7709-2010; bruno, Valeria/F-3146-2012; Riozzi, Barbara/A-8737-2013; Nicoletti, Ferdinando/K-4410-2016; Bucci, Domenico/G-6747-2011; Caraci, Filippo/K-2262-2016; Bucci, Domenico/AAA-5475-2019; Nicoletti, Ferdinando/A-2446-2010	motolese, marta/0000-0001-8211-7728; Orlando, Rosamaria/0000-0001-9369-1450; Busceti, Carla Letizia/0000-0002-1417-1893; Battaglia, Giuseppe/0000-0001-7571-3417; bruno, Valeria/0000-0003-4231-0739; Riozzi, Barbara/0000-0003-2050-1489; Caraci, Filippo/0000-0002-9867-6054; Bucci, Domenico/0000-0003-3239-2435; NICOLETTI, Ferdinando/0000-0003-3366-7269; Nicoletti, Ferdinando/0000-0003-0917-443X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Support was provided by institutional funds (Ricerca Corrente 2009-2010 from the Italian Ministry of Health to Istituto Neurologico Mediterraneo Neuromed, Pozzilli; Istituto C. Mondino, Pavia; and Istituto San Raffaele Pisana, Roma). Salaries to university people are from university funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 1998, J CEREBR BLOOD F MET, V18, P274, DOI 10.1097/00004647-199803000-00005; Adamska M, 2003, DEV BIOL, V255, P350, DOI 10.1016/S0012-1606(02)00114-8; Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; ARMANINI MP, 1990, BRAIN RES, V532, P7, DOI 10.1016/0006-8993(90)91734-X; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Boku S, 2009, NEUROPSYCHOPHARMACOL, V34, P805, DOI 10.1038/npp.2008.198; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Brouwer JP, 2005, EUR J ENDOCRINOL, V152, P185, DOI 10.1530/eje.1.01828; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Busceti CL, 2008, J NEUROSCI, V28, P3234, DOI 10.1523/JNEUROSCI.0159-08.2008; Busceti CL, 2007, EPILEPSIA, V48, P694, DOI 10.1111/j.1528-1167.2007.01055.x; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Caricasole A, 2003, TRENDS PHARMACOL SCI, V24, P233, DOI 10.1016/S0165-6147(03)00100-7; Conrad CD, 2007, J NEUROSCI, V27, P8278, DOI 10.1523/JNEUROSCI.2121-07.2007; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; de Jong IEM, 2007, BEHAV BRAIN RES, V177, P329, DOI 10.1016/j.bbr.2006.11.015; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Haynes LE, 2001, NEUROSCIENCE, V104, P57, DOI 10.1016/S0306-4522(01)00070-7; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Johnson SA, 2009, NEUROSCIENCE, V163, P34, DOI 10.1016/j.neuroscience.2009.06.005; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; King MA, 2002, METHODS, V28, P293, DOI 10.1016/S1046-2023(02)00235-9; Kleen JK, 2006, BEHAV NEUROSCI, V120, P842, DOI 10.1037/0735-7044.120.4.842; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LAWRENCE MS, 1994, BRAIN RES, V646, P303, DOI 10.1016/0006-8993(94)90094-9; Lenox RH, 2000, J CLIN PSYCHIAT, V61, P5; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; McLaughlin KJ, 2007, BRAIN RES, V1161, P56, DOI 10.1016/j.brainres.2007.05.042; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morales-Medina JC, 2009, J CHEM NEUROANAT, V38, P266, DOI 10.1016/j.jchemneu.2009.05.009; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Parker KJ, 2003, HORM BEHAV, V43, P60, DOI 10.1016/S0018-506X(02)00016-8; Roy M, 2003, NEUROENDOCRINOLOGY, V77, P24, DOI 10.1159/000068337; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STUART DA, 1995, J NEUROSCI METH, V61, P5, DOI 10.1016/0165-0270(95)00017-O; Ueda J, 2005, AM J PHYSIOL-GASTR L, V288, pG842, DOI 10.1152/ajpgi.00463.2004; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Wood GE, 2004, P NATL ACAD SCI USA, V101, P3973, DOI 10.1073/pnas.0400208101; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Yusim A, 2000, BRAIN RES, V870, P109, DOI 10.1016/S0006-8993(00)02407-0	71	48	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16447	10.1371/journal.pone.0016447	http://dx.doi.org/10.1371/journal.pone.0016447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304589	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900050
J	Chowdhury, S; Erickson, SW; MacLeod, SL; Cleves, MA; Hu, P; Karim, MA; Hobbs, CA				Chowdhury, Shimul; Erickson, Stephen W.; MacLeod, Stewart L.; Cleves, Mario A.; Hu, Ping; Karim, Mohammad A.; Hobbs, Charlotte A.			Maternal Genome-Wide DNA Methylation Patterns and Congenital Heart Defects	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTIONS; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; BIRTH-DEFECTS; RISK; EXPRESSION; HYPOMETHYLATION; FOLATE; ASSOCIATION	The majority of congenital heart defects (CHDs) are thought to result from the interaction between multiple genetic, epigenetic, environmental, and lifestyle factors. Epigenetic mechanisms are attractive targets in the study of complex diseases because they may be altered by environmental factors and dietary interventions. We conducted a population based, case-control study of genome-wide maternal DNA methylation to determine if alterations in gene-specific methylation were associated with CHDs. Using the Illumina Infinium Human Methylation27 BeadChip, we assessed maternal gene-specific methylation in over 27,000 CpG sites from DNA isolated from peripheral blood lymphocytes. Our study sample included 180 mothers with non-syndromic CHD-affected pregnancies (cases) and 187 mothers with unaffected pregnancies (controls). Using a multi-factorial statistical model, we observed differential methylation between cases and controls at multiple CpG sites, although no CpG site reached the most stringent level of genome-wide statistical significance. The majority of differentially methylated CpG sites were hypermethylated in cases and located within CpG islands. Gene Set Enrichment Analysis (GSEA) revealed that the genes of interest were enriched in multiple biological processes involved in fetal development. Associations with canonical pathways previously shown to be involved in fetal organogenesis were also observed. We present preliminary evidence that alterations in maternal DNA methylation may be associated with CHDs. Our results suggest that further studies involving maternal epigenetic patterns and CHDs are warranted. Multiple candidate processes and pathways for future study have been identified.	[Chowdhury, Shimul; Erickson, Stephen W.; MacLeod, Stewart L.; Cleves, Mario A.; Hu, Ping; Karim, Mohammad A.; Hobbs, Charlotte A.] Univ Arkansas Med Sci, Dept Pediat, Coll Med, Arkansas Childrens Hosp,Res Inst, Little Rock, AR 72205 USA	Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Chowdhury, S (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Coll Med, Arkansas Childrens Hosp,Res Inst, Little Rock, AR 72205 USA.	schowdhury@uams.edu	Pillay, Nischalan/F-9536-2012		National Institute for Child Health and Development [5-R01-HD039054-08]; Centers for Disease Control and Prevention [3-U50DD613236-10W1]; Arkansas Biosciences Institute; University of Arkansas for Medical Sciences College of Medicine Children's University Medical Group; CENTERS FOR DISEASE CONTROL AND PREVENTION [U50DD613236] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039054] Funding Source: NIH RePORTER	National Institute for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Arkansas Biosciences Institute; University of Arkansas for Medical Sciences College of Medicine Children's University Medical Group; CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research is supported by grants from the National Institute for Child Health and Development (5-R01-HD039054-08), the Centers for Disease Control and Prevention (3-U50DD613236-10W1), the Arkansas Biosciences Institute (the major research component of the Tobacco Settlement Proceeds Act of 2000), and the University of Arkansas for Medical Sciences College of Medicine Children's University Medical Group Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2009, AM J RESP CRIT CARE, V179; Baker JE, 2004, ANTIOXID REDOX SIGN, V6, P423, DOI 10.1089/152308604322899495; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Bottini E, 1998, DIS MARKERS, V14, P143, DOI 10.1155/1998/861096; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Candiloro ILM, 2009, CANCER PREV RES, V2, P862, DOI 10.1158/1940-6207.CAPR-09-0056; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Cooney CA, 2002, J NUTR, V132, p2393S; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Doolin MT, 2002, AM J HUM GENET, V71, P1222, DOI 10.1086/344209; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrlich M, 2003, J CELL BIOCHEM, V88, P899, DOI 10.1002/jcb.10464; Enquobahrie DA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-56; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Filkowski JN, 2010, CARCINOGENESIS, V31, P1110, DOI 10.1093/carcin/bgp300; Furness DLF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.020; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hobbs CA, 2005, AM J CLIN NUTR, V81, P147; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Hoyert DL, 2003, BIRTH DEFECTS RES A, V67, P651, DOI 10.1002/bdra.10117; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Joziasse IC, 2008, BASIC RES CARDIOL, V103, P216, DOI 10.1007/s00395-008-0713-4; Jugessur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011493; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Kile ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013730; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li DQ, 2006, J NUTR, V136, P1774, DOI 10.1093/jn/136.7.1774; Li DQ, 2005, AM J CLIN NUTR, V82, P188, DOI 10.1093/ajcn/82.1.188; Liu L, 2008, CURR ISSUES MOL BIOL, V10, P25, DOI 10.21775/cimb.010.025; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Mitchell LE, 2005, AM J EPIDEMIOL, V162, P676, DOI 10.1093/aje/kwi249; Morgan DK, 2008, MAMM GENOME, V19, P394, DOI 10.1007/s00335-008-9124-y; Nyirenda MJ, 2006, DIABETOLOGIA, V49, P1412, DOI 10.1007/s00125-006-0188-5; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oommen AA, 2005, J NUTR BIOCHEM, V16, P74, DOI 10.1016/j.jnutbio.2004.08.004; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; POPLIKER M, 1987, DEV BIOL, V119, P38, DOI 10.1016/0012-1606(87)90204-1; Qing M, 2003, J AM COLL CARDIOL, V41, P2266, DOI 10.1016/S0735-1097(03)00477-7; R Core Team, 2018, R LANG ENV STAT COMP; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun CJ, 2009, J PERINAT MED, V37, P609, DOI 10.1515/JPM.2009.103; Teschendorff AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008274; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; van Driel LMJW, 2008, OBSTET GYNECOL, V112, P277, DOI 10.1097/AOG.0b013e31817dd058; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; WOLF M, 2010, CURR OPIN CARDIOL; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32; Zhu HP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-128; 2007, J CLIN INVEST, V117, P2369	70	53	59	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16506	10.1371/journal.pone.0016506	http://dx.doi.org/10.1371/journal.pone.0016506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21297937	gold, Green Published, Green Submitted			2022-12-27	WOS:000286523400040
J	Xie, YY; Yang, D; He, QY; Songyang, Z				Xie, Yiying; Yang, Dong; He, Quanyuan; Songyang, Zhou			Zebrafish as a Model System to Study the Physiological Function of Telomeric Protein TPP1	PLOS ONE			English	Article							LENGTH REGULATOR TRF1; ADRENOCORTICAL DYSPLASIA; DAMAGE RESPONSE; HUMAN-DISEASE; COMPLEX; POT1; MOUSE; MICE; CELL; LOCALIZATION	Telomeres are specialized chromatin structures at the end of chromosomes. Telomere dysfunction can lead to chromosomal abnormalities, DNA damage responses, and even cancer. In mammalian cells, a six-protein complex (telosome/shelterin) is assembled on the telomeres through the interactions between various domain structures of the six telomere proteins (POT1, TPP1, TIN2, TRF1, TRF2 and RAP1), and functions in telomere maintenance and protection. Within the telosome, TPP1 interacts directly with POT1 and TIN2 and help to mediate telosome assembly. Mechanisms of telomere regulation have been extensively studied in a variety of model organisms. For example, the physiological roles of telomere-targeted proteins have been assessed in mice through homozygous inactivation. In these cases, early embryonic lethality has prevented further studies of these proteins in embryogenesis and development. As a model system, zebrafish offers unique advantages such as genetic similarities with human, rapid developmental cycles, and ease of manipulation of its embryos. In this report, we detailed the identification of zebrafish homologues of TPP1, POT1, and TIN2, and showed that the domain structures and interactions of these telosome components appeared intact in zebrafish. Importantly, knocking down TPP1 led to multiple abnormalities in zebrafish embryogenesis, including neural death, heart malformation, and caudal defect. And these embryos displayed extensive apoptosis. These results underline the importance of TPP1 in zebrafish embryogenesis, and highlight the feasibility and advantages of investigating the signaling pathways and physiological function of telomere proteins in zebrafish.	[Xie, Yiying; Yang, Dong; He, Quanyuan] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Songyang, Zhou] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Baylor College of Medicine; Sun Yat Sen University	Xie, YY (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	songyang@bcm.edu			NCI [CA133249]; NIGMS [GM081627]; Welch Foundation [Q-1673]; NATIONAL CANCER INSTITUTE [R01CA133249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI (http://www.nih.gov) CA133249, NIGMS (http://www.nih.gov) GM081627, and the Welch Foundation (http://www.welch1.org/) Q-1673. Z.S. is a Leukemia and Lymphoma Society Scholar (http://lls.org/hm_lls). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2005, BIOCHEM BIOPH RES CO, V331, P881, DOI 10.1016/j.bbrc.2005.03.211; Barut BA, 2000, PHYSIOL GENOMICS, V2, P49, DOI 10.1152/physiolgenomics.2000.2.2.49; BEAMER WG, 1994, J ENDOCRINOL, V141, P33, DOI 10.1677/joe.0.1410033; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen LY, 2007, MOL CELL BIOL; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; Corey DR, 2001, GENOME BIOL, V2; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; Gornung E, 1998, GENOME, V41, P136, DOI 10.1139/gen-41-1-136; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Kajstura J, 2006, ANTIOXID REDOX SIGN, V8, P2125, DOI 10.1089/ars.2006.8.2125; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Keegan CE, 2005, HUM MOL GENET, V14, P113, DOI 10.1093/hmg/ddi011; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; McChesney PA, 2005, ZEBRAFISH, V1, P349, DOI 10.1089/zeb.2005.1.349; Nadal-Ginard B, 2003, J CLIN INVEST, V111, P1457, DOI 10.1172/JCI200318611; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Vlangos CN, 2009, DEV BIOL; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Yeh LK, 2008, J BIOL CHEM, V283, P506, DOI 10.1074/jbc.M707656200	43	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16440	10.1371/journal.pone.0016440	http://dx.doi.org/10.1371/journal.pone.0016440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311760	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200012
J	Cui, JA; Liu, JH; Li, YH; Shi, TL				Cui, Jian; Liu, Jinghua; Li, Yuhua; Shi, Tieliu			Integrative Identification of Arabidopsis Mitochondrial Proteome and Its Function Exploitation through Protein Interaction Network	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; LOCALIZING PROTEINS; ELECTRON-TRANSPORT; EXPRESSION DATA; CELL; PREDICTION; SEQUENCE; STRESS; BIOSYNTHESIS; DATABASE	Mitochondria are major players on the production of energy, and host several key reactions involved in basic metabolism and biosynthesis of essential molecules. Currently, the majority of nucleus-encoded mitochondrial proteins are unknown even for model plant Arabidopsis. We reported a computational framework for predicting Arabidopsis mitochondrial proteins based on a probabilistic model, called Naive Bayesian Network, which integrates disparate genomic data generated from eight bioinformatics tools, multiple orthologous mappings, protein domain properties and co-expression patterns using 1,027 microarray profiles. Through this approach, we predicted 2,311 candidate mitochondrial proteins with 84.67% accuracy and 2.53% FPR performances. Together with those experimental confirmed proteins, 2,585 mitochondria proteins (named CoreMitoP) were identified, we explored those proteins with unknown functions based on protein-protein interaction network (PIN) and annotated novel functions for 26.65% CoreMitoP proteins. Moreover, we found newly predicted mitochondrial proteins embedded in particular subnetworks of the PIN, mainly functioning in response to diverse environmental stresses, like salt, draught, cold, and wound etc. Candidate mitochondrial proteins involved in those physiological acitivites provide useful targets for further investigation. Assigned functions also provide comprehensive information for Arabidopsis mitochondrial proteome.	[Cui, Jian; Li, Yuhua; Shi, Tieliu] E China Normal Univ, Coll Life Sci, Ctr Bioinformat, Shanghai 200062, Peoples R China; [Cui, Jian; Li, Yuhua] E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Cui, Jian; Shi, Tieliu] NE Forestry Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Liu, Jinghua] So Med Univ, Guangzhou, Guangdong, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China; [Cui, Jian; Liu, Jinghua; Li, Yuhua; Shi, Tieliu] NE Forestry Univ, Daqing Inst Biotechnol, Daqing, Heilongjiang, Peoples R China	East China Normal University; East China Normal University; Northeast Forestry University - China; Southern Medical University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Northeast Forestry University - China	Cui, JA (corresponding author), E China Normal Univ, Coll Life Sci, Ctr Bioinformat, Shanghai 200062, Peoples R China.	lyhshen@126.com; tlshi@sibs.ac.cn			National 973 Key Basic Research Program [2008CB713807, 2007CB108800]; National High Technology Research and Development Program of China (863 project) [2006AA02Z320]; National Natural Science Foundation of China [90408010, 30870575]	National 973 Key Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China (863 project)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National 973 Key Basic Research Program (Grant Nos. 2008CB713807 and 2007CB108800), the National High Technology Research and Development Program of China (863 project) (Grant No. 2006AA02Z320), the National Natural Science Foundation of China (Grant No. 90408010 and 30870575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balk J, 1999, FEBS LETT, V463, P151, DOI 10.1016/S0014-5793(99)01611-7; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bardel J, 2002, PROTEOMICS, V2, P880, DOI 10.1002/1615-9861(200207)2:7<880::AID-PROT880>3.0.CO;2-0; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Bota DA, 2001, MITOCHONDRION, V1, P33, DOI 10.1016/S1567-7249(01)00005-8; Cai YD, 2003, BIOCHEM BIOPH RES CO, V305, P407, DOI 10.1016/S0006-291X(03)00775-7; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P230, DOI 10.1006/mcbr.2001.0285; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cui J, 2008, NUCLEIC ACIDS RES, V36, pD999, DOI 10.1093/nar/gkm844; DAVID M, 2006, BASIC PRACTICE STAT; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; Gong XQ, 2010, SCI CHINA LIFE SCI, V53, P1152, DOI 10.1007/s11427-010-4050-0; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; Haas BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-7; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Heazlewood JL, 2005, PLANT PHYSIOL, V139, P598, DOI 10.1104/pp.105.065532; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang J, 2005, ACTA BIOTHEOR, V53, P39, DOI 10.1007/s10441-005-7002-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Karlberg EOL, 2003, NAT REV GENET, V4, P391, DOI 10.1038/nrg1063; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lee CM, 1999, J BIOL CHEM, V274, P20937, DOI 10.1074/jbc.274.30.20937; Li LF, 2010, SCI CHINA LIFE SCI, V53, P131, DOI 10.1007/s11427-010-0012-9; Li SJ, 2006, PLANT PHYSIOL, V141, P527, DOI 10.1104/pp.106.078881; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Marcotte EM, 2000, P NATL ACAD SCI USA, V97, P12115, DOI 10.1073/pnas.220399497; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Millar AH, 2005, TRENDS PLANT SCI, V10, P36, DOI 10.1016/j.tplants.2004.12.002; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Nair R, 2002, PROTEIN SCI, V11, P2836, DOI 10.1110/ps.0207402; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Rebeille F, 1997, EMBO J, V16, P947, DOI 10.1093/emboj/16.5.947; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; Vianello A, 2007, PHYSIOL PLANTARUM, V129, P242, DOI 10.1111/j.1399-3054.2006.00767.x; Werhahn W, 2002, ELECTROPHORESIS, V23, P640, DOI 10.1002/1522-2683(200202)23:4&lt;640::AID-ELPS640&gt;3.0.CO;2-F; Yuan Z, 1999, FEBS LETT, V451, P23, DOI 10.1016/S0014-5793(99)00506-2; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	84	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16022	10.1371/journal.pone.0016022	http://dx.doi.org/10.1371/journal.pone.0016022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297957	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300032
J	Genet, F; Jourdan, C; Schnitzler, A; Lautridou, C; Guillemot, D; Judet, T; Poiraudeau, S; Denormandie, P				Genet, Francois; Jourdan, Claire; Schnitzler, Alexis; Lautridou, Christine; Guillemot, Didier; Judet, Thierry; Poiraudeau, Serge; Denormandie, Philippe			Troublesome Heterotopic Ossification after Central Nervous System Damage: A Survey of 570 Surgeries	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; HUMORAL-FACTORS; EARLY EXCISION; BONE-FORMATION; RISK-FACTORS; HEAD-TRAUMA; RESECTION; CLASSIFICATION; ELBOW	Background: Heterotopic ossification (HO) is a frequent complication after central nervous system (CNS) damage but has seldom been studied. We aimed to investigate features of HO for the first time in a large sample and the rate of early recurrence of HO in terms of the time of surgery. Methodology/Principal Findings: We retrospectively analyzed data from an anonymous prospective survey of patients undergoing surgery between May 1993 and November 2009 in our institution for troublesome HO related to acquired neurological disease. Demographic and HO characteristics and neurological etiologies were recorded. For 357 consecutive patients, we collected data on 539 first surgeries for HO (129 surgeries for multiple sites). During the follow-up, recurrences requiring another surgery appeared in 31 cases (5.8% [31/539]; 95% confidence interval [CI]: 3.8%-7.8%; 27 patients). Most HO requiring surgery occurred after traumatic brain injury (199 patients [55.7%]), then spinal cord injury (86 [24.0%]), stroke (42 [11.8%]) and cerebral anoxia (30 [8.6%]). The hip was the primary site of HO (328 [60.9%]), then the elbow (115 [21.3%]), knee (77 [14.3%]) and shoulder (19 [3.5%]). For all patients, 181 of the surgeries were performed within the first year after the CNS damage, without recurrence of HO. Recurrence was not associated with etiology (p = 0.46), sex (p = 1.00), age at CNS damage (p = 0.2), multisite localization (p = 0.34), or delay to surgery (p = 0.7). Conclusions/Significance: In patients with CNS damage, troublesome HO and recurrence occurs most frequently after traumatic brain injury and appears frequently in the hip and elbow. Early surgery for HO is not a factor of recurrence.	[Genet, Francois; Jourdan, Claire; Schnitzler, Alexis] Hop Raymond Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Judet, Thierry; Denormandie, Philippe] Hop Raymond Poincare, Serv Chirurg Orthoped & Traumatol, Garches, France; [Guillemot, Didier] Hop Raymond Poincare, Unite Fonct Sante Publ, Garches, France; [Poiraudeau, Serge] Hop Cochin, Serv Med Phys & Readaptat, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Genet, F (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, Garches, France.	francois.genet@rpc.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016; Guillemot, Didier/AAN-3051-2020	Poiraudeau, Serge/0000-0002-1988-9124; Guillemot, Didier/0000-0002-8497-1765				Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Beingessner DM, 2000, J HAND SURG-AM, V25A, P483, DOI 10.1053/jhsu.2000.6922; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano C, 2009, ORTHOPEDICS, V32; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; da Paz AC, 2007, MED HYPOTHESES, V68, P67, DOI 10.1016/j.mehy.2006.06.035; de Palma L, 2002, ORTHOPEDICS, V25, P665; Denys P, 1996, BRAIN INJURY, V10, P149, DOI 10.1080/026990596124656; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; HARAN M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003321.PUB3; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Pelissier J., 2002, Annales de Readaptation et de Medecine Physique, V45, P188, DOI 10.1016/S0168-6054(02)00202-7; Riklin C, 2003, SPINAL CORD, V41, P192, DOI 10.1038/sj.sc.3101421; Rogers R C, 1988, Brain Inj, V2, P169, DOI 10.3109/02699058809150941; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; Shehab D, 2002, J NUCL MED, V43, P346; Silver J R, 1969, Paraplegia, V7, P220; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	37	64	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16632	10.1371/journal.pone.0016632	http://dx.doi.org/10.1371/journal.pone.0016632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304993	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300104
J	Kim, Y; Joshi, SD; Messner, WC; LeDuc, PR; Davidson, LA				Kim, YongTae; Joshi, Sagar D.; Messner, William C.; LeDuc, Philip R.; Davidson, Lance A.			Detection of Dynamic Spatiotemporal Response to Periodic Chemical Stimulation in a Xenopus Embryonic Tissue	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; INDUCTION; TRANSLOCATION; LOCALIZATION; SIGNALS; SPACE; CELLS; TIME	Embryonic development is guided by a complex and integrated set of stimuli that results in collective system-wide organization that is both time and space regulated. These regulatory interactions result in the emergence of highly functional units, which are correlated to frequency-modulated stimulation profiles. We have determined the dynamic response of vertebrate embryonic tissues to highly controlled, time-varying localized chemical stimulation using a microfluidic system with feedback control. Our approach has enabled localized spatiotemporal manipulation of the steroid hormone dexamethasone (DEX) in Animal Cap (AC) tissues isolated from gastrulating Xenopus embryos. Using this approach we investigated cell-scale responses to precisely controlled stimulation by tracking the redistribution of a GFP-tagged DEX-reporter constructed from the human glucocorticoid receptor (GR). We exposed defined regions of a single AC explant to different stimulation conditions-continuous stimulation, periodic stimulation, and no stimulation. We observed collective behavior of the GR transport into the nucleus was first-order. Furthermore, the dynamic response was well-modeled by a first-order differential equation with a single time derivative. The model predicted that responses to periodic stimulations closely matched the results of the frequency-based experiments. We find that stimulation with localized bursts versus continuous stimulation can result in highly distinct responses. This finding is critical as controlled space and time exposure to growth factors is a hallmark of complex processes in embryonic development. These complex responses to cellular signaling and transport machinery were similar to emergent behaviors in other complex systems, suggesting that even within a complex embryonic tissue, the overall system can converge toward a predictive first-order response.	[Kim, YongTae; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Kim, YongTae; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Kim, YongTae; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Joshi, Sagar D.; Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Joshi, Sagar D.; Davidson, Lance A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, Y (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	lad43@pitt.edu	Kim, YongTae/A-9839-2010; LeDuc, Philip/M-1103-2014	LeDuc, Philip/0000-0001-6397-2905; Kim, YongTae/0000-0002-8835-8247	National Science Foundation, (NSF) [CMS0555513]; Office of Naval Research; National Institutes of Health [R01-HD044750]; American Heart Association; Dowd-ICES; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019259] Funding Source: NIH RePORTER	National Science Foundation, (NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Dowd-ICES; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Science Foundation, (NSF Grant Number CMS0555513), the Office of Naval Research, the National Institutes of Health (R01-HD044750), and the American Heart Association (Beginning Grant-in-Aid), and the Dowd-ICES Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi T, 2003, INT J DEV BIOL, V47, P405; Ariizumi T, 2001, INT J DEV BIOL, V45, P273; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blitz IL, 2006, SEMIN CELL DEV BIOL, V17, P133, DOI 10.1016/j.semcdb.2005.11.002; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Davidson LA, 2004, GENE EXPR PATTERNS, V4, P457, DOI 10.1016/j.modgep.2004.01.001; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Francois P, 2009, NATURE, V461, pE1, DOI 10.1038/nature08305; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gilbert SF, 2006, DEV BIOL; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; HUTCHISON KA, 1993, ANN NY ACAD SCI, V684, P35, DOI 10.1111/j.1749-6632.1993.tb32269.x; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Joshi SD, 2010, EXP CELL RES, V316, P103, DOI 10.1016/j.yexcr.2009.08.005; JOSHI SD, 2010, J VIS EXP, V39; KAYBK, 1991, METHOD CELL BIOL, V36, P663; KESSLER DS, 1994, SCIENCE, V266, P596, DOI 10.1126/science.7939714; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0; Kim Y, 2010, J AM CHEM SOC, V132, P1339, DOI 10.1021/ja9079572; Kim Y, 2009, LAB CHIP, V9, P2603, DOI 10.1039/b822423d; KOLM PJ, 1995, DEV BIOL, V171, P267, DOI 10.1006/dbio.1995.1279; Kowalczyk B, 2009, LANGMUIR, V25, P1905, DOI 10.1021/la803287u; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kuczenski B, 2007, LAB CHIP, V7, P647, DOI 10.1039/b617065j; Kuczenski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004847; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Moussy Y, 2006, BIOTECHNOL PROGR, V22, P819, DOI 10.1021/bp060031j; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Okino MS, 1998, CHEM REV, V98, P391, DOI 10.1021/cr950223l; Pennathur S, 2008, LAB CHIP, V8, P383, DOI 10.1039/b801448p; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Smith JC, 2008, PHILOS T R SOC B, V363, P1387, DOI 10.1098/rstb.2007.2256; Smith JC, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002477; Vogel S., 2003, COMP BIOMECHANICS LI; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WILSON P, 1991, DEVELOPMENT, V112, P289; Wolpert Lewis, 2009, Int J Dev Biol, V53, P659, DOI 10.1387/ijdb.072559mr	48	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14624	10.1371/journal.pone.0014624	http://dx.doi.org/10.1371/journal.pone.0014624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305055	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000286834300008
J	Rogvi, RA; Mathiasen, R; Greisen, G				Rogvi, Rasmus A.; Mathiasen, Rene; Greisen, Gorm			Defining Smallness for Gestational Age in the Early Years of the Danish Medical Birth Registry	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; INTRAUTERINE GROWTH; PRENATAL EXPOSURE; CEREBRAL-PALSY; SWEDISH MEN; WEIGHT; RISK; PRETERM; TERM; ASSOCIATION	Background: Being born small for gestational age (SGA) is associated with decreased insulin sensitivity and increased blood pressure in childhood, but the association with clinical disease in early adulthood is less certain. The Danish Medical Birth Registry has registered all births in Denmark since 1973, but due to variable data quality, data is most often used only from 1981 onwards, and birth registers in other countries may have similar problems for the early years. We wanted to examine whether the data can be used for identification of children born SGA and used in future research. Methodology/Principal Findings: All persons born between 1974 and 1996 were identified in the Danish Medical Birth Registry (n = 1.704.890). Immigrants and children without data on gestational age and birth weight were excluded, and a total of 1.348.106 children were included in the analysis. The difference between the different variables used in the history of the registry were examined, and the quality of data in the birth registry from 1974-1981 was examined and compared to subsequent years. Data on birth weight and gestational age in the early years of the registry is inconsistent, and the identification of children born SGA is inaccurate, with 49% false-positives. The biggest source of error is due to the rough and inaccurate intervals used for gestational age. By using -3 standard deviations as a cut-off for the identification of children born SGA, the number of false-positives was reduced to 9%, while the amount of false-negatives were increased. Conclusion: Choosing -3 standard deviations for identifying children born SGA is a viable, though not optimal solution for identifying children born SGA. Overall the data in the registry is of sufficient quality to be used in further medical research.	[Rogvi, Rasmus A.; Mathiasen, Rene; Greisen, Gorm] Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Rogvi, RA (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark.	rasmus@rogvi.dk	Greisen, Gorm/AAA-6463-2022	Greisen, Gorm/0000-0001-8042-3262	Elsass Foundation	Elsass Foundation	The funds for data collection were granted by the Elsass Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR E, 1990, AM J OBSTET GYNECOL, V162, P229, DOI 10.1016/0002-9378(90)90856-3; Dahlquist G, 1996, BRIT MED J, V313, P1174, DOI 10.1136/bmj.313.7066.1174; DE ROOIJ, 2007, AM J CLIN NUTR, V86, P1219; de Rooij SR, 2006, DIABETES CARE, V29, P1897, DOI 10.2337/dc06-0460; Ehrenstein V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-14; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1511, DOI 10.1016/S0002-9378(96)70099-6; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Levy-Marchal Claire, 2004, Semin Neonatol, V9, P67, DOI 10.1016/j.siny.2003.08.001; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Poulsen P, 1997, DIABETOLOGIA, V40, P439, DOI 10.1007/s001250050698; Pulver LS, 2009, PEDIATRICS, V123, pE1072, DOI 10.1542/peds.2008-3288; Reinehr T, 2009, EUR J ENDOCRINOL, V160, P579, DOI 10.1530/EJE-08-0914; Schack-Nielsen L, 2006, OBESITY, V14, P1257, DOI 10.1038/oby.2006.143; Selling KE, 2008, EPIDEMIOLOGY, V19, P63, DOI 10.1097/EDE.0b013e318159074b; *SUNDH, 2009, DOC DAN MED BIRTH RE; Willemsen RH, 2009, J CLIN ENDOCR METAB, V94, P1695, DOI 10.1210/jc.2008-1769	23	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16668	10.1371/journal.pone.0016668	http://dx.doi.org/10.1371/journal.pone.0016668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304958	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300113
J	Sarkari, F; Wang, XQ; Nguyen, T; Frappier, L				Sarkari, Feroz; Wang, Xueqi; Nguyen, Tin; Frappier, Lori			The Herpesvirus Associated Ubiquitin Specific Protease, USP7, Is a Negative Regulator of PML Proteins and PML Nuclear Bodies	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; 135-KDA CELLULAR-PROTEIN; TUMOR-SUPPRESSOR; ARSENIC TRIOXIDE; BINDING DOMAIN; E3 LIGASE; ANTIGEN 1; P53; HAUSP; ICP0	The PML tumor suppressor is the founding component of the multiprotein nuclear structures known as PML nuclear bodies (PML-NBs), which control several cellular functions including apoptosis and antiviral effects. The ubiquitin specific protease USP7 (also called HAUSP) is known to associate with PML-NBs and to be a tight binding partner of two herpesvirus proteins that disrupt PML NBs. Here we investigated whether USP7 itself regulates PML-NBs. Silencing of USP7 was found to increase the number of PML-NBs, to increase the levels of PML protein and to inhibit PML polyubiquitylation in nasopharyngeal carcinoma cells. This effect of USP7 was independent of p53 as PML loss was observed in p53-null cells. PML-NBs disruption was induced by USP7 overexpression independently of its catalytic activity and was induced by either of the protein interaction domains of USP7, each of which localized to PML-NBs. USP7 also disrupted NBs formed from some single PML isoforms, most notably isoforms I and IV. CK2 alpha and RNF4, which are known regulators of PML, were dispensable for USP7-associated PML-NB disruption. The results are consistent with a novel model of PML regulation where a deubiquitylase disrupts PML-NBs through recruitment of another cellular protein(s) to PML NBs, independently of its catalytic activity.	[Sarkari, Feroz; Wang, Xueqi; Nguyen, Tin; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Sarkari, F (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lori.frappier@utoronto.ca			Canadian Institutes of Health Research [93652]; National Cancer Institute of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported by a research grant (93652) from the Canadian Institutes of Health Research and a National Cancer Institute of Canada studentship to F.S. L.F. is a tier 1 Canada Research Chair in Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antrobus R, 2008, VIRUS RES, V137, P64, DOI 10.1016/j.virusres.2008.05.017; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bousquet-Dubouch MP, 2009, MOL CELL PROTEOMICS, V8, P1150, DOI 10.1074/mcp.M800193-MCP200; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Cuchet D, 2011, J CELL SCI, V124, P280, DOI 10.1242/jcs.075390; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Everett RD, 2008, J VIROL, V82, P8871, DOI 10.1128/JVI.00613-08; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Gambacorta M, 1996, AM J PATHOL, V149, P2023; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; KOKEN MHM, 1995, ONCOGENE, V10, P1315; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lallemand-Breitenbach V, 2006, CELL, V126, P244, DOI 10.1016/j.cell.2006.07.004; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MEREDITH M, 1995, VIROLOGY, V209, P174, DOI 10.1006/viro.1995.1241; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Miller WH, 2002, CANCER RES, V62, P3893; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Reineke EL, 2009, INT J BIOL SCI, V5, P366; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shan J, 2008, Ernst Schering Found Symp Proc, P127; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sivachandran N, 2010, J VIROL, V84, P11113, DOI 10.1128/JVI.01183-10; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; SUN Y, 1992, P NATL ACAD SCI USA, V89, P6516, DOI 10.1073/pnas.89.14.6516; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang S, 2009, J VIROL, V83, P11704, DOI 10.1128/JVI.00931-09; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200	59	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16598	10.1371/journal.pone.0016598	http://dx.doi.org/10.1371/journal.pone.0016598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305000	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300095
J	Uzochukwu, BSC; Onwujekwe, E; Ezuma, NN; Ezeoke, OP; Ajuba, MO; Sibeudu, FT				Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel; Ezuma, Nkoli N.; Ezeoke, Ogochukwu P.; Ajuba, Miriam O.; Sibeudu, Florence T.			Improving Rational Treatment of Malaria: Perceptions and Influence of RDTs on Prescribing Behaviour of Health Workers in Southeast Nigeria	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; UNCOMPLICATED MALARIA; RANDOMIZED-TRIAL; FACILITIES; CHILDREN; PREDICTORS; ERROR; MANAGEMENT; DISTRICT; TANZANIA	Introduction: Developments in rapid diagnostic tests (RDTs) have opened new possibilities for improved remote malaria diagnosis that is independent of microscopic diagnosis. Studies in some settings have tried to assess the influence of RDTs on the prescribing behaviour of health workers, but such information is generally lacking in Nigeria and many parts of sub-Saharan Africa. This study analysed health workers' perceptions of RDTs and their potential influence on their prescribing and treatment practices after their introduction. Methods: The study was conducted in four health centers in the Enugu East local government of Enugu State, Nigeria. All 32 health workers in the health centers where RDTs were deployed were interviewed by field workers. Information was sought on their perception of symptoms-based, RDT-based, and microscopy-based malaria diagnoses. In addition, prescription analysis was carried out on 400 prescriptions before and 12 months after RDT deployment. Results: The majority of the health workers perceived RDTs to be more effective for malaria diagnosis than microscopy and clinical diagnosis. They also felt that the benefits of RDTs included increased use of RDTs in the facilities and the tendency to prescribe more Artemisinin-based combination therapies (ACTs) and less chloroquine and SP. Some of the health workers experienced some difficulties in the process of using RDT kits. ACTs were prescribed in 74% of RDT-negative results. Conclusions/Significance: RDT-supported malaria diagnosis may have led to the overprescription of ACTs, with the drug being prescribed to people with RDT-negative results. However, the prescription of other antimalarial drugs that are not first-line drugs has been reduced. Efforts should be made to encourage health workers to trust RDT results and prescribe ACTs only to those with positive RDT results. In-depth studies are needed to determine why health workers continue to prescribe ACTs in RDT-negative results.	[Uzochukwu, Benjamin S. C.] Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel; Ezuma, Nkoli N.; Ezeoke, Ogochukwu P.; Ajuba, Miriam O.] Univ Nigeria, Coll Med, Hlth Policy Res Grp, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel; Ezeoke, Ogochukwu P.] Univ Nigeria, Coll Med, Dept Hlth Adm & Management, Enugu, Nigeria; [Ezuma, Nkoli N.] Univ Nigeria, Dept Sociol, Nsukka, Nigeria; [Ajuba, Miriam O.] Enugu State Univ Technol, Dept Community Med, Enugu, Nigeria; [Sibeudu, Florence T.] Nnamdi Azikiwe Univ, Dept Nursing Sci, Awka, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria; University of Nigeria	Uzochukwu, BSC (corresponding author), Univ Nigeria, Coll Med, Dept Community Med, Enugu Campus, Enugu, Nigeria.	bscuzochukwu@yahoo.com	Sibeudu, Florence/ABF-9104-2021; Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285; Sibeudu, Florence Tochukwu/0000-0001-6213-4539	UNICEF [A50076]; World Bank/World Health Organization (WHO)	UNICEF; World Bank/World Health Organization (WHO)(World Health Organization)	This study received financial support under the Multilateral Initiative on Malaria A50076 through the The United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante F. A., 2003, EC BURDEN MALA UNPUB; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Bisoffi Z, 2008, BRIT MED J, V336, P168, DOI 10.1136/bmj.39401.486655.80; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Bojang KA, 2000, TROP MED INT HEALTH, V5, P231, DOI 10.1046/j.1365-3156.2000.00538.x; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; DACREMONT V, 2008, ASTMH 57 ANN M 7 11; *EN STAT MIN HLTH, 2008, MAL SIT EN STAT NIG; Federal Government of Nigeria, 2007, OFFICIAL GAZETTE LAG, V24, P94; Federal Ministry of Health, 2005, NAT ANT TREATM GUID; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Luchavez J, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-149; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Onwujekwe O, 2000, HEALTH POLICY, V54, P143, DOI 10.1016/S0168-8510(00)00105-6; Osterholt DM, 2006, TROP MED INT HEALTH, V11, P1147, DOI 10.1111/j.1365-3156.2006.01666.x; *PRES MAL IN, 2009, MAL OP PLAN MOP; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rolland E, 2006, TROP MED INT HEALTH, V11, P398, DOI 10.1111/j.1365-3156.2006.01580.x; Rowe AK, 2000, AM J EPIDEMIOL, V151, P1029, DOI 10.1093/oxfordjournals.aje.a010131; Rowe AK, 2003, INT J EPIDEMIOL, V32, P296, DOI 10.1093/ije/dyg063; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Uzochukwu B, 2005, HEALTH POLICY, V75, P1, DOI 10.1016/j.healthpol.2005.01.019; Uzochukwu BSC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-265; Uzochukwu BS, 2002, HEALTH POLICY PLANN, V17, P378, DOI 10.1093/heapol/17.4.378; UZOCHUKWU BSC, 2008, COST EFFECTIVE UNPUB; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, WHO GUID TREATM MAL; *WHO, 2003, MAL RAP DIAGN MAK WO; *WHO UNICEF, 2003, WHOCDSMAL20031093; World Health Organization, 1993, INVESTIGATE DRUG USE; Zurovac D, 2005, BRIT MED J, V331, P734, DOI 10.1136/bmj.331.7519.734; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	42	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14627	10.1371/journal.pone.0014627	http://dx.doi.org/10.1371/journal.pone.0014627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21297938	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300009
J	Wolff, C; Schott, C; Porschewski, P; Reischauer, B; Becker, KF				Wolff, Claudia; Schott, Christina; Porschewski, Peter; Reischauer, Bilge; Becker, Karl-Friedrich			Successful Protein Extraction from Over-Fixed and Long-Term Stored Formalin-Fixed Tissues	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; E-CADHERIN; EXPRESSION; FIXATION; SECTIONS; DURATION	One of the major breakthroughs in molecular pathology during the last decade was the successful extraction of full-length proteins from formalin-fixed and paraffin-embedded (FFPE) clinical tissues. However, only limited data are available for the protein extraction efficiency of over-fixed tissues and FFPE blocks that had been stored for more than 15 years in pathology archives. In this study we evaluated the protein extraction efficiency of FFPE tissues which had been formalin-fixed for up to 144 hours and tissue blocks that were stored for 20 years, comparing an established and a new commercial buffer system. Although there is a decrease in protein yield with increasing fixation time, the new buffer system allows a protein recovery of 66% from 144 hours fixed tissues compared to tissues that were fixed for 6 hours. Using the established extraction procedure, less than 50% protein recovery was seen. Similarly, the protein extraction efficiency decreases with longer storage times of the paraffin blocks. Comparing the two buffer systems, we found that 50% more proteins can be extracted from FFPE blocks that were stored for 20 years when the new buffer system is used. Taken together, our data show that the new buffer system is superior compared to the established one. Because tissue fixation times vary in the routine clinical setting and pathology archives contain billions of FFPE tissues blocks, our data are highly relevant for research, diagnosis, and treatment of disease.	[Wolff, Claudia; Schott, Christina; Reischauer, Bilge; Becker, Karl-Friedrich] Tech Univ Munich, Inst Pathol, Munich, Germany; [Porschewski, Peter] Qiagen GmbH, Hilden, Germany	Technical University of Munich; QIAGEN GmbH	Wolff, C (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	kf.becker@lrz.tum.de	Becker, Karl-Friedrich/D-3636-2015	Becker, Karl-Friedrich/0000-0002-6801-4498	BMBF (Bundesministerium fur Bildung und Forschung) [01GR0805]	BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This study was supported by the NGFN (Nationale Genomforschungsnetz) Project of the BMBF (Bundesministerium fur Bildung und Forschung; www.bmbf.de; grant no. 01GR0805). The NGFN/BMBF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PP (employee of Qiagen GmbH) participated in the experiment design and contributed reagents.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Ahram M, 2003, PROTEOMICS, V3, P413, DOI 10.1002/pmic.200390056; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Becker KF, 2008, PROTEOM CLIN APPL, V2, P737, DOI 10.1002/prca.200780106; BECKER KF, 2008, TOPATJ, V2, P44; Bhudevi B, 2003, J VIROL METHODS, V109, P25, DOI 10.1016/S0166-0934(03)00040-5; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Chetty R, 2009, PANCREAS, V38, P338, DOI 10.1097/MPA.0b013e318183d74a; Chu WS, 2005, LAB INVEST, V85, P1416, DOI 10.1038/labinvest.3700337; Chung JY, 2008, PROTEOM CLIN APPL, V2, P1539, DOI 10.1002/prca.200800005; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Ikeda K, 1998, J HISTOCHEM CYTOCHEM, V46, P397, DOI 10.1177/002215549804600314; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504; Pryczynicz A, 2010, FOLIA HISTOCHEM CYTO, V48, P128, DOI 10.2478/v10042-008-0089-1; Shi SR, 2006, J HISTOCHEM CYTOCHEM, V54, P739, DOI 10.1369/jhc.5B6851.2006; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5	20	50	50	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16353	10.1371/journal.pone.0016353	http://dx.doi.org/10.1371/journal.pone.0016353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305021	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300055
J	Itskov, PM; Vinnik, E; Diamond, ME				Itskov, Pavel M.; Vinnik, Ekaterina; Diamond, Mathew E.			Hippocampal Representation of Touch-Guided Behavior in Rats: Persistent and Independent Traces of Stimulus and Reward Location	PLOS ONE			English	Article							TACTILE INFORMATION; BARREL CORTEX; SPIKE TRAIN; MEMORY; PLACE; OBJECT; CELLS; MECHANISMS; DYNAMICS; PATTERNS	Understanding the mechanisms by which sensory experiences are stored remains a compelling challenge for neuroscience. Previous work has described how the activity of neurons in the sensory cortex allows rats to discriminate the physical features of an object contacted with their whiskers. But to date there is no evidence about how neurons represent the behavioural significance of tactile stimuli, or how they are encoded in memory. To investigate these issues, we recorded single-unit firing and local field potentials from the CA1 region of hippocampus while rats performed a task in which tactile stimuli specified reward location. On each trial the rat touched a textured plate with its whiskers, and then turned towards the Left or Right water spout. Two textures were associated with each reward location. To determine the influence of the rat's position on sensory coding, we placed it on a second platform in the same room where it performed the identical texture discrimination task. Over 25 percent of the sampled neurons encoded texture identity - their firing differed for two stimuli associated with the same reward location - and over 50 percent of neurons encoded the reward location with which the stimuli were associated. The neuronal population carried texture and reward location signals continuously, from the moment of stimulus contact until the end of reward collection. The set of neurons discriminating between one texture pair was found to be independent of, and partially overlapping, the set of neurons encoding the discrimination between a different texture pair. In a given neuron, the presence of a tactile signal was uncorrelated with the presence, magnitude, or timing of reward location signals. These experiments indicate that neurons in CA1 form a texture representation independently of the action the stimulus is associated with and retain the stimulus representation through reward collection.	[Itskov, Pavel M.; Vinnik, Ekaterina; Diamond, Mathew E.] SISSA, Sector Cognit Neurosci, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Itskov, PM (corresponding author), SISSA, Sector Cognit Neurosci, I-34014 Trieste, Italy.	itskovpa@gmail.com		Itskov, Pavel/0000-0002-2191-7083; Vinnik, Ekaterina/0000-0001-6853-1156; DIAMOND, Mathew Ernest/0000-0003-2286-4566	Human Frontier Science Program [RG0041/2009-C]; European Community [BIOTACT-21590]; Compagnia San Paolo; Italian Institute of Technology; Ministry of Economic Development	Human Frontier Science Program(Human Frontier Science Program); European Community(European Commission); Compagnia San Paolo(Compagnia di San Paolo); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Ministry of Economic Development(Ministry of Economic Development, Italy)	This work was supported by grants from Human Frontier Science Program (contract RG0041/2009-C), the European Community (contract BIOTACT-21590), the Compagnia San Paolo, the Italian Institute of Technology through the BMI Project, and the Ministry of Economic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MI, 2003, J NEUROSCI, V23, P8827; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; HEIMENDAHL MV, 2007, PLOS BIOL, V5, pE305, DOI DOI 10.1371/JOURNAL.PBIO.0050305; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jutras MJ, 2010, P NATL ACAD SCI USA, V107, P401, DOI 10.1073/pnas.0908378107; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lottem E, 2009, J NEUROSCI, V29, P11686, DOI 10.1523/JNEUROSCI.0705-09.2009; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pereira A, 2007, P NATL ACAD SCI USA, V104, P18286, DOI 10.1073/pnas.0708611104; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tulving E., 1972, ORG MEMORY, P423; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	54	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16462	10.1371/journal.pone.0016462	http://dx.doi.org/10.1371/journal.pone.0016462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305039	Green Submitted, gold, Green Published			2022-12-27	WOS:000286664100034
J	Mao, LM; Yang, PZ; Hou, SP; Li, FZ; Kijlstra, A				Mao, Liming; Yang, Peizeng; Hou, Shengping; Li, Fuzhen; Kijlstra, Aize			Label-Free Proteomics Reveals Decreased Expression of CD18 and AKNA in Peripheral CD4(+) T Cells from Patients with Vogt-Koyanagi-Harada Syndrome	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; MEMBRANE-PROTEINS; HUMAN NEUTROPHILS; DISEASE; APOPTOSIS; MOUSE; INFLAMMATION; LYMPHOCYTES; TECHNOLOGY; UVEITIS	Vogt-Koyanagi-Harada (VKH) syndrome is a systemic autoimmune disease. CD4(+) T cells have been shown to be involved in autoimmune diseases including VKH syndrome. To screen aberrantly expressed membrane proteins in CD4(+) T cell from patients with active VKH syndrome, blood samples were taken from five patients with active VKH syndrome and five healthy individuals. A label-free quantitative proteomic strategy was used to identify the differently expressed proteins between the two groups. The results revealed that the expression of 102 peptides was significantly altered (p<0.05) between two groups and matched amino acid sequences of proteins deposited in the international protein index (ipi.HUMAN.v3.36.fasta). The identified peptides corresponded to 64 proteins, in which 30 showed more than a 1.5-fold difference between the two groups. The decreased expression of CD18 and AKNA transcription factor (AKNA), both being three-fold lower than controls in expression identified by the label-free method, was further confirmed in an additional group of five active VKH patients and six normal individuals using the Western blot technique. A significantly decreased expression of CD18 and AKNA suggests a role for both proteins in the pathogenesis of this syndrome.	[Mao, Liming; Yang, Peizeng; Hou, Shengping; Li, Fuzhen] Chongqing Med Univ, Chongqing Eye Inst, Lab Ophthalmol, Affiliated Hosp 1, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Maastricht University	Mao, LM (corresponding author), Chongqing Med Univ, Chongqing Eye Inst, Lab Ophthalmol, Affiliated Hosp 1, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013; Hou, Shengping/E-5250-2013	Mao, Liming/0000-0002-9740-820X	National Natural Science Foundation [30973242]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing [2008115]; Project of Medical Science and Technology of Chongqing [2008-1-15]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; PAR-EU	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing; Project of Medical Science and Technology of Chongqing; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); PAR-EU	This work was supported by National Natural Science Foundation Project (30973242), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, Key Project of Health Bureau of Chongqing (2008115), Project of Medical Science and Technology of Chongqing (2008-1-15), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), and PAR-EU SCHOLARS PROGRAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER O, 1992, FEBS LETT, V299, P15, DOI 10.1016/0014-5793(92)80089-Y; Chambers G, 2000, J PATHOL, V192, P280, DOI 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Friedman David B, 2007, Methods Mol Biol, V367, P219; Ghosh S, 2006, J IMMUNOL, V177, P2486, DOI 10.4049/jimmunol.177.4.2486; Gillardon F, 2007, J NEUROCHEM, V101, P1483, DOI 10.1111/j.1471-4159.2006.04438.x; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hu XF, 2009, OMICS, V13, P291, DOI 10.1089/omi.2009.0016; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Johansson C, 2006, PROTEOMICS, V6, P4475, DOI 10.1002/pmic.200500921; Jungblut PR, 1999, ELECTROPHORESIS, V20, P2100; Kavallaris M, 2005, MED J AUSTRALIA, V182, P575, DOI 10.5694/j.1326-5377.2005.tb06817.x; Klein E, 2004, CONTRIB NEPHROL, V141, P25; Kraemer KH, 2004, NAT GENET, V36, P677, DOI 10.1038/ng0704-677; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Larsson J, 2000, INFLAMM RES, V49, P452, DOI 10.1007/s000110050616; Le Bihan T, 2006, J PROTEOME RES, V5, P2701, DOI 10.1021/pr060190y; Li B, 2005, BRIT J OPHTHALMOL, V89, P1410, DOI 10.1136/bjo.2005.074062; Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007; McGregor E, 2003, HUM MOL GENET, V12, pR135, DOI 10.1093/hmg/ddg278; Ohta K, 2002, OCUL IMMUNOL INFLAMM, V10, P93, DOI 10.1076/ocii.10.2.93.13984; Quintana LF, 2009, MOL CELL PROTEOMICS, V8, P1658, DOI 10.1074/mcp.M900059-MCP200; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Shin Tae-kyun, 2003, J Vet Sci, V4, P9; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; Sigle KJ, 2006, JAVMA-J AM VET MED A, V228, P543, DOI 10.2460/javma.228.4.543; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Walzog B, 1997, FASEB J, V11, P1177, DOI 10.1096/fasebj.11.13.9367353; Wang HL, 2009, J INVEST DERMATOL, V129, P1100, DOI 10.1038/jid.2009.43; Watanabe M, 2004, CLIN EXP IMMUNOL, V136, P555, DOI 10.1111/j.1365-2249.2004.02482.x; WILSON RW, 1993, J IMMUNOL, V151, P1571; Wright GL, 2003, J BIOMED BIOTECHNOL, P215, DOI 10.1155/S1110724303002997; Wu MX, 1996, J IMMUNOL, V157, P707; Xu H, 2008, J PROTEOME RES, V7, P1098, DOI 10.1021/pr7006768; Xue H, 2010, J PROTEOME RES, V9, P545, DOI 10.1021/pr9008817; Xun ZY, 2009, J PROTEOME RES, V8, P4500, DOI 10.1021/pr9006238; Yamaki K, 2000, EXP EYE RES, V71, P361, DOI 10.1006/exer.2000.0893; Yamaki Kunihiko, 2002, International Ophthalmology Clinics, V42, P13; Yang PZ, 2002, OCUL IMMUNOL INFLAMM, V10, P47, DOI 10.1076/ocii.10.1.47.10331; Yang PZ, 2001, OCUL IMMUNOL INFLAMM, V9, P185, DOI 10.1076/ocii.9.3.185.3961; Zhang LJ, 2005, PROTEOMICS, V5, P4510, DOI 10.1002/pmic.200401318	44	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14616	10.1371/journal.pone.0014616	http://dx.doi.org/10.1371/journal.pone.0014616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297967	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100003
J	Chen, XA; Cho, K; Singer, BH; Zhang, HP				Chen, Xiang; Cho, Kelly; Singer, Burton H.; Zhang, Heping			The Nuclear Transcription Factor PKNOX2 Is a Candidate Gene for Substance Dependence in European-Origin Women	PLOS ONE			English	Article							NICOTINE DEPENDENCE; ALCOHOL DEPENDENCE; ASSOCIATION; RISK; RECEPTOR; PREVALENCE; MARIJUANA; GENOTYPES; SUBUNIT; COCAINE	Substance dependence or addiction is a complex environmental and genetic disorder that results in serious health and socio-economic consequences. Multiple substance dependence categories together, rather than any one individual addiction outcome, may explain the genetic variability of such disorder. In our study, we defined a composite substance dependence phenotype derived from six individual diagnoses: addiction to nicotine, alcohol, marijuana, cocaine, opiates or other drugs as a whole. Using data from several genomewide case-control studies, we identified a strong (Odds ratio = 1.77) and significant (p-value = 7E-8) association signal with a novel gene, PBX/knotted 1 homeobox 2 (PKNOX2), on chromosome 11 with the composite phenotype in European-origin women. The association signal is not as significant when individual outcomes for addiction are considered, or in males or African-origin population. Our findings underscore the importance of considering multiple addiction types and the importance of considering population and gender stratification when analyzing data with heterogeneous population.	[Chen, Xiang; Cho, Kelly; Zhang, Heping] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Singer, Burton H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Yale University; State University System of Florida; University of Florida	Chen, XA (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.	heping.zhang@yale.edu	Chen, Xiang/N-2524-2018; Zhang, He/GXN-0028-2022	Chen, Xiang/0000-0002-2499-8261; 	National Institutes of Health [K02DA017713, R01DA016750, T32 MH014235, U01 HG004446, U10 AA008401, P01 CA089392, R01 DA013423, HHSN268200782096C]; National Institutes of Health Genes, Environment, and Health Initiative [U01 HG004422, U01HG004438]; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004422, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA017713, R01DA013423, R01DA016750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Genes, Environment, and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grants K02DA017713, R01DA016750, and T32 MH014235. Study of Addiction: Genetics and Environment (SAGE) was supported by National Institutes of Health Genes, Environment, and Health Initiative Grant U01 HG004422. Study of Addiction: Genetics and Environment is one of the genome-wide association studies funded as part of the Gene Environment Association Studies under Genes, Environment, and Health Initiative. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the Gene Environment Association Studies Coordinating Center, which is supported by National Institutes of Health Grant U01 HG004446. Assistance with data cleaning was provided by the National Center for Biotechnology Information. Support for collection of datasets and samples was provided by the Collaborative Study on the Genetics of Alcoholism, which is supported by National Institutes of Health Grant U10 AA008401; the Collaborative Genetic Study of Nicotine Dependence, which is supported by National Institutes of Health Grant P01 CA089392; and the Family Study of Cocaine Dependence which is supported by National Institutes of Health Grant R01 DA013423. Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research and was supported by National Institutes of Health Genes, Environment, and Health Initiative Grant U01HG004438, the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and National Institutes of Health contract HHSN268200782096C, "High throughput genotyping for studying the genetic contributions to human disease." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adhikari B., 2009, Morbidity and Mortality Weekly Report, V58, P29; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Breslau N, 2001, ARCH GEN PSYCHIAT, V58, P810, DOI 10.1001/archpsyc.58.9.810; Curtin K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-448; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Edenberg HJ, 2006, ADDICT BIOL, V11, P386, DOI 10.1111/j.1369-1600.2006.00035.x; Hartel DM, 2006, CLIN INFECT DIS, V43, P525, DOI 10.1086/505978; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Karch DL, 2006, INJURY PREV, V12, P22, DOI 10.1136/ip.2006.013557; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Luo ZH, 2008, NICOTINE TOB RES, V10, P1223, DOI 10.1080/14622200802163266; MAEZAWA Y, 1995, ALCOHOL CLIN EXP RES, V19, P951, DOI 10.1111/j.1530-0277.1995.tb00972.x; Makhija Nita J, 2007, Int J Adolesc Med Health, V19, P53; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redden DT, 2006, PLOS GENET, V2, P1254, DOI 10.1371/journal.pgen.0020137; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Reich T, 1996, ALCOHOL CLIN EXP RES, V20, pA133, DOI 10.1111/j.1530-0277.1996.tb01763.x; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Song JZ, 2003, AM J MED GENET B, V117B, P39, DOI 10.1002/ajmg.b.10022; True WR, 1999, AM J MED GENET, V88, P391, DOI 10.1002/(SICI)1096-8628(19990820)88:4<391::AID-AJMG17>3.0.CO;2-L; Uhl George R., 1995, P1793	35	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16002	10.1371/journal.pone.0016002	http://dx.doi.org/10.1371/journal.pone.0016002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298047	gold, Green Submitted, Green Published			2022-12-27	WOS:000286663900021
J	Cury, JC; Araujo, FV; Coelho-Souza, SA; Peixoto, RS; Oliveira, JAL; Santos, HF; Davila, AMR; Rosado, AS				Cury, Juliano C.; Araujo, Fabio V.; Coelho-Souza, Sergio A.; Peixoto, Raquel S.; Oliveira, Joana A. L.; Santos, Henrique F.; Davila, Alberto M. R.; Rosado, Alexandre S.			Microbial Diversity of a Brazilian Coastal Region Influenced by an Upwelling System and Anthropogenic Activity	PLOS ONE			English	Article							CABO FRIO BRAZIL; GRADIENT GEL-ELECTROPHORESIS; ARCHAEAL ASSEMBLAGES; PLANKTONIC ARCHAEA; CLONE LIBRARIES; WATER MASSES; MARINE; BACTERIAL; BACTERIOPLANKTON; COMMUNITY	Background: Upwelling systems are characterised by an intense primary biomass production in the surface (warmest) water after the outcrop of the bottom (coldest) water, which is rich in nutrients. Although it is known that the microbial assemblage plays an important role in the food chain of marine systems and that the upwelling systems that occur in southwest Brazil drive the complex dynamics of the food chain, little is known about the microbial composition present in this region. Methodology/Principal Findings: We carried out a molecular survey based on SSU rRNA gene from the three domains of the phylogenetic tree of life present in a tropical upwelling region (Arraial do Cabo, Rio de Janeiro, Brazil). The aim was to analyse the horizontal and vertical variations of the microbial composition in two geographically close areas influenced by anthropogenic activity (sewage disposal/port activity) and upwelling phenomena, respectively. A lower estimated diversity of microorganisms of the three domains of the phylogenetic tree of life was found in the water of the area influenced by anthropogenic activity compared to the area influenced by upwelling phenomena. We observed a heterogenic distribution of the relative abundance of taxonomic groups, especially in the Archaea and Eukarya domains. The bacterial community was dominated by Proteobacteria, Cyanobacteria and Bacteroidetes phyla, whereas the microeukaryotic community was dominated by Metazoa, Fungi, Alveolata and Stramenopile. The estimated archaeal diversity was the lowest of the three domains and was dominated by uncharacterised marine Crenarchaeota that were most closely related to Marine Group I. Conclusions/Significance: The variety of conditions and the presence of different microbial assemblages indicated that the area of Arraial do Cabo can be used as a model for detailed studies that contemplate the correlation between pollution-indicating parameters and the depletion of microbial diversity in areas close to anthropogenic activity; functional roles and geochemical processes; phylogeny of the uncharacterised diversity; and seasonal variations of the microbial assemblages.	[Cury, Juliano C.; Peixoto, Raquel S.; Santos, Henrique F.; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Lab Mol Microbial Ecol, Rio de Janeiro, Brazil; [Araujo, Fabio V.] FFP UERJ, DCIEN, Microbiol Lab, Rio De Janeiro, Brazil; [Coelho-Souza, Sergio A.] Univ Fed Rio de Janeiro, INPeTAm IBCCF, Rio de Janeiro, Brazil; [Cury, Juliano C.; Oliveira, Joana A. L.; Davila, Alberto M. R.] Fiocruz MS, IOC, Lab Computat Biol & Syst, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Cury, JC (corresponding author), Univ Fed Rio de Janeiro, Lab Mol Microbial Ecol, Rio de Janeiro, Brazil.	jccury@hotmail.com	Santos, Henrique/AAI-9410-2020; Coelho-Souza, Sergio/E-1856-2013; Rosado, Alexandre Soares/G-1955-2012; Dávila, Alberto M. R./AAJ-4647-2021; Araujo, Fábio/AAS-9624-2020; Peixoto, Raquel/V-2554-2019; Santos, Henrique Fragoso dos/G-3697-2014	Santos, Henrique/0000-0001-8850-7399; Rosado, Alexandre Soares/0000-0001-5135-1394; Dávila, Alberto M. R./0000-0002-6918-7673; Araujo, Fábio/0000-0002-1931-7302; Santos, Henrique Fragoso dos/0000-0001-8850-7399; Cury, Juliano/0000-0002-1450-5726; Coelho de Souza, Sergio Augusto/0000-0003-0701-6892; Peixoto, Raquel/0000-0002-9536-3132	Brazilian National Research Council (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	JCC, ASR and RSP greatly appreciate the support of Brazilian National Research Council (CNPq) and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2007, FEMS MICROBIOL ECOL, V60, P98, DOI 10.1111/j.1574-6941.2006.00276.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APHA AWWA and WEF, 2000, STAND METH EXAM WAT; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Campos EJD, 2000, GEOPHYS RES LETT, V27, P751, DOI 10.1029/1999GL010502; Carvalho Wanderson Fernandes de, 2004, Braz. j. oceanogr., V52, P35, DOI 10.1590/S1679-87592004000100004; Castelao RM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025182; Cathrine SJ, 2009, MYCOL RES, V113, P100, DOI 10.1016/j.mycres.2008.08.009; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; DeLong EF, 2003, ASM NEWS, V69, P503; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Dubelaar GBJ, 1999, CYTOMETRY, V37, P247, DOI 10.1002/(SICI)1097-0320(19991201)37:4<247::AID-CYTO1>3.0.CO;2-9; Durisch-Kaiser E, 2005, APPL ENVIRON MICROB, V71, P8099, DOI 10.1128/AEM.71.12.8099-8106.2005; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Felsenstein J., 1993, PHYLOGENETIC INFEREN; FERREIRA C. E. L., 2004, J COASTAL RES, V3, P1340; FUERST JA, 1995, MICROBIOL-UK, V141, P1493, DOI 10.1099/13500872-141-7-1493; Fuhrman JA., 2008, MICROBIAL ECOLOGY OC, P45, DOI 10.1002/9780470281840.ch3; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Garren M, 2008, ENVIRON MICROBIOL, V10, P2299, DOI 10.1111/j.1462-2920.2008.01654.x; Giovannoni SJ, 1996, P NATL ACAD SCI USA, V93, P7979, DOI 10.1073/pnas.93.15.7979; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; GONZALEZRODRIGUEZ E, 1992, J PLANKTON RES, V14, P289, DOI 10.1093/plankt/14.2.289; GONZALEZRODRIGUEZ E, 1994, HYDROBIOLOGIA, V294, P145, DOI 10.1007/BF00016855; GOOD IJ, 1956, BIOMETRIKA, V43, P45; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Guenther M, 2008, MAR ECOL PROG SER, V363, P109, DOI 10.3354/meps07458; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Hershberger PK, 2008, J PARASITOL, V94, P1055, DOI 10.1645/GE-1553.1; Heuer H., 1997, Modern soil microbiology., P353; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, V2, P243, DOI DOI 10.1002/9780470281840.CH8; KIRCHMAN DL, 1995, DEEP-SEA RES PT II, V42, P603, DOI 10.1016/0967-0645(95)00021-H; Koch K, 2009, ENVIRON MICROBIOL, V11, P657, DOI 10.1111/j.1462-2920.2008.01836.x; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Lim E, PHYLOGENETIC D UNPUB; Lovejoy C, 2002, LIMNOL OCEANOGR, V47, P1819, DOI 10.4319/lo.2002.47.6.1819; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Marshall WL, 2008, PROTIST, V159, P415, DOI 10.1016/j.protis.2008.03.003; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; McArthur J.V., 2006, MICROBIAL ECOLOGY EV; MCMANUS GB, 1988, MAR ECOL PROG SER, V43, P11, DOI 10.3354/meps043011; McManus GB, 2007, HYDROBIOLOGIA, V575, P69, DOI 10.1007/s10750-006-0279-9; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Moon-van der Staay S. Y, 2001, NATURE, V409, P607; Moyer CL, 1998, DEEP-SEA RES PT II, V45, P303, DOI 10.1016/S0967-0645(97)00081-7; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Nagata T., 2008, MICROBIAL ECOLOGY OC, DOI [10.1002/9780470281840.ch7, DOI 10.1002/9780470281840.CH7]; Op den Camp HJM, 2007, BIOLOGY OF THE NITROGEN CYCLE, P245, DOI 10.1016/B978-044452857-5.50017-5; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Pereira GC, 2009, BRAZ J MICROBIOL, V40, P857, DOI [10.1590/S1517-83822009000400017, 10.1590/S1517-838220090004000017]; Pereira GC, 2009, ECOL MODEL, V220, P1506, DOI 10.1016/j.ecolmodel.2009.03.025; Pereira GC, 2008, BRAZ J OCEANOGR, V56, P1, DOI 10.1590/S1679-87592008000100001; Perreault NN, 2007, APPL ENVIRON MICROB, V73, P1532, DOI 10.1128/AEM.01729-06; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rodrigues RR, 2001, CONT SHELF RES, V21, P371, DOI 10.1016/S0278-4343(00)00094-7; Sambrook J, 2001, MOL CLONING LAB MANU; Santos HF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012437; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shannon C. E., 1949, MATH THEORY COMMUNIC; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; SOROKIN YI, 1979, HYDROBIOLOGIA, V62, P165, DOI 10.1007/BF00037508; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terrado R, 2009, AQUAT MICROB ECOL, V56, P25, DOI 10.3354/ame01327; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tibbles BJ, 1996, AQUAT MICROB ECOL, V11, P239, DOI 10.3354/ame011239; Valentin JL, 2001, ECOL STU AN, V144, P97; VALENTIN JL, 1987, CONT SHELF RES, V7, P77, DOI 10.1016/0278-4343(87)90065-3; VALENTIN JL, 1984, HYDROBIOLOGIA, V113, P183, DOI 10.1007/BF00026607; VALENTIN JL, 1984, MAR BIOL, V82, P259, DOI 10.1007/BF00392407; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; VINOGRADOV ME, 1978, MAR BIOL, V48, P357, DOI 10.1007/BF00391640; Walsh DA, 2005, ENVIRON MICROBIOL, V7, P1655, DOI 10.1111/j.1462-2920.2005.00864.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	98	40	43	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16553	10.1371/journal.pone.0016553	http://dx.doi.org/10.1371/journal.pone.0016553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304582	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900069
J	Houdelier, C; Lumineau, S; Bertin, A; Guibert, F; De Margerie, E; Augery, M; Richard-Yris, MA				Houdelier, Cecilia; Lumineau, Sophie; Bertin, Aline; Guibert, Floriane; De Margerie, Emmanuel; Augery, Matthieu; Richard-Yris, Marie-Annick			Development of Fearfulness in Birds: Genetic Factors Modulate Non-Genetic Maternal Influences	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; JAPANESE-QUAIL; EMOTIONAL REACTIVITY; TONIC IMMOBILITY; BEHAVIOR; MICE; FEAR; STRESS; CHICKS; CARE	The development of fearfulness and the capacity of animals to cope with stressful events are particularly sensitive to early experience with mothers in a wide range of species. However, intrinsic characteristics of young animals can modulate maternal influence. This study evaluated the effect of intrinsic fearfulness on non-genetic maternal influence. Quail chicks, divergently selected for either higher (LTI) or lower fearfulness (STI) and from a control line (C), were cross-fostered by LTI or STI mothers. Behavioural tests estimated the chicks' emotional profiles after separation from the mother. Whatever their genotype, the fearfulness of chicks adopted by LTI mothers was higher than that of chicks adopted by STI mothers. However, genetic background affected the strength of maternal effects: the least emotional chicks (STI) were the least affected by early experience with mothers. We demonstrated that young animal's intrinsic fearfulness affects strongly their sensitivity to non-genetic maternal influences. A young animal's behavioural characteristics play a fundamental role in its own behavioural development processes.	[Houdelier, Cecilia; Lumineau, Sophie; Guibert, Floriane; De Margerie, Emmanuel; Augery, Matthieu; Richard-Yris, Marie-Annick] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Bertin, Aline] Univ Tours Haras Nationaux, CNRS, INRA, UMR Physiol Reprod & Comportements 85, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); INRAE	Houdelier, C (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	cecilia.houdelier@univ-rennes1.fr		Lumineau, Sophie/0000-0002-2076-9947; de Margerie, Emmanuel/0000-0002-5380-3355	CNRS (National Committee of Scientific Research); University of Rennes 1	CNRS (National Committee of Scientific Research)(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	The experiment was financed by the authors' regular funding from research organizations (CNRS (National Committee of Scientific Research) and University of Rennes 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Archer J., 1976, P231; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Brinks V, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.008.2007, 10.3389/neuro.08/008.2007]; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Calatayud F, 2001, PHYSIOL BEHAV, V74, P355, DOI 10.1016/S0031-9384(01)00566-2; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Crews D, 2008, FRONT NEUROENDOCRIN, V29, P344, DOI 10.1016/j.yfrne.2008.01.003; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Formanek L, 2008, ETHOLOGY, V114, P817, DOI 10.1111/j.1439-0310.2008.01536.x; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; GALLUP GG, 1977, PSYCHOL REC, V27, P41, DOI 10.1007/BF03394432; GEBHARDT MD, 1993, J EVOLUTION BIOL, V6, P17, DOI 10.1046/j.1420-9101.1993.6010017.x; Hager R, 2009, P ROY SOC B-BIOL SCI, V276, P2949, DOI 10.1098/rspb.2009.0515; Hazard D, 2008, GEN COMP ENDOCR, V155, P288, DOI 10.1016/j.ygcen.2007.05.009; Jablonca E, 2005, EVOLUTION 4 DIMENSIO; JONES RB, 1978, BRIT POULTRY SCI, V19, P725, DOI 10.1080/00071667808416535; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1987, COGNITIVE ASPECTS SO, P40; Jones RB, 1996, WORLDS POULT SCI J, P133; Kendrick KM, 2001, HORM BEHAV, V40, P322, DOI 10.1006/hbeh.2001.1672; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LARSSON K, 1992, EVOLUTION, V46, P235, DOI 10.1111/j.1558-5646.1992.tb01998.x; Launay F., 1993, CONSEQUENCES COMPORT; LEBOUCHER G, 1991, ETHOL ECOL EVOL, V3, P101, DOI 10.1080/08927014.1991.9525377; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Mameli M, 2004, BRIT J PHILOS SCI, V55, P35, DOI 10.1093/bjps/55.1.35; Marx BP, 2008, CLIN PSYCHOL-SCI PR, V15, P74, DOI 10.1111/j.1468-2850.2008.00112.x; Mills A. D., 1994, COMPORTEMENT BIEN ET, P127; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; ORCUTT FS, 1976, AUK, V93, P135; Perre Y, 2002, APPL ANIM BEHAV SCI, V75, P133, DOI 10.1016/S0168-1591(01)00189-7; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Price E. O., 1998, GENETICS BEHAV DOMES; Richard-Yris M. A., 1994, COMPORTEMENT ADAPTAT, P61; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; RINGO J, 1986, BEHAVIOUR, V97, P226, DOI 10.1163/156853986X00612; Sandi C, 2008, FRONT NEUROSCI-SWITZ, V2, P134, DOI 10.3389/neuro.01.042.2008; Shettleworth, 2010, COGNITION EVOLUTION; TURROVINCENT I, 1995, BEHAV PROCESS, V34, P23, DOI 10.1016/0376-6357(94)00045-I; Wauters AM, 2002, DEV PSYCHOBIOL, V41, P25, DOI 10.1002/dev.10042; WECHSLER B, 1995, APPL ANIM BEHAV SCI, V43, P123, DOI 10.1016/0168-1591(95)00557-9	48	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14604	10.1371/journal.pone.0014604	http://dx.doi.org/10.1371/journal.pone.0014604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298038	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900008
J	Galli, C; Bernasconi, R; Solda, T; Calanca, V; Molinari, M				Galli, Carmela; Bernasconi, Riccardo; Solda, Tatiana; Calanca, Verena; Molinari, Maurizio			Malectin Participates in a Backup Glycoprotein Quality Control Pathway in the Mammalian ER	PLOS ONE			English	Article							EARLY SECRETORY PATHWAY; ALPHA-D-MANNOSIDASE; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; INFLUENZA HEMAGGLUTININ; BINDING PROTEIN; CALNEXIN CYCLE; DEGRADATION; CALRETICULIN; CONSEQUENCES	Malectin is a conserved, endoplasmic reticulum (ER)-resident lectin that recognizes high mannose oligosaccharides displaying terminal glucose residues. Here we show that Malectin is an ER stress-induced protein that selectively associates with glycopolypeptides without affecting their entry and their retention in the Calnexin chaperone system. Analysis of the obligate Calnexin client influenza virus hemagglutinin (HA) revealed that Calnexin and Malectin associated with different timing to different HA conformers and that Malectin associated with misfolded HA. Analysis of the facultative Calnexin clients NHK and alpha 1-antitrypsin (alpha 1AT) revealed that induction of Malectin expression to simulate conditions of ER stress resulted in persistent association between the ER lectin and the model cargo glycoproteins, interfered with processing of cargo-linked oligosaccharides and reduced cargo secretion. We propose that Malectin intervention is activated upon ER stress to inhibit secretion of defective gene products that might be generated under conditions of aberrant functioning of the ER quality control machinery.	[Galli, Carmela; Bernasconi, Riccardo; Solda, Tatiana; Calanca, Verena; Molinari, Maurizio] Inst Biomed Res, Bellinzona, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Galli, C (corresponding author), Inst Biomed Res, Bellinzona, Switzerland.	maurizio.molinari@irb.unisi.ch	Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair; Swiss National Science Foundation; ONELIFE Advisors SA	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ONELIFE Advisors SA	M.M. is supported by grants from the Foundation for Research on Neurodegenerative Diseases, the Fondazione San Salvatore, the Swiss National Center of Competence in Research on Neural Plasticity and Repair, the Swiss National Science Foundation, and ONELIFE Advisors SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HIRAIZUMI S, 1993, J BIOL CHEM, V268, P9927; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Muller LN, 2010, ORG BIOMOL CHEM, V8, P3294, DOI 10.1039/c004502k; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; ROTHMAN JE, 1984, J CELL BIOL, V99, P248, DOI 10.1083/jcb.99.1.248; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schallus T, 2010, GLYCOBIOLOGY, V20, P1010, DOI 10.1093/glycob/cwq059; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Vanoni O, 2008, MOL BIOL CELL, V19, P4086, DOI 10.1091/mbc.E08-05-0459; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang JX, 1997, MOL BIOL CELL, V8, P1943, DOI 10.1091/mbc.8.10.1943	42	61	62	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16304	10.1371/journal.pone.0016304	http://dx.doi.org/10.1371/journal.pone.0016304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298103	gold, Green Published			2022-12-27	WOS:000286662800024
J	Simonsen, KT; Nielsen, G; Bjerrum, JV; Kruse, T; Kallipolitis, BH; Moller-Jensen, J				Simonsen, Karina T.; Nielsen, Gorm; Bjerrum, Janni Vester; Kruse, Thomas; Kallipolitis, Birgitte H.; Moller-Jensen, Jakob			A Role for the RNA Chaperone Hfq in Controlling Adherent-Invasive Escherichia coli Colonization and Virulence	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; CAENORHABDITIS-ELEGANS; STRAIN LF82; ILEAL MUCOSA; SALMONELLA-TYPHIMURIUM; BACTERIAL-FLORA; HIGH PREVALENCE; MODEL HOST	Adherent-invasive Escherichia coli (AIEC) has been linked with the onset and perpetuation of inflammatory bowel diseases. The AIEC strain LF82 was originally isolated from an ileal biopsy from a patient with Crohn's disease. The pathogenesis of LF82 results from its abnormal adherence to and subsequent invasion of the intestinal epithelium coupled with its ability to survive phagocytosis by macrophages once it has crossed the intestinal barrier. To gain further insight into AIEC pathogenesis we employed the nematode Caenorhabditis elegans as an in vivo infection model. We demonstrate that AIEC strain LF82 forms a persistent infection in C. elegans, thereby reducing the host lifespan significantly. This host killing phenotype was associated with massive bacterial colonization of the nematode intestine and damage to the intestinal epithelial surface. C. elegans killing was independent of known LF82 virulence determinants but was abolished by deletion of the LF82 hfq gene, which encodes an RNA chaperone involved in mediating posttranscriptional gene regulation by small non-coding RNAs. This finding reveals that important aspects of LF82 pathogenesis are controlled at the posttranscriptional level by riboregulation. The role of Hfq in LF82 virulence was independent of its function in regulating RpoS and RpoE activity. Further, LF82 Delta hfq mutants were non-motile, impaired in cell invasion and highly sensitive to various chemical stress conditions, reinforcing the multifaceted function of Hfq in mediating bacterial adaptation. This study highlights the usefulness of simple non-mammalian infection systems for the identification and analysis of bacterial virulence factors.	[Simonsen, Karina T.; Nielsen, Gorm; Bjerrum, Janni Vester; Kallipolitis, Birgitte H.; Moller-Jensen, Jakob] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Kruse, Thomas] Novozymes, Bagsvaerd, Denmark	University of Southern Denmark; Novozymes	Simonsen, KT (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	jakobm@bmb.sdu.dk	Møller-Jensen, Jakob/AAO-8480-2020	Møller-Jensen, Jakob/0000-0002-6008-3771; Kallipolitis, Birgitte H./0000-0003-1233-9776; Kruse, Thomas/0000-0002-2619-7388	The Danish Colitis-Crohn Association; The Danish Natural Science Research Council; The Danish Council for Strategic Research	The Danish Colitis-Crohn Association; The Danish Natural Science Research Council(Det Frie Forskningsrad (DFF)); The Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by The Danish Colitis-Crohn Association, The Danish Natural Science Research Council and The Danish Council for Strategic Research. TK is affiliated with Novozymes A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Bringer MA, 2005, INFECT IMMUN, V73, P712, DOI 10.1128/IAI.73.2.712-721.2005; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Darfeuille-Michaud A, 2002, INT J MED MICROBIOL, V292, P185, DOI 10.1078/1438-4221-00201; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dienst D, 2008, MICROBIOL-SGM, V154, P3134, DOI 10.1099/mic.0.2008/020222-0; Dogan B, 2008, EXPERT REV CLIN IMMU, V4, P133, DOI 10.1586/1744666X.4.2.133; Eaves-Pyles T, 2008, INT J MED MICROBIOL, V298, P397, DOI 10.1016/j.ijmm.2007.05.011; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mellies JL, 2006, INFECT IMMUN, V74, P64, DOI 10.1128/IAI.74.1.64-72.2006; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Rolhion N, 2007, MOL MICROBIOL, V63, P1684, DOI 10.1111/j.1365-2958.2007.05638.x; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; van Asten FJAM, 2004, INT J MED MICROBIOL, V294, P395, DOI 10.1016/j.ijmm.2004.07.012; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	51	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16387	10.1371/journal.pone.0016387	http://dx.doi.org/10.1371/journal.pone.0016387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298102	gold, Green Published, Green Submitted			2022-12-27	WOS:000286662800036
J	Johnson, JR; Roos, A; Berg, T; Nord, M; Fuxe, J				Johnson, Jill R.; Roos, Abraham; Berg, Tove; Nord, Magnus; Fuxe, Jonas			Chronic Respiratory Aeroallergen Exposure in Mice Induces Epithelial-Mesenchymal Transition in the Large Airways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; MAMMARY CARCINOMAS; IMMUNE-RESPONSES; INFLAMMATION; CELLS; ALLIANCE; PATHWAYS; EMT	Chronic allergic asthma is characterized by Th2-polarized inflammation and leads to airway remodeling and fibrosis but the mechanisms involved are not clear. To determine whether epithelial-mesenchymal transition contributes to airway remodeling in asthma, we induced allergic airway inflammation in mice by intranasal administration of house dust mite (HDM) extract for up to 15 consecutive weeks. We report that respiratory exposure to HDM led to significant airway inflammation and thickening of the smooth muscle layer in the wall of the large airways. Transforming growth factor beta-1 (TGF-beta 1) levels increased in mouse airways while epithelial cells lost expression of E-cadherin and occludin and gained expression of the mesenchymal proteins vimentin, alpha-smooth muscle actin (alpha-SMA) and pro-collagen I. We also observed increased expression and nuclear translocation of Snail1, a transcriptional repressor of E-cadherin and a potent inducer of EMT, in the airway epithelial cells of HDM-exposed mice. Furthermore, fate-mapping studies revealed migration of airway epithelial cells into the sub-epithelial regions of the airway wall. These results show the contribution of EMT to airway remodeling in chronic asthma-like inflammation and suggest that Th2-polarized airway inflammation can trigger invasion of epithelial cells into the subepithelial regions of the airway wall where they contribute to fibrosis, demonstrating a previously unknown plasticity of the airway epithelium in allergic airway disease.	[Johnson, Jill R.; Berg, Tove; Fuxe, Jonas] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [Roos, Abraham; Nord, Magnus] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med, Div Resp Med,Lung Res Lab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Johnson, JR (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden.	jonas.fuxe@ki.se	Fuxe, Jonas/T-4433-2017; berg, tove/H-9916-2012	Fuxe, Jonas/0000-0003-4576-9377; Johnson, Jill/0000-0002-5149-0084	Swedish Research Council [2008-2598]; Swedish Childhood Cancer Foundation [PROJ08/108]; Swedish Cancer Society [CAN 2009/1211]; Swedish Wenner-Gren Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Wenner-Gren Foundations	J.F. was supported by grants from The Swedish Research Council (2008-2598), the Swedish Childhood Cancer Foundation (PROJ08/108), the Swedish Cancer Society (CAN 2009/1211). J.R.J. was supported by the Swedish Wenner-Gren Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Hackett TL, 2007, CURR OPIN ALLERGY CL, V7, P63, DOI 10.1097/ACI.0b013e328013d61b; Heijink IH, 2010, AM J RESP CELL MOL, V42, P69, DOI 10.1165/rcmb.2008-0449OC; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Johnson JR, 2007, AM J PHYSIOL-LUNG C, V293, pL730, DOI 10.1152/ajplung.00056.2007; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kariyawasam HH, 2009, J ALLERGY CLIN IMMUN, V124, P454, DOI 10.1016/j.jaci.2009.06.022; Llop-Guevara A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002426; Lloyd CM, 2010, NAT MED, V16, P273, DOI 10.1038/nm0310-273; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saunders R, 2009, J ALLERGY CLIN IMMUN, V123, P376, DOI 10.1016/j.jaci.2008.10.048; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	35	90	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16175	10.1371/journal.pone.0016175	http://dx.doi.org/10.1371/journal.pone.0016175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283768	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000286522200032
J	Hauber, HP; Ruller, S; Muller, E; Hansen, E; Zabel, P				Hauber, Hans-Peter; Rueller, Stefan; Mueller, Ernst; Hansen, Eike; Zabel, Peter			Pharyngeal Lavage Lymphocytosis in Patients with Obstructive Sleep Apnea: A Preliminary Observation	PLOS ONE			English	Article							HEART HEALTH; INFLAMMATION; ASSOCIATION; ADULTS	Background: Upper airway inflammation has been previously demonstrated in obstructive sleep apnea (OSA). However, investigation has been hampered by the necessity of invasive tissue biopsies. Objective: To evaluate the pharyngeal lavage (PHAL) as a new tool to analyze mucosal inflammation in the pharynx of patients with sleep-related disordered breathing. Patients and Methods: 36 patients with a diagnosis of OSA, 14 patients with heavy snorer syndrome (HS) or body position dependent OSA (bd-OSA), and 14 healthy volunteers underwent PHAL. Inflammatory cell counts were compared. Results: Neutrophils were the predominant cells in PHAL in all groups (94.3%+/-0.7%, 98.5%+/-0.6%, 94.3%+/-0.7%, and 96.2%+/-1.4%). OSA patients had significantly increased numbers of lymphocytes (3.2%+/-0.4%) compared to bd-OSA/HS and controls group (0.5%+/-0.1% and 0.6%+/-0.2%, respectively; P<0.05). Patients with moderate to severe OSA had significantly higher numbers of lymphocytes compared to patients with mild OSA (P<0.05). Conclusions: Data from this study suggest that PHAL is a feasible tool to investigate upper airway inflammation in OSA. In addition, PHAL demonstrates lymphocytic inflammation of the pharynx in OSA patients. Future studies are warranted to evaluate whether PHAL can be used to monitor disease and whether lymphocytic inflammation is affected by OSA treatment.	[Hauber, Hans-Peter; Rueller, Stefan; Mueller, Ernst; Hansen, Eike; Zabel, Peter] Res Ctr Borstel, Med Clin, Sleep Disorder Unit, Borstel, Germany	Forschungszentrum Borstel	Hauber, HP (corresponding author), Res Ctr Borstel, Med Clin, Sleep Disorder Unit, Borstel, Germany.	hphauber@fz-borstel.de						Almendros I, 2008, EUR RESPIR J, V32, P399, DOI 10.1183/09031936.00161607; Boyd JH, 2004, AM J RESP CRIT CARE, V170, P541, DOI 10.1164/rccm.200308-1100OC; FRIDBERG D, 1999, ACTA OTO-LARYNGOL, V119, P925; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Hauber H.P., 2009, ATEMWEG LUNGENKRANK, V35, P373, DOI 10.5414/ATP35373; Kato M, 2000, CIRCULATION, V102, P2607; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Ohga E, 1999, J APPL PHYSIOL, V87, P10, DOI 10.1152/jappl.1999.87.1.10; PRAUSE W, 2006, J NEUROL NEUROCHIR P, V7, P43; RUBINSTEIN I, 1995, LARYNGOSCOPE, V105, P175, DOI 10.1288/00005537-199502000-00012; Sabato R, 2006, Monaldi Arch Chest Dis, V65, P102; Sekosan M, 1996, LARYNGOSCOPE, V106, P1018, DOI 10.1097/00005537-199608000-00021; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	15	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16277	10.1371/journal.pone.0016277	http://dx.doi.org/10.1371/journal.pone.0016277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283819	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600036
J	Kring, SII; Barefoot, J; Brummett, BH; Boyle, SH; Siegler, IC; Toubro, S; Hansen, T; Astrup, A; Pedersen, O; Williams, RB; Sorensen, TIA				Kring, Sofia I. Iqbal; Barefoot, John; Brummett, Beverly H.; Boyle, Stephen H.; Siegler, Ilene C.; Toubro, Soren; Hansen, Torben; Astrup, Arne; Pedersen, Oluf; Williams, Redford B.; Sorensen, Thorkild I. A.			Associations between APOE Variants and Metabolic Traits and the Impact of Psychological Stress	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; SLEEP QUALITY; BODY-WEIGHT; OBESITY; RISK; RESISTANCE; GENOTYPE; MEN	Objective: In a previous study, we observed that associations between APOE rs439401 and metabolic traits were moderated by chronic stress. Thus, in a population of stressed and non-stressed Danish men, we examined whether associations between APOE rs439401 and a panel of metabolic quantitative traits, all metabolic traits which may lead to T2D and CVD were moderated by psychological stress. Methods: Obese young men (n = 475, BMI >= 31.0 kg/m(2)) and a randomly selected control group (n = 709) identified from a population of 141,800 men were re-examined in two surveys (S-46: mean age 46, S-49: mean age 49 years) where anthropometric and biochemical measures were available. Psychological stress factors were assessed by a self-administered 7-item questionnaire. Each item had the possible response categories "yes" and "no" and assessed familial problems and conflicts. Summing positive responses constituted a stress item score, which was then dichotomized into stressed and non-stressed. Logistic regression analysis, applying a recessive genetic model, was used to assess odds ratios (OR) of the associations between APOE rs439401 genotypes and adverse levels of metabolic traits. Results: The APOE rs439401 TT-genotype associated positively with BMI (OR = 1.09 [1.01; 1.17]), waist circumference (OR = 1.09 [1.02; 1.17]) in stressed men at S-46. Positive associations were observed for fasting plasma glucose (OR = 1.42 [1.07; 1.87]), serum triglycerides (OR = 1.41 [1.05; 1.91]) and with fasting plasma insulin (OR = 1.48 [1.05; 2.08]) in stressed men at S-49. Rs439401 TT-genotype also associated positively with surrogate measures of insulin resistance (HOMA-IR; OR = 1.21 [1.03; 1.41]) and inversely with insulin sensitivity (Stumvoll index; OR = 0.90 [0.82; 0.99], BIGTT-S(I); OR = 0.60 [0.43; 0.85]) in stressed men. No significant associations were observed in non-stressed men, albeit the estimates showed similar but weaker trends as in stressed men. Conclusion: The present results suggest that the APOE rs439401 TT-genotype is associated with an adverse metabolic profile in a population of psychologically stressed Danish men.	[Kring, Sofia I. Iqbal; Sorensen, Thorkild I. A.] Inst Prevent Med, Copenhagen, Denmark; [Kring, Sofia I. Iqbal] Univ Copenhagen, Ctr Pharmacogen, Copenhagen, Denmark; [Barefoot, John; Brummett, Beverly H.; Boyle, Stephen H.; Siegler, Ilene C.; Williams, Redford B.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Toubro, Soren] Hvidovre Univ Hosp, Res Clin Nutr, DK-2650 Hvidovre, Denmark; [Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Astrup, Arne] Univ Copenhagen, Dept Human Nutr, Ctr Adv Food Res, Fac Life Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	University of Copenhagen; Duke University; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; University of Southern Denmark; University of Copenhagen; University of Copenhagen; Aarhus University	Kring, SII (corresponding author), Inst Prevent Med, Copenhagen, Denmark.	si@ipm.regionh.dk	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Astrup, Arne/B-1407-2015	Pedersen, Oluf/0000-0002-3321-3972; Astrup, Arne/0000-0001-8968-8996	Center for Pharmacogenomics at the University of Copenhagen, Denmark; NHLBI [P01HL36587]; Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036587] Funding Source: NIH RePORTER	Center for Pharmacogenomics at the University of Copenhagen, Denmark; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was financially supported by Center for Pharmacogenomics at the University of Copenhagen, Denmark, and by NHLBI grant P01HL36587 and the Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Brummett BH, 2007, PSYCHOSOM MED, V69, P621, DOI 10.1097/PSY.0b013e31814b8de6; Brummett BH, 2007, PSYCHOSOM MED, V69, P396, DOI 10.1097/PSY.0b013e31806d040b; Brummett BH, 2006, HEALTH PSYCHOL, V25, P220, DOI 10.1037/0278-6133.25.2.220; Buemann B, 2005, INT J OBESITY, V29, P624, DOI 10.1038/sj.ijo.0802929; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; FUMERON F, 1988, CLIN GENET, V34, P258; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Jemaa R, 2006, CLIN BIOCHEM, V39, P816, DOI 10.1016/j.clinbiochem.2006.04.018; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kring SII, 2010, PSYCHOSOM MED, V72, P427, DOI 10.1097/PSY.0b013e3181de30ad; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Prescott E, 2003, INT J EPIDEMIOL, V32, P990, DOI 10.1093/ije/dyg235; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; SONNEHOLM S, 1989, BRIT MED J, V299, P767, DOI 10.1136/bmj.299.6702.767; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; *WHO, 2003, PHYS STAT US INT ANT	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15745	10.1371/journal.pone.0015745	http://dx.doi.org/10.1371/journal.pone.0015745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283811	Green Published, gold			2022-12-27	WOS:000286520600009
J	St Hill, CA; Baharo-Hassan, D; Farooqui, M				St Hill, Catherine A.; Baharo-Hassan, Dahabo; Farooqui, Mariya			C2-O-sLe(X) Glycoproteins Are E-Selectin Ligands that Regulate Invasion of Human Colon and Hepatic Carcinoma Cells	PLOS ONE			English	Article							SIALYL-LEWIS-X; CORE 2 BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; INFLAMMATION-INDUCED EXPRESSION; P-SELECTIN; COLORECTAL-CANCER; MONOCLONAL-ANTIBODY; LEUKOCYTE ADHESION; O-GLYCANS; EPITHELIAL EXPRESSION; DEPENDENT ADHESION	Similar to mechanisms of recruitment of activated leukocytes to inflamed tissues, selectins mediate adhesion and extravasation of circulating cancer cells. Our objective was to determine whether sialyl Lewis X modified core 2 O-glycans (C2-O-sLe(X)) present on colon and hepatic carcinoma cells promote their adhesion and invasion. We examined membrane expression of C2-O-sLe(X), selectin binding, invasion of human colon and hepatic carcinoma cell lines, and mRNA levels of alpha-2,3 fucosyltransferase (FucT-III) and core 2 beta-1,6 N-acetylglucosaminyltransferase (C2GnT1) genes, necessary for C2-O-sLe(X) synthesis, by quantitative reverse-transcriptase (RT) PCR. Synthesis of core 2 branched O-glycans decorated by sLe(X) is dependent on C2GnT1 function and thus we determined enzyme activity of C2GnT1. The cell lines that expressed C2GnT1 and FucT-III mRNA by quantitative RT-PCR were highly positive for C2-O-sLe(X) by flow cytometry, and colon carcinoma cells possessed highly active C2GnT1 enzyme. Cells bound avidly to E-selection but not to P-and L-selectin. Gene knock-down of C2GnT1 in colon and hepatic carcinoma cells using short hairpin RNAs (shRNA) resulted in a 40-90% decrease in C2-O-sLe(X) and a 30-50% decrease in E-selectin binding compared to control cells. Invasion of hepatic and colon carcinoma cells containing C2GnT1 shRNA was significantly reduced compared to control cells in Matrigel assays and C2GnT1 activity was down-regulated in the latter cells. The sLe(X) epitope was predominantly distributed on core 2 O-glycans on colon and hepatic carcinoma cells. Our findings indicate that C2GnT1 gene expression and the resulting C2-O-sLe(X) carbohydrates produced mediate the adhesive and invasive behaviors of human carcinomas which may influence their metastatic potential.	[St Hill, Catherine A.; Baharo-Hassan, Dahabo; Farooqui, Mariya] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	St Hill, CA (corresponding author), Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA.	sthil001@umn.edu		Farooqui, Mariya/0000-0002-2136-8694	National Institutes of Health, National Cancer Institute [5KO8CA111829-04]; NATIONAL CANCER INSTITUTE [K08CA111829] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funds from the National Institutes of Health, National Cancer Institute grant 5KO8CA111829-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BERG EL, 1992, BIOCHEM BIOPH RES CO, V184, P1048, DOI 10.1016/0006-291X(92)90697-J; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Brinkman-van der Linden ECM, 1998, GLYCOCONJUGATE J, V15, P177, DOI 10.1023/A:1006972307166; BROCKHAUSEN I, 1991, CANCER RES, V51, P1257; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; DEGRAAF TW, 1993, J EXP MED, V177, P657, DOI 10.1084/jem.177.3.657; Descheny L, 2006, J INVEST DERMATOL, V126, P2065, DOI 10.1038/sj.jid.5700364; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Haier J, 2000, ANN SURG, V231, P11, DOI 10.1097/00000658-200001000-00003; Hakomori S, 1996, CANCER RES, V56, P5309; Harada T, 1998, J HEPATOL, V28, P231, DOI 10.1016/0168-8278(88)80010-2; Hill CAS, 2005, CANCER LETT, V217, P105, DOI 10.1016/j.canlet.2004.06.038; Hiraga Y, 1998, ONCOLOGY-BASEL, V55, P307, DOI 10.1159/000011868; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; IRIMURA T, 1993, SEMIN CANCER BIOL, V4, P319; Ito K, 2001, J GASTROENTEROL, V36, P823, DOI 10.1007/s005350170004; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Katnik I, 1996, GLYCOCONJUGATE J, V13, P1043, DOI 10.1007/BF01053200; Lafrenie R M, 1993, Cell Biophys, V23, P3; LARSEN E, 1990, CELL, V63, P467, DOI 10.1016/0092-8674(90)90443-I; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lee MJ, 2003, MODERN PATHOL, V16, P403, DOI 10.1097/01.MP.0000067683.84284.66; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Machida E, 2001, CANCER RES, V61, P2226; MANNORI G, 1995, CANCER RES, V55, P4425; MITSAKOS A, 1988, BIOL CHEM H-S, V369, P661, DOI 10.1515/bchm3.1988.369.2.661; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; NAKAMORI S, 1993, CANCER RES, V53, P3632; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Ni ZY, 2006, J IMMUNOL, V177, P4742, DOI 10.4049/jimmunol.177.7.4742; PAULI BU, 1990, CANCER METAST REV, V9, P175, DOI 10.1007/BF00046359; Prorok-Hamon Maelle, 2006, V347, P171; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Renkonen J, 1997, INT J CANCER, V74, P296; Renkonen J, 2000, APMIS, V108, P705, DOI 10.1034/j.1600-0463.2000.d01-18.x; Renkonen J, 2001, APMIS, V109, P500, DOI 10.1111/j.1600-0463.2001.apm090703.x; SAITOH O, 1991, BLOOD, V77, P1491; SAWADA R, 1994, J BIOL CHEM, V269, P1425; Shimodaira K, 1997, CANCER RES, V57, P5201; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Smith MJ, 2004, J BIOL CHEM, V279, P21984, DOI 10.1074/jbc.M402731200; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; St Hill CA, 2003, J LEUKOCYTE BIOL, V73, P464, DOI 10.1189/jlb.1002491; St Hill CA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-79; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; URDAL DL, 1983, BLOOD, V62, P1022; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; WEISS L, 1989, CLIN EXP METASTAS, V7, P127, DOI 10.1007/BF01787020; WILLIAMS D, 1980, J BIOL CHEM, V255, P1247; Yago T, 2003, J BIOL CHEM, V278, P37987, DOI 10.1074/jbc.M305778200; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; Zhang Bao-Hua, 2002, Hepatobiliary Pancreat Dis Int, V1, P80; Zhang K, 1996, J CELL BIOCHEM, V60, P538, DOI 10.1002/(SICI)1097-4644(19960315)60:4<538::AID-JCB10>3.3.CO;2-A	64	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16281	10.1371/journal.pone.0016281	http://dx.doi.org/10.1371/journal.pone.0016281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283832	Green Submitted, Green Published, gold			2022-12-27	WOS:000286520600037
J	Straub, C; Quillardet, P; Vergalli, J; de Marsac, NT; Humbert, JF				Straub, Cecile; Quillardet, Philippe; Vergalli, Julia; de Marsac, Nicole Tandeau; Humbert, Jean-Francois			A Day in the Life of Microcystis aeruginosa Strain PCC 7806 as Revealed by a Transcriptomic Analysis	PLOS ONE			English	Article							CYANOBACTERIA; EXPRESSION; METABOLISM; BUOYANCY; PCC-6803; CLOCK; LIGHT	The cyanobacterium, Microcystis aeruginosa, is able to proliferate in a wide range of freshwater ecosystems and to produce many secondary metabolites that are a threat to human and animal health. The dynamic of this production and more globally the metabolism of this species is still poorly known. A DNA microarray based on the genome of M. aeruginosa PCC 7806 was constructed and used to study the dynamics of gene expression in this cyanobacterium during the light/dark cycle, because light is a critical factor for this species, like for other photosynthetic microorganisms. This first application of transcriptomics to a Microcystis species has revealed that more than 25% of the genes displayed significant changes in their transcript abundance during the light/dark cycle and in particular during the dark/light transition. The metabolism of M. aeruginosa is compartmentalized between the light period, during which carbon uptake, photosynthesis and the reductive pentose phosphate pathway lead to the synthesis of glycogen, and the dark period, during which glycogen degradation, the oxidative pentose phosphate pathway, the TCA branched pathway and ammonium uptake promote amino acid biosynthesis. We also show that the biosynthesis of secondary metabolites, such as microcystins, aeruginosin and cyanopeptolin, occur essentially during the light period, suggesting that these metabolites may interact with the diurnal part of the central metabolism.	[Straub, Cecile; Quillardet, Philippe] Inst Pasteur, Unite Dynam Genome, Paris, France; [Vergalli, Julia] Univ Paul Cezanne, Inst Mediterraneen Ecol & Paleoecol, UMR CNRS 6116, Fac St Jerome, Marseille, France; [de Marsac, Nicole Tandeau] Univ Aix Marseille, CNRS UPR9043, Chim Bacterienne Lab, Marseille, France; [Humbert, Jean-Francois] INRA, UMR BIOEMCO, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Straub, C (corresponding author), Inst Pasteur, Unite Dynam Genome, Paris, France.	humbert@biologie.ens.fr	Vergalli, Julia/AAQ-2604-2021	Humbert, Jean-Francois/0000-0002-1519-5651; Vergalli, Julia/0000-0003-3253-6275	ANR (French governemental agency for the research)	ANR (French governemental agency for the research)(French National Research Agency (ANR))	This work has been funded by the ANR (French governemental agency for the research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSSIBA S, 1989, PLANT CELL PHYSIOL, V30, P303, DOI 10.1093/oxfordjournals.pcp.a077743; Briand JF, 2003, VET RES, V34, P361, DOI 10.1051/vetres:2003019; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Cooley JW, 2000, J BACTERIOL, V182, P714, DOI 10.1128/JB.182.3.714-722.2000; de Marsac NT, 2001, J APPL PHYCOL, V13, P287; Elvitigala T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-226; Finzi-Hart JA, 2009, P NATL ACAD SCI USA, V106, P6345, DOI 10.1073/pnas.0810547106; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gill RT, 2002, J BACTERIOL, V184, P3671, DOI 10.1128/JB.184.13.3671-3681.2002; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; IBELINGS BW, 1991, ARCH HYDROBIOL, V120, P385; Imamura S, 2009, GENE REGUL SYST BIO, V3, P65; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; KUIPERGOODMAN T, 1999, TOXIC CYANOBACTERIA, P41; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rabouille S, 2003, CR BIOL, V326, P349, DOI 10.1016/S1631-0691(03)00123-9; REYNOLDS CS, 1976, HYDROBIOLOGIA, V48, P17, DOI 10.1007/BF00033486; REYNOLDS CS, 1975, BIOL REV, V50, P437, DOI 10.1111/j.1469-185X.1975.tb01060.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; TAN X, 2007, J ENVIRON SCI, V21, P892; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toepel J, 2009, J PHYCOL, V45, P610, DOI 10.1111/j.1529-8817.2009.00674.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermaas W. F. J., 2001, ENCY LIFE SCI, DOI [10.1038/npg.els.0001670, DOI 10.1038/NPG.ELS.0001670]; Wu ZX, 2008, PHYCOLOGIA, V47, P98, DOI 10.2216/07-49.1; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	33	71	74	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16208	10.1371/journal.pone.0016208	http://dx.doi.org/10.1371/journal.pone.0016208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283831	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600032
J	Wang, WL; Hong, JR; Lin, GH; Liu, WT; Gong, HY; Lu, MW; Lin, CC; Wu, JL				Wang, Wei-Lun; Hong, Jiann-Ruey; Lin, Gen-Hwa; Liu, Wangta; Gong, Hong-Yi; Lu, Ming-Wei; Lin, Ching-Chun; Wu, Jen-Leih			Stage-Specific Expression of TNF alpha Regulates Bad/Bid-Mediated Apoptosis and RIP1/ROS-Mediated Secondary Necrosis in Birnavirus-Infected Fish Cells	PLOS ONE			English	Article							VIRUS INDUCES APOPTOSIS; NF-KAPPA-B; GENE-EXPRESSION; IN-VITRO; DEATH; PROTEIN; KINASE; ACTIVATION; IDENTIFICATION; POLYPROTEIN	Infectious pancreatic necrosis virus (IPNV) can induce Bad-mediated apoptosis followed by secondary necrosis in fish cells, but it is not known how these two types of cell death are regulated by IPNV. We found that IPNV infection can regulate Bad/Bid-mediated apoptotic and Rip1/ROS-mediated necrotic death pathways via the up-regulation of TNF alpha in zebrafish ZF4 cells. Using a DNA microarray and quantitative RT-PCR analyses, two major subsets of differentially expressed genes were characterized, including the innate immune response gene TNF alpha and the pro-apoptotic genes Bad and Bid. In the early replication stage (0-6 h post-infection, or p.i.), we observed that the pro-inflammatory cytokine TNF alpha underwent a rapid sixfold induction. Then, during the early-middle replication stages (6-12 h p.i.), TNF alpha level was eight-fold induction and the pro-apoptotic Bcl-2 family members Bad and Bid were up-regulated. Furthermore, specific inhibitors of TNF alpha expression (AG-126 or TNF alpha-specific siRNA) were used to block apoptotic and necrotic death signaling during the early or early-middle stages of IPNV infection. Inhibition of TNF alpha expression dramatically reduced the Bad/Bid-mediated apoptotic and Rip1/ROS-mediated necrotic cell death pathways and rescued host cell viability. Moreover, we used Rip1-specific inhibitors (Nec-1 and Rip1-specific siRNA) to block Rip1 expression. The Rip1/ROS-mediated secondary necrotic pathway appeared to be reduced in IPNV-infected fish cells during the middle-late stage of infection (12-18 h p.i.). Taken together, our results indicate that IPNV triggers two death pathways via up-stream induction of the pro-inflammatory cytokine TNF alpha, and these results may provide new insights into the pathogenesis of RNA viruses.	[Wang, Wei-Lun; Wu, Jen-Leih] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Wang, Wei-Lun; Lin, Gen-Hwa; Liu, Wangta; Lin, Ching-Chun; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Hong, Jiann-Ruey] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Gong, Hong-Yi; Lu, Ming-Wei] Natl Taiwan Ocean Univ, Dept Aquaculture, Chilung, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan Ocean University	Wang, WL (corresponding author), Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan.	jlwu@gate.sinica.edu.tw	Gong, Hong-Yi/ABE-2571-2020	Gong, Hong-Yi/0000-0002-6240-0582	National Science Council, Taiwan, Republic of China [NSC95-2313-B-001-004, NSC96-2313-B-001-001]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was funded by grants (NSC95-2313-B-001-004, NSC96-2313-B-001-001) awarded to Dr. Jen-Leih Wu from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict CA, 2003, CYTOKINE GROWTH F R, V14, P349, DOI 10.1016/S1359-6101(03)00030-3; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Chen PC, 2010, FISH SHELLFISH IMMUN, V28, P344, DOI 10.1016/j.fsi.2009.11.014; Chiu CL, 2010, APOPTOSIS, V15, P653, DOI 10.1007/s10495-010-0468-x; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; DOBOS P, 1977, J VIROL, V21, P242, DOI 10.1128/JVI.21.1.242-258.1977; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; DUNCAN R, 1987, J VIROL, V61, P3655, DOI 10.1128/JVI.61.12.3655-3664.1987; DUNCAN R, 1991, VIROLOGY, V181, P541, DOI 10.1016/0042-6822(91)90887-H; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; HERMAN B, 1988, FASEB J, V2, P146, DOI 10.1096/fasebj.2.2.3342967; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hong JR, 2008, J FISH DIS, V31, P451, DOI 10.1111/j.1365-2761.2008.00928.x; Hong JR, 2005, J FISH DIS, V28, P133, DOI 10.1111/j.1365-2761.2004.00604.x; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; Hong JR, 2002, CELL DEATH DIFFER, V9, P113, DOI 10.1038/sj/cdd/4400933; Hong JR, 2002, VIROLOGY, V295, P217, DOI 10.1006/viro.2001.1336; Hong JR, 1999, J VIROL, V73, P5056, DOI 10.1128/JVI.73.6.5056-5063.1999; Hong JR, 1999, VIRUS RES, V63, P75, DOI 10.1016/S0168-1702(99)00060-X; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; JEURISSEN SHM, 1992, J VIROL, V66, P7383, DOI 10.1128/JVI.66.12.7383-7388.1992; KAIN SR, 1994, BIOTECHNIQUES, V17, P982; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; LaPatra SE, 2000, BLOOD CELL MOL DIS, V26, P445, DOI 10.1006/bcmd.2000.0320; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; MAGYAR G, 1994, VIROLOGY, V204, P580, DOI 10.1006/viro.1994.1572; MAJNO G, 1995, AM J PATHOL, V146, P3; MEURER R, 1989, BIOCHEM BIOPH RES CO, V159, P763, DOI 10.1016/0006-291X(89)90060-0; Morgan MJ, 2008, CELL RES, V18, P343, DOI 10.1038/cr.2008.31; NICHOLSON BL, 1974, J VIROL, V14, P180, DOI 10.1128/JVI.14.1.180-182.1974; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Santi N, 2005, VIROLOGY, V342, P13, DOI 10.1016/j.virol.2005.07.028; Sato A, 2008, GENOMICS, V92, P9, DOI 10.1016/j.ygeno.2008.02.002; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shakibaei M, 2005, ANTIOXID REDOX SIGN, V7, P482, DOI 10.1089/ars.2005.7.482; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vanden Berghe T, 2007, MOL CELL, V26, P769, DOI 10.1016/j.molcel.2007.06.002; Vandenabeele P, 2008, TRENDS BIOCHEM SCI, V33, P352, DOI 10.1016/j.tibs.2008.05.007; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	50	48	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16740	10.1371/journal.pone.0016740	http://dx.doi.org/10.1371/journal.pone.0016740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304825	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600020
J	Kimura, J; Ichii, O; Otsuka, S; Kanazawa, T; Namiki, Y; Hashimoto, Y; Kon, Y				Kimura, Junpei; Ichii, Osamu; Otsuka, Saori; Kanazawa, Tomonori; Namiki, Yuka; Hashimoto, Yoshiharu; Kon, Yasuhiro			Quantitative and Qualitative Urinary Cellular Patterns Correlate with Progression of Murine Glomerulonephritis	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TUBULAR EPITHELIAL-CELLS; PODOCYTE-ASSOCIATED MOLECULES; CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; GLOMERULAR-DISEASES; TELOMERIC REGION; IGA NEPHROPATHY; INJURY; COMPLEMENT	The kidney is a nonregenerative organ composed of numerous functional nephrons and collecting ducts (CDs). Glomerular and tubulointerstitial damages decrease the number of functional nephrons and cause anatomical and physiological alterations resulting in renal dysfunction. It has recently been reported that nephron constituent cells are dropped into the urine in several pathological conditions associated with renal functional deterioration. We investigated the quantitative and qualitative urinary cellular patterns in a murine glomerulonephritis model and elucidated the correlation between cellular patterns and renal pathology. Urinary cytology and renal histopathology were analyzed in BXSB/MpJ (BXSB; glomerulonephritis model) and C57BL/6 (B6; control) mice. Urinary cytology revealed that the number of urinary cells in BXSB mice changed according to the histometric score of glomerulonephritis and urinary albumin; however, no correlation was detected for the levels of blood urea nitrogen and creatinine. The expression of specific markers for podocytes, distal tubules (DTs), and CDs was detected in BXSB urine. Cells immunopositive for Wilms tumor 1 (podocyte marker) and interleukin-1 family, member 6 (damaged DT and CD marker) in the kidney significantly decreased and increased in BXSB versus B6, respectively. In the PCR array analysis of inflammatory cytokines and chemokines, Il10, Cxcl2, C3, and Il1rn showed relatively higher expression in BXSB kidneys than in B6 kidneys. In particular, the highest expression of C3 mRNA was detected in the urine from BXSB mice. Furthermore, C3 protein and mRNA were localized in the epithelia of damaged nephrons. These findings suggest that epithelial cells of the glomerulus, DT, and CD are dropped into the urine, and that these patterns are associated with renal pathology progression. We conclude that evaluation of urinary cellular patterns plays a key role in the early, noninvasive diagnosis of renal disease.	[Kimura, Junpei; Ichii, Osamu; Otsuka, Saori; Kanazawa, Tomonori; Kon, Yasuhiro] Hokkaido Univ, Anat Lab, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Namiki, Yuka; Hashimoto, Yoshiharu] Hokkaido Univ, Off Fac Dev & Teaching Enriched Vet Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kimura, J (corresponding author), Hokkaido Univ, Anat Lab, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	y-kon@vetmed.hokudai.ac.jp	kimura, junpei/GXM-5106-2022; Kon, Yasuhiro/F-8525-2012; Otsuka, Saori/F-8531-2012	Kon, Yasuhiro/0000-0002-8859-6122	Kuribayashi Foundation [21-1]; Hokkaido University; Japanese Association of Veterinary Anatomists in Obihiro [2010.9.16-18];  [21880002]	Kuribayashi Foundation; Hokkaido University; Japanese Association of Veterinary Anatomists in Obihiro; 	This work was supported by grants from Grant-in-Aid for Young Scientists (Start-Up, no. 21880002), the Kuribayashi Foundation (no. 21-1), and open-type research projects in Hokkaido University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was chosen for the Encouragement Award (Undergraduate section) at the 150th Japanese Association of Veterinary Anatomists in Obihiro (2010.9.16-18). We sincerely thank all individuals involved in this study.	Abe K, 2004, CLIN EXP IMMUNOL, V136, P60, DOI 10.1111/j.1365-2249.2004.02411.x; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; BROOIMANS RA, 1991, J CLIN INVEST, V88, P379, DOI 10.1172/JCI115314; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; David S, 1997, NEPHROL DIAL TRANSPL, V12, P51, DOI 10.1093/ndt/12.1.51; FINCO DR, 1976, J AM VET MED ASSOC, V168, P593; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Hara M, 1998, AM J NEPHROL, V18, P35, DOI 10.1159/000013302; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; Hara M, 2007, CLIN J AM SOC NEPHRO, V2, P231, DOI 10.2215/CJN.01470506; Ichii O, 2009, LUPUS, V18, P491, DOI 10.1177/0961203308098989; Ichii O, 2008, HISTOL HISTOPATHOL, V23, P411, DOI 10.14670/HH-23.411; Ichii O, 2010, LAB INVEST, V90, P459, DOI 10.1038/labinvest.2009.148; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kovesdy CP, 2009, NEPHROLOGY, V14, P408, DOI 10.1111/j.1440-1797.2009.01119.x; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Nakai S, 2008, THER APHER DIAL, V12, P428, DOI 10.1111/j.1744-9987.2008.00634.x; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Nakatsue T, 2005, KIDNEY INT, V67, P2239, DOI 10.1111/j.1523-1755.2005.00328.x; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Reiser J, 2002, NEPHROL DIAL TRANSPL, V17, P951, DOI 10.1093/ndt/17.6.951; RYAN GB, 1975, KIDNEY INT, V8, P219, DOI 10.1038/ki.1975.105; Sacks SH, 1996, J AM SOC NEPHROL, V7, P2314; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schocklmann HO, 1999, KIDNEY INT, V56, P1199, DOI 10.1046/j.1523-1755.1999.00710.x; Sheerin NS, 2008, FASEB J, V22, P1065, DOI 10.1096/fj.07-8719com; Skoberne A, 2009, AM J PHYSIOL-RENAL, V296, pF230, DOI 10.1152/ajprenal.90507.2008; Szeto CC, 2005, CLIN CHIM ACTA, V361, P182, DOI 10.1016/j.cccn.2005.05.016; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; UEKI A, 1987, IMMUNOLOGY, V61, P11; Wang G, 2008, EUR J ENDOCRINOL, V158, P317, DOI 10.1530/EJE-07-0708; Wang G, 2007, J RHEUMATOL, V34, P2358; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222	44	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16472	10.1371/journal.pone.0016472	http://dx.doi.org/10.1371/journal.pone.0016472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304992	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300068
J	Liu, XC; Lin, ZR; Zhou, T; Zong, RR; He, H; Liu, Z; Ma, JX; Liu, ZG; Zhou, YP				Liu, Xiaochen; Lin, Zhirong; Zhou, Tong; Zong, Ronrong; He, Hui; Liu, Zhen; Ma, Jian-xing; Liu, Zuguo; Zhou, Yueping			Anti-Angiogenic and Anti-Inflammatory Effects of SERPINA3K on Corneal Injury	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; KALLIKREIN-BINDING PROTEIN; ENDOTHELIAL GROWTH-FACTOR; RETINAL NEOVASCULARIZATION; DIABETIC-NEPHROPATHY; VEGF; INHIBITOR; RECEPTOR; EYE; PURIFICATION	SERPINA3K is a member of the serine proteinase inhibitor ( SERPIN) family. Here we evaluated the therapeutic effects of SERPINA3K on neovascularization and inflammation in a rat cornea alkali burn model that is commonly employed to study corneal wounding. Topical treatment of the injured rat cornea with SERPINA3K ( 20 mu g/eye/day) for 7 days significantly decreased the neovascular area, compared with the groups treated with BSA or PBS. The SERPINA3K treatment also ameliorated the corneal inflammation as evaluated by the inflammatory index. Furthermore, SERPINA3K enhanced the recovery of corneal epithelium after the alkali injury. Toward the mechanism of action, SERPINA3K down-regulated the expression of the pro-angiogenic and pro-inflammatory factors, vascular endothelial growth factor and tumor necrosis factor-alpha and up-regulated the expression of the anti-angiogenic factor, pigment epithelium-derived factor. SERPINA3K specifically inhibited growth of vascular endothelial cells. Meanwhile, SERPINA3K significantly up-regulated the expression of EGFR in the corneal epithelium. These findings suggest that SERPINA3K has therapeutic potential for corneal inflammation and NV.	[Liu, Xiaochen; Lin, Zhirong; Zhou, Tong; Zong, Ronrong; He, Hui; Liu, Zhen; Liu, Zuguo; Zhou, Yueping] Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Peoples R China; [Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	Xiamen University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Liu, XC (corresponding author), Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Peoples R China.	zuguol@yahoo.com; ypzhou@yahoo.com						Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; CHAI KX, 1991, J BIOL CHEM, V266, P16029; CHAO J, 1990, J BIOL CHEM, V265, P16394; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fornoni A, 2008, CURR DIABETES REV, V4, P10, DOI 10.2174/157339908783502361; Gao G, 2003, DIABETOLOGIA, V46, P689, DOI 10.1007/s00125-003-1085-9; Gao GQ, 2001, FEBS LETT, V489, P270, DOI 10.1016/S0014-5793(01)02110-X; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Heo SH, 2010, J CELL PHYSIOL, V224, P734, DOI 10.1002/jcp.22175; Horsley MB, 2010, CURR OPIN OPHTHALMOL, V21, P112, DOI 10.1097/ICU.0b013e3283360aad; Jenkins Alicia, 2008, Diabetes Res Clin Pract, V82, pe5, DOI 10.1016/j.diabres.2008.06.019; Khaw PT, 2004, BRIT MED J, V328, P36, DOI 10.1136/bmj.328.7430.36; King GL, 2000, NEW ENGL J MED, V342, P349, DOI 10.1056/NEJM200002033420511; Kuo Irene C, 2004, Curr Opin Ophthalmol, V15, P311, DOI 10.1097/00055735-200408000-00006; Laria C, 1997, OPHTHALMIC RES, V29, P145, DOI 10.1159/000268009; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; Michalova K, 2008, CURR ALLERGY ASTHM R, V8, P339, DOI 10.1007/s11882-008-0054-2; Miller JW, 1997, AM J PATHOL, V151, P13; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Pauly A, 2007, INVEST OPHTH VIS SCI, V48, P5473, DOI 10.1167/iovs.06-0728; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Spranger J, 2001, DIABETES, V50, P2641, DOI 10.2337/diabetes.50.12.2641; Wang JJ, 2008, AM J PHYSIOL-RENAL, V294, pF1166, DOI 10.1152/ajprenal.00375.2007; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330; ZHOU GX, 1992, J BIOL CHEM, V267, P25873	35	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16712	10.1371/journal.pone.0016712	http://dx.doi.org/10.1371/journal.pone.0016712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304961	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300127
J	Paterniti, I; Mazzon, E; Gil, C; Impellizzeri, D; Palomo, V; Redondo, M; Perez, DI; Esposito, E; Martinez, A; Cuzzocrea, S				Paterniti, Irene; Mazzon, Emanuela; Gil, Carmen; Impellizzeri, Daniela; Palomo, Valle; Redondo, Myriam; Perez, Daniel I.; Esposito, Emanuela; Martinez, Ana; Cuzzocrea, Salvatore			PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; CELL-DEATH; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; MESSENGER-RNA; EXPRESSION; APOPTOSIS; PHOSPHODIESTERASES; NEURONS	Background: Primary traumatic mechanical injury to the spinal cord (SCI) causes the death of a number of neurons that to date can neither be recovered nor regenerated. During the last years our group has been involved in the design, synthesis and evaluation of PDE7 inhibitors as new innovative drugs for several neurological disorders. Our working hypothesis is based on two different facts. Firstly, neuroinflammation is modulated by cAMP levels, thus the key role for phosphodiesterases (PDEs), which hydrolyze cAMP, is undoubtedly demonstrated. On the other hand, PDE7 is expressed simultaneously on leukocytes and on the brain, highlighting the potential crucial role of PDE7 as drug target for neuroinflammation. Methodology/Principal Findings: Here we present two chemically diverse families of PDE7 inhibitors, designed using computational techniques such as virtual screening and neuronal networks. We report their biological profile and their efficacy in an experimental SCI model induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. We have selected two candidates, namely S14 and VP1.15, as PDE7 inhibitors. These compounds increase cAMP production both in macrophage and neuronal cell lines. Regarding drug-like properties, compounds were able to cross the blood brain barrier using parallel artificial membranes (PAMPA) methodology. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, and production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with S14 and VP1.15, two PDE7 inhibitors, significantly reduced the degree of spinal cord inflammation, tissue injury (histological score), and TNF-alpha, IL-6, COX-2 and iNOS expression. Conclusions/Significance: All these data together led us to propose PDE7 inhibitors, and specifically S14 and VP1.15, as potential drug candidates to be further studied for the treatment of SCI.	[Paterniti, Irene; Impellizzeri, Daniela; Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Mazzon, Emanuela; Esposito, Emanuela; Cuzzocrea, Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Gil, Carmen; Palomo, Valle; Redondo, Myriam; Perez, Daniel I.; Martinez, Ana] CSIC, Inst Quim Med, E-28006 Madrid, Spain	University of Messina; IRCCS Bonino Pulejo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG)	Paterniti, I (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	Mazzon, Emanuela/AAL-4334-2020; del Valle Palomo Ruiz, María/N-2932-2016; Martinez, Ana/L-6414-2014; Perez Fernandez, Daniel Ignacio/L-6245-2014; Gil, Carmen/J-8932-2014	del Valle Palomo Ruiz, María/0000-0002-1473-4086; Martinez, Ana/0000-0002-2707-8110; Perez Fernandez, Daniel Ignacio/0000-0003-1774-4471; Gil, Carmen/0000-0002-3882-6081; mazzon, emanuela/0000-0002-5073-717X; Esposito, Emanuela/0000-0002-2663-6387; Impellizzeri, Daniela/0000-0001-9492-3161	MICINN; ISCiii [SAF2009-13015-CO2-01, RD0060/0015]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); ISCiii(Instituto de Salud Carlos III)	The financial support of MICINN and ISCiii (projects no. SAF2009-13015-CO2-01 and RD0060/0015, programs SAF and RETICS respectively) are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Castano T, 2009, CHEMMEDCHEM, V4, P866, DOI 10.1002/cmdc.200900043; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; Castro A, 2008, EUR J MED CHEM, V43, P1349, DOI 10.1016/j.ejmech.2007.10.027; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Choi SH, 2003, NEUROBIOL DIS, V14, P181, DOI 10.1016/S0969-9961(03)00085-8; Choi SH, 2003, J NEUROSCI, V23, P5877; Combs CK, 2001, J NEUROSCI, V21, P1179; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Crivori P, 2000, J MED CHEM, V43, P2204, DOI 10.1021/jm990968+; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; de Castro R, 2004, EXP NEUROL, V190, P414, DOI 10.1016/j.expneurol.2004.05.046; Di L, 2003, EUR J MED CHEM, V38, P223, DOI 10.1016/S0223-5234(03)00012-6; Dyke HJ, 2002, EXPERT OPIN INV DRUG, V11, P1; Essayan DM, 1999, BIOCHEM PHARMACOL, V57, P965, DOI 10.1016/S0006-2952(98)00331-1; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Genovese T, 2006, J NEUROSURG-SPINE, V4, P145, DOI 10.3171/spi.2006.4.2.145; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Giembycz MA, 2005, CURR OPIN PHARMACOL, V5, P238, DOI 10.1016/j.coph.2005.04.001; Gil C, 2009, J NEUROCHEM, V110, P119; Gil C, 2008, EXPERT OPIN THER PAT, V18, P1127, DOI 10.1517/13543776.18.10.1127; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; Hong GY, 2010, J SURG RES, V159, P565, DOI 10.1016/j.jss.2008.12.018; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Lee R, 2002, CELL SIGNAL, V14, P277, DOI 10.1016/S0898-6568(01)00250-9; Levy M L, 1999, Neurosurg Focus, V6, pe11; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Maegele M, 2005, CRIT CARE MED, V33, P1136, DOI 10.1097/01.CCM.0000163269.42524.50; Manning CD, 1999, BRIT J PHARMACOL, V128, P1393, DOI 10.1038/sj.bjp.0702911; MARTINEZ AC, 2009, 5 IMINO SUBSTITUTED; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Mullane K, 1989, Prog Clin Biol Res, V301, P39; Nakata A, 2002, CLIN EXP IMMUNOL, V128, P460, DOI 10.1046/j.1365-2249.2002.01856.x; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rahman A, 2004, AM J PHYSIOL-LUNG C, V287, pL1017, DOI 10.1152/ajplung.00072.2004; Redondo M, 2009, DRUG FUTURE, V34, P142; Reyes-Irisarri E, 2005, NEUROSCIENCE, V132, P1173, DOI 10.1016/j.neuroscience.2005.01.050; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Sirin BH, 2002, ACTA CARDIOL, V57, P279, DOI 10.2143/AC.57.4.2005427; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; vanAsperen J, 1997, J PHARM SCI, V86, P881, DOI 10.1021/js9701364; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Yang GC, 2003, J IMMUNOL, V171, P6414, DOI 10.4049/jimmunol.171.12.6414	65	56	60	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15937	10.1371/journal.pone.0015937	http://dx.doi.org/10.1371/journal.pone.0015937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297958	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300030
J	Shankar, S; Nall, D; Tang, SN; Meeker, D; Passarini, J; Sharma, J; Srivastava, RK				Shankar, Sharmila; Nall, Dara; Tang, Su-Ni; Meeker, Daniel; Passarini, Jenna; Sharma, Jay; Srivastava, Rakesh K.			Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and Kras(G12D) Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							BREAST-CANCER; DRUG-RESISTANCE; PROSPECTIVE IDENTIFICATION; NONALCOHOLIC COMPOUNDS; MOLECULAR-MECHANISMS; SELF-RENEWAL; CARCINOMA; METASTASIS; NANOG; MARKER	Background: Cancer stem cells (CSCs) can proliferate and self-renew extensively due to their ability to express anti-apoptotic and drug resistant proteins, thus sustaining tumor growth. Therefore, the strategy to eradicate CSCs might have significant clinical implications. The objectives of this study were to examine the molecular mechanisms by which resveratrol inhibits stem cell characteristics of pancreatic CSCs derived from human primary tumors and Kras(G12D) transgenic mice. Methodology/Principal Findings: Human pancreatic CSCs (CD133(+)CD44(+)CD24(+)ESA(+)) are highly tumorigenic and form subcutaneous tumors in NOD/SCID mice. Human pancreatic CSCs expressing high levels of CD133, CD24, CD44, ESA, and aldehyde dehydrogenase also express significantly more Nanog, Oct-4, Notch1, MDR1 and ABCG2 than normal pancreatic tissues and primary pancreatic cancer cells. Similarly, CSCs from Kras(G12D) mice express significantly higher levels of Nanog and Oct-4 than pancreatic tissues from Pdx-Cre mice. Resveratrol inhibits the growth (size and weight) and development (PanIN lesions) of pancreatic cancer in Kras(G12D) mice. Resveratrol inhibits the self-renewal capacity of pancreatic CSCs derived from human primary tumors and Kras(G12D) mice. Resveratrol induces apoptosis by activating capase-3/7 and inhibiting the expression of Bcl-2 and XIAP in human CSCs. Resveratrol inhibits pluripotency maintaining factors (Nanog, Sox-2, c-Myc and Oct-4) and drug resistance gene ABCG2 in CSCs. Inhibition of Nanog by shRNA enhances the inhibitory effects of resveratrol on self-renewal capacity of CSCs. Finally, resveratrol inhibits CSC's migration and invasion and markers of epithelial-mesenchymal transition (Zeb-1, Slug and Snail). Conclusions/Significance: These data suggest that resveratrol inhibits pancreatic cancer stem cell characteristics in human and Kras(G12D) transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. In conclusion, resveratrol can be used for the management of pancreatic cancer.	[Shankar, Sharmila; Nall, Dara] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Tang, Su-Ni; Meeker, Daniel; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA; [Passarini, Jenna; Sharma, Jay] Celprogen, San Pedro, CA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Shankar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	rsrivastava@kumc.edu						Aggarwal BB, 2004, EXPERT OPIN INV DRUG, V13, P1327, DOI 10.1517/13543784.13.10.1327; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alison MR, 2008, CELL TISSUE RES, V331, P109, DOI 10.1007/s00441-007-0510-7; BATTULA VL, 2010, STEM CELLS; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan C, 2008, INT J ONCOL, V33, P415, DOI 10.3892/ijo_00000023; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Clarke MF, 2008, ADV EXP MED BIOL, V617, P17, DOI 10.1007/978-0-387-69080-3_2; CLAY MR, 2010, HEAD NECK; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Ding Xian-Zhong, 2002, Pancreas, V25, pe71, DOI 10.1097/00006676-200211000-00024; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Feick P, 2007, PANCREATOLOGY, V7, P124, DOI 10.1159/000104237; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gerloff A, 2010, INT J ENV RES PUB HE, V7, P1093, DOI 10.3390/ijerph7031093; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Harikumar KB, 2010, INT J CANCER, V127, P257, DOI 10.1002/ijc.25041; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoei-Hansen CE, 2004, MOL HUM REPROD, V10, P423, DOI 10.1093/molehr/gah059; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ischenko I, 2010, LANGENBECK ARCH SURG, V395, P1, DOI 10.1007/s00423-009-0502-z; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Kallifatidis G, 2008, GUT; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; LI G, 2010, CLIN EXP METASTASIS; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Lu KH, 2009, CHILD NERV SYST, V25, P543, DOI 10.1007/s00381-009-0826-6; Ma ZH, 2005, WORLD J GASTROENTERO, V11, P3171, DOI 10.3748/wjg.v11.i21.3171; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; PAPAILIOU J, 2010, INT J COLORECTAL DIS; Pervaiz S, 2004, DRUG RESIST UPDATE, V7, P333, DOI 10.1016/j.drup.2004.11.001; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; RAIMONDI C, 2010, CURR CANC DRUG TARGE; Rasheed Z, 2010, J VIS EXP; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sarkar FH, 2010, CANCER METAST REV, V29, P383, DOI 10.1007/s10555-010-9233-4; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; SINGH A, 2010, ONCOGENE; Singh SK, 2003, CANCER RES, V63, P5821; Srivastava RK, 2010, FRONT BIOSC IN PRESS; Sun SY, 2010, BIOCHEM BIOPH RES CO, V396, P843, DOI 10.1016/j.bbrc.2010.04.170; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tang Su-Ni, 2010, J Mol Signal, V5, P14, DOI 10.1186/1750-2187-5-14; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; Wang L, 2010, INT J CANC; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579	83	211	225	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16530	10.1371/journal.pone.0016530	http://dx.doi.org/10.1371/journal.pone.0016530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304978	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300078
J	Mukherjee, A; Badal, Y; Nguyen, XT; Miller, J; Chenna, A; Tahir, H; Newton, A; Parry, G; Williams, S				Mukherjee, Ali; Badal, Youssouf; Nguyen, Xuan-Thao; Miller, Johanna; Chenna, Ahmed; Tahir, Hasan; Newton, Alicia; Parry, Gordon; Williams, Stephen			Profiling the HER3/PI3K Pathway in Breast Tumors Using Proximity-Directed Assays Identifies Correlations between Protein Complexes and Phosphoproteins	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR; PHOSPHATIDYLINOSITOL-3-OH KINASE; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; GENE AMPLIFICATION; POOR-PROGNOSIS; ERBB RECEPTORS; CELL-LINES; CANCER	Background: The identification of patients for targeted antineoplastic therapies requires accurate measurement of therapeutic targets and associated signaling complexes. HER3 signaling through heterodimerization is an important growth-promoting mechanism in several tumor types and may be a principal resistance mechanism by which EGFR and HER2 expressing tumors elude targeted therapies. Current methods that can study these interactions are inadequate for formalin-fixed, paraffin-embedded (FFPE) tumor samples. Methodology and Principal Findings: Herein, we describe a panel of proximity-directed assays capable of measuring protein-interactions and phosphorylation in FFPE samples in the HER3/PI3K/Akt pathway and examine the capability of these assays to inform on the functional state of the pathway. We used FFPE breast cancer cell line and tumor models for this study. In breast cancer cell lines we observe both ligand-dependent and independent activation of the pathway and strong correlations between measured activation of key analytes. When selected cell lines are treated with HER2 inhibitors, we not only observe the expected molecular effects based on mechanism of action knowledge, but also novel effects of HER2 inhibition on key targets in the HER receptor pathway. Significantly, in a xenograft model of delayed tumor fixation, HER3 phosphorylation is unstable, while alternate measures of pathway activation, such as formation of the HER3PI3K complex is preserved. Measurements in breast tumor samples showed correlations between HER3 phosphorylation and receptor interactions, obviating the need to use phosphorylation as a surrogate for HER3 activation. Significance: This assay system is capable of quantitatively measuring therapeutically relevant responses and enables molecular profiling of receptor networks in both preclinical and tumor models.	[Mukherjee, Ali; Badal, Youssouf; Nguyen, Xuan-Thao; Miller, Johanna; Chenna, Ahmed; Tahir, Hasan; Newton, Alicia; Parry, Gordon; Williams, Stephen] Monogram Biosci, Dept Oncol, San Francisco, CA USA		Mukherjee, A (corresponding author), Monogram Biosci, Dept Oncol, San Francisco, CA USA.	amukherjee@monogrambio.com			Monogram Biosciences	Monogram Biosciences	Study design, data collection and analysis, decision to publish, and preparation of the manuscript were done by employees of Monogram Biosciences. The research described in this manuscript was performed at Monogram Biosciences. All authors are employees of Monogram Biosciences. All authors received funding, including salaries, equipment, supplies, reimbursement for attending symposia, etc, from Monogram Biosciences.	AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Albanell J, 2001, JNCI-J NATL CANCER I, V93, P1830, DOI 10.1093/jnci/93.24.1830; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bhargava R, 2001, HUM PATHOL, V32, P1344, DOI 10.1053/hupa.2001.29668; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; DUA R, 2009, BREAST CANC IN PRESS; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Johnston S, 2008, J CLIN ONCOL, V26, P1066, DOI 10.1200/JCO.2007.13.9949; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kong A, 2006, CANCER RES, V66, P2834, DOI 10.1158/0008-5472.CAN-05-2994; Koos B, 2009, AM J PATHOL, V175, P1631, DOI 10.2353/ajpath.2009.081022; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mandell JW, 2008, HISTOCHEM CELL BIOL, V130, P465, DOI 10.1007/s00418-008-0474-z; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Menendez JA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1773; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith BL, 2004, BRIT J CANCER, V91, P1190, DOI 10.1038/sj.bjc.6602090; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Winters ZE, 2003, BREAST CANCER RES, V5, pR242, DOI 10.1186/bcr654; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zieba A, 2010, CLIN CHEM, V56, P99, DOI 10.1373/clinchem.2009.134452	42	17	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16443	10.1371/journal.pone.0016443	http://dx.doi.org/10.1371/journal.pone.0016443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297994	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100032
J	Tomaselli, S; Megiorni, F; Lin, L; Mazzilli, MC; Gerrelli, D; Majore, S; Grammatico, P; Achermann, JC				Tomaselli, Sara; Megiorni, Francesca; Lin, Lin; Mazzilli, Maria Cristina; Gerrelli, Dianne; Majore, Silvia; Grammatico, Paola; Achermann, John C.			Human RSPO1/R-spondin1 Is Expressed during Early Ovary Development and Augments beta-Catenin Signaling	PLOS ONE			English	Article							SEX DETERMINATION REVEALS; GENE-EXPRESSION; R-SPONDIN; GONADAL DEVELOPMENT; ADULT OVARIES; R-SPONDIN1; DIFFERENTIATION; REVERSAL; RSPO1; ACTIVATION	Human testis development starts from around 42 days post conception with a transient wave of SRY expression followed by up-regulation of testis specific genes and a distinct set of morphological, paracrine and endocrine events. Although anatomical changes in the ovary are less marked, a distinct sub-set of ovary specific genes are also expressed during this time. The furin-domain containing peptide R-spondin1 (RSPO1) has recently emerged as an important regulator of ovary development through up-regulation of the WNT/beta-catenin pathway to oppose testis formation. Here, we show that RSPO1 is upregulated in the ovary but not in the testis during critical early stages of gonad development in humans (between 6-9 weeks post conception), whereas the expression of the related genes WNT4 and CTNNB1 (encoding beta catenin) is not significantly different between these tissues. Furthermore, reduced R-spondin1 function in the ovotestis of an individual (46,XX) with a RSPO1 mutation leads to reduced beta-catenin protein and WNT4 mRNA levels, consistent with down regulation of ovarian pathways. Transfection of wildtype RSPO1 cDNA resulted in weak dose-dependent activation of a beta-catenin responsive TOPFLASH reporter (1.8 fold maximum), whereas co-transfection of CTNNB1 (encoding beta-catenin) with RSPO1 resulted in dose-dependent synergistic augmentation of this reporter (approximately 10 fold). Furthermore, R-spondin1 showed strong nuclear localization in several different cell lines. Taken together, these data show that R-spondin1 is upregulated during critical stages of early human ovary development and may function as a tissue-specific amplifier of beta-catenin signaling to oppose testis determination.	[Tomaselli, Sara; Majore, Silvia; Grammatico, Paola] Univ Roma La Sapienza, S Camillo Forlanini Hosp, Dept Mol Med, Rome, Italy; [Tomaselli, Sara; Lin, Lin; Achermann, John C.] UCL Inst Child Hlth, Dev Endocrinol Res Grp, London, England; [Megiorni, Francesca; Mazzilli, Maria Cristina] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Gerrelli, Dianne] UCL Inst Child Hlth, Neural Dev Unit, London, England	Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; University of London; University College London; Sapienza University Rome; University of London; University College London	Tomaselli, S (corresponding author), Univ Roma La Sapienza, S Camillo Forlanini Hosp, Dept Mol Med, Rome, Italy.	j.achermann@ich.ucl.ac.uk	Megiorni, Francesca/AAC-1597-2019; Majore, Silvia/AAH-1210-2019; Achermann, John/N-2906-2019; Achermann, John/C-5476-2008	Megiorni, Francesca/0000-0003-3705-3248; Achermann, John/0000-0001-8787-6272; Achermann, John/0000-0001-8787-6272; Majore, Silvia/0000-0001-7153-9351	Medical Research Council [G0700089]; Wellcome Trust [082557]; MIUR [COFIN 2008 CAP7245/1]; Auriga ONLUS; Medical Research Council [G9900837] Funding Source: researchfish; MRC [G9900837, G0700089] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MIUR(Ministry of Education, Universities and Research (MIUR)); Auriga ONLUS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JCA is a Wellcome Trust Senior Fellow in Clinical Science [079666]. The Human Developmental Biology Resource receives funding from the Medical Research Council [G0700089] and The Wellcome Trust [082557]. This work was partially supported by a grant from MIUR (COFIN 2008 CAP7245/1) and by the Auriga ONLUS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Buscara L, 2009, TRANSGENIC RES, V18, P649, DOI 10.1007/s11248-009-9247-2; Chadi S, 2009, BIOCHEM BIOPH RES CO, V390, P1040, DOI 10.1016/j.bbrc.2009.10.104; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dignam DJ, 1983, NUCLEIC ACIDS RES, V11, P1475; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V317, P106, DOI 10.1016/j.mce.2009.11.013; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kocer A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-36; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Mendonca BB, 2009, CLIN ENDOCRINOL, V70, P173, DOI 10.1111/j.1365-2265.2008.03392.x; Mizusaki H, 2003, MOL ENDOCRINOL, V17, P507, DOI 10.1210/me.2002-0362; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	43	61	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16366	10.1371/journal.pone.0016366	http://dx.doi.org/10.1371/journal.pone.0016366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297984	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100024
J	Das, A; Xu, HB; Wang, XL; Yau, CL; Veazey, RS; Pahar, B				Das, Arpita; Xu, Huanbin; Wang, Xiaolei; Yau, Canddy L.; Veazey, Ronald S.; Pahar, Bapi			Double-Positive CD21+CD27+B Cells Are Highly Proliferating Memory Cells and Their Distribution Differs in Mucosal and Peripheral Tissues	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; NEONATAL RHESUS MACAQUES; CD4(+)CD8(+) T-CELLS; B-CELLS; HUMORAL IMMUNITY; POLYCLONAL ACTIVATION; HIV-INFECTION; LYMPHOCYTES; EXPRESSION; CD27	Background: Several B-cell defects arise in HIV infected patients, particularly in patients with chronic infection and high viral load. Loss of memory B cells (CD27(+) B cells) in peripheral blood and lymphoid tissues is one of the major B cell dysfunctions in HIV and simian immunodeficiency virus (SIV) infection. Despite several studies, definitive identification of memory B cells based on CD27 surface expression has not been described. Similarly, the rates of cell turnover in different B cell subpopulation from lymphoid and mucosal tissues have not been well documented. In this study, we demonstrate the presence of memory B cell populations and define their distribution, frequency and immunophenotype with regards to activation, proliferation, maturation, and antibody production in normal rhesus macaques from different lymphoid tissues. Methodology/Principal Findings: Thirteen healthy, uninfected rhesus macaques were selected for this study. CD20(+) B cells were isolated from peripheral blood and sorted based on CD27 and CD21 surface markers to define memory B cell population. All the B cell subpopulation was further characterized phenotypically and their cell turnover rates were evaluated in vivo following bromodeoxyuridine (BrdU) inoculation. Double positive (DP) CD21(+)CD27(+) B cells in both peripheral and lymphoid tissues are memory B cells, able to produce antibody by polyclonal activation, and without T cell help. Peripheral and lymphoid DP CD21(+)CD27(+) B cells were also able to become activated and proliferate at higher rates than other B cell subpopulations. Increased turnover of tonsillar memory B cells were identified compared to other tissues examined. Conclusions/Significance: We suggest that this DP memory B cells play a major role in the immune system and their function and proliferation might have an important role in HIV/SIV mediated B cell dysregulation and pathogenesis.	[Das, Arpita] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Xu, Huanbin; Wang, Xiaolei; Veazey, Ronald S.; Pahar, Bapi] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Yau, Canddy L.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat, New Orleans, LA USA	Tulane University; Tulane University; Tulane University	Das, A (corresponding author), Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA.	bpahar@tulane.edu	Xu, Huanbin/S-4870-2019; Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X; Das, Arpita/0000-0002-5878-7091	National Institutes of Health [P20 RR020159, R21 AI080395, RR000164, 106719-40-RGRL]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080395] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by National Institutes of Health grants P20 RR020159, R21 AI080395 (BP) and RR000164, and amfAR grant-106719-40-RGRL (BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Erdei A, 2009, MOL IMMUNOL, V46, P2767, DOI 10.1016/j.molimm.2009.05.181; Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Kacani L, 2000, J VIROL, V74, P7997, DOI 10.1128/JVI.74.17.7997-8002.2000; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Lu FX, 1999, INFECT IMMUN, V67, P6321; MAURER D, 1990, EUR J IMMUNOL, V20, P2679, DOI 10.1002/eji.1830201223; MAURER D, 1992, J IMMUNOL, V148, P3700; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Nagumo H, 1998, IMMUNOLOGY, V94, P388, DOI 10.1046/j.1365-2567.1998.00521.x; Pahar B, 2006, EUR J IMMUNOL, V36, P583, DOI 10.1002/eji.200535520; Pahar B, 2006, VACCINE, V24, P6839, DOI 10.1016/j.vaccine.2006.06.050; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Veazey RS, 1997, CLIN IMMUNOL IMMUNOP, V82, P230, DOI 10.1006/clin.1996.4318; Veazey RS, 2003, J VIROL, V77, P8783, DOI 10.1128/JVI.77.16.8783-8792.2003; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Wang XL, 2007, BLOOD, V109, P1174, DOI 10.1182/blood-2006-04-015172; Wang XL, 2008, BLOOD, V112, P4981, DOI 10.1182/blood-2008-05-160077; Williams MB, 1998, J IMMUNOL, V161, P4227; Zinkernagel RM, 2000, PHILOS T R SOC B, V355, P369, DOI 10.1098/rstb.2000.0576	51	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16524	10.1371/journal.pone.0016524	http://dx.doi.org/10.1371/journal.pone.0016524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304587	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900061
J	Gascoin-Lachambre, G; Brauner, R; Duche, L; Chalumeau, M				Gascoin-Lachambre, Geraldine; Brauner, Raja; Duche, Laetitia; Chalumeau, Martin			Pituitary Stalk Interruption Syndrome: Diagnostic Delay and Sensitivity of the Auxological Criteria of the Growth Hormone Research Society	PLOS ONE			English	Article							GH DEFICIENCY; SHORT STATURE; LONG-TERM; HEALTH-CARE; WORK-UP; CHILDREN; CHILDHOOD; PREVALENCE; GUIDELINES; HEIGHT	Objectives: To study the diagnostic delay for pituitary stalk interruption syndrome (PSIS) with growth hormone deficiency (GHD) and the sensitivity of the auxological criteria of the Growth Hormone Research Society (GHRS) consensus guidelines. Methods: A single-center retrospective case-cohort study covering records from January 2000 through December 2007 evaluated the performance of each GHRS auxological criterion for patients with GHD and PSIS. Diagnostic delay was calculated as the difference between the age at which the earliest GHRS criterion could have been observed and the age at diagnosis of PSIS with GHD. A diagnostic delay exceeding one year was defined as late diagnosis. Results: The study included 21 patients, 16 (76%) of whom had isolated GHD and 5 (24%) multiple pituitary hormone deficiencies. The median age at diagnosis was 3.6 years (interquartile range, IQR, 2.6-5.5). The median diagnostic delay was 2.3 years (range 0-12.6; IQR 1.5-3.6), with late diagnosis for 17 patients (81%). Height more than 1.5 SDS below target height was the most effective criterion: 90% of the patients met the criterion before diagnosis at a median age of 1 year, and it was the first criterion to be fulfilled for 84%. Conclusion: In our cohort, the delay for diagnosis of PSIS with GHD was long and could have been reduced by using the GHRS criteria, in particular, height more than 1.5 SDS below the target height. The specificity of such a strategy needs to be tested in healthy populations.	[Gascoin-Lachambre, Geraldine; Brauner, Raja; Duche, Laetitia] Univ Paris 05, Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Gascoin-Lachambre, Geraldine] Univ Paris 05, Grp Hosp Cochin St Vincent de Paul, Serv Med Neonatale Port Royal, AP HP, Paris, France; [Duche, Laetitia; Chalumeau, Martin] Univ Paris 05, Hop Necker Enfants Malad, Serv Pediat Gen, AP HP, Le Kremlin Bicetre, France; [Duche, Laetitia; Chalumeau, Martin] Hop St Vincent de Paul, INSERM, U953,drens Hlth, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Gascoin-Lachambre, G (corresponding author), Univ Paris 05, Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France.	martin.chalumeau@nck.aphp.fr	Chalumeau, Martin/F-4293-2017	Chalumeau, Martin/0000-0001-8175-3706				Albertsson-Wikland K, 1990, Acta Paediatr Scand Suppl, V370, P115; Albertsson-Wikland K, 1990, ACTA PAEDIATR SC   S, V370, P121; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Arrigo T, 1998, EUR J ENDOCRINOL, V139, P84, DOI 10.1530/eje.0.1390084; Badaru A, 2004, TRENDS ENDOCRIN MET, V15, P252, DOI 10.1016/j.tem.2004.06.004; BAO XL, 1992, CHINESE MED J-PEKING, V105, P401; Carayol M, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, pS37; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Duche L, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-29; Fayter D, 2008, ARCH DIS CHILD, V93, P278, DOI 10.1136/adc.2006.109843; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Grote FK, 2008, ARCH DIS CHILD, V93, P212, DOI 10.1136/adc.2007.120188; Grote FK, 2005, J PEDIATR ENDOCR MET, V18, P1031; Grote FK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-77; Grote FK, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-21; Grumbach MM, 1998, HORM RES, V49, P41, DOI 10.1159/000053087; Hall DMB, 2000, ARCH DIS CHILD, V82, P10, DOI 10.1136/adc.82.1.10; Hanew K, 2006, ENDOCR J, V53, P259, DOI 10.1507/endocrj.53.259; Hindmarsh PC, 2004, ARCH DIS CHILD, V89, P296, DOI 10.1136/adc.2003.039560; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Juul A, 2002, HORM RES, V58, P233, DOI 10.1159/000066265; Le Ray C, 2006, OBSTET GYNECOL, V107, P1269; Lemaire P, 2009, MED SCI MONITOR, V15, pMT5; LINDSAY R, 1994, J PEDIATR-US, V125, P29, DOI 10.1016/S0022-3476(94)70117-2; Louvel M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-29; Maghnie M, 1999, J CLIN ENDOCR METAB, V84, P1324, DOI 10.1210/jc.84.4.1324; Marcu Mariana, 2008, BMC Endocr Disord, V8, P7, DOI 10.1186/1472-6823-8-7; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Oostdijk W, 2009, HORM RES, V72, P206, DOI 10.1159/000236082; PENEAU S, 2007, OBES REV, V8, P22; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Pinto G, 1999, ANN ENDOCRINOL-PARIS, V60, P224; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rottembourg D, 2008, CLIN ENDOCRINOL, V69, P105, DOI 10.1111/j.1365-2265.2007.03155.x; Sempe M, 1979, AUXOLOGIE METHODE SE, P1; Sizonenko PC, 2001, GROWTH HORM IGF RES, V11, P137, DOI 10.1054/ghir.2001.0203; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Tauber M, 2005, HORM RES, V64, P266, DOI 10.1159/000089425; Trivin C, 2006, J PEDIATR ENDOCR MET, V19, P481; van Buuren S, 2004, ARCH DIS CHILD, V89, P336, DOI 10.1136/adc.2003.027839; van Buuren S, 2004, ARCH DIS CHILD, V89, P351, DOI 10.1136/adc.2003.038208; VIMPANI GV, 1977, BMJ-BRIT MED J, V2, P427, DOI 10.1136/bmj.2.6084.427	44	25	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16367	10.1371/journal.pone.0016367	http://dx.doi.org/10.1371/journal.pone.0016367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298012	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900041
J	van Rijn, CM; Krijnen, H; Menting-Hermeling, S; Coenen, AML				van Rijn, Clementina M.; Krijnen, Hans; Menting-Hermeling, Saskia; Coenen, Anton M. L.			Decapitation in Rats: Latency to Unconsciousness and the 'Wave of Death'	PLOS ONE			English	Article							EVOKED-POTENTIALS; ELECTROENCEPHALOGRAM; EUTHANASIA; EEG; BROILERS; DEPTH	The question whether decapitation is a humane method of euthanasia in awake animals is being debated. To gather arguments in this debate, obsolete rats were decapitated while recording the EEG, both of awake rats and of anesthetized rats. Following decapitation a fast and global loss of power of the EEG was observed; the power in the 13-100 Hz frequency band, expressing cognitive activity, decreased according to an exponential decay function to half the initial value within 4 seconds. Whereas the pre-decapitation EEG of the anesthetized animals showed a burst suppression pattern quite different from the awake animals, the power in the postdecapitation EEG did not differ between the two groups. This might indicate that either the power of the EEG does not correlate well with consciousness or that consciousness is briefly regained in the anesthetized group after decapitation. Remarkably, after 50 seconds (awake group) or 80 seconds (anesthetized group) following decapitation, a high amplitude slow wave was observed. The EEG before this wave had more power than the signal after the wave. This wave might be due to a simultaneous massive loss of membrane potentials of the neurons. Still functioning ion channels, which keep the membrane potential intact before the wave, might explain the observed power difference. Two conclusions were drawn from this experiment. It is likely that consciousness vanishes within seconds after decapitation, implying that decapitation is a quick and not an inhumane method of euthanasia. It seems that the massive wave which can be recorded approximately one minute after decapitation reflects the ultimate border between life and death. This observation might have implications in the discussions on the appropriate time for organ donation.	[van Rijn, Clementina M.; Krijnen, Hans; Menting-Hermeling, Saskia; Coenen, Anton M. L.] Radboud Univ Nijmegen, Dept Biol Psychol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	van Rijn, CM (corresponding author), Radboud Univ Nijmegen, Dept Biol Psychol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	t.vanrijn@donders.ru.nl	van Rijn, Clementina/D-5828-2012	van Rijn, Clementina/0000-0002-1103-6338				ALLRED JB, 1986, J NUTR, V116, P1859, DOI 10.1093/jn/116.9.1859; Auyong DB, 2010, ANESTH ANALG, V110, P1428, DOI 10.1213/ANE.0b013e3181d27067; BURES J, 1957, PFLUG ARCH GES PHYS, V264, P325, DOI 10.1007/BF00364173; Chawla LS, 2009, J PALLIAT MED, V12, P1095, DOI 10.1089/jpm.2009.0159; COENEN AML, 1995, NEUROSCI BIOBEHAV R, V19, P447, DOI 10.1016/0149-7634(95)00010-C; DERR RF, 1991, LIFE SCI, V49, P1399, DOI 10.1016/0024-3205(91)90391-N; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P253, DOI 10.1016/0892-0362(92)90004-T; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; MIKESKA JA, 1975, LAB ANIM SCI, V25, P175; Prinz S, 2010, POULTRY SCI, V89, P1275, DOI 10.3382/ps.2009-00136; Raj ABM, 2004, ANIM WELFARE, V13, P159; van den Broek PLC, 2006, EUR J ANAESTH, V23, P391, DOI 10.1017/S0265021505001857; VANDERWOLF CH, 1988, BRAIN RES, V451, P340, DOI 10.1016/0006-8993(88)90780-9; Voss L, 2007, BEST PRACT RES-CLIN, V21, P313, DOI 10.1016/j.bpa.2007.04.003	14	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16514	10.1371/journal.pone.0016514	http://dx.doi.org/10.1371/journal.pone.0016514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304584	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900060
J	Zhang, HH; Gogada, R; Yadav, N; Lella, RK; Badeaux, M; Ayres, M; Gandhi, V; Tang, DG; Chandra, D				Zhang, Honghao; Gogada, Raghu; Yadav, Neelu; Lella, Ravi K.; Badeaux, Mark; Ayres, Mary; Gandhi, Varsha; Tang, Dean G.; Chandra, Dhyan			Defective Molecular Timer in the Absence of Nucleotides Leads to Inefficient Caspase Activation	PLOS ONE			English	Article							CYTOCHROME-C; APOPTOSOME FORMATION; APAF-1 APOPTOSOME; STRUCTURAL BASIS; CELL-DEATH; XIAP; PROCASPASE-9; BINDING; INHIBITION; MECHANISM	In the intrinsic death pathway, cytochrome C (CC) released from mitochondria to the cytosol triggers Apaf-1 apoptosome formation and subsequent caspase activation. This process can be recapitulated using recombinant Apaf-1 and CC in the presence of nucleotides ATP or dATP [(d)ATP] or using fresh cytosol and CC without the need of exogenous nucleotides. Surprisingly, we found that stored cytosols failed to support CC-initiated caspase activation. Storage of cytosols at different temperatures led to the loss of all (deoxy)nucleotides including (d)ATP. Addition of (d)ATP to such stored cytosols partially restored CC-initiated caspase activation. Nevertheless, CC could not induce complete caspase-9/3 activation in stored cytosols, even with the addition of (d)ATP, despite robust Apaf-1 oligomerization. The Apaf-1 apoptosome, which functions as a proteolytic-based molecular timer appeared to be defective as auto-processing of recruited procaspase-9 was inhibited. Far Western analysis revealed that procaspase-9 directly interacted with Apaf-1 and this interaction was reduced in the presence of physiological levels of ATP. Co-incubation of recombinant Apaf-1 and procaspase-9 prior to CC and ATP addition inhibited CC-induced caspase activity. These findings suggest that in the absence of nucleotide such as ATP, direct association of procaspase-9 with Apaf-1 leads to defective molecular timer, and thus, inhibits apoptosome-mediated caspase activation. Altogether, our results provide novel insight on nucleotide regulation of apoptosome.	[Zhang, Honghao; Gogada, Raghu; Yadav, Neelu; Lella, Ravi K.; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Badeaux, Mark; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Ayres, Mary; Gandhi, Varsha] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Zhang, HH (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org	Gogada, Raghu/AAG-6624-2019; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Gogada, Raghu/0000-0003-0933-7999; Chandra, Dhyan/0000-0001-7272-9384; Zhang, Honghao/0000-0002-2338-6992	National Institutes of Health [CA123142, ES015888, ES015893-01A1, CA57629, CA85915]; National Cancer Institute Center [CA16056]; Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA085915, R01CA057629, P30CA016056, K01CA123142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015893, R01ES015888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a National Institutes of Health K01 award CA123142 to DC, National Cancer Institute Center grant CA16056 to Roswell Park Cancer Institute, and institutional start-up support to DC. The authors also acknowledge support by grants from the National Institutes of Health (ES015888 and ES015893-01A1 to DGT, and CA57629 and CA85915 to VG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.291pe62; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; CRAIG DB, 1991, BIOCHEM J, V279, P781, DOI 10.1042/bj2790781; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Gandhi V, 2001, CANCER RES, V61, P5474; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Martin AG, 2004, BIOCHEM BIOPH RES CO, V319, P944, DOI 10.1016/j.bbrc.2004.05.084; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; MILLER DS, 1986, J BIOL CHEM, V261, P13911; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samali A, 2007, APOPTOSIS, V12, P465, DOI 10.1007/s10495-006-0017-9; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; XIE CX, 1995, CANCER RES, V55, P2847; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16379	10.1371/journal.pone.0016379	http://dx.doi.org/10.1371/journal.pone.0016379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21297999	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900044
J	Traversa, G; Spila-Alegiani, S; Bianchi, C; degli Atti, MC; Frova, L; Massari, M; Raschetti, R; Salmaso, S; Tomba, GS				Traversa, Giuseppe; Spila-Alegiani, Stefania; Bianchi, Clara; degli Atti, Marta Ciofi; Frova, Luisa; Massari, Marco; Raschetti, Roberto; Salmaso, Stefania; Tomba, Gianpaolo Scalia		Hera Study Grp	Sudden Unexpected Deaths and Vaccinations during the First Two Years of Life in Italy: A Case Series Study	PLOS ONE			English	Article							TETANUS-PERTUSSIS IMMUNIZATION; INFANT-DEATH; ADVERSE REACTIONS; DIPHTHERIA; POLIOMYELITIS; VACCINES; RISK	Background: The signal of an association between vaccination in the second year of life with a hexavalent vaccine and sudden unexpected deaths (SUD) in the two days following vaccination was reported in Germany in 2003. A study to establish whether the immunisation with hexavalent vaccines increased the short term risk of SUD in infants was conducted in Italy. Methodology/Principal Findings: The reference population comprises around 3 million infants vaccinated in Italy in the study period 1999-2004 (1.5 million received hexavalent vaccines). Events of SUD in infants aged 1-23 months were identified through the death certificates. Vaccination history was retrieved from immunisation registries. Association between immunisation and death was assessed adopting a case series design focusing on the risk periods 0-1, 0-7, and 0-14 days after immunisation. Among the 604 infants who died of SUD, 244 (40%) had received at least one vaccination. Four deaths occurred within two days from vaccination with the hexavalent vaccines (RR = 1.5; 95% CI 0.6 to 4.2). The RRs for the risk periods 0-7 and 0-14 were 2.0 (95% CI 1.2 to 3.5) and 1.5 (95% CI 0.9 to 2.4). The increased risk was limited to the first dose (RR = 2.2; 95% CI 1.1 to 4.4), whereas no increase was observed for the second and third doses combined. Conclusions: The RRs of SUD for any vaccines and any risk periods, even when greater than 1, were almost an order of magnitude lower than the estimates in Germany. The limited increase in RRs found in Italy appears confined to the first dose and may be partly explained by a residual uncontrolled confounding effect of age.	[Traversa, Giuseppe; Spila-Alegiani, Stefania; Bianchi, Clara; Massari, Marco; Raschetti, Roberto; Salmaso, Stefania] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [degli Atti, Marta Ciofi] Bambino Gesu Pediat Hosp, Med Direct, Rome, Italy; [Frova, Luisa] Italian Natl Inst Stat ISTAT, Rome, Italy; [Tomba, Gianpaolo Scalia] Univ Roma Tor Vergata, Dept Math, Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; University of Rome Tor Vergata	Traversa, G (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy.	stefania.spila@iss.it	Spinelli, Angela/K-2004-2018; degli Atti, Marta Ciofi/K-4650-2018; Michelozzi, Paola/J-8608-2016; Ancarani, Cristina/AAB-6152-2022; Frova, Luisa/GOH-1169-2022	Spinelli, Angela/0000-0002-4068-3569; degli Atti, Marta Ciofi/0000-0001-6492-4497; Michelozzi, Paola/0000-0002-1646-2555; Ancarani, Cristina/0000-0003-1251-4589; Di Spiezio Sardo, Attilio/0000-0001-6485-5735; Frova, Luisa/0000-0002-4594-1125	Italian Medicines Agency	Italian Medicines Agency	Only public resources (National Institutes of Health, ISTAT and NHS) were used in conducting the study. An ad hoc funding was provided by the Italian Medicines Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atti MLC, 2004, VACCINE, V22, P4351, DOI 10.1016/j.vaccine.2004.04.026; BARAFF LJ, 1983, PEDIATR INFECT DIS J, V2, P7, DOI 10.1097/00006454-198301000-00003; BERNIER RH, 1982, J PEDIATR-US, V101, P419, DOI 10.1016/S0022-3476(82)80076-0; BOUVIERCOLLE MH, 1989, INT J EPIDEMIOL, V18, P121, DOI 10.1093/ije/18.1.121; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Fleming PJ, 2001, BMJ-BRIT MED J, V322, P822, DOI 10.1136/bmj.322.7290.822; GRIFFIN MR, 1988, NEW ENGL J MED, V319, P618, DOI 10.1056/NEJM198809083191006; *HER STUD GROUP, 2007, 0734 ISTISAN; *HER STUD GROUP, 2005, 052 ISTISAN; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; Hutcheson R, 1979, MMWR-MORBID MORTAL W, V28, P131; Jonville-Bera AP, 2001, BRIT J CLIN PHARMACO, V51, P271, DOI 10.1046/j.1365-2125.2001.00341.x; JONVILLEBERA AP, 1995, FUNDAM CLIN PHARM, V9, P263, DOI 10.1111/j.1472-8206.1995.tb00294.x; Jorch G, 2007, VACCINE, V25, P5707, DOI 10.1016/j.vaccine.2007.02.068; Mitchell EA, 1995, ARCH DIS CHILD, V73, P498, DOI 10.1136/adc.73.6.498; *OP U STAT GROUP, US STATA SELF CONTR; StataCorp L, 2007, STAT DAT AN STAT SOF; TAYLOR EM, 1982, LANCET, V2, P721; von Kries R, 2005, EUR J PEDIATR, V164, P61, DOI 10.1007/s00431-004-1594-7; WALKER AM, 1987, AM J PUBLIC HEALTH, V77, P945, DOI 10.2105/AJPH.77.8.945; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; *WHO EUR CDCP OFF, 2010, OUTBR POL TAJ 2010 R	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16363	10.1371/journal.pone.0016363	http://dx.doi.org/10.1371/journal.pone.0016363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298113	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800030
J	Lin, TC; Lee, TC; Hsu, SL; Yang, CS				Lin, Tsung-Chieh; Lee, Tien-Chiang; Hsu, Shih-Lan; Yang, Chung-Shi			The Molecular Mechanism of Leptin Secretion and Expression Induced by Aristolochic Acid in Kidney Fibroblast	PLOS ONE			English	Article							BINDING PROTEIN-ALPHA; MOUSE OBESE GENE; TGF-BETA; RAT ADIPOCYTES; IN-VIVO; OB GENE; RECEPTOR; INSULIN; ACTIVATION; CELLS	Background: Leptin is a peptide hormone playing pivotal role in regulating food intake and energy expenditure. Growing evidence has suggested the pro-inflammatory and fibrogenic properties of leptin. In addition, patients with renal fibrosis have higher level of plasma leptin, which was due to the increased leptin production. Aristolochic acid (AA) is a botanical toxin characterized to associate with the development of renal fibrosis including tubulointerstitial fibrosis. However, whether leptin is upregulated to participate in AA-induced kidney fibrosis remain completely unknown. Methodology/Principal Findings: In this study, leptin expression was increased by sublethal dose of AA in kidney fibroblast NRK49f determined by enzyme-linked immunosorbent assay and Western blot. Data from real-time reverse transcriptase-polymerase chain reaction revealed that leptin was upregulated by AA at transcriptional level. DNA binding activity of CCAAT enhancer binding protein alpha (C/EBP alpha), one of the transcription factors for leptin gene, was enhanced in DNA affinity precipitation assay and chromatin immunoprecipitation experiments. Knockdown of C/EBP alpha expression by small interfering RNA markedly reduced AA-induced leptin expression. Moreover, AA promoted Akt interaction with p-PDK1, and increased phosphorylated activation of Akt. Akt knockdown, and inhibition of Akt signaling by LY294002 and mTOR inhibitor rapamycin reduced leptin expression. Furthermore, treatment of LY294002 or rapamycin significantly suppressed AAinduced C/EBP alpha DNA-binding activity. These results suggest that Akt and C/EBP alpha activation were involved in AA-regulated leptin expression. Conclusions/Significance: Our findings demonstrate the first that AA could induce secretion and expression of fibrogenic leptin in kidney fibroblasts, which reveal potential involvement of leptin in the progression of kidney fibrosis in aristolochic acid nephropathy.	[Lin, Tsung-Chieh; Yang, Chung-Shi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lee, Tien-Chiang; Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Yang, Chung-Shi] Ctr Nanomed Res, Natl Hlth Res Inst, Miaoli, Taiwan	National Defense Medical Center; Taichung Veterans General Hospital; National Health Research Institutes - Taiwan	Lin, TC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	h2326@vghtc.gov.tw; cyang@nhri.org.tw	Yang, Chung-Shi/E-3999-2010		Taichung Veterans General Hospital [TCVGH977313C, TCVGH-NCNU987901]; National Chi Nan University [TCVGH-NCNU987901]; National Science Council (Taiwan) [NSC98-3112-B-075A-001-]	Taichung Veterans General Hospital; National Chi Nan University; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the Taichung Veterans General Hospital (TCVGH977313C), the Taichung Veterans General Hospital and National Chi Nan University (TCVGH-NCNU987901), and National Science Council (Taiwan) (NSC98-3112-B-075A-001-) to Dr. Shih-Lan Hsu. http://web1.nsc.gov.tw/mp.aspx?mp=7, http://www.vghtc.gov.tw/portal/english/introduction.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; Barr VA, 1997, ENDOCRINOLOGY, V138, P4463, DOI 10.1210/en.138.10.4463; Bradley RL, 1999, DIABETES, V48, P272, DOI 10.2337/diabetes.48.2.272; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chakrabarti P, 2008, MOL ENDOCRINOL, V22, P2260, DOI 10.1210/me.2008-0148; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Debelle FD, 2002, J AM SOC NEPHROL, V13, P431, DOI 10.1681/ASN.V132431; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Glasow A, 2001, J CLIN ENDOCR METAB, V86, P4472, DOI 10.1210/jc.86.9.4472; Han DC, 2001, KIDNEY INT, V59, P1315, DOI 10.1046/j.1523-1755.2001.0590041315.x; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Kumpers P, 2007, AM J PHYSIOL-RENAL, V293, pF1355, DOI 10.1152/ajprenal.00003.2007; Lan HY, 2003, CURR OPIN NEPHROL HY, V12, P25, DOI 10.1097/00041552-200301000-00005; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Lee MJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1230, DOI 10.1152/ajpendo.90927.2008; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Meng XJ, 2008, CARCINOGENESIS, V29, P1013, DOI 10.1093/carcin/bgn035; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Qamar A, 2006, DIGEST DIS SCI, V51, P1697, DOI 10.1007/s10620-006-9244-8; Roberts ISD, 1997, J CLIN PATHOL, V50, P123, DOI 10.1136/jcp.50.2.123; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Villarreal D, 2000, KIDNEY INT, V58, P989, DOI 10.1046/j.1523-1755.2000.00256.x; Wang Yan-Yan, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P476; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Yoshida T, 1996, EUR J ENDOCRINOL, V135, P619, DOI 10.1530/eje.0.1350619; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004129; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	40	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16654	10.1371/journal.pone.0016654	http://dx.doi.org/10.1371/journal.pone.0016654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304902	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600012
J	Haworth, CMA; Asbury, K; Dale, PS; Plomin, R				Haworth, Claire M. A.; Asbury, Kathryn; Dale, Philip S.; Plomin, Robert			Added Value Measures in Education Show Genetic as Well as Environmental Influence	PLOS ONE			English	Article							MONOZYGOTIC TWIN DIFFERENCES; CORE SKILLS TEST; BEHAVIOR PROBLEMS; GENERALIST GENES; SCHOOL; ACHIEVEMENT; MULTIVARIATE; ABILITY; ASSOCIATION; COGNITION	Does achievement independent of ability or previous attainment provide a purer measure of the added value of school? In a study of 4000 pairs of 12-year-old twins in the UK, we measured achievement with year-long teacher assessments as well as tests. Raw achievement shows moderate heritability (about 50%) and modest shared environmental influences (25%). Unexpectedly, we show that for indices of the added value of school, genetic influences remain moderate (around 50%), and the shared (school) environment is less important (about 12%). The pervasiveness of genetic influence in how and how much children learn is compatible with an active view of learning in which children create their own educational experiences in part on the basis of their genetic propensities.	[Haworth, Claire M. A.; Asbury, Kathryn; Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Dale, Philip S.] Univ New Mexico, Dept Speech & Hearing Sci, Albuquerque, NM 87131 USA	University of London; King's College London; University of New Mexico	Haworth, CMA (corresponding author), Kings Coll London, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	Claire.Haworth@kcl.ac.uk	Dale, Philip S/A-2254-2009; Plomin, Robert/B-8911-2008; Haworth, Claire M.A./C-7073-2009	Dale, Philip S/0000-0002-7697-8510; Haworth, Claire M.A./0000-0002-8608-289X; Plomin, Robert/0000-0002-0756-3629	United Kingdom Medical Research Council [G0500079]; United States National Institutes of Health [HD44454, HD46167]; joint Medical Research Council (MRC); Economic and Social Research Council (ESRC) [G0802681]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044454] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046167] Funding Source: NIH RePORTER; Medical Research Council [G0500079, G0802681, G19/2, G9817803B] Funding Source: researchfish; MRC [G0802681, G19/2, G0500079] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); joint Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Twins Early Development Study (TEDS) is supported by a program grant (G0500079) from the United Kingdom Medical Research Council (www.mrc.ac.uk); the work on school environments and academic achievement is supported by grants from the United States National Institutes of Health (HD44454 and HD46167; www.nichd.nih.gov). CMAH is supported by a joint Medical Research Council (MRC), and Economic and Social Research Council (ESRC) fellowship (G0802681; www.mrc.ac.uk and www.esrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbury K, 2008, TWIN RES HUM GENET, V11, P586, DOI 10.1375/twin.11.6.586; Bartels M, 2002, TWIN RES, V5, P544, DOI 10.1375/136905202762342017; Bates TC, 2004, AUST J PSYCHOL, V56, P115, DOI 10.1080/00049530410001734847; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; Davis Oliver S P, 2009, Cogn Neuropsychiatry, V14, P312, DOI 10.1080/13546800902797106; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Department for education and skills, 2004, DEP ED SKILLS 5 YEAR; GOAL plc, 2002, GOAL FORM ASS LIT KE; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P149, DOI 10.2307/2983475; Gorard S, 2008, EDUC REV, V60, P179, DOI 10.1080/00131910801934185; Greven CU, 2009, PSYCHOL SCI, V20, P753, DOI 10.1111/j.1467-9280.2009.02366.x; Haworth CMA, 2007, TWIN RES HUM GENET, V10, P554, DOI 10.1375/twin.10.4.554; Haworth CMA, 2008, INTELLIGENCE, V36, P694, DOI 10.1016/j.intell.2008.04.002; Jensen A.R., 1998, G FACTOR SCI MENTAL; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Kovas Y, 2007, J LEARN DISABIL-US, V40, P554, DOI 10.1177/00222194070400060601; Ladd HF, 2002, ECON EDUC REV, V21, P1, DOI 10.1016/S0272-7757(00)00039-X; Light JG, 1998, HUM BIOL, V70, P215; Loehlin J., 1976, HEREDITY ENV PERSONA, DOI DOI 10.7560/730038; Machin S, 2006, 57 CTR EC ED; Markwardt Jr.FC, 1997, PREABODY INDIVIDUAL; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; McCaffrey DF, 2004, J EDUC BEHAV STAT, V29, P67, DOI 10.3102/10769986029001067; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Neale M. C., 2006, MX STAT MODELING, V7th; Neale MC, 2001, METHODOLOGY GENETIC; nferNelson, 1999, MATH 5 14 SERIES; Oliver BR, 2008, J CHILD PSYCHOL PSYC, V49, P646, DOI 10.1111/j.1469-7610.2008.01891.x; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Petrill SA, 2007, MATH LEARNING DISABI; Pike A, 1996, J CHILD PSYCHOL PSYC, V37, P695, DOI 10.1111/j.1469-7610.1996.tb01461.x; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Plomin R, 2003, BRIT J EDUC PSYCHOL, V73, P3, DOI 10.1348/000709903762869888; PLOMIN R, 1987, BEHAV BRAIN SCI, V10, P1, DOI 10.1017/S0140525X00055941; Plomin R., 2008, BEHAV GENET; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Raudenbush SW, 2004, J EDUC BEHAV STAT, V29, P121, DOI 10.3102/10769986029001121; Raven J.C., 1984, LONDON H K LEWIS ITA; Raven J.C., 1998, ADV PROGR MATRICES; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Taylor J, 2006, OXFORD B ECON STAT, V68, P203, DOI 10.1111/j.1468-0084.2006.00159.x; The National Curriculum, 2004, HDB SEC TEACH ENGL N; Thomas S, 2007, OXFORD REV EDUC, V33, P261, DOI 10.1080/03054980701366116; THOMPSON LA, 1991, PSYCHOL SCI, V2, P158, DOI 10.1111/j.1467-9280.1991.tb00124.x; Trouton A, 2002, TWIN RES, V5, P444, DOI 10.1375/136905202320906255; Wainwright MA, 2005, TWIN RES HUM GENET, V8, P602, DOI 10.1375/twin.8.6.602; Wainwright MA, 2005, BEHAV GENET, V35, P133, DOI 10.1007/s10519-004-1014-9; Wechsler D., 1992, WECHSLER INTELLIGENC; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T	53	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16006	10.1371/journal.pone.0016006	http://dx.doi.org/10.1371/journal.pone.0016006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	717IF	21311598	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200006
J	Miele, M; Costantini, S; Colonna, G				Miele, Marco; Costantini, Susan; Colonna, Giovanni			Structural and Functional Similarities between Osmotin from Nicotiana Tabacum Seeds and Human Adiponectin	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN SECONDARY STRUCTURE; PLANT ANTIFUNGAL PROTEIN; MOLECULAR RECOGNITION; CELIAC-DISEASE; RECEPTOR; DOCKING; PREDICTION; CLONING; MATRIX	Osmotin, a plant protein, specifically binds a seven transmembrane domain receptor-like protein to exert its biological activity via a RAS2/cAMP signaling pathway. The receptor protein is encoded in the gene ORE20/PHO36 and the mammalian homolog of PHO36 is a receptor for the human hormone adiponectin (ADIPOR1). Moreover it is known that the osmotin domain I can be overlapped to the beta-barrel domain of adiponectin. Therefore, these observations and some already existing structural and biological data open a window on a possible use of the osmotin or of its derivative as adiponectin agonist. We have modelled the three-dimensional structure of the adiponectin trimer (ADIPOQ), and two ADIPOR1 and PHO36 receptors. Moreover, we have also modelled the following complexes: ADIPOQ/ADIPOR1, osmotin/PHO36 and osmotin/ADIPOR1. We have then shown the structural determinants of these interactions and their physico-chemical features and analyzed the related interaction residues involved in the formation of the complexes. The stability of the modelled structures and their complexes was always evaluated and controlled by molecular dynamics. On the basis of these results a 9 residues osmotin peptide was selected and its interaction with ADIPOR1 and PHO36 was modelled and analysed in term of energetic stability by molecular dynamics. To confirm in vivo the molecular modelling data, osmotin has been purified from nicotiana tabacum seeds and its nine residues peptide synthesized. We have used cultured human synovial fibroblasts that respond to adiponectin by increasing the expression of IL-6, TNF-alpha and IL-1beta via ADIPOR1. The biological effect on fibroblasts of osmotin and its peptide derivative has been found similar to that of adiponectin confirming the results found in silico.	[Miele, Marco] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy; [Miele, Marco] Univ Naples 2, CRISCEB Interdept Res Ctr Computat & Biotechnol S, Naples, Italy; [Costantini, Susan; Colonna, Giovanni] CROM Oncol Res Ctr Mercogliano Fiorentino Lo Vuol, Mercogliano, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Miele, M (corresponding author), Univ Naples 2, Dept Biochem & Biophys, Naples, Italy.	susan.costantini@unina2.it	Costantini, Susan/J-9914-2018; Colonna, Giovanni/AAY-3568-2021	Colonna, Giovanni/0000-0002-0473-1455; Costantini, Susan/0000-0002-7538-4657; miele, marco/0000-0002-5463-1129				Autiero I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006226; Capone F, 2010, EUR CYTOKINE NETW, V21, P99, DOI 10.1684/ecn.2010.0192; Costantini S, 2007, COMPUT BIOL CHEM, V31, P196, DOI 10.1016/j.compbiolchem.2007.03.010; Costantini S, 2005, J MOL GRAPH MODEL, V23, P419, DOI 10.1016/j.jmgm.2004.12.002; Costantini S, 2010, SERIES PROTEIN BIOCH; Costantini S, 2008, FISH SHELLFISH IMMUN, V25, P782, DOI 10.1016/j.fsi.2008.03.020; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Costantini S, 2009, PROTEIN PEPTIDE LETT, V16, P1057, DOI 10.2174/092986609789055313; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Mariconda M, 2007, J INFECTION, V54, P375, DOI 10.1016/j.jinf.2006.06.006; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; Mashiach E, 2010, NUCLEIC ACIDS RES, V38, pW457, DOI 10.1093/nar/gkq373; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Min K, 2004, PROTEINS, V54, P170, DOI 10.1002/prot.10571; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paladino A, 2008, BIOCHEM BIOPH RES CO, V367, P26, DOI 10.1016/j.bbrc.2007.12.102; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Shih CYT, 2001, PLANT SCI, V160, P817, DOI 10.1016/S0168-9452(00)00450-7; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trotta T, 2009, MOL IMMUNOL, V47, P332, DOI 10.1016/j.molimm.2009.09.013; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yun DJ, 1998, MOL CELL, V1, P807, DOI 10.1016/S1097-2765(00)80080-5	42	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16690	10.1371/journal.pone.0016690	http://dx.doi.org/10.1371/journal.pone.0016690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311758	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036200031
J	Vitali, M; Picazo, F; Prokazov, Y; Duci, A; Turbin, E; Gotze, C; Llopis, J; Hartig, R; Visser, AJWG; Zuschratter, W				Vitali, Marco; Picazo, Fernando; Prokazov, Yury; Duci, Alessandro; Turbin, Evgeny; Goetze, Christian; Llopis, Juan; Hartig, Roland; Visser, Antonie J. W. G.; Zuschratter, Werner			Wide-Field Multi-Parameter FLIM: Long-Term Minimal Invasive Observation of Proteins in Living Cells	PLOS ONE			English	Article							LIFETIME IMAGING MICROSCOPY; RESONANCE ENERGY-TRANSFER; FLUORESCENT PROTEIN; GLOBAL ANALYSIS; FRET; TRANSPORT; DAMAGE; TIME	Time-domain Fluorescence Lifetime Imaging Microscopy (FLIM) is a remarkable tool to monitor the dynamics of fluorophore-tagged protein domains inside living cells. We propose a Wide-Field Multi-Parameter FLIM method (WFMP-FLIM) aimed to monitor continuously living cells under minimum light intensity at a given illumination energy dose. A powerful data analysis technique applied to the WFMP-FLIM data sets allows to optimize the estimation accuracy of physical parameters at very low fluorescence signal levels approaching the lower bound theoretical limit. We demonstrate the efficiency of WFMP-FLIM by presenting two independent and relevant long-term experiments in cell biology: 1) FRET analysis of simultaneously recorded donor and acceptor fluorescence in living HeLa cells and 2) tracking of mitochondrial transport combined with fluorescence lifetime analysis in neuronal processes.	[Vitali, Marco; Prokazov, Yury; Turbin, Evgeny; Zuschratter, Werner] Leibniz Inst Neurobiol, Magdeburg, Germany; [Picazo, Fernando; Llopis, Juan] Univ Castilla La Mancha, Albacete, Spain; [Duci, Alessandro; Goetze, Christian] Arivis Multiple Image Tools GmbH, Rostock, Germany; [Turbin, Evgeny] Russian Res Ctr, Kurchatov Inst, Moscow, Russia; [Hartig, Roland] Otto Von Guericke Univ, Magdeburg, Germany; [Visser, Antonie J. W. G.] Wageningen Univ, Wageningen, Netherlands	Leibniz Institut fur Neurobiologie (LIN); Universidad de Castilla-La Mancha; National Research Centre - Kurchatov Institute; Otto von Guericke University; Wageningen University & Research	Vitali, M (corresponding author), Berlin Inst Technol, Berlin, Germany.	zuschratter@ifn-magdeburg.de	Romo, José A./J-3024-2012; Llopis, Juan/I-2622-2012	Romo, José A./0000-0003-2907-580X; Llopis, Juan/0000-0002-9460-0642; Hartig, Roland/0000-0002-3706-7458	European Union [STRP 013880, MRTN-2005-019481]; German Ministry of Education and Research, BMBF [FKZ 13N10077]; German Research Foundation, DFG [SFB 854, FOR 521 HA 3498/1-1/2]; Spanish Ministry of Science and Innovation MICINN/FEDER [BFU2008-03288]; Consejeria de Sanidad, Junta de Comunidades de Castilla-La Mancha [JI4002R2]; Centro Regional de Investigaciones Biomedicas	European Union(European Commission); German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation, DFG(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation MICINN/FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Sanidad, Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Centro Regional de Investigaciones Biomedicas	This work was supported by grants from the European Union, EU FP6 STRP 013880 (AV, MV, YP, WZ), EU FP6 MRTN-2005-019481 (AD, AV, CG, JL, MV, YP, WZ), German Ministry of Education and Research, BMBF FKZ 13N10077 (MV, ET, WZ), German Research Foundation, DFG SFB 854 TPZ (YP, WZ), DFG, FOR 521 HA 3498/1-1/2 (RH, WZ), Spanish Ministry of Science and Innovation MICINN/FEDER BFU2008-03288 (JL). FP held fellowships from Consejeria de Sanidad, Junta de Comunidades de Castilla-La Mancha (JI4002R2), and Centro Regional de Investigaciones Biomedicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJZER Z, 1991, EUR BIOPHYS J BIOPHY, V20, P247, DOI 10.1007/BF00450560; BANKER G, 1998, CULTURING NERVE CELL; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Becker W, 2005, ADV TIME CORRELATED; Bernas T, 2004, J MICROSC-OXFORD, V215, P281, DOI 10.1111/j.0022-2720.2004.01377.x; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOENS N, 1990, PHOTOCHEM PHOTOBIOL, V52, P911, DOI 10.1111/j.1751-1097.1990.tb08702.x; Boens N, 2007, ANAL CHEM, V79, P2137, DOI 10.1021/ac062160k; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; De Vos WH, 2009, CYTOM PART A, V75A, P428, DOI 10.1002/cyto.a.20699; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Gadella TWJ, 2009, LAB TECH BIOCHEM MOL, V33, P395, DOI 10.1016/S0075-7535(08)00009-0; Gerritsen HC, 2002, J MICROSC-OXFORD, V206, P218, DOI 10.1046/j.1365-2818.2002.01031.x; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Greenbaum L, 2000, BIOL CHEM, V381, P1251, DOI 10.1515/BC.2000.153; Gunkel Manuel, 2009, Biotechnology Journal, V4, P927, DOI 10.1002/biot.200900005; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Jose M, 2008, BIOPHYS J, V94, P1483, DOI 10.1529/biophysj.107.111674; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kay S. M., 1993, FUNDAMENTALS STAT SI; Kemnitz K, 1997, J FLUORESC, V7, P93; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Laptenok SP, 2010, PHYS CHEM CHEM PHYS, V12, P7593, DOI 10.1039/b919700a; Laurence TA, 2010, NAT METHODS, V7, P338, DOI 10.1038/nmeth0510-338; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Maus M, 2001, ANAL CHEM, V73, P2078, DOI 10.1021/ac000877g; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Millington M, 2007, BIOPHYS CHEM, V127, P155, DOI 10.1016/j.bpc.2007.01.008; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; O'Connor D. V., 1984, TIME CORRELATED SING; Pelet S, 2004, BIOPHYS J, V87, P2807, DOI 10.1529/biophysj.104.045492; Petrasek Z, 2009, PHOTOSYNTH RES, V102, P157, DOI 10.1007/s11120-009-9444-0; Prokazov Y, 2009, NUCL INSTRUM METH A, V604, P221, DOI 10.1016/j.nima.2009.01.074; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; Visser AJWG, 2010, EUR BIOPHYS J BIOPHY, V39, P241, DOI 10.1007/s00249-009-0528-8	48	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e15820	10.1371/journal.pone.0015820	http://dx.doi.org/10.1371/journal.pone.0015820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311595	Green Submitted, Green Published, gold			2022-12-27	WOS:000287036200005
J	Foscarin, S; Ponchione, D; Pajaj, E; Leto, K; Gawlak, M; Wilczynski, GM; Rossi, F; Carulli, D				Foscarin, Simona; Ponchione, Danilo; Pajaj, Ermira; Leto, Ketty; Gawlak, Maciej; Wilczynski, Grzegorz M.; Rossi, Ferdinando; Carulli, Daniela			Experience-Dependent Plasticity and Modulation of Growth Regulatory Molecules at Central Synapses	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; CEREBELLAR GABAERGIC INTERNEURONS; CHONDROITIN SULFATE PROTEOGLYCAN; PERINEURONAL NETS; GENE-EXPRESSION; RAT CEREBELLUM; NERVOUS-SYSTEM; NEURITE GROWTH; MATRIX METALLOPROTEINASES	Structural remodeling or repair of neural circuits depends on the balance between intrinsic neuronal properties and regulatory cues present in the surrounding microenvironment. These processes are also influenced by experience, but it is still unclear how external stimuli modulate growth-regulatory mechanisms in the central nervous system. We asked whether environmental stimulation promotes neuronal plasticity by modifying the expression of growth-inhibitory molecules, specifically those of the extracellular matrix. We examined the effects of an enriched environment on neuritic remodeling and modulation of perineuronal nets in the deep cerebellar nuclei of adult mice. Perineuronal nets are meshworks of extracellular matrix that enwrap the neuronal perikaryon and restrict plasticity in the adult CNS. We found that exposure to an enriched environment induces significant morphological changes of Purkinje and precerebellar axon terminals in the cerebellar nuclei, accompanied by a conspicuous reduction of perineuronal nets. In the animals reared in an enriched environment, cerebellar nuclear neurons show decreased expression of mRNAs coding for key matrix components (as shown by real time PCR experiments), and enhanced activity of matrix degrading enzymes (matrix metalloproteinases 2 and 9), which was assessed by in situ zymography. Accordingly, we found that in mutant mice lacking a crucial perineuronal net component, cartilage link protein 1, perineuronal nets around cerebellar neurons are disrupted and plasticity of Purkinje cell terminal is enhanced. Moreover, all the effects of environmental stimulation are amplified if the afferent Purkinje axons are endowed with enhanced intrinsic growth capabilities, induced by overexpression of GAP-43. Our observations show that the maintenance and growth-inhibitory function of perineuronal nets are regulated by a dynamic interplay between pre-and postsynaptic neurons. External stimuli act on this interaction and shift the balance between synthesis and removal of matrix components in order to facilitate neuritic growth by locally dampening the activity of inhibitory cues.	[Foscarin, Simona; Ponchione, Danilo; Pajaj, Ermira; Leto, Ketty; Rossi, Ferdinando; Carulli, Daniela] Univ Turin, Dept Neurosci, NIT, Turin, Italy; [Foscarin, Simona; Ponchione, Danilo; Pajaj, Ermira; Leto, Ketty; Rossi, Ferdinando; Carulli, Daniela] Univ Turin, Neurosci Inst Cavalieri Ottolenghi Fdn NICO, Turin, Italy; [Gawlak, Maciej; Wilczynski, Grzegorz M.] Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, Warsaw, Poland	University of Turin; University of Turin; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Foscarin, S (corresponding author), Univ Turin, Dept Neurosci, NIT, Turin, Italy.	ferdinando.rossi@unito.it	Carulli, Daniela/AEQ-2246-2022	Gawlak, Maciej/0000-0002-7241-6326; Carulli, Daniela/0000-0003-1365-7063; Wilczynski, Grzegorz/0000-0001-6667-0291	International Foundation for Research in Paraplegia (IFP - Zurich); Regione Piemonte; MIUR; Polish-Norwegian; NENS	International Foundation for Research in Paraplegia (IFP - Zurich); Regione Piemonte(Regione Piemonte); MIUR(Ministry of Education, Universities and Research (MIUR)); Polish-Norwegian; NENS	The work was supported by the International Foundation for Research in Paraplegia (IFP - Zurich), Regione Piemonte, MIUR ex 60% and Polish-Norwegian Research Grant (to GW). SF was recipient of a NENS Stipend for Training Stay to visit the Nencki Institute in Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Baroncelli L, 2010, EXP NEUROL, V226, P100, DOI 10.1016/j.expneurol.2010.08.009; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Buffo A, 1997, J NEUROSCI, V17, P8778; Buffo A, 2000, J NEUROSCI, V20, P2275; Caroni P, 1997, J CELL BIOL, V136, P679, DOI 10.1083/jcb.136.3.679; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Corvetti L, 2005, J NEUROSCI, V25, P7150, DOI 10.1523/JNEUROSCI.0683-05.2005; Czipri M, 2003, J BIOL CHEM, V278, P39214, DOI 10.1074/jbc.M303329200; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fawcett JW, 2009, NAT MED, V15, P735, DOI 10.1038/nm0709-735; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Foscarin S, 2009, EUR J NEUROSCI, V30, P1837, DOI 10.1111/j.1460-9568.2009.06985.x; Gawlak M, 2009, NEUROSCIENCE, V158, P167, DOI 10.1016/j.neuroscience.2008.05.045; Ghiani CA, 2007, GLIA, V55, P966, DOI 10.1002/glia.20521; Gianola S, 2004, EUR J NEUROSCI, V19, P819, DOI 10.1111/j.0953-816X.2004.03190.x; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Hoebeek FE, 2008, CEREBELLUM, V7, P547, DOI 10.1007/s12311-008-0086-0; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Kaczmarek L, 2002, EMBO J, V21, P6643, DOI 10.1093/emboj/cdf676; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P290, DOI 10.1006/nlme.1998.3828; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Miyata S, 2004, BRAIN RES, V1017, P163, DOI 10.1016/j.brainres.2004.05.034; Morita S, 2010, NEUROSCIENCE, V166, P1068, DOI 10.1016/j.neuroscience.2010.01.041; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Person AL, 2010, NEURON, V66, P550, DOI 10.1016/j.neuron.2010.04.024; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Powell CM, 2006, NEUROBIOL LEARN MEM, V85, P2, DOI 10.1016/j.nlm.2005.08.014; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Reeves TM, 2003, J NEUROSCI, V23, P10182; Reimers S, 2007, EUR J NEUROSCI, V25, P2640, DOI 10.1111/j.1460-9568.2007.05514.x; ROSSI F, 1987, NEUROSCIENCE, V22, P99, DOI 10.1016/0306-4522(87)90201-6; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Vaillant C, 1999, J NEUROSCI, V19, P4994; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	55	87	87	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16666	10.1371/journal.pone.0016666	http://dx.doi.org/10.1371/journal.pone.0016666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304956	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300112
J	Nestor, MW; Cai, X; Stone, MR; Bloch, RJ; Thompson, SM				Nestor, Michael W.; Cai, Xiang; Stone, Michele R.; Bloch, Robert J.; Thompson, Scott M.			The Actin Binding Domain of beta I-Spectrin Regulates the Morphological and Functional Dynamics of Dendritic Spines	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; F-ACTIN; NMDA RECEPTORS; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; MOLECULAR-MECHANISMS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY	Actin microfilaments regulate the size, shape and mobility of dendritic spines and are in turn regulated by actin binding proteins and small GTPases. The beta I isoform of spectrin, a protein that links the actin cytoskeleton to membrane proteins, is present in spines. To understand its function, we expressed its actin-binding domain (ABD) in CA1 pyramidal neurons in hippocampal slice cultures. The ABD of beta I-spectrin bundled actin in principal dendrites and was concentrated in dendritic spines, where it significantly increased the size of the spine head. These effects were not observed after expression of homologous ABDs of utrophin, dystrophin, and alpha-actinin. Treatment of slice cultures with latrunculin-B significantly decreased spine head size and decreased actin-GFP fluorescence in cells expressing the ABD of alpha-actinin, but not the ABD of beta I-spectrin, suggesting that its presence inhibits actin depolymerization. We also observed an increase in the area of GFP-tagged PSD-95 in the spine head and an increase in the amplitude of mEPSCs at spines expressing the ABD of beta I-spectrin. The effects of the beta I-spectrin ABD on spine size and mEPSC amplitude were mimicked by expressing wild-type Rac3, a small GTPase that co-immunoprecipitates specifically with beta I-spectrin in extracts of cultured cortical neurons. Spine size was normal in cells co-expressing a dominant negative Rac3 construct with the beta I-spectrin ABD. We suggest that beta I-spectrin is a synaptic protein that can modulate both the morphological and functional dynamics of dendritic spines, perhaps via interaction with actin and Rac3.	[Nestor, Michael W.; Cai, Xiang; Stone, Michele R.; Bloch, Robert J.; Thompson, Scott M.] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA; [Nestor, Michael W.; Bloch, Robert J.; Thompson, Scott M.] Univ Maryland, Program Neurosci, Sch Med, Baltimore, MD 21201 USA; [Nestor, Michael W.; Bloch, Robert J.; Thompson, Scott M.] Univ Maryland, Training Program Integrat Membrane Biol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Nestor, MW (corresponding author), Natl Inst Child Hlth & Dev, NIH, Bethesda, MD USA.	sthom003@umaryland.edu	Cai, Xiang/AAD-8012-2021; Thompson, Scott M/K-8921-2015		Muscular Dystrophy Association [T32 GM08181, T32 NS07375]; National Institutes of Health [R01 HL75106, R01 MH65488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by stipends to MWN from T32 GM08181, to MRS from T32 NS07375, and from grants from the Muscular Dystrophy Association (RJB) and the National Institutes of Health (R01 HL75106 to RJB and R01 MH65488 to SMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DW, 1998, J NEUROSCI, V18, P2423; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; CALVERT R, 1980, EUR J BIOCHEM, V107, P355; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COLEMAN TR, 1987, J CELL BIOL, V104, P519, DOI 10.1083/jcb.104.3.519; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Corbetta S, 2008, BEHAV BRAIN RES, V186, P246, DOI 10.1016/j.bbr.2007.08.019; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Galkin VE, 2002, J CELL BIOL, V157, P243, DOI 10.1083/jcb.200111097; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hering H, 2003, J NEUROSCI, V23, P11759; HUGHES CA, 1995, J BIOL CHEM, V270, P18990, DOI 10.1074/jbc.270.32.18990; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Li XL, 1996, J BIOL CHEM, V271, P15695, DOI 10.1074/jbc.271.26.15695; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malosio ML, 1997, J NEUROSCI, V17, P6717; MARKHAM JA, 1986, DEV BRAIN RES, V27, P263, DOI 10.1016/0165-3806(86)90253-1; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; MCALLISTER AK, 2000, BIOL TRANSFECTION NE, P11; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Oray S, 2006, CEREB CORTEX, V16, P730, DOI 10.1093/cercor/bhj019; Orioli D, 2006, MOL BIOL CELL, V17, P2391, DOI 10.1091/mbc.E05-08-0753; Ouyang Y, 2005, EUR J NEUROSCI, V22, P2995, DOI 10.1111/j.1460-9568.2005.04521.x; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Shen L, 2000, J NEUROSCI, V20, P7932; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stone MR, 2005, MOL BIOL CELL, V16, P4280, DOI 10.1091/mbc.E05-02-0112; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Ursitti JA, 2001, DEV BRAIN RES, V129, P81, DOI 10.1016/S0165-3806(01)00160-2; Viel A, 1996, CURR OPIN CELL BIOL, V8, P49, DOI 10.1016/S0955-0674(96)80048-2; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhang WD, 2000, HIPPOCAMPUS, V10, P512, DOI 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M; Zhou DX, 1998, MOL BIOL CELL, V9, P47, DOI 10.1091/mbc.9.1.47; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	78	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16197	10.1371/journal.pone.0016197	http://dx.doi.org/10.1371/journal.pone.0016197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297961	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300040
J	Tretyakov, K; Laur, S; Vilo, J				Tretyakov, Konstantin; Laur, Sven; Vilo, Jaak			G = MAT: Linking Transcription Factor Expression and DNA Binding Data	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; GENOMIC SCALE; NETWORKS; PROFILES; IDENTIFICATION; REGRESSION; PROGRAMS; GROWTH; SITES	Transcription factors are proteins that bind to motifs on the DNA and thus affect gene expression regulation. The qualitative description of the corresponding processes is therefore important for a better understanding of essential biological mechanisms. However, wet lab experiments targeted at the discovery of the regulatory interplay between transcription factors and binding sites are expensive. We propose a new, purely computational method for finding putative associations between transcription factors and motifs. This method is based on a linear model that combines sequence information with expression data. We present various methods for model parameter estimation and show, via experiments on simulated data, that these methods are reliable. Finally, we examine the performance of this model on biological data and conclude that it can indeed be used to discover meaningful associations. The developed software is available as a web tool and Scilab source code at http://biit.cs.ut.ee/gmat/.	[Tretyakov, Konstantin; Laur, Sven] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia; [Vilo, Jaak] Quretec, Tartu, Estonia	University of Tartu	Tretyakov, K (corresponding author), Univ Tartu, Inst Comp Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	vilo@ut.ee	Laur, Sven/ABA-9120-2021; Vilo, Jaak/AAK-2228-2020; Vilo, Jaak/A-7183-2008	Vilo, Jaak/0000-0001-5604-4107; Vilo, Jaak/0000-0001-5604-4107	Estonian Center of Excellence in Computer Science (EXCS); Estonian Science Foundation [ETF7437]; European Union [LSHG-CT-2005-518254]	Estonian Center of Excellence in Computer Science (EXCS); Estonian Science Foundation; European Union(European Commission)	This work was supported by the European Regional Development Fund through the Estonian Center of Excellence in Computer Science (EXCS), the Estonian Science Foundation grant ETF7437, and the European Union FP6 NoE ENFIN (LSHG-CT-2005-518254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HAEUSSLER M, 2005, 5714 INR RES; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Kao KC, 2004, P NATL ACAD SCI USA, V101, P641, DOI 10.1073/pnas.0305287101; Keles S, 2002, BIOINFORMATICS, V18, P1167, DOI 10.1093/bioinformatics/18.9.1167; Kundaje A, 2007, ANN NY ACAD SCI, V1115, P178, DOI 10.1196/annals.1407.020; Latchman D. S., 2005, GENE REGULATION EUKA; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Lu L, 2005, CURR GENET, V48, P235, DOI 10.1007/s00294-005-0023-4; Ma J., 2006, GENE EXPRESSION REGU; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Middendorf M, 2004, BIOINFORMATICS, V20, P232, DOI 10.1093/bioinformatics/bth923; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; POTTHOFF RF, 1964, BIOMETRIKA, V51, P313, DOI [10.2307/2334137, 10.1093/biomet/51.3-4.313]; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Rao C. R, 2007, LINEAR MODELS GEN LE; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rep M, 1999, MOL CELL BIOL, V19, P5474; RHODE PR, 1989, GENE DEV, V3, P1926, DOI 10.1101/gad.3.12a.1926; Rhodes DR, 2002, CANCER RES, V62, P4427; Ruan JH, 2006, BIOINFORMATICS, V22, P332, DOI 10.1093/bioinformatics/bti792; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Soinov LA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r6; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vilo J, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P384; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; [No title captured]	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14559	10.1371/journal.pone.0014559	http://dx.doi.org/10.1371/journal.pone.0014559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297945	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300001
J	Davis, MI; Puhl, HL				Davis, Margaret I.; Puhl, Henry L., III			Nr4a1-eGFP Is a Marker of Striosome-Matrix Architecture, Development and Activity in the Extended Striatum	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MU-OPIOID RECEPTOR; COMPARTMENTAL ORGANIZATION; TRANSCRIPTION FACTORS; SUBSTANCE-P; DOPAMINE D1; RAT-BRAIN; NGFI-B; IMMUNOCYTOCHEMICAL LOCALIZATION; TOPOGRAPHICAL ORGANIZATION	Transgenic mice expressing eGFP under population specific promoters are widely used in neuroscience to identify specific subsets of neurons in situ and as sensors of neuronal activity in vivo. Mice expressing eGFP from a bacterial artificial chromosome under the Nr4a1 promoter have high expression within the basal ganglia, particularly within the striosome compartments and striatal-like regions of the extended amygdala (bed nucleus of the stria terminalis, striatal fundus, central amygdaloid nucleus and intercalated cells). Grossly, eGFP expression is inverse to the matrix marker calbindin 28K and overlaps with mu-opioid receptor immunoreactivity in the striatum. This pattern of expression is similar to Drd1, but not Drd2, dopamine receptor driven eGFP expression in structures targeted by medium spiny neuron afferents. Striosomal expression is strong developmentally where Nr4a1-eGFP expression overlaps with Drd1, TrkB, tyrosine hydroxylase and phospho-ERK, but not phospho-CREB, immunoreactivity in "dopamine islands''. Exposure of adolescent mice to methylphenidate resulted in an increase in eGFP in both compartments in the dorsolateral striatum but eGFP expression remained brighter in the striosomes. To address the role of activity in Nr4a1-eGFP expression, primary striatal cultures were prepared from neonatal mice and treated with forskolin, BDNF, SKF-83822 or high extracellular potassium and eGFP was measured fluorometrically in lysates. eGFP was induced in both neurons and contaminating glia in response to forskolin but SKF-83822, brain derived neurotrophic factor and depolarization increased eGFP in neuronal-like cells selectively. High levels of eGFP were primarily associated with Drd1+ neurons in vitro detected by immunofluorescence; however similar to 15% of the brightly expressing cells contained punctate met-enkephalin immunoreactivity. The Nr4a1-GFP mouse strain will be a useful model for examining the connectivity, physiology, activity and development of the striosome system.	[Davis, Margaret I.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD USA; [Puhl, Henry L., III] NIAAA, Lab Mol Physiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Davis, MI (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD USA.	midavis@mail.nih.gov	Davis, Margaret/F-4165-2010	Davis, Margaret/0000-0002-0489-8351; Puhl, Henry/0000-0003-3095-7201	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural and Biomedical Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural and Biomedical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural and Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2008, PROG NEURO-PSYCHOPH, V32, P1957, DOI 10.1016/j.pnpbp.2008.09.021; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Ammon S, 2003, MOL BRAIN RES, V112, P113, DOI 10.1016/S0169-328X(03)00057-3; Backman C, 2002, SYNAPSE, V44, P158, DOI 10.1002/syn.10065; Barth AL, 2007, CURR OPIN NEUROBIOL, V17, P567, DOI 10.1016/j.conb.2007.10.003; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berretta S, 1997, J NEUROSCI, V17, P4752; BONDY GP, 1991, CELL GROWTH DIFFER, V2, P203; Bourhis E, 2009, PSYCHOPHARMACOLOGY, V202, P635, DOI 10.1007/s00213-008-1343-0; BOWEN WD, 1981, P NATL ACAD SCI-BIOL, V78, P4818, DOI 10.1073/pnas.78.8.4818; Breuer O, 2005, NEUROSCI LETT, V385, P198, DOI 10.1016/j.neulet.2005.05.029; Bubser M, 2000, EUR J NEUROSCI, V12, P1591, DOI 10.1046/j.1460-9568.2000.00052.x; CAILLE I, 1995, EUR J NEUROSCI, V7, P714, DOI 10.1111/j.1460-9568.1995.tb00675.x; Canales JJ, 2005, NEUROBIOL LEARN MEM, V83, P93, DOI 10.1016/j.nlm.2004.10.006; Capper-Loup C, 2002, J NEUROSCI, V22, P6218; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Costantini LC, 1999, NEUROSCIENCE, V89, P505, DOI 10.1016/S0306-4522(98)00287-5; DESBAN M, 1993, NEUROSCIENCE, V57, P661, DOI 10.1016/0306-4522(93)90013-6; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; EDLEY SM, 1984, BRAIN RES, V305, P27, DOI 10.1016/0006-8993(84)91116-8; FISHELL G, 1987, J NEUROSCI, V7, P1969; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fujiyama F, 2006, EUR J NEUROSCI, V24, P2813, DOI 10.1111/j.1460-9568.2006.05177.x; Fuxe K, 2003, NEUROSCIENCE, V119, P733, DOI 10.1016/S0306-4522(03)00148-9; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1987, J NEUROSCI, V7, P3935; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GOTO S, 1989, EXP BRAIN RES, V77, P442, DOI 10.1007/BF00275004; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; GRAYBIEL AM, 1984, NEUROSCIENCE, V13, P1157, DOI 10.1016/0306-4522(84)90293-8; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hartig W, 2003, J COMP NEUROL, V465, P1, DOI 10.1002/cne.10789; Hassoun AT, 2007, J NEUROSCI METH, V166, P178, DOI 10.1016/j.jneumeth.2007.07.008; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KANEKO T, 1995, NEUROSCI LETT, V184, P149, DOI 10.1016/0304-3940(94)11192-L; KANG SA, BIOCH PHARM, V80, P867; Kaoru T, 2010, NEUROSCIENCE, V166, P220, DOI 10.1016/j.neuroscience.2009.12.004; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; Koshimizu Y, 2008, EUR J NEUROSCI, V28, P2053, DOI 10.1111/j.1460-9568.2008.06502.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; Lam BYH, 2009, J BIOL CHEM, V284, P12562, DOI 10.1074/jbc.M901121200; Lawhorn C, 2009, NEUROSCIENCE, V163, P109, DOI 10.1016/j.neuroscience.2009.05.021; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; LIU FC, 1995, J NEUROSCI, V15, P2367, DOI 10.1523/JNEUROSCI.15-03-02367.1995; LIU FC, 1992, J COMP NEUROL, V320, P304, DOI 10.1002/cne.903200304; Liu FC, 1998, DEV NEUROSCI-BASEL, V20, P229, DOI 10.1159/000017316; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lynch WJ, 2008, BRAIN RES, V1213, P166, DOI 10.1016/j.brainres.2008.02.106; Maheux J, 2005, J PHARMACOL EXP THER, V313, P460, DOI 10.1124/jpet.104.080184; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; MILLHOUSE OE, 1986, J COMP NEUROL, V247, P246, DOI 10.1002/cne.902470209; Miura M, 2007, J NEUROSCI, V27, P9721, DOI 10.1523/JNEUROSCI.2993-07.2007; MURRIN LC, 1984, NEUROSCI LETT, V47, P155, DOI 10.1016/0304-3940(84)90422-1; No H, 2010, NEUROCHEM INT, V56, P620, DOI 10.1016/j.neuint.2010.01.005; OLSON L, 1972, BRAIN RES, V44, P283, DOI 10.1016/0006-8993(72)90385-X; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; PENNY GR, 1986, NEUROSCIENCE, V17, P1011, DOI 10.1016/0306-4522(86)90076-X; PERT CB, 1976, P NATL ACAD SCI USA, V73, P3729, DOI 10.1073/pnas.73.10.3729; RAO PA, 1991, DEV BRAIN RES, V60, P161, DOI 10.1016/0165-3806(91)90045-K; Seifert U, 1998, BRAIN RES, V795, P227, DOI 10.1016/S0006-8993(98)00298-4; SNYDERKELLER AM, 1991, J NEUROSCI, V11, P810; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; Tan A, 2000, J NEUROCHEM, V74, P2074, DOI 10.1046/j.1471-4159.2000.0742074.x; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; VOORN P, 1989, J COMP NEUROL, V289, P189, DOI 10.1002/cne.902890202; Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010; Wang H, 1996, J COMP NEUROL, V375, P659, DOI 10.1002/(SICI)1096-9861(19961125)375:4<659::AID-CNE7>3.0.CO;2-0; Wang HB, 2007, NEUROSCI LETT, V425, P195, DOI 10.1016/j.neulet.2007.08.033; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; Werme M, 2000, MOL BRAIN RES, V76, P18, DOI 10.1016/S0169-328X(99)00327-7; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; ZAHM DS, 1991, BRAIN RES, V552, P164, DOI 10.1016/0006-8993(91)90675-L; 1993, J COMP NEUROL, V337, P267	86	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16619	10.1371/journal.pone.0016619	http://dx.doi.org/10.1371/journal.pone.0016619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305052	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100051
J	Chen, C; Wei, Y; Hummel, M; Hoffmann, TK; Gross, M; Kaufmann, AM; Albers, AE				Chen, Chao; Wei, Yan; Hummel, Michael; Hoffmann, Thomas K.; Gross, Manfred; Kaufmann, Andreas M.; Albers, Andreas E.			Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1; BREAST-CANCER; TUMOR PROGRESSION; MARKER; IDENTIFICATION; PHENOTYPE; TUMORIGENICITY; SUBPOPULATION; POPULATIONS; METASTASIS	Initiation, growth, recurrence, and metastasis of head and neck squamous cell carcinomas (HNSCC) have been related to the behavior of cancer stem cells (CSC) that can be identified by their aldehyde-dehydrogenase-isoform-1 (ALDH1) activity. We quantified and enriched ALDH1(+) cells within HNSCC cell lines and subsequently characterized their phenotypical and functional properties like invasion capacity and epithelial-mesenchymal transition (EMT). Spheroid culture enriched CSC from five HNSCC cell lines by up to 5-fold. In spheroid-derived cells (SDC) and the parental monolayer-derived cell line ALDH1, CD44, CD24, E-Cadherin, alpha-SMA, and Vimentin expression was compared by flow-cytometry and immunofluorescence together with proliferation and cell cycle analysis. Invasion activity was evaluated by Matrigel assay and expression of stemness-related transcription factors (TF) Nanog, Oct3/4, Sox2 and EMT-related genes Snail1 and 2, and Twist by real-time PCR. All cell lines formed spheroids that could self-renew and be serially re-passaged. ALDH1 expression was significantly higher in SDC. ALDH1+ cells showed increased colony-formation. The proportion of cells with a putative CSC marker constellation of CD44(+)/CD24(-) was highly variable (0.5% to 96%) in monolayer and spheroid cultures and overlapped in 0%-33% with the CD44(+)/CD24(-)/ALDH1(+) cell subset. SDC had significantly higher invading activity. mRNA of the stemness-related genes Sox2, Nanog, and Oct3/4 was significantly increased in SDC of all cell lines. Twist was significantly increased in two while Snail2 showed a significant increase in one and a significant decrease in SDC of two cell lines. SDC had a higher G0 phase proportion, showed high-level expression of alpha-SMA and Vimentin, but significantly decreased E-Cadherin expression. HNSCC-lines harbor potential CSC, characterized by ALDH1 and stemness marker TF expression as well as properties like invasiveness, quiescence, and EMT. CSC can be enriched by anchorage-independent culture techniques, which may be important for the investigation of their contribution to therapy resistance, tumor recurrence and metastasis.	[Chen, Chao; Wei, Yan; Albers, Andreas E.] Charite, Dept Otolaryngol Head & Neck Surg, D-13353 Berlin, Germany; [Hummel, Michael] Charite, Dept Pathol, D-13353 Berlin, Germany; [Hoffmann, Thomas K.] Univ Essen Gesamthsch, Dept Otolaryngol Head & Neck Surg, Essen, Germany; [Gross, Manfred] Charite, Dept Audiol & Phoniatr, D-13353 Berlin, Germany; [Kaufmann, Andreas M.] Charite, Clin Gynecol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chen, C (corresponding author), Charite, Dept Otolaryngol Head & Neck Surg, D-13353 Berlin, Germany.	andreas.albers@charite.de	Albers, Andreas E./AAP-4669-2021; Albers, Andreas E./AAP-4649-2021	Albers, Andreas E./0000-0001-5614-9873; Albers, Andreas E./0000-0001-5614-9873; Hummel, Michael/0000-0001-6717-605X; Kaufmann, Andreas/0000-0001-7732-3009	Charite-Universitatsmedizin	Charite-Universitatsmedizin	The study was funded entirely by money from Charite-Universitatsmedizin. No external funding sources for this study were used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Ballo H, 1999, ANTICANCER RES, V19, P3827; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chen YC, 2010, ORAL ONCOL, V46, P158, DOI 10.1016/j.oraloncology.2009.11.007; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hay ED, 1995, ACTA ANAT, V154, P8; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ji JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008065; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MASHBERG A, 1993, NEW ENGL J MED, V328, P1783; MASTERS JRW, 2002, HEAD NECK CANC HUMAN, P185; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Perez-Pomares JM, 2002, ANAT RECORD, V268, P343, DOI 10.1002/ar.10165; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Santini MT, 1999, INT J RADIAT BIOL, V75, P787, DOI 10.1080/095530099139845; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	51	34	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16466	10.1371/journal.pone.0016466	http://dx.doi.org/10.1371/journal.pone.0016466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304586	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900054
J	Ezquer, F; Ezquer, M; Simon, V; Conget, P				Ezquer, Fernando; Ezquer, Marcelo; Simon, Valeska; Conget, Paulette			The Antidiabetic Effect of MSCs Is Not Impaired by Insulin Prophylaxis and Is Not Improved by a Second Dose of Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEPATOCYTE GROWTH-FACTOR; VERSUS-HOST-DISEASE; BONE-MARROW-CELLS; STROMAL CELLS; ISLET TRANSPLANTATION; PROGENITOR CELLS; DIABETIC MICE; IN-VITRO; TISSUE-REPAIR	Type 1 diabetes mellitus (T1D) is due to autoimmune destruction of pancreatic beta-cells. Previously, we have shown that intravenously administered bone marrow-derived multipotent mesenchymal stromal cells (MSCs) allows pancreatic islet recovery, improves insulin secretion and reverts hyperglycemia in low doses streptozotocin (STZ)-induced diabetic mice. Here we evaluate whether insulin prophylaxis and the administration of a second dose of cells affect the antidiabetic therapeutic effect of MSC transplantation. Insulitis and subsequent elimination of pancreatic beta-cells was promoted in C57BL/6 mice by the injection of 40 mg/kg/day STZ for five days. Twenty-four days later, diabetic mice were distributed into experimental groups according to if they received or not insulin and/or one or two doses of healthy donor-derived MSCs. Three and half months later: glycemia, pancreatic islets number, insulinemia, glycated hemoglobin level and glucose tolerance were determined in animals that did not received exogenous insulin for the last 1.5 months. Also, we characterized MSCs isolated from mice healthy or diabetic. The therapeutic effect of MSC transplantation was observed in diabetic mice that received or not insulin prophylaxis. Improvements were similar irrespective if they received one or two doses of cells. Compared to MSCs from healthy mice, MSCs from diabetic mice had the same proliferation and adipogenic potentials, but were less abundant, with altered immunophenotype and no osteogenic potential. Our preclinical results should be taken into account when designing phase II clinical trials aimed to evaluate MSC transplantation in patients with T1D. Cells should be isolated form healthy donor, insulin prophylaxis could be maintained and a second dose, after an elapse of two months, appears unnecessary in the medium-term.	[Ezquer, Fernando; Ezquer, Marcelo; Simon, Valeska; Conget, Paulette] Univ Desarrollo, Clin Alemana, Fac Med, Inst Ciencias, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo	Ezquer, F (corresponding author), Univ Desarrollo, Clin Alemana, Fac Med, Inst Ciencias, Santiago, Chile.	pconget@udd.cl	Ezquer, Fernando/AHC-7601-2022	Ezquer, Marcelo/0000-0002-2064-3041; Ezquer, Fernando/0000-0002-7696-4215; Conget, Paulette/0000-0002-2530-7936	Fondo Nacional de Desarrollo Cientifico y Tecnologico [11085033]; Proyecto Bicentenario de Ciencia y Tecnologia [PSD-34]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Bicentenario de Ciencia y Tecnologia	This work was supported by grants Fondo Nacional de Desarrollo Cientifico y Tecnologico # 11085033 to F. E. and Proyecto Bicentenario de Ciencia y Tecnologia # PSD-34 to P. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Arsie MP, 2000, ACTA DIABETOL, V37, P1, DOI 10.1007/s005920070028; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dai CS, 2003, J BIOL CHEM, V278, P27080, DOI 10.1074/jbc.M211947200; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong QY, 2008, CLIN INVEST MED, V31, pE328; Ezquer F, 2009, BIOL BLOOD MARROW TR, V15, P1354, DOI 10.1016/j.bbmt.2009.07.022; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; George M, 2002, J CLIN INVEST, V109, P1153, DOI 10.1172/JCI200212969; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Herold KC, 1997, J AUTOIMMUN, V10, P17, DOI 10.1006/jaut.1996.0108; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Izumida Y, 2005, BIOCHEM BIOPH RES CO, V333, P273, DOI 10.1016/j.bbrc.2005.05.100; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Karabatas LM, 2005, PANCREAS, V30, P318, DOI 10.1097/01.mpa.0000161888.02244.7a; Khan M, 2010, STEM CELLS IN PRESS; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Liu ZH, 2009, J CELL MOL MED, V13, P3427, DOI 10.1111/j.1582-4934.2008.00502.x; Marzorati S, 2007, EXPERT OPIN BIOL TH, V7, P1627, DOI 10.1517/14712598.7.11.1627; McCall MD, 2010, CLIN SCI, V118, P87, DOI 10.1042/CS20090072; Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Stolzing A, 2010, CELLS TISSUES ORGANS, V191, P453, DOI 10.1159/000281826; Sun Y, 2007, CHINESE MED J-PEKING, V120, P771, DOI 10.1097/00029330-200705010-00007; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; TJALVE H, 1983, UPSALA J MED SCI, P145; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100	56	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16566	10.1371/journal.pone.0016566	http://dx.doi.org/10.1371/journal.pone.0016566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304603	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900073
J	Fragel-Madeira, L; Meletti, T; Mariante, RM; Monteiro, RQ; Einicker-Lamas, M; Bernardo, RR; Lopes, AH; Linden, R				Fragel-Madeira, Lucianne; Meletti, Tamara; Mariante, Rafael M.; Monteiro, Robson Q.; Einicker-Lamas, Marcelo; Bernardo, Robson R.; Lopes, Angela H.; Linden, Rafael			Platelet Activating Factor Blocks Interkinetic Nuclear Migration in Retinal Progenitors through an Arrest of the Cell Cycle at the S/G2 Transition	PLOS ONE			English	Article							INFLAMMATORY LIPID MEDIATORS; DNA-DAMAGE CHECKPOINT; NEURONAL MIGRATION; ISCHEMIC RETINOPATHY; CYTOPLASMIC DYNEIN; KINASE ACTIVATION; PROTEIN-KINASES; IN-VITRO; S-PHASE; LIS1	Nuclear migration is regulated by the LIS1 protein, which is the regulatory subunit of platelet activating factor (PAF) acetylhydrolase, an enzyme complex that inactivates the lipid mediator PAF. Among other functions, PAF modulates cell proliferation, but its effects upon mechanisms of the cell cycle are unknown. Here we show that PAF inhibited interkinetic nuclear migration (IKNM) in retinal proliferating progenitors. The lipid did not, however, affect the velocity of nuclear migration in cells that escaped IKNM blockade. The effect depended on the PAF receptor, Erk and p38 pathways and Chk1. PAF induced no cell death, nor a reduction in nucleotide incorporation, which rules out an intra-S checkpoint. Notwithstanding, the expected increase in cyclin B1 content during G2-phase was prevented in the proliferating cells. We conclude that PAF blocks interkinetic nuclear migration in retinal progenitor cells through an unusual arrest of the cell cycle at the transition from S to G2 phases. These data suggest the operation, in the developing retina, of a checkpoint that monitors the transition from S to G2 phases of the cell cycle.	[Fragel-Madeira, Lucianne; Meletti, Tamara; Mariante, Rafael M.; Einicker-Lamas, Marcelo; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, Brazil; [Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil; [Bernardo, Robson R.] Univ Fed Rio de Janeiro, Inst Chem, Rio De Janeiro, Brazil; [Lopes, Angela H.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fragel-Madeira, L (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Niteroi, RJ, Brazil.	rlinden@biof.ufrj.br	de Queiroz Monteiro, Robson/M-7097-2019; Linden, Rafael/F-2275-2011; Lopes, Angela/AAX-2501-2021; Fisiologia, Ciencias Biologicas/C-2407-2012; Mariante, Rafael/AAM-6010-2021; Fragel-Madeira, Lucianne/I-2208-2016; Fragel-Madeira, Lucianne/V-1665-2019; Mariante, Rafael/A-2971-2015; bernardo, robson roney/C-6163-2018; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Monteiro, Robson/GRX-0672-2022	Linden, Rafael/0000-0003-3287-336X; Mariante, Rafael/0000-0001-8024-9612; Fragel-Madeira, Lucianne/0000-0001-6747-2828; Mariante, Rafael/0000-0001-8024-9612; bernardo, robson roney/0000-0002-0035-5149; Monteiro, Robson/0000-0002-5260-2332; Hampshire Lopes, Angela/0000-0003-0660-4596	CNPq; FINEP; CEPG-UFRJ; FAPERJ; PRONEX-MCT; FUJB-UFRJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CEPG-UFRJ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PRONEX-MCT; FUJB-UFRJ	This investigation was supported by grants from CNPq, FINEP, CEPG-UFRJ, FAPERJ, PRONEX-MCT, and FUJB-UFRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Beauchamp MH, 2002, INVEST OPHTH VIS SCI, V43, P3327; Bix GJ, 1998, J NEUROSCI, V18, P307; Boije H, 2009, DEV BIOL, V330, P105, DOI 10.1016/j.ydbio.2009.03.013; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Boye Erik, 2009, V521, P55, DOI [10.1007/978-1-60327-815-7_4, 10.1007/978-1-60327-817-5_4]; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; CASTROFARIANETO HC, 1990, J PHARM PHARMACOL, V42, P203, DOI 10.1111/j.2042-7158.1990.tb05388.x; Cerella C, 2009, APOPTOSIS, V14, P641, DOI 10.1007/s10495-009-0328-8; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; Chin CF, 2010, MOL CELL BIOL, V30, P22, DOI 10.1128/MCB.00687-09; Chou YH, 2007, FOOD CHEM TOXICOL, V45, P1356, DOI 10.1016/j.fct.2007.01.012; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; Cook JG, 2009, FRONT BIOSCI-LANDMRK, V14, P5013, DOI 10.2741/3584; DEARAUJO EG, 1993, EUR J NEUROSCI, V5, P1181; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; DOVER R, 1994, HISTOCHEMISTRY, V102, P383, DOI 10.1007/BF00268909; Carneiro ACD, 2008, DEV NEUROBIOL, V68, P620, DOI 10.1002/dneu.20613; Faretta M, 1998, CYTOMETRY, V31, P53; Frade JM, 2002, PROG BRAIN RES, V136, P67; Francis Dennis, 2008, SEB Exp Biol Ser, V59, P81; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Grallert B, 2008, CELL CYCLE, V7, P2315, DOI 10.4161/cc.6389; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Hardy P, 2005, PHARMACOL REP, V57, P169; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayes NL, 2000, DEV NEUROSCI-BASEL, V22, P44, DOI 10.1159/000017426; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; JANERO DR, 1988, THROMB RES, V50, P789, DOI 10.1016/0049-3848(88)90339-8; Latasa MJ, 2009, INT J DEV BIOL, V53, P895, DOI 10.1387/ijdb.082721ml; Kanno T, 1999, DIABETES, V48, P1741, DOI 10.2337/diabetes.48.9.1741; Kubrusly RCC, 2008, NEUROCHEM INT, V53, P63, DOI 10.1016/j.neuint.2008.05.002; LINDEN R, 1986, HISTOCHEMISTRY, V85, P335, DOI 10.1007/BF00493486; Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; MARTINS MA, 1987, EUR J PHARMACOL, V136, P353, DOI 10.1016/0014-2999(87)90308-6; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MAZZOTTI G, 1990, J HISTOCHEM CYTOCHEM, V38, P13, DOI 10.1177/38.1.2403578; McCormick C, 2010, EUR J PHARMACOL, V641, P160, DOI 10.1016/j.ejphar.2010.04.035; MESSIER PE, 1978, EXPERIENTIA, V34, P289, DOI 10.1007/BF01922992; Miyata T, 2008, DEV GROWTH DIFFER, V50, pS105, DOI 10.1111/j.1440-169x.2007.00980.x; Mogila V, 2006, DEV CELL, V11, P575, DOI 10.1016/j.devcel.2006.08.010; Monteiro RQ, 1997, TOXICON, V35, P649, DOI 10.1016/S0041-0101(96)00176-6; Moriguchi S, 2009, HIPPOCAMPUS, V19, P844, DOI 10.1002/hipo.20572; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Nakayama R, 1997, BIOSCI BIOTECH BIOCH, V61, P631, DOI 10.1271/bbb.61.631; Nelson RJ, 1998, NEUROSCI BIOBEHAV R, V22, P453, DOI 10.1016/S0149-7634(97)00053-5; Nojima H, 2006, GENOME DYN, V1, P131, DOI 10.1159/000092505; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Oshima K, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-112; Panaro MA, 2007, IMMUNOPHARM IMMUNOT, V29, P201, DOI 10.1080/08923970701511942; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Qiu I, 2001, BIOCHEM BIOPH RES CO, V287, P1017, DOI 10.1006/bbrc.2001.5691; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; SAMBASIVARAO K, 1963, J LIPID RES, V4, P106; Sarkaria JN, 1999, CANCER RES, V59, P4375; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Shukla SD, 1996, ADV EXP MED BIOL, V416, P153; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Tokuoka SM, 2003, EUR J NEUROSCI, V18, P563, DOI 10.1046/j.1460-9568.2003.02778.x; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; VASQUEZBRAVO YLAR, 1993, J LIPID MEDIATOR, V8, P135; Wang HM, 2003, ONCOGENE, V22, P2186, DOI 10.1038/sj.onc.1206348; Weltzin MM, 2010, J PHARMACOL EXP THER, V334, P917, DOI 10.1124/jpet.110.167684; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; YAVIN E, 1977, ANAL BIOCHEM, V80, P430, DOI 10.1016/0003-2697(77)90665-0; YOUSUFZAI SYK, 1985, BIOCHEM J, V228, P697, DOI 10.1042/bj2280697; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhuang SH, 2007, CLIN CANCER RES, V13, P7480, DOI 10.1158/1078-0432.CCR-06-2883	95	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16058	10.1371/journal.pone.0016058	http://dx.doi.org/10.1371/journal.pone.0016058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298035	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900022
J	Yamada, M; Ihara, M; Okamoto, Y; Maki, T; Washida, K; Kitamura, A; Hase, Y; Ito, H; Takao, K; Miyakawa, T; Kalaria, RN; Tomimoto, H; Takahashi, R				Yamada, Mahito; Ihara, Masafumi; Okamoto, Yoko; Maki, Takakuni; Washida, Kazuo; Kitamura, Akihiro; Hase, Yoshiki; Ito, Hidefumi; Takao, Keizo; Miyakawa, Tsuyoshi; Kalaria, Raj N.; Tomimoto, Hidekazu; Takahashi, Ryosuke			The Influence of Chronic Cerebral Hypoperfusion on Cognitive Function and Amyloid beta Metabolism in APP Overexpressing Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATHOGENESIS; WHITE-MATTER LESIONS; TRANSGENIC MICE; MOUSE MODEL; VASCULAR DEMENTIA; PLAQUE-FORMATION; WORKING-MEMORY; EXPRESSION; HYPOXIA; IMPAIRMENT	Background and Purpose: Cognitive impairment resulting from cerebrovascular insufficiency has been termed vascular cognitive impairment, and is generally accepted to be distinct from Alzheimer's disease resulting from a neurodegenerative process. However, it is clear that this simple dichotomy may need revision in light of the apparent occurrence of several shared features between Alzheimer's disease and vascular cognitive impairment. Nevertheless, it still remains largely unknown whether the burden of vascular-and Alzheimer-type neuropathology are independent or interdependent. Therefore, we investigated whether chronic cerebral hypoperfusion influences cognitive ability or amyloid beta deposition in amyloid precursor protein (APP) overexpressing transgenic mice. Methods: Two months old mice overexpressing a mutant form of the human APP bearing both the Swedish and Indiana mutations (APP(Sw/Ind)-Tg mice), or their wild-type littermates, were subjected to chronic cerebral hypoperfusion with bilateral common carotid artery stenosis (BCAS) using microcoils or sham operation. Barnes maze test performance and histopathological findings were analyzed at eight months old by 262 factorial experimental designs with four groups. Results: BCAS-operated APP(Sw/Ind)-Tg mice showed significantly impaired learning ability compared to the other three groups of mice. Two-way repeated measures analysis of variance showed a synergistic interaction between the APP genotype and BCAS operation in inducing learning impairment. The cognitive performances were significantly correlated with the neuronal densities. BCAS significantly reduced the density of Nissl-stained neurons and silver-stained cored plaques in the hippocampus of APP(Sw/Ind)-Tg mice but increased the amount of filter-trap amyloid beta in the extracellular-enriched soluble brain fraction, compared to those from sham operated mice. Conclusions: The results suggest interaction between chronic cerebral hypoperfusion and APP(Sw/Ind) overexpression in cognitive decline in mice through enhanced neuronal loss and altered amyloid beta metabolism.	[Yamada, Mahito; Ihara, Masafumi; Okamoto, Yoko; Maki, Takakuni; Washida, Kazuo; Kitamura, Akihiro; Hase, Yoshiki; Ito, Hidefumi; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Takao, Keizo] Natl Inst Physiol Sci, Sect Behav Anal, Ctr Genet Anal Behav, Aichi, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Aichi, Japan; [Kalaria, Raj N.] Newcastle Univ, Inst Ageing & Hlth, WRC, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 514, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University; Newcastle University - UK; Mie University	Yamada, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan.	ihara@kuhp.kyoto-u.ac.jp	Kalaria, Raj/AAX-2630-2020; Ihara, Masafumi/O-5020-2019; Takao, Keizo/B-9527-2008; 眞木, 崇州/AAO-1160-2020; Miyakawa, Tsuyoshi/A-7741-2008	Ihara, Masafumi/0000-0002-7102-4048; Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200	Japanese Ministry of Education, Culture, Sports, Science and Technology; Mitsubishi Pharma Research Foundation; Medical Research Council [G0700718] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23390233] Funding Source: KAKEN; MRC [G0700718] Funding Source: UKRI	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grants-in-Aid for Exploratory Research and Integrative Brain Research (IBR-shien) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp), and a grant from the Mitsubishi Pharma Research Foundation (http://di.mt-pharma.co.jp/zaidan/default.htm) and by Global COE Program "Center for Frontier Medicine" funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, NAT MED, V10, P117, DOI 10.1038/nm0204-117; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Deschaintre Y, 2009, NEUROLOGY, V73, P674, DOI 10.1212/WNL.0b013e3181b59bf3; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hemming ML, 2007, NEUROBIOL DIS, V26, P273, DOI 10.1016/j.nbd.2007.01.004; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Kalaria R, 2002, J NEUROL SCI, V203, P29, DOI 10.1016/S0022-510X(02)00256-3; Kalaria RN, 1996, PHARMACOL THERAPEUT, V72, P193, DOI 10.1016/S0163-7258(96)00116-7; Kitaguchi H, 2007, NEUROSCI LETT, V417, P128, DOI 10.1016/j.neulet.2007.02.021; Kitaguchi H, 2009, BRAIN RES, V1294, P202, DOI 10.1016/j.brainres.2009.07.078; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; Mattson MP, 2000, J NEUROSCI, V20, P1358; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakaji K, 2006, STROKE, V37, P2816, DOI 10.1161/01.STR.0000244808.17972.55; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Thal DR, 2008, ACTA NEUROPATHOL, V115, P599, DOI 10.1007/s00401-008-0366-2; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	38	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16567	10.1371/journal.pone.0016567	http://dx.doi.org/10.1371/journal.pone.0016567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305033	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900074
J	Li, SY; Yang, D; Yeung, CM; Yu, WY; Chang, RCC; So, KF; Wong, D; Lo, ACY				Li, Suk-Yee; Yang, Di; Yeung, Chung-Man; Yu, Wing-Yan; Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.			Lycium Barbarum Polysaccharides Reduce Neuronal Damage, Blood-Retinal Barrier Disruption and Oxidative Stress in Retinal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							AMYLOID PEPTIDE NEUROTOXICITY; CEREBRAL-ARTERY OCCLUSION; ISCHEMIA-REPERFUSION; MULLER CELLS; RAT RETINA; IN-VIVO; SYNCHROTRON-RADIATION; DIABETIC-NEUROPATHY; PROTEIN COMPLEX; MOUSE RETINA	Neuronal cell death, glial cell activation, retinal swelling and oxidative injury are complications in retinal ischemia/reperfusion (I/R) injuries. Lycium barbarum polysaccharides (LBP), extracts from the wolfberries, are good for "eye health'' according to Chinese medicine. The aim of our present study is to explore the use of LBP in retinal I/R injury. Retinal I/R injury was induced by surgical occlusion of the internal carotid artery. Prior to induction of ischemia, mice were treated orally with either vehicle (PBS) or LBP (1 mg/kg) once a day for 1 week. Paraffin-embedded retinal sections were prepared. Viable cells were counted; apoptosis was assessed using TUNEL assay. Expression levels of glial fibrillary acidic protein (GFAP), aquaporin-4 (AQP4), poly(ADP-ribose) (PAR) and nitrotyrosine (NT) were investigated by immunohistochemistry. The integrity of blood-retinal barrier (BRB) was examined by IgG extravasations. Apoptosis and decreased viable cell count were found in the ganglion cell layer (GCL) and the inner nuclear layer (INL) of the vehicle-treated I/R retina. Additionally, increased retinal thickness, GFAP activation, AQP4 up-regulation, IgG extravasations and PAR expression levels were observed in the vehicle-treated I/R retina. Many of these changes were diminished or abolished in the LBP-treated I/R retina. Pre-treatment with LBP for 1 week effectively protected the retina from neuronal death, apoptosis, glial cell activation, aquaporin water channel up-regulation, disruption of BRB and oxidative stress. The present study suggests that LBP may have a neuroprotective role to play in ocular diseases for which I/R is a feature.	[Li, Suk-Yee; Yang, Di; Yeung, Chung-Man; Yu, Wing-Yan; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Wong, David] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Li, SY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China.	amylo@hkucc.hku.hk	Wong, Sai Hung David/D-8482-2015; Chang, Raymond Chuen-Chung/C-1107-2009; Lo, Amy C. Y./C-1195-2009	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Lo, Amy C. Y./0000-0003-4239-6851; YU, Wing Yan/0000-0003-4980-3712; So, Kwok-Fai/0000-0003-4039-4246	Small Project Funding; The University of Hong Kong	Small Project Funding; The University of Hong Kong(University of Hong Kong)	This project was supported by the Small Project Funding (C.M. Yeung) and the University Development Fund from The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J HUAZHONG U SCI TEC; Aslan M, 2006, FREE RADICAL RES, V40, P147, DOI 10.1080/10715760500456219; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Chatterjee PK, 2000, FASEB J, V14, P641, DOI 10.1096/fasebj.14.5.641; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Cheung AKH, 2007, EXP EYE RES, V85, P608, DOI 10.1016/j.exer.2007.07.013; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P47; Da T, 2004, INVEST OPHTH VIS SCI, V45, pU96; Dijk F, 2004, BRAIN RES, V1026, P205, DOI 10.1016/j.brainres.2004.08.014; DREIXLER JC, 2010, EXP EYE RES; Du Guang, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P518; El-Remessy AB, 2003, AM J PATHOL, V163, P1997, DOI 10.1016/S0002-9440(10)63558-4; Erdelyi K, 2005, CELL MOL LIFE SCI, V62, P751, DOI 10.1007/s00018-004-4506-0; Fernandez DC, 2009, J NEUROCHEM, V111, P488, DOI 10.1111/j.1471-4159.2009.06334.x; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Gan L, 2004, INT IMMUNOPHARMACOL, V4, P563, DOI 10.1016/j.intimp.2004.01.023; Gan L, 2003, EUR J PHARMACOL, V471, P217, DOI 10.1016/S0014-2999(03)01827-2; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gong HY, 2005, CANCER BIOTHER RADIO, V20, P155, DOI 10.1089/cbr.2005.20.155; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; Ha KT, 2005, J ETHNOPHARMACOL, V96, P529, DOI 10.1016/j.jep.2004.09.054; Hai-Yang Gong, 2004, J Exp Ther Oncol, V4, P181; Haurigot V, 2009, J BIOL CHEM, V284, P22961, DOI 10.1074/jbc.M109.014787; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Huang Xiaolan, 2003, Wei Sheng Yan Jiu, V32, P599; Iandiev I, 2006, NEUROSCI LETT, V408, P108, DOI 10.1016/j.neulet.2006.08.084; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Ji D, 2008, NEUROCHEM INT, V52, P786, DOI 10.1016/j.neuint.2007.09.012; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kidoguchi K, 2006, STROKE, V37, P1856, DOI 10.1161/01.STR.0000226904.96059.a6; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; LEAL EC, 2010, DIABETES; Lelong DC, 2007, STROKE, V38, P3237, DOI 10.1161/STROKEAHA.107.499319; Li SY, 2010, INT J MOL SCI, V11, P2109, DOI 10.3390/ijms11052109; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024; Luo Q, 2004, LIFE SCI, V76, P137, DOI 10.1016/j.lfs.2004.04.056; Melena J, 2003, BRAIN RES, V989, P128, DOI 10.1016/S0006-8993(03)03375-4; Miranda M, 2010, FREE RADICAL BIO MED, V48, P216, DOI 10.1016/j.freeradbiomed.2009.10.042; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nakajima Y, 2009, CURR EYE RES, V34, P311, DOI 10.1080/02713680902745408; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Obrosova IG, 2005, DIABETES, V54, P3435, DOI 10.2337/diabetes.54.12.3435; Obrosova IG, 2004, DIABETES, V53, P711, DOI 10.2337/diabetes.53.3.711; Palamalai V, 2006, MOL VIS, V12, P1543; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Sarthy V P, 2000, Arch Soc Esp Oftalmol, V75, P367; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Schwartz M, 2005, J NEUROL SCI, V233, P163, DOI 10.1016/j.jns.2005.03.014; Steele EC, 2008, STROKE, V39, P2099, DOI 10.1161/STROKEAHA.107.504357; Tamaki Masahiro, 2006, Kobe Journal of Medical Sciences, V52, P111; Verkman AS, 2008, PROG RETIN EYE RES, V27, P420, DOI 10.1016/j.preteyeres.2008.04.001; Wu H, 2006, YAKUGAKU ZASSHI, V126, P365, DOI 10.1248/yakushi.126.365; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010	66	125	141	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16380	10.1371/journal.pone.0016380	http://dx.doi.org/10.1371/journal.pone.0016380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298100	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800034
J	Jacobs, L; Emmerechts, J; Hoylaerts, MF; Mathieu, C; Hoet, PH; Nemery, B; Nawrot, TS				Jacobs, Lotte; Emmerechts, Jan; Hoylaerts, Marc F.; Mathieu, Chantal; Hoet, Peter H.; Nemery, Benoit; Nawrot, Tim S.			Traffic Air Pollution and Oxidized LDL	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LONG-TERM EXPOSURE; ATHEROSCLEROSIS; INFLAMMATION; DISEASE; PLASMA; MACROPHAGES; ENVIRONMENT; MORTALITY; MARKER	Background: Epidemiologic studies indirectly suggest that air pollution accelerates atherosclerosis. We hypothesized that individual exposure to particulate matter (PM) derived from fossil fuel would correlate with plasma concentrations of oxidized low-density lipoprotein (LDL), taken as a marker of atherosclerosis. We tested this hypothesis in patients with diabetes, who are at high risk for atherosclerosis. Methodology/Principal Findings: In a cross-sectional study of non-smoking adult outpatients with diabetes we assessed individual chronic exposure to PM by measuring the area occupied by carbon in airway macrophages, collected by sputum induction and by determining the distance from the patient's residence to a major road, through geocoding. These exposure indices were regressed against plasma concentrations of oxidized LDL, von Willebrand factor and plasminogen activator inhibitor 1 (PAI-1). We could assess the carbon load of airway macrophages in 79 subjects (58 percent). Each doubling in the distance of residence from major roads was associated with a 0.027 mu m(2) decrease (95% confidence interval (CI): -0.048 to -0.0051) in the carbon load of airway macrophages. Independently from other covariates, we found that each increase of 0.25 mu m(2) [interquartile range (IQR)] in carbon load was associated with an increase of 7.3 U/L (95% CI: 1.3 to 13.3) in plasma oxidized LDL. Each doubling in distance of residence from major roads was associated with a decrease of -2.9 U/L (95% CI: -5.2 to -0.72) in oxidized LDL. Neither the carbon load of macrophages nor the distance from residence to major roads, were associated with plasma von Willebrand factor or PAI-1. Conclusions: The observed positive association, in a susceptible group of the general population, between plasma oxidized LDL levels and either the carbon load of airway macrophages or the proximity of the subject's residence to busy roads suggests a proatherogenic effect of traffic air pollution.	[Jacobs, Lotte; Hoet, Peter H.; Nemery, Benoit; Nawrot, Tim S.] Katholieke Univ Leuven, Unit Lung Toxicol, Leuven, Belgium; [Emmerechts, Jan; Hoylaerts, Marc F.] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Mathieu, Chantal] Katholieke Univ Leuven, Dept Endocrinol, Leuven, Belgium; [Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium	KU Leuven; KU Leuven; KU Leuven; Hasselt University	Jacobs, L (corresponding author), Katholieke Univ Leuven, Unit Lung Toxicol, Leuven, Belgium.	ben.nemery@med.kuleuven.be	Nawrot, Tim/AAA-4531-2019; mathieu, chantal/ABD-5505-2021; Hoet, Peter/H-9987-2013	mathieu, chantal/0000-0002-4055-5233; Nemery, Benoit/0000-0003-0571-4689; Hoylaerts, Marc/0000-0002-6474-3933; Nawrot, Tim/0000-0002-3583-3593; Hoet, Peter/0000-0002-0292-6603	Ministry of the Flemish Community (Department of Economics, Science and Innovation); Ministry of the Flemish Community (Flemish Agency for Care and Health); Ministry of the Flemish Community (Department of Environment, Nature and Energy); Flemish Fund for Scientific Research (FWO-Vlaanderen, krediet aan navorsers); Excellentie financiering KULeuven [EF/05/13]	Ministry of the Flemish Community (Department of Economics, Science and Innovation); Ministry of the Flemish Community (Flemish Agency for Care and Health); Ministry of the Flemish Community (Department of Environment, Nature and Energy); Flemish Fund for Scientific Research (FWO-Vlaanderen, krediet aan navorsers)(FWO); Excellentie financiering KULeuven(KU Leuven)	The studies of the Flemish Center of Expertise on Environment and Health were commissioned, financed and steered by the Ministry of the Flemish Community (Department of Economics, Science and Innovation; Flemish Agency for Care and Health; Department of Environment, Nature and Energy). T Nawrot received a grant of the Flemish Fund for Scientific Research (FWO-Vlaanderen, krediet aan navorsers). The center for Molecular and Vascular Biology is supported by the "Excellentie financiering KULeuven" (EF/05/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Brodsky SV, 2002, CIRCULATION, V106, P2372, DOI 10.1161/01.CIR.0000033972.90653.AF; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Soares SRC, 2009, ATHEROSCLEROSIS, V207, P368, DOI 10.1016/j.atherosclerosis.2009.04.041; Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127; Fredrikson GN, 2003, J INTERN MED, V253, P425, DOI 10.1046/j.1365-2796.2003.01128.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Holvoet P, 2007, ATHEROSCLEROSIS, V194, P245, DOI 10.1016/j.atherosclerosis.2006.08.002; Horvath Beata, 2004, Exp Clin Cardiol, V9, P31; Jacobs L, 2010, ENVIRON HEALTH PERSP, V118, P191, DOI 10.1289/ehp.0900942; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Kulkarni NS, 2005, SCI TOTAL ENVIRON, V345, P23, DOI 10.1016/j.scitotenv.2004.10.016; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Nawrot TS, 2006, EUR HEART J, V27, P2269, DOI 10.1093/eurheartj/ehl221; O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Pizzichini E, 1996, EUR RESPIR J, V9, P1174, DOI 10.1183/09031936.96.09061174; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schwartz J, 2005, AM J RESP CRIT CARE, V172, P1529, DOI 10.1164/rccm.200412-1698OC; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Tani S, 2004, ATHEROSCLEROSIS, V175, P7, DOI 10.1016/j.atherosclerosis.2004.01.035; Wallenfeldt K, 2004, J INTERN MED, V256, P413, DOI 10.1111/j.1365-2796.2004.01402.x	35	52	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16200	10.1371/journal.pone.0016200	http://dx.doi.org/10.1371/journal.pone.0016200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283820	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600029
J	Wamain, Y; Tallet, J; Zanone, PG; Longcamp, M				Wamain, Yannick; Tallet, Jessica; Zanone, Pier-Giorgio; Longcamp, Marieke			"Biological Geometry Perception": Visual Discrimination of Eccentricity Is Related to Individual Motor Preferences	PLOS ONE			English	Article							MOTION PERCEPTION; COORDINATION DYNAMICS; APPARENT MOTION; PREMOTOR CORTEX; FRONTAL-CORTEX; HUMAN-BODY; MOVEMENTS; HAND; REPRESENTATION; INFORMATION	Background: In the continuum between a stroke and a circle including all possible ellipses, some eccentricities seem more "biologically preferred" than others by the motor system, probably because they imply less demanding coordination patterns. Based on the idea that biological motion perception relies on knowledge of the laws that govern the motor system, we investigated whether motorically preferential and non-preferential eccentricities are visually discriminated differently. In contrast with previous studies that were interested in the effect of kinematic/time features of movements on their visual perception, we focused on geometric/spatial features, and therefore used a static visual display. Methodology/Principal Findings: In a dual-task paradigm, participants visually discriminated 13 static ellipses of various eccentricities while performing a finger-thumb opposition sequence with either the dominant or the non-dominant hand. Our assumption was that because the movements used to trace ellipses are strongly lateralized, a motor task performed with the dominant hand should affect the simultaneous visual discrimination more strongly. We found that visual discrimination was not affected when the motor task was performed by the non-dominant hand. Conversely, it was impaired when the motor task was performed with the dominant hand, but only for the ellipses that we defined as preferred by the motor system, based on an assessment of individual preferences during an independent graphomotor task. Conclusions/Significance: Visual discrimination of ellipses depends on the state of the motor neural networks controlling the dominant hand, but only when their eccentricity is "biologically preferred". Importantly, this effect emerges on the basis of a static display, suggesting that what we call "biologica geometry", i.e., geometric features resulting from preferential movements is relevant information for the visual processing of bidimensional shapes.	[Wamain, Yannick; Tallet, Jessica; Zanone, Pier-Giorgio; Longcamp, Marieke] Univ Toulouse, Lab Adaptat Percept Motrice & Apprentissage, Toulouse, France; [Longcamp, Marieke] Univ Aix Marseille 2, CNRS, Inst Neurosci Cognit Mediterranee, Marseille, France	Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Wamain, Y (corresponding author), Univ Toulouse, Lab Adaptat Percept Motrice & Apprentissage, Toulouse, France.	longcamp@cict.fr	Zanone, Pier-Giorgio/B-7165-2011	Zanone, Pier-Giorgio/0000-0002-6744-9772; TALLET, Jessica/0000-0002-2832-6112; Longcamp, Marieke/0000-0003-0454-2934	French Ministry of Research and Education; Paul Sabatier University	French Ministry of Research and Education; Paul Sabatier University	The French Ministry of Research and Education supported YW. The Paul Sabatier University provided funding for experimental materials, and attendance to meetings where previous versions of the work were presented. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, P886; Ahlstrom V, 1997, PERCEPTION, V26, P1539, DOI 10.1068/p261539; Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Athenes S, 2004, HUM MOVEMENT SCI, V23, P621, DOI 10.1016/j.humov.2004.10.004; BABCOCK MK, 1988, AM J PSYCHOL, V101, P111, DOI 10.2307/1422797; Beilock SL, 2007, PSYCHOL SCI, V18, P51, DOI 10.1111/j.1467-9280.2007.01848.x; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bidet-Ildei C, 2006, PERCEPTION, V35, P1137, DOI 10.1068/p5482; Buchanan JJ, 1996, BIOL CYBERN, V74, P41, DOI 10.1007/BF00199136; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Casile A, 2010, CEREB CORTEX, V20, P1647, DOI 10.1093/cercor/bhp229; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Deiber MP, 2001, CLIN NEUROPHYSIOL, V112, P1419, DOI 10.1016/S1388-2457(01)00536-3; Dipietro L, 2007, J NEUROPHYSIOL, V98, P757, DOI 10.1152/jn.01295.2006; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Dounskaia N, 2000, EXP BRAIN RES, V135, P127, DOI 10.1007/s002210000495; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; FREYD JJ, 1983, MEM COGNITION, V11, P342, DOI 10.3758/BF03202447; FREYD JJ, 1987, PSYCHOL REV, V94, P427, DOI 10.1037/0033-295X.94.4.427; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Grossman ED, 1999, VISION RES, V39, P3721, DOI 10.1016/S0042-6989(99)00084-X; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; James KH, 2006, NEUROPSYCHOLOGIA, V44, P2937, DOI 10.1016/j.neuropsychologia.2006.06.026; James KH, 2009, J EXP PSYCHOL GEN, V138, P416, DOI 10.1037/a0015836; James KH, 2009, COGN NEUROPSYCHOL, V26, P91, DOI 10.1080/02643290802425914; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Kandel S, 2000, PERCEPTION, V29, P953, DOI 10.1068/p2864; Kandel S, 2000, PERCEPT PSYCHOPHYS, V62, P706, DOI 10.3758/BF03206917; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Levit-Binnun N, 2006, EXP BRAIN RES, V172, P533, DOI 10.1007/s00221-006-0355-4; Liu BX, 2002, PERCEPT PSYCHOPHYS, V64, P1227, DOI 10.3758/BF03194768; Longcamp M, 2006, NEUROIMAGE, V33, P681, DOI 10.1016/j.neuroimage.2006.06.042; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; LURCAT L, 1974, ETUDES ACTE GRAPHIQU; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; MCFARLAND K, 1978, PERCEPT PSYCHOPHYS, V23, P344, DOI 10.3758/BF03199720; MCFARLAND K, 1978, CORTEX, V14, P102, DOI 10.1016/S0010-9452(78)80012-4; MCFARLAND K, 1978, NEUROPSYCHOLOGIA, V16, P735, DOI 10.1016/0028-3932(78)90008-8; Meary D, 2005, PERCEPTION, V34, P1061, DOI 10.1068/p3388; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Musseler J, 1997, J EXP PSYCHOL HUMAN, V23, P861, DOI 10.1037/0096-1523.23.3.861; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orliaguet JP, 1997, PERCEPTION, V26, P905, DOI 10.1068/p260905; PITTENGER JB, 1985, PERCEPTION, V14, P247, DOI 10.1068/p140247; Polyakov F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000427; Polyakov F, 2009, BIOL CYBERN, V100, P159, DOI 10.1007/s00422-008-0287-0; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proverbio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005389; Reina GA, 2003, HUM MOVEMENT SCI, V22, P137, DOI 10.1016/S0167-9457(02)00156-2; ROLAND PE, 1980, J NEUROPHYSIOL, V43, P137, DOI 10.1152/jn.1980.43.1.137; RUNESON S, 1981, J EXP PSYCHOL HUMAN, V7, P733, DOI 10.1037/0096-1523.7.4.733; Sallagoity I, 2004, MOTOR CONTROL, V8, P405, DOI 10.1123/mcj.8.4.405; Saumier D, 2005, BRAIN COGNITION, V59, P299, DOI 10.1016/j.bandc.2004.02.060; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schubo A, 2001, PSYCHOL RES-PSYCH FO, V65, P145, DOI 10.1007/s004260100061; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Schwartz AB, 2004, SCIENCE, V303, P380, DOI 10.1126/science.1087788; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; SHIFFRAR M, 1993, PSYCHOL SCI, V4, P379, DOI 10.1111/j.1467-9280.1993.tb00585.x; SHIFFRAR M, 1990, PSYCHOL SCI, V1, P257, DOI 10.1111/j.1467-9280.1990.tb00210.x; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Sosnik R, 2007, COGN NEURODYNAMICS, V1, P341, DOI 10.1007/s11571-007-9025-x; STAPPERS PJ, 1993, B PSYCHONOMIC SOC, V31, P125; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; Torres E, 2006, J NEUROPHYSIOL, V96, P2613, DOI 10.1152/jn.00188.2006; VIVIANI P, 1989, PERCEPT PSYCHOPHYS, V46, P266, DOI 10.3758/BF03208089; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; Viviani P, 2002, ATTENTION PERFORM, V19, P406; VIVIANI P, 1991, J EXP PSYCHOL HUMAN, V17, P198, DOI 10.1037/0096-1523.17.1.198; Wexler M, 1998, COGNITION, V68, P77, DOI 10.1016/S0010-0277(98)00032-8; Whitaker D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001930; Yang SJ, 2009, J EXP PSYCHOL LEARN, V35, P1359, DOI 10.1037/a0016547; Zanker JM, 1999, NATURWISSENSCHAFTEN, V86, P492, DOI 10.1007/s001140050661; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	83	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15995	10.1371/journal.pone.0015995	http://dx.doi.org/10.1371/journal.pone.0015995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OH	21283813	gold, Green Published, Green Submitted			2022-12-27	WOS:000286520600018
J	Hutchinson, S; Sims, S; O'Hara, G; Silk, J; Gileadi, U; Cerundolo, V; Klenerman, P				Hutchinson, Sarah; Sims, Stuart; O'Hara, Geraldine; Silk, Jon; Gileadi, Uzi; Cerundolo, Vincenzo; Klenerman, Paul			A Dominant Role for the Immunoproteasome in CD8(+) T Cell Responses to Murine Cytomegalovirus	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IN-VIVO; SELECTIVE INHIBITOR; ANTIGENIC PEPTIDES; GAMMA-INTERFERON; IMMUNE-RESPONSE; SUBUNIT LMP7; INFECTION; EXPRESSION	Murine cytomegalovirus (MCMV) is an important animal model of human cytomegalovirus (HCMV), a beta-Herpesvirus that infects the majority of the world's population and causes disease in neonates and immunocompromised adults. CD8(+) T cells are a major part of the immune response to MCMV and HCMV. Processing of peptides for presentation to CD8(+) T cells may be critically dependent on the immunoproteasome, expression of which is affected by MCMV. However, the overall importance of the immunoproteasome in the generation of immunodominant peptides from MCMV is not known. We therefore examined the role of the immunoproteasome in stimulation of CD8(+) T cell responses to MCMV - both conventional memory responses and those undergoing long-term expansion or "inflation". We infected LMP7(-/-) and C57BL/6 mice with MCMV or with newly-generated recombinant vaccinia viruses (rVVs) encoding the immunodominant MCMV protein M45 in either full-length or epitope-only minigene form. We analysed CD8(+) T cell responses using intracellular cytokine stain (ICS) and MHC Class I tetramer staining for a panel of MCMV-derived epitopes. We showed a critical role for immunoproteasome in MCMV affecting all epitopes studied. Interestingly we found that memory "inflating" epitopes demonstrate reduced immunoproteasome dependence compared to non-inflating epitopes. M45-specific responses induced by rVVs remain immunoproteasome-dependent. These results help to define a critical restriction point for CD8(+) T cell epitopes in natural cytomegalovirus (CMV) infection and potentially in vaccine strategies against this and other viruses.	[Hutchinson, Sarah; Sims, Stuart; O'Hara, Geraldine; Klenerman, Paul] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Silk, Jon; Gileadi, Uzi; Cerundolo, Vincenzo] John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Immunol Grp, Nuffield Dept Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Hutchinson, S (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Peter Medawar Bldg Pathogen Res, Oxford, England.	paul.klenerman@ndm.ox.ac.uk		klenerman, paul/0000-0003-4307-9161; Silk, Jonathan/0000-0001-7693-967X; Gileadi, Uzi/0000-0001-7348-9204; sims, stuart/0000-0002-6327-0927; Cerundolo, Vincenzo/0000-0003-0040-3793	Medical Research Council; Wellcome Trust [WT061100MA]; National Institute for Health Research Biomedical Research Centre (Oxford); National Institutes of Health [U19 (NIAID 1U19AI082630-01)]; James Martin School for the 21st Century, Oxford; MRC [G1000800] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630] Funding Source: NIH RePORTER; Cancer Research UK [11331] Funding Source: researchfish; Medical Research Council [G1000800] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research Biomedical Research Centre (Oxford)(National Institute for Health Research (NIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Martin School for the 21st Century, Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S Hutchinson was funded by a Medical Research Council studentship. This work was funded by the Wellcome Trust (WT061100MA), the National Institute for Health Research Biomedical Research Centre (Oxford), the National Institutes of Health U19 (NIAID 1U19AI082630-01) and the James Martin School for the 21st Century, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler M, 2004, J IMMUNOL, V173, P3925, DOI 10.4049/jimmunol.173.6.3925; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gold MC, 2002, J IMMUNOL, V169, P359, DOI 10.4049/jimmunol.169.1.359; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Holtappels R, 2004, J EXP MED, V199, P131, DOI 10.1084/jem.20031582; Holtappels R, 2002, J VIROL, V76, P151, DOI 10.1128/JVI.76.1.151-164.2002; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Khan S, 2004, J VIROL, V78, P1831, DOI 10.1128/JVI.78.4.1831-1842.2004; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lathbury LJ, 1996, J GEN VIROL, V77, P2605, DOI 10.1099/0022-1317-77-10-2605; Macagno A, 1999, EUR J IMMUNOL, V29, P4037, DOI 10.1002/(SICI)1521-4141(199912)29:12<4037::AID-IMMU4037>3.0.CO;2-T; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; Moss P, 2004, HUM IMMUNOL, V65, P456, DOI 10.1016/j.humimm.2004.02.014; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Nil A, 2004, EUR J IMMUNOL, V34, P2681, DOI 10.1002/eji.200425032; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Osterloh P, 2006, P NATL ACAD SCI USA, V103, P5042, DOI 10.1073/pnas.0509256103; Pahl-Seibert MF, 2005, J VIROL, V79, P5400, DOI 10.1128/JVI.79.9.5400-5413.2005; Palmowski MJ, 2006, J IMMUNOL, V177, P983, DOI 10.4049/jimmunol.177.2.983; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; Podlech J, 1998, J GEN VIROL, V79, P2099, DOI 10.1099/0022-1317-79-9-2099; Polic B, 1996, J GEN VIROL, V77, P217, DOI 10.1099/0022-1317-77-2-217; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; REDDEHASE MJ, 1984, J IMMUNOL, V132, P482; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; REDDEHASE MJ, 1984, EUR J IMMUNOL, V14, P56, DOI 10.1002/eji.1830140111; Robek MD, 2007, J VIROL, V81, P483, DOI 10.1128/JVI.01779-06; Salem ML, 2000, INT J IMMUNOPHARMACO, V22, P707, DOI 10.1016/S0192-0561(00)00033-3; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tu L, 2009, EUR J IMMUNOL, V39, P3385, DOI 10.1002/eji.200839117; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401	50	73	73	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14646	10.1371/journal.pone.0014646	http://dx.doi.org/10.1371/journal.pone.0014646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304910	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000287036600001
J	Rosell, A; Vilalta, A; Garcia-Berrocoso, T; Fernandez-Cadenas, I; Domingues-Montanari, S; Cuadrado, E; Delgado, P; Ribo, M; Martinez-Saez, E; Ortega-Aznar, A; Montaner, J				Rosell, Anna; Vilalta, Anna; Garcia-Berrocoso, Teresa; Fernandez-Cadenas, Israel; Domingues-Montanari, Sophie; Cuadrado, Eloy; Delgado, Pilar; Ribo, Marc; Martinez-Saez, Elena; Ortega-Aznar, Arantxa; Montaner, Joan			Brain Perihematoma Genomic Profile Following Spontaneous Human Intracerebral Hemorrhage	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; NEURAL STEM/PROGENITOR CELLS; BLOOD MONONUCLEAR-CELLS; FOCAL CEREBRAL-ISCHEMIA; GENE-EXPRESSION; FACTOR-VII; STROKE; NEUROGENESIS; APOPTOSIS; LINGO-1	Background: Spontaneous intracerebral hemorrhage (ICH) represents about 15% of all strokes and is associated with high mortality rates. Our aim was to identify the gene expression changes and biological pathways altered in the brain following ICH. Methodology/Principal Findings: Twelve brain samples were obtained from four deceased patients who suffered an ICH including perihematomal tissue (PH) and the corresponding contralateral white (CW) and grey (CG) matter. Affymetrix GeneChip platform for analysis of over 47,000 transcripts was conducted. Microarray Analysis Suite 5.0 was used to process array images and the Ingenuity Pathway Analysis System was used to analyze biological mechanisms and functions of the genes. We identified 468 genes in the PH areas displaying a different expression pattern with a fold change between -3.74 and +5.16 when compared to the contralateral areas (291 overexpressed and 177 underexpressed). The top genes which appeared most significantly overexpressed in the PH areas codify for cytokines, chemokines, coagulation factors, cell growth and proliferation factors while the underexpressed codify for proteins involved in cell cycle or neurotrophins. Validation and replication studies at gene and protein level in brain samples confirmed microarray results. Conclusions: The genomic responses identified in this study provide valuable information about potential biomarkers and target molecules altered in the perihematomal regions.	[Rosell, Anna; Vilalta, Anna; Garcia-Berrocoso, Teresa; Fernandez-Cadenas, Israel; Domingues-Montanari, Sophie; Cuadrado, Eloy; Delgado, Pilar; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall dHebron, Inst Recerca, Neurovasc Res Lab, E-08193 Barcelona, Spain; [Rosell, Anna; Vilalta, Anna; Garcia-Berrocoso, Teresa; Fernandez-Cadenas, Israel; Domingues-Montanari, Sophie; Cuadrado, Eloy; Delgado, Pilar; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall dHebron, Inst Recerca, Dept Neurol, E-08193 Barcelona, Spain; [Ribo, Marc; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, E-08193 Barcelona, Spain; [Ribo, Marc; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall dHebron, Stroke Unit, E-08193 Barcelona, Spain; [Martinez-Saez, Elena; Ortega-Aznar, Arantxa] Univ Autonoma Barcelona, Hosp Vall dHebron, Neuropathol Unit, Dept Pathol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Rosell, A (corresponding author), Univ Autonoma Barcelona, Hosp Vall dHebron, Inst Recerca, Neurovasc Res Lab, E-08193 Barcelona, Spain.	31862jmv@comb.cat	Montaner, Joan/D-3063-2015; Ribo, Marc/ABG-3202-2021; Martinez-Saez, Elena/E-9097-2018	Montaner, Joan/0000-0003-4845-2279; Ribo, Marc/0000-0001-9242-043X; Martinez-Saez, Elena/0000-0001-6004-5364; Rosell Novel, Anna/0000-0003-1082-3599; GARCIA-BERROCOSO, TERESA/0000-0001-8072-8533; Vilalta, Anna/0000-0002-2183-072X; Delgado Martinez, Maria Pilar/0000-0002-1628-4488; Fernandez-Cadenas, Israel/0000-0003-4821-2363	Spanish Ministry of Health (Instituto de Salud Carlos III) [CP09/00265, CP09/00136, FI09/00017, CM09/00143]; Fondo de Investigaciones Sanitarias [FIS PI05/322, PI08/0361]; Spanish stroke research network RENEVAS [RD06/0026/0010]	Spanish Ministry of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish stroke research network RENEVAS	A.R. (CP09/00265) and P.D. (CP09/00136) are supported by the Miguel Servet programme from the Spanish Ministry of Health (Instituto de Salud Carlos III). T.G.-B. holds a predoctoral grant (FI09/00017) from the Spanish Ministry of Health (Instituto de Salud Carlos III) and E.M.-S. holds a research training contract (Rio Hortega, CM09/00143) from the Spanish Ministry of Health (Instituto de Salud Carlos III). This work has been supported by research grants from the Fondo de Investigaciones Sanitarias (FIS PI05/322 and PI08/0361) and the Spanish stroke research network RENEVAS (RD06/0026/0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Carmichael ST, 2008, J CEREBR BLOOD F MET, V28, P1860, DOI 10.1038/jcbfm.2008.77; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Grau AJ, 2001, J NEUROL SCI, V192, P41, DOI 10.1016/S0022-510X(01)00590-1; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hua Y, 2002, J CEREBR BLOOD F MET, V22, P55, DOI 10.1097/00004647-200201000-00007; Inaji M, 2003, ACTA NEUROCHIR SUPPL, V86, P445; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kim YD, 2002, BRAIN RES BULL, V58, P491, DOI 10.1016/S0361-9230(02)00823-7; Kostulas N, 1998, STROKE, V29, P462, DOI 10.1161/01.STR.29.2.462; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kummer JA, 2007, CELL DEATH DIFFER, V14, P1486, DOI 10.1038/sj.cdd.4402152; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Li ZQ, 2009, BRAIN RES, V1264, P98, DOI 10.1016/j.brainres.2009.01.055; Lijnen HR, 2005, J THROMB HAEMOST, V3, P35, DOI 10.1111/j.1538-7836.2004.00827.x; Lu AG, 2006, J CEREBR BLOOD F MET, V26, P230, DOI 10.1038/sj.jcbfm.9600183; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mayer SA, 2009, STROKE, V40, P833, DOI 10.1161/STROKEAHA.108.524470; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mitsios N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-93; Montaner J, 2003, J CEREBR BLOOD F MET, V23, P1403, DOI 10.1097/01.WCB.0000100044.07481.97; Moore DF, 2005, CIRCULATION, V111, P212, DOI 10.1161/01.CIR.0000152105.79665.C6; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nakagomi T, 2009, EUR J NEUROSCI, V29, P1842, DOI 10.1111/j.1460-9568.2009.06732.x; Nakayama D, 2010, EUR J NEUROSCI, V31, P90, DOI 10.1111/j.1460-9568.2009.07043.x; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Rao VLR, 2002, J NEUROCHEM, V83, P1072, DOI 10.1046/j.1471-4159.2002.01208.x; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rudick RA, 2008, EXPERT OPIN BIOL TH, V8, P1561, DOI [10.1517/14712598.8.10.1561, 10.1517/14712598.8.10.1561 ]; Shen JF, 2008, J CEREBR BLOOD F MET, V28, P1460, DOI 10.1038/jcbfm.2008.37; Shimamura M, 2006, HYPERTENSION, V47, P742, DOI 10.1161/01.HYP.0000208598.57687.3e; Sibille E, 2008, J NEUROSCI METH, V167, P198, DOI 10.1016/j.jneumeth.2007.08.009; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; Vikman P, 2006, EUR J NEUROL, V13, P1324, DOI 10.1111/j.1468-1331.2006.01496.x; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41	44	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16750	10.1371/journal.pone.0016750	http://dx.doi.org/10.1371/journal.pone.0016750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311749	Green Published, Green Submitted, gold			2022-12-27	WOS:000287036200038
J	Han, XN; Mann, E; Gilbert, S; Guan, YF; Steinbrecher, KA; Montrose, MH; Cohen, MB				Han, Xiaonan; Mann, Elizabeth; Gilbert, Shila; Guan, Yanfang; Steinbrecher, Kris A.; Montrose, Marshall H.; Cohen, Mitchell B.			Loss of Guanylyl Cyclase C (GCC) Signaling Leads to Dysfunctional Intestinal Barrier	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; INFLAMMATORY-BOWEL-DISEASE; TIGHT JUNCTION DYSFUNCTION; EPITHELIAL-CELLS; IN-VIVO; IFN-GAMMA; ENTEROTOXIN RECEPTOR; COLORECTAL-CANCER; TRANSCRIPTION 5B; INTERFERON-GAMMA	Background: Guanylyl Cyclase C (GCC) signaling via uroguanylin (UGN) and guanylin activation is a critical mediator of intestinal fluid homeostasis, intestinal cell proliferation/apoptosis, and tumorigenesis. As a mechanism for some of these effects, we hypothesized that GCC signaling mediates regulation of intestinal barrier function. Methodology/Principal Findings: Paracellular permeability of intestinal segments was assessed in wild type (WT) and GCC deficient (GCC-/-) mice with and without lipopolysaccharide (LPS) challenge, as well as in UGN deficient (UGN-/-) mice. IFN gamma and myosin light chain kinase (MLCK) levels were determined by real time PCR. Expression of tight junction proteins (TJPs), phosphorylation of myosin II regulatory light chain (MLC), and STAT1 activation were examined in intestinal epithelial cells (IECs) and intestinal mucosa. The permeability of Caco-2 and HT-29 IEC monolayers, grown on Transwell filters was determined in the absence and presence of GCC RNA interference (RNAi). We found that intestinal permeability was increased in GCC-/- and UGN-/- mice compared to WT, accompanied by increased IFN gamma levels, MLCK and STAT1 activation in IECs. LPS challenge promotes greater IFN gamma and STAT1 activation in IECs of GCC-/- mice compared to WT mice. Claudin-2 and JAM-A expression were reduced in GCC deficient intestine; the level of phosphorylated MLC in IECs was significantly increased in GCC-/- and UGN-/- mice compared to WT. GCC knockdown induced MLC phosphorylation, increased permeability in IEC monolayers under basal conditions, and enhanced TNF alpha and IFN gamma-induced monolayer hyperpermeability. Conclusions/Significance: GCC signaling plays a protective role in the integrity of the intestinal mucosal barrier by regulating MLCK activation and TJ disassembly. GCC signaling activation may therefore represent a novel mechanism in maintaining the small bowel barrier in response to injury.	[Han, Xiaonan; Mann, Elizabeth; Gilbert, Shila; Steinbrecher, Kris A.; Cohen, Mitchell B.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Guan, Yanfang; Montrose, Marshall H.] Univ Cincinnati, Dept Mol & Cellular Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Han, XN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA.	xiaonan.han@cchmc.org		Cohen, Mitchell/0000-0002-4412-350X; Han, Xiaonan/0000-0001-5368-6489	Clinical and Translational Research Award [KL2 RR026315]; Crohn's and Colitis Foundation of America; Cincinnati Children's Research Foundation; USPHS [R01 DK 47318, R21 DK074976, P30 DK0789392]; NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, KL2TR000078] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR026315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047318, R21DK074976] Funding Source: NIH RePORTER	Clinical and Translational Research Award; Crohn's and Colitis Foundation of America; Cincinnati Children's Research Foundation; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Clinical and Translational Research Award KL2 RR026315 (XH), Crohn's and Colitis Foundation of America (XH), and Cincinnati Children's Research Foundation Trustee Award (XH), USPHS grants R01 DK 47318 (MC), R21 DK074976 (MHM), and P30 DK0789392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was completed in part in NIH-funded digestive health center (DHC) and Laser Mircodissection Core at Cincinnati Children's Hospital Medical Center. Eleana Laws provides a technical supports in genotyping mice.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Buccigrossi V, 2010, PEDIAT RES; Carrithers SL, 1996, P NATL ACAD SCI USA, V93, P14827, DOI 10.1073/pnas.93.25.14827; Ceponis PJM, 2003, INFECT IMMUN, V71, P1396, DOI 10.1128/IAI.71.3.1396-1404.2003; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; COHEN MB, 1995, BIOCHEM BIOPH RES CO, V209, P803, DOI 10.1006/bbrc.1995.1571; Drudy D, 2001, J MED MICROBIOL, V50, P526, DOI 10.1099/0022-1317-50-6-526; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; EUTAMENE H, 2009, NEUROGASTROENTEROL M; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Garin-Laflam MP, 2009, AM J PHYSIOL-GASTR L, V296, pG740, DOI 10.1152/ajpgi.90268.2008; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Guan YF, 2009, AM J PHYSIOL-GASTR L, V297, pG187, DOI 10.1152/ajpgi.90595.2008; Han X, 2009, GUT, V58, P49, DOI 10.1136/gut.2007.145094; Han XN, 2006, AM J PATHOL, V169, P1999, DOI 10.2353/ajpath.2006.060186; Han XN, 2010, GUT, V59, P1066, DOI 10.1136/gut.2009.203893; Han XN, 2005, GASTROENTEROLOGY, V129, P185, DOI 10.1053/j.gastro.2005.05.018; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Han XN, 2003, J PHARMACOL EXP THER, V307, P443, DOI 10.1124/jpet.103.056556; Han XN, 2003, SHOCK, V19, P229, DOI 10.1097/00024382-200303000-00006; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Johnston JM, 2009, AM J GASTROENTEROL, V104, P125, DOI 10.1038/ajg.2008.59; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Leclercq IA, 2003, GASTROENTEROLOGY, V124, P1451, DOI 10.1016/S0016-5085(03)00270-1; Li P, 2009, DRUG NEWS PERSPECT, V22, P313, DOI 10.1358/dnp.2009.22.6.1395254; Li P, 2007, AM J PATHOL, V171, P1847, DOI 10.2353/ajpath.2007.070198; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; LIN JE, 2010, GASTROENTEROLOGY; Lin JE, 2009, FUTURE ONCOL, V5, P509, DOI 10.2217/FON.09.14; Lorenz JN, 2003, J CLIN INVEST, V112, P1244, DOI 10.1172/JCI200318743; Lubbe WJ, 2009, CANCER RES, V69, P3529, DOI 10.1158/0008-5472.CAN-09-0067; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mazzarella G, 2003, AM J PATHOL, V162, P1845, DOI 10.1016/S0002-9440(10)64319-2; Michl P, 2003, CANCER RES, V63, P6265; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Moriez R, 2005, AM J PATHOL, V167, P1071, DOI 10.1016/S0002-9440(10)61196-0; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Qian X, 2000, ENDOCRINOLOGY, V141, P3210, DOI 10.1210/en.141.9.3210; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Song X, 2008, HISTOL HISTOPATHOL, V23, P673, DOI 10.14670/HH-23.673; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Swenson ES, 1996, BIOCHEM BIOPH RES CO, V225, P1009, DOI 10.1006/bbrc.1996.1286; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wisner DM, 2008, J SURG RES, V144, P1, DOI 10.1016/j.jss.2007.03.059; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang W, 1999, FASEB J, V13, P913, DOI 10.1096/fasebj.13.8.913	62	50	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16139	10.1371/journal.pone.0016139	http://dx.doi.org/10.1371/journal.pone.0016139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305056	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300035
J	Hill, LD; York, TP; Kusanovic, JP; Gomez, R; Eaves, LJ; Romero, R; Strauss, JF				Hill, Lori D.; York, Timothy P.; Kusanovic, Juan P.; Gomez, Ricardo; Eaves, Lindon J.; Romero, Roberto; Strauss, Jerome F., III			Epistasis between COMT and MTHFR in Maternal-Fetal Dyads Increases Risk for Preeclampsia	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; SOLUBLE ENDOGLIN; DEVELOP PREECLAMPSIA; PARKINSONS-DISEASE; GROWTH RESTRICTION; ANGIOGENIC FACTORS; NORMAL-PREGNANCY; GESTATIONAL-AGE; SPIRAL ARTERIES	Preeclampsia is a leading cause of perinatal morbidity and mortality. This disorder is thought to be multifactorial in origin, with multiple genes, environmental and social factors, contributing to disease. One proposed mechanism is placental hypoxia-driven imbalances in angiogenic and anti-angiogenic factors, causing endothelial cell dysfunction. Catechol-O-methyltransferase (Comt)-deficient pregnant mice have a preeclampsia phenotype that is reversed by exogenous 2-methoxyestradiol (2-ME), an estrogen metabolite generated by COMT. 2-ME inhibits Hypoxia Inducible Factor 1 alpha, a transcription factor mediating hypoxic responses. COMT has been shown to interact with methylenetetrahydrofolate reductase (MTHFR), which modulates the availability of S-adenosylmethionine (SAM), a COMT cofactor. Variations in MTHFR have been associated with preeclampsia. By accounting for allelic variation in both genes, the role of COMT has been clarified. COMT allelic variation is linked to enzyme activity and four single nucleotide polymorphisms (SNPs) (rs6269, rs4633, rs4680, and rs4818) form haplotypes that characterize COMT activity. We tested for association between COMT haplotypes and the MTHFR 677 C -> T polymorphism and preeclampsia risk in 1103 Chilean maternal-fetal dyads. The maternal ACCG COMT haplotype was associated with reduced risk for preeclampsia (P = 0.004), and that risk increased linearly from low to high activity haplotypes (P = 0.003). In fetal samples, we found that the fetal ATCA COMT haplotype and the fetal MTHFR minor "T'' allele interact to increase preeclampsia risk (p = 0.022). We found a higher than expected number of patients with preeclampsia with both the fetal risk alleles alone (P = 0.052) and the fetal risk alleles in combination with a maternal balancing allele (P, 0.001). This non-random distribution was not observed in controls (P = 0.341 and P = 0.219, respectively). Our findings demonstrate a role for both maternal and fetal COMT in preeclampsia and highlight the importance of including allelic variation in MTHFR.	[Hill, Lori D.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Sch Med, Richmond, VA 23284 USA; [York, Timothy P.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [York, Timothy P.; Eaves, Lindon J.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA USA; [Kusanovic, Juan P.; Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Kusanovic, Juan P.; Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA; [Kusanovic, Juan P.; Gomez, Ricardo] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Santiago, Chile; [Kusanovic, Juan P.; Gomez, Ricardo] Pontificia Univ Catolica Chile, Dept Obstet & Gynecol, Santiago, Chile	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad de Chile; Pontificia Universidad Catolica de Chile	Hill, LD (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Sch Med, Richmond, VA 23284 USA.	jfstrauss@vcu.edu	Kusanovic, Juan Pedro/R-8616-2019; Kusanovic, Juan Pedro/AAM-5782-2020; Romero, Roberto/A-5268-2019	Kusanovic, Juan Pedro/0000-0003-0640-2070; Gomez, Ricardo/0000-0001-9267-304X; Romero, Roberto/0000-0002-4448-5121	NCMHD [P60 MD002256]; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS [N01 HD-2-3342]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	NCMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported in part by grants from the NCMHD P60 MD002256 (JFS) and the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS, N01 HD-2-3342 (JFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologist, 2002, INT J GYNAECOL OBSTE, V77, P67; Annerbrink K, 2008, METABOLISM, V57, P708, DOI 10.1016/j.metabol.2008.01.012; BARNEA ER, 1988, AM J PERINAT, V5, P121, DOI 10.1055/s-2007-999669; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker CM, 2008, AM J PATHOL, V172, P534, DOI 10.2353/ajpath.2008.061244; Bialecka M, 2008, PHARMACOGENET GENOM, V18, P815, DOI 10.1097/FPC.0b013e328306c2f2; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; BROSENS I, 1964, J OBSTET GYN BR COMM, V71, P222; BROSENS IA, 1988, TROPHOBLAST RES, V3, P61; Caniggia I, 2002, PLACENTA, V23, pS47, DOI 10.1053/plac.2002.0815; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303; Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Domschke K, 2007, AM J MED GENET B, V144B, P667, DOI 10.1002/ajmg.b.30494; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fan JB, 2005, BIOL PSYCHIAT, V57, P139, DOI 10.1016/j.biopsych.2004.10.018; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Glaser B, 2006, AM J PSYCHIAT, V163, P537, DOI 10.1176/appi.ajp.163.3.537; Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469; Goddard KAB, 2007, HUM HERED, V63, P1, DOI 10.1159/000097926; Gonzalez R, 2004, REV MED CHILE, V132, P1155; Halleland H, 2009, AM J MED GENET B, V150B, P403, DOI 10.1002/ajmg.b.30831; Huber JC, 2002, MATURITAS, V41, pS55; Ilhan N, 2008, ARCH MED RES, V39, P125, DOI 10.1016/j.arcmed.2007.07.009; Kadyrov M, 2006, AM J OBSTET GYNECOL, V194, P557, DOI 10.1016/j.ajog.2005.07.035; Kadyrov M, 2003, PLACENTA, V24, P540, DOI 10.1053/plac.2002.0946; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kosmas IP, 2004, J HYPERTENS, V22, P1655, DOI 10.1097/00004872-200409000-00004; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Large V, 1998, DIABETES METAB, V24, P409; Lee SB, 2010, AM J PATHOL, V176, P710, DOI 10.2353/ajpath.2010.090513; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Parimi N, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-60; Powers RW, 2008, REPROD SCI, V15, P374, DOI 10.1177/1933719107311780; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raijmakers MTM, 2001, EUR J OBSTET GYN R B, V95, P226, DOI 10.1016/S0301-2115(00)00497-8; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; ROBERTS JM, 1991, AM J HYPERTENS, V4, P700, DOI 10.1093/ajh/4.8.700; ROBERTS JM, 1991, SEMIN PERINATOL, V15, P86; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2009, J MATERN-FETAL NEO M, V22, P636, DOI 10.1080/14767050902784171; Rutherford K, 2006, BIOCHEMISTRY-US, V45, P2178, DOI 10.1021/bi051988i; Salonen RH, 2000, AM J MED GENET, V91, P256; Sata F, 2006, PHARMACOGENET GENOM, V16, P775, DOI 10.1097/01.fpc.0000230116.49452.c0; Schneider JA, 1998, AM J HUM GENET, V62, P1258, DOI 10.1086/301836; Schwahn B, 2001, Am J Pharmacogenomics, V1, P189, DOI 10.2165/00129785-200101030-00004; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stevenson RE, 1997, AM J HUM GENET, V60, P229; Tai CH, 2002, ACTA MED OKAYAMA, V56, P1; Tworoger SS, 2004, OBES RES, V12, P972, DOI 10.1038/oby.2004.119; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Walsh SW, 2007, TRENDS ENDOCRIN MET, V18, P365, DOI 10.1016/j.tem.2007.09.003; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	71	47	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16681	10.1371/journal.pone.0016681	http://dx.doi.org/10.1371/journal.pone.0016681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304959	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300120
J	Latrasse, D; Germann, S; Houba-Herin, N; Dubois, E; Bui-Prodhomme, D; Hourcade, D; Juul-Jensen, T; Le Roux, C; Majira, A; Simoncello, N; Granier, F; Taconnat, L; Renou, JP; Gaudin, V				Latrasse, David; Germann, Sophie; Houba-Herin, Nicole; Dubois, Emeline; Bui-Prodhomme, Duyen; Hourcade, Delphine; Juul-Jensen, Trine; Le Roux, Clementine; Majira, Amel; Simoncello, Nathalie; Granier, Fabienne; Taconnat, Ludivine; Renou, Jean-Pierre; Gaudin, Valerie			Control of Flowering and Cell Fate by LIF2, an RNA Binding Partner of the Polycomb Complex Component LHP1	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; SERINE/ARGININE-RICH PROTEINS; H3 LYSINE-9 METHYLATION; LIVING PLANT-CELLS; ARABIDOPSIS-THALIANA; HETEROCHROMATIN PROTEIN-1; GENE-EXPRESSION; DOMAIN PROTEINS; NONCODING RNAS; LOCUS-T	Polycomb Repressive Complexes (PRC) modulate the epigenetic status of key cell fate and developmental regulators in eukaryotes. The chromo domain protein LIKE HETEROCHROMATIN PROTEIN1 (LHP1) is a subunit of a plant PRC1-like complex in Arabidopsis thaliana and recognizes histone H3 lysine 27 trimethylation, a silencing epigenetic mark deposited by the PRC2 complex. We have identified and studied an LHP1-Interacting Factor2 (LIF2). LIF2 protein has RNA recognition motifs and belongs to the large hnRNP protein family, which is involved in RNA processing. LIF2 interacts in vivo, in the cell nucleus, with the LHP1 chromo shadow domain. Expression of LIF2 was detected predominantly in vascular and meristematic tissues. Loss-of-function of LIF2 modifies flowering time, floral developmental homeostasis and gynoecium growth determination. lif2 ovaries have indeterminate growth and produce ectopic inflorescences with severely affected flowers showing proliferation of ectopic stigmatic papillae and ovules in short-day conditions. To look at how LIF2 acts relative to LHP1, we conducted transcriptome analyses in lif2 and lhp1 and identified a common set of deregulated genes, which showed significant enrichment in stress-response genes. By comparing expression of LHP1 targets in lif2, lhp1 and lif2 lhp1 mutants we showed that LIF2 can either antagonize or act with LHP1. Interestingly, repression of the FLC floral transcriptional regulator in lif2 mutant is accompanied by an increase in H3K27 trimethylation at the locus, without any change in LHP1 binding, suggesting that LHP1 is targeted independently from LIF2 and that LHP1 binding does not strictly correlate with gene expression. LIF2, involved in cell identity and cell fate decision, may modulate the activity of LHP1 at specific loci, during specific developmental windows or in response to environmental cues that control cell fate determination. These results highlight a novel link between plant RNA processing and Polycomb regulation.	[Latrasse, David; Germann, Sophie; Houba-Herin, Nicole; Dubois, Emeline; Bui-Prodhomme, Duyen; Hourcade, Delphine; Juul-Jensen, Trine; Le Roux, Clementine; Majira, Amel; Simoncello, Nathalie; Granier, Fabienne; Gaudin, Valerie] INRA Ctr Versailles Grignon, Inst JP Bourgin, INRA AgroParisTech UMR1318, Versailles, France; [Germann, Sophie] Ctr Leon Berard, INSERM, U590, F-69373 Lyon, France; [Dubois, Emeline] CNRS, Ctr Genet Mol, FRE3144, Gif Sur Yvette, France; [Bui-Prodhomme, Duyen] INRA Ctr Bordeaux, UMR 619, Villenave Dornon, France; [Taconnat, Ludivine; Renou, Jean-Pierre] Unite Rech Genom Vegetale, Evry, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Latrasse, D (corresponding author), INRA Ctr Versailles Grignon, Inst JP Bourgin, INRA AgroParisTech UMR1318, Versailles, France.	valerie.gaudin@versailles.inra.fr	Le Roux, Clementine/B-4761-2018	Le Roux, Clementine/0000-0003-1689-6211; Gaudin, Valerie/0000-0002-1356-5567; Dubois, Emeline/0000-0002-2515-9128	INRA; French research ministry; French Cancer Research Association (ARC); Agence Nationale de la Recherche; Ile de France Canceropole; French Ministry of Research [ACI 03-3-135]; French Cancer Research Association; Canceropole Ile de France; INRA CJS;  [ANR-08-BLAN-0200]	INRA; French research ministry(Ministry of Research, France); French Cancer Research Association (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ile de France Canceropole(Region Ile-de-France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Cancer Research Association(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile de France(Region Ile-de-France); INRA CJS; 	This work was supported by INRA, the French research ministry, the French Cancer Research Association (ARC), the Agence Nationale de la Recherche and the Ile de France Canceropole. SG was supported by PhD fellowships from the French Ministry of Research (ACI 03-3-135) and from the French Cancer Research Association, DL by the ANR-08-BLAN-0200 postdoctoral fellowship, TJJ by an INRA postdoctoral fellowship, NS by a Canceropole Ile de France PhD fellowship, and CL by a INRA CJS PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Aichinger E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000605; Ali GS, 2006, J CELL SCI, V119, P3527, DOI 10.1242/jcs.03144; ALVAREZ J, 1992, PLANT J, V2, P103, DOI 10.1111/j.1365-313X.1992.00103.x; Ameyar-Zazoua M, 2009, J BIOL CHEM, V284, P27974, DOI 10.1074/jbc.M109.037929; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brancorsini S, 2008, CELL CYCLE, V7, P1415, DOI 10.4161/cc.7.10.5835; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Calonje M, 2008, PLANT CELL, V20, P277, DOI 10.1105/tpc.106.049957; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; CHEN D, 2010, CELL RES; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Cui HC, 2009, PLANT J, V58, P1016, DOI 10.1111/j.1365-313X.2009.03839.x; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Exner V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005335; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; Fletcher JC, 2001, DEVELOPMENT, V128, P1323; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Germann S, 2006, PLANT J, V48, P153, DOI 10.1111/j.1365-313X.2006.02859.x; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; He YH, 2009, MOL PLANT, V2, P554, DOI 10.1093/mp/ssp005; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hornyik C, 2010, BIOCHEM SOC T, V38, P1077, DOI 10.1042/BST0381077; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; James P, 1996, GENETICS, V144, P1425; Kalyna M, 2004, BIOCHEM SOC T, V32, P561, DOI 10.1042/BST0320561; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KIM DH, 2008, P NATL ACAD SCI US; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kohler C, 2010, CURR OPIN GENET DEV, V20, P541, DOI 10.1016/j.gde.2010.04.015; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu SM, 2007, PLANT J, V52, P914, DOI 10.1111/j.1365-313X.2007.03286.x; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; LORKOVIC ZJ, 2009, TRENDS PLANT SCI; Ludwig-Muller J, 2000, PLANT PHYSIOL, V123, P949, DOI 10.1104/pp.123.3.949; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Malyavantham KS, 2008, J CELL BIOCHEM, V105, P391, DOI 10.1002/jcb.21834; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Odoux E, 2003, ANN BOT-LONDON, V92, P437, DOI 10.1093/aob/mcg150; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Okamuro JK, 1996, P NATL ACAD SCI USA, V93, P13831, DOI 10.1073/pnas.93.24.13831; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Palanivelu R, 2000, PLANT J, V22, P187, DOI 10.1046/j.1365-313x.2000.00721.x; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Poduska B, 2003, GENETICS, V163, P1457; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Prunet N, 2008, PLANT CELL, V20, P901, DOI 10.1105/tpc.107.053306; Quesada V, 2005, INT J DEV BIOL, V49, P773, DOI 10.1387/ijdb.051995vq; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; RIPOLL J, 2009, DEV BIOL; Rodrigues JCM, 2010, SEX PLANT REPROD, V23, P123, DOI 10.1007/s00497-009-0131-2; Sablowski R, 2007, J EXP BOT, V58, P899, DOI 10.1093/jxb/erm002; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; SCHATLOWSKI N, 2008, SEMIN CELL DEV BIOL; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Streitner C, 2008, PLANT J, V56, P239, DOI 10.1111/j.1365-313X.2008.03591.x; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; TERRANOVA R, 2008, DEV CELL; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tillemans V, 2005, PLANT J, V41, P567, DOI 10.1111/j.1365-313X.2004.02321.x; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Voinnet O, 2003, TRENDS PLANT SCI, V8, P307, DOI 10.1016/S1360-1385(03)00129-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286; Yu Y, 2004, PLANT J, V40, P699, DOI 10.1111/j.1365-313X.2004.02240.x; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	135	51	55	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16592	10.1371/journal.pone.0016592	http://dx.doi.org/10.1371/journal.pone.0016592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304947	gold, Green Published			2022-12-27	WOS:000286834300094
J	McArt, DG; Zhang, SD				McArt, Darragh G.; Zhang, Shu-Dong			Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TRANS-RETINOIC ACID; BREAST-CANCER; HEMATOPOIETIC-CELLS; CERVICAL-CANCER; COLON-CANCER; IN-VITRO; EXPRESSION; APOPTOSIS; ALPHA	Connectivity mapping is a recently developed technique for discovering the underlying connections between different biological states based on gene-expression similarities. The sscMap method has been shown to provide enhanced sensitivity in mapping meaningful connections leading to testable biological hypotheses and in identifying drug candidates with particular pharmacological and/or toxicological properties. Challenges remain, however, as to how to prioritise the large number of discovered connections in an unbiased manner such that the success rate of any following-up investigation can be maximised. We introduce a new concept, gene-signature perturbation, which aims to test whether an identified connection is stable enough against systematic minor changes (perturbation) to the gene-signature. We applied the perturbation method to three independent datasets obtained from the GEO database: acute myeloid leukemia (AML), cervical cancer, and breast cancer treated with letrozole. We demonstrate that the perturbation approach helps to identify meaningful biological connections which suggest the most relevant candidate drugs. In the case of AML, we found that the prevalent compounds were retinoic acids and PPAR gamma activators. For cervical cancer, our results suggested that potential drugs are likely to involve the EGFR pathway; and with the breast cancer dataset, we identified candidates that are involved in prostaglandin inhibition. Thus the gene-signature perturbation approach added real values to the whole connectivity mapping process, allowing for increased specificity in the identification of possible therapeutic candidates.	[McArt, Darragh G.; Zhang, Shu-Dong] Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland	Queens University Belfast	McArt, DG (corresponding author), Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland.	s.zhang@qub.ac.uk	Zhang, Shu-Dong/G-1269-2010	Zhang, Shu-Dong/0000-0002-7721-0167; McArt, Darragh/0000-0001-6426-8776	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	This work was supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu K, 2009, ANTICANCER RES, V29, P2195; Bilotas M, 2010, FERTIL STERIL, V93, P2513, DOI 10.1016/j.fertnstert.2009.08.058; BODEY GP, 1982, REV INFECT DIS, V4, P579; BORGUNDVAAG B, 1992, ENDOCRINOLOGY, V130, P3453, DOI 10.1210/en.130.6.3453; Braconi C, 2009, CANCER-AM CANCER SOC, V115, P3738, DOI 10.1002/cncr.24417; Calle EE, 1996, AM J EPIDEMIOL, V144, P645, DOI 10.1093/oxfordjournals.aje.a008976; CASS CE, 1992, CANCER RES, V52, P5879; Cheng CK, 2008, BLOOD, V112, P3391, DOI 10.1182/blood-2008-02-137083; De Preter K, 2009, CLIN CANCER RES, V15, P3690, DOI 10.1158/1078-0432.CCR-08-2699; Do B, 2007, J CHROMATOGR B, V845, P104, DOI 10.1016/j.jchromb.2006.07.057; Eads D, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng CL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-411; Friedman M, 2003, FOOD CHEM TOXICOL, V41, P61, DOI 10.1016/S0278-6915(02)00205-3; Gariglio P, 2009, ARCH MED RES, V40, P449, DOI 10.1016/j.arcmed.2009.08.002; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil-Ad I, 2006, ONCOL REP, V15, P107; Gullans SR, 2006, NEW ENGL J MED, V355, P2042, DOI 10.1056/NEJMcibr065953; Haferlach Torsten, 2008, Hematology Am Soc Hematol Educ Program, P400, DOI 10.1182/asheducation-2008.1.400; Han M, 2008, EUR J OBSTET GYN R B, V138, P83, DOI 10.1016/j.ejogrb.2007.05.021; Hiscox S, 2009, MATURITAS, V63, P275, DOI 10.1016/j.maturitas.2009.05.008; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Kim HJ, 2007, CANCER RES, V67, P2595, DOI 10.1158/0008-5472.CAN-06-3043; Klopper JP, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-16; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le XF, 1999, J BIOL CHEM, V274, P21651, DOI 10.1074/jbc.274.31.21651; Lee MH, 2009, CANCER RES, V69, P7449, DOI 10.1158/0008-5472.CAN-09-1266; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; del Campo JM, 2008, GYNECOL ONCOL, V110, pS72, DOI 10.1016/j.ygyno.2008.04.016; Mayani H, 2009, LEUKEMIA RES, V33, P624, DOI 10.1016/j.leukres.2008.11.011; McNamara S, 2008, CLIN CANCER RES, V14, P5311, DOI 10.1158/1078-0432.CCR-08-1081; Miller WR, 2007, PHARMACOGENET GENOM, V17, P813, DOI 10.1097/FPC.0b013e32820b853a; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; Park SJ, 2009, BIOCHEM PHARMACOL, V77, P1328, DOI 10.1016/j.bcp.2008.12.027; Park SJ, 2010, CANCER LETT, V292, P54, DOI 10.1016/j.canlet.2009.11.004; Roumier C, 2009, PHARMACOGENOMICS, V10, P1839, DOI [10.2217/pgs.09.130, 10.2217/PGS.09.130]; Rybaczyk LA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-134; Sabnis GJ, 2005, CANCER RES, V65, P3903, DOI 10.1158/0008-5472.CAN-04-4092; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; SAVA G, 1989, CLIN EXP METASTAS, V7, P671, DOI 10.1007/BF01753677; Sayan BS, 2010, BIOCHEM BIOPH RES CO, V391, P1748, DOI 10.1016/j.bbrc.2009.12.147; Schroder O, 2006, J LIPID RES, V47, P1071, DOI 10.1194/jlr.M600008-JLR200; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Seufferlein T, 2002, BRIT J CANCER, V86, P1188, DOI 10.1038/sj/bjc/6600186; Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014; Soto AM, 2008, BASIC CLIN PHARMACOL, V102, P125, DOI 10.1111/j.1742-7843.2007.00165.x; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Tallman MS, 1997, NEW ENGL J MED, V337, P1021, DOI 10.1056/NEJM199710093371501; Teranishi F, 2009, CANCER SCI, V100, P770, DOI 10.1111/j.1349-7006.2009.01084.x; Tsai DE, 2008, CLIN CANCER RES, V14, P5619, DOI 10.1158/1078-0432.CCR-07-5185; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang JS, 2008, BASIC CLIN PHARMACOL, V103, P336, DOI 10.1111/j.1742-7843.2008.00298.x; Wendeburg L, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-26; Wiklund ED, 2010, INT J CANCER, V126, P28, DOI 10.1002/ijc.24813; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Zhan SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-389; Zhang SD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-258	65	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16382	10.1371/journal.pone.0016382	http://dx.doi.org/10.1371/journal.pone.0016382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305029	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300057
J	Thomas, B; Mandir, AS; West, N; Liu, Y; Andrabi, SA; Stirling, W; Dawson, VL; Dawson, TM; Lee, MK				Thomas, Bobby; Mandir, Allen S.; West, Neva; Liu, Ying; Andrabi, Shaida A.; Stirling, Wanda; Dawson, Valina L.; Dawson, Ted M.; Lee, Michael K.			Resistance to MPTP-Neurotoxicity in alpha-Synuclein Knockout Mice Is Complemented by Human alpha-Synuclein and Associated with Increased beta-Synuclein and Akt Activation	PLOS ONE			English	Article							DOPAMINERGIC NEURON LOSS; NIGRA PARS COMPACTA; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; LEWY BODY; TRANSGENIC MICE; UP-REGULATION; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; HIPPOCAMPAL SEROTONIN; STEREOLOGICAL METHODS	Genetic and biochemical abnormalities of alpha-synuclein are associated with the pathogenesis of Parkinson's disease. In the present study we investigated the in vivo interaction of mouse and human alpha-synuclein with the potent parkinsonian neurotoxin, MPTP. We find that while lack of mouse alpha-synuclein in mice is associated with reduced vulnerability to MPTP, increased levels of human alpha-synuclein expression is not associated with obvious changes in the vulnerability of dopaminergic neurons to MPTP. However, expressing human alpha-synuclein variants (human wild type or A53T) in the alpha-synuclein null mice completely restores the vulnerability of nigral dopaminergic neurons to MPTP. These results indicate that human alpha-synuclein can functionally replace mouse alpha-synuclein in regard to vulnerability of dopaminergic neurons to MPTP-toxicity. Significantly, alpha-synuclein null mice and wild type mice were equally sensitive to neurodegeneration induced by 2'NH2-MPTP, a MPTP analog that is selective for serotoninergic and noradrenergic neurons. These results suggest that effects of alpha-synuclein on MPTP like compounds are selective for nigral dopaminergic neurons. Immunoblot analysis of beta-synuclein and Akt levels in the mice reveals selective increases in beta-synuclein and phosphorylated Akt levels in ventral midbrain, but not in other brain regions, of alpha-synuclein null mice, implicating the a-synuclein-level dependent regulation of beta-synuclein expression in modulation of MPTP-toxicity by alpha-synuclein. Together these findings provide new mechanistic insights on the role alpha-synuclein in modulating neurodegenerative phenotypes by regulation of Akt-mediated cell survival signaling in vivo.	[Thomas, Bobby; Andrabi, Shaida A.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Baltimore, MD USA; [Thomas, Bobby; Mandir, Allen S.; Andrabi, Shaida A.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [West, Neva; Liu, Ying; Stirling, Wanda; Lee, Michael K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Thomas, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.	tdawson@jhmi.edu; mklee@umn.edu	Andrabi, Shaida/I-6167-2012; Lee, Michael K/D-9491-2013; Dawson, Valina/Y-9757-2019	Andrabi, Shaida/0000-0002-3305-2638; Lee, Michael K/0000-0001-5865-9682; Dawson, Valina/0000-0002-2915-3970	Morris K. Udall Parkinson's Disease Research Center; National Institutes of Health-National Institute of Neurological Disorders and Stroke [NS 38377, NS 38065]; NIH [NS06885, NS062165]; US Public Health Service [K08-NS020235]; Parkinson Disease Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062165, R56NS038065, P01NS038065, R01NS060885, R01NS038065, P50NS038377] Funding Source: NIH RePORTER	Morris K. Udall Parkinson's Disease Research Center; National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Parkinson Disease Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Morris K. Udall Parkinson's Disease Research Center and National Institutes of Health-National Institute of Neurological Disorders and Stroke grants (NS 38377, NS 38065). B. T. is supported by NIH grants (NS06885 and NS062165). A. S. M. was supported by US Public Health Service Clinical Investigator Development Award (K08-NS020235), the Parkinson Disease Foundation International Grant and is a recipient of the George C. Cotzias Award of the American Parkinson Disease Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Andrews AM, 1996, MOL PHARMACOL, V50, P1511; ANDREWS AM, 1993, J NEUROCHEM, V60, P1167, DOI 10.1111/j.1471-4159.1993.tb03271.x; ANDREWS AM, 1993, J PHARMACOL EXP THER, V267, P1432; ANDREWS AM, 1993, EUR J PHARMACOL, V250, P215, DOI 10.1016/0014-2999(93)90384-T; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bergman H, 2002, MOVEMENT DISORD, V17, pS28, DOI 10.1002/mds.10140; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dong ZZ, 2002, J NEUROBIOL, V53, P1, DOI 10.1002/neu.10094; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; FAHERTY CJ, 2004, CELL DEATH PARKINSON; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; FRANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA, pR22; Fukuda T, 2001, NEUROPATHOLOGY, V21, P323, DOI 10.1046/j.1440-1789.2001.00402.x; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; KLIVENYI P, 2005, NEUROBIOL DIS; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lehmensiek V, 2002, NEUROREPORT, V13, P1279, DOI 10.1097/00001756-200207190-00013; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Maj MC, 2010, BIOCHEM BIOPH RES CO, V399, P331, DOI 10.1016/j.bbrc.2010.07.033; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; NIETO M, 2005, NEUROBIOL AGING; Ohashi S, 2006, NEUROSCI LETT, V401, P183, DOI 10.1016/j.neulet.2006.03.017; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Przedborski S, 1998, MOVEMENT DISORD, V13, P35; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Przedborski S, 2001, J NEUROCHEM, V76, P637, DOI 10.1046/j.1471-4159.2001.00174.x; Rathke-Hartlieb S, 2001, J NEUROCHEM, V77, P1181, DOI 10.1046/j.1471-4159.2001.00366.x; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Schluter OM, 2003, NEUROSCIENCE, V118, P985, DOI 10.1016/S0306-4522(03)00036-8; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Thomas B, 2007, NEUROBIOL DIS, V26, P312, DOI 10.1016/j.nbd.2006.12.021; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	73	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16706	10.1371/journal.pone.0016706	http://dx.doi.org/10.1371/journal.pone.0016706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304957	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300125
J	Via, M; Gignoux, CR; Roth, LA; Fejerman, L; Galanter, J; Choudhry, S; Toro-Labrador, G; Viera-Vera, J; Oleksyk, TK; Beckman, K; Ziv, E; Risch, N; Burchard, EG; Martinez-Cruzado, JC				Via, Marc; Gignoux, Christopher R.; Roth, Lindsey A.; Fejerman, Laura; Galanter, Joshua; Choudhry, Shweta; Toro-Labrador, Gladys; Viera-Vera, Jorge; Oleksyk, Taras K.; Beckman, Kenneth; Ziv, Elad; Risch, Neil; Burchard, Esteban Gonzalez; Martinez-Cruzado, Juan Carlos			History Shaped the Geographic Distribution of Genomic Admixture on the Island of Puerto Rico	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; NON-JEWISH AMERICANS; POPULATION-STRUCTURE; GENETIC ANCESTRY; AFRICAN-AMERICANS; SPANISH ANCESTRY; WIDE PATTERNS; ASSOCIATION; DIVERSITY; FREQUENCIES	Contemporary genetic variation among Latin Americans human groups reflects population migrations shaped by complex historical, social and economic factors. Consequently, admixture patterns may vary by geographic regions ranging from countries to neighborhoods. We examined the geographic variation of admixture across the island of Puerto Rico and the degree to which it could be explained by historic and social events. We analyzed a census-based sample of 642 Puerto Rican individuals that were genotyped for 93 ancestry informative markers (AIMs) to estimate African, European and Native American ancestry. Socioeconomic status (SES) data and geographic location were obtained for each individual. There was significant geographic variation of ancestry across the island. In particular, African ancestry demonstrated a decreasing East to West gradient that was partially explained by historical factors linked to the colonial sugar plantation system. SES also demonstrated a parallel decreasing cline from East to West. However, at a local level, SES and African ancestry were negatively correlated. European ancestry was strongly negatively correlated with African ancestry and therefore showed patterns complementary to African ancestry. By contrast, Native American ancestry showed little variation across the island and across individuals and appears to have played little social role historically. The observed geographic distributions of SES and genetic variation relate to historical social events and mating patterns, and have substantial implications for the design of studies in the recently admixed Puerto Rican population. More generally, our results demonstrate the importance of incorporating social and geographic data with genetics when studying contemporary admixed populations.	[Via, Marc; Roth, Lindsey A.; Galanter, Joshua; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Via, Marc; Gignoux, Christopher R.; Fejerman, Laura; Choudhry, Shweta; Ziv, Elad; Risch, Neil; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Fejerman, Laura; Ziv, Elad] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Choudhry, Shweta] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Toro-Labrador, Gladys; Martinez-Cruzado, Juan Carlos] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Viera-Vera, Jorge; Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Beckman, Kenneth] Univ Minnesota, Dept Genet Cell Biol & Dev Biol, Minneapolis, MN USA; [Risch, Neil] Kaiser Permanente, Div Res, Oakland, CA USA; [Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Minnesota System; University of Minnesota Twin Cities; Kaiser Permanente; University of California System; University of California San Francisco	Via, M (corresponding author), Univ Barcelona, Lab Anthropol, Dept Anim Biol, Barcelona, Spain.	mvia@ub.edu; Esteban@sfgh.ucsf.edu; juancarlos.martinez@upr.edu	Ziv, Elad/L-5396-2014; Taras, Oleksyk/J-8805-2013; Via, Marc/L-6511-2014	Taras, Oleksyk/0000-0002-8148-3918; Via, Marc/0000-0002-9966-9921; Fejerman, Laura/0000-0003-3179-1151; Galanter, Joshua/0000-0002-2561-6384	National Institutes of Health [HL078885, HL088133, U19 AI077439, ES015794]; Flight Attendant Medical Research Institute (FAMRI); RWJ Amos Medical Faculty Development; American Thoracic Society 'Breakthrough Opportunities in Lung Disease' (BOLD); Tobacco-Related Disease Research Program New Investigator Award [15KT-0008]; Beatriu de Pinos Postdoctoral [BP-A 10144]; UCSF; Sandler Center for Basic Research in Asthma; Sandler Family Supporting Foundation; Direct For Education and Human Resources [0841338] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133, R01HL078885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI); RWJ Amos Medical Faculty Development; American Thoracic Society 'Breakthrough Opportunities in Lung Disease' (BOLD); Tobacco-Related Disease Research Program New Investigator Award(University of California System); Beatriu de Pinos Postdoctoral; UCSF; Sandler Center for Basic Research in Asthma; Sandler Family Supporting Foundation; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (HL078885, HL088133, U19 AI077439, ES015794), Flight Attendant Medical Research Institute (FAMRI), and the RWJ Amos Medical Faculty Development Award to EGB, American Thoracic Society 'Breakthrough Opportunities in Lung Disease' (BOLD) Award and Tobacco-Related Disease Research Program New Investigator Award (15KT-0008) to SC, Beatriu de Pinos Postdoctoral Grant (2006 BP-A 10144) to MV, UCSF Chancellor's Fellowship to CG, and the Sandler Center for Basic Research in Asthma and the Sandler Family Supporting Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; ARCE CH, 1987, HISPANIC J BEHAV SCI, V9, P19, DOI 10.1177/073998638703090102; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; BAIZ EG, 2000, SIGLO BLANCO ESTUDIO, V16, pR18; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN, pxi; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Choudhry S, 2006, AM J RESP CRIT CARE, V174, P1086, DOI [10.1164/RCCM.200605-596OC, 10.1164/rccm.200605-596OC]; DECORDOBA PT, 1831, MEMORIAS GEOGRAFICAS; Diaz Soler Luis M., 2005, HIST ESCLAVITUD NEGR; Ellis NA, 1998, AM J HUM GENET, V63, P1685, DOI 10.1086/302167; Falush D, 2003, GENETICS, V164, P1567; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; FOTHERINGHAM AS, 2002, GEOGRAPHICALLY WEIGH, pR12; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Huizing M, 2001, AM J HUM GENET, V69, P1022, DOI 10.1086/324168; ISAAKS EH, 1989, APPL GEOSTATISTICS, pR19; John EM, 2007, JAMA-J AM MED ASSOC, V298, P2869, DOI 10.1001/jama.298.24.2869; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Klein Herbert S., 1986, AFRICAN SLAVERY LATI; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martinez-Cruzado JC, 2005, AM J PHYS ANTHROPOL, V128, P131, DOI 10.1002/ajpa.20108; Martinez-Cruzado JC, 2001, HUM BIOL, V73, P491, DOI 10.1353/hub.2001.0056; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Mintz Sidney W, 1953, AM HIST REV, V33, P224; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Moscoso Francisco, 2008, CACIQUES ALDEAS POBL; Mullineaux LG, 2003, CANCER-AM CANCER SOC, V98, P597, DOI 10.1002/cncr.11533; Nazario M. Alvarez, 1974, ELEMENTO AFRONEGROID; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; Pritchard JK, 2000, GENETICS, V155, P945; Relethford JH, 2008, AM J PHYS ANTHROPOL, V136, P1, DOI 10.1002/ajpa.20789; Risch N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r132; SALZANO FM, 2002, EVOLUTION GENETICS L, pR16; SANGER JP, 1900, 1899 CENSUS REPORT P; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; STOLCKE V, 1974, MARRIAGE CLASS COLOU, pR10; TELLES EE, 1990, SOC SCI QUART, V71, P682; *US BUR CENS, 2001, CENS POP; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505	48	68	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16513	10.1371/journal.pone.0016513	http://dx.doi.org/10.1371/journal.pone.0016513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304981	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300074
J	Gerstner, JR; Vanderheyden, WM; Shaw, PJ; Landry, CF; Yin, JCP				Gerstner, Jason R.; Vanderheyden, William M.; Shaw, Paul J.; Landry, Charles F.; Yin, Jerry C. P.			Fatty-Acid Binding Proteins Modulate Sleep and Enhance Long-Term Memory Consolidation in Drosophila	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; BRAIN GENE-EXPRESSION; EYE-MOVEMENT SLEEP; NUCLEAR RECEPTORS; MOUSE-BRAIN; PROSTAGLANDIN D-2; WAKING EXPERIENCE; DEPENDENT MEMORY; CIRCADIAN CLOCK; PPAR-ALPHA	Sleep is thought to be important for memory consolidation, since sleep deprivation has been shown to interfere with memory processing. However, the effects of augmenting sleep on memory formation are not well known, and testing the role of sleep in memory enhancement has been limited to pharmacological and behavioral approaches. Here we test the effect of overexpressing the brain-type fatty acid binding protein (Fabp7) on sleep and long-term memory (LTM) formation in Drosophila melanogaster. Transgenic flies carrying the murine Fabp7 or the Drosophila homologue dFabp had reduced baseline sleep but normal LTM, while Fabp induction produced increases in both net sleep and LTM. We also define a post-training consolidation "window" that is sufficient for the observed Fabp-mediated memory enhancement. Since Fabp overexpression increases consolidated daytime sleep bouts, these data support a role for longer naps in improving memory and provide a novel role for lipid-binding proteins in regulating memory consolidation concurrently with changes in behavioral state.	[Gerstner, Jason R.; Yin, Jerry C. P.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Vanderheyden, William M.; Shaw, Paul J.] Washington Univ, Sch Med, St Louis, MO USA; [Landry, Charles F.] Scarab Genom LLC, Madison, WI USA; [Yin, Jerry C. P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Yin, Jerry C. P.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gerstner, JR (corresponding author), Univ Penn, Sch Med, Ctr Sleep & Circadian Neurobiol, Translat Res Labs, Philadelphia, PA 19104 USA.	gerstner@upenn.edu; jcyin@wisc.edu	Gerstner, Jason/J-3778-2013	Gerstner, Jason/0000-0003-3113-6974	National Institutes of Health [MH60774, GM07507]; Waisman Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waisman Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the National Institutes of Health (MH60774 to JC), its Training Grant Program (GM07507), and start up funds from the Waisman Center (to JCY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Brawn TP, 2008, LEARN MEMORY, V15, P815, DOI 10.1101/lm.1180908; Brawn TP, 2010, J NEUROSCI, V30, P609, DOI 10.1523/JNEUROSCI.4237-09.2010; Cai DJ, 2009, BEHAV NEUROSCI, V123, P713, DOI 10.1037/a0016415; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Cirelli C, 2006, J NEUROCHEM, V98, P1632, DOI 10.1111/j.1471-4159.2006.04058.x; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Datta S, 2008, EUR J NEUROSCI, V27, P1876, DOI 10.1111/j.1460-9568.2008.06166.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gerstner JR, 2006, NEUROSCIENCE, V139, P1435, DOI 10.1016/j.neuroscience.2006.01.020; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; Gerstner JR, 2010, AGING-US, V2, P251, DOI 10.18632/aging.100144; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Gerstner JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001631; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Glaser ST, 2009, NEUROSCIENCE, V163, P594, DOI 10.1016/j.neuroscience.2009.06.043; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Helledie T, 2000, J LIPID RES, V41, P1740; Huang ZL, 2007, CURR OPIN PHARMACOL, V7, P33, DOI 10.1016/j.coph.2006.09.004; INOUE S, 1984, P NATL ACAD SCI-BIOL, V81, P6240, DOI 10.1073/pnas.81.19.6240; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Kondratova AA, 2010, AGING-US, V2, P285; Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417; Lyons LC, 2006, J BIOL RHYTHM, V21, P245, DOI 10.1177/0748730406289890; Lyons LC, 2009, LEARN MEMORY, V16, P19, DOI 10.1101/lm.1146009; MATSUMURA H, 1991, P NATL ACAD SCI USA, V88, P9046, DOI 10.1073/pnas.88.20.9046; Mazzola C, 2009, LEARN MEMORY, V16, P332, DOI 10.1101/lm.1145209; McDermott CM, 2003, J NEUROSCI, V23, P9687; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Murillo-Rodniguez E, 2006, LIFE SCI, V79, P30, DOI 10.1016/j.lfs.2005.12.028; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Owada Y, 1996, MOL BRAIN RES, V42, P156, DOI 10.1016/S0169-328X(96)00182-9; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Pandey HP, 1995, BIOCHEM MOL BIOL INT, V37, P431; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Schulze G, 2004, MED HYPOTHESES, V63, P203, DOI 10.1016/j.mehy.2004.02.040; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; SMITH C, 1988, PHYSIOL BEHAV, V43, P213, DOI 10.1016/0031-9384(88)90240-5; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Terao A, 2003, NEUROSCIENCE, V120, P1115, DOI 10.1016/S0306-4522(03)00395-6; Terao A, 2005, NEUROSCIENCE; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Tucker MA, 2008, SLEEP, V31, P197, DOI 10.1093/sleep/31.2.197; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Vertes RP, 2005, SLEEP, V28, P1228, DOI 10.1093/sleep/28.10.1228; Wamsley EJ, 2010, LEARN MEMORY, V17, P332, DOI 10.1101/lm.1828310; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wetzel W, 2003, EUR J NEUROSCI, V18, P2611, DOI 10.1046/j.1460-9568.2003.02890.x; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Zimmerman JE, 2006, PHYSIOL GENOMICS, V27, P337, DOI 10.1152/physiolgenomics.00030.2006	82	50	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15890	10.1371/journal.pone.0015890	http://dx.doi.org/10.1371/journal.pone.0015890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298037	Green Published, gold			2022-12-27	WOS:000286663900018
J	Moitra, K; Scally, M; Mcgee, K; Lancaster, G; Gold, B; Dean, M				Moitra, Karobi; Scally, Mark; McGee, Kate; Lancaster, Germaine; Gold, Bert; Dean, Michael			Molecular Evolutionary Analysis of ABCB5: The Ancestral Gene Is a Full Transporter with Potentially Deleterious Single Nucleotide Polymorphisms	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; HUMAN-MALIGNANT MELANOMA; CANCER STEM-CELLS; PROTEIN SEQUENCES; CODON ALIGNMENTS; LEUKEMIA-CELLS; COILED-COILS; PREDICTION; MODEL; CHEMORESISTANCE	Background: ABCB5 is a member of the ABC protein superfamily, which includes the transporters ABCB1, ABCC1 and ABCG2 responsible for causing drug resistance in cancer patients and also several other transporters that have been linked to human disease. The ABCB5 full transporter (ABCB5.ts) is expressed in human testis and its functional significance is presently unknown. Another variant of this transporter, ABCB5 beta posses a "half-transporter-like'' structure and is expressed in melanoma stem cells, normal melanocytes, and other types of pigment cells. ABCB5 beta has important clinical implications, as it may be involved with multidrug resistance in melanoma stem cells, allowing these stem cells to survive chemotherapeutic regimes. Methodology/Principal Findings: We constructed and examined in detail topological structures of the human ABCB5 protein and determined in-silico the cSNPs (coding single nucleotide polymorphisms) that may affect its function. Evolutionary analysis of ABCB5 indicated that ABCB5, ABCB1, ABCB4, and ABCB11 share a common ancestor, which began duplicating early in the evolutionary history of chordates. This suggests that ABCB5 has evolved as a full transporter throughout its evolutionary history. Conclusions/Significance: From our in-silco analysis of cSNPs we found that a large number of non-synonymous cSNPs map to important functional regions of the protein suggesting that these SNPs if present in human populations may play a role in diseases associated with ABCB5. From phylogenetic analyses, we have shown that ABCB5 evolved as a full transporter throughout its evolutionary history with an absence of any major shifts in selection between the various lineages suggesting that the function of ABCB5 has been maintained during mammalian evolution. This finding would suggest that ABCB5 beta may have evolved to play a specific role in human pigment cells and/or melanoma cells where it is predominantly expressed.	[Moitra, Karobi; Scally, Mark; McGee, Kate; Lancaster, Germaine; Gold, Bert; Dean, Michael] NCI, Expt Immunol Lab, Human Genet Sect, Canc & Inflammat Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Moitra, K (corresponding author), NCI, Expt Immunol Lab, Human Genet Sect, Canc & Inflammat Program, Frederick, MD 21701 USA.	deanm@mail.nih.gov	Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; 	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000098; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Calcagno Anna Maria, 2007, Current Drug Delivery, V4, P324, DOI 10.2174/156720107782151241; Chen KG, 2005, PIGM CELL RES, V18, P102, DOI 10.1111/j.1600-0749.2005.00214.x; Cheung ST, 2010, GASTROENTER IN PRESS; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Frank NY, 2009, LEUKEMIA RES, V33, P1303, DOI 10.1016/j.leukres.2009.04.035; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jamison DC, 2003, BIOINFORMATICS, V19, P679, DOI 10.1093/bioinformatics/btg214; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalow W, 2001, PHARMACOGENOMICS; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lehne G, 2009, LEUKEMIA RES, V33, P1379, DOI 10.1016/j.leukres.2009.03.028; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; Wu HJ, 2008, MOL BIOTECHNOL, V39, P21, DOI 10.1007/s12033-007-9024-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	41	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16318	10.1371/journal.pone.0016318	http://dx.doi.org/10.1371/journal.pone.0016318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298007	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900032
J	Patel, R; Martin, RM; Kramer, MS; Oken, E; Bogdanovich, N; Matush, L; Smith, GD; Lawlor, DA				Patel, Rita; Martin, Richard M.; Kramer, Michael S.; Oken, Emily; Bogdanovich, Natalia; Matush, Lidia; Smith, George Davey; Lawlor, Debbie A.			Familial Associations of Adiposity: Findings from a Cross-Sectional Study of 12,181 Parental-Offspring Trios from Belarus	PLOS ONE			English	Article							BODY-MASS INDEX; FETAL OVERNUTRITION HYPOTHESIS; CARDIOVASCULAR RISK; CHILD OVERWEIGHT; MOTHER-DAUGHTER; OBESITY; WEIGHT; PREGNANCY; PREVALENCE	Background: It is suggested that maternal adiposity has a stronger association with offspring adiposity than does paternal adiposity. Furthermore, a recent small study reported gender assortment in parental-offspring adiposity associations. We aimed to examine these associations in one of the largest studies to date using data from a low-middle income country that has recently undergone a major political and economic transition. Methods and Principal Findings: In a cross-sectional study of 12,181 parental-offspring trios from Belarus (mean age (SD) of mothers 31.7 (4.9), fathers 34.1 (5.1) and children 6.6 (0.3) at time of assessment), we found positive graded associations of mother's and father's BMI with offspring adiposity. There was no evidence that these associations differed between mothers and fathers. For example, the odds ratio of offspring overweight or obesity (based on BMI) comparing obese and overweight mothers to normal weight mothers was 2.03 (95% CI 1.77, 2.31) in fully adjusted models; the equivalent result for father's overweight/obesity was 1.81 (1.58, 2.07). Equivalent results for offspring being in the top 10% waist circumference were 1.91 (1.67, 2.18) comparing obese/overweight to normal weight mothers and 1.72 (1.53, 1.95) comparing obese/overweight to normal weight fathers. Similarly, results for offspring being in the top 10% of percent fat mass were 1.58 (1.36, 1.84) and 1.76 (1.49, 2.07), for mother's and father's obese/overweight exposures respectively. There was no strong or consistent evidence of gender assortment - i.e. associations of maternal adiposity exposures with offspring outcomes were similar in magnitude for their daughters compared to equivalent associations in their sons and paternal associations were also similar in sons and daughters. Conclusions/Significance: These findings suggest that genetic and/or shared familial environment explain family clustering of adiposity. Interventions aimed at changing overall family lifestyle are likely to be important for population level obesity prevention.	[Patel, Rita; Martin, Richard M.; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Martin, Richard M.; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Kramer, Michael S.] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3A 2T5, Canada; [Kramer, Michael S.] McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada; [Oken, Emily] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Bogdanovich, Natalia; Matush, Lidia] Natl Res & Appl Med Mother & Child Ctr, Minsk, BELARUS	University of Bristol; University of Bristol; McGill University; McGill University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Patel, R (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Canadian Institutes of Health Research; US National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK077659]; European Union [FOOD-DT-2005-007036]; UK Medical Research Council [G0600705]; University of Bristol; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659, P30DK040561] Funding Source: NIH RePORTER; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PROBIT study is supported by a grant from the Canadian Institutes of Health Research. The US National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK077659) provides funding for DAL's work on this study. The European Union's project on Early Nutrition Programming: Long-term Efficacy and Safety Trials (FOOD-DT-2005-007036) provided funding for RP and for RMM and GDS's work on this study. The UK Medical Research Council provides funding for the MRC Centre for Causal Analyses in Translational Epidemiology (G0600705). RP is recipient of a University of Bristol Departmental PhD bursary. The views expressed in this study are those of the authors and not necessarily the funding bodies. Authors had access to the data and DAL, MK & RP acted as guarantors for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Hui LL, 2003, INT J OBESITY, V27, P1411, DOI 10.1038/sj.ijo.0802423; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1848; Kivimaki M, 2007, AM J CLIN NUTR, V86, P1509, DOI 10.1093/ajcn/86.5.1509; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kuh D., 2004, LIFE COURSE APPROACH, P189, DOI DOI 10.1093/ACPROF:OSO/9780198578154.003.0008; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Lawlor DA, 2010, CIRCULATION IN PRESS; Lawlor DA., 2009, FAMILY MATTERS DESIG, DOI [DOI 10.1093/ACPROF:OSO/9780199231034.001.0001, 10.1093/acprof:oso/9780199231034.001.0001]; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lawlor DA, 2008, PLOS MED, V5, P484, DOI 10.1371/journal.pmed.0050033; Leary S, 2010, INT J OBESITY, V34, P1191, DOI 10.1038/ijo.2010.60; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Lobstein T, 2007, INT J PEDIATR OBES, V2, P62, DOI 10.1080/17477160601103948; Martin RM, 2009, ADV EXP MED BIOL, V646, P41, DOI 10.1007/978-1-4020-9173-5_4; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Perez-Pastor EM, 2009, INT J OBESITY, V33, P727, DOI 10.1038/ijo.2009.76; PETTITT D J, 1988, Journal of Obesity and Weight Regulation, V7, P61; Sekine Michikazu, 2002, J Epidemiol, V12, P33; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; SORENSEN TIA, 1992, INT J OBESITY, V16, P227; Steer CD, 2009, HUM BIOL, V2000, P447; Subramanian SV, 2010, PEDIATRICS, V126, pE663, DOI 10.1542/peds.2010-0222; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Whitlock G, 2001, EUR J EPIDEMIOL, V17, P907, DOI 10.1023/A:1016228410194	35	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14607	10.1371/journal.pone.0014607	http://dx.doi.org/10.1371/journal.pone.0014607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298034	Green Submitted, gold, Green Published			2022-12-27	WOS:000286663900011
J	Zhang, F; Zhai, HQ; Paterson, AH; Xu, JL; Gao, YM; Zheng, TQ; Wu, RL; Fu, BY; Ali, J; Li, ZK				Zhang, Fan; Zhai, Hu-Qu; Paterson, Andrew H.; Xu, Jian-Long; Gao, Yong-Ming; Zheng, Tian-Qing; Wu, Rong-Ling; Fu, Bin-Ying; Ali, Jauhar; Li, Zhi-Kang			Dissecting Genetic Networks Underlying Complex Phenotypes: The Theoretical Framework	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; OVERDOMINANT EPISTATIC LOCI; INBRED RICE POPULATION; DROSOPHILA-MELANOGASTER; INBREEDING DEPRESSION; ARTIFICIAL SELECTION; GREEN-REVOLUTION; YIELD COMPONENTS; GIBBERELLIN; EVOLUTION	Great progress has been made in genetic dissection of quantitative trait variation during the past two decades, but many studies still reveal only a small fraction of quantitative trait loci (QTLs), and epistasis remains elusive. We integrate contemporary knowledge of signal transduction pathways with principles of quantitative and population genetics to characterize genetic networks underlying complex traits, using a model founded upon one-way functional dependency of downstream genes on upstream regulators (the principle of hierarchy) and mutual functional dependency among related genes (functional genetic units, FGU). Both simulated and real data suggest that complementary epistasis contributes greatly to quantitative trait variation, and obscures the phenotypic effects of many 'downstream' loci in pathways. The mathematical relationships between the main effects and epistatic effects of genes acting at different levels of signaling pathways were established using the quantitative and population genetic parameters. Both loss of function and "co-adapted'' gene complexes formed by multiple alleles with differentiated functions (effects) are predicted to be frequent types of allelic diversity at loci that contribute to the genetic variation of complex traits in populations. Downstream FGUs appear to be more vulnerable to loss of function than their upstream regulators, but this vulnerability is apparently compensated by different FGUs of similar functions. Other predictions from the model may account for puzzling results regarding responses to selection, genotype by environment interaction, and the genetic basis of heterosis.	[Zhang, Fan; Zhai, Hu-Qu; Xu, Jian-Long; Gao, Yong-Ming; Zheng, Tian-Qing; Fu, Bin-Ying; Li, Zhi-Kang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Paterson, Andrew H.; Ali, Jauhar] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wu, Rong-Ling] Penn State Univ, Ctr Stat Genet, Hershey, PA USA; [Li, Zhi-Kang] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Manila 1099, Philippines	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; CGIAR; International Rice Research Institute (IRRI)	Zhang, F (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	lizhk@caas.net.cn	Xu, Jianlong/AAI-8310-2020; Ali, Jauhar Ali or A. Jauhar/E-4432-2012	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607	China National Natural Science Foundation [U0631002]; Ministry of Agriculture of China [2006-G51]; Ministry of Science and Technology of China [2010AA101806, 2003CB114308]; CGIAR [12]; Rockefeller Foundation [2005 FS029]; Bill & Melinda Gates Foundation [OPP51587]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Ministry of Science and Technology of China(Ministry of Science and Technology, China); CGIAR(CGIAR); Rockefeller Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was funded by grants from the China National Natural Science Foundation (#U0631002), the "948'' Program of the Ministry of Agriculture of China (#2006-G51), the "863'' program (#2010AA101806) and "973'' Program (#2003CB114308) from the Ministry of Science and Technology of China, the Generation Challenge Program (#12) of CGIAR, the Rockefeller Foundation (#2005 FS029) and the Bill & Melinda Gates Foundation (OPP51587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylor DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000029; BENNETT JH, 1954, ANN EUGENIC, V18, P311; Calvo AP, 2004, J PLANT GROWTH REGUL, V23, P44, DOI 10.1007/s00344-004-0074-7; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cooper M, 2005, AUST J AGR RES, V56, P895, DOI 10.1071/AR05154; Cooper Mark, 2002, Complexity, V7, P31, DOI 10.1002/cplx.10044; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; DEFRIES JC, 1978, BEHAV GENET, V8, P3, DOI 10.1007/BF01067700; DOEBLEY J, 1995, GENETICS, V141, P333; Falconer D. S., 1981, INTRO QUANTITATIVE G; FALCONER DS, 1955, COLD SPRING HARB SYM, V20, P178, DOI 10.1101/SQB.1955.020.01.018; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; HILL WG, 1992, ANNU REV ECOL SYST, V23, P287, DOI 10.1146/annurev.es.23.110192.001443; HILL WG, 1986, GENET RES, V48, P41, DOI 10.1017/S0016672300024642; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Johannsen W., 1909, ELEMENTE EXAKTEN ERB; Kao CH, 2002, GENETICS, V160, P1243; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; LARK KG, 1995, P NATL ACAD SCI USA, V92, P4656, DOI 10.1073/pnas.92.10.4656; Li ZK, 2006, P NATL ACAD SCI USA, V103, P7994, DOI 10.1073/pnas.0507492103; Li ZK, 1997, GENETICS, V145, P453; Li ZK, 1997, GENETICS, V145, P1139; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Li ZK, 2001, GENETICS, V158, P1737; Luo LJ, 2001, GENETICS, V158, P1755; Mackay TFC, 2005, GENETICS, V170, P1723, DOI 10.1534/genetics.104.032581; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malmberg RL, 2005, GENET RES, V86, P89, DOI 10.1017/S0016672305007780; Malmberg RL, 2005, GENETICS, V171, P2013, DOI 10.1534/genetics.105.046078; Mariani L, 2004, PROG BIOPHYS MOL BIO, V86, P45, DOI 10.1016/j.pbiomolbio.2004.02.007; Mather K, 1982, BIOMETRICAL GENETICS; Mei HW, 2005, THEOR APPL GENET, V110, P649, DOI 10.1007/s00122-004-1890-7; Mei HW, 2003, THEOR APPL GENET, V107, P89, DOI 10.1007/s00122-003-1192-5; Melchinger AE, 1998, GENETICS, V149, P383; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Peccoud J, 2004, GENETICS, V166, P1715, DOI 10.1534/genetics.166.4.1715; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Podlich DW, 1998, BIOINFORMATICS, V14, P632, DOI 10.1093/bioinformatics/14.7.632; Sanjuan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002663; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Stanton ML, 2000, EVOLUTION, V54, P93, DOI 10.1111/j.0014-3820.2000.tb00011.x; Steffens B, 2005, PLANT PHYSIOL, V139, P713, DOI 10.1104/pp.105.064469; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Tong JP, 2007, GENET RES, V89, P221, DOI 10.1017/S0016672307009020; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Vellend M, 2005, AM NAT, V166, P199, DOI 10.1086/431318; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Weir BS., 1996, METHODS DISCRETE POP; WELBERGEN P, 1992, BEHAV GENET, V22, P113, DOI 10.1007/BF01066796; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhuang JY, 1997, THEOR APPL GENET, V95, P799, DOI 10.1007/s001220050628	66	21	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14541	10.1371/journal.pone.0014541	http://dx.doi.org/10.1371/journal.pone.0014541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283795	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200003
J	Adhikary, T; Kaddatz, K; Finkernagel, F; Schonbauer, A; Meissner, W; Scharfe, M; Jarek, M; Blocker, H; Muller-Brusselbach, S; Muller, R				Adhikary, Till; Kaddatz, Kerstin; Finkernagel, Florian; Schoenbauer, Anne; Meissner, Wolfgang; Scharfe, Maren; Jarek, Michael; Bloecker, Helmut; Mueller-Bruesselbach, Sabine; Mueller, Rolf			Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-beta/delta (PPAR beta/delta)	PLOS ONE			English	Article							CANCER-CELL-LINES; SIGNALING PATHWAY; RESPONSE ELEMENT; GAMMA-RXR; COREPRESSOR; LIGANDS; BINDING; BETA; BIOINFORMATICS; DETERMINANTS	Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors with essential functions in lipid, glucose and energy homeostasis, cell differentiation, inflammation and metabolic disorders, and represent important drug targets. PPARs heterodimerize with retinoid X receptors (RXRs) and can form transcriptional activator or repressor complexes at specific DNA elements (PPREs). It is believed that the decision between repression and activation is generally governed by a ligand-mediated switch. We have performed genomewide analyses of agonist-treated and PPAR beta/delta-depleted human myofibroblasts to test this hypothesis and to identify global principles of PPAR beta/delta-mediated gene regulation. Chromatin immunoprecipitation sequencing (ChIP-Seq) of PPAR beta/delta, H3K4me3 and RNA polymerase II enrichment sites combined with transcriptional profiling enabled the definition of 112 bona fide PPAR beta/delta target genes showing either of three distinct types of transcriptional response: (I) ligand-independent repression by PPAR beta/delta; (II) ligand-induced activation and/or derepression by PPAR beta/delta; and (III) ligand-independent activation by PPAR beta/delta. These data identify PPRE-mediated repression as a major mechanism of transcriptional regulation by PPAR beta/delta, but, unexpectedly, also show that only a subset of repressed genes are activated by a ligand-mediated switch. Our results also suggest that the type of transcriptional response by a given target gene is connected to the structure of its associated PPRE(s) and the biological function of its encoded protein. These observations have important implications for understanding the regulatory PPAR network and PPAR beta/delta ligand-based drugs.	[Adhikary, Till; Kaddatz, Kerstin; Finkernagel, Florian; Schoenbauer, Anne; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Scharfe, Maren; Jarek, Michael; Bloecker, Helmut] Helmholtz Ctr Infect Res HZI, Braunschweig, Germany	Philipps University Marburg; Helmholtz Association; Helmholtz-Center for Infection Research	Adhikary, T (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany.	rmueller@imt.uni-marburg.de	Müller, Rolf/L-4997-2016; Adhikary, Till/O-5678-2018	Müller, Rolf/0000-0003-3339-4248; Adhikary, Till/0000-0003-1951-5605	Deutsche Forschungsgemeinschaft [Mu601/12-1, SFB-TR17/A3]; Genomics and Bioinformatics Core Units [SFB-TR17]; LOEWE-Schwerpunkt "Tumor and Inflammation"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Genomics and Bioinformatics Core Units; LOEWE-Schwerpunkt "Tumor and Inflammation"	This work was supported by the Deutsche Forschungsgemeinschaft (Mu601/12-1 and SFB-TR17/A3) and by the Genomics and Bioinformatics Core Units of the SFB-TR17 and the LOEWE-Schwerpunkt "Tumor and Inflammation." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2010, CARDIOVASC RES, V85, P701, DOI 10.1093/cvr/cvp365; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girroir EE, 2008, TOXICOLOGY, V243, P236, DOI 10.1016/j.tox.2007.10.023; Grimaldi PA, 2010, CURR OPIN LIPIDOL, V21, P186, DOI 10.1097/MOL.0b013e32833884a4; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Muller R, 2008, PPAR RES, V2008, DOI 10.1155/2008/534294; Muller-Brusselbach S, 2007, EMBO J, V26, P3686, DOI 10.1038/sj.emboj.7601803; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; OISHI Y, 2008, NAT MED; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Semple RK, 2005, ENDOCRINOLOGY, V146, P1871, DOI 10.1210/en.2004-1405; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Stockert J, 2011, NUCLEIC ACIDS RES, V39, P119, DOI 10.1093/nar/gkq773; van der Meer D.L., 2010, NUCL ACIDS RES; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zandi PP, 2008, ARCH GEN PSYCHIAT, V65, P785, DOI 10.1001/archpsyc.65.7.785; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	64	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16344	10.1371/journal.pone.0016344	http://dx.doi.org/10.1371/journal.pone.0016344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283829	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600042
J	Rosbottom, A; Gibney, H; Kaiser, P; Hartley, C; Smith, RF; Robinson, R; Kipar, A; Williams, DJL				Rosbottom, Anne; Gibney, Helen; Kaiser, Peter; Hartley, Catherine; Smith, Robert F.; Robinson, Rebecca; Kipar, Anja; Williams, Diana J. L.			Up Regulation of the Maternal Immune Response in the Placenta of Cattle Naturally Infected with Neospora caninum	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INTERFERON-GAMMA; PREGNANT CATTLE; LISTERIA-MONOCYTOGENES; IFN-GAMMA; TROPHOBLAST; ABORTION; PATHOGENESIS; INOCULATION; LYMPHOCYTES	Neospora caninum is an intracellular protozoan parasite which is a major cause of abortion in cattle worldwide. It forms persistent infections which recrudesce during pregnancy leading to foetal infection and in a proportion of cases, abortion. The mechanisms underlying abortion are not understood. In this study, recrudescence of a persistent infection in eight naturally infected cows occurred between 20 and 33 weeks of gestation. Animals were killed at the time of recrudescence and parasites were detected in the placentae and foetuses. An active maternal immune response consisting of an infiltration of CD4+ and CD8+ T cells and a 46-49 fold increase in interferon-gamma and interleukin-4 mRNA was detected. Other cytokines, notably interleukin-12 p40, interleukin-10 and tumour necrosis factor-alpha were also significantly increased and Major Histocompatibility Class II antigen was expressed on maternal and foetal epithelial and stromal fibroblastoid cells. Significantly, despite the presence of an active maternal immune response in the placenta, all the foetuses were alive at the time of maternal euthanasia. There was evidence of parasites within foetal tissues; their distribution was restricted to the central nervous system and skeletal muscle and their presence was associated with tissue necrosis and a non-suppurative inflammatory response involving lymphocytes and macrophages, irrespective of the gestational age of the foetus. Whilst an active maternal immune response to a pathogen in the placenta is generally considered to be damaging to the foetal trophoblast, our findings suggest that the presence of a parasite-induced maternal immune response in the placenta is not detrimental to foetal survival but may contribute to the control of placental parasitosis.	[Rosbottom, Anne; Gibney, Helen; Hartley, Catherine; Robinson, Rebecca; Kipar, Anja; Williams, Diana J. L.] Univ Liverpool, Dept Vet Pathol, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Kaiser, Peter] Inst Anim Hlth, Compton, Berks, England; [Smith, Robert F.] Vet Teaching Hosp, Dept Vet Clin Sci, Neston, England	University of Liverpool; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Liverpool	Rosbottom, A (corresponding author), Univ Liverpool, Dept Vet Pathol, Sch Vet Sci, POB 147, Liverpool L69 3BX, Merseyside, England.	williadj@liv.ac.uk	Kipar, Anja/L-7214-2014	Kipar, Anja/0000-0001-7289-3459; Smith, Robert/0000-0003-0944-310X	Wellcome Trust [GR066695MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grant number GR066695MA from the Wellcome Trust. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. www.wellcome.ac.uk	Abram M, 2002, VIRCHOWS ARCH, V441, P368, DOI 10.1007/s00428-002-0649-2; Andrianarivo AG, 2001, PARASITOL RES, V87, P817, DOI 10.1007/s004360100442; ATHANASSAKIS I, 1995, AM J REPROD IMMUNOL, V34, P281, DOI 10.1111/j.1600-0897.1995.tb00954.x; Athanassakis I, 2000, J INTERF CYTOK RES, V20, P823, DOI 10.1089/10799900050151094; Barber EM, 2005, INFECT IMMUN, V73, P6322, DOI 10.1128/IAI.73.10.6322-6331.2005; Bartley PM, 2004, J COMP PATHOL, V130, P81, DOI 10.1016/j.jcpa.2003.08.003; Collantes-Fernandez E, 2006, THERIOGENOLOGY, V65, P629, DOI 10.1016/j.theriogenology.2005.06.003; Davies CJ, 2007, J ANIM SCI, V85, pE32, DOI 10.2527/jas.2006-492; Dubey JP, 2006, J COMP PATHOL, V134, P267, DOI 10.1016/j.jcpa.2005.11.004; Dubey JP, 1996, VET PARASITOL, V67, P1, DOI 10.1016/S0304-4017(96)01035-7; Entrican G, 2009, VET MICROBIOL, V135, P98, DOI 10.1016/j.vetmic.2008.09.028; Gibney EH, 2008, INT J PARASITOL, V38, P579, DOI 10.1016/j.ijpara.2007.09.015; Guy CS, 2001, VET REC, V149, P443, DOI 10.1136/vr.149.15.443; HEIN WR, 1988, IMMUNOLOGY, V64, P621; INNES EA, 1995, J COMP PATHOL, V113, P95, DOI 10.1016/S0021-9975(05)80075-1; Innes EA, 2002, TRENDS PARASITOL, V18, P497, DOI 10.1016/S1471-4922(02)02372-3; Kim S, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-22; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Krishnan L, 1996, J IMMUNOL, V156, P653; Krishnan L, 2010, AM J REPROD IMMUNOL, V63, P54, DOI 10.1111/j.1600-0897.2009.00766.x; Lopez-Gatius F, 2007, THERIOGENOLOGY, V68, P1067, DOI 10.1016/j.theriogenology.2007.08.006; Maley SW, 2003, J COMP PATHOL, V129, P186, DOI 10.1016/S0021-9975(03)00032-X; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mor G, 2008, ANN NY ACAD SCI, V1127, P121, DOI 10.1196/annals.1434.006; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Rosbottom A, 2007, PARASITE IMMUNOL, V29, P219, DOI 10.1111/j.1365-3024.2007.00936.x; Rosbottom A, 2008, INFECT IMMUN, V76, P2352, DOI 10.1128/IAI.01780-06; Staska LM, 2005, INFECT IMMUN, V73, P1321, DOI 10.1128/IAI.73.3.1321-1329.2005; Staska LM, 2003, INFECT IMMUN, V71, P3272, DOI 10.1128/IAI.71.6.3272-3279.2003; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tierney TJ, 1997, VET IMMUNOL IMMUNOP, V59, P369, DOI 10.1016/S0165-2427(97)00076-7; Tierney TJ, 1997, VET IMMUNOL IMMUNOP, V57, P229, DOI 10.1016/S0165-2427(97)00011-1; Trees AJ, 2005, TRENDS PARASITOL, V21, P558, DOI 10.1016/j.pt.2005.09.005; Uggla A, 1998, INT J PARASITOL, V28, P1467, DOI 10.1016/S0020-7519(98)00110-6; von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Williams DJL, 2009, PARASITOLOGY, V136, P1895, DOI 10.1017/S0031182009990588; Williams DJL, 1999, VET REC, V145, P571, DOI 10.1136/vr.145.20.571; Williams DJL, 2000, PARASITOLOGY, V121, P347, DOI 10.1017/S0031182099006587	40	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15799	10.1371/journal.pone.0015799	http://dx.doi.org/10.1371/journal.pone.0015799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283810	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600012
J	Sun, WY; Chang, SS; Fu, YM; Liu, Y; Califano, JA				Sun, Wenyue; Chang, Steven S.; Fu, Yumei; Liu, Yan; Califano, Joseph A.			Chronic CSE Treatment Induces the Growth of Normal Oral Keratinocytes via PDK2 Upregulation, Increased Glycolysis and HIF1 alpha Stabilization	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MITOCHONDRIAL-DNA MUTATIONS; CANCER-CELLS; PYRUVATE-DEHYDROGENASE; CIGARETTE-SMOKING; PROSTATE-CANCER; LUNG-CANCER; NECK-CANCER; HEAD; EXPRESSION	Background: Exposure to cigarette smoke is a major risk factor for head and neck squamous cell carcinoma (HNSCC). We have previously established a chronic cigarette smoke extract (CSE)-treated human oral normal keratinocyte model, demonstrating an elevated frequency of mitochondrial mutations in CSE treated cells. Using this model we further characterized the mechanism by which chronic CSE treatment induces increased cellular proliferation. Methodology/Principal Findings: We demonstrate that chronic CSE treatment upregulates PDK2 expression, decreases PDH activity and thereby increases the glycolytic metabolites pyruvate and lactate. We also found that the chronic CSE treatment enhanced HIF1 alpha accumulation through increased pyruvate and lactate production in a manner selectively reversible by ascorbate. Use of a HIF1 alpha small molecule inhibitor blocked the growth induced by chronic CSE treatment in OKF6 cells. Furthermore, chronic CSE treatment was found to increase ROS (reactive oxygen species) production, and application of the ROS scavengers N-acetylcysteine abrogated the expression of PDK2 and HIF1 alpha. Notably, treatment with dichloroacetate, a PDK2 inhibitor, also decreased the HIF1 alpha expression as well as cell proliferation in chronic CSE treated OKF6 cells. Conclusions/Significance: Our findings suggest that chronic CSE treatment contribute to cell growth via increased ROS production through mitochondrial mutations, upregulation of PDK2, attenuating PDH activity thereby increasing glycolytic metabolites, resulting in HIF1 alpha stabilization. This study suggests a role for chronic tobacco exposure in the development of aerobic glycolysis and normoxic HIF alpha activation as a part of HNSCC initiation. These data may provide insights into development of chemopreventive strategies for smoking related cancers.	[Sun, Wenyue; Chang, Steven S.; Fu, Yumei; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Liu, Yan] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Sun, WY (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu		Sun, Wenyue/0000-0003-1673-0895	Flight Attendant Medical Research Institute; National Cancer Institute [5P50CA096784-05, U01CA084986]; NATIONAL CANCER INSTITUTE [P50CA096784, U01CA084986] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by a Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the National Cancer Institute SPORE (5P50CA096784-05) and EDRN U01CA084986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; CARP H, 1978, AM REV RESPIR DIS, V118, P617; CHANG SS, 2009, INT J CANC; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Hockenbery DM, 2002, CANCER CELL, V2, P1, DOI 10.1016/S1535-6108(02)00087-9; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Liu Y, 2007, LUNG CANCER, V56, P307, DOI 10.1016/j.lungcan.2007.01.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Sharifi N, 2008, CLIN CANCER RES, V14, P6073, DOI 10.1158/1078-0432.CCR-08-0591; Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930; Tan DJ, 2008, CARCINOGENESIS, V29, P1170, DOI 10.1093/carcin/bgn034; WARBURG O, 1956, SCIENCE, V124, P269; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	29	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16207	10.1371/journal.pone.0016207	http://dx.doi.org/10.1371/journal.pone.0016207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283817	Green Submitted, Green Published, gold			2022-12-27	WOS:000286520600031
J	Borst, A; Weber, F				Borst, Alexander; Weber, Franz			Neural Action Fields for Optic Flow Based Navigation: A Simulation Study of the Fly Lobula Plate Network	PLOS ONE			English	Article							MOTION-SENSITIVE NEURONS; INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; VISUAL RESPONSE PROPERTIES; GIANT VERTICAL CELLS; TANGENTIAL CELLS; BLOWFLY CALLIPHORA; HORIZONTAL CELLS; SELF-MOTION; DROSOPHILA-MELANOGASTER; MEMBRANE-PROPERTIES	Optic flow based navigation is a fundamental way of visual course control described in many different species including man. In the fly, an essential part of optic flow analysis is performed in the lobula plate, a retinotopic map of motion in the environment. There, the so-called lobula plate tangential cells possess large receptive fields with different preferred directions in different parts of the visual field. Previous studies demonstrated an extensive connectivity between different tangential cells, providing, in principle, the structural basis for their large and complex receptive fields. We present a network simulation of the tangential cells, comprising most of the neurons studied so far (22 on each hemisphere) with all the known connectivity between them. On their dendrite, model neurons receive input from a retinotopic array of Reichardt-type motion detectors. Model neurons exhibit receptive fields much like their natural counterparts, demonstrating that the connectivity between the lobula plate tangential cells indeed can account for their complex receptive field structure. We describe the tuning of a model neuron to particular types of ego-motion (rotation as well as translation around/along a given body axis) by its 'action field'. As we show for model neurons of the vertical system (VS-cells), each of them displays a different type of action field, i.e., responds maximally when the fly is rotating around a particular body axis. However, the tuning width of the rotational action fields is relatively broad, comparable to the one with dendritic input only. The additional intra-lobula-plate connectivity mainly reduces their translational action field amplitude, i.e., their sensitivity to translational movements along any body axis of the fly.	[Borst, Alexander; Weber, Franz] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany	Max Planck Society	Borst, A (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany.	borst@neuro.mpg.de			Max-Planck-Society	Max-Planck-Society(Max Planck Society)	This work was supported by the Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1961, SENSORY COMMUNICATIO; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; Borst A, 1996, J COMPUT NEUROSCI, V3, P313, DOI 10.1007/BF00161091; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Brotz TM, 1996, J NEUROPHYSIOL, V76, P1786, DOI 10.1152/jn.1996.76.3.1786; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; Cuntz H, 2007, P NATL ACAD SCI USA, V104, P10229, DOI 10.1073/pnas.0703697104; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; ECKERT H, 1983, J INSECT PHYSIOL, V29, P547, DOI 10.1016/0022-1910(83)90020-3; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; EGELHAAF M, 1993, J NEUROPHYSIOL, V69, P340, DOI 10.1152/jn.1993.69.2.340; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Farrow K, 2003, J NEUROSCI, V23, P9805; Farrow K, 2006, NAT NEUROSCI, V9, P1312, DOI 10.1038/nn1769; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franz MO, 2000, BIOL CYBERN, V83, P185, DOI 10.1007/s004220000163; Franz MO, 2004, NEURAL COMPUT, V16, P2245, DOI 10.1162/0899766041941899; Gauck V, 1997, J COMP NEUROL, V381, P489; Gibson JJ, 1950, PERCEPTION VISUAL WO; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1996, NATURE, V379, P639, DOI 10.1038/379639a0; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2000, J NEUROPHYSIOL, V83, P1039, DOI 10.1152/jn.2000.83.2.1039; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; Haag J, 2005, J COMP PHYSIOL A, V191, P445, DOI 10.1007/s00359-005-0605-0; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2007, FRONT NEUROSCI-SWITZ, V1, P111, DOI 10.3389/neuro.01.1.1.008.2007; Haag J, 2007, J NEUROSCI, V27, P1992, DOI 10.1523/JNEUROSCI.4393-06.2007; Haag J, 2008, J NEUROSCI, V28, P14435, DOI 10.1523/JNEUROSCI.3603-08.2008; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P179, DOI 10.1007/BF00619212; HENGSTENBERG R, 1977, NATURE, V270, P338, DOI 10.1038/270338a0; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P163, DOI 10.1007/BF00619211; Horstmann W, 2000, EUR J NEUROSCI, V12, P2157, DOI 10.1046/j.1460-9568.2000.00094.x; Huston SJ, 2008, PLOS BIOL, V6, P1468, DOI 10.1371/journal.pbio.0060173; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Kalb J, 2006, J NEUROSCI, V26, P7898, DOI 10.1523/JNEUROSCI.1327-06.2006; Karmeier K, 2006, J NEUROPHYSIOL, V96, P1602, DOI 10.1152/jn.00023.2006; Karmeier K, 2005, J NEUROPHYSIOL, V94, P2182, DOI 10.1152/jn.00278.2005; Karmeier K, 2003, J NEUROPHYSIOL, V90, P1626, DOI 10.1152/jn.00234.2003; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Kurtz R, 2001, J NEUROSCI, V21, P6957, DOI 10.1523/JNEUROSCI.21-17-06957.2001; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Lindemann JP, 2005, J NEUROSCI, V25, P6435, DOI 10.1523/JNEUROSCI.1132-05.2005; Nordstrom K, 2008, CURR BIOL, V18, P661, DOI 10.1016/j.cub.2008.03.061; Petrowitz R, 2000, J COMP PHYSIOL A, V186, P737, DOI 10.1007/s003590000127; Raghu SV, 2007, J COMP NEUROL, V502, P598, DOI 10.1002/cne.21319; REICHARDT W, 1979, BIOL CYBERN, V35, P81, DOI 10.1007/BF00337434; REICHARDT W, 1987, J COMPUT PHYSL A, V161, P674; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Weber F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015013; Wertz A, 2008, J NEUROSCI, V28, P3131, DOI 10.1523/JNEUROSCI.5460-07.2008; Wertz A, 2009, J NEUROSCI, V29, P14993, DOI 10.1523/JNEUROSCI.3786-09.2009; Wertz A, 2009, J COMP PHYSIOL A, V195, P1107, DOI 10.1007/s00359-009-0481-0	67	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16303	10.1371/journal.pone.0016303	http://dx.doi.org/10.1371/journal.pone.0016303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305019	Green Published, gold			2022-12-27	WOS:000286834300048
J	Pekar, S; Martisova, M; Bilde, T				Pekar, Stano; Martisova, Martina; Bilde, Trine			Intersexual Trophic Niche Partitioning in an Ant-Eating Spider (Araneae: Zodariidae)	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; NATURAL-POPULATIONS; ECOLOGICAL CAUSES; MORTALITY COSTS; SELECTION; FECUNDITY; EVOLUTION; DIET; CONSEQUENCES; MORPHOLOGY	Background: Divergence in trophic niche between the sexes may function to reduce competition between the sexes ("intersexual niche partitioning hypothesis"), or may be result from differential selection among the sexes on maximizing reproductive output ("sexual selection hypothesis"). The latter may lead to higher energy demands in females driven by fecundity selection, while males invest in mate searching. We tested predictions of the two hypotheses underlying intersexual trophic niche partitioning in a natural population of spiders. Zodarion jozefienae spiders specialize on Messor barbarus ants that are polymorphic in body size and hence comprise potential trophic niches for the spider, making this system well-suited to study intersexual trophic niche partitioning. \ Methodology/Principal Findings: Comparative analysis of trophic morphology (the chelicerae) and body size of males, females and juveniles demonstrated highly female biased SSD (Sexual Size Dimorphism) in body size, body weight, and in the size of chelicerae, the latter arising from sex-specific growth patterns in trophic morphology. In the field, female spiders actively selected ant sub-castes that were larger than the average prey size, and larger than ants captured by juveniles and males. Female fecundity was highly positively correlated with female body mass, which reflects foraging success during the adult stage. Females in laboratory experiments preferred the large ant sub-castes and displayed higher capture efficiency. In contrast, males occupied a different trophic niche and showed reduced foraging effort and reduced prey capture and feeding efficiency compared with females and juveniles. Conclusions/Significance: Our data indicate that female-biased dimorphism in trophic morphology and body size correlate with sex-specific reproductive strategies. We propose that intersexual trophic niche partitioning is shaped primarily by fecundity selection in females, and results from sex-differences in the route to successful reproduction where females are selected to maximize energy intake and fecundity, while males switch from foraging to invest in mating effort.	[Pekar, Stano; Martisova, Martina] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Bilde, Trine] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	Masaryk University Brno; Aarhus University	Pekar, S (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	pekar@sci.muni.cz	Pekar, Stano/F-4148-2010; Bilde, Trine/J-2872-2013; Bilde, Trine/AAS-2098-2020	Pekar, Stano/0000-0002-0197-5040; Bilde, Trine/0000-0002-0341-161X; Bilde, Trine/0000-0002-0341-161X	Ministry of Education, Youth and Sports of the Czech Republic [0021622416]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Grant no. 0021622416 (Ministry of Education, Youth and Sports of the Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; BOSMANS R, 1994, EOS, V69, P115; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; CASTILLA AM, 1991, J HERPETOL, V25, P30, DOI 10.2307/1564791; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Crawley M. J, 2002, STAT COMPUTING INTRO; Delph LF, 2005, AM NAT, V166, pS1, DOI 10.1086/462434; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Haeger JF, 1999, INSECT SOC, V46, P1; HEAD G, 1995, EVOLUTION, V49, P776, DOI 10.1111/j.1558-5646.1995.tb02313.x; Holldobler B., 1990, pi; Houston AI, 2007, BEHAV ECOL, V18, P241, DOI 10.1093/beheco/arl080; HOUSTON D, 1993, J ANIM ECOL, V62, P737, DOI 10.2307/5393; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Lindeman PV, 2003, CAN J ZOOL, V81, P1185, DOI 10.1139/Z03-101; Lindsay WR, 2009, ANIM BEHAV, V77, P1525, DOI 10.1016/j.anbehav.2009.02.027; Luiselli L, 1996, OECOLOGIA, V106, P100, DOI 10.1007/BF00334412; Martisova M, 2009, ANIM BEHAV, V78, P1115, DOI 10.1016/j.anbehav.2009.07.025; Pekar S, 2005, J ARACHNOL, V33, P50, DOI 10.1636/S03-2; Pekar S, 2004, J INSECT BEHAV, V17, P555, DOI 10.1023/B:JOIR.0000042541.23748.d7; Pinheiro J, 2001, MIXED EFFECTS MODELS; POLLARD SD, 1995, ANIM BEHAV, V49, P1443, DOI 10.1016/0003-3472(95)90065-9; POLLARD SD, 1994, J ZOOL, V234, P203, DOI 10.1111/j.1469-7998.1994.tb06068.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; R Development Core Team, 2007, R LANG ENV STAT COMP; Santos X, 2000, ECOGRAPHY, V23, P185, DOI 10.1111/j.1600-0587.2000.tb00274.x; Schneider JM, 1998, OIKOS, V83, P496, DOI 10.2307/3546677; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; Serrano-Meneses MA, 2006, OIKOS, V113, P385, DOI 10.1111/j.0030-1299.2006.14246.x; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Shine Richard, 1993, P49; SIMPSON MR, 1995, ECOLOGY, V76, P795, DOI 10.2307/1939345; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; SUTER RB, 1990, J ARACHNOL, V18, P263; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; Walker SE, 2002, CAN J ZOOL, V80, P679, DOI 10.1139/Z02-037; Walker SE, 2001, AM MIDL NAT, V146, P161, DOI 10.1674/0003-0031(2001)146[0161:SDIFRA]2.0.CO;2	41	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14603	10.1371/journal.pone.0014603	http://dx.doi.org/10.1371/journal.pone.0014603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298048	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900007
J	Rubinoff, D; Holland, BS; Jose, MS; Powell, JA				Rubinoff, Daniel; Holland, Brenden S.; Jose, Michael San; Powell, Jerry A.			Geographic Proximity Not a Prerequisite for Invasion: Hawaii Not the Source of California Invasion by Light Brown Apple Moth (Epiphyas postvittana)	PLOS ONE			English	Article							DNA POLYMORPHISM; POPULATION; EVOLUTION; SEQUENCES; SOFTWARE; PATTERNS; PRIMERS; BIOLOGY	Background: The light brown apple moth (LBAM), Epiphyas postvittana (Walker), is native to Australia but invaded England, New Zealand, and Hawaii more than 100 years ago. In temperate climates, LBAM can be a major agricultural pest. In 2006 LBAM was discovered in California, instigating eradication efforts and quarantine against Hawaiian agriculture, the assumption being that Hawaii was the source of the California infestation. Genetic relationships among populations in Hawaii, California, and New Zealand are crucial to understanding LBAM invasion dynamics across the Pacific. Methodology/Principal Findings: We sequenced mitochondrial DNA (mtDNA) from 1293 LBAM individuals from California (695), Hawaii (448), New Zealand (147), and Australia (3) to examine haplotype diversity and structure among introduced populations, and evaluate the null hypothesis that invasive populations are from a single panmictic source. However, invasive populations in California and New Zealand harbor deep genetic diversity, whereas Hawaii shows low level, shallow diversity. Conclusions/Significance: LBAM recently has established itself in California, but was in Hawaii and New Zealand for hundreds of generations, yet California and New Zealand show similar levels of genetic diversity relative to Hawaii. Thus, there is no clear relationship between duration of invasion and genetic structure. Demographic statistics suggest rapid expansion occurring in California and past expansions in New Zealand; multiple introductions of diverse, genetically fragmented lineages could contribute to these patterns. Hawaii and California share no haplotypes, therefore, Hawaii is not the source of the California introduction. Paradoxically, Hawaii and California share multiple haplotypes with New Zealand. New Zealand may be the source for the California and Hawaii infestations, but the introductions were independent, and Hawaii was invaded only once. This has significant implications for quarantine, and suggests that probability of invasion is not directly related to geographic distance. Surprisingly, Hawaiian LBAM populations have much lower genetic diversity than California, despite being older.	[Rubinoff, Daniel; Holland, Brenden S.] Univ Hawaii, Pacific Biosci Res Ctr, Ctr Conservat Res & Training, Honolulu, HI 96822 USA; [Powell, Jerry A.] Univ Calif Berkeley, Essig Museum Entomol, Berkeley, CA 94720 USA	University of Hawaii System; University of California System; University of California Berkeley	Rubinoff, D (corresponding author), Univ Hawaii, Pacific Biosci Res Ctr, Ctr Conservat Res & Training, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu	San Jose, Michael/N-8376-2019; Holland, Brenden/H-9872-2013; holland, brenden/J-5630-2019	San Jose, Michael/0000-0001-9877-2794; holland, brenden/0000-0002-7832-8589	United States Department of Agriculture-National Institute of Food and Agriculture [58-5320-9-430]; USDA Cooperative State Research, Education, and Extension Service [HAW00942-H, HAW00956-H]; United States Army Oahu Natural Resources Program	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Army Oahu Natural Resources Program	Research funding was provided by United States Department of Agriculture-National Institute of Food and Agriculture Agreement No. 58-5320-9-430 and USDA Cooperative State Research, Education, and Extension Service project HAW00942-H and HAW00956-H, both administered by the College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa. BSH was supported by a grant from the United States Army Oahu Natural Resources Program during preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley JD, 1956, B ENTOMOL RES, V47, P104; BRIGHT C, 1998, LIFE OUT BOUNDS; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Brown John W., 2010, American Entomologist, V56, P34; Carey JR, 1996, ECOLOGY, V77, P1690, DOI 10.2307/2265775; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DUMBLETON L. J., 1932, NEW ZEALAND JOUR SCI AND TECHNOL, V14, P83; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1993, GENETICS, V133, P693; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Howarth, 1982, CAMBR P 3 C EUR LEP, P74; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Nei M, 1987, MOL EVOLUTIONARY GEN, P254, DOI [10.7312/nei-92038, DOI 10.7312/NEI-92038]; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rubinoff D, 2010, PAC SCI, V64, P23, DOI 10.2984/64.1.023; Simberloff D, 2004, BIOL INVASIONS, V6, P161, DOI 10.1023/B:BINV.0000022133.49752.46; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1991, GENETICS, V129, P555; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TAJIMA F, 1989, GENETICS, V123, P585; Zimmerman EC., 1978, INSECTS HAWAII 1, V9	26	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16361	10.1371/journal.pone.0016361	http://dx.doi.org/10.1371/journal.pone.0016361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298019	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900040
J	Coler, RN; Bertholet, S; Moutaftsi, M; Guderian, JA; Windish, HP; Baldwin, SL; Laughlin, EM; Duthie, MS; Fox, CB; Carter, D; Friede, M; Vedvick, TS; Reed, SG				Coler, Rhea N.; Bertholet, Sylvie; Moutaftsi, Magdalini; Guderian, Jeff A.; Windish, Hillarie Plessner; Baldwin, Susan L.; Laughlin, Elsa M.; Duthie, Malcolm S.; Fox, Christopher B.; Carter, Darrick; Friede, Martin; Vedvick, Thomas S.; Reed, Steven G.			Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant	PLOS ONE			English	Article							INNATE IMMUNITY; LIPOPOLYSACCHARIDE RECOGNITION; BACTERIAL LIPOPOLYSACCHARIDES; MYCOBACTERIUM-TUBERCULOSIS; CUTANEOUS LEISHMANIASIS; TLR4-MD-2 COMPLEX; DENDRITIC CELLS; HUMAN MD-2; IMMUNOGENICITY; TLR4	Innate immune responses to vaccine adjuvants based on lipopolysaccharide (LPS), a component of Gram-negative bacterial cell walls, are driven by Toll-like receptor (TLR) 4 and adaptor proteins including MyD88 and TRIF, leading to the production of inflammatory cytokines, type I interferons, and chemokines. We report here on the characterization of a synthetic hexaacylated lipid A derivative, denoted as glucopyranosyl lipid adjuvant (GLA). We assessed the effects of GLA on murine and human dendritic cells (DC) by combining microarray, mRNA and protein multiplex assays and flow cytometry analyses. We demonstrate that GLA has multifunctional immunomodulatory activity similar to naturally-derived monophosphory lipid A (MPL) on murine DC, including the production of inflammatory cytokines, chemokines, DC maturation and antigen-presenting functions. In contrast, hexaacylated GLA was overall more potent on a molar basis than heterogeneous MPL when tested on human DC and peripheral blood mononuclear cells (PBMC). When administered in vivo, GLA enhanced the immunogenicity of co-administered recombinant antigens, producing strong cell-mediated immunity and a qualitative T(H)1 response. We conclude that the GLA adjuvant stimulates and directs innate and adaptive immune responses by inducing DC maturation and the concomitant release of pro-inflammatory cytokines and chemokines associated with immune cell trafficking, activities which have important implications for the development of future vaccine adjuvants.	[Coler, Rhea N.; Bertholet, Sylvie; Moutaftsi, Magdalini; Guderian, Jeff A.; Windish, Hillarie Plessner; Baldwin, Susan L.; Laughlin, Elsa M.; Duthie, Malcolm S.; Fox, Christopher B.; Carter, Darrick; Vedvick, Thomas S.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Friede, Martin] World Hlth Org, Initiat Vaccine Res, Geneva, Switzerland; [Reed, Steven G.] Immune Design Corp, Seattle, WA USA	World Health Organization	Coler, RN (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	sreed@idri.org	Rivet, Catherine A/M-7978-2014; Carter, Darrick/N-3304-2016	Carter, Darrick/0000-0001-5901-3402; Duthie, Malcolm/0000-0002-8515-5516; Fox, Christopher/0000-0002-4644-2619	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI-044373, AI-067251, AI-25479, HHSN272200800045C, U01-AI078054]; Bill and Melinda Gates Foundation [42387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078054, R01AI044373, UC1AI067251] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grants AI-044373 and AI-067251 to S.G.R., and contracts AI-25479 and #HHSN272200800045C, and grant U01-AI078054 to R.N.C. and by grant 42387 from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by funds and personnel from Immune Design Corporation. Immune Design Corporation had a role in the study design and collection, and review of the manuscript.	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2009, VACCINE, V27, P7036, DOI 10.1016/j.vaccine.2009.09.066; Brandenburg K, 2004, CURR TOP MED CHEM, V4, P1127, DOI 10.2174/1568026043388213; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; Edelman R, 2002, MOL BIOTECHNOL, V21, P129, DOI 10.1385/MB:21:2:129; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Fox CB, 2008, COLLOID SURFACE B, V65, P98, DOI 10.1016/j.colsurfb.2008.03.003; Fox CB, 2010, SUBCELL BIOCHEM, V53, P303, DOI 10.1007/978-90-481-9078-2_14; GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Nascimento E, 2010, VACCINE, V28, P6581, DOI 10.1016/j.vaccine.2010.07.063; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Qureshi N, 1997, J BIOL CHEM, V272, P10594; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Raman VS, 2009, INFECT IMMUN, V77, P5623, DOI 10.1128/IAI.00508-09; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; Wack A, 2005, CURR OPIN IMMUNOL, V17, P411, DOI 10.1016/j.coi.2005.05.005; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	43	231	281	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16333	10.1371/journal.pone.0016333	http://dx.doi.org/10.1371/journal.pone.0016333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298114	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800027
J	Purwar, R; Campbell, J; Murphy, G; Richards, WG; Clark, RA; Kupper, TS				Purwar, Rahul; Campbell, James; Murphy, George; Richards, William G.; Clark, Rachael A.; Kupper, Thomas S.			Resident Memory T Cells (T-RM) Are Abundant in Human Lung: Diversity, Function, and Antigen Specificity	PLOS ONE			English	Article							HUMAN SKIN; CHEMOKINE RECEPTORS; PERIPHERAL-TISSUES; IMMUNE; EXPRESSION; MIGRATION; RESPONSES; RECALL	Recent studies have shown that tissue resident memory T cells (T-RM) are critical to antiviral host defense in peripheral tissues. This new appreciation of T-RM that reside in epithelial tissues and mediate host defense has been studied most extensively in skin: adult human skin contains large numbers of functional T-RM that express skin specific markers. Indeed, more than twice as many T cells reside in skin as in peripheral blood. This T cell population has a diverse T cell receptor repertoire, and can produce a broad array of cytokines. More recently, we have begun to examine other epithelial tissues for the presence of resident T cells. In the present study, we asked whether analogous populations of resident T cells could be found in human lung. We were able to demonstrate abundant resident T cells in human lung-more than 10 billion T cells were present. Lung T cells were largely of the effector memory T cell (T-EM) phenotype, though small numbers of central memory T cells (T-CM) and T regulatory cells (T-reg) could be identified. Lung T cells had a diverse T cell receptor repertoire and subsets produced IL-17, IL-4, IFN gamma, as well as TNF alpha. A significant number of lung T-RM CD4+ Th cells produced more than one cytokine, identifying them as "multifunctional'' Th1 type cells. Finally, lung T-RM, but not T-RM resident to skin or T cells from blood, proliferated in response to influenza virus. This work suggests that normal human lung contains large numbers of T-RM cells, and these cells are poised to respond to recall antigens previously encountered through lung mucosa. This population of T cells may contribute to the pathogenesis of asthma and other T cell mediated lung diseases.	[Purwar, Rahul; Campbell, James; Clark, Rachael A.; Kupper, Thomas S.] Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Murphy, George] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Richards, William G.] Brigham & Womens Hosp, Tissue Bank, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Purwar, R (corresponding author), Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, 75 Francis St, Boston, MA 02115 USA.	tkupper@partners.org	Kupper, Thomas/O-4962-2019		National Institutes of Health (NIH) [RO1 AI-41707-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056720, R01AR065807] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institutes of Health (NIH, www.nih.gov) and the grant number is RO1 AI-41707-10 to Thomas S. Kupper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Clark JG, 2004, AM J RESP CELL MOL, V30, P220, DOI 10.1165/rcmb.2003-0208OC; Clark RA, 2005, J CLIN INVEST, V115, P3239, DOI 10.1172/JCI24731; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HOLT PG, 1988, IMMUNOLOGY, V64, P649; HOLT PG, 1986, CLIN EXP IMMUNOL, V66, P188; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Liu L., NAT MED, V16, P224; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; PICKER LJ, 1994, EUR J IMMUNOL, V24, P1269, DOI 10.1002/eji.1830240605; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Sauer KA, 2006, NAT PROTOC, V1, P2870, DOI 10.1038/nprot.2006.435; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496	24	226	230	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16245	10.1371/journal.pone.0016245	http://dx.doi.org/10.1371/journal.pone.0016245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298112	Green Submitted, Green Published, gold			2022-12-27	WOS:000286662800019
J	Schmucker, S; Martelli, A; Colin, F; Page, A; Wattenhofer-Donze, M; Reutenauer, L; Puccio, H				Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene			Mammalian Frataxin: An Essential Function for Cellular Viability through an Interaction with a Preformed ISCU/NFS1/ISD11 Iron-Sulfur Assembly Complex	PLOS ONE			English	Article							YEAST FRATAXIN; FRIEDREICHS-ATAXIA; CLUSTER BIOSYNTHESIS; 2FE-2S CLUSTERS; BINDING; BIOGENESIS; SCAFFOLD; PROTEIN; ISD11; CYAY	Background: Frataxin, the mitochondrial protein deficient in Friedreich ataxia, a rare autosomal recessive neurodegenerative disorder, is thought to be involved in multiple iron-dependent mitochondrial pathways. In particular, frataxin plays an important role in the formation of iron-sulfur (Fe-S) clusters biogenesis. Methodology/Principal Findings: We present data providing new insights into the interactions of mammalian frataxin with the Fe-S assembly complex by combining in vitro and in vivo approaches. Through immunoprecipitation experiments, we show that the main endogenous interactors of a recombinant mature human frataxin are ISCU, NFS1 and ISD11, the components of the core Fe-S assembly complex. Furthemore, using a heterologous expression system, we demonstrate that mammalian frataxin interacts with the preformed core complex, rather than with the individual components. The quaternary complex can be isolated in a stable form and has a molecular mass of approximate to 190 kDa. Finally, we demonstrate that the mature human FXN81-210 form of frataxin is the essential functional form in vivo. Conclusions/Significance: Our results suggest that the interaction of frataxin with the core ISCU/NFS1/ISD11 complex most likely defines the essential function of frataxin. Our results provide new elements important for further understanding the early steps of de novo Fe-S cluster biosynthesis.	[Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] IGBMC, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] INSERM, U596, Illkirch Graffenstaden, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] CNRS, UMR7104, Illkirch Graffenstaden, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] Univ Strasbourg, Strasbourg, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France	Schmucker, S (corresponding author), IGBMC, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France.	hpuccio@igbmc.fr	Puccio, Hélène/G-1717-2013	Puccio, Hélène/0000-0003-4711-2248; Martelli, Alain/0000-0001-5246-565X; COLIN, Florent/0000-0002-0527-2879	French National Agency for Research [ANR-05-MRAR-013-01]; EC under the European Research Council (ERC) [206634/ISCATAXIA, 242193/EFACTS]; French Ministry for Research; American Friedreich Ataxia Research Alliance; Association Francaise pour l'Ataxie de Friedreich	French National Agency for Research(French National Research Agency (ANR)); EC under the European Research Council (ERC)(European Research Council (ERC)); French Ministry for Research(Ministry of Research, France); American Friedreich Ataxia Research Alliance; Association Francaise pour l'Ataxie de Friedreich	This work was supported by the French National Agency for Research (ANR-05-MRAR-013-01) and the EC under the European Research Council (ERC) grant 206634/ISCATAXIA and under the FP7 grant 242193/EFACTS to H.P. S.S. was supported by the French Ministry for Research (MRT award), A. M. by the American Friedreich Ataxia Research Alliance, and M.W.D. by the Association Francaise pour l'Ataxie de Friedreich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; Pandolfo M, 2009, J NEUROL, V256, P1, DOI 10.1007/s00415-009-1001-4; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2009, FEBS J, V276, P6669, DOI 10.1111/j.1742-4658.2009.07381.x; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	39	182	187	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16199	10.1371/journal.pone.0016199	http://dx.doi.org/10.1371/journal.pone.0016199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298097	Green Submitted, gold, Green Published			2022-12-27	WOS:000286662800018
J	Shorning, BY; Griffiths, D; Clarke, AR				Shorning, Boris Y.; Griffiths, David; Clarke, Alan R.			Lkb1 and Pten Synergise to Suppress mTOR-Mediated Tumorigenesis and Epithelial-Mesenchymal Transition in the Mouse Bladder	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; TUMOR-SUPPRESSOR; GLUCOSE-TRANSPORTER; GENE-EXPRESSION; CELL CARCINOMA; TGF-BETA; CANCER; HYPOXIA; INVASIVENESS; PATHWAY	The AKT/PI3K/mTOR pathway is frequently altered in a range of human tumours, including bladder cancer. Here we report the phenotype of mice characterised by deletion of two key players in mTOR regulation, Pten and Lkb1, in a range of tissues including the mouse urothelium. Despite widespread recombination within the range of epithelial tissues, the primary phenotype we observe is the rapid onset of bladder tumorigenesis, with median onset of approximately 100 days. Single deletion of either Pten or Lkb1 had no effect on bladder cell proliferation or tumour formation. However, simultaneous deletion of Lkb1 and Pten led to an upregulation of the mTOR pathway and the hypoxia marker GLUT1, increased bladder epithelial cell proliferation and ultimately tumorigenesis. Bladder tissue also exhibited characteristic features of epithelial-mesenchymal transition, with loss of the epithelial markers E-cadherin and the tight junction protein ZO-1, and increases in the mesenchymal marker vimentin as well as nuclear localization of epithelial-mesenchymal transition (EMT) regulator Snail. We show that these effects were all dependent upon mTOR activity, as rapamycin treatment blocked both EMT and tumorigenesis. Our data therefore establish clear synergy between Lkb1 and Pten in controlling the mTOR pathway within bladder epithelium, and show that loss of this control leads to the disturbance of epithelial structure, EMT and ultimately tumorigenesis.	[Shorning, Boris Y.; Clarke, Alan R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Griffiths, David] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Shorning, BY (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	shorningb@cf.ac.uk	clarke, alan r/P-2820-2014; Clarke, Alan R/A-6256-2008	Clarke, Alan/0000-0002-4281-426X	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2008, EMBO REP, V9, P322, DOI 10.1038/embor.2008.30; Alessi DR, 2001, BIOCHEM SOC T, V29, P1, DOI 10.1042/bst029a059; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; BEHRENS J, 1994, INVAS METAST, V14, P61; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Bruyere F, 2010, UROL ONCOL-SEMIN ORI, V28, P591, DOI 10.1016/j.urolonc.2008.11.005; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cappellen D, 1997, ONCOGENE, V14, P3059, DOI 10.1038/sj.onc.1201154; Chang SG, 2000, UROLOGY, V55, P448, DOI 10.1016/S0090-4295(99)00474-4; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; CLAVEL J, 1989, INT J CANCER, V44, P605, DOI 10.1002/ijc.2910440408; Eble JN, 2004, PATHOLOGY GENETICS T; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Grille SJ, 2003, CANCER RES, V63, P2172; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; HABUCHI T, 1995, ONCOGENE, V11, P1671; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JENSEN OM, 1990, EUR J CANCER, V26, P1167; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; MELAMED MR, 1964, CANCER, V17, P1533, DOI 10.1002/1097-0142(196412)17:12<1533::AID-CNCR2820171205>3.0.CO;2-7; Miyoshi H, 2002, CANCER RES, V62, P2261; Peinado H, 2008, NAT CELL BIOL, V10, P253, DOI 10.1038/ncb0308-253; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; SILVERBERG E, 1989, CA-CANCER J CLIN, V39, P3; SILVERMAN DT, 1989, J NATL CANCER I, V81, P1480, DOI 10.1093/jnci/81.19.1480; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Syrigos KN, 1995, INT J CANCER, V64, P367, DOI 10.1002/ijc.2910640603; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tsuruta H, 2006, CANCER RES, V66, P8389, DOI 10.1158/0008-5472.CAN-05-4627; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WALKER BE, 1960, AM J ANAT, V107, P95, DOI 10.1002/aja.1001070202; Yan W, 2009, BIOCHEM BIOPH RES CO, V382, P631, DOI 10.1016/j.bbrc.2009.03.088; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zundel W, 2000, GENE DEV, V14, P391	63	55	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16209	10.1371/journal.pone.0016209	http://dx.doi.org/10.1371/journal.pone.0016209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283818	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000286520600033
J	Takano, K; Okamoto, T; Okada, J; Tanaka, S; Angkawidjaja, C; Koga, Y; Kanaya, S				Takano, Kazufumi; Okamoto, Tomohiro; Okada, Jun; Tanaka, Shun-ichi; Angkawidjaja, Clement; Koga, Yuichi; Kanaya, Shigenori			Stabilization by Fusion to the C-terminus of Hyperthermophile Sulfolobus tokodaii RNase HI: A Possibility of Protein Stabilization Tag	PLOS ONE			English	Article							COLI RIBONUCLEASE HI; STABILITY; SUPPRESSOR; EVOLUTION	RNase HI from the hyperthermophile Sulfolobus tokodaii (Sto-RNase HI) is stabilized by its C-terminal residues. In this work, the stabilization effect of the Sto-RNase HI C-terminal residues was investigated in detail by thermodynamic measurements of the stability of variants lacking the disulfide bond (C58/145A), or the six C-terminal residues (Delta C6) and by structural analysis of Delta C6. The results showed that the C-terminal does not affect overall structure and stabilization is caused by local interactions of the C-terminal, suggesting that the C-terminal residues could be used as a "stabilization tag." The Sto-RNase HI C-terminal residues (-IGCIILT) were introduced as a tag on three proteins. Each chimeric protein was more stable than its wild-type protein. These results suggested the possibility of a simple stabilization technique using a stabilization tag such as Sto-RNase HI C-terminal residues.	[Takano, Kazufumi; Okamoto, Tomohiro; Okada, Jun; Tanaka, Shun-ichi; Angkawidjaja, Clement; Koga, Yuichi; Kanaya, Shigenori] Osaka Univ, Dept Mat & Life Sci, Osaka, Japan; [Takano, Kazufumi] Japan Sci & Technol Agcy, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takano, K (corresponding author), Osaka Univ, Dept Mat & Life Sci, Osaka, Japan.	ktakano@mls.eng.osaka-u.ac.jp		Angkawidjaja, Clement/0000-0002-5019-2536; Takano, Kazufumi/0000-0002-7548-7314	Ministry of Education, Culture, Sports, Science, and Technology of Japan; New Energy and Industrial Technology Development Organization (NEDO) of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by an Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUNGER AT, 1998, ACTA CRYSTALLOGR A, V47, P110; Dong HJ, 2008, J MOL BIOL, V378, P264, DOI 10.1016/j.jmb.2008.02.039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu Y, 2010, BIOCHEMISTRY-US, V49, P6420, DOI 10.1021/bi100489x; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Hailey DW, 2002, METHOD ENZYMOL, V351, P34; HARUKI M, 1994, J BIOL CHEM, V269, P26904; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; KANAYA S, 1991, J BIOL CHEM, V266, P6038; Kato A, 2007, BIOPOLYMERS, V85, P12, DOI 10.1002/bip.20596; KIMURA S, 1992, J BIOL CHEM, V267, P21535; Kondo N, 2009, ANAL BIOCHEM, V385, P278, DOI 10.1016/j.ab.2008.10.050; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matsuura T, 1999, NAT BIOTECHNOL, V17, P58, DOI 10.1038/5232; Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612; Mukaiyama A, 2004, BIOCHEMISTRY-US, V43, P13859, DOI 10.1021/bi0487645; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-207; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Schulenburg C, 2010, CHEMBIOCHEM, V11, P978, DOI 10.1002/cbic.200900773; Soling A, 2002, FEBS LETT, V527, P153, DOI 10.1016/S0014-5793(02)03201-5; Tadokoro T, 2008, BIOCHEMISTRY-US, V47, P8040, DOI 10.1021/bi800246e; Tadokoro T, 2007, BIOCHEMISTRY-US, V46, P7460, DOI 10.1021/bi7001423; Takano K, 2006, FEBS J, V273, P150, DOI 10.1111/j.1742-4658.2005.05051.x; Takano K, 2007, PROTEINS, V68, P617, DOI 10.1002/prot.21451; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang M, 2010, BIOCHEMISTRY-US, V49, P4318, DOI 10.1021/bi100118k; Watanabe K, 2006, J MOL BIOL, V355, P664, DOI 10.1016/j.jmb.2005.10.011; You DJ, 2007, BIOCHEMISTRY-US, V46, P11494, DOI 10.1021/bi700830f; You DJ, 2006, ACTA CRYSTALLOGR F, V62, P781, DOI 10.1107/S1744309106024420	33	12	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16226	10.1371/journal.pone.0016226	http://dx.doi.org/10.1371/journal.pone.0016226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283826	gold, Green Published, Green Submitted			2022-12-27	WOS:000286520600034
J	Ross, DE; Flynn, JM; Baron, DB; Gralnick, JA; Bond, DR				Ross, Daniel E.; Flynn, Jeffrey M.; Baron, Daniel B.; Gralnick, Jeffrey A.; Bond, Daniel R.			Towards Electrosynthesis in Shewanella: Energetics of Reversing the Mtr Pathway for Reductive Metabolism	PLOS ONE			English	Article							EXTRACELLULAR ELECTRON-TRANSFER; ONEIDENSIS STRAIN MR-1; PUTREFACIENS MR-1; OUTER-MEMBRANE; FUMARATE REDUCTASE; FLAVOCYTOCHROME-C; ELECTROCHEMICAL CHARACTERIZATION; ANAEROBIC RESPIRATION; ESCHERICHIA-COLI; CYTOCHROME CYMA	Bioelectrochemical systems rely on microorganisms to link complex oxidation/reduction reactions to electrodes. For example, in Shewanella oneidensis strain MR-1, an electron transfer conduit consisting of cytochromes and structural proteins, known as the Mtr respiratory pathway, catalyzes electron flow fromcytoplasmic oxidative reactions to electrodes. Reversing this electron flow to drive microbial reductive metabolism offers a possible route for electrosynthesis of high value fuels and chemicals. We examined electron flow from electrodes into Shewanella to determine the feasibility of this process, the molecular components of reductive electron flow, and what driving forces were required. Addition of fumarate to a film of S. oneidensis adhering to a graphite electrode poised at -0.36 V versus standard hydrogen electrode (SHE) immediately led to electron uptake, while a mutant lacking the periplasmic fumarate reductase FccA was unable to utilize electrodes for fumarate reduction. Deletion of the gene encoding the outer membrane cytochrome-anchoring protein MtrB eliminated 88% of fumarate reduction. A mutant lacking the periplasmic cytochrome MtrA demonstrated more severe defects. Surprisingly, disruption of menC, which prevents menaquinone biosynthesis, eliminated 85% of electron flux. Deletion of the gene encoding the quinone-linked cytochrome CymA had a similar negative effect, which showed that electrons primarily flowed from outer membrane cytochromes into the quinone pool, and back to periplasmic FccA. Soluble redox mediators only partially restored electron transfer in mutants, suggesting that soluble shuttles could not replace periplasmic protein-protein interactions. This work demonstrates that the Mtr pathway can power reductive reactions, shows this conduit is functionally reversible, and provides new evidence for distinct CymA: MtrA and CymA: FccA respiratory units.	[Ross, Daniel E.; Flynn, Jeffrey M.; Baron, Daniel B.; Gralnick, Jeffrey A.; Bond, Daniel R.] Univ Minnesota Twin Cities, BioTechnol Inst, St Paul, MN 55108 USA; [Gralnick, Jeffrey A.; Bond, Daniel R.] Univ Minnesota Twin Cities, Dept Microbiol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ross, DE (corresponding author), Univ Minnesota Twin Cities, BioTechnol Inst, St Paul, MN 55108 USA.	dbond@umn.edu	Ross, Daniel/ABA-1747-2020	Ross, Daniel/0000-0002-8272-1877; Gralnick, Jeffrey/0000-0001-9250-7770; Bond, Daniel/0000-0001-8083-7107	College of Biological Sciences; BioTechnology Institute; Initiative for Renewable Energy and the Environment (Institute on the Environment) at the University of Minnesota [DG-0015-08]; National Science Foundation [CBET-0756296]	College of Biological Sciences; BioTechnology Institute(Ankara University); Initiative for Renewable Energy and the Environment (Institute on the Environment) at the University of Minnesota(University of Minnesota System); National Science Foundation(National Science Foundation (NSF))	This work was supported by the College of Biological Sciences, the BioTechnology Institute and by a Discovery Grant DG-0015-08 awarded to D.R.B and J.A.G. from the Initiative for Renewable Energy and the Environment (Institute on the Environment) at the University of Minnesota, and the National Science Foundation (grant CBET-0756296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron D, 2009, J BIOL CHEM, V284, P28865, DOI 10.1074/jbc.M109.043455; Beliaev AS, 2001, MOL MICROBIOL, V39, P722, DOI 10.1046/j.1365-2958.2001.02257.x; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Butt JN, 2000, BIOPHYS J, V78, P1001, DOI 10.1016/S0006-3495(00)76658-6; Coursolle D, 2010, MOL MICROBIOL, V77, P995, DOI 10.1111/j.1365-2958.2010.07266.x; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Firer-Sherwood M, 2008, J BIOL INORG CHEM, V13, P849, DOI 10.1007/s00775-008-0398-z; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gregory KB, 2005, ENVIRON SCI TECHNOL, V39, P8943, DOI 10.1021/es050457e; Gregory KB, 2004, ENVIRON MICROBIOL, V6, P596, DOI 10.1111/j.1462-2920.2004.00593.x; GUEST JR, 1977, J BACTERIOL, V130, P1038, DOI 10.1128/JB.130.3.1038-1046.1977; Hartshorne RS, 2007, J BIOL INORG CHEM, V12, P1083, DOI 10.1007/s00775-007-0278-y; Hartshorne RS, 2009, P NATL ACAD SCI USA, V106, P22169, DOI 10.1073/pnas.0900086106; Hau HH, 2008, APPL ENVIRON MICROB, V74, P6880, DOI 10.1128/AEM.00840-08; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meitl LA, 2009, GEOCHIM COSMOCHIM AC, V73, P5292, DOI 10.1016/j.gca.2009.06.021; MORRIS CJ, 1994, BIOCHEM J, V302, P587, DOI 10.1042/bj3020587; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Myers CR, 2002, APPL ENVIRON MICROB, V68, P5585, DOI 10.1128/AEM.68.11.5585-5594.2002; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; Nevin KP, 2010, MICROBIAL ELECTROSYN; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; PEALING SL, 1995, BIOCHEMISTRY-US, V34, P6153, DOI 10.1021/bi00018a018; PEALING SL, 1993, BIOCHEMISTRY-US, V32, P3829, DOI 10.1021/bi00065a041; Pessanha M, 2009, BBA-BIOENERGETICS, V1787, P113, DOI 10.1016/j.bbabio.2008.11.007; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Reardon CL, 2010, GEOBIOLOGY, V8, P56, DOI 10.1111/j.1472-4669.2009.00226.x; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Ross DE, 2009, APPL ENVIRON MICROB, V75, P5218, DOI 10.1128/AEM.00544-09; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Schuetz B, 2009, APPL ENVIRON MICROB, V75, P7789, DOI 10.1128/AEM.01834-09; Schwalb C, 2002, BIOCHEM SOC T, V30, P658, DOI 10.1042/bst0300658; SHARMA V, 1993, J BACTERIOL, V175, P4917, DOI 10.1128/JB.175.15.4917-4921.1993; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Srikanth S, 2008, BIOTECHNOL BIOENG, V99, P1065, DOI 10.1002/bit.21671; Strycharz SM, 2008, APPL ENVIRON MICROB, V74, P5943, DOI 10.1128/AEM.00961-08; Strycharz SM, 2010, BIOELECTROCHEMISTRY, DOI [10.1016/j.bioele chem.2010.07.005, DOI 10.1016/J.BIOELECHEM]; Turner KL, 1999, BIOCHEMISTRY-US, V38, P3302, DOI 10.1021/bi9826308; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Xiong YJ, 2006, J AM CHEM SOC, V128, P13978, DOI 10.1021/ja063526d	47	224	232	22	194	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16649	10.1371/journal.pone.0016649	http://dx.doi.org/10.1371/journal.pone.0016649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311751	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200027
J	Sutton-Grier, AE; Wright, JP; McGill, BM; Richardson, C				Sutton-Grier, Ariana E.; Wright, Justin P.; McGill, Bonnie M.; Richardson, Curtis			Environmental Conditions Influence the Plant Functional Diversity Effect on Potential Denitrification	PLOS ONE			English	Article							SPECIES RICHNESS; ELEVATED CO2; BIODIVERSITY; SOIL; CARBON; PRODUCTIVITY; COMMUNITIES; NITRIFICATION; AVAILABILITY; BACTERIAL	Global biodiversity loss has prompted research on the relationship between species diversity and ecosystem functioning. Few studies have examined how plant diversity impacts belowground processes; even fewer have examined how varying resource levels can influence the effect of plant diversity on microbial activity. In a field experiment in a restored wetland, we examined the role of plant trait diversity (or functional diversity, (FD)) and its interactions with natural levels of variability of soil properties, on a microbial process, denitrification potential (DNP). We demonstrated that FD significantly affected microbial DNP through its interactions with soil conditions; increasing FD led to increased DNP but mainly at higher levels of soil resources. Our results suggest that the effect of species diversity on ecosystem functioning may depend on environmental factors such as resource availability. Future biodiversity experiments should examine how natural levels of environmental variability impact the importance of biodiversity to ecosystem functioning.	[Sutton-Grier, Ariana E.; Richardson, Curtis] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27710 USA; [Wright, Justin P.; McGill, Bonnie M.] Duke Univ, Dept Biol, Durham, NC USA	Duke University; Duke University	Sutton-Grier, AE (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27710 USA.	ariana.suttongrier@gmail.com	Richardson, Curt/P-5905-2019; Wright, Justin/AAG-6461-2019; Richardson, Curtis J/A-8202-2009; McGill, Bonnie/AAT-7426-2020	Wright, Justin/0000-0002-9102-5347; McGill, Bonnie/0000-0002-5417-3519; Sutton-Grier, Ariana/0000-0002-1242-7728	National Science Foundation (NSF) [DEB0508763]; Association of University Women Educational Foundation; Society of Wetland Scientist Student Research Grant; Duke Wetlands Center Case Study Endowment; USDA Natural Resources Conservation Service; Smithsonian Environmental Research Center	National Science Foundation (NSF)(National Science Foundation (NSF)); Association of University Women Educational Foundation; Society of Wetland Scientist Student Research Grant; Duke Wetlands Center Case Study Endowment; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA)); Smithsonian Environmental Research Center(Smithsonian InstitutionSmithsonian Environmental Research Center)	This work was supported by National Science Foundation (NSF) Grant DEB0508763, an NSF Graduate Research Fellowship (http://www.nsfgrfp.org); an American Fellowship from the Association of University Women Educational Foundation (http://www.aauw.org/education/fga); a Society of Wetland Scientist Student Research Grant (http://www.sws.org/studentgrants); the Duke Wetlands Center Case Study Endowment (http://www.nicholas.duke.edu/wetland); and a grant from the USDA Natural Resources Conservation Service (http://www.nrcs.usda.gov). AS-G was also partially supported by a Smithsonian Fellowship from the Smithsonian Environmental Research Center (http://www.serc.si.edu/pro_training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; Bell T., 2009, BIODIVERSITY ECOSYST, P121, DOI DOI 10.1093/ACPROF:OSO/9780199547951.003.0009; Bouchard V, 2007, ECOLOGY, V88, P2903, DOI 10.1890/06-1144.1; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chabrerie O, 2001, ESTUARIES, V24, P1088, DOI 10.2307/1353020; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Clement JC, 2002, J ENVIRON QUAL, V31, P1025, DOI 10.2134/jeq2002.1025; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ettema CH, 1999, SOIL BIOL BIOCHEM, V31, P1609, DOI 10.1016/S0038-0717(99)00071-1; Eviner VT, 2003, ANNU REV ECOL EVOL S, V34, P455, DOI 10.1146/annurev.ecolsys.34.011802.132342; Farrar J, 2003, ECOLOGY, V84, P827, DOI 10.1890/0012-9658(2003)084[0827:HRCTFO]2.0.CO;2; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Groffman P., 1994, CURRENT TOPICS WETLA, V1, P15, DOI DOI 10.1016/J.GEOMORPH.2006.01.010; GROFFMAN PM, 1987, PLANT SOIL, V97, P445, DOI 10.1007/BF02383235; Groffman PM, 1999, LT EC RES NETWK SER, V2, P272; Groffman PM, 2003, J ENVIRON QUAL, V32, P1144, DOI 10.2134/jeq2003.1144; Hall K., 2003, RECOMMENDED NATIVE P; He JS, 2002, OIKOS, V97, P337, DOI 10.1034/j.1600-0706.2002.970304.x; Hernandez ME, 2007, J ENVIRON QUAL, V36, P333, DOI 10.2134/jeq2006.0139; Hill AR, 2004, SOIL SCI SOC AM J, V68, P320, DOI 10.2136/sssaj2004.0320; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hume NP, 2002, SOIL SCI SOC AM J, V66, P1706, DOI 10.2136/sssaj2002.1706; JENSEN CR, 1969, AGRON J, V61, P474, DOI 10.2134/agronj1969.00021962006100030045x; KIRBY RM, 1971, SOIL CONSERVATION DU; Lanta V, 2006, ACTA OECOL, V29, P85, DOI 10.1016/j.actao.2005.08.003; Lin YF, 2002, ENVIRON POLLUT, V119, P413, DOI 10.1016/S0269-7491(01)00299-8; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lowrance R, 2001, J ENVIRON QUAL, V30, P617, DOI 10.2134/jeq2001.302617x; Maynard DG, 1993, SOIL SAMPLING METHOD, P25; McGill BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011618; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pinay G, 2007, SOIL BIOL BIOCHEM, V39, P33, DOI 10.1016/j.soilbio.2006.05.018; R Core Team, 2018, R LANG ENV STAT COMP; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V411, P824, DOI 10.1038/35081122; SCHIPPER LA, 1994, J ENVIRON QUAL, V23, P923, DOI 10.2134/jeq1994.00472425002300050012x; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Sutton-Grier AE, 2011, SOIL BIOL BIOCHEM, V43, P413, DOI 10.1016/j.soilbio.2010.11.009; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Voroney R.P., 1993, SOIL SAMPLING METHOD, P277; Wacker L, 2009, ECOLOGY, V90, P637, DOI 10.1890/07-1946.1; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	58	18	20	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16584	10.1371/journal.pone.0016584	http://dx.doi.org/10.1371/journal.pone.0016584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311768	Green Submitted, Green Published, gold			2022-12-27	WOS:000287036200021
J	Wu, ZH; Min, L; Chen, DF; Hao, DS; Duan, YH; Qiu, GX; Wang, YP				Wu, Zhihong; Min, Li; Chen, Dafu; Hao, Dongsheng; Duan, Yuanhui; Qiu, Guixing; Wang, Yipeng			Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; GROUP GENE BMI-1; SELF-RENEWAL; LUNG-CANCER; STEM-CELLS; EXPRESSION; CHEMOTHERAPY; CARCINOMA; SURVIVAL; TUMORIGENICITY	Background: BMI-1 is a member of the polycomb group of genes (PcGs), and it has been implicated in the development and progression of several malignancies, but its role in osteosarcoma remains to be elucidated. Methodology/Principal Findings: In the present study, we found that BMI-1 was overexpressed in different types of osteosarcomas. Downregulation of BMI-1 by lentivirus mediated RNA interference (RNAi) significantly impaired cell viability and colony formation in vitro and tumorigenesis in vivo of osteosarcoma cells. BMI-1 knockdown sensitized cells to cisplatin-induced apoptosis through inhibition of PI3K/AKT pathway. Moreover, BMI-1-depletion-induced phenotype could be rescued by forced expression of BMI-1 wobble mutant which is resistant to inhibition by the small interfering RNA (siRNA). Conclusions/Significance: These findings suggest a crucial role for BMI-1 in osteosarcoma pathogenesis.	[Wu, Zhihong; Min, Li; Hao, Dongsheng; Duan, Yuanhui; Qiu, Guixing; Wang, Yipeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed, Beijing 100037, Peoples R China; [Wu, Zhihong; Min, Li; Hao, Dongsheng; Duan, Yuanhui; Qiu, Guixing; Wang, Yipeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Dafu] Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, ZH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed, Beijing 100037, Peoples R China.	wongyp@yeah.net	wu, zhi/GXH-3041-2022	Wang, Yipeng/0000-0001-9769-9839; Qiu, Guixing/0000-0002-4597-9350				Bachmann IM, 2008, MODERN PATHOL, V21, P583, DOI 10.1038/modpathol.2008.17; Brognard J, 2001, CANCER RES, V61, P3986; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Dimri GP, 2002, CANCER RES, V62, P4736; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Dukers DF, 2004, AM J PATHOL, V164, P873, DOI 10.1016/S0002-9440(10)63175-6; Engelsen IB, 2008, BRIT J CANCER, V98, P1662, DOI 10.1038/sj.bjc.6604360; Ferrari S, 2005, J CLIN ONCOL, V23, P8845, DOI 10.1200/JCO.2004.00.5785; Ferrari S, 2003, J CLIN ONCOL, V21, P710, DOI 10.1200/JCO.2003.03.141; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Meltzer Paul S, 2007, Cell Stem Cell, V1, P13, DOI 10.1016/j.stem.2007.05.011; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Qin L, 2008, BIOCHEM BIOPH RES CO, V371, P531, DOI 10.1016/j.bbrc.2008.04.117; Raaphorst FM, 2003, TRENDS IMMUNOL, V24, P522, DOI 10.1016/S1471-4906(03)00241-2; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791	24	57	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e14648	10.1371/journal.pone.0014648	http://dx.doi.org/10.1371/journal.pone.0014648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311599	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036200004
J	Jia, KZ; Zhu, Y; Zhang, YP; Li, Y				Jia, Kaizhi; Zhu, Yan; Zhang, Yanping; Li, Yin			Group II Intron-Anchored Gene Deletion in Clostridium	PLOS ONE			English	Article							ACETOBUTYLICUM ATCC 824; DOWN-REGULATION; ESCHERICHIA-COLI; TARGETRON VECTOR; PERFRINGENS; OVEREXPRESSION; DEHYDROGENASE; INACTIVATION; DISRUPTION; DIFFICILE	Clostridium plays an important role in commercial and medical use, for which targeted gene deletion is difficult. We proposed an intron-anchored gene deletion approach for Clostridium, which combines the advantage of the group II intron "ClosTron'' system and homologous recombination. In this approach, an intron carrying a fragment homologous to upstream or downstream of the target site was first inserted into the genome by retrotransposition, followed by homologous recombination, resulting in gene deletion. A functional unknown operon CAC1493-1494 located in the chromosome, and an operon ctfAB located in the megaplasmid of C. acetobutylicum DSM1731 were successfully deleted by using this approach, without leaving antibiotic marker in the genome. We therefore propose this approach can be used for targeted gene deletion in Clostridium. This approach might also be applicable for gene deletion in other bacterial species if group II intron retrotransposition system is established.	[Jia, Kaizhi; Zhu, Yan; Zhang, Yanping; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Jia, KZ (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	yli@im.ac.cn	Li, Yin/C-6644-2009; jia, kaizhi/D-5383-2011; zhu, yan/B-2915-2011; Zhang, Yanping/C-7114-2009; Zhu, Yan/M-3779-2016	Li, Yin/0000-0003-0995-3070; Zhu, Yan/0000-0001-7342-3782	National Basic Research Program of China (973 Project) [2007CB707803, 2011CBA00807]; National Science Foundation of China [31000024]; Chinese Academy of Sciences	National Basic Research Program of China (973 Project)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Project, #2007CB707803 and 2011CBA00807), National Science Foundation of China (31000024) and Hundreds Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; Borden JR, 2010, METAB ENG, V12, P268, DOI 10.1016/j.ymben.2009.12.004; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Chiarezza M, 2009, INFECT IMMUN, V77, P4421, DOI 10.1128/IAI.00548-09; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Dong HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009038; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Ezeji TC, 2007, CURR OPIN BIOTECH, V18, P220, DOI 10.1016/j.copbio.2007.04.002; Green EM, 1996, MICROBIOL-SGM, V142, P2079, DOI 10.1099/13500872-142-8-2079; Green EM, 1996, APPL BIOCHEM BIOTECH, V57-8, P213, DOI 10.1007/BF02941702; Harris LM, 2002, J BACTERIOL, V184, P3586, DOI 10.1128/JB.184.13.3586-3597.2002; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hebert CG, 2008, CURR OPIN BIOTECH, V19, P500, DOI 10.1016/j.copbio.2008.08.006; Jiang Y, 2009, METAB ENG, V11, P284, DOI 10.1016/j.ymben.2009.06.002; JOHNSTON NC, J LIPID RES, V71, P1953; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Liyanage H, 2001, APPL ENVIRON MICROB, V67, P2004, DOI 10.1128/AEM.67.5.2004-2010.2001; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; Mendez M, 2008, J BACTERIOL, V190, P48, DOI 10.1128/JB.01407-07; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; Mukhopadhyay A, 2008, CURR OPIN BIOTECH, V19, P228, DOI 10.1016/j.copbio.2008.05.003; Mullany P, 1996, GENE, V174, P145, DOI 10.1016/0378-1119(96)00511-2; Nakayama SI, 2008, APPL MICROBIOL BIOT, V78, P483, DOI 10.1007/s00253-007-1323-z; Nakotte S, 1998, APPL MICROBIOL BIOT, V50, P564, DOI 10.1007/s002530051335; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Otte B, 2009, APPL ENVIRON MICROB, V75, P7610, DOI 10.1128/AEM.01774-09; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Raju D, 2005, APPL ENVIRON MICROB, V71, P7618, DOI 10.1128/AEM.71.11.7618-7620.2005; Raju D, 2007, APPL ENVIRON MICROB, V73, P2048, DOI 10.1128/AEM.02500-06; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Rodriguez SA, 2009, METHODS, V49, P270, DOI 10.1016/j.ymeth.2009.04.011; Sambrook J, 2001, MOL CLONING LAB MANU; Scotcher MC, 2005, APPL ENVIRON MICROB, V71, P1987, DOI 10.1128/AEM.71.4.1987-1995.2005; Scotcher MC, 2005, J BACTERIOL, V187, P1930, DOI 10.1128/JB.187.6.1930-1936.2005; Sengupta S, 2008, NUCLEIC ACIDS RES, V36, P4310, DOI 10.1093/nar/gkn355; Shao L, 2007, CELL RES, V17, P963, DOI 10.1038/cr.2007.91; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Sillers R, 2009, BIOTECHNOL BIOENG, V102, P38, DOI 10.1002/bit.22058; Tomas CA, 2003, APPL ENVIRON MICROB, V69, P4951, DOI 10.1128/AEM.69.8.4951-4965.2003; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; Tummala SB, 2003, J BACTERIOL, V185, P3644, DOI 10.1128/JB.185.12.3644-3653.2003; Tummala SB, 2003, J BACTERIOL, V185, P1923, DOI 10.1128/JB.185.6.1923-1934.2003; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Weingart OG, 2010, APPL ENVIRON MICROB, V76, P3293, DOI 10.1128/AEM.02937-09; WILKINSON SR, 1994, MICROBIOL-SGM, V140, P89, DOI 10.1099/13500872-140-1-89; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248	56	20	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16693	10.1371/journal.pone.0016693	http://dx.doi.org/10.1371/journal.pone.0016693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304965	gold, Green Submitted, Green Published			2022-12-27	WOS:000286834300123
J	Miloslavich, P; Klein, E; Diaz, JM; Hernandez, CE; Bigatti, G; Campos, L; Artigas, F; Castillo, J; Penchaszadeh, PE; Neill, PE; Carranza, A; Retana, MV; de Astarloa, JMD; Lewis, M; Yorio, P; Piriz, ML; Rodriguez, D; Yoneshigue-Valentin, Y; Gamboa, L; Martin, A				Miloslavich, Patricia; Klein, Eduardo; Diaz, Juan M.; Hernandez, Cristian E.; Bigatti, Gregorio; Campos, Lucia; Artigas, Felipe; Castillo, Julio; Penchaszadeh, Pablo E.; Neill, Paula E.; Carranza, Alvar; Retana, Maria V.; Diaz de Astarloa, Juan M.; Lewis, Mirtha; Yorio, Pablo; Piriz, Maria L.; Rodriguez, Diego; Yoneshigue-Valentin, Yocie; Gamboa, Luiz; Martin, Alberto			Marine Biodiversity in the Atlantic and Pacific Coasts of South America: Knowledge and Gaps	PLOS ONE			English	Review							DE-LA-PLATA; HUMBOLDT CURRENT SYSTEM; ANOXIC CARIACO BASIN; OXYGEN MINIMUM ZONE; SOUTHEASTERN PACIFIC; COMMUNITY STRUCTURE; UPWELLING AREA; CENTRAL CHILE; GUANABARA BAY; CONCEPCION SIMILAR-TO-36-DEGREES-S	The marine areas of South America (SA) include almost 30,000 km of coastline and encompass three different oceanic domains-the Caribbean, the Pacific, and the Atlantic-ranging in latitude from 12 degrees N to 55 degrees S. The 10 countries that border these coasts have different research capabilities and taxonomic traditions that affect taxonomic knowledge. This paper analyzes the status of knowledge of marine biodiversity in five subregions along the Atlantic and Pacific coasts of South America (SA): the Tropical East Pacific, the Humboldt Current, the Patagonian Shelf, the Brazilian Shelves, and the Tropical West Atlantic, and it provides a review of ecosystem threats and regional marine conservation strategies. South American marine biodiversity is least well known in the tropical subregions (with the exception of Costa Rica and Panama). Differences in total biodiversity were observed between the Atlantic and Pacific oceans at the same latitude. In the north of the continent, the Tropical East Pacific is richer in species than the Tropical West Atlantic, however, when standardized by coastal length, there is very little difference among them. In the south, the Humboldt Current system is much richer than the Patagonian Shelf. An analysis of endemism shows that 75% of the species are reported within only one of the SA regions, while about 22% of the species of SA are not reported elsewhere in the world. National and regional initiatives focusing on new exploration, especially to unknown areas and ecosystems, as well as collaboration among countries are fundamental to achieving the goal of completing inventories of species diversity and distribution. These inventories will allow accurate interpretation of the biogeography of its two oceanic coasts and latitudinal trends, and will also provide relevant information for science based policies.	[Miloslavich, Patricia; Klein, Eduardo; Castillo, Julio; Martin, Alberto] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela; [Miloslavich, Patricia; Klein, Eduardo; Castillo, Julio; Martin, Alberto] Ctr Biodiversidad Marina, Caracas, Venezuela; [Diaz, Juan M.] Univ Nacl Colombia, Bogota, Colombia; [Hernandez, Cristian E.] Univ Concepcion, Lab Diversidad Mol & Filoinformat, Dept Zool, Fac Ciencias Nat & Oceanog, Concepcion, Chile; [Bigatti, Gregorio; Retana, Maria V.; Lewis, Mirtha; Yorio, Pablo; Piriz, Maria L.] CNR, Patagonian Natl Ctr, Puerto Madryn, Chubut, Argentina; [Campos, Lucia; Yoneshigue-Valentin, Yocie] Univ Fed Rio de Janeiro, Dept Zool, Inst Biol, Rio De Janeiro, Brazil; [Artigas, Felipe] Univ Lille Nord France, CNRS, UMR LOG 8187, MREN,ULCO Lab Oceanol & Geosci, Wimereux, France; [Penchaszadeh, Pablo E.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Neill, Paula E.] Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol Costera, Concepcion, Chile; [Carranza, Alvar] Museo Nacl Hist Nat, Montevideo, Uruguay; [Diaz de Astarloa, Juan M.; Rodriguez, Diego] Univ Nacl Mar del Plata, Natl Res Council, Inst Invest Marinas & Costeras, Fac Ciencias Exactas & Nat, Mar Del Plata, Buenos Aires, Argentina; [Gamboa, Luiz] Univ Fed Fluminense, Rio De Janeiro, Brazil	Simon Bolivar University; Universidad Nacional de Colombia; Universidad de Concepcion; Universidade Federal do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad Catolica de la Santisima Concepcion; National University of Mar del Plata; Universidade Federal Fluminense	Miloslavich, P (corresponding author), Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela.	pmilos@usb.ve	Penchaszadeh, Pablo/ABB-8472-2021; Gamboa, Luiz/AAL-5904-2021; Hernández, Cristián E./GLS-1111-2022; de Astarloa, Juan Diaz/F-5395-2012; Carranza, Alvar/J-8270-2019; Hernández, Cristián E./C-4414-2012; Artigas, Luis Felipe/L-1264-2016; Hernández, Cristián E./AAS-1286-2020; Yoneshigue Valentin, yocie/D-7602-2013; Rodríguez, Diego/L-3172-2013; Campos, Lucia/L-9539-2013	Penchaszadeh, Pablo/0000-0002-2043-8814; Hernández, Cristián E./0000-0002-9811-2881; Carranza, Alvar/0000-0003-3016-7955; Hernández, Cristián E./0000-0002-9811-2881; Rodríguez, Diego/0000-0002-5080-3739; Lewis, Mirtha/0000-0001-6262-6226; Campos, Lucia/0000-0002-3648-7450; Klein, Eduardo/0000-0003-2935-7065; Miloslavich, Patricia/0000-0001-5409-1401; BIGATTI, GREGORIO/0000-0001-7053-6802	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	A grant was received from the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU CR, 2006, TAXONOMIA DISTRIBUIC; Abreu PC, 2007, J EXP MAR BIOL ECOL, V347, P88, DOI 10.1016/j.jembe.2007.03.012; ABREU PC, 1995, ESTUAR COAST SHELF S, V40, P219, DOI 10.1016/S0272-7714(05)80006-X; Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; AGARD JBR, 2000, SEAS MILLENNIUM ENV; ALEEM AA, 2002, OCEANOGRAPHIC HIST P, P316; ALIO J, 1991, U ZULIA MARACAIBO, V42, P7; ALTENA C, 1968, MOLLUSCA SURINAM STU, V10, P153; ALTENA C, 1965, ZOOLOGISCHE VERHANDE, V101, P3; ALTENA C, 1975, AM MALACOL B UNION, V38, P45; ALTENA C, 1965, GEOLOGIE NIJNBOUN, V48, P75; ALTENA CO, 1971, ZOOLOGISCHE MEDEDELI, V45, P75; ALTENA COV, 1971, ZOOLOGISCHE VERHANDE, V119, P1; ALTUVE D, 1996, 3 C CIENT U OR RES; ALTUVE D, 1996, MEM 1 JORN TECN REG, P153; ALVES RRN, 2004, TROPICAL OCEANOGRAPH, V32, P23, DOI DOI 10.5914/TROPOCEAN.V32I1.5031; Alves-de-Souza C, 2008, J PLANKTON RES, V30, P1233, DOI 10.1093/plankt/fbn079; Amaral A.C.Z., 2003, BIODIVERSIDADE BENTI; Amaral ACZ, 2005, CONSERV BIOL, V19, P625, DOI 10.1111/j.1523-1739.2005.00692.x; AMARAL ACZ, 2004, SERIE DOCUMENTOS REV; AMARAL ACZ, 2005, MANUAL IDENTIFICACAO; AMOROCHO DF, 2001, SANTA MARTA SERIE PU, V7; Anabalon V, 2007, PROG OCEANOGR, V75, P396, DOI 10.1016/j.pocean.2007.08.023; Arantes RCM, 2009, MAR ECOL PROG SER, V397, P71, DOI 10.3354/meps08230; Araujo FG, 2001, ESTUAR COAST SHELF S, V52, P729, DOI 10.1006/ecss.2001.0778; AREAS MO, 2006, SAUDE AMBIENTE REV, V1, P14; Artigas LF, 2008, REV BIOL TROP, V56, P183; Artigas Luis Felipe, 2003, Gayana (Concepc.), V67, P302; Astorga A, 2003, ECOL LETT, V6, P420, DOI 10.1046/j.1461-0248.2003.00445.x; BAKUN A, 1999, LARGE MARINE ECOSYST; Balech E., 1954, Revista de Biologia Marina Valparaiso, V4, P184; Bardi J, 2009, ZOOTAXA, P41, DOI 10.11646/zootaxa.2198.1.4; Barragan JM, 2003, COAST MANAGE, V31, P55, DOI 10.1080/08920750390168309; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; BATE C. S ., 1888, REPORT SCI RESULTS V, V24, P1; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bellini Claudio, 2000, Marine Turtle Newsletter, V87, P11; Bertness MD, 2006, ECOL MONOGR, V76, P439, DOI 10.1890/0012-9615(2006)076[0439:TCSOWA]2.0.CO;2; Bigatti G., 2008, ESTADO CONSERVACION, P105; Bigatti G, 2009, MAR POLLUT BULL, V58, P695, DOI 10.1016/j.marpolbul.2009.01.001; BIGELOW HB, 1911, B MUS COMP ZOOL HARV, V38, P171; Bigelow Henry B., 1909, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V37; *BIRD LIF INT, 2004, RES GLOB PROC TRACK; Bottjer D, 2007, PROG OCEANOGR, V75, P415, DOI 10.1016/j.pocean.2007.08.024; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Boltovskoy D, 2005, SCI MAR, V69, P17, DOI 10.3989/scimar.2005.69s217; BOLTOVSKOY D, 1981, MAR PLATA PUBLICACIO; BOLTOVSKOY D, 2008, ESTADO CONSERVACION, P62; BONE D, 2004, CONSERVACION USO SUS; Bone D, 2007, INTERCIENCIA, V32, P477; Bonnet Barbara Rocha Pinto, 1994, Neritica, V8, P99; Borzone CA, 1999, MAR ECOL-P S Z N I, V20, P131, DOI 10.1046/j.1439-0485.1999.00070.x; Boschi E.E, 2004, VIDA ENTRE MAREAS VE; BOUCHET P, 1987, REPPORTS CAMPAGNES M; BOUCHET P, 2006, EXPLORATION MARINE B, P32; Bouzon JL., 2007, Braz. J. Biol., V67, P321, DOI 10.1590/S1519-69842007000200018; Brandini FP, 2000, DEEP-SEA RES PT I, V47, P1015, DOI 10.1016/S0967-0637(99)00075-8; BRANDINI FP, 1997, PLANCTONOLOGIA PLATA; BRANDINI FP, 2006, AMBIENTE OCEANOGRAFI, P459; *BRASIL, 1997, DIR AMB SET PESQ DIA; Brasil, 2000, DECRETO ESTADUAL 220; BRATTSTROM H, 1983, SARSIA, V68, P289, DOI 10.1080/00364827.1983.10420583; Breves-Ramos A, 2005, BRAZ ARCH BIOL TECHN, V48, P951, DOI 10.1590/S1516-89132005000800012; BRIGGS J C, 1974, P475; Brink KH., 1998, COAST SEGMENT, P273; Brogim Rosemary A., 1997, Iheringia Serie Zoologia, V83, P35; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Bugoni Leandro, 2001, Marine Turtle Newsletter, V94, P7; Burone L, 2006, SCI MAR, V70, P203, DOI 10.3989/scimar.2006.70n2203; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Calliari D, 2005, CONT SHELF RES, V25, P197, DOI 10.1016/j.csr.2004.09.009; Calliari Danilo, 2003, Gayana (Concepc.), V67, P341; CAMPOS LS, 2010, PROJETO CAR IN PRESS, V2; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; CAMUS PA, 1990, REV CHIL HIST NAT, V63, P11; CANETE G, 2008, ESTADO CONSERVACION, P501; Canete JI, 1999, SCI MAR, V63, P243, DOI 10.3989/scimar.1999.63s1243; CANTERA JR, 1991, VELIGER, V34, P85; Capella Juan J., 2002, Aquatic Mammals, V28, P67; CAPELO JC, 2004, B RAP EVALUACION BIO, V37, P55; Carranza A., 2007, Animal Biodiversity and Conservation, V30, P161; Carranza Alvar, 2007, Pan-American Journal of Aquatic Sciences, V2, P255; Carranza A, 2008, CONT SHELF RES, V28, P788, DOI 10.1016/j.csr.2007.12.010; Carranza A, 2009, MAR BIOL, V156, P1917, DOI 10.1007/s00227-009-1224-z; Carreto JI, 2008, CONT SHELF RES, V28, P1589, DOI 10.1016/j.csr.2007.02.012; CARVALHO FC, 2008, BRAZ J OCEA IN PRESS; Casas G, 2004, BIOL INVASIONS, V6, P411, DOI 10.1023/B:BINV.0000041555.29305.41; Castilla Juan C., 2009, V204, P439; CASTRO B. M. F., 1998, SEA, P209; Castro C.B., 2006, BIODIVERSIDADE BENTO, V18, P147; Castro CB, 2001, B MAR SCI, V69, P357; Chatwin A, 2007, PRIORITIES COASTAL M; CINTRA IHA, 2007, B TECNICO CIENTIFICO, V7, P135, DOI DOI 10.17080/1676-5664/BTCC.V7N1P135-152; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Clarke A, 1997, MARINE BIODIVERSITY-BOOK, P122, DOI 10.1017/CBO9780511752360.007; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; COELHO PA, 1993, B TEC CIENT CEPENE, V1, P129; COELHO PA, 1993, B TEC CIENT CEPENE, V1, P73; Coelho Petronio Alves, 2006, Zootaxa, V1221, P41; Coll J, 1999, BOT MAR, V42, P129, DOI 10.1515/BOT.1999.016; COLONNELLO G, 2004, B RAP EVALUACION BIO, V37, P37; Coradin L, 2006, ESPECIES EXOTICAS IN; CORREA ID, 2009, COASTS COLOMBIA; Cortes J, 2003, LATIN AMERICAN CORAL REEFS, P361, DOI 10.1016/B978-044451388-5/50017-5; COSEL RV, 1977, VELIGER, V19, P422; COSTA PAS, 2005, RIO JANEIRO SERIE DO, P57; COSTA PAS, 2005, SERIE DOCUMENTOS REV; Costa R. C., 2000, P BIOL SOC WASH, V113, P776; Costello M., 2007, OCEAN BIOGEOGRAPHIC; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Couto Erminda C.G., 2003, Gayana, V67, P327; *CPPS, 2008, INF REUN GRUP AD HOC; Crame JA, 1997, J BIOGEOGR, V24, P1, DOI 10.1111/j.1365-2699.1997.tb00045.x; Croxall J, 2009, ATLAS MAR PATAGONICO; Cruz Manuel, 2003, Gayana (Concepc.), V67, P232; CUBITTO MA, 1996, INT BIODETERIO BIODE, V37, P123; Cuevasa LA, 2004, DEEP-SEA RES PT II, V51, P2427, DOI 10.1016/j.dsr2.2004.07.026; CURTIN TB, 1986, CONT SHELF RES, V6, P31, DOI 10.1016/0278-4343(86)90052-X; Cusson M, 2005, MAR ECOL PROG SER, V297, P1, DOI 10.3354/meps297001; D'Antonio C, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P59; da Silveira ICA, 2008, DYNAM ATMOS OCEANS, V45, P187, DOI 10.1016/j.dynatmoce.2008.01.002; DAHL E, 1960, PROC R SOC SER B-BIO, V152, P631, DOI 10.1098/rspb.1960.0070; Dall William Healey, 1908, Proceedings of the United States National Museum Smithsonian Institution Washington, V34; DAMUTH JE, 1988, AAPG BULL, V72, P885; DASILVA PCM, 1971, FERTILITY SEA, P469; Figueiredo MAD, 2007, CIENC MAR, V33, P427; de Oliveira Santos Marcos Cesar, 2001, Journal of Cetacean Research and Management Special Issue, V2, P153; Defeo O., 2009, HACIA MANEJO ECOSIST; DELL R K, 1971, Records of the Dominion Museum (Wellington), V7, P155; DEROA EZ, 2005, FRENTE ATLANTICO VEN, V1, P127; DIAZ JM, 2000, SANTA MARTA COLOMBIA, V5; Díaz Juan M, 2003, Gayana (Concepc.), V67, P261; Diaz Juan M., 1995, Caribbean Journal of Science, V31, P104; Diaz-Munoz G, 2005, CARIBB J SCI, V41, P360; DIBENEDITTO AP, 1997, CAPTURA PEQUENOS CET, V91; DIBENEDITTO AP, 2001, CIENCIA HOJE, V29, P66; DIDOMENICO M, 2008, MAR ECOL, V29, P1; DIEZ MJ, 2006, DISTRIBUCION BATIMET; DORBIGNY A, 1846, VOYAGE AM MERIDIONAL, P1; Dutra G. F., 2005, RAP B BIOL ASSESSMEN, V38; EAUK W, 2003, LARGE MARINE ECOSYST, P375; *EC, 2009, ENCY BRIT; EHLBERS K, 2003, ANAIS MANGROVE 2003; Ekman S., 1953, P417; Engle VD, 1999, J BIOGEOGR, V26, P1007, DOI 10.1046/j.1365-2699.1999.00341.x; Escalente R., 1991, International Council for Bird Preservation Technical Publication, V11, P159; Escribano R, 2004, DEEP-SEA RES PT II, V51, P2389, DOI 10.1016/j.dsr2.2004.08.011; Escribano Rubén, 2003, Gayana (Concepc.), V67, P190; FALCAO APC, 2010, PROJETO CAR IN PRESS; Falcon LI, 2008, MAR GENOM, V1, P55, DOI 10.1016/j.margen.2008.06.005; Favero Marco, 2005, Hornero, V20, P95; *FCMPAI FPLCDMPYAD, 2008, SINT EST CONS MAR PA; Feitoza Bertran M., 2003, Aqua (Miradolo Terme), V7, P61; Fernandez M, 2005, CONSERV BIOL, V19, P1752, DOI 10.1111/j.1523-1739.2005.00277.x; Fernandez M, 2000, REV CHIL HIST NAT, V73, P797; FERNANDEZBACA J, 2007, PRIORITIES COASTAL M, P44; Ferreira B.P., 2001, INT NEWSLETT COAST M, V38, P22; Fiedler PC, 2006, PROG OCEANOGR, V69, P94, DOI 10.1016/j.pocean.2006.03.006; FILHO ECO, 1978, PUBL I PESQUI TECNOL, V1107, P1; *FISH CTR U BRIT C, 2009, SEA US GLOB DAT MAR; Floeter SR, 2007, J ANIM ECOL, V76, P105, DOI 10.1111/j.1365-2656.2006.01178.x; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Floeter SR, 2006, BIOL CONSERV, V128, P391, DOI 10.1016/j.biocon.2005.10.005; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; FLORES C, 1978, THESIS U ORIENTE; Flores G C., 1964, Lagena, VNo. 1, P19; FOREST J, 1967, ANN I OCEANOGR MONAC, V45; Fransozo A, 1998, J CRUSTACEAN BIOL, V18, P738, DOI 10.2307/1549150; Fransozo Adilson, 1992, Revista Brasileira de Biologia, V52, P667; FREDOU FL, 2007, COL VOL SCI PAP ICCA, V60, P518; Gallardo CS, 2001, MAR BIOL, V138, P547, DOI 10.1007/s002270000477; GALLARDO VA, 1987, ENVIRON INT, V13, P71, DOI 10.1016/0160-4120(87)90045-6; Gallardo VA, 2007, INT MICROBIOL, V10, P97, DOI 10.2436/20.1501.01.14; Gallardo VA, 2007, PROC SPIE, V6694, DOI 10.1117/12.782209; GAMBOA LAP, 1981, EARTH PLANET SC LETT, V52, P410, DOI 10.1016/0012-821X(81)90193-X; GAMBOA LAP, 1984, MAR GEOL, V58, P35, DOI DOI 10.1016/0025-3227(84)90115-4; Gappa Juan Lopez, 2006, Zootaxa, V1342, P1; Garla Ricardo Clapis, 2009, Marine Biodiversity Records, V2, pe109, DOI 10.1017/S1755267209000670; GARTH JOHN S., 1948, BULL AMER MUS NAT HIST, V92, P1; GEISE L, 1988, Revista Brasileira de Zoologia, V4, P341; GERGOLE MC, 1998, BOL INST PESCA, V25, P1; GERHARDINGER LC, 2007, MMA SERIE AREAS PROT, P107; GEYER WR, 1995, J GEOPHYS RES-OCEANS, V100, P2321, DOI 10.1029/94JC02657; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Glynn PW, 2003, LATIN AMERICAN CORAL REEFS, P449, DOI 10.1016/B978-044451388-5/50020-5; GLYNN PW, 1973, SCIENCE, V180, P504, DOI 10.1126/science.180.4085.504; GOMES LAO, 1986, REUNION TRABAJO EXPE, P122; GOMES RS, 2006, ILHAS OCEANICAS BRAS, P180; Gomez Martha L., 2006, Actualidades Biologicas (Medellin), V28, P125; Gomez N, 2004, ESTUAR COAST SHELF S, V61, P301, DOI 10.1016/j.ecss.2004.05.007; Gonzalez HE, 2007, PROG OCEANOGR, V75, P435, DOI 10.1016/j.pocean.2007.08.025; GORDON AL, 1981, DEEP-SEA RES, V28, P1239, DOI 10.1016/0198-0149(81)90033-9; Gordon DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010905; Graco M, 2001, LIMNOL OCEANOGR, V46, P821, DOI 10.4319/lo.2001.46.4.0821; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Gray JS, 2001, POLAR BIOL, V24, P633, DOI 10.1007/s003000100244; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Grob C, 2007, MAR ECOL PROG SER, V332, P53, DOI 10.3354/meps332053; GUIRY MD, 2010, ALGAE BASE; Gusmao J, 2006, MAR BIOL, V149, P491, DOI 10.1007/s00227-005-0232-x; Gusmao J, 2005, GENET MOL BIOL, V28, P165, DOI 10.1590/S1415-47572005000100029; Gutierrez D, 2000, MAR ECOL PROG SER, V202, P81, DOI 10.3354/meps202081; HAIG J, 1966, ANN I OCEANOGR PARIS, V44, P351; HAIG J, 1957, AM MUS NOVIT, P17; HAIMOVICI M, 1997, SUBTROPICAL CONVERGE, P183; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Hassel Lucas B., 2003, Latin American Journal of Aquatic Mammals, V2, P47; HAUSSERMANN V, 2009, NATURE FOCUS; HAZIN FHV, 2008, COL VOL SCI PAP ICCA, V62, P1560; HAZIN FHV, 2009, DINAMICA POPULACOES, P197; HAZIN FHV, 2008, SHARKS OPEN OCEAN BI, P213; HAZIN FHV, 2008, COL VOL SCI PAP ICCA, V62, P404; HAZIN H, 2008, COL VOL SCI PAP ICCA, V62, P934; HAZIN H, 2008, COL VOL SCI PAP ICCA, V62, P1167; Heileman S., 2008, 18 UNEP, P749; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Hernandez CE, 2005, ECOGRAPHY, V28, P363, DOI 10.1111/j.0906-7590.2005.04013.x; Hernandez KL, 2007, J EXP MAR BIOL ECOL, V343, P82, DOI 10.1016/j.jembe.2006.11.008; HERNANDEZBECERR.DU, 2003, PLANCTOLOGIA MEXICAN, P1; Herrera L, 2006, J MARINE SYST, V61, P13, DOI 10.1016/j.jmarsys.2005.11.010; HERTLEIN LG, 1955, B AM MUS NAT HIST, V107, P163; Hill AE, 1998, SEA, V10, P21; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hovland Martin, 2008, P1; Iken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013845; *INTECMAR USB, 2004, EST IMP AMB PROGR DE; Isaac VJ, 2009, J APPL ICHTHYOL, V25, P244, DOI 10.1111/j.1439-0426.2009.01274.x; ISAAC VJ, 1992, SERIE ESTUDOS PESCA, V1; Jablonski S, 2008, OCEAN COAST MANAGE, V51, P536, DOI 10.1016/j.ocecoaman.2008.06.008; JINNO K, 1999, RIO JAN 6 C INT SOC; JOHN DM, 1994, BOT MAR, V37, P235, DOI 10.1515/botm.1994.37.3.235; Joly A.B., 1967, I PESQ, V4, P1; JUNQUEIRA AOR, 2009, INFORM ESPECIES EXOT, P145; KIKUCHI RKP, 1999, SITIOS GEOLOGICOS PA; KINAS PG, 1998, BRAZIL REP INT WHAL, V48, P447; KLEIN E, 2009, PRIORIDADES CONSERVA; KONAR B, 2010, LIFE WORLDS OCEANS D; Konar B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013195; LAGE H, 2008, ATLANTICA, V30, P161; Lana Paulo Cunha, 2006, Check List, V2, P30; Lana PC, 1997, B MAR SCI, V60, P433; Lana PC., 1996, BENTOS COSTA BRASILE; LANA PC, 2004, BIODIVERSIDADE BENTO, P114; Lancellotti DA, 2000, REV CHIL HIST NAT, V73, P99, DOI 10.4067/S0716-078X2000000100011; Lancellotti DA, 1999, J BIOGEOGR, V26, P1001, DOI 10.1046/j.1365-2699.1999.00344.x; LARES LB, 1987, U ZULIA MARACAIBO, V38, P266; LASSO CA, 2008, BIODIVERSIDAD ANIMAL; Lavrado H.P., 2000, NAUPLIUS, V8, P15; LAVRADO HP, 2007, ATLAS INVERTEBRADO 1, V1; LAVRADO HP, 2006, BIODIVERSIDADE BENTO, V1; Lazoski Cristiano, 1999, Memoirs of the Queensland Museum, V44, P299; LEAL J.H., 1991, MARINE PROSOBRANCH G; Lee MR, 2008, REV CHIL HIST NAT, V81, P51; Leite Ferreira Carlos Eduardo, 2009, V204, P459; LENZ H, 1914, DTSCH SUDPOLAR EXPED, V15, P257; Levin L, 2002, PROG OCEANOGR, V53, P1, DOI 10.1016/S0079-6611(02)00022-8; Levipan HA, 2007, PROG OCEANOGR, V75, P531, DOI 10.1016/j.pocean.2007.08.029; Licursi M, 2006, J MARINE SYST, V62, P35, DOI 10.1016/j.jmarsys.2006.03.002; Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006; Littler D.S., 2000, CARIBBEAN REEF PLANT, P542; LODI L, 1990, BIOTEMAS, V3, P47; Lodi Liliane, 1996, Papeis Avulsos de Zoologia (Sao Paulo), V39, P307; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Lopez B., 1998, RIO ORINOCO APROVECH; Lopez Beatriz, 1996, Acta Biologica Venezuelica, V16, P45; Lopez Beatriz, 1996, Memoria de la Sociedad de Ciencias Naturales La Salle, V54, P51; Gappa JL, 2007, POLAR BIOL, V30, P679, DOI 10.1007/s00300-006-0225-3; Lozada M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-50; Lutz Vivian A, 2003, Gayana (Concepc.), V67, P371; Madrid VM, 2001, FEMS MICROBIOL ECOL, V37, P197, DOI 10.1111/j.1574-6941.2001.tb00867.x; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; MAHIQUES MM, 2005, AN ACAD BRAS CIENC, V77, P595; MAIDA M, 1997, P INT CORAL REEF S, V8, P263; MARCANO L, 1992, 3 WORKSH BIOL EC MOD, P1; MARCANO L, 1972, EVALUACION PRELIMINA, P151; Marcovaldi MA, 1999, BIOL CONSERV, V91, P35, DOI 10.1016/S0006-3207(99)00043-9; MARIANI S, 1996, BIOL MAR MEDIT, V3, P155; Marin VH, 2007, CONT SHELF RES, V27, P731, DOI 10.1016/j.csr.2006.11.014; Marini MA, 2005, MEGADIVERSIDADE, V1, P95; MARTIN A, 2007, LINEA BASE AMBIENTAL; MARTIN A, 2007, CARACAS VENEZUELA PE; MARTIN A, 2003, ESTUDIO INTEGRADO CO, P71; MARTINEZPARDO R, 1990, PALAEOGEOGR PALAEOCL, V77, P263, DOI 10.1016/0031-0182(90)90180-F; Mascarenhas R, 2004, MAR POLLUT BULL, V49, P354, DOI 10.1016/j.marpolbul.2004.05.006; Mate JL, 2003, LATIN AMERICAN CORAL REEFS, P387, DOI 10.1016/B978-044451388-5/50018-7; MAYTIA S, 1979, MEM SEM EC BENT SED, P149; McGinley M, 2008, ENCY EARTH; MCGLINLEY M, 2008, ENCY EARTH; MENDOZA J, 1994, MEM SOC CIEN NAT LA, V49, P65; MIETHKE S, 2007, PRIORITIES COASTAL M, P24; MIGOTTO AE, 1997, BIODIVERSIDADE ESTAD, V3; Milessi AC, 2005, FISH RES, V74, P223, DOI 10.1016/j.fishres.2005.02.002; MILOSLAVICH P, 2008, YOK JAP WORLD FISH C; Miloslavich Patricia, 2003, Gayana (Concepc.), V67, P275; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; *MMA, 2006, PROGR REVIZEE AV POT; *MMA, 2006, PROB DEZ AN AT PROBI; MOLINET R, 2008, EVALUACION RECURSOS; MOORE WS, 1986, J GEOPHYS RES-OCEANS, V91, P2574, DOI 10.1029/JC091iC02p02574; Morales CE, 2007, PROG OCEANOGR, V75, P452, DOI 10.1016/j.pocean.2007.08.026; Morales CE, 1999, J MAR RES, V57, P909, DOI 10.1357/002224099321514097; Moreno RA, 2006, J BIOGEOGR, V33, P750, DOI 10.1111/j.1365-2699.2005.01394.x; Morete Maria E., 2003, Latin American Journal of Aquatic Mammals, V2, P21; MOTHES B, 2006, EDUFPA, V1, P97; Mothes B, 2006, REV BRAS ZOOL, V23, P667, DOI 10.1590/S0101-81752006000300009; Mugetti AC, 2004, AMBIO, V33, P78, DOI 10.1639/0044-7447(2004)033[0078:AHMILP]2.0.CO;2; MULLER A. C. P., 2004, MANUAL IDENTIFICACAO, V1; NEGRI RM, 2004, VIDA ENTRE MAREAS VE, P73; NETTO S, 1999, HYDROBIOLOGIA, V400, P1573; Netto SA, 1997, ESTUAR COAST SHELF S, V44, P641, DOI 10.1006/ecss.1996.0154; NEVES TS, 2006, AVES OCEANICAS SUAS; NITTROUER CA, 1986, CONT SHELF RES, V6, P151, DOI 10.1016/0278-4343(86)90058-0; Nobrega R, 2004, J EXP MAR BIOL ECOL, V303, P173, DOI 10.1016/j.jembe.2003.11.009; NOVOA D, 1982, RECURSOS PESQUEROA R; NOVOA D, 2000, PESCA GOLFO PARIA DE; NOVOA D, 1974, PESQUERIA VENEZOLANA; O'Dor R.K., 2003, Gayana (Concepc.), V67, P145; OGDEN J, 2004, CIENCIA HOY, V13, P23; Olguin HF, 2006, J PLANKTON RES, V28, P1107, DOI 10.1093/plankt/fbl045; OMENA EP, 1993, ACTA BIOL LEOPOLDENS, V15, P37; ORENSANZ JM, 2008, ESTADO CONSERVACION, P677; Orensanz Jose Maria (Lobo), 2002, Biological Invasions, V4, P115; PALOMARES MLD, 2009, SEA LIFE BASE; PARENTE CL, 2007, BIOTA NEOTROP, V7, P1; *PDVSA, 2002, PROYECT PLAT DELT SI; PEDROSA BM, 2002, REV EC NORDESTE FORT, V33, P574; PEDROSA P, 2006, GEOCHIM BRAS, V20, P104, DOI DOI 10.21715/GB.V20I1.238; PENCHASZADEH PE, 2005, INVASORES INVERTEBRA, P377; PEREIRA G, 2004, B RAP EVALUACION BIO, V37, P61; Pereira Guido, 1996, Acta Biologica Venezuelica, V16, P93; PEREZ JA, 2007, SERIE AREAS PROTEGID, V4, P211; Pezzuto PR, 2008, LAT AM J AQUAT RES, V36, P245, DOI 10.3856/vol36-issue2-fulltext-7; Piccini C, 2006, APPL ENVIRON MICROB, V72, P6560, DOI 10.1128/AEM.01089-06; Pinedo M. C., 1999, Journal of Cetacean Research and Management, V1, P179; Pinedo MC., 1992, CETACEOS PINIPEDES B; PINEDO MC, 1986, MORTALIDADE PONTOPOR, V1, P187; PINHEIRO LA, 2004, REV CIENT U FEDERAL, V4, P1; Piola A. R., 1997, MAR ARGENTINO SUS RE, P119; PIOLA AR, 2009, ATLAS MAR PATAGONICO, P54; PIOLA AR, 2008, ESTADO CONSERVACION, P1; Pires DO, 2009, MAR ECOL PROG SER, V397, P103, DOI 10.3354/meps08322; Pires-Vanin Ana Maria Setubal, 1993, Publicacao Especial do Instituto Oceanografico (Sao Paulo), V10, P137; PIRESVANIN AMS, 2008, OCEANOGRAFIA ECOSSIS; Pizzorno Jose Luis A., 1998, Report of the International Whaling Commission, V48, P443; PODESTA GP, 1991, J CLIMATE, V4, P457, DOI 10.1175/1520-0442(1991)004<0457:TACOSD>2.0.CO;2; PONTE V, 1990, THESIS U CENTRAL VEN; Popovich CA, 2008, CONT SHELF RES, V28, P236, DOI 10.1016/j.csr.2007.08.001; PRATES AP, 2007, SERIE AREAS PROTEGID, V4; PRATES AP, 2007, PRIORITIES COASTAL M, P15; PRESCOTT JRV, 1989, BIOMASS YIELDS GEOGR, V111, P395; QUESADA MA, 2006, AMBIENTES MARINO COS; Ramos Renata M. A., 2001, Journal of Cetacean Research and Management, V3, P321; RAMOS RMA, 1997, DETERMINACAO IDADE B; Rangel CA, 2007, BRAZ J OCEANOGR, V55, P7, DOI 10.1590/S1679-87592007000100002; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Robertson D.R., 2002, SHORE FISHES TROPICA; Rocha R.M., 2009, ESTADO ARTE PERSPECT; RODRIGUEZ G, 1982, J CRUSTACEAN BIOL, V2, P378, DOI 10.2307/1548054; Rohwer F, 2001, CORAL REEFS, V20, P85; Rollins HB., 1986, GEOARCHAEOLOGY, V1, P3; ROSAS FCW, 1991, BASES CIENTIFICAS ES, P405; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSSIWONGTSCHOW.C, 2006, AMBIENTE OCEANOGRAFI; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Salaman P., 2008, P1; Sales JBL., 2009, B MUSEU PARAENSE EM, V4, P27, DOI [10.46357/bcnaturais.v4i1.668, DOI 10.46357/BCNATURAIS.V4I1.668]; Santelices B, 2000, REV CHIL HIST NAT, V73, P605; Santi L, 2006, J COASTAL RES, P1127; Santi L, 2009, BRAZ J OCEANOGR, V57, P287, DOI 10.1590/S1679-87592009000400004; Santoferrara L, 2009, J PLANKTON RES, V31, P837, DOI 10.1093/plankt/fbp033; Santos Maria do Carmo Ferrao, 2007, Boletim Tecnico Cientifico do CEPENE, V15, P57; SANTOS MCF, 2006, B TEC CIENT CEPENE, V14, P141; SAPOZNIKOW A, 2008, INDICADORES COBERTUR; Saul AD, 1995, ARQ BIOL TECNOL, V38, P1053; SCARABINO F, 2004, COMUNICACIONES SOC M, V8, P267; SCARABINO F, 2006, BASES CONSERVACION M, P113; SCARABINO F, 2004, COMUNICACIONES SOC M, V8, P305; SCHWINDT E, 2008, ESTADO CONSERVACION, P274; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sellanes J, 2004, J MAR BIOL ASSOC UK, V84, P1065, DOI 10.1017/S0025315404010422h; Sellanes J, 2010, MAR ECOL-EVOL PERSP, V31, P111, DOI 10.1111/j.1439-0485.2009.00332.x; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Siciliano S, 1999, Z SAUGETIERKD, V64, P251; SICILIANO S, 1994, REPORT INT WHALING C, V15, P241; SICILIANO S, 1997, THESIS IB UFRRJ SERO; Sick H., 1997, ORNITOLOGIA BRASILEI; SILVA CMM, 2006, ILLUSTRATED GUIDE MA; SILVA CMM, 2003, GUIA ILUSTRADO ESPON; SILVA JM, 2005, AQUAT J ICHTHYOL AQU, V9, P161; SILVA KG, 2004, THESIS FUNDACAO U FE; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; SILVEIRA ICA, 1994, J GEOPHYS RES, V99, P22501, DOI DOI 10.1029/94JC01776; Soto-Ramirez N, 2008, INT J SYST EVOL MICR, V58, P125, DOI 10.1099/ijs.0.65008-0; Sousa L, 2004, SERIE DOCUMENTOS REV; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; SPINIELLO P, 2005, FRENTE ATLANTICO VEN, V1, P31; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Sullivan Sealey K., 1999, SETTING GEOGRAPHIC P; Tarazona Juan, 2003, Gayana (Concepc.), V67, P206; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; TORRES AM, 1997, GEOL PALAK ONT I U K, V82, P145; Valderrama D, 2009, ZOOL J LINN SOC-LOND, V157, P1, DOI 10.1111/j.1096-3642.2009.00522.x; Valdovinos C, 2003, ECOGRAPHY, V26, P139, DOI 10.1034/j.1600-0587.2003.03349.x; Valentin JL, 2001, ECOL STU AN, V144, P97; VALENTIN JL, 1984, MAR BIOL, V82, P259, DOI 10.1007/BF00392407; Teso S. Valeria, 2009, Rev. Mus. Argent. Cienc. Nat., V11, P7; Van R Altena C. O., 1966, Zoologische Mededeelingen Leiden, V41, P233; VANUCCI M, 1999, MANGUEZAIS SINTESE P; VARELA M, 1996, MEM SOC CIEN NAT LA, V46, P49; VARELA M, 1983, MEM SOC CIEN NAT LA, V120, P89; Vaske Junior Teodoro, 2008, Pan-American Journal of Aquatic Sciences, V3, P46; Vaske T, 2005, J APPL ICHTHYOL, V21, P75, DOI 10.1111/j.1439-0426.2004.00600.x; VASQUEZ E, 1989, Annales de Limnologie, V25, P107; VAZQUEZ E, 1980, MEM SOC CIEN NAT LA, V113, P139; VERAS DP, 2009, DINAMICA POPULACOES, V5, P255; VIANA DL, 2008, COLLECT VOL SCI PAP, V62, P1662; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Vieira RP, 2007, MICROB ECOL, V54, P460, DOI 10.1007/s00248-007-9261-y; Villac Maria Celia, 2008, Biota Neotropica, V8, P151; VILLAC MC, 2004, HARMFUL ALGAE 2002, P56; Vink A, 2000, REV PALAEOBOT PALYNO, V112, P247, DOI 10.1016/S0034-6667(00)00046-4; VIVIANI CA, 1979, STUD NEOTROP FAUNA E, V14, P65, DOI 10.1080/01650527909360548; WEHRTMANN I, 2009, MONOGRAPHIAE BIOL, V86; West Robert Cooper, 1957, PACIFIC LOWLANDS COL; WHITE R.W., 2002, DISTRIBUTION SEABIRD; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Woods RW, 1997, ATLAS BREEDING BIRDS; Yoneshigue-Valentin Y, 2006, BIODIVERSIDADE BENT, P67; YONESHIGUEBRAGA Y, 1970, PUBLCOES I PESQ MA O, V42, P1; YONESHIGUEBRAGA Y, 1970, PUBLCOES I PESQ MA O, V45, P1; YONESHIGUEBRAGA Y, 1971, PUBL I PESQ MAR RIO, V56, P1; YORIO P, 1998, AREAS PROTEGIDAS COS; Yorio P, 1998, ATLAS DISTRIBUCION R; Zapata FA, 2003, LATIN AMERICAN CORAL REEFS, P419, DOI 10.1016/B978-044451388-5/50019-9; ZAPATA FA, 2001, SERIE PUBL ESP I INV, V7, P41; Zapata FA, 2007, J BIOGEOGR, V34, P38, DOI 10.1111/j.1365-2699.2006.01586.x; ZARENKOV NA, 1970, REPORTS SOVIET ANTAR, P153; Zelaya DG, 2005, SCI MAR, V69, P113, DOI 10.3989/scimar.2005.69s2113; Zerbini Alexandre N., 1997, Report of the International Whaling Commission, V47, P407; Zerbini Alexandre N., 1996, Report of the International Whaling Commission, V46, P333; ZOPPI E, 2006, ESTUDIO LINEA BASE A, P372	446	62	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14631	10.1371/journal.pone.0014631	http://dx.doi.org/10.1371/journal.pone.0014631			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304960	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300013
J	Morton, AJ; Avanzo, L				Morton, A. Jennifer; Avanzo, Laura			Executive Decision-Making in the Domestic Sheep	PLOS ONE			English	Article							PREFRONTAL SEROTONIN DEPLETION; LARGE ANIMAL-MODELS; ATTENTIONAL-SET; HUNTINGTONS-DISEASE; COGNITIVE DEFICITS; EXCITOTOXIC LESIONS; PARKINSONS-DISEASE; BASAL FOREBRAIN; FRONTAL-CORTEX; NEUROPSYCHOLOGY	Two new large animal models of Huntington's disease (HD) have been developed recently, an old world monkey (macaque) and a sheep. Macaques, with their large brains and complex repertoire of behaviors are the 'gold-standard' laboratory animals for testing cognitive function, but there are many practical and ethical issues that must be resolved before HD macaques can be used for pre-clinical research. By contrast, despite their comparable brain size, sheep do not enjoy a reputation for intelligence, and are not used for pre-clinical cognitive testing. Given that cognitive decline is a major therapeutic target in HD, the feasibility of testing cognitive function in sheep must be explored if they are to be considered seriously as models of HD. Here we tested the ability of sheep to perform tests of executive function (discrimination learning, reversal learning and attentional set-shifting). Significantly, we found that not only could sheep perform discrimination learning and reversals, but they could also perform the intradimensional (ID) and extradimensional (ED) set-shifting tasks that are sensitive tests of cognitive dysfunction in humans. Their performance on the ID/ED shifts mirrored that seen in humans and macaques, with significantly more errors to reach criterion in the ED than the ID shift. Thus, sheep can perform 'executive' cognitive tasks that are an important part of the primate behavioral repertoire, but which have never been shown previously to exist in any other large animal. Sheep have great potential, not only for use as a large animal model of HD, but also for studying cognitive function and the evolution of complex behaviours in normal animals.	[Morton, A. Jennifer; Avanzo, Laura] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Morton, AJ (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	ajm41@cam.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346	Royal Society	Royal Society(Royal Society of London)	This work was funded by a Royal Society Leverhulme Senior Research Fellowship to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2003, J COGNITIVE NEUROSCI, V15, P629, DOI 10.1162/jocn.2003.15.5.629; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Brigman JL, 2005, BEHAV NEUROSCI, V119, P839, DOI 10.1037/0735-7044.119.3.839; Ceaser AE, 2008, BIOL PSYCHIAT, V64, P782, DOI 10.1016/j.biopsych.2008.05.009; Chan AWS, 2009, J MOL CELL BIOL, V1, P13, DOI 10.1093/jmcb/mjp009; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clarke HF, 2007, CEREB CORTEX, V17, P18, DOI 10.1093/cercor/bhj120; Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Colacicco G, 2002, BEHAV BRAIN RES, V132, P95, DOI 10.1016/S0166-4328(01)00391-6; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Decamp E, 2004, EUR J NEUROSCI, V20, P1371, DOI 10.1111/j.1460-9568.2004.03586.x; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1996, BEHAV NEUROSCI, V110, P872, DOI 10.1037/0735-7044.110.5.872; Dias R, 1997, J NEUROSCI, V17, P9285; Dorion AA, 2002, NEUROPSYCHOLOGIA, V40, P946, DOI 10.1016/S0028-3932(01)00150-6; DOWNES JJ, 1989, NEUROPSYCHOLOGIA, V27, P1329, DOI 10.1016/0028-3932(89)90128-0; ELLIOTT R, 1995, PSYCHOL MED, V25, P619, DOI 10.1017/S0033291700033523; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Garner JP, 2006, BEHAV BRAIN RES, V173, P53, DOI 10.1016/j.bbr.2006.06.002; Gauntlett-Gilbert J, 1999, NEUROPSYCHOLOGIA, V37, P605, DOI 10.1016/S0028-3932(98)00049-9; Jacobsen JC, 2010, HUM MOL GENET, V19, P1873, DOI 10.1093/hmg/ddq063; Joyce E, 2002, BRIT J PSYCHIAT, V181, pS38, DOI 10.1192/bjp.181.43.s38; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Lau DH, 2010, BLOOD PRESSURE, V19, P119, DOI 10.3109/08037050903576767; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lee C, 2006, APPL ANIM BEHAV SCI, V96, P43, DOI 10.1016/j.applanim.2005.06.001; Mackintosh N. J, 1983, CONDITIONING ASS LEA; Matrai J, 2010, CURR OPIN HEMATOL, V17, P387, DOI 10.1097/MOH.0b013e32833cd4bd; McCoy JG, 2010, BEHAV BRAIN RES, V210, P123, DOI 10.1016/j.bbr.2010.01.043; Mellon EA, 2010, P NATL ACAD SCI USA, V107, P11787, DOI 10.1073/pnas.1006951107; Moore TL, 2009, BEHAV NEUROSCI, V123, P231, DOI 10.1037/a0014723; Moore TL, 2003, NEUROBIOL AGING, V24, P125, DOI 10.1016/S0197-4580(02)00054-4; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; OWEN AM, 1991, NEUROPSYCHOLOGIA, V29, P993, DOI 10.1016/0028-3932(91)90063-E; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; Passingham R, 2009, CURR OPIN NEUROBIOL, V19, P6, DOI 10.1016/j.conb.2009.01.002; Patel DD, 2010, PSYCHOL MED, V40, P921, DOI 10.1017/S0033291709991255; Pedersen CS, 2009, J NEUROSCI METH, V185, P66, DOI 10.1016/j.jneumeth.2009.09.014; PRICE EO, 1980, APPL ANIM ETHOL, V6, P331, DOI 10.1016/0304-3762(80)90133-9; Reefmann N, 2009, PHYSIOL BEHAV, V98, P235, DOI 10.1016/j.physbeh.2009.05.017; Reinwald S, 2008, J BONE MINER RES, V23, P1353, DOI 10.1359/JBMR.080516; Reynolds LP, 2010, J ANIM SCI, V88, pE61, DOI 10.2527/jas.2009-2359; ROBBINS TW, 1994, J NEUROL NEUROSUR PS, V57, P79, DOI 10.1136/jnnp.57.1.79; ROBERTS AC, 1992, NEUROSCIENCE, V47, P251, DOI 10.1016/0306-4522(92)90241-S; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Shafritz KM, 2005, NEUROIMAGE, V25, P600, DOI 10.1016/j.neuroimage.2004.12.054; SLAMECKA NJ, 1968, PSYCHOL BULL, V69, P423, DOI 10.1037/h0025762; Tait DS, 2007, EUR J NEUROSCI, V25, P3719, DOI 10.1111/j.1460-9568.2007.05612.x; Tait DS, 2008, BEHAV BRAIN RES, V187, P100, DOI 10.1016/j.bbr.2007.08.035; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975	56	50	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15752	10.1371/journal.pone.0015752	http://dx.doi.org/10.1371/journal.pone.0015752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305061	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300024
J	Ruberto, G; Vassos, E; Lewis, CM; Tatarelli, R; Girardi, P; Collier, D; Frangou, S				Ruberto, Gaia; Vassos, Evangelos; Lewis, Cathryn M.; Tatarelli, Roberto; Girardi, Paolo; Collier, David; Frangou, Sophia			The Cognitive Impact of the ANK3 Risk Variant for Bipolar Disorder: Initial Evidence of Selectivity to Signal Detection during Sustained Attention	PLOS ONE			English	Article							SODIUM-CHANNELS; VISUAL-CORTEX; RATING-SCALE; CHANNELOPATHIES; ENDOPHENOTYPES; SENSITIVITY; MECHANISMS	Background: Abnormalities in cognition have been reported in patients with Bipolar Disorder (BD) and their first degree relatives, suggesting that susceptibility genes for BD may impact on cognitive processes. Recent genome-wide genetic studies have reported a strong association with BD in a single nucleotide polymorphism (SNP) (rs10994336) within ANK3, which codes for Ankyrin 3. This protein is involved in facilitating the propagation of action potentials by regulating the assembly of sodium gated ion channels. Since ANK3 influences the efficiency of transmission of neuronal impulses, allelic variation in this gene may have widespread cognitive effects. Preclinical data suggest that this may principally apply to sequential signal detection, a core process of sustained attention. Methodology/Principal Findings: One hundred and eighty-nine individuals of white British descent were genotyped for the ANK3 rs10994336 polymorphism and received diagnostic interviews and comprehensive neurocognitive assessment of their general intellectual ability, memory, decision making, response inhibition and sustained attention. Participants comprised euthymic BD patients (n = 47), their unaffected first-degree relatives (n = 75) and healthy controls (n = 67). The risk allele T was associated with reduced sensitivity in target detection (p = 0.0004) and increased errors of commission (p = 0.0018) during sustained attention regardless of diagnosis. We found no effect of the ANK3 genotype on general intellectual ability, memory, decision making and response inhibition. Conclusions/Significance: Our results suggest that allelic variation in ANK3 impacts cognitive processes associated with signal detection and this mechanism may relate to risk for BD. However, our results require independent replication and confirmation that ANK3 (rs10994336) is a direct functional variant.	[Ruberto, Gaia; Frangou, Sophia] Kings Coll London, Sect Neurobiol Psychosis, Inst Psychiat, London WC2R 2LS, England; [Vassos, Evangelos; Lewis, Cathryn M.; Collier, David] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Sch Med, Div Genet & Mol Med, London WC2R 2LS, England; [Ruberto, Gaia; Tatarelli, Roberto; Girardi, Paolo] Univ Roma La Sapienza, Dept Psychiat, St Andrea Hosp, Med Sch 2, Rome, Italy	University of London; King's College London; University of London; King's College London; University of London; King's College London; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Ruberto, G (corresponding author), Kings Coll London, Sect Neurobiol Psychosis, Inst Psychiat, London WC2R 2LS, England.	sophia.frangou@kcl.ac.uk	Vassos, Evangelos/F-9825-2013; Lewis, Cathryn M/A-5225-2010; Frangou, Sophia/A-2672-2013; Lewis, Cathryn/M-8766-2019; Collier, David A/D-1649-2011	Vassos, Evangelos/0000-0001-6363-0438; Lewis, Cathryn M/0000-0002-8249-8476; Lewis, Cathryn/0000-0002-8249-8476; Collier, David A/0000-0003-4087-1559; Tatarelli, Roberto/0000-0003-4396-2632; Frangou, Sophia/0000-0002-3210-6470	Medical Research Council [G9817803B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Cohen J., 1988, STAT POWER ANAL BEHA; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; De Geus EJC, 2001, EUR PSYCHOL, V6, P241, DOI 10.1027//1016-9040.6.4.241; Dhingra NK, 2005, J NEUROSCI, V25, P8097, DOI 10.1523/JNEUROSCI.1962-05.2005; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; First MB, 2001, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1935, DOI 10.1152/jn.1997.78.4.1935; Frangou S, 2009, BIOCHEM SOC T, V37, P1085, DOI 10.1042/BST0371085; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Glahn DC, 2010, ARCH GEN PSYCHIAT, V67, P168, DOI 10.1001/archgenpsychiatry.2009.184; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HEATON RK, WISCONSIN CARD SORTI; Huang X, 2007, BIPOLAR DISORD, V9, P298, DOI 10.1111/j.1399-5618.2007.00429.x; Kumar CTS, 2010, SCHIZOPHR RES, V124, P152, DOI 10.1016/j.schres.2010.07.006; Lambert S, 1997, J NEUROSCI, V17, P7025; Lewis M, 2009, EUR PSYCHIAT, V24, P464, DOI 10.1016/j.eurpsy.2009.03.004; Maxwell M., 1992, MANUAL FOR THE FIGS; Meola G, 2009, J NEUROL NEUROSUR PS, V80, P360, DOI 10.1136/jnnp.2008.164046; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; NUECHTERLEIN KH, 1983, SCIENCE, V220, P327, DOI 10.1126/science.6836276; Nuechterlein KH, 1992, MANUAL COMPUTE UNPUB; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Schimpf R, 2009, HERZ, V34, P281, DOI 10.1007/s00059-009-3238-1; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Swann AC, 2003, J AFFECT DISORDERS, V73, P105, DOI 10.1016/S0165-0327(02)00328-2; Trenerry MR, STROOP NEUROPSYCHOLO; Wechsler D, WECHSLER ADULT INTEL; Wechsler D., WECHSLER MEMORY SCAL; White HS, 2007, INT REV NEUROBIOL, V81, P85, DOI 10.1016//S0074-7742(06)81006-8; Yanagita T, 2007, NEUROPHARMACOLOGY, V53, P881, DOI 10.1016/j.neuropharm.2007.08.018; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	45	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16671	10.1371/journal.pone.0016671	http://dx.doi.org/10.1371/journal.pone.0016671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304963	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300116
J	Spencer, B; Marr, RA; Gindi, R; Potkar, R; Michael, S; Adame, A; Rockenstein, E; Verma, IM; Masliah, E				Spencer, Brian; Marr, Robert A.; Gindi, Ryan; Potkar, Rewati; Michael, Sarah; Adame, Anthony; Rockenstein, Edward; Verma, Inder M.; Masliah, Eliezer			Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces A beta Toxicity in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA; TRANSGENIC MICE; PLAQUE-FORMATION; IN-VIVO; NEUTRAL ENDOPEPTIDASE; TAU PHOSPHORYLATION; PEPTIDE DEGRADATION; LENTIVIRAL VECTORS; NEPRILYSIN; OLIGOMERS	Alzheimer's disease (AD), an incurable, progressive neurodegenerative disorder, is the most common form of dementia. Therapeutic options have been elusive due to the inability to deliver proteins across the blood-brain barrier (BBB). In order to improve the therapeutic potential for AD, we utilized a promising new approach for delivery of proteins across the BBB. We generated a lentivirus vector expressing the amyloid beta-degrading enzyme, neprilysin, fused to the ApoB transport domain and delivered this by intra-peritoneal injection to amyloid protein precursor (APP) transgenic model of AD. Treated mice had reduced levels of A beta, reduced plaques and increased synaptic density in the CNS. Furthermore, mice treated with the neprilysin targeting the CNS had a reversal of memory deficits. Thus, the addition of the ApoB transport domain to the secreted neprilysin generated a non-invasive therapeutic approach that may be a potential treatment in patients with AD.	[Spencer, Brian; Gindi, Ryan; Potkar, Rewati; Michael, Sarah; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Marr, Robert A.] Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, Dept Neurosci, N Chicago, IL USA; [Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, San Diego, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Rosalind Franklin University Medical & Science; Salk Institute; University of California System; University of California San Diego	Spencer, B (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			National Institutes of Health [AG022074, AG18440, AG010435]; NATIONAL INSTITUTE ON AGING [R37AG018440, P01AG010435, R01AG018440, P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health AG022074, AG18440, AG010435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis DN, 2007, J NEUROCHEM, V103, P216, DOI 10.1111/j.1471-4159.2007.04704.x; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; CONNELLY JC, 1993, J LEUKOCYTE BIOL, V53, P685, DOI 10.1002/jlb.53.6.685; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Cuello AC, 2008, NEURODEGENER DIS, V5, P146, DOI 10.1159/000113686; Cuello AC, 2005, BRAIN PATHOL, V15, P66; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hof PR, 1996, J AM GERIATR SOC, V44, P857, DOI 10.1111/j.1532-5415.1996.tb03748.x; Hong CS, 2006, GENE THER, V13, P1068, DOI 10.1038/sj.gt.3302719; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Huang F, 1999, AM J PATHOL, V155, P1741, DOI 10.1016/S0002-9440(10)65489-2; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; IIJIMAANDO K, 2008, J BIOL CHEM; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Marr RA, 2010, CURR ALZHEIMER RES, V7, P223, DOI 10.2174/156720510791050849; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Mohajeri MH, 2004, FEBS LETT, V562, P16, DOI 10.1016/S0014-5793(04)00169-3; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Poon HF, 2004, BRAIN RES, V1018, P86, DOI 10.1016/j.brainres.2004.05.048; Ray J, 1997, P NATL ACAD SCI USA, V94, P7047, DOI 10.1073/pnas.94.13.7047; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHIPP MA, 1991, BLOOD, V78, P1834; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Spencer B. J., 2007, P NATL ACAD SCI US; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; Terry Robert D., 1994, P179; Tian JZ, 2009, CURR ALZHEIMER RES, V6, P118, DOI 10.2174/156720509787602942; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yang LL, 2009, J PHARM PHARMACOL, V61, P375, DOI [10.1211/jpp/61.03.0013, 10.1211/jpp.61.03.0013]	55	55	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16575	10.1371/journal.pone.0016575	http://dx.doi.org/10.1371/journal.pone.0016575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304989	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300089
J	Takahashi, N; Ohashi, S; Sadykov, MR; Mizutani-Ui, Y; Kobayashi, I				Takahashi, Noriko; Ohashi, Seishi; Sadykov, Marat R.; Mizutani-Ui, Yoko; Kobayashi, Ichizo			IS-Linked Movement of a Restriction-Modification System	PLOS ONE			English	Article							TOXIN-ANTITOXIN LOCI; MODIFICATION GENE; GENOME; SEQUENCE; ENDONUCLEASE; INSERTION; PLASMIDS; BEHAVIOR; ELEMENTS; ABSENCE	Potential mobility of restriction-modification systems has been suggested by evolutionary/bioinformatic analysis of prokaryotic genomes. Here we demonstrate in vivo movement of a restriction-modification system within a genome under a laboratory condition. After blocking replication of a temperature-sensitive plasmid carrying a PaeR7I restriction-modification system in Escherichia coli cells, the plasmid was found integrated into the chromosome of the surviving cells. Sequence analysis revealed that, in the majority of products, the restriction-modification system was linked to chromosomal insertion sequences (ISs). Three types of products were: (I) apparent co-integration of the plasmid and the chromosome at a chromosomal IS1 or IS5 copy (24/28 analyzed); (II) de novo insertion of IS1 with the entire plasmid except for a 1-3 bp terminal deletion (2/28); and (III) reciprocal crossing-over between the plasmid and the chromosome involving 1-3 bp of sequence identity (2/28). An R-negative mutation apparently decreased the efficiency of successful integration by two orders of magnitude. Reconstruction experiments demonstrated that the restriction-dependence was mainly due to selection against cells without proper integration: their growth was inhibited by the restriction enzyme action. These results demonstrate collaboration of a mobile element and a restriction-modification system for successful joint migration. This collaboration may have promoted the spread and, therefore, the long-term persistence of these complexes and restriction-modification systems in a wide range of prokaryotes.	[Takahashi, Noriko; Sadykov, Marat R.; Kobayashi, Ichizo] Univ Tokyo, Grad Sch Frontier Sci, Lab Social Genome Sci, Dept Med Genome Sci,Minato Ku, Tokyo, Japan; [Takahashi, Noriko; Ohashi, Seishi; Sadykov, Marat R.; Mizutani-Ui, Yoko; Kobayashi, Ichizo] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Ohashi, Seishi; Kobayashi, Ichizo] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Minato Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Takahashi, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Lab Social Genome Sci, Dept Med Genome Sci,Minato Ku, Tokyo, Japan.	ikobaya@ims.u-tokyo.ac.jp	Kobayashi, Ichizo/GVT-8377-2022; Sadykov, Marat/H-3147-2011	Sadykov, Marat/0000-0001-7090-1929; Kobayashi, Ichizo/0000-0002-3854-1879	Japan Society for the Promotion of Science (JSPS) [19790316, 19657002, 21370001]; MEXT; Uehara Memorial Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (19790316, 19657002, 21370001, 19657002); the 21st century COE project and the Global COE project and the Medical Genome Science program from MEXT; Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ASAI T, 1993, EMBO J, V12, P3287, DOI 10.1002/j.1460-2075.1993.tb05998.x; Asakura Y, 2009, NUCLEIC ACIDS RES, V37, P3021, DOI 10.1093/nar/gkp148; AVILA P, 1984, MOL GEN GENET, V195, P288, DOI 10.1007/BF00332761; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BYRAPPA S, 1995, GENOME RES, V5, P404, DOI 10.1101/gr.5.4.404; Chen JH, 1998, J BACTERIOL, V180, P5279, DOI 10.1128/JB.180.19.5279-5283.1998; Chinen A, 2000, GENE, V259, P109, DOI 10.1016/S0378-1119(00)00459-5; Cousineau B, 2000, NATURE, V404, P1018, DOI 10.1038/35010029; ENGLER JA, 1981, GENE, V14, P155, DOI 10.1016/0378-1119(81)90111-6; Fukuda E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r163; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; GAMAS P, 1985, NATURE, V317, P458, DOI 10.1038/317458a0; GINGERAS TR, 1983, P NATL ACAD SCI-BIOL, V80, P402, DOI 10.1073/pnas.80.2.402; Gunn JS, 1997, NUCLEIC ACIDS RES, V25, P4147, DOI 10.1093/nar/25.20.4147; Handa N, 2000, J BACTERIOL, V182, P2218, DOI 10.1128/JB.182.8.2218-2229.2000; Handa N, 2001, MOL MICROBIOL, V40, P932, DOI 10.1046/j.1365-2958.2001.02436.x; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; HURST GDD, 1992, NATURE, V356, P659, DOI 10.1038/356659a0; Ichige A, 2005, J BACTERIOL, V187, P6612, DOI 10.1128/JB.187.19.6612-6621.2005; IIDA S, 1986, GENE, V45, P233, DOI 10.1016/0378-1119(86)90260-X; Khan F, 2010, NUCLEIC ACIDS RES, V38, P3019, DOI 10.1093/nar/gkp1221; Kita K, 1999, J BACTERIOL, V181, P6822, DOI 10.1128/JB.181.21.6822-6827.1999; Kobayashi I, 2004, NUCL ACID M, V14, P19; Kobayashi I, 2004, PLASMID BIOLOGY, P105; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KUSANO K, 1995, P NATL ACAD SCI USA, V92, P11095, DOI 10.1073/pnas.92.24.11095; Mochizuki A, 2006, GENETICS, V172, P1309, DOI 10.1534/genetics.105.042895; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; OCHMAN H, 1988, GENETICS, V120, P621; Ohno S, 2008, J BACTERIOL, V190, P2039, DOI 10.1128/JB.01319-07; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; POLARD P, 1994, J BACTERIOL, V176, P1192, DOI 10.1128/JB.176.4.1192-1196.1994; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Rochepeau P, 1997, MOL GEN GENET, V256, P387, DOI 10.1007/s004380050582; Sadykov M, 2003, MOL MICROBIOL, V48, P417, DOI 10.1046/j.1365-2958.2003.03464.x; SCHNETZ K, 1992, P NATL ACAD SCI USA, V89, P1244, DOI 10.1073/pnas.89.4.1244; STAHL MM, 1983, P NATL ACAD SCI-BIOL, V80, P2310, DOI 10.1073/pnas.80.8.2310; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; TAKAHASHI N, 1990, P NATL ACAD SCI USA, V87, P2790, DOI 10.1073/pnas.87.7.2790; Yahara K, 2009, P NATL ACAD SCI USA, V106, P18861, DOI 10.1073/pnas.0908404106	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16554	10.1371/journal.pone.0016554	http://dx.doi.org/10.1371/journal.pone.0016554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305031	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300085
J	van Eeden, PE; Wiese, MD; Aulfrey, S; Hales, BJ; Stone, SF; Brown, SGA				van Eeden, Pauline E.; Wiese, Michael D.; Aulfrey, Susan; Hales, Belinda J.; Stone, Shelley F.; Brown, Simon G. A.			Using Time-Resolved Fluorescence to Measure Serum Venom-Specific IgE and IgG	PLOS ONE			English	Article							JUMPER ANT VENOM; ALLERGY; DIAGNOSIS; PREVALENCE; ANTIBODIES; HISTAMINE; SEVERITY; RELEASE; HISTORY; DISEASE	We adapted DELFIA (TM) (dissociation-enhanced lanthanide fluoroimmunoassay), a time resolved fluorescence method, to quantitate whole venom specific and allergenic peptide- specific IgE (sIgE), sIgG(1) and sIgG(4) in serum from people clinically allergic to Australian native ant venoms, of which the predominant cause of allergy is jack jumper ant venom (JJAV). Intra-assay CV was 6.3% and inter-assay CV was 13.7% for JJAV sIgE. DELFIA and Phadia CAP JJAV sIgE results correlated well and had similar sensitivity and specificity for the detection of JJAV sIgE against intradermal skin testing as the gold standard. DELFIA was easily adapted for detecting sIgE to a panel of other native ant venoms.	[van Eeden, Pauline E.; Aulfrey, Susan; Stone, Shelley F.; Brown, Simon G. A.] Univ Western Australia, Ctr Clin Res Emergency Med, Western Australian Inst Med Res, Perth, WA 6009, Australia; [Wiese, Michael D.] Univ S Australia, Samson Inst Hlth Res, Adelaide, SA 5001, Australia; [Wiese, Michael D.; Brown, Simon G. A.] Royal Hobart Hosp, Dept Med, Hobart, Tas, Australia; [Hales, Belinda J.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, Australia; [Brown, Simon G. A.] Royal Perth Hosp, Dept Emergency Med, Perth, WA, Australia	University of Western Australia; University of South Australia; Royal Hobart Hospital; Telethon Kids Institute; University of Western Australia; Royal Perth Hospital; University of Western Australia	van Eeden, PE (corresponding author), Univ Western Australia, Ctr Clin Res Emergency Med, Western Australian Inst Med Res, Perth, WA 6009, Australia.	Pauline.vaneeden@uwa.edu.au	Wiese, Michael D/A-4743-2011; van Eeden, Pauline/O-8713-2014; Stone, Shelley/C-3804-2013; van Eeden, Pauline/H-4952-2014; Hales, Belinda J/C-3858-2013	Wiese, Michael D/0000-0002-3255-9242; Hales, Belinda J/0000-0003-2193-3996; Brown, Simon/0000-0002-9961-0890	National Health and Medical Research Council (NHMRC) [40405, 513901]; Fremantle Hospital Medical Research Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Fremantle Hospital Medical Research Foundation	This work was funded by National Health and Medical Research Council (NHMRC) Project Grant 40405, NHMRC Career Development Award 513901 (SGA Brown) and the Fremantle Hospital Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Brown SGA, 2003, LANCET, V361, P1001, DOI 10.1016/S0140-6736(03)12827-9; Brown SGA, 2003, J ALLERGY CLIN IMMUN, V111, P187, DOI 10.1067/mai.2003.48; Davies NW, 2004, TOXICON, V43, P173, DOI 10.1016/j.toxicon.2003.11.021; Douglas RG, 1998, J ALLERGY CLIN IMMUN, V101, P129, DOI 10.1016/S0091-6749(98)70206-4; Eberlein-Konig B, 2006, ALLERGY, V61, P1084, DOI 10.1111/j.1398-9995.2006.01122.x; EWAN PW, 1990, ALLERGY, V45, P22, DOI 10.1111/j.1398-9995.1990.tb01080.x; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; Hales BJ, 2004, INT ARCH ALLERGY IMM, V135, P101, DOI 10.1159/000080652; Maly FE, 1997, J INVEST ALLERG CLIN, V7, P217; Paganelli R, 1998, ALLERGY, V53, P763; Paris-Kohler A, 2000, J ALLERGY CLIN IMMUN, V105, P339, DOI 10.1016/S0091-6749(00)90085-X; Pumphrey RSH, 2000, J CLIN PATHOL, V53, P273, DOI 10.1136/jcp.53.4.273; Sainte-Laudy J, 2000, CLIN EXP ALLERGY, V30, P1166, DOI 10.1046/j.1365-2222.2000.00863.x; Smith DR, 2001, CLIN DIAGN LAB IMMUN, V8, P1070, DOI 10.1128/CDLI.8.6.1070-1075.2001; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Wiese MD, 2007, ALLERGY, V62, P437, DOI 10.1111/j.1398-9995.2007.01320.x; Wiese MD, 2006, TOXICON, V47, P208, DOI 10.1016/j.toxicon.2005.10.018; Wiese MD, 2008, J PHARMACEUT BIOMED, V46, P58, DOI 10.1016/j.jpba.2007.08.028	20	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16741	10.1371/journal.pone.0016741	http://dx.doi.org/10.1371/journal.pone.0016741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304970	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000286834300129
J	Wafar, M; Venkataraman, K; Ingole, B; Khan, SA; LokaBharathi, P				Wafar, Mohideen; Venkataraman, Krishnamurthy; Ingole, Baban; Khan, Syed Ajmal; LokaBharathi, Ponnapakkam			State of Knowledge of Coastal and Marine Biodiversity of Indian Ocean Countries	PLOS ONE			English	Review							ECOSYSTEMS	The Indian Ocean (IO) extends over 30% of the global ocean area and is rimmed by 36 littoral and 11 hinterland nations sustaining about 30% of the world's population. The landlocked character of the ocean along its northern boundary and the resultant seasonally reversing wind and sea surface circulation patterns are features unique to the IO. The IO also accounts for 30% of the global coral reef cover, 40,000 km(2) of mangroves, some of the world's largest estuaries, and 9 large marine ecosystems. Numerous expeditions and institutional efforts in the last two centuries have contributed greatly to our knowledge of coastal and marine biodiversity within the IO. The current inventory, as seen from the Ocean Biogeographic Information System, stands at 34,989 species, but the status of knowledge is not uniform among countries. Lack of human, institutional, and technical capabilities in some IO countries is the main cause for the heterogeneous level of growth in our understanding of the biodiversity of the IO. The gaps in knowledge extend to several smaller taxa and to large parts of the shelf and deep-sea ecosystems, including seamounts. Habitat loss, uncontrolled developmental activities in the coastal zone, overextraction of resources, and coastal pollution are serious constraints on maintenance of highly diverse biota, especially in countries like those of the IO, where environmental regulations are weak.	[Wafar, Mohideen; Ingole, Baban; LokaBharathi, Ponnapakkam] Natl Inst Oceanog, Div Biol Oceanog, Panaji, Goa, India; [Venkataraman, Krishnamurthy] Zool Survey India, Marine Biol Reg Ctr, Madras, Tamil Nadu, India; [Khan, Syed Ajmal] Ctr Adv Study Marine Biol, Fac Marine Sci, Parangipettai, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Zoological survey of India	Wafar, M (corresponding author), Natl Inst Oceanog, Div Biol Oceanog, Panaji, Goa, India.	mwafar@gmail.com	Ingole, Baban Shravan/GLR-9722-2022	Ingole, Baban/0000-0001-6096-6980	Census of Marine Life Secretariat	Census of Marine Life Secretariat	The source of funding for this work is the Census of Marine Life Secretariat. The funders had no role in study design, data collection and analysis and preparation of the manuscript except to the extent of having the manuscript subjected to internal review to conform with the pattern agreed upon for the publication in the collection "Marine biodiversity and biogeography - regional comparisons of global issues".	[Anonymous], 1997, WORLD MANGROVE ATLAS; [Anonymous], 2002, FIELD GUIDE SEASHORE; BELYANINA TN, 1992, J ICHTHYOL+, V32, P41; BERGHE EV, 2005, INDIAN J MAR SCI, V34, P128; Bhattathiri PMA, 2001, INDIAN OCEAN - A PERSPECTIVE, VOLS 1 AND 2, P271; Bourmaud CAF, 2005, INDIAN J MAR SCI, V34, P98; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Chun C., 1900, TIEFEN WELTMEERES SC; COLLETTE BB, 1991, B MAR SCI, V48, P1; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; DANIEL R, 1977, P S WARM WATER ZOOPL, P124; DAS A, 2009, 4 INT S CHEM BAS EC; DEBILIUS H, 2000, RED SEA REEF GUIDE; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; GEYNRIKH AK, 1992, OCEANOLOGY, V32, P84; GONSALVES MJ, 2009, INT CENS MAR MICR 45; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Griffiths CL, 2005, INDIAN J MAR SCI, V34, P35; Gupta RS, 2001, INDIAN OCEAN - A PERSPECTIVE, VOLS 1 AND 2, P327; HAPLERN BS, 2008, SCIENCE, V319, P948; Helmcke J. G., 1940, Wiss Ergebn Deuts Tiefsee Exped 1898-9 Jena, V24, P215; Hutomo M, 2005, INDIAN J MAR SCI, V34, P88; Ingole B, 2005, INDIAN J MAR SCI, V34, P27; *IOGOOS, 2002, STRAWM 1 IOGOOS M MA; Kathiresan K, 2005, INDIAN J MAR SCI, V34, P104; Keesing J, 2005, INDIAN J MAR SCI, V34, P11; Krishnan KP, 2006, GEOMICROBIOL J, V23, P31, DOI 10.1080/01490450500398286; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Mazlan AG, 2005, INDIAN J MAR SCI, V34, P76; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; MOISEYEV YV, 1986, OCEANOLOGY, V26, P86; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Nair V. R., 1977, P S WARM WAT ZOOPL N, P168; Nesis K. N., 1986, OCEANOLOGY, V26, P91; Oza RM, 2001, REVISED CHECKLIST IN; Parin N.V., 1985, OCEANOLOGY, V25, P781; Pasternak FA, 1964, T I OKEANOLOGII AKAD, V69, P183; Pasternak FA, 1976, T I OKEANOL AKAD NAU, V99, P45; PETTERSSON H, 1957, REP SWED DEEP SEA EX, V1, P1; QASIM S Z, 1978, Indian Journal of Marine Sciences, V7, P84; QASIM S Z, 1977, Indian Journal of Marine Sciences, V6, P122; Qasim S.Z., 1999, INDIAN OCEAN IMAGES; Qasim S. Z., 1998, GLIMPSES INDIAN OCEA; Qasim S. Z., 1990, RESOURCE MANAG OPTIM, V7, P141; Richmond M. D., 2001, MARINE SCI DEV TANZA, P241; Romanov E.V., 2003, 991 FAO; ROYAN J P, 1978, Indian Journal of Marine Sciences, V7, P116; Sherman K., 2009, 182 UNEP; Tomczak M., 1994, REGIONAL OCEANOGRAPH; Venkataraman K, 2005, INDIAN J MAR SCI, V34, P57; Veron J.E.N., 2000, CORALS WORLD, V1-3; WAFAR M, 2005, ENCY COASTAL SCI, P557; Wafar S, 2001, INDIAN OCEAN - A PERSPECTIVE, VOLS 1 AND 2, P539; WIN K, 1977, P S WARM WATER ZOOPL, P93; ZEITZCHEL B, 1973, BIOL INDIAN OCEAN	55	65	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14613	10.1371/journal.pone.0014613	http://dx.doi.org/10.1371/journal.pone.0014613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297949	gold, Green Submitted, Green Published			2022-12-27	WOS:000286834300005
J	Wang, ZR; Ren, XM; Wang, D; Guan, YM; Xia, L				Wang, Zhuoran; Ren, Xiaomei; Wang, Dong; Guan, Yongmei; Xia, Lei			Effects of Thioglycolic Acid on Parthenogenetic Activation of Xenopus Oocytes	PLOS ONE			English	Article							PROTEIN-KINASE; MOUSE EGGS; MATURATION; TRANSITION; HAIRDRESSERS; CYCLIN	Background: Existing in Permanent-wave solutions (PWS), thioglycolic acid (TGA) is widely used in hairdressing industry for its contribution to hair styling. However, the toxicity of TGA, especially its reproductive toxicity, gradually calls the attention of more and more researchers. Method: In this work, xenopus oocytes were pretreated with different concentration of TGA, and then activated by calcium ionophore A23187. During culture, the oocytes activation rates were taken note at different time after adding calcium ionophore A23187. At the end of the culture period, the nuclear status was detected under confocal microscope. In addition, some other samples were collected for Western-Blotting analysis. Result: TGA significantly inhibited the oocytes activation rate and pronuclear formation. It may be resulted from the inhibition of the degradation of p-ERK1, Mos and CyclinB2. Conclusion: TGA inhibits in vitro parthenogenetic activation of xenopus oocytes with inhibited the degradation of proteins involved in mitogenic-activated protein kinase (MAPK) and maturation-promoting factor (MPF) pathways.	[Wang, Zhuoran; Guan, Yongmei; Xia, Lei] Harbin Med Coll, Affiliated Hosp 1, Dept Reprod Med, Harbin, Peoples R China; [Ren, Xiaomei; Wang, Dong] Harbin Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Wang, Dong] Mudanjiang Med Coll, Sch Publ Hlth, Mudanjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Mudanjiang Medical University	Wang, ZR (corresponding author), Harbin Med Coll, Affiliated Hosp 1, Dept Reprod Med, Harbin, Peoples R China.	xialeiivf@126.com			National Nature Science Foundation of China [30400356]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (number 30400356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 1996, J CELL SCI, V109, P239; Becker Bret E., 2006, V322, P69; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Castro A, 2003, J BIOL CHEM, V278, P2236, DOI 10.1074/jbc.M207894200; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Gan HF, 2003, J OCCUP HEALTH, V45, P400, DOI 10.1539/joh.45.400; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GLOTZER AWM, 1991, NATURE, V349, P132; Hill WG, 2005, AM J PHYSIOL-RENAL, V289, pF217, DOI 10.1152/ajprenal.00022.2005; Hou SY, 2008, TOXICOL IND HEALTH, V24, P227, DOI 10.1177/0748233708095862; Iwao Y, 1996, DEV BIOL, V177, P558, DOI 10.1006/dbio.1996.0185; Kersemaekers WM, 1997, EPIDEMIOLOGY, V8, P396, DOI 10.1097/00001648-199707000-00008; Peters C, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-24; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; Rylander L, 2002, OCCUP ENVIRON MED, V59, P517, DOI 10.1136/oem.59.8.517; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SONG CH, 1994, J HARBIN MED U, V28, P387; Song Chunhua, 1990, IND HLTH OCCUP DIS, V16, P142; SONG CHZ, 2002, CHINESE J IND MED, V15, P78; SUN HLQ, 1997, J REPROD DEVELOP, V43, P189; Sun QY, 1998, ZYGOTE, V6, P277, DOI 10.1017/S0967199498000227; Sun QY, 1999, Z NATURFORSCH C, V54, P285; Tatemoto H, 2001, ZYGOTE, V9, P15, DOI 10.1017/S0967199401001034; [夏蕾 XIA Lei], 2009, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V21, P302; ZHANG GQ, 1990, HLTH TOXICOL, V4, P89; Zhang L, 2009, J TOXICOL ENV HEAL A, V72, P1123, DOI 10.1080/15287390902953519	28	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16220	10.1371/journal.pone.0016220	http://dx.doi.org/10.1371/journal.pone.0016220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297954	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300041
J	Wit, N; Krijger, PHL; van den Berk, PCM; Jacobs, H				Wit, Niek; Krijger, Peter H. L.; van den Berk, Paul C. M.; Jacobs, Heinz			Lysine Residue 185 of Rad1 Is a Topological but Not a Functional Counterpart of Lysine Residue 164 of PCNA	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; DNA-POLYMERASE-ETA; 9-1-1 CHECKPOINT CLAMP; SOMATIC HYPERMUTATION; TRANSLESION SYNTHESIS; MOLECULAR-MECHANISMS; GENE HYPERMUTATION; DAMAGE RESPONSE; MOUSE; UBIQUITIN	Monoubiquitylation of the homotrimeric DNA sliding clamp PCNA at lysine residue 164 (PCNA(K164)) is a highly conserved, DNA damage-inducible process that is mediated by the E2/E3 complex Rad6/Rad18. This ubiquitylation event recruits translesion synthesis (TLS) polymerases capable of replicating across damaged DNA templates. Besides PCNA, the Rad6/Rad18 complex was recently shown in yeast to ubiquitylate also 9-1-1, a heterotrimeric DNA sliding clamp composed of Rad9, Rad1, and Hus1 in a DNA damage-inducible manner. Based on the highly similar crystal structures of PCNA and 9-1-1, K185 of Rad1 (Rad1(K185)) was identified as the only topological equivalent of PCNA(K164). To investigate a potential role of posttranslational modifications of Rad1(K185) in DNA damage management, we here generated a mouse model with a conditional deletable Rad1(K185R) allele. The Rad1(K185) residue was found to be dispensable for Chk1 activation, DNA damage survival, and class switch recombination of immunoglobulin genes as well as recruitment of TLS polymerases during somatic hypermutation of immunoglobulin genes. Our data indicate that Rad1(K185) is not a functional counterpart of PCNA(K164).	[Wit, Niek; Krijger, Peter H. L.; van den Berk, Paul C. M.; Jacobs, Heinz] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Wit, N (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	h.jacobs@nki.nl		Jacobs, Heinz/0000-0001-6227-9850; Krijger, Peter/0000-0003-1702-348X	Netherlands Organisation for Scientific Research [NWO 917.56.328]; Dutch Cancer foundation [NKI-2008-4112]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer foundation(KWF Kankerbestrijding)	This work was funded by the Netherlands Organisation for Scientific Research (VIDI program NWO 917.56.328) and the Dutch Cancer foundation (KWF grant NKI-2008-4112) to HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LL, 2010, J BIOL CHEM, V285, P35267, DOI 10.1074/jbc.M110.161208; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Davies AA, 2010, CELL, V141, P1080, DOI 10.1016/j.cell.2010.04.039; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Faili A, 2009, J IMMUNOL, V182, P6353, DOI 10.4049/jimmunol.0900177; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Han L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-67; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Krijger PHL, 2009, J EXP MED, V206, P2603, DOI 10.1084/jem.20091707; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Langerak P, 2009, PHILOS T R SOC B, V364, P621, DOI 10.1098/rstb.2008.0223; Levitt PS, 2005, GENOMICS, V86, P212, DOI 10.1016/j.ygeno.2005.04.007; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, pR108, DOI 10.1016/S0960-9822(02)00674-7; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16669	10.1371/journal.pone.0016669	http://dx.doi.org/10.1371/journal.pone.0016669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304913	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300114
J	Thirant, C; Bessette, B; Varlet, P; Puget, S; Cadusseau, J; Tavares, SD; Studler, JM; Silvestre, DC; Susini, A; Villa, C; Miquel, C; Bogeas, A; Surena, AL; Dias-Morais, A; Leonard, N; Pflumio, F; Bieche, I; Boussin, FD; Sainte-Rose, C; Grill, J; Daumas-Duport, C; Chneiweiss, H; Junier, MP				Thirant, Cecile; Bessette, Barbara; Varlet, Pascale; Puget, Stephanie; Cadusseau, Josette; Tavares, Silvina Dos Reis; Studler, Jeanne-Marie; Silvestre, David Carlos; Susini, Aurelie; Villa, Chiara; Miquel, Catherine; Bogeas, Alexandra; Surena, Anne-Laure; Dias-Morais, Amelia; Leonard, Nadine; Pflumio, Francoise; Bieche, Ivan; Boussin, Francois D.; Sainte-Rose, Christian; Grill, Jacques; Daumas-Duport, Catherine; Chneiweiss, Herve; Junier, Marie-Pierre			Clinical Relevance of Tumor Cells with Stem-Like Properties in Pediatric Brain Tumors	PLOS ONE			English	Article							NEURAL STEM; IN-VITRO; GLIOBLASTOMA-MULTIFORME; NEUROSPHERE FORMATION; PRECURSOR CELLS; NERVOUS-SYSTEM; GROWTH-FACTOR; RADIAL GLIA; CANCER; EXPRESSION	Background: Primitive brain tumors are the leading cause of cancer-related death in children. Tumor cells with stem-like properties (TSCs), thought to account for tumorigenesis and therapeutic resistance, have been isolated from high-grade gliomas in adults. Whether TSCs are a common component of pediatric brain tumors and are of clinical relevance remains to be determined. Methodology/Principal Findings: Tumor cells with self-renewal properties were isolated with cell biology techniques from a majority of 55 pediatric brain tumors samples, regardless of their histopathologies and grades of malignancy (57% of embryonal tumors, 57% of low-grade gliomas and neuro-glial tumors, 70% of ependymomas, 91% of high-grade gliomas). Most high-grade glioma-derived oncospheres (10/12) sustained long-term self-renewal akin to neural stem cells (>7 self-renewals), whereas cells with limited renewing abilities akin to neural progenitors dominated in all other tumors. Regardless of tumor entities, the young age group was associated with self-renewal properties akin to neural stem cells (P = 0.05, chi-square test). Survival analysis of the cohort showed an association between isolation of cells with long-term self-renewal abilities and a higher patient mortality rate (P = 0.013, log-rank test). Sampling of low-and high-grade glioma cultures showed that self-renewing cells forming oncospheres shared a molecular profile comprising embryonic and neural stem cell markers. Further characterization performed on subsets of high-grade gliomas and one low-grade glioma culture showed combination of this profile with mesenchymal markers, the radio-chemoresistance of the cells and the formation of aggressive tumors after intracerebral grafting. Conclusions/Significance: In brain tumors affecting adult patients, TSCs have been isolated only from high-grade gliomas. In contrast, our data show that tumor cells with stem cell-like or progenitor-like properties can be isolated from a wide range of histological sub-types and grades of pediatric brain tumors. They suggest that cellular mechanisms fueling tumor development differ between adult and pediatric brain tumors.	[Thirant, Cecile; Bessette, Barbara; Varlet, Pascale; Tavares, Silvina Dos Reis; Studler, Jeanne-Marie; Villa, Chiara; Miquel, Catherine; Bogeas, Alexandra; Surena, Anne-Laure; Dias-Morais, Amelia; Leonard, Nadine; Daumas-Duport, Catherine; Chneiweiss, Herve; Junier, Marie-Pierre] Univ Paris 05, Team Glial Plast, INSERM, UMR894, Paris, France; [Varlet, Pascale; Villa, Chiara; Miquel, Catherine; Leonard, Nadine; Daumas-Duport, Catherine; Junier, Marie-Pierre] Hosp St Anne, Dept Neuropathol, Paris, France; [Puget, Stephanie; Sainte-Rose, Christian] Univ Paris 05, Necker Hosp, Pediat Neurosurg Dept, Paris, France; [Puget, Stephanie; Grill, Jacques] Gustave Roussy Canc Inst, CNRS UMR 8203, Villejuif, France; [Cadusseau, Josette] Univ Paris 12, Inserm U955, Team 10, Creteil, France; [Studler, Jeanne-Marie] Coll France, F-75231 Paris, France; [Silvestre, David Carlos; Boussin, Francois D.] Univ Paris 07, CEA, INSERM, Lab Radiopathol UMR 967, Fontenay Aux Roses, France; [Susini, Aurelie; Bieche, Ivan] Hop Rene Huguenin, Inst Curie, INSERM U735, Lab Oncogenet, St Cloud, France; [Pflumio, Francoise] Univ Paris 07, CEA, INSERM, Lab Cellules Souches Hematopoiet & Leucem,UMR U96, Fontenay Aux Roses, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Thirant, C (corresponding author), Univ Paris 05, Team Glial Plast, INSERM, UMR894, Paris, France.	marie-pierre.junier@inserm.fr	Bessette, Barbara/G-2317-2015; Bièche, Ivan/O-7399-2017; miquel, catherine/B-5536-2013; Grill, Jacques/R-8093-2019; Pflumio, Francoise/E-2074-2017; Thirant, Cecile/CAG-6257-2022; herve, chneiweiss/Q-6818-2019	Bessette, Barbara/0000-0001-6673-3694; Bièche, Ivan/0000-0002-2430-5429; herve, chneiweiss/0000-0001-7675-5061; Boussin, francois/0000-0003-3778-4403; Pflumio, Francoise/0000-0001-8995-596X; Thirant, Cecile/0000-0003-3873-5240; VARLET, pascale/0000-0002-8164-1517	Institut National du Cancer (INCa); Association pour la Recherche sur le Cancer (ARC); Ile de France Cancer stem cell network (INCa/ARC and INCa-CSC network Ile-de-France); Region Ile-de-France; Fondation pour la Recherche Medicale	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ile de France Cancer stem cell network (INCa/ARC and INCa-CSC network Ile-de-France)(Region Ile-de-FranceInstitut National du Cancer (INCA) France); Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This research was supported by Institut National du Cancer (INCa), Association pour la Recherche sur le Cancer (ARC), and the Ile de France Cancer stem cell network (grants INCa/ARC and INCa-CSC network Ile-de-France), the Region Ile-de-France (study fellowships to CT and AB), and the Fondation pour la Recherche Medicale (study fellowships to ALS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bieche I, 2001, ONCOGENE, V20, P8109, DOI 10.1038/sj.onc.1204917; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Bredel M, 1999, CLIN CANCER RES, V5, P1786; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Dai C, 2003, CANCER J, V9, P72, DOI 10.1097/00130404-200303000-00002; Dufour C, 2009, STEM CELLS, V27, P2373, DOI 10.1002/stem.155; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Grimmer MR, 2006, CURR OPIN PEDIATR, V18, P634, DOI 10.1097/MOP.0b013e32801080fe; Gritti A, 2001, PROTOCOLS NEURAL CEL, P173, DOI DOI 10.1385/1-59259-207-4:173; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kalifa C, 2005, J NEURO-ONCOL, V75, P279, DOI 10.1007/s11060-005-6752-x; Katsetos CD, 2009, J CELL PHYSIOL, V221, P514, DOI 10.1002/jcp.21884; Kelley TW, 2005, DIAGN MOL PATHOL, V14, P1, DOI 10.1097/01.pdm.0000138207.96718.85; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; Nakamura M, 2007, NEURO-ONCOLOGY, V9, P113, DOI 10.1215/15228517-2006-036; Nicolis SK, 2007, NEUROBIOL DIS, V25, P217, DOI 10.1016/j.nbd.2006.08.022; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Panosyan EH, 2010, PEDIATR BLOOD CANCER, V55, P644, DOI 10.1002/pbc.22627; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Real C, 2006, DEV BIOL, V300, P656, DOI 10.1016/j.ydbio.2006.09.032; Sharif A, 2007, ONCOGENE, V26, P2695, DOI 10.1038/sj.onc.1210071; Sharif A, 2004, NEUROSCIENCE, V126, P263, DOI 10.1016/j.neuroscience.2004.02.039; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sung T, 2000, BRAIN PATHOL, V10, P249, DOI 10.1111/j.1750-3639.2000.tb00258.x; Sutter R, 2007, BBA-REV CANCER, V1776, P125, DOI 10.1016/j.bbcan.2007.07.006; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Varlet P, 2004, NEUROSURGERY, V55, P1377, DOI 10.1227/01.NEU.0000143033.36582.40; Varlet P, 2005, NEUROCHIRURGIE, V51, P239; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	59	48	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16375	10.1371/journal.pone.0016375	http://dx.doi.org/10.1371/journal.pone.0016375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297991	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100026
J	Yamauchi, JG; Nemecz, A; Quoc, TN; Muller, A; Schroeder, LF; Talley, TT; Lindstrom, J; Kleinfeld, D; Taylor, P				Yamauchi, John G.; Nemecz, Akos; Quoc Thang Nguyen; Muller, Arnaud; Schroeder, Lee F.; Talley, Todd T.; Lindstrom, Jon; Kleinfeld, David; Taylor, Palmer			Characterizing Ligand-Gated Ion Channel Receptors with Genetically Encoded Ca++ Sensors	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; HIGH-THROUGHPUT ELECTROPHYSIOLOGY; COGNITIVE DEFICITS; EXPRESSION; AGONIST; SUBUNIT; TRANSITIONS; ALZHEIMERS; REPORTERS; BINDING	We present a cell based system and experimental approach to characterize agonist and antagonist selectivity for ligand-gated ion channels (LGIC) by developing sensor cells stably expressing a Ca2+ permeable LGIC and a genetically encoded Forster (or fluorescence) resonance energy transfer (FRET)-based calcium sensor. In particular, we describe separate lines with human alpha 7 and human alpha 4 beta 2 nicotinic acetylcholine receptors, mouse 5-HT3A serotonin receptors and a chimera of human alpha 7/mouse 5-HT3A receptors. Complete concentration-response curves for agonists and Schild plots of antagonists were generated from these sensors and the results validate known pharmacology of the receptors tested. Concentration-response relations can be generated from either the initial rate or maximal amplitudes of FRET-signal. Although assaying at a medium throughput level, this pharmacological fluorescence detection technique employs a clonal line for stability and has versatility for screening laboratory generated congeners as agonists or antagonists on multiple subtypes of ligand-gated ion channels. The clonal sensor lines are also compatible with in vivo usage to measure indirectly receptor activation by endogenous neurotransmitters.	[Yamauchi, John G.; Nemecz, Akos; Talley, Todd T.; Taylor, Palmer] Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Yamauchi, John G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Nemecz, Akos] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Quoc Thang Nguyen; Muller, Arnaud; Schroeder, Lee F.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Lindstrom, Jon] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania	Yamauchi, JG (corresponding author), Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu		Talley, Todd/0000-0002-1077-1947	National Institutes of Health (NIH) [R01-GM18360-39, U01-DA019372, R01-DA029706]; NSF [GK-12 0742551];  [GM-07752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029706, R01DA030929, U01DA019372] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) grants R01-GM18360-39, U01-DA019372 (PT), and R01-DA029706 (DK). AN and JGY acknowledge support by training grant GM-07752. JGY also acknowledges support from NSF GK-12 0742551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Chavez-Noriega LE, 2000, NEUROPHARMACOLOGY, V39, P2543, DOI 10.1016/S0028-3908(00)00134-9; Craig PJ, 2004, EUR J PHARMACOL, V502, P31, DOI 10.1016/j.ejphar.2004.08.042; Davies ARL, 1999, NEUROPHARMACOLOGY, V38, P679, DOI 10.1016/S0028-3908(98)00221-4; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Drobac E, 2010, J NEUROSCI RES, V88, P695, DOI 10.1002/jnr.22249; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Dunlop J, 2007, BIOCHEM PHARMACOL, V74, P1172, DOI 10.1016/j.bcp.2007.07.006; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Freedman R, 2008, AM J PSYCHIAT, V165, P1040, DOI 10.1176/appi.ajp.2008.07071135; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kleinfeld D, 2005, PLOS BIOL, V3, P1685, DOI 10.1371/journal.pbio.0030355; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Newhouse PA, 1997, DRUG AGING, V11, P206, DOI 10.2165/00002512-199711030-00005; NGUYEN QT, 2009, NAT NEUROSCI, V13, P127; Papke RL, 2005, NEUROSCI LETT, V378, P140, DOI 10.1016/j.neulet.2004.12.025; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; RIZZI JP, 1990, J MED CHEM, V33, P2721, DOI 10.1021/jm00172a007; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; ROSEN T, 1990, J MED CHEM, V33, P2715, DOI 10.1021/jm00172a006; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Sidach SS, 2009, J NEUROSCI METH, V182, P17, DOI 10.1016/j.jneumeth.2009.05.014; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1981, J BIOL CHEM, V256, P6692; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; TAYLOR P, 1990, P1; Warpman U, 1995, NEUROREPORT, V6, P2419, DOI 10.1097/00001756-199511270-00033; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008	42	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16519	10.1371/journal.pone.0016519	http://dx.doi.org/10.1371/journal.pone.0016519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305050	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100042
J	Moreau, S; Verdenaud, M; Ott, T; Letort, S; de Billy, F; Niebel, A; Gouzy, J; de Carvalho-Niebel, F; Gamas, P				Moreau, Sandra; Verdenaud, Marion; Ott, Thomas; Letort, Sebastien; de Billy, Francoise; Niebel, Andreas; Gouzy, Jerome; de Carvalho-Niebel, Fernanda; Gamas, Pascal			Transcription Reprogramming during Root Nodule Development in Medicago truncatula	PLOS ONE			English	Article							SUBTRACTIVE HYBRIDIZATION APPROACH; FACTOR SIGNAL-TRANSDUCTION; FALSE DISCOVERY RATE; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-MELILOTI; GENE-EXPRESSION; ARBUSCULAR MYCORRHIZA; LOTUS-JAPONICUS; ARABIDOPSIS-THALIANA; POTENTIAL REGULATORS	Many genes which are associated with root nodule development and activity in the model legume Medicago truncatula have been described. However information on precise stages of activation of these genes and their corresponding transcriptional regulators is often lacking. Whether these regulators are shared with other plant developmental programs also remains an open question. Here detailed microarray analyses have been used to study the transcriptome of root nodules induced by either wild type or mutant strains of Sinorhizobium meliloti. In this way we have defined eight major activation patterns in nodules and identified associated potential regulatory genes. We have shown that transcription reprogramming during consecutive stages of nodule differentiation occurs in four major phases, respectively associated with (i) early signalling events and/or bacterial infection; plant cell differentiation that is either (ii) independent or (iii) dependent on bacteroid differentiation; (iv) nitrogen fixation. Differential expression of several genes involved in cytokinin biosynthesis was observed in early symbiotic nodule zones, suggesting that cytokinin levels are actively controlled in this region. Taking advantage of databases recently developed for M. truncatula, we identified a small subset of gene expression regulators that were exclusively or predominantly expressed in nodules, whereas most other regulators were also activated under other conditions, and notably in response to abiotic or biotic stresses. We found evidence suggesting the activation of the jasmonate pathway in both wild type and mutant nodules, thus raising questions about the role of jasmonate during nodule development. Finally, quantitative RT-PCR was used to analyse the expression of a series of nodule regulator and marker genes at early symbiotic stages in roots and allowed us to distinguish several early stages of gene expression activation or repression.	[Moreau, Sandra; Verdenaud, Marion; Ott, Thomas; Letort, Sebastien; de Billy, Francoise; Niebel, Andreas; Gouzy, Jerome; de Carvalho-Niebel, Fernanda; Gamas, Pascal] Inst Natl Rech Agronom, Ctr Natl Rech Sci, Lab Interact Plantes Microorganismes, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Moreau, S (corresponding author), Inst Natl Rech Agronom, Ctr Natl Rech Sci, Lab Interact Plantes Microorganismes, Castanet Tolosan, France.	Pascal.Gamas@toulouse.inra.fr	de Carvalho-Niebel, Fernanda/E-3762-2018; Gouzy, Jerome/AAH-4977-2020; Ott, Thomas/H-8192-2013; Ott, Thomas/G-7056-2011; NIEBEL, Andreas/AAL-7687-2020	de Carvalho-Niebel, Fernanda/0000-0002-5596-9420; Gouzy, Jerome/0000-0001-5695-4557; Ott, Thomas/0000-0002-4494-9811; Verdenaud, Marion/0000-0002-4071-0782; Niebel, Andreas/0000-0002-3402-8381; Moreau, Sandra/0000-0003-1643-7883; Gamas, Pascal/0000-0002-6253-4249	EU; INRA; Marie-Curie Intra-European Fellowship [024587-Nodule Remorin]; Agence Nationale de la Recherche [ANR LEGoo GPLA06026G, ANR SYMbiMICS PCS-08-GENO-106]	EU(European Commission); INRA; Marie-Curie Intra-European Fellowship(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by an EU grant (FP6 Grain Legume integrated project, GLIP) and an INRA grant (AgroBI). Thomas Ott was supported by a Marie-Curie Intra-European Fellowship (024587-Nodule Remorin) and Marion Verdenaud and Sebastien Letort by grants from the Agence Nationale de la Recherche (ANR LEGoo GPLA06026G for both, as well as ANR SYMbiMICS PCS-08-GENO-106 for M. Verdenaud). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Barsch A, 2006, MOL PLANT MICROBE IN, V19, P998, DOI 10.1094/MPMI-19-0998; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobik C, 2006, J BACTERIOL, V188, P4890, DOI 10.1128/JB.00251-06; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Bozso Z, 2009, PLANT MOL BIOL, V70, P627, DOI 10.1007/s11103-009-9496-8; Catoira R, 2001, DEVELOPMENT, V128, P1507; Combier JP, 2008, CURR PLANT SCI BIOT, V42, P221; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cornbier JP, 2008, MOL PLANT MICROBE IN, V21, P1118, DOI 10.1094/MPMI-21-8-1118; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; Den Herder G, 2009, CURR OPIN PLANT BIOL, V12, P491, DOI 10.1016/j.pbi.2009.05.010; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Ferguson BJ, 2003, J PLANT GROWTH REGUL, V22, P47, DOI 10.1007/s00344-003-0032-9; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Floss DS, 2008, PLANT J, V56, P86, DOI 10.1111/j.1365-313X.2008.03575.x; Frugier F, 2000, GENE DEV, V14, P475; Frugier F, 2008, TRENDS PLANT SCI, V13, P115, DOI 10.1016/j.tplants.2008.01.003; GALLUSCI P, 1991, PLANT MOL BIOL, V17, P335, DOI 10.1007/BF00040629; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Godiard L, 2007, MOL PLANT MICROBE IN, V20, P321, DOI 10.1094/MPMI-20-3-0321; Gruber V, 2009, MOL GENET GENOMICS, V281, P55, DOI 10.1007/s00438-008-0392-8; Grunwald U, 2009, PLANTA, V229, P1023, DOI 10.1007/s00425-008-0877-z; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hause B, 2009, PHYTOCHEMISTRY, V70, P1589, DOI 10.1016/j.phytochem.2009.07.003; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Heidstra R, 1997, MOL PLANT MICROBE IN, V10, P215, DOI 10.1094/MPMI.1997.10.2.215; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Kiss E, 2009, PLANT PHYSIOL, V151, P1239, DOI 10.1104/pp.109.143933; Kuster H, 2007, PHYTOCHEMISTRY, V68, P19, DOI 10.1016/j.phytochem.2006.09.026; Kuppusamy KT, 2004, PLANT PHYSIOL, V136, P3682, DOI 10.1104/pp.104.045575; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Mathesius U., 2007, MEDICAGO TRUNCATULA; Mathis R, 1999, MOL PLANT MICROBE IN, V12, P544, DOI 10.1094/MPMI.1999.12.6.544; Maunoury N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009519; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Middleton PH, 2007, PLANT CELL, V19, P1221, DOI 10.1105/tpc.106.048264; Mithofer A, 2002, TRENDS PLANT SCI, V7, P440, DOI 10.1016/S1360-1385(02)02336-1; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Murakami Y, 2006, DNA RES, V13, P255, DOI 10.1093/dnares/dsl017; Naito Y, 2000, PLANT PHYSIOL, V124, P1087, DOI 10.1104/pp.124.3.1087; Naoumkina M, 2007, P NATL ACAD SCI USA, V104, P17909, DOI 10.1073/pnas.0708697104; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; Niebel FD, 1998, MOL PLANT MICROBE IN, V11, P504; NIEHAUS K, 1993, PLANTA, V190, P415; Oldroyd GED, 2003, PLANT PHYSIOL, V131, P1027, DOI 10.1104/pp.102.010710; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Peiter E, 2007, PLANT PHYSIOL, V145, P192, DOI 10.1104/pp.107.097261; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; PICHON M, 1992, PLANT CELL, V4, P1199, DOI 10.1105/tpc.4.10.1199; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Riely BK, 2007, PLANT J, V49, P208, DOI 10.1111/j.1365-313X.2006.02957.x; Rodo AP, 2008, J EXP BOT, V59, P2673, DOI 10.1093/jxb/ern137; Ruffel S, 2008, PLANT PHYSIOL, V146, P2020, DOI 10.1104/pp.107.115667; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schneider M, 2009, J PROTEOMICS, V72, P567, DOI 10.1016/j.jprot.2008.11.010; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tellstrom V, 2007, PLANT PHYSIOL, V143, P825, DOI 10.1104/pp.106.090985; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Town CD, 2006, CURR OPIN PLANT BIOL, V9, P122, DOI 10.1016/j.pbi.2006.01.004; Tretner C, 2008, J EXP BOT, V59, P2847, DOI 10.1093/jxb/ern145; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VANDEWIEL C, 1990, PLANT CELL, V2, P1009, DOI 10.1105/tpc.2.10.1009; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Yang C, 1994, PLANT PHYSIOL, V98, P143	101	77	77	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16463	10.1371/journal.pone.0016463	http://dx.doi.org/10.1371/journal.pone.0016463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304580	Green Published, gold			2022-12-27	WOS:000286663900052
J	Birnie, K; Cooper, R; Martin, RM; Kuh, D; Sayer, AA; Alvarado, BE; Bayer, A; Christensen, K; Cho, SI; Cooper, C; Corley, J; Craig, L; Deary, IJ; Demakakos, P; Ebrahim, S; Gallacher, J; Gow, AJ; Gunnell, D; Haas, S; Hemmingsson, T; Inskip, H; Jang, SN; Noronha, K; Osler, M; Palloni, A; Rasmussen, F; Santos-Eggimann, B; Spagnoli, J; Starr, J; Steptoe, A; Syddall, H; Tynelius, P; Weir, D; Whalley, LJ; Zunzunegui, MV; Ben-Shlomo, Y; Hardy, R				Birnie, Kate; Cooper, Rachel; Martin, Richard M.; Kuh, Diana; Sayer, Avan Aihie; Alvarado, Beatriz E.; Bayer, Antony; Christensen, Kaare; Cho, Sung-il; Cooper, Cyrus; Corley, Janie; Craig, Leone; Deary, Ian J.; Demakakos, Panayotes; Ebrahim, Shah; Gallacher, John; Gow, Alan J.; Gunnell, David; Haas, Steven; Hemmingsson, Tomas; Inskip, Hazel; Jang, Soong-nang; Noronha, Kenya; Osler, Merete; Palloni, Alberto; Rasmussen, Finn; Santos-Eggimann, Brigitte; Spagnoli, Jacques; Starr, John; Steptoe, Andrew; Syddall, Holly; Tynelius, Per; Weir, David; Whalley, Lawrence J.; Zunzunegui, Maria Victoria; Ben-Shlomo, Yoav; Hardy, Rebecca		HALCyon Study Team	Childhood Socioeconomic Position and Objectively Measured Physical Capability Levels in Adulthood: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CAUSE-SPECIFIC MORTALITY; CORONARY-HEART-DISEASE; LIFE-COURSE APPROACH; EARLY OLD-AGE; MUSCLE STRENGTH; COHORT PROFILE; GRIP STRENGTH; FOLLOW-UP; SOCIAL INEQUALITIES; FUNCTIONAL REACH	Background: Grip strength, walking speed, chair rising and standing balance time are objective measures of physical capability that characterise current health and predict survival in older populations. Socioeconomic position (SEP) in childhood may influence the peak level of physical capability achieved in early adulthood, thereby affecting levels in later adulthood. We have undertaken a systematic review with meta-analyses to test the hypothesis that adverse childhood SEP is associated with lower levels of objectively measured physical capability in adulthood. Methods and Findings: Relevant studies published by May 2010 were identified through literature searches using EMBASE and MEDLINE. Unpublished results were obtained from study investigators. Results were provided by all study investigators in a standard format and pooled using random-effects meta-analyses. 19 studies were included in the review. Total sample sizes in meta-analyses ranged from N = 17,215 for chair rise time to N = 1,061,855 for grip strength. Although heterogeneity was detected, there was consistent evidence in age adjusted models that lower childhood SEP was associated with modest reductions in physical capability levels in adulthood: comparing the lowest with the highest childhood SEP there was a reduction in grip strength of 0.13 standard deviations (95% CI: 0.06, 0.21), a reduction in mean walking speed of 0.07 m/s (0.05, 0.10), an increase in mean chair rise time of 6% (4%, 8%) and an odds ratio of an inability to balance for 5s of 1.26 (1.02, 1.55). Adjustment for the potential mediating factors, adult SEP and body size attenuated associations greatly. However, despite this attenuation, for walking speed and chair rise time, there was still evidence of moderate associations. Conclusions: Policies targeting socioeconomic inequalities in childhood may have additional benefits in promoting the maintenance of independence in later life.	[Birnie, Kate; Martin, Richard M.; Gunnell, David; Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Cooper, Rachel; Kuh, Diana; Hardy, Rebecca] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Cooper, Rachel; Kuh, Diana; Hardy, Rebecca] UCL, Div Populat Hlth, London, England; [Sayer, Avan Aihie; Cooper, Cyrus; Inskip, Hazel; Syddall, Holly] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Alvarado, Beatriz E.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Bayer, Antony; Gallacher, John] Cardiff Univ, Dept Primary Care & Publ Hlth, Ctr Hlth Sci Res, Cardiff, S Glam, Wales; [Christensen, Kaare] Univ So Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark; [Christensen, Kaare] Univ So Denmark, Inst Publ Hlth, Danish Aging Res Ctr, Odense, Denmark; [Cho, Sung-il] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Cho, Sung-il] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Cooper, Cyrus] Univ Oxford, Natl Inst Hlth, Oxford, England; [Cooper, Cyrus] Univ Oxford, Res Musculoskeletal Biomed Res Unit, Oxford, England; [Corley, Janie; Deary, Ian J.; Gow, Alan J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Corley, Janie; Deary, Ian J.; Gow, Alan J.; Starr, John] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Craig, Leone; Whalley, Lawrence J.] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Craig, Leone] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Demakakos, Panayotes; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London, England; [Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Haas, Steven] Arizona State Univ, Sch Social & Family Dynam, Tempe, AZ USA; [Hemmingsson, Tomas] Karolinska Inst, Div Occupat & Environm Med, Dept Publ Hlth Sci, Stockholm, Sweden; [Jang, Soong-nang] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Noronha, Kenya] Univ Fed Minas Gerais, Dept Econ, Belo Horizonte, MG, Brazil; [Osler, Merete] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Palloni, Alberto] Univ Wisconsin, Ctr Demog & Ecol, Madison, WI 53706 USA; [Santos-Eggimann, Brigitte; Spagnoli, Jacques] Univ Hosp Ctr, Inst Social & Prevent Med, Lausanne, Switzerland; [Santos-Eggimann, Brigitte; Spagnoli, Jacques] Univ Lausanne, Lausanne, Switzerland; [Starr, John] Univ Edinburgh, Dept Geriatr Med, Edinburgh, Midlothian, Scotland; [Weir, David] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Zunzunegui, Maria Victoria] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada	University of Bristol; University of London; University College London; University of London; University College London; University of Southampton; Queens University - Canada; Cardiff University; University of Southern Denmark; University of Southern Denmark; Seoul National University (SNU); Seoul National University (SNU); University of Oxford; University of Oxford; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Aberdeen; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Arizona State University; Arizona State University-Tempe; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Universidade Federal de Minas Gerais; University of Copenhagen; University of Wisconsin System; University of Wisconsin Madison; University of Lausanne; University of Edinburgh; University of Michigan System; University of Michigan; Universite de Montreal	Birnie, K (corresponding author), Univ Bristol, Dept Social Med, Bristol, Avon, England.	r.cooper@nshd.mrc.ac.uk	whalley, lawrence j/E-9019-2011; Christensen, Kaare/C-2360-2009; Bayer, Antony/H-4376-2019; Deary, Ian J/C-6297-2009; Kuh, Diana/L-6019-2014; Sayer, Avan Aihie/A-4359-2012; Bayer, Antony/H-4434-2019; Cooper, Rachel/ABE-3768-2021; Gow, Alan J/A-6070-2009; Osler, Merete/AAF-7885-2019; Steptoe, Andrew/Y-2440-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Jang, Soong-nang/AAC-1322-2020; Gunnell, David/ABE-6653-2020; Hardy, Rebecca/AFR-1989-2022; Inskip, Hazel/L-5467-2018	Christensen, Kaare/0000-0002-5429-5292; Deary, Ian J/0000-0002-1733-263X; Kuh, Diana/0000-0001-7386-2857; Bayer, Antony/0000-0002-7514-248X; Cooper, Rachel/0000-0003-3370-5720; Gow, Alan J/0000-0002-3320-4531; Ben-Shlomo, Yoav/0000-0001-6648-3007; Jang, Soong-nang/0000-0003-2621-945X; Gunnell, David/0000-0002-0829-6470; Inskip, Hazel/0000-0001-8897-1749; Martin, Richard/0000-0002-7992-7719; Steptoe, Andrew/0000-0001-7808-4943; Rasmussen, Finn/0000-0001-7915-7809; Osler, Merete/0000-0002-6921-220X; Hardy, Rebecca/0000-0001-9949-0799; Demakakos, Panayotes/0000-0002-7663-2122; Aihie Sayer, Avan/0000-0003-1283-6457; Cooper, Cyrus/0000-0003-3510-0709; Hemmingsson, Tomas/0000-0001-6156-3964; Santos-Eggimann, Brigitte/0000-0001-9115-6147; Zunzunegui, Maria-Victoria/0000-0003-0827-2804; von Zglinicki, Thomas/0000-0002-5939-0248; McNeill, Geraldine/0000-0003-0373-650X; Shiels, Paul/0000-0002-7577-9843; Tynelius, Per/0000-0001-8155-7406	New Dynamics of Ageing [RES-353-25-0001]; United Kingdom Medical Research Council; Medical Research Council; World Cancer Research Fund; Research into Ageing [302]; United Kingdom Survivors; Economic and Social Research Council; Wellcome Trust; British Heart Foundation; Biological Sciences Research Council; Alzheimer Research Trust; Biotechnology and Biological Sciences Research Council; Royal Society-Wolfson; Chief Scientist Office of the Scottish Government; Help the Aged; BBSRC; EPSRC; ESRC; MRC; Economic and Social Research Council [ES/G007543/1, ES/G00773X/1] Funding Source: researchfish; Medical Research Council [U1475000004, U1475000002, U1475000001, MC_UP_A620_1017, G0700704, MC_U123092721, MC_U123092720, MC_UP_A620_1014, MC_UP_A620_1015, G0700704B, G0601333] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish; ESRC [ES/G00773X/1, ES/G007543/1] Funding Source: UKRI; MRC [MC_U123092720, MC_U123092721, G0700704, G0601333, MC_UP_A620_1017, MC_UP_A620_1015] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [U01AG009740, R37AG025216] Funding Source: NIH RePORTER	New Dynamics of Ageing; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Research into Ageing; United Kingdom Survivors; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society-Wolfson(Royal Society of London); Chief Scientist Office of the Scottish Government; Help the Aged; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	KB is funded by a Research into Ageing PhD studentship (grant reference: 302). RC is receiving support from the HALCyon programme funded by the New Dynamics of Ageing (RES-353-25-0001). DK and RH are supported by the United Kingdom Medical Research Council. The Caerphilly Prospective Study was undertaken by the former MRC Epidemiology Unit (South Wales), and the Department of Social Medicine, University of Bristol, acts as the data custodian. The Boyd Orr cohort has received funding from the Medical Research Council, the World Cancer Research Fund, Research into Ageing, United Kingdom Survivors, the Economic and Social Research Council, the Wellcome Trust, and the British Heart Foundation. The Aberdeen Birth Cohort 1936 data collection was funded by the Biological Sciences Research Council (wave 1), the Alzheimer Research Trust and a career development award to LJW by the Wellcome Trust. The LBC1921 data were collected by grants from the Biotechnology and Biological Sciences Research Council (wave 1), a Royal Society-Wolfson Research Merit Award to IJD (wave 2), and the Chief Scientist Office of the Scottish Government (wave 3). The LBC1936 data were collected by a Research into Ageing programme grant; this research continues as part of the Help the Aged-funded Disconnected Mind project. The work was undertaken within The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the BBSRC, EPSRC, ESRC and MRC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado BE, 2008, J GERONTOL A-BIOL, V63, P1399, DOI 10.1093/gerona/63.12.1399; [Anonymous], 1984, J Epidemiol Community Health, V38, P259; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; BASSEY EJ, 1993, CLIN SCI, V84, P331, DOI 10.1042/cs0840331; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; BIRNIE K, 2010, J EPIDEMIOL IN PRESS; Breeze E, 1999, J EPIDEMIOL COMMUN H, V53, P765, DOI 10.1136/jech.53.12.765; Brunner E, 2009, J GERONTOL A-BIOL, V64, P1082, DOI 10.1093/gerona/glp078; Buchman AS, 2007, NEUROEPIDEMIOLOGY, V29, P66, DOI 10.1159/000109498; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; Chandola T, 2007, BRIT MED J, V334, P990, DOI 10.1136/bmj.39167.439792.55; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Frankel S, 1999, AM J EPIDEMIOL, V150, P1081, DOI 10.1093/oxfordjournals.aje.a009932; Fries JF, 2000, VACCINE, V18, P1584, DOI 10.1016/S0264-410X(99)00490-9; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Guralnik JM, 2006, J GERONTOL A-BIOL, V61, P694, DOI 10.1093/gerona/61.7.694; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haas S, 2008, SOC SCI MED, V66, P849, DOI 10.1016/j.socscimed.2007.11.004; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Henneberg M, 2001, AM J PHYS ANTHROPOL, V115, P62, DOI 10.1002/ajpa.1057; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; Jang SN, 2009, SOC SCI MED, V69, P1608, DOI 10.1016/j.socscimed.2009.09.007; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kaplan GA, 1997, AM J PUBLIC HEALTH, V87, P1409, DOI 10.2105/AJPH.87.9.1409; Kuh D, 2002, AM J EPIDEMIOL, V156, P627, DOI 10.1093/aje/kwf099; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Kuh D, 2006, AM J EPIDEMIOL, V164, P110, DOI 10.1093/aje/kwj193; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P1386, DOI 10.2105/AJPH.94.8.1386; Lawlor DA, 2006, AM J EPIDEMIOL, V164, P907, DOI 10.1093/aje/kwj319; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; Marmot M, 2010, FAIR SOC HLTH LIVES; Marmot M, 2002, HLTH WEALTH LIFESTYL; Martin RM, 2005, INT J EPIDEMIOL, V34, P742, DOI 10.1093/ije/dyi124; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monteverde M, 2009, POP STUD-J DEMOG, V63, P21, DOI 10.1080/00324720802621583; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Osler M, 2007, INT J EPIDEMIOL, V36, P77, DOI 10.1093/ije/dyl266; Osler M, 2009, SOC SCI MED, V68, P1425, DOI 10.1016/j.socscimed.2009.01.014; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rasmussen F, 2006, TWIN RES HUM GENET, V9, P883, DOI 10.1375/183242706779462741; Rautio N, 2005, SOC SCI MED, V60, P2405, DOI 10.1016/j.socscimed.2004.11.029; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Rockwood K, 2000, J GERONTOL A-BIOL, V55, pM70; Santos-Eggimann Brigitte, 2008, BMC Geriatr, V8, P20, DOI 10.1186/1471-2318-8-20; Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930; Seematter-Bagnoud Laurence, 2006, Eur J Ageing, V3, P41, DOI 10.1007/s10433-006-0022-4; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Siniarska A, 1992, Stud Hum Ecol, V10, P165; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; Starr JM, 2000, AGE AGEING, V29, P523, DOI 10.1093/ageing/29.6.523; *STATACORP LP, 2009, STATACORP STAT REL 1; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Syddall HE, 2010, INT J EPIDEMIOL, V39, P36, DOI 10.1093/ije/dyn275; Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127; Syddall H, 2009, J AGING HEALTH, V21, P913, DOI 10.1177/0898264309340793; THEORELL T, 1982, SOC SCI MED, V16, P469, DOI 10.1016/0277-9536(82)90055-7; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Turrell G, 2007, J EPIDEMIOL COMMUN H, V61, P723, DOI 10.1136/jech.2006.050609; Tyas SL, 2007, AGE AGEING, V36, P650, DOI 10.1093/ageing/afm120; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wolanski N, 1992, Stud Hum Ecol, V10, P243; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Zhang YQ, 2002, AM J EPIDEMIOL, V156, P1021, DOI 10.1093/aje/kwf141	76	100	100	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15564	10.1371/journal.pone.0015564	http://dx.doi.org/10.1371/journal.pone.0015564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21297868	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000286662800009
J	Martellini, JA; Cole, AL; Svoboda, P; Stuchlik, O; Chen, LM; Chai, KX; Gangrade, BK; Sorensen, OE; Pohl, J; Cole, AM				Martellini, Julie A.; Cole, Amy L.; Svoboda, Pavel; Stuchlik, Olga; Chen, Li-Mei; Chai, Karl X.; Gangrade, Bhushan K.; Sorensen, Ole E.; Pohl, Jan; Cole, Alexander M.			HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma	PLOS ONE			English	Article							SEMEN-MEDIATED ENHANCEMENT; ANTIMICROBIAL PEPTIDES; SEMENOGELIN-I; INFECTION; DEFENSINS; ANTIGEN; INHIBITOR; SUBSTRATE; FLUID; SEVI	We recently reported that HIV-1 infection can be inhibited by innate antimicrobial components of human seminal plasma (SP). Conversely, naturally occurring peptidic fragments from the SP-derived prostatic acid phosphatase ( PAP) have been reported to form amyloid fibrils called "SEVI'' and enhance HIV-1 infection in vitro. In order to understand the biological consequence of this proviral effect, we extended these studies in the presence of human SP. PAP-derived peptides were agitated to form SEVI and incubated in the presence or absence of SP. While PAP-derived peptides and SEVI alone were proviral, the presence of 1% SP ablated their proviral activity in several different anti-HIV-1 assays. The anti-HIV-1 activity of SP was concentration dependent and was reduced following filtration. Supraphysiological concentrations of PAP peptides and SEVI incubated with diluted SP were degraded within hours, with SP exhibiting proteolytic activity at dilutions as high as 1:200. Sub-physiological concentrations of two prominent proteases of SP, prostate-specific antigen (PSA) and matriptase, could degrade physiological and supraphysiological concentrations of PAP peptides and SEVI. While human SP is a complex biological fluid, containing both antiviral and proviral factors, our results suggest that PAP peptides and SEVI may be subject to naturally occurring proteolytic components capable of reducing their proviral activity.	[Martellini, Julie A.; Cole, Amy L.; Chen, Li-Mei; Chai, Karl X.; Cole, Alexander M.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Biomol Sci Ctr,Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Svoboda, Pavel; Pohl, Jan] Emory Univ, Microchem & Prote Facil, Atlanta, GA 30322 USA; [Svoboda, Pavel; Stuchlik, Olga; Pohl, Jan] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Div Safety Res, Atlanta, GA USA; [Gangrade, Bhushan K.] Ctr Reprod Med, Orlando, FL USA; [Sorensen, Ole E.] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden	State University System of Florida; University of Central Florida; Emory University; Centers for Disease Control & Prevention - USA; Lund University	Martellini, JA (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Biomol Sci Ctr,Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	acole@mail.ucf.edu		Sorensen, Ole E./0000-0001-8681-6921	National Institutes of Health [R01 AI052017, U19 AI065430]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052017, U19AI065430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by the National Institutes of Health: Grants R01 AI052017; and, U19 AI065430 (Project 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeon F, 2004, BIOL REPROD, V70, P768, DOI 10.1095/biolreprod.103.022533; Brillard-Bourdet M, 2002, EUR J BIOCHEM, V269, P390, DOI 10.1046/j.0014-2956.2001.02667.x; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; CHRISTOPHERHENN.J, 2008, ANIM HEALTH RES REV, P1; Cole AM, 2003, EXPERT OPIN THER TAR, V7, P329, DOI 10.1517/eott.7.3.329.22436; Com E, 2003, BIOL REPROD, V68, P95, DOI 10.1095/biolreprod.102.005389; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1997, SEMIN HEMATOL, V34, P343; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106; KELLY RW, 1995, HUM REPROD, V10, P1686, DOI 10.1093/oxfordjournals.humrep.a136156; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; LILJA H, 1985, FEBS LETT, V182, P181, DOI 10.1016/0014-5793(85)81179-0; LILJA H, 1993, WORLD J UROL, V11, P188; LILJA H, 1988, SCAND J CLIN LAB INV, V48, P13; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; Mangoni ME, 1996, FEBS LETT, V383, P93, DOI 10.1016/0014-5793(96)00236-0; MARDH PA, 1975, SCAND J UROL NEPHROL, V9, P17, DOI 10.3109/00365597509139907; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; MOULAEI T, 2010, PROTEIN SCI; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sorensen OE, 2003, J BIOL CHEM, V278, P28540, DOI 10.1074/jbc.M301608200; TAYLOR PW, 1952, SURG GYNECOL OBSTET, V94, P662; von Horsten HH, 2002, BIOL REPROD, V67, P804, DOI 10.1095/biolreprod.102.004564; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; YU JX, 1994, J BIOL CHEM, V269, P18843; Zhao H, 2008, PEPTIDES, V29, P505, DOI 10.1016/j.peptides.2008.01.009	35	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16285	10.1371/journal.pone.0016285	http://dx.doi.org/10.1371/journal.pone.0016285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283773	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200047
J	Borde, C; Barnay-Verdier, S; Gaillard, C; Hocini, H; Marechal, V; Gozlan, J				Borde, Chloe; Barnay-Verdier, Stephanie; Gaillard, Claire; Hocini, Hakim; Marechal, Vincent; Gozlan, Joel			Stepwise Release of Biologically Active HMGB1 during HSV-2 Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; GROUP BOX-1 PROTEIN; HIGH-MOBILITY-GROUP-BOX-1 PROTEIN; HIV-1 REPLICATION; IMMUNE-RESPONSES; DENDRITIC CELLS; GENITAL HERPES; TISSUE-DAMAGE; TYPE-2; INDUCTION	Background: High mobility group box 1 protein (HMGB1) is a major endogenous danger signal that triggers inflammation and immunity during septic and aseptic stresses. HMGB1 recently emerged as a key soluble factor in the pathogenesis of various infectious diseases, but nothing is known of its behaviour during herpesvirus infection. We therefore investigated the dynamics and biological effects of HMGB1 during HSV-2 infection of epithelial HEC-1 cells. Methodology/Principal Findings: Despite a transcriptional shutdown of HMGB1 gene expression during infection, the intracellular pool of HMGB1 protein remained unaffected, indicating its remarkable stability. However, the dynamics of HMGB1 was deeply modified in infected cells. Whereas viral multiplication was concomitant with apoptosis and HMGB1 retention on chromatin, a subsequent release of HMGB1 was observed in response to HSV-2 mediated necrosis. Importantly, extracellular HMGB1 was biologically active. Indeed, HMGB1-containing supernatants from HSV-2 infected cells induced the migration of fibroblasts from murine or human origin, and reactivated HIV-1 from latently infected T lymphocytes. These effects were specifically linked to HMGB1 since they were blocked by glycyrrhizin or by a neutralizing anti-HMGB1 antibody, and were mediated through TLR2 and the receptor for Advanced Glycation End-products (RAGE). Finally, we show that genital HSV-2 active infections also promote HMGB1 release in vivo, strengthening the clinical relevance of our experimental data. Conclusions: These observations target HMGB1 as an important actor during HSV-2 genital infection, notably in the setting of HSV-HIV co-infection.	[Borde, Chloe; Barnay-Verdier, Stephanie; Gaillard, Claire; Marechal, Vincent; Gozlan, Joel] Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers,UMRS872, Paris, France; [Hocini, Hakim] Hop Henri Mondor, INSERM, Inst Mondor Rech Biomed, U955, F-94010 Creteil, France; [Gozlan, Joel] Hop St Antoine, Serv Bacteriol Virol, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Borde, C (corresponding author), Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers,UMRS872, Paris, France.	joel.gozlan@sat.aphp.fr	GOZLAN, Joël/P-6014-2017; marechal, vincent/P-7719-2017	Barnay-Verdier, Stephanie/0000-0002-4615-3059	Ministere de l'Enseignement Superieur et de la Recherche Francais; Reseau Herpesvirus et Cancer; La Ligue contre le Cancer; SIDACTION; ANRS	Ministere de l'Enseignement Superieur et de la Recherche Francais; Reseau Herpesvirus et Cancer; La Ligue contre le Cancer(Ligue nationale contre le cancer); SIDACTION; ANRS(ANRSFrench National Research Agency (ANR))	C. Borde received a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche Francais, from the Reseau Herpesvirus et Cancer and from La Ligue contre le Cancer. This work was partly supported by SIDACTION and ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; BARQASHO B, J GEN VIROL; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; ERLICH KS, 1987, CLIN LAB MED, V7, P759, DOI 10.1016/S0272-2712(18)30715-7; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gaillard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002855; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Han JY, 2009, J VIROL, V83, P2765, DOI 10.1128/JVI.02088-08; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jerome KR, 2001, ARCH VIROL, V146, P2219, DOI 10.1007/s007050170032; Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; LeGoff J, 2007, AIDS, V21, P1569, DOI 10.1097/QAD.0b013e32825a69bd; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotfi R, 2009, J IMMUNOL, V183, P5023, DOI 10.4049/jimmunol.0900504; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Matis J, 2001, ACTA VIROL, V45, P269; Mayaud P, 2009, J INFECT DIS, V200, P216, DOI 10.1086/599991; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; NGUYENMLAB AJ, 2009, VIRUSES, V1, P965; Nowak P, 2006, CYTOKINE, V34, P17, DOI 10.1016/j.cyto.2006.03.010; Pachot A, 2005, CLIN IMMUNOL, V114, P61, DOI 10.1016/j.clim.2004.08.015; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Patel AR, 2009, INT J DERMATOL, V48, P36, DOI 10.1111/j.1365-4632.2009.03788.x; Popovic PJ, 2006, J IMMUNOL, V177, P8701, DOI 10.4049/jimmunol.177.12.8701; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Sunden-Cullberg J, 2006, CURR OPIN INFECT DIS, V19, P231, DOI 10.1097/01.qco.0000224816.96986.67; Taddeo B, 2002, P NATL ACAD SCI USA, V99, P17031, DOI 10.1073/pnas.252588599; Thapa M, 2008, Open Immunol J, V1, P33, DOI 10.2174/1874226200801010033; Thierry S, 2007, AIDS, V21, P283, DOI 10.1097/QAD.0b013e3280115b50; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Urbonaviciute V, 2009, AUTOIMMUNITY, V42, P305, DOI 10.1080/08916930902831803; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; YANG HLJ, 2010, ADDITION DITHIOTHREI; Zhang X, 2009, MUCOSAL IMMUNOL, V2, P129, DOI 10.1038/mi.2008.81	54	41	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16145	10.1371/journal.pone.0016145	http://dx.doi.org/10.1371/journal.pone.0016145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283827	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600025
J	Cabezas, F; Lagos, J; Cespedes, C; Vio, CP; Bronfman, M; Marzolo, MP				Cabezas, Felipe; Lagos, Jonathan; Cespedes, Carlos; Vio, Carlos P.; Bronfman, Miguel; Marzolo, Maria-Paz			Megalin/LRP2 Expression Is Induced by Peroxisome Proliferator-Activated Receptor -Alpha and -Gamma: Implications for PPARs' Roles in Renal Function	PLOS ONE			English	Article							PROXIMAL TUBULAR CELLS; ANGIOTENSIN-II; GENE-EXPRESSION; MEDIATED ENDOCYTOSIS; ALBUMIN REABSORPTION; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; MICE LACKING; FATTY-ACIDS; PIOGLITAZONE	Background: Megalin is a large endocytic receptor with relevant functions during development and adult life. It is expressed at the apical surface of several epithelial cell types, including proximal tubule cells (PTCs) in the kidney, where it internalizes apolipoproteins, vitamins and hormones with their corresponding carrier proteins and signaling molecules. Despite the important physiological roles of megalin little is known about the regulation of its expression. By analyzing the human megalin promoter, we found three response elements for the peroxisomal proliferator-activated receptor (PPAR). The objective of this study was to test whether megalin expression is regulated by the PPARs. Methodology/Principal Findings: Treatment of epithelial cell lines with PPAR alpha or PPAR gamma ligands increased megalin mRNA and protein expression. The stimulation of megalin mRNA expression was blocked by the addition of specific PPAR alpha or PPAR gamma antagonists. Furthermore, PPAR bound to three PPAR response elements located in the megalin promoter, as shown by EMSA, and PPAR alpha and its agonist activated a luciferase construct containing a portion of the megalin promoter and the first response element. Accordingly, the activation of PPAR alpha and PPAR gamma enhanced megalin expression in mouse kidney. As previously observed, high concentrations of bovine serum albumin (BSA) decreased megalin in PTCs in vitro; however, PTCs pretreated with PPAR alpha and PPAR gamma agonists avoided this BSA-mediated reduction of megalin expression. Finally, we found that megalin expression was significantly inhibited in the PTCs of rats that were injected with BSA to induce tubulointerstitial damage and proteinuria. Treatment of these rats with PPAR gamma agonists counteracted the reduction in megalin expression and the proteinuria induced by BSA. Conclusions: PPAR alpha/gamma and their agonists positively control megalin expression. This regulation could have an important impact on several megalin-mediated physiological processes and on pathophysiologies such as chronic kidney disease associated with diabetes and hypertension, in which megalin expression is impaired.	[Cabezas, Felipe; Lagos, Jonathan; Bronfman, Miguel; Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Cespedes, Carlos; Vio, Carlos P.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Cabezas, F (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Alameda 340, Santiago, Chile.	mmarzolo@bio.puc.cl	Céspedes, Carlos Leonardo/D-3138-2013	Céspedes, Carlos Leonardo/0000-0002-3715-3268; Vio, Carlos/0000-0003-1850-5958; , Carlos Cespedes/0000-0003-0297-7598	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica, CHILE) [1070373]; Proyecto Nucleo Milenio [P07/011-F]; Fondos del Programa Iniciativa Cientifica Milenio (ICM) [1080590];  [PFB 12-2007]	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica, CHILE)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Nucleo Milenio; Fondos del Programa Iniciativa Cientifica Milenio (ICM); 	This work was supported by Grants: Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica, CHILE) Grants 1070373 and Proyecto Nucleo Milenio P07/011-F, Fondos del Programa Iniciativa Cientifica Milenio (ICM) (www.iniciativamilenio.cl) to MPM and 1080590 to CPV (www.fondecyt.cl). PFB 12-2007 to CPV and MB (www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed NM, 2004, J BIOL CHEM, V279, P49747, DOI 10.1074/jbc.M408268200; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; Ardiles LG, 2006, KIDNEY INT, V69, P53, DOI 10.1038/sj.ki.5000005; Banks T, 2008, J HYPERTENS, V26, P468, DOI 10.1097/HJH.0b013e3282f2f0f3; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bulhak AA, 2009, AM J PHYSIOL-HEART C, V296, pH719, DOI 10.1152/ajpheart.00394.2008; Calkin AC, 2006, NEPHROL DIAL TRANSPL, V21, P2399, DOI 10.1093/ndt/gfl212; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Chinetti-Gbaguidi Giulia, 2005, Curr Atheroscler Rep, V7, P396, DOI 10.1007/s11883-005-0053-x; Christensen EI, 1998, RENAL FAILURE, V20, P191, DOI 10.3109/08860229809045102; Christensen EI, 2002, PEDIATR NEPHROL, V17, P993, DOI 10.1007/s00467-002-0956-5; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Cimini A, 2005, NEUROSCIENCE, V130, P325, DOI 10.1016/j.neuroscience.2004.09.043; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; CZEKAY RP, 1995, J CELL SCI, V108, P1433; DIETRICH MO, 2007, NEUROBIOL AGING; EDDY AA, 1989, AM J PATHOL, V135, P719; Erranz B, 2004, J LIPID RES, V45, P2185, DOI 10.1194/jlr.M400235-JLR200; Fang HL, 2005, MOL PHARMACOL, V67, P1257, DOI 10.1124/mol.104.005389; Fleming CE, 2009, J NEUROSCI, V29, P3220, DOI 10.1523/JNEUROSCI.6012-08.2009; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fujigaki Y, 2009, NEPHROL DIAL TRANSPL, V24, P2686, DOI 10.1093/ndt/gfp199; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; Giral H, 2007, TOXICOL IN VITRO, V21, P1066, DOI 10.1016/j.tiv.2007.03.021; Gonzalez-Villalobos R, 2006, AM J PHYSIOL-RENAL, V290, pF1270, DOI 10.1152/ajprenal.00164.2005; Gonzalez-Villalobos R, 2005, AM J PHYSIOL-RENAL, V288, pF420, DOI 10.1152/ajprenal.00243.2004; Guan YF, 2004, J AM SOC NEPHROL, V15, P2801, DOI 10.1097/01.ASN.0000139067.83419.46; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF1013, DOI 10.1152/ajprenal.1997.273.6.F1013; Guggino SE, 2007, NAT CLIN PRACT NEPHR, V3, P449, DOI 10.1038/ncpneph0541; Hama H, 2004, ENDOCRINOLOGY, V145, P3935, DOI 10.1210/en.2004-0074; Hayden MR, 2010, AM J NEPHROL, V31, P262, DOI 10.1159/000278757; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Imano E, 1998, DIABETES CARE, V21, P2135, DOI 10.2337/diacare.21.12.2135; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Knutson A, 1998, DNA CELL BIOL, V17, P551, DOI 10.1089/dna.1998.17.551; Kumpers P, 2007, AM J PHYSIOL-RENAL, V293, pF1355, DOI 10.1152/ajprenal.00003.2007; Lee BH, 2009, PEDIATR NEPHROL, V24, P2211, DOI 10.1007/s00467-009-1238-2; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Li RF, 2007, FEBS LETT, V581, P3311, DOI 10.1016/j.febslet.2007.06.017; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Liu W, 1998, EUR J CLIN INVEST, V28, P100; Madeddu P, 2001, KIDNEY INT, V59, P2233, DOI 10.1046/j.1523-1755.2001.00738.x; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Marino M, 2001, THYROID, V11, P47, DOI 10.1089/10507250150500667; Marzolo MP, 2003, TRAFFIC, V4, P273, DOI 10.1034/j.1600-0854.2003.00081.x; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; McCarthy RA, 2003, J CELL SCI, V116, P955, DOI 10.1242/jcs.00313; Miyazaki Y, 2007, KIDNEY INT, V72, P1367, DOI 10.1038/sj.ki.5002516; Mysiorek C, 2009, CURR NEUROVASC RES, V6, P181, DOI 10.2174/156720209788970081; Nakamura T, 2000, J DIABETES COMPLICAT, V14, P250, DOI 10.1016/S1056-8727(00)00124-0; Nakamura T, 2001, METABOLISM, V50, P1193, DOI 10.1053/meta.2001.26703; Nakamura T, 2006, DIABETES-METAB RES, V22, P385, DOI 10.1002/dmrr.633; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Odera K, 2007, BIOGERONTOLOGY, V8, P505, DOI 10.1007/s10522-007-9093-7; Orlando RA, 1998, J AM SOC NEPHROL, V9, P1759; Oyama Y, 2005, LAB INVEST, V85, P522, DOI 10.1038/labinvest.3700240; Pan GD, 2005, WORLD J GASTROENTERO, V11, P6061, DOI 10.3748/wjg.v11.i38.6061; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Roberts TJM, 2009, AM J PHYSIOL-HEART C, V297, pH1347, DOI 10.1152/ajpheart.00630.2009; Rokos CL, 1997, J BIOL CHEM, V272, P13452, DOI 10.1074/jbc.272.20.13452; Salas SP, 2007, HYPERTENSION, V50, P773, DOI 10.1161/HYPERTENSIONAHA.107.094540; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Shibata T, 2000, BRIT J PHARMACOL, V130, P495, DOI 10.1038/sj.bjp.0703328; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Stanton BA, 2004, KIDNEY; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Tojo A, 2003, HYPERTENS RES, V26, P413, DOI 10.1291/hypres.26.413; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Vinuesa E, 2008, AM J PHYSIOL-RENAL, V295, pF1554, DOI 10.1152/ajprenal.90250.2008; Vio CP, 2001, J AM SOC NEPHROL, V12, P649, DOI 10.1681/ASN.V124649; Watanabe T, 2004, PEDIATR NEPHROL, V19, P1305, DOI 10.1007/s00467-004-1605-y; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Wolf G, 2006, CONTRIB NEPHROL, V151, P175, DOI 10.1159/000095328; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF966, DOI 10.1152/ajprenal.1999.277.6.F966; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zafiriou S, 2004, KIDNEY INT, V65, P1647, DOI 10.1111/j.1523-1755.2004.00574.x; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	98	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16794	10.1371/journal.pone.0016794	http://dx.doi.org/10.1371/journal.pone.0016794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311715	Green Published, Green Submitted, gold			2022-12-27	WOS:000287036200041
J	Alvarez-Loayza, P; White, JF; Torres, MS; Balslev, H; Kristiansen, T; Svenning, JC; Gil, N				Alvarez-Loayza, Patricia; White, James F., Jr.; Torres, Monica S.; Balslev, Henrik; Kristiansen, Thea; Svenning, Jens-Christian; Gil, Nathalie			Light Converts Endosymbiotic Fungus to Pathogen, Influencing Seedling Survival and Niche-Space Filling of a Common Tropical Tree, Iriartea deltoidea	PLOS ONE			English	Article							SPATIAL-PATTERNS; MORTALITY; ENDOPHYTES; BOTRYOSPHAERIACEAE; DIVERSIFICATION; DISTRIBUTIONS; POPULATIONS; DIVERSITY; DOMINANCE; SYMBIOSIS	Pathogens are hypothesized to play an important role in the maintenance of tropical forest plant species richness. Notably, species richness may be promoted by incomplete filling of niche space due interactions of host populations with their pathogens. A potentially important group of pathogens are endophytic fungi, which asymptomatically colonize plants and are diverse and abundant in tropical ecosystems. Endophytes may alter competitive abilities of host individuals and improve host fitness under stress, but may also become pathogenic. Little is known of the impacts of endophytes on niche-space filling of their hosts. Here we evaluate how a widespread fungal endophyte infecting a common tropical palm influences its recruitment and survival in natural ecosystems, and whether this impact is modulated by the abiotic environment, potentially constraining host niche-space filling. Iriartea deltoidea dominates many wet lowland Neotropical forests. Diplodia mutila is a common asymptomatic endophyte in mature plants; however, it causes disease in some seedlings. We investigated the effects of light availability on D. mutila disease expression. We found I. deltoidea seedlings to preferentially occur under shady conditions. Correspondingly, we also found that high light triggers endophyte pathogenicity, while low light favors endosymbiotic development, constraining recruitment of endophyte-infested seedlings to shaded understory by reducing seedling survival in direct light. Pathogenicity of D. mutila under high light is proposed to result from light-induced production of H2O2 by the fungus, triggering hypersensitivity, cell death, and tissue necrosis in the palm. This is the first study to demonstrate that endophytes respond to abiotic factors to influence plant distributions in natural ecosystems; and the first to identify light as a factor influencing where an endophyte is placed on the endosymbiont-pathogen continuum. Our findings show that pathogens can indeed constrain niche-space filling of otherwise successful tropical plant species, providing unoccupied niche space for other species.	[Alvarez-Loayza, Patricia; White, James F., Jr.; Torres, Monica S.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Alvarez-Loayza, Patricia] Duke Univ, Nicholas Sch Environm, Ctr Trop Conservat, Durham, NC 27708 USA; [Balslev, Henrik; Kristiansen, Thea; Svenning, Jens-Christian] Aarhus Univ, Ecoinformat & Biodivers Grp, Dept Biol Sci, Aarhus, Denmark; [Gil, Nathalie] Univ Nacl San Antonio de Abad, Cuzco, Peru	Rutgers State University New Brunswick; Duke University; Aarhus University	Alvarez-Loayza, P (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA.	pcaz@duke.edu	Balslev, Hendrik/AAE-4071-2020; Balslev, Henrik/J-9191-2013; Svenning, Jens-Christian/C-8977-2012; White, James F/C-2280-2009	Balslev, Henrik/0000-0002-7101-7120; Svenning, Jens-Christian/0000-0002-3415-0862; Alvarez-Loayza, Patricia/0000-0002-0090-4013; White, James/0000-0002-6780-7066	Rutgers University; Organization for Tropical Studies; Amazon Conservation Association (ACA); New Jersey Agricultural Experiment Station; Danish Natural Science Research Council [272-06-0476, 272-07-0242]; European Community [212631]	Rutgers University; Organization for Tropical Studies; Amazon Conservation Association (ACA); New Jersey Agricultural Experiment Station; Danish Natural Science Research Council(Danish Natural Science Research Council); European Community(European Commission)	P. Alvarez-Loayza was supported by Rutgers University Fellowship, Pre-Dissertation Travel Grant, and the Francis J. Bossuyt Fellowship from the Organization for Tropical Studies, and Amazon Conservation Association (ACA). This research was also financially supported by the New Jersey Agricultural Experiment Station, the Danish Natural Science Research Council (grants 272-06-0476 and 272-07-0242) and the European Community FP7 programme PALMS project (grant agreement 212631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios GN, 2005, PLANT PATHOLOGY; Alvarez-Loayza P, 2008, PLANT PATHOL, V57, P382, DOI 10.1111/j.1365-3059.2007.01747.x; ALVAREZLOAYZA P, 2009, THESIS RUTGERS U NEW; Arnold AE, 2007, J TROP ECOL, V23, P369, DOI 10.1017/S0266467407004038; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; CONNELL J H, 1971, P298; Crous PW, 2006, STUD MYCOL, P235, DOI 10.3114/sim.55.1.235; Damm U, 2007, MYCOLOGIA, V99, P664, DOI 10.3852/mycologia.99.5.664; Grubb PJ, 2008, ANN BOT-LONDON, V101, P1379, DOI 10.1093/aob/mcn047; Hood LA, 2004, J ECOL, V92, P816, DOI 10.1111/j.0022-0477.2004.00917.x; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kristiansen T, 2009, ACTA OECOL, V35, P554, DOI 10.1016/j.actao.2009.05.001; Kuldau GA, 2000, BOOK SOIL P, P85; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Macia MJ, 2005, J TROP ECOL, V21, P613, DOI 10.1017/S0266467405002579; Mittler R, 1997, J CELL SCI, V110, P1333; Munkres KD., 1990, FUNG GENET NEWSLETT, V37, P24, DOI DOI 10.4148/1941-4765.1477; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Panter SN, 2002, ADV BOT RES, V38, P251, DOI 10.1016/S0065-2296(02)38032-7; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Petrini O., 1986, MICROBIOLOGY PHYLLOS, P175; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; PITMAN NCA, 2007, OVERVIEW LOS AMIGOS; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; RAVISHANKAR JP, 1995, BOT MAR, V38, P413, DOI 10.1515/botm.1995.38.1-6.413; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P1265, DOI 10.1073/pnas.0913626107; Rodriguez R. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P261, DOI 10.1023/B:MITI.0000029922.31110.97; Schulz B, 1998, SYMBIOSIS, V25, P213; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Slippers Bernard, 2007, Fungal Biology Reviews, V21, P90, DOI 10.1016/j.fbr.2007.06.002; Sutton B. C., 1980, The Coelomycetes. Fungi imperfecti with pycnidia, acervuli and stromata.; Svenning JC, 1999, J TROP ECOL, V15, P355, DOI 10.1017/S0266467499000875; Svenning JC, 2001, BOT REV, V67, P1, DOI 10.1007/BF02857848; Terborgh J, 2001, J TROP ECOL, V17, P695, DOI 10.1017/S0266467401001511; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Wattenberg I., 1995, Ecotropica, V1, P21	43	104	108	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16386	10.1371/journal.pone.0016386	http://dx.doi.org/10.1371/journal.pone.0016386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305008	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300058
J	Crucitti, T; Jespers, V; Mulenga, C; Khondowe, S; Vandepitte, J; Buve, A				Crucitti, Tania; Jespers, Vicky; Mulenga, Chanda; Khondowe, Shepherd; Vandepitte, Judith; Buve, Anne			Non-Sexual Transmission of Trichomonas vaginalis in Adolescent Girls Attending School in Ndola, Zambia	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED DISEASES; HIV-1; INFECTION; EPIDEMIOLOGY; ACQUISITION; PREVALENCE; WOMEN; RISK; PCR	Objectives: To identify risk factors for trichomoniasis among young women in Ndola, Zambia. Method: The study was a cross-sectional study among adolescent girls aged 13-16 years in Ndola, Zambia. Study participants were recruited from schools in selected administrative areas that represented the different socio-economic strata in town. Consenting participants were interviewed about their socio-demographic characteristics; sexual behaviour; and hygiene practices. Self-administered vaginal swabs were tested for Trichomonas vaginalis. HSV-2 antibodies were determined on serum to validate the self-reported sexual activity. Results: A total of 460 girls participated in the study. The overall prevalence of trichomoniasis was 27.1%, 33.9% among girls who reported that they had ever had sex and 24.7% among virgins. In multivariate analysis the only statistically significant risk factor for trichomoniasis was inconsistent use of soap. For the virgins, none of the risk factors was significantly associated with trichomoniasis, but the association with use of soap (not always versus always) and type of toilet used (pit latrine/bush versus flush toilet) was of borderline significance. Conclusion: We found a high prevalence of trichomoniasis in girls in Ndola who reported that they had never had sex. We postulate that the high prevalence of trichomoniasis in virgins in Ndola is due to non-sexual transmission of trichomoniasis via shared bathing water and inconsistent use of soap.	[Crucitti, Tania] Inst Trop Med, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Jespers, Vicky; Vandepitte, Judith; Buve, Anne] Inst Trop Med, HIV STI Epidemiol & Control Unit, B-2000 Antwerp, Belgium; [Mulenga, Chanda; Khondowe, Shepherd] Trop Dis Res Ctr, Ndola, Zambia	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Crucitti, T (corresponding author), Inst Trop Med, HIV STI Reference Lab, B-2000 Antwerp, Belgium.	tcrucitti@itg.be	Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AAB-9967-2019	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038	Directorate General for Development Cooperation of the Belgian Government [904100]	Directorate General for Development Cooperation of the Belgian Government	This study was made possible thanks to a grant from the Directorate General for Development Cooperation of the Belgian Government (AIDS Impuls Fonds no904100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Sarkodie Y, 2007, SEX TRANSM INFECT, V83, P130, DOI 10.1136/sti.2006.020941; ADUSARKODIE Y, 1995, GENITOURIN MED, V71, P199; BURCH TA, 1959, AM J TROP MED HYG, V8, P312, DOI 10.4269/ajtmh.1959.8.312; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Buve A, 2001, AIDS, V15, pS79, DOI 10.1097/00002030-200108004-00009; CATES W, 1993, AM J OBSTET GYNECOL, V169, P341, DOI 10.1016/0002-9378(93)90085-W; CHAPPAZ G, 1961, Rev Fr Gynecol Obstet, V56, P677; CHARLES SX, 1991, J TROP PEDIATRICS, V37, P90, DOI 10.1093/tropej/37.2.90; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Crucitti T, 2003, SEX TRANSM INFECT, V79, P393, DOI 10.1136/sti.79.5.393; Crucitti T, 2010, SEX TRANSM DIS, V37, P223, DOI 10.1097/OLQ.0b013e3181c21f93; FOUTS A, 1980, J INFECT DIS, V41, P137; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; KENGNE P, 1994, CELL MOL BIOL, V40, P819; Kissinger P, 2009, SEX TRANSM DIS, V36, P11, DOI 10.1097/OLQ.0b013e318186decf; Krieger H, 1995, Gesundheitswesen, V57, P812; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Peterson K, 2010, SEX TRANSM INFECT, V86, P353, DOI 10.1136/sti.2010.043125; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Shaio MF, 1997, J CLIN MICROBIOL, V35, P132, DOI 10.1128/JCM.35.1.132-138.1997; UNAIDS/WHO, 2008, UNAIDS WHO EP FACT S; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; 1957, TRICHOMONAS INFECT, P1239	26	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16310	10.1371/journal.pone.0016310	http://dx.doi.org/10.1371/journal.pone.0016310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305023	Green Published, gold			2022-12-27	WOS:000286834300049
J	Harner, S; Noessner, E; Nadas, K; Leumann-Runge, A; Schiemann, M; Faber, FL; Heinrich, J; Krauss-Etschmann, S				Harner, Susanne; Noessner, Elfriede; Nadas, Korinna; Leumann-Runge, Anke; Schiemann, Matthias; Faber, Fabienne L.; Heinrich, Joachim; Krauss-Etschmann, Susanne			Cord Blood V alpha 24-V beta 11(+) Natural Killer T Cells Display a Th2-Chemokine Receptor Profile and Cytokine Responses	PLOS ONE			English	Article							INVARIANT NKT CELLS; CUTTING EDGE; LYMPHOCYTES; SUBSETS; CD4(+); REQUIREMENTS; ENVIRONMENT; EXPRESSION; V-ALPHA-24; PROTECTION	Background: The fetal immune system is characterized by a Th2 bias but it is unclear how the Th2 predominance is established. Natural killer T (NKT) cells are a rare subset of T cells with immune regulatory functions and are already activated in utero. To test the hypothesis that NKT cells are part of the regulatory network that sets the fetal Th2 predominance, percentages of V alpha 24(+)V beta 11(+) NKT cells expressing Th1/Th2-related chemokine receptors (CKR) were assessed in cord blood. Furthermore, IL-4 and IFN-gamma secreting NKT cells were quantified within the single CKR+ subsets. Results: Cord blood NKT cells expressed the Th2-related CCR4 and CCR8 at significantly higher frequencies compared to peripheral blood NKT cells from adults, while CXCR3(+) and CCR5(+) cord blood NKT cells (Th1-related) were present at lower percentages. Within CD4(neg) CD8(neg) (DN) NKT cells, the frequency of IL-4 producing NKT cells was significantly higher in cord blood, while frequencies of IFN-gamma secreting DN NKT cells tended to be lower. A further subanalysis showed that the higher percentage of IL-4 secreting DN NKT cells was restricted to CCR3(+), CCR4(+), CCR5(+), CCR6(+), CCR7(+), CCR8(+) and CXCR4(+) DN subsets in cord blood. This resulted in significantly decreased IFN-gamma/IL-4 ratios of CCR3+, CCR6+ and CCR8+ cord blood DN NKT cells. Sequencing of VA24AJ18 T cell receptor (TCR) transcripts in sorted cord blood V alpha 24V beta 11 cells confirmed the invariant TCR alpha-chain ruling out the possibility that these cells represent an unusual subset of conventional T cells. Conclusions: Despite the heterogeneity of cord blood NKT cells, we observed a clear Th2-bias at the phenotypic and functional level which was mainly found in the DN subset. Therefore, we speculate that NKT cells are important for the initiation and control of the fetal Th2 environment which is needed to maintain tolerance towards self-antigens as well as non-inherited maternal antigens.	[Harner, Susanne; Krauss-Etschmann, Susanne] Ludwig Maximilians Univ Hosp, Comprehens Pneumol Ctr, Grosshadern, Germany; [Noessner, Elfriede] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Grosshadern, Germany; [Schiemann, Matthias] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Schiemann, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Immune Monitoring, Neuherberg, Germany; [Harner, Susanne; Nadas, Korinna; Leumann-Runge, Anke; Faber, Fabienne L.; Krauss-Etschmann, Susanne] Univ Munich, Childrens Hosp, D-8000 Munich, Germany; [Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Harner, S (corresponding author), Ludwig Maximilians Univ Hosp, Comprehens Pneumol Ctr, Grosshadern, Germany.	susanne.krauss-etschmann@med.uni-muenchen.de	Krauss-Etschmann, Susanne/H-5198-2018; Heinrich, Joachim/N-1720-2013	Krauss-Etschmann, Susanne/0000-0001-5945-5702; Heinrich, Joachim/0000-0002-9620-1629	Helmholtz Center Munich; Deutsche Forschungsgemeinschaft [SFB-TR36]	Helmholtz Center Munich(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was financed with resources provided by the Helmholtz Center Munich. This work was also supported by grants from the Deutsche Forschungsgemeinschaft SFB-TR36 (to EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baev DV, 2004, BLOOD, V104, P4150, DOI 10.1182/blood-2004-04-1629; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Ege MJ, 2008, J ALLERGY CLIN IMMUN, V122, P407, DOI 10.1016/j.jaci.2008.06.011; Eger KA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000050; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Huang Y, 2008, J IMMUNOL, V180, P2367, DOI 10.4049/jimmunol.180.4.2367; Kadowaki N, 2001, J EXP MED, V193, P1221, DOI 10.1084/jem.193.10.1221; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Nowak M, 2007, INT REV IMMUNOL, V26, P95, DOI 10.1080/08830180601070195; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Piccinni MP, 2010, J REPROD IMMUNOL, V85, P71, DOI 10.1016/j.jri.2010.01.006; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Prell C, 2003, IMMUNOBIOLOGY, V208, P367, DOI 10.1078/0171-2985-00284; Prussin C, 1997, J IMMUNOL, V159, P5862; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Sandberg JK, 2004, P NATL ACAD SCI USA, V101, P7058, DOI 10.1073/pnas.0305986101; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Uemura Y, 2008, INT IMMUNOL, V20, P405, DOI 10.1093/intimm/dxn001; van der Vliet HJJ, 2000, BLOOD, V95, P2440, DOI 10.1182/blood.V95.7.2440.007k35_2440_2442	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15714	10.1371/journal.pone.0015714	http://dx.doi.org/10.1371/journal.pone.0015714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305060	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300023
J	Larkin, EK; Gebretsadik, T; Koestner, N; Newman, MS; Liu, ZW; Carroll, KN; Minton, P; Woodward, K; Hartert, TV				Larkin, Emma K.; Gebretsadik, Tebeb; Koestner, Nathan; Newman, Mark S.; Liu, Zhouwen; Carroll, Kecia N.; Minton, Patricia; Woodward, Kim; Hartert, Tina V.			Agreement of Blood Spot Card Measurements of Vitamin D Levels with Serum, Whole Blood Specimen Types and a Dietary Recall Instrument	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS-D; NATIONAL-HEALTH; ASSAY; PREVENTION; ASTHMA; D-2	Background: The ability to measure 25-hydroxyvitamin D (25OHD) levels from blood spot cards can simplify sample collection versus samples obtained by venipuncture, particularly in populations in whom it is difficult to draw blood. We sought to validate the use of blood spot samples for the measurement of 25OHD compared to serum or whole blood samples and correlate the measured levels with intake estimated from dietary recall. Methods: Utilizing 109 biological mothers of infants enrolled in the Tennessee Children's Respiratory Initiative cohort, we measured 25OHD levels through highly selective liquid chromatography-tandem mass spectrometry on samples from blood spot cards, serum, and whole blood collected at enrollment. Dietary questionnaires (n = 65) were used to assess 25OHD intake by dietary recall. Sample collection measures were assessed for agreement and 25OHD levels for association with dietary 25OHD intake. Results: The mean absolute differences (95% CI) in 25OHD levels measured between whole blood and blood spot (n = 50 pairs) or serum and blood spot (n = 20) were 3.2 (95% CI: 1.6, 4.8) ng/ml and 1.5 (95% CI:-0.5,3.4) ng/mL. Intake by dietary recall was marginally associated with 25OHD levels after adjustment for current smoking and race in linear regression. Discussion: 25OHD levels determined by mass spectrometry from blood spot cards, serum and whole blood show relatively good agreement, although 25OHD levels are slightly lower when measured by blood spot cards. Blood spot samples are a less invasive means of obtaining 25OHD measurements, particularly in large population-based samples, or among children when venipuncture may decrease study participation.	[Larkin, Emma K.; Koestner, Nathan; Minton, Patricia; Woodward, Kim; Hartert, Tina V.] Vanderbilt Univ, Dept Med, Div Allergy Pulm & Crit Care, Nashville, TN 37203 USA; [Gebretsadik, Tebeb; Liu, Zhouwen] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Carroll, Kecia N.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Newman, Mark S.] ZRT Lab, Beaverton, OR USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Larkin, EK (corresponding author), Vanderbilt Univ, Dept Med, Div Allergy Pulm & Crit Care, Nashville, TN 37203 USA.	Emma.Larkin@Vanderbilt.edu			NIH [K24 AI 77930, CTSA RR24975 (Vanderbilt)]; Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI077930] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This was a fee for service relationship with ZRT Laboratory who did not supply funding. Funding was supplied by NIH K24 AI 77930 (TVH), Thrasher Research Fund (TVH), NIH CTSA RR24975 (Vanderbilt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; BELSEY R, 1971, J CLIN ENDOCR METAB, V33, P554, DOI 10.1210/jcem-33-3-554; Binkley N, 2008, J CLIN ENDOCR METAB, V93, P1804, DOI 10.1210/jc.2007-2340; Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; BREHM JM, 2010, J ALLERGY CLIN IMMUN; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Carter GD, 2009, ANN CLIN BIOCHEM, V46, P79, DOI 10.1258/acb.2008.008135; Chen HP, 2008, CLIN CHIM ACTA, V391, P6, DOI 10.1016/j.cca.2008.01.017; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2010, PAEDIATR PERINAT EP, V24, P303, DOI 10.1111/j.1365-3016.2010.01105.x; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; GLOWACKI J, 2004, CURR OPIN ENDOCRINOL, V11, P353; HADDAD JG, 1971, J CLIN ENDOCR METAB, V33, P992, DOI 10.1210/jcem-33-6-992; Hartert TV, 2010, RESPIROLOGY, V15, P691, DOI 10.1111/j.1440-1843.2010.01743.x; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3128, DOI 10.1210/jc.2005-0162; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2004, J CLIN ENDOCR METAB, V89, P3149, DOI 10.1210/jc.2004-0682; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; LAI JK, 2010, MOL NUTR FOOD RES; Leino A, 2008, CLIN CHEM, V54, P2059, DOI 10.1373/clinchem.2008.111732; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Newman Mark S, 2009, J Diabetes Sci Technol, V3, P156; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; Roth H J, 2001, Clin Lab, V47, P357; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Singh RJ, 2010, METHODS MOL BIOL, V603, P509, DOI 10.1007/978-1-60761-459-3_50; Souberbielle JC, 2006, JOINT BONE SPINE, V73, P249, DOI 10.1016/j.jbspin.2006.01.003; Terry AH, 2005, CLIN CHEM, V51, P1565, DOI 10.1373/clinchem.2005.054239; Trang HM, 1998, AM J CLIN NUTR, V68, P854, DOI 10.1093/ajcn/68.4.854; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	36	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16602	10.1371/journal.pone.0016602	http://dx.doi.org/10.1371/journal.pone.0016602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304997	gold, Green Submitted, Green Published			2022-12-27	WOS:000286834300097
J	McMahon, SM; Metcalf, CJE; Woodall, CW				McMahon, Sean M.; Metcalf, Charlotte J. E.; Woodall, Christopher W.			High-Dimensional Coexistence of Temperate Tree Species: Functional Traits, Demographic Rates, Life-History Stages, and Their Physical Context	PLOS ONE			English	Article							NEOTROPICAL RAIN-FOREST; TRADE-OFFS; LONG-TERM; GROWTH; MORTALITY; CANOPY; RECRUITMENT; DIVERSITY; ABUNDANCE; PATTERNS	Theoretical models indicate that trade-offs between growth and survival strategies of tree species can lead to coexistence across life history stages (ontogeny) and physical conditions experienced by individuals. There exist predicted physiological mechanisms regulating these trade-offs, such as an investment in leaf characters that may increase survival in stressful environments at the expense of investment in bole or root growth. Confirming these mechanisms, however, requires that potential environmental, ontogenetic, and trait influences are analyzed together. Here, we infer growth and mortality of tree species given size, site, and light characteristics from forest inventory data from Wisconsin to test hypotheses about growth-survival trade-offs given species functional trait values under different ontogenetic and environmental states. A series of regression analyses including traits and rates their interactions with environmental and ontogenetic stages supported the relationships between traits and vital rates expected from the expectations from tree physiology. A combined model including interactions between all variables indicated that relationships between demographic rates and functional traits supports growth-survival trade-offs and their differences across species in high-dimensional niche space. The combined model explained 65% of the variation in tree growth and supports a concept of community coexistence similar to Hutchinson's n-dimensional hypervolume and not a low-dimensional niche model or neutral model.	[McMahon, Sean M.] Smithsonian Environm Res Ctr, Ctr Trop Forest Sci, Smithsonian Trop Res Inst, Edgewater, MD 21037 USA; [Metcalf, Charlotte J. E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Woodall, Christopher W.] US Forest Serv, St Paul, MN USA	Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Tropical Research Institute; University of Oxford; United States Department of Agriculture (USDA); United States Forest Service	McMahon, SM (corresponding author), Smithsonian Environm Res Ctr, Ctr Trop Forest Sci, Smithsonian Trop Res Inst, POB 28, Edgewater, MD 21037 USA.	mcmahons@si.edu		Woodall, Christopher/0000-0001-8076-6214	HSBC through the Smithsonian Tropical Research Institute; Smithsonian Institution	HSBC through the Smithsonian Tropical Research Institute; Smithsonian Institution(Smithsonian Institution)	HSBC Climate Partnership partially funded the work of SMM as a recent postdoctoral fellowship awarded through the Smithsonian Tropical Research Institute. The funders (HSBC Bank) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding was through the Smithsonian Institution and has funded SMM's current postdoctoral position. This indirect support of SMM has no influence on the ability of the authors to follow all Plos ONE policies concerning data sharing and materials. There are no current external funding sources for this study.	Abe S, 1998, J VEG SCI, V9, P787, DOI 10.2307/3237044; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; BECHTOLD WA, 2005, FOREST INVENTORY ANA, pSRS80; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; BROKAW NVL, 1989, ECOLOGY, V70, P538, DOI 10.2307/1940196; Brown PM, 2005, ECOLOGY, V86, P3030, DOI 10.1890/05-0034; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; CENTRE WA, 2004, WOOD DENSITY DATABAS; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Clark DA, 2001, ECOLOGY, V82, P1460, DOI 10.1890/0012-9658(2001)082[1460:GTTCTH]2.0.CO;2; Clark DA, 1999, ECOL APPL, V9, P981, DOI 10.1890/1051-0761(1999)009[0981:ATGOTR]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Marks CO, 2007, EVOLUTION, V61, P455, DOI 10.1111/j.1742-4658.2007.00021.x; MCMAHON S, 2009, PREDICTIVE FRAMEWORK; Meinzer FC, 2003, OECOLOGIA, V134, P1, DOI 10.1007/s00442-002-1088-0; Metcalf CJE, 2009, J TROP ECOL, V25, P1, DOI 10.1017/S0266467408005646; MILTON K, 1994, J ECOL, V82, P79, DOI 10.2307/2261388; Mohan JE, 2007, ECOL APPL, V17, P1198, DOI 10.1890/05-1690; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Platt WJ, 2002, ECOLOGY, V83, P1566, DOI 10.1890/0012-9658(2002)083[1566:IOLSDP]2.0.CO;2; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Team RDC, 2010, R LANG ENV STAT COMP; TILMAN GD, 1984, ECOLOGY, V65, P1445, DOI 10.2307/1939125; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	36	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16253	10.1371/journal.pone.0016253	http://dx.doi.org/10.1371/journal.pone.0016253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305020	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300046
J	Santi, SA; Lee, H				Santi, Stacey A.; Lee, Hoyun			Ablation of Akt2 Induces Autophagy through Cell Cycle Arrest, the Downregulation of p70S6K, and the Deregulation of Mitochondria in MDA-MB231 Cells	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; KINASE INHIBITOR P27(KIP1); ACTIVATED PROTEIN-KINASE; OVARIAN-CANCER CELLS; BREAST-CANCER; DEPENDENT PHOSPHORYLATION; INSULIN-RESISTANCE; ENERGY-METABOLISM; AMP KINASE; PATHWAY	Background: Akt/PKB is a promising anticancer therapeutic target, since abnormally elevated Akt activity is directly correlated to tumor development, progression, poor prognosis and resistance to cancer therapies. Currently, the unique role of each Akt isoform and their relevance to human breast cancer are poorly understood. Methodology/Principal Findings: We previously found that Akt1, 2 and 3 are localized at specific subcellular compartments (the cytoplasm, mitochondria and nucleus, respectively), raising the possibility that each isoform may have unique functions and employ different regulation mechanisms. By systematically studying Akt-ablated MDA-MB231 breast cancer cells with isoform-specific siRNA, we here show that Akt2 is the most relevant isoform to cell proliferation and survival in our cancer model. Prolonged ablation of Akt2 with siRNA resulted in cell-cycle arrest in G0/G1 by downregulating Cdk2 and cyclin D, and upregulating p27. The analysis of the Akt downstream signaling pathways suggested that Akt2 specifically targets and activates the p70S6K signaling pathway. We also found that Akt2 ablation initially resulted in an increase in the mitochondrial volume concomitantly with the upregulation of PGC-1 alpha, a regulator of mitochondrial biogenesis. Prolonged ablation of Akt2, but not Akt1 or Akt3, eventually led to cell death by autophagy of the mitochondria (i.e., mitophagy). Conclusions/Significance: Collectively, our data demonstrates that Akt2 augments cell proliferation by facilitating cell cycle progression through the upregulation of the cell cycle engine, and protects a cell from pathological autophagy by modulating mitochondrial homeostasis. Our data, thus, raises the possibility that Akt2 can be an effective anticancer target for the control of (breast) cancer.	[Santi, Stacey A.; Lee, Hoyun] Sudbury Reg Hosp, Reg Canc Program, Tumor Biol Grp, Sudbury, ON, Canada; [Santi, Stacey A.; Lee, Hoyun] Univ Ottawa, Sch Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada; [Lee, Hoyun] No Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada	Health Sciences North; University of Ottawa; Northern Ontario School of Medicine	Santi, SA (corresponding author), Sudbury Reg Hosp, Reg Canc Program, Tumor Biol Grp, Sudbury, ON, Canada.	hlee@hrsrh.on.ca			Canadian Breast Cancer Foundation (CBCF, Ontario Chapter); Northern Cancer Research Foundation (NCRF); University of Ottawa	Canadian Breast Cancer Foundation (CBCF, Ontario Chapter); Northern Cancer Research Foundation (NCRF); University of Ottawa	This work was supported, in part, by a research grant from the Canadian Breast Cancer Foundation (CBCF, Ontario Chapter) and Northern Cancer Research Foundation (NCRF) to H.L. S.S. was a recipient of an NCRF bursary and a University of Ottawa Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Arboleda MJ, 2003, CANCER RES, V63, P196; Bacqueville D, 1998, BIOCHEM BIOPH RES CO, V244, P630, DOI 10.1006/bbrc.1997.7885; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujiwara K, 2007, INT J ONCOL, V31, P753; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hembruff SL, 2005, ANAL BIOCHEM, V345, P237, DOI 10.1016/j.ab.2005.07.014; HERONMILHAVET L, 2006, MOL CELL BIOL; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Jin J, 2005, ONCOGENE, V24, P5459, DOI 10.1038/sj.onc.1208704; Jun T., 1999, SCI STKE, V1999, pPE1; Kim EH, 2007, CANCER RES, V67, P6314, DOI 10.1158/0008-5472.CAN-06-4217; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MENG Q, 2006, CELL SIGNAL; Munafo DB, 2001, J CELL SCI, V114, P3619; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; NOSKE A, 2006, CANC LETT; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rassidakis GZ, 2005, BLOOD, V105, P827, DOI 10.1182/blood-2004-06-2125; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Rosner M, 2006, MUTAT RES-REV MUTAT, V613, P10, DOI 10.1016/j.mrrev.2006.03.001; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Shapira M, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1533; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Veilleux A, 2010, MOL ENDOCRINOL, V24, P766, DOI 10.1210/me.2009-0328; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang G, 1999, ONCOGENE, V18, P5204, DOI 10.1038/sj.onc.1202912; YANG W, 2010, CELL SIGNAL; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	63	54	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14614	10.1371/journal.pone.0014614	http://dx.doi.org/10.1371/journal.pone.0014614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297943	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300006
J	Zhu, L; Sacco, T; Strata, P; Sacchetti, B				Zhu, Lan; Sacco, Tiziana; Strata, Piergiorgio; Sacchetti, Benedetto			Basolateral Amygdala Inactivation Impairs Learning-Induced Long-Term Potentiation in the Cerebellar Cortex	PLOS ONE			English	Article							REVERSIBLE INACTIVATION; ESSENTIAL INVOLVEMENT; MEMORY CONSOLIDATION; NEURONAL PLASTICITY; SYNAPTIC CHANGES; DENTATE GYRUS; FEAR MEMORIES; HEART-RATE; RATS; HIPPOCAMPUS	Learning to fear dangerous situations requires the participation of basolateral amygdala (BLA). In the present study, we provide evidence that BLA is necessary for the synaptic strengthening occurring during memory formation in the cerebellum in rats. In the cerebellar vermis the parallel fibers (PF) to Purkinje cell (PC) synapse is potentiated one day following fear learning. Pretraining BLA inactivation impaired such a learning-induced long-term potentiation (LTP). Similarly, cerebellar LTP is affected when BLA is blocked shortly, but not 6 h, after training. The latter result shows that the effects of BLA inactivation on cerebellar plasticity, when present, are specifically related to memory processes and not due to an interference with sensory or motor functions. These data indicate that fear memory induces cerebellar LTP provided that a heterosynaptic input coming from BLA sets the proper local conditions. Therefore, in the cerebellum, learning-induced plasticity is a heterosynaptic phenomenon that requires inputs from other regions. Studies employing the electrically-induced LTP in order to clarify the cellular mechanisms of memory should therefore take into account the inputs arriving from other brain sites, considering them as integrative units. Based on previous and the present findings, we proposed that BLA enables learning-related plasticity to be formed in the cerebellum in order to respond appropriately to new stimuli or situations.	[Zhu, Lan; Sacco, Tiziana; Strata, Piergiorgio; Sacchetti, Benedetto] Univ Turin, Dept Neurosci, Turin, Italy; [Strata, Piergiorgio; Sacchetti, Benedetto] Natl Inst Neurosci Italy, Turin, Italy	University of Turin	Zhu, L (corresponding author), Univ Leicester, Maurice Shock Med Sci Bldg, Leicester, Leics, England.	benedetto.sacchetti@unito.it	Sacchetti, Benedetto/AAG-2916-2022; Sacchetti, Benedetto/AFK-4141-2022	Sacchetti, Benedetto/0000-0002-8695-8310; Zhu, Lan/0000-0001-5643-1019	Italian Space Agency; European Community [512039]; MIUR, Regione Piemonte; Compagnia San Paolo Foundation	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); European Community(European Commission); MIUR, Regione Piemonte(Ministry of Education, Universities and Research (MIUR)Regione Piemonte); Compagnia San Paolo Foundation(Compagnia di San Paolo)	This work was supported by grants of the Italian Space Agency, the European Community [512039 contract number to P.S.], MIUR, Regione Piemonte and Compagnia San Paolo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 1999, J NEUROSCI, V19, P10530; BERNTSON GG, 1982, PHYSIOL PSYCHOL, V10, P2; BRIONI JD, 1989, BRAIN RES, V487, P105, DOI 10.1016/0006-8993(89)90945-1; Cavdar S, 2001, J ANAT, V198, P463, DOI 10.1046/j.1469-7580.2001.19840463.x; Chen SWC, 2006, J NEUROSCI, V26, P233, DOI 10.1523/JNEUROSCI.2890-05.2006; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dow R. S., 1958, PHYSL PATHOLOGY CERE; Dringenberg HC, 2004, EUR J NEUROSCI, V20, P557, DOI 10.1111/j.1460-9568.2004.03515.x; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; HEATH RG, 1974, EXP NEUROL, V45, P268, DOI 10.1016/0014-4886(74)90118-6; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006; IKEGAYA Y, 1995, BRAIN RES, V671, P351, DOI 10.1016/0006-8993(94)01403-5; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Lee T, 2004, J NEUROSCI, V24, P3242, DOI 10.1523/JNEUROSCI.5382-03.2004; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LIANG KC, 1982, BEHAV BRAIN RES, V4, P237, DOI 10.1016/0166-4328(82)90002-X; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Popescu AT, 2007, P NATL ACAD SCI USA, V104, P341, DOI 10.1073/pnas.0609831104; Poremba A, 1997, J NEUROSCI, V17, P5237; Saab CY, 2003, BRAIN RES REV, V42, P85, DOI 10.1016/S0165-0173(03)00151-6; Sacchetti B, 2005, NEUROSCIENTIST, V11, P217, DOI 10.1177/1073858405276428; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sacchetti B, 2001, EUR J NEUROSCI, V13, P2291, DOI 10.1046/j.0953-816x.2001.01609.x; Sacchetti B, 2007, EUR J NEUROSCI, V25, P2875, DOI 10.1111/j.1460-9568.2007.05508.x; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; SANANES CB, 1992, BEHAV NEUROSCI, V106, P72, DOI 10.1037/0735-7044.106.1.72; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; Schweighofer N, 2004, BRAIN RES REV, V44, P103, DOI 10.1016/j.brainresrev.2003.10.004; SEBASTIANI L, 1992, EXP BRAIN RES, V88, P193, DOI 10.1007/BF02259141; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Snider RS, 1944, J NEUROPHYSIOL, V7, P331, DOI 10.1152/jn.1944.7.6.331; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; SUPPLE WF, 1990, BEHAV NEUROSCI, V104, P934; SUPPLE WF, 1993, J NEUROSCI, V13, P3705; Vafaei AA, 2007, NEUROBIOL LEARN MEM, V88, P87, DOI 10.1016/j.nlm.2007.02.004; Vazdarjanova A, 2001, EUR J NEUROSCI, V14, P709, DOI 10.1046/j.0953-816x.2001.01696.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999; Zhu L, 2007, EUR J NEUROSCI, V26, P219, DOI 10.1111/j.1460-9568.2007.05632.x	60	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16673	10.1371/journal.pone.0016673	http://dx.doi.org/10.1371/journal.pone.0016673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304962	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300117
J	Dumitrescu, L; Glenn, K; Brown-Gentry, K; Shephard, C; Wong, M; Rieder, MJ; Smith, JD; Nickerson, DA; Crawford, DC				Dumitrescu, Logan; Glenn, Kimberly; Brown-Gentry, Kristin; Shephard, Cynthia; Wong, Michelle; Rieder, Mark J.; Smith, Joshua D.; Nickerson, Deborah A.; Crawford, Dana C.			Variation in LPA Is Associated with Lp(a) Levels in Three Populations from the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA LIPOPROTEIN(A) CONCENTRATIONS; SINGLE-NUCLEOTIDE POLYMORPHISMS; NON-HISPANIC WHITES; WHOLE-GENOME ASSOCIATION; APOLIPOPROTEIN-A-I; AFRICAN-AMERICANS; LINKAGE-DISEQUILIBRIUM; SERUM-LIPOPROTEIN; ARTERY-DISEASE	The distribution of lipoprotein(a) [Lp(a)] levels can differ dramatically across diverse racial/ethnic populations. The extent to which genetic variation in LPA can explain these differences is not fully understood. To explore this, 19 LPA tagSNPs were genotyped in 7,159 participants from the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III is a diverse population-based survey with DNA samples linked to hundreds of quantitative traits, including serum Lp(a). Tests of association between LPA variants and transformed Lp(a) levels were performed across the three different NHANES subpopulations (non-Hispanic whites, non-Hispanic blacks, and Mexican Americans). At a significance threshold of p<0.0001, 15 of the 19 SNPs tested were strongly associated with Lp(a) levels in at least one subpopulation, six in at least two subpopulations, and none in all three subpopulations. In non-Hispanic whites, three variants were associated with Lp(a) levels, including previously known rs6919246 (p = 1.18x10(-30)). Additionally, 12 and 6 variants had significant associations in non-Hispanic blacks and Mexican Americans, respectively. The additive effects of these associated alleles explained up to 11% of the variance observed for Lp(a) levels in the different racial/ethnic populations. The findings reported here replicate previous candidate gene and genome-wide association studies for Lp(a) levels in European-descent populations and extend these findings to other populations. While we demonstrate that LPA is an important contributor to Lp(a) levels regardless of race/ethnicity, the lack of generalization of associations across all subpopulations suggests that specific LPA variants may be contributing to the observed Lp(a) between-population variance.	[Dumitrescu, Logan; Glenn, Kimberly; Brown-Gentry, Kristin; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA; [Dumitrescu, Logan; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Shephard, Cynthia; Wong, Michelle; Rieder, Mark J.; Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle	Dumitrescu, L (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA.	crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012	Crawford, Dana/0000-0002-6437-6248; Glenn, Kimberly/0000-0002-6765-5592	National Heart, Lung, and Blood Institute (NHLBI) [N01-HV-48195]; NIH [U01 HL66682, U01 HL66642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682, U01HL066642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Genotyping services were provided by the Johns Hopkins University under federal contract number (N01-HV-48195) from the National Heart, Lung, and Blood Institute (NHLBI). This work was funded, in part, by NIH grants U01 HL66682 (DAN) and U01 HL66642 (DAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 1998, HUM BIOL, V70, P477; [Anonymous], 2003, NATURE, V426, P789; Bamshad M, 2005, JAMA-J AM MED ASSOC, V294, P937, DOI 10.1001/jama.294.8.937; Barkley RA, 2003, J LIPID RES, V44, P1301, DOI 10.1194/jlr.M300163-JLR200; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Berglund L, 2004, ARTERIOSCL THROM VAS, V24, pE30; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Boomsma D I, 2000, Twin Res, V3, P152, DOI 10.1375/136905200320565436; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Centers for Disease Control and Prevention, 2004, PLAN OP 3 NAT HLTH N; Centers for disease control and prevention, 1996, 3 NAT HLTH NUTR EX S; Chang MH, 2009, AM J EPIDEMIOL, V169, P54, DOI 10.1093/aje/kwn286; Chiu L, 2000, HUM BIOL, V72, P821; Choudhry Shweta, 2007, Proc Am Thorac Soc, V4, P226, DOI 10.1513/pats.200701-029AW; Chretien JP, 2006, J MED GENET, V43, P917, DOI 10.1136/jmg.2006.042119; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crawford DC, 2008, HUM HERED, V66, P199, DOI 10.1159/000143403; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GUYTON JR, 1985, ARTERIOSCLEROSIS, V5, P265, DOI 10.1161/01.ATV.5.3.265; HAFFNER SM, 1992, AM J EPIDEMIOL, V136, P1060, DOI 10.1093/oxfordjournals.aje.a116571; HEISS G, 1984, AM HEART J, V108, P807, DOI 10.1016/0002-8703(84)90676-8; Kamboh MI, 1997, AM J EPIDEMIOL, V146, P1011, DOI 10.1093/oxfordjournals.aje.a009229; Kraft HG, 1996, EUR J HUM GENET, V4, P74; KRAFT HG, 1995, HUM GENET, V95, P275; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Lanktree MB, 2009, J LIPID RES, V50, P768, DOI 10.1194/jlr.D800050-JLR200; Lohr S.L., 1999, SAMPLING DESIGN ANAL; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, pE116; Marcovina SM, 1996, J LIPID RES, V37, P2569; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; MOLITERNO DJ, 1995, ARTERIOSCL THROM VAS, V15, P850, DOI 10.1161/01.ATV.15.7.850; Mooser V, 1997, AM J HUM GENET, V61, P402, DOI 10.1086/514851; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; Ogorelkova M, 2001, HUM MOL GENET, V10, P815, DOI 10.1093/hmg/10.8.815; PENDERGRASS S, 2010, BIODATA MIN IN PRESS; Pendergrass S, 2011, BIOCOMPUT-PAC SYM, P265; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rainwater DL, 1997, ATHEROSCLEROSIS, V128, P223, DOI 10.1016/S0021-9150(96)05993-X; Schmidt K, 2006, EUR J HUM GENET, V14, P190, DOI 10.1038/sj.ejhg.5201512; Scholz M, 1999, EUR J HUM GENET, V7, P169, DOI 10.1038/sj.ejhg.5200290; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SORRENTINO MJ, 1992, AM J MED, V93, P658, DOI 10.1016/0002-9343(92)90199-L; SRINIVASAN SR, 1991, CIRCULATION, V84, P160, DOI 10.1161/01.CIR.84.1.160; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938	51	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16604	10.1371/journal.pone.0016604	http://dx.doi.org/10.1371/journal.pone.0016604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305047	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100048
J	Mammi, C; Pastore, D; Lombardo, MF; Ferrelli, F; Caprio, M; Consoli, C; Tesauro, M; Gatta, L; Fini, M; Federici, M; Sbraccia, P; Donadel, G; Bellia, A; Rosano, GM; Fabbri, A; Lauro, D				Mammi, Caterina; Pastore, Donatella; Lombardo, Marco F.; Ferrelli, Francesca; Caprio, Massimiliano; Consoli, Claudia; Tesauro, Manfredi; Gatta, Lucia; Fini, Massimo; Federici, Massimo; Sbraccia, Paolo; Donadel, Giulia; Bellia, Alfonso; Rosano, Giuseppe M.; Fabbri, Andrea; Lauro, Davide			Sildenafil Reduces Insulin-Resistance in Human Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CA2+-INDEPENDENT ACTIVATION; PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; ORAL SILDENAFIL; PHOSPHORYLATION; AKT; INHIBITORS; PHOSPHATASE; DYSFUNCTION	Background: The efficacy of Phosphodiesterase 5 (PDE5) inhibitors to re-establish endothelial function is reduced in diabetic patients. Recent evidences suggest that therapy with PDE5 inhibitors, i.e. sildenafil, may increase the expression of nitric oxide synthase (NOS) proteins in the heart and cardiomyocytes. In this study we analyzed the effect of sildenafil on endothelial cells in insulin resistance conditions in vitro. Methodology/Principal Findings: Human umbilical vein endothelial cells (HUVECs) were treated with insulin in presence of glucose 30 mM (HG) and glucosamine 10 mM (Gluc-N) with or without sildenafil. Insulin increased the expression of PDE5 and eNOS mRNA assayed by Real time-PCR. Cytofluorimetric analysis showed that sildenafil significantly increased NO production in basal condition. This effect was partially inhibited by the PI3K inhibitor LY 294002 and completely inhibited by the NOS inhibitor L-NAME. Akt-1 and eNOS activation was reduced in conditions mimicking insulin resistance and completely restored by sildenafil treatment. Conversely sildenafil treatment can counteract this noxious effect by increasing NO production through eNOS activation and reducing oxidative stress induced by hyperglycaemia and glucosamine. Conclusions/Significance: These data indicate that sildenafil might improve NOS activity of endothelial cells in insulin resistance conditions and suggest the potential therapeutic use of sildenafil for improving vascular function in diabetic patients.	[Mammi, Caterina; Caprio, Massimiliano] IRCCS San Raffaele Pisana, Ctr Clin & Basic Res, Rome, Italy; [Pastore, Donatella; Lombardo, Marco F.; Ferrelli, Francesca; Tesauro, Manfredi; Federici, Massimo; Sbraccia, Paolo; Donadel, Giulia; Bellia, Alfonso; Fabbri, Andrea; Lauro, Davide] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Consoli, Claudia; Gatta, Lucia; Fini, Massimo; Rosano, Giuseppe M.] San Raffaele Sulmona, Laquila, Italy; [Fabbri, Andrea] Univ Roma Tor Vergata, Osped S Eugenio & CTO A Alesini, Dept Internal Med, Unit Endocrinol, Rome, Italy	Center Clinical & Basic Research; IRCCS San Raffaele Pisana; University of Rome Tor Vergata; Sant'Eugenio Hospital; University of Rome Tor Vergata	Mammi, C (corresponding author), IRCCS San Raffaele Pisana, Ctr Clin & Basic Res, Rome, Italy.	d.lauro@med.uniroma2.it	Federici, Massimo/G-9940-2012; bellia, alfonso/AIA-9860-2022; Lauro, Davide/K-4683-2018; Rosano, Giuseppe M. C./K-8718-2018; Fini, Massimo/AAA-9948-2021; Donadel, Giulia/M-1900-2019; Caprio, Massimiliano/J-3020-2012; Gatta, Lucia/I-9985-2018	Federici, Massimo/0000-0003-4989-5194; Rosano, Giuseppe M. C./0000-0003-4023-2263; Donadel, Giulia/0000-0002-2454-5940; Caprio, Massimiliano/0000-0003-0722-7163; Gatta, Lucia/0000-0002-9232-2693; mammi, caterina/0000-0002-2687-4422; Lauro, Davide/0000-0002-8597-4415	University Tor Vergata; Ministero dell'Universita e della Ricerca; Department of Health (Tremoli); Fondazione Roma - Rome Foundation [2008-2009]	University Tor Vergata; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Department of Health (Tremoli); Fondazione Roma - Rome Foundation(Fondazione Roma)	This work has been funded by Institutional funding from University Tor Vergata, PRIN 2007 (Progetti Ricerca Interesse Nazionale) Ministero dell'Universita e della Ricerca, 2007, to A. F.) and by Department of Health RF 2007 (Tremoli), Fondazione Roma - Rome Foundation Research Grant 2008-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2000, Heart, V84, pE4, DOI 10.1136/heart.84.2.e4; ALVARADOVASQUEZ N, 2007, DIABETES METAB RES R; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Chou SH, 2006, EXP BIOL MED, V231, P954; Deedwania PC, 2004, CARDIOL CLIN, V22, pXI, DOI 10.1016/j.ccl.2004.07.004; Desouza C, 2002, DIABETES CARE, V25, P1336, DOI 10.2337/diacare.25.8.1336; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Favot L, 2003, THROMB HAEMOSTASIS, V90, P334, DOI 10.1160/TH03-02-0084; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 1999, P NATL ACAD SCI USA, V96, P1123, DOI 10.1073/pnas.96.3.1123; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Francis SH, 2003, INT J IMPOT RES, V15, P369, DOI 10.1038/sj.ijir.3901040; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Katz SD, 2000, J AM COLL CARDIOL, V36, P845, DOI 10.1016/S0735-1097(00)00790-7; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Luedders DW, 2006, J CARDIOVASC PHARM, V47, P365; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michelakis E, 2002, CIRCULATION, V105, P2398, DOI 10.1161/01.CIR.0000016641.12984.DC; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Milara J, 2010, EUR J PHARM SCI, V39, P363, DOI 10.1016/j.ejps.2010.01.005; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Nelson BA, 2002, AM J PHYSIOL-ENDOC M, V282, pE497, DOI 10.1152/ajpendo.00438.2001; Park K, 2008, EUR UROL, V53, P1282, DOI 10.1016/j.eururo.2008.01.032; Prasad S, 2000, NEW ENGL J MED, V343, P1342, DOI 10.1056/NEJM200011023431814; Puerta E, 2009, J NEUROCHEM, V108, P755, DOI 10.1111/j.1471-4159.2008.05825.x; Reffelmann T, 2003, CIRCULATION, V108, P239, DOI 10.1161/01.CIR.0000081166.87607.E2; Salt IP, 2003, J BIOL CHEM, V278, P18791, DOI 10.1074/jbc.M210618200; Sebkhi A, 2003, CIRCULATION, V107, P3230, DOI 10.1161/01.CIR.0000074226.20466.B1; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Wilkens H, 2001, CIRCULATION, V104, P1218, DOI 10.1161/hc3601.096826; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59	39	36	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14542	10.1371/journal.pone.0014542	http://dx.doi.org/10.1371/journal.pone.0014542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297971	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100001
J	Becker, A; Chao, DY; Zhang, X; Salt, DE; Baxter, I				Becker, Anthony; Chao, Dai-Yin; Zhang, Xu; Salt, David E.; Baxter, Ivan			Bulk Segregant Analysis Using Single Nucleotide Polymorphism Microarrays	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS-THALIANA; MARKERS; GENOME; IDENTIFICATION; ASSOCIATION; INTERVAL; LINES	Bulk segregant analysis (BSA) using microarrays, and extreme array mapping (XAM) have recently been used to rapidly identify genomic regions associated with phenotypes in multiple species. These experiments, however, require the identification of single feature polymorphisms (SFP) between the cross parents for each new combination of genotypes, which raises the cost of experiments. The availability of the genomic polymorphism data in Arabidopsis thaliana, coupled with the efficient designs of Single Nucleotide Polymorphism (SNP) genotyping arrays removes the requirement for SFP detection and lowers the per array cost, thereby lowering the overall cost per experiment. To demonstrate that these approaches would be functional on SNP arrays and determine confidence intervals, we analyzed hybridizations of natural accessions to the Arabidopsis ATSNPTILE array and simulated BSA or XAM given a variety of gene models, populations, and bulk selection parameters. Our results show a striking degree of correlation between the genotyping output of both methods, which suggests that the benefit of SFP genotyping in context of BSA can be had with the cheaper, more efficient SNP arrays. As a final proof of concept, we hybridized the DNA from bulks of an F2 mapping population of a Sulfur and Selenium ionomics mutant to both the Arabidopsis ATTILE1R and ATSNPTILE arrays, which produced almost identical results. We have produced R scripts that prompt the user for the required parameters and perform the BSA analysis using the ATSNPTILE1 array and have provided them as supplemental data files.	[Becker, Anthony; Baxter, Ivan] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Chao, Dai-Yin; Salt, David E.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA; [Zhang, Xu] Univ Chicago, Dept Genet, Chicago, IL 60637 USA; [Baxter, Ivan] ARS, Plant Genet Res Unit, USDA, St Louis, MO USA	Donald Danforth Plant Science Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Chicago; United States Department of Agriculture (USDA)	Becker, A (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	ibaxter@danforthcenter.org	Baxter, Ivan R/A-1052-2009; Becker, Anthony/AAS-1402-2020; Chao, Daiyin/A-5213-2013	Baxter, Ivan R/0000-0001-6680-1722; ?, ??/0000-0003-2832-4800	National Institutes of Health [R01 GM078536]; National Science Foundation [IOS-0419695]; United States Department of Agriculture-Agricultural Research Service [CRIS 21000-028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER; Direct For Biological Sciences [0851838] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge the support of National Institutes of Health grant # R01 GM078536 (www.nih.gov) to DES and IB; National Science Foundation grant # IOS-0419695 (www.nsf.gov) to DES. AB was a participant in the Donald Danforth Plant Science Center Research Experience for Undergraduates program, NSF DBI-0851838. IB is supported by United States Department of Agriculture-Agricultural Research Service CRIS 21000-028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; BRAUER MJ, 2006, GENETICS, V106; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Kaczorowski KA, 2008, PLANT GENOME-US, V1, P89, DOI 10.3835/plantgenome2008.04.0207; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Smemo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000287; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zhu T, 2007, TRENDS PLANT SCI, V12, P196, DOI 10.1016/j.tplants.2007.03.013	17	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15993	10.1371/journal.pone.0015993	http://dx.doi.org/10.1371/journal.pone.0015993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21297997	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900020
J	Christofferson, RC; Mores, CN				Christofferson, Rebecca C.; Mores, Christopher N.			Estimating the Magnitude and Direction of Altered Arbovirus Transmission Due to Viral Phenotype	PLOS ONE			English	Article							WEST-NILE-VIRUS; CULEX-PIPIENS DIPTERA; VECTOR COMPETENCE; AEDES-AEGYPTI; DENGUE VIRUS; LABORATORY TRANSMISSION; JAPANESE ENCEPHALITIS; VERTICAL TRANSMISSION; MALARIA TRANSMISSION; EXTRINSIC INCUBATION	Vectorial capacity is a measure of the transmission potential of a vector borne pathogen within a susceptible population. Vector competence, a component of the vectorial capacity equation, is the ability of an arthropod to transmit an infectious agent following exposure to that agent. Comparisons of arbovirus strain-specific vector competence estimates have been used to support observed or hypothesized differences in transmission capability. Typically, such comparisons are made at a single time point during the extrinsic incubation period, the time in days it takes for the virus to replicate and disseminate to the salivary glands. However, vectorial capacity includes crucial parameters needed to effectively evaluate transmission capability, though often this is based on the discrete vector competence values. Utilization of the rate of change of vector competence over a range of days gives a more accurate measurement of the transmission potential. Accordingly, we investigated the rate of change in vector competence of dengue virus in Aedes aegypti mosquitoes and the resulting vectorial capacity curves. The areas under the curves represent the effective vector competence and the cumulative transmission potentials of arboviruses within a population of mosquitoes. We used the calculated area under the curve for each virus strain and the corresponding variance estimates to test for differences in cumulative transmission potentials between strains of dengue virus based on our dynamic model. To further characterize differences between dengue strains, we devised a displacement index interpreted as the capability of a newly introduced strain to displace the established, dominant circulating strain. The displacement index can be used to better understand the transmission dynamics in systems where multiple strains/serotypes circulate or even multiple arbovirus species. The use of a rate of a rate of change based model of vectorial capacity and the informative calculations of the displacement index will lead to better measurements of the differences in transmission potential of arboviruses.	[Christofferson, Rebecca C.; Mores, Christopher N.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	cmores@lsu.edu		Mores, Christopher/0000-0001-6678-9049	National Institutes of Health [5P20RR020159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by National Institutes of Health award #5P20RR020159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Arunachalam N, 2008, INDIAN J MED RES, V127, P395; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Black William C. IV, 1996, P393; BOROMISA RD, 1987, J AM MOSQUITO CONTR, V3, P378; Chisenhall DM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-106; CLARKE DK, 1993, J VIROL, V67, P222, DOI 10.1128/JVI.67.1.222-228.1993; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; DILL GM, 1978, COMPUTER ANAL SUGARC, P31; Dye C., 1995, P260, DOI 10.1017/CBO9780511629396.010; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; DYE C, 1986, Parasitology Today, V2, P203; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; Ghosh AK, 2002, INSECT BIOCHEM MOLEC, V32, P1325, DOI 10.1016/S0965-1748(02)00095-4; Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272; Hardy J. L., 1988, The arboviruses: epidemiology and ecology. Volume I., P87; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; KRAMER LD, 1983, AM J TROP MED HYG, V32, P1130, DOI 10.4269/ajtmh.1983.32.1130; Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Moncayo AC, 2004, EMERG INFECT DIS, V10, P1790, DOI 10.3201/eid1010.030846; Mores CN, 2007, VECTOR-BORNE ZOONOT, V7, P279, DOI 10.1089/vbz.2006.0557; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; Rattanarithikul R, 1996, AM J TROP MED HYG, V54, P114, DOI 10.4269/ajtmh.1996.54.114; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39; Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101; Sithiprasasna Ratana, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P505; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Turell MJ, 2006, J MED ENTOMOL, V43, P1076, DOI 10.1603/0022-2585(2006)43[1076:LTOJEW]2.0.CO;2; Turell MJ, 2006, J MED ENTOMOL, V43, P296, DOI 10.1603/0022-2585(2006)043[0296:LTOJEA]2.0.CO;2; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; VANDENHURK AF, 2009, VECTOR BORNE ZOONOTI; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	49	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16298	10.1371/journal.pone.0016298	http://dx.doi.org/10.1371/journal.pone.0016298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298018	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900029
J	Waltert, M; Bobo, KS; Kaupa, S; Montoya, ML; Nsanyi, MS; Fermon, H				Waltert, Matthias; Bobo, Kadiri Serge; Kaupa, Stefanie; Leija Montoya, Marcela; Nsanyi, Moses Sainge; Fermon, Heleen			Assessing Conservation Values: Biodiversity and Endemicity in Tropical Land Use Systems	PLOS ONE			English	Article							SPECIES RICHNESS; AGROFORESTRY SYSTEMS; FOREST CONVERSION; DIVERSITY; FARMLAND; PLANTS; BIRDS; TAXA; ASSEMBLAGES; BUTTERFLIES	Despite an increasing amount of data on the effects of tropical land use on continental forest fauna and flora, it is debatable whether the choice of the indicator variables allows for a proper evaluation of the role of modified habitats in mitigating the global biodiversity crisis. While many single-taxon studies have highlighted that species with narrow geographic ranges especially suffer from habitat modification, there is no multi-taxa study available which consistently focuses on geographic range composition of the studied indicator groups. We compiled geographic range data for 180 bird, 119 butterfly, 204 tree and 219 understorey plant species sampled along a gradient of habitat modification ranging from near-primary forest through young secondary forest and agroforestry systems to annual crops in the southwestern lowlands of Cameroon. We found very similar patterns of declining species richness with increasing habitat modification between taxon-specific groups of similar geographic range categories. At the 8 km 2 spatial level, estimated richness of endemic species declined in all groups by 21% (birds) to 91% (trees) from forests to annual crops, while estimated richness of widespread species increased by +101% (trees) to +275% (understorey plants), or remained stable (-2%, butterflies). Even traditional agroforestry systems lost estimated endemic species richness by -18% (birds) to -90% (understorey plants). Endemic species richness of one taxon explained between 37% and 57% of others (positive correlations) and taxon-specific richness in widespread species explained up to 76% of variation in richness of endemic species (negative correlations). The key implication of this study is that the range size aspect is fundamental in assessments of conservation value via species inventory data from modified habitats. The study also suggests that even ecologically friendly agricultural matrices may be of much lower value for tropical conservation than indicated by mere biodiversity value.	[Waltert, Matthias; Fermon, Heleen] Univ Gottingen, Dept Conservat Biol, Gottingen, Germany; [Bobo, Kadiri Serge] Univ Dschang, Dept Forestry, Dschang, Cameroon; [Leija Montoya, Marcela] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Nuevo Leon, Mexico; [Nsanyi, Moses Sainge] Univ Buea, Fac Sci, Dept Plant & Anim Sci, CTFS,KFDP,Bot Programme, Buea, Cameroon	University of Gottingen; Universidad Autonoma de Nuevo Leon	Waltert, M (corresponding author), Univ Gottingen, Dept Conservat Biol, Gottingen, Germany.	mwalter@gwdg.de	Waltert, Matthias/E-9134-2010	Waltert, Matthias/0000-0001-7053-0291	German Academic Exchange Service (DAAD); German Society for Tropical Ornithology (GTO); African Nature e.V.; Volkswagen Foundation, Hanover, Germany	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Society for Tropical Ornithology (GTO); African Nature e.V.; Volkswagen Foundation, Hanover, Germany(Volkswagen)	This study was supported financially by the German Academic Exchange Service (DAAD), the German Society for Tropical Ornithology (GTO), African Nature e.V., and the Volkswagen Foundation, Hanover, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MEASURING MONITORING; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Bobo KS, 2006, BIODIVERS CONSERV, V15, P4097, DOI 10.1007/s10531-005-3368-6; Bobo KS, 2006, J INSECT CONSERV, V10, P29, DOI 10.1007/s10841-005-8564-x; Borrow N, 2001, BIRDS W AFRICA; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Brown LH, 1982, BIRDS AFRICA, V1; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Chazdon RL, 1998, MAN BIOSPH, V20, P285; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; COLWELL RK, 2000, ESTIMATES STAT ESTIM; D'Abrera B, 1980, BUTTERFLIES AFROTROP, P593; D'Abrera B., 1997, BUTTERFLIES AFROTROP; Davis S.D., 1994, CTR PLANT DIVERSITY, V1; de Vries P.J., 1988, Journal of Research on the Lepidoptera, V26, P98; DeVries PJ, 1987, BUTTERFLIES COSTA RI; Dunn RR, 2005, GLOBAL ECOL BIOGEOGR, V14, P359, DOI 10.1111/j.1466-822x.2005.00155.x; Fermon H, 2000, J INSECT CONSERV, V4, P173, DOI 10.1023/A:1009638808635; Fishpool L. D., 2001, IMPORTANT BIRD AREAS; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Harvey CA, 2007, BIODIVERS CONSERV, V16, P2257, DOI 10.1007/s10531-007-9194-2; HECQ J, 1997, EUPHAEDRA LAMBILLION; HELTSHE JF, 1983, BIOMETRICS, V39, P1, DOI 10.2307/2530802; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; Keith S., 1992, BIRDS AFRICA, V4; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Klein AM, 2002, CONSERV BIOL, V16, P1003, DOI 10.1046/j.1523-1739.2002.00499.x; Larsen TB, 1997, KORUP BUTTERFLIES BI; Larson TB, 2005, BUTTERFLIES W AFRICA, V1-2; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lewis OT, 1998, BIOL CONSERV, V85, P113, DOI 10.1016/S0006-3207(97)00136-5; Nichols JD, 1998, CONSERV BIOL, V12, P1390, DOI 10.1046/j.1523-1739.1998.97331.x; Oates J.F., 1996, AFRICAN PRIMATES STA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Perfecto I, 2003, BIODIVERS CONSERV, V12, P1239, DOI 10.1023/A:1023039921916; Rodewald P.G., 1994, BIRD CONSERV INT, V4, P1, DOI DOI 10.1017/S095927090000263X; Rydon A., 1964, J LEPID SOC, V18, P51; Scales BR, 2008, ENVIRON CONSERV, V35, P160, DOI 10.1017/S0376892908004840; Schroth G, 2004, AGROFORESTRY BIODIVE; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; THOMAS CD, 1991, BIOL CONSERV, V55, P269, DOI 10.1016/0006-3207(91)90032-5; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Waltert M, 2005, ECOL APPL, V15, P1351, DOI 10.1890/04-1002; Waltert M, 2004, CONSERV BIOL, V18, P1339, DOI 10.1111/j.1523-1739.2004.00127.x; Waltert M, 2002, ORYX, V36, P257, DOI 10.1017/S0030605302000479; Weist M, 2010, MAMM BIOL, V75, P567, DOI 10.1016/j.mambio.2009.09.004; White F., 1983, VEGETATION AFRICA DE	52	42	45	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16238	10.1371/journal.pone.0016238	http://dx.doi.org/10.1371/journal.pone.0016238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298054	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000286663900025
J	Wu, JSJ; Shih, FY; Chiu, CH; Yeh, YL; Yan, JJ; King, CC; Ho, MS				Wu, Jiunn-Shyan Julian; Shih, Fu-Yuan; Chiu, Chan-Hsien; Yeh, Yuan-Lih; Yan, Jer-Jea; King, Chwan-Chuen; Ho, Mei-Shang			Evaluation of an Adjustable Epidemiologic Information System	PLOS ONE			English	Article							OUTBREAK	Background: In order to facilitate public health response and to achieve early control of infectious disease epidemics, an adjustable epidemiologic information system (AEIS) was established in the Taiwan public health network in February 2006. Methodology/Principal Findings: The performance of AEIS for the period 2006 through 2008 was evaluated based on a number of response times (RT) and the public health impact. After implementation of the system, the apparent overall shortened RT was mainly due to the shortening of personnel response time (PRT) and the time needed to draft a new questionnaire that incurred as personnel-system interface (PSI); PRT dropped from a fluctuating range of 9.8 similar to 28.8 days in the first four months to <10 days in the following months and remained low till 2008 (0.88 +/- 1.52 days). The PSIs for newly emerged infectious diseases were 2.6 and 3.4 person-hours for H5N1 in 2007 and chikungunya in 2008, respectively, a much improvement from 1142.5 person-hours for SARS in 2003. The duration of each rubella epidemic cluster was evaluated as public health impact and showed a shortening trend (p = 0.019) that concurred with the shortening of PRT from 64.8 +/- 47.3 to 25.2 +/- 38.2 hours per cluster (p < 0.0001). Conclusions/Significance: The first evaluation of the novel instrument AEIS that had been used to assist Taiwan's multi-level government for infectious diseases control demonstrated that it was well integrated into the existing public health infrastructure. It provided flexible tools and computer algorithms with friendly interface for timely data collection, integration, and analysis; as a result, it shortened RTs, filled in gaps of personnel lacking sufficient experiences, created a more efficient flow of response, and identified asymptomatic/mild cases early to minimize further spreading. With further development, AEIS is anticipated to be useful in the application of other acute public health events needing immediate orchestrated data collection and public health actions.	[Wu, Jiunn-Shyan Julian; Chiu, Chan-Hsien; Yeh, Yuan-Lih; Yan, Jer-Jea] Taiwan Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Wu, Jiunn-Shyan Julian; King, Chwan-Chuen; Ho, Mei-Shang] Natl Taiwan Univ, Inst Epidemiol, Coll Publ Hlth, Taipei 10764, Taiwan; [Shih, Fu-Yuan] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Ho, Mei-Shang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan	Wu, JSJ (corresponding author), Taiwan Ctr Dis Control, Dept Hlth, Taipei, Taiwan.	homs@ibms.sinica.edu.tw		King, Chwan-Chuen/0000-0002-6078-2601; SHIH, FUH-YUAN/0000-0002-7755-0110	Government Budget of Taiwan Centers for Diseases Control, Department of Health, Taipei, Taiwan, R.O.C.	Government Budget of Taiwan Centers for Diseases Control, Department of Health, Taipei, Taiwan, R.O.C.	This study was supported by a Government Budget of Taiwan Centers for Diseases Control, Department of Health, Taipei, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], COUNC STAT TERR EP B, P30341; Chang SC, 1999, TAIWAN EPIDEMIOLOGY, V15, P113; Chao DY, 1997, TAIWAN EPIDEMIOLOGY, V13, P1; Chen KL, 2003, TAIWAN EPIDEMIOLOGY, V19, P1; Chiou CS, 1997, TAIWAN EPIDEMIOLOGY, V13, P211; Chiu CS, 1999, TAIWAN EPIDEMIOLOGY, V15, P153; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Jiang DD, 2002, TAIWAN EPIDEMIOLOGY, V18, P289; Jiang DD, 2004, TAIWAN EPIDEMIOLOGY, V20, P129; Jiang DD, 2002, TAIWAN EPIDEMIOLOGY, V18, P159; Jiang DD, 1999, TAIWAN EPIDEMIOLOGY, V15, P95; Lai HK, 1998, TAIWAN EPIDEMIOLOGY, V14, P189; Lai HK, 2003, TAIWAN EPIDEMIOLOGY, V19, P317; Lane Shannon J, 2006, BMC Med Inform Decis Mak, V6, P23, DOI 10.1186/1472-6947-6-23; Lu JJY, 1999, TAIWAN EPIDEMIOLOGY, V15, P197; Lu KL, 1998, TAIWAN EPIDEMIOLOGY, V14, P77; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Miller JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010425; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; Shih FY, 2007, INFECT CONT HOSP EP, V28, P354, DOI 10.1086/508835; Taiwan Centers for Disease Control, 2009, AL WORK HLTH; Tseng SH, 2004, TAIWAN EPIDEMIOLOGY, V20, P73; *WHO, 2004, WHO GUID GLOB SURV I; Yu P, 2009, INT J MED INFORM, V78, P532, DOI 10.1016/j.ijmedinf.2009.03.002	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14596	10.1371/journal.pone.0014596	http://dx.doi.org/10.1371/journal.pone.0014596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298043	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900003
J	Amanso, AM; Debbas, V; Laurindo, FRM				Amanso, Angelica M.; Debbas, Victor; Laurindo, Francisco R. M.			Proteasome Inhibition Represses Unfolded Protein Response and Nox4, Sensitizing Vascular Cells to Endoplasmic Reticulum Stress-Induced Death	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NADPH OXIDASE ACTIVITY; OXIDATIVE STRESS; ER STRESS; NAD(P)H OXIDASE; MITOCHONDRIAL DYSFUNCTION; DISULFIDE-ISOMERASE; SIGNAL-TRANSDUCTION; CARCINOMA-CELLS; MESSENGER-RNA	Background: Endoplasmic reticulum (ER) stress has pathophysiological relevance in vascular diseases and merges with proteasome function. Proteasome inhibition induces cell stress and may have therapeutic implications. However, whether proteasome inhibition potentiates ER stress-induced apoptosis and the possible mechanisms involved in this process are unclear. Methodology/Principal Findings: Here we show that proteasome inhibition with MG132, per se at non-lethal levels, sensitized vascular smooth muscle cells to caspase-3 activation and cell death during ER stress induced by tunicamycin (Tn). This effect was accompanied by suppression of both proadaptive (KDEL chaperones) and proapoptotic (CHOP/GADD153) unfolded protein response markers, although, intriguingly, the splicing of XBP1 was markedly enhanced and sustained. In parallel, proteasome inhibition completely prevented ER stress-induced increase in NADPH oxidase activity, as well as increases in Nox4 isoform and protein disulfide isomerase mRNA expression. Increased Akt phosphorylation due to proteasome inhibition partially offset the proapoptotic effect of Tn or MG132. Although proteasome inhibition enhanced oxidative stress, reactive oxygen species scavenging had no net effect on sensitization to Tn or MG132-induced cell death. Conclusion/Relevance: These data indicate unfolded protein response-independent pathways whereby proteasome inhibition sensitizes vascular smooth muscle to ER stress-mediated cell death. This may be relevant to understand the therapeutic potential of such compounds in vascular disease associated with increased neointimal hyperplasia.	[Amanso, Angelica M.; Debbas, Victor; Laurindo, Francisco R. M.] Univ Sao Paulo, Sch Med, Vasc Biol Lab, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo	Amanso, AM (corresponding author), Univ Sao Paulo, Sch Med, Vasc Biol Lab, Heart Inst InCor, Sao Paulo, Brazil.	francisco.laurindo@incor.usp.br	Debbas, Victor/J-9475-2012; Laurindo, Francisco R/J-6575-2015		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/13683-0, 09/54764-6]; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em BioMedicina (Redoxoma, CNPq); Fundacao Zerbini	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em BioMedicina (Redoxoma, CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Zerbini	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Processes 04/13683-0 and 09/54764-6), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em BioMedicina (Redoxoma, CNPq) and Fundacao Zerbini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Dickhout JG, 2006, CIRCULATION, V114, P1796, DOI 10.1161/CIRCULATIONAHA.106.656744; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dreger H, 2010, CARDIOVASC RES, V85, P395, DOI 10.1093/cvr/cvp279; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Feng B, 2010, J CARDIOVASC PHARM, V55, P129, DOI 10.1097/FJC.0b013e3181c87f8e; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Laurindo FRM, 2008, ANTIOXID REDOX SIGN, V10, P1101, DOI 10.1089/ars.2007.2011; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Ludwig A, 2008, CIRC RES, V102, pE37, DOI 10.1161/CIRCRESAHA.107.168963; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Meiners S, 2002, CIRCULATION, V105, P483, DOI 10.1161/hc0402.102951; OLEJNICZAK SH, 2010, BLOOD           1007; Papa L, 2008, APOPTOSIS, V13, P588, DOI 10.1007/s10495-008-0182-0; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Van Herck JL, 2010, BASIC RES CARDIOL, V105, P39, DOI 10.1007/s00395-009-0054-y; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yamamoto N, 2007, J BIOL CHEM, V282, P4364, DOI 10.1074/jbc.M603712200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019	54	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14591	10.1371/journal.pone.0014591	http://dx.doi.org/10.1371/journal.pone.0014591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297867	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800004
J	Boxall, R; Porteous, DJ; Thomson, PA				Boxall, Ruth; Porteous, David J.; Thomson, Pippa A.			DISC1 and Huntington's Disease - Overlapping Pathways of Vulnerability to Neurological Disorder?	PLOS ONE			English	Article							R6/2 MOUSE MODEL; GENE-TRANSCRIPTION; SCHIZOPHRENIA; ASSOCIATION; DISRUPTED-IN-SCHIZOPHRENIA-1; PSYCHOPATHOLOGY; SUSCEPTIBILITY; SYMPTOMS; PROTEINS; DEFICITS	We re-annotated the interacting partners of the neuronal scaffold protein DISC1 using a knowledge-based approach that incorporated recent protein interaction data and published literature to. This revealed two highly connected networks. These networks feature cellular function and maintenance, and cell signaling. Of potentially greatest interest was the novel finding of a high degree of connectivity between the DISC1 scaffold protein, linked to psychiatric illness, and huntingtin, the protein which is mutated in Huntington's disease. The potential link between DISC1, huntingtin and their interacting partners may open new areas of research into the effects of pathway dysregulation in severe neurological disorders.	[Boxall, Ruth; Porteous, David J.; Thomson, Pippa A.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Mol Med Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh	Boxall, R (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Mol Med Ctr, Edinburgh, Midlothian, Scotland.	Pippa.Thomson@ed.ac.uk	Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Boxall, Ruth/0000-0003-0356-3549	MRC; RCUK [GR/T27983/01]; Medical Research Council [G0700704B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RB is funded by an MRC 4 year PhD award. PAT is partially funded by an RCUK fellowship (GR/T27983/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Bradshaw NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1091, DOI 10.1016/j.bbrc.2008.10.120; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Chen TC, 2009, J PROTEOME RES, V8, P4943, DOI 10.1021/pr900325f; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Datta SR, 2010, MOL PSYCHIATR, V15, P615, DOI 10.1038/mp.2008.128; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Gargiulo M, 2009, EUR J HUM GENET, V17, P165, DOI 10.1038/ejhg.2008.146; Giampa C, 2009, EUR J NEUROSCI, V29, P902, DOI 10.1111/j.1460-9568.2009.06649.x; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Humbert S, 2010, EMBO REP, V11, P899, DOI 10.1038/embor.2010.182; Jason GW, 1997, ARCH NEUROL-CHICAGO, V54, P1081, DOI 10.1001/archneur.1997.00550210019008; Kirkwood SC, 2001, ARCH NEUROL-CHICAGO, V58, P273, DOI 10.1001/archneur.58.2.273; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moens LN, 2010, AM J MED GENET B, V153B, P1240, DOI 10.1002/ajmg.b.31088; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peavy GM, 2010, MOVEMENT DISORD, V25, P1163, DOI 10.1002/mds.22953; Perlis RH, 2010, AM J PSYCHIAT, V167, P574, DOI 10.1176/appi.ajp.2009.09070973; Sack GH, 2010, J BIOENERG BIOMEMBR, V42, P189, DOI 10.1007/s10863-010-9291-x; Sawa A, 2001, J MOL MED, V79, P375, DOI 10.1007/s001090100223; Sawamura N, 2008, MOL PSYCHIATR, V13, P1138, DOI 10.1038/mp.2008.101; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; SHIWACH R, 1994, ACTA PSYCHIAT SCAND, V90, P241, DOI 10.1111/j.1600-0447.1994.tb01587.x; Slaughter J R, 2001, CNS Spectr, V6, P306; Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014; Tsuang D, 1998, AM J MED GENET, V81, P323, DOI 10.1002/(SICI)1096-8628(19980710)81:4<323::AID-AJMG9>3.3.CO;2-M; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; Verny C, 2007, EUR J NEUROL, V14, P1344, DOI 10.1111/j.1468-1331.2007.01975.x; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Yohrling GJ, 2003, MOL CELL NEUROSCI, V23, P28, DOI 10.1016/S1044-7431(03)00032-0; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	45	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16263	10.1371/journal.pone.0016263	http://dx.doi.org/10.1371/journal.pone.0016263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298101	gold, Green Submitted, Green Published			2022-12-27	WOS:000286662800020
J	Rickabaugh, TM; Kilpatrick, RD; Hultin, LE; Hultin, PM; Hausner, MA; Sugar, CA; Althoff, KN; Margolick, JB; Rinaldo, CR; Detels, R; Phair, J; Effros, RB; Jamieson, BD				Rickabaugh, Tammy M.; Kilpatrick, Ryan D.; Hultin, Lance E.; Hultin, Patricia M.; Hausner, Mary Ann; Sugar, Catherine A.; Althoff, Keri N.; Margolick, Joseph B.; Rinaldo, Charles R.; Detels, Roger; Phair, John; Effros, Rita B.; Jamieson, Beth D.			The Dual Impact of HIV-1 Infection and Aging on Naive CD4(+) T-Cells: Additive and Distinct Patterns of Impairment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MARKED INCREASE; MORTALITY-RATES; ANAL CANCER; IN-VIVO; AT-RISK; AIDS; AGE; RESTORATION	HIV-1-infected adults over the age of 50 years progress to AIDS more rapidly than adults in their twenties or thirties. In addition, HIV-1-infected individuals receiving antiretroviral therapy (ART) present with clinical diseases, such as various cancers and liver disease, more commonly seen in older uninfected adults. These observations suggest that HIV-1 infection in older persons can have detrimental immunological effects that are not completely reversed by ART. As naive T-cells are critically important in responses to neoantigens, we first analyzed two subsets (CD45RA(+)CD31(+) and CD45RA(+)CD31(-)) within the naive CD4(+) T-cell compartment in young (20-32 years old) and older (39-58 years old), ART-naive, HIV-1 seropositive individuals within 1-3 years of infection and in age-matched seronegative controls. HIV-1 infection in the young cohort was associated with lower absolute numbers of, and shorter telomere lengths within, both CD45RA(+)CD31(+)CD4(+) and CD45RA(+)CD31(-)CD4(+) T-cell subsets in comparison to age-matched seronegative controls, changes that resembled seronegative individuals who were decades older. Longitudinal analysis provided evidence of thymic emigration and reconstitution of CD45RA(+)CD31(+)CD4(+) T-cells two years post-ART, but minimal reconstitution of the CD45RA(+)CD31(-)CD4(+) subset, which could impair de novo immune responses. For both ART-naive and ART-treated HIV-1-infected adults, a renewable pool of thymic emigrants is necessary to maintain CD4(+) T-cell homeostasis. Overall, these results offer a partial explanation both for the faster disease progression of older adults and the observation that viral responders to ART present with clinical diseases associated with older adults.	[Rickabaugh, Tammy M.; Kilpatrick, Ryan D.; Hultin, Lance E.; Hausner, Mary Ann; Effros, Rita B.; Jamieson, Beth D.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Dept Med, Los Angeles, CA 90095 USA; [Effros, Rita B.] Univ Calif Los Angeles, UCLA AIDS Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Sugar, Catherine A.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Althoff, Keri N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Margolick, Joseph B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Kilpatrick, Ryan D.; Hultin, Patricia M.; Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Phair, John] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Northwestern University; Feinberg School of Medicine	Rickabaugh, TM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Dept Med, Los Angeles, CA 90095 USA.	jamieson@mednet.ucla.edu	Serei, Virian D/B-4616-2015; Althoff, Keri N/HGC-5595-2022	Althoff, Keri/0000-0002-5068-6595; Kilpatrick, Ryan/0000-0003-1388-3669	NIAID [5RO1-AI-058845]; NIA [1RO1-AG-030327]; National Institutes of Health [CA-16042, AI-28697]; National Cancer Institute [5 T32 CA009120]; National Institute of Allergy and Infectious Diseases; National Cancer Institute and the National Heart, Lung and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; NATIONAL CANCER INSTITUTE [T32CA009120, P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, U01AI035042, U01AI037613, U01AI035039, U01AI035043, R01AI058845, U01AI035041, U01AI037984, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030327, R01AG032422] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute and the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIAID Grant 5RO1-AI-058845 and NIA Grant 1RO1-AG-030327 awarded to B. D. Jamieson, P. I. T. M. Rickabaugh was also supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award, 5 T32 CA009120, from the National Cancer Institute. The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute: UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Arnold DM, 2006, BLOOD, V108, P460, DOI 10.1182/blood-2005-11-4407; Aspinall R, 2000, J CLIN IMMUNOL, V20, P250, DOI 10.1023/A:1006611518223; Azevedo RI, 2009, BLOOD, V113, P2999, DOI 10.1182/blood-2008-07-166223; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V282, P356, DOI 10.1006/bbrc.2001.4533; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V284, pE481, DOI 10.1152/ajpendo.00319.2002; Bestilny LJ, 2000, AIDS, V14, P771, DOI 10.1097/00002030-200005050-00002; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chattopadhyay PK, 2006, AIDS RES HUM RETROV, V22, P501, DOI 10.1089/aid.2006.22.501; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Dorrucci M, 2001, J ACQ IMMUN DEF SYND, V26, P377, DOI 10.1097/00126334-200104010-00016; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Effros RB, 2000, MECH AGEING DEV, V121, P161; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Engels EA, 2010, JAIDS-J ACQ IMM DEF, V54, P78, DOI 10.1097/01.qai.0000371677.48743.8d; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Herndler-Brandstetter D, 2006, WIEN MED WOCHENSCHR, V156, P130, DOI 10.1007/s10354-006-0267-8; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hooshyar D, 2007, AIDS, V21, P2093, DOI 10.1097/QAD.0b013e3282e9a664; Hsue PY, 2008, AIDS, V22, P825, DOI 10.1097/QAD.0b013e3282f7cd42; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Hultin L, 2006, MANUAL OF MOLECULAR AND CLINICAL LABORATORY IMMUNOLOGY, 7TH EDITION, P147; Iyer SB, 1998, CYTOMETRY, V33, P206, DOI 10.1002/(SICI)1097-0320(19981001)33:2<206::AID-CYTO15>3.0.CO;2-Y; IYER SB, 1997, 233496 BDIS; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Lange CG, 2002, CLIN IMMUNOL, V102, P154, DOI 10.1006/clim.2001.5164; Lucas GM, 2007, AIDS, V21, P2435, DOI 10.1097/QAD.0b013e32827038ad; MASCOLINI M, 2010, RES INITIATIVE TREAT, V15, P1; Nichols WS, 1999, SCAND J IMMUNOL, V49, P302, DOI 10.1046/j.1365-3083.1999.00505.x; Pham T, 2003, CLIN DIAGN LAB IMMUN, V10, P323, DOI 10.1128/CDLI.10.2.323-328.2003; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; PLAEGERMARSHALL S, 1993, J ACQ IMMUN DEF SYND, V6, P984; Pommier JP, 1997, VIROLOGY, V231, P148, DOI 10.1006/viro.1997.8512; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; Richardson MW, 2000, BIOMED PHARMACOTHER, V54, P21, DOI 10.1016/S0753-3322(00)88637-0; Robertson JD, 2000, BRIT J HAEMATOL, V109, P272, DOI 10.1046/j.1365-2141.2000.01970.x; RODRIGUEZ B, 2010, CLIN IMMUNOL; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; ROSENBERG PS, 1994, AIDS, V8, P803, DOI 10.1097/00002030-199406000-00013; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Sergio G, 2008, INFLAMM RES, V57, P558, DOI 10.1007/s00011-008-7243-2; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; Thomas J, 2003, JAIDS-J ACQ IMM DEF, V33, P281, DOI 10.1097/00126334-200307010-00001; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Vignoli M, 1998, AIDS, V12, P999, DOI 10.1097/00002030-199809000-00005; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Whisler RL, 1996, CELL IMMUNOL, V168, P201, DOI 10.1006/cimm.1996.0067; Wolthers KC, 1999, AIDS RES HUM RETROV, V15, P1053, DOI 10.1089/088922299310340; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	71	57	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16459	10.1371/journal.pone.0016459	http://dx.doi.org/10.1371/journal.pone.0016459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298072	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000286662800044
J	Welsh, J; Zinser, LN; Mianecki-Morton, L; Martin, J; Waltz, SE; James, H; Zinser, GM				Welsh, JoEllen; Zinser, Lindsay N.; Mianecki-Morton, Laurel; Martin, Jamie; Waltz, Susan E.; James, Howard; Zinser, Glendon M.			Age-Related Changes in the Epithelial and Stromal Compartments of the Mammary Gland in Normocalcemic Mice Lacking the Vitamin D-3 Receptor	PLOS ONE			English	Article							MINERAL ION HOMEOSTASIS; BREAST-CANCER CELLS; ADIPOSE-TISSUE; KNOCKOUT MICE; 1,25-DIHYDROXYVITAMIN D-3; INDUCED TUMORIGENESIS; DIETARY CALCIUM; ABLATED MICE; MUTANT MICE; GROWTH	The vitamin D-3 receptor (VDR) serves as a negative growth regulator during mammary gland development via suppression of branching morphogenesis during puberty and modulation of differentiation and apoptosis during pregnancy, lactation and involution. To assess the role of the VDR in the aging mammary gland, we utilized 12, 14, and 16 month old VDR knockout (KO) and wild type (WT) mice for assessment of integrity of the epithelial and stromal compartments, steroid hormone levels and signaling pathways. Our data indicate that VDR ablation is associated with ductal ectasia of the primary mammary ducts, loss of secondary and tertiary ductal branches and atrophy of the mammary fat pad. In association with loss of the white adipose tissue compartment, smooth muscle actin staining is increased in glands from VDR KO mice, suggesting a change in the stromal microenviroment. Activation of caspase-3 and increased Bax expression in mammary tissue of VDR KO mice suggests that enhanced apoptosis may contribute to loss of ductal branching. These morphological changes in the glands of VDR KO mice are associated with ovarian failure and reduced serum 17 beta-estradiol. VDR KO mice also exhibit progressive loss of adipose tissue stores, hypoleptinemia and increased metabolic rate with age. These developmental studies indicate that, under normocalcemic conditions, loss of VDR signaling is associated with age-related estrogen deficiency, disruption of epithelial ductal branching, abnormal energy expenditure and atrophy of the mammary adipose compartment.	[Welsh, JoEllen] SUNY Albany, Canc Res Ctr, Rensselaer, NY USA; [Zinser, Lindsay N.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Mianecki-Morton, Laurel] Univ Michigan, Ann Arbor, MI 48109 USA; [Martin, Jamie] Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Waltz, Susan E.; Zinser, Glendon M.] Univ Cincinnati, Cincinnati, OH USA; [Waltz, Susan E.; James, Howard] Cincinnati Shriners Hosp, Cincinnati, OH USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University of Michigan System; University of Michigan; Brown University; Hasbro Children's Hospital; University of Cincinnati	Welsh, J (corresponding author), SUNY Albany, Canc Res Ctr, Rensselaer, NY USA.	zinserg@ucmail.uc.edu		Waltz, Susan/0000-0003-3572-4642	National Institutes of Health [CA69700, CA100002]; DOD [DAMD17-00-1-0644]; Susan G. Komen Breast Cancer Foundation [PDF0403052]; BIRCWH [HD051953-01]; Shriners Hospital for Children [8950]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051953] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069700, R01CA100002] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); BIRCWH; Shriners Hospital for Children; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by grants from the National Institutes of Health (CA69700, JW) and (CA100002, SEW), DOD Breast Cancer Research Program (DAMD17-00-1-0644, JW), a post-doctoral award to GMZ from the Susan G. Komen Breast Cancer Foundation (PDF0403052), a BIRCWH fellowship award to GMZ (HD051953-01), and a grant from Shriners Hospital for Children (#8950, SEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Bruce D, 2009, INT IMMUNOL, V21, P113, DOI 10.1093/intimm/dxn129; Cooke PS, 2001, MOL CELL ENDOCRINOL, V178, P147, DOI 10.1016/S0303-7207(01)00414-2; Couldrey C, 2002, DEV DYNAM, V223, P459, DOI 10.1002/dvdy.10065; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; ERBEN RG, HEMATOL ONCOL; Eriksen EF, 2002, BIOGERONTOLOGY, V3, P73, DOI 10.1023/A:1015263514765; Fendrick JL, 1998, J MAMMARY GLAND BIOL, V3, P7, DOI 10.1023/A:1018766000275; Froicu M, 2006, IMMUNOLOGY, V117, P310, DOI 10.1111/j.1365-2567.2005.02290.x; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Haslam Sandra Z, 2005, Breast Dis, V24, P71; Haslam SZ, 2002, J MAMMARY GLAND BIOL, V7, P93, DOI 10.1023/A:1015726608146; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Johnson JA, 1996, HISTOCHEM CELL BIOL, V105, P7, DOI 10.1007/BF01450873; Johnson LE, 2001, J NUTR, V131, P1787, DOI 10.1093/jn/131.6.1787; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kanazawa T, 1999, CELL BIOL INT, V23, P481, DOI 10.1006/cbir.1999.0406; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lamote I, 2004, STEROIDS, V69, P145, DOI 10.1016/j.steroids.2003.12.008; LANDSKRONEREIGE.S, DEV BIOL, V344, P968; LEFEBVRE MF, 1995, BREAST CANCER RES TR, V33, P189, DOI 10.1007/BF00665943; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Metcalfe AD, 1999, J CELL SCI, V112, P1771; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Narvaez CJ, 2001, J BIOL CHEM, V276, P9101, DOI 10.1074/jbc.M006876200; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Parra P, 2008, J NUTR BIOCHEM, V19, P109, DOI 10.1016/j.jnutbio.2007.01.009; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; SimboliCampbell M, 1996, J STEROID BIOCHEM, V58, P367, DOI 10.1016/0960-0760(96)00055-6; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; WONG KE, 2009, AM J PHYSL ENDOCRINO; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zinser G, 2002, DEVELOPMENT, V129, P3067; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024; Zinser GM, 2004, MOL ENDOCRINOL, V18, P2208, DOI 10.1210/me.2003-0469; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103; Zou J, 2008, AUDIOL NEURO-OTOL, V13, P219, DOI 10.1159/000115431	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16479	10.1371/journal.pone.0016479	http://dx.doi.org/10.1371/journal.pone.0016479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298063	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800045
J	Hansson, J; Vasan, RS; Arnlov, J; Ingelsson, E; Lind, L; Larsson, A; Michaelsson, K; Sundstrom, J				Hansson, Jonas; Vasan, Ramachandran S.; Arnlov, Johan; Ingelsson, Erik; Lind, Lars; Larsson, Anders; Michaelsson, Karl; Sundstrom, Johan			Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; PLASMA TISSUE INHIBITOR; LONG-TERM SURVIVAL; E-DEFICIENT MICE; METALLOPROTEINASE INHIBITION; CARDIOVASCULAR-DISEASE; INDEPENDENT PREDICTOR; LUNG-CANCER; MATRIX-METALLOPROTEINASE-9; SERUM	Objective: Turnover of the extracellular matrix in all solid organs is governed mainly by a balance between the degrading matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). An altered extracellular matrix metabolism has been implicated in a variety of diseases. We investigated relations of serum levels of MMP-9 and TIMP-1 to mortality risk from an etiological perspective. Design: The prospective Uppsala Longitudinal Study of Adult Men (ULSAM) cohort, followed from 1991-1995 for up to 18.1 years. A random population-based sample of 1,082 71-year-old men, no loss to follow-up. Endpoints were all-cause (n = 628), cardiovascular (n = 230), non-cardiovascular (n = 398) and cancer mortality (n = 178), and fatal or non-fatal myocardial infarction (n = 138) or stroke (n = 163). Results: Serum MMP-9 and TIMP-1 levels were associated with risk of all-cause mortality (Cox proportional hazard ratio [HR] per standard deviation 1.10, 95% confidence interval [CI] 1.03-1.19; and 1.11, 1.02-1.20; respectively). TIMP-1 levels were mainly related to risks of cardiovascular mortality and stroke (HR per standard deviation 1.22, 95% CI 1.09-1.37; and 1.18, 1.04-1.35; respectively). All relations except those of TIMP-1 to stroke risk were attenuated by adjustment for cardiovascular disease risk factors. Relations in a subsample without cardiovascular disease or cancer were similar to those in the total sample. Conclusion: In this community-based cohort of elderly men, serum MMP-9 and TIMP-1 levels were related to mortality risk. An altered extracellular matrix metabolism may be involved in several detrimental pathways, and circulating MMP-9 or TIMP-1 levels may be relevant markers thereof.	[Hansson, Jonas; Lind, Lars; Sundstrom, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Vasan, Ramachandran S.; Larsson, Anders] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Vasan, Ramachandran S.; Larsson, Anders] Boston Univ, Sch Med, Cardiol Sect, Boston Med Ctr, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Larsson, Anders] Boston Univ, Sch Med, Sect Prevent Med, Boston Med Ctr, Boston, MA 02118 USA; [Arnlov, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Sci, Falun, Sweden; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Michaelsson, Karl; Sundstrom, Johan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Uppsala University; Framingham Heart Study; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Uppsala University; Dalarna University; Karolinska Institutet; Uppsala University; Uppsala University	Hansson, J (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	johan.sundstrom@medsci.uu.se	Larsson, Agneta/AAT-9546-2020; Michaelsson, Karl/AAM-9094-2021; Sundström, Johan/A-6286-2009; Ärnlöv, Johan/AAF-2746-2019; Sundstrom, Johan/R-2139-2019	Larsson, Agneta/0000-0002-8692-249X; Sundström, Johan/0000-0003-2247-8454; Ärnlöv, Johan/0000-0002-6933-4637; Sundstrom, Johan/0000-0003-2247-8454; Michaelsson, Karl/0000-0003-2815-1217; Ramachandran, Vasan/0000-0001-7357-5970	Swedish Research Council (vr.se) [522-2007-5942]; Swedish Heart Lung Foundation (hjart-lungfonden.se) [20041151]	Swedish Research Council (vr.se)(Swedish Research Council); Swedish Heart Lung Foundation (hjart-lungfonden.se)(Swedish Heart-Lung Foundation)	The study was funded by the Swedish Research Council (vr.se), grant 522-2007-5942, and the Swedish Heart Lung Foundation (hjart-lungfonden.se), grant 20041151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Belvisi MG, 2003, INFLAMM RES, V52, P95, DOI 10.1007/s000110300020; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Byberg L, 1998, ARTERIOSCL THROM VAS, V18, P258, DOI 10.1161/01.ATV.18.2.258; Castellanos M, 2003, STROKE, V34, P40, DOI 10.1161/01.STR.0000046764.57344.31; Cavusoglu E, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.029; Chancey AL, 2002, CIRCULATION, V105, P1983, DOI 10.1161/01.CIR.0000014686.73212.DA; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Dorman Gyorgy, 2007, Recent Pat Cardiovasc Drug Discov, V2, P186, DOI 10.2174/157489007782418964; Eldrup N, 2006, CIRCULATION, V114, P1847, DOI 10.1161/CIRCULATIONAHA.105.593483; Fong KM, 1996, CLIN CANCER RES, V2, P1369; Frantz S, 2008, EUR J HEART FAIL, V10, P388, DOI 10.1016/j.ejheart.2008.02.015; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; George J, 2005, AM HEART J, V150, P484, DOI 10.1016/j.ahj.2004.11.016; HANSSON J, 2009, EUR J CARDIOVASC PRE; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; JEFFERIS BJ, ATHEROSCLEROSIS, V208, P557; Jung K, 2008, ARTERIOSCL THROM VAS, V28, pE15, DOI 10.1161/ATVBAHA.107.158790; Klein G, 2004, CRIT REV ONCOL HEMAT, V50, P87, DOI 10.1016/j.critevonc.2003.09.001; Lijnen HR, 2003, PATHOPHYSIOL HAEMO T, V33, P275, DOI 10.1159/000083814; Lubos E, 2006, EUR HEART J, V27, P150, DOI 10.1093/eurheartj/ehi582; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Montaner J, 2003, STROKE, V34, P2851, DOI 10.1161/01.STR.0000098648.54429.1C; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Peterson JT, 2001, CIRCULATION, V103, P2303; Rouet-Benzineb P, 1999, EUR J HEART FAIL, V1, P337, DOI 10.1016/S1388-9842(99)00048-3; Rouis M, 1999, CIRCULATION, V100, P533, DOI 10.1161/01.CIR.100.5.533; Rouy D, 2005, ANAL BIOCHEM, V338, P294, DOI 10.1016/j.ab.2004.10.052; Silence J, 2002, CIRC RES, V90, P897, DOI 10.1161/01.RES.0000016501.56641.83; Spinale FG, 1999, CIRC RES, V85, P364, DOI 10.1161/01.RES.85.4.364; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sundstrom J, 2004, EUR HEART J, V25, P1509, DOI 10.1016/j.ehj.2004.05.029; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Sundstrom J, 2006, CURR OPIN LIPIDOL, V17, P45, DOI 10.1097/01.mol.0000203891.34890.b5; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; Turunen MP, 2002, MOL THER, V6, P306, DOI 10.1006/mthe.2002.0668; VELAGALETI RS, ARTERIOSCLER THROMB; West MJ, 2008, EUR HEART J, V29, P923, DOI 10.1093/eurheartj/ehn007; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Ylisirnio S, 2000, ANTICANCER RES, V20, P1311; Yoshikawa T, 2009, GASTRIC CANCER, V12, P31, DOI 10.1007/s10120-008-0494-3; Yukawa N, 2007, ONCOLOGY-BASEL, V72, P205, DOI 10.1159/000112827	45	77	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16185	10.1371/journal.pone.0016185	http://dx.doi.org/10.1371/journal.pone.0016185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283828	gold, Green Published, Green Submitted			2022-12-27	WOS:000286520600027
J	Kozmikova, I; Smolikova, J; Vlcek, C; Kozmik, Z				Kozmikova, Iryna; Smolikova, Jana; Vlcek, Cestmir; Kozmik, Zbynek			Conservation and Diversification of an Ancestral Chordate Gene Regulatory Network for Dorsoventral Patterning	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; HOMEOBOX GENE; BETA-CATENIN; SIGNALING PATHWAY; XENOPUS MESODERM; TRANSCRIPTIONAL REPRESSOR; NEGATIVE REGULATOR; DNA-BINDING; AMPHIOXUS; EMBRYOS	Formation of a dorsoventral axis is a key event in the early development of most animal embryos. It is well established that bone morphogenetic proteins (Bmps) and Wnts are key mediators of dorsoventral patterning in vertebrates. In the cephalochordate amphioxus, genes encoding Bmps and transcription factors downstream of Bmp signaling such as Vent are expressed in patterns reminiscent of those of their vertebrate orthologues. However, the key question is whether the conservation of expression patterns of network constituents implies conservation of functional network interactions, and if so, how an increased functional complexity can evolve. Using heterologous systems, namely by reporter gene assays in mammalian cell lines and by transgenesis in medaka fish, we have compared the gene regulatory network implicated in dorsoventral patterning of the basal chordate amphioxus and vertebrates. We found that Bmp but not canonical Wnt signaling regulates promoters of genes encoding homeodomain proteins AmphiVent1 and AmphiVent2. Furthermore, AmphiVent1 and AmphiVent2 promoters appear to be correctly regulated in the context of a vertebrate embryo. Finally, we show that AmphiVent1 is able to directly repress promoters of AmphiGoosecoid and AmphiChordin genes. Repression of genes encoding dorsal-specific signaling molecule Chordin and transcription factor Goosecoid by Xenopus and zebrafish Vent genes represents a key regulatory interaction during vertebrate axis formation. Our data indicate high evolutionary conservation of a core Bmp-triggered gene regulatory network for dorsoventral patterning in chordates and suggest that co-option of the canonical Wnt signaling pathway for dorsoventral patterning in vertebrates represents one of the innovations through which an increased morphological complexity of vertebrate embryo is achieved.	[Kozmikova, Iryna; Smolikova, Jana; Vlcek, Cestmir; Kozmik, Zbynek] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Kozmikova, I (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.	kozmik@img.cas.cz	Kozmik, Zbynek/I-8807-2014	Kozmik, Zbynek/0000-0002-5850-2105	Grant Agency of Czech Academy of Sciences [IAA500520604, IAA500520908]; Academy of Sciences of the Czech Republic [AV0Z50520514]	Grant Agency of Czech Academy of Sciences; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Grant Agency of Czech Academy of Sciences (IAA500520604 and IAA500520908 to Z.K.). Institute of Molecular Genetics is supported by the Academy of Sciences of the Czech Republic (AV0Z50520514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Barkai N, 2009, FEBS J, V276, P1196, DOI 10.1111/j.1742-4658.2008.06854.x; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; DALE L, 1992, DEVELOPMENT, V115, P573; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Friedle H, 2002, J BIOL CHEM, V277, P23872, DOI 10.1074/jbc.M201831200; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Henningfeld KA, 2000, J BIOL CHEM, V275, P21827, DOI 10.1074/jbc.M000978200; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Holland LZ, 2007, INTEGR COMP BIOL, V47, P360, DOI 10.1093/icb/icm064; Holland LZ, 2005, DEV DYNAM, V233, P1430, DOI 10.1002/dvdy.20473; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Imai Y, 2001, DEVELOPMENT, V128, P2407; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kawahara A, 2000, GENESIS, V28, P58, DOI 10.1002/1526-968X(200010)28:2<58::AID-GENE30>3.0.CO;2-N; Kobayashi M, 2001, DEV BIOL, V232, P315, DOI 10.1006/dbio.2001.0185; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Lapraz F, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000248; Larder R, 2009, J BIOL CHEM, V284, P16966, DOI 10.1074/jbc.M109.002485; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Melby AE, 2000, DEV BIOL, V224, P275, DOI 10.1006/dbio.2000.9780; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Onai T, 2009, DEV BIOL, V332, P223, DOI 10.1016/j.ydbio.2009.05.571; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Plouhinec JL, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001701; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schubert M, 2000, EVOL DEV, V2, P85, DOI 10.1046/j.1525-142x.2000.00047.x; Schuler-Metz A, 2000, J BIOL CHEM, V275, P34365, DOI 10.1074/jbc.M003915200; Shimada A, 2008, DEVELOPMENT, V135, P281, DOI 10.1242/dev.011494; Trindade M, 1999, DEV BIOL, V216, P442, DOI 10.1006/dbio.1999.9507; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; YAMAMOTO T, 1975, MEDAKA KILLIFISH BIO; Yu JK, 2002, DEV DYNAM, V225, P289, DOI 10.1002/dvdy.10173; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	61	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14650	10.1371/journal.pone.0014650	http://dx.doi.org/10.1371/journal.pone.0014650			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304903	Green Published, gold			2022-12-27	WOS:000287036600003
J	Vacher, C; Kossler, TM; Hochberg, ME; Weis, AE				Vacher, Corinne; Kossler, Tanya M.; Hochberg, Michael E.; Weis, Arthur E.			Impact of Interspecific Hybridization between Crops and Weedy Relatives on the Evolution of Flowering Time in Weedy Phenotypes	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RAPE BRASSICA-NAPUS; OILSEED RAPE; GENE FLOW; COMPETITION AFFECTS; BT TRANSGENES; F-1 HYBRIDS; WILD; PLANT; FITNESS	Background: Like conventional crops, some GM cultivars may readily hybridize with their wild or weedy relatives. The progressive introgression of transgenes into wild or weedy populations thus appears inevitable, and we are now faced with the challenge of determining the possible evolutionary effects of these transgenes. The aim of this study was to gain insight into the impact of interspecific hybridization between transgenic plants and weedy relatives on the evolution of the weedy phenotype. Methodology/Principal Findings: Experimental populations of weedy birdseed rape (Brassica rapa) and transgenic rapeseed (B. napus) were grown under glasshouse conditions. Hybridization opportunities with transgenic plants and phenotypic traits (including phenological, morphological and reproductive traits) were measured for each weedy individual. We show that weedy individuals that flowered later and for longer periods were more likely to receive transgenic pollen from crops and weed x crop hybrids. Because stem diameter is correlated with flowering time, plants with wider stems were also more likely to be pollinated by transgenic plants. We also show that the weedy plants with the highest probability of hybridization had the lowest fecundity. Conclusion/Significance: Our results suggest that weeds flowering late and for long periods are less fit because they have a higher probability of hybridizing with crops or weed x crop hybrids. This may result in counter-selection against this subset of weed phenotypes, and a shorter earlier flowering period. It is noteworthy that this potential evolution in flowering time does not depend on the presence of the transgene in the crop. Evolution in flowering time may even be counter-balanced by positive selection acting on the transgene if the latter was positively associated with maternal genes promoting late flowering and long flowering periods. Unfortunately, we could not verify this association in the present experiment.	[Vacher, Corinne] INRA, Biodiversite Genes & Communaute UMR1202, Cestas, France; [Vacher, Corinne; Hochberg, Michael E.] Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France; [Kossler, Tanya M.; Weis, Arthur E.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Vacher, Corinne] Duke Univ, Dept Biol, Durham, NC USA; [Weis, Arthur E.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of California System; University of California Irvine; Duke University; University of Toronto	Vacher, C (corresponding author), INRA, Biodiversite Genes & Communaute UMR1202, Cestas, France.	corinne.vacher@pierroton.inra.fr	Vacher, Corinne/ABG-8163-2020; Vacher, Corinne/J-1777-2012; Vacher, Corinne/Q-3182-2019	Vacher, Corinne/0000-0003-3023-6113; Vacher, Corinne/0000-0003-3023-6113; 	French Ministere de la Recherche et de l'Enseignement Superieur; United States National Science Foundation [DEB-034530]; National Science and Engineering Research Council of Canada	French Ministere de la Recherche et de l'Enseignement Superieur; United States National Science Foundation(National Science Foundation (NSF)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support came from the French Ministere de la Recherche et de l'Enseignement Superieur (Program: Impact of Biotechnologies in Agro-Ecosystems), and grants from the United States National Science Foundation (Grant: DEB-034530) and the National Science and Engineering Research Council of Canada to AEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1992, TRENDS ECOL EVOL, V7, P401, DOI 10.1016/0169-5347(92)90020-C; Allainguillaume J, 2006, MOL ECOL, V15, P1175, DOI 10.1111/j.1365-294X.2006.02856.x; [Anonymous], SAS STAT SOFTW VERS; Cresswell JE, 1995, FUNCT ECOL, V9, P829, DOI 10.2307/2389980; Cresswell JE, 2000, ECOL ENTOMOL, V25, P19, DOI 10.1046/j.1365-2311.2000.00230.x; Cummings CL, 2002, ECOL APPL, V12, P1661, DOI 10.1890/1051-0761(2002)012[1661:FSIASC]2.0.CO;2; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Di K, 2009, PEST MANAG SCI, V65, P753, DOI 10.1002/ps.1749; DORN LA, 1991, EVOLUTION, V45, P371, DOI 10.1111/j.1558-5646.1991.tb04411.x; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; FitzJohn RG, 2007, EUPHYTICA, V158, P209, DOI 10.1007/s10681-007-9444-0; Franke DM, 2006, INT J PLANT SCI, V167, P83, DOI 10.1086/497648; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Halfhill MD, 2005, MOL ECOL, V14, P3177, DOI 10.1111/j.1365-294X.2005.02649.x; Halfhill MD, 2001, THEOR APPL GENET, V103, P659, DOI 10.1007/s001220100613; Hall L, 2000, WEED SCI, V48, P688, DOI 10.1614/0043-1745(2000)048[0688:PFBHRB]2.0.CO;2; Harper BK, 1999, NAT BIOTECHNOL, V17, P1125, DOI 10.1038/15114; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hauser TP, 1998, HEREDITY, V81, P429, DOI 10.1046/j.1365-2540.1998.00424.x; Hauser TP, 1997, AM J BOT, V84, P756, DOI 10.2307/2445811; Hegde SG, 2006, EVOLUTION, V60, P1187, DOI 10.1111/j.0014-3820.2006.tb01197.x; Johannessen MM, 2006, HEREDITY, V96, P360, DOI 10.1038/sj.hdy.6800796; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; Johannessen MM, 2006, EUPHYTICA, V150, P17, DOI 10.1007/s10681-006-9083-x; Pallett DW, 2006, ANN APPL BIOL, V148, P147, DOI 10.1111/j.1744-7348.2006.00049.x; Pertl M, 2002, HEREDITY, V89, P212, DOI 10.1038/sj.hdy.6800131; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Simard MJ, 2006, CAN J BOT, V84, P1842, DOI 10.1139/B06-135; Snow A, 2009, MOL ECOL, V18, P569, DOI 10.1111/j.1365-294X.2008.04063.x; Stewart CN, 1997, MOL ECOL, V6, P773, DOI 10.1046/j.1365-294X.1997.00239.x; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Vacher C, 2004, THEOR APPL GENET, V109, P806, DOI 10.1007/s00122-004-1696-7; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Warwick SI, 2003, THEOR APPL GENET, V107, P528, DOI 10.1007/s00122-003-1278-0; Weis AE, 2004, AM J BOT, V91, P825, DOI 10.3732/ajb.91.6.825; Weis AE, 2005, EVOL ECOL RES, V7, P161; Wilkinson MJ, 2003, SCIENCE, V302, P457, DOI 10.1126/science.1088200	44	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14649	10.1371/journal.pone.0014649	http://dx.doi.org/10.1371/journal.pone.0014649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304909	Green Published, gold			2022-12-27	WOS:000287036600002
J	Zhang, F; Guo, XO; Deng, HW				Zhang, Feng; Guo, Xiong; Deng, Hong-Wen			Multilocus Association Testing of Quantitative Traits Based on Partial Least-Squares Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE SNPS; GENE-GENE; REGRESSION; PATHWAY; DISEASE; POWER; ADAMTS-1	Because of combining the genetic information of multiple loci, multilocus association studies (MLAS) are expected to be more powerful than single locus association studies (SLAS) in disease genes mapping. However, some researchers found that MLAS had similar or reduced power relative to SLAS, which was partly attributed to the increased degrees of freedom (dfs) in MLAS. Based on partial least-squares (PLS) analysis, we develop a MLAS approach, while avoiding large dfs in MLAS. In this approach, genotypes are first decomposed into the PLS components that not only capture majority of the genetic information of multiple loci, but also are relevant for target traits. The extracted PLS components are then regressed on target traits to detect association under multilinear regression. Simulation study based on real data from the HapMap project were used to assess the performance of our PLS-based MLAS as well as other popular multilinear regression-based MLAS approaches under various scenarios, considering genetic effects and linkage disequilibrium structure of candidate genetic regions. Using PLS-based MLAS approach, we conducted a genome-wide MLAS of lean body mass, and compared it with our previous genome-wide SLAS of lean body mass. Simulations and real data analyses results support the improved power of our PLS-based MLAS in disease genes mapping relative to other three MLAS approaches investigated in this study. We aim to provide an effective and powerful MLAS approach, which may help to overcome the limitations of SLAS in disease genes mapping.	[Zhang, Feng; Guo, Xiong] Xi An Jiao Tong Univ, Coll Med, Fac Publ Hlth, Key Lab Environm & Gene Related Dis,Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Univ Missouri, Sch Med, Dept Orthoped Surg, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA	Xi'an Jiaotong University; University of Shanghai for Science & Technology; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Zhang, F (corresponding author), Xi An Jiao Tong Univ, Coll Med, Fac Publ Hlth, Key Lab Environm & Gene Related Dis,Minist Educ, Xian 710049, Shaanxi, Peoples R China.	fzhxjtu@mail.xjtu.edu.cn; dengh@umkc.edu		Deng, Hong-Wen/0000-0002-0387-8818	NIH [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; National Science Foundation of China, HuNan Province; Xi'an Jiaotong University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China, HuNan Province(National Natural Science Foundation of China (NSFC)); Xi'an Jiaotong University(Xi'an Jiaotong University); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were supported by grants from NIH (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973). The study also benefited from grants from National Science Foundation of China, HuNan Province, and Xi'an Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan N, 2006, MATEMATIKA, V22, P109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Choi JW, 2004, ANN CLIN LAB SCI, V34, P400; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gunther W, 2005, ACTA HISTOCHEM, V107, P121, DOI 10.1016/j.acthis.2004.07.009; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; HELLAND IS, 1988, COMMUN STAT SIMULAT, V17, P581, DOI 10.1080/03610918808812681; HELLAND IS, 1990, SCAND J STAT, V17, P97; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Liu YJ, 2010, OBESITY, V18, P2339, DOI 10.1038/oby.2010.83; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marttinen P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-443; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Miles RR, 2000, ENDOCRINOLOGY, V141, P4533, DOI 10.1210/en.141.12.4533; Nicolas P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-303; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Flaherty J, 2006, APOPTOSIS, V11, P2103, DOI 10.1007/s10495-006-0196-4; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Rosenberg PS, 2006, STAT MED, V25, P3134, DOI 10.1002/sim.2407; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schork NJ, 1997, AM J RESP CRIT CARE, V156, pS103, DOI 10.1164/ajrccm.156.4.12-tac-5; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wang T, 2009, GENET EPIDEMIOL, V33, P6, DOI 10.1002/gepi.20351; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Yeniay O, 2002, HACET J MATH STAT, V31, P99; Zhang K, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-51; Zhang LS, 2010, J BONE MINER RES, V25, P1572, DOI 10.1002/jbmr.36	43	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16739	10.1371/journal.pone.0016739	http://dx.doi.org/10.1371/journal.pone.0016739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304821	gold, Green Submitted, Green Published			2022-12-27	WOS:000287036600019
J	Bajardi, P; Poletto, C; Ramasco, JJ; Tizzoni, M; Colizza, V; Vespignani, A				Bajardi, Paolo; Poletto, Chiara; Ramasco, Jose J.; Tizzoni, Michele; Colizza, Vittoria; Vespignani, Alessandro			Human Mobility Networks, Travel Restrictions, and the Global Spread of 2009 H1N1 Pandemic	PLOS ONE			English	Article							INFLUENZA; STRATEGIES; SYSTEMS; IMPACT; MODEL	After the emergence of the H1N1 influenza in 2009, some countries responded with travel-related controls during the early stage of the outbreak in an attempt to contain or slow down its international spread. These controls along with self-imposed travel limitations contributed to a decline of about 40% in international air traffic to/from Mexico following the international alert. However, no containment was achieved by such restrictions and the virus was able to reach pandemic proportions in a short time. When gauging the value and efficacy of mobility and travel restrictions it is crucial to rely on epidemic models that integrate the wide range of features characterizing human mobility and the many options available to public health organizations for responding to a pandemic. Here we present a comprehensive computational and theoretical study of the role of travel restrictions in halting and delaying pandemics by using a model that explicitly integrates air travel and short-range mobility data with high-resolution demographic data across the world and that is validated by the accumulation of data from the 2009 H1N1 pandemic. We explore alternative scenarios for the 2009 H1N1 pandemic by assessing the potential impact of mobility restrictions that vary with respect to their magnitude and their position in the pandemic timeline. We provide a quantitative discussion of the delay obtained by different mobility restrictions and the likelihood of containing outbreaks of infectious diseases at their source, confirming the limited value and feasibility of international travel restrictions. These results are rationalized in the theoretical framework characterizing the invasion dynamics of the epidemics at the metapopulation level.	[Bajardi, Paolo; Poletto, Chiara; Tizzoni, Michele] Inst Sci Interchange ISI, Computat Epidemiol Lab, Turin, Italy; [Bajardi, Paolo] CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France; [Ramasco, Jose J.] Inst Fis Interdisciplinary Sistemas Complejos IFI, CSIC UIB, Palma de Mallorca, Spain; [Tizzoni, Michele] Politecn Torino, Scuola Dottorato, Turin, Italy; [Colizza, Vittoria] INSERM, U707, Paris, France; [Colizza, Vittoria] UPMC Univ Paris 06, Fac Med Pierre & Marie Curie, UMR S 707, Paris, France; [Colizza, Vittoria] Inst Sci Interchange ISI, Complex Syst Lagrange Lab, Turin, Italy; [Vespignani, Alessandro] Indiana Univ, Ctr Complex Networks & Syst Res CNetS, Sch Informat & Comp, Bloomington, IN USA; [Vespignani, Alessandro] Indiana Univ, Pervas Technol Inst, Bloomington, IN USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Polytechnic University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bajardi, P (corresponding author), Inst Sci Interchange ISI, Computat Epidemiol Lab, Turin, Italy.	vittoria.colizza@inserm.fr; alexv@indiana.edu	Bajardi, Paolo/AAE-2416-2022; Tizzoni, Michele/H-6442-2016; Ramasco, Jose Javier/F-2860-2010; Tizzoni, Michele/AAE-8036-2020; Bajardi, Paolo/J-6180-2012	Bajardi, Paolo/0000-0001-8865-4495; Tizzoni, Michele/0000-0001-7246-2341; Ramasco, Jose Javier/0000-0003-2499-6095; Tizzoni, Michele/0000-0001-7246-2341; Poletto, Chiara/0000-0002-4051-1716; Colizza, Vittoria/0000-0002-2113-2374; Vespignani, Alessandro/0000-0003-3419-4205	National Institutes of Health [R21-DA024259]; Lilly Endowment [2008 1639-000]; EC-ICT [231807 (EPIWORK)]; EC-FET [233847 (DYNANETS)]; ERC [ERC-2007-Stg204863 (EPIFOR)];  [DTRA-1-0910039]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment; EC-ICT; EC-FET; ERC(European Research Council (ERC)European Commission); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work has been partially funded by the National Institutes of Health R21-DA024259 award, the Lilly Endowment grant 2008 1639-000 and the DTRA-1-0910039 award to AV; the EC-ICT contract no. 231807 (EPIWORK) to AV and VC; the EC-FET contract no. 233847 (DYNANETS) to AV, VC, and JJR; the ERC Ideas contract n.ERC-2007-Stg204863 (EPIFOR) to VC, PB, CP, and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; CIESIN, 2005, GRIDD POP WORLD VERS; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Flahault A., 1991, MATH POPUL STUD, V3, P1; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gautreau A, 2008, J THEOR BIOL, V251, P509, DOI 10.1016/j.jtbi.2007.12.001; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Harris TE, 1989, THEORY BRANCHING PRO; *HLTH PROT AG HLTH, 2009, EURO SURVEILL, V14; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Murray J.D, 2005, MATH BIOL; Novel influenza A(H1N1) investigation team, 2009, EURO SURVEILL, V14, P19295; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; *SECR COM TRANSP, 2009, B MENS EST OP; *SECR SAL, BROT INF RESP AG GLO; Tomba GS, 2008, MATH BIOSCI, V214, P70, DOI 10.1016/j.mbs.2008.02.009; Vazquez A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.038702; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503; 2010, INFLUENZA A H1N1 MEA	40	276	280	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16591	10.1371/journal.pone.0016591	http://dx.doi.org/10.1371/journal.pone.0016591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304943	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300093
J	Battke, F; Nieselt, K				Battke, Florian; Nieselt, Kay			Mayday SeaSight: Combined Analysis of Deep Sequencing and Microarray Data	PLOS ONE			English	Article							RNA-SEQ; GENOME; SYSTEM	Recently emerged deep sequencing technologies offer new high-throughput methods to quantify gene expression, epigenetic modifications and DNA-protein binding. From a computational point of view, the data is very different from that produced by the already established microarray technology, providing a new perspective on the samples under study and complementing microarray gene expression data. Software offering the integrated analysis of data from different technologies is of growing importance as new data emerge in systems biology studies. MAYDAY is an extensible platform for visual data exploration and interactive analysis and provides many methods for dissecting complex transcriptome datasets. We present MAYDAY SEASIGHT, an extension that allows to integrate data from different platforms such as deep sequencing and microarrays. It offers methods for computing expression values from mapped reads and raw microarray data, background correction and normalization and linking microarray probes to genomic coordinates. It is now possible to use MAYDAY's wealth of methods to analyze sequencing data and to combine data from different technologies in one analysis.	[Battke, Florian; Nieselt, Kay] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany	Eberhard Karls University of Tubingen	Battke, F (corresponding author), Univ Tubingen, Ctr Bioinformat, Tubingen, Germany.	battke@informatik.uni-tuebingen.de		Nieselt, Kay/0000-0002-1283-7065; Battke, Florian/0000-0001-6021-5837	ERA-NET [GEN2006-27745-E/SYS]; University of Tubingen	ERA-NET; University of Tubingen	This project was supported in part by grants of the ERA-NET SysMO Project [GEN2006-27745-E/SYS] (http://www.sysmo.net/). Additional funding was received from the University of Tubingen by way of KN holding tenure there. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Dietzsch J, 2006, BIOINFORMATICS, V22, P1010, DOI 10.1093/bioinformatics/btl070; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; GEHLENBORG N, 2005, INFORM VISUALIZATION, V4, P164, DOI DOI 10.1057/PALGRAVE.IVS.9500094; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; HORNER DS, 2009, BRIEF BIOINFORM; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kadota K, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-8; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Symons S, 2010, J INTEGRATIVE BIOINF, V7, P115; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; [No title captured]	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16345	10.1371/journal.pone.0016345	http://dx.doi.org/10.1371/journal.pone.0016345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305015	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300053
J	Chapuis, E; Pages, S; Emelianoff, V; Givaudan, A; Ferdy, JB				Chapuis, Elodie; Pages, Sylvie; Emelianoff, Vanya; Givaudan, Alain; Ferdy, Jean-Baptiste			Virulence and Pathogen Multiplication: A Serial Passage Experiment in the Hypervirulent Bacterial Insect-Pathogen Xenorhabdus nematophila	PLOS ONE			English	Article							ENTOMOPATHOGENIC NEMATODES; EXPERIMENTAL EVOLUTION; GENUS XENORHABDUS; PHASE VARIATION; TRADE-OFF; PHOTORHABDUS; PARASITES; MOTILITY; ENTEROBACTERIACEAE; ADAPTATION	The trade-off hypothesis proposes that the evolution of pathogens' virulence is shaped by a link between virulence and contagiousness. This link is often assumed to come from the fact that pathogens are contagious only if they can reach high parasitic load in the infected host. In this paper we present an experimental test of the hypothesis that selection on fast replication can affect virulence. In a serial passage experiment, we selected 80 lines of the bacterial insect-pathogen Xenorhabdus nematophila to multiply fast in an artificial culture medium. This selection resulted in shortened lag phase in our selected bacteria. We then injected these bacteria into insects and observed an increase in virulence. This could be taken as a sign that virulence in Xenorhabdus is linked to fast multiplication. But we found, among the selected lineages, either no link or a positive correlation between lag duration and virulence: the most virulent bacteria were the last to start multiplying. We then surveyed phenotypes that are under the control of the flhDC super regulon, which has been shown to be involved in Xenorhabdus virulence. We found that, in one treatment, the flhDC regulon has evolved rapidly, but that the changes we observed were not connected to virulence. All together, these results indicate that virulence is, in Xenorhabdus as in many other pathogens, a multifactorial trait. Being able to grow fast is one way to be virulent. But other ways exist which renders the evolution of virulence hard to predict.	[Chapuis, Elodie; Emelianoff, Vanya] Ctr Biol & Management Populat, Montpellier, France; [Pages, Sylvie; Givaudan, Alain] Univ Montpellier 2, UMR INRA UM2 1133, Lab EMIP, Montpellier, France; [Ferdy, Jean-Baptiste] Univ Toulouse 3, UMR CNRS UPS 5174, Lab Evolut & Diversite Biol, F-31062 Toulouse, France	INRAE; Universite de Montpellier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS)	Chapuis, E (corresponding author), Ctr Biol & Management Populat, Montpellier, France.	ferdy@cict.fr	chapuis, elodie/AAF-8000-2021; Chapuis, Elodie/N-5406-2018	Chapuis, Elodie/0000-0003-2299-0992; FERDY, Jean-Baptiste/0000-0002-4020-1208	French National Research Agency [ANR-06-JCJC-0102]	French National Research Agency(French National Research Agency (ANR))	This work has been funded by the French National Research Agency (www.agence-nationale-recherche.fr, grant ANR-06-JCJC-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; AKHURST RJ, 1988, J GEN MICROBIOL, V134, P1835; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Atkinson B., 2008, KINSHIP MIXED EFFECT; BAGHDIGUIAN S, 1993, BIOL CELL, V79, P177, DOI 10.1016/0248-4900(93)90254-C; Boemare N, 1997, SYMBIOSIS, V22, P167; BOEMARE NE, 1992, APPL ENVIRON MICROB, V58, P3032, DOI 10.1128/AEM.58.9.3032-3037.1992; Brillard J, 2001, APPL ENVIRON MICROB, V67, P2515, DOI 10.1128/AEM.67.6.2515-2525.2001; Chapuis E, 2009, J EVOLUTION BIOL, V22, P2104, DOI 10.1111/j.1420-9101.2009.01829.x; Cowles KN, 2007, CELL MICROBIOL, V9, P1311, DOI 10.1111/j.1462-5822.2006.00873.x; Dray S., 2007, R NEWS, V7, P47; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Emelianoff V, 2008, EVOLUTION, V62, P932, DOI 10.1111/j.1558-5646.2008.00319.x; Emelianoff V, 2007, PARASITOL RES, V100, P657, DOI 10.1007/s00436-006-0284-y; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; FENNER F, 1965, MYXOMATOSIS; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; GIVAUDAN A, 1995, APPL ENVIRON MICROB, V61, P1408, DOI 10.1128/AEM.61.4.1408-1413.1995; Goodrich-Blair H, 2007, CURR OPIN MICROBIOL, V10, P225, DOI 10.1016/j.mib.2007.05.006; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Herrera M, 2007, PLOS PATHOG, V3, P498, DOI 10.1371/journal.ppat.0030053; JUBELIN G, DYNAMIC EXPRES UNPUB; Lanois A, 2008, MOL MICROBIOL, V68, P516, DOI 10.1111/j.1365-2958.2008.06168.x; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; R Core Team, 2020, R LANG ENV STAT COMP; Restif O, 2009, INFECT GENET EVOL, V9, P108, DOI 10.1016/j.meegid.2008.09.007; Richards GR, 2008, J BACTERIOL, V190, P4870, DOI 10.1128/JB.00358-08; Richards GR, 2009, CELL MICROBIOL, V11, P1025, DOI 10.1111/j.1462-5822.2009.01322.x; Sicard M, 2004, J EVOLUTION BIOL, V17, P985, DOI 10.1111/j.1420-9101.2004.00748.x; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Therneau T, 2009, SURVIVAL SURVIVAL AN; Tran EEH, 2009, APPL ENVIRON MICROB, V75, P4007, DOI 10.1128/AEM.02658-08; Vigneux F, 2008, J EVOLUTION BIOL, V21, P1245, DOI 10.1111/j.1420-9101.2008.01576.x; Vigneux F, 2007, J BIOL CHEM, V282, P9571, DOI 10.1074/jbc.M604301200; Volgyi A, 1998, APPL ENVIRON MICROB, V64, P1188; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	42	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15872	10.1371/journal.pone.0015872	http://dx.doi.org/10.1371/journal.pone.0015872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305003	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300028
J	Gonon, F; Bezard, E; Boraud, T				Gonon, Francois; Bezard, Erwan; Boraud, Thomas			Misrepresentation of Neuroscience Data Might Give Rise to Misleading Conclusions in the Media: The Case of Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; CHILDREN; ADULTS; GENE; PSYCHOSTIMULANTS; PUBLICATION; SEROTONIN; PRESS; ADHD	Background: There is often a huge gap between neurobiological facts and firm conclusions stated by the media. Data misrepresentation in the conclusions and summaries of neuroscience articles might contribute to this gap. Methodology/Principal Findings: Using the case of attention deficit hyperactivity disorder (ADHD), we identified three types of misrepresentation. The first relies on prominent inconsistencies between results and claimed conclusions and was observed in two scientific reports dealing with ADHD. Only one out of the 61 media articles echoing both scientific reports adequately described the results and, thus questioned the claimed conclusion. The second type of misrepresentation consists in putting a firm conclusion in the summary while raw data that strongly limit the claim are only given in the results section. To quantify this misrepresentation we analyzed the summaries of all articles asserting that polymorphisms of the gene coding for the D4 dopaminergic receptor are associated with ADHD. Only 25 summaries out of 159 also mentioned that this association confers a small risk. This misrepresentation is also observed in most media articles reporting on ADHD and the D4 gene. The third misrepresentation consists in extrapolating basic and pre-clinical findings to new therapeutic prospects in inappropriate ways. Indeed, analysis of all ADHD-related studies in mice showed that 23% of the conclusions were overstated. The frequency of this overstatement was positively related with the impact factor of the journal. Conclusion/Significance: Data misrepresentations are frequent in the scientific literature dealing with ADHD and may contribute to the appearance of misleading conclusions in the media. In synergy with citation distortions and publication biases they influence social representations and bias the scientific evidence in favor of the view that ADHD is primarily caused by biological factors. We discuss the social consequences and the causes of data misrepresentations and suggest a few corrective actions.	[Gonon, Francois; Bezard, Erwan; Boraud, Thomas] Univ Bordeaux, Inst Malad Neurodegenerat, Bordeaux, France; [Gonon, Francois; Bezard, Erwan; Boraud, Thomas] CNRS, UMR 5293, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Gonon, F (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, Bordeaux, France.	francois.gonon@u-bordeaux2.fr	Bezard, Erwan/A-8173-2008; Bezard, Erwan/ABD-5153-2021	Bezard, Erwan/0000-0002-0410-4638	Centre National de la Recherche Scientifique (CNRS); University of Bordeaux; Institut des Sciences de la Communication du CNRS (ISCC); Agence Nationale de la Recherche (ANR VSN-RAP); La Region Aquitaine	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux; Institut des Sciences de la Communication du CNRS (ISCC); Agence Nationale de la Recherche (ANR VSN-RAP)(French National Research Agency (ANR)); La Region Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the University of Bordeaux, and by grants from the Institut des Sciences de la Communication du CNRS (ISCC), from the Agence Nationale de la Recherche (ANR VSN-RAP), and from La Region Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaresi WJ, 2007, J DEV BEHAV PEDIATR, V28, P274, DOI 10.1097/DBP.0b013e3180cabc28; Blight A, 2009, SPINAL CORD, V47, P713, DOI 10.1038/sc.2008.179; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Dentzer S, 2009, NEW ENGL J MED, V360, P1, DOI 10.1056/NEJMp0805753; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Findling RL, 1996, J CHILD ADOL PSYCHOP, V6, P165, DOI 10.1089/cap.1996.6.165; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Gonon F, 2009, TRENDS NEUROSCI, V32, P2, DOI 10.1016/j.tins.2008.09.010; Gornick MC, 2007, AM J MED GENET B, V144B, P379, DOI 10.1002/ajmg.b.30460; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Heiser P, 2004, NEUROSCI BIOBEHAV R, V28, P625, DOI 10.1016/j.neubiorev.2004.09.010; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lawrence PA, 2003, NATURE, V422, P259, DOI 10.1038/422259a; MCKHANN G, 2007, RES MUST PASS ETHICA; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Pliszka SR, 1996, J AM ACAD CHILD PSY, V35, P264, DOI 10.1097/00004583-199603000-00006; Popper CW, 1997, J CLIN PSYCHIAT, V58, P14; RAPOPORT JL, 1978, SCIENCE, V199, P560, DOI 10.1126/science.341313; Singh I, 2009, NATURE, V460, P202, DOI 10.1038/460202a; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Valenstein E., 1988, BLAMING BRAIN; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Wakefield, 2007, LOSS SADNESS PSYCHIA; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	32	37	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14618	10.1371/journal.pone.0014618	http://dx.doi.org/10.1371/journal.pone.0014618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21297951	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300007
J	Ostermann, J; Reddy, EA; Shorter, MM; Muiruri, C; Mtalo, A; Itemba, DK; Njau, B; Bartlett, JA; Crump, JA; Thielman, NM				Ostermann, Jan; Reddy, Elizabeth A.; Shorter, Meghan M.; Muiruri, Charles; Mtalo, Antipas; Itemba, Dafrosa K.; Njau, Bernard; Bartlett, John A.; Crump, John A.; Thielman, Nathan M.			Who Tests, Who Doesn't, and Why? Uptake of Mobile HIV Counseling and Testing in the Kilimanjaro Region of Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; VOLUNTARY; COMMUNITY; ATTITUDES; STIGMA; INTERVENTION; HIV/AIDS; ZIMBABWE	Background: Optimally, expanded HIV testing programs should reduce barriers to testing while attracting new and high-risk testers. We assessed barriers to testing and HIV risk among clients participating in mobile voluntary counseling and testing (MVCT) campaigns in four rural villages in the Kilimanjaro Region of Tanzania. Methods: Between December 2007 and April 2008, 878 MVCT participants and 506 randomly selected community residents who did not access MVCT were surveyed. Gender-specific logistic regression models were used to describe differences in socioeconomic characteristics, HIV exposure risk, testing histories, HIV related stigma, and attitudes toward testing between MVCT participants and community residents who did not access MVCT. Gender-specific logistic regression models were used to describe differences in socioeconomic characteristics, HIV exposure risk, testing histories, HIV related stigma, and attitudes toward testing, between the two groups. Results: MVCT clients reported greater HIV exposure risk (OR 1.20 [1.04 to 1.38] for males; OR 1.11 [1.03 to 1.19] for females). Female MVCT clients were more likely to report low household expenditures (OR 1.47 [1.04 to 2.05]), male clients reported higher rates of unstable income sources (OR 1.99 [1.22 to 3.24]). First-time testers were more likely than non-testers to cite distance to testing sites as a reason for not having previously tested (OR 2.17 [1.05 to 4.48] for males; OR 5.95 [2.85 to 12.45] for females). HIV-related stigma, fears of testing or test disclosure, and not being able to leave work were strongly associated with non-participation in MVCT (ORs from 0.11 to 0.84). Conclusions: MVCT attracted clients with increased exposure risk and fewer economic resources; HIV related stigma and testing-related fears remained barriers to testing. MVCT did not disproportionately attract either first-time or frequent repeat testers. Educational campaigns to reduce stigma and fears of testing could improve the effectiveness of MVCT in attracting new and high-risk populations.	[Ostermann, Jan; Bartlett, John A.; Crump, John A.; Thielman, Nathan M.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA; [Ostermann, Jan] Duke Univ, Ctr Hlth Policy, Durham, NC USA; [Reddy, Elizabeth A.; Shorter, Meghan M.; Muiruri, Charles; Bartlett, John A.; Crump, John A.; Thielman, Nathan M.] Duke Univ, Med Ctr, Durham, NC USA; [Mtalo, Antipas; Itemba, Dafrosa K.] KIWAKKUKI Women AIDS Kilimanjaro, Moshi, Tanzania; [Njau, Bernard; Bartlett, John A.; Crump, John A.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Njau, Bernard; Bartlett, John A.; Crump, John A.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania	Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre	Ostermann, J (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA.	n.thielman@duke.edu	Crump, John A./AAZ-6412-2020; Njau, Bernard/AAI-2152-2020; Ostermann, Jan/GQB-4743-2022; Crump, John A./AAZ-6289-2020; Thielman, Nathan/R-5142-2019	Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Thielman, Nathan/0000-0001-8152-2879; Ostermann, Jan/0000-0002-8236-9500	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH) [P30 AI 64518]; Fogarty International Center AIDS International Training and Research Program [NIH D43 TW006732]; Duke Clinical Trials Unit and Clinical Research Sites [NIH U01 AI06984]; International Studies on AIDS Associated Coinfections (ISAAC) [NIH U01 AI-03-036]; AIDS Research and Training Grant [NIH T32 AI007392-18]; Hubert-Yeargan Center for Global Health, Duke University Medical Center; FOGARTY INTERNATIONAL CENTER [D43TW006732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007392, P30AI064518] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Duke Clinical Trials Unit and Clinical Research Sites; International Studies on AIDS Associated Coinfections (ISAAC); AIDS Research and Training Grant; Hubert-Yeargan Center for Global Health, Duke University Medical Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary source of funding for this study was the Duke University Center for AIDS Research (CFAR), supported by the National Institutes of Health (NIH; www.nih.gov) (P30 AI 64518). Various investigators were also supported by the following: Fogarty International Center AIDS International Training and Research Program (NIH D43 TW006732; Dr. Njau), Duke Clinical Trials Unit and Clinical Research Sites (NIH U01 AI06984: Drs. Bartlett, Crump, and Thielman), International Studies on AIDS Associated Coinfections (ISAAC) award (NIH U01 AI-03-036; Dr. Bartlett, Dr. Crump, Mrs. Itemba, Mr. Mtalo, Mr. Muiruri, and Dr. Thielman), AIDS Research and Training Grant (NIH T32 AI007392-18; Dr. Reddy), Hubert-Yeargan Center for Global Health, Duke University Medical Center (http://www.dukeglobalhealth.org) (Dr. Shorter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Baiden F, 2007, J BIOSOC SCI, V39, P721, DOI 10.1017/S0021932006001829; Chu HY, 2005, INT J STD AIDS, V16, P691, DOI 10.1258/095646205774357307; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Day JH, 2003, AIDS CARE, V15, P665, DOI 10.1080/0954012030001595140; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; Mbopi-Keou FX, 2007, AIDS, V21, P1994, DOI 10.1097/QAD.0b013e3282f006c3; Middelkoop K, 2006, SEX TRANSM DIS, V33, P524, DOI 10.1097/01.olq.0000219295.50291.1d; MOHAMMED I, 2009, 16 C RETR OPP INF PO; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Nyanzi-Wakholi B, 2009, AIDS CARE, V21, P903, DOI 10.1080/09540120802657498; Nyblade L, 2006, CAN WE MEASURE HIV A; Ole-Nguyaine S, 2004, ANN TROP MED PARASIT, V98, P171, DOI 10.1179/000349804225003163; Pettifor A, 2010, AIDS BEHAV, V14, P913, DOI 10.1007/s10461-008-9462-5; *PROJ ACC, 2010, PHAS 3 RAND CONTR TR; Shorter MM, 2009, JAIDS-J ACQ IMM DEF, V52, P648, DOI 10.1097/QAI.0b013e3181b31a6a; *TANZ NAT BUR STAT, 2002, POP HOUS CENS VILL S; Tanzania Commission for AIDS (TACAIDS) ZACZ National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and Macro International Inc, 2008, TANZ HIV AIDS MAL IN; The United Republic of Tanzania Ministry of Health National AIDS Control Programme, 2005, NAT GUID VOL COUNS T; *WHO, 2009, GOV CIV SOC EXP ACC	26	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16488	10.1371/journal.pone.0016488	http://dx.doi.org/10.1371/journal.pone.0016488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21304973	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300070
J	Azzolin, L; Antolini, N; Calderan, A; Ruzza, P; Sciacovelli, M; Marin, O; Mammi, S; Bernardi, P; Rasola, A				Azzolin, Luca; Antolini, Nicola; Calderan, Andrea; Ruzza, Paolo; Sciacovelli, Marco; Marin, Oriano; Mammi, Stefano; Bernardi, Paolo; Rasola, Andrea			Antamanide, a Derivative of Amanita phalloides, Is a Novel Inhibitor of the Mitochondrial Permeability Transition Pore	PLOS ONE			English	Article							CYCLOSPORINE-A; CYCLOPHILIN-D; MUSCULAR-DYSTROPHY; IMMUNOSUPPRESSIVE ACTIVITY; LIVER-MITOCHONDRIA; OXIDATIVE STRESS; POTENT INHIBITOR; INNER MEMBRANE; CANCER-CELLS; DEATH	Antamanide is a cyclic decapeptide derived from the fungus Amanita phalloides. Here we show that antamanide inhibits the mitochondrial permeability transition pore, a central effector of cell death induction, by targeting the pore regulator cyclophilin D. Indeed, (i) permeability transition pore inhibition by antamanide is not additive with the cyclophilin D-binding drug cyclosporin A, (ii) the inhibitory action of antamanide on the pore requires phosphate, as previously shown for cyclosporin A; (iii) antamanide is ineffective in mitochondria or cells derived from cyclophilin D null animals, and (iv) abolishes CyP-D peptidyl-prolyl cis-trans isomerase activity. Permeability transition pore inhibition by antamanide needs two critical residues in the peptide ring, Phe6 and Phe9, and is additive with ubiquinone 0, which acts on the pore in a cyclophilin D-independent fashion. Antamanide also abrogates mitochondrial depolarization and the ensuing cell death caused by two well-characterized pore inducers, clotrimazole and a hexokinase II N-terminal peptide. Our findings have implications for the comprehension of cyclophilin D activity on the permeability transition pore and for the development of novel pore-targeting drugs exploitable as cell death inhibitors.	[Azzolin, Luca; Sciacovelli, Marco; Bernardi, Paolo; Rasola, Andrea] Univ Padua, Dept Biomed Sci, Padua, Italy; [Azzolin, Luca; Sciacovelli, Marco; Bernardi, Paolo; Rasola, Andrea] CNR, Inst Neurosci, Padua, Italy; [Antolini, Nicola; Calderan, Andrea; Ruzza, Paolo; Mammi, Stefano] Univ Padua, Dept Chem Sci, Padua, Italy; [Antolini, Nicola; Calderan, Andrea; Ruzza, Paolo; Mammi, Stefano] CNR, Inst Biomol Chem, Padua, Italy; [Marin, Oriano] Univ Padua, Dept Biol Chem, Padua, Italy; [Marin, Oriano; Bernardi, Paolo] Univ Padua, Venetian Inst Mol Med, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Veneto Institute Molecular Medicine	Azzolin, L (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	andrea.rasola@unipd.it	Sciacovelli, Marco/AAJ-1145-2020; Bernardi, Paolo/C-3656-2008; Azzolin, Luca/K-8012-2016; Ruzza, Paolo/N-6030-2015	Bernardi, Paolo/0000-0001-9187-3736; Azzolin, Luca/0000-0002-2425-6153; Ruzza, Paolo/0000-0002-5596-9295; Rasola, Andrea/0000-0003-4522-3008; CALDERAN, ANDREA/0000-0003-4763-0782	Progetti di Ricerca di Interesse Nazionale del Ministero dell'Universita e della Ricerca; Associazione Italiana Ricerca sul Cancro [8722]; Progetti di Ateneo dell'Universita di Padova	Progetti di Ricerca di Interesse Nazionale del Ministero dell'Universita e della Ricerca; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Progetti di Ateneo dell'Universita di Padova	This work was made possible by grants from Progetti di Ricerca di Interesse Nazionale del Ministero dell'Universita e della Ricerca (to P. B.), from Associazione Italiana Ricerca sul Cancro (P. B., project number 8722), and from Progetti di Ateneo dell'Universita di Padova (A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodeo P, 1998, J PEPT RES, V51, P180; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Choi KJ, 2007, CANCER RES, V67, P3654, DOI 10.1158/0008-5472.CAN-06-1759; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; CONNERN CP, 1992, BIOCHEM J, V284, P381, DOI 10.1042/bj2840381; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; CROMPTON M, 1988, BIOCHEM J, V255, P357; DAVIDSON AM, 1990, BIOCHEM J, V268, P147, DOI 10.1042/bj2680147; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fassetta M, 2006, CELL SIGNAL, V18, P1967, DOI 10.1016/j.cellsig.2006.03.005; Fehrenbach T, 2003, N-S ARCH PHARMACOL, V368, P415, DOI 10.1007/s00210-003-0814-4; FLOERSHEIM GL, 1976, N-S ARCH PHARMACOL, V293, P171, DOI 10.1007/BF00499223; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Gallay PA, 2009, CLIN LIVER DIS, V13, P403, DOI 10.1016/j.cld.2009.05.002; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gramaglia D, 2004, CELL DEATH DIFFER, V11, P342, DOI 10.1038/sj.cdd.4401326; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Letschert K, 2006, TOXICOL SCI, V91, P140, DOI 10.1093/toxsci/kfj141; Li ZY, 2008, MOL CELL PROTEOMICS, V7, P1810, DOI 10.1074/mcp.M700544-MCP200; Maraldi NM, 2009, ADV ENZYME REGUL, V49, P197, DOI 10.1016/j.advenzreg.2008.12.009; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; MUNTER K, 1986, BIOCHIM BIOPHYS ACTA, V860, P91, DOI 10.1016/0005-2736(86)90502-X; Nicholson LK, 2007, MOL CELL, V25, P483, DOI 10.1016/j.molcel.2007.02.005; NIELSEN O, 1986, ACTA PHARMACOL TOX, V59, P249; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Qadir M, 2005, CLIN CANCER RES, V11, P2320, DOI 10.1158/1078-0432.CCR-04-1725; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285; Rezzani R, 2006, HISTOL HISTOPATHOL, V21, P301, DOI 10.14670/HH-21.301; Rigoni M, 2008, J BIOL CHEM, V283, P34013, DOI 10.1074/jbc.M803243200; Ruzza P, 1999, J PEPT RES, V53, P442, DOI 10.1034/j.1399-3011.1999.00018.x; SIEMION IZ, 1992, PEPTIDES, V13, P1233, DOI 10.1016/0196-9781(92)90034-Z; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; WELBOURN R, 1991, J APPL PHYSIOL, V70, P1364, DOI 10.1152/jappl.1991.70.3.1364; WIECZOREK Z, 1993, PEPTIDES, V14, P1, DOI 10.1016/0196-9781(93)90003-Y; WIELAND T, 1984, P NATL ACAD SCI-BIOL, V81, P5232, DOI 10.1073/pnas.81.16.5232; WIELAND T, 1968, ANGEW CHEM INT EDIT, V7, P204, DOI 10.1002/anie.196802041; Zheng JM, 2008, CANCER RES, V68, P7769, DOI 10.1158/0008-5472.CAN-08-0639	53	36	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16280	10.1371/journal.pone.0016280	http://dx.doi.org/10.1371/journal.pone.0016280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297983	Green Submitted, Green Published, gold			2022-12-27	WOS:000286664100017
J	Krueger, F; Andrews, SR; Osborne, CS				Krueger, Felix; Andrews, Simon R.; Osborne, Cameron S.			Large Scale Loss of Data in Low-Diversity Illumina Sequencing Libraries Can Be Recovered by Deferred Cluster Calling	PLOS ONE			English	Article								Massively parallel DNA sequencing is capable of sequencing tens of millions of DNA fragments at the same time. However, sequence bias in the initial cycles, which are used to determine the coordinates of individual clusters, causes a loss of fidelity in cluster identification on Illumina Genome Analysers. This can result in a significant reduction in the numbers of clusters that can be analysed. Such low sample diversity is an intrinsic problem of sequencing libraries that are generated by restriction enzyme digestion, such as e4C-seq or reduced-representation libraries. Similarly, this problem can also arise through the combined sequencing of barcoded, multiplexed libraries. We describe a procedure to defer the mapping of cluster coordinates until low-diversity sequences have been passed. This simple procedure can recover substantial amounts of next generation sequencing data that would otherwise be lost.	[Krueger, Felix; Andrews, Simon R.] Babraham Inst, Bioinformat Grp, Cambridge, England; [Osborne, Cameron S.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Krueger, F (corresponding author), Babraham Inst, Bioinformat Grp, Cambridge, England.	cameron.osborne@bbsrc.ac.uk	Osborne, Cameron/N-1398-2017; Krueger, Felix/J-3340-2019	Osborne, Cameron/0000-0003-4126-2499; Ficz, Gabriella/0000-0001-9313-9578; Krueger, Felix/0000-0002-5513-3324	BBSRC (UK); Leukaemia and Lymphoma Research; BBSRC [BBS/E/B/0000H212] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H212] Funding Source: researchfish	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia and Lymphoma Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding provided by the BBSRC (UK). CSO is supported by a Bennett Research Fellowship from Leukaemia and Lymphoma Research (http://www.bbsrc.ac.uk/ and http://www.beatbloodcancers.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496	7	61	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16607	10.1371/journal.pone.0016607	http://dx.doi.org/10.1371/journal.pone.0016607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305042	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100049
J	Lorenz, WA; Clote, P				Lorenz, William A.; Clote, Peter			Computing the Partition Function for Kinetically Trapped RNA Secondary Structures	PLOS ONE			English	Article							NEAREST-NEIGHBOR PARAMETERS; WEB SERVER; STRUCTURE PREDICTION; FOLDING KINETICS; ALGORITHM; OLIGORIBONUCLEOTIDES; STABILITY; RESPECT; BINDING	An RNA secondary structure is locally optimal if there is no lower energy structure that can be obtained by the addition or removal of a single base pair, where energy is defined according to the widely accepted Turner nearest neighbor model. Locally optimal structures form kinetic traps, since any evolution away from a locally optimal structure must involve energetically unfavorable folding steps. Here, we present a novel, efficient algorithm to compute the partition function over all locally optimal secondary structures of a given RNA sequence. Our software, RNALOCOPT runs in O(n(3)) time and O(n(2)) space. Additionally, RNALOCOPT samples a user-specified number of structures from the Boltzmann subensemble of all locally optimal structures. We apply RNALOCOPT to show that (1) the number of locally optimal structures is far fewer than the total number of structures - indeed, the number of locally optimal structures approximately equal to the square root of the number of all structures, (2) the structural diversity of this subensemble may be either similar to or quite different from the structural diversity of the entire Boltzmann ensemble, a situation that depends on the type of input RNA, (3) the (modified) maximum expected accuracy structure, computed by taking into account base pairing frequencies of locally optimal structures, is a more accurate prediction of the native structure than other current thermodynamics-based methods. The software RNALOCOPT constitutes a technical breakthrough in our study of the folding landscape for RNA secondary structures. For the first time, locally optimal structures (kinetic traps in the Turner energy model) can be rapidly generated for long RNA sequences, previously impossible with methods that involved exhaustive enumeration. Use of locally optimal structure leads to state-of-the-art secondary structure prediction, as benchmarked against methods involving the computation of minimum free energy and of maximum expected accuracy. Web server and source code available at http://bioinformatics.bc.edu/clotelab/RNAlocopt/.	[Lorenz, William A.] Denison Univ, Dept Math & Comp Sci, Granville, OH 43023 USA; [Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Denison University; Boston College	Lorenz, WA (corresponding author), Denison Univ, Dept Math & Comp Sci, Granville, OH 43023 USA.	clote@bc.edu			National Science Foundation [DBI-0543506, DMS-0817971]; Division Of Mathematical Sciences [0817971] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Research was supported by the National Science Foundation under grants DBI-0543506 and DMS-0817971. Additional support was provided PC in the form of a Chair of Excellence by the Digiteo Foundation. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; BANERJEE AR, 1993, BIOCHEMISTRY-US, V32, P153, DOI 10.1021/bi00052a021; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Clote P, 2005, J COMPUT BIOL, V12, P83, DOI 10.1089/cmb.2005.12.83; Clote P, 2005, NUCLEIC ACIDS RES, V33, pW600, DOI 10.1093/nar/gki382; Clote P, 2006, J COMPUT BIOL, V13, P1640, DOI 10.1089/cmb.2006.13.1640; Clote Peter, 2009, Journal of Bioinformatics and Computational Biology, V7, P869, DOI 10.1142/S0219720009004333; Danilova Ludmlla V., 2006, Journal of Bioinformatics and Computational Biology, V4, P589, DOI 10.1142/S0219720006001904; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dotu I, 2010, NUCLEIC ACIDS RES, V38, P1711, DOI 10.1093/nar/gkp1054; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Flamm C., 2007, Foundations of Genetic Algorithms, P194; Flamm C, 2002, Z PHYS CHEM, V216, P155, DOI 10.1524/zpch.2002.216.2.155; Franch T, 1997, J MOL BIOL, V273, P38, DOI 10.1006/jmbi.1997.1294; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gillespie D., 1977, J COMPUT PHYS, V22, P2340; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; HE L, 1991, BIOCHEMISTRY-US, V30, P11124, DOI 10.1021/bi00110a015; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOFACKER IL, 2010, RNA; Isambert H, 2009, METHODS, V49, P189, DOI 10.1016/j.ymeth.2009.06.005; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; Kiryu H, 2007, BIOINFORMATICS, V23, P434, DOI 10.1093/bioinformatics/btl636; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; LECUYER KA, 1993, BIOCHEMISTRY-US, V32, P5301, DOI 10.1021/bi00071a004; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mathews DH, 2002, BIOCHEMISTRY-US, V41, P869, DOI 10.1021/bi011441d; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Morgan SR, 1998, J PHYS A-MATH GEN, V31, P3153, DOI 10.1088/0305-4470/31/14/005; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; PERITZ AE, 1991, BIOCHEMISTRY-US, V30, P6428, DOI 10.1021/bi00240a013; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Shapiro BA, 2001, J MOL BIOL, V312, P27, DOI 10.1006/jmbi.2001.4931; Stadler P. F., 2003, Genetic Programming and Evolvable Machines, V4, P7, DOI 10.1023/A:1021821009420; STEIN PR, 1979, DISCRETE MATH, V26, P261, DOI 10.1016/0012-365X(79)90033-5; Tang XY, 2008, J MOL BIOL, V381, P1055, DOI 10.1016/j.jmb.2008.02.007; Tang XY, 2005, J COMPUT BIOL, V12, P862, DOI 10.1089/cmb.2005.12.862; Taufer M, 2009, NUCLEIC ACIDS RES, V37, pD127, DOI 10.1093/nar/gkn806; THACHUK C, 2010, PAC S BIOCOMPUT; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Waldispuhl J, 2007, J COMPUT BIOL, V14, P190, DOI 10.1089/cmb.2006.0012; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Wiese KC, 2005, IEEE T NANOBIOSCI, V4, P212, DOI 10.1109/TNB.2005.853646; Wolfinger MT, 2004, J PHYS A-MATH GEN, V37, P4731, DOI 10.1088/0305-4470/37/17/005; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuker Michael, 1986, LECT MATH LIFE SCI, P87	60	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16178	10.1371/journal.pone.0016178	http://dx.doi.org/10.1371/journal.pone.0016178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297972	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100014
J	Scheckhuber, CQ; Houthoofd, K; Weil, AC; Werner, A; De Vreese, A; Vanfleteren, JR; Osiewacz, HD				Scheckhuber, Christian Q.; Houthoofd, Koen; Weil, Andrea C.; Werner, Alexandra; De Vreese, Annemie; Vanfleteren, Jacques R.; Osiewacz, Heinz D.			Alternative Oxidase Dependent Respiration Leads to an Increased Mitochondrial Content in Two Long-Lived Mutants of the Ageing Model Podospora anserina	PLOS ONE			English	Article							LIFE-SPAN CONTROL; OXIDATIVE STRESS; DNA REARRANGEMENTS; COPPER; EXPRESSION; GENE; SENESCENCE; DIFFERENTIATION; RESTRICTION; BIOGENESIS	The retrograde response constitutes an important signalling pathway from mitochondria to the nucleus which induces several genes to allow compensation of mitochondrial impairments. In the filamentous ascomycete Podospora anserina, an example for such a response is the induction of a nuclear-encoded and iron-dependent alternative oxidase (AOX) occurring when cytochrome-c oxidase (COX) dependent respiration is affected. Several long-lived mutants are known which predominantly or exclusively respire via AOX. Here we show that two AOX-utilising mutants, grisea and PaCox17::ble, are able to compensate partially for lowered OXPHOS efficiency resulting from AOX-dependent respiration by increasing mitochondrial content. At the physiological level this is demonstrated by an elevated oxygen consumption and increased heat production. However, in the two mutants, ATP levels do not reach WT levels. Interestingly, mutant PaCox17:: ble is characterized by a highly increased release of the reactive oxygen species (ROS) hydrogen peroxide. Both grisea and PaCox17:: ble contain elevated levels of mitochondrial proteins involved in quality control, i. e. LON protease and the molecular chaperone HSP60. Taken together, our work demonstrates that AOX-dependent respiration in two mutants of the ageing model P. anserina is linked to a novel mechanism involved in the retrograde response pathway, mitochondrial biogenesis, which might also play an important role for cellular maintenance in other organisms.	[Scheckhuber, Christian Q.; Weil, Andrea C.; Werner, Alexandra; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Fac Biosci, Frankfurt, Germany; [Houthoofd, Koen; De Vreese, Annemie; Vanfleteren, Jacques R.] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Houthoofd, Koen; De Vreese, Annemie; Vanfleteren, Jacques R.] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium	Goethe University Frankfurt; Ghent University; Ghent University	Scheckhuber, CQ (corresponding author), Goethe Univ Frankfurt, Fac Biosci, Frankfurt, Germany.	scheckhuber@bio.uni-frankfurt.de	Osiewacz, Heinz D./D-3454-2011; Scheckhuber, Christian Q./A-6462-2012	Scheckhuber, Christian Q./0000-0002-2924-7547	European Commission [FP6-512020, FP6-518230]; Cluster of Excellence Macromolecular Complexes	European Commission(European CommissionEuropean Commission Joint Research Centre); Cluster of Excellence Macromolecular Complexes	The experimental work of the authors was supported by grants from the European Commission (contract FP6-512020, Acronym MiMage; contract FP6-518230, Acronym Proteomage) and the Cluster of Excellence Macromolecular Complexes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; BELCOUR L, 1981, CURR GENET, V3, P13, DOI 10.1007/BF00419575; Borghouts C, 2000, CURR GENET, V37, P268, DOI 10.1007/s002940050528; Borghouts C, 1997, P NATL ACAD SCI USA, V94, P10768, DOI 10.1073/pnas.94.20.10768; Borghouts C, 2002, INT J BIOCHEM CELL B, V34, P1355, DOI 10.1016/S1357-2725(02)00078-X; Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; CORBISIER P, 1987, ANAL BIOCHEM, V164, P240, DOI 10.1016/0003-2697(87)90392-7; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Karbowski M, 2001, J CELL SCI, V114, P281; Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200; Krause F, 2006, ANN NY ACAD SCI, V1067, P106, DOI 10.1196/annals.1354.013; KUCK U, 1981, CURR GENET, V3, P151, DOI 10.1007/BF00365719; KUCK U, 1985, CURR GENET, V10, P59, DOI 10.1007/BF00418494; Kunstmann B, 2009, AGING-US, V1, P1; Kunstmann B, 2008, AGING CELL, V7, P651, DOI 10.1111/j.1474-9726.2008.00412.x; Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lenaerts I, 2002, ANAL BIOCHEM, V311, P90, DOI 10.1016/S0003-2697(02)00397-4; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lorin S, 2001, MOL MICROBIOL, V42, P1259, DOI 10.1046/j.1365-2958.2001.02690.x; Lorin S, 2006, BBA-BIOENERGETICS, V1757, P604, DOI 10.1016/j.bbabio.2006.03.005; Luce K, 2010, PROTEIN METABOLISM H, P1; Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893; Maassen JA, 2002, J ENDOCRINOL INVEST, V25, P477, DOI 10.1007/BF03344042; Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Munkres KD., 1990, FUNG GENET NEWSLETT, V37, P24, DOI DOI 10.4148/1941-4765.1477; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Osiewacz HD, 2002, MECH AGEING DEV, V123, P755, DOI 10.1016/S0047-6374(01)00421-3; Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211; Osiewacz HD, 2010, ANN NY ACAD SCI, V1197, P54, DOI 10.1111/j.1749-6632.2010.05190.x; PRILLINGER H, 1977, MOL GEN GENET, V156, P333, DOI 10.1007/BF00267190; RIDDER R, 1992, CURR GENET, V21, P207, DOI 10.1007/BF00336843; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; RIZET G, 1953, CR HEBD ACAD SCI, V237, P838; Samper E, 2009, FREE RADICAL BIO MED, V46, P387, DOI 10.1016/j.freeradbiomed.2008.10.036; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scheckhuber CQ, 2008, MOL GENET GENOMICS, V280, P365, DOI 10.1007/s00438-008-0378-6; Scheckhuber Christian Q., 2008, Biotechnology Journal, V3, P781, DOI 10.1002/biot.200800010; Sellem CH, 2007, FUNGAL GENET BIOL, V44, P648, DOI 10.1016/j.fgb.2006.09.005; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zintel S, 2010, EXP GERONTOL, V45, P525, DOI 10.1016/j.exger.2010.01.006	59	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16620	10.1371/journal.pone.0016620	http://dx.doi.org/10.1371/journal.pone.0016620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305036	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900082
J	Sobhani, I; Tap, J; Roudot-Thoraval, F; Roperch, JP; Letulle, S; Langella, P; Corthier, G; Jeanne, TVN; Furet, JP				Sobhani, Iradj; Tap, Julien; Roudot-Thoraval, Francoise; Roperch, Jean P.; Letulle, Sophie; Langella, Philippe; Corthier, Gerard; Jeanne Tran Van Nhieu; Furet, Jean P.			Microbial Dysbiosis in Colorectal Cancer (CRC) Patients	PLOS ONE			English	Article							PROMOTES COLON TUMORIGENESIS; 16S RIBOSOMAL-RNA; HUMAN GUT; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; QUANTITATIVE PCR; FECAL MICROBIOTA; IMMUNE-RESPONSE; DIFFERENTIATION; COMMUNITIES	The composition of the human intestinal microbiota is linked to health status. The aim was to analyze the microbiota of normal and colon cancer patients in order to establish cancer-related dysbiosis. Patients and Methods: Stool bacterial DNA was extracted prior to colonoscopy from 179 patients: 60 with colorectal cancer, and 119 with normal colonoscopy. Bacterial genes obtained by pyrosequencing of 12 stool samples (6 Normal and 6 Cancer) were subjected to a validated Principal Component Analysis (PCA) test. The dominant and subdominant bacterial population (C. leptum, C. coccoides, Bacteroides/Prevotella, Lactobacillus/Leuconostoc/Pediococcus groups, Bifidobacterium genus, and E. coli, and Faecalibacterium prausnitzii species) were quantified in all individuals using qPCR and specific IL17 producer cells in the intestinal mucosa were characterized using immunohistochemistry. Findings: Pyrosequencing (Minimal sequence 200 nucleotide reads) revealed 80% of all sequences could be assigned to a total of 819 taxa based on default parameter of Classifier software. The phylogenetic core in Cancer individuals was different from that in Normal individuals according to the PCA analysis, with trends towards differences in the dominant and subdominant families of bacteria. Consequently, All-bacteria [log(10) (bacteria/g of stool)] in Normal, and Cancer individuals were similar [11.88 +/- 0.35, and 11.80 +/- 0.56, respectively, (P = 0.16)], according to qPCR values whereas among all dominant and subdominant species only those of Bacteroides/Prevotella were higher (All bacteria-specific bacterium; P = 0.009) in Cancer (-1.04 +/- 0.55) than in Normal (-1.40 +/- 0.83) individuals. IL17 immunoreactive cells were significantly expressed more in the normal mucosa of cancer patients than in those with normal colonoscopy. Conclusion: This is the first large series to demonstrate a composition change in the microbiota of colon cancer patients with possible impact on mucosal immune response. These data open new filed for mass screening and pathophysiology investigations.	[Sobhani, Iradj; Roperch, Jean P.] APHP, Dept Gastroenterol, Creteil, France; [Sobhani, Iradj; Roperch, Jean P.] Univ Paris Est Creteil, UPEC, Creteil, France; [Tap, Julien; Langella, Philippe; Corthier, Gerard; Furet, Jean P.] INRA, UMR1319, Micalis Inst, Jouy En Josas, France; [Roudot-Thoraval, Francoise; Jeanne Tran Van Nhieu] Univ Paris 12, Creteil, France; [Letulle, Sophie] Grp Hosp Henri Mondor, INSERM, CIC 006, Creteil, France; [Jeanne Tran Van Nhieu] APHP, Dept Pathol, Creteil, France; [Sobhani, Iradj; Roperch, Jean P.] APHP, LIC EA4393, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Sobhani, I (corresponding author), APHP, Dept Gastroenterol, Creteil, France.	iradj.sobhani@hmn.aphp.fr	VAN NHIEU, Jeanne TRAN/R-5235-2018; Tap, Julien/E-5760-2010; Langella, Philippe/N-8368-2017; SOBHANI, Iradj/A-3973-2013	Tap, Julien/0000-0001-8998-5413; Langella, Philippe/0000-0001-5960-4341; 	Canceropole Ile de France, CoMiCa; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa 2007-2010 project, (Charles Debray association-ACD); LNCC (French National League against Cancer), CCR INSERM Promotion (2004-2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloulou N, 2008, CANCER RES, V68, P9413, DOI 10.1158/0008-5472.CAN-08-0909; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Dove WF, 1997, CANCER RES, V57, P812; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sobhani I, 2009, GUT, V58, P743, DOI 10.1136/gut.2008.175521; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006074; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	33	537	577	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16393	10.1371/journal.pone.0016393	http://dx.doi.org/10.1371/journal.pone.0016393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21297998	Green Published, gold			2022-12-27	WOS:000286663900045
J	Sorbye, SW; Kilvaer, T; Valkov, A; Donnem, T; Smeland, E; Al-Shibli, K; Bremnes, RM; Busund, LT				Sorbye, Sveinung W.; Kilvaer, Thomas; Valkov, Andrej; Donnem, Tom; Smeland, Eivind; Al-Shibli, Khalid; Bremnes, Roy M.; Busund, Lill-Tove			Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; CELL LUNG-CARCINOMA; CD8(+) T-CELLS; OVARIAN-CANCER; IMMUNE-RESPONSE; SURVIVAL; DISEASE; OUTCOMES; RELAPSE; SIZE	Purpose: The purpose of this study was to clarify the prognostic significance of lymphocyte infiltration in soft tissue sarcomas (STS). Prognostic markers in potentially curable STS should guide therapy after surgical resection. The immune status at the time of resection may be important, but the prognostic significance of tumor infiltrating lymphocytes is controversial as the immune system has conflicting roles during cancer development. Experimental Design: Tissue microarrays from 249 patients with STS were constructed from duplicate cores of viable and representative neoplastic tumor areas. Immunohistochemistry was used to evaluate the CD3+, CD4+, CD8+, CD20+ and CD45+ lymphocytes in tumors. Results: In univariate analyses, increased numbers of CD4+ (P = 0.008) and CD20+ (P = 0.006) lymphocytes in tumor correlated significantly with an improved disease-specific survival (DSS) in patients with wide resection margins (n = 108). In patients with non-wide resection margins (n = 141) increased numbers of CD3+ (P = 0.028) lymphocytes in tumor correlated significantly with shorter DSS. In multivariate analyses, a high number of CD20+ lymphocytes (HR = 5.5, CI 95% = 1.6-18.6, P = 0.006) in the tumor was an independent positive prognostic factor for DSS in patients with wide resections margins. Conclusions: High density of CD20+ lymphocytes in STS with wide resection margins is an independent positive prognostic indicator for these patients. Further research is needed to define if CD20+ cells can modify tumors in a way that reduces disease progression and metastatic potential.	[Sorbye, Sveinung W.; Valkov, Andrej; Busund, Lill-Tove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Sorbye, Sveinung W.; Kilvaer, Thomas; Valkov, Andrej; Al-Shibli, Khalid; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Donnem, Tom; Smeland, Eivind; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Donnem, Tom; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sorbye, SW (corresponding author), Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway.	sveinung.sorbye@unn.no	Kilvaer, Thomas/AAI-7418-2020; Sorbye, Sveinung Wergeland/AAE-7208-2020	Kilvaer, Thomas/0000-0003-1669-0117; Sorbye, Sveinung Wergeland/0000-0002-8250-3992	Northern Norway Regional Health Authority	Northern Norway Regional Health Authority	The work was supported by the Northern Norway Regional Health Authority (Helse Nord RHF, http://www.helse-nord.no/?lang=en_US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Ancuta E, 2009, ROM J MORPHOL EMBRYO, V50, P651; Costello Regis T., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P83; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Dickinson IC, 2006, ANZ J SURG, V76, P104, DOI 10.1111/j.1445-2197.2006.03615.x; Dong HP, 2006, AM J CLIN PATHOL, V125, P451, DOI 10.1309/15B66DQMFYYM78CJ; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eerola AK, 2000, CLIN CANCER RES, V6, P1875; Enarsson K, 2007, EUR J IMMUNOL, V37, P282, DOI 10.1002/eji.200636183; Engellau J, 2004, CANCER-AM CANCER SOC, V100, P2233, DOI 10.1002/cncr.20254; Gimotty PA, 2007, DIS MARKERS, V23, P445, DOI 10.1155/2007/508350; GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Hong C, 2006, J IMMUNOL, V177, P6747, DOI 10.4049/jimmunol.177.10.6747; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; Karja V, 2005, ANTICANCER RES, V25, P4435; Kiatisevi Piya, 2006, Journal of the Medical Association of Thailand, V89, P334; Koea JB, 2003, ANN SURG ONCOL, V10, P432, DOI 10.1245/ASO.2003.05.014; Kondratiev S, 2004, CLIN CANCER RES, V10, P4450, DOI 10.1158/1078-0432.CCR-0732-3; Mendenhall WM, 2005, CANCER-AM CANCER SOC, V104, P669, DOI 10.1002/cncr.21264; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Mukai S, 1999, CANCER RES, V59, P5245; Naito Y, 1998, CANCER RES, V58, P3491; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; Oshikiri T, 2003, J SURG ONCOL, V84, P224, DOI 10.1002/jso.10321; Ottaiano A, 2005, ANTICANCER RES, V25, P4519; Pelletier MP, 2001, CAN J SURG, V44, P180; Pretscher D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-292; RANEY RB, 1983, CANCER-AM CANCER SOC, V52, P44, DOI 10.1002/1097-0142(19830701)52:1<44::AID-CNCR2820520110>3.0.CO;2-V; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Schumacher K, 2001, CANCER RES, V61, P3932; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; SIKORA K, 1983, BRIT J CANCER, V47, P135, DOI 10.1038/bjc.1983.16; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Staibano S, 2006, INT J IMMUNOPATH PH, V19, P171; Thornton K, 2008, SURG CLIN N AM, V88, P647, DOI 10.1016/j.suc.2008.03.004; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Wahlin BE, 2007, CLIN CANCER RES, V13, P388, DOI 10.1158/1078-0432.CCR-06-1734; YANG RS, 1995, CANCER-AM CANCER SOC, V76, P1398, DOI 10.1002/1097-0142(19951015)76:8<1398::AID-CNCR2820760815>3.0.CO;2-B; Zagars GK, 2003, INT J RADIAT ONCOL, V57, P739, DOI 10.1016/S0360-3016(03)00714-4; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	43	67	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14611	10.1371/journal.pone.0014611	http://dx.doi.org/10.1371/journal.pone.0014611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298041	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900013
J	Benhamou, S				Benhamou, Simon			Dynamic Approach to Space and Habitat Use Based on Biased Random Bridges	PLOS ONE			English	Article							HOME-RANGE; ANIMAL MOVEMENTS; RESOURCE SELECTION; TELEMETRY DATA; RANDOM-WALK; MODELS; AUTOCORRELATION; DIFFUSION; ESTIMATORS; PREFERENCE	Background: Although habitat use reflects a dynamic process, most studies assess habitat use statically as if an animal's successively recorded locations reflected a point rather than a movement process. By relying on the activity time between successive locations instead of the local density of individual locations, movement-based methods can substantially improve the biological relevance of utilization distribution (UD) estimates (i.e. the relative frequencies with which an animal uses the various areas of its home range, HR). One such method rests on Brownian bridges (BBs). Its theoretical foundation (purely and constantly diffusive movements) is paradoxically inconsistent with both HR settlement and habitat selection. An alternative involves movement-based kernel density estimation (MKDE) through location interpolation, which may be applied to various movement behaviours but lacks a sound theoretical basis. Methodology/Principal Findings: I introduce the concept of a biased random (advective-diffusive) bridge (BRB) and show that the MKDE method is a practical means to estimate UDs based on simplified (isotropically diffusive) BRBs. The equation governing BRBs is constrained by the maximum delay between successive relocations warranting constant within-bridge advection (allowed to vary between bridges) but remains otherwise similar to the BB equation. Despite its theoretical inconsistencies, the BB method can therefore be applied to animals that regularly reorientate within their HRs and adapt their movements to the habitats crossed, provided that they were relocated with a high enough frequency. Conclusions/Significance: Biased random walks can approximate various movement types at short times from a given relocation. Their simplified form constitutes an effective trade-off between too simple, unrealistic movement models, such as Brownian motion, and more sophisticated and realistic ones, such as biased correlated random walks (BCRWs), which are too complex to yield functional bridges. Relying on simplified BRBs proves to be the most reliable and easily usable way to estimate UDs from serially correlated relocations and raw activity information.	CNRS, CEFE, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Benhamou, S (corresponding author), CNRS, CEFE, Montpellier, France.	simon.benhamou@cefe.cnrs.fr						Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; BENHAMOU S, 1989, J THEOR BIOL, V139, P379, DOI 10.1016/S0022-5193(89)80216-4; Benhamou S, 2010, ENCY BEHAV NEUROCIEN, V2, P497, DOI DOI 10.1016/B978-0-08-045396-5.00106-8; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Blackwell PG, 1997, ECOL MODEL, V100, P87, DOI 10.1016/S0304-3800(97)00153-1; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Bullard F., 1999, ESTIMATING HOME RANG; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Codling EA, 2010, ECOLOGY, V91, P3106, DOI 10.1890/09-1729.1; CORNELIS D, 2010, SPATIOTEMPORAL UNPUB; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dettki H, 2008, J WILDLIFE MANAGE, V72, P535, DOI 10.2193/2006-363; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Moorcroft PR, 2006, P ROY SOC B-BIOL SCI, V273, P1651, DOI 10.1098/rspb.2005.3439; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nielson RM, 2009, ECOLOGY, V90, P2956, DOI 10.1890/08-1562.1; Otis DL, 1999, J WILDLIFE MANAGE, V63, P1039, DOI 10.2307/3802819; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Silverman B.W., 1986, DENSITY ESTIMATION S; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Worton J. B., 1989, ECOLOGY, V70, P164	38	178	179	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14592	10.1371/journal.pone.0014592	http://dx.doi.org/10.1371/journal.pone.0014592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297869	gold, Green Published, Green Submitted			2022-12-27	WOS:000286662800005
J	Woodard, A; Wood, DO				Woodard, Andrew; Wood, David O.			Analysis of Convergent Gene Transcripts in the Obligate Intracellular Bacterium Rickettsia prowazekii	PLOS ONE			English	Article							TERMINATION; TYPHUS; RNAS; GLTA	Termination of transcription is an important component of bacterial gene expression. However, little is known concerning this process in the obligate intracellular pathogen and model for reductive evolution, Rickettsia prowazekii. To assess transcriptional termination in this bacterium, transcripts of convergent gene pairs, some containing predicted intrinsic terminators, were analyzed. These analyses revealed that, rather than terminating at a specific site within the intervening region between the convergent genes, most of the transcripts demonstrated either a lack of termination within this region, which generated antisense RNA, or a putative non-site-specific termination that occurred throughout the intervening sequence. Transcripts terminating at predicted intrinsic terminators, as well as at a putative Rho-dependant terminator, were also examined and found to vary based on the rickettsial host environment. These results suggest that transcriptional termination, or lack thereof, plays a role in rickettsial gene regulation.	[Woodard, Andrew; Wood, David O.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of South Alabama	Woodard, A (corresponding author), Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	dowood@jaguar1.usouthal.edu			National Institute of Allergy and Infectious Disease [AI020384]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020384, R37AI020384, R56AI020384] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institute of Allergy and Infectious Disease grant AI020384 to DOW. http://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; BOZEMAN FM, 1975, NATURE, V255, P545, DOI 10.1038/255545a0; Cai J, 1997, ACTA VIROL, V41, P285; CAI J, 1995, GENE, V163, P115, DOI 10.1016/0378-1119(95)00365-D; CAI J, 1993, J BACTERIOL, V175, P5725, DOI 10.1128/JB.175.17.5725-5727.1993; Cai J, 1996, J BACTERIOL, V178, P5543, DOI 10.1128/jb.178.18.5543-5545.1996; Chao CC, 2004, PROTEOMICS, V4, P1280, DOI 10.1002/pmic.200300775; DING HF, 1993, J BIOL CHEM, V268, P3897; DING HF, 1990, J BACTERIOL, V172, P5624, DOI 10.1128/jb.172.10.5624-5630.1990; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Italiani VCS, 2002, MOL MICROBIOL, V44, P181, DOI 10.1046/j.1365-2958.2002.02865.x; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Reynolds MG, 2003, EMERG INFECT DIS, V9, P1341; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shaw EI, 1997, J BACTERIOL, V179, P6448, DOI 10.1128/jb.179.20.6448-6452.1997; SHAW EI, 1997, THESIS U S ALABAMA M; Tucker AM, 2005, ANN NY ACAD SCI, V1063, P35, DOI 10.1196/annals.1355.005; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WINKLER HH, 1976, J BIOL CHEM, V251, P389	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16537	10.1371/journal.pone.0016537	http://dx.doi.org/10.1371/journal.pone.0016537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298070	gold, Green Published, Green Submitted			2022-12-27	WOS:000286662800053
J	Al-Jallad, HF; Myneni, VD; Piercy-Kotb, SA; Chabot, N; Mulani, A; Keillor, JW; Kaartinen, MT				Al-Jallad, Hadil F.; Myneni, Vamsee D.; Piercy-Kotb, Sarah A.; Chabot, Nicolas; Mulani, Amina; Keillor, Jeffrey W.; Kaartinen, Mari T.			Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule Dynamics	PLOS ONE			English	Article							COAGULATION-FACTOR-XIII; FIBRONECTIN-BINDING SITE; TISSUE TRANSGLUTAMINASE; CELL-SURFACE; CROSS-LINKING; ASCORBIC-ACID; TARGETED INACTIVATION; SIGNALING PATHWAYS; 3T3 FIBROBLASTS; IN-SITU	Transglutaminase activity, arising potentially from transglutaminase 2 (TG2) and Factor XIIIA (FXIIIA), has been linked to osteoblast differentiation where it is required for type I collagen and fibronectin matrix deposition. In this study we have used an irreversible TG-inhibitor to 'block -and-track' enzyme(s) targeted during osteoblast differentiation. We show that the irreversible TG-inhibitor is highly potent in inhibiting osteoblast differentiation and mineralization and reduces secretion of both fibronectin and type I collagen and their release from the cell surface. Tracking of the dansyl probe by Western blotting and immunofluorescence microscopy demonstrated that the inhibitor targets plasma membrane-associated FXIIIA. TG2 appears not to contribute to crosslinking activity on the osteoblast surface. Inhibition of FXIIIA with NC9 resulted in defective secretory vesicle delivery to the plasma membrane which was attributable to a disorganized microtubule network and decreased microtubule association with the plasma membrane. NC9 inhibition of FXIIIA resulted in destabilization of microtubules as assessed by cellular Glu-tubulin levels. Furthermore, NC9 blocked modification of Glu-tubulin into 150 kDa high-molecular weight Glu-tubulin form which was specifically localized to the plasma membrane. FXIIIA enzyme and its crosslinking activity were colocalized with plasma membrane-associated tubulin, and thus, it appears that FXIIIA crosslinking activity is directed towards stabilizing the interaction of microtubules with the plasma membrane. Our work provides the first mechanistic cues as to how transglutaminase activity could affect protein secretion and matrix deposition in osteoblasts and suggests a novel function for plasma membrane FXIIIA in microtubule dynamics.	[Al-Jallad, Hadil F.; Myneni, Vamsee D.; Piercy-Kotb, Sarah A.; Kaartinen, Mari T.] McGill Univ, Div Biomed Sci, Fac Dent, Montreal, PQ, Canada; [Chabot, Nicolas; Mulani, Amina; Keillor, Jeffrey W.] Univ Montreal, Dept Chem, Fac Arts & Sci, Montreal, PQ H3C 3J7, Canada; [Piercy-Kotb, Sarah A.; Kaartinen, Mari T.] McGill Univ, Fac Med, Dept Med, Div Expt Med, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University	Al-Jallad, HF (corresponding author), McGill Univ, Div Biomed Sci, Fac Dent, Montreal, PQ, Canada.	mari.kaartinen@mcgill.ca		Kaartinen, Mari/0000-0003-2999-6502	Canadian Institutes of Health Research (CIHR) [MOP-89827]; Natural Sciences and Engineering Research Council of Canada (NSERC) [184034-2009]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research (CIHR) grant number MOP-89827 (http://www.cihr.ca) and Natural Sciences and Engineering Research Council of Canada (NSERC) grant number 184034-2009 (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 1996, MOL CELL BIOCHEM, V162, P43; Adany R, 2003, CELL MOL LIFE SCI, V60, P1049, DOI 10.1007/s00018-003-2178-9; AESCHLIMANN D, 1991, J BIOL CHEM, V266, P15308; AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Aeschlimann Daniel, 1996, Seminars in Thrombosis and Hemostasis, V22, P437; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Al-Jallad HF, 2006, MATRIX BIOL, V25, P135, DOI 10.1016/j.matbio.2005.11.001; Allan VJ, 2000, PRACT APPROACH SER, V218, P1; Bernstein EF, 1996, J AM ACAD DERMATOL, V34, P209, DOI 10.1016/S0190-9622(96)80114-9; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Cordell PA, 2010, BLOOD, V115, P2674, DOI 10.1182/blood-2009-08-231316; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; de Macedo P, 2002, BIOORGAN MED CHEM, V10, P355, DOI 10.1016/S0968-0896(01)00292-9; Del Duca S, 2009, BIOCHEM J, V418, P651, DOI 10.1042/BJ20081781; DIEGELMA.RF, 1972, P NATL ACAD SCI USA, V69, P892, DOI 10.1073/pnas.69.4.892; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Facchiano F, 2006, FRONT BIOSCI, V11, P1758, DOI 10.2741/1921; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Forsprecher J, 2009, AMINO ACIDS, V36, P747, DOI 10.1007/s00726-008-0125-7; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1990, J BONE MINER RES, V5, P1157; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hsieh L, 2008, HAEMOPHILIA, V14, P1190, DOI 10.1111/j.1365-2516.2008.01857.x; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Inbal A, 2005, THROMB HAEMOSTASIS, V94, P432, DOI 10.1160/TH05-04-0291; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Johnson KA, 2005, J BIOL CHEM, V280, P15004, DOI 10.1074/jbc.M500962200; Johnson KA, 2003, J BIOL CHEM, V278, P18824, DOI 10.1074/jbc.M301055200; Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262; Jones RA, 1997, J CELL SCI, V110, P2461; Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lauer P, 2002, THROMB HAEMOSTASIS, V88, P967, DOI 10.1055/s-0037-1613342; Linder S, 2000, J CELL SCI, V113, P4165; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LYNCH GW, 1987, J BIOL CHEM, V262, P1772; MACCIONI RB, 1986, EXP CELL RES, V167, P266, DOI 10.1016/0014-4827(86)90224-7; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; McKee MD, 2005, CELLS TISSUES ORGANS, V181, P176, DOI 10.1159/000091379; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nabavi N, 2008, J BIOL CHEM, V283, P19678, DOI 10.1074/jbc.M802517200; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094; Nakano Y, 2007, BONE, V41, P549, DOI 10.1016/j.bone.2007.06.011; Nakano Y, 2007, J HISTOCHEM CYTOCHEM, V55, P675, DOI 10.1369/jhc.6A7091.2007; Nakano Y, 2010, J CELL PHYSIOL, V223, P260, DOI 10.1002/jcp.22034; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nurminskaya M, 2006, FRONT BIOSCI-LANDMRK, V11, P1591, DOI 10.2741/1907; Nurminskaya M, 1998, J CELL BIOL, V142, P1135, DOI 10.1083/jcb.142.4.1135; Nurminskaya M, 2003, DEV BIOL, V263, P139, DOI 10.1016/S0012-1606(03)00445-7; Nurminskaya MV, 2002, J ORTHOPAED RES, V20, P575, DOI 10.1016/S0736-0266(01)00146-2; Nurminskaya MV, 2002, DEV DYNAM, V223, P24, DOI 10.1002/dvdy.1230; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; PAYE M, 1989, HAEMOSTASIS, V19, P274; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; Schmoranzer J, 2003, MOL BIOL CELL, V14, P1558, DOI 10.1091/mbc.E02-08-0500; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; SPERANZA ML, 1987, COLLAGEN REL RES, V7, P115; Tarantino U, 2009, AMINO ACIDS, V36, P679, DOI 10.1007/s00726-008-0133-7; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Tucholski J, 1999, J NEUROCHEM, V73, P1871; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; WANG D, 1999, J BONE MINER RES, V9, P843; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022	101	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15893	10.1371/journal.pone.0015893	http://dx.doi.org/10.1371/journal.pone.0015893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283799	gold, Green Published, Green Submitted			2022-12-27	WOS:000286522200017
J	Li, Y; Fu, L; Wong, AMG; Fan, YH; Li, MX; Bei, JX; Jia, WH; Zeng, YX; Chan, D; Cheung, KMC; Sham, P; Chua, D; Guan, XY; Song, YQ				Li, Yan; Fu, Li; Wong, Alissa Michelle Go; Fan, Yan-Hui; Li, Miao-Xin; Bei, Jin-Xin; Jia, Wei-Hua; Zeng, Yi-Xin; Chan, Danny; Cheung, Kenneth M. C.; Sham, Pak; Chua, Daniel; Guan, Xin-Yuan; Song, You-Qiang			Identification of Genes with Allelic Imbalance on 6p Associated with Nasopharyngeal Carcinoma in Southern Chinese	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; POLYMORPHISM; EXPRESSION; RECEPTOR; HOMOZYGOSITY; METASTASIS; ESTROGEN; LINKAGE; NEDD9; CELLS	Nasopharyngeal carcinoma (NPC) is a malignancy of epithelial origin. The etiology of NPC is complex and includes multiple genetic and environmental factors. We employed case-control analysis to study the association of chromosome 6p regions with NPC. In total, 360 subjects and 360 healthy controls were included, and 233 single nucleotide polymorphisms (SNPs) on 6p were examined. Significant single-marker associations were found for SNPs rs2267633 (p = 4.49 x 10(-5)), rs2076483 (most significant, p = 3.36 x 10(-5)), and rs29230 (p = 1.43 x 10(-4)). The highly associated genes were the gamma-amino butyric acid B receptor 1 (GABBR1), human leukocyte antigen (HLA-A), and HLA complex group 9 (HCG9). Haplotypic associations were found for haplotypes AAA (located within GABBR1, p-value = 6.46 x 10(-5)) and TT (located within HLA-A, p = 0.0014). Further investigation of the homozygous genotype frequencies between cases and controls suggested that micro-deletion regions occur in GABBR1 and neural precursor cell expressed developmentally down-regulated 9 (NEDD9). Quantitative real-time polymerase chain reaction (qPCR) using 11 pairs of NPC biopsy samples confirmed the significant decline in GABBR1 and NEDD9 mRNA expression in the cancer tissues compared to the adjacent non-tumor tissue (p<0.05). Our study demonstrates that multiple chromosome 6p susceptibility loci contribute to the risk of NPC, possibly though GABBR1 and NEDD9 loss of function.	[Li, Yan; Fan, Yan-Hui; Li, Miao-Xin; Chan, Danny; Song, You-Qiang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Fu, Li; Wong, Alissa Michelle Go; Chua, Daniel; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Bei, Jin-Xin; Jia, Wei-Hua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Bei, Jin-Xin; Jia, Wei-Hua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Cheung, Kenneth M. C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Chan, Danny; Sham, Pak; Song, You-Qiang] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Li, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	xyguan@hku.hk; songy@hku.hk	Song, You-qiang/C-4401-2009; Bei, Jin-Xin/AAO-1259-2020; Fu, Li/F-7182-2010; Fan, Yanhui/J-4659-2016; Song, You-Qiang/E-5207-2011; /A-3639-2009; Chan, Danny/C-4203-2009; Guan, Xin-Yuan/A-3639-2009	Fu, Li/0000-0003-2643-6278; Fan, Yanhui/0000-0001-9677-3777; /0000-0003-1874-9805; Wong, Alissa/0000-0001-7858-1368; Song, You-Qiang/0000-0001-9407-2256; Cheung, Kenneth/0000-0001-8304-0419; Chan, Danny/0000-0003-3824-5778; Guan, Xin-Yuan/0000-0002-4485-6017	Research Fund for the Control of Infectious Diseases (RFCID) [08070652]; AO Foundation (AOSPINE) [AOSBRC-07-02]	Research Fund for the Control of Infectious Diseases (RFCID); AO Foundation (AOSPINE)	The study is supported by a grant from the Research Fund for the Control of Infectious Diseases (RFCID: http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html) (no. 08070652, YQS) and AO Foundation (AOSPINE (AOSBRC-07-02; http://www.aospine.org/history.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Buterin T, 2006, CARCINOGENESIS, V27, P1567, DOI [10.1093/carcin/bci339, 10.1093/carcin/bgi339]; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chen Shuang-ling, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P305; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Deng L, 2002, ACTA BIOCH BIOPH SIN, V34, P16; Dutt A, 2007, CURR OPIN ONCOL, V19, P43, DOI 10.1097/CCO.0b013e328011a8c1; HO JHC, 1978, INT J RADIAT ONCOL, V4, P182; [黄腾波 Huang Tengbo], 2002, [中华医学遗传学杂志, Chinese Journal of Medical Genetics], V19, P134; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; LANIER A, 1980, CANCER-AM CANCER SOC, V46, P2100, DOI 10.1002/1097-0142(19801101)46:9<2100::AID-CNCR2820460932>3.0.CO;2-G; LERMAN MI, 1987, CARCINOGENESIS, V8, P121, DOI 10.1093/carcin/8.1.121; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Merrill RA, 2004, DEV DYNAM, V231, P564, DOI 10.1002/dvdy.20159; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Nazar-Stewart V, 1999, CANCER EPIDEM BIOMAR, V8, P547; Ooi EE, 1997, INT J CANCER, V74, P229; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Schuller HM, 2008, CANCER-AM CANCER SOC, V112, P767, DOI 10.1002/cncr.23231; Sheu JJC, 2009, CANCER EPIDEM BIOMAR, V18, P2709, DOI 10.1158/1055-9965.EPI-09-0349; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Song LB, 2006, CANCER LETT, V242, P258, DOI 10.1016/j.canlet.2005.11.013; Tai ALS, 2006, CANCER RES, V66, P4133, DOI 10.1158/0008-5472.CAN-05-2775; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200; Zhou XF, 2007, COMP FUNCT GENOM, DOI 10.1155/2007/57513	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14562	10.1371/journal.pone.0014562	http://dx.doi.org/10.1371/journal.pone.0014562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283797	gold, Green Published			2022-12-27	WOS:000286522200005
J	Saridaki, Z; Tzardi, M; Papadaki, C; Sfakianaki, M; Pega, F; Kalikaki, A; Tsakalaki, E; Trypaki, M; Messaritakis, I; Stathopoulos, E; Mavroudis, D; Georgoulias, V; Souglakos, J				Saridaki, Zacharenia; Tzardi, Maria; Papadaki, Chara; Sfakianaki, Maria; Pega, Fraga; Kalikaki, Aristea; Tsakalaki, Eleftheria; Trypaki, Maria; Messaritakis, Ippokratis; Stathopoulos, Efstathios; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John			Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in >= 2(nd) Line Cetuximab-Based Therapy of Colorectal Cancer Patients	PLOS ONE			English	Article							GENE COPY NUMBER; PLUS IRINOTECAN; PREDICTS; FLUOROURACIL; LEUCOVORIN; RESISTANCE; SURVIVAL; EFFICACY; BENEFIT; EGFR	Background: To investigate the predictive significance of KRAS, BRAF, PIK3CA mutational status, AREG- EREG mRNA expression, PTEN protein expression and skin rash in metastatic colorectal cancer (mCRC) patients treated with cetuximab containing salvage chemotherapy. Methods: Primary tumors from 112 mCRC patients were analyzed. The worst skin toxicity during treatment was recorded. Results: KRAS, BRAF and PIK3CA mutations were present in 37 (33%), 8 (7.2%) and 11 (9.8%) cases, respectively, PTEN was lost in 21 (19.8%) cases, AREG and EREG were overexpressed in 48 (45%) and 51 (49%) cases. In the whole study population, time to tumor progression (TTP) and overall survival (OS) was significantly lower in patients with KRAS (p = 0.001 and p = 0.026, respectively) or BRAF (p = 0.001 and p<0.0001, respectively) mutant tumors, downregulation of AREG (p = 0.018 and p = 0.013, respectively) or EREG (p = 0.002 and p = 0.004, respectively) and grade 0-1 skin rash (p<0.0001 and p<0.0001, respectively). In KRAS wt patients TTP and OS was significantly lower in patients with BRAF (p = 0.0001 and p<0.0001, respectively) mutant tumors, downregulation of AREG (p = 0.021 and p = 0.004, respectively) or EREG (p = 0.0001 and p<0.0001, respectively) and grade 0-1 skin rash (p<0.0001 and p<0.0001, respectively). TTP was significantly lower in patients with PIK3CA mutations (p = 0.01) or lost PTEN (p = 0.002). Multivariate analysis revealed KRAS (Hazard Ratio [HR] 4.3, p<0.0001), BRAF mutation (HR: 5.1, p<0.0001), EREG low expression (HR: 1.6, p = 0.021) and absence of severe/moderate skin rash (HR: 4.0, p<0.0001) as independent prognostic factors for decreased TTP. Similarly, KRAS (HR 2.9, p = 0.01), BRAF mutation (HR: 3.0, p = 0.001), EREG low expression (HR: 1.7, p = 0.021), absecence of severe/moderate skin rash (HR: 3.7, p<0.0001) and the presence of undifferantited tumours (HR: 2.2, p = 0.001) were revealed as independent prognostic factors for decreased OS. Conclusions: These results underscore that KRAS-BRAF mutations and EREG expression can be used as biomarkers to further select patients undergoing anti-EGFR treatment.	[Saridaki, Zacharenia; Papadaki, Chara; Sfakianaki, Maria; Pega, Fraga; Kalikaki, Aristea; Tsakalaki, Eleftheria; Trypaki, Maria; Messaritakis, Ippokratis; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece; [Saridaki, Zacharenia; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Crete, Greece; [Tzardi, Maria; Stathopoulos, Efstathios] Univ Gen Hosp, Pathol Lab, Iraklion, Crete, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Saridaki, Z (corresponding author), Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece.	georgsec@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019	PAPADAKI, CHARA/0000-0002-4591-3757; Pega, Fraga/0000-0002-2794-3565; Messaritakis, Ippokratis/0000-0003-1877-500X	Cretan Association for Biomedical Research (CABR)	Cretan Association for Biomedical Research (CABR)	Dr. Z. Saridaki is a recipient of a Cretan Association for Biomedical Research (CABR) research fellowship. No current external funding sources for this study.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; DE RW, 2010, LANCET ONCOL; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard J, 2010, J CLIN ONCOL, V28; DOUILLARD J, 2009, ANNONCOL SUPP; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Papadaki C, 2009, CLIN CANCER RES, V15, P3827, DOI 10.1158/1078-0432.CCR-08-3027; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Prenen Hans, 2009, Eur J Cancer, V45 Suppl 1, P70, DOI 10.1016/S0959-8049(09)70018-8; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Razis E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-234; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Saridaki Z, 2010, BRIT J CANCER, V102, P1762, DOI 10.1038/sj.bjc.6605694; Saridaki Z, 2010, WORLD J GASTROENTERO, V16, P1177, DOI 10.3748/wjg.v16.i10.1177; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Segaert Siegfried, 2009, Eur J Cancer, V45 Suppl 1, P295, DOI 10.1016/S0959-8049(09)70044-9; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; Tabernero J, 2010, J CLIN ONCOL, V28, P1181, DOI 10.1200/JCO.2009.22.6043; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Torres J, 2001, EUR J CANCER, V37, P114, DOI 10.1016/S0959-8049(00)00366-X; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wong R, 2008, J CLIN ONCOL, V26, P5668, DOI 10.1200/JCO.2008.19.5024; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	45	105	117	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15980	10.1371/journal.pone.0015980	http://dx.doi.org/10.1371/journal.pone.0015980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283802	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200019
J	Domingo-Gil, E; Toribio, R; Najera, JL; Esteban, M; Ventoso, I				Domingo-Gil, Elena; Toribio, Rene; Luis Najera, Jose; Esteban, Mariano; Ventoso, Ivan			Diversity in Viral Anti-PKR Mechanisms: A Remarkable Case of Evolutionary Convergence	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; SINDBIS VIRUS-INFECTION; VACCINIA VIRUS; NS1 PROTEIN; TRANSGENIC MICE; INNATE IMMUNITY; HEPATITIS-C; HOST-RANGE; E3L GENE	Most viruses express during infection products that prevent or neutralize the effect of the host dsRNA activated protein kinase (PKR). Translation of Sindbis virus (SINV) mRNA escapes to PKR activation and eIF2 phosphorylation in infected cells by a mechanism that requires a stem loop structure in viral 26S mRNA termed DLP to initiate translation in the absence of functional eIF2. Unlike the rest of viruses tested, we found that Alphavirus infection allowed a strong PKR activation and eIF2 alpha phosphorylation in vitro and in infected animals so that the presence of DLP structure in mRNA was critical for translation and replication of SINV. Interestingly, infection of MEFs with some viruses that express PKR inhibitors prevented eIF2 alpha phosphorylation after superinfection with SINV, suggesting that viral anti-PKR mechanisms could be exchangeable. Thus, translation of SINV mutant lacking the DLP structure (Delta DLP) in 26S mRNA was partially rescued in cells expressing vaccinia virus (VV) E3 protein, a known inhibitor of PKR. This case of heterotypic complementation among evolutionary distant viruses confirmed experimentally a remarkable case of convergent evolution in viral anti-PKR mechanisms. Our data reinforce the critical role of PKR in regulating virus-host interaction and reveal the versatility of viruses to find different solutions to solve the same conflict.	[Domingo-Gil, Elena; Toribio, Rene; Ventoso, Ivan] Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain; [Domingo-Gil, Elena; Toribio, Rene; Ventoso, Ivan] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [Luis Najera, Jose; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Domingo-Gil, E (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain.	iventoso@cbm.uam.es	Ventoso, Iván/N-4018-2014; Esteban, Mariano/ABG-5375-2020; Toribio, René/AAI-1444-2019	Ventoso, Iván/0000-0001-7887-3520; Esteban, Mariano/0000-0003-0846-2827; Toribio, René/0000-0002-4847-629X; Najera, jose Luis/0000-0001-7798-3330	Comunidad de Madrid; Ministerio de Ciencia e Innovacion [SAF2006-09810, SAF2008-02036]; Fundacion Mutua Madrilena [FMM 2008]; VIRUS-HOST programme	Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); VIRUS-HOST programme	This work was supported in part from the VIRUS-HOST interaction programme (Comunidad de Madrid) and by grants from the Ministerio de Ciencia e Innovacion (SAF2006-09810; SAF2008-02036) and the Fundacion Mutua Madrilena (FMM 2008). The institutional support from Fundacion Ramon Areces is also acknowledged. E.D was a recipient of VIRUS-HOST programme postdoctoral contract. R.T. was a recipient of the SAF2006-09810 contract and I.V. was a researcher of Ramon y Cajal Programme. The elaboration of this work took about 2 years and the estimated cost was 3000 euros excluding salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; BLACK TL, 1993, J VIROL, V67, P791, DOI 10.1128/JVI.67.2.791-800.1993; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Burke CW, 2009, VIROLOGY, V395, P121, DOI 10.1016/j.virol.2009.08.039; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Domingo-Gil E, 2008, J VIROL, V82, P254, DOI 10.1128/JVI.01384-07; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gorchakov R, 2004, J VIROL, V78, P8455, DOI 10.1128/JVI.78.16.8455-8467.2004; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; JACKSON AC, 1988, LAB INVEST, V58, P503; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Mohr I, 2004, INT REV IMMUNOL, V23, P199, DOI 10.1080/08830180490265600; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; RODRIGUEZ JF, 1988, P NATL ACAD SCI USA, V85, P1667, DOI 10.1073/pnas.85.5.1667; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Rothenburg S, 2009, NAT STRUCT MOL BIOL, V16, P63, DOI 10.1038/nsmb.1529; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Suthar MS, 2009, CELL MICROBIOL, V11, P880, DOI 10.1111/j.1462-5822.2009.01311.x; TORIBIO R, 2010, P NATL ACAD SCI US; VANVALEN L, 1974, NATURE, V252, P298; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Webber C, 2004, CURR BIOL, V14, pR332, DOI 10.1016/j.cub.2004.04.016; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	55	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16711	10.1371/journal.pone.0016711	http://dx.doi.org/10.1371/journal.pone.0016711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311764	Green Submitted, gold, Green Published			2022-12-27	WOS:000287036200035
J	Clemons, A; Haugen, M; Le, C; Mori, A; Tomchaney, M; Severson, DW; Duman-Scheel, M				Clemons, Anthony; Haugen, Morgan; Le, Christy; Mori, Akio; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly			siRNA-Mediated Gene Targeting in Aedes aegypti Embryos Reveals That Frazzled Regulates Vector Mosquito CNS Development	PLOS ONE			English	Article							CRUSTACEAN ORCHESTIA-CAVIMANA; DISTANTLY RELATED ARTHROPODS; ANOPHELES-GAMBIAE; AXON GUIDANCE; AMPHIPOD CRUSTACEAN; COMMISSURAL AXONS; PROVIDES EVIDENCE; GENOME SEQUENCE; MIDLINE CELLS; NANOS NOS	Although mosquito genome projects uncovered orthologues of many known developmental regulatory genes, extremely little is known about the development of vector mosquitoes. Here, we investigate the role of the Netrin receptor frazzled (fra) during embryonic nerve cord development of two vector mosquito species. Fra expression is detected in neurons just prior to and during axonogenesis in the embryonic ventral nerve cord of Aedes aegypti (dengue vector) and Anopheles gambiae (malaria vector). Analysis of fra function was investigated through siRNA-mediated knockdown in Ae. aegypti embryos. Confirmation of fra knockdown, which was maintained throughout embryogenesis, indicated that microinjection of siRNA is an effective method for studying gene function in Ae. aegypti embryos. Loss of fra during Ae. aegypti development results in thin and missing commissural axons. These defects are qualitatively similar to those observed in Dr. melanogaster fra null mutants. However, the Aa. aegypti knockdown phenotype is stronger and bears resemblance to the Drosophila commissureless mutant phenotype. The results of this investigation, the first targeted knockdown of a gene during vector mosquito embryogenesis, suggest that although Fra plays a critical role during development of the Ae. aegypti ventral nerve cord, mechanisms regulating embryonic commissural axon guidance have evolved in distantly related insects.	[Clemons, Anthony; Le, Christy; Mori, Akio; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Clemons, Anthony; Le, Christy; Mori, Akio; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Clemons, Anthony; Haugen, Morgan; Severson, David W.; Duman-Scheel, Molly] Indiana Univ, Sch Med, Dept Med & Mol Genet, South Bend, IN 46615 USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Clemons, A (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	mscheel@nd.edu			University of Notre Dame College of Science; NIAID [R01AI081795-01]; NINDS [R15 NS 048904-0]; IUSM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS048904] Funding Source: NIH RePORTER	University of Notre Dame College of Science; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); IUSM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Christy Le and Michael Tomchaney were supported by the University of Notre Dame College of Science Summer Undergraduate Research Fellowship program. This work was supported by the following awards to MDS: NIAID Award R01AI081795-01, NINDS Award R15 NS 048904-0, and an IUSM Research Support Funds Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adelman ZN, 2007, P NATL ACAD SCI USA, V104, P9970, DOI 10.1073/pnas.0701515104; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Browne WE, 2006, DEV GENES EVOL, V216, P581, DOI 10.1007/s00427-006-0074-7; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Chen XH, 2008, ACTA CRYSTALLOGR E, V64, pM1253, DOI 10.1107/S1600536808028171; Christophers SR., 1960, AEDES AEGYPTI YELLOW; Clemons A, 2010, COLD SPRING HARB PRO; DOE CQ, 1993, DEV DROSOPHILA MELAN, P1091; Duman-Scheel M, 1999, DEVELOPMENT, V126, P2327; Duman-Scheel M, 2009, CURR DRUG TARGETS, V10, P602, DOI 10.2174/138945009788680428; Duman-Scheel M, 2007, EVOL DEV, V9, P131, DOI 10.1111/j.1525-142X.2007.00144.x; Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020; Gerberding M, 1999, DEV GENES EVOL, V209, P91, DOI 10.1007/s004270050231; Gerberding M, 2001, DEV BIOL, V235, P397, DOI 10.1006/dbio.2001.0302; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HAUGEN M, 2010, COLD SPRING HARBOR P; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; JASINSKIENE N, 2007, J VISUALIZED EXPT, V5; Juhn J, 2008, INSECT MOL BIOL, V17, P545, DOI 10.1111/j.1365-2583.2008.00823.x; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Morlais I, 2003, MOL GENET GENOMICS, V269, P753, DOI 10.1007/s00438-003-0882-7; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; PATEL N, 1996, IN SITU HYBRIDIZATIO, P357; RAMINANI L N, 1975, International Journal of Insect Morphology and Embryology, V4, P517, DOI 10.1016/0020-7322(75)90028-8; RAMINANI LN, 1978, INT J INSECT MORPHOL, V7, P273, DOI 10.1016/0020-7322(78)90009-0; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Simanton W, 2009, EVOL DEV, V11, P260, DOI 10.1111/j.1525-142X.2009.00328.x; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25	40	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16730	10.1371/journal.pone.0016730	http://dx.doi.org/10.1371/journal.pone.0016730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304954	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300128
J	Homberg, JR; Olivier, JDA; Blom, T; Arentsen, T; van Brunschot, C; Schipper, P; Korte-Bouws, G; van Luijtelaar, G; Reneman, L				Homberg, Judith R.; Olivier, Jocelien D. A.; Blom, Tom; Arentsen, Tim; van Brunschot, Chantal; Schipper, Pieter; Korte-Bouws, Gerdien; van Luijtelaar, Gilles; Reneman, Liesbeth			Fluoxetine Exerts Age-Dependent Effects on Behavior and Amygdala Neuroplasticity in the Rat	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SEROTONIN REUPTAKE INHIBITORS; PSA-NCAM EXPRESSION; PREPULSE INHIBITION; METABOLITE NORFLUOXETINE; POLYSIALIC ACID; REM-SLEEP; DEPRESSION; SERUM; BRAIN	The selective serotonin reuptake inhibitor (SSRI) Prozac (R) (fluoxetine) is the only registered antidepressant to treat depression in children and adolescents. Yet, while the safety of SSRIs has been well established in adults, serotonin exerts neurotrophic actions in the developing brain and thereby may have harmful effects in adolescents. Here we treated adolescent and adult rats chronically with fluoxetine (12 mg/kg) at postnatal day (PND) 25 to 46 and from PND 67 to 88, respectively, and tested the animals 7-14 days after the last injection when (nor) fluoxetine in blood plasma had been washed out, as determined by HPLC. Plasma (nor) fluoxetine levels were also measured 5 hrs after the last fluoxetine injection, and matched clinical levels. Adolescent rats displayed increased behavioral despair in the forced swim test, which was not seen in adult fluoxetine treated rats. In addition, beneficial effects of fluoxetine on wakefulness as measured by electroencephalography in adults was not seen in adolescent rats, and age-dependent effects on the acoustic startle response and prepulse inhibition were observed. On the other hand, adolescent rats showed resilience to the anorexic effects of fluoxetine. Exploratory behavior in the open field test was not affected by fluoxetine treatment, but anxiety levels in the elevated plus maze test were increased in both adolescent and adult fluoxetine treated rats. Finally, in the amygdala, but not the dorsal raphe nucleus and medial prefrontal cortex, the number of PSA-NCAM (marker for synaptic remodeling) immunoreactive neurons was increased in adolescent rats, and decreased in adult rats, as a consequence of chronic fluoxetine treatment. No fluoxetine-induced changes in 5-HT1A receptor immunoreactivity were observed. In conclusion, we show that fluoxetine exerts both harmful and beneficial age-dependent effects on depressive behavior, body weight and wakefulness, which may relate, in part, to differential fluoxetine-induced neuroplasticity in the amygdala.	[Homberg, Judith R.; Olivier, Jocelien D. A.; Blom, Tom; Arentsen, Tim; van Brunschot, Chantal; Schipper, Pieter] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Ctr Neurosci,Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [van Luijtelaar, Gilles] Radboud Univ Nijmegen, Ctr Cognit, Donders Inst Brain Cognit & Behav, Dept Biol Psychol, NL-6525 ED Nijmegen, Netherlands; [Korte-Bouws, Gerdien] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Homberg, JR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Ctr Neurosci,Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.	j.homberg@cns.umcn.nl	van Luijtelaar, Gilles/D-2290-2010; Homberg, Judith R/D-2473-2010; Homberg, J.R./N-4172-2019	Reneman, Liesbeth/0000-0002-5912-9971; Olivier, Jocelien/0000-0003-4654-9763	Netherlands organization for health research and development [916. 86.125]	Netherlands organization for health research and development(Netherlands Organization for Health Research and Development)	This work is funded by the Netherlands organization for health research and development (Veni nr. 916. 86.125), awarded to L. Reneman. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 1998, J CHROMATOGR B, V707, P175, DOI 10.1016/S0378-4347(97)00588-4; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Amsterdam JD, 1997, AM J PSYCHIAT, V154, P963; Argyropoulos SV, 2005, INT REV PSYCHIATR, V17, P237, DOI 10.1080/09540260500104458; BAKALIAN MJ, 1990, BRAIN RES, V528, P300, DOI 10.1016/0006-8993(90)91671-3; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bhansali P, 2007, J NEUROSCI, V27, P1467, DOI 10.1523/JNEUROSCI.4632-06.2007; Bhatia SK, 2007, AM FAM PHYSICIAN, V75, P73; Blier P, 2010, NEURON, V65, P1, DOI 10.1016/j.neuron.2009.12.028; Bourdeaux R, 1998, J PHARM PHARMACOL, V50, P1387, DOI 10.1111/j.2042-7158.1998.tb03364.x; Castro JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008618; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898; Dulawa SC, 1997, PSYCHOPHARMACOLOGY, V132, P125, DOI 10.1007/s002130050328; Duverneuil C, 2003, THER DRUG MONIT, V25, P565, DOI 10.1097/00007691-200310000-00005; Farid M, 2000, NEUROPSYCHOPHARMACOL, V23, P623, DOI 10.1016/S0893-133X(00)00163-9; Feige B, 2002, NEUROPSYCHOPHARMACOL, V26, P246, DOI 10.1016/S0893-133X(01)00314-1; FULLER RW, 1994, J NEURAL TRANSM-GEN, V96, P165, DOI 10.1007/BF01294784; GARATTINI S, 1989, BRIT J PSYCHIAT, V155, P41, DOI 10.1192/S0007125000291757; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Giedke H, 2002, SLEEP MED REV, V6, P361, DOI 10.1053/smrv.2002.0235; Gogos A, 2005, PHARMACOL BIOCHEM BE, V81, P664, DOI 10.1016/j.pbb.2005.05.007; Gogos A, 2008, BEHAV PHARMACOL, V19, P548, DOI 10.1097/FBP.0b013e32830cd822; Grzegorzewska M, 2010, NEUROSCIENCE, V166, P122, DOI 10.1016/j.neuroscience.2009.12.015; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hefner K, 2007, BEHAV BRAIN RES, V182, P344, DOI 10.1016/j.bbr.2007.03.032; Hensler JG, 2002, NEUROPSYCHOPHARMACOL, V26, P565, DOI 10.1016/S0893-133X(01)00395-5; Homberg JR, 2008, PSYCHOPHARMACOLOGY, V200, P367, DOI 10.1007/s00213-008-1212-x; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Iniguez SD, 2010, BIOL PSYCHIAT, V67, P1057, DOI 10.1016/j.biopsych.2009.12.033; Ivarsson M, 2005, EUR J PHARMACOL, V522, P63, DOI 10.1016/j.ejphar.2005.08.050; Kecskemeti V, 2005, BRAIN RES BULL, V67, P126, DOI 10.1016/j.brainresbull.2005.06.027; Kirov R, 2002, NEUROSCI LETT, V322, P134, DOI 10.1016/S0304-3940(02)00096-4; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kurt Mehmet, 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P173; LaRoche RB, 2007, NEUROTOXICOL TERATOL, V29, P96, DOI 10.1016/j.ntt.2006.11.008; Lundmark J, 2001, THER DRUG MONIT, V23, P139, DOI 10.1097/00007691-200104000-00008; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Mason SS, 2009, EUR J PHARMACOL, V602, P306, DOI 10.1016/j.ejphar.2008.11.010; McEwen BS, 2004, EUR NEUROPSYCHOPHARM, V14, pS497, DOI 10.1016/j.euroneuro.2004.09.008; Monti JM, 2006, BEHAV BRAIN RES, V167, P245, DOI 10.1016/j.bbr.2005.09.025; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Norcross M, 2008, PSYCHOPHARMACOLOGY, V200, P413, DOI 10.1007/s00213-008-1215-7; Oh JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2197, DOI 10.1038/npp.2009.47; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P865, DOI 10.1001/archpsyc.63.8.865; Olivier JDA, 2008, PSYCHOPHARMACOLOGY, V200, P243, DOI 10.1007/s00213-008-1201-0; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; ORSULAK PJ, 1988, CLIN CHEM, V34, P1875; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Popa D, 2008, J NEUROSCI, V28, P3546, DOI 10.1523/JNEUROSCI.4006-07.2008; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P624, DOI 10.1016/j.nlm.2006.12.001; Seki T, 1998, J NEUROSCI, V18, P3757; Shanahan NA, 2009, BIOL PSYCHIAT, V65, P401, DOI 10.1016/j.biopsych.2008.09.026; Simon GE, 2006, NEW ENGL J MED, V355, P2722, DOI 10.1056/NEJMp068270; SIPES TA, 1994, NEUROPHARMACOLOGY, V33, P441, DOI 10.1016/0028-3908(94)90074-4; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Strauss WL, 2002, AM J PSYCHIAT, V159, P755, DOI 10.1176/appi.ajp.159.5.755; Thase ME, 1998, J CLIN PSYCHIAT, V59, P55; Usala T, 2008, EUR NEUROPSYCHOPHARM, V18, P62, DOI 10.1016/j.euroneuro.2007.06.001; vanLuijtelaar ELJM, 1997, ACTA NEUROBIOL EXP, V57, P113; Varea E, 2007, EUR NEUROPSYCHOPHARM, V17, P546, DOI 10.1016/j.euroneuro.2007.01.001; Varea E, 2007, NEUROPSYCHOPHARMACOL, V32, P803, DOI 10.1038/sj.npp.1301183; Varea E, 2009, NEUROBIOL AGING, V30, P808, DOI 10.1016/j.neurobiolaging.2007.08.016; Vazquez-Palacios G, 2010, PHARMACOL BIOCHEM BE, V94, P503, DOI 10.1016/j.pbb.2009.11.004; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Yew DT, 2009, MICROSC RES TECHNIQ, V72, P684, DOI 10.1002/jemt.20717; Zito JM, 2002, PEDIATRICS, V109, P721, DOI 10.1542/peds.109.5.721	69	68	70	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16646	10.1371/journal.pone.0016646	http://dx.doi.org/10.1371/journal.pone.0016646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304948	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300106
J	Matsuo, K; Bettaieb, A; Nagata, N; Matsuo, I; Keilhack, H; Haj, FG				Matsuo, Kosuke; Bettaieb, Ahmed; Nagata, Naoto; Matsuo, Izumi; Keilhack, Heike; Haj, Fawaz G.			Regulation of Brown Fat Adipogenesis by Protein Tyrosine Phosphatase 1B	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; PHOSPHOINOSITIDE 3-KINASE; TRANSCRIPTIONAL CONTROL; GLUCOSE-UPTAKE; ENDOPLASMIC-RETICULUM; ENERGY-EXPENDITURE; 3T3-L1 ADIPOCYTES; BETA-CATENIN	Background: Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of insulin signaling and energy balance, but its role in brown fat adipogenesis requires additional investigation. Methodology/Principal Findings: To precisely determine the role of PTP1B in adipogenesis, we established preadipocyte cell lines from wild type and PTP1B knockout (KO) mice. In addition, we reconstituted KO cells with wild type, substrate-trapping (D/A) and sumoylation-resistant (K/R) PTP1B mutants, then characterized differentiation and signaling in these cells. KO, D/A- and WT-reconstituted cells fully differentiated into mature adipocytes with KO and D/A cells exhibiting a trend for enhanced differentiation. In contrast, K/R cells exhibited marked attenuation in differentiation and lipid accumulation compared with WT cells. Expression of adipogenic markers PPAR gamma, C/EBP alpha, C/EBP delta, and PGC1 alpha mirrored the differentiation pattern. In addition, the differentiation deficit in K/R cells could be reversed completely by the PPAR gamma activator troglitazone. PTP1B deficiency enhanced insulin receptor (IR) and insulin receptor substrate 1 (IRS1) tyrosyl phosphorylation, while K/R cells exhibited attenuated insulin-induced IR and IRS1 phosphorylation and glucose uptake compared with WT cells. In addition, substrate-trapping studies revealed that IRS1 is a substrate for PTP1B in brown adipocytes. Moreover, KO, D/A and K/R cells exhibited elevated AMPK and ACC phosphorylation compared with WT cells. Conclusions: These data indicate that PTP1B is a modulator of brown fat adipogenesis and suggest that adipocyte differentiation requires regulated expression of PTP1B.	[Matsuo, Kosuke; Bettaieb, Ahmed; Nagata, Naoto; Matsuo, Izumi; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Keilhack, Heike] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	University of California System; University of California Davis; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Matsuo, K (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	fghaj@ucdavis.edu	NAGATA, Naoto/D-9261-2012	NAGATA, Naoto/0000-0002-2389-2334	National Institutes of Health (NIH) [R01 CA49152, R56 DK084317]; Center for Health and Nutrition Research (University of California Davis); American Diabetes Association [7-06-JF-28]; Juvenile Diabetes Research Foundation [1-2009-337]; NATIONAL CANCER INSTITUTE [R01CA049152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084317] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Health and Nutrition Research (University of California Davis); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Initial portions of this study were performed in the laboratory of Dr. Benjamin Neel (National Institutes of Health (NIH) grant R01 CA49152). This work was supported by a grant from the Center for Health and Nutrition Research (University of California Davis), a Junior Faculty Award from American Diabetes Association (7-06-JF-28), Research Grant from the Juvenile Diabetes Research Foundation (1-2009-337), and NIH grant R56 DK084317 to F. G. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided financial support for salary of personnel conducting the research and reagents used in these studies.	Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; Camp HS, 2002, TRENDS MOL MED, V8, P442, DOI 10.1016/S1471-4914(02)02396-1; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; DELIBEGOVIC M, 2008, DIABETES; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Entingh AJ, 2003, J BIOL CHEM, V278, P33377, DOI 10.1074/jbc.M303056200; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Frevert EU, 1998, J BIOL CHEM, V273, P25480, DOI 10.1074/jbc.273.39.25480; Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Valverde AM, 1999, DIABETES, V48, P2122, DOI 10.2337/diabetes.48.11.2122; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Zabolotny JM, 2004, J BIOL CHEM, V279, P24844, DOI 10.1074/jbc.M310688200	62	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16446	10.1371/journal.pone.0016446	http://dx.doi.org/10.1371/journal.pone.0016446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305007	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300065
J	Penrod, NM; Poku, KA; Vaughn, DE; Asselbergs, FW; Brown, NJ; Moore, JH; Williams, SM				Penrod, Nadia M.; Poku, Kwabena A.; Vaughn, Douglas E.; Asselbergs, Folkert W.; Brown, Nancy J.; Moore, Jason H.; Williams, Scott M.			Epistatic Interactions in Genetic Regulation of t-PA and PAI-1 Levels in a Ghanaian Population	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; RENIN-ANGIOTENSIN SYSTEM; MYOCARDIAL-INFARCTION; FIBRINOLYTIC SYSTEMS; BRADYKININ; POLYMORPHISMS; DISEASE; RELEASE	The proteins, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), act in concert to balance thrombus formation and degradation, thereby modulating the development of arterial thrombosis and excessive bleeding. PAI-1 is upregulated by the renin-angiotensin system (RAS), specifically by angiotensin II, the product of angiotensin converting enzyme (ACE) cleavage of angiotensin I, which is produced by the cleavage of angiotensinogen (AGT) by renin (REN). ACE indirectly stimulates the release of t-PA which, in turn, activates the corresponding fibrinolytic system. Single polymorphisms in these pathways have been shown to significantly impact plasma levels of t-PA and PAI-1 differently in Ghanaian males and females. Here we explore the involvement of epistatic interactions between the same polymorphisms in central genes of the RAS and fibrinolytic systems on plasma t-PA and PAI-1 levels within the same population (n = 992). Statistical modeling of pairwise interactions was done using two-way ANOVA between polymorphisms in the ETNK2, RENIN, ACE, PAI-1, t-PA, and AGT genes. The most significant interactions that associated with t-PA levels were between the ETNK2 A6135G and the REN T9435C polymorphisms in females (p = 0.006) and the REN T9435C and the TPA I/D polymorphisms (p = 0.005) in males. The most significant interactions for PAI-1 levels were with REN T9435C and the TPA I/D polymorphisms (p = 0.001) in females, and the association of REN G6567T with the TPA I/D polymorphisms (p = 0.032) in males. Our results provide evidence for multiple genetic effects that may not be detected using single SNP analysis. Because t-PA and PAI-1 have been implicated in cardiovascular disease these results support the idea that the genetic architecture of cardiovascular disease is complex. Therefore, it is necessary to consider the relationship between interacting polymorphisms of pathway specific genes that predict t-PA and PAI-1 levels.	[Penrod, Nadia M.; Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Poku, Kwabena A.] Univ Ghana, Sch Business, Human Serv Management & Publ Adm, Legon, Ghana; [Vaughn, Douglas E.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Brown, Nancy J.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA	Dartmouth College; University of Ghana; Vanderbilt University; Utrecht University; Utrecht University Medical Center; Vanderbilt University; Dartmouth College; Vanderbilt University	Penrod, NM (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH USA.	smwilliams@chgr.mc.vanderbilt.edu	Williams, Scott/Q-4812-2019; Moore, Jason H./AAV-9645-2021; Williams, Scott/B-9491-2012; Asselbergs, Folkert W./ABD-6752-2021	Williams, Scott/0000-0002-4835-9544; Moore, Jason H./0000-0002-5015-1099; Asselbergs, Folkert W./0000-0002-1692-8669	National Institutes of Health [HL65234]; ZonMW Clinical Fellowship [90700342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW Clinical Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL65234. Dr. F. W. Asselbergs is supported by a ZonMW Clinical Fellowship (grant 90700342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2007, J THROMB HAEMOST, V5, P313, DOI 10.1111/j.1538-7836.2007.02311.x; Asselbergs FW, 2007, HUM GENET, V122, P275, DOI 10.1007/s00439-007-0400-9; Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2006, THROMB HAEMOSTASIS, V96, P471, DOI 10.1160/TH06-06-0335; Brown NJ, 1998, HYPERTENSION, V32, P965, DOI 10.1161/01.HYP.32.6.965; Brown NJ, 1999, HYPERTENSION, V33, P1431, DOI 10.1161/01.HYP.33.6.1431; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; FRANCIS RB, 1988, AM HEART J, V115, P776, DOI 10.1016/0002-8703(88)90878-2; Margaglione M, 1997, ARTERIOSCL THROM VAS, V17, P2082, DOI 10.1161/01.ATV.17.10.2082; MARGAGLIONE M, 1994, ARTERIOSCLER THROMB, V14, P1741, DOI 10.1161/01.ATV.14.11.1741; MEADE TW, 1993, LANCET, V342, P1076, DOI 10.1016/0140-6736(93)92062-X; MOORE JH, 2005, BIOESSAYS IN PRESS; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Pretorius M, 2003, CIRCULATION, V107, P579, DOI 10.1161/01.CIR.0000046268.59922.A4; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHNEIDERMAN J, 1992, P NATL ACAD SCI USA, V89, P6998, DOI 10.1073/pnas.89.15.6998; Schoenhard JA, 2008, HUM GENET, V124, P479, DOI 10.1007/s00439-008-0573-x; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tian Y, 2006, J BIOL CHEM, V281, P28438, DOI 10.1074/jbc.M605861200; Williams SM, 2007, ETHNIC DIS, V17, P492	23	3	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16639	10.1371/journal.pone.0016639	http://dx.doi.org/10.1371/journal.pone.0016639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304999	gold, Green Published			2022-12-27	WOS:000286834300105
J	Place, TL; Fitzgerald, MP; Venkataraman, S; Vorrink, SU; Case, AJ; Teoh, MLT; Domann, FE				Place, Trenton L.; Fitzgerald, Matthew P.; Venkataraman, Sujatha; Vorrink, Sabine U.; Case, Adam J.; Teoh, Melissa L. T.; Domann, Frederick E.			Aberrant Promoter CpG Methylation Is a Mechanism for Impaired PHD3 Expression in a Diverse Set of Malignant Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL-HYDROXYLASES; PROLINE HYDROXYLATION; OXYGEN SENSOR; HIF-ALPHA; HIF-1-ALPHA; FACTOR-1; HIF-2-ALPHA; STABILITY; THERAPY	Background: The prolyl-hydroxylase domain family of enzymes (PHD1-3) plays an important role in the cellular response to hypoxia by negatively regulating HIF-alpha proteins. Disruption of this process can lead to up-regulation of factors that promote tumorigenesis. We observed decreased basal expression of PHD3 in prostate cancer tissue and tumor cell lines representing diverse tissues of origin. Furthermore, some cancer lines displayed a failure of PHD3 mRNA induction when introduced to a hypoxic environment. This study explores the mechanism by which malignancies neither basally express PHD3 nor induce PHD3 under hypoxic conditions. Methodology/Principal Findings: Using bisulfite sequencing and methylated DNA enrichment procedures, we identified human PHD3 promoter hypermethylation in prostate, breast, melanoma and renal carcinoma cell lines. In contrast, non-transformed human prostate and breast epithelial cell lines contained PHD3 CpG islands that were unmethylated and responded normally to hypoxia by upregulating PHD3 mRNA. Only treatment of cells lines containing PHD3 promoter hypermethylation with the demethylating drug 5-aza-2 '-deoxycytidine significantly increased the expression of PHD3. Conclusions/Significance: We conclude that expression of PHD3 is silenced by aberrant CpG methylation of the PHD3 promoter in a subset of human carcinoma cell lines of diverse origin and that this aberrant cytosine methylation status is the mechanism by which these cancer cell lines fail to upregulate PHD3 mRNA. We further show that a loss of PHD3 expression does not correlate with an increase in HIF-1 alpha protein levels or an increase in the transcriptional activity of HIF, suggesting that loss of PHD3 may convey a selective advantage in some cancers by affecting pathway(s) other than HIF.	[Place, Trenton L.; Domann, Frederick E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Fitzgerald, Matthew P.; Case, Adam J.; Teoh, Melissa L. T.; Domann, Frederick E.] Univ Iowa, Free Radical & Radiat Biol Program, Iowa City, IA USA; [Fitzgerald, Matthew P.; Case, Adam J.; Teoh, Melissa L. T.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA USA; [Venkataraman, Sujatha] Univ Colorado Denver, Aurora, CO USA; [Vorrink, Sabine U.; Domann, Frederick E.] Univ Iowa, Human Toxicol Program, Iowa City, IA USA; [Domann, Frederick E.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Domann, Frederick E.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Iowa; University of Iowa; University of Iowa	Place, TL (corresponding author), Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA.	frederick-domann@uiowa.edu		Case, Adam/0000-0003-3404-1428; Domann, Frederick/0000-0002-0489-2179	National Institutes of Health (NIH) [R01CA115438, R01CA073612]; DOD [W81XWH-08-1-0112]; Susan G. Komen for the Cure [KG080437]; NIH Cancer Center [P30CA086862]; NIEHS [2P42ES013661]; NIH [T32GM073610]; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA115438, R01CA073612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073610] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants R01CA115438 (FED), R01CA073612 (FED), DOD grant W81XWH-08-1-0112 (AJC), and the Susan G. Komen for the Cure grant KG080437 (MLT). SV received a project development grant from NIH Cancer Center Support, grant P30CA086862. SUV received partial salary support from NIEHS 2P42ES013661, and AJC received partial salary support from NIH T32GM073610. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; CYR A, ANTIOXID REDOX SIGNA; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Domann FE, 2004, AM J PATHOL, V164, P1883, DOI 10.1016/S0002-9440(10)63748-0; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FU J, J BIOL CHEM, V285, P8927; HATZIMICHAEL E, 2009, EUR J HAEMATOL; HENZE AT, CANC RES, V70, P357; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; HUANG KT, HISTOPATHOLOGY; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; LIU Y, BIOCH BIOPHYS RES CO, V401, P231; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; MAIER HJ, CANC LETT, V295, P214; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; PASANEN A, INT J BIOCH CELL BIO, V42, P1189; Rose SL, 2006, GYNECOL ONCOL, V102, P319, DOI 10.1016/j.ygyno.2005.12.025; Salnikow K, 1999, CARCINOGENESIS, V20, P1819, DOI 10.1093/carcin/20.9.1819; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; XUE J, 2009, GASTROENTEROLOGY; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	39	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14617	10.1371/journal.pone.0014617	http://dx.doi.org/10.1371/journal.pone.0014617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297970	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100004
J	Yun, CS; Nishida, H				Yun, Choong-Soo; Nishida, Hiromi			Distribution of Introns in Fungal Histone Genes	PLOS ONE			English	Article							MESSENGER-RNA; CELL-CYCLE; H2A GENE; EXPRESSION; MOUSE; SEQUENCE; UNIQUE	Saccharomycotina and Taphrinomycotina lack intron in their histone genes, except for an intron in one of histone H4 genes of Yarrowia lipolytica. On the other hand, Basidiomycota and Perizomycotina have introns in their histone genes. We compared the distributions of 81, 47, 79, and 98 introns in the fungal histone H2A, H2B, H3, and H4 genes, respectively. Based on the multiple alignments of the amino acid sequences of histones, we identified 19, 13, 31, and 22 intron insertion sites in the histone H2A, H2B, H3, and H4 genes, respectively. Surprisingly only one hot spot of introns in the histone H2A gene is shared between Basidiomycota and Perizomycotina, suggesting that most of introns of Basidiomycota and Perizomycotina were acquired independently. Our findings suggest that the common ancestor of Ascomycota and Basidiomycota maybe had a few introns in the histone genes. In the course of fungal evolution, Saccharomycotina and Taphrinomycotina lost the histone introns; Basidiomycota and Perizomycotina acquired other introns independently. In addition, most of the introns have sequence similarity among introns of phylogenetically close species, strongly suggesting that horizontal intron transfer events between phylogenetically distant species have not occurred recently in the fungal histone genes.	[Yun, Choong-Soo; Nishida, Hiromi] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan	University of Tokyo	Yun, CS (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan.	hnishida@iu.a.u-tokyo.ac.jp	YUN, Choong-Soo/C-7453-2017; Nishida, Hiromi/B-1635-2008	YUN, Choong-Soo/0000-0001-7128-2584	Institute for Fermentation, Osaka (IFO), Japan	Institute for Fermentation, Osaka (IFO), Japan(Institute for Fermentation (IFO))	This study was supported in part by a grant from the Institute for Fermentation, Osaka (IFO), Japan to HN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHABOUTE ME, 1993, BIOCHIMIE, V75, P523, DOI 10.1016/0300-9084(93)90057-Y; EHINGER A, 1990, MOL GEN GENET, V222, P416, DOI 10.1007/BF00633848; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513; Kuramae EE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-134; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; MAY GS, 1987, GENE, V58, P59, DOI 10.1016/0378-1119(87)90029-1; Nishida H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-108; NISHIDA H, 1993, MOL BIOL EVOL, V10, P431; Nishida H, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-10; Nishida Hiromi, 1994, Mycoscience, V35, P361, DOI 10.1007/BF02268506; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pearson WR, 1998, J MOL BIOL, V276, P71, DOI 10.1006/jmbi.1997.1525; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; WOUDT LP, 1983, NUCLEIC ACIDS RES, V11, P5347, DOI 10.1093/nar/11.16.5347; Xu ZH, 2010, MYCOLOGIA, V102, P337, DOI 10.3852/08-189	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16548	10.1371/journal.pone.0016548	http://dx.doi.org/10.1371/journal.pone.0016548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304581	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900068
J	Chellappa, SL; Steiner, R; Blattner, P; Oelhafen, P; Gotz, T; Cajochen, C				Chellappa, Sarah Laxhmi; Steiner, Roland; Blattner, Peter; Oelhafen, Peter; Goetz, Thomas; Cajochen, Christian			Non-Visual Effects of Light on Melatonin, Alertness and Cognitive Performance: Can Blue-Enriched Light Keep Us Alert?	PLOS ONE			English	Article							HUMAN CIRCADIAN CLOCK; BRIGHT LIGHT; BODY-TEMPERATURE; HIGH-SENSITIVITY; ACTION SPECTRUM; GANGLION-CELLS; SLEEP; VIGILANCE; EXPOSURE; PHASE	Background: Light exposure can cascade numerous effects on the human circadian process via the non-imaging forming system, whose spectral relevance is highest in the short-wavelength range. Here we investigated if commercially available compact fluorescent lamps with different colour temperatures can impact on alertness and cognitive performance. Methods: Sixteen healthy young men were studied in a balanced cross-over design with light exposure of 3 different light settings (compact fluorescent lamps with light of 40 lux at 6500K and at 2500K and incandescent lamps of 40 lux at 3000K) during 2 h in the evening. Results: Exposure to light at 6500K induced greater melatonin suppression, together with enhanced subjective alertness, well-being and visual comfort. With respect to cognitive performance, light at 6500K led to significantly faster reaction times in tasks associated with sustained attention (Psychomotor Vigilance and GO/NOGO Task), but not in tasks associated with executive function (Paced Visual Serial Addition Task). This cognitive improvement was strongly related with attenuated salivary melatonin levels, particularly for the light condition at 6500K. Conclusions: Our findings suggest that the sensitivity of the human alerting and cognitive response to polychromatic light at levels as low as 40 lux, is blue-shifted relative to the three-cone visual photopic system. Thus, the selection of commercially available compact fluorescent lights with different colour temperatures significantly impacts on circadian physiology and cognitive performance at home and in the workplace.	[Chellappa, Sarah Laxhmi; Goetz, Thomas; Cajochen, Christian] Univ Basel, Hosp Psychiat, Ctr Chronobiol, Basel, Switzerland; [Steiner, Roland; Oelhafen, Peter] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Chellappa, Sarah Laxhmi] CAPES Fdn, Minist Educ, Brasilia, DF, Brazil; [Blattner, Peter] Fed Off Metrol METAS, Bern, Switzerland	University of Basel; University of Basel; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Swiss Federal Institute for Metrology (METAS)	Chellappa, SL (corresponding author), Univ Basel, Hosp Psychiat, Ctr Chronobiol, Basel, Switzerland.	Christian.Cajochen@upkbs.ch	Cajochen, Christian/N-6748-2014	Chellappa, Sarah L./0000-0002-6190-464X; Blattner, Peter/0000-0003-0681-2096	Schweizerisches Bundesamt fur Gesundheit	Schweizerisches Bundesamt fur Gesundheit	This research was supported by the Schweizerisches Bundesamt fur Gesundheit (http://www.bag.admin.ch/themen/strahlung/00053/00921/00922/index.html?lang=de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADIA P, 1991, PHYSIOL BEHAV, V50, P583, DOI 10.1016/0031-9384(91)90549-4; Barry RJ, 2003, INT J PSYCHOPHYSIOL, V47, P187, DOI 10.1016/S0167-8760(02)00151-4; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Boyce P. R., 2004, Lighting Research & Technology, V36, P283, DOI 10.1191/11477153504li118oa; Brainard GC, 2001, J NEUROSCI, V21, P6405; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cajochen C, 1998, J SLEEP RES, V7, P145, DOI 10.1046/j.1365-2869.1998.00106.x; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; CAMPBELL SS, 1990, PHYSIOL BEHAV, V48, P317, DOI 10.1016/0031-9384(90)90320-4; Dinges DF, 1997, SLEEP, V20, P267; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2005, SLEEP, V28, P1059; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; Foret J, 1996, CHRONOBIOL INT, V13, P35, DOI 10.3109/07420529609040840; GILLBERG M, 1994, SLEEP, V17, P236, DOI 10.1093/sleep/17.3.236; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Lavoie S, 2003, CHRONOBIOL INT, V20, P1019, DOI 10.1081/CBI-120025534; Lockley SW, 2006, CURR BIOL, V16, pR795, DOI 10.1016/j.cub.2006.08.039; Lockley SW, 2006, SLEEP, V29, P161; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Munch M, 2006, AM J PHYSIOL-REG I, V290, pR1421, DOI 10.1152/ajpregu.00478.2005; Paul MA, 2007, AVIAT SPACE ENVIR MD, V78, P645; Perrin F, 2004, CURR BIOL, V14, P1842, DOI 10.1016/j.cub.2004.09.082; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Sack RL, 2007, SLEEP, V30, P1484, DOI 10.1093/sleep/30.11.1484; Smith MR, 2009, SLEEP MED, V10, P287, DOI 10.1016/j.sleep.2008.05.005; Smith MR, 2009, CHRONOBIOL INT, V26, P709, DOI 10.1080/07420520902927742; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; TORSVALL L, 1980, SCAND J WORK ENV HEA, V6, P283, DOI 10.5271/sjweh.2608; VANDEWALLE G, 2006, J SLEEP RES; VANDEWALLE G, 2007, CEREB CORTEX; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Verwey WB, 1996, J EXP PSYCHOL-APPL, V2, P270, DOI 10.1037/1076-898X.2.3.270; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Warman VL, 2003, NEUROSCI LETT, V342, P37, DOI 10.1016/S0304-3940(03)00223-4; WEBER JM, 1997, SLEEP RES, V26, P757	44	269	285	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16429	10.1371/journal.pone.0016429	http://dx.doi.org/10.1371/journal.pone.0016429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298068	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800040
J	Huang, Y; Morozov, A				Huang, Ying; Morozov, Alexei			Hippocampal Deletion of BDNF Gene Attenuates Gamma Oscillations in Area CA1 by Up-Regulating 5-HT3 Receptor	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; IN-VITRO; GABAERGIC TRANSMISSION; INTERNEURON NETWORKS; PREFRONTAL CORTEX; CA2+ OSCILLATIONS; MESSENGER-RNA; BEHAVING RAT; BRAIN; SEROTONIN	Background: Pyramidal neurons in the hippocampal area CA3 express high levels of BDNF, but how this BDNF contributes to oscillatory properties of hippocampus is unknown. Methodology/Principal Findings: Here we examined carbachol-induced gamma oscillations in hippocampal slices lacking BDNF gene in the area CA3. The power of oscillations was reduced in the hippocampal area CA1, which coincided with increases in the expression and activity of 5-HT3 receptor. Pharmacological block of this receptor partially restored power of gamma oscillations in slices from KO mice, but had no effect in slices from WT mice. Conclusion/Significance: These data suggest that BDNF facilitates gamma oscillations in the hippocampus by attenuating signaling through 5-HT3 receptor. Thus, BDNF modulates hippocampal oscillations through serotonergic system.	[Huang, Ying; Morozov, Alexei] NIMH, Unit Behav Genet, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA; [Huang, Ying] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Fudan University	Huang, Y (corresponding author), NIMH, Unit Behav Genet, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA.	morozova@mail.nih.gov			National Institutes of Health National Institute of Mental Health	National Institutes of Health National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by the National Institutes of Health National Institute of Mental Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin I, 2008, J PHYSIOL-LONDON, V586, P1885, DOI 10.1113/jphysiol.2007.148627; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berghuis P, 2004, EUR J NEUROSCI, V20, P1290, DOI 10.1111/j.1460-9568.2004.03561.x; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bookout A. L., 2006, CURRENT PROTOCOLS MO; BRAGIN A, 1995, J NEUROSCI, V15, P47; Choi IS, 2007, J NEUROCHEM, V103, P2342, DOI 10.1111/j.1471-4159.2007.04945.x; Conner JM, 1997, J NEUROSCI, V17, P2295; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; FARZAN F, BRAIN, V133, P1505; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fujisawa S, 2004, BIOPHYS J, V86, P1820, DOI 10.1016/S0006-3495(04)74249-6; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Holm MM, 2009, J NEUROSCI, V29, P12412, DOI 10.1523/JNEUROSCI.2978-09.2009; Hughes JR, 2008, EPILEPSY BEHAV, V13, P25, DOI 10.1016/j.yebeh.2008.01.011; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; Jin X, 2003, J NEUROSCI, V23, P5662; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; MAMOUNAS LA, 1991, J COMP NEUROL, V314, P558, DOI 10.1002/cne.903140312; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Papke RL, 2004, BIOORG MED CHEM LETT, V14, P1849, DOI 10.1016/j.bmcl.2003.09.104; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Popescu AT, 2009, NAT NEUROSCI, V12, P801, DOI 10.1038/nn.2305; Puig MV, 2010, J NEUROSCI, V30, P2211, DOI 10.1523/JNEUROSCI.3335-09.2010; ROPERT N, 1991, J PHYSIOL-LONDON, V441, P121, DOI 10.1113/jphysiol.1991.sp018742; Sakai N, 1997, BRAIN RES, V778, P318, DOI 10.1016/S0006-8993(97)01052-4; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Turner TJ, 2004, NEUROSCIENCE, V129, P703, DOI 10.1016/j.neuroscience.2004.08.020; van Deursen JA, 2008, J NEURAL TRANSM, V115, P1301, DOI 10.1007/s00702-008-0083-y; van Vugt MK, 2010, J NEUROSCI, V30, P2694, DOI 10.1523/JNEUROSCI.0567-09.2010; Whittington MA, 2000, PHARMACOL THERAPEUT, V86, P171, DOI 10.1016/S0163-7258(00)00038-3; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yamada MK, 2002, J NEUROSCI, V22, P7580; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	50	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16480	10.1371/journal.pone.0016480	http://dx.doi.org/10.1371/journal.pone.0016480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298058	Green Submitted, Green Published, gold			2022-12-27	WOS:000286662800046
J	Liu, YY; Hao, ML; Li, P; Shu, H				Liu, Youyi; Hao, Meiling; Li, Ping; Shu, Hua			Timed Picture Naming Norms for Mandarin Chinese	PLOS ONE			English	Article							NAME AGREEMENT; VISUAL COMPLEXITY; ACQUISITION NORMS; IMAGE AGREEMENT; PSYCHOLINGUISTIC VARIABLES; SUBJECTIVE FREQUENCY; SPEECH PRODUCTION; WORD-FREQUENCY; OBJECTIVE AGE; AOA NORMS	The present study reports timed norms for 435 object pictures in Mandarin Chinese. These data include naming latency, name agreement, concept agreement, word length, and age of acquisition (AoA) based on children's naming and adult ratings, and several other adult ratings of concept familiarity, subjective word frequency, image agreement, image variability, and visual complexity. Furthermore, we examined factors that influence the naming latencies of the pictures. The results show that concept familiarity, AoA, concept agreement, name agreement, and image agreement are significant predictors of naming latencies, whereas subjective word frequency is not a reliable determinant. These results are discussed in light of picture naming data in other languages. An item-based index for the norms is provided in the Table S1.	[Liu, Youyi; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Hao, Meiling] Beijing Language & Culture Univ, Ctr Studies Chinese Language 2, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Liu, YY (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	psykylin@gmail.com		Li, Ping/0000-0002-3314-943X	Natural Science Foundation of China [30900392, 30870758]; Natural Science Foundation of USA [OISE-0968369]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of USA; Fund for Foreign Scholars in University Research and Teaching Programs	This work was supported Natural Science Foundation of China (30900392, 30870758) to YL and HS, from the Partnership for International Research and Education Program (OISE-0968369) of the Natural Science Foundation of USA, and from the Fund for Foreign Scholars in University Research and Teaching Programs (B07008) to both PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Alario FX, 2004, BEHAV RES METH INS C, V36, P140, DOI 10.3758/BF03195559; Almeida J, 2007, PSYCHON B REV, V14, P1177, DOI 10.3758/BF03193109; Alvarez B, 2007, BEHAV RES METHODS, V39, P377, DOI 10.3758/BF03193006; Balota DA, 2001, MEM COGNITION, V29, P639, DOI 10.3758/BF03200465; Barry C, 1997, Q J EXP PSYCHOL-A, V50, P560, DOI 10.1080/783663595; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Bonin P, 2002, BRIT J PSYCHOL, V93, P89, DOI 10.1348/000712602162463; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; CARROLL JB, 1973, J VERB LEARN VERB BE, V12, P563, DOI 10.1016/S0022-5371(73)80036-2; Chalard M, 2003, EUR J COGN PSYCHOL, V15, P209, DOI 10.1080/09541440244000076; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; DeLeon J, 2007, BRAIN, V130, P1408, DOI 10.1093/brain/awm011; Desrochers A, 2009, BEHAV RES METHODS, V41, P546, DOI 10.3758/BRM.41.2.546; Ellis AW, 2000, J EXP PSYCHOL LEARN, V26, P1103, DOI 10.1037//0278-7393.26.5.1103; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; GILHOOLY KJ, 1980, BRIT J PSYCHOL, V71, P105, DOI 10.1111/j.2044-8295.1980.tb02736.x; GILHOOLY KJ, 1977, BEHAV RES METH INSTR, V9, P12, DOI 10.3758/BF03202210; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; HOWELL DC, 2002, STAT METHODS PHYCHOL, pR14; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Johnson CJ, 1996, PSYCHOL BULL, V120, P113, DOI 10.1037/0033-2909.120.1.113; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; LACHMAN R, 1974, J VERB LEARN VERB BE, V13, P613, DOI 10.1016/S0022-5371(74)80049-6; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; Morrison CM, 1997, Q J EXP PSYCHOL-A, V50, P528, DOI 10.1080/027249897392017; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Perez MA, 2005, EUR J COGN PSYCHOL, V17, P179, DOI 10.1080/09541440340000547; Pind J, 2002, SCAND J PSYCHOL, V43, P221, DOI 10.1111/1467-9450.00290; RAVEN JC, 1954, GUIDE USING MILL HIL; Roach A., 1996, CLIN APHASIOLOGY, V24, P121, DOI 10.1037/t56477-000; Severens E, 2005, ACTA PSYCHOL, V119, P159, DOI 10.1016/j.actpsy.2005.01.002; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Weekes BS, 2007, BEHAV RES METHODS, V39, P335, DOI 10.3758/BF03193165; Xing, 1997, 5 WORLD CHIN TEACH S; [张清芳 Zhang Qingfang], 2003, [心理学报, Acta Psychologica Sinica], V35, P447; 舒华, 1989, [心理学报, Acta Psychologica Sinica], V21, P389	38	29	30	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16505	10.1371/journal.pone.0016505	http://dx.doi.org/10.1371/journal.pone.0016505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298065	Green Submitted, Green Published, gold			2022-12-27	WOS:000286662800051
J	Marzoli, D; Palumbo, R; Di Domenico, A; Penolazzi, B; Garganese, P; Tommasi, L				Marzoli, Daniele; Palumbo, Rocco; Di Domenico, Alberto; Penolazzi, Barbara; Garganese, Patrizia; Tommasi, Luca			The Relation between Self-Reported Empathy and Motor Identification with Imagined Agents	PLOS ONE			English	Article							VISUAL PERSPECTIVE-TAKING; GENDER-DIFFERENCES; SEX-DIFFERENCES; EMOTIONAL CONTAGION; FUNCTIONAL-ANATOMY; MIMICRY REACTIONS; EMBODIED EMPATHY; MENTAL ROTATION; SPATIAL ABILITY; MIRROR SYSTEM	Background: In a previous study, we found that when required to imagine another person performing an action, participants reported a higher correspondence between their own handedness and the hand used by the imagined person when the agent was seen from the back compared to when the agent was seen from the front. This result was explained as evidence of a greater involvement of motor areas in the back-view perspective, possibly indicating a greater proneness to put oneself in the agent's shoes in such a condition. In turn, the proneness to put oneself in another's shoes could also be considered as a cue of greater identification with the other, that is a form of empathy. If this is the case, the proportion of lateral matches vs mismatches should be different for subjects with high and low self-reported empathy. In the present study, we aimed at testing this hypothesis. Methodology/Principal Findings: Participants were required to imagine a person performing a single manual action in a back view and to indicate the hand used by the imagined person during movement execution. Consistent with our hypothesis, the proportion of matching between the handedness of participants and the handedness of agents imagined was higher for participants scoring high in a self-report measure of empathy. Importantly, this relationship was specific for females. Conclusions/Significance: At least for females, our data seem to corroborate the idea of a link between self-reported empathy and motor identification with imagined agents. This sex-specific result is consistent with neuroimaging studies indicating a stronger involvement of action representations during emotional and empathic processing in females than in males. In sum, our findings underline the possibility of employing behavioral research as a test-bed for theories deriving from functional studies suggesting a link between empathic processing and the activation of motor-related areas.	[Marzoli, Daniele] Univ Ferrara, Dept Biomed Sci & Adv Therapy, I-44100 Ferrara, Italy; [Marzoli, Daniele; Palumbo, Rocco; Di Domenico, Alberto; Penolazzi, Barbara; Garganese, Patrizia; Tommasi, Luca] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Penolazzi, Barbara] Univ Alma Mater Studiorum, Dept Psychol, Bologna, Italy	University of Ferrara; G d'Annunzio University of Chieti-Pescara; University of Bologna	Marzoli, D (corresponding author), Univ Ferrara, Dept Biomed Sci & Adv Therapy, I-44100 Ferrara, Italy.	d.marzoli@unich.it	Palumbo, Rocco/M-3593-2019; Di Domenico, Alberto/O-2111-2015; Palumbo, Rocco/R-6572-2017; Di Domenico, Alberto/AIB-7965-2022; Tommasi, Luca/F-3638-2012; Palumbo, Rocco/H-7375-2014	Palumbo, Rocco/0000-0002-2385-5840; Di Domenico, Alberto/0000-0002-9962-2891; Palumbo, Rocco/0000-0002-2385-5840; Di Domenico, Alberto/0000-0002-9962-2891; Palumbo, Rocco/0000-0002-2385-5840; Tommasi, Luca/0000-0003-0664-714X; PENOLAZZI, Barbara/0000-0001-8717-6233	Commission of the European Communities [28806]	Commission of the European Communities(European Commission)	This research is part of the project EDCBNL (Evolution and Development of Cognitive, Behavioural and Neural Lateralization, 2006-2009) supported by the Commission of the European Communities within the framework of the specific research and technological development program 'Integrating and strengthening the European Research Area' initiative 'What it means to be human' through a financial grant to Luca Tommasi, grant number 28806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero P., 2006, TPM, V13, P107; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Avenanti A, 2009, NEUROIMAGE, V44, P275, DOI 10.1016/j.neuroimage.2008.08.001; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Blanke O, 2010, BRAIN TOPOGR, V23, P321, DOI 10.1007/s10548-010-0138-x; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2007, NEUROREPORT, V18, P887, DOI 10.1097/WNR.0b013e3280ebb486; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; Costantini M, 2008, EUR J NEUROSCI, V28, P1222, DOI 10.1111/j.1460-9568.2008.06406.x; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; Davis M., 1996, EMPATHY SOCIAL PSYCH; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Fukushima H, 2006, SOC COGN AFFECT NEUR, V1, P149, DOI 10.1093/scan/nsl020; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Gardner MR, 2010, BRAIN COGNITION, V73, P35, DOI 10.1016/j.bandc.2010.02.002; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Han SH, 2008, BRAIN RES, V1196, P85, DOI 10.1016/j.brainres.2007.12.062; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; Hooker CI, 2008, SOC COGN AFFECT NEUR, V3, P204, DOI 10.1093/scan/nsn019; Hooker CI, 2010, BRAIN RES, V1308, P100, DOI 10.1016/j.brainres.2009.10.006; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Kaiser S, 2008, NEUROPSYCHOLOGIA, V46, P2524, DOI 10.1016/j.neuropsychologia.2008.04.013; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Leiberg S, 2006, PROG BRAIN RES, V156, P419, DOI 10.1016/S0079-6123(06)56023-6; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lewis JW, 2006, J COGNITIVE NEUROSCI, V18, P1314, DOI 10.1162/jocn.2006.18.8.1314; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; Marzoli D, 2011, BRAIN COGNITION, V75, P51, DOI 10.1016/j.bandc.2010.10.002; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Meneghini AM, 2006, RICERCHE PSICOLOGIA, V29, P123; Minio-Paluello I, 2006, SOC NEUROSCI, V1, P320, DOI 10.1080/17470910601035954; Minio-Paluello I, 2009, BIOL PSYCHIAT, V65, P55, DOI 10.1016/j.biopsych.2008.08.006; Mohr C, 2010, BRIT J PSYCHOL, V101, P277, DOI 10.1348/000712609X457450; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Pelgrims B, 2009, CEREB CORTEX, V19, P2298, DOI 10.1093/cercor/bhn248; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schaefer M, 2009, HUM BRAIN MAPP, V30, P2722, DOI 10.1002/hbm.20701; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Seurinck R, 2004, NEUROIMAGE, V23, P1440, DOI 10.1016/j.neuroimage.2004.08.010; Shimada S, 2010, NEUROPSYCHOLOGIA, V48, P1930, DOI 10.1016/j.neuropsychologia.2010.03.012; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Thakkar KN, 2010, COGN NEUROPSYCHIATRY, V15, P477, DOI 10.1080/13546801003711350; Thakkar KN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005864; Wild B, 2003, PSYCHIAT RES-NEUROIM, V123, P17, DOI 10.1016/S0925-4927(03)00006-4; Willems RM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.039.2009; Yang CY, 2009, BRAIN RES, V1251, P176, DOI 10.1016/j.brainres.2008.11.062	84	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14595	10.1371/journal.pone.0014595	http://dx.doi.org/10.1371/journal.pone.0014595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298089	Green Submitted, gold, Green Published			2022-12-27	WOS:000286662800007
J	El-Maarri, O; Walier, M; Behne, F; van Uum, J; Singer, H; Diaz-Lacava, A; Nusgen, N; Niemann, B; Watzka, M; Reinsberg, J; van der Ven, H; Wienker, T; Stoffel-Wagner, B; Schwaab, R; Oldenburg, J				El-Maarri, Osman; Walier, Maja; Behne, Frank; van Ueuem, Jan; Singer, Heike; Diaz-Lacava, Amalia; Nuesgen, Nicole; Niemann, Barbara; Watzka, Matthias; Reinsberg, Jochen; van der Ven, Hans; Wienker, Thomas; Stoffel-Wagner, Birgit; Schwaab, Rainer; Oldenburg, Johannes			Methylation at Global LINE-1 Repeats in Human Blood Are Affected by Gender but Not by Age or Natural Hormone Cycles	PLOS ONE			English	Article							CPG ISLAND LOCI; IP-RP-HPLC; DNA-METHYLATION; STABLY EXPRESSES; HUMAN-CELLS; LIFE-SPAN; HYPOMETHYLATION; SITES; HYPERMETHYLATION; CARCINOGENESIS	Previously, we reported on inter-individual and gender specific variations of LINE-1 methylation in healthy individuals. In this study, we investigated whether this variability could be influenced by age or sex hormones in humans. To this end, we studied LINE-1 methylation in vivo in blood-derived DNA from individuals aged 18 to 64 years and from young healthy females at various hormone levels during the menstrual cycle. Our results show that no significant association with age was observed. However, the previously reported increase of LINE-1 methylation in males was reconfirmed. In females, although no correlation between LINE-1 or Alu methylation and hormone levels was observed, a significant stable individual specific level of methylation was noted. In vitro results largely confirmed these findings, as neither estrogen nor dihydrotestosterone affected LINE-1 or Alu methylation in Hek293T, HUVEC, or MDA-kb2 cell lines. In contrast, a decrease in methylation was observed in estrogen-treated T47-Kbluc cell lines strongly expressing estrogen receptor. The very low expression of estrogen receptor in blood cells could explain the observed insensitivity of methylation at LINE-1 to natural hormonal variations in females. In conclusion, neither natural cycle of hormones nor age has a detectable effect on the LINE-1 methylation in peripheral blood cells, while gender remains an important factor.	[El-Maarri, Osman; Behne, Frank; van Ueuem, Jan; Singer, Heike; Nuesgen, Nicole; Niemann, Barbara; Watzka, Matthias; Schwaab, Rainer; Oldenburg, Johannes] Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany; [Walier, Maja; Diaz-Lacava, Amalia; Wienker, Thomas] Univ Bonn, IMBIE, D-5300 Bonn, Germany; [Reinsberg, Jochen; van der Ven, Hans] Univ Bonn, Dept Gynecol Endocrinol & Reprod Med, D-5300 Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-5300 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn	El-Maarri, O (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany.	osman.elmaarri@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020	El-Maarri, Osman/0000-0002-6859-5819; Oldenburg, Johannes/0000-0002-1585-4100	Institute of Experimental Hematology and Transfusion Medicine, University Clinic of Bonn; German Research Council [DFG EL 499/2-1]	Institute of Experimental Hematology and Transfusion Medicine, University Clinic of Bonn; German Research Council(German Research Foundation (DFG))	The study was supported by institutional fund of the Institute of Experimental Hematology and Transfusion Medicine, University Clinic of Bonn. Additionally the work in the lab of OEM is supported by a German Research Council grant (DFG EL 499/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniagu SO, 2009, TOXICOLOGY, V256, P143, DOI 10.1016/j.tox.2008.10.017; Asquith B, 2009, TRENDS IMMUNOL, V30, P182, DOI 10.1016/j.it.2009.01.003; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; El-Maarri O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e25; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri Osman, 2004, Methods Mol Biol, V287, P195; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Iacopetta B, 2007, CANCER SCI, V98, P1454, DOI 10.1111/j.1349-7006.2007.00548.x; JINTARIDTH P, 2010, PHYSL GENOMICS; Kaneda A, 2004, CANCER SCI, V95, P58, DOI 10.1111/j.1349-7006.2004.tb03171.x; Knudsen PS, 2007, CYTOGENET GENOME RES, V116, P24, DOI 10.1159/000097414; Kovalchuk O, 2007, CELL CYCLE, V6, P2010, DOI 10.4161/cc.6.16.4549; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Pavanello S, 2009, INT J CANCER, V125, P1692, DOI 10.1002/ijc.24492; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; STEINBACH KH, 1979, BLUT, V39, P27, DOI 10.1007/BF01008072; Swerdloff RS, 1998, BAILLIERE CLIN ENDOC, V12, P501, DOI 10.1016/S0950-351X(98)80267-X; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takai D, 2000, JPN J CLIN ONCOL, V30, P306, DOI 10.1093/jjco/hyd079; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; THAYER RE, 1993, GENE, V133, P273, DOI 10.1016/0378-1119(93)90651-I; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; WHITELAW DM, 1966, BLOOD-J HEMATOL, V28, P455, DOI 10.1182/blood.V28.3.455.455; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107	53	67	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16252	10.1371/journal.pone.0016252	http://dx.doi.org/10.1371/journal.pone.0016252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21311577	Green Submitted, Green Published, gold			2022-12-27	WOS:000286520600035
J	Paradise, RK; Lauffenburger, DA; Van Vliet, KJ				Paradise, Ranjani K.; Lauffenburger, Douglas A.; Van Vliet, Krystyn J.			Acidic Extracellular pH Promotes Activation of Integrin alpha(v)beta(3)	PLOS ONE			English	Article							CELL-MIGRATION SPEED; HUMAN-MELANOMA CELLS; CONFORMATIONAL FLEXIBILITY; LIGAND RECOGNITION; INTRACELLULAR PH; INTERSTITIAL PH; BINDING-SITES; OUTSIDE-IN; III DOMAIN; ADHESION	Acidic extracellular pH is characteristic of the cell microenvironment in several important physiological and pathological contexts. Although it is well established that acidic extracellular pH can have profound effects on processes such as cell adhesion and migration, the underlying molecular mechanisms are largely unknown. Integrin receptors physically connect cells to the extracellular matrix, and are thus likely to modulate cell responses to extracellular conditions. Here, we examine the role of acidic extracellular pH in regulating activation of integrin alpha(v)beta(3). Through computational molecular dynamics simulations, we find that acidic extracellular pH promotes opening of the alpha(v)beta(3) headpiece, indicating that acidic pH can thereby facilitate integrin activation. This prediction is consistent with our flow cytometry and atomic force microscope-mediated force spectroscopy assays of integrin alpha(v)beta(3) on live cells, which both demonstrate that acidic pH promotes activation at the intact cell surface. Finally, quantification of cell morphology and migration measurements shows that acidic extracellular pH affects cell behavior in a manner that is consistent with increased integrin activation. Taken together, these computational and experimental results suggest a new and complementary mechanism of integrin activation regulation, with associated implications for cell adhesion and migration in regions of altered pH that are relevant to wound healing and cancer.	[Paradise, Ranjani K.; Lauffenburger, Douglas A.; Van Vliet, Krystyn J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Paradise, RK (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	krystyn@mit.edu			National Institute of Biomedical Imaging and Bioengineering [T32EB006348]; MIT; NIH [U54-GM069668]; NSF; Singapore-MIT Alliance for Research & Technology (SMART) Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); MIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Singapore-MIT Alliance for Research & Technology (SMART) Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Award Number T32EB006348 from the National Institute of Biomedical Imaging and Bioengineering and the MIT Collamore-Rogers Fellowship (RKP), the NIH Cell Migration Consortium Grant U54-GM069668 (DAL and RKP), the NSF CAREER Award (KJVV and RKP), and the Singapore-MIT Alliance for Research & Technology (SMART) Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group (KJVV and RKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; DICKINSON RB, 1993, AICHE J; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Faff L, 2000, BRAIN RES, V853, P22, DOI 10.1016/S0006-8993(99)02221-0; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KATO Y, 1992, J BIOL CHEM, V267, P11424; Koide A, 2001, BIOCHEMISTRY-US, V40, P10326, DOI 10.1021/bi010916y; Krishnan R, 2009, J MOL MODEL, V15, P1383, DOI 10.1007/s00894-009-0504-3; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Mallik B, 2008, BIOTECHNOL PROGR, V24, P48, DOI 10.1021/bp0700915; MARTIN GR, 1994, CANCER RES, V54, P5670; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Palecek SP, 1998, J CELL SCI, V111, P929; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tan J, 2005, BIOMATERIALS, V26, P3663, DOI 10.1016/j.biomaterials.2004.09.053; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhang XH, 2004, BIOPHYS J, V87, P3470, DOI 10.1529/biophysj.104.045690	58	93	95	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15746	10.1371/journal.pone.0015746	http://dx.doi.org/10.1371/journal.pone.0015746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283814	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600010
J	Hirsch, J; Misson, J; Crisp, PA; David, P; Bayle, V; Estavillo, GM; Javot, H; Chiarenza, S; Mallory, AC; Maizel, A; Declerck, M; Pogson, BJ; Vaucheret, H; Crespi, M; Desnos, T; Thibaud, MC; Nussaume, L; Marin, E				Hirsch, Judith; Misson, Julie; Crisp, Peter A.; David, Pascale; Bayle, Vincent; Estavillo, Gonzalo M.; Javot, Helene; Chiarenza, Serge; Mallory, Allison C.; Maizel, Alexis; Declerck, Marie; Pogson, Barry J.; Vaucheret, Herve; Crespi, Martin; Desnos, Thierry; Thibaud, Marie-Christine; Nussaume, Laurent; Marin, Elena			A Novel fry1 Allele Reveals the Existence of a Mutant Phenotype Unrelated to 5 '-> 3 ' Exoribonuclease (XRN) Activities in Arabidopsis thaliana Roots	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; 3(2),5-BISPHOSPHATE NUCLEOTIDASE; PHOSPHATE STARVATION; NEGATIVE REGULATOR; GENE; EXPRESSION; TOLERANCE; MERISTEM; FIERY1; DIFFERENTIATION	Background: Mutations in the FRY1/SAL1 Arabidopsis locus are highly pleiotropic, affecting drought tolerance, leaf shape and root growth. FRY1 encodes a nucleotide phosphatase that in vitro has inositol polyphosphate 1-phosphatase and 3',(2'),5'-bisphosphate nucleotide phosphatase activities. It is not clear which activity mediates each of the diverse biological functions of FRY1 in planta. Principal Findings: A fry1 mutant was identified in a genetic screen for Arabidopsis mutants deregulated in the expression of Pi High affinity Transporter 1;4 (PHT1;4). Histological analysis revealed that, in roots, FRY1 expression was restricted to the stele and meristems. The fry1 mutant displayed an altered root architecture phenotype and an increased drought tolerance. All of the phenotypes analyzed were complemented with the AHL gene encoding a protein that converts 3'-polyadenosine 5'-phosphate (PAP) into AMP and Pi. PAP is known to inhibit exoribonucleases (XRN) in vitro. Accordingly, an xrn triple mutant with mutations in all three XRNs shared the fry1 drought tolerance and root architecture phenotypes. Interestingly these two traits were also complemented by grafting, revealing that drought tolerance was primarily conferred by the rosette and that the root architecture can be complemented by long-distance regulation derived from leaves. By contrast, PHT1 expression was not altered in xrn mutants or in grafting experiments. Thus, PHT1 up-regulation probably resulted from a local depletion of Pi in the fry1 stele. This hypothesis is supported by the identification of other genes modulated by Pi deficiency in the stele, which are found induced in a fry1 background. Conclusions/Significance: Our results indicate that the 3',(2'),5'-bisphosphate nucleotide phosphatase activity of FRY1 is involved in long-distance as well as local regulatory activities in roots. The local up-regulation of PHT1 genes transcription in roots likely results from local depletion of Pi and is independent of the XRNs.	[Hirsch, Judith; Misson, Julie; David, Pascale; Bayle, Vincent; Javot, Helene; Chiarenza, Serge; Desnos, Thierry; Thibaud, Marie-Christine; Nussaume, Laurent; Marin, Elena] CNRS, CEA, DSV IBEB, Lab Biol Dev Plantes,UMR 6191, St Paul Les Durance, France; [Crisp, Peter A.; Estavillo, Gonzalo M.; Pogson, Barry J.] Australian Natl Univ, ARC Ctr Excellence Plant Energy Biol, Res Sch Biol, Canberra, ACT, Australia; [Mallory, Allison C.; Vaucheret, Herve] INRA, Inst Jean Pierre Bourgin, UMR 1318, F-78026 Versailles, France; [Maizel, Alexis] Univ Heidelberg, Dept Stem Cell Biol, Heidelberg, Germany; [Declerck, Marie; Crespi, Martin] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); Australian National University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Hirsch, J (corresponding author), UMR BGPI, Campus Int Baillarguet,TA A54-K, Montpellier, France.	elena.marin@cea.fr	Javot, Helene/AAX-8986-2021; NUSSAUME, Laurent/AAA-5980-2022; Estavillo, Gonzalo/I-1774-2013; NUSSAUME, Laurent/AAB-8312-2020; Maizel, Alexis/D-3560-2012; Crespi, Martin/AAB-1424-2020; Crisp, Peter/AAE-7643-2021; Pogson, Barry/C-9953-2009	Javot, Helene/0000-0002-4577-2747; NUSSAUME, Laurent/0000-0002-9445-2563; Estavillo, Gonzalo/0000-0003-4634-5103; Maizel, Alexis/0000-0001-6843-1059; Crespi, Martin/0000-0002-5698-9482; Crisp, Peter/0000-0002-3655-0130; Pogson, Barry/0000-0003-1869-2423; DESNOS, Thierry/0000-0002-6585-1362; VAUCHERET, HERVE/0000-0002-9986-0988	ANR-GENOPLANT [RIBOROOT-ANR06 GPLA 011]; CEA agency; RNG (Reseau National des Genopoles, Evry, France)	ANR-GENOPLANT(French National Research Agency (ANR)); CEA agency; RNG (Reseau National des Genopoles, Evry, France)	This work was supported by an ANR-GENOPLANT grant (RIBOROOT-ANR06 GPLA 011) and the CEA agency. Array hybridizations have been partly supported by RNG (Reseau National des Genopoles, Evry, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Cazale AC, 2009, J EXP BOT, V60, P2653, DOI 10.1093/jxb/erp109; Chen H, 2010, PLANT CELL ENV; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kim BH, 2009, PLANT J, V58, P208, DOI 10.1111/j.1365-313X.2008.03770.x; Klimyuk VI, 1995, MOL GEN GENET, V249, P357, DOI 10.1007/BF00287097; Logemann E, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-16; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marin E, 2006, PLANT SCI, V171, P84, DOI 10.1016/j.plantsci.2006.02.014; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; PELSY F, 1991, PLANT SCI, V76, P109, DOI 10.1016/0168-9452(91)90224-V; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Sarrobert C, 2000, PLANT J, V24, P357, DOI 10.1046/j.1365-313x.2000.00884.x; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Van Norman JM, 2004, CURR BIOL, V14, P1739, DOI 10.1016/j.cub.2004.09.045; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Woo NS, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-27; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901	32	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16724	10.1371/journal.pone.0016724	http://dx.doi.org/10.1371/journal.pone.0016724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304819	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600017
J	Zhang, CY; Wu, NN; Liu, J; Ge, QJ; Huang, Y; Ren, QA; Feng, QC; He, GL				Zhang, Chiyu; Wu, Nana; Liu, Jun; Ge, Qinjuan; Huang, Yan; Ren, Qian; Feng, Qingchuan; He, Guangli			HCV Subtype Characterization among Injection Drug Users: Implication for a Crucial Role of Zhenjiang in HCV Transmission in China	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; GENOTYPE DISTRIBUTION; GENETIC DIVERSITY; HIGH PREVALENCE; HEROIN USERS; HIV-1; EPIDEMIOLOGY; INFECTION; COINFECTION; SPREAD	Background: HCV transmission is closely associated with drug-trafficking routes in China. However, the transmission route of HCV in Eastern China remains unclear. Here, we investigate the role of Zhenjiang city of Jiangsu province, an important transportation hub linking Shanghai with other regions of China, in HCV transmission. Methodology/Principal Findings: A total of 141 whole blood samples were collected from injection drug users (IDUs) in Zhenjiang and then tested for HCV infection. Of them, 115 HCV positive plasmas were subjected to RNA extraction, RT-PCR amplification, and sequencing. The subtype characterization and the evolutionary origin of HCV strains circulating in Zhenjiang were determined using polygenetic or phylogeographic analyses. Seven HCV subtypes 1b, 2a, 3a, 3b, 6a, 6e and 6n were detected among Zhenjiang IDUs, showing a complex HCV epidemic. The most predominant subtypes were 3a (38%) and 1b (26.8%). Among these subtypes, subtypes 3b, 6n and 6e originated from Southwestern China (i.e., Yunnan and/or Guangxi), subtypes 2a and 6a from Southern China (i.e., Guangdong), subtype 1b from Central (i.e., Henan) and Northwestern (i.e., Xinjiang) China, and subtype 3a from Southwestern (i.e., Yunnan) and Northwestern (i.e., Xinjiang) China. From Zhenjiang, subtypes 1b and 2a were further spread to Eastern (i.e., Shanghai) and Northern (i.e., Beijing) China, respectively. Conclusions/Significance: The mixing of seven HCV subtypes in Zhenjiang from all quarters of China indicates that as an important middle station, Zhenjiang plays a crucial role in HCV transmission, just as it is important in population migration between other regions of China and Eastern China.	[Zhang, Chiyu; Wu, Nana; Liu, Jun; Huang, Yan; Ren, Qian; Feng, Qingchuan] Jiangsu Univ, Inst Life Sci, Jiangsu, Peoples R China; [Ge, Qinjuan; He, Guangli] Zhenjiang Ctr Dis Control & Prevent, Jiangsu, Peoples R China; [Feng, Qingchuan] Zhengzhou Univ, Coll Basic Med, Dept Cell Biol & Med Genet, Zhengzhou, Herts, Peoples R China	Jiangsu University; Zhengzhou University	Zhang, CY (corresponding author), Jiangsu Univ, Inst Life Sci, Jiangsu, Peoples R China.	zhangcy1999@hotmail.com			Jiangsu University; Jiangsu Health International Exchange Program	Jiangsu University; Jiangsu Health International Exchange Program	This study was supported by the "Top-notch personnel'' Project of Jiangsu University (to C. Zhang) and Jiangsu Health International Exchange Program (to G. He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; BAO YP, 2010, CURR OPIN PSYCHIAT; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Forns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Peng JS, 2008, VIRUS RES, V135, P191, DOI 10.1016/j.virusres.2008.01.017; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243; STUYVER L, 1994, P NATL ACAD SCI USA, V91, P10134, DOI 10.1073/pnas.91.21.10134; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Sy Theodore, 2006, Int J Med Sci, V3, P41; Takebe Y, 2010, VACCINE, V28, pB39, DOI 10.1016/j.vaccine.2009.07.101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Yu XF, 2001, AIDS, V15, P523, DOI 10.1097/00002030-200103090-00012; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang MH, 2010, OCCUP HLTH, V26, P2335; Zhou DXM, 2006, J MED VIROL, V78, P574, DOI 10.1002/jmv.20578	33	33	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16817	10.1371/journal.pone.0016817	http://dx.doi.org/10.1371/journal.pone.0016817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304823	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600029
J	Sun, JL; Zhao, LN; Teng, LJ; Lin, F; Zhang, HN; Li, ZN; Gao, QA				Sun, Jialin; Zhao, Lina; Teng, Lijie; Lin, Feng; Zhang, Hongna; Li, Zhengnan; Gao, Qiang			Solid Tumor-Targeted Infiltrating Cytotoxic T Lymphocytes Retained by a Superantigen Fusion Protein	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STAPHYLOCOCCAL ENTEROTOXIN-A; SINGLE-CHAIN ANTIBODY; IFN-GAMMA; BISPECIFIC ANTIBODIES; APOPTOSIS; CELLS; EXPRESSION; THERAPY; MICE	Successful immune-mediated regression of solid tumors is difficult because of the small number of cytotoxic T lymphocytes (CTLs) that were traffic to the tumor site. Here, the targeting of tumor-specific infiltrating CTLs was dependent on a fusion protein consisting of human epidermal growth factor (EGF) and staphylococcal enterotoxin A (SEA) with the D227A mutation. EGF-SEA strongly restrained the growth of murine solid sarcoma 180 (S180) tumors (control versus EGF-SEA, mean tumor weight: 1.013 versus 0.197 g, difference = 0.816 g). In mice treated with EGF-SEA, CD4(+), CD8(+) and SEA-reactive T lymphocytes were enriched around the EGFR expressing tumor cells. The EGF receptors were potentially phosphorylated by EGF-SEA stimulation and the fusion protein promoted T cells to release the tumoricidal cytokines interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha). Intratumoral CTLs secreted cytolytic pore-forming perforins and granzyme B proteins near the surface of carcinomas, causing the death of many tumor cells. We additionally show that labeled EGF-SEA was directly targeted to the tumor tissue after intravenous (i.v.) injection. The findings demonstrate that antibody-like EGF-SEA plays an important role in arresting CTLs in the solid tumor site and has therapeutic potential as a tumor-targeting agent.	[Sun, Jialin; Zhao, Lina; Teng, Lijie; Lin, Feng; Zhang, Hongna; Li, Zhengnan; Gao, Qiang] Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Microbiol, Tianjin, Peoples R China	Tianjin University Science & Technology	Sun, JL (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Microbiol, Tianjin, Peoples R China.	jialinsun@tust.edu.cn	Sun, Jialin/GYV-0601-2022		Tianjin Science Program [06YFJZJC02600, 08JCZDJC15100]; National Natural Science Foundation of China [30770444, 31071126]	Tianjin Science Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported two grants (06YFJZJC02600 and 08JCZDJC15100) from the Tianjin Science Program (http://www.tstc.gov.cn/) and National Natural Science Foundation of China (No. 30770444, 31071126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano R, 2002, FEBS LETT, V528, P70, DOI 10.1016/S0014-5793(02)03254-4; Brandl C, 2007, CANCER IMMUNOL IMMUN, V56, P1551, DOI 10.1007/s00262-007-0298-z; Chavez-Galan L, 2009, CELL MOL IMMUNOL, V6, P15, DOI 10.1038/cmi.2009.3; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Dasgupta S, 2006, MOL THER, V13, P183, DOI 10.1016/j.ymthe.2005.06.481; DOHLSTEN M, 1995, P NATL ACAD SCI USA, V92, P9791, DOI 10.1073/pnas.92.21.9791; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; Hansson J, 1997, P NATL ACAD SCI USA, V94, P2489, DOI 10.1073/pnas.94.6.2489; HUANG IY, 1987, J BIOL CHEM, V262, P7006; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Liu Q, 2003, EUR SURG RES, V35, P457, DOI 10.1159/000073383; Liu TF, 2005, CLIN CANCER RES, V11, P329; Loffler A, 2000, BLOOD, V95, P2098, DOI 10.1182/blood.V95.6.2098; Manzke O, 2001, INT J CANCER, V91, P516, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1069>3.0.CO;2-A; Melder RJ, 2002, NEOPLASIA, V4, P3, DOI 10.1038/sj.neo.7900209; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; PFEIFFER A, 1990, GASTROENTEROLOGY, V98, P961, DOI 10.1016/0016-5085(90)90020-2; POCKAJ BA, 1994, CANCER, V73, P1731, DOI 10.1002/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H; Psarras K, 1998, PROTEIN ENG, V11, P1285, DOI 10.1093/protein/11.12.1285; Riccioli A, 2000, J IMMUNOL, V165, P743, DOI 10.4049/jimmunol.165.2.743; Riesenberg R, 2001, J HISTOCHEM CYTOCHEM, V49, P911, DOI 10.1177/002215540104900711; Rosendahl A, 1998, J IMMUNOL, V160, P5309; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; SHAW JP, 1991, J BIOL CHEM, V266, P21118; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; Tordsson J, 2000, INT J CANCER, V87, P559, DOI 10.1002/1097-0215(20000815)87:4<559::AID-IJC16>3.0.CO;2-#; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; WHITESIDE TL, 1992, INVAS METAST, V12, P128; Xu XL, 1998, CANCER RES, V58, P2832; YOUNG JD, 1986, CELL, V46, P641, DOI 10.1016/0092-8674(86)90336-3	36	8	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16642	10.1371/journal.pone.0016642	http://dx.doi.org/10.1371/journal.pone.0016642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311755	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200026
J	Ellrichmann, G; Petrasch-Parwez, E; Lee, DH; Reick, C; Arning, L; Saft, C; Gold, R; Linker, RA				Ellrichmann, Gisa; Petrasch-Parwez, Elisabeth; Lee, De-Hyung; Reick, Christiane; Arning, Larissa; Saft, Carsten; Gold, Ralf; Linker, Ralf A.			Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; INTRACELLULAR CALCIUM; MUTANT HUNTINGTIN; DIMETHYL-FUMARATE; OXIDATIVE DAMAGE; MOTOR DEFICITS; IN-VIVO; MICE; EXPRESSION; NEURODEGENERATION	Huntington's disease (HD) is an autosomal dominantly inherited progressive neurodegenerative disease. The exact sequel of events finally resulting in neurodegeneration is only partially understood and there is no established protective treatment so far. Some lines of evidence speak for the contribution of oxidative stress to neuronal tissue damage. The fumaric acid ester dimethylfumarate (DMF) is a new disease modifying therapy currently in phase III studies for relapsing-remitting multiple sclerosis. DMF potentially exerts neuroprotective effects via induction of the transcription factor "nuclear factor E2-related factor 2'' (Nrf2) and detoxification pathways. Thus, we investigated here the therapeutic efficacy of DMF in R6/2 and YAC128 HD transgenic mice which mimic many aspects of HD and are characterized by an enhanced generation of free radicals in neurons. Treatment with DMF significantly prevented weight loss in R6/2 mice between postnatal days 80-90. At the same time, DMF treatment led to an attenuated motor impairment as measured by the clasping score. Average survival in the DMF group was 100.5 days vs. 94.0 days in the placebo group. In the histological analysis on day 80, DMF treatment resulted in a significant preservation of morphologically intact neurons in the striatum as well as in the motor cortex. DMF treatment resulted in an increased Nrf2 immunoreactivity in neuronal subpopulations, but not in astrocytes. These beneficial effects were corroborated in YAC128 mice which, after one year of DMF treatment, also displayed reduced dyskinesia as well as a preservation of neurons. In conclusion, DMF may exert beneficial effects in mouse models of HD. Given its excellent side effect profile, further studies with DMF as new therapeutic approach in HD and other neurodegenerative diseases are warranted.	[Ellrichmann, Gisa; Lee, De-Hyung; Reick, Christiane; Saft, Carsten; Gold, Ralf; Linker, Ralf A.] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany; [Petrasch-Parwez, Elisabeth] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-4630 Bochum, Germany; [Arning, Larissa] Ruhr Univ Bochum, Dept Human Genet, D-4630 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Ellrichmann, G (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany.	ralf.linker@uk-erlangen.de	Linker, Ralf/AAD-8884-2020	Saft, Carsten/0000-0002-3983-7292				Ang ET, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00025; Begleiter A, 2003, CANCER EPIDEM BIOMAR, V12, P566; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Clarke KA, 1999, PHYSIOL BEHAV, V66, P723, DOI 10.1016/S0031-9384(98)00343-6; Clifford JJ, 2002, NEUROSCIENCE, V109, P81, DOI 10.1016/S0306-4522(01)00409-2; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; deJong P, 1996, EUR J IMMUNOL, V26, P2067, DOI 10.1002/eji.1830260916; Duffy S, 1998, J NEUROCHEM, V71, P69; Fernandez-Checa JC, 2010, CNS NEUROL DISORD-DR, V9, P439, DOI 10.2174/187152710791556113; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gil JM, 2009, BRAIN RES REV, V59, P410, DOI 10.1016/j.brainresrev.2008.12.001; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Iannicola C, 2000, J NEUROCHEM, V75, P830, DOI 10.1046/j.1471-4159.2000.0750830.x; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kumar P, 2010, PHARMACOL REP, V62, P1; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; LINKER RA, BRAIN IN PRESS; Linker Ralf A, 2008, Expert Rev Neurother, V8, P1683, DOI 10.1586/14737175.8.11.1683; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009793; Moharregh-Khiabani D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011769; Mrowietz U, 1999, BRIT J DERMATOL, V141, P424; Ockenfels HM, 1998, BRIT J DERMATOL, V139, P390; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Petrasch-Parwez E, 2007, J COMP NEUROL, V501, P716, DOI 10.1002/cne.21272; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; SCHWECKENDIEK W, 1959, Med Monatsschr, V13, P103; Sebok B, 1998, EUR J DERMATOL, V8, P29; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Su JYC, 1999, NEUROSCI LETT, V273, P109, DOI 10.1016/S0304-3940(99)00634-5; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Thiessen A, 2010, NEUROSCI LETT, V475, P56, DOI 10.1016/j.neulet.2010.03.048; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vandermeeren M, 1997, BIOCHEM BIOPH RES CO, V234, P19, DOI 10.1006/bbrc.1997.6570; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; Yu ZX, 2003, J NEUROSCI, V23, P2193	69	111	133	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16172	10.1371/journal.pone.0016172	http://dx.doi.org/10.1371/journal.pone.0016172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297955	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300039
J	Miller, CA; Hampton, O; Coarfa, C; Milosavljevic, A				Miller, Christopher A.; Hampton, Oliver; Coarfa, Cristian; Milosavljevic, Aleksandar			ReadDepth: A Parallel R Package for Detecting Copy Number Alterations from Short Sequencing Reads	PLOS ONE			English	Article							GENOMIC DISORDERS; MICROARRAYS; CANCER	Copy number alterations are important contributors to many genetic diseases, including cancer. We present the readDepth package for R, which can detect these aberrations by measuring the depth of coverage obtained by massively parallel sequencing of the genome. In addition to achieving higher accuracy than existing packages, our tool runs much faster by utilizing multi-core architectures to parallelize the processing of these large data sets. In contrast to other published methods, readDepth does not require the sequencing of a reference sample, and uses a robust statistical model that accounts for overdispersed data. It includes a method for effectively increasing the resolution obtained from low-coverage experiments by utilizing breakpoint information from paired end sequencing to do positional refinement. We also demonstrate a method for inferring copy number using reads generated by whole-genome bisulfite sequencing, thus enabling integrative study of epigenomic and copy number alterations. Finally, we apply this tool to two genomes, showing that it performs well on genomes sequenced to both low and high coverage. The readDepth package runs on Linux and MacOSX, is released under the Apache 2.0 license, and is available at http://code.google.com/p/readdepth/.	[Miller, Christopher A.; Hampton, Oliver; Milosavljevic, Aleksandar] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Miller, Christopher A.; Hampton, Oliver; Coarfa, Cristian; Milosavljevic, Aleksandar] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Miller, CA (corresponding author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.	amilosav@bcm.edu	Miller, Christopher A./A-1060-2009	Miller, Christopher A./0000-0003-4266-6700	NIH, National Human Genome Research Institute [R01-HG004009, R21-HG004554]; National Cancer Institute [R33-CA114151]; NIH Epigenomics Roadmap Initiative, National Institute on Drug Addiction [U01 DA025956]; NATIONAL CANCER INSTITUTE [R33CA114151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004009, R21HG004554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA025956] Funding Source: NIH RePORTER	NIH, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Epigenomics Roadmap Initiative, National Institute on Drug Addiction; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research has been funded by the NIH grants R01-HG004009 and R21-HG004554 from the National Human Genome Research Institute, R33-CA114151 from the National Cancer Institute, and the NIH Epigenomics Roadmap Initiative grant U01 DA025956 from the National Institute on Drug Addiction to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; [Anonymous], 2010, R LANG ENV STAT COMP; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Castle JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-244; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Coarfa C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-572; Cohen P., 2002, APPL MULTIPLE REGRES; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	25	146	166	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16327	10.1371/journal.pone.0016327	http://dx.doi.org/10.1371/journal.pone.0016327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305028	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300050
J	Overman, AR; Scholtz, RV				Overman, Allen R.; Scholtz, Richard V., III			Model of Yield Response of Corn to Plant Population and Absorption of Solar Energy	PLOS ONE			English	Article							GRAIN-YIELD; DENSITY	Biomass yield of agronomic crops is influenced by a number of factors, including crop species, soil type, applied nutrients, water availability, and plant population. This article is focused on dependence of biomass yield (Mg ha(-1) and g plant(-1)) on plant population (plants m(-2)). Analysis includes data from the literature for three independent studies with the warm-season annual corn (Zea mays L.) grown in the United States. Data are analyzed with a simple exponential mathematical model which contains two parameters, viz. Y(m) (Mg ha(-1)) for maximum yield at high plant population and c (m(2) plant(-1)) for the population response coefficient. This analysis leads to a new parameter called characteristic plant population, x(c) = 1/c (plants m(-2)). The model is shown to describe the data rather well for the three field studies. In one study measurements were made of solar radiation at different positions in the plant canopy. The coefficient of absorption of solar energy was assumed to be the same as c and provided a physical basis for the exponential model. The three studies showed no definitive peak in yield with plant population, but generally exhibited asymptotic approach to maximum yield with increased plant population. Values of xc were very similar for the three field studies with the same crop species.	[Overman, Allen R.; Scholtz, Richard V., III] Univ Florida, Agr & Biol Engn Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Overman, AR (corresponding author), Univ Florida, Agr & Biol Engn Dept, Gainesville, FL 32611 USA.	rscholtz@ufl.edu	Scholtz, Richard/F-9513-2011	Scholtz, Richard/0000-0001-8989-0131	Florida Experiment Station; Marston Science Library staff; University of Florida	Florida Experiment Station; Marston Science Library staff; University of Florida(University of Florida)	The funding of this analysis was provided by the Florida Experiment Station. The authors express appreciation to Amy G. Buhler, Marston Science Library staff, for assistance with funding for the publishing costs of this article as part of the commitment of the University of Florida to open access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Publication of this article was funded in part by the University of Florida Open-Access publishing Fund. The authors express appreciation to Amy G. Buhler, Marston Science Library staff. We also thank students in the graduate course ABE 6933 Mathematical and Statistical Characteristics of Nonlinear Regression Models for many helpful oral and written review comments on the manuscript.	Cox WJ, 1997, J PROD AGRIC, V10, P405, DOI 10.2134/jpa1997.0405; Cusicanqui JA, 1999, AGRON J, V91, P911, DOI 10.2134/agronj1999.916911x; HASHEMIDEZFOULI A, 1992, AGRON J, V84, P547, DOI 10.2134/agronj1992.00021962008400040001x; HAWKINS BS, 1972, RES B U GEORGIA AGR, V101; KITTRELL BU, 1975, TOBACCO SCI, V19, P119; MCKEE CG, 1978, TOBACCO SCI, V22, P94; Overman AR, 2006, COMMUN SOIL SCI PLAN, V37, P1157, DOI 10.1080/00103620600623350; OVERMAN AR, 2002, MATH MODELS PLANT GR; PRINE GM, 1977, SOIL CROP SCI SOC FL, V36, P157; Ratkowsky D., 1983, NONLINEAR REGRESSION; RHOADS FM, 1979, SOIL CROP SCI SOC FL, V38, P78; SCARSBROOK CE, 1973, ALABAMA AGR EXPT STA, V450; WURR DCE, 1993, J AGR SCI, V120, P63, DOI 10.1017/S0021859600073597	13	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16117	10.1371/journal.pone.0016117	http://dx.doi.org/10.1371/journal.pone.0016117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297960	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300034
J	Simonson, TS; Xing, JC; Barrett, R; Jerah, E; Loa, P; Zhang, YH; Watkins, WS; Witherspoon, DJ; Huff, CD; Woodward, S; Mowry, B; Jorde, LB				Simonson, Tatum S.; Xing, Jinchuan; Barrett, Robert; Jerah, Edward; Loa, Peter; Zhang, Yuhua; Watkins, W. Scott; Witherspoon, David J.; Huff, Chad D.; Woodward, Scott; Mowry, Bryan; Jorde, Lynn B.			Ancestry of the Iban Is Predominantly Southeast Asian: Genetic Evidence from Autosomal, Mitochondrial, and Y Chromosomes	PLOS ONE			English	Article							AUSTRONESIAN-SPEAKING PEOPLES; MODERN HUMANS; POPULATION-GENETICS; LAST DEGLACIATION; HUMAN DISPERSALS; NEW-GUINEA; EAST-ASIA; DIVERSITY; GENOME; DNA	Humans reached present-day Island Southeast Asia (ISEA) in one of the first major human migrations out of Africa. Population movements in the millennia following this initial settlement are thought to have greatly influenced the genetic makeup of current inhabitants, yet the extent attributed to different events is not clear. Recent studies suggest that south-to-north gene flow largely influenced present-day patterns of genetic variation in Southeast Asian populations and that late Pleistocene and early Holocene migrations from Southeast Asia are responsible for a substantial proportion of ISEA ancestry. Archaeological and linguistic evidence suggests that the ancestors of present-day inhabitants came mainly from north-to-south migrations from Taiwan and throughout ISEA approximately 4,000 years ago. We report a large-scale genetic analysis of human variation in the Iban population from the Malaysian state of Sarawak in northwestern Borneo, located in the center of ISEA. Genome-wide single-nucleotide polymorphism (SNP) markers analyzed here suggest that the Iban exhibit greatest genetic similarity to Indonesian and mainland Southeast Asian populations. The most common non-recombining Y (NRY) and mitochondrial (mt) DNA haplogroups present in the Iban are associated with populations of Southeast Asia. We conclude that migrations from Southeast Asia made a large contribution to Iban ancestry, although evidence of potential gene flow from Taiwan is also seen in uniparentally inherited marker data.	[Simonson, Tatum S.; Xing, Jinchuan; Zhang, Yuhua; Watkins, W. Scott; Witherspoon, David J.; Huff, Chad D.; Jorde, Lynn B.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Barrett, Robert; Jerah, Edward; Loa, Peter] Univ Adelaide, Dept Psychiat, Adelaide, SA, Australia; [Barrett, Robert; Jerah, Edward; Loa, Peter] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Woodward, Scott] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Mowry, Bryan] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Mowry, Bryan] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Utah System of Higher Education; University of Utah; University of Adelaide; Royal Adelaide Hospital; Queensland Centre for Mental Health Research; University of Queensland	Simonson, TS (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu	Xing, Jinchuan/A-2489-2012; Loa, Peter/T-3217-2019; Mowry, Bryan/G-5046-2010	Mowry, Bryan/0000-0002-4115-5645; Loa, Peter/0000-0001-7653-5392	Australian National Health and Medical Research Council [9937625, 49669]; NIH [GM-59290, T-32]; NSF [BCS-0218370]; University of Luxembourg; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Luxembourg; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Australian National Health and Medical Research Council grants 9937625, 49669; NIH Grant GM-59290 and NSF Grant BCS-0218370. Funding was provided by the University of Luxembourg Institute for Systems Biology Program to C.D.H. T.S.S. is supported by NIH Genetics Training Grant T-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BALLINGER SW, 1992, GENETICS, V130, P139; BARKER G, 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; BELLWOOD P, 1991, SCI AM, V265; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; BLUST R, 1995, J WORLD PREHIST, V9, P453, DOI 10.1007/BF02221119; BROTHWELL DR, 1960, SARAWAK MUS J, V9, P323; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Chang YM, 2009, FORENSIC SCI INT-GEN, V3, pE77, DOI 10.1016/j.fsigen.2008.07.007; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Dhaliwal JS, 2010, TISSUE ANTIGENS, V75, P166, DOI 10.1111/j.1399-0039.2009.01410.x; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; DIAMOND JM, 1988, NATURE, V336, P308; EXCOFFIER L, 2006, EVOLUTIONARY BIOINFO, V1; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Oota H, 2001, HUM BIOL, V73, P225, DOI 10.1353/hub.2001.0023; Oppenheimer S., 1998, EDEN E DROWNED CONTI; Pelejero C, 1999, EARTH PLANET SC LETT, V171, P661, DOI 10.1016/S0012-821X(99)00178-8; SATHIAMURTHY EVH, 2006, NATURAL HIST; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Su B, 1999, AM J HUM GENET, V65, pA399; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Trivedi R, 2006, J HUM GENET, V51, P217, DOI 10.1007/s10038-005-0349-2; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Watkins WS, 2005, ANN HUM GENET, V69, P680, DOI 10.1046/j.1529-8817.2005.00200.x; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485; Wooding S, 2004, HUM GENET, V115, P221, DOI 10.1007/s00439-004-1130-x; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	50	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16338	10.1371/journal.pone.0016338	http://dx.doi.org/10.1371/journal.pone.0016338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305013	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300052
J	Chen, PL; Fann, CSJ; Chu, CC; Chang, CC; Chang, SW; Hsieh, HY; Lin, M; Yang, WS; Chang, TC				Chen, Pei-Lung; Fann, Cathy Shen-Jang; Chu, Chen-Chung; Chang, Chien-Ching; Chang, Su-Wei; Hsieh, Hsin-Yi; Lin, Marie; Yang, Wei-Shiung; Chang, Tien-Chun			Comprehensive Genotyping in Two Homogeneous Graves' Disease Samples Reveals Major and Novel HLA Association Alleles	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; LEUKOCYTE ANTIGEN REGION; GENOME-WIDE ASSOCIATION; HONG-KONG CHINESE; HISTOCOMPATIBILITY COMPLEX; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; JAPANESE PATIENTS; P-VALUES; POPULATION	Background: Graves' disease (GD) is the leading cause of hyperthyroidism and thyroid eye disease inherited as a complex trait. Although geoepidemiology studies showed relatively higher prevalence of GD in Asians than in Caucasians, previous genetic studies were contradictory concerning whether and/or which human leukocyte antigen (HLA) alleles are associated with GD in Asians. Methodology/Principal Findings: We conducted a case-control association study (499 unrelated GD cases and 504 controls) and a replication in an independent family sample (419 GD individuals and their 282 relatives in 165 families). To minimize genetic and phenotypic heterogeneity, we included only ethnic Chinese Han population in Taiwan and excluded subjects with hypothyroidism. We performed direct and comprehensive genotyping of six classical HLA loci (HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1) to 4-digit resolution. Combining the data of two sample populations, we found that B*46:01 (odds ratio under dominant model [OR] = 1.33, Bonferroni corrected combined P [P(Bc)] = 1.17x10(-2)), DPB1*05:01 (OR = 2.34, P(Bc) = 2.58x10(-10)), DQB1*03:02 (OR = 0.62, P(Bc) = 1.97x10(-2)), DRB1*15:01 (OR = 1.68, P(Bc) = 1.22x10(-2)) and DRB1*16:02 (OR = 2.63, P(Bc) = 1.46x10(-5)) were associated with GD. HLA-DPB1*05:01 is the major gene of GD in our population and singly accounts for 48.4% of population-attributable risk. Conclusions/Significance: These GD-associated alleles we identified in ethnic Chinese Hans, and those identified in other Asian studies, are totally distinct from the known associated alleles in Caucasians. Identification of population-specific association alleles is the critical first step for individualized medicine. Furthermore, comparison between different susceptibility/protective alleles across populations could facilitate generation of novel hypothesis about GD pathophysiology and indicate a new direction for future investigation.	[Chen, Pei-Lung] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Chen, Pei-Lung; Yang, Wei-Shiung; Chang, Tien-Chun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Fann, Cathy Shen-Jang; Chang, Chien-Ching; Chang, Su-Wei; Hsieh, Hsin-Yi] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Fann, Cathy Shen-Jang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chu, Chen-Chung; Lin, Marie] Mackay Mem Hosp, Transfus Med Lab, Dept Med Res, Taipei, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung; Chang, Tien-Chun] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Taiwan University; National Taiwan University	Chen, PL (corresponding author), Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan.	wsyang@ntu.edu.tw; tienchunchang@ntu.edu.tw	Fann, Cathy SJ/F-9410-2010; Chen, Pei-Lung/A-3520-2010	Fann, Cathy SJ/0000-0001-9025-2276; Chen, Pei-Lung/0000-0002-5640-3074; YANG, WEI-SHIUNG/0000-0001-5087-373X; Chang, Tien-Chun/0000-0003-3385-2026	National Science Council, Taiwan (NSC) [91-3112-B-002-003, 92-3112-B-002-009, 93-3112-B-002-015, 95-3112-B-002-026, 96-3112-B-002-017, 97-3112-B-002-004]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC# 91-3112-B-002-003, 92-3112-B-002-009, 93-3112-B-002-015, 95-3112-B-002-026, 96-3112-B-002-017 and 97-3112-B-002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi H, 2004, TRENDS ENDOCRIN MET, V15, P234, DOI 10.1016/j.tem.2004.05.002; Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Brix TH, 1998, THYROID, V8, P727, DOI 10.1089/thy.1998.8.727; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; CAVAN DA, 1994, CLIN ENDOCRINOL, V40, P63, DOI 10.1111/j.1365-2265.1994.tb02444.x; CHAN SH, 1978, TISSUE ANTIGENS, V12, P109, DOI 10.1111/j.1399-0039.1978.tb01306.x; Chen PL, 2007, CLIN ENDOCRINOL, V66, P646, DOI 10.1111/j.1365-2265.2007.02787.x; CHO BY, 1987, TISSUE ANTIGENS, V30, P119; Chu CC, 2006, IMMUNOBIOLOGY HUMAN, P611; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; DONG RP, 1992, HUM IMMUNOL, V35, P165, DOI 10.1016/0198-8859(92)90101-R; Erlich HA, 2001, IMMUNITY, V14, P347, DOI 10.1016/S1074-7613(01)00115-7; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HAWKINS BR, 1985, CLIN ENDOCRINOL, V23, P245, DOI 10.1111/j.1365-2265.1985.tb00220.x; Heward JM, 1998, J CLIN ENDOCR METAB, V83, P3394, DOI 10.1210/jc.83.10.3394; Huang SM, 2003, TISSUE ANTIGENS, V61, P154, DOI 10.1034/j.1399-0039.2003.00016.x; INOUE D, 1992, CLIN ENDOCRINOL, V36, P75, DOI 10.1111/j.1365-2265.1992.tb02905.x; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jacobson EM, 2008, J AUTOIMMUN, V30, P58, DOI 10.1016/j.jaut.2007.11.010; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kawasaki A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2516; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Kochi Y, 2010, NAT REV RHEUMATOL, V6, P290, DOI 10.1038/nrrheum.2010.23; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Meyer D, 2006, IMMUNOBIOLOGY HUMAN, P653; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; ONUMA H, 1994, HUM IMMUNOL, V39, P195, DOI 10.1016/0198-8859(94)90260-7; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Park MH, 2005, HUM IMMUNOL, V66, P741, DOI 10.1016/j.humimm.2005.03.001; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; SEKI T, 1993, HEPATOLOGY, V18, pA218, DOI 10.1016/0270-9139(93)92397-I; Shapira Y, 2010, J AUTOIMMUN, V34, pJ168, DOI 10.1016/j.jaut.2009.11.018; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Simmonds MJ, 2004, CLIN EXP IMMUNOL, V136, P1, DOI 10.1111/j.1365-2249.2004.02424.x; Sloka J S, 2005, J Autoimmune Dis, V2, P9, DOI 10.1186/1740-2557-2-9; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; Takahashi M, 2006, HUM IMMUNOL, V67, P47, DOI 10.1016/j.humimm.2006.02.023; Taylor JC, 2006, J CLIN ENDOCR METAB, V91, P646, DOI 10.1210/jc.2005-0686; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; TSAI K-S, 1989, Taiwan yixuehui zazhi, V88, P336; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Weetman AP, 2009, HORM METAB RES, V41, P421, DOI 10.1055/s-0029-1214415; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; WESTFALL PH, 1993, BIOMETRICS, V49, P941, DOI 10.2307/2532216; Wong GWK, 1999, CLIN ENDOCRINOL, V50, P493; Wongsurawat T, 2006, TISSUE ANTIGENS, V67, P79, DOI 10.1111/j.1399-0039.2005.00498.x; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; YEO PPB, 1989, TISSUE ANTIGENS, V34, P179, DOI 10.1111/j.1399-0039.1989.tb01734.x	56	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16635	10.1371/journal.pone.0016635	http://dx.doi.org/10.1371/journal.pone.0016635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21307958	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100052
J	Gozzi, A; Turrini, G; Piccoli, L; Massagrande, M; Amantini, D; Antolini, M; Martinelli, P; Cesari, N; Montanari, D; Tessari, M; Corsi, M; Bifone, A				Gozzi, Alessandro; Turrini, Giuliano; Piccoli, Laura; Massagrande, Mario; Amantini, David; Antolini, Marinella; Martinelli, Prisca; Cesari, Nicola; Montanari, Dino; Tessari, Michela; Corsi, Mauro; Bifone, Angelo			Functional Magnetic Resonance Imaging Reveals Different Neural Substrates for the Effects of Orexin-1 and Orexin-2 Receptor Antagonists	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; CEREBRAL BLOOD-VOLUME; PHARMACOLOGICAL MRI; DRUG DISCOVERY; KNOCKOUT MICE; RAT-BRAIN; SLEEP; NEURONS; REWARD; ACTIVATION	Orexins are neuro-modulatory peptides involved in the control of diverse physiological functions through interaction with two receptors, orexin-1 (OX1R) and orexin-2 (OX2R). Recent evidence in pre-clinical models points toward a putative dichotomic role of the two receptors, with OX2R predominantly involved in the regulation of the sleep/wake cycle and arousal, and the OX1R being more specifically involved in reward processing and motivated behaviour. However, the specific neural substrates underlying these distinct processes in the rat brain remain to be elucidated. Here we used functional magnetic resonance imaging (fMRI) in the rat to map the modulatory effect of selective OXR blockade on the functional response produced by D-amphetamine, a psychostimulant and arousing drug that stimulates orexigenic activity. OXR blockade was produced by GSK1059865 and JNJ1037049, two novel OX1R and OX2R antagonists with unprecedented selectivity at the counter receptor type. Both drugs inhibited the functional response to D-amphetamine albeit with distinct neuroanatomical patterns: GSK1059865 focally modulated functional responses in striatal terminals, whereas JNJ1037049 induced a widespread pattern of attenuation characterised by a prominent cortical involvement. At the same doses tested in the fMRI study, JNJ1037049 exhibited robust hypnotic properties, while GSK1059865 failed to display significant sleep-promoting effects, but significantly reduced drug-seeking behaviour in cocaine-induced conditioned place preference. Collectively, these findings highlight an essential contribution of the OX2R in modulating cortical activity and arousal, an effect that is consistent with the robust hypnotic effect exhibited by JNJ1037049. The subcortical and striatal pattern observed with GSK1059865 represent a possible neurofunctional correlate for the modulatory role of OX1R in controlling reward-processing and goal-oriented behaviours in the rat.	[Gozzi, Alessandro; Bifone, Angelo] Ist Italiano Tecnol, Ctr Nanotechnol Innovat, Pisa, Italy; [Gozzi, Alessandro; Turrini, Giuliano; Piccoli, Laura; Massagrande, Mario; Amantini, David; Antolini, Marinella; Martinelli, Prisca; Cesari, Nicola; Montanari, Dino; Tessari, Michela; Corsi, Mauro; Bifone, Angelo] GlaxoSmithKline Med Res Ctr, Verona, Italy	Istituto Italiano di Tecnologia - IIT; GlaxoSmithKline	Gozzi, A (corresponding author), Ist Italiano Tecnol, Ctr Nanotechnol Innovat, Pisa, Italy.	alessandro.gozzi@iit.it	Gozzi, Alessandro/K-6342-2016	Gozzi, Alessandro/0000-0002-5731-4137	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This work was funded by GlaxoSmithKline. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro G., 2009, Pyridine Derivatives Used to Treat Orexin Related Disorders, Patent No. [WO2009124956A1., 2009124956]; Aston-Jones G, 2009, NEUROPHARMACOLOGY, V56, P112, DOI 10.1016/j.neuropharm.2008.06.060; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen YCI, 2001, J MAGN RESON IMAGING, V14, P517, DOI 10.1002/jmri.1215; Coleman PJ, 2010, EXPERT OPIN THER PAT, V20, P307, DOI 10.1517/13543770903567085; Dugovic C, 2009, J PHARMACOL EXP THER, V330, P142, DOI 10.1124/jpet.109.152009; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; Fadel J, 2002, J NEUROSCI, V22, P6742; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Ferrari L, 2010, J NEUROSCI METH, V186, P143, DOI 10.1016/j.jneumeth.2009.11.005; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gompf H, 2009, ANESTHESIOLOGY, V111, P1001, DOI 10.1097/ALN.0b013e3181b764b3; Gozzi A, 2008, PSYCHOPHARMACOLOGY, V201, P273, DOI 10.1007/s00213-008-1271-z; Gozzi A, 2008, NEUROPSYCHOPHARMACOL, V33, P1690, DOI 10.1038/sj.npp.1301547; Gozzi A, 2007, MAGN RESON IMAGING, V25, P826, DOI 10.1016/j.mri.2007.03.003; Gozzi A, 2010, PSYCHOPHARMACOLOGY, V209, P37, DOI 10.1007/s00213-009-1772-4; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Horan B, 2000, SYNAPSE, V35, P160, DOI 10.1002/(SICI)1098-2396(200002)35:2<160::AID-SYN9>3.3.CO;2-F; Kalvass JC, 2002, BIOPHARM DRUG DISPOS, V23, P327, DOI 10.1002/bdd.325; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Maquet P, 2000, J SLEEP RES, V9, P207; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McAtee LC, 2004, BIOORG MED CHEM LETT, V14, P4225, DOI 10.1016/j.bmcl.2004.06.032; Micheli F, 2007, J MED CHEM, V50, P5076, DOI 10.1021/jm0705612; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Paxinos G., 1998, RAT BRAIN STEREOTACT; Peyron C, 1998, J NEUROSCI, V18, P9996; Read KD, 2010, EXPERT OPIN DRUG MET, V6, P337, DOI 10.1517/17425250903559873; RUNLAKSHANA O, 1959, BRIT J PHARMACOL, V14, P48; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Scammell TE, 2005, NAT NEUROSCI, V8, P1286, DOI 10.1038/nn1005-1286; Schwarz A, 2004, SYNAPSE, V54, P1, DOI 10.1002/syn.20055; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Schwarz AJ, 2007, J NEUROSCI METH, V159, P346, DOI 10.1016/j.jneumeth.2006.07.017; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Schwarz AJ, 2003, MAGN RESON IMAGING, V21, P1191, DOI 10.1016/j.mri.2003.08.020; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Smith MI, 2003, NEUROSCI LETT, V341, P256, DOI 10.1016/S0304-3940(03)00066-1; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Willie JT, 2001, SLEEP, V24, pA24; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Zaharchuk G, 1999, STROKE, V30, P2197, DOI 10.1161/01.STR.30.10.2197	54	83	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16406	10.1371/journal.pone.0016406	http://dx.doi.org/10.1371/journal.pone.0016406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21307957	Green Submitted, Green Published, gold			2022-12-27	WOS:000286664100027
J	Wagoner, J; Morishima, C; Graf, TN; Oberlies, NH; Teissier, E; Pecheur, EI; Tavis, JE; Polyak, SJ				Wagoner, Jessica; Morishima, Chihiro; Graf, Tyler N.; Oberlies, Nicholas H.; Teissier, Elodie; Pecheur, Eve-Isabelle; Tavis, John E.; Polyak, Stephen J.			Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; MILK THISTLE EXTRACT; NF-KAPPA-B; OXIDATIVE STRESS; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; RANDOMIZED-TRIAL; PLUS RIBAVIRIN; RNA-POLYMERASE	Silymarin prevents liver disease in many experimental rodent models, and is the most popular botanical medicine consumed by patients with hepatitis C. Silibinin is a major component of silymarin, consisting of the flavonolignans silybin A and silybin B, which are insoluble in aqueous solution. A chemically modified and soluble version of silibinin, SIL, has been shown to potently reduce hepatitis C virus (HCV) RNA levels in vivo when administered intravenously. Silymarin and silibinin inhibit HCV infection in cell culture by targeting multiple steps in the virus lifecycle. We tested the hepatoprotective profiles of SIL and silibinin in assays that measure antiviral and anti-inflammatory functions. Both mixtures inhibited fusion of HCV pseudoparticles (HCVpp) with fluorescent liposomes in a dose-dependent fashion. SIL inhibited 5 clinical genotype 1b isolates of NS5B RNA dependent RNA polymerase (RdRp) activity better than silibinin, with IC50 values of 40-85 mu M. The enhanced activity of SIL may have been in part due to inhibition of NS5B binding to RNA templates. However, inhibition of the RdRps by both mixtures plateaued at 43-73%, suggesting that the products are poor overall inhibitors of RdRp. Silibinin did not inhibit HCV replication in subgenomic genotype 1b or 2a replicon cell lines, but it did inhibit JFH-1 infection. In contrast, SIL inhibited 1b but not 2a subgenomic replicons and also inhibited JFH-1 infection. Both mixtures inhibited production of progeny virus particles. Silibinin but not SIL inhibited NF-kappa B- and IFN-B-dependent transcription in Huh7 cells. However, both mixtures inhibited T cell proliferation to similar degrees. These data underscore the differences and similarities between the intravenous and oral formulations of silibinin, which could influence the clinical effects of this mixture on patients with chronic liver diseases.	[Wagoner, Jessica; Morishima, Chihiro; Polyak, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Polyak, Stephen J.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Polyak, Stephen J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Graf, Tyler N.; Oberlies, Nicholas H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA; [Teissier, Elodie; Pecheur, Eve-Isabelle] Univ Lyon 1, Inst Biol & Chim Prot, Lyon Biosci Gerland IFR128, CNRS,UMR 5086, F-69365 Lyon, France; [Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Greensboro; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Saint Louis University	Wagoner, J (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	polyak@uw.edu	Oberlies, Nicholas/D-8162-2011; Polyak, Stephen/B-5743-2011	Oberlies, Nicholas/0000-0002-0354-8464; Graf, Tyler/0000-0003-4145-2815; Pecheur, Eve/0000-0002-8613-862X; Morishima, Chihiro/0000-0001-5330-9464	NCCAM, National Institutes of Health (NIH) [AT002895]; NCI, NIH [R01 CA104286]; NIH [R21 CA125321]; Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS); NATIONAL CANCER INSTITUTE [R01CA104286, R21CA125321] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT002895] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	NCCAM, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	SJP is partially supported by National Institutes of Health (NIH) grant AT002895 from NCCAM. TNG and NHO were partially supported via NIH grant R01 CA104286 from NCI. JET is partially supported by NIH grant R21 CA125321. EIP is supported by the Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Brandon-Warner E, 2010, CANCER LETT, V291, P120, DOI 10.1016/j.canlet.2009.10.004; Brantley SJ, 2010, J PHARMACOL EXP THER, V332, P1081, DOI 10.1124/jpet.109.161927; Bureau C, 2001, J BIOL CHEM, V276, P23077, DOI 10.1074/jbc.M100698200; Cannon NA, 2009, J VIRAL HEPATITIS, V16, P595, DOI 10.1111/j.1365-2893.2009.01109.x; CAO F, 2010, J VIRAL HEPAT; Carr DJJ, 2006, CURR TOP MICROBIOL, V303, P47, DOI 10.1007/978-3-540-33397-5_3; CAVALIERI C, 2007, INTRAVENOUS MILK THI; Chaudhuri S, 2010, J PHOTOCH PHOTOBIO B, V98, P12, DOI 10.1016/j.jphotobiol.2009.10.002; Chaudhuri S, 2009, BIOPHYS CHEM, V139, P29, DOI 10.1016/j.bpc.2008.09.018; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Falasca K, 2008, J MED VIROL, V80, P1900, DOI 10.1002/jmv.21292; Ferenci P, 2008, GASTROENTEROLOGY, V135, P1561, DOI 10.1053/j.gastro.2008.07.072; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Fried MW, 2000, AM J GASTROENTEROL, V95, P3225, DOI 10.1111/j.1572-0241.2000.03433.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Glass WG, 2003, CURR OPIN ALLERGY CL, V3, P467, DOI 10.1097/01.all.0000104448.09202.91; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Graf TN, 2007, PLANTA MED, V73, P1495, DOI 10.1055/s-2007-990239; Hawke RL, 2010, J CLIN PHARMACOL, V50, P434, DOI 10.1177/0091270009347475; Kim CS, 2010, ANTICANCER RES, V30, P79; Kroll DJ, 2007, INTEGR CANCER THER, V6, P110, DOI 10.1177/1534735407301825; Lai MMC, 2002, GASTROENTEROLOGY, V122, P568, DOI 10.1053/gast.2002.31474; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Liu JP, 2003, AM J GASTROENTEROL, V98, P538, DOI 10.1111/j.1572-0241.2003.07298.x; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mayer KE, 2005, J VIRAL HEPATITIS, V12, P559, DOI 10.1111/j.1365-2893.2005.00636.x; Melchjorsen J, 2003, J LEUKOCYTE BIOL, V74, P331, DOI 10.1189/jlb.1102577; Melhem A, 2005, J CLIN GASTROENTEROL, V39, P737, DOI 10.1097/01.mcg.0000174023.73472.29; MORISHIMA C, 2010, GASTROENTEROLOGY; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; *NCCAM, 2003, HEP C COMPL ALT MED, P2; Neumann UP, 2010, J HEPATOL; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Pecheur EI, 2007, BIOCHEMISTRY-US, V46, P6050, DOI 10.1021/bi700181j; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Plumlee CR, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-89; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Seeff LB, 2008, HEPATOLOGY, V47, P605, DOI 10.1002/hep.22044; Tripp Ralph A, 2005, Proc Am Thorac Soc, V2, P147, DOI 10.1513/pats.200502-014AW; Vendemiale G, 2001, EUR J CLIN INVEST, V31, P54, DOI 10.1046/j.1365-2362.2001.00747.x; WAGONER J, 2010, HEPATOLOGY IN PRESS; Wagoner J, 2007, J VIROL, V81, P309, DOI 10.1128/JVI.01411-06; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587; Wen Z, 2008, DRUG METAB DISPOS, V36, P65, DOI 10.1124/dmd.107.017566; Wu JW, 2007, J PHARMACEUT BIOMED, V45, P635, DOI 10.1016/j.jpba.2007.06.026; Wu JW, 2009, J ETHNOPHARMACOL, V121, P185, DOI 10.1016/j.jep.2008.10.036	55	53	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16464	10.1371/journal.pone.0016464	http://dx.doi.org/10.1371/journal.pone.0016464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297992	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100035
J	Ng, OT; Lin, L; Laeyendecker, O; Quinn, TC; Sun, YJ; Lee, CC; Leo, YS				Ng, Oon Tek; Lin, Li; Laeyendecker, Oliver; Quinn, Thomas C.; Sun, Yong Jiang; Lee, Cheng Chuan; Leo, Yee Sin			Increased Rate of CD4+T-Cell Decline and Faster Time to Antiretroviral Therapy in HIV-1 Subtype CRF01_AE Infected Seroconverters in Singapore	PLOS ONE			English	Article							DISEASE PROGRESSION; VIRAL SUBTYPE; THAILAND; UGANDA; HEALTH; IMPACT	Background: It remains controversial as to whether HIV-1 subtypes influence disease progression. Singapore offers a unique opportunity to address this issue due to the presence of co-circulating subtypes. We compared subtype CRF01_AE and non-CRF01_AE infected patients, with regards to estimated annual rate of CD4+ T-cell loss and time from estimated data of seroconversion (EDS) to antiretroviral therapy (ART). Methods: We recruited ART-naive patients with known dates of seroconversion between October 2002 and December 2007 at the Singapore Communicable Disease Centre, the national reference treatment centre. Multilevel mixed-effects models were used to analyse the rate of CD4+ T-cell decline. Time from EDS to ART was analyzed with the Kaplan-Meier survival method and compared with Cox proportional hazards models. Results: 54 patients with previously assigned HIV-1 subtypes (24 CRF01_AE, 17 B, 8 B', 1 CRF33_01B, 3 CRF34_01B and 1 G) were observed for 89 patient-years. Subtype CRF01_AE and non-CRF01_AE infected patients did not differ in age, gender, risk factor, rate of symptomatic seroconversion, baseline CD4+ T-cell count, log(10) viral load or haemoglobin concentration. The estimated annual rate of CD4+ T-cell loss was 58 cells/mm(3)/year (95% CI: 7 to 109; P = 0.027) greater in subtype CRF01_AE infected patients compared to non-CRF01_AE patients, after adjusting for age, baseline CD4+ T-cell count and baseline log(10) viral load. The median time from EDS to ART was 1.8 years faster comparing CRF01_AE to non-CRF01_AE infected patient with a 2.5 times (95% CI: 1.2-5.0; P = 0.013) higher hazard for ART initiation, after controlling for age, baseline CD4+ T-cell count and baseline log(10) viral load. Conclusions: Infecting subtype significantly impacted the rate of CD4+ T-cell loss and time to treatment in this cohort. Studies to understand the biological basis for this difference could further our understanding of HIV pathogenesis.	[Ng, Oon Tek; Laeyendecker, Oliver; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Ng, Oon Tek; Lin, Li; Sun, Yong Jiang; Lee, Cheng Chuan; Leo, Yee Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Baltimore, MD USA	Johns Hopkins University; Tan Tock Seng Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA)	Ng, OT (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.	oong@jhsph.edu	Laeyendecker, Oliver B/B-9331-2009	Laeyendecker, Oliver/0000-0002-6429-4760	Singapore National Medical Research Training Fellowship [MH 95:03/8-169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361] Funding Source: NIH RePORTER	Singapore National Medical Research Training Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A Singapore National Medical Research Training Fellowship grant (MH 95:03/8-169) provided salary support for OT Ng. Additional support was provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003; Joint United Nations Program on HIV/AIDS (UNAIDS) WHOW, 2007, AIDS EP UPD; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f; Kiwanuka N, 2009, J ACQUIRED IMMUNE DE; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Nelson KE, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000299410.37152.17; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Touloumi G, 2003, JAIDS-J ACQ IMM DEF, V34, P76, DOI 10.1097/00126334-200309010-00012; *US DEP HHS, GUID US ANT AG HIV 1; WHO, 2008, WHO STAT INF SYST CO	18	42	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15738	10.1371/journal.pone.0015738	http://dx.doi.org/10.1371/journal.pone.0015738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298051	gold, Green Submitted, Green Published			2022-12-27	WOS:000286663900017
J	Okkels, F; Dufva, M; Bruus, H				Okkels, Fridolin; Dufva, Martin; Bruus, Henrik			Optimal Homogenization of Perfusion Flows in Microfluidic Bio-Reactors: A Numerical Study	PLOS ONE			English	Article							TOPOLOGY OPTIMIZATION; CULTURE; DESIGN	In recent years, the interest in small-scale bio-reactors has increased dramatically. To ensure homogeneous conditions within the complete area of perfused microfluidic bio-reactors, we develop a general design of a continually feed bio-reactor with uniform perfusion flow. This is achieved by introducing a specific type of perfusion inlet to the reaction area. The geometry of these inlets are found using the methods of topology optimization and shape optimization. The results are compared with two different analytic models, from which a general parametric description of the design is obtained and tested numerically. Such a parametric description will generally be beneficial for the design of a broad range of microfluidic bioreactors used for, e. g., cell culturing and analysis and in feeding bio-arrays.	[Okkels, Fridolin; Dufva, Martin; Bruus, Henrik] Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Okkels, F (corresponding author), Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	Fridolin.Okkels@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Bruus, Henrik/C-4475-2008; Dufva, Martin/D-1873-2012; Okkels, Fridolin/A-3205-2012	Bruus, Henrik/0000-0001-5827-2939; Dufva, Martin/0000-0001-5449-0189; Okkels, Fridolin/0000-0001-7444-1253	European Commision [IST-016554]; Carlsberg Foundation, Denmark [2006-01-0580]; Danish Agency for Science, Technology and Innovation [274-08-0122]	European Commision; Carlsberg Foundation, Denmark(Carlsberg Foundation); Danish Agency for Science, Technology and Innovation	During the time span in which the work to be published was conducted, FO was supported by the European Commision through the project SMART Bio-Micro Electro Mechanical System (Bio-MEMS) grant no. IST-016554 (www.smartbiomems.com), the Carlsberg Foundation, Denmark grant no. 2006-01-0580 (www.carlsbergfondet.dk), and The Danish Agency for Science, Technology and Innovation, grant no. 274-08-0122 (en.fi.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2; Borrvall T, 2003, INT J NUMER METH FL, V41, P77, DOI 10.1002/fld.426; Bruus H., 2008, OXFORD MASTER SERIES; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Korin N, 2007, LAB CHIP, V7, P611, DOI 10.1039/b702392h; Krishnan M, 2006, ANAL CHEM, V76, P6254; Okkels F, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016301; Olesen LH, 2006, INT J NUMER METH ENG, V65, P975, DOI 10.1002/nme.1468; Petronis S, 2006, BIOTECHNIQUES, V40, P368, DOI 10.2144/000112122; Stangegaard M, 2006, LAB CHIP, V6, P1045, DOI 10.1039/b603379b; Stangegaard M, 2006, MOL BIOSYST, V2, P421, DOI 10.1039/b608239d; Yu HM, 2005, LAB CHIP, V5, P1089, DOI 10.1039/b504403k	16	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14574	10.1371/journal.pone.0014574	http://dx.doi.org/10.1371/journal.pone.0014574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298040	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900001
J	Tang, Y; Pan, XJ; Chen, Y; Tai, PC; Sui, SF				Tang, Ying; Pan, Xijiang; Chen, Yong; Tai, Phang C.; Sui, Sen-Fang			Dimeric SecA Couples the Preprotein Translocation in an Asymmetric Manner	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; PRECURSOR PROTEINS; SIGNAL PEPTIDES; FULL-LENGTH; ATPASE; CHAPERONE; MEMBRANE; COMPLEX; MOTOR	The Sec translocase mediates the post-translational translocation of a number of preproteins through the inner membrane in bacteria. In the initiatory translocation step, SecB targets the preprotein to the translocase by specific interaction with its receptor SecA. The latter is the ATPase of Sec translocase which mediates the post-translational translocation of preprotein through the protein-conducting channel SecYEG in the bacterial inner membrane. We examined the structures of Escherichia coli Sec intermediates in solution as visualized by negatively stained electron microscopy in order to probe the oligomeric states of SecA during this process. The symmetric interaction pattern between the SecA dimer and SecB becomes asymmetric in the presence of proOmpA, and one of the SecA protomers predominantly binds to SecB/proOmpA. Our results suggest that during preprotein translocation, the two SecA protomers are different in structure and may play different roles.	[Tang, Ying; Pan, Xijiang; Chen, Yong; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Tai, Phang C.] Georgia State Univ, Dept Biol, Atlanta, GA USA	Tsinghua University; University System of Georgia; Georgia State University	Tang, Y (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Chen, Yong/AAF-9915-2020	Chen, Yong/0000-0001-5857-6086; Sui, Sen-Fang/0000-0001-5253-2592	National Natural Science Foundation of China [30830028]; National Basic Research program of China [2010CB833706/2010CB912400]; National Institutes of Health [GM34766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034766] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Natural Science Foundation of China (30830028), the National Basic Research program of China (2010CB833706/2010CB912400) (S.F.S.) and the National Institutes of Health (GM34766 to P.C.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud C, 2002, J BIOL CHEM, V277, P13724, DOI 10.1074/jbc.M200047200; Chen Y, 2008, J BIOL CHEM, V283, P28783, DOI 10.1074/jbc.C800160200; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Economou A, 2002, MOL MEMBR BIOL, V19, P159, DOI 10.1080/09687680210152609; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Muller JP, 2000, BIOCHEM J, V348, P367, DOI 10.1042/0264-6021:3480367; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Triplett TL, 2001, J BIOL CHEM, V276, P19648, DOI 10.1074/jbc.M100098200; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Zhou JH, 2005, MOL MICROBIOL, V58, P349, DOI 10.1111/j.1365-2958.2005.04842.x	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16498	10.1371/journal.pone.0016498	http://dx.doi.org/10.1371/journal.pone.0016498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304597	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900057
J	Kita, A; Li, C; Yu, Y; Umeda, N; Doi, A; Yasuda, M; Ishiwata, S; Taga, A; Horiuchi, Y; Sugiura, R				Kita, Ayako; Li, Cuifang; Yu, Yang; Umeda, Nanae; Doi, Akira; Yasuda, Mitsuko; Ishiwata, Shunji; Taga, Atsushi; Horiuchi, Yoshitaka; Sugiura, Reiko			Role of the Small GTPase Rho3 in Golgi/Endosome Trafficking through Functional Interaction with Adaptin in Fission Yeast	PLOS ONE			English	Article							AFFINITY CAPILLARY-ELECTROPHORESIS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; POLARIZED EXOCYTOSIS; DISTINCT PHENOTYPES; SECRETORY PATHWAY; EXOCYST COMPLEX; CELL-SEPARATION; GENE; PROTEIN	Background: We had previously identified the mutant allele of apm1(+) that encodes a homolog of the mammalian mu 1A subunit of the clathrin-associated adaptor protein-1 (AP-1) complex, and we demonstrated the role of Apm1 in Golgi/endosome trafficking, secretion, and vacuole fusion in fission yeast. Methodology/Principal Findings: In the present study, we isolated rho3+, which encodes a Rho-family small GTPase, an important regulator of exocystosis, as a multicopy-suppressor of the temperature-sensitive growth of the apm1-1 mutant cells. Overexpression of Rho3 suppressed the Cl- sensitivity and immunosuppressant sensitivity of the apm1-1 mutant cells. Overexpression of Rho3 also suppressed the fragmentation of vacuoles, and the accumulation of v-SNARE Syb1 in Golgi/endosomes and partially suppressed the defective secretion associated with apm1-deletion cells. Notably, electron microscopic observation of the rho3-deletion cells revealed the accumulation of abnormal Golgi-like structures, vacuole fragmentation, and accumulation of secretory vesicles; these phenotypes were very similar to those of the apm1-deletion cells. Furthermore, the rho3-deletion cells and apm1-deletion cells showed very similar phenotypic characteristics, including the sensitivity to the immunosuppressant FK506, the cell wall-damaging agent micafungin, Cl-, and valproic acid. Green fluorescent protein (GFP)-Rho3 was localized at Golgi/endosomes as well as the plasma membrane and division site. Finally, Rho3 was shown to form a complex with Apm1 as well as with other subunits of the clathrin-associated AP-1 complex in a GTP- and effector domain-dependent manner. Conclusions/Significance: Taken together, our findings reveal a novel role of Rho3 in the regulation of Golgi/endosome trafficking and suggest that clathrin-associated adaptor protein-1 and Rho3 co-ordinate in intracellular transport in fission yeast. To the best of our knowledge, this study provides the first evidence of a direct link between the small GTPase Rho and the clathrin-associated adaptor protein-1 in membrane trafficking.	[Kita, Ayako; Li, Cuifang; Yu, Yang; Umeda, Nanae; Doi, Akira; Yasuda, Mitsuko; Ishiwata, Shunji; Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan; [Taga, Atsushi] Kinki Univ, Sch Pharmaceut Sci, Lab Pharmaceut Analyt Chem, Higashiosaka, Osaka 577, Japan; [Horiuchi, Yoshitaka] Kinki Univ, Life Sci Res Inst, Osakasayama, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University)	Kita, A (corresponding author), Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan.	sugiurar@phar.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [11J10625] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by Grant-in-Aid for Scientific Research on Innovative Areas, and research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.org.kobe-u.ac.jp/rna/english.html) (to RS). This work was also financially supported by "Antiaging Center Project" for Private Universities from Ministry of Education, Culture, Sports, Science and Technology (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Brennwald P, 2007, FEBS LETT, V581, P2119, DOI 10.1016/j.febslet.2007.03.043; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Edamatsu M, 2003, BIOCHEM BIOPH RES CO, V301, P641, DOI 10.1016/S0006-291X(03)00017-2; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Imai J, 1996, GENETICS, V142, P359; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Taga A, 2008, J PHARMACEUT BIOMED, V46, P395, DOI 10.1016/j.jpba.2007.10.002; Taga A, 2010, J PHARMACEUT BIOMED, V53, P1332, DOI 10.1016/j.jpba.2010.07.009; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Toda T, 1996, MOL CELL BIOL, V16, P6752; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501	27	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16842	10.1371/journal.pone.0016842	http://dx.doi.org/10.1371/journal.pone.0016842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304827	gold, Green Submitted, Green Published			2022-12-27	WOS:000287036600032
J	Xia, XA; Yan, JH; Shen, YF; Tang, KX; Yin, J; Zhang, YH; Yang, DJ; Liang, H; Ye, JP; Weng, JP				Xia, Xuan; Yan, Jinhua; Shen, Yunfeng; Tang, Kuanxiao; Yin, Jun; Zhang, Yanhua; Yang, Dongjie; Liang, Hua; Ye, Jianping; Weng, Jianping			Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FOXO TRANSCRIPTION FACTORS; ELEMENT-BINDING PROTEIN; INSULIN-RESISTANCE; MECHANISM DISTINCT; LIPID HOMEOSTASIS; MUSCLE ATROPHY; LIVER; EXPRESSION; CARBOHYDRATE	Berberine (BBR) is a compound originally identified in a Chinese herbal medicine Huanglian (Coptis chinensis French). It improves glucose metabolism in type 2 diabetic patients. The mechanisms involve in activation of adenosine monophosphate activated protein kinase (AMPK) and improvement of insulin sensitivity. However, it is not clear if BBR reduces blood glucose through other mechanism. In this study, we addressed this issue by examining liver response to BBR in diabetic rats, in which hyperglycemia was induced in Sprague-Dawley rats by high fat diet. We observed that BBR decreased fasting glucose significantly. Gluconeogenic genes, Phosphoenolpyruvate carboxykinase (PEPCK) and Glucose-6-phosphatase (G6Pase), were decreased in liver by BBR. Hepatic steatosis was also reduced by BBR and expression of fatty acid synthase (FAS) was inhibited in liver. Activities of transcription factors including Forkhead transcription factor O1 (FoxO1), sterol regulatory element-binding protein 1c (SREBP1) and carbohydrate responsive element-binding protein (ChREBP) were decreased. Insulin signaling pathway was not altered in the liver. In cultured hepatocytes, BBR inhibited oxygen consumption and reduced intracellular adenosine triphosphate (ATP) level. The data suggest that BBR improves fasting blood glucose by direct inhibition of gluconeogenesis in liver. This activity is not dependent on insulin action. The gluconeogenic inhibition is likely a result of mitochondria inhibition by BBR. The observation supports that BBR improves glucose metabolism through an insulin-independent pathway.	[Xia, Xuan; Yan, Jinhua; Shen, Yunfeng; Tang, Kuanxiao; Zhang, Yanhua; Liang, Hua; Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Yang, Dongjie] Sun Yat Sen Univ, Dept Gastrointestinal Pancreat Surg, Affiliated Hosp 1, Guangzhou, Peoples R China; [Yin, Jun; Ye, Jianping] Louisiana State Univ, Pennington Biomed Res Ctr, Eunice, LA USA	Sun Yat Sen University; Sun Yat Sen University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University at Eunice	Xia, XA (corresponding author), Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou, Peoples R China.	wjianp@mail.sysu.edu.cn	Ye, Jianping/N-1998-2017; xia, xuan/AAX-3796-2020	Ye, Jianping/0000-0003-3875-365X; xia, xuan/0000-0002-4788-1971; Weng, Jianping/0000-0002-7889-1697	973 Program of China [2006CB503902]; Program for Changjiang Scholars and Innovative Research Team in University (985 project) [PCSIRT 0947]; National Science Fund for Distinguished Young Scholars [81025005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, P30DK072476, R56DK068036] Funding Source: NIH RePORTER	973 Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University (985 project)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by 973 Program of China 2006CB503902, Program for Changjiang Scholars and Innovative Research Team in University (985 project PCSIRT 0947), National Science Fund for Distinguished Young Scholars 81025005 (to Jianping Weng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto MC, 2003, TOXICOL LETT, V146, P37, DOI 10.1016/j.toxlet.2003.09.007; Bi Y, 2009, METABOLISM, V58, P779, DOI 10.1016/j.metabol.2009.01.011; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Ko BS, 2005, BIOL PHARM BULL, V28, P1431, DOI 10.1248/bpb.28.1431; Kong WJ, 2009, METABOLISM, V58, P109, DOI 10.1016/j.metabol.2008.08.013; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lu SS, 2009, J ENDOCRINOL, V200, P159, DOI 10.1677/JOE-08-0419; MIKES V, 1985, J BIOENERG BIOMEMBR, V17, P23, DOI 10.1007/BF00744986; MIKES V, 1983, BIOCHIM BIOPHYS ACTA, V723, P231, DOI 10.1016/0005-2728(83)90122-6; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang HL, 2010, DIABETES, V59, P1879, DOI 10.2337/db10-0207; Wang Liang, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2017; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Yu YL, 2010, BIOCHEM PHARMACOL, V79, P1000, DOI 10.1016/j.bcp.2009.11.017; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhou LB, 2007, METABOLISM, V56, P405, DOI 10.1016/j.metabol.2006.10.025	34	201	230	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16556	10.1371/journal.pone.0016556	http://dx.doi.org/10.1371/journal.pone.0016556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304897	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600009
J	Bailey, I; Gibson, GG; Plant, K; Graham, M; Plant, N				Bailey, Ian; Gibson, G. Gordon; Plant, Kathryn; Graham, Mark; Plant, Nick			A PXR-Mediated Negative Feedback Loop Attenuates the Expression of CYP3A in Response to the PXR Agonist Pregnenalone-16 alpha-Carbonitrile	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; INTERACTION NETWORKS; NUCLEAR RECEPTORS; HUMAN HEPATOCYTES; LITHOCHOLIC ACID; OXIDATIVE STRESS; MICROARRAY DATA	The nuclear receptor superfamily of ligand-activated transcription factors plays a central role in the regulation of cellular responses to chemical challenge. Nuclear receptors are activated by a wide range of both endogenous and exogenous chemicals, and their target genes include those involved in the metabolism and transport of the activating chemical. Such target gene activation, thus, acts to remove the stimulating xenobiotic or to maintain homeostatic levels of endogenous chemicals. Given the dual nature of this system it is important to understand how these two roles are balanced, such that xenobiotics are efficiently removed while not impacting negatively on homeostasis of endogenous chemicals. Using DNA microarray technology we have examined the transcriptome response of primary rat hepatocytes to two nuclear receptor ligands: Pregnenalone-16 alpha-carbonitrile (PCN), a xenobiotic PXR agonist, and lithocholic acid, an endogenous mixed PXR/VDR/FXR agonist. We demonstrate that despite differences in the profile of activated nuclear receptors, transcriptome responses for these two ligands are broadly similar at lower concentrations, indicating a conserved general response. However, as concentrations of stimulating ligand rises, the transcriptome responses diverge, reflecting a need for specific responses to the two stimulating chemicals. Finally, we demonstrate a novel feed-back loop for PXR, whereby ligand-activation of PXR suppresses transcription of the PXR gene, acting to attenuate PXR protein expression levels at higher ligand concentrations. Through in silico simulation we demonstrate that this feed-back loop is an important factor to prevent hyperexpression of PXR target genes such as CYP3A and confirm these findings in vitro. This novel insight into the regulation of the PXR-mediated regulatory signal networks provides a potential mechanistic rationale for the robustness in steroid homeostasis within the cell.	[Bailey, Ian; Gibson, G. Gordon; Plant, Kathryn; Plant, Nick] Univ Surrey, Fac Hlth & Med Sci, Ctr Toxicol, Surrey, England; [Graham, Mark] AstraZeneca R&D Charnwood, Safety Assessment, Leicester, Leics, England	University of Surrey; AstraZeneca	Bailey, I (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Ctr Toxicol, Surrey, England.	N.Plant@Surrey.ac.uk	Plant, Nick/E-4510-2011	Plant, Nick/0000-0003-4332-8308; Plant, Kate/0000-0002-6120-5419; Bailey, Ian/0000-0001-9262-0669	AstraZeneca; The Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council [EP/E500293/1] Funding Source: researchfish	AstraZeneca(AstraZeneca); The Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by AstraZeneca and The Biotechnology and Biological Sciences Research Council (BBSRC). Dr. Mark Graham (AstraZeneca) provided input into the study design, data collection and analysis, and preparation of the manuscript.	Aouabdi S, 2006, DRUG METAB DISPOS, V34, P138, DOI 10.1124/dmd.105.006064; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Sankary W, 2001, DRUG METAB DISPOS, V29, P1499; Eloranta JJ, 2005, METHOD ENZYMOL, V400, P511, DOI 10.1016/S0076-6879(05)00028-5; Gibson GG, 2006, DRUG METAB REV, V38, P31, DOI 10.1080/03602530600569810; Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200; Guzelian J, 2006, TOXICOL SCI, V94, P379, DOI 10.1093/toxsci/kfl116; Howe K, 2009, DRUG METAB DISPOS, V37, P391, DOI 10.1124/dmd.108.022921; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Khan AA, 2009, EUR J PHARM SCI, V37, P115, DOI 10.1016/j.ejps.2009.01.006; Kimura T, 2008, J HEALTH SCI, V54, P251, DOI 10.1248/jhs.54.251; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lichti-Kaiser K, 2009, J PHARMACOL EXP THER, V331, P65, DOI 10.1124/jpet.109.157180; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Makishima M, 2005, J PHARMACOL SCI, V97, P177, DOI 10.1254/jphs.FMJ04008X4; Masson D, 2005, ARTERIOSCL THROM VAS, V25, P2164, DOI 10.1161/01.ATV.0000183674.88817.fb; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nehring JA, 2007, P NATL ACAD SCI USA, V104, P10006, DOI 10.1073/pnas.0703512104; Nomoto M, 2009, BIOL PHARM BULL, V32, P172, DOI 10.1248/bpb.32.172; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Pascussi JM, 2000, MOL PHARMACOL, V58, P1441, DOI 10.1124/mol.58.6.1441; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Phillips A, 2005, DRUG METAB DISPOS, V33, P233, DOI 10.1124/dmd.104.001461; Plant KE, 2006, PHARMACOGENET GENOM, V16, P647, DOI 10.1097/01.fpc.0000220570.82842.4d; Plant N, 2004, TOXICOLOGY, V202, P21, DOI 10.1016/j.tox.2004.06.028; Plant N, 2009, XENOBIOTICA, V39, P597, DOI 10.1080/00498250903098218; Plant N, 2003, MOL TOXICOLOGY; Plant N, 2007, BBA-GEN SUBJECTS, V1770, P478, DOI 10.1016/j.bbagen.2006.09.024; Plant NJ, 2003, CURR OPIN DRUG DI DE, V6, P50; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Roberts RA, 1997, FUND APPL TOXICOL, V38, P107, DOI 10.1006/faat.1997.2331; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmiedlin-Ren P, 2001, DRUG METAB DISPOS, V29, P1446; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Slatter JG, 2006, XENOBIOTICA, V36, P902, DOI 10.1080/00498250600861694; Smirlis D, 2001, J BIOL CHEM, V276, P12822, DOI 10.1074/jbc.M005930200; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Tan KP, 2007, MOL PHARMACOL, V72, P1380, DOI 10.1124/mol.107.039370; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175	51	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16703	10.1371/journal.pone.0016703	http://dx.doi.org/10.1371/journal.pone.0016703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311750	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200034
J	Hnilicova, J; Hozeifi, S; Duskova, E; Icha, J; Tomankova, T; Stanek, D				Hnilicova, Jarmila; Hozeifi, Samira; Duskova, Eva; Icha, Jaroslav; Tomankova, Tereza; Stanek, David			Histone Deacetylase Activity Modulates Alternative Splicing	PLOS ONE			English	Article							PRE-MESSENGER-RNA; FIBRONECTIN EIIIB EXON; II TRANSCRIPTION; SR PROTEINS; IN-VIVO; CHROMATIN; ELONGATION; POLYMERASE; ACETYLATION; RECRUITMENT	There is increasing evidence to suggest that splicing decisions are largely made when the nascent RNA is still associated with chromatin. Here we demonstrate that activity of histone deacetylases (HDACs) influences splice site selection. Using splicing-sensitive microarrays, we identified similar to 700 genes whose splicing was altered after HDAC inhibition. We provided evidence that HDAC inhibition induced histone H4 acetylation and increased RNA Polymerase II (Pol II) processivity along an alternatively spliced element. In addition, HDAC inhibition reduced co-transcriptional association of the splicing regulator SRp40 with the target fibronectin exon. We further showed that the depletion of HDAC1 had similar effect on fibronectin alternative splicing as global HDAC inhibition. Importantly, this effect was reversed upon expression of mouse HDAC1 but not a catalytically inactive mutant. These results provide a molecular insight into a complex modulation of splicing by HDACs and chromatin modifications.	[Hnilicova, Jarmila; Hozeifi, Samira; Duskova, Eva; Icha, Jaroslav; Tomankova, Tereza; Stanek, David] Inst Mol Genet AS CR, Dept RNA Biol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Hnilicova, J (corresponding author), Inst Mol Genet AS CR, Dept RNA Biol, Prague, Czech Republic.	stanek@img.cas.cz	Stanek, David/G-9576-2013; Hnilicova, Jarmila/J-5019-2014; Dyskova, Tereza/A-3026-2015	Stanek, David/0000-0002-5865-175X; Hnilicova, Jarmila/0000-0002-0953-491X; Dyskova, Tereza/0000-0003-1705-4657; Icha, Jaroslav/0000-0002-0657-3278	Max Planck Society; Czech Science Foundation [P305/10/0424]; Academy of Sciences of the Czech Republic [KAN200520801, AV0Z50520514]	Max Planck Society(Max Planck Society); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This project was supported by grants from the Max Planck Society (the Partner group program), the Czech Science Foundation (P305/10/0424) and from the Academy of Sciences of the Czech Republic (KAN200520801, AV0Z50520514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Blackwell L, 2008, LIFE SCI, V82, P1050, DOI 10.1016/j.lfs.2008.03.004; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Das R, 2006, GENE DEV, V20, P1100, DOI 10.1101/gad.1397406; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Huranova M, 2009, HUM MOL GENET, V18, P2014, DOI 10.1093/hmg/ddp125; Irimia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005800; Kadener S, 2002, P NATL ACAD SCI USA, V99, P8185, DOI 10.1073/pnas.122246099; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Kotovic KM, 2003, MOL CELL BIOL, V23, P5768, DOI 10.1128/MCB.23.16.5768-5779.2003; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lim LP, 1998, MOL CELL BIOL, V18, P3900, DOI 10.1128/MCB.18.7.3900; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; NORTON PA, 1993, BIOCHEM BIOPH RES CO, V195, P215, DOI 10.1006/bbrc.1993.2032; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; TILGNER H, 2009, NAT STRUCT MOL BIOL; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhou JH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S10	55	104	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16727	10.1371/journal.pone.0016727	http://dx.doi.org/10.1371/journal.pone.0016727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311748	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200036
J	Jaiswal, AS; Banerjee, S; Aneja, R; Sarkar, FH; Ostrov, DA; Narayan, S				Jaiswal, Aruna S.; Banerjee, Sanjeev; Aneja, Ritu; Sarkar, Fazlul H.; Ostrov, David A.; Narayan, Satya			DNA Polymerase beta as a Novel Target for Chemotherapeutic Intervention of Colorectal Cancer	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; BASE EXCISION-REPAIR; MISMATCH REPAIR; LONG-PATCH; CELL-LINES; PHASE-I; TEMOZOLOMIDE; APC; MUTATIONS; PROTEIN	Chemoprevention presents a major strategy for the medical management of colorectal cancer. Most drugs used for colorectal cancer therapy induce DNA-alkylation damage, which is primarily repaired by the base excision repair (BER) pathway. Thus, blockade of BER pathway is an attractive option to inhibit the spread of colorectal cancer. Using an in silico approach, we performed a structure-based screen by docking small-molecules onto DNA polymerase beta (Pol-beta) and identified a potent anti-Pol-beta compound, NSC-124854. Our goal was to examine whether NSC-124854 could enhance the therapeutic efficacy of DNA-alkylating agent, Temozolomide (TMZ), by blocking BER. First, we determined the specificity of NSC-124854 for Pol-beta by examining in vitro activities of APE1, Fen1, DNA ligase I, and Pol-beta-directed single nucleotide (SN)and long-patch (LP)-BER. Second, we investigated the effect of NSC-124854 on the efficacy of TMZ to inhibit the growth of mismatch repair (MMR)-deficient and MMR-proficient colon cancer cell lines using in vitro clonogenic assays. Third, we explored the effect of NSC-124854 on TMZ-induced in vivo tumor growth inhibition of MMR-deficient and MMR-proficient colonic xenografts implanted in female homozygous SCID mice. Our data showed that NSC-124854 has high specificity to Pol-beta and blocked Pol-beta-directed SN- and LP-BER activities in in vitro reconstituted system. Furthermore, NSC-124854 effectively induced the sensitivity of TMZ to MMR-deficient and MMR-proficient colon cancer cells both in vitro cell culture and in vivo xenograft models. Our findings suggest a potential novel strategy for the development of highly specific structure-based inhibitor for the prevention of colonic tumor progression.	[Jaiswal, Aruna S.; Narayan, Satya] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Ostrov, David A.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	State University System of Florida; University of Florida; Barbara Ann Karmanos Cancer Institute; Wayne State University; University System of Georgia; Georgia State University; State University System of Florida; University of Florida	Jaiswal, AS (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	snarayan@ufl.edu			National Cancer Institute, National Institutes of Health, Bethesda, MD, USA [R01 CA-097031, CA-100247]; NATIONAL CANCER INSTITUTE [R01CA100247, R01CA097031] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute, National Institutes of Health, Bethesda, MD, USA (R01 CA-097031 and CA-100247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2010, ONCOLOGY-NY, V24, P417; Adhikari S, 2008, ANTI-CANCER AGENT ME, V8, P351, DOI 10.2174/187152008784220366; Balusu R, 2007, BIOCHEMISTRY-US, V46, P13961, DOI 10.1021/bi701632e; Barcellos GB, 2008, CURR DRUG TARGETS, V9, P1084, DOI 10.2174/138945008786949388; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bei R, 2010, RECENT PAT ANTI-CANC, V5, P172, DOI 10.2174/157489210791760526; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brandes AA, 2002, ONCOLOGY-BASEL, V63, P38, DOI 10.1159/000065718; Cai W, 2010, BRIT J CANCER, V103, P1369, DOI 10.1038/sj.bjc.6605927; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P327, DOI 10.2174/138945010790711941; Deka J, 1999, ONCOGENE, V18, P5654, DOI 10.1038/sj.onc.1202944; Dhaliwal B., 2009, Infectious Disorders - Drug Targets, V9, P557; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hainsworth JD, 2010, CANCER-AM CANCER SOC, V116, P3663, DOI 10.1002/cncr.25275; Horton JK, 2007, DNA REPAIR, V6, P530, DOI 10.1016/j.dnarep.2006.10.016; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Jacob S, 2001, CANCER RES, V61, P6555; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Jaiswal AS, 2006, BIOCHEMISTRY-US, V45, P15903, DOI 10.1021/bi0607958; Jaiswal AS, 2009, MOL CANCER RES, V7, P1973, DOI 10.1158/1541-7786.MCR-09-0309; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Khan OA, 2008, BRIT J CANCER, V98, P1614, DOI 10.1038/sj.bjc.6604366; KOI M, 1994, CANCER RES, V54, P4308; Kouzmenko AP, 2008, ONCOGENE, V27, P4888, DOI 10.1038/onc.2008.127; Kroemer RT, 2007, CURR PROTEIN PEPT SC, V8, P312; Kundu CN, 2007, ONCOGENE, V26, P1428, DOI 10.1038/sj.onc.1209925; Kundu CN, 2007, CARCINOGENESIS, V28, P2089, DOI 10.1093/carcin/bgm125; Liu L, 1999, CLIN CANCER RES, V5, P2908; Liu Lili, 2004, Curr Opin Investig Drugs, V5, P623; Liu LL, 2002, CLIN CANCER RES, V8, P2985; Liu LL, 1996, CANCER RES, V56, P5375; Liu LL, 2006, CLIN CANCER RES, V12, P328, DOI 10.1158/1078-0432.CCR-05-2543; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Narayan S, 2005, J BIOL CHEM, V280, P6942, DOI 10.1074/jbc.M409200200; Narayan Satya, 2003, Mol Cancer, V2, P41, DOI 10.1186/1476-4598-2-41; NEWLANDS ES, 1992, BRIT J CANCER, V65, P287, DOI 10.1038/bjc.1992.57; Panda H, 2009, BIOCHEMISTRY-US, V48, P9952, DOI 10.1021/bi9010754; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Seiter K, 2002, J CLIN ONCOL, V20, P3249, DOI 10.1200/JCO.2002.01.030; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Spiro TP, 2001, CLIN CANCER RES, V7, P2309; Taverna P, 2000, CANCER CHEMOTH PHARM, V46, P507, DOI 10.1007/s002800000186; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Tentori L, 1998, J PHARMACOL EXP THER, V285, P884; Thompson Patricia A, 2009, Expert Rev Gastroenterol Hepatol, V3, P369, DOI 10.1586/egh.09.28; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Trudeau ME, 2006, ANN ONCOL, V17, P952, DOI 10.1093/annonc/mdl056; Veselovsky A. V., 2003, Current Drug Targets - Infectious Disorders, V3, P33, DOI 10.2174/1568005033342145; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	67	38	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16691	10.1371/journal.pone.0016691	http://dx.doi.org/10.1371/journal.pone.0016691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311763	Green Published, gold			2022-12-27	WOS:000287036200032
J	Margam, VM; Coates, BS; Hellmich, RL; Agunbiade, T; Seufferheld, MJ; Sun, WL; Ba, MN; Sanon, A; Binso-Dabire, CL; Baoua, I; Ishiyaku, MF; Covas, FG; Srinivasan, R; Armstrong, J; Murdock, LL; Pittendrigh, BR				Margam, Venu M.; Coates, Brad S.; Hellmich, Richard L.; Agunbiade, Tolulope; Seufferheld, Manfredo J.; Sun, Weilin; Ba, Malick N.; Sanon, Antoine; Binso-Dabire, Clementine L.; Baoua, Ibrahim; Ishiyaku, Mohammad F.; Covas, Fernando G.; Srinivasan, Ramasamy; Armstrong, Joel; Murdock, Larry L.; Pittendrigh, Barry R.			Mitochondrial Genome Sequence and Expression Profiling for the Legume Pod Borer Maruca vitrata (Lepidoptera: Crambidae)	PLOS ONE			English	Article							TRANSFER-RNA GENES; MESSENGER-RNA; NUCLEOTIDE-SEQUENCE; PUNCTUATION MODEL; CODON USAGE; TRANSCRIPTION; DNA; DROSOPHILA; IDENTIFICATION; TRANSLATION	We report the assembly of the 14,054 bp near complete sequencing of the mitochondrial genome of the legume pod borer (LPB), Maruca vitrata (Lepidoptera: Crambidae), which we subsequently used to estimate divergence and relationships within the lepidopteran lineage. The arrangement and orientation of the 13 protein-coding, 2 rRNA, and 19 tRNA genes sequenced was typical of insect mitochondrial DNA sequences described to date. The sequence contained a high A+T content of 80.1% and a bias for the use of codons with A or T nucleotides in the 3rd position. Transcript mapping with midgut and salivary gland ESTs for mitochondrial genome annotation showed that translation from protein-coding genes initiates and terminates at standard mitochondrial codons, except for the coxI gene, which may start from an arginine CGA codon. The genomic copy of coxII terminates at a T nucleotide, and a proposed polyadenylation mechanism for completion of the TAA stop codon was confirmed by comparisons to EST data. EST contig data further showed that mature M. vitrata mitochondrial transcripts are monocistronic, except for bicistronic transcripts for overlapping genes nd4/nd4L and nd6/cytb, and a tricistronic transcript for atp8/atp6/coxIII. This processing of polycistronic mitochondrial transcripts adheres to the tRNA punctuated cleavage mechanism, whereby mature transcripts are cleaved only at intervening tRNA gene sequences. In contrast, the tricistronic atp8/atp6/coxIII in Drosophila is present as separate atp8/atp6 and coxIII transcripts despite the lack of an intervening tRNA. Our results indicate that mitochondrial processing mechanisms vary between arthropod species, and that it is crucial to use transcriptional information to obtain full annotation of mitochondrial genomes.	[Margam, Venu M.; Murdock, Larry L.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Coates, Brad S.; Hellmich, Richard L.] Iowa State Univ, USDA ARS, Corn Insect & Crop Genet Res Unit, Genet Lab, Ames, IA USA; [Agunbiade, Tolulope; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Champaign, IL 61820 USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Champaign, IL 61820 USA; [Ba, Malick N.; Sanon, Antoine; Binso-Dabire, Clementine L.] Inst Environm & Rech Agricoles INERA, Stn Kamboinse, Ouagadougou, Burkina Faso; [Baoua, Ibrahim] Inst Natl Rech Agron Niger, Maradi, Niger; [Ishiyaku, Mohammad F.] Ahmadu Bello Univ, Inst Agr Res, Dept Plant Sci, Zaria, Nigeria; [Covas, Fernando G.] Univ Puerto Rico, Mayaguez, PR USA; [Srinivasan, Ramasamy] AVRDC World Vegetable Ctr, Tainan, Taiwan; [Armstrong, Joel] Commonweatlth Sci & Ind Res Org, Black Mt, ACT, Australia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Ahmadu Bello University; Institute for Agricultural Research, Samaru, Zaria; University of Puerto Rico; University of Puerto Rico Mayaguez; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Margam, VM (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	pittendr@illinois.edu	Sanon, Antoine/H-7203-2016; Ramasamy, Srinivasan/N-1686-2019; Ba, Malick Niango/I-8557-2012; Armstrong, Joel/E-6873-2011; Margam, Venu M/E-5876-2010	Sanon, Antoine/0000-0002-2046-8503; Ramasamy, Srinivasan/0000-0002-8454-7331; Ba, Malick Niango/0000-0001-7323-8739; Margam, Venu/0000-0001-6510-4618; Coates, Brad/0000-0001-8908-1529	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005]	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID))	This research has been made possible through support provided to the Dry Grains Pulses Collaborative Research Support Program (CRSP) by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Grant No. EDH-A-00-07-00005. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arodokoun DY, 2006, AGR ECOSYST ENVIRON, V113, P320, DOI 10.1016/j.agee.2005.10.014; BERTHIER F, 1986, NUCLEIC ACIDS RES, V14, P4519, DOI 10.1093/nar/14.11.4519; BINDRA OS, 1968, 2 ANN WORKSH PULS CR; Bobrowicz AJ, 2008, BIOCHEM SOC T, V36, P517, DOI 10.1042/BST0360517; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bravo JP, 2008, BRAZ ARCH BIOL TECHN, V51, P671, DOI 10.1590/S1516-89132008000400004; CHINH NT, 2000, LEGUMES RICE BASED C, P111; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; CHURCHILL GA, 1989, B MATH BIOL, V51, P79; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Coates BS, 2005, INT J BIOL SCI, V1, P13; CROZIER RH, 1993, GENETICS, V133, P97; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hong GY, 2009, ACTA BIOCH BIOPH SIN, V41, P446, DOI 10.1093/abbs/gmp030; Huang CC, 2003, BIOCONTROL, V48, P407, DOI 10.1023/A:1024751300838; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Jiang Wen-Ping, 2010, Yichuan, V32, P153, DOI 10.3724/SP.J.1005.2010.00153; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; KATAYAMA J, 1984, B KYOTO PREFECT I AG, V12, P27; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Kumar S, 2001, GENETICS, V158, P1321; Lee ES, 2006, GENE, V373, P52, DOI 10.1016/j.gene.2006.01.003; LEONARD M. D., 1931, Journal of Economic Entomology, V24, P466, DOI 10.1093/jee/24.2.466; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margam VM, 2010, MOL BIOL REP; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pan MH, 2008, SCI CHINA SER C, V51, P693, DOI 10.1007/s11427-008-0097-6; Patnaik H. P., 1986, Legume Research, V9, P7; Piechota J, 2006, ACTA BIOCHIM POL, V53, P157; Piwowarski J, 2003, J MOL BIOL, V329, P853, DOI 10.1016/S0022-2836(03)00528-X; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; RAHEJA AJ, 1974, P 1 IITA GRAIN LEG I, P295; RAHMAN MM, 1989, BANG J SCI RES, V7, P27; Ruppel RF, 1962, AGR TROP, V18, P650; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Samuels AK, 2005, GENE, V349, P43, DOI 10.1016/j.gene.2004.12.037; Scheibye-Alsing K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-367; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; SHARMA HC, 1999, INFORM B ICRISAT, V55; SINGH SR, 1979, ANNU REV ENTOMOL, V24, P255, DOI 10.1146/annurev.en.24.010179.001351; Soeun M., 2001, Legumes in rice-based cropping systems in tropical Asia: constraints and opportunities, P4; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor T. A., 1967, Journal of the West African Science Association, V12, P111; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Torres TT, 2009, NUCLEIC ACIDS RES, V37, P7509, DOI 10.1093/nar/gkp856; Ulrichs Ch., 2001, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V13, P283; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW84, DOI 10.1093/nar/gkl227; Xia XH, 1996, GENETICS, V144, P1309; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zardoya R, 2001, P NATL ACAD SCI USA, V98, P7380, DOI 10.1073/pnas.111455498	71	49	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16444	10.1371/journal.pone.0016444	http://dx.doi.org/10.1371/journal.pone.0016444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311752	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200013
J	Dal-Pan, A; Pifferi, F; Marchal, J; Picq, JL; Aujard, F				Dal-Pan, Alexandre; Pifferi, Fabien; Marchal, Julia; Picq, Jean-Luc; Aujard, Fabienne		RESTRIKAL Consortium	Cognitive Performances Are Selectively Enhanced during Chronic Caloric Restriction or Resveratrol Supplementation in a Primate	PLOS ONE			English	Article							MOUSE LEMUR PRIMATES; DIETARY RESTRICTION; OXIDATIVE STRESS; RHESUS-MONKEYS; LIFE-SPAN; MEMORY; RATS; DISEASE; BEHAVIOR; SYSTEM	Effects of an 18-month treatment with a moderate, chronic caloric restriction (CR) or an oral supplementation with resveratrol (RSV), a potential CR mimetic, on cognitive and motor performances were studied in non-human primates, grey mouse lemurs (Microcebus murinus). Thirty-three adult male mouse lemurs were assigned to three different groups: a control (CTL) group fed ad libitum, a CR group fed 70% of the CTL caloric intake, and an RSV group (RSV supplementation of 200 mg.kg(-1).day(-1)) fed ad libitum. Three different cognitive tests, two motor tests, one emotional test and an analysis of cortisol level were performed in each group. Compared to CTL animals, CR or RSV animals did not show any change in motor performances evaluated by rotarod and jump tests, but an increase in spontaneous locomotor activity was observed in both groups. Working memory was improved by both treatments in the spontaneous alternation task. Despite a trend for CR group, only RSV supplementation increased spatial memory performances in the circular platform task. Finally, none of these treatments induced additional stress to the animals as reflected by similar results in the open field test and cortisol analyses compared to CTL animals. The present data provided the earliest evidence for a beneficial effect of CR or RSV supplementation on specific cognitive functions in a primate. Taken together, these results suggest that RSV could be a good candidate to mimic long-term CR effects and support the growing evidences that nutritional interventions can have beneficial effects on brain functions even in adults.	[Dal-Pan, Alexandre; Pifferi, Fabien; Marchal, Julia; Aujard, Fabienne] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Picq, Jean-Luc] Univ Paris 08, Lab Psychopathol & Neuropsychol, UFR Psychol, St Denis, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite Paris-VIII	Dal-Pan, A (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France.	aujard@mnhn.fr		Pifferi, Fabien/0000-0001-9316-1935	French National Research Agency [ANR-06-PNRA-010-01]; Foundation for French Medical Research	French National Research Agency(French National Research Agency (ANR)); Foundation for French Medical Research	This work was carried out with the financial support of The French National Research Agency (project ANR-06-PNRA-010-01) and the Foundation for French Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM J, 2009, REJUVENATION RES, V12; Allard JS, 2009, MOL CELL ENDOCRINOL, V299, P58, DOI 10.1016/j.mce.2008.10.018; Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005; Antoniadis EA, 2000, BEHAV BRAIN RES, V111, P25, DOI 10.1016/S0166-4328(00)00145-5; Babovic D, 2008, NEUROSCIENCE, V155, P1021, DOI 10.1016/j.neuroscience.2008.07.006; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BATTIG K, 1960, J COMP PHYSIOL PSYCH, V53, P400, DOI 10.1037/h0047392; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; DALPAN A, 2010, AGE DORDR; DAS D, 2010, HEART FAILURE REV; Denburg NL, 2003, EMOTION, V3, P239, DOI 10.1037/1528-3542.3.3.239; Dhenain M, 2003, MAGNET RESON MED, V50, P984, DOI 10.1002/mrm.10612; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Genin F, 2000, PHYSIOL BEHAV, V71, P315, DOI 10.1016/S0031-9384(00)00335-8; Genin F, 2003, COMP BIOCHEM PHYS B, V136, P71, DOI 10.1016/S1096-4959(03)00172-6; GIROUD S, 2008, AM J PHYSIOL-REG I, pR1958; Giroud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008823; Gold PE, 2005, NEUROBIOL AGING, V26, pS60, DOI 10.1016/j.neurobiolaging.2005.09.002; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ingram DK, 2007, NEUROSCIENCE, V145, P1359, DOI 10.1016/j.neuroscience.2006.10.031; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; JONES DNC, 1995, J NEUROSCI, V15, P7282; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; KRASKA A, 2010, NEUROBIOLOGY AGING; Kumar A, 2007, PHARMACOLOGY, V79, P17, DOI 10.1159/000097511; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Markowska AL, 1999, NEUROBIOL AGING, V20, P177, DOI 10.1016/S0197-4580(99)00031-7; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; ROSSI L, 2008, NEUROCHEMICAL RES; SCHMATZ R, 2009, EUROPEAN J IN PRESS; Sharma M, 2002, LIFE SCI, V71, P2489, DOI 10.1016/S0024-3205(02)02083-0; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; SPINDLER SR, 2009, AGEING RES REV UNPUB; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5; Weatherall D., 2006, USE NONHUMAN PRIMATE; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Weindruch R, 2001, J GERONTOL A-BIOL, V56, P20, DOI 10.1093/gerona/56.suppl_1.20; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106; Wu AG, 2003, NEUROSCI LETT, V339, P166, DOI 10.1016/S0304-3940(03)00008-9; Yanai S, 2004, NEUROBIOL AGING, V25, P325, DOI 10.1016/S0197-4580(03)00115-5	52	93	95	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16581	10.1371/journal.pone.0016581	http://dx.doi.org/10.1371/journal.pone.0016581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304942	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300091
J	Flutre, T; Duprat, E; Feuillet, C; Quesneville, H				Flutre, Timothee; Duprat, Elodie; Feuillet, Catherine; Quesneville, Hadi			Considering Transposable Element Diversification in De Novo Annotation Approaches	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENOME SEQUENCE; TANDEM REPEATS; IDENTIFICATION; CLASSIFICATION; DNA; EVOLUTION; TRANSPOSITION; FAMILIES; EFFICIENT	Transposable elements (TEs) are mobile, repetitive DNA sequences that are almost ubiquitous in prokaryotic and eukaryotic genomes. They have a large impact on genome structure, function and evolution. With the recent development of high-throughput sequencing methods, many genome sequences have become available, making possible comparative studies of TE dynamics at an unprecedented scale. Several methods have been proposed for the de novo identification of TEs in sequenced genomes. Most begin with the detection of genomic repeats, but the subsequent steps for defining TE families differ. High-quality TE annotations are available for the Drosophila melanogaster and Arabidopsis thaliana genome sequences, providing a solid basis for the benchmarking of such methods. We compared the performance of specific algorithms for the clustering of interspersed repeats and found that only a particular combination of algorithms detected TE families with good recovery of the reference sequences. We then applied a new procedure for reconciling the different clustering results and classifying TE sequences. The whole approach was implemented in a pipeline using the REPET package. Finally, we show that our combined approach highlights the dynamics of well defined TE families by making it possible to identify structural variations among their copies. This approach makes it possible to annotate TE families and to study their diversification in a single analysis, improving our understanding of TE dynamics at the whole-genome scale and for diverse species.	[Flutre, Timothee; Quesneville, Hadi] INRA Ctr Versailles Grignon, Unite Rech Genom Info, UR 1164, Versailles, France; [Duprat, Elodie] Univ Paris Diderot, Inst Mineral & Phys Milieux Condenses, IPGP, UPMC,CNRS,UMR 7590, Paris, France; [Feuillet, Catherine] INRA Domaine Crouel, UMR 1095, Clermont Ferrand, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; INRAE	Flutre, T (corresponding author), INRA Ctr Versailles Grignon, Unite Rech Genom Info, UR 1164, Versailles, France.	Hadi.quesneville@versailles.inra.fr	Quesneville, Hadi/AAG-1048-2020	Quesneville, Hadi/0000-0003-3001-4908; Duprat, Elodie/0000-0003-4150-6967; Flutre, Timothee/0000-0003-4489-4782	Institut National de la Recherche Agronomique (INRA) (ASC); Universite Pierre et Marie Curie (UPMC) (ATER); Agence Nationale de la Recherche [ANR-05-MMSA-0010]	Institut National de la Recherche Agronomique (INRA) (ASC); Universite Pierre et Marie Curie (UPMC) (ATER); Agence Nationale de la Recherche(French National Research Agency (ANR))	Timothee Flutre was funded by the Institut National de la Recherche Agronomique (INRA) (ASC), Elodie Duprat held a fellowship from the Universite Pierre et Marie Curie (UPMC) (ATER) and this work was funded by a grant from the Agence Nationale de la Recherche (ANR-05-MMSA-0010) to Hadi Quesneville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*12 DROS GEN CONS, 2007, NATURE, V450, P203; ABAD P, 2008, NAT BIOTECHNOL, P909; Abrusan G, 2009, BIOINFORMATICS, V25, P1329, DOI 10.1093/bioinformatics/btp084; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Brookfield JFY, 2005, NAT REV GENET, V6, P128, DOI 10.1038/nrg1524; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2009, GENOME BIOL EVOL, V1, P205, DOI 10.1093/gbe/evp023; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Gu WJ, 2008, ANAL BIOCHEM, V380, P77, DOI 10.1016/j.ab.2008.05.015; Herpin A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000844; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Jiang N, 2002, PLANT PHYSIOL, V130, P1697, DOI 10.1104/pp.015412; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; MAYR E, 1981, SCIENCE, V214, P510, DOI 10.1126/science.214.4520.510; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Newman JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000031; NOTREDAME C, 2007, PLOS COMPUTATIONAL B, V3; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; QUESNEVILLE H, 2003, J MOL EVOLUATION, P57; Quesneville H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-214; Rasmussen KR, 2006, J COMPUT BIOL, V13, P296, DOI 10.1089/cmb.2006.13.296; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Saha S, 2008, NUCLEIC ACIDS RES, V36, P2284, DOI 10.1093/nar/gkn064; SANTANGELO A, 2007, PLOS GENETICS, V3; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Tempel S, 2007, GENE, V403, P18, DOI 10.1016/j.gene.2007.06.030; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	64	285	286	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16526	10.1371/journal.pone.0016526	http://dx.doi.org/10.1371/journal.pone.0016526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304975	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300077
J	Luque, SP; Fried, R				Luque, Sebastian P.; Fried, Roland			Recursive Filtering for Zero Offset Correction of Diving Depth Time Series with GNU R Package diveMove	PLOS ONE			English	Article							LEATHERBACK TURTLES; DERMOCHELYS-CORIACEA; BEHAVIOR; MIGRATION; PENGUINS	Zero offset correction of diving depth measured by time-depth recorders is required to remove artifacts arising from temporal changes in accuracy of pressure transducers. Currently used methods for this procedure are in the proprietary software domain, where researchers cannot study it in sufficient detail, so they have little or no control over how their data were changed. GNU R package diveMove implements a procedure in the Free Software domain that consists of recursively smoothing and filtering the input time series using moving quantiles. This paper describes, demonstrates, and evaluates the proposed method by using a "perfect" data set, which is subsequently corrupted to provide input for the proposed procedure. The method is evaluated by comparing the corrected time series to the original, uncorrupted, data set from an Antarctic fur seal (Arctocephalus gazella Peters, 1875). The Root Mean Square Error of the corrected data set, relative to the "perfect" data set, was nearly identical to the magnitude of noise introduced into the latter. The method, thus, provides a flexible, reliable, and efficient mechanism to perform zero offset correction for analyses of diving behaviour. We illustrate applications of the method to data sets from four species with large differences in diving behaviour, measured using different sampling protocols and instrument characteristics.	[Luque, Sebastian P.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Fried, Roland] Tech Univ Dortmund, Fak Stat, Dortmund, Germany	University of Manitoba; Dortmund University of Technology	Luque, SP (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	spluque@gmail.com	Fried, Roland/AAB-9091-2020	LUQUE, SONIA/0000-0002-3215-320X	Institut Polaire Francais Paul Emile Victor (IPEV); Centre National de la Recherche Scientifique	Institut Polaire Francais Paul Emile Victor (IPEV); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This research was funded by grants from Institut Polaire Francais Paul Emile Victor (IPEV) and Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Elliott KH, 2010, AQUAT BIOL, V8, P221, DOI 10.3354/ab00236; Fossette S, 2007, MAR ECOL PROG SER, V338, P233, DOI 10.3354/meps338233; Hays GC, 2004, ANIM BEHAV, V67, P733, DOI 10.1016/j.anbehav.2003.08.011; Hooker SK, 2001, MAMMAL REV, V31, P81, DOI 10.1046/j.1365-2907.2001.00080.x; Houghton JDR, 2008, J EXP BIOL, V211, P2566, DOI 10.1242/jeb.020065; Hull CL, 2000, CAN J ZOOL, V78, P333, DOI 10.1139/cjz-78-3-333; Laidre KL, 2002, CAN J ZOOL, V80, P624, DOI 10.1139/Z02-041; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; Scheffer A, 2010, PROG OCEANOGR, V86, P232, DOI 10.1016/j.pocean.2010.04.008; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Spence-Bailey LM, 2007, J COMP PHYSIOL B, V177, P483, DOI 10.1007/s00360-007-0146-7; Tuszynski J., 2009, CATOOLS TOOLS MOVING; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101	15	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e15850	10.1371/journal.pone.0015850	http://dx.doi.org/10.1371/journal.pone.0015850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297976	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100011
J	Zhu, DL; Shi, JP; Zhang, YD; Wang, BR; Liu, W; Chen, ZC; Tong, QA				Zhu, Donglin; Shi, Jingping; Zhang, Yingdong; Wang, Bianrong; Liu, Wei; Chen, Zhicong; Tong, Qiang			Central Angiotensin II Stimulation Promotes beta Amyloid Production in Sprague Dawley Rats	PLOS ONE			English	Article							AT(1) RECEPTOR EXPRESSION; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PRECURSOR PROTEIN; ALPHA-SECRETASE; UP-REGULATION; PARAVENTRICULAR NUCLEUS; COGNITIVE IMPAIRMENT; STRESS INCREASES; TAU PATHOLOGY	Background: Stress and various stress hormones, including catecholamines and glucocorticoids, have recently been implicated in the pathogenesis of Alzheimer's disease (AD), which represents the greatest unresolved medical challenge in neurology. Angiotensin receptor blockers have shown benefits in AD and prone-to-AD animals. However, the mechanisms responsible for their efficacy remain unknown, and no studies have directly addressed the role of central angiotensin II (Ang II), a fundamental stress hormone, in the pathogenesis of AD. The present study focused on the role of central Ang II in amyloidogenesis, the critical process in AD neuropathology, and aimed to provide direct evidence for the role of this stress hormone in the pathogenesis of AD. Methodology/Principal Findings: Increased central Ang II levels during stress response were modeled by intracerebroventricular (ICV) administration of graded doses of Ang II (6 ng/hr low dose, 60 ng/hr medium dose, and 600 ng/hr high dose, all delivered at a rate of 0.25 mu l/hr) to male Sprague Dawley rats (280-310 g) via osmotic pumps. After 1 week of continuous Ang II infusion, the stimulation of Ang II type 1 receptors was accompanied by the modulation of amyloid precursor protein, alpha-, beta- and gamma-secretase, and increased beta amyloid production. These effects could be completely abolished by concomitant ICV infusion of losartan, indicating that central Ang II played a causative role in these alterations. Conclusions/Significance: Central Ang II is essential to the stress response, and the results of this study suggest that increased central Ang II levels play an important role in amyloidogenesis during stress, and that central Ang II-directed stress prevention and treatment might represent a novel anti-AD strategy.	[Zhu, Donglin; Shi, Jingping; Zhang, Yingdong; Liu, Wei; Chen, Zhicong; Tong, Qiang] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Peoples R China; [Wang, Bianrong] Nanjing Univ, Sch Med, Dept Neurol, Nanjing 210008, Peoples R China	Nanjing Medical University; Nanjing University	Zhu, DL (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Peoples R China.	profshijp@yahoo.com.cn	Shi, Jing/HHS-6413-2022		Medical Science and Technology Development Foundation, Nanjing Department of Health [ZKX08035]	Medical Science and Technology Development Foundation, Nanjing Department of Health	This study is supported by Key Project of Medical Science and Technology Development Foundation, Nanjing Department of Health (NO.ZKX08035, http://www.njh.gov.cn/html/list_83.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1995, J NEUROENDOCRINOL, V7, P775, DOI 10.1111/j.1365-2826.1995.tb00714.x; Armando I, 2001, ENDOCRINOLOGY, V142, P3880, DOI 10.1210/en.142.9.3880; BARNES JM, 1989, BRAIN RES, V491, P136, DOI 10.1016/0006-8993(89)90095-4; BARNES JM, 1990, BRAIN RES, V507, P341, DOI 10.1016/0006-8993(90)90294-L; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Carter DB, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-6; CASTREN E, 1988, ENDOCRINOLOGY, V122, P370, DOI 10.1210/endo-122-1-370; Chan SHH, 2007, J HYPERTENS, V25, P1845, DOI 10.1097/HJH.0b013e328217b286; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Danielyan L, 2010, REJUV RES, V13, P195, DOI 10.1089/rej.2009.0944; Das U N, 2005, J Assoc Physicians India, V53, P472; de la Torre JC, 2010, J ALZHEIMERS DIS, V20, P687, DOI 10.3233/JAD-2010-091580; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fogari R, 2003, J HUM HYPERTENS, V17, P781, DOI 10.1038/sj.jhh.1001613; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hamdi HK, 2004, BIOCHEM BIOPH RES CO, V318, P187, DOI 10.1016/j.bbrc.2004.04.004; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Huttunen HJ, 2007, FEBS LETT, V581, P1688, DOI 10.1016/j.febslet.2007.03.056; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lahiri Debomoy K., 2006, Current Alzheimer Research, V3, P475, DOI 10.2174/156720506779025224; Lee S, 2008, BRAIN RES, V1207, P19, DOI 10.1016/j.brainres.2008.02.016; Lee Sebum, 2010, Front Biosci (Elite Ed), V2, P22, DOI 10.2741/e61; Leong DS, 2002, NEUROENDOCRINOLOGY, V75, P227, DOI 10.1159/000054714; Li WZ, 2010, EUR J PHARMACOL, V628, P108, DOI 10.1016/j.ejphar.2009.11.045; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu L, 2008, NEUROBIOL DIS, V31, P46, DOI 10.1016/j.nbd.2008.03.005; Lu J, 2008, BRAIN RES, V1219, P127, DOI 10.1016/j.brainres.2008.04.057; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Mitsuda N, 2001, J BIOL CHEM, V276, P9688, DOI 10.1074/jbc.M006153200; Moellenhoff E, 2001, AM J PHYSIOL-REG I, V280, pR1095, DOI 10.1152/ajpregu.2001.280.4.R1095; Mogi M, 2008, BIOCHEM BIOPH RES CO, V375, P446, DOI 10.1016/j.bbrc.2008.08.032; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nishida Y, 2009, J BIOL CHEM, V284, P33400, DOI 10.1074/jbc.M109.054056; Pan YX, 2007, HYPERTENSION, V49, P519, DOI 10.1161/01.HYP.0000256955.74461.93; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Peng JF, 2001, REGUL PEPTIDES, V97, P91, DOI 10.1016/S0167-0115(00)00218-4; Poon IO, 2008, PHARMACOTHERAPY, V28, P366, DOI 10.1592/phco.28.3.366; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Quiroz-Baez R, 2009, NEUROCHEM INT, V55, P662, DOI 10.1016/j.neuint.2009.06.012; Raghavendra V, 2001, NEUROPEPTIDES, V35, P65, DOI 10.1054/npep.2000.0845; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Saavedra JM, 2007, STRESS, V10, P185, DOI 10.1080/10253890701350735; Saavedra JM, 2006, J HYPERTENS, V24, pS131, DOI 10.1097/01.hjh.0000220418.09021.ee; Salloway S, 2009, CLEV CLIN J MED, V76, P49, DOI 10.3949/ccjm.76a.072178; Savaskan E, 2001, NEUROBIOL AGING, V22, P541, DOI 10.1016/S0197-4580(00)00259-1; Savaskan E, 1991, DEMENT GERIATR COGN, V2, P314; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; SUMNERS C, 1983, AM J PHYSIOL, V244, pR257, DOI 10.1152/ajpregu.1983.244.2.R257; Sumners C, 2002, CLIN EXP PHARMACOL P, V29, P483, DOI 10.1046/j.1440-1681.2002.03660.x; Takeda S, 2009, HYPERTENSION, V54, P1345, DOI 10.1161/HYPERTENSIONAHA.109.138586; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tan ZS, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt29; Tedesco MA, 1999, AM J HYPERTENS, V12, p117A; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tota S, 2009, BEHAV BRAIN RES, V199, P235, DOI 10.1016/j.bbr.2008.11.044; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wei SG, 2008, HYPERTENSION, V52, P679, DOI 10.1161/HYPERTENSIONAHA.108.113639; Wei SG, 2009, AM J PHYSIOL-HEART C, V296, pH1425, DOI 10.1152/ajpheart.00942.2008; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Wray S, 2009, J NEUROSCI, V29, P9665, DOI 10.1523/JNEUROSCI.2234-09.2009; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang G, 1996, BIOL SIGNAL, V5, P1; Yang Gang, 1993, Biological Signals, V2, P166; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Yu NN, 2010, BRAIN RES, V1317, P305, DOI 10.1016/j.brainres.2009.12.087; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	89	76	78	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16037	10.1371/journal.pone.0016037	http://dx.doi.org/10.1371/journal.pone.0016037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297982	gold, Green Submitted, Green Published			2022-12-27	WOS:000286664100012
J	Otsubo, T; Akiyama, Y; Hashimoto, Y; Shimada, S; Goto, K; Yuasa, Y				Otsubo, Takeshi; Akiyama, Yoshimitsu; Hashimoto, Yutaka; Shimada, Shu; Goto, Kentaro; Yuasa, Yasuhito			MicroRNA-126 Inhibits SOX2 Expression and Contributes to Gastric Carcinogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; VASCULAR INTEGRITY; CYCLE ARREST; CANCER; MIR-126; GROWTH; DIFFERENTIATION; TARGETS; GENE	Background: SRY (sex-determining region Y)-box 2 (SOX2) is a crucial transcription factor for the maintenance of embryonic stem cell pluripotency and the determination of cell fate. Previously, we demonstrated that SOX2 plays important roles in growth inhibition through cell cycle arrest and apoptosis, and that SOX2 expression is frequently down-regulated in gastric cancers. However, the mechanisms underlying loss of SOX2 expression and its target genes involved in gastric carcinogenesis remain largely unknown. Here, we assessed whether microRNAs ( miRNAs) regulate SOX2 expression in gastric cancers. Furthermore, we attempted to find downstream target genes of SOX2 contributing to gastric carcinogenesis. Methodology/Principal Findings: We performed in silico analysis and focused on miRNA-126 (miR-126) as a potential SOX2 regulator. Gain-and loss-of function experiments and luciferase assays revealed that miR-126 inhibited SOX2 expression by targeting two binding sites in the 3'-untranslated region (3'-UTR) of SOX2 mRNA in multiple cell lines. In addition, miR-126 was highly expressed in some cultured and primary gastric cancer cells with low SOX2 protein levels. Furthermore, exogenous miR-126 over-expression as well as siRNA-mediated knockdown of SOX2 significantly enhanced the anchorage-dependent and -independent growth of gastric cancer cell lines. We next performed microarray analysis after SOX2 overexpression in a gastric cancer cell line, and found that expression of the placenta-specific 1 (PLAC1) gene was significantly down-regulated by SOX2 over-expression. siRNA- and miR-126-mediated SOX2 knockdown experiments revealed that miR-126 positively regulated PLAC1 expression through suppression of SOX2 expression in gastric cancer cells. Conclusions: Taken together, our results indicate that miR-126 is a novel miRNA that targets SOX2, and PLAC1 may be a novel downstream target gene of SOX2 in gastric cancer cells. These findings suggest that aberrant over-expression of miR-126 and consequent SOX2 down-regulation may contribute to gastric carcinogenesis.	[Otsubo, Takeshi; Akiyama, Yoshimitsu; Hashimoto, Yutaka; Shimada, Shu; Goto, Kentaro; Yuasa, Yasuhito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Otsubo, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	yuasa.monc@tmd.ac.jp	Goto, Kentaro/ABF-8384-2021; Otsubo, Takeshi/G-6123-2014; Hashimoto, Yutaka/B-9821-2017	Goto, Kentaro/0000-0002-0089-9779; Hashimoto, Yutaka/0000-0003-2188-2957	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for the Promotion of Science (JSPS) A3 Foresight Program (YY and YA), and Research Fellowships of JSPS for Young Scientists (TO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cammarata G, 2010, AM J HEMATOL, V85, P331, DOI 10.1002/ajh.21667; Chen Jing, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P124; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fant M, 2010, PRENATAL DIAG, V30, P497, DOI 10.1002/pd.2506; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li XL, 2004, INT J ONCOL, V24, P257; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Tani Y, 2007, J CANCER RES CLIN, V133, P263, DOI 10.1007/s00432-006-0165-x; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	36	141	160	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16617	10.1371/journal.pone.0016617	http://dx.doi.org/10.1371/journal.pone.0016617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304604	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900081
J	Sun, XY; Hayashi, Y; Xu, S; Kanou, Y; Takagishi, Y; Tang, YP; Murata, Y				Sun, Xiao-yang; Hayashi, Yoshitaka; Xu, Sai; Kanou, Yasuhiko; Takagishi, Yoshiko; Tang, Ya-ping; Murata, Yoshiharu			Inactivation of the Rcan2 Gene in Mice Ameliorates the Age- and Diet-Induced Obesity by Causing a Reduction in Food Intake	PLOS ONE			English	Article							THYROID-HORMONE; ENERGY-EXPENDITURE; CALCINEURIN; LEPTIN; FAT; ZAKI-4; FAMILY; HYPOTHALAMUS; EXPRESSION; REGULATORS	Obesity is a serious international health problem that increases the risk of several diet-related chronic diseases. The genetic factors predisposing to obesity are little understood. Rcan2 was originally identified as a thyroid hormone-responsive gene. In the mouse, two splicing variants that harbor distinct tissue-specific expression patterns have been identified: Rcan2-3 is expressed predominately in the brain, whereas Rcan2-1 is expressed in the brain and other tissues such as the heart and skeletal muscle. Here, we show that Rcan2 plays an important role in the development of age-and diet-induced obesity. We found that although the loss of Rcan2 function in mice slowed growth in the first few weeks after birth, it also significantly ameliorated age-and diet-induced obesity in the mice by causing a reduction in food intake rather than increased energy expenditure. Rcan2 expression was most prominent in the ventromedial, dorsomedial and paraventricular hypothalamic nuclei governing energy balance. Fasting and refeeding experiment showed that only Rcan2-3 mRNA expression is upregulated in the hypothalamus by fasting, and loss of Rcan2 significantly attenuates the hyperphagic response to starvation. Using double-mutant (Lep(ob/ob) Rcan2(-/-)) mice, we were also able to demonstrate that Rcan2 and leptin regulate body weight through different pathways. Our findings indicate that there may be an Rcan2-dependent mechanism which regulates food intake and promotes weight gain through a leptin-independent pathway. This study provides novel information on the control of body weight in mice and should improve our understanding of the mechanisms of obesity in humans.	[Sun, Xiao-yang; Hayashi, Yoshitaka; Xu, Sai; Kanou, Yasuhiko; Takagishi, Yoshiko; Murata, Yoshiharu] Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Recognit, Nagoya, Aichi 464, Japan; [Tang, Ya-ping] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA	Nagoya University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sun, XY (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Recognit, Nagoya, Aichi 464, Japan.	ymurata@riem.nagoya-u.ac.jp	Tang, Ya-Ping/A-1035-2011; Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Tang, Ya-Ping/0000-0002-0445-4072	Ministry of Education, Science, Sports and Culture, Japan [14370324]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research (B) No. 14370324 and by the 21st Century COE program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" from the Ministry of Education, Science, Sports and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P827, DOI 10.1111/j.1365-2826.2008.01721.x; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Miyazaki T, 1996, J BIOL CHEM, V271, P14567, DOI 10.1074/jbc.271.24.14567; Mizuno Y, 2004, EUR J ENDOCRINOL, V150, P371, DOI 10.1530/eje.0.1500371; Morgan PJ, 2006, PROG BRAIN RES, V153, P325, DOI 10.1016/S0079-6123(06)53019-5; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Sola C, 1999, J NEUROSCI RES, V57, P651, DOI 10.1002/(SICI)1097-4547(19990901)57:5<651::AID-JNR7>3.0.CO;2-G; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	35	16	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14605	10.1371/journal.pone.0014605	http://dx.doi.org/10.1371/journal.pone.0014605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298050	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900009
J	Vigan-Womas, I; Guillotte, M; Juillerat, A; Vallieres, C; Lewit-Bentley, A; Tall, A; Baril, L; Bentley, GA; Mercereau-Puijalon, O				Vigan-Womas, Ines; Guillotte, Micheline; Juillerat, Alexandre; Vallieres, Cindy; Lewit-Bentley, Anita; Tall, Adama; Baril, Laurence; Bentley, Graham A.; Mercereau-Puijalon, Odile			Allelic Diversity of the Plasmodium falciparum Erythrocyte Membrane Protein 1 Entails Variant-Specific Red Cell Surface Epitopes	PLOS ONE			English	Article							CROSS-REACTIVE ANTIBODIES; PREGNANCY-ASSOCIATED MALARIA; SEVERE CHILDHOOD MALARIA; CHONDROITIN SULFATE-A; VAR GENE-EXPRESSION; INFECTED ERYTHROCYTES; FUNCTIONAL SPECIALIZATION; ACQUIRED-IMMUNITY; CLINICAL MALARIA; CEREBRAL MALARIA	The clonally variant Plasmodium falciparum PfEMP1 adhesin is a virulence factor and a prime target of humoral immunity. It is encoded by a repertoire of functionally differentiated var genes, which display architectural diversity and allelic polymorphism. Their serological relationship is key to understanding the evolutionary constraints on this gene family and rational vaccine design. Here, we investigated the Palo Alto/VarO and IT4/R29 and 3D7/PF13_003 parasites lines. VarO and R29 form rosettes with uninfected erythrocytes, a phenotype associated with severe malaria. They express an allelic Cys2/group A NTS-DBL1 alpha(1) PfEMP1 domain implicated in rosetting, whose 3D7 ortholog is encoded by PF13_0003. Using these three recombinant NTS-DBL1 alpha(1) domains, we elicited antibodies in mice that were used to develop monovariant cultures by panning selection. The 3D7/PF13_0003 parasites formed rosettes, revealing a correlation between sequence identity and virulence phenotype. The antibodies cross-reacted with the allelic domains in ELISA but only minimally with the Cys4/group B/C PFL1955w NTS-DBL1 alpha. By contrast, they were variant-specific in surface seroreactivity of the monovariant-infected red cells by FACS analysis and in rosette-disruption assays. Thus, while ELISA can differentiate serogroups, surface reactivity assays define the more restrictive serotypes. Irrespective of cumulated exposure to infection, antibodies acquired by humans living in a malaria-endemic area also displayed a variant-specific surface reactivity. Although seroprevalence exceeded 90% for each rosetting line, the kinetics of acquistion of surface-reactive antibodies differed in the younger age groups. These data indicate that humans acquire an antibody repertoire to non-overlapping serotypes within a serogroup, consistent with an antibody-driven diversification pressure at the population level. In addition, the data provide important information for vaccine design, as production of a vaccine targeting rosetting PfEMP1 adhesins will require engineering to induce variant-transcending responses or combining multiple serotypes to elicit a broad spectrum of immunity.	[Vigan-Womas, Ines; Guillotte, Micheline; Vallieres, Cindy; Mercereau-Puijalon, Odile] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Vigan-Womas, Ines; Guillotte, Micheline; Vallieres, Cindy; Mercereau-Puijalon, Odile] CNRS, URA 2581, Paris, France; [Juillerat, Alexandre; Lewit-Bentley, Anita; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Paris, France; [Juillerat, Alexandre; Lewit-Bentley, Anita; Bentley, Graham A.] CNRS, URA 2185, Paris, France; [Tall, Adama; Baril, Laurence] Inst Pasteur, Unite Epidemiol Maladies Infectieuses, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Vigan-Womas, I (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, Paris, France.	odile.puijalon@pasteur.fr	Ines, VIGAN-WOMAS/I-8604-2012; Vallieres, Cindy/AAV-3381-2020; Mercereau-Puijalon, Odile/AAA-2242-2020; Ines, VIGAN-WOMAS/A-7846-2017	Ines, VIGAN-WOMAS/0000-0001-7848-9297; Vallieres, Cindy/0000-0001-6409-1296; Ines, VIGAN-WOMAS/0000-0001-7848-9297; Baril, Laurence/0000-0003-2346-883X	French National Research Agency (Agence Nationale de la Recherche) [ANR-07-MIME-021-0]; European Union [FP7/2007-2013, Nu 242095 (Evimalar)]	French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); European Union(European Commission)	This work was supported by the French National Research Agency (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes, grant ANR-07-MIME-021-0), which provided a fellowship to A. J.. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement Nu 242095 (Evimalar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2008, J INFECT DIS, V197, P1350, DOI 10.1086/586905; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Chattopadhyay R, 2003, INFECT IMMUN, V71, P597, DOI 10.1128/IAI.71.2.597-604.2003; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; Costa FTM, 2003, J INFECT DIS, V188, P153, DOI 10.1086/375800; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Hviid L, 2003, INFECT IMMUN, V71, P2296, DOI 10.1128/IAI.71.4.2296.2003; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2007, J IMMUNOL, V178, P428, DOI 10.4049/jimmunol.178.1.428; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Mackintosh CL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-155; Magistrado PA, 2007, INFECT IMMUN, V75, P2415, DOI 10.1128/IAI.00951-06; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; Mercereau-Puijalon O, 2008, TRANSFUS CLIN BIOL, V15, P62, DOI 10.1016/j.tracli.2008.04.003; Moll K, 2007, INFECT IMMUN, V75, P211, DOI 10.1128/IAI.00749-06; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; Nielsen MA, 2004, INFECT IMMUN, V72, P3531, DOI 10.1128/IAI.72.6.3531-3535.2004; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Noranate N, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-219; Normark J, 2007, P NATL ACAD SCI US; Oguariri RM, 2003, PARASITOL RES, V90, P467, DOI 10.1007/s00436-003-0884-8; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; ROWE A, 1994, EXP PARASITOL, V79, P506, DOI 10.1006/expr.1994.1111; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Staalso T, 1998, IMMUNOL LETT, V60, P121, DOI 10.1016/S0165-2478(97)00143-0; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	61	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16544	10.1371/journal.pone.0016544	http://dx.doi.org/10.1371/journal.pone.0016544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298021	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900067
J	Pol, D; Garrido, A; Cerda, IA				Pol, Diego; Garrido, Alberto; Cerda, Ignacio A.			A New Sauropodomorph Dinosaur from the Early Jurassic of Patagonia and the Origin and Evolution of the Sauropod-type Sacrum	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; ANATOMY; SAURISCHIA; VERTEBRAE; ONTOGENY; GERMANY; TAXA	Background: The origin of sauropod dinosaurs is one of the major landmarks of dinosaur evolution but is still poorly understood. This drastic transformation involved major skeletal modifications, including a shift from the small and gracile condition of primitive sauropodomorphs to the gigantic and quadrupedal condition of sauropods. Recent findings in the Late Triassic-Early Jurassic of Gondwana provide critical evidence to understand the origin and early evolution of sauropods. Methodology/Principal Findings: A new sauropodomorph dinosaur, Leonerasaurus taquetrensis gen. et sp. nov., is described from the Las Leoneras Formation of Central Patagonia (Argentina). The new taxon is diagnosed by the presence of anterior unserrated teeth with a low spoon-shaped crown, amphicoelous and acamerate vertebral centra, four sacral vertebrae, and humeral deltopectoral crest low and medially deflected along its distal half. The phylogenetic analysis depicts Leonerasaurus as one of the closest outgroups of Sauropoda, being the sister taxon of a clade of large bodied taxa composed of Melanorosaurus and Sauropoda. Conclusions/Significance: The dental and postcranial anatomy of Leonerasaurus supports its close affinities with basal sauropods. Despite the small size and plesiomorphic skeletal anatomy of Leonerasaurus, the four vertebrae that compose its sacrum resemble that of the large-bodied primitive sauropods. This shows that the appearance of the sauropod-type of sacrum predated the marked increase in body size that characterizes the origins of sauropods, rejecting a causal explanation and evolutionary linkage between this sacral configuration and body size. Alternative phylogenetic placements of Leonerasaurus as a basal anchisaurian imply a convergent acquisition of the sauropod-type sacrum in the new small-bodied taxon, also rejecting an evolutionary dependence of sacral configuration and body size in sauropodomorphs. This and other recent discoveries are showing that the characteristic sauropod body plan evolved gradually, with a step-wise pattern of character appearance.	[Pol, Diego] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Argentina; [Garrido, Alberto] Museo Prov Ciencias Nat Prof Dr Juan A Olsache, Zapala, Argentina; [Cerda, Ignacio A.] Univ Nacjonal Comahue, CONICET, INBIOMA, Museo Geol & Paleontol, Neuquen, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Pol, D (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Argentina.	dpol@mef.org.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517	Fundacion Egidio Feruglio; Paleontological Exploration of Patagonia; Fundacion Antorchas; University of Louisville; Agencia Nacional de Promocion de Ciencia y Tecnica [PICT 1756, DFGRA1012/9-1]	Fundacion Egidio Feruglio; Paleontological Exploration of Patagonia; Fundacion Antorchas; University of Louisville; Agencia Nacional de Promocion de Ciencia y Tecnica	Fieldwork was funded by the Fundacion Egidio Feruglio and the Paleontological Exploration of Patagonia, Fundacion Antorchas, and University of Louisville to Guillermo Rougier. Research was funded by the Agencia Nacional de Promocion de Ciencia y Tecnica, PICT 1756 and DFGRA1012/9-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2008, GEODIVERSITAS, V30, P345; Aragon E, 2003, J S AM EARTH SCI, V16, P91, DOI 10.1016/S0895-9811(03)00046-4; Barrett PM, 2007, ZOOL J LINN SOC-LOND, V150, P319, DOI 10.1111/j.1096-3642.2007.00290.x; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bonaparte J.F., 1986, P247; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BONETTI MIR, 1963, REV MUSEO ARG CIENC, V1, P23; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P157; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Carreira-Perpinan MA., 2005, ADV NEURAL INF PROCE, V17, P225; Castanet J., 1993, BONE, P245; Charig A. J., 1965, Proceedings of the Linnean Society of London, V176, P197; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; CODDINGTON J, 1994, CLADISTICS, V10, P415; Colbert E. H., 1964, American Museum Novitates, VNo. 2181, P1; Escapa I, 2008, AMEGHINIANA, V45, P633; Figari E.G., 1993, 12 C GEOL ARG C EXPL, P66; Franzese J, 2003, J S AM EARTH SCI, V16, P81, DOI 10.1016/S0895-9811(03)00020-8; Galton P.M., 1990, P320; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2000, Journal of Vertebrate Paleontology, V20, p43A; Galton PM, 1999, NEUES JAHRB GEOL P-A, V213, P19, DOI 10.1127/njgpa/213/1999/19; Galton PM, 2000, NEUES JAHRB GEOL P-A, V216, P233; Galton PM, 2005, LIFE O PAST, P1; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff P, 2008, CLADISTICS, V24, P91; Herbst R., 1968, AMEGHINIANA, V5, P183; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Kearney M, 2002, SYST BIOL, V51, P369, DOI 10.1080/10635150252899824; Kutty TS, 2007, J PALEONTOL, V81, P1218, DOI 10.1666/04-074.1; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer Max Cardoso, 2003, Paleobios, V23, P1; Macdonald D, 2003, MAR PETROL GEOL, V20, P287, DOI 10.1016/S0264-8172(03)00045-X; McIntosh J.S., 1990, P345; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Moser Markus, 2003, Zitteliana Reihe B, V24, P5; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Nakayama C., 1973, 5 C GEOL ARG BUEN AI, V3, P269; NIETO DS, 2004, SERVICIO GEOLOGICO M, V265, P72; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; NULLO FE, 1983, SERVICIO GEOLOOGICO, V199; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PAGE R, 2000, GEOLOGIA ARGENTINA, P460; Pine S, 2007, J VERTEBR PALEONTOL, V27, p130A; Pol Diego, 2007, Historical Biology, V19, P125, DOI 10.1080/08912960601140085; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SERENO CP, 2005, STEM ARCHOSAURIA TAX; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; SPALLETTI LA, 1988, REV ASOC GEOL ARGENT, V43, P544; Tang F., 2001, COMPLETE SAUROPOD JI, P128; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P, 2007, GEOL MAG, V144, P247, DOI 10.1017/S0016756806003062; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; WALKER RG, 1984, GEOSCIENCE CANADA RE, V1, P71; Wilkinson M, 2000, SYST BIOL, V49, P754, DOI 10.1080/106351500750049815; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; Yadagiri P, 2001, J VERTEBR PALEONTOL, V21, P242, DOI 10.1671/0272-4634(2001)021[0242:TOOKYA]2.0.CO;2; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2004, Postilla, V230, P1; Yates AM, 2010, PALAEONTOLOGY, V53, P739, DOI 10.1111/j.1475-4983.2010.00952.x; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x	77	59	61	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14572	10.1371/journal.pone.0014572	http://dx.doi.org/10.1371/journal.pone.0014572			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298087	Green Published, gold			2022-12-27	WOS:000286662800002
J	Suwanwela, J; Lee, J; Lin, A; Ucer, TC; Devlin, H; Sinsheimer, J; Garrett, NR; Nishimura, I				Suwanwela, Jaijam; Lee, Jaehoon; Lin, Audrey; Ucer, T. Cemal; Devlin, Hugh; Sinsheimer, Janet; Garrett, Neal R.; Nishimura, Ichiro			A Genetic Association Study of Single Nucleotide Polymorphisms in FGFR1OP2/wit3.0 and Long-Term Atrophy of Edentulous Mandible	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; TOOTH EXTRACTION; RESIDUAL RIDGE; COMPLETE DENTURES; MINERAL DENSITY; ORAL FINDINGS; OSTEOPOROSIS; OVARIECTOMY; HEIGHT; MUCOSA	Background: After dental extraction, the external surface of alveolar bone undergoes resorption at various rates, and a group of patients develop excessive jawbone atrophy. Oral mucosa overlying the atrophied jawbone is unusually thin; therefore, we have hypothesized that excessive jawbone atrophy may be associated with abnormal oral mucosa contraction. FGFR1OP2/wit3.0, a cytoskeleton molecule initially identified in oral wound fibroblasts, has been shown to induce oral mucosa contraction after dental extraction. This study examined the genetic association between single nucleotide polymorphisms (SNPs) of FGFR1OP2/wit3.0 and excessive atrophy of edentulous mandible. Methods and Findings: First, the expression of FGFR1OP2/wit3.0 was determined in gingival tissues of 8 subjects before and after dental extraction. In situ hybridization revealed that all subject increased FGFR1OP2/wit3.0 expression in the postoperative oral mucosa tissues; however, significantly high levels of FGFR1OP2/wit3.0 were observed in 3 out of 8 subjects. In a separate study, 20 long-term edentulous subjects (66.4+/-9.4 years) were recruited. Tag-SNPs in the FGFR1OP2/wit3.0 allele were determined by Taqman-based polymerase chain reaction. The mandibular bone height was determined following the American College of Prosthodontists (ACP) protocol. Subjects with minor allele of rs840869 or rs859024 were found in the highly atrophied group by the ACP classification (Chi square test, p = 0.0384 and p = 0.0565, respectively; Fisher's Exact, p = 0.0515 and p = 0.2604, respectively). The linear regression analysis indicated a suggestive association between rs859024 and the decreased bone heights (Mann-Whitney, p = 0.06). The average bone height of the subjects with rs840869 or rs859024 minor alleles (10.6+/-3.2 mm and 9.6+/-3.2 mm, respectively) was significantly smaller than that of those subjects with the major alleles (14.2+/-4.5 mm, p<0.05). Conclusions: The patients with the minor allele of rs840869 or rs859024 were associated with excessive atrophy of edentulous mandible. This study may provide the basis for a genetic marker identifying susceptible individuals to develop jawbone atrophy after dental extraction.	[Suwanwela, Jaijam; Lee, Jaehoon; Lin, Audrey; Garrett, Neal R.; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA; [Suwanwela, Jaijam; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Suwanwela, Jaijam] Chulalongkorn Univ, Dept Prosthodont, Fac Dent, Bangkok, Thailand; [Lee, Jaehoon] Yonsei Univ, Coll Dent, Dept Prosthodont, Seoul 120749, South Korea; [Ucer, T. Cemal; Devlin, Hugh] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Sinsheimer, Janet] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Sinsheimer, Janet] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chulalongkorn University; Yonsei University; Yonsei University Health System; University of Manchester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Suwanwela, J (corresponding author), Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA.	inishimura@dentistry.ucla.edu	DEVLIN, HUGH/G-6077-2010	DEVLIN, HUGH/0000-0002-5120-747X; Lee, Jae Hoon/0000-0003-2281-8885	UCLA; National Center for Research Resources, National Institutes of Health (NCRR/NIH) [C06 RR014529]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER	UCLA(University of California System); National Center for Research Resources, National Institutes of Health (NCRR/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported, in part, by UCLA Academic Senate Grant. This investigation was conducted in part in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR014529 from the National Center for Research Resources, National Institutes of Health (NCRR/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bollen AM, 2004, OSTEOPOROSIS INT, V15, P970, DOI 10.1007/s00198-004-1695-1; Carlsson GE, 1998, J PROSTHET DENT, V79, P17, DOI 10.1016/S0022-3913(98)70188-X; Devlin H, 1997, J BONE MINER RES, V12, P2061, DOI 10.1359/jbmr.1997.12.12.2061; DEVLIN H, 1994, J PROSTHET DENT, V71, P478, DOI 10.1016/0022-3913(94)90186-4; Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x; Grand EK, 2004, GENE CHROMOSOME CANC, V40, P78, DOI 10.1002/gcc.20023; Horner K, 1998, DENTOMAXILLOFAC RAD, V27, P17, DOI 10.1038/sj.dmfr.4600307; HSIEH YD, 1995, ARCH ORAL BIOL, V40, P529, DOI 10.1016/0003-9969(94)00197-J; Jahangiri L, 1998, J PROSTHET DENT, V80, P224, DOI 10.1016/S0022-3913(98)70116-7; Kingsmill VJ, 1999, CRIT REV ORAL BIOL M, V10, P384, DOI 10.1177/10454411990100030801; KLEMETTI E, 1993, SCAND J DENT RES, V101, P166; KRAJICEK DD, 1984, J PROSTHET DENT, V52, P682, DOI 10.1016/0022-3913(84)90141-0; KRIBBS PJ, 1983, J PROSTHET DENT, V50, P719, DOI 10.1016/0022-3913(83)90215-9; KRIBBS PJ, 1983, J PROSTHET DENT, V50, P576, DOI 10.1016/0022-3913(83)90584-X; LI XH, 1994, J PROSTHET DENT, V72, P324, DOI 10.1016/0022-3913(94)90348-4; Lin A, 2010, CELL ADHES MIGR, V4, P396, DOI 10.4161/cam.4.3.11917; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Luvizuto ER, 2010, BONE, V46, P1021, DOI 10.1016/j.bone.2009.12.016; McGarry T J, 1999, J Prosthodont, V8, P27, DOI 10.1111/j.1532-849X.1999.tb00005.x; Mulot C, 2005, J BIOMED BIOTECHNOL, P291, DOI 10.1155/JBB.2005.291; Nasser M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006087; Pereira MC, 2007, J ORAL MAXIL SURG, V65, P2248, DOI 10.1016/j.joms.2006.11.040; SCHROEDER HE, 1986, CELL TISSUE RES, V243, P661; SHOJI K, 2010, ARCH ORAL BIOL; Simpson H E, 1969, Br Dent J, V126, P550; Sukotjo C, 2003, J BIOL CHEM, V278, P51527, DOI 10.1074/jbc.M309616200; Sukotjo C, 2002, J DENT RES, V81, P229, DOI 10.1177/154405910208100402; TURCK D, 1965, J PROSTHET DENT, V15, P419, DOI 10.1016/S0022-3913(65)80010-5; Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x; WARD VJ, 1977, J ORAL REHABIL, V4, P83, DOI 10.1111/j.1365-2842.1977.tb00969.x; WATSON IB, 1982, J PROSTHET DENT, V47, P133, DOI 10.1016/0022-3913(82)90176-7	34	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16204	10.1371/journal.pone.0016204	http://dx.doi.org/10.1371/journal.pone.0016204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283824	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600030
J	Frauer, C; Rottach, A; Meilinger, D; Bultmann, S; Fellinger, K; Hasenoder, S; Wang, MX; Qin, WH; Soding, J; Spada, F; Leonhardt, H				Frauer, Carina; Rottach, Andrea; Meilinger, Daniela; Bultmann, Sebastian; Fellinger, Karin; Hasenoeder, Stefan; Wang, Mengxi; Qin, Weihua; Soeding, Johannes; Spada, Fabio; Leonhardt, Heinrich			Different Binding Properties and Function of CXXC Zinc Finger Domains in Dnmt1 and Tet1	PLOS ONE			English	Article							DNA CYTOSINE-5 METHYLTRANSFERASE; ACUTE MYELOID-LEUKEMIA; CATALYTIC DOMAIN; MAMMALIAN DNA; METHYLATION; PROTEIN; MLL; GENE; REPLICATION; MAINTENANCE	Several mammalian proteins involved in chromatin and DNA modification contain CXXC zinc finger domains. We compared the structure and function of the CXXC domains in the DNA methyltransferase Dnmt1 and the methylcytosine dioxygenase Tet1. Sequence alignment showed that both CXXC domains have a very similar framework but differ in the central tip region. Based on the known structure of a similar MLL1 domain we developed homology models and designed expression constructs for the isolated CXXC domains of Dnmt1 and Tet1 accordingly. We show that the CXXC domain of Tet1 has no DNA binding activity and is dispensable for catalytic activity in vivo. In contrast, the CXXC domain of Dnmt1 selectively binds DNA substrates containing unmethylated CpG sites. Surprisingly, a Dnmt1 mutant construct lacking the CXXC domain formed covalent complexes with cytosine bases both in vitro and in vivo and rescued DNA methylation patterns in dnmt1(-/-) embryonic stem cells (ESCs) just as efficiently as wild type Dnmt1. Interestingly, neither wild type nor Delta CXXC Dnmt1 re-methylated imprinted CpG sites of the H19a promoter in dnmt1(-/-) ESCs, arguing against a role of the CXXC domain in restraining Dnmt1 methyltransferase activity on unmethylated CpG sites.	[Frauer, Carina; Rottach, Andrea; Meilinger, Daniela; Bultmann, Sebastian; Fellinger, Karin; Hasenoeder, Stefan; Wang, Mengxi; Qin, Weihua; Spada, Fabio; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Frauer, Carina; Rottach, Andrea; Meilinger, Daniela; Bultmann, Sebastian; Fellinger, Karin; Hasenoeder, Stefan; Wang, Mengxi; Qin, Weihua; Spada, Fabio; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich CIPSM, Planegg Martinsried, Germany; [Soeding, Johannes] Univ Munich, Gene Ctr Munich, Munich, Germany	University of Munich; University of Munich; University of Munich	Frauer, C (corresponding author), Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	f.spada@lmu.de; h.leonhardt@lmu.de	Söding, Johannes/A-3341-2013; Leonhardt, Heinrich/B-2791-2014; Spada, Fabio/J-4354-2013; Bultmann, Sebastian/AAC-7729-2020	Söding, Johannes/0000-0001-9642-8244; Spada, Fabio/0000-0002-7148-9013; 	Deutsche Forschungsgemeinschaft (DFG) [SFB646, TR5]; Nanosystem Initiative Munich (NIM); Center for NanoScience (CeNS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Nanosystem Initiative Munich (NIM); Center for NanoScience (CeNS)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB646 and TR5; http://www.dfg.de/en/index.jsp), the Nanosystem Initiative Munich (NIM; http://www.nano-initiative-munich.de/) and the Center for NanoScience (CeNS; http://www.cens.de/) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Bacolla A, 2001, J BIOL CHEM, V276, P18605, DOI 10.1074/jbc.M100404200; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Easwaran HP, 2005, CELL CYCLE, V4, P453, DOI 10.4161/cc.4.3.1525; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2008, ANAL BIOCHEM, V373, P176, DOI 10.1016/j.ab.2007.10.016; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Frauer C, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1029; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Katoh M, 2004, INT J ONCOL, V25, P1193; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mohseni-Zadeh S, 2004, COMPUT BIOL CHEM, V28, P211, DOI 10.1016/j.compbiolchem.2004.03.002; Ono R, 2002, CANCER RES, V62, P4075; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Pradhan S, 2003, BIOCHEMISTRY-US, V42, P5321, DOI 10.1021/bi034160+; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spada F, 2006, ADV ENZYME REGUL, V46, P224, DOI 10.1016/j.advenzreg.2006.01.011; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zimmermann C, 1997, BIOL CHEM, V378, P393, DOI 10.1515/bchm.1997.378.5.393	65	71	76	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16627	10.1371/journal.pone.0016627	http://dx.doi.org/10.1371/journal.pone.0016627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311766	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036200025
J	Bjorkelund, H; Gedda, L; Andersson, K				Bjorkelund, Hanna; Gedda, Lars; Andersson, Karl			Comparing the Epidermal Growth Factor Interaction with Four Different Cell Lines: Intriguing Effects Imply Strong Dependency of Cellular Context	PLOS ONE			English	Article							FACTOR RECEPTOR FAMILY; TYROSINE KINASE; ZD1839 IRESSA; LIVING CELLS; LUNG-CANCER; INHIBITOR; GEFITINIB; OPTIMIZATION; DIMERIZATION; SUPPRESSES	The interaction of the epidermal growth factor (EGF) with its receptor (EGFR) is known to be complex, and the common over-expression of EGF receptor family members in a multitude of tumors makes it important to decipher this interaction and the following signaling pathways. We have investigated the affinity and kinetics of I-125-EGF binding to EGFR in four human tumor cell lines, each using four culturing conditions, in real time by use of LigandTracer (R). Highly repeatable and precise measurements show that the overall apparent affinity of the I-125-EGF - EGFR interaction is greatly dependent on cell line at normal culturing conditions, ranging from K-D approximate to 200 pM on SKBR3 cells to K-D approximate to 8 nM on A431 cells. The I-125-EGF - EGFR binding curves (irrespective of cell line) have strong signs of multiple simultaneous interactions. Furthermore, for the cell lines A431 and SKOV3, gefitinib treatment increases the I-125-EGF - EGFR affinity, in particular when the cells are starved. The I-125-EGF - EGFR interaction on cell line U343 is sensitive to starvation while as on SKBR3 it is insensitive to gefitinib and starvation. The intriguing pattern of the binding characteristics proves that the cellular context is important when deciphering how EGF interacts with EGFR. From a general perspective, care is advisable when generalizing ligand-receptor interaction results across multiple cell-lines.	[Bjorkelund, Hanna; Andersson, Karl] Ridgeview Instruments AB, Uppsala, Sweden; [Bjorkelund, Hanna; Gedda, Lars; Andersson, Karl] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden	Uppsala University	Bjorkelund, H (corresponding author), Ridgeview Instruments AB, Uppsala, Sweden.	hanna@ridgeviewinstruments.com		Gedda, Lars/0000-0002-3746-6811; Andersson, Karl/0000-0001-9141-9242	Uppsala University; Ridgeview Instruments AB (RIAB)	Uppsala University; Ridgeview Instruments AB (RIAB)	This project was jointly funded by Uppsala University and Ridgeview Instruments AB (RIAB). Hanna Bjorkelund and Karl Andersson participated in the study on the same conditions as university employees, i.e., without any restrictions on study design and what data to include in the publication. The role of RIAB was solely to provide access to LigandTracer devices and to pay the salaries of Hanna Bjorkelund and Karl Andersson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorke H, 2006, APPL RADIAT ISOTOPES, V64, P901, DOI 10.1016/j.apradiso.2006.03.002; BJORKELUND H, 2010, J MOL RECOGNIT; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Hendriks BS, 2006, IEE P SYST BIOL, V153, P457, DOI 10.1049/ip-syb:20050108; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Khomyakova E, 2008, BIOTECHNIQUES, V44, P109, DOI 10.2144/000112622; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Leuchowius KJ, 2009, CYTOM PART A, V75A, P833, DOI 10.1002/cyto.a.20771; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Mayawala K, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-41; Moasser MM, 2001, CANCER RES, V61, P7184; Nishimura Y, 2007, HISTOCHEM CELL BIOL, V127, P541, DOI 10.1007/s00418-007-0281-y; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; PHILLIPS RM, 1990, JNCI-J NATL CANCER I, V82, P1457, DOI 10.1093/jnci/82.18.1457; SHECHTER Y, 1978, P NATL ACAD SCI USA, V75, P5788, DOI 10.1073/pnas.75.12.5788; SORKIN A, 1991, J BIOL CHEM, V266, P23453; Sundberg AL, 2003, EUR J NUCL MED MOL I, V30, P1348, DOI 10.1007/s00259-003-1308-9; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Velikyan I, 2005, J NUCL MED, V46, P1881; Wakeling AE, 2002, CANCER RES, V62, P5749; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	24	39	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16536	10.1371/journal.pone.0016536	http://dx.doi.org/10.1371/journal.pone.0016536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304974	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300081
J	Yang, AC; Fuh, JL; Huang, NE; Shia, BC; Peng, CK; Wang, SJ				Yang, Albert C.; Fuh, Jong-Ling; Huang, Norden E.; Shia, Ben-Chang; Peng, Chung-Kang; Wang, Shuu-Jiun			Temporal Associations between Weather and Headache: Analysis by Empirical Mode Decomposition	PLOS ONE			English	Article							NONSTATIONARY TIME-SERIES; POPULATION-BASED SURVEY; BAROMETRIC-PRESSURE; MIGRAINE HEADACHE; CHINOOK WINDS	Background: Patients frequently report that weather changes trigger headache or worsen existing headache symptoms. Recently, the method of empirical mode decomposition (EMD) has been used to delineate temporal relationships in certain diseases, and we applied this technique to identify intrinsic weather components associated with headache incidence data derived from a large-scale epidemiological survey of headache in the Greater Taipei area. Methodology/Principal Findings: The study sample consisted of 52 randomly selected headache patients. The weather time-series parameters were detrended by the EMD method into a set of embedded oscillatory components, i.e. intrinsic mode functions (IMFs). Multiple linear regression models with forward stepwise methods were used to analyze the temporal associations between weather and headaches. We found no associations between the raw time series of weather variables and headache incidence. For decomposed intrinsic weather IMFs, temperature, sunshine duration, humidity, pressure, and maximal wind speed were associated with headache incidence during the cold period, whereas only maximal wind speed was associated during the warm period. In analyses examining all significant weather variables, IMFs derived from temperature and sunshine duration data accounted for up to 33.3% of the variance in headache incidence during the cold period. The association of headache incidence and weather IMFs in the cold period coincided with the cold fronts. Conclusions/Significance: Using EMD analysis, we found a significant association between headache and intrinsic weather components, which was not detected by direct comparisons of raw weather data. Contributing weather parameters may vary in different geographic regions and different seasons.	[Yang, Albert C.] Chu Tung Vet Hosp, Dept Psychiat, Hsin Chu Cty, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Albert C.; Huang, Norden E.; Peng, Chung-Kang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Huang, Norden E.] Natl Cent Univ, Res Ctr Adapt Data Anal, Chungli 32054, Taiwan; [Shia, Ben-Chang] Fu Jen Catholic Univ, Dept Stat & Informat Sci, Taipei Cty, Taiwan; [Peng, Chung-Kang] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med,Beth Is, Boston, MA USA	National Yang Ming Chiao Tung University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; Fu Jen Catholic University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wang, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan.	sjwang@vghtpe.gov.tw	Peng, Chung-Kang/E-1489-2011; Peng, Chung-Kang/N-1308-2019	Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833; Fuh, Jong-Ling/0000-0001-9135-3351; Yang, Albert Chih-Chieh/0000-0003-2794-9649; Wang, Shuu-Jiun/0000-0001-5179-5358	Taipei-Veterans General Hospital [V97A-061, V100C-059, V100C-087, VGHUST 100-G7-1-1, VGHUST 100-G7-1-3]; National Science Council (NSC) of Taiwan [NSC 96-2314-B-075-075, 98-2314-B-010-019-MY2, NSC 99-2911-I-008-100]; Ministry of Education, Taipei, Taiwan	Taipei-Veterans General Hospital(Taipei Veterans General Hospital); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taipei, Taiwan	The study was supported in part by a grant from Taipei-Veterans General Hospital (V97A-061, V100C-059, V100C-087, VGHUST 100-G7-1-1, VGHUST 100-G7-1-3), the National Science Council (NSC) of Taiwan (NSC 96-2314-B-075-075, 98-2314-B-010-019-MY2), NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 99-2911-I-008-100), and the Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkelund SI, 2008, CEPHALALGIA, V28, P1277, DOI 10.1111/j.1468-2982.2008.01676.x; *CENTR WEATH BUR, 1997, AGR B; Cooke LJ, 2000, NEUROLOGY, V54, P302, DOI 10.1212/WNL.54.2.302; CULL RE, 1981, HEADACHE, V21, P102, DOI 10.1111/j.1526-4610.1981.hed2103102.x; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Djuric D., 1994, WEATHER ANAL; GOMERSALL J D, 1973, International Journal of Biometeorology, V17, P285, DOI 10.1007/BF01804622; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; *INT WOM RIGHTS AC, 1988, CONV EL ALL FORMS DI, P1; Kaniecki R, 2003, JAMA-J AM MED ASSOC, V289, P1430, DOI 10.1001/jama.289.11.1430; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Mukamal KJ, 2009, NEUROLOGY, V72, P922, DOI 10.1212/01.wnl.0000344152.56020.94; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; OSTERMAN PO, 1981, INT J BIOMETEOROL, V25, P39, DOI 10.1007/BF02184436; Piorecky J, 1997, HEADACHE, V37, P153, DOI 10.1046/j.1526-4610.1997.3703153.x; Prince PB, 2004, HEADACHE, V44, P596, DOI 10.1111/j.1526-4610.2004.446008.x; Raskin N, 1988, HEADACHE; RUSSELL MB, 1992, CEPHALALGIA, V12, P369, DOI 10.1111/j.1468-2982.1992.00369.x; SCHULMAN J, 1980, INT J BIOMETEOROL, V24, P263, DOI 10.1007/BF02249796; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Vaitl D, 2001, HEADACHE, V41, P845, DOI 10.1046/j.1526-4610.2001.041009845.x; Villeneuve PJ, 2006, HEADACHE, V46, P64, DOI 10.1111/j.1526-4610.2006.00322.x; Wang SJ, 2000, CEPHALALGIA, V20, P566, DOI 10.1046/j.1468-2982.2000.00085.x; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Zivadinov R, 2003, CEPHALALGIA, V23, P336, DOI 10.1046/j.1468-2982.2003.00544.x	27	34	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14612	10.1371/journal.pone.0014612	http://dx.doi.org/10.1371/journal.pone.0014612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297940	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300004
J	Hauge, ER; Berle, JO; Oedegaard, KJ; Holsten, F; Fasmer, OB				Hauge, Erik R.; Berle, Jan Oystein; Oedegaard, Ketil J.; Holsten, Fred; Fasmer, Ole Bernt			Nonlinear Analysis of Motor Activity Shows Differences between Schizophrenia and Depression: A Study Using Fourier Analysis and Sample Entropy	PLOS ONE			English	Article							APPROXIMATE ENTROPY; BIPOLAR DISORDER; VARIABILITY; CHAOS; MOOD; COMPLEXITY; REGULARITY; ACTIGRAPHY; SLEEP; SCALE	The purpose of this study has been to describe motor activity data obtained by using wrist-worn actigraphs in patients with schizophrenia and major depression by the use of linear and non-linear methods of analysis. Different time frames were investigated, i.e., activity counts measured every minute for up to five hours and activity counts made hourly for up to two weeks. The results show that motor activity was lower in the schizophrenic patients and in patients with major depression, compared to controls. Using one minute intervals the depressed patients had a higher standard deviation (SD) compared to both the schizophrenic patients and the controls. The ratio between the root mean square successive differences (RMSSD) and SD was higher in the schizophrenic patients compared to controls. The Fourier analysis of the activity counts measured every minute showed that the relation between variance in the low and the high frequency range was lower in the schizophrenic patients compared to the controls. The sample entropy was higher in the schizophrenic patients compared to controls in the time series from the activity counts made every minute. The main conclusions of the study are that schizophrenic and depressive patients have distinctly different profiles of motor activity and that the results differ according to period length analysed.	[Hauge, Erik R.] Olaviken Psychiat Hosp, Bergen, Norway; [Berle, Jan Oystein; Oedegaard, Ketil J.; Holsten, Fred; Fasmer, Ole Bernt] Haukeland Hosp, Div Psychiat, N-5021 Bergen, Norway; [Oedegaard, Ketil J.; Holsten, Fred; Fasmer, Ole Bernt] Univ Bergen, Fac Med & Dent, Sect Psychiat, Dept Clin Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen	Hauge, ER (corresponding author), Olaviken Psychiat Hosp, Bergen, Norway.	e.r.hauge@gmail.com			legacy of Gerda Meyer Nyquist Gulbrandson and Gerdt Meyer Nyquist; Western Norway Regional Health Authority; Eli Lilly and Company	legacy of Gerda Meyer Nyquist Gulbrandson and Gerdt Meyer Nyquist; Western Norway Regional Health Authority; Eli Lilly and Company(Eli Lilly)	This research has been supported by unrestricted grants from the legacy of Gerda Meyer Nyquist Gulbrandson and Gerdt Meyer Nyquist and from Western Norway Regional Health Authority. E. R. Hauge has received an unrestricted grant from Eli Lilly and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo D, 2006, PHYSIOL MEAS, V27, P241, DOI 10.1088/0967-3334/27/3/003; Aboy M, 2007, P ANN INT IEEE EMBS, P5943; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Boonstra AM, 2007, SLEEP, V30, P433, DOI 10.1093/sleep/30.4.433; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Di Mascio M, 1999, NEUROSCIENCE, V92, P237, DOI 10.1016/S0306-4522(98)00757-X; EHLERS CL, 1995, ARCH GEN PSYCHIAT, V52, P960; Farrow TFD, 2005, BRIT J PSYCHIAT, V187, P481, DOI 10.1192/bjp.187.5.481; Fasmer O B, 2001, World J Biol Psychiatry, V2, P149; Glenn T, 2006, BIPOLAR DISORD, V8, P424, DOI 10.1111/j.1399-5618.2006.00373.x; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; GOTTSCHALK A, 1995, ARCH GEN PSYCHIAT, V52, P947; Heiby EM, 2003, PSYCHOL ASSESSMENT, V15, P426, DOI 10.1037/1040-3590.15.3.426; Hornero R, 2006, IEEE T BIO-MED ENG, V53, P210, DOI 10.1109/TBME.2005.862547; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Ilias Ioannis, 2002, Endocr Regul, V36, P63; Jones SH, 2005, BIPOLAR DISORD, V7, P176, DOI 10.1111/j.1399-5618.2005.00187.x; Kaiser S, 2008, BRAIN COGNITION, V66, P73, DOI 10.1016/j.bandc.2007.05.007; Kim D, 2005, SCHIZOPHR RES, V76, P55, DOI 10.1016/j.schres.2004.10.011; Kramlinger KG, 1996, BRIT J PSYCHIAT, V168, P314, DOI 10.1192/bjp.168.3.314; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Liu PY, 2007, AM J PHYSIOL-ENDOC M, V293, pE1409, DOI 10.1152/ajpendo.00365.2007; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Patterson JV, 2000, ARCH GEN PSYCHIAT, V57, P57, DOI 10.1001/archpsyc.57.1.57; Paulus MP, 2003, BIOL PSYCHIAT, V53, P3, DOI 10.1016/S0006-3223(02)01701-8; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Russell Vivienne A, 2006, Behav Brain Funct, V2, P30, DOI 10.1186/1744-9081-2-30; Tschacher W, 1997, BIOL PSYCHIAT, V41, P428, DOI 10.1016/S0006-3223(96)00039-X; Tuzcu V, 2006, EUROPACE, V8, P398, DOI 10.1093/europace/eul031; van Someren EJW, 1998, IEEE T BIO-MED ENG, V45, P386, DOI 10.1109/10.661163; VANHILTEN JJ, 1993, ELECTROEN CLIN NEURO, V89, P359, DOI 10.1016/0168-5597(93)90076-2; WOOD AC, 2009, J AM ACAD CHILD ADOL; Woyshville MJ, 1999, BIOL PSYCHIAT, V45, P261, DOI 10.1016/S0006-3223(98)00152-8; Yeragani VK, 2003, BIPOLAR DISORD, V5, P279, DOI 10.1034/j.1399-5618.2003.00012.x	35	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16291	10.1371/journal.pone.0016291	http://dx.doi.org/10.1371/journal.pone.0016291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JX	21297977	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100019
J	Aira, M; Dominguez, J				Aira, Manuel; Dominguez, Jorge			Earthworm Effects without Earthworms: Inoculation of Raw Organic Matter with Worm-Worked Substrates Alters Microbial Community Functioning	PLOS ONE			English	Article							EISENIA-FOETIDA OLIGOCHAETA; LUMBRICUS-TERRESTRIS; BIOMASS; SOIL; CARBON; GUT; MINERALIZATION; DECOMPOSITION; RESPIRATION; BIOVOLUME	Background: Earthworms are key organisms in organic matter decomposition because of the interactions they establish with soil microorganisms. They enhance decomposition rates through the joint action of direct effects (i.e. effects due to direct earthworm activity such as digestion, burrowing, etc) and indirect effects (i.e. effects derived from earthworm activities such as cast ageing). Here we test whether indirect earthworm effects affect microbial community functioning in the substrate, as when earthworms are present (i.e., direct effects). Methodology/Principal Findings: To address these questions we inoculated fresh organic matter (pig manure) with worm-worked substrates (vermicompost) produced by three different earthworm species. Two doses of each vermicompost were used (2.5 and 10%). We hypothesized that the presence of worm-worked material in the fresh organic matter will result in an inoculum of different microorganisms and nutrients. This inoculum should interact with microbial communities in fresh organic matter, thus promoting modifications similar to those found when earthworms are present. Inoculation of worm-worked substrates provoked significant increases in microbial biomass and enzyme activities (beta-glucosidase, cellulase, phosphatase and protease). These indirect effects were similar to, although lower than, those obtained in pig manure with earthworms (direct and indirect earthworm effects). In general, the effects were not dose-dependent, suggesting the existence of a threshold at which they were triggered. Conclusion/Significance: Our data reveal that the relationships between earthworms and microorganisms are far from being understood, and suggest the existence of several positive feedbacks during earthworm activity as a result of the interactions between direct and indirect effects, since their combination produces stronger modifications to microbial biomass and enzyme activity.	[Aira, Manuel; Dominguez, Jorge] Univ Vigo, Fac Biol, Dept Ecol & Biol Anim, Vigo 36310, Spain	Universidade de Vigo	Aira, M (corresponding author), Univ Vigo, Fac Biol, Dept Ecol & Biol Anim, Vigo 36310, Spain.	aira@uvigo.es	Aira, Manuel/B-4506-2016; Domínguez, Jorge/T-7647-2019; Domínguez, Jorge/M-2046-2014	Aira, Manuel/0000-0002-2513-4609; Domínguez, Jorge/0000-0002-4313-8582; Domínguez, Jorge/0000-0002-4313-8582	Parga Pondal Fellow Program; Xunta de Galicia [07MRU023383PR]; Spanish Ministerio de Ciencia e Innovacion [CTM2009-08477]	Parga Pondal Fellow Program; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Manuel Aira is financially supported by Parga Pondal Fellow Program. This research was financially supported by the Xunta de Galicia (Project No. 07MRU023383PR) and the Spanish Ministerio de Ciencia e Innovacion (CTM2009-08477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2006, EUR J SOIL BIOL, V42, pS127, DOI 10.1016/j.ejsobi.2006.07.039; Aira M, 2009, J HAZARD MATER, V162, P1404, DOI 10.1016/j.jhazmat.2008.06.031; Aira M, 2008, SOIL BIOL BIOCHEM, V40, P2511, DOI 10.1016/j.soilbio.2008.06.010; Aira M, 2007, SCI TOTAL ENVIRON, V385, P252, DOI 10.1016/j.scitotenv.2007.06.031; Aira M, 2007, MICROB ECOL, V54, P662, DOI 10.1007/s00248-007-9223-4; Aira M, 2007, J ENVIRON QUAL, V36, P448, DOI 10.2134/jeq2006.0262; Aira M, 2010, APPL SOIL ECOL, V46, P143, DOI 10.1016/j.apsoil.2010.06.001; Aira M, 2010, BIORESOURCE TECHNOL, V101, P7173, DOI 10.1016/j.biortech.2010.03.137; Aira M, 2006, MICROB ECOL, V52, P738, DOI 10.1007/s00248-006-9109-x; Alef K., 1995, METHODS APPL SOIL MI, P335; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1155, DOI 10.1016/j.soilbio.2009.02.025; Benitez E, 2000, BIOL FERT SOILS, V31, P489, DOI 10.1007/s003740000197; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Depkat-Jakob PS, 2010, APPL ENVIRON MICROB, V76, P6205, DOI 10.1128/AEM.01373-10; Dominguez J, 2004, ECOSYSTEMS, V7, P672, DOI 10.1007/s10021-004-0150-7; Dominguez J, 2010, MICROBES AT WORK: FROM WASTES TO RESOURCES, P93, DOI 10.1007/978-3-642-04043-6_5; EDWARDS CA, 1996, BIOL ECOLOGY EARTHWO, P440; EIVAZI F, 1977, SOIL BIOL BIOCHEM, V9, P167, DOI 10.1016/0038-0717(77)90070-0; EIVAZI F, 1988, SOIL BIOL BIOCHEM, V20, P601, DOI 10.1016/0038-0717(88)90141-1; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; JUMA NG, 1978, SOIL SCI, V126, P101, DOI 10.1097/00010694-197808000-00006; Knapp BA, 2009, SOIL BIOL BIOCHEM, V41, P2299, DOI 10.1016/j.soilbio.2009.08.011; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Lavelle P., 2001, SOIL ECOLOGY; Lores M, 2006, SOIL BIOL BIOCHEM, V38, P2993, DOI 10.1016/j.soilbio.2006.05.001; Mikola J, 1998, OIKOS, V82, P158, DOI 10.2307/3546926; Monroy F, 2008, APPL SOIL ECOL, V39, P127, DOI 10.1016/j.apsoil.2007.11.011; Nechitaylo TY, 2010, MICROB ECOL, V59, P574, DOI 10.1007/s00248-009-9604-y; R Development Core Team, 2007, R LANG ENV STAT COMP; Sampedro L, 2008, APPL SOIL ECOL, V38, P91, DOI 10.1016/j.apsoil.2007.10.008; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SCHINNER F, 1990, SOIL BIOL BIOCHEM, V22, P511, DOI 10.1016/0038-0717(90)90187-5; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Singleton DR, 2003, SOIL BIOL BIOCHEM, V35, P1547, DOI 10.1016/S0038-0717(03)00244-X; SINSABAUGH RL, 1994, SOIL BIOL BIOCHEM, V26, P1305, DOI 10.1016/0038-0717(94)90211-9; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; SINSABAUGH RL, 1993, ECOLOGY, V74, P1594, DOI 10.2307/1940087; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; Tiunov AV, 1999, SOIL BIOL BIOCHEM, V31, P2039, DOI 10.1016/S0038-0717(99)00127-3; Tiunov AV, 2000, SOIL BIOL BIOCHEM, V32, P265, DOI 10.1016/S0038-0717(99)00165-0; Tiunov AV, 2004, OECOLOGIA, V138, P83, DOI 10.1007/s00442-003-1391-4; Tripathi G, 2004, BIORESOURCE TECHNOL, V92, P275, DOI 10.1016/j.biortech.2003.09.005; Vivas A, 2009, BIORESOURCE TECHNOL, V100, P1319, DOI 10.1016/j.biortech.2008.08.014; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Zhang BG, 2000, SOIL BIOL BIOCHEM, V32, P2055, DOI 10.1016/S0038-0717(00)00111-5	48	39	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16354	10.1371/journal.pone.0016354	http://dx.doi.org/10.1371/journal.pone.0016354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298016	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900039
J	Kleger, A; Loebnitz, C; Pusapati, GV; Armacki, M; Muller, M; Tumpel, S; Illing, A; Hartmann, D; Brunner, C; Liebau, S; Rudolph, KL; Adler, G; Seufferlein, T				Kleger, Alexander; Loebnitz, Christiane; Pusapati, Ganesh V.; Armacki, Milena; Mueller, Martin; Tuempel, Stefan; Illing, Anett; Hartmann, Daniel; Brunner, Cornelia; Liebau, Stefan; Rudolph, Karl L.; Adler, Guido; Seufferlein, Thomas			Protein Kinase D2 Is an Essential Regulator of Murine Myoblast Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANS-GOLGI NETWORK; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; CCKB/GASTRIN RECEPTOR; MOUSE EMBRYOGENESIS; C2C12 MYOBLASTS; PAX7 EXPRESSION; SATELLITE CELLS; UP-REGULATION	Muscle differentiation is a highly conserved process that occurs through the activation of quiescent satellite cells whose progeny proliferate, differentiate, and fuse to generate new myofibers. A defined pattern of myogenic transcription factors is orchestrated during this process and is regulated via distinct signaling cascades involving various intracellular signaling pathways, including members of the protein kinase C (PKC) family. The protein kinase D (PKD) isoenzymes PKD1, -2, and -3, are prominent downstream targets of PKCs and phospholipase D in various biological systems including mouse and could hence play a role in muscle differentiation. In the present study, we used a mouse myoblast cell line (C2C12) as an in vitro model to investigate the role of PKDs, in particular PKD2, in muscle stem cell differentiation. We show that C2C12 cells express all PKD isoforms with PKD2 being highly expressed. Furthermore, we demonstrate that PKD2 is specifically phosphorylated/activated during the initiation of mouse myoblast differentiation. Selective inhibition of PKCs or PKDs by pharmacological inhibitors blocked myotube formation. Depletion of PKD2 by shRNAs resulted in a marked inhibition of myoblast cell fusion. PKD2-depleted cells exhibit impaired regulation of muscle development-associated genes while the proliferative capacity remains unaltered. Vice versa forced expression of PKD2 increases myoblast differentiation. These findings were confirmed in primary mouse satellite cells where myotube fusion was also decreased upon inhibition of PKDs. Active PKD2 induced transcriptional activation of myocyte enhancer factor 2D and repression of Pax3 transcriptional activity. In conclusion, we identify PKDs, in particular PKD2, as a major mediator of muscle cell differentiation in vitro and thereby as a potential novel target for the modulation of muscle regeneration.	[Kleger, Alexander; Loebnitz, Christiane; Pusapati, Ganesh V.; Mueller, Martin; Adler, Guido] Univ Ulm, Dept Internal Med 1, D-7900 Ulm, Germany; [Kleger, Alexander; Tuempel, Stefan; Illing, Anett; Hartmann, Daniel; Rudolph, Karl L.] Univ Ulm, Inst Mol Med, D-7900 Ulm, Germany; [Kleger, Alexander; Tuempel, Stefan; Illing, Anett; Hartmann, Daniel; Rudolph, Karl L.] Univ Ulm, Max Planck Res Dept Stem Cell Aging, D-7900 Ulm, Germany; [Hartmann, Daniel] Tech Univ Munich, Dept Surg, Munich, Germany; [Brunner, Cornelia] Univ Ulm, Inst Physiol Chem, D-7900 Ulm, Germany; [Liebau, Stefan] Univ Ulm, Inst Anat & Cell Biol, D-7900 Ulm, Germany; [Armacki, Milena; Seufferlein, Thomas] Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Technical University of Munich; Ulm University; Ulm University; Martin Luther University Halle Wittenberg	Kleger, A (corresponding author), Univ Ulm, Dept Internal Med 1, D-7900 Ulm, Germany.	thomas.seufferlein@uk-halle.de	Liebau, Stefan/C-3374-2015; Brunner, Cornelia/H-8893-2018; Seufferlein, Thomas TW/P-7147-2018; Brunner, Cornelia/L-1291-2013	Liebau, Stefan/0000-0003-0721-8187; Brunner, Cornelia/0000-0002-6456-5508; Kleger, Alexander/0000-0003-0592-5232; Rudolph, Karl Lenhard/0000-0002-4839-2862; Hartmann, Daniel/0000-0003-4366-8986; Pusapati, Ganesh/0000-0002-1406-2566	Medical Faculty of Ulm University [L.SBR.0011]; Graduate College 1041 of Ulm University [1041]; Deutsche Forschungsgemeinschaft (DFG) [SFB 518]	Medical Faculty of Ulm University; Graduate College 1041 of Ulm University; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	A.K. is supported by a fellowship provided by the Medical Faculty of Ulm University (Bausteinprogramm, L.SBR.0011). C. L. was supported by a fellowship of the Graduate College 1041 of Ulm University. The main part of this study was funded by the Deutsche Forschungsgemeinschaft (DFG) ( T. S., SFB 518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Czifra G, 2006, CELL SIGNAL, V18, P1461, DOI 10.1016/j.cellsig.2005.11.007; Diel P, 2008, J MOL ENDOCRINOL, V40, P231, DOI 10.1677/JME-07-0175; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Faenza I, 2007, ENDOCRINOLOGY, V148, P1108, DOI 10.1210/en.2006-1003; Fanzani A, 2006, FEBS J, V273, P3709, DOI 10.1111/j.1742-4658.2006.05380.x; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gaboardi GC, 2010, CELL SIGNAL, V22, P629, DOI 10.1016/j.cellsig.2009.11.017; Geng J, 2009, BIOCHEM BIOPH RES CO, V388, P517, DOI 10.1016/j.bbrc.2009.08.025; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Kleger A, 2007, CELL SIGNAL, V19, P367, DOI 10.1016/j.cellsig.2006.07.015; Kuisk IR, 1996, DEV BIOL, V174, P1, DOI 10.1006/dbio.1996.0046; LEE SJ, 1995, BIOCHEM BIOPH RES CO, V206, P194, DOI 10.1006/bbrc.1995.1027; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Mirandola P, 2006, BLOOD, V107, P508, DOI 10.1182/blood-2005-07-2676; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Prelle K, 2000, BIOCHEM BIOPH RES CO, V277, P631, DOI 10.1006/bbrc.2000.3737; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Qiang YW, 2004, BLOOD, V103, P301, DOI 10.1182/blood-2003-06-2066; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sturany S, 2002, J BIOL CHEM, V277, P29431, DOI 10.1074/jbc.M200934200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang HX, 2008, MOL BIOL CELL, V19, P1519, DOI 10.1091/mbc.E07-08-0817; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; YOUNG AP, J CELL SCI; Young AP, 2010, J CELL SCI, V123, P2632, DOI 10.1242/jcs.061606; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	60	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14599	10.1371/journal.pone.0014599	http://dx.doi.org/10.1371/journal.pone.0014599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298052	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900004
J	Nahum, L; Gabriel, D; Schnider, A				Nahum, Louis; Gabriel, Damien; Schnider, Armin			Human Processing of Behaviorally Relevant and Irrelevant Absence of Expected Rewards: A High-Resolution ERP Study	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; SPONTANEOUS CONFABULATIONS; PREFRONTAL CORTEX; HUMAN BRAIN; NEURONAL-ACTIVITY; MONETARY REWARD; ONGOING REALITY; FRONTAL-CORTEX; MEMORY TRACES; POTENTIALS	Acute lesions of the posterior medial orbitofrontal cortex (OFC) in humans may induce a state of reality confusion marked by confabulation, disorientation, and currently inappropriate actions. This clinical state is strongly associated with an inability to abandon previously valid anticipations, that is, extinction capacity. In healthy subjects, the filtering of memories according to their relation with ongoing reality is associated with activity in posterior medial OFC (area 13) and electrophysiologically expressed at 220-300 ms. These observations indicate that the human OFC also functions as a generic reality monitoring system. For this function, it is presumably more important for the OFC to evaluate the current behavioral appropriateness of anticipations rather than their hedonic value. In the present study, we put this hypothesis to the test. Participants performed a reversal learning task with intermittent absence of reward delivery. High-density evoked potential analysis showed that the omission of expected reward induced a specific electrocortical response in trials signaling the necessity to abandon the hitherto reward predicting choice, but not when omission of reward had no such connotation. This processing difference occurred at 200-300 ms. Source estimation using inverse solution analysis indicated that it emanated from the posterior medial OFC. We suggest that the human brain uses this signal from the OFC to keep thought and behavior in phase with reality.	[Nahum, Louis; Gabriel, Damien; Schnider, Armin] Univ Geneva, Sch Med, Dept Clin Neurosci & Dermatol, Lab Cognit Neurorehabil, CH-1211 Geneva, Switzerland; [Schnider, Armin] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurorehabil, Geneva, Switzerland	University of Geneva; University of Geneva	Nahum, L (corresponding author), Univ Geneva, Sch Med, Dept Clin Neurosci & Dermatol, Lab Cognit Neurorehabil, CH-1211 Geneva, Switzerland.	armin.schnider@hcuge.ch		gabriel, damien/0000-0001-5413-3640	Swiss National Science Foundation [320030-132447]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation to AS (grant no. 320030-132447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2000, NEUROPSYCHOLOGIA, V38, P1342, DOI 10.1016/S0028-3932(00)00046-4; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; Chase H.W., 2010, J COGN NEUROSCI; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Elliott R, 2010, CEREB CORTEX, V20, P198, DOI 10.1093/cercor/bhp092; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Ghahremani DG, 2010, CEREB CORTEX, V20, P1843, DOI 10.1093/cercor/bhp247; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; James C, 2009, HIPPOCAMPUS, V19, P371, DOI 10.1002/hipo.20526; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Lantz G, 2001, BRAIN TOPOGR, V14, P139, DOI 10.1023/A:1012996930489; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Lehmann S, 2007, NEUROPSYCHOLOGIA, V45, P1757, DOI 10.1016/j.neuropsychologia.2006.12.018; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Metcalf K, 2007, COGN NEUROPSYCHOL, V24, P23, DOI 10.1080/02643290600694901; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 1999, NEWS PHYSIOL SCI, V14, P206; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Michel CM., 2009, ELECT NEUROIMAGING, P111; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Murray MM, 2008, NEUROIMAGE, V39, P847, DOI 10.1016/j.neuroimage.2007.09.002; Nahum L, 2010, HIPPOCAMPUS; Nahum L, 2010, CORTEX; Nahum L, 2009, HUM BRAIN MAPP, V30, P2120, DOI 10.1002/hbm.20654; Nahum L, 2009, BIOL PSYCHIAT, V65, P966, DOI 10.1016/j.biopsych.2009.01.007; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Ouyang M, 2005, P NATL ACAD SCI USA, V102, P9347, DOI 10.1073/pnas.0502315102; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; PAVLOV P, 1927, CONDITIONED REFLEXES; Pegna AJ, 2002, NEUROREPORT, V13, P965, DOI 10.1097/00001756-200205240-00013; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Ptak R, 2001, NEUROLOGY, V56, P1597, DOI 10.1212/WNL.56.11.1597; Ramnani N, 2004, NEUROIMAGE, V23, P777, DOI 10.1016/j.neuroimage.2004.07.028; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; ROSENKILDE CE, 1981, BRAIN RES, V209, P375, DOI 10.1016/0006-8993(81)90160-8; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; Schnider A, 2010, NEUROSCIENCE, V167, P583, DOI 10.1016/j.neuroscience.2010.02.044; Schnider A, 2002, CEREB CORTEX, V12, P54, DOI 10.1093/cercor/12.1.54; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; Schnider A., 2008, CONFABULATING MIND B; Schnider A, 2008, NEUROLOGIE COMPORTEM; Schnider A, 2007, NEUROIMAGE, V35, P1348, DOI 10.1016/j.neuroimage.2007.01.047; Schnider A, 2005, NEUROPSYCHOLOGIA, V43, P316, DOI 10.1016/j.neuropsychologia.2004.07.003; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Schultz W., 2006, ORBITOFRONTAL CORTEX, P173; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Stenger V. A., 2006, ORBITOFRONTAL CORTEX, P423; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Treyer V, 2003, J COGNITIVE NEUROSCI, V15, P610, DOI 10.1162/089892903321662985; VAUGHAN HG, 1982, ANN NY ACAD SCI, V388, P125, DOI 10.1111/j.1749-6632.1982.tb50788.x; Willis ML, 2010, NEUROIMAGE, V50, P329, DOI 10.1016/j.neuroimage.2009.11.071	78	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16173	10.1371/journal.pone.0016173	http://dx.doi.org/10.1371/journal.pone.0016173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JV	21298049	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900024
J	Shan, JF; Javitch, JA; Shi, L; Weinstein, H				Shan, Jufang; Javitch, Jonathan A.; Shi, Lei; Weinstein, Harel			The Substrate-Driven Transition to an Inward-Facing Conformation in the Functional Mechanism of the Dopamine Transporter	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; HUMAN NOREPINEPHRINE TRANSPORTER; HUMAN-NORADRENALINE-TRANSPORTER; STEERED MOLECULAR-DYNAMICS; RAT SEROTONIN TRANSPORTER; TRANSMEMBRANE DOMAIN-I; NEUROTRANSMITTER TRANSPORTERS; BINDING-SITE; BACTERIAL HOMOLOG; COCAINE BINDING	Background: The dopamine transporter (DAT), a member of the neurotransmitter: Na+ symporter (NSS) family, terminates dopaminergic neurotransmission and is a major molecular target for psychostimulants such as cocaine and amphetamine, and for the treatment of attention deficit disorder and depression. The crystal structures of the prokaryotic NSS homolog of DAT, the leucine transporter LeuT, have provided critical structural insights about the occluded and outward-facing conformations visited during the substrate transport, but only limited clues regarding mechanism. To understand the transport mechanism in DAT we have used a homology model based on the LeuT structure in a computational protocol validated previously for LeuT, in which steered molecular dynamics (SMD) simulations guide the substrate along a pathway leading from the extracellular end to the intracellular (cytoplasmic) end. Methodology/Principal Findings: Key findings are (1) a second substrate binding site in the extracellular vestibule, and (2) models of the conformational states identified as occluded, doubly occupied, and inward-facing. The transition between these states involve a spatially ordered sequence of interactions between the two substrate-binding sites, followed by rearrangements in structural elements located between the primary binding site and the cytoplasmic end. These rearrangements are facilitated by identified conserved hinge regions and a reorganization of interaction networks that had been identified as gates. Conclusions/Significance: Computational simulations supported by information available from experiments in DAT and other NSS transporters have produced a detailed mechanistic proposal for the dynamic changes associated with substrate transport in DAT. This allosteric mechanism is triggered by the binding of substrate in the S2 site in the presence of the substrate in the S1 site. Specific structural elements involved in this mechanism, and their roles in the conformational transitions illuminated here describe, a specific substrate-driven allosteric mechanism that is directly amenable to experiment as shown previously for LeuT.	[Shan, Jufang; Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Cornell University; Cornell University; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University	Shan, JF (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	les2007@med.cornell.edu; haw2002@med.cornell.edu	Shi, Lei/AAV-1321-2020; WEINSTEIN, HAREL/O-8245-2019	Shi, Lei/0000-0002-4137-096X; WEINSTEIN, HAREL/0000-0003-3473-9818; Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health, National Institute on Drug Abuse [DA012408, DA023694, DA022413, DA17293]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017293, R00DA023694, P01DA012408, K05DA022413] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants from the National Institute on Drug Abuse (DA012408, DA023694, DA022413, and DA17293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Burgess KSD, 1999, J NEUROCHEM, V73, P656, DOI 10.1046/j.1471-4159.1999.0730656.x; Case D, 2006, AMBER 9; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Crawley M.J., 2007, R BOOK; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Damm KL, 2006, BIOPHYS J, V90, P4558, DOI 10.1529/biophysj.105.066654; Dar DE, 2005, BIOCHEM PHARMACOL, V70, P461, DOI 10.1016/j.bcp.2005.04.032; Dodd JR, 2005, J BIOL CHEM, V280, P32649, DOI 10.1074/jbc.M506723200; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Elling CE, 1997, FOLD DES, V2, pS76, DOI 10.1016/S1359-0278(97)00068-0; Enkavi G, 2010, BIOCHEMISTRY-US, V49, P1105, DOI 10.1021/bi901412a; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gedeon PC, 2010, PROTEINS, V78, P797, DOI 10.1002/prot.22601; Goldberg NR, 2003, EUR J PHARMACOL, V479, P3, DOI 10.1016/j.ejphar.2003.08.052; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Gouaux E, 2009, PHILOS T R SOC B, V364, P149, DOI 10.1098/rstb.2008.0181; Gracia L., 2005, RMSDTT RMSD TRAJECTO; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Itokawa M, 2000, MOL PHARMACOL, V57, P1093; Itokawa M, 2002, MOL BRAIN RES, V108, P71, DOI 10.1016/S0169-328X(02)00515-6; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; Jensen MO, 2007, BIOPHYS J, V93, P92, DOI 10.1529/biophysj.107.103994; Kamdar G, 2001, J BIOL CHEM, V276, P4038, DOI 10.1074/jbc.M008483200; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; KITAYAMA S, 1993, SYNAPSE, V15, P58, DOI 10.1002/syn.890150107; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lin ZC, 2000, FASEB J, V14, P715, DOI 10.1096/fasebj.14.5.715; Lin ZC, 2003, J BIOL CHEM, V278, P20162, DOI 10.1074/jbc.M209584200; Lin ZC, 2005, J NEUROCHEM, V94, P276, DOI 10.1111/j.1471-4159.2005.03196.x; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mezei M, 2010, J COMPUT CHEM, V31, P2658, DOI 10.1002/jcc.21551; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Norregaard L, 2003, J BIOL CHEM, V278, P30587, DOI 10.1074/jbc.M303854200; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Paczkowski FA, 2004, J NEUROCHEM, V88, P203, DOI 10.1046/j.1471-4159.2003.02149.x; Paczkowski FA, 2002, PHARMACOGENETICS, V12, P165, DOI 10.1097/00008571-200203000-00010; Penado KMY, 1998, J BIOL CHEM, V273, P28098, DOI 10.1074/jbc.273.43.28098; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plenge P, 2005, NEUROSCI LETT, V383, P203, DOI 10.1016/j.neulet.2005.04.028; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Shi L, 2010, PHIL PA 10 IEEE INT; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh R, 2002, J PEPT RES, V60, P357, DOI 10.1034/j.1399-3011.2002.21065.x; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Sucic S, 2005, J NEUROCHEM, V94, P1620, DOI 10.1111/j.1471-4159.2005.03316.x; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Visiers I, 2002, METHOD ENZYMOL, V343, P329; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	96	96	98	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16350	10.1371/journal.pone.0016350	http://dx.doi.org/10.1371/journal.pone.0016350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298009	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900038
J	Ditt, V; Lusebrink, J; Tillmann, RL; Schildgen, V; Schildgen, O				Ditt, Vanessa; Luesebrink, Jessica; Tillmann, Ramona Liza; Schildgen, Verena; Schildgen, Oliver			Respiratory Infections by HMPV and RSV Are Clinically Indistinguishable but Induce Different Host Response in Aged Individuals	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTION; NF-KAPPA-B; SYNCYTIAL VIRUS; BALB/C MICE; NONSTRUCTURAL PROTEINS; IMMUNE-RESPONSE; NS1; IMMUNOSENESCENCE; CHILDREN; DISEASE	Background: Human metapneumovirus and respiratory syncytial virus can cause severe respiratory diseases, especially in infants, young children, and the elderly. So far it remains unclear why infections in the elderly become life threatening despite the presence of neutralizing antibodies in the serum, and to which extent double infections worsen the clinical course. Methods: Young and aged BALB/c-mice were infected with RSV or/and HMPV. Appearance of the mice was observed during course of infection. On day 5 p.i. animals were dispatched by cervical dislocation and levels of TNF-alpha and NF-kappa B were determined. Results: The observation of activity, weight and appearance of the different mice showed no differences among the tested groups. Despite this, the immunologic response depends on the animals' age and the virus they were infected with. In young animals, NF-kappa B levels were elevated if infected with HMPV and HMPV/RSV but remained low in RSV infections, whereas in aged animals the opposite was observed: solely RSV-infected animals showed elevated levels of NF-kappa B. TNF-alpha was slightly elevated in HMPV-infected young and old animals, but only in young animals this elevation was significant. Conclusions: Contrary to other studies, no weight loss or change in activity despite productive lung infection with the different viruses were observed. This may be due to the weaker anaesthesia or the lesser volume of virus solution used, leading to less stress in the animals. The observed differences in TNF-alpha and NF-kappa B elevation lead to the assumption that young and old individuals have different mechanisms to react against the viruses.	[Ditt, Vanessa; Luesebrink, Jessica; Tillmann, Ramona Liza; Schildgen, Verena; Schildgen, Oliver] Univ Bonn, Inst Virol, D-5300 Bonn, Germany	University of Bonn	Ditt, V (corresponding author), Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.	schildgeno@kliniken-koeln.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	European Commission [LSHM-CT-2006-037276]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission (RespViruses, LSHM-CT-2006-037276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Alvarez R, 2004, J VIROL, V78, P14003, DOI 10.1128/JVI.78.24.14003-14011.2004; Bitko V, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-28; Bitko V, 2007, J VIROL, V81, P1786, DOI 10.1128/JVI.01420-06; Darniot M, 2005, VACCINE, V23, P4473, DOI 10.1016/j.vaccine.2005.04.027; Darniot M, 2009, J VIROL, V83, P3323, DOI 10.1128/JVI.02198-08; DARNIOT M, 2009, J VIROL; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06; Huck B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-6; LING Z, 2009, J VIROL; Ling Z, 2008, PROTEIN EXPRES PURIF, V57, P261, DOI 10.1016/j.pep.2007.09.017; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Louie JK, 2007, J INFECT DIS, V196, P705, DOI 10.1086/519846; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mok H, 2008, J VIROL, V82, P11410, DOI 10.1128/JVI.01688-08; Moore EC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-116; Muller A, 2007, EUR J MED RES, V12, P183; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pawelec G, 2004, TRENDS IMMUNOL, V25, P406, DOI 10.1016/j.it.2004.05.006; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Schildgen O, 2005, J VIROL, V79, P7273, DOI 10.1128/JVI.79.11.7273-7278.2005; Schildgen O, 2005, EMERG INFECT DIS, V11, P467, DOI 10.3201/eid1103.040676; Schildgen V, 2010, J VIROL METHODS, V163, P74, DOI 10.1016/j.jviromet.2009.08.024; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spetch L, 2008, J GEN VIROL, V89, P2709, DOI 10.1099/vir.0.2008/003301-0; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tillmann RL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001357; van den Hoogen BG, 2007, CLIN INFECT DIS, V44, P1159, DOI 10.1086/513295; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Velayudhan BT, 2006, EMERG INFECT DIS, V12, P1853; von Linstow ML, 2008, EUR J PEDIATR, V167, P1125, DOI 10.1007/s00431-007-0643-4; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4	37	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16314	10.1371/journal.pone.0016314	http://dx.doi.org/10.1371/journal.pone.0016314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298115	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800025
J	Jaspers, K; Versluis, B; Leiner, T; Dijkstra, P; Oostendorp, M; van Golde, JM; Post, MJ; Backes, WH				Jaspers, Karolien; Versluis, Bas; Leiner, Tim; Dijkstra, Petra; Oostendorp, Marlies; van Golde, Jolanda M.; Post, Mark J.; Backes, Walter H.			MR Angiography of Collateral Arteries in a Hind Limb Ischemia Model: Comparison between Blood Pool Agent Gadomer and Small Contrast Agent Gd-DTPA	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; P792; GROWTH	The objective of this study was to compare the blood pool agent Gadomer with a small contrast agent for the visualization of ultra-small, collateral arteries (diameter<1 mm) with high resolution steady-state MR angiography (SS-MRA) in a rabbit hind limb ischemia model. Ten rabbits underwent unilateral femoral artery ligation. On days 14 and 21, high resolution SS-MRA (voxel size 0.49x0.49x0.50 mm(3)) was performed on a 3 Tesla clinical system after administration of either Gadomer (dose: 0.10 mmol/kg) or a small contrast agent (gadopentetate dimeglumine (Gd-DTPA), dose: 0.20 mmol/kg). All animals received both contrast agents on separate days. Selective intra-arterial x-ray angiograms (XRAs) were obtained in the ligated limb as a reference. The number of collaterals was counted by two independent observers. Image quality was evaluated with the contrast-to-noise ratio (CNR) in the femoral artery and collateral arteries. CNR for Gadomer was higher in both the femoral artery (Gadomer: 73 +/- 5 (mean +/- SE); Gd-DTPA: 40 +/- 3; p<0.01) and collateral arteries (Gadomer: 18 +/- 4; Gd-DTPA: 9 +/- 1; p = 0.04). Neither day of acquisition nor contrast agent used influenced the number of identified collateral arteries (p = 0.30 and p = 0.14, respectively). An average of 4.5 +/- 1.0 (day 14, mean +/- SD) and 5.3 +/- 1.2 (day 21) collaterals was found, which was comparable to XRA (5.6 +/- 1.7, averaged over days 14 and 21; p>0.10). Inter-observer variation was 24% and 18% for Gadomer and Gd-DTPA, respectively. In conclusion, blood pool agent Gadomer improved vessel conspicuity compared to Gd-DTPA. Steady-state MRA can be considered as an excellent non-invasive alternative to intra-arterial XRA for the visualization of ultra-small collateral arteries.	[Jaspers, Karolien; Versluis, Bas; Leiner, Tim; Oostendorp, Marlies; Post, Mark J.; Backes, Walter H.] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Jaspers, Karolien; Versluis, Bas; Leiner, Tim; Oostendorp, Marlies; van Golde, Jolanda M.; Backes, Walter H.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Dijkstra, Petra] Maastricht Univ, Cent Anim Facil, Maastricht, Netherlands; [Backes, Walter H.] GROW Sch Oncol & Dev Biol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Jaspers, K (corresponding author), Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	w.backes@mumc.nl		Backes, Walter H/0000-0001-7905-0681	Netherlands Heart Foundation [2005B178]; Center for Translational Molecular Medicine	Netherlands Heart Foundation(Netherlands Heart Foundation); Center for Translational Molecular Medicine	This study was supported by the Netherlands Heart Foundation (grant 2005B178) and the Center for Translational Molecular Medicine (Eminence project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes WH, 2008, J VASC SURG, V48, P261, DOI 10.1016/j.jvs.2008.03.015; Baumgartner I, 2005, RADIOLOGY, V234, P833, DOI 10.1148/radiol.2343031440; Bonel HM, 2009, RADIOLOGY, V253, P879, DOI 10.1148/radiol.2533081627; Bremerich J, 2007, EUR RADIOL, V17, P3017, DOI 10.1007/s00330-007-0712-0; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Clarke SE, 2000, RADIOLOGY, V214, P787, DOI 10.1148/radiology.214.3.r00mr25787; Corot C, 2003, INVEST RADIOL, V38, P311, DOI 10.1097/01.rli.0000066814.82006.be; de Lussanet QG, 2006, NMR BIOMED, V19, P77, DOI 10.1002/nbm.1003; Dong Q, 1998, INVEST RADIOL, V33, P699, DOI 10.1097/00004424-199809000-00026; Hadizadeh DR, 2008, RADIOLOGY, V249, P701, DOI 10.1148/radiol.2492072033; Herborn CU, 2004, RADIOLOGY, V233, P567, DOI 10.1148/radiol.2332031545; Jaspers K, 2010, MED PHYS, V37, P5746, DOI 10.1118/1.3484057; Jaspers K, 2009, MAGN RESON MED, V62, P779, DOI 10.1002/mrm.22035; LEINER T, 2008, CLIN BLOOD POOL MR I; Li DB, 2001, RADIOLOGY, V218, P670, DOI 10.1148/radiology.218.3.r01mr03670; LONGLAND C J, 1953, Postgrad Med J, V29, P456; Maki JH, 2009, J MAGN RESON IMAGING, V30, P1085, DOI 10.1002/jmri.21961; Misselwitz B, 2001, MAGN RESON MATER PHY, V12, P128, DOI 10.1016/S1352-8661(01)00109-0; Nielsen YW, 2009, ACAD RADIOL, V16, P654, DOI 10.1016/j.acra.2008.12.018; Port M, 2001, INVEST RADIOL, V36, P445, DOI 10.1097/00004424-200108000-00002; Port M, 2001, MAGN RESON MATER PHY, V12, P121, DOI 10.1007/BF02668093; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Schirmer SH, 2004, CARDIOVASC RES, V64, P356, DOI 10.1016/j.cardiores.2004.06.022; Swan JS, 2002, RADIOLOGY, V225, P43, DOI 10.1148/radiol.2251011292; Wang Y, 2001, INVEST RADIOL, V36, P170, DOI 10.1097/00004424-200103000-00006; Wecksell MB, 2001, INVEST RADIOL, V36, P422, DOI 10.1097/00004424-200107000-00008; Zhuang ZW, 2006, RADIOLOGY, V240, P698, DOI 10.1148/radiol.2403050976	28	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16159	10.1371/journal.pone.0016159	http://dx.doi.org/10.1371/journal.pone.0016159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298092	Green Submitted, Green Published, gold			2022-12-27	WOS:000286662800017
J	Pezzulo, AA; Gutierrez, J; Duschner, KS; McConnell, KS; Taft, PJ; Ernst, SE; Yahr, TL; Rahmouni, K; Klesney-Tait, J; Stoltz, DA; Zabner, J				Pezzulo, Alejandro A.; Gutierrez, Jeydith; Duschner, Kelly S.; McConnell, Kelly S.; Taft, Peter J.; Ernst, Sarah E.; Yahr, Timothy L.; Rahmouni, Kamal; Klesney-Tait, Julia; Stoltz, David A.; Zabner, Joseph			Glucose Depletion in the Airway Surface Liquid Is Essential for Sterility of the Airways	PLOS ONE			English	Article							ARTERIAL TORTUOSITY SYNDROME; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CANDIDATE GENE; SLC2A10 GLUT10; OBESE GENE; EPITHELIA; TRANSPORTERS; PNEUMONIA; CLONING	Diabetes mellitus predisposes the host to bacterial infections. Moreover, hyperglycemia has been shown to be an independent risk factor for respiratory infections. The luminal surface of airway epithelia is covered by a thin layer of airway surface liquid (ASL) and is normally sterile despite constant exposure to bacteria. The balance between bacterial growth and killing in the airway determines the outcome of exposure to inhaled or aspirated bacteria: infection or sterility. We hypothesized that restriction of carbon sources-including glucose-in the ASL is required for sterility of the lungs. We found that airway epithelia deplete glucose from the ASL via a novel mechanism involving polarized expression of GLUT-1 and GLUT-10, intracellular glucose phosphorylation, and low relative paracellular glucose permeability in well-differentiated cultures of human airway epithelia and in segments of airway epithelia excised from human tracheas. Moreover, we found that increased glucose concentration in the ASL augments growth of P. aeruginosa in vitro and in the lungs of hyperglycemic ob/ob and db/db mice in vivo. In contrast, hyperglycemia had no effect on intrapulmonary bacterial growth of a P. aeruginosa mutant that is unable to utilize glucose as a carbon source. Our data suggest that depletion of glucose in the airway epithelial surface is a novel mechanism for innate immunity. This mechanism is important for sterility of the airways and has implications in hyperglycemia and conditions that result in disruption of the epithelial barrier in the lung.	[Pezzulo, Alejandro A.; Gutierrez, Jeydith; Duschner, Kelly S.; McConnell, Kelly S.; Taft, Peter J.; Ernst, Sarah E.; Rahmouni, Kamal; Klesney-Tait, Julia; Stoltz, David A.; Zabner, Joseph] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Yahr, Timothy L.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Pezzulo, AA (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu	Gutierrez, Jeydith/AAM-9438-2020; Rahmouni, Kamal/Y-1788-2019	Gutierrez, Jeydith/0000-0001-7596-1779; Pezzulo, Alejandro/0000-0001-7544-5109; Stoltz, David/0000-0003-0893-9015; Rahmouni, Kamal/0000-0001-5136-6748; Klesney-Tait, julia/0000-0002-0261-8395; Yahr, Timothy/0000-0001-9054-8704; Zabner, Joseph/0000-0002-9606-1339	University of Iowa Department of Internal Medicine; National Heart, Lung and Blood Institute [HL51670, HL091842]; National Institutes of Diabetes and Digestive and Kidney Diseases [DK54759]; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	University of Iowa Department of Internal Medicine; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a University of Iowa Department of Internal Medicine Translational Research Pilot Grant, and in part by National Heart, Lung and Blood Institute HL51670 and HL091842, National Institutes of Diabetes and Digestive and Kidney Diseases DK54759 and a Cystic Fibrosis Foundation RDP Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2008, PEDIATRICS, V122, P229, DOI 10.1542/peds.2007-3192; Baker EH, 2007, J APPL PHYSIOL, V102, P1969, DOI 10.1152/japplphysiol.01425.2006; Baker EH, 2006, P NUTR SOC, V65, P227, DOI 10.1079/PNS2006499; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Beatson SA, 2002, J BACTERIOL, V184, P3598, DOI 10.1128/KB.184.13.3598-3604.2002; Bento JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-42; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Coucke PJ, 2003, J MED GENET, V40, P747, DOI 10.1136/jmg.40.10.747; CUSKEY SM, 1985, J BACTERIOL, V162, P865, DOI 10.1128/JB.162.3.865-871.1985; Dawson PA, 2001, MOL GENET METAB, V74, P186, DOI 10.1006/mgme.2001.3212; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; Fischer AJ, 2009, AM J RESP CELL MOL, V40, P189, DOI 10.1165/rcmb.2008-0240OC; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HOLTUG K, 1996, SCAND J GASTROENTE S, V216, P95; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; JOHANSON WG, 1969, NEW ENGL J MED, V281, P1137, DOI 10.1056/NEJM196911202812101; Kalsi KK, 2008, PFLUG ARCH EUR J PHY, V456, P991, DOI 10.1007/s00424-008-0459-8; Kalsi KK, 2009, PFLUG ARCH EUR J PHY, V457, P1061, DOI 10.1007/s00424-008-0576-4; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Landry JS, 2001, J GEN PHYSIOL, V117, P419, DOI 10.1085/jgp.117.5.419; LEE WS, 1994, J BIOL CHEM, V269, P12032; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Lin WH, 2006, DIABETOLOGIA, V49, P1214, DOI 10.1007/s00125-006-0218-3; Mager S, 2003, EUR J PHARMACOL, V479, P263, DOI 10.1016/j.ejphar.2003.08.075; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; McVie-Wylie AJ, 2001, GENOMICS, V72, P113, DOI 10.1006/geno.2000.6457; Mohlke KL, 2005, MOL GENET METAB, V85, P323, DOI 10.1016/j.ymgme.2005.04.011; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Motulsky H., 1995, INTUITIVE BIOSTATIST; PEREZDIAZ J, 1977, AM J PHYSIOL, V232, pE394, DOI 10.1152/ajpendo.1977.232.4.E394; Philips BJ, 2005, THORAX, V60, P761, DOI 10.1136/thx.2004.035766; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Rakhimova E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001685; Reading PC, 1998, J VIROL, V72, P6884, DOI 10.1128/JVI.72.8.6884-6887.1998; RITCHINGS BW, 1995, INFECT IMMUN, V63, P4868, DOI 10.1128/IAI.63.12.4868-4876.1995; Saumon G, 1996, AM J PHYSIOL-LUNG C, V270, pL183, DOI 10.1152/ajplung.1996.270.2.L183; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vardakas KZ, 2007, DIABETIC MED, V24, P1168, DOI 10.1111/j.1464-5491.2007.02234.x; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Wessels MW, 2004, AM J MED GENET A, V131A, P134, DOI 10.1002/ajmg.a.30272; WIDDICOMBE JH, 1995, RESP PHYSIOL, V99, P3, DOI 10.1016/0034-5687(94)00095-H; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	54	78	81	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16166	10.1371/journal.pone.0016166	http://dx.doi.org/10.1371/journal.pone.0016166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21311590	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522200030
J	Costantini, LM; Gilberti, RM; Knecht, DA				Costantini, Lindsey M.; Gilberti, Renee M.; Knecht, David A.			The Phagocytosis and Toxicity of Amorphous Silica	PLOS ONE			English	Article							MOUSE ALVEOLAR MACROPHAGES; CRYSTALLINE SILICA; NANOPARTICLES; INHALATION; RESPONSES; CELLS; RATS; CYTOTOXICITY; PARTICLES; SIZE	Background: Inhalation of crystalline silica is known to cause an inflammatory reaction and chronic exposure leads to lung fibrosis and can progress into the disease, silicosis. Cultured macrophages bind crystalline silica particles, phagocytose them, and rapidly undergo apoptotic and necrotic death. The mechanism by which particles are bound and internalized and the reason particles are toxic is unclear. Amorphous silica has been considered to be a less toxic form, but this view is controversial. We compared the uptake and toxicity of amorphous silica to crystalline silica. Methodology/Principal Findings: Amorphous silica particles are phagocytosed by macrophage cells and a single internalized particle is capable of killing a cell. Fluorescent dextran is released from endo-lysosomes within two hours after silica treatment and Caspase-3 activation occurs within 4 hours. Interestingly, toxicity is specific to macrophage cell lines. Other cell types are resistant to silica particle toxicity even though they internalize the particles. The large and uniform size of the spherical, amorphous silica particles allowed us to monitor them during the uptake process. In mCherry-actin transfected macrophages, actin rings began to form 1-3 minutes after silica binding and the actin coat disassembled rapidly following particle internalization. Pre-loading cells with fluorescent dextran allowed us to visualize the fusion of phagosomes with endosomes during internalization. These markers provided two new ways to visualize and quantify particle internalization. At 37 degrees C the rate of amorphous silica internalization was very rapid regardless of particle coating. However, at room temperature, opsonized silica is internalized much faster than non-opsonized silica. Conclusions/Significance: Our results indicate that amorphous and crystalline silica are both phagocytosed and both toxic to mouse alveolar macrophage (MH-S) cells. The pathway leading to apoptosis appears to be similar in both cases. However, the result suggests a mechanistic difference between Fc gamma RIIA receptor-mediated and non-opsonized silica particle phagocytosis.	[Costantini, Lindsey M.; Gilberti, Renee M.; Knecht, David A.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Costantini, LM (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	david.knecht@uconn.edu	Gilberti, Renee M./AAN-2226-2021	Knecht, David/0000-0001-6103-4296	Robert Leet and Clara Guthrie Patterson Trust; University of Connecticut Research Foundation	Robert Leet and Clara Guthrie Patterson Trust; University of Connecticut Research Foundation	This work was funded by grants from the Robert Leet and Clara Guthrie Patterson Trust Fund and the University of Connecticut Research Foundation to DAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts JHE, 2007, FOOD CHEM TOXICOL, V45, P1856, DOI 10.1016/j.fct.2007.04.001; Balduzzi M, 2004, ENVIRON RES, V96, P62, DOI 10.1016/j.envres.2003.11.004; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Castranova V, 1996, SILICA SILICA INDUCE; El-Sibai M, 2008, EXP CELL RES, V314, P1540, DOI 10.1016/j.yexcr.2008.01.016; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; Gilberti RM, 2008, AM J RESP CELL MOL, V39, P619, DOI 10.1165/rcmb.2008-0046OC; Hetland RB, 2001, HUM EXP TOXICOL, V20, P46, DOI 10.1191/096032701676225130; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Johnston CJ, 2000, TOXICOL SCI, V56, P405, DOI 10.1093/toxsci/56.2.405; May RC, 2001, J CELL SCI, V114, P1061; Merget R, 2002, ARCH TOXICOL, V75, P625, DOI 10.1007/S002040100266; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Sayes CM, 2007, TOXICOL SCI, V97, P163, DOI 10.1093/toxsci/kfm018; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Thibodeau M, 2003, TOXICOL SCI, V76, P91, DOI 10.1093/toxsci/kfg178; Thibodeau MS, 2004, TOXICOL SCI, V80, P34, DOI 10.1093/toxsci/kfh121; THIBODEAU MS, 2004, MOL MECH SILICA INDU; WAGNER GR, 1995, AM J PUBLIC HEALTH, V85, P1346, DOI 10.2105/AJPH.85.10.1346; Warheit DB, 1995, SCAND J WORK ENV HEA, V21, P19; Waters KM, 2009, TOXICOL SCI, V107, P553, DOI 10.1093/toxsci/kfn250	24	74	74	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e14647	10.1371/journal.pone.0014647	http://dx.doi.org/10.1371/journal.pone.0014647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311600	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036200003
J	Holme, P				Holme, Petter			Metabolic Robustness and Network Modularity: A Model Study	PLOS ONE			English	Article							GRAPHS	Background: Several studies have mentioned network modularity-that a network can easily be decomposed into subgraphs that are densely connected within and weakly connected between each other-as a factor affecting metabolic robustness. In this paper we measure the relation between network modularity and several aspects of robustness directly in a model system of metabolism. Methodology/Principal Findings: By using a model for generating chemical reaction systems where one can tune the network modularity, we find that robustness increases with modularity for changes in the concentrations of metabolites, whereas it decreases with changes in the expression of enzymes. The same modularity scaling is true for the speed of relaxation after the perturbations. Conclusions/Significance: Modularity is not a general principle for making metabolism either more or less robust; this question needs to be addressed specifically for different types of perturbations of the system.	[Holme, Petter] Umea Univ, Dept Phys, Umea, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea	Umea University; Sungkyunkwan University (SKKU)	Holme, P (corresponding author), Umea Univ, Dept Phys, Umea, Sweden.	petter.holme@physics.umu.se	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096	Swedish Foundation for Strategic Research; Swedish Research Council; Ministry of Education, Science and Technology (MEST) [R31-2008-000-10029-0]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Swedish Foundation for Strategic Research, the Swedish Research Council, and the WCU program through the National Research Foundation (NRF) of the Republic of Korea funded by the Ministry of Education, Science and Technology (MEST) (R31-2008-000-10029-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Eum S, 2007, 2007 2ND BIO-INSPIRED MODELS OF NETWORKS, INFORMATION AND COMPUTING SYSTEMS (BIONETICS), P80; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Holme P, 2010, CHINESE SCI BULL, V55, P3161, DOI 10.1007/s11434-010-4086-3; Holme P, 2009, J R SOC INTERFACE, V6, P1027, DOI 10.1098/rsif.2008.0489; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Kaneko K, 2006; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Li X, 2009, 2009 OHIO COLLABORATIVE CONFERENCE ON BIOINFORMATICS, PROCEEDINGS, P104, DOI 10.1109/OCCBIO.2009.29; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Snel B, 2004, GENOME RES, V14, P391, DOI 10.1101/gr.1969504; Viana MP, 2009, MOL BIOSYST, V5, P255, DOI 10.1039/b814188f; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Zhao J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-311; Zhao J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-386	23	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16605	10.1371/journal.pone.0016605	http://dx.doi.org/10.1371/journal.pone.0016605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311770	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036200023
J	Yong, J; Lacan, G; Dang, H; Hsieh, T; Middleton, B; Wasserfall, C; Tian, JD; Melega, WP; Kaufman, DL				Yong, Jing; Lacan, Goran; Dang, Hoa; Hsieh, Terry; Middleton, Blake; Wasserfall, Clive; Tian, Jide; Melega, William P.; Kaufman, Daniel L.			BCG Vaccine-Induced Neuroprotection in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BACILLE-CALMETTE-GUERIN; MYELIN BASIC-PROTEIN; DIABETES-PRONE MICE; REGULATORY T-CELLS; MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; ANIMAL-MODEL	There is a growing interest in using vaccination with CNS antigens to induce autoreactive T cell responses that home to damaged areas in the CNS and ameliorate neurodegenerative disease. Neuroprotective vaccine studies have focused on administering oligodendrocyte antigens or Copaxone (R) in complete Freund's adjuvant (CFA). Theoretical considerations, however, suggest that vaccination with a neuronal antigen may induce more robust neuroprotective immune responses. We assessed the neuroprotective potential of vaccines containing tyrosine hydroxylase (a neuronal protein involved in dopamine synthesis) or Copaxone (R) in CFA in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Surprisingly, we observed that the main beneficial factor in these vaccines was the CFA. Since the major immunogenic component in CFA is Mycobacterium tuberculosis, which closely related to the bacille Calmette-Guerin (BCG) that is used in human vaccines, we tested BCG vaccination in the MPTP mouse model. We observed that BCG vaccination partially preserved markers of striatal dopamine system integrity and prevented an increase in activated microglia in the substantia nigra of MPTP-treated mice. These results support a new neuroprotective vaccine paradigm in which general (nonself-reactive) immune stimulation in the periphery can limit potentially deleterious microglial responses to a neuronal insult and exert a neurorestorative effect in the CNS. Accordingly, BCG vaccination may provide a new strategy to augment current treatments for a wide range of neuropathological conditions.	[Yong, Jing; Lacan, Goran; Dang, Hoa; Hsieh, Terry; Middleton, Blake; Tian, Jide; Melega, William P.; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wasserfall, Clive] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA	University of California System; University of California Los Angeles; State University System of Florida; University of Florida	Kaufman, DL (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	dkaufman@mednet.ucla.edu	Yong, Jing/I-2150-2012; wasserfall, clive/J-9078-2012; Kaufman, Daniel/AAU-1228-2021; Wasserfall, Clive/ABF-9385-2020	Yong, Jing/0000-0001-8579-1558; wasserfall, clive/0000-0002-3522-8932; Kaufman, Daniel/0000-0002-9844-5918; Wasserfall, Clive/0000-0002-3522-8932	American Parkinson's Disease Association; Michael J. Fox Foundation; National Institutes of Health [R21NS049121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS049121] Funding Source: NIH RePORTER	American Parkinson's Disease Association; Michael J. Fox Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Parkinson's Disease Association, the Michael J. Fox Foundation and the National Institutes of Health (R21NS049121) to DLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Armentero MT, 2006, NEUROBIOL DIS, V24, P492, DOI 10.1016/j.nbd.2006.08.016; Bakalash S, 2005, J MOL MED, V83, P904, DOI 10.1007/s00109-005-0689-6; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; BENNUN A, 1995, J IMMUNOL, V154, P2939; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boska MD, 2005, J NEUROSCI, V25, P1691, DOI 10.1523/JNEUROSCI.4364-04.2005; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Czlonkowska Anna, 2002, Med Sci Monit, V8, pRA165; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Fine P., 1999, ISSUES RELATING USE; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter HH, 2003, J NEUROIMMUNOL, V134, P25, DOI 10.1016/S0165-5728(02)00358-2; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; Kumar M, 1999, IMMUNOLOGY, V97, P515; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Kurkowska-Jastrzebska I, 2005, NEUROSCIENCE, V131, P247, DOI 10.1016/j.neuroscience.2004.10.027; Laurie C, 2007, J NEUROIMMUNOL, V183, P60, DOI 10.1016/j.jneuroim.2006.11.009; McGeer PL, 2001, ADV NEUROL, V86, P83; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Nevo U, 2003, TRENDS MOL MED, V9, P88, DOI 10.1016/S1471-4914(03)00024-8; O'Neil ML, 2006, SYNAPSE, V60, P465, DOI 10.1002/syn.20320; Olcott AP, 2005, J IMMUNOL, V175, P1991, DOI 10.4049/jimmunol.175.3.1991; Paolillo A, 2003, J NEUROL, V250, P247, DOI 10.1007/s00415-003-0967-6; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Pennathur S, 1999, J BIOL CHEM, V274, P34621, DOI 10.1074/jbc.274.49.34621; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Ristori G, 1999, NEUROLOGY, V53, P1588, DOI 10.1212/WNL.53.7.1588; Rodriguez M, 2007, NEUROBIOL DIS, V28, P316, DOI 10.1016/j.nbd.2007.07.024; Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Schwartz M, 2000, IMMUNOL TODAY, V21, P265, DOI 10.1016/S0167-5699(00)01633-9; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Sewell DL, 2003, CLIN DIAGN LAB IMMUN, V10, P564, DOI 10.1128/CDLi.10.4.564-572.2003; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; TEITELBAUM D, 1988, P NATL ACAD SCI USA, V85, P9724, DOI 10.1073/pnas.85.24.9724; TEIXEIRA HC, 1995, IMMUNOL LETT, V46, P15, DOI 10.1016/0165-2478(95)00009-T; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tian J, 2009, DIABETES, V58, P1939, DOI 10.2337/db09-0451; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yip HC, 1999, J IMMUNOL, V162, P3942	66	38	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16610	10.1371/journal.pone.0016610	http://dx.doi.org/10.1371/journal.pone.0016610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304945	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300098
J	Horn, S; Durka, W; Wolf, R; Ermala, A; Stubbe, A; Stubbe, M; Hofreiter, M				Horn, Susanne; Durka, Walter; Wolf, Ronny; Ermala, Aslak; Stubbe, Annegret; Stubbe, Michael; Hofreiter, Michael			Mitochondrial Genomes Reveal Slow Rates of Molecular Evolution and the Timing of Speciation in Beavers (Castor), One of the Largest Rodent Species	PLOS ONE			English	Article							PHYLOGENY; LONGEVITY; SUPPORT; CLOCK; FIBER; MODEL	Background: Beavers are one of the largest and ecologically most distinct rodent species. Little is known about their evolution and even their closest phylogenetic relatives have not yet been identified with certainty. Similarly, little is known about the timing of divergence events within the genus Castor. Methodology/Principal Findings: We sequenced complete mitochondrial genomes from both extant beaver species and used these sequences to place beavers in the phylogenetic tree of rodents and date their divergence from other rodents as well as the divergence events within the genus Castor. Our analyses support the phylogenetic position of beavers as a sister lineage to the scaly tailed squirrel Anomalurus within the mouse related clade. Molecular dating places the divergence time of the lineages leading to beavers and Anomalurus as early as around 54 million years ago (mya). The living beaver species, Castor canadensis from North America and Castor fiber from Eurasia, although similar in appearance, appear to have diverged from a common ancestor more than seven mya. This result is consistent with the hypothesis that a migration of Castor from Eurasia to North America as early as 7.5 mya could have initiated their speciation. We date the common ancestor of the extant Eurasian beaver relict populations to around 210,000 years ago, much earlier than previously thought. Finally, the substitution rate of Castor mitochondrial DNA is considerably lower than that of other rodents. We found evidence that this is correlated with the longer life span of beavers compared to other rodents. Conclusions/Significance: A phylogenetic analysis of mitochondrial genome sequences suggests a sister-group relationship between Castor and Anomalurus, and allows molecular dating of species divergence in congruence with paleontological data. The implementation of a relaxed molecular clock enabled us to estimate mitochondrial substitution rates and to evaluate the effect of life history traits on it.	[Horn, Susanne; Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Durka, Walter] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Wolf, Ronny] Univ Leipzig, Dept Mol Evolut & Anim Systemat, Leipzig, Germany; [Ermala, Aslak] Finnish Game & Fisheries Res Inst, Helsinki, Finland; [Stubbe, Annegret; Stubbe, Michael] Univ Halle Wittenberg, Inst Zool, Wittenberg, Germany	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Natural Resources Institute Finland (Luke); Martin Luther University Halle Wittenberg	Horn, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	horn@eva.mpg.de	Durka, Walter/E-4667-2010; Hofreiter, Michael/A-3996-2017	Durka, Walter/0000-0002-6611-2246; Hofreiter, Michael/0000-0003-0441-4705	Volkswagen Foundation; Max Planck Society	Volkswagen Foundation(Volkswagen); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Volkswagen Foundation and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; [Anonymous], 2014, TRACER V1 6; Baker B. W., 2003, BEAVER CASTOR CANADE, V2nd; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Choate JR, 1998, J MAMMAL, V79, P1416; Churakov G, 2010, MOL BIOL EVOL, V27, P1315, DOI 10.1093/molbev/msq019; Djoshkin W. W., 1972, BIBER ALTEN NEUEN WE; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Farwick A, 2006, SYST BIOL, V55, P936, DOI 10.1080/10635150601064806; FLYNN LJ, 2007, EVOLUTION TERTIARY M; Galtier N, 2009, BIOL LETTERS, V5, P413, DOI 10.1098/rsbl.2008.0662; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; GREEN R, 2009, COLD SPRING HARB LAB; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Halley Duncan J., 2003, Lutra, V46, P91; HERVE P, 1997, J MOL EVOL, V45, P712; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Horner DS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-16; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Hugueney M, 1996, PALEOBIOLOGY, V22, P507, DOI 10.1017/S0094837300016493; Jobson RW, 2010, MOL BIOL EVOL, V27, P840, DOI 10.1093/molbev/msp293; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Knapp M, 2009, MOL ECOL, V18, P1225, DOI 10.1111/j.1365-294X.2009.04088.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lavrov L. S., 1983, ACTA ZOOL FENN, V174, P87; Lin YH, 2002, GENE, V294, P119, DOI 10.1016/S0378-1119(02)00695-9; LINDSAY EH, 1984, ANNU REV EARTH PL SC, V12, P445, DOI 10.1146/annurev.ea.12.050184.002305; LYCHEV GF, 1983, ISTORIA EVOLUTSYA SI, P179; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Montgelard C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-321; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rybczynski Natalia, 2007, Journal of Mammalian Evolution, V14, P1, DOI 10.1007/s10914-006-9017-3; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thomas JA, 2006, P NATL ACAD SCI USA, V103, P7366, DOI 10.1073/pnas.0510251103; VERON G, 1992, MAMMALIA, V56, P87, DOI 10.1515/mamm.1992.56.1.87; WARD OG, 1991, GENOME, V34, P324, DOI 10.1139/g91-053; Welch JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-53; WOOD AE, 1959, EVOLUTION, V13, P354, DOI 10.1111/j.1558-5646.1959.tb03022.x; Xu Xiaofeng, 1994, National Science Museum Monographs, V8, P77	51	44	46	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14622	10.1371/journal.pone.0014622	http://dx.doi.org/10.1371/journal.pone.0014622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21307956	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100007
J	Ramaswamy, R; Sbalzarini, IF; Gonzalez-Segredo, N				Ramaswamy, Rajesh; Sbalzarini, Ivo F.; Gonzalez-Segredo, Nelido			Noise-Induced Modulation of the Relaxation Kinetics around a Non-Equilibrium Steady State of Non-Linear Chemical Reaction Networks	PLOS ONE			English	Article							FLUCTUATIONS; OSCILLATIONS; MODELS	Stochastic effects from correlated noise non-trivially modulate the kinetics of non-linear chemical reaction networks. This is especially important in systems where reactions are confined to small volumes and reactants are delivered in bursts. We characterise how the two noise sources confinement and burst modulate the relaxation kinetics of a non-linear reaction network around a non-equilibrium steady state. We find that the lifetimes of species change with burst input and confinement. Confinement increases the lifetimes of all species that are involved in any non-linear reaction as a reactant. Burst monotonically increases or decreases lifetimes. Competition between burst-induced and confinement-induced modulation may hence lead to a non-monotonic modulation. We quantify lifetime as the integral of the time autocorrelation function (ACF) of concentration fluctuations around a non-equilibrium steady state of the reaction network. Furthermore, we look at the first and second derivatives of the ACF, each of which is affected in opposite ways by burst and confinement. This allows discriminating between these two noise sources. We analytically derive the ACF from the linear Fokker-Planck approximation of the chemical master equation in order to establish a baseline for the burst-induced modulation at low confinement. Effects of higher confinement are then studied using a partial-propensity stochastic simulation algorithm. The results presented here may help understand the mechanisms that deviate stochastic kinetics from its deterministic counterpart. In addition, they may be instrumental when using fluorescence-lifetime imaging microscopy (FLIM) or fluorescence-correlation spectroscopy (FCS) to measure confinement and burst in systems with known reaction rates, or, alternatively, to correct for the effects of confinement and burst when experimentally measuring reaction rates.	[Ramaswamy, Rajesh; Sbalzarini, Ivo F.; Gonzalez-Segredo, Nelido] ETH, Inst Theoret Comp Sci, Zurich, Switzerland; [Ramaswamy, Rajesh; Sbalzarini, Ivo F.; Gonzalez-Segredo, Nelido] ETH, Swiss Inst Bioinformat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Ramaswamy, R (corresponding author), ETH, Inst Theoret Comp Sci, Zurich, Switzerland.	rajeshr@ethz.ch	Sbalzarini, Ivo F/B-2789-2017; Sbalzarini, Ivo F/A-2724-2008	Sbalzarini, Ivo Fabian/0000-0003-4414-4340	Swiss SystemsX.ch initiative [WingX, LipidX-2008/011]	Swiss SystemsX.ch initiative	RR was financed by a grant from the Swiss SystemsX.ch initiative (grant WingX), evaluated by the Swiss National Science Foundation. This project was also supported with a grant from the Swiss SystemsX.ch initiative, grant LipidX-2008/011 to IFS. The funding agency had no role in the conception, design, carrying out, or analysis of the work, nor in the decision to publish or preparation of the manuscript.	Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; GARDINER CW, 1976, J STAT PHYS, V14, P307, DOI 10.1007/BF01030197; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218103; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; Kim J, 2007, PLOS COMPUT BIOL, V3, P2190, DOI 10.1371/journal.pcbi.0030218; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Leyvraz F, 2003, PHYS REP, V383, P95, DOI 10.1016/S0370-1573(03)00241-2; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Mouri K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005131; Nishikawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011224; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Qian H, 2002, P NATL ACAD SCI USA, V99, P10376, DOI 10.1073/pnas.152007599; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramaswamy R, 2010, AIP CONF PROC, V1281, P1338, DOI 10.1063/1.3497968; Ramaswamy R, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3154624; Shibata T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056218; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Turner MS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168301; VANDONGEN PGJ, 1987, J STAT PHYS, V49, P927, DOI 10.1007/BF01017554; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Zhao YQ, 2008, TRAFFIC, V9, P2253, DOI 10.1111/j.1600-0854.2008.00819.x	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16045	10.1371/journal.pone.0016045	http://dx.doi.org/10.1371/journal.pone.0016045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297975	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000286664100013
J	Chasseigneaux, S; Dinc, L; Rose, C; Chabret, C; Coulpier, F; Topilko, P; Mauger, G; Allinquant, B				Chasseigneaux, Stephanie; Dinc, Levent; Rose, Christiane; Chabret, Claude; Coulpier, Fanny; Topilko, Piotr; Mauger, Gweltas; Allinquant, Bernadette			Secreted Amyloid Precursor Protein beta and Secreted Amyloid Precursor Protein alpha Induce Axon Outgrowth In Vitro through Egr1 Signaling Pathway	PLOS ONE			English	Article							HEPARIN-BINDING DOMAIN; AMINO-TERMINAL REGION; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; BRAIN-DEVELOPMENT; APP BINDS; NEURONS; CELLS; FORM; DIFFERENTIATION	Background: sAPP alpha released after alpha secretase cleavage of Amyloid Precursor Protein (APP) has several functions including the stimulation of neurite outgrowth although detailed morphometric analysis has not been done. Two domains involved in this function have been described and are present in sAPP beta released at the first step of amyloid peptide cleavage, raising the possibility that sAPP beta could also stimulate neurite outgrowth. We investigated the morphological effects of sAPP alpha and sAPP beta on primary neurons and identified a key signaling event required for the changes observed. Methodology/Principal Findings: Final concentrations of 50 to 150 nM bacterial recombinant sAPP alpha or sAPP beta added to primary neuronal cultures after 1 day in vitro decreased cell adhesion 24 hours later and primary dendrite length 96 hours later. 150 nM sAPP alpha and sAPP beta induced a similar increase of axon outgrowth, although this increase was already significant at 100 nM sAPP alpha. These morphological changes induced by sAPPs were also observed when added to differentiated neurons at 5 days in vitro. Real time PCR and immunocytochemistry showed that sAPP alpha and sAPP beta stimulated Egr1 expression downstream of MAPK/ERK activation. Furthermore, in primary neurons from Egr1 -/- mice, sAPPs affected dendritic length but did not induce any increase of axon length. Conclusion/Significance: sAPP alpha and sAPP beta decrease cell adhesion and increase axon elongation. These morphological changes are similar to what has been observed in response to heparan sulfate. The sAPP alpha/sAPP beta stimulated increase in axon growth requires Egr1 signaling. These data suggest that sAPP beta is not deleterious per se. Since sAPP beta and sAPP alpha are present in the embryonic brain, these two APP metabolites might play a role in axon outgrowth during development and in response to brain damage.	[Chasseigneaux, Stephanie; Dinc, Levent; Rose, Christiane; Chabret, Claude; Mauger, Gweltas; Allinquant, Bernadette] INSERM, U894, Paris, France; [Chasseigneaux, Stephanie; Dinc, Levent; Rose, Christiane; Chabret, Claude; Mauger, Gweltas; Allinquant, Bernadette] Univ Paris 05, Paris, France; [Coulpier, Fanny; Topilko, Piotr] Ecole Normale Super, Inst Biol, Dev Biol Sect, INSERM,U1024,CNRS,UMR 8197, F-75231 Paris, France; [Coulpier, Fanny] Ecole Normale Super, Plate Forme Transcriptome INSERM U1024, Inst Biol, CNRS,UMR 8197, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Chasseigneaux, S (corresponding author), INSERM, U894, Paris, France.	bernadette.allinquant@inserm.fr	Chasseigneaux, Stephanie/A-4291-2017	Chasseigneaux, Stephanie/0000-0003-2859-371X	Association pour la Recherche sur la Maladie d'Alzheimer; INSERM; Departement de la Recherche Clinique et du Developpement [AP-HP PCR 08006]	Association pour la Recherche sur la Maladie d'Alzheimer; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Departement de la Recherche Clinique et du Developpement	This work was supported by Association pour la Recherche sur la Maladie d'Alzheimer; INSERM; Departement de la Recherche Clinique et du Developpement, AP-HP PCR 08006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; GREENBERG SM, 1995, NEUROSCI LETT, V198, P52, DOI 10.1016/0304-3940(95)11944-R; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; LAFONT F, 1993, J CELL SCI, V104, P433; LAFONT F, 1992, DEVELOPMENT, V114, P17; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Pignatelli M, 1999, FEBS LETT, V461, P37, DOI 10.1016/S0014-5793(99)01420-9; PROCHIANTZ A, 1990, PROG BRAIN RES, V86, P331; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; WILLIAMSON TG, 1995, J NEUROCHEM, V65, P2201; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15	32	68	72	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16301	10.1371/journal.pone.0016301	http://dx.doi.org/10.1371/journal.pone.0016301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298006	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900031
J	Davis, JL; Huang, L; Worodria, W; Masur, H; Cattamanchi, A; Huber, C; Miller, C; Conville, PS; Murray, P; Kovacs, JA				Davis, J. Lucian; Huang, Laurence; Worodria, William; Masur, Henry; Cattamanchi, Adithya; Huber, Charles; Miller, Cecily; Conville, Patricia S.; Murray, Patrick; Kovacs, Joseph A.			Nucleic Acid Amplification Tests for Diagnosis of Smear-Negative TB in a High HIV-Prevalence Setting: A Prospective Cohort Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PULMONARY TUBERCULOSIS; COST-EFFECTIVENESS; MICROSCOPY; SPUTUM; SECA1; PCR	Background: Nucleic acid amplification tests are sensitive for identifying Mycobacterium tuberculosis in populations with positive sputum smears for acid-fast bacilli, but less sensitive in sputum-smear-negative populations. Few studies have evaluated the clinical impact of these tests in low-income countries with high burdens of TB and HIV. Methods: We prospectively enrolled 211 consecutive adults with cough >= 2 weeks and negative sputum smears at Mulago Hospital in Kampala, Uganda. We tested a single early-morning sputum specimen for Mycobacterium tuberculosis DNA using two nucleic acid amplification tests: a novel in-house polymerase chain reaction targeting the mycobacterial secA1 gene, and the commercial Amplified (R) Mycobacterium tuberculosis Direct (MTD) test (Gen-Probe Inc, San Diego, CA). We calculated the diagnostic accuracy of these index tests in reference to a primary microbiologic gold standard (positive mycobacterial culture of sputum or bronchoalveolar lavage fluid), and measured their likely clinical impact on additional tuberculosis cases detected among those not prescribed initial TB treatment. Results: Of 211 patients enrolled, 170 (81%) were HIV-seropositive, with median CD4+ T-cell count 78 cells/mL (interquartile range 29-203). Among HIV-seropositive patients, 94 (55%) reported taking co-trimoxazole prophylaxis and 29 (17%) reported taking antiretroviral therapy. Seventy-five patients (36%) had culture-confirmed TB. Sensitivity of MTD was 39% (95% CI 28-51) and that of secA1 was 24% (95% CI 15-35). Both tests had specificities of 95% (95% CI 90-98). The MTD test correctly identified 18 (24%) TB patients not treated at discharge and led to a 72% relative increase in the smear-negative case detection rate. Conclusions: The secA1 and MTD nucleic acid amplification tests had moderate sensitivity and high specificity for TB in a predominantly HIV-seropositive population with negative sputum smears. Although newer, more sensitive nucleic acid assays may enhance detection of Mycobacterium tuberculosis in sputum, even currently available tests can provide substantial clinical impact in smear-negative populations.	[Davis, J. Lucian; Huang, Laurence; Cattamanchi, Adithya; Miller, Cecily] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Davis, J. Lucian; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Francis J Curry Int TB Ctr, San Francisco, CA 94143 USA; [Masur, Henry; Kovacs, Joseph A.] Natl Inst Hlth Clin Ctr, Dept Crit Care Med, Bethesda, MD USA; [Huber, Charles; Conville, Patricia S.; Murray, Patrick] Natl Inst Hlth Clin Ctr, Dept Lab Med, Bethesda, MD USA; [Worodria, William] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Davis, J. Lucian; Huang, Laurence; Worodria, William; Cattamanchi, Adithya] Makerere Univ, Univ Calif San Francisco Res Collaborat, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Makerere University; Mulago National Referral Hospital; Makerere University	Davis, JL (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	Lucian.Davis@ucsf.edu	Kovacs, Joseph/AAU-6105-2021; Abrams, William R/A-5782-2008; Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019	Kovacs, Joseph/0000-0002-5191-9880; Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; 	National Institutes of Health [NIH T32HL007185, NIH P30AI027763, NIH K23AI080147, NIH K23HL094141, NIH K24HL087713, NIH R01HL090335]; NIH Bench-to-Bedside; National Center for Research Resources [KL2RR024130]; National Institutes of Health Clinical Center; National Institute of Allergy and Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, T32HL007185, R01HL090335, K23HL094141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI080147, P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Bench-to-Bedside(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the following grants from the National Institutes of Health (to individual authors whose initials are noted in parentheses): NIH T32HL007185 (JLD), NIH P30AI027763 (JLD), NIH K23AI080147 (JLD), NIH K23HL094141 (AC), NIH K24HL087713 (LH), NIH R01HL090335 (LH), and NIH Bench-to-Bedside (JAK and LH). This work was also supported in part by the National Center for Research Resources (KL2RR024130) and by the Intramural Research Program of the National Institutes of Health Clinical Center and the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cambanis A, 2007, INT J TUBERC LUNG D, V11, P40; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi A, 2008, J CLIN MICROBIOL, V46, P3325, DOI 10.1128/JCM.01175-08; Cattamanchi A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-75; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Davis JL, 2009, CLIN INFECT DIS, V48, P725, DOI 10.1086/597038; Dowdy DW, 2008, INT J TUBERC LUNG D, V12, P1021; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Flores LL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-55; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; International Union against Tuberculosis and Lung Disease (IUATLD), 2000, TECHN GUID SPUT EX T, V5; Kambashi B, 2001, INT J TUBERC LUNG D, V5, P364; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kivihya-Ndugga L, 2004, J CLIN MICROBIOL, V42, P1012, DOI 10.1128/JCM.42.3.1012-1015.2004; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lord Sarah J, 2009, Med Decis Making, V29, pE1, DOI 10.1177/0272989X09340584; Organization WH, 2009, PATHW BETT DIAGN TUB; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P509, DOI 10.1586/14737159.6.4.509; Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; van Cleeff M, 2005, INT J TUBERC LUNG D, V9, P877; WHO, 2010, GLOB TB CONTR REP 20; Worodria W, 2010, EUR RESPIR J, V36, P446, DOI 10.1183/09031936.00010210; Yoo SDJ, 2010, JAIDS-J ACQ IMM DEF, V54, P269, DOI 10.1097/QAI.0b013e3181ce6b19; Zelazny AM, 2005, J CLIN MICROBIOL, V43, P1051, DOI 10.1128/JCM.43.3.1051-1058.2005	30	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16321	10.1371/journal.pone.0016321	http://dx.doi.org/10.1371/journal.pone.0016321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298001	Green Submitted, gold, Green Published			2022-12-27	WOS:000286663900035
J	Gheorghe, KR; Thurlings, RM; Westman, M; Boumans, MJ; Malmstrom, V; Trollmo, C; Korotkova, M; Jakobsson, PJ; Tak, PP				Gheorghe, Karina Roxana; Thurlings, Rogier M.; Westman, Marie; Boumans, Maartje J.; Malmstrom, Vivianne; Trollmo, Christina; Korotkova, Marina; Jakobsson, Per-Johan; Tak, Paul-Peter			Prostaglandin E-2 Synthesizing Enzymes in Rheumatoid Arthritis B Cells and the Effects of B Cell Depleting Therapy on Enzyme Expression	PLOS ONE			English	Article							CYCLOOXYGENASE-2 EXPRESSION; SYNOVIAL FIBROBLASTS; ANTIBODY-PRODUCTION; CYCLIC-AMP; LYMPHOCYTES; TISSUE; OSTEOARTHRITIS; INFLAMMATION; VALIDATION; ACTIVATION	Introduction: B cells may play an important role in promoting immune activation in the rheumatoid synovium and can produce prostaglandin E-2 (PGE(2)) when activated. In its turn, PGE(2) formed by cyclooxygenase (COX) and microsomal prostaglandin E-2 synthase 1 (MPGES1) contributes to the rheumatoid arthritis (RA) pathological process. Therapeutic depletion of B cells results in important improvement in controlling disease activity in rheumatoid patients. Therefore we investigated the expression of PGE(2) pathway enzymes in RA B cells and evaluated the effects of B cell depleting therapy on their expression in RA tissue. Methods: B cells expressing MPGES1 and COX-2 were identified by flow cytometry in in vitro stimulated and control mononuclear cells isolated from synovial fluid and peripheral blood of RA patients. Synovial biopsies were obtained from 24 RA patients before and at two consecutive time points after rituximab therapy. Expression of MPGES1, COX-1 and COX-2, as well as interleukin (IL)-1 beta and IL-6, known inducers of MPGES1, was quantified in immunostained biopsy sections using computerized image analysis. Results: Expression of MPGES1 or COX-2 was significantly upregulated upon stimulation of B cells from blood and synovial fluid while control cells displayed no detectable enzymes. In synovial biopsy sections, the expression of MPGES1, COX-1 or COX-2 was resistant to rituximab therapy at 8 or 16 weeks after start of treatment. Furthermore expression of IL-1 beta in the synovial tissue remained unchanged, while IL-6 tended to decrease after therapy. Conclusions: Therapy with B cell depleting agents, although efficient in achieving good clinical and radiographic response in RA patients, leaves important inflammatory pathways in the rheumatoid synovium essentially unaffected.	[Gheorghe, Karina Roxana; Westman, Marie; Malmstrom, Vivianne; Trollmo, Christina; Korotkova, Marina; Jakobsson, Per-Johan] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Thurlings, Rogier M.; Boumans, Maartje J.; Tak, Paul-Peter] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Korotkova, Marina] Actar AB Inc, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Gheorghe, KR (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	per-johan.jakobsson@ki.se	Jakobsson, Per-Johan/ABC-5594-2021; Thurlings, R.M./L-4689-2015		Swedish Research Council; Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Swedish Society of Medicine; Marianne and Marcus Wallenberg foundation; Karolinska Institutet Foundation; European Commission; Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Swedish Society of Medicine; Marianne and Marcus Wallenberg foundation; Karolinska Institutet Foundation(Karolinska Institutet); European Commission(European CommissionEuropean Commission Joint Research Centre); Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association	This study was supported by The Swedish Research Council, The Swedish Rheumatism Association, King Gustaf V 80 years Foundation, The Swedish Society of Medicine, Marianne and Marcus Wallenberg foundation, Karolinska Institutet Foundation and European Commission Sixth Framework Program Autocure, the Center for Translational Molecular Medicine (TRACER), and the Dutch Arthritis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Soria MA, 2006, ANN RHEUM DIS, V65, P998, DOI 10.1136/ard.2005.046920; Arras M, 2006, AM J RESP CELL MOL, V34, P573, DOI 10.1165/rcmb.2004-0383OC; Bernard MP, 2007, CLIN IMMUNOL, V125, P138, DOI 10.1016/j.clim.2007.07.006; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; DORNER T, PHARM THER, V125, P464; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Haringman JJ, 2005, ARTHRITIS RES THER, V7, pR862, DOI 10.1186/ar1757; Hinz B, 2000, BIOCHEM BIOPH RES CO, V278, P790, DOI 10.1006/bbrc.2000.3885; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Jacobi AM, 2010, CURR OPIN PHARMACOL, V10, P316, DOI 10.1016/j.coph.2010.02.002; Klimiuk PA, 1997, AM J PATHOL, V151, P1311; Korotkova M, 2005, ARTHRITIS RHEUM-US, V52, P3439, DOI 10.1002/art.21390; Kraan MC, 2002, ARTHRITIS RHEUM-US, V46, P2034, DOI 10.1002/art.10556; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; LEE H, 2010, J IMMUNOL; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mongini PKA, 2006, J IMMUNOL, V176, P6736, DOI 10.4049/jimmunol.176.11.6736; Murn J, 2008, J EXP MED, V205, P3091, DOI 10.1084/jem.20081163; Pino MS, 2005, CANCER BIOL THER, V4, P1263, DOI 10.4161/cbt.4.11.2138; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; SANO H, 1992, J CLIN INVEST, V89, P97, DOI 10.1172/JCI115591; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; Siegle I, 1998, ARTHRITIS RHEUM-US, V41, P122, DOI 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.3.CO;2-#; Steiner Gunter, 2002, Arthritis Res, V4 Suppl 2, pS1, DOI 10.1186/ar551; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Teng YKO, 2009, ANN RHEUM DIS, V68, P1011, DOI 10.1136/ard.2008.092791; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; ULFGREN AK, 1995, ANN RHEUM DIS, V54, P654, DOI 10.1136/ard.54.8.654; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	34	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16378	10.1371/journal.pone.0016378	http://dx.doi.org/10.1371/journal.pone.0016378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298002	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900043
J	Wang, Z; Xia, YA; Ji, XA				Wang, Zheng; Xia, Yuan; Ji, Xiang			Clutch Frequency Affects the Offspring Size-Number Trade-Off in Lizards	PLOS ONE			English	Article							EGG-SIZE; REPRODUCTIVE TRAITS; LACERTA-VIVIPARA; EVOLUTION; MANIPULATION; CONSTRAINTS; POPULATION; PLASTICITY; SELECTION; FITNESS	Background: Studies of lizards have shown that offspring size cannot be altered by manipulating clutch size in species with a high clutch frequency. This raises a question of whether clutch frequency has a key role in influencing the offspring size-number trade-off in lizards. Methodology/Principal Findings: To test the hypothesis that females reproducing more frequently are less likely to tradeoff offspring size against offspring number, we applied the follicle ablation technique to female Eremias argus (Lacertidae) from Handan (HD) and Gonghe (GH), the two populations that differ in clutch frequency. Follicle ablation resulted in enlargement of egg size in GH females, but not in HD females. GH females switched from producing a larger number of smaller eggs in the first clutch to a smaller number of larger eggs in the second clutch; HD females showed a similar pattern of seasonal shifts in egg size, but kept clutch size constant between the first two clutches. Thus, the egg size-number trade-off was evident in GH females, but not in HD females. Conclusions/Significance: As HD females (mean = 3.1 clutches per year) reproduce more frequently than do GH females (mean = 1.6 clutches per year), our data therefore validate the hypothesis tested. Our data also provide an inference that maximization of maternal fitness could be achieved in females by diverting a large enough, rather than a higher-than-usual, fraction of the available energy to individual offspring in a given reproductive episode.	[Wang, Zheng; Ji, Xiang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Xia, Yuan] Hangzhou Normal Univ, Sch Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Nanjing Normal University; Hangzhou Normal University	Wang, Z (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	xji@mail.hz.zj.cn			Natural Science Foundation of China [30770378]; Chinese Ministry of Education [20070319006]; Nanjing Normal University [0319PM0902]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Nanjing Normal University	The project was supported by the Natural Science Foundation of China (30770378), Chinese Ministry of Education (20070319006) and Nanjing Normal University (0319PM0902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, SCIENCE, V292, P1710, DOI 10.1126/science.1059910; Ballinger R.E., 1983, P241; Bashey F, 2008, OIKOS, V117, P104, DOI 10.1111/j.2007.0030-1299.16094.x; BAUWENS D, 1987, HOLARCTIC ECOL, V10, P120; Bernardo J, 1996, AM ZOOL, V36, P216; Boersma M, 1997, EVOL ECOL, V11, P439, DOI 10.1023/A:1018484824003; Caley MJ, 2001, EVOLUTION, V55, P1245; Du WG, 2005, BIOL LETTERS, V1, P98, DOI 10.1098/rsbl.2004.0268; DUFAURE JP, 1961, ARCH ANAT MICROSC MO, V50, P309; Hao Qi-Lei, 2006, Acta Zoologica Sinica, V52, P1049; Janzen FJ, 2009, J EVOLUTION BIOL, V22, P2222, DOI 10.1111/j.1420-9101.2009.01838.x; Ji X, 2006, J COMP PHYSIOL B, V176, P521, DOI 10.1007/s00360-006-0074-y; Ji X, 2006, BIOL J LINN SOC, V88, P453, DOI 10.1111/j.1095-8312.2006.00633.x; Ji X, 2009, OECOLOGIA, V159, P689, DOI 10.1007/s00442-008-1252-2; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jordan MA, 2002, OECOLOGIA, V130, P44, DOI 10.1007/s004420100776; Li H, 2009, EVOL ECOL, V23, P777, DOI 10.1007/s10682-008-9272-2; Luo LG, 2010, J EXP BIOL, V213, P2073, DOI 10.1242/jeb.041137; Olsson M, 2002, FUNCT ECOL, V16, P135, DOI 10.1046/j.0269-8463.2001.00600.x; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Roff Derek, 2002, pi; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; Sinervo B, 1996, EVOLUTION, V50, P1299, DOI 10.1111/j.1558-5646.1996.tb02370.x; SINERVO B, 1991, J EXP ZOOL, V257, P252, DOI 10.1002/jez.1402570216; SINERVO B, 1991, SCIENCE, V252, P1300, DOI 10.1126/science.252.5010.1300; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Taborsky B, 2006, BIOL LETTERS, V2, P225, DOI 10.1098/rsbl.2005.0422; Uller T, 2010, OECOLOGIA, V162, P663, DOI 10.1007/s00442-009-1503-x; Wang Z, 2009, AMPHIBIA-REPTILIA, V30, P361, DOI 10.1163/156853809788795119; WINKLER DW, 1987, AM NAT, V129, P708, DOI 10.1086/284667; XIA Y, 2010, THESIS HANGZHOU NORM; ZHAO KT, 1999, FAUNA SINICA REPTILI, V2, P219	32	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16585	10.1371/journal.pone.0016585	http://dx.doi.org/10.1371/journal.pone.0016585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305034	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900077
J	Courtiol, E; Amat, C; Thevenet, M; Messaoudi, B; Garcia, S; Buonviso, N				Courtiol, Emmanuelle; Amat, Corine; Thevenet, Marc; Messaoudi, Belkacem; Garcia, Samuel; Buonviso, Nathalie			Reshaping of Bulbar Odor Response by Nasal Flow Rate in the Rat	PLOS ONE			English	Article							MAMMALIAN OLFACTORY-BULB; RECEPTOR NEURON INPUT; UNIT-ACTIVITY; AIR-FLOW; SNIFFING BEHAVIOR; RESPIRATORY CYCLE; ANESTHETIZED RAT; SENSORY MAP; PATTERNS; REPRESENTATION	Background: The impact of respiratory dynamics on odor response has been poorly studied at the olfactory bulb level. However, it has been shown that sniffing in the behaving rodent is highly dynamic and varies both in frequency and flow rate. Bulbar odor response could vary with these sniffing parameter variations. Consequently, it is necessary to understand how nasal airflow can modify and shape odor response at the olfactory bulb level. Methodology and Principal Findings: To assess this question, we used a double cannulation and simulated nasal airflow protocol on anesthetized rats to uncouple nasal airflow from animal respiration. Both mitral/tufted cell extracellular unit activity and local field potentials (LFPs) were recorded. We found that airflow changes in the normal range were sufficient to substantially reorganize the response of the olfactory bulb. In particular, cellular odor-evoked activities, LFP oscillations and spike phase-locking to LFPs were strongly modified by nasal flow rate. Conclusion: Our results indicate the importance of reconsidering the notion of odor coding as odor response at the bulbar level is ceaselessly modified by respiratory dynamics.	[Courtiol, Emmanuelle; Amat, Corine; Thevenet, Marc; Messaoudi, Belkacem; Garcia, Samuel; Buonviso, Nathalie] Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Courtiol, E (corresponding author), Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France.	ecourtiol@olfac.univ-lyon1.fr	Courtiol, Emmanuelle/N-9316-2017; Buonviso, Nathalie/G-8467-2017; amat, corine/O-1089-2017	Courtiol, Emmanuelle/0000-0002-7197-1117; Buonviso, Nathalie/0000-0002-0018-1695; GARCIA, Samuel/0000-0001-6389-9779	Agence Nationale de la Recherche [ANR-07-NEURO-030]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from "Agence Nationale de la Recherche" (#ANR-07-NEURO-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Cenier T, 2008, EUR J NEUROSCI, V27, P1432, DOI 10.1111/j.1460-9568.2008.06123.x; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; Duchamp-Viret P, 2005, J NEUROBIOL, V65, P97, DOI 10.1002/neu.20177; Fontanini A, 2003, J NEUROSCI, V23, P7993; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Garcia Samuel, 2009, Front Neuroinform, V3, P14, DOI 10.3389/neuro.11.014.2009; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Homma R, 2009, EUR J NEUROSCI, V29, P1027, DOI 10.1111/j.1460-9568.2009.06644.x; Imai T, 2007, CURR OPIN NEUROBIOL, V17, P507, DOI 10.1016/j.conb.2007.08.002; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kent PF, 1996, J NEUROSCI, V16, P345; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOZELL MM, 1970, J GEN PHYSIOL, V56, P46, DOI 10.1085/jgp.56.1.46; MOZELL MM, 1964, NATURE, V203, P1181, DOI 10.1038/2031181a0; Nagao H, 2002, MICROSC RES TECHNIQ, V58, P168, DOI 10.1002/jemt.10146; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Oka Y, 2009, J NEUROSCI, V29, P12070, DOI 10.1523/JNEUROSCI.1415-09.2009; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; PRITCHARD R, 1961, SCI AM, V204, P72, DOI 10.1038/scientificamerican0661-72; RAVEL N, 1987, EXP BRAIN RES, V65, P623; Roux SG, 2006, J NEUROSCI METH, V152, P173, DOI 10.1016/j.jneumeth.2005.09.004; Roux SG, 2007, J NEUROSCI METH, V160, P135, DOI 10.1016/j.jneumeth.2006.09.001; Schoenfeld TA, 2006, CHEM SENSES, V31, P131, DOI 10.1093/chemse/bjj015; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Scott JW, 2006, CHEM SENSES, V31, pA15; Scott-Johnson PE, 2000, CHEM SENSES, V25, P761, DOI 10.1093/chemse/25.6.761; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Tristan C, 2009, EUR J NEUROSCI, V29, P921, DOI 10.1111/j.1460-9568.2009.06651.x; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	47	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16445	10.1371/journal.pone.0016445	http://dx.doi.org/10.1371/journal.pone.0016445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298064	Green Published, gold			2022-12-27	WOS:000286662800041
J	Ma, XJ; Lin, LG; Qin, GJ; Lu, XP; Fiorotto, M; Dixit, VD; Sun, YX				Ma, Xiaojun; Lin, Ligen; Qin, Guijun; Lu, Xinping; Fiorotto, Marta; Dixit, Vishwa D.; Sun, Yuxiang			Ablations of Ghrelin and Ghrelin Receptor Exhibit Differential Metabolic Phenotypes and Thermogenic Capacity during Aging	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; HORMONE SECRETAGOGUE RECEPTOR; DES-ACYL GHRELIN; GROWTH-HORMONE; FOOD-INTAKE; ENERGY-EXPENDITURE; ADAPTIVE THERMOGENESIS; BODY-COMPOSITION; ACTIVE GHRELIN; HUMAN OBESITY	Background: Obesity is a hallmark of aging in many Western societies, and is a precursor to numerous serious age-related diseases. Ghrelin (Ghrl), via its receptor (growth hormone secretagogue receptor, GHS-R), is shown to stimulate GH secretion and appetite. Surprisingly, our previous studies showed that Ghrl(-/-) mice have impaired thermoregulatory responses to cold and fasting stresses, while Ghsr(-/-) mice are adaptive. Methodology/Principal Findings: To elucidate the mechanism, we analyzed the complete metabolic profiles of younger (3-4 months) and older (10-12 months) Ghrl(-/-) and Ghsr(-/-) mice. Food intake and locomotor activity were comparable for both null mice and their wild-type (WT) counterparts, regardless of age. There was also no difference in body composition between younger null mice and their WT counterparts. As the WT mice aged, as expected, the fat/lean ratio increased and energy expenditure (EE) decreased. Remarkably, however, older Ghsr(-/-) mice exhibited reduced fat/lean ratio and increased EE when compared to older WT mice, thus retaining a youthful lean and high EE phenotype; in comparison, there was no significant difference with EE in Ghrl(-/-) mice. In line with the EE data, the thermogenic regulator, uncoupling protein 1 (UCP1), was significantly up-regulated in brown adipose tissue (BAT) of Ghsr(-/-) mice, but not in Ghrl(-/-) mice. Conclusions: Our data therefore suggest that GHS-R ablation activates adaptive thermogenic function(s) in BAT and increases EE, thereby enabling the retention of a lean phenotype. This is the first direct evidence that the ghrelin signaling pathway regulates fat-burning BAT to affect energy balance during aging. This regulation is likely mediated through an as-yet-unidentified new ligand of GHS-R.	[Ma, Xiaojun; Qin, Guijun] Zhengzhou Univ, Affiliated Hosp 1, Dept Internal Med, Div Endocrinol, Zhengzhou, Peoples R China; [Ma, Xiaojun; Lin, Ligen; Fiorotto, Marta; Sun, Yuxiang] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat,Baylor Coll Med, Houston, TX 77030 USA; [Lu, Xinping] NIDDKD, Digest Dis Branch, NIH, Bethesda, MD 20892 USA; [Dixit, Vishwa D.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Lab Neuroendocrine Immunol, Baton Rouge, LA USA; [Sun, Yuxiang] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Zhengzhou University; Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Baylor College of Medicine	Ma, XJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Internal Med, Div Endocrinol, Zhengzhou, Peoples R China.	yuxiangs@bcm.edu	Lin, Ligen/ABC-1078-2020	Lin, Ligen/0000-0002-6799-5327	USDA/ARS CRIS [6250-51000-055]; NIH/NIA [1R03AG029641-01]; NIH-Diabetes and Endocrinology Research Center at Baylor College of Medicine [P30DK079638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG029641] Funding Source: NIH RePORTER	USDA/ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-Diabetes and Endocrinology Research Center at Baylor College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are very grateful to the agencies which supported this work: USDA/ARS CRIS fund ARS 6250-51000-055 (YS), NIH/NIA grant 1R03AG029641-01 (YS) and the NIH-Diabetes and Endocrinology Research Center (P30DK079638) at Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyasu H, 2002, ENDOCRINOLOGY, V143, P3341, DOI 10.1210/en.2002-220225; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bresciani E, 2006, J ENDOCRINOL INVEST, V29, pRC16, DOI 10.1007/BF03344175; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, NAT MED, V16, P965; Carlini VP, 2007, BIOCHEM BIOPH RES CO, V352, P907, DOI 10.1016/j.bbrc.2006.11.112; Cassoni P, 2004, EUR J ENDOCRINOL, V150, P173, DOI 10.1530/eje.0.1500173; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DELHANTY PJ, 1749, PLOS ONE, V5; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; Franco Celina, 2006, Metabolic Syndrome and Related Disorders, V4, P51, DOI 10.1089/met.2006.4.51; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552; Holdstock C, 2003, J CLIN ENDOCR METAB, V88, P3177, DOI 10.1210/jc.2002-021734; Hosoda Hiroshi, 2002, Mol Interv, V2, P494, DOI 10.1124/mi.2.8.494; Jastroch M, 2008, PHYSIOL GENOMICS, V32, P161, DOI 10.1152/physiolgenomics.00183.2007; Justo R, 2005, MITOCHONDRION, V5, P45, DOI 10.1016/j.mito.2004.09.003; Kerckhoffs DAJM, 1998, AM J PHYSIOL-ENDOC M, V274, pE1075, DOI 10.1152/ajpendo.1998.274.6.E1075; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Krems C, 2005, EUR J CLIN NUTR, V59, P255, DOI 10.1038/sj.ejcn.1602066; Lagaud GJ, 2007, BIOCHEM BIOPH RES CO, V357, P264, DOI 10.1016/j.bbrc.2007.03.138; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lopez M., NAT MED, V16, P1001; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marzullo P, 2004, J CLIN ENDOCR METAB, V89, P936, DOI 10.1210/jc.2003-031328; MATTSON MP, AGEING RES REV, V9, P69; Morley JE, 2001, NUTRITION, V17, P660, DOI 10.1016/S0899-9007(01)00574-3; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Obici S, 2002, J CLIN INVEST, V109, P1599, DOI 10.1172/JCI0215258; Palik E, 2007, DIABETES RES CLIN PR, V76, P351, DOI 10.1016/j.diabres.2006.09.005; PFANNENBERG C, DIABETES, V59, P1789; Riis ALD, 2003, J CLIN ENDOCR METAB, V88, P853, DOI 10.1210/jc.2002-021302; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Roti E, 2000, INT J OBESITY, V24, pS113, DOI 10.1038/sj.ijo.0801293; Shetty P, 2005, PUBLIC HEALTH NUTR, V8, P994, DOI 10.1079/PHN2005792; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060; Smith RG, 2005, TRENDS ENDOCRIN MET, V16, P436, DOI 10.1016/j.tem.2005.09.004; St-Onge MP, 2005, CURR OPIN CLIN NUTR, V8, P523; St-Pierre DH, 2004, J CLIN ENDOCR METAB, V89, P5993, DOI 10.1210/jc.2004-0613; STONGE MP, NUTRITION, V26, P152; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Szentirmai E, 2009, P NATL ACAD SCI USA, V106, P14069, DOI 10.1073/pnas.0903090106; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Thielemans L, 2007, J RECEPT SIG TRANSD, V27, P309, DOI 10.1080/10799890701519587; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; Valle A, 2008, REJUV RES, V11, P597, DOI 10.1089/rej.2007.0626; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WABITSCH M, 1995, METABOLISM, V44, P45, DOI 10.1016/0026-0495(95)90220-1; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; WISKIN AE, ARCH DIS CHILD; Wolthers T, 1996, J CLIN ENDOCR METAB, V81, P1416, DOI 10.1210/jc.81.4.1416; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yasuda T, 2003, NEUROSCI LETT, V349, P75, DOI 10.1016/S0304-3940(03)00789-4; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	73	53	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16391	10.1371/journal.pone.0016391	http://dx.doi.org/10.1371/journal.pone.0016391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298106	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800038
J	Rueness, EK; Asmyhr, MG; Sillero-Zubiri, C; Macdonald, DW; Bekele, A; Atickem, A; Stenseth, NC				Rueness, Eli Knispel; Asmyhr, Maria Gulbrandsen; Sillero-Zubiri, Claudio; Macdonald, David W.; Bekele, Afework; Atickem, Anagaw; Stenseth, Nils Chr.			The Cryptic African Wolf: Canis aureus lupaster Is Not a Golden Jackal and Is Not Endemic to Egypt	PLOS ONE			English	Article							CYTOCHROME-B SEQUENCES; MITOCHONDRIAL-DNA; POPULATION; EVOLUTION	The Egyptian jackal (Canis aureus lupaster) has hitherto been considered a large, rare subspecies of the golden jackal (C. aureus). It has maintained its taxonomical status to date, despite studies demonstrating morphological similarities to the grey wolf (C. lupus). We have analyzed 2055 bp of mitochondrial DNA from C. a. lupaster and investigated the similarity to C. aureus and C. lupus. Through phylogenetic comparison with all wild wolf-like canids (based on 726 bp of the Cytochrome b gene) we conclusively (100% bootstrap support) place the Egyptian jackal within the grey wolf species complex, together with the Holarctic wolf, the Indian wolf and the Himalayan wolf. Like the two latter taxa, C. a. lupaster seems to represent an ancient wolf lineage which most likely colonized Africa prior to the northern hemisphere radiation. We thus refer to C. a. lupaster as the African wolf. Furthermore, we have detected C. a. lupaster individuals at two localities in the Ethiopian highlands, extending the distribution by at least 2,500 km southeast. The only grey wolf species to inhabit the African continent is a cryptic species for which the conservation status urgently needs assessment.	[Rueness, Eli Knispel; Asmyhr, Maria Gulbrandsen; Atickem, Anagaw; Stenseth, Nils Chr.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Sillero-Zubiri, Claudio; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; [Bekele, Afework] Univ Addis Ababa, Fac Sci, Dept Biol, Addis Ababa, Ethiopia	University of Oslo; University of Oxford; Addis Ababa University	Rueness, EK (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	n.c.stenseth@bio.uio.no	Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399	University of Oslo	University of Oslo	Funding was provided by the University of Oslo (www.uio.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; FERGUSON WW, 1981, MAMMALIA, V45, P459, DOI 10.1515/mamm.1981.45.4.459; HUXLEY TH, 1880, CRANIAL DENTAL CHARA; JANCZEWSKI DN, 1995, MOL BIOL EVOL, V12, P690; JHALA YV, 2008, IUCN 2009 IUCN RED L; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KRYSTUFEK B, 1990, FOLIA ZOOL, V39, P291; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MACDONALD DW, 1979, BEHAV ECOL SOCIOBIOL, V5, P17, DOI 10.1007/BF00302692; NASSEF M, 2003, THESIS U LEEDS; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Sillero-Zubiri C, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P311; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tiwari J, 2004, CANID NEWS, V7, P5; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532; Zachos FE, 2009, BIOCHEM GENET, V47, P241, DOI 10.1007/s10528-009-9221-y	22	78	84	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16385	10.1371/journal.pone.0016385	http://dx.doi.org/10.1371/journal.pone.0016385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298107	Green Published, gold			2022-12-27	WOS:000286662800035
J	Anteau, MJ; Afton, AD				Anteau, Michael J.; Afton, Alan D.			Lipid Catabolism of Invertebrate Predator Indicates Widespread Wetland Ecosystem Degradation	PLOS ONE			English	Article							SPRING CONDITION HYPOTHESIS; SCAUP AYTHYA-AFFINIS; LESSER SCAUP; MISSISSIPPI-RIVER; UPPER-MIDWEST; WESTERN SANDPIPERS; MIGRATION; METABOLITES; CONSISTENT; RESERVES	Animals frequently undergo periods when they accumulate lipid reserves for subsequent energetically expensive activities, such as migration or breeding. During such periods, daily lipid-reserve dynamics (DLD) of sentinel species can quantify how landscape modifications affect function, health, and resilience of ecosystems. Aythya affinis (Eyton 1838; lesser scaup; diving duck) are macroinvertebrate predators; they migrate through an agriculturally dominated landscape in spring where they select wetlands with the greatest food density to refuel and accumulate lipid reserves for subsequent reproduction. We index DLD by measuring plasma-lipid metabolites of female scaup (n = 459) that were refueling at 75 spring migration stopover areas distributed across the upper Midwest, USA. We also indexed DLD for females (n = 44) refueling on a riverine site (Pool 19) south of our upper Midwest study area. We found that mean DLD estimates were significantly (P < 0.05) less than zero in all ecophysiographic regions of the upper Midwest, and the greatest negative value was in the Iowa Prairie Pothole region (-31.6). Mean DLD was 16.8 at Pool 19 and was markedly greater than in any region of the upper Midwest. Our results indicate that females catabolized rather than stored lipid reserves throughout the upper Midwest. Moreover, levels of lipid catabolism are alarming, because scaup use the best quality wetlands available within a given stopover area. Accordingly, these results provide evidence of wetland ecosystem degradation across this large agricultural landscape and document affects that are carried-up through several trophic levels. Interestingly, storing of lipids by scaup at Pool 19 likely reflects similar ecosystem perturbations as observed in the upper Midwest because wetland drainage and agricultural runoff nutrifies the riverine habitat that scaup use at Pool 19. Finally, our results underscore how using this novel technique to monitor DLD, of a carefully selected sentinel species, can index ecosystem health at a landscape scale.	[Anteau, Michael J.] Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Afton, Alan D.] Louisiana State Univ, Louisiana Cooperat Fish & Wildlife Res Unit, US Geol Survey, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; United States Department of the Interior; United States Geological Survey	Anteau, MJ (corresponding author), US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA.	manteau@usgs.gov		Anteau, Michael/0000-0002-5173-5870	Ducks Unlimited Inc. USA; Federal and Winchester Cartridge Companies; Iowa Department of Natural Resources; IWWR of Ducks Unlimited Canada; Graduate School and the School of Renewable Natural Resources at Louisiana State University; Louisiana Department of Wildlife and Fisheries, Louisiana State University; Minnesota Department of Natural Resources; Minnesota Waterfowl Association; North Dakota Game and Fish Department; Prairie Pothole Joint Venture; Upper Mississippi River and Great Lakes Region Joint Venture; USFWS Regions 3 and 6 HAPET offices; USGS-Louisiana Cooperative Fish and Wildlife Research Unit; USGS-National Wetlands Research Center	Ducks Unlimited Inc. USA; Federal and Winchester Cartridge Companies; Iowa Department of Natural Resources; IWWR of Ducks Unlimited Canada; Graduate School and the School of Renewable Natural Resources at Louisiana State University; Louisiana Department of Wildlife and Fisheries, Louisiana State University; Minnesota Department of Natural Resources; Minnesota Waterfowl Association; North Dakota Game and Fish Department; Prairie Pothole Joint Venture; Upper Mississippi River and Great Lakes Region Joint Venture; USFWS Regions 3 and 6 HAPET offices(US Fish & Wildlife Service); USGS-Louisiana Cooperative Fish and Wildlife Research Unit; USGS-National Wetlands Research Center	The following organizations provided financial or in-kind support: Ducks Unlimited Inc. USA, Federal and Winchester Cartridge Companies, Iowa Department of Natural Resources, IWWR of Ducks Unlimited Canada, IWWR of Ducks Unlimited Canada through the Bonnycastle Fellowship, the Graduate School and the School of Renewable Natural Resources at Louisiana State University, Louisiana Department of Wildlife and Fisheries, Louisiana State University through the Bosch Fellowship, Minnesota Department of Natural Resources, Minnesota Waterfowl Association, North Dakota Game and Fish Department, Prairie Pothole Joint Venture, Upper Mississippi River and Great Lakes Region Joint Venture, USFWS Regions 3 and 6 HAPET offices, USGS-Louisiana Cooperative Fish and Wildlife Research Unit, and USGS-National Wetlands Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFTON AD, 1991, CONDOR, V93, P89, DOI 10.2307/1368610; Afton AD, 2001, J WILDLIFE MANAGE, V65, P781, DOI 10.2307/3803028; AFTON AD, 1991, CAN J ZOOL, V69, P328, DOI 10.1139/z91-053; Anteau M. J., 2006, THESIS LOUISIANA STA THESIS LOUISIANA STA; Anteau MJ, 2008, AUK, V125, P354, DOI 10.1525/auk.2008.06255; Anteau MJ, 2008, WATERBIRDS, V31, P97, DOI 10.1675/1524-4695(2008)31[97:DOLSDS]2.0.CO;2; Anteau MJ, 2008, WETLANDS, V28, P184, DOI 10.1672/07-53.1; Anteau MJ, 2006, CAN J ZOOL, V84, P779, DOI 10.1139/Z06-047; Anteau MJ, 2009, AUK, V126, P873, DOI 10.1525/auk.2009.08193; Anteau MJ, 2009, WETLANDS, V29, P704, DOI 10.1672/08-157.1; Anteau MJ, 2004, AUK, V121, P917, DOI 10.1642/0004-8038(2004)121[0917:NROLSA]2.0.CO;2; ANTEAU MJ, 2010, HYDROBIOLOG IN PRESS; Arzel C, 2006, J ORNITHOL, V147, P167, DOI 10.1007/s10336-006-0054-8; Bartzen BA, 2010, ECOL APPL, V20, P525, DOI 10.1890/08-1650.1; Bellrose F, 1980, DUCKS GEESE SWANS N; Berthold P, 2001, AUK, V2nd; Besser JM, 2004, ENVIRON SCI TECHNOL, V38, P6210, DOI 10.1021/es049715i; Euliss NH, 2008, WETLANDS, V28, P553, DOI 10.1672/07-154.1; Euliss NH, 2006, SCI TOTAL ENVIRON, V361, P179, DOI 10.1016/j.scitotenv.2005.06.007; Euliss NH, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P471; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Gannes LZ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P1, DOI 10.1086/319315; Gleason RA, 1998, GREAT PLAINS RES, V8, P97; GLEASON RA, 2008, ECOSYSTEM SERVICES D; Goolsby DA, 2001, J ENVIRON QUAL, V30, P329, DOI 10.2134/jeq2001.302329x; Guglielmo CG, 2002, AUK, V119, P437, DOI 10.1642/0004-8038(2002)119[0437:EAISOV]2.0.CO;2; Jenni L, 1996, FUNCT ECOL, V10, P73, DOI 10.2307/2390264; Krapu GL, 2004, J WILDLIFE MANAGE, V68, P332, DOI 10.2193/0022-541X(2004)068[0332:DPOPFW]2.0.CO;2; KRULL JN, 1970, J WILDLIFE MANAGE, V34, P707, DOI 10.2307/3799135; Lyons JE, 2008, OECOLOGIA, V155, P417, DOI 10.1007/s00442-007-0921-x; Morris JD, 2002, SMALL RUMINANT RES, V43, P157, DOI 10.1016/S0921-4488(01)00266-8; Pace RM, 1999, J WILDLIFE MANAGE, V63, P389, DOI 10.2307/3802524; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Rabalais NN, 1996, ESTUARIES, V19, P386, DOI 10.2307/1352458; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Seaman DAA, 2006, AUK, V123, P563, DOI 10.1642/0004-8038(2006)123[563:LPSDIR]2.0.CO;2; Strand KA, 2008, HYDROBIOLOGIA, V598, P389, DOI 10.1007/s10750-007-9178-y; THOMPSON D, 1973, J WILDLIFE MANAGE, V37, P367, DOI 10.2307/3800128; Williams TD, 1999, AUK, V116, P994, DOI 10.2307/4089679; WILSON DM, 1995, HYDROBIOLOGIA, V304, P209, DOI 10.1007/BF02329315; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2; Zimmer KD, 2001, ECOSYSTEMS, V4, P346, DOI 10.1007/s10021-001-0016-1	44	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16029	10.1371/journal.pone.0016029	http://dx.doi.org/10.1371/journal.pone.0016029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283806	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600020
J	Carpaij, N; Willems, RJL; Rice, TW; Weinstein, RA; Hinds, J; Witney, AA; Lindsay, JA; Bonten, MJM; Fluit, AC				Carpaij, Neeltje; Willems, Rob J. L.; Rice, Thomas W.; Weinstein, Robert A.; Hinds, Jason; Witney, Adam A.; Lindsay, Jodi A.; Bonten, Marc J. M.; Fluit, Ad C.			Genetic Variation in Spatio-Temporal Confined USA300 Community-Associated MRSA Isolates: A Shift from Clonal Dispersion to Genetic Evolution?	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; METHICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; SKIN INFECTIONS; UNITED-STATES; STRAIN; PNEUMONIA; AUSTRALIA; SEQUENCE	Introduction: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are increasingly isolated, with USA300-0114 being the predominant clone in the USA. Comparative whole genome sequencing of USA300 isolates collected in 2002, 2003 and 2005 showed a limited number of single nucleotide polymorphisms and regions of difference. This suggests that USA300 has undergone rapid clonal expansion without great genomic diversification. However, whole genome comparison of CA-MRSA has been limited to isolates belonging to USA300. The aim of this study was to compare the genetic repertoire of different CA-MRSA clones with that of HA-MRSA from the USA and Europe through comparative genomic hybridization (CGH) to identify genetic clues that may explain the successful and rapid emergence of CA-MRSA. Materials and Methods: Hierarchical clustering based on CGH of 48 MRSA isolates from the community and nosocomial infections from Europe and the USA revealed dispersed clustering of the 19 CA-MRSA isolates. This means that these 19 CA-MRSA isolates do not share a unique genetic make-up. Only the PVL genes were commonly present in all CA-MRSA isolates. However, 10 genes were variably present among 14 USA300 isolates. Most of these genes were present on mobile elements. Conclusion: The genetic variation present among the 14 USA300 isolates is remarkable considering the fact that the isolates were recovered within one month and originated from a confined geographic area, suggesting continuous evolution of this clone.	[Carpaij, Neeltje; Willems, Rob J. L.; Bonten, Marc J. M.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Rice, Thomas W.] John H Stroger Jr Hosp Cook Cty Chicago, Div Infect Dis, Chicago, IL USA; [Weinstein, Robert A.] Rush Univ, Med Ctr, Dept Infect Dis, Chicago, IL 60612 USA; [Hinds, Jason; Witney, Adam A.] St Georges Univ London, Dept Cellular & Mol Med, Bacterial Microarray Grp, London, England	Utrecht University; Utrecht University Medical Center; John H Stroger Junior Hospital Cook County; Rush University; St Georges University London	Carpaij, N (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	N.Carpaij-2@umcutrecht.nl	Lindsay, Jodi/B-9565-2008; Lindsay, Jodi/ABH-8205-2020; Willems, Rob JL/E-3681-2010	Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Willems, Rob JL/0000-0002-7370-0812; Witney, Adam/0000-0003-4561-7170; Hinds, Jason/0000-0002-2739-1908	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]; Wellcome Trust	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission)	M.J.M.B. was supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). We acknowledge The Wellcome Trust for funding BuG@S (the Bacterial Microarray Group at St George's University of London) for supply of the microarray and advice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2009, CAN J EMERG MED, V11, P439; Arvidsson PI, 2005, CHEM BIODIVERS, V2, P401, DOI 10.1002/cbdv.200590020; Bukhari EE, 2009, SAUDI MED J, V30, P1595; Carpaij N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-522; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Elston JWT, 2009, J HOSP INFECT, V72, P307, DOI 10.1016/j.jhin.2009.05.001; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fontanilla JM, 2010, J CLIN MICROBIOL, V48, P609, DOI 10.1128/JCM.02297-09; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho PL, 2008, DIAGN MICR INFEC DIS, V61, P245, DOI 10.1016/j.diagmicrobio.2007.12.015; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Klein E, 2009, EMERG INFECT DIS, V15, P1925, DOI 10.3201/eid1512.081341; Larsen AR, 2009, J CLIN MICROBIOL, V47, P3765, DOI 10.1128/JCM.00934-09; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Monecke S, 2009, CLIN MICROBIOL INFEC, V15, P770, DOI 10.1111/j.1469-0691.2009.02792.x; National Committee for Clinical Laboratory Standards NCCLS, 2000, M7A5 NCCLS; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; van der Flier M, 2003, Ned Tijdschr Geneeskd, V147, P1076; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16419	10.1371/journal.pone.0016419	http://dx.doi.org/10.1371/journal.pone.0016419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326601	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000287037000009
J	Castillo-Trivino, T; Mowry, EM; Gajofatto, A; Chabas, D; Crabtree-Hartman, E; Cree, BA; Goodin, DS; Green, AJ; Okuda, DT; Pelletier, D; Zamvil, SS; Vittinghoff, E; Waubant, E				Castillo-Trivino, Tamara; Mowry, Ellen M.; Gajofatto, Alberto; Chabas, Dorothee; Crabtree-Hartman, Elizabeth; Cree, Bruce A.; Goodin, Douglas S.; Green, Ari J.; Okuda, Darin T.; Pelletier, Daniel; Zamvil, Scott S.; Vittinghoff, Eric; Waubant, Emmanuelle			Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PLUS INTERFERON BETA-1A; COMBINATION THERAPY; NATALIZUMAB; MITOXANTRONE; TRIAL; CYCLOPHOSPHAMIDE; MULTICENTER; MS	Background: Multiple sclerosis (MS) patients with breakthrough disease on immunomodulatory drugs are frequently offered to switch to natalizumab or immunosuppressants. The effect of natalizumab monotherapy in patients with breakthrough disease is unknown. Methods: This is an open-label retrospective cohort study of 993 patients seen at least four times at the University of California San Francisco MS Center, 95 had breakthrough disease on first-line therapy (60 patients switched to natalizumab, 22 to immunosuppressants and 13 declined the switch [non-switchers]). We used Poisson regression adjusted for potential confounders to compare the relapse rate within and across groups before and after the switch. Results: In the within-group analyses, the relapse rate decreased by 70% (95% CI 50,82%; p < 0.001) in switchers to natalizumab and by 77% (95% CI 59,87%; p < 0.001) in switchers to immunosuppressants; relapse rate in non-switchers did not decrease (6%, p = 0.87). Relative to the reduction among non-switchers, the relapse rate was reduced by 68% among natalizumab switchers (95% CI 19,87%; p = 0.017) and by 76% among the immunosuppressant switchers (95% CI 36,91%; p = 0.004). Conclusions: Switching to natalizumab or immunosuppressants in patients with breakthrough disease is effective in reducing clinical activity of relapsing MS. The magnitude of the effect and the risk-benefit ratio should be evaluated in randomized clinical trials and prospective cohort studies.	[Castillo-Trivino, Tamara; Mowry, Ellen M.; Chabas, Dorothee; Crabtree-Hartman, Elizabeth; Cree, Bruce A.; Goodin, Douglas S.; Green, Ari J.; Okuda, Darin T.; Pelletier, Daniel; Zamvil, Scott S.; Waubant, Emmanuelle] Univ Calif San Francisco, Multiple Sclerosis Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Castillo-Trivino, Tamara] Hosp Donostia, Dept Neurol, Multiple Sclerosis Unit, San Sebastian, Spain; [Gajofatto, Alberto] Univ Verona, Dept Neurol & Vision Sci, I-37100 Verona, Italy; [Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University Hospital Donostia; University of Verona; University of California System; University of California San Francisco	Castillo-Trivino, T (corresponding author), Univ Calif San Francisco, Multiple Sclerosis Ctr, Dept Neurol, San Francisco, CA 94143 USA.	emmanuelle.waubant@ucsf.edu	Castillo, Tamara/ABH-4121-2020; Castillo, Tamara/GYQ-5428-2022; Cree, Bruce C/AAV-6109-2020	Cree, Bruce C/0000-0001-7689-2533; Gajofatto, Alberto/0000-0001-6539-0458; Mowry, Ellen/0000-0003-0623-5188; Castillo-Trivino, Tamara/0000-0002-9249-3185; Okuda, Darin/0000-0002-6499-1523	Partners MS Center; Foundation ILUNDAIN Fundazioa	Partners MS Center; Foundation ILUNDAIN Fundazioa	This study was supported by a Clinical Research Fellowship Award from the Partners MS Center and by the Foundation ILUNDAIN Fundazioa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caon C, 2006, EUR J NEUROL, V13, P471, DOI 10.1111/j.1468-1331.2006.01273.x; Carra A, 2008, EUR J NEUROL, V15, P386, DOI 10.1111/j.1468-1331.2008.02071.x; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Conway D, 2010, LANCET NEUROL, V9, P299, DOI 10.1016/S1474-4422(10)70007-7; Ellis R, 2009, MULT SCLER J, V15, P505, DOI 10.1177/1352458508100967; *FOOD DRUG ADM, NAT INF MARK TYS; Gajofatto A, 2009, MULT SCLER J, V15, P50, DOI 10.1177/1352458508096687; Ghalie RG, 2002, NEUROLOGY, V59, P909, DOI 10.1212/WNL.59.6.909; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; KAUFMAN MD, 2010, MULT SCLER      1206; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Putzki N, 2010, EUR J NEUROL, V17, P31, DOI 10.1111/j.1468-1331.2009.02728.x; RADIS CD, 1995, ARTHRITIS RHEUM, V38, P1120, DOI 10.1002/art.1780380815; Radue EW, 2010, J NEUROL SCI, V292, P28, DOI 10.1016/j.jns.2010.02.012; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick RA, 2009, LANCET NEUROL, V8, P545, DOI 10.1016/S1474-4422(09)70082-1; Smith DR, 2005, MULT SCLER J, V11, P573, DOI 10.1191/1352458505ms1210oa; Waubant E, 2003, NEUROLOGY, V61, P184, DOI 10.1212/01.WNL.0000078888.07196.0B; West TW, 2010, ANN NEUROL, V68, P395, DOI 10.1002/ana.22163	21	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16664	10.1371/journal.pone.0016664	http://dx.doi.org/10.1371/journal.pone.0016664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304907	Green Submitted, Green Published, gold			2022-12-27	WOS:000287036600013
J	Lee, KT; Byun, MJ; Kang, KS; Park, EW; Lee, SH; Cho, S; Kim, H; Kim, KW; Lee, T; Park, JE; Park, W; Shin, D; Park, HS; Jeon, JT; Choi, BH; Jang, GW; Choi, SH; Kim, DW; Lim, D; Park, HS; Park, MR; Ott, J; Schook, LB; Kim, TH; Kim, H				Lee, Kyung-Tai; Byun, Mi-Jeong; Kang, Kyung-Soo; Park, Eung-Woo; Lee, Seung-Hwan; Cho, Seoae; Kim, HyoYoung; Kim, Kyu-Won; Lee, TaeHeon; Park, Jong-Eun; Park, WonCheoul; Shin, DongHyun; Park, Hong-Seog; Jeon, Jin-Tae; Choi, Bong-Hwan; Jang, Gul-Won; Choi, Sang-Haeng; Kim, Dae-Won; Lim, Dajeong; Park, Hae-Suk; Park, Mi-Rim; Ott, Jurg; Schook, Lawrence B.; Kim, Tae-Hun; Kim, Heebal			Neuronal Genes for Subcutaneous Fat Thickness in Human and Pig Are Identified by Local Genomic Sequencing and Combined SNP Association Study	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INTRAMUSCULAR FAT; BODY-COMPOSITION; WIDE ASSOCIATION; CANDIDATE GENES; NEURITE OUTGROWTH; BACKFAT THICKNESS; PROTEIN; OBESITY; SCAN	Obesity represents a major global public health problem that increases the risk for cardiovascular or metabolic disease. The pigs represent an exceptional biomedical model related to energy metabolism and obesity in humans. To pinpoint causal genetic factors for a common form of obesity, we conducted local genomic de novo sequencing, 18.2 Mb, of a porcine QTL region affecting fatness traits, and carried out SNP association studies for backfat thickness and intramuscular fat content in pigs. In order to relate the association studies in pigs to human obesity, we performed a targeted genome wide association study for subcutaneous fat thickness in a cohort population of 8,842 Korean individuals. These combined association studies in human and pig revealed a significant SNP located in a gene family with sequence similarity 73, member A (FAM73A) associated with subscapular skin-fold thickness in humans (rs4121165, GC-corrected p-value = 0.0000175) and with backfat thickness in pigs (ASGA0029495, p-value = 0.000031). Our combined association studies also suggest that eight neuronal genes are responsible for subcutaneous fat thickness: NEGR1, SLC44A5, PDE4B, LPHN2, ELTD1, ST6GALNAC3, ST6GALNAC5, and TTLL7. These results provide strong support for a major involvement of the CNS in the genetic predisposition to a common form of obesity.	[Lee, Kyung-Tai; Byun, Mi-Jeong; Kang, Kyung-Soo; Park, Eung-Woo; Lee, Seung-Hwan; Choi, Bong-Hwan; Jang, Gul-Won; Lim, Dajeong; Park, Hae-Suk; Park, Mi-Rim; Kim, Tae-Hun] Rural Dev Adm, Natl Inst Anim Sci, Div Anim Genom & Bioinformat, Suwon, South Korea; [Byun, Mi-Jeong; Cho, Seoae; Kim, Kyu-Won; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kim, HyoYoung; Lee, TaeHeon; Park, Jong-Eun; Park, WonCheoul; Shin, DongHyun; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, HyoYoung; Kim, Kyu-Won; Lee, TaeHeon; Park, Jong-Eun; Park, WonCheoul; Shin, DongHyun; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Park, Hong-Seog; Choi, Sang-Haeng] Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon, South Korea; [Jeon, Jin-Tae] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea; [Kim, Dae-Won] Natl Inst Hlth, Div Malaria & Parasit Dis, Seoul, South Korea; [Ott, Jurg] Beijing Inst Genom, Beijing, Peoples R China; [Schook, Lawrence B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Gyeongsang National University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Illinois System; University of Illinois Urbana-Champaign	Lee, KT (corresponding author), Rural Dev Adm, Natl Inst Anim Sci, Div Anim Genom & Bioinformat, Suwon, South Korea.	thkim63@korea.kr; heebal@snu.ac.kr	Kim, Heebal/A-8889-2016; Park, Hae-Sim/S-7974-2019; Kim, Kyu Won/AAJ-7213-2020	Kim, Heebal/0000-0003-3064-1303; Park, Hae-Sim/0000-0003-2614-0303; Schook, Lawrence/0000-0002-6580-8364; Park, WonCheoul/0000-0003-3140-5628; Lee, Seung Hwan/0000-0003-1508-4887	National Institute of Animal Science [PJ006711]; Rural Development Administration, Republic of Korea [20050301034467]; Korean National Institute of Health in Korea	National Institute of Animal Science(National Institute of Animal Science, Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Korean National Institute of Health in Korea	This work was supported by 2-5-13 Agenda research (PJ006711) from the National Institute of Animal Science and by a grant (20050301034467) from the BioGreen 21 Program, Rural Development Administration, Republic of Korea. This research was also supported by the Korea Association Resource (KARE) project funded by the Korean National Institute of Health in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, ARCH GEN PSYCHIAT, V65, P713, DOI 10.1001/archpsyc.65.6.713; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Choy YH, 2002, ASIAN AUSTRAL J ANIM, V15, P1178, DOI 10.5713/ajas.2002.1178; Choy YH, 2002, ASIAN AUSTRAL J ANIM, V15, P1080, DOI 10.5713/ajas.2002.1080; Dahlin A, 2009, J PHARMACOL EXP THER, V329, P558, DOI 10.1124/jpet.108.149831; de Koning DJ, 1999, GENETICS, V152, P1679; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Edwards D, 2007, J ANIMAL SCI; Gerbens F, 2000, J ANIM SCI, V78, P552; Gerbens F, 1999, J ANIM SCI, V77, P846; Gilmour A., 2006, ASREML USER GUIDE RE; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Grindflek E, 2001, MAMM GENOME, V12, P299, DOI 10.1007/s003350010278; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Henderson C. R, 1984, APPL LINEAR MODELS A; Hodgkinson CA, 2010, P NATL ACAD SCI USA, V107, P8695, DOI 10.1073/pnas.0908134107; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Jeon AT, 2003, MOL CELLS, V16, P113; Kahler AK, 2010, AM J MED GENET B, V153B, P86, DOI 10.1002/ajmg.b.30958; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lakka TA, 2001, ATHEROSCLEROSIS, V154, P497, DOI 10.1016/S0021-9150(00)00514-1; Lang JC, 1998, EMBO J, V17, P648, DOI 10.1093/emboj/17.3.648; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Malek M, 2001, MAMM GENOME, V12, P637, DOI 10.1007/s003350020019; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Mohrmann M, 2006, MEAT SCI, V72, P518, DOI 10.1016/j.meatsci.2005.08.020; Nagy E, 2008, INT J OBESITY, V32, pS58, DOI 10.1038/ijo.2008.184; Neugebauer N, 2010, ANIMAL, V4, P672, DOI 10.1017/S1751731109991625; Okajima T, 1999, J BIOL CHEM, V274, P30557, DOI 10.1074/jbc.274.43.30557; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2000, MAMM GENOME, V11, P344, DOI 10.1007/s003350010065; Ovilo C, 2002, GENET SEL EVOL, V34, P465, DOI 10.1051/gse:2002018; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schafer M, 2005, MOL CELL NEUROSCI, V29, P580, DOI 10.1016/j.mcn.2005.04.010; Schneider KL, 2006, NUCLEIC ACIDS RES, V34, pD407, DOI 10.1093/nar/gkj134; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Suzuki K, 2009, J ANIM SCI, V87, P2209, DOI 10.2527/jas.2008-0866; Szyda J, 2003, GENET RES, V81, P65, DOI 10.1017/S0016672302006043; Takai Daiya, 2003, In Silico Biology, V3, P235; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Uleberg E, 2005, J ANIM BREED GENET, V122, P1, DOI 10.1111/j.1439-0388.2004.00496.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	58	53	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16356	10.1371/journal.pone.0016356	http://dx.doi.org/10.1371/journal.pone.0016356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311593	gold, Green Published			2022-12-27	WOS:000287036200010
J	Berdyshev, EV; Gorshkova, I; Usatyuk, P; Kalari, S; Zhao, YT; Pyne, NJ; Pyne, S; Sabbadini, RA; Garcia, JGN; Natarajan, V				Berdyshev, Evgeny V.; Gorshkova, Irina; Usatyuk, Peter; Kalari, Satish; Zhao, Yutong; Pyne, Nigel J.; Pyne, Susan; Sabbadini, Roger A.; Garcia, Joe G. N.; Natarajan, Viswanathan			Intracellular S1P Generation Is Essential for S1P-Induced Motility of Human Lung Endothelial Cells: Role of Sphingosine Kinase 1 and S1P Lyase	PLOS ONE			English	Article							SPHINGOSINE-1-PHOSPHATE LYASE; SPHINGOLIPID METABOLISM; RECEPTOR EDG-1; 1-PHOSPHATE; MIGRATION; PROTEIN; PROLIFERATION; TRANSPORTER; ACTIVATION; FAMILY	Background: Earlier we have shown that extracellular sphingosine-1-phosphate (S1P) induces migration of human pulmonary artery endothelial cells (HPAECs) through the activation of S1P(1) receptor, PKC epsilon, and PLD2-PKC zeta-Rac1 signaling cascade. As endothelial cells generate intracellular S1P, here we have investigated the role of sphingosine kinases (SphKs) and S1P lyase (S1PL), that regulate intracellular S1P accumulation, in HPAEC motility. Methodology/Principal Findings: Inhibition of SphK activity with a SphK inhibitor 2-(p-Hydroxyanilino)-4-(p-Chlorophenyl) Thiazole or down-regulation of Sphk1, but not SphK2, with siRNA decreased S1P(int), and attenuated S1P(ext) or serum-induced motility of HPAECs. On the contrary, inhibition of S1PL with 4-deoxypyridoxine or knockdown of S1PL with siRNA increased S1P(int) and potentiated motility of HPAECs to S1P(ext) or serum. S1P(ext) mediates cell motility through activation of Rac1 and IQGAP1 signal transduction in HPAECs. Silencing of SphK1 by siRNA attenuated Rac1 and IQGAP1 translocation to the cell periphery; however, knockdown of S1PL with siRNA or 4-deoxypyridoxine augmented activated Rac1 and stimulated Rac1 and IQGAP1 translocation to cell periphery. The increased cell motility mediated by down-regulation was S1PL was pertussis toxin sensitive suggesting "inside-out" signaling of intracellularly generated S1P. Although S1P did not accumulate significantly in media under basal or S1PL knockdown conditions, addition of sodium vanadate increased S1P levels in the medium and inside the cells most likely by blocking phosphatases including lipid phosphate phosphatases (LPPs). Furthermore, addition of anti-S1P mAb to the incubation medium blocked S1P(ext) or 4-deoxypyridoxine-dependent endothelial cell motility. Conclusions/Significance: These results suggest S1P(ext) mediated endothelial cell motility is dependent on intracellular S1P production, which is regulated, in part, by SphK1 and S1PL.	[Berdyshev, Evgeny V.; Gorshkova, Irina; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Usatyuk, Peter; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Kalari, Satish] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Zhao, Yutong] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA USA; [Pyne, Nigel J.; Pyne, Susan] Univ Strathclyde, Cell Biol Grp, Glasgow, Lanark, Scotland; [Sabbadini, Roger A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Sabbadini, Roger A.] Lpath Inc, San Diego, CA USA; [Berdyshev, Evgeny V.; Gorshkova, Irina; Usatyuk, Peter; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; City of Hope; Beckman Research Institute of City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Strathclyde; California State University System; San Diego State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Berdyshev, EV (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	visnatar@uic.edu	Kalari, Satish/C-6967-2012; Pyne, Susan/AAF-5001-2019	Pyne, Susan/0000-0002-6608-9584; Pyne, Nigel/0000-0002-5657-4578	National Institutes of Health [R01 HL 079396]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091916, P01HL098050, R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health R01 HL 079396 to V. Natarajan. This funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Lpath Inc. provided the anti-s1P antibody for experiments listed unnder Figure 13. Lpath did play a role in the decision to publish and in the preparation of the manuscript.	Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Clair T, 2003, CANCER RES, V63, P5446; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; French KJ, 2003, CANCER RES, V63, P5962; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gellings Lowe N, 2009, CARDIOVASC RES, V82, P303, DOI 10.1093/cvr/cvp056; Gorshkova IA, 2005, FASEB J, V19, pA282; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Harvey KA, 2010, MOL CELL BIOCHEM, V342, P7, DOI 10.1007/s11010-010-0461-2; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kiss Z, 1997, FEBS LETT, V412, P197, DOI 10.1016/S0014-5793(97)00776-X; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; Olivera A, 2001, PROSTAG OTH LIPID M, V64, P123, DOI 10.1016/S0090-6980(01)00108-3; Osada M, 2002, BIOCHEM BIOPH RES CO, V299, P483, DOI 10.1016/S0006-291X(02)02671-2; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Ozaki Harunobu, 2003, J Atheroscler Thromb, V10, P125; Pyne S, 2000, PHARMACOL THERAPEUT, V88, P115, DOI 10.1016/S0163-7258(00)00084-X; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schwalm S, 2010, BRIT J PHARMACOL, V160, P1641, DOI 10.1111/j.1476-5381.2010.00818.x; Sensken SC, 2010, J IMMUNOL, V184, P4133, DOI 10.4049/jimmunol.0903358; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Usatyuk PV, 2006, J BIOL CHEM, V281, P35554, DOI 10.1074/jbc.M607305200; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Yu H, 2009, GENES CELLS, V14, P597, DOI 10.1111/j.1365-2443.2009.01295.x; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	55	38	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16571	10.1371/journal.pone.0016571	http://dx.doi.org/10.1371/journal.pone.0016571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304987	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000286834300088
J	Harvey, JJW; Lewsey, MG; Patel, K; Westwood, J; Heimstadt, S; Carr, JP; Baulcombe, DC				Harvey, Jagger J. W.; Lewsey, Mathew G.; Patel, Kanu; Westwood, Jack; Heimstaedt, Susanne; Carr, John P.; Baulcombe, David C.			An Antiviral Defense Role of AGO2 in Plants	PLOS ONE			English	Article							POTATO-VIRUS-X; SILENCING SUPPRESSOR; ARGONAUTE PROTEINS; RNA INTERFERENCE; DNA METHYLATION; SALICYLIC-ACID; ARABIDOPSIS; GENE; EXPRESSION; PATHWAY	Background: Argonaute (AGO) proteins bind to small-interfering (si) RNAs and micro (mi)RNAs to target RNA silencing against viruses, transgenes and in regulation of mRNAs. Plants encode multiple AGO proteins but, in Arabidopsis, only AGO1 is known to have an antiviral role. Methodology/Principal Findings: To uncover the roles of specific AGOs in limiting virus accumulation we inoculated turnip crinkle virus (TCV) to Arabidopsis plants that were mutant for each of the ten AGO genes. The viral symptoms on most of the plants were the same as on wild type plants although the ago2 mutants were markedly hyper-susceptible to this virus. ago2 plants were also hyper-susceptible to cucumber mosaic virus (CMV), confirming that the antiviral role of AGO2 is not specific to a single virus. For both viruses, this phenotype was associated with transient increase in virus accumulation. In wild type plants the AGO2 protein was induced by TCV and CMV infection. Conclusions/Significance: Based on these results we propose that there are multiple layers to RNA-mediated defense and counter-defense in the interactions between plants and their viruses. AGO1 represents a first layer. With some viruses, including TCV and CMV, this layer is overcome by viral suppressors of silencing that can target AGO1 and a second layer involving AGO2 limits virus accumulation. The second layer is activated when the first layer is suppressed because AGO2 is repressed by AGO1 via miR403. The activation of the second layer is therefore a direct consequence of the loss of the first layer of defense.	[Harvey, Jagger J. W.; Lewsey, Mathew G.; Patel, Kanu; Westwood, Jack; Heimstaedt, Susanne; Carr, John P.; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Cambridge	Harvey, JJW (corresponding author), Int Livestock Res Inst, Nairobi, Kenya.	dcb40@cam.ac.uk	Carr, John Peter/N-7707-2019; Westwood, Jack/I-4325-2012; Lewsey, Mathew G/AAE-8530-2019; Carr, John/H-5646-2016	Carr, John Peter/0000-0002-5028-2160; Carr, John/0000-0002-5028-2160; Lewsey, Mathew/0000-0002-2631-4337; Baulcombe, David/0000-0003-0780-6878	Gatsby Charitable Foundation; Royal Society; U.S. National Science Foundation; Postdoctoral Research Fellowship [0512081]; Biotechnology and Biological Research Council [BB/D008204/1]; Leverhulme Trust [F/09 741/F]; Biotechnology and Biological Sciences Research Council [BB/C006739/1, BB/D008204/1, BB/C006739/2] Funding Source: researchfish; BBSRC [BB/D008204/1] Funding Source: UKRI	Gatsby Charitable Foundation; Royal Society(Royal Society of London); U.S. National Science Foundation(National Science Foundation (NSF)); Postdoctoral Research Fellowship; Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DCB is a Royal Society Research Professor and the work was supported by the Gatsby Charitable Foundation (http://www.gatsby.org.uk) and the Royal Society (http://royalsociety.org/). JJWH was supported by U.S. National Science Foundation (http://www.nsf.gov) Postdoctoral Research Fellowship 0512081. MGL was supported by Biotechnology and Biological Research Council (http://www.bbsrc.ac.uk) Grant BB/D008204/1 and Leverhulme Trust (http://www.leverhulme.ac.uk) grant F/09 741/F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; CARPENTER CD, 1995, J MOL BIOL, V245, P608, DOI 10.1006/jmbi.1994.0050; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/j.1364-3703.2010.00634.x, 10.1111/J.1364-3703.2010.00634.X]; Chivasa S, 1997, PLANT CELL, V9, P547, DOI 10.1105/tpc.9.4.547; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Diez J, 1998, METH MOL B, V81, P211; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Lewsey MG, 2009, J GEN VIROL, V90, P3010, DOI 10.1099/vir.0.014555-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; MCCONNELL JR, 1995, DEV GENET, V16, P358, DOI 10.1002/dvg.1020160409; Moissiard G, 2004, MOL PLANT PATHOL, V5, P71, DOI 10.1111/j.1364-3703.2004.00207.x; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Naylor M, 1998, MOL PLANT MICROBE IN, V11, P860, DOI 10.1094/MPMI.1998.11.9.860; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sambrook J, 2001, MOL CLONING LAB MANU; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603	38	236	247	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14639	10.1371/journal.pone.0014639	http://dx.doi.org/10.1371/journal.pone.0014639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305057	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300020
J	Xie, H; Jing, XH; Li, X; Lin, ZS; Plant, E; Zoueva, O; Yang, H; Ye, ZP				Xie, Hang; Jing, Xianghong; Li, Xing; Lin, Zhengshi; Plant, Ewan; Zoueva, Olga; Yang, Hong; Ye, Zhiping			Immunogenicity and Cross-Reactivity of 2009-2010 Inactivated Seasonal Influenza Vaccine in US Adults and Elderly	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; ANTIBODY-RESPONSES; UNITED-STATES; VIRUS; CHILDREN; AGE; INFECTION; STRAINS; SERUM; MATCH	The campaign of 2009-2010 Northern Hemisphere seasonal vaccination was concurrent with the 2009 H1N1 pandemic. Using a hemagglutination inhibition (HAI) assay, we evaluated the immunogenicity and cross-reactivity of 2009-2010 inactivated trivalent influenza vaccine (TIV) in US adult and elderly populations. Vaccination of TIV resulted in a robust boost on the antibody response of all subjects to seasonal A/Brisbane/59/2007 (H1N1) and A/Uruguay/716/2007 (H3N2) with over 70% of recipients reaching a seroprotective titer of 40. B/Brisbane/60/2008 was the least immunogenic among the three seasonal vaccine strains with <30% of TIV recipients reaching a seroprotective titer of 40. TIV vaccination also induced a moderate boost on the pandemic specific antibody responses. Twenty-four percent of adults and 36% of elderly reached a seroprotective HAI titer of 40 or more against pandemic A/South Carolina/18/2009 (H1N1) after receiving TIV compared to 4% and 7% at the beginning of vaccination, respectively. In addition, 22% of adults and 34% of elderly showed an increase of 4-fold or more in A/South Carolina/18/2009 specific HAI titers after TIV vaccination. The pandemic specific cross-reactive antibodies strongly correlated with the post-vaccination HAI titers against the seasonal H3N2 vaccine strain in all subjects.	[Xie, Hang; Jing, Xianghong; Li, Xing; Lin, Zhengshi; Plant, Ewan; Zoueva, Olga; Ye, Zhiping] US FDA, Lab Resp Viral Dis, Div Viral Prod, Off Vaccine Res & Review, Bethesda, MD 20014 USA; [Yang, Hong] US FDA, Ctr Biol Evaluat & Res, Off Biostat & Epidemiol, Bethesda, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Xie, H (corresponding author), US FDA, Lab Resp Viral Dis, Div Viral Prod, Off Vaccine Res & Review, Bethesda, MD 20014 USA.	Hang.Xie@fda.hhs.gov; Zhiping.Ye@fda.hhs.gov	Plant, Ewan/AAB-1911-2020; Xie, Hang/AAC-9092-2019	Plant, Ewan/0000-0003-0166-5939; Xie, Hang/0000-0001-8318-5554	Center for Biologics Evaluation; Research/Food and Drug Administration	Center for Biologics Evaluation; Research/Food and Drug Administration	This study was supported by Center for Biologics Evaluation and Research/Food and Drug Administration institutional research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Ding H., 2010, Morbidity and Mortality Weekly Report, V59, P477; Eisenberg KW, 2008, PEDIATRICS, V122, P911, DOI 10.1542/peds.2007-3304; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Joshi AY, 2009, VACCINE, V27, P4457, DOI 10.1016/j.vaccine.2009.05.038; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Loeb M, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091588; Mossad SB, 2008, CLEV CLIN J MED, V75, P865, DOI 10.3949/ccjm.75a.08088; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; World Health Organization, 2010, REC VIR INFL VACC US	27	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16650	10.1371/journal.pone.0016650	http://dx.doi.org/10.1371/journal.pone.0016650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304946	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300109
J	Alvarez, S; Blanco, A; Fresno, M; Munoz-Fernandez, MA				Alvarez, Susana; Blanco, Almudena; Fresno, Manuel; Angeles Munoz-Fernandez, Ma			TNF-alpha Contributes to Caspase-3 Independent Apoptosis in Neuroblastoma Cells: Role of NFAT	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR NFAT1; ACTIVATED T-CELLS; NERVOUS-SYSTEM; UP-REGULATION; NUCLEAR FACTOR; CALCINEURIN; EXPRESSION; ASTROCYTES; DEATH	There is increasing evidence that soluble factors in inflammatory central nervous system diseases not only regulate the inflammatory process but also directly influence electrophysiological membrane properties of neurons and astrocytes. In this context, the cytokine TNF-alpha (tumor necrosis factor-alpha) has complex injury promoting, as well as protective, effects on neuronal viability. Up-regulated TNF-alpha expression has also been found in various neurodegenerative diseases such as cerebral malaria, AIDS dementia, Alzheimer's disease, multiple sclerosis, and stroke, suggesting a potential pathogenic role of TNF-alpha in these diseases as well. We used the neuroblastoma cells SK-N-MC. Transcriptional activity was measured using luciferase reporter gene assays by using lipofectin. We performed cotransfection experiments of NFAT (nuclear factor of activated T cells) promoter constructed with a dominant negative version of NFAT (dn-NFAT). Cell death was performed by MTT (3-(4,5-dimethylthiazol-2-yl) 5,5-diphenyltetrazolium bromide) and TUNEL assays. NFAT translocation was confirmed by Western blot. Involvement of NFAT in cell death was assessed by using VIVIT. P53, Fas-L, caspase-3, and caspase-9 expressions were carried out by Western blot. The mechanisms involved in TNF-alpha-induced cell death were assessed by using microarray analysis. TNF-alpha causes neuronal cell death in the absence of glia. TNF-alpha treatment results in nuclear translocation of NFAT through activation of calcineurin in a Ca2+ independent manner. We demonstrated the involvement of FasL/Fas, cytochrome c, and caspase-9 but the lack of caspase-3 activation. NB cell death was absolutely reverted in the presence of VIVIT, and partially diminished by anti-Fas treatment. These data demonstrate that TNF-alpha promotes FasL expression through NFAT activation in neuroblastoma cells and this event leads to increased apoptosis through independent caspase-3 activation.	[Alvarez, Susana; Fresno, Manuel] Univ Autonoma Madrid, Ctr Biol Mol, Consejo Super Invest Cient, E-28049 Madrid, Spain; [Blanco, Almudena; Angeles Munoz-Fernandez, Ma] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); General University Gregorio Maranon Hospital	Alvarez, S (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, Consejo Super Invest Cient, E-28049 Madrid, Spain.	mmunoz.hgugm@madrid.salud.org		, Susana/0000-0001-8573-9370; Munoz-Fernandez/0000-0002-0813-4500; Fresno Escudero, Manuel/0000-0002-9223-5477	Fondos de Investigacion Sanitaria [INTRASALUD PI09/02029, P509102669]; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RETIC RD06/0006/0035]; Fundacion para la Investigacion y Prevencion del SIDA en Espana, FIPSE [240800/09]; Fundacion Caja Navarra; RED RICET [RD06/0021]; Programa Nacional de Salud of Spain [SAF2005-02220]; Laboratorios del Dr. Esteve; EU, European Commission [LSH-CT-2004-005033]; Fundacion Ramon Areces; Comunidad Autonoma de Madrid [SAL/2001/2004]; FIS [CD06/00321]; Comunidad de Madrid [S-SAL-0159-2006]	Fondos de Investigacion Sanitaria(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa Sanitaria ISCIII; Fundacion para la Investigacion y Prevencion del SIDA en Espana, FIPSE; Fundacion Caja Navarra; RED RICET; Programa Nacional de Salud of Spain; Laboratorios del Dr. Esteve; EU, European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Ramon Areces; Comunidad Autonoma de Madrid(Comunidad de Madrid); FIS(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from Fondos de Investigacion Sanitaria (INTRASALUD PI09/02029, P509102669) Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RETIC RD06/0006/0035), Fundacion para la Investigacion y Prevencion del SIDA en Espana, FIPSE (240800/09) and Fundacion Caja Navarra to MAM-F; from RED RICET (RD06/0021), Programa Nacional de Salud of Spain (SAF2005-02220), Laboratorios del Dr. Esteve, the 6th EU Framework Programme European Commission (Integrated project EICOSANOX, LSH-CT-2004-005033 and MAIN Network of Excellence) and the Fundacion Ramon Areces to MF; from Comunidad Autonoma de Madrid (SAL/2001/2004) to both MAM-F and MF. SA is supported by a fellowship of FIS (CD06/00321). AB is supported by a fellowship of Comunidad de Madrid S-SAL-0159-2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Assandri R, 1999, J PHYSIOL-LONDON, V516, P343, DOI 10.1111/j.1469-7793.1999.0343v.x; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; de Gregorio R, 2001, J BIOL CHEM, V276, P27003, DOI 10.1074/jbc.M100885200; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Figiel I, 2007, BRAIN RES, V1131, P17, DOI 10.1016/j.brainres.2006.10.095; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hamawy MM, 2003, DRUG NEWS PERSPECT, V16, P277, DOI 10.1358/dnp.2003.16.5.829315; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Herbein G, 2008, TRENDS IMMUNOL, V29, P61, DOI 10.1016/j.it.2007.10.008; Hui KK, 2009, J CELL MOL MED; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klettner A, 2003, BRIT J PHARMACOL, V138, P1004, DOI 10.1038/sj.bjp.0705132; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lambertsen KL, 2007, NEUROSCIENCE, V144, P934, DOI 10.1016/j.neuroscience.2006.10.046; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pender MP, 2001, GLIA, V36, P137, DOI 10.1002/glia.1103; Pong K, 2003, CNS NEUROL DISORD-DR, V2, P349, DOI 10.2174/1568007033482652; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; SEN S, 1992, FEBS LETT, V307, P122, DOI 10.1016/0014-5793(92)80914-3; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Viviani B, 2004, TOXICOL LETT, V149, P85, DOI 10.1016/j.toxlet.2003.12.022; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189	43	64	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16100	10.1371/journal.pone.0016100	http://dx.doi.org/10.1371/journal.pone.0016100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298033	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900023
J	Gasi, D; van der Korput, HA; Douben, HC; de Klein, A; de Ridder, CM; van Weerden, WM; Trapman, J				Gasi, Delila; van der Korput, Hetty A.; Douben, Hannie C.; de Klein, Annelies; de Ridder, Corrina M.; van Weerden, Wytske M.; Trapman, Jan			Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation	PLOS ONE			English	Article							ETS FAMILY; FUSION; HETEROGENEITY; TMPRSS2	ETV1 is overexpressed in a subset of clinical prostate cancers as a fusion transcript with many different partners. However, ETV1 can also be overexpressed as a full-length transcript. Full-length ETV1 protein functions differently from truncated ETV1 produced by fusion genes. In this study we describe the genetic background of full-length ETV1 overexpression and the biological properties of different full-length ETV1 isoforms in prostate cancer. Break-apart FISH showed in five out of six patient samples with overexpression of full-length ETV1 a genomic rearrangement of the gene, indicating frequent translocation. We were able to study the rearrangements in more detail in two tumors. In the first tumor 5'-RACE on cDNA showed linkage of the complete ETV1 transcript to the first exon of a prostate-specific two exon ncRNA gene that maps on chromosome 14 (EST14). This resulted in the expression of both full-length ETV1 transcripts and EST14-ETV1 fusion transcripts. In chromosome spreads of a xenograft derived from the second prostate cancer we observed a complex ETV1 translocation involving a chromosome 7 fragment that harbors ETV1 and fragments of chromosomes 4 and 10. Further studies revealed the overexpression of several different full-length transcripts, giving rise to four protein isoforms with different N-terminal regions. Even the shortest isoform synthesized by full-length ETV1 stimulated in vitro anchorage-independent growth of PNT2C2 prostate cells. This contrasts the lack of activity of even shorter N-truncated ETV1 produced by fusion transcripts. Our findings that in clinical prostate cancer overexpression of full-length ETV1 is due to genomic rearrangements involving different chromosomes and the identification of a shortened biologically active ETV1 isoform are highly relevant for understanding the mechanism of ETV1 function in prostate cancer.	[Gasi, Delila; van der Korput, Hetty A.; Trapman, Jan] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Douben, Hannie C.; de Klein, Annelies] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [de Ridder, Corrina M.; van Weerden, Wytske M.] Erasmus Univ, Dept Urol, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gasi, D (corresponding author), Erasmus Univ, Dept Pathol, Med Ctr, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.trapman@erasmusmc.nl	Tandefelt, Delila Gasi/ABI-1558-2020	Gasi Tandefelt, Delila/0000-0002-9490-6588	European Union	European Union(European Commission)	This study was supported by a Marie Curie Grant (Cancure) provided by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, BRIT J CANCER, V99, P314, DOI 10.1038/sj.bjc.6604472; Eussen BH, 2007, EUR J MED GENET, V50, P112, DOI 10.1016/j.ejmg.2006.10.006; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x	14	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16332	10.1371/journal.pone.0016332	http://dx.doi.org/10.1371/journal.pone.0016332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298110	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800026
J	Matsumoto, Y; Katayama, K; Okamoto, T; Yamada, K; Takashima, N; Nagao, S; Aruga, J				Matsumoto, Yoshifumi; Katayama, Kei-ichi; Okamoto, Takehito; Yamada, Kazuyuki; Takashima, Noriko; Nagao, Soichi; Aruga, Jun			Impaired Auditory-Vestibular Functions and Behavioral Abnormalities of Slitrk6-Deficient Mice	PLOS ONE			English	Article							MOUSE MODELS; EXPRESSION; SLITRK1; HEARING; BRAIN; NEUROTROPHIN-3; ASSOCIATION; RESPONSES; STRAINS	A recent study revealed that Slitrk6, a transmembrane protein containing a leucine-rich repeat domain, has a critical role in the development of the inner ear neural circuit. However, it is still unknown how the absence of Slitrk6 affects auditory and vestibular functions. In addition, the role of Slitrk6 in regions of the central nervous system, including the dorsal thalamus, has not been addressed. To understand the physiological role of Slitrk6, Slitrk6-knockout (KO) mice were subjected to systematic behavioral analyses including auditory and vestibular function tests. Compared to wild-type mice, the auditory brainstem response (ABR) of Slitrk6-KO mice indicated a mid-frequency range (8-16 kHz) hearing loss and reduction of the first ABR wave. The auditory startle response was also reduced. A vestibulo-ocular reflex (VOR) test showed decreased vertical (head movement-induced) VOR gains and normal horizontal VOR. In an open field test, locomotor activity was reduced; the tendency to be in the center region was increased, but only in the first 5 min of the test, indicating altered adaptive responses to a novel environment. Altered adaptive responses were also found in a hole-board test in which head-dip behavior was increased and advanced. Aside from these abnormalities, no clear abnormalities were noted in the mood, anxiety, learning, spatial memory, or fear memory-related behavioral tests. These results indicate that the Slitrk6-KO mouse can serve as a model of hereditary sensorineural deafness. Furthermore, the altered responses of Slitrk6-KO mice to the novel environment suggest a role of Slitrk6 in some cognitive functions.	[Matsumoto, Yoshifumi; Katayama, Kei-ichi; Takashima, Noriko; Aruga, Jun] RIKEN, BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan; [Okamoto, Takehito; Nagao, Soichi] RIKEN, BSI, Lab Motor Learning Control, Wako, Saitama, Japan; [Yamada, Kazuyuki] RIKEN, BSI, Support Unit Anim Expt, Wako, Saitama, Japan	RIKEN; RIKEN; RIKEN	Matsumoto, Y (corresponding author), RIKEN, BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan.	jaruga@brain.riken.jp	Aruga, Jun/H-5837-2011; Katayama, Kei-ichi/J-4699-2013	Aruga, Jun/0000-0001-7936-1375; Katayama, Kei-ichi/0000-0003-0527-4644	RIKEN Brain Science Institute (BSI); Japan Society for the Promotion of Science	RIKEN Brain Science Institute (BSI); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by RIKEN Brain Science Institute (BSI) and supported by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Aruga J, 2003, GENE EXPR PATTERNS, V3, P727, DOI 10.1016/S1567-133X(03)00141-8; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Bonsch D, 2009, HNO, V57, P371, DOI 10.1007/s00106-008-1832-9; BUTLER AB, 1995, BRAIN BEHAV EVOLUT, V46, P209, DOI 10.1159/000113275; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; Carnicero E, 2002, NEUROSCI LETT, V321, P149, DOI 10.1016/S0304-3940(01)02501-0; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; Harrod CG, 2003, BRAIN RES, V972, P75, DOI 10.1016/S0006-8993(03)02505-8; JASTREBOFF PJ, 1979, BIOL CYBERN, V33, P113, DOI 10.1007/BF00355259; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Katayama K, 2009, PLOS ONE, V4, pA151, DOI 10.1371/journal.pone.0007786; Katoh A, 1998, P NATL ACAD SCI USA, V95, P7705, DOI 10.1073/pnas.95.13.7705; Korres SG, 2007, MED SCI MONITOR, V13, pCR275; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Miranda DM, 2009, AM J MED GENET B, V150B, P483, DOI 10.1002/ajmg.b.30840; Noushi F, 2005, OTOL NEUROTOL, V26, P528, DOI 10.1097/01.mao.0000169780.84588.a5; Nunez A, 2007, ADV ANAT EMBRYOL CEL, V187, P1; OREILLY RC, OTOL NEUROT IN PRESS; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PITON A, MOL PSYCHIA IN PRESS; Sakatani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008309; Salvinelli F, 2004, Clin Ter, V155, P395; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Staecker H, 1996, NEUROREPORT, V7, P889, DOI 10.1097/00001756-199603220-00011; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; Wiener-Vacher SR, 2008, INT J AUDIOL, V47, P578, DOI 10.1080/14992020802334358; Willott James F, 2006, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0821bs34; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	35	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16497	10.1371/journal.pone.0016497	http://dx.doi.org/10.1371/journal.pone.0016497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298075	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800048
J	Richardson, BD; Ling, LL; Uteshev, VV; Caspary, DM				Richardson, Ben D.; Ling, Lynne L.; Uteshev, Victor V.; Caspary, Donald M.			Extrasynaptic GABA(A) Receptors and Tonic Inhibition in Rat Auditory Thalamus	PLOS ONE			English	Article							MEDIAL GENICULATE-BODY; INFERIOR COLLICULUS; DENTATE GYRUS; NEURONS; PROJECTIONS; SUBUNITS; BINDING; BRAIN; AUTORADIOGRAPHY; AGONISTS	Background: Neural inhibition plays an important role in auditory processing and attentional gating. Extrasynaptic GABA(A) receptors (GABA(A)R), containing alpha(4)and delta GABA(A)R subunits, are thought to be activated by GABA spillover outside of the synapse following release resulting in a tonic inhibitory Cl- current which could account for up to 90% of total inhibition in visual and somatosensory thalamus. However, the presence of this unique type of inhibition has not been identified in auditory thalamus. Methodology/Principal Findings: The present study used gaboxadol, a partially selective potent agonist for delta-subunit containing GABA(A) receptor constructs to elucidate the presence of extrasynaptic GABA(A)Rs using both a quantitative receptor binding assay and patch-clamp electrophysiology in thalamic brain slices. Intense [H-3]gaboxadol binding was found to be localized to the MGB while whole cell recordings from MGB neurons in the presence of gaboxadol demonstrated the expression of delta-subunit containing GABA(A)Rs capable of mediating a tonic inhibitory Cl- current. Conclusions/Significance: Potent tonic inhibitory GABA(A)R responses mediated by extrasynaptic receptors may be important in understanding how acoustic information is processed by auditory thalamic neurons as it ascends to auditory cortex. In addition to affecting cellular behavior and possibly neurotransmission, functional extrasynaptic delta-subunit containing GABA(A)Rs may represent a novel pharmacological target for the treatment of auditory pathologies including temporal processing disorders or tinnitus.	[Richardson, Ben D.; Ling, Lynne L.; Uteshev, Victor V.; Caspary, Donald M.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Richardson, BD (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	dcaspary@siumed.edu	Richardson, Ben/GNP-5689-2022; Richardson, Ben/B-2922-2012	Richardson, Ben/0000-0003-0403-4956; 	NIH [DC008532, DC00151]; Merck & Co., Inc. (Rahway, NJ); Merck; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008532, R01DC000151, R56DC000151] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck & Co., Inc. (Rahway, NJ)(Merck & Company); Merck(Merck & Company); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH DC008532 and DC00151 as well as Merck & Co., Inc. (Rahway, NJ). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The binding aspect of the present study results from a research grant from Merck to study gaboxadol as a possible treatment for an auditory disorder and does not alter our adherence to all of the PLoS ONE policies on sharing data and materials. Merck has since dropped any interests in or rights to this drug. There are no proprietary restrictions of any kind on the dissemination of information regarding the findings from these studies. Merck provided the tritiated gaboxadol as part of the grant. None of the authors have any contractual relationship with Merck.	Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bartlett EL, 2007, J NEUROPHYSIOL, V97, P1005, DOI 10.1152/jn.00593.2006; Bartlett EL, 1999, J NEUROPHYSIOL, V81, P1999, DOI 10.1152/jn.1999.81.5.1999; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Caspary DM, 2008, J EXP BIOL, V211, P1781, DOI 10.1242/jeb.013581; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Clerici WJ, 1998, J COMP NEUROL, V399, P110, DOI 10.1002/(SICI)1096-9861(19980914)399:1<110::AID-CNE9>3.0.CO;2-4; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Cotillon-Williams N, 2008, J NEUROPHYSIOL, V99, P1137, DOI 10.1152/jn.01159.2007; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Friemel A, 2007, BRAIN RES, V1170, P39, DOI 10.1016/j.brainres.2007.07.031; Herd MB, 2009, EUR J NEUROSCI, V29, P1177, DOI 10.1111/j.1460-9568.2009.06680.x; Hu B, 2003, EXP BRAIN RES, V153, P543, DOI 10.1007/s00221-003-1611-5; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; MILBRANDT JC, 1995, NEUROSCIENCE, V67, P713, DOI 10.1016/0306-4522(95)00082-T; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; PAN HS, 1983, J NEUROSCI, V3, P1189; Paxinos W.C., 1998, RAT BRAIN STEREOTAXI; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Peruzzi D, 1997, J NEUROSCI, V17, P3766; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; ROUILLER EM, 1985, NEUROSCI LETT, V53, P227, DOI 10.1016/0304-3940(85)90190-9; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Winer JA, 1996, P NATL ACAD SCI USA, V93, P3083, DOI 10.1073/pnas.93.7.3083; Winer JA, 1996, P NATL ACAD SCI USA, V93, P8005, DOI 10.1073/pnas.93.15.8005; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373	36	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16508	10.1371/journal.pone.0016508	http://dx.doi.org/10.1371/journal.pone.0016508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298071	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800052
J	Torloni, MR; Betran, AP; Souza, JP; Widmer, M; Allen, T; Gulmezoglu, M; Merialdi, M				Torloni, Maria Regina; Betran, Ana Pilar; Souza, Joao Paulo; Widmer, Mariana; Allen, Tomas; Gulmezoglu, Metin; Merialdi, Mario			Classifications for Cesarean Section: A Systematic Review	PLOS ONE			English	Article							DELIVERY; RATES	Background: Rising cesarean section (CS) rates are a major public health concern and cause worldwide debates. To propose and implement effective measures to reduce or increase CS rates where necessary requires an appropriate classification. Despite several existing CS classifications, there has not yet been a systematic review of these. This study aimed to 1) identify the main CS classifications used worldwide, 2) analyze advantages and deficiencies of each system. Methods and Findings: Three electronic databases were searched for classifications published 1968-2008. Two reviewers independently assessed classifications using a form created based on items rated as important by international experts. Seven domains (ease, clarity, mutually exclusive categories, totally inclusive classification, prospective identification of categories, reproducibility, implementability) were assessed and graded. Classifications were tested in 12 hypothetical clinical case-scenarios. From a total of 2948 citations, 60 were selected for full-text evaluation and 27 classifications identified. Indications classifications present important limitations and their overall score ranged from 2-9 (maximum grade = 14). Degree of urgency classifications also had several drawbacks (overall scores 6-9). Woman-based classifications performed best (scores 5-14). Other types of classifications require data not routinely collected and may not be relevant in all settings (scores 3-8). Conclusions: This review and critical appraisal of CS classifications is a methodologically sound contribution to establish the basis for the appropriate monitoring and rational use of CS. Results suggest that women-based classifications in general, and Robson's classification, in particular, would be in the best position to fulfill current international and local needs and that efforts to develop an internationally applicable CS classification would be most appropriately placed in building upon this classification. The use of a single CS classification will facilitate auditing, analyzing and comparing CS rates across different settings and help to create and implement effective strategies specifically targeted to optimize CS rates where necessary.	[Torloni, Maria Regina] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil; [Torloni, Maria Regina] Brazilian Cochrane Ctr, Sao Paulo, Brazil; [Betran, Ana Pilar; Souza, Joao Paulo; Widmer, Mariana; Gulmezoglu, Metin; Merialdi, Mario] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland; [Allen, Tomas] World Hlth Org, Dept Knowledge Management & Sharing, Geneva, Switzerland	Universidade Federal de Sao Paulo (UNIFESP); World Health Organization; World Health Organization	Torloni, MR (corresponding author), Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.	ginecologia@terra.com.br	Souza, João Paulo/G-1982-2010	Souza, João Paulo/0000-0002-2288-4244				Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; ANDERSON GM, 1984, NEW ENGL J MED, V311, P887, DOI 10.1056/NEJM198410043111405; Belizan JM, 2007, EPIDEMIOLOGY, V18, P485, DOI 10.1097/EDE.0b013e318068646a; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Calvo A, 2009, ACTA OBSTET GYN SCAN, V88, P842, DOI 10.1080/00016340903015313; Cisse C T, 1998, Sante, V8, P369; Cleary R, 1996, BRIT J OBSTET GYNAEC, V103, P223, DOI 10.1111/j.1471-0528.1996.tb09710.x; Denk CE, 2006, BIRTH-ISS PERINAT C, V33, P203, DOI 10.1111/j.1523-536X.2006.00105.x; *DEP RHR, 2004, WHO GLOB SURV UNPUB; GREGORY KD, 1994, OBSTET GYNECOL, V84, P574; GUIDOTTI R, 2008, SAFETY CS RESO UNPUB; Huissoud C, 2009, J GYNECOL OBST BIO R, V38, P51, DOI 10.1016/j.jgyn.2008.09.011; Kushtagi P, 2008, J POSTGRAD MED, V54, P52, DOI 10.4103/0022-3859.39195; Lieberman E, 1998, OBSTET GYNECOL, V92, P1; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; *NAT I CHILD HLTH, 1981, DDHS PUBL, P82; National Institute of Alcohol Abuse and Alcoholism, 2004, CLIN PRACT GUID QUAL, P1; NICO R, 1990, OBSTET GINECOL LAT A, V48, P242; Nicopoullos J D M, 2003, J Obstet Gynaecol, V23, P381; NOTZON FC, 1994, AM J OBSTET GYNECOL, V170, P495, DOI 10.1016/S0002-9378(94)70217-9; ODRISCOLL K, 1984, OBSTET GYNECOL, V63, P485; PATERSON CM, 1991, BRIT J OBSTET GYNAEC, V98, P1073, DOI 10.1111/j.1471-0528.1991.tb15357.x; Prytherch Helen, 2007, BMC Pregnancy Childbirth, V7, P16, DOI 10.1186/1471-2393-7-16; Robson MS, 1996, AM J OBSTET GYNECOL, V174, P199, DOI 10.1016/S0002-9378(96)70394-0; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Stanton C, 2008, BIRTH-ISS PERINAT C, V35, P204, DOI 10.1111/j.1523-536X.2008.00241.x; Thomas J., 2001, NATL SENTINEL CAESAR; *UON NETW, 2000, TACKL UNM NEED MAJ O, P1; VAN DJ, 2009, INT J GYNECOL OBSTET, V107, P16, DOI DOI 10.1016/J.IJGO.2009.05.001; Wagner M, 2001, INT J GYNECOL OBSTET, V75, pS25, DOI 10.1016/S0020-7292(01)00519-7; *WHO, 1992, INT STAT CLASS DIS R, P721	32	182	191	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14566	10.1371/journal.pone.0014566	http://dx.doi.org/10.1371/journal.pone.0014566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283801	Green Published, gold			2022-12-27	WOS:000286522200007
J	Thesen, T; Quinn, BT; Carlson, C; Devinsky, O; DuBois, J; McDonald, CR; French, J; Leventer, R; Felsovalyi, O; Wang, XY; Halgren, E; Kuzniecky, R				Thesen, Thomas; Quinn, Brian T.; Carlson, Chad; Devinsky, Orrin; DuBois, Jonathan; McDonald, Carrie R.; French, Jacqueline; Leventer, Richard; Felsovalyi, Olga; Wang, Xiuyuan; Halgren, Eric; Kuzniecky, Ruben			Detection of Epileptogenic Cortical Malformations with Surface-Based MRI Morphometry	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; TEMPORAL-LOBE EPILEPSY; CEREBRAL-CORTEX; GRAY-MATTER; COORDINATE SYSTEM; WHITE-MATTER; DYSPLASIA; GYRIFICATION; SURGERY; CLASSIFICATION	Magnetic resonance imaging has revolutionized the detection of structural abnormalities in patients with epilepsy. However, many focal abnormalities remain undetected in routine visual inspection. Here we use an automated, surface-based method for quantifying morphometric features related to epileptogenic cortical malformations to detect abnormal cortical thickness and blurred gray-white matter boundaries. Using MRI morphometry at 3T with surface-based spherical averaging techniques that precisely align anatomical structures between individual brains, we compared single patients with known lesions to a large normal control group to detect clusters of abnormal cortical thickness, gray-white matter contrast, local gyrification, sulcal depth, jacobian distance and curvature. To assess the effects of threshold and smoothing on detection sensitivity and specificity, we systematically varied these parameters with different thresholds and smoothing levels. To test the effectiveness of the technique to detect lesions of epileptogenic character, we compared the detected structural abnormalities to expert-tracings, intracranial EEG, pathology and surgical outcome in a homogeneous patient sample. With optimal parameters and by combining thickness and GWC, the surface-based detection method identified 92% of cortical lesions (sensitivity) with few false positives (96% specificity), successfully discriminating patients from controls 94% of the time. The detected structural abnormalities were related to the seizure onset zones, abnormal histology and positive outcome in all surgical patients. However, the method failed to adequately describe lesion extent in most cases. Automated surface-based MRI morphometry, if used with optimized parameters, may be a valuable additional clinical tool to improve the detection of subtle or previously occult malformations and therefore could improve identification of patients with intractable focal epilepsy who may benefit from surgery.	[Thesen, Thomas; Quinn, Brian T.; Carlson, Chad; Devinsky, Orrin; DuBois, Jonathan; French, Jacqueline; Felsovalyi, Olga; Wang, Xiuyuan; Kuzniecky, Ruben] NYU, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Thesen, Thomas; McDonald, Carrie R.; Halgren, Eric] Univ Calif San Diego, Multimodal Imaging Lab, San Diego, CA 92103 USA; [Quinn, Brian T.] NYU, Ctr Neural Sci, New York, NY 10016 USA; [Leventer, Richard] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Melbourne, Vic, Australia	New York University; University of California System; University of California San Diego; New York University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Thesen, T (corresponding author), NYU, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10016 USA.	thomas.thesen@med.nyu.edu	Wang, Xiuyuan/A-7500-2013; French, Jacqueline A/G-6795-2013	Wang, Xiuyuan/0000-0001-6356-3386; French, Jacqueline A/0000-0003-2242-8027; Carlson, Chad/0000-0001-6490-7814; Devinsky, Orrin/0000-0003-0044-4632; DuBois, Jonathan/0000-0002-4629-8354	FACES (Finding a Cure for Epilepsy and Seizures; National Institutes of Health [RO1 NS018741, K23 NS056091-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS056091, R01NS018741] Funding Source: NIH RePORTER	FACES (Finding a Cure for Epilepsy and Seizures; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by FACES (Finding a Cure for Epilepsy and Seizures [TT]; http://faces.med.nyu.edu/) and the National Institutes of Health (RO1 NS018741 [EH], K23 NS056091-01 [CM]; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Barkovich AJ, 1996, J CLIN NEUROPHYSIOL, V13, P481, DOI 10.1097/00004691-199611000-00003; Barkovich AJ, 2001, CURR OPIN NEUROL, V14, P145, DOI 10.1097/00019052-200104000-00002; Bernasconi N, 2004, NEUROIMAGE, V23, P717, DOI 10.1016/j.neuroimage.2004.06.015; Besson P, 2008, LECT NOTES COMPUT SC, V5241, P645, DOI 10.1007/978-3-540-85988-8_77; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Bonilha L, 2006, EPILEPSIA, V47, P908, DOI 10.1111/j.1528-1167.2006.00548.x; Colliot O, 2006, NEUROIMAGE, V29, P162, DOI 10.1016/j.neuroimage.2005.07.021; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fauser S, 2009, BRAIN, V132, P2079, DOI 10.1093/brain/awp145; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Hakimi AS, 2008, EPILEPSY BEHAV, V13, P96, DOI 10.1016/j.yebeh.2008.02.003; Kippenhan JS, 2005, J NEUROSCI, V25, P7840, DOI 10.1523/JNEUROSCI.1722-05.2005; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Madan N, 2009, EPILEPSIA, V50, P9, DOI 10.1111/j.1528-1167.2009.02292.x; McDonald CR, 2008, EPILEPSIA, V49, P794, DOI 10.1111/j.1528-1167.2008.01539.x; Mehta S, 2003, NEUROIMAGE, V20, P1438, DOI 10.1016/S1053-8119(03)00377-X; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; Peterson BS, 2009, P NATL ACAD SCI USA, V106, P6273, DOI 10.1073/pnas.0805311106; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Sisodiya SM, 2004, BRAIN, V127, P2383, DOI 10.1093/brain/awh312; Sisodiya SM, 2000, BRAIN, V123, P1075, DOI 10.1093/brain/123.6.1075; Wellmer J, 2010, NEUROSURGERY, V66, P187, DOI 10.1227/01.NEU.0000359329.92781.B7; Westlye LT, 2009, NEUROIMAGE, V47, P1545, DOI 10.1016/j.neuroimage.2009.05.084; Wilke M, 2003, NEUROIMAGE, V20, P330, DOI 10.1016/S1053-8119(03)00296-9; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	33	58	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16430	10.1371/journal.pone.0016430	http://dx.doi.org/10.1371/journal.pone.0016430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326599	Green Published, gold			2022-12-27	WOS:000287037000010
J	Morris, JJ; Johnson, ZI; Szul, MJ; Keller, M; Zinser, ER				Morris, J. Jeffrey; Johnson, Zackary I.; Szul, Martin J.; Keller, Martin; Zinser, Erik R.			Dependence of the Cyanobacterium Prochlorococcus on Hydrogen Peroxide Scavenging Microbes for Growth at the Ocean's Surface	PLOS ONE			English	Article							OXIDATIVE STRESS; PHOTOCHEMICAL FORMATION; IRON SPECIATION; ATLANTIC-OCEAN; PACIFIC-OCEAN; PHYTOPLANKTON; LIGHT; SYNECHOCOCCUS; ECOTYPES; WATERS	The phytoplankton community in the oligotrophic open ocean is numerically dominated by the cyanobacterium Prochlorococcus, accounting for approximately half of all photosynthesis. In the illuminated euphotic zone where Prochlorococcus grows, reactive oxygen species are continuously generated via photochemical reactions with dissolved organic matter. However, Prochlorococcus genomes lack catalase and additional protective mechanisms common in other aerobes, and this genus is highly susceptible to oxidative damage from hydrogen peroxide (HOOH). In this study we showed that the extant microbial community plays a vital, previously unrecognized role in cross-protecting Prochlorococcus from oxidative damage in the surface mixed layer of the oligotrophic ocean. Microbes are the primary HOOH sink in marine systems, and in the absence of the microbial community, surface waters in the Atlantic and Pacific Ocean accumulated HOOH to concentrations that were lethal for Prochlorococcus cultures. In laboratory experiments with the marine heterotroph Alteromonas sp., serving as a proxy for the natural community of HOOH-degrading microbes, bacterial depletion of HOOH from the extracellular milieu prevented oxidative damage to the cell envelope and photosystems of co-cultured Prochlorococcus, and facilitated the growth of Prochlorococcus at ecologically-relevant cell concentrations. Curiously, the more recently evolved lineages of Prochlorococcus that exploit the surface mixed layer niche were also the most sensitive to HOOH. The genomic streamlining of these evolved lineages during adaptation to the high-light exposed upper euphotic zone thus appears to be coincident with an acquired dependency on the extant HOOH-consuming community. These results underscore the importance of (indirect) biotic interactions in establishing niche boundaries, and highlight the impacts that community-level responses to stress may have in the ecological and evolutionary outcomes for co-existing species.	[Morris, J. Jeffrey; Szul, Martin J.; Zinser, Erik R.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Johnson, Zackary I.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Keller, Martin] Oak Ridge Natl Lab, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; Duke University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Morris, JJ (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	ezinser@utk.edu	Johnson, Zackary I/E-4601-2011; Keller, Martin/C-4416-2012	Johnson, Zackary I/0000-0003-0793-8512; Morris, James/0000-0001-9079-0082	NSF [OCE0526072, OCE0550798]; Phycological Society of America; Direct For Biological Sciences [0959630] Funding Source: National Science Foundation; Directorate For Geosciences [1031064] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Phycological Society of America; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grants OCE0526072 to ERZ and OCE0550798 to ZIJ, and a Phycological Society of America grant-in-aid to JJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; [Anonymous], 2002, PHOTOSYNTHETICA; Avery GB, 2005, MAR CHEM, V97, P236, DOI 10.1016/j.marchem.2005.03.006; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Bertilsson S, 2005, VIE MILIEU, V55, P225; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Fazzini RAB, 2010, ENVIRON MICROBIOL, V12, P2436, DOI 10.1111/j.1462-2920.2010.02217.x; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Cavender-Bares KK, 1998, LIMNOL OCEANOGR, V43, P1383, DOI 10.4319/lo.1998.43.6.1383; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; COOPER WJ, 1988, ENVIRON SCI TECHNOL, V22, P1156, DOI 10.1021/es00175a004; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; COOPER WJ, 1990, CAN J FISH AQUAT SCI, V47, P888, DOI 10.1139/f90-102; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; de-Bashan LE, 2008, J PHYCOL, V44, P938, DOI 10.1111/j.1529-8817.2008.00533.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DiTullio GR, 2003, MAR ECOL PROG SER, V255, P55, DOI 10.3354/meps255055; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; DRAPER WM, 1983, ARCH ENVIRON CON TOX, V12, P121, DOI 10.1007/BF01055010; DUBININ AV, 1992, MICROBIOLOGY+, V61, P41; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Dummermuth AL, 2003, J EXP MAR BIOL ECOL, V289, P103, DOI 10.1016/S0022-0981(03)00042-X; Eaton A. D., 2005, STANDARD METHODS EXA; Fogg G.E., 1987, ALGAL CULTURES PHYTO; Gerringa LJA, 2004, J SEA RES, V51, P3, DOI 10.1016/j.seares.2003.03.002; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; GOERICKE R, 1993, DEEP-SEA RES PT I, V40, P2283, DOI 10.1016/0967-0637(93)90104-B; Halliwell B., 2007, FREE RADICALS BIOL M; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hanson AK, 2001, MAR CHEM, V75, P69, DOI 10.1016/S0304-4203(01)00027-5; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Heck DE, 2003, J BIOL CHEM, V278, P22432, DOI 10.1074/jbc.C300048200; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; JOHNSON KS, 1989, DEEP-SEA RES, V36, P241, DOI 10.1016/0198-0149(89)90136-2; Johnson ZI, 2004, MAR ECOL PROG SER, V283, P73, DOI 10.3354/meps283073; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kieber RJ, 2001, ATMOS ENVIRON, V35, P6041, DOI 10.1016/S1352-2310(01)00199-6; King DW, 2007, ANAL CHEM, V79, P4169, DOI 10.1021/ac062228w; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kranner I, 2005, P NATL ACAD SCI USA, V102, P3141, DOI 10.1073/pnas.0407716102; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; LEPEZUNIGA JL, 1987, J IMMUNOL METHODS, V103, P145, DOI 10.1016/0022-1759(87)90253-5; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Marais GAB, 2008, GENETICA, V134, P205, DOI 10.1007/s10709-007-9226-6; Marchetti A, 2010, LIMNOL OCEANOGR, V55, P11, DOI 10.4319/lo.2010.55.1.0011; MILLER WL, 1994, MAR CHEM, V48, P17, DOI 10.1016/0304-4203(94)90059-0; MOFFETT JW, 1987, ENVIRON SCI TECHNOL, V21, P804, DOI 10.1021/es00162a012; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; MOUGET JL, 1995, FEMS MICROBIOL ECOL, V18, P35, DOI 10.1016/0168-6496(95)00038-C; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Paerl HW, 1996, MICROB ECOL, V31, P225; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Partensky F, 1996, DEEP-SEA RES PT I, V43, P1191, DOI 10.1016/0967-0637(96)00056-8; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; PENA MMO, 1995, J BIOL CHEM, V270, P22478, DOI 10.1074/jbc.270.38.22478; Petasne RG, 1997, MAR CHEM, V56, P215, DOI 10.1016/S0304-4203(96)00072-2; Ras J, 2008, BIOGEOSCIENCES, V5, P353, DOI 10.5194/bg-5-353-2008; Richier S, 2005, J EXP BIOL, V208, P277, DOI 10.1242/jeb.01368; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Samuilov VD, 1999, BIOCHEMISTRY-MOSCOW+, V64, P47; Sarthou G, 2007, MAR CHEM, V104, P186, DOI 10.1016/j.marchem.2006.11.004; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schreiber U, 1996, FEBS LETT, V397, P131, DOI 10.1016/S0014-5793(96)01176-3; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; THOMPSON AW, 2009, THESIS MIT CAMBRIDGE; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06; TYTLER EM, 1984, FEMS MICROBIOL LETT, V23, P239; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; Vieira-Silva S, 2010, TRENDS ECOL EVOL, V25, P319, DOI 10.1016/j.tree.2010.03.001; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Willey JD, 2004, J ATMOS CHEM, V47, P209, DOI 10.1023/B:JOCH.0000021087.19846.e1; Xenopoulos MA, 1997, PHOTOCHEM PHOTOBIOL, V66, P471, DOI 10.1111/j.1751-1097.1997.tb03175.x; Yuan JC, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000908; Yuan JC, 2000, ATMOS ENVIRON, V34, P3973, DOI 10.1016/S1352-2310(00)00167-9; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; ZEPP RG, 2002, ENVIRON SCI TECHNOL, V26, P313; ZIGLER JS, 1985, IN VITRO CELL DEV B, V21, P282; ZIKA RG, 1985, MAR CHEM, V17, P265, DOI 10.1016/0304-4203(85)90015-5; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	98	181	186	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16805	10.1371/journal.pone.0016805	http://dx.doi.org/10.1371/journal.pone.0016805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304826	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600026
J	Mu, XD; Peng, HR; Pan, HY; Huard, J; Li, Y				Mu, Xiaodong; Peng, Hairong; Pan, Haiying; Huard, Johnny; Li, Yong			Study of Muscle Cell Dedifferentiation after Skeletal Muscle Injury of Mice with a Cre-Lox System	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DEFINED FACTORS; GENE-THERAPY; FUSION; REGENERATION; EXPRESSION; MARROW; MOUSE; LINEAGES	Background: Dedifferentiation of muscle cells in the tissue of mammals has yet to be observed. One of the challenges facing the study of skeletal muscle cell dedifferentiation is the availability of a reliable model that can confidentially distinguish differentiated cell populations of myotubes and non-fused mononuclear cells, including stem cells that can coexist within the population of cells being studied. Methodology/Principal Findings: In the current study, we created a Cre/Lox-beta-galactosidase system, which can specifically tag differentiated multinuclear myotubes and myotube-generated mononuclear cells based on the activation of the marker gene, beta-galactosidase. By using this system in an adult mouse model, we found that beta-galactosidase positive mononuclear cells were generated from beta-galactosidase positive multinuclear myofibers upon muscle injury. We also demonstrated that these mononuclear cells can develop into a variety of different muscle cell lineages, i.e., myoblasts, satellite cells, and muscle derived stem cells. Conclusions/Significance: These novel findings demonstrated, for the first time, that cellular dedifferentiation of skeletal muscle cells actually occurs in mammalian skeletal muscle following traumatic injury in vivo.	[Mu, Xiaodong; Pan, Haiying; Huard, Johnny; Li, Yong] UPMC, Lab Mol Pathol, Stem Cell Res Ctr SCRC, Childrens Hosp, Pittsburgh, PA USA; [Mu, Xiaodong; Peng, Hairong; Huard, Johnny; Li, Yong] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Huard, Johnny; Li, Yong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Li, Yong] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mu, XD (corresponding author), UPMC, Lab Mol Pathol, Stem Cell Res Ctr SCRC, Childrens Hosp, Pittsburgh, PA USA.	yongli@pitt.edu	Mu, Xiaodong/A-2474-2012; Li, Yong/AAM-2367-2021	Li, Yong/0000-0001-7956-9600	Department of Defense (DOD) [W81XWH-06-1-0406, 23RYX9132N613]; National Institutes of Health [NIH1R21AR055725]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055725] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study received support from the Department of Defense (DOD, W81XWH-06-1-0406 & 23RYX9132N613) and the National Institutes of Health (NIH1R21AR055725) grants to Dr. Yong Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas O, 2009, BRIT J DERMATOL, V161, P228, DOI 10.1111/j.1365-2133.2009.09250.x; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Chen XP, 2005, MOL BIOL CELL, V16, P3140, DOI 10.1091/mbc.E05-03-0218; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Howatson G, 2008, SPORTS MED, V38, P483, DOI 10.2165/00007256-200838060-00004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li Y, 2010, JOVE-J VIS EXP, DOI [10.3791/2011, DOI 10.3791/2011]; Liu SV, 2008, STEM CELLS DEV, V17, P391, DOI 10.1089/scd.2008.0062; Loof S, 2007, CELL CYCLE, V6, P1096, DOI 10.4161/cc.6.9.4141; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Morrison JI, 2007, DEV DYNAM, V236, P481, DOI 10.1002/dvdy.21019; MU X, 2010, J CELLULAR MOL MED; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rodi N, 2004, TRENDS MOL MED, V10, P93, DOI 10.1016/j.molmed.2004.01.010; Ryffel GU, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng044; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Slack JMW, 2006, TRENDS CELL BIOL, V16, P273, DOI 10.1016/j.tcb.2006.04.007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	30	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16699	10.1371/journal.pone.0016699	http://dx.doi.org/10.1371/journal.pone.0016699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304901	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000287036600014
J	Tilahun, AY; Holz, M; Wu, TT; David, CS; Rajagopalan, G				Tilahun, Ashenafi Y.; Holz, Marah; Wu, Tsung-Teh; David, Chella S.; Rajagopalan, Govindarajan			Interferon Gamma-Dependent Intestinal Pathology Contributes to the Lethality in Bacterial Superantigen-Induced Toxic Shock Syndrome	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; HUMAN-LEUKOCYTE ANTIGEN-DQ8; IFN-GAMMA; TRANSGENIC MICE; INTRANASAL EXPOSURE; BARRIER FUNCTION; ACTIVATION; DISEASE; MODEL; INDUCTION	Toxic shock syndrome (TSS) caused by the superantigen exotoxins of Staphylococcus aureus and Streptococcus pyogenes is characterized by robust T cell activation, profound elevation in systemic levels of multiple cytokines, including interferon-gamma (IFN-gamma), followed by multiple organ dysfunction and often death. As IFN-gamma possesses pro- as well as anti-inflammatory properties, we delineated its role in the pathogenesis of TSS. Antibody-mediated in vivo neutralization of IFN-gamma or targeted disruption of IFN-gamma gene conferred significant protection from lethal TSS in HLA-DR3 transgenic mice. Following systemic high dose SEB challenge, whereas the HLA-DR3. IFN-gamma(+/+) mice became sick and succumbed to TSS, HLA-DR3. IFN-gamma(-/-) mice appeared healthy and were significantly protected from SEB-induced lethality. SEB-induced systemic cytokine storm was significantly blunted in HLA-DR3. IFN-gamma(-/-) transgenic mice. Serum concentrations of several cytokines (IL-4, IL-10, IL-12p40 and IL-17) and chemokines (KC, rantes, eotaxin and MCP-1) were significantly lower in HLA-DR3. IFN-gamma(-/-) transgenic mice. However, SEB-induced T cell expansion in the spleens was unaffected and expansion of SEB-reactive TCR Vb8(+) CD4(+) and CD8(+) T cells was even more pronounced in HLA-DR3. IFN-gamma(-/-) transgenic mice when compared to HLA-DR3. IFN-gamma(+/+) mice. A systematic histopathological examination of several vital organs revealed that both HLA-DR3. IFN-gamma(+/+) and HLA-DR3. IFN-gamma(-/-) transgenic mice displayed comparable severe inflammatory changes in lungs, and liver during TSS. Remarkably, whereas the small intestines fromHLA-DR3. IFN-gamma(+/+) transgenic mice displayed significant pathological changes during TSS, the architecture of small intestines in HLA-DR3. IFN-gamma(-/-) transgenic mice was preserved. In concordance with these histopathological changes, the gut permeability to macromolecules was dramatically increased in HLA-DR3. IFN-gamma(+/+) but not HLA-DR3. IFN-gamma(-/-) mice during TSS. Overall, IFN-gamma seemed to play a lethal role in the immunopathogenesis of TSS by inflicting fatal small bowel pathology. Our study thus identifies the important role for IFN-gamma in TSS.	[Tilahun, Ashenafi Y.; Holz, Marah; David, Chella S.; Rajagopalan, Govindarajan] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Wu, Tsung-Teh] Mayo Clin, Coll Med, Dept Anat Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Tilahun, AY (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	rajagopalan.govindarajan@mayo.edu			NIH [1R01AI068741]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH grant 1R01AI068741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Dinges MM, 2001, INFECT IMMUN, V69, P1256, DOI 10.1128/IAI.69.3.1256-1264.2001; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Guy-Grand D, 1998, EUR J IMMUNOL, V28, P730, DOI 10.1002/(SICI)1521-4141(199802)28:02<730::AID-IMMU730>3.0.CO;2-U; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; John CC, 2009, CLIN INFECT DIS, V49, P1893, DOI 10.1086/648441; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Lavoie PM, 1999, IMMUNOL REV, V168, P257, DOI 10.1111/j.1600-065X.1999.tb01297.x; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Madsen JM, 2001, CLIN LAB MED, V21, P593; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MIETHKE T, 1993, EUR J IMMUNOL, V23, P1494, DOI 10.1002/eji.1830230715; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Moreill P, 2009, MANDELL DOUGLAS BENN; Murray RJ, 2005, INTERN MED J, V35, pS106, DOI 10.1111/j.1444-0903.2005.00984.x; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Pinna GS, 2008, CURR OPIN INFECT DIS, V21, P263, DOI 10.1097/QCO.0b013e3282fbf9cd; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Rajagopalan G, 2004, INFECT IMMUN, V72, P6733, DOI 10.1128/IAI.72.11.6733-6737.2004; Rajagopalan G, 2006, INFECT IMMUN, V74, P1284, DOI 10.1128/IAI.74.2.1284-1296.2006; Rajagopalan G, 2005, CLIN DIAGN LAB IMMUN, V12, P1119, DOI 10.1128/CDLI.12.9.1119-1122.2005; Rajagopalan G, 2003, TISSUE ANTIGENS, V62, P149, DOI 10.1034/j.1399-0039.2003.00088.x; Rajagopalan G, 2009, PHYSL GENOMICS, p9038592008; Rajagopalan G, 2006, INFECT IMMUN, V74, P6016, DOI 10.1128/IAI.00671-06; Rajagopalan G, 2006, SHOCK, V25, P647, DOI 10.1097/01.shk.0000209565.92445.7d; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Roy CJ, 2005, INFECT IMMUN, V73, P2452, DOI 10.1128/IAI.73.4.2452-2460.2005; Sheikh SZ, 2010, J IMMUNOL, V184, P4069, DOI 10.4049/jimmunol.0903600; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Singh JA, COCHRANE DATABASE SY, V7; Takahashi N, 1998, LANCET, V351, P1614, DOI 10.1016/S0140-6736(97)11125-4; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tilahun AY, 2010, MOL THERAPY IN PRESS; TODD JK, 1985, ANNU REV MED, V36, P337; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Welcher BC, 2002, J INFECT DIS, V186, P501, DOI 10.1086/341828	50	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16764	10.1371/journal.pone.0016764	http://dx.doi.org/10.1371/journal.pone.0016764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304813	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600022
J	Uttl, B				Uttl, Bob			Transparent Meta-Analysis: Does Aging Spare Prospective Memory with Focal vs. Non-Focal Cues?	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; RETROSPECTIVE MEMORY; WORKING-MEMORY; REMEMBERING INTENTIONS; INDIVIDUAL-DIFFERENCES; PERFORMANCE; OLDER; RETRIEVAL; YOUNGER; REALIZATION	Background: Prospective memory (ProM) is the ability to become aware of a previously-formed plan at the right time and place. For over twenty years, researchers have been debating whether prospective memory declines with aging or whether it is spared by aging and, most recently, whether aging spares prospective memory with focal vs. non-focal cues. Two recent meta-analyses examining these claims did not include all relevant studies and ignored prevalent ceiling effects, age confounds, and did not distinguish between prospective memory subdomains (e. g., ProM proper, vigilance, habitual ProM) (see Uttl, 2008, PLoS ONE). The present meta-analysis focuses on the following questions: Does prospective memory decline with aging? Does prospective memory with focal vs. non-focal cues decline with aging? Does the size of age-related declines with focal vs. non-focal cues vary across ProM subdomains? And are age-related declines in ProM smaller than age-related declines in retrospective memory? Methods and Findings: A meta-analysis of event-cued ProM using data visualization and modeling, robust count methods, and conventional meta-analysis techniques revealed that first, the size of age-related declines in ProM with both focal and non-focal cues are large. Second, age-related declines in ProM with focal cues are larger in ProM proper and smaller in vigilance. Third, age-related declines in ProM proper with focal cues are as large as age-related declines in recall measures of retrospective memory. Conclusions: The results are consistent with Craik's (1983) proposal that age-related declines on ProM tasks are generally large, support the distinction between ProM proper vs. vigilance, and directly contradict widespread claims that ProM, with or without focal cues, is spared by aging.	Mt Royal Univ, Dept Psychol, Calgary, AB, Canada	Mount Royal University	Uttl, B (corresponding author), Mt Royal Univ, Dept Psychol, Calgary, AB, Canada.	buttl@mtroyal.ca						Bailey PE, 2010, Q J EXP PSYCHOL, V63, P646, DOI 10.1080/17470210903521797; Bastin C., 2002, CURRENT PSYCHOL LETT, V7, P105; Birt A, 2003, DISS ABSTR INT B; Cherry K, 2003, AGE DIFFERENCES PROS, P49; Cherry KE, 1999, PSYCHOL AGING, V14, P60, DOI 10.1037/0882-7974.14.1.60; Cherry KE, 2001, MEMORY, V9, P177, DOI 10.1080/09658210143000092; COCKBURN J, 1994, BRIT J PSYCHOL, V85, P273, DOI 10.1111/j.2044-8295.1994.tb02523.x; Cohen AL, 2003, CAN J EXP PSYCHOL, V57, P274, DOI 10.1037/h0087431; Cohen AL, 2001, AGING NEUROPSYCHOL C, V8, P1, DOI 10.1076/anec.8.1.1.845; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; Cuttler C, 2007, SCAND J PSYCHOL, V48, P215, DOI 10.1111/j.1467-9450.2007.00570.x; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; d'Ydewalle G, 1999, EUR J COGN PSYCHOL, V11, P219, DOI 10.1080/713752309; Davidson A.C., 1997, BOOTSTRAP METHODS TH; Delbello R., 2001, PSICOLOGICA, V22, P97, DOI DOI 10.5334/pb-52-2-3-205; DOBBS AR, 1987, CAN J PSYCHOL, V41, P209, DOI 10.1037/h0084152; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Einstein GO, 1998, PSYCHOL SCI, V9, P284, DOI 10.1111/1467-9280.00056; Farrimond S, 2006, APPL COGNITIVE PSYCH, V20, P533, DOI 10.1002/acp.1202; Fernandes MA, 2000, J EXP PSYCHOL GEN, V129, P155, DOI 10.1037/0096-3445.129.2.155; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Graf P, 2002, LIFESPAN DEV HUMAN M, P255; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Kliegel M, 2006, DEV NEUROPSYCHOL, V30, P819, DOI 10.1207/s15326942dn3003_4; Knight RG, 2008, INT PSYCHOGERIATR, V20, P124, DOI 10.1017/S1041610207005923; Krippendorff K., 2018, CONTENT ANAL INTRO I, V4th ed.; Kvavilashvili L, 2009, MEMORY, V17, P180, DOI 10.1080/09658210802194366; LAVOIE D, 1994, PSYCHOL AGING, V9, P539, DOI 10.1037/0882-7974.9.4.539; Logie R, 2004, EUR J COGN PSYCHOL, V16, P441, DOI 10.1080/09541440340000114; Logie RH, 2009, PSYCHOL AGING, V24, P767, DOI 10.1037/a0015479; MANTYLA T, 1994, J GERONTOL, V49, pP276, DOI 10.1093/geronj/49.6.P276; Mantyla T, 1993, Memory, V1, P203, DOI 10.1080/09658219308258233; Mantyla T, 1997, AGING NEUROPSYCHOL C, V4, P81, DOI 10.1080/13825589708256638; Marsh RL, 2007, AGING NEUROPSYCHOL C, V14, P168, DOI 10.1080/138255891007074; Marsh RL, 2002, MEM COGNITION, V30, P302, DOI 10.3758/BF03195291; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Maylor E, 1996, DOES PROSPECTIVE MEM, P173; Maylor EA, 1998, AGING NEUROPSYCHOL C, V5, P107, DOI 10.1076/anec.5.2.107.599; MAYLOR EA, 1993, PSYCHOL AGING, V8, P420, DOI 10.1037/0882-7974.8.3.420; Maylor EA, 1996, PSYCHOL AGING, V11, P74, DOI 10.1037/0882-7974.11.1.74; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2003, PSYCHOL AGING, V18, P823, DOI 10.1037/0882-7974.18.4.823; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; McDermott K, 2004, APPL COGNITIVE PSYCH, V18, P349, DOI 10.1002/acp.977; Meier B, 2000, APPL COGNITIVE PSYCH, V14, pS11, DOI 10.1002/acp.768; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; Reese CM, 2002, AGING NEUROPSYCHOL C, V9, P98, DOI 10.1076/anec.9.2.98.9546; Rendell P, 1999, J GERONTOLOGY; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Shapiro S, 1999, J EXP PSYCHOL-APPL, V5, P169, DOI 10.1037/1076-898X.5.2.169; Skladzien EM, 2010, AGING NEUROPSYCHOL C, V17, P240, DOI 10.1080/13825580903265673; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; TOMBAUGH TN, 1995, CLIN NEUROPSYCHOL, V9, P135, DOI 10.1080/13854049508401595; Uttl B, 2006, AGING NEUROPSYCHOL C, V13, P141, DOI 10.1080/138255890969618; Uttl B, 2005, DYNAMIC COGNITIVE PROCESSES, P273, DOI 10.1007/4-431-27431-6_12; Uttl B, 2005, PSYCHOL SCI, V16, P460; Uttl B, 2002, ARCH CLIN NEUROPSYCH, V17, P567, DOI 10.1016/S0887-6177(01)00135-4; Uttl B, 2001, CONSCIOUS COGN, V10, P451, DOI 10.1006/ccog.2001.0505; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; VERHAEGHEN P, 1993, J GERONTOL, V48, pP157, DOI 10.1093/geronj/48.4.P157; Vogels WWA, 2002, BRAIN COGNITION, V49, P341, DOI 10.1006/brcg.2001.1504; West R, 1999, PSYCHOL AGING, V14, P264, DOI 10.1037/0882-7974.14.2.264; West R, 2005, PSYCHOPHYSIOLOGY, V42, P698, DOI 10.1111/j.1469-8986.2005.00361.x; West R, 2003, PSYCHOL AGING, V18, P461, DOI 10.1037/0882-7974.18.3.461; West R, 2001, NEUROREPORT, V12, P2855, DOI 10.1097/00001756-200109170-00020; West R, 2001, PSYCHOL AGING, V16, P682, DOI 10.1037//0882-7974.16.4.682; West R., 1988, PRACTICAL ASPECTS ME, V2, P119; Zimmermann TD, 2006, Q J EXP PSYCHOL, V59, P2040, DOI 10.1080/17470210600917835; Zollig J, 2007, NEUROPSYCHOLOGIA, V45, P3299, DOI 10.1016/j.neuropsychologia.2007.06.010	91	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16618	10.1371/journal.pone.0016618	http://dx.doi.org/10.1371/journal.pone.0016618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	717IJ	21304905	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600011
J	Watanabe, S; Wakasugi, K				Watanabe, Seiji; Wakasugi, Keisuke			Module M1 of Zebrafish Neuroglobin Acts as a Structural and Functional Protein Building Block for a Cell-Membrane-Penetrating Activity	PLOS ONE			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; ARGININE-RICH PEPTIDES; BETA2/NEUROD PROTEIN; LIGAND-BINDING; IN-VIVO; TRANSDUCTION; HEMOGLOBIN; DELIVERY; OXYGEN; EXPRESSION	Neuroglobin (Ngb) is a recently discovered vertebrate globin that is expressed in the brain and can reversibly bind oxygen. Mammalian Ngb is involved in neuroprotection during oxidative stress that occurs, for example, during ischemia and reperfusion. Recently, we found that zebrafish, but not human, Ngb can translocate into cells. Moreover, we demonstrated that a chimeric ZHHH Ngb protein, in which the module M1 of human Ngb is replaced by the corresponding region of zebrafish Ngb, can penetrate cell membranes and protect cells against oxidative stress-induced cell death, suggesting that module M1 of zebrafish Ngb is important for protein transduction. Furthermore, we recently showed that Lys7, Lys9, Lys21, and Lys23 in module M1 of zebrafish Ngb are crucial for protein transduction activity. In the present study, we have investigated whether module M1 of zebrafish Ngb can be used as a building block to create novel cell-membrane penetrating folded proteins. First, we engineered a chimeric myoglobin (Mb), in which module M1 of zebrafish Ngb was fused to the N-terminus of full-length human Mb, and investigated its functional and structural properties. Our results showed that this chimeric Mb protein is stable and forms almost the same heme environment and alpha-helical structure as human wild-type Mb. In addition, we demonstrated that chimeric Mb has a cell-membrane-penetrating activity similar to zebrafish Ngb. Moreover, we found that glycosaminoglycan is crucial for the cell-membrane-penetrating activity of chimeric Mb as well as that of zebrafish Ngb. These results enable us to conclude that such module substitutions will facilitate the design and production of novel functional proteins.	[Watanabe, Seiji; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Watanabe, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	wakasugi@bio.c.u-tokyo.ac.jp	Wakasugi, Keisuke/AAQ-1642-2020	Wakasugi, Keisuke/0000-0002-8408-5616; Watanabe, Seiji/0000-0001-8038-7919	Japan Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [21117506]; JSPS	Japan Science and Technology(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Science and Technology (to K. W.) and Grant-in-Aid 21117506 for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. W.). S. W. was supported by the JSPS Research Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; BLAKE CCF, 1979, NATURE, V277, P598, DOI 10.1038/277598a0; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fedorov A, 2003, GENOME RES, V13, P1155, DOI 10.1101/gr.1008203; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Go M., 1985, Advances in Biophysics, V19, P91; GO M, 1983, P NATL ACAD SCI-BIOL, V80, P1964, DOI 10.1073/pnas.80.7.1964; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; KERSANACH R, 1994, NATURE, V367, P387, DOI 10.1038/367387a0; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Long MY, 1996, P NATL ACAD SCI USA, V93, P7727, DOI 10.1073/pnas.93.15.7727; Mendoza V, 2005, TRANSPL P, V37, P237, DOI 10.1016/j.transproceed.2004.12.270; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Noguchi H, 2005, DIABETES, V54, P2859, DOI 10.2337/diabetes.54.10.2859; Noguchi H, 2007, HUM GENE THER, V18, P10, DOI 10.1089/hum.2006.118; Peroni D, 2007, NEUROSCI LETT, V421, P110, DOI 10.1016/j.neulet.2007.05.046; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SHIH MC, 1988, SCIENCE, V242, P1164, DOI 10.1126/science.3055302; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; VARADARAJAN R, 1989, BIOCHEMISTRY-US, V28, P3771, DOI 10.1021/bi00435a022; Wakasugi K, 2005, ANN NY ACAD SCI, V1053, P220, DOI 10.1196/annals.1344.020; Wakasugi K, 2005, BIOCHEM BIOPH RES CO, V330, P591, DOI 10.1016/j.bbrc.2005.03.021; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P2943, DOI 10.1021/bi0477539; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P225, DOI 10.1021/bi048313k; Wakasugi K, 1997, BIOPHYS CHEM, V68, P265, DOI 10.1016/S0301-4622(97)80556-X; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; WAKASUGI K, 1994, J BIOL CHEM, V269, P18750; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P5266, DOI 10.1021/bi800286m; Watanabe S, 2008, BIOCHEM BIOPH RES CO, V369, P695, DOI 10.1016/j.bbrc.2008.02.089; Watanabe S, 2010, FEBS LETT, V584, P2467, DOI 10.1016/j.febslet.2010.04.054; Wystub S, 2003, NEUROSCI LETT, V346, P114, DOI 10.1016/S0304-3940(03)00563-9; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360; Zhou GY, 2008, BIOTECHNOL APPL BIOC, V49, P25, DOI 10.1042/BA20070061	51	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16808	10.1371/journal.pone.0016808	http://dx.doi.org/10.1371/journal.pone.0016808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304818	Green Published, Green Submitted, gold			2022-12-27	WOS:000287036600027
J	Garske, T; Yu, HJ; Peng, ZB; Ye, M; Zhou, H; Cheng, XW; Wu, JB; Ferguson, N				Garske, Tini; Yu, Hongjie; Peng, Zhibin; Ye, Min; Zhou, Hang; Cheng, Xiaowen; Wu, Jiabing; Ferguson, Neil			Travel Patterns in China	PLOS ONE			English	Article							SYSTEM; DETERMINANTS	The spread of infectious disease epidemics is mediated by human travel. Yet human mobility patterns vary substantially between countries and regions. Quantifying the frequency of travel and length of journeys in well-defined population is therefore critical for predicting the likely speed and pattern of spread of emerging infectious diseases, such as a new influenza pandemic. Here we present the results of a large population survey undertaken in 2007 in two areas of China: Shenzhen city in Guangdong province, and Huangshan city in Anhui province. In each area, 10,000 randomly selected individuals were interviewed, and data on regular and occasional journeys collected. Travel behaviour was examined as a function of age, sex, economic status and home location. Women and children were generally found to travel shorter distances than men. Travel patterns in the economically developed Shenzhen region are shown to resemble those in developed and economically advanced middle income countries with a significant fraction of the population commuting over distances in excess of 50 km. Conversely, in the less developed rural region of Anhui, travel was much more local, with very few journeys over 30 km. Travel patterns in both populations were well-fitted by a gravity model with a lognormal kernel function. The results provide the first quantitative information on human travel patterns in modern China, and suggest that a pandemic emerging in a less developed area of rural China might spread geographically sufficiently slowly for containment to be feasible, while spatial spread in the more economically developed areas might be expected to be much more rapid, making containment more difficult.	[Garske, Tini; Ferguson, Neil] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, London, England; [Yu, Hongjie; Peng, Zhibin; Ye, Min; Zhou, Hang] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Cheng, Xiaowen] Shenzhen Ctr Dis Control & Prevent, Dept Communicable Dis Prevent & Control, Shenzhen, Peoples R China; [Wu, Jiabing] Anhui Prov Ctr Dis Control & Prevent, Dept Communicable Dis Prevent & Control, Hefei, Peoples R China	Imperial College London; Chinese Center for Disease Control & Prevention; Shenzhen Center for Disease Control & Prevention (SZCDC)	Garske, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, London, England.	t.garske@imperial.ac.uk	Yu, Hongjie/GZK-5351-2022; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093	United States National Institutes of Health [U19 AI51915]; People's Republic of China and United States Collaborative Program on Emerging and Re-emerging Infectious Diseases; Ministry of Science and Technology of the People's Republic of China [2004BA519A17, 2004BA519A71, 2006BAD06A02]; Medical Research Council UK; EU; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719B, G0600719] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); People's Republic of China and United States Collaborative Program on Emerging and Re-emerging Infectious Diseases; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the United States National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915), the People's Republic of China and United States Collaborative Program on Emerging and Re-emerging Infectious Diseases, the Ministry of Science and Technology of the People's Republic of China (2004BA519A17, 2004BA519A71 and 2006BAD06A02), the Medical Research Council UK and the EU Framework 7 FluModCont project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this study are those of the authors and do not represent the policy of the Chinese Center for Disease Control and Prevention.	Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Lee BS, 2003, URBAN STUD, V40, P1283, DOI 10.1080/0042098032000084604; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lu Y, 2007, ASIAN PAC MIGR J, V16, P29, DOI 10.1177/011719680701600102; Ngai P, 2007, FEM ECON, V13, P239, DOI 10.1080/13545700701439465; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wu XG, 2004, DEMOGRAPHY, V41, P363, DOI 10.1353/dem.2004.0010; Wu XG, 2007, AM J SOCIOL, V113, P415, DOI 10.1086/518905	17	23	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16364	10.1371/journal.pone.0016364	http://dx.doi.org/10.1371/journal.pone.0016364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	717IF	21311745	Green Submitted, Green Published, gold			2022-12-27	WOS:000287036200011
J	Schleinitz, D; Kloting, N; Bottcher, Y; Wolf, S; Dietrich, K; Tonjes, A; Breitfeld, J; Enigk, B; Halbritter, J; Korner, A; Schon, MR; Jenkner, J; Tseng, YH; Lohmann, T; Dressler, M; Stumvoll, M; Bluher, M; Kovacs, P				Schleinitz, Dorit; Kloeting, Nora; Boettcher, Yvonne; Wolf, Sara; Dietrich, Kerstin; Toenjes, Anke; Breitfeld, Jana; Enigk, Beate; Halbritter, Jan; Koerner, Antje; Schoen, Michael R.; Jenkner, Jost; Tseng, Yu-Hua; Lohmann, Tobias; Dressler, Miriam; Stumvoll, Michael; Blueher, Matthias; Kovacs, Peter			Genetic and Evolutionary Analyses of the Human Bone Morphogenetic Protein Receptor 2 (BMPR2) in the Pathophysiology of Obesity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HAPLOTYPE RECONSTRUCTION; PHYLOGENETIC ANALYSIS; POPULATION; EXPRESSION; VARIANTS; CELLS; LOCI; FAT	Objective: Human bone morphogenetic protein receptor 2 (BMPR2) is essential for BMP signalling and may be involved in the regulation of adipogenesis. The BMPR2 locus has been suggested as target of recent selection in human populations. We hypothesized that BMPR2 might have a role in the pathophysiology of obesity. Research Design and Methods: Evolutionary analyses (dN/dS, Fst, iHS) were conducted in vertebrates and human populations. BMPR2 mRNA expression was measured in 190 paired samples of visceral and subcutaneous adipose tissue. The gene was sequenced in 48 DNA samples. Nine representative single nucleotide polymorphisms (SNPs) were genotyped for subsequent association studies on quantitative traits related to obesity in 1830 German Caucasians. An independent cohort of 925 Sorbs was used for replication. Finally, relation of genotypes to mRNA in fat was examined. Results: The evolutionary analyses indicated signatures of selection on the BMPR2 locus. BMPR2 mRNA expression was significantly increased both in visceral and subcutaneous adipose tissue of 37 overweight (BMI>25 and <30 kg/m(2)) and 80 obese (BMI>30 kg/m(2)) compared with 44 lean subjects (BMI<25 kg/m(2)) (P<0.001). In a case-control study including lean and obese subjects, two intronic SNPs (rs6717924, rs13426118) were associated with obesity (adjusted P<0.05). Combined analyses including the initial cohort and the Sorbs confirmed a consistent effect for rs6717924 (combined P=0.01) on obesity. Moreover, rs6717924 was associated with higher BMPR2 mRNA expression in visceral adipose tissue. Conclusion: Combined BMPR2 genotype-phenotype-mRNA expression data as well as evolutionary aspects suggest a role of BMPR2 in the pathophysiology of obesity.	[Schleinitz, Dorit; Dietrich, Kerstin; Breitfeld, Jana; Enigk, Beate; Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Kloeting, Nora; Boettcher, Yvonne; Wolf, Sara; Toenjes, Anke; Halbritter, Jan; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Toenjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, Leipzig, Germany; [Schoen, Michael R.; Jenkner, Jost] Municipal Clin Karlsruhe, Clin Visceral Surg, Karlsruhe, Germany; [Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Lohmann, Tobias; Dressler, Miriam] Municipal Clin, Dresden, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Municipal Hospital Karlsruhe; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Schleinitz, D (corresponding author), Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany.	bluma@medizin.uni-leipzig.de; peter.kovacs@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Stumvoll, Michael/ABE-1121-2021; Tseng, Yu-Hua/AAE-6471-2021	Körner, Antje/0000-0001-6001-0356; Stumvoll, Michael/0000-0001-6225-8240; Tseng, Yu-Hua/0000-0003-2053-9559; Kovacs, Peter/0000-0002-0290-5423; Schon, Michael/0000-0002-0698-4130	Federal Ministry of Education and Research, Competence Network Obesity [FKZ 01GI0829]; NGFNplus [FKZ 01GI0827]; Deutsche Forschungsgemeinschaft (DFG); German Diabetes Association [BL 833/1-1, Stu192/6-1, KO 3512/1-1, KO 3880/1-1]; National Institutes of Health (USA) [R01 DK077097, P30 DK040561]; DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R01DK077097] Funding Source: NIH RePORTER	Federal Ministry of Education and Research, Competence Network Obesity; NGFNplus; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Diabetes Association; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Federal Ministry of Education and Research, Competence Network Obesity (FKZ 01GI0829), the NGFNplus (FKZ 01GI0827), Deutsche Forschungsgemeinschaft (DFG), the Clinical Research Group "Atherobesity'' KFO 152 (projects BL 833/1-1 to MB, and Stu192/6-1 (MS), KO 3512/1-1 to AK, KO 3880/1-1 to PK), from the German Diabetes Association (to DS and PK), from the National Institutes of Health (USA) grants R01 DK077097 and P30 DK040561 (to YHT) and DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland; to MS, PK, MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Austin ED, 2009, SEMIN RESP CRIT CARE, V30, P386, DOI 10.1055/s-0029-1233308; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Bottcher Y, 2009, DIABETES, V58, P2119, DOI 10.2337/db08-1458; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Massague J, 1996, CANCER SURV, V27, P41; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nett PC, 2006, LIFE SCI, V78, P2213, DOI 10.1016/j.lfs.2005.09.026; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeh CH, 2009, HORM METAB RES, V41, P605, DOI 10.1055/s-0029-1220736	36	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16155	10.1371/journal.pone.0016155	http://dx.doi.org/10.1371/journal.pone.0016155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311592	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200008
J	Allentoft, ME; Oskam, C; Houston, J; Hale, ML; Gilbert, MTP; Rasmussen, M; Spencer, P; Jacomb, C; Willerslev, E; Holdaway, RN; Bunce, M				Allentoft, Morten E.; Oskam, Charlotte; Houston, Jayne; Hale, Marie L.; Gilbert, M. Thomas P.; Rasmussen, Morten; Spencer, Peter; Jacomb, Christopher; Willerslev, Eske; Holdaway, Richard N.; Bunce, Michael			Profiling the Dead: Generating Microsatellite Data from Fossil Bones of Extinct Megafauna-Protocols, Problems, and Prospects	PLOS ONE			English	Article							GENOTYPING ERRORS; SOUTH ISLAND; DNA; SAMPLES; MARKERS; MOA; POPULATIONS; LOCI; AMPLIFICATION; CONSEQUENCES	We present the first set of microsatellite markers developed exclusively for an extinct taxon. Microsatellite data have been analysed in thousands of genetic studies on extant species but the technology can be problematic when applied to low copy number (LCN) DNA. It is therefore rarely used on substrates more than a few decades old. Now, with the primers and protocols presented here, microsatellite markers are available to study the extinct New Zealand moa (Aves: Dinornithiformes) and, as with single nucleotide polymorphism (SNP) technology, the markers represent a means by which the field of ancient DNA can (preservation allowing) move on from its reliance on mitochondrial DNA. Candidate markers were identified using high throughput sequencing technology (GS-FLX) on DNA extracted from fossil moa bone and eggshell. From the 'shotgun' reads, >60 primer pairs were designed and tested on DNA from bones of the South Island giant moa (Dinornis robustus). Six polymorphic loci were characterised and used to assess measures of genetic diversity. Because of low template numbers, typical of ancient DNA, allelic dropout was observed in 36-70% of the PCR reactions at each microsatellite marker. However, a comprehensive survey of allelic dropout, combined with supporting quantitative PCR data, allowed us to establish a set of criteria that maximised data fidelity. Finally, we demonstrated the viability of the primers and the protocols, by compiling a full Dinornis microsatellite dataset representing fossils of c. 600-5000 years of age. A multi-locus genotype was obtained from 74 individuals (84% success rate), and the data showed no signs of being compromised by allelic dropout. The methodology presented here provides a framework by which to generate and evaluate microsatellite data from samples of much greater antiquity than attempted before, and opens new opportunities for ancient DNA research.	[Allentoft, Morten E.; Oskam, Charlotte; Houston, Jayne; Bunce, Michael] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Perth, WA, Australia; [Allentoft, Morten E.; Hale, Marie L.; Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Gilbert, M. Thomas P.; Rasmussen, Morten; Willerslev, Eske] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Spencer, Peter] Murdoch Univ, Sch Biol Sci & Biotechnol, Wildlife Identificat Lab, Perth, WA, Australia; [Jacomb, Christopher] Univ Otago, Dept Anthropol, Dunedin, New Zealand; [Holdaway, Richard N.] Palaecol Res Ltd, Christchurch, New Zealand	Murdoch University; University of Canterbury; Murdoch University; University of Otago	Allentoft, ME (corresponding author), Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Perth, WA, Australia.	morten.allentoft@gmail.com; m.bunce@murdoch.edu.au	Willerslev, Eske/AAA-5686-2019; Oskam, Charlotte/N-4097-2018; Gilbert, Marcus TP/A-8936-2013; Spencer, Peter/T-1042-2019; Willerslev, Eske/A-9619-2011	Oskam, Charlotte/0000-0001-8886-2120; Gilbert, Marcus TP/0000-0002-5805-7195; Willerslev, Eske/0000-0002-7081-6748; Bunce, Michael/0000-0002-0302-4206; Allentoft, Morten/0000-0003-4424-3568; Spencer, Peter/0000-0002-4938-2615	Australian Research Council [DP0771971, FT0991741]; Royal Society of New Zealand [09-UOO-164, 06-PAL-001-EEB]	Australian Research Council(Australian Research Council); Royal Society of New Zealand(Royal Society of New Zealand)	Financial support was provided to MB by the Australian Research Council (DP0771971 and FT0991741), The Marsden Fund of the Royal Society of New Zealand (Contracts 09-UOO-164 to CJ, SPAR and 06-PAL-001-EEB to RNH Palaecol Research Ltd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Allentoft ME, 2010, QUATERNARY SCI REV, V29, P753, DOI 10.1016/j.quascirev.2009.11.022; Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Balogh MK, 2003, FORENSIC SCI INT, V137, P188, DOI 10.1016/j.forsciint.2003.07.001; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bourke BP, 2010, CONSERV GENET, V11, P1837, DOI 10.1007/s10592-010-0076-x; Brennan PLR, 2008, MOL ECOL RESOUR, V8, P933, DOI 10.1111/j.1755-0998.2008.02122.x; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Clay C, 2010, CONSERV GENET RESOUR, V2, P301, DOI 10.1007/s12686-010-9211-8; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duckett PE, 2010, CONSERV GENET RESOUR, V2, P349, DOI 10.1007/s12686-010-9248-8; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Huang Y, 2008, CYTOGENET GENOME RES, V121, P130, DOI 10.1159/000125838; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Kimwele CN, 1998, MOL ECOL, V7, P249; Maricic T, 2009, BIOTECHNIQUES, V46, P51, DOI 10.2144/000113042; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Miller CR, 2002, GENETICS, V160, P357; MILLER JM, 2010, CONSERV GENET, DOI DOI 10.1007/S10592-10010-10149-X; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P498, DOI 10.1111/j.1755-0998.2008.02502.x; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Parsons KM, 2001, MOL ECOL NOTES, V1, P341, DOI 10.1046/j.1471-8278.2001.00098.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pertoldi C, 2001, P ROY SOC B-BIOL SCI, V268, P1775, DOI 10.1098/rspb.2001.1762; Petren K, 2010, PHILOS T R SOC B, V365, P1009, DOI 10.1098/rstb.2009.0316; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Roeder AD, 2009, FORENSIC SCI INT-GEN, V3, P128, DOI 10.1016/j.fsigen.2008.12.004; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Sefc KM, 2003, AUK, V120, P982, DOI 10.1642/0004-8038(2003)120[0982:MAFMFS]2.0.CO;2; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tang B, 2003, GENOME, V46, P833, DOI [10.1139/g03-059, 10.1139/G03-059]; Taylor EL, 1999, MOL ECOL, V8, P1963, DOI 10.1046/j.1365-294x.1999.00778-4.x; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Ward WK, 1998, ANIM GENET, V29, P331; Wattier R, 1998, MOL ECOL, V7, P1569, DOI 10.1046/j.1365-294x.1998.00477.x; Whitehouse AM, 2001, MOL ECOL, V10, P2139, DOI 10.1046/j.0962-1083.2001.01356.x; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wood JR, 2008, QUATERNARY SCI REV, V27, P2593, DOI 10.1016/j.quascirev.2008.09.019; Wood Jamie R., 2008, Journal of Taphonomy, V6, P1; Worthy TH, 1996, J ROY SOC NEW ZEAL, V26, P275, DOI 10.1080/03014223.1996.9517514; WORTHY TH, 2002, LOST WORLD MOA; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	59	39	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16670	10.1371/journal.pone.0016670	http://dx.doi.org/10.1371/journal.pone.0016670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304955	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300115
J	Grills, C; Jithesh, PV; Blayney, J; Zhang, SD; Fennell, DA				Grills, Claire; Jithesh, Puthen V.; Blayney, Jaine; Zhang, Shu-Dong; Fennell, Dean A.			Gene Expression Meta-Analysis Identifies VDAC1 as a Predictor of Poor Outcome in Early Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VINORELBINE PLUS CISPLATIN; DEPENDENT ANION CHANNEL; CYTOCHROME-C; PROGNOSTIC VALUE; HEXOKINASE-II; BINDING; MITOCHONDRIA; ACTIVATION; MORTALIN	Background: The bioenergetic status of non-small cell lung cancer correlates with tumour aggressiveness. The voltage dependent anion channel type 1 (VDAC1) is a component of the mitochondrial permeability transition pore, regulates mitochondrial ATP/ADP exchange suggesting that its over-expression could be associated with energy dependent processes including increased proliferation and invasiveness. To test this hypothesis, we conducted an in vivo gene-expression meta-analysis of surgically resected non-small cell lung cancer (NSCLC) using 602 individual expression profiles, to examine the impact of VDAC1 on survival. Methodology/Principal Findings: High VDAC1 expression was associated with shorter overall survival with hazard ratio (HR) = 0.6639 (95% confidence interval (CI) 0.4528 to 0.9721), p = 0.035352 corresponding to 52 versus 101 months. VDAC1 predicted shorter time to recurrence and was shown to be an independent prognostic factor compared with histology, gender, age, nodal stage and tumour stage in a Cox multivariate analysis. Supervised analysis of all the datasets identified a 6-gene signature comprising HNRNPC, HSPA4, HSPA9, UBE2D2, CSNK1A1 and G3BP1 with overlapping functions involving regulation of protein turnover, RAS-RAF-MEK pathway and transcription. VDAC1 predicted survival in breast cancer and myeloma and an unsupervised analysis revealed enrichment of the VDAC1 signature in specific subsets. Conclusions: In summary, gene expression analysis identifies VDAC1 gene expression as a predictor of poor outcome in NSCLC and other cancers and is associated with dysregulation of a conserved set of biological pathways, which may be causally associated with aggressive tumour behaviour.	[Grills, Claire; Jithesh, Puthen V.; Blayney, Jaine; Zhang, Shu-Dong; Fennell, Dean A.] Queens Univ Belfast, Ctr Biomed Informat, Belfast, Antrim, North Ireland; [Fennell, Dean A.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Grills, C (corresponding author), Queens Univ Belfast, Ctr Biomed Informat, Belfast, Antrim, North Ireland.	c.grills@qub.ac.uk	Jithesh, Puthen/O-8573-2015; Zhang, Shu-Dong/G-1269-2010; Jithesh, Puthen Veettil/O-6262-2019	Jithesh, Puthen/0000-0001-7747-0930; Zhang, Shu-Dong/0000-0002-7721-0167; Jithesh, Puthen Veettil/0000-0001-7747-0930	Department of Employment and Learning; Cancer Research United Kingdom	Department of Employment and Learning; Cancer Research United Kingdom(Cancer Research UK)	CG is funded by the Department of Employment and Learning. DAF is funded by Cancer Research United Kingdom on a Clinician Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; [Anonymous], 2010, R LANG ENV STAT COMP; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Dakubo GD, 2006, J CLIN PATHOL, V59, P10, DOI 10.1136/jcp.2005.027664; Dooms C, 2009, J THORAC ONCOL, V4, P822, DOI 10.1097/JTO.0b013e3181a97df7; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Galluzzi L, 2008, ONCOGENE, V27, P4633, DOI 10.1038/onc.2008.114; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hoang JK, 2008, J CLIN ONCOL, V26, P1459, DOI 10.1200/JCO.2007.14.3628; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Kumarswamy R, 2009, MITOCHONDRION, V9, P1, DOI 10.1016/j.mito.2008.10.003; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rho M, 2007, ANTICANCER RES, V27, P251; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumaran SK, 2010, MOL CELL, V37, P768, DOI 10.1016/j.molcel.2010.02.015; Vallieres Eric, 2007, Thorac Surg Clin, V17, P279, DOI 10.1016/j.thorsurg.2007.03.001; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wadhwa R, 2003, BIOCHEM BIOPH RES CO, V302, P735, DOI 10.1016/S0006-291X(03)00226-2; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang HZ, 2007, WORLD J GASTROENTERO, V13, P4126, DOI 10.3748/wjg.v13.i30.4126; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; [No title captured]; [No title captured]	51	41	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14635	10.1371/journal.pone.0014635	http://dx.doi.org/10.1371/journal.pone.0014635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297950	gold, Green Submitted, Green Published			2022-12-27	WOS:000286834300017
J	Pecoraro, V; Zerulla, K; Lange, C; Soppa, J				Pecoraro, Vito; Zerulla, Karolin; Lange, Christian; Soppa, Joerg			Quantification of Ploidy in Proteobacteria Revealed the Existence of Monoploid, (Mero-)Oligoploid and Polyploid Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-CYCLE; REPLICATION; CHROMOSOME; RADIATION; GROWTH; GENE	Bacteria are generally assumed to be monoploid (haploid). This assumption is mainly based on generalization of the results obtained with the most intensely studied model bacterium, Escherichia coli (a gamma-proteobacterium), which is monoploid during very slow growth. However, several species of proteobacteria are oligo- or polyploid, respectively. To get a better overview of the distribution of ploidy levels, genome copy numbers were quantified in four species of three different groups of proteobacteria. A recently developed Real Time PCR approach, which had been used to determine the ploidy levels of halophilic archaea, was optimized for the quantification of genome copy numbers of bacteria. Slow-growing (doubling time 103 minutes) and fast-growing (doubling time 25 minutes) E. coli cultures were used as a positive control. The copy numbers of the origin and terminus region of the chromosome were determined and the results were in excellent agreement with published data. The approach was also used to determine the ploidy levels of Caulobacter crescentus (an alpha-proteobacterium) and Wolinella succinogenes (an epsilon-proteobacterium), both of which are monoploid. In contrast, Pseudomonas putida (a gamma-proteobacterium) contains 20 genome copies and is thus polyploid. A survey of the proteobacteria with experimentally-determined genome copy numbers revealed that only three to four of 11 species are monoploid and thus monoploidy is not typical for proteobacteria. The ploidy level is not conserved within the groups of proteobacteria, and there are no obvious correlations between the ploidy levels with other parameters like genome size, optimal growth temperature or mode of life.	[Pecoraro, Vito; Zerulla, Karolin; Lange, Christian; Soppa, Joerg] Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, Frankfurt, Germany	Goethe University Frankfurt	Pecoraro, V (corresponding author), Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, Frankfurt, Germany.	Soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840	German Research Council (DFG) [So264/16-1]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Council (DFG), Project So264/16-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; BREMER H, 1996, ESCHERIA COLI SALMON; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; HELMSTETTER CH, 1996, ESCHERIA COLI SALMON; Hildenbrand C, 2011, J BACTERIOL, V193, P734, DOI 10.1128/JB.01016-10; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Kern M, 2009, BBA-BIOENERGETICS, V1787, P646, DOI 10.1016/j.bbabio.2008.12.010; KITTEN T, 1992, GENETICS, V132, P311; Komaki K, 2000, INSECT BIOCHEM MOLEC, V30, P253, DOI 10.1016/S0965-1748(99)00125-3; KROGER A, 1994, CHROMATOFOCUSSING PR, P141; Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346; Mackwan RR, 2007, GENETICS, V176, P697, DOI 10.1534/genetics.106.069666; MALDONADO R, 1994, J BACTERIOL, V176, P3911, DOI 10.1128/JB.176.13.3911-3919.1994; MALDONADO R, 1992, GENETICS, V132, P869; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Nodop A, 2008, PLANT PHYSIOL, V147, P747, DOI 10.1104/pp.107.114058; POSTGATE JR, 1984, J GEN MICROBIOL, V130, P1597; Riddle NC, 2010, THEOR APPL GENET, V120, P341, DOI 10.1007/s00122-009-1113-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; SKARSTAD K, 1983, J BACTERIOL, V154, P656, DOI 10.1128/JB.154.2.656-662.1983; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Spence E, 2004, J BIOL CHEM, V279, P55792, DOI 10.1074/jbc.M411041200; Suh MH, 2000, GENETICA, V110, P101, DOI 10.1023/A:1017976920135; Takahama K, 2004, PLANT CELL PHYSIOL, V45, P333, DOI 10.1093/pcp/pch041; Thanbichler M, 2009, CURR OPIN MICROBIOL, V12, P715, DOI 10.1016/j.mib.2009.09.013; Tobiason DM, 2006, PLOS BIOL, V4, P1069, DOI 10.1371/journal.pbio.0040185; Tobiason DM, 2010, J BACTERIOL, V192, P2160, DOI 10.1128/JB.01593-09; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	38	63	65	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16392	10.1371/journal.pone.0016392	http://dx.doi.org/10.1371/journal.pone.0016392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305010	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300060
J	Yang, Y; Dai, M; Wilson, TM; Omelchenko, I; Klimek, JE; Wilmarth, PA; David, LL; Nuttall, AL; Gillespie, PG; Shi, XR				Yang, Yue; Dai, Min; Wilson, Teresa M.; Omelchenko, Irina; Klimek, John E.; Wilmarth, Phillip A.; David, Larry L.; Nuttall, Alfred L.; Gillespie, Peter G.; Shi, Xiaorui			Na+/K+-ATPase alpha 1 Identified as an Abundant Protein in the Blood-Labyrinth Barrier That Plays an Essential Role in the Barrier Integrity	PLOS ONE			English	Article							COCHLEAR LATERAL WALL; TIGHT JUNCTION FORMATION; KIDNEY EPITHELIAL-CELLS; AMINO-ACID-SEQUENCE; QUIET-AGED GERBILS; STRIA VASCULARIS; NOISE EXPOSURE; KINASE-C; OCCLUDIN PHOSPHORYLATION; NA,K-ATPASE ACTIVITY	Background: The endothelial-blood/tissue barrier is critical for maintaining tissue homeostasis. The ear harbors a unique endothelial-blood/tissue barrier which we term "blood-labyrinth-barrier". This barrier is critical for maintaining inner ear homeostasis. Disruption of the blood-labyrinth-barrier is closely associated with a number of hearing disorders. Many proteins of the blood-brain-barrier and blood-retinal-barrier have been identified, leading to significant advances in understanding their tissue specific functions. In contrast, capillaries in the ear are small in volume and anatomically complex. This presents a challenge for protein analysis studies, which has resulted in limited knowledge of the molecular and functional components of the blood-labyrinth-barrier. In this study, we developed a novel method for isolation of the stria vascularis capillary from CBA/CaJ mouse cochlea and provided the first database of protein components in the blood-labyrinth barrier as well as evidence that the interaction of Na+/K+-ATPase alpha 1 (ATP1A1) with protein kinase C eta (PKC eta) and occludin is one of the mechanisms of loud sound-induced vascular permeability increase. Methodology/Principal Findings: Using a mass-spectrometry, shotgun-proteomics approach combined with a novel "sandwich-dissociation" method, more than 600 proteins from isolated stria vascularis capillaries were identified from adult CBA/CaJ mouse cochlea. The ion transporter ATP1A1 was the most abundant protein in the blood-labyrinth barrier. Pharmacological inhibition of ATP1A1 activity resulted in hyperphosphorylation of tight junction proteins such as occludin which increased the blood-labyrinth-barrier permeability. PKC eta directly interacted with ATP1A1 and was an essential mediator of ATP1A1-initiated occludin phosphorylation. Moreover, this identified signaling pathway was involved in the breakdown of the blood-labyrinth-barrier resulting from loud sound trauma. Conclusions/Significance: The results presented here provide a novel method for capillary isolation from the inner ear and the first database on protein components in the blood-labyrinth-barrier. Additionally, we found that ATP1A1 interaction with PKC eta and occludin was involved in the integrity of the blood-labyrinth-barrier.	[Yang, Yue; Dai, Min; Wilson, Teresa M.; Omelchenko, Irina; Nuttall, Alfred L.; Gillespie, Peter G.; Shi, Xiaorui] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA; [Nuttall, Alfred L.; Shi, Xiaorui] Shanghai Jiao Tong Univ, Renji Hosp, Dept Otolaryngol, Shanghai 200030, Peoples R China; [Shi, Xiaorui] Chinese Acad Med Sci, Inst Microcirculat, Beijing 100037, Peoples R China; [Shi, Xiaorui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gillespie, Peter G.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; University of Michigan System; University of Michigan; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Oregon Health & Science University	Yang, Y (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	shix@ohsu.edu	Dai, Min/B-9908-2012	Barr-Gillespie, Peter/0000-0002-9787-5860	National Institutes of Health [R03-DC008888, R01-NIDCD DC010844, R01-DC000105, P30-DC005983]; Oregon Opportunity funds; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000105, R01DC010844, R03DC008888, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Opportunity funds; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants R03-DC008888 (X.S.), R01-NIDCD DC010844 (X.S.), R01-DC000105 (A.L.N.), P30-DC005983, and Oregon Opportunity funds to the Oregon Health & Science University Proteomics Shared Resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1980, NATURE, V287, P235, DOI 10.1038/287235a0; Calabria AR, 2006, DRUG DISCOV TODAY, V11, P792, DOI 10.1016/j.drudis.2006.07.006; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Clifford RE, 2009, ANN OTO RHINOL LARYN, V118, P417, DOI 10.1177/000348940911800604; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; DOI K, 1992, ACTA OTO-LARYNGOL, V112, P667, DOI 10.3109/00016489209137457; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; EISENBERG HM, 1979, SCIENCE, V206, P1083, DOI 10.1126/science.227060; Fechter LD, 2007, TOXICOL SCI, V98, P510, DOI 10.1093/toxsci/kfm101; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GRATTON MA, 1995, HEARING RES, V82, P44; GRATTON MA, 1995, HEARING RES, V83, P43, DOI 10.1016/0378-5955(94)00188-V; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hirose K, 2003, JARO, V4, P339, DOI 10.1007/s10162-002-3036-4; Hsu CJ, 2000, HEARING RES, V142, P203, DOI 10.1016/S0378-5955(00)00020-4; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Juhn S K, 2001, Int Tinnitus J, V7, P72; JUHN SK, 1981, ACTA OTO-LARYNGOL, V91, P529, DOI 10.3109/00016488109138538; Klein M, 2008, INFECTION, V36, P2, DOI 10.1007/s15010-007-7153-1; Lamm K, 1996, Audiol Neurootol, V1, P148; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Lin DW, 1997, OTOLARYNG HEAD NECK, V117, P530, DOI 10.1016/S0194-5998(97)70026-3; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McFadden Sandra L., 2001, Noise Health, V3, P49; Minami SB, 2007, BRAIN RES, V1148, P83, DOI 10.1016/j.brainres.2007.02.021; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Motoyama A, 2008, ANAL CHEM, V80, P7187, DOI 10.1021/ac8013669; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; Musch MW, 2006, AM J PHYSIOL-GASTR L, V290, pG222, DOI 10.1152/ajpgi.00301.2005; Muto S, 2000, KIDNEY INT, V57, P1617, DOI 10.1046/j.1523-1755.2000.00006.x; Nuttall Alfred L., 1999, Noise Health, V2, P17; Ohlemiller KK, 2008, HEARING RES, V245, P5, DOI 10.1016/j.heares.2008.08.007; OSADA S, 1990, J BIOL CHEM, V265, P22434; Pottiez G, 2009, BRAIN RES REV, V62, P83, DOI 10.1016/j.brainresrev.2009.09.004; Rajasekaran AK, 2003, ANN NY ACAD SCI, V986, P649, DOI 10.1111/j.1749-6632.2003.tb07276.x; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2007, AM J PHYSIOL-GASTR L, V292, pG124, DOI 10.1152/ajpgi.00297.2006; SANTI PA, 1978, OTOLARYNG HEAD NECK, V86, P354, DOI 10.1177/019459987808600229; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Shi XR, 2009, AM J PATHOL, V174, P1692, DOI 10.2353/ajpath.2009.080739; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; Skou JC, 2004, BIOSCIENCE REP, V24, P436, DOI 10.1007/s10540-005-2740-9; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Stockwin LH, 2006, J PROTEOME RES, V5, P2996, DOI 10.1021/pr0601739; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Suzuki M, 2002, HEARING RES, V164, P12, DOI 10.1016/S0378-5955(01)00397-5; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Takeuchi S, 2001, HEARING RES, V155, P103, DOI 10.1016/S0378-5955(01)00252-0; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x	55	88	98	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16547	10.1371/journal.pone.0016547	http://dx.doi.org/10.1371/journal.pone.0016547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304972	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300082
J	Barbu, S; Cabanes, G; Le Maner-Idrissi, G				Barbu, Stephanie; Cabanes, Guenael; Le Maner-Idrissi, Gaid			Boys and Girls on the Playground: Sex Differences in Social Development Are Not Stable across Early Childhood	PLOS ONE			English	Article							FETAL TESTOSTERONE; GENDER-DIFFERENCES; TYPED BEHAVIOR; PLAY; CHILDREN; PRETEND	Sex differences in human social behaviors and abilities have long been a question of public and scientific interest. Females are usually assumed to be more socially oriented and skilful than males. However, despite an extensive literature, the very existence of sex differences remains a matter of discussion while some studies found no sex differences whereas others reported differences that were either congruent or not with gender stereotypes. Moreover, the magnitude, consistency and stability across time of the differences remain an open question, especially during childhood. As play provides an excellent window into children's social development, we investigated whether and how sex differences change in social play across early childhood. Following a cross-sectional design, 164 children aged from 2 to 6 years old, divided into four age groups, were observed during outdoor free play at nursery school. We showed that sex differences are not stable over time evidencing a developmental gap between girls and boys. Social and structured forms of play emerge systematically earlier in girls than in boys leading to subsequent sex differences in favor of girls at some ages, successively in associative play at 3-4 years, cooperative play at 4-5 years, and social interactions with peers at 5-6 years. Preschool boys also display more solitary play than preschool girls, especially when young. Nevertheless, while boys catch up and girls move on towards more complex play, sex differences in social play patterns are reversed in favor of boys at the following ages, such as in associative play at 4-5 years and cooperative play at 5-6 years. This developmental perspective contributes to resolve apparent discrepancies between single-snapshot studies. A better understanding of the dynamics of sex differences in typical social development should also provide insights into atypical social developments which exhibit sex differences in prevalence, such as autism.	[Barbu, Stephanie; Cabanes, Guenael] Univ Rennes 1, Lab EthoS Ethol Anim & Humaine, CNRS, UMR 6552, Rennes, France; [Le Maner-Idrissi, Gaid] Univ Rennes 2, Ctr Rech Psychol Cognit & Commun, Lab Psychol Dev & Educ, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Universite Rennes 2	Barbu, S (corresponding author), Univ Rennes 1, Lab EthoS Ethol Anim & Humaine, CNRS, UMR 6552, Rennes, France.	stephanie.barbu@univ-rennes1.fr	Cabanes, Guénaël/H-3109-2013	Cabanes, Guénaël/0000-0002-8225-7242	French National Agency of Research; Young Researchers Program	French National Agency of Research(French National Research Agency (ANR)); Young Researchers Program	This research was funded by the French National Agency of Research with the Young Researchers Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Berenbaum SA, 2008, SEX DIFFERENCES BRAI, P275; Blakemore J., 2009, GENDER DEV; Bornstein M.H., 2004, FIRST LANG, V24, P267, DOI [10.1177/0142723704045681, DOI 10.1177/0142723704045681]; BRENNER M, 1979, INSTR SCI, V8, P91, DOI 10.1007/BF00054984; Charman T, 2002, SOC DEV, V11, P1, DOI 10.1111/1467-9507.00183; Cherney I.D., 2003, ED PSYCHOL, V23, P95, DOI [10.1080/01443410303222, DOI 10.1080/01443410303222]; Colwell MJ, 2005, SEX ROLES, V52, P497, DOI 10.1007/s11199-005-3716-8; Connellan J, 2000, INFANT BEHAV DEV, V23, P113, DOI 10.1016/S0163-6383(00)00032-1; Coplan R. J., 2008, HDB PEER INTERACTION, P143; Coplan Robert J., 2006, PLAY BIRTH 12 CONTEX, P75; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Fromberg D.P., 2006, PLAY BIRTH 12 CONTEX; Galsworthy MJ, 2000, DEVELOPMENTAL SCI, V3, P206, DOI 10.1111/1467-7687.00114; Golombok S, 2008, CHILD DEV, V79, P1583, DOI 10.1111/j.1467-8624.2008.01207.x; Goncu A., 2007, PLAY DEV EVOLUTIONAR; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; HARRIS PL, 2006, COGNITION PERCEPTION, P811; HITTELMAN JH, 1979, MERRILL PALMER QUART, V25, P171; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; HOWES C, 1992, DEV PSYCHOL, V28, P961, DOI 10.1037/0012-1649.28.5.961; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; Iervolino AC, 2005, CHILD DEV, V76, P826, DOI 10.1111/j.1467-8624.2005.00880.x; Jadva V, 2010, ARCH SEX BEHAV, V39, P1261, DOI 10.1007/s10508-010-9618-z; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Leaper C, 2004, DEV PSYCHOL, V40, P993, DOI 10.1037/0012-1649.40.6.993; Leeb RT, 2004, SEX ROLES, V50, P1, DOI 10.1023/B:SERS.0000011068.42663.ce; Lippa Richard A., 2005, GENDER NATURE NURTUR, V2nd, DOI 10.4324/9781410612946; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P319, DOI 10.1016/S0163-6383(02)00095-4; Lutchmaya S, 2002, INFANT BEHAV DEV, V24, P418; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; MACCOBY EE, 1990, AM PSYCHOL, V45, P513, DOI 10.1037/0003-066X.45.4.513; Martin CL, 2001, DEV PSYCHOL, V37, P431, DOI 10.1037//0012-1649.37.3.431; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Mehl MR, 2007, SCIENCE, V317, P82, DOI 10.1126/science.1139940; MORISSET CE, 1995, DEV PSYCHOL, V31, P851, DOI 10.1037/0012-1649.31.5.851; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; Nagy E, 2007, INFANT CHILD DEV, V16, P267, DOI 10.1002/icd.497; Parten MB, 1932, J ABNORM SOC PSYCH, V27, P243, DOI 10.1037/h0074524; Pellegrini A. D., 1998, CHILD PSYCHOL PSYCHI, V3, P51, DOI [10.1017/S1360641798001476, 10.1111/1475-3588.00212, DOI 10.1111/1475-3588.00212]; Robinson CC, 2003, EARLY CHILD RES Q, V18, P3, DOI 10.1016/S0885-2006(03)00003-6; Rubin K.H., 2006, HDB CHILD PSYCHOL, P571, DOI 10.1002/9780470147658.chpsy0310; Ruble D. N., 2006, HDB CHILD PSYCHOL SO, P858; Smith P., 2007, CONTRIBUTION WORKING; Walker S, 2005, J GENET PSYCHOL, V166, P297, DOI 10.3200/GNTP.166.3.297-312; Walker S, 2002, J GENET PSYCHOL, V163, P197, DOI 10.1080/00221320209598677; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001	51	53	53	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16407	10.1371/journal.pone.0016407	http://dx.doi.org/10.1371/journal.pone.0016407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JX	21297987	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100028
J	Ding, H; Tsai, CG; Gutierrez, RA; Zhou, F; Buchy, P; Deubel, V; Zhou, P				Ding, Heng; Tsai, Cheguo; Gutierrez, Ramona Alikiiteaga; Zhou, Fan; Buchy, Philippe; Deubel, Vincent; Zhou, Paul			Superior Neutralizing Antibody Response and Protection in Mice Vaccinated with Heterologous DNA Prime and Virus Like Particle Boost against HPAI H5N1 Virus	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; LETHAL CHALLENGE; GENE DELIVERY; A VIRUS; IMMUNOGENICITY; IMMUNITY; FERRETS; VECTOR; SAFETY; IMMUNIZATION	Background: Although DNA plasmid and virus-like particle (VLP) vaccines have been individually tested against highly pathogenic avian influenza (HPAI) H5N1 viruses, the combination of both vaccines into a heterologous prime-boost strategy against HPAI H5N1 viruses has not been reported before. Methodology/Principal Findings: We constructed DNA plasmid encoding H5HA (A/Shenzhen/406H/06, subclade 2.3.4) and generated VLP expressing the same H5HA and N1NA. We then compared neutralizing antibody responses and immune protection elicited with heterologous DNA-VLP, homologous DNA-DNA and VLP-VLP prime-boost strategies against HPAI H5N1 viruses in mice. We demonstrate that DNA-VLP elicits the highest neutralizing antibody titers among the three prime-boost strategies, whereas DNA-DNA elicits higher neutralizing antibody titers than VLP-VLP. We show that although all three prime-boost strategies protect mice from death caused by 10 MLD50 of homologous and heterologous H5N1 challenge, only DNA-VLP and DNA-DNA protect mice from infection as manifested by no weight loss and no lung pathology. In addition, we show that although DNA-VLP and DNA-DNA protect mice from death caused by 1,000 MLD50 of homologous H5N1 challenge, only DNA-VLP protects mice from infection. Moreover, we show that after 1,000 MLD50 of heterologous H5N1 challenge, while all mice in PBS, VLP-VLP and DNA-DNA died, 3 of 6 mice in DNA-VLP actually survived. Finally, we show that DNA-VLP completely protects mice from infection after 1,000 MLD50 of homologous H5N1 challenge even when the challenge was administrated at 60 days post the boost. Conclusions/Significance: These results provide strong support for clinical evaluation of heterologous DNA-VLP prime-boost strategy as a public health intervention against a possible H5N1 pandemic.	[Ding, Heng; Tsai, Cheguo; Zhou, Fan; Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Gutierrez, Ramona Alikiiteaga; Buchy, Philippe; Deubel, Vincent] Inst Pasteur Cambodia, Phnom Penh, Cambodia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Ding, H (corresponding author), Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China.	blzhou@sibs.ac.cn	Cai, Cheguo/K-3747-2019	Zhou, Fan/0000-0001-9918-3422; BUCHY, Philippe/0000-0003-1372-3008	French Ministry of Health; Chinese National Science Foundation [30671922]; National Science and Technology Major Projects [2008ZX10001-010, 2009ZX10004-105, 2009ZX10004-016]; Li Ka-Shing Foundation of Hong Kong; EC (RIVERS)	French Ministry of Health; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; Li Ka-Shing Foundation of Hong Kong; EC (RIVERS)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by research grants from the French Ministry of Health, the Chinese National Science Foundation (#30671922), National Science and Technology Major Projects (#2008ZX10001-010; #2009ZX10004-105; #2009ZX10004-016), the Li Ka-Shing Foundation of Hong Kong and the EC (RIVERS). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Bot Adrian, 1997, Frontiers in Bioscience (online), V2, pD173; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bublot M, 2007, AVIAN DIS, V51, P498, DOI 10.1637/7624-042706R.1; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Bukreyev A, 2005, J VIROL, V79, P13275, DOI 10.1128/JVI.79.21.13275-13284.2005; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Crevar CJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-131; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gonzalez-Fernandez A, 1998, IMMUNOLOGY, V93, P149; Gutierrez RA, 2009, VIRUSES-BASEL, V1, P335, DOI 10.3390/v1030335; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Ikeno D, 2009, VACCINE, V27, P3121, DOI 10.1016/j.vaccine.2009.01.007; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Lu XH, 2006, VACCINE, V24, P6588, DOI 10.1016/j.vaccine.2006.05.039; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pan ZM, 2010, CLIN VACCINE IMMUNOL, V17, P518, DOI 10.1128/CVI.00387-09; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 1999, VACCINE, V17, P1355, DOI 10.1016/S0264-410X(98)00390-9; Sabarth N, 2010, VACCINE, V28, P650, DOI 10.1016/j.vaccine.2009.10.105; Sharpe M, 2007, VACCINE, V25, P6392, DOI 10.1016/j.vaccine.2007.06.009; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Steensels M, 2009, VACCINE, V27, P646, DOI 10.1016/j.vaccine.2008.11.044; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Szecsi J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-70; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tsai CG, 2009, VACCINE, V27, P6777, DOI 10.1016/j.vaccine.2009.08.056; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; World Health Organization, CUM NUMB CONF HUM CA; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	50	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16563	10.1371/journal.pone.0016563	http://dx.doi.org/10.1371/journal.pone.0016563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305045	Green Published, gold			2022-12-27	WOS:000286664100043
J	Keller, B; Yang, T; Chen, YQ; Munivez, E; Bertin, T; Zabel, B; Lee, B				Keller, Bettina; Yang, Tao; Chen, Yuqing; Munivez, Elda; Bertin, Terry; Zabel, Bernhard; Lee, Brendan			Interaction of TGF beta and BMP Signaling Pathways during Chondrogenesis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN-2; CHONDROCYTE DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; EXPRESSION PATTERNS; TRANSGENIC MICE; II RECEPTOR; LONG BONES; MOUSE; CARTILAGE	TGF beta and BMP signaling pathways exhibit antagonistic activities during the development of many tissues. Although the crosstalk between BMP and TGF beta signaling pathways is well established in bone development, the relationship between these two pathways is less well defined during cartilage development and postnatal homeostasis. We generated hypomorphic mouse models of cartilage-specific loss of BMP and TGF beta signaling to assess the interaction of these pathways in postnatal growth plate homeostasis. We further used the chondrogenic ATDC5 cell line to test effects of BMP and TGF beta signaling on each other's downstream targets. We found that conditional deletion of Smad1 in chondrocytes resulted in a shortening of the growth plate. The addition of Smad5 haploinsufficiency led to a more severe phenotype with shorter prehypertrophic and hypertrophic zones and decreased chondrocyte proliferation. The opposite growth plate phenotype was observed in a transgenic mouse model of decreased chondrocytic TGF beta signaling that was generated by expressing a dominant negative form of the TGF beta receptor I (Delta T beta RI) in cartilage. Histological analysis demonstrated elongated growth plates with enhanced lhh expression, as well as an increased proliferation rate with altered production of extracellular matrix components. In contrast, in chondrogenic ATDC5 cells, TGF beta was able to enhance BMP signaling, while BMP2 significantly reduces levels of TGF signaling. In summary, our data demonstrate that during endochondral ossification, BMP and TGF beta signaling can have antagonistic effects on chondrocyte proliferation and differentiation in vivo. We also found evidence of direct interaction between the two signaling pathways in a cell model of chondrogenesis in vitro.	[Keller, Bettina; Yang, Tao; Chen, Yuqing; Munivez, Elda; Bertin, Terry; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zabel, Bernhard] Univ Hosp Freiburg, Ctr Pediat & Adolescence Med, Freiburg, Germany	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Freiburg	Keller, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.tmc.edu			Deutsche Forschungsgemeinschaft DFG [Za96/10-2/3]; National Institutes of Health [DE016990, HD22657, ES11253]; Rolanette and Berdon Bone Disease Program of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rolanette and Berdon Bone Disease Program of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Deutsche Forschungsgemeinschaft DFG Za96/10-2/3 (B.Z.), by the National Institutes of Health DE016990 (BL), HD22657 (BL), ES11253 (BL) and by the Rolanette and Berdon Bone Disease Program of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen Y, 2002, FEBS LETT, V517, P277, DOI 10.1016/S0014-5793(02)02648-0; Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Faucheux C, 1997, BIOCHEM BIOPH RES CO, V241, P787, DOI 10.1006/bbrc.1997.7792; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; GATHERER D, 1990, DEVELOPMENT, V110, P445; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hsiao YC, 2004, GENESIS, V39, P122, DOI 10.1002/gene.20038; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mehlhorn AT, 2007, CELL PROLIFERAT, V40, P809, DOI 10.1111/j.1365-2184.2007.00473.x; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Minina E, 2001, DEVELOPMENT, V128, P4523; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Morello R, 2008, J CELL PHYSIOL, V217, P127, DOI 10.1002/jcp.21483; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEVELOPMENT, V110, P609; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Sakou T, 1999, J BONE MINER RES, V14, P1145, DOI 10.1359/jbmr.1999.14.7.1145; SANDBERG M, 1988, DEV BIOL, V130, P324, DOI 10.1016/0012-1606(88)90438-1; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Song B, 2009, CYTOKINE GROWTH F R, V20, P379, DOI 10.1016/j.cytogfr.2009.10.010; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yang T, 2010, J CLIN INVEST, V120, P2474, DOI 10.1172/JCI42150; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yew KH, 2005, J BIOL CHEM, V280, P32209, DOI 10.1074/jbc.M505465200; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; ZHOU G, 1995, J CELL SCI, V108, P3677; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	47	103	111	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16421	10.1371/journal.pone.0016421	http://dx.doi.org/10.1371/journal.pone.0016421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297990	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100031
J	Berger, T; Pfeifer, B; Hanser, FF; Hintringer, F; Fischer, G; Netzer, M; Trieb, T; Stuehlinger, M; Dichtl, W; Baumgartner, C; Pachinger, O; Seger, M				Berger, Thomas; Pfeifer, Bernhard; Hanser, Friedrich F.; Hintringer, Florian; Fischer, Gerald; Netzer, Michael; Trieb, Thomas; Stuehlinger, Markus; Dichtl, Wolfgang; Baumgartner, Christian; Pachinger, Otmar; Seger, Michael			Single-Beat Noninvasive Imaging of Ventricular Endocardial and Epicardial Activation in Patients Undergoing CRT	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; CARDIAC-RESYNCHRONIZATION THERAPY; HEART-FAILURE; MODEL; ELECTROPHYSIOLOGY; ATRIAL	Background: Little is known about the effect of cardiac resynchronization therapy (CRT) on endo-and epicardial ventricular activation. Noninvasive imaging of cardiac electrophysiology (NICE) is a novel imaging tool for visualization of both epi- and endocardial ventricular electrical activation. Methodology/Principal Findings: NICE was performed in ten patients with congestive heart failure (CHF) undergoing CRT and in ten patients without structural heart disease (control group). NICE is a fusion of data from high-resolution ECG mapping with a model of the patient's individual cardiothoracic anatomy created from magnetic resonance imaging. Beat-to-beat endocardial and epicardial ventricular activation sequences were computed during native rhythm as well as during ventricular pacing using a bidomain theory-based heart model to solve the related inverse problem. During right ventricular (RV) pacing control patients showed a deterioration of the ventricular activation sequence similar to the intrinsic activation pattern of CHF patients. Left ventricular propagation velocities were significantly decreased in CHF patients as compared to the control group (1.6 +/- 0.4 versus 2.1 +/- 0.5 m/sec; p<0.05). CHF patients showed right-to-left septal activation with the latest activation epicardially in the lateral wall of the left ventricle. Biventricular pacing resulted in a resynchronization of the ventricular activation sequence and in a marked decrease of total LV activation duration as compared to intrinsic conduction and RV pacing (129 +/- 16 versus 157 +/- 28 and 173 +/- 25 ms; both p<0.05). Conclusions/Significance: Endocardial and epicardial ventricular activation can be visualized noninvasively by NICE. Identification of individual ventricular activation properties may help identify responders to CRT and to further improve response to CRT by facilitating a patient-specific lead placement and device programming.	[Berger, Thomas; Hintringer, Florian; Stuehlinger, Markus; Dichtl, Wolfgang; Pachinger, Otmar] Med Univ Innsbruck, Div Cardiol, Dept Internal Med 3, Innsbruck, Austria; [Pfeifer, Bernhard; Hanser, Friedrich F.; Fischer, Gerald; Netzer, Michael; Baumgartner, Christian; Seger, Michael] Univ Hlth Sci Med Informat & Technol UMIT, Inst Elect Elect & Bioengn, Hall In Tirol, Austria; [Trieb, Thomas] Med Univ Innsbruck, Dept Radiol 1, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Berger, T (corresponding author), Med Univ Innsbruck, Div Cardiol, Dept Internal Med 3, Innsbruck, Austria.	thomas.berger@uki.at	Berger, Thomas U/HGA-3594-2022; Dichtl, Wolfgang/H-7128-2017	Dichtl, Wolfgang/0000-0002-0421-2110; Netzer, Michael/0000-0001-7536-9257; Baumgartner, Christian/0000-0002-3763-5195; Fischer, Gerald/0000-0002-7292-2333; Pfeifer, Bernhard/0000-0003-1507-1015	Austrian Science Fund (FWF, Fonds zur Forderung der wissenschaftlichen Forschung) [START Y144]; Oesterreichische Nationalbank Jubilaumsfond [11183]; European Heart Rhythm Association (European Society of Cardiology)	Austrian Science Fund (FWF, Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Oesterreichische Nationalbank Jubilaumsfond; European Heart Rhythm Association (European Society of Cardiology)	This study was financially supported by the Austrian Science Fund (FWF, Fonds zur Forderung der wissenschaftlichen Forschung), Grant START Y144 and by Oesterreichische Nationalbank Jubilaumsfond (Jubilaumsfondsprojekt Nr. 11183). TB received an one year EP-fellowship grant from the European Heart Rhythm Association (European Society of Cardiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors state, in accordance with their funders, that they agree to the PLoS ONE policies on sharing data and materials.	Agricola E, 2006, HEART, V92, P1390, DOI 10.1136/hrt.2005.082115; Aiba T, 2009, CIRCULATION, V119, P1220, DOI 10.1161/CIRCULATIONAHA.108.794834; Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; Berger T, 2005, J CARDIOVASC ELECTR, V16, P611, DOI 10.1046/j.1540-8167.2005.40496.x; Berger T, 2006, J AM COLL CARDIOL, V48, P2045, DOI 10.1016/j.jacc.2006.08.019; Breithardt OA, 2003, J AM COLL CARDIOL, V42, P486, DOI 10.1016/S0735-1097(03)00709-5; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cheng LK, 2003, IEEE T BIO-MED ENG, V50, P11, DOI 10.1109/TBME.2002.807326; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Fantoni C, 2005, J CARDIOVASC ELECTR, V16, P112, DOI 10.1046/j.1540-8167.2005.40777.x; Fischer G, 2005, METHOD INFORM MED, V44, P674; Fischer G, 2002, IEEE T BIO-MED ENG, V49, P217, DOI 10.1109/10.983455; Fish JM, 2005, J AM COLL CARDIOL, V46, P2340, DOI 10.1016/j.jacc.2005.08.035; GREENSITE F, 1993, IEEE T BIO-MED ENG, V40, P1210, DOI 10.1109/10.250576; Han CZ, 2008, IEEE T MED IMAGING, V27, P1622, DOI 10.1109/TMI.2008.929094; Hayes JJ, 2006, J AM COLL CARDIOL, V48, P1628, DOI 10.1016/j.jacc.2006.05.071; Huiskamp G, 1997, IEEE T BIO-MED ENG, V44, P433, DOI 10.1109/10.581930; Lambiase PD, 2004, HEART, V90, P44, DOI 10.1136/heart.90.1.44; Modre R, 2003, J CARDIOVASC ELECTR, V14, P712, DOI 10.1046/j.1540-8167.2003.02558.x; Pfeifer B, 2006, METHOD INFORM MED, V45, P19; Ramanathan C, 2004, NAT MED, V10, P422, DOI 10.1038/nm1011; Ritter P, 1999, EUROPACE, V1, P126, DOI 10.1053/eupc.1998.0032; Rodriguez LM, 2003, J CARDIOVASC ELECTR, V14, P135, DOI 10.1046/j.1540-8167.2003.02421.x; Tilg B, 2002, IEEE T MED IMAGING, V21, P1031, DOI 10.1109/TMI.2002.804438	24	31	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16255	10.1371/journal.pone.0016255	http://dx.doi.org/10.1371/journal.pone.0016255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298045	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900026
J	Fierro-Gonzalez, JC; Cornils, A; Alcedo, J; Miranda-Vizuete, A; Swoboda, P				Fierro-Gonzalez, Juan Carlos; Cornils, Astrid; Alcedo, Joy; Miranda-Vizuete, Antonio; Swoboda, Peter			The Thioredoxin TRX-1 Modulates the Function of the Insulin-Like Neuropeptide DAF-28 during Dauer Formation in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; SITE-DIRECTED MUTAGENESIS; C-ELEGANS; LARVAL DEVELOPMENT; LIFE-SPAN; CHEMOSENSORY NEURONS; GENETIC-ANALYSIS; LONGEVITY; EXPRESSION; HOMOLOG	Thioredoxins comprise a conserved family of redox regulators involved in many biological processes, including stress resistance and aging. We report that the C. elegans thioredoxin TRX-1 acts in ASJ head sensory neurons as a novel modulator of the insulin-like neuropeptide DAF-28 during dauer formation. We show that increased formation of stress-resistant, long-lived dauer larvae in mutants for the gene encoding the insulin-like neuropeptide DAF-28 requires TRX-1 acting in ASJ neurons, upstream of the insulin-like receptor DAF-2. Genetic rescue experiments demonstrate that redox-independent functions of TRX-1 specifically in ASJ neurons are needed for the dauer formation constitutive (Daf-c) phenotype of daf-28 mutants. GFP reporters of trx-1 and daf-28 show opposing expression patterns in dauers (i.e. trx-1 is up-regulated and daf-28 is down-regulated), an effect that is not observed in growing L2/L3 larvae. In addition, functional TRX-1 is required for the down-regulation of a GFP reporter of daf-28 during dauer formation, a process that is likely subject to DAF-28-mediated feedback regulation. Our findings demonstrate that TRX-1 modulates DAF-28 signaling by contributing to the down-regulation of daf-28 expression during dauer formation. We propose that TRX-1 acts as a fluctuating neuronal signaling modulator within ASJ neurons to monitor the adjustment of neuropeptide expression, including insulin-like proteins, during dauer formation in response to adverse environmental conditions.	[Fierro-Gonzalez, Juan Carlos; Swoboda, Peter] Karolinska Inst, Ctr Biosci NOVUM, Dept Biosci & Nutr, Huddinge, Sweden; [Cornils, Astrid; Alcedo, Joy] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Miranda-Vizuete, Antonio] Univ Pablo de Olavide, CABD CSIC, Dept Fisiol Anat & Biol Celular, Seville, Spain; [Miranda-Vizuete, Antonio] Univ Seville, Consejo Super Invest Cient, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain	Karolinska Institutet; Friedrich Miescher Institute for Biomedical Research; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Fierro-Gonzalez, JC (corresponding author), Karolinska Inst, Ctr Biosci NOVUM, Dept Biosci & Nutr, Huddinge, Sweden.	amirviz@upo.es; peter.swoboda@ki.se	IBIS, REDOX/J-7473-2017; Fierro-González, Juan Carlos/F-8430-2010; IBIS, FISIOLOGIA/O-9485-2015; Miranda-Vizuete, Antonio/D-6927-2012	Fierro-González, Juan Carlos/0000-0003-4871-1621; Miranda-Vizuete, Antonio/0000-0002-6856-5396; Alcedo, Joy/0000-0002-5279-6640; Swoboda, Peter/0000-0001-6416-8572	Swedish Foundation for Strategic Research; Swedish Research Council; NordForsk Nordic C. elegans Network; Instituto de Salud Carlos III [PI050065, PI080557]; Fondo Social Europeo, FEDER; Junta de Andalucia [CVI-3629, CVI-2697]; Novartis Research Foundation	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); NordForsk Nordic C. elegans Network; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Social Europeo, FEDER(European Social Fund (ESF)European Commission); Junta de Andalucia(Junta de Andalucia); Novartis Research Foundation	This study was supported by grants from The Swedish Foundation for Strategic Research, The Swedish Research Council and The NordForsk Nordic C. elegans Network to PS; from Instituto de Salud Carlos III (Projects PI050065 and PI080557, co-financed by Fondo Social Europeo, FEDER) and Junta de Andalucia (Projects CVI-3629 and CVI-2697) to AMV; and from The Novartis Research Foundation to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Birnby DA, 2000, GENETICS, V155, P85; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BRENNER S, 1974, GENETICS, V77, P71; Carroll BT, 2006, J BIOL CHEM, V281, P35989, DOI 10.1074/jbc.M606086200; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Edgley M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf051; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; Hu P.J., 2007, DAUER, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; HUBER HE, 1986, J BIOL CHEM, V261, P5006; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jee C, 2005, GENES CELLS, V10, P1203, DOI 10.1111/j.1365-2443.2005.00913.x; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kell A, 2007, FREE RADICAL BIO MED, V43, P1560, DOI 10.1016/j.freeradbiomed.2007.08.025; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; MALONE EA, 1994, GENETICS, V136, P879; Malone EA, 1996, GENETICS, V143, P1193; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; MULLER EGD, 1995, ARCH BIOCHEM BIOPHYS, V318, P356, DOI 10.1006/abbi.1995.1240; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Pekkari K, 2003, FEBS LETT, V539, P143, DOI 10.1016/S0014-5793(03)00214-X; PellicenaPalle A, 1997, MECH DEVELOP, V62, P61, DOI 10.1016/S0925-4773(96)00650-8; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; RUSSEL M, 1986, J BIOL CHEM, V261, P4997; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Stiernagle Theresa, 2006, WormBook, P1; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; TONISSEN K, 1993, J BIOL CHEM, V268, P22485; VOWELS JJ, 1992, GENETICS, V130, P105; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532	57	15	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16561	10.1371/journal.pone.0016561	http://dx.doi.org/10.1371/journal.pone.0016561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304598	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900071
J	Faucherre, A; Lopez-Schier, H				Faucherre, Adele; Lopez-Schier, Hernan			Delaying Gal4-Driven Gene Expression in the Zebrafish with Morpholinos and Gal80	PLOS ONE			English	Article							TRANSGENE EXPRESSION; NEURAL CIRCUITRY; MOSAIC ANALYSIS; TRAP APPROACH; AMINO-ACIDS; DROSOPHILA; GAL4-VP16; SYSTEM; NOTCH	The modular Gal4/UAS gene expression system has become an indispensable tool in modern biology. Several large-scale gene-and enhancer-trap screens in the zebrafish have generated hundreds of transgenic lines expressing Gal4 in unique patterns. However, the early embryonic expression of the Gal4 severely limits their use for studies on regeneration or behavior because UAS-driven effectors could disrupt normal organogenesis. To overcome this limitation, we explored the use of the Gal4 repressor Gal80 in transient assays and with stable transgenes to temporally control Gal4 activity. We also validated a strategy to delay Gal4-driven gene expression using a morpholino targeted to Gal4. The first approach is limited to transgenes expressing the native Gal4. The morphant approach can also be applied to transgenic lines expressing the Gal4-VP16 fusion protein. It promises to become a standard approach to delay Gal4-driven transgene expression and enhance the genetic toolkit for the zebrafish.	[Faucherre, Adele; Lopez-Schier, Hernan] Ctr Regulac Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Faucherre, A (corresponding author), Ctr Regulac Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain.	hernanls@crg.es		Faucherre, Adele/0000-0002-6099-3898	AGAUR [2009-SGR-305]; European Research Council [ERC-2007-StG SENSORINEURAL]; European Union; Ministerio de Ciencia e Innovacion of Spain	AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the AGAUR 2009-SGR-305 and by a grant from the European Research Council (ERC-2007-StG SENSORINEURAL). A. F. was supported by an Intra-European Marie Curie fellowship from the European Union and H. L. S. by the Ramon y Cajal programme of the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BRAND AH, 1993, DEVELOPMENT, V118, P401; Collins RT, 2010, NAT METHODS, V7, P219, DOI [10.1038/NMETH.1423, 10.1038/nmeth.1423]; CROSTON GE, 1992, GENE DEV, V6, P2270, DOI 10.1101/gad.6.12a.2270; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Ogura E, 2009, DEV DYNAM, V238, P641, DOI 10.1002/dvdy.21863; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Pujol-Marti J, 2010, DEV DYNAM, V239, P1919, DOI 10.1002/dvdy.22320; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Westerfield M, 2007, ZEBRAFISH BOOK; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16587	10.1371/journal.pone.0016587	http://dx.doi.org/10.1371/journal.pone.0016587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298067	Green Submitted, Green Published, gold			2022-12-27	WOS:000286662800057
J	Lass-Hennemann, J; Kuehl, LK; Schulz, A; Oitzl, MS; Schachinger, H				Lass-Hennemann, Johanna; Kuehl, Linn K.; Schulz, Andre; Oitzl, Melly S.; Schachinger, Hartmut			Stress Strengthens Memory of First Impressions of Others' Positive Personality Traits	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; PITUITARY-ADRENAL AXIS; COLD-PRESSOR TEST; COGNITIVE REPRESENTATION; CONSOLIDATION; RETRIEVAL; AMYGDALA; AROUSAL; ASSOCIATIONS; ORGANIZATION	Encounters with strangers bear potential for social conflict and stress, but also allow the formation of alliances. First impressions of other people play a critical role in the formation of alliances, since they provide a learned base to infer the other's future social attitude. Stress can facilitate emotional memories but it is unknown whether stress strengthens our memory for newly acquired impressions of other people's personality traits. To answer this question, we subjected 60 students (37 females, 23 males) to an impression-formation task, viewing portraits together with brief positive vs. negative behavior descriptions, followed by a 3-min cold pressor stress test or a non-stressful control procedure. The next day, novel and old portraits were paired with single trait adjectives, the old portraits with a trait adjective matching the previous day's behavior description. After a filler task, portraits were presented again and subjects were asked to recall the trait adjective. Cued recall was higher for old (previously implied) than the novel portraits' trait adjectives, indicating validity of the applied test procedures. Overall, recall rate of implied trait adjectives did not differ between the stress and the control group. However, while the control group showed a better memory performance for others' implied negative personality traits, the stress group showed enhanced recall for others' implied positive personality traits. This result indicates that post-learning stress affects consolidation of first impressions in a valence-specific manner. We propose that the stress-induced strengthening of memory of others' positive traits forms an important cue for the formation of alliances in stressful conditions.	[Lass-Hennemann, Johanna; Kuehl, Linn K.; Schulz, Andre; Schachinger, Hartmut] Univ Trier, Inst Psychobiol, Trier, Germany; [Oitzl, Melly S.] Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands	Universitat Trier; Leiden University; Leiden University - Excl LUMC	Lass-Hennemann, J (corresponding author), Univ Trier, Inst Psychobiol, Trier, Germany.	lass-hennemann@mx.uni-saarland.de	Schulz, André/AAC-5576-2021	Schulz, André/0000-0002-9381-2651	German Research Foundation (Deutsche Forschungsgemeinschaft: DFG) [GRK 1389/1]; International Research Training Group	German Research Foundation (Deutsche Forschungsgemeinschaft: DFG)(German Research Foundation (DFG)); International Research Training Group	This research was funded by the International Research Training Group "Psychoneuroendocrinology of Stress: From Molecules and Genes to Affect and Cognition" funded by the German Research Foundation (Deutsche Forschungsgemeinschaft: DFG), grant GRK 1389/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares LD, 2010, LEARN MEMORY, V17, P202, DOI 10.1101/lm.1721010; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; CARLSTON DE, 1995, J PERS SOC PSYCHOL, V69, P420, DOI 10.1037/0022-3514.69.3.429; CARLSTON DE, 1994, J PERS SOC PSYCHOL, V66, P840, DOI 10.1037/0022-3514.66.5.840; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Hager W, 1994, HDB DEUTSCHSPRACHIGE; HAMILTON DL, 1989, J PERS SOC PSYCHOL, V57, P925, DOI 10.1037/0022-3514.57.6.925; HAMILTON DL, 1980, J PERS SOC PSYCHOL, V39, P1050, DOI 10.1037/h0077711; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; HASTIE R, 1979, J PERS SOC PSYCHOL, V37, P25, DOI 10.1037/0022-3514.37.1.25; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Liu DLJ, 2008, NEUROBIOL LEARN MEM, V89, P36, DOI 10.1016/j.nlm.2007.09.001; LOVALLO W, 1975, PSYCHOPHYSIOLOGY, V12, P268, DOI 10.1111/j.1469-8986.1975.tb01289.x; Maner JK, 2005, J PERS SOC PSYCHOL, V88, P63, DOI 10.1037/0022-3514.88.1.63; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Mitchell JP, 2006, SOC COGN AFFECT NEUR, V1, P49, DOI 10.1093/scan/nsl007; Mitchell JP, 2005, NEUROIMAGE, V26, P251, DOI 10.1016/j.neuroimage.2005.01.031; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Neumann ID, 2000, REGUL PEPTIDES, V96, P31, DOI 10.1016/S0167-0115(00)00197-X; Neumann ID, 2000, J NEUROENDOCRINOL, V12, P235; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; Smeets T, 2008, PSYCHONEUROENDOCRINO, V33, P1378, DOI 10.1016/j.psyneuen.2008.07.009; SRULL TK, 1989, PSYCHOL REV, V96, P58, DOI 10.1037/0033-295X.96.1.58; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P195, DOI 10.1093/scan/nsn013; Todorov A, 2007, NEUROPSYCHOLOGIA, V45, P163, DOI 10.1016/j.neuropsychologia.2006.04.018; Uleman JS, 2005, NEW UNCONSCIOUS; WYER RS, 1984, J EXP SOC PSYCHOL, V20, P445, DOI 10.1016/0022-1031(84)90037-4; Zorawski M, 2002, NEUROBIOL LEARN MEM, V78, P458, DOI 10.1006/nlme.2002.4075	37	12	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16389	10.1371/journal.pone.0016389	http://dx.doi.org/10.1371/journal.pone.0016389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298099	Green Published, gold			2022-12-27	WOS:000286662800037
J	Yeo, RA; Gangestad, SW; Liu, JY; Calhoun, VD; Hutchison, KE				Yeo, Ronald A.; Gangestad, Steven W.; Liu, Jingyu; Calhoun, Vince D.; Hutchison, Kent E.			Rare Copy Number Deletions Predict Individual Variation in Intelligence	PLOS ONE			English	Article							HUMAN GENOME; COGNITIVE-ABILITY; EARLY ADULTHOOD; DEVELOPMENTAL INSTABILITY; SEGMENTAL DUPLICATIONS; FLUCTUATING ASYMMETRY; BRAIN-DEVELOPMENT; MENTAL-DISORDERS; GENETIC OVERLAP; YOUNG-CHILDREN	Phenotypic variation in human intellectual functioning shows substantial heritability, as demonstrated by a long history of behavior genetic studies. Many recent molecular genetic studies have attempted to uncover specific genetic variations responsible for this heritability, but identified effects capture little variance and have proven difficult to replicate. The present study, motivated an interest in "mutation load'' emerging from evolutionary perspectives, examined the importance of the number of rare (or infrequent) copy number variations (CNVs), and the total number of base pairs included in such deletions, for psychometric intelligence. Genetic data was collected using the Illumina 1MDuoBeadChip Array from a sample of 202 adult individuals with alcohol dependence, and a subset of these (N = 77) had been administered the Wechsler Abbreviated Scale of Intelligence (WASI). After removing CNV outliers, the impact of rare genetic deletions on psychometric intelligence was investigated in 74 individuals. The total length of the rare deletions significantly and negatively predicted intelligence (r = -.30, p = .01). As prior studies have indicated greater heritability in individuals with relatively higher parental socioeconomic status (SES), we also examined the impact of ethnicity (Anglo/White vs. Other), as a proxy measure of SES; these groups did not differ on any genetic variable. This categorical variable significantly moderated the effect of length of deletions on intelligence, with larger effects being noted in the Anglo/White group. Overall, these results suggest that rare deletions (between 5% and 1% population frequency or less) adversely affect intellectual functioning, and that pleotropic effects might partly account for the association of intelligence with health and mental health status. Significant limitations of this research, including issues of generalizability and CNV measurement, are discussed.	[Yeo, Ronald A.; Gangestad, Steven W.; Hutchison, Kent E.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Liu, Jingyu; Calhoun, Vince D.; Hutchison, Kent E.] Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA; [Liu, Jingyu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Hutchison, Kent E.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of New Mexico; Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of Colorado System; University of Colorado Boulder	Yeo, RA (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	ryeo@unm.edu	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747; Gangestad, Steven/0000-0002-8879-4348; Liu, Jingyu/0000-0002-1724-7523	National Institute on Alcoholism and Alcohol Abuse [AA012238, AA013930]; National Institute of Biomedical Imaging and Bioengineering [R01EB005846]; Mind Research Network; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012238, R29AA012238] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Mind Research Network; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by grants from the National Institute on Alcoholism and Alcohol Abuse (AA012238 and AA013930; KH), the National Institute of Biomedical Imaging and Bioengineering (R01EB005846; VDC) and a grant from the Mind Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEN R, 2010, USING EVOLUTIONARY T; Arden R, 2009, INTELLIGENCE, V37, P581, DOI 10.1016/j.intell.2009.03.008; Banks GC, 2010, INTELLIGENCE, V38, P393, DOI 10.1016/j.intell.2010.04.003; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2006, J EPIDEMIOL COMMUN H, V60, P872, DOI 10.1136/jech.2005.045039; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; BOURQUE E, 2010, PSYCHOL MED IN PRESS; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; CHEN J, P IEEE BIOI IN PRESS; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Der G, 2009, INTELLIGENCE, V37, P573, DOI 10.1016/j.intell.2008.12.002; DONOVAN DM, 1984, ALCOHOL CLIN EXP RES, V8, P470, DOI 10.1111/j.1530-0277.1984.tb05704.x; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Finn PR, 2004, J ABNORM PSYCHOL, V113, P569, DOI 10.1037/0021-843X.113.4.569; Furlow FB, 1997, P ROY SOC B-BIOL SCI, V264, P823, DOI 10.1098/rspb.1997.0115; Gale CR, 2010, EPIDEMIOLOGY, V21, P70, DOI 10.1097/EDE.0b013e3181c17da8; Gale CR, 2009, INTELLIGENCE, V37, P592, DOI 10.1016/j.intell.2008.09.002; Gangestad SW, 2010, PERS INDIV DIFFER, V49, P289, DOI 10.1016/j.paid.2010.03.005; Gangestad SW, 1999, J EVOLUTION BIOL, V12, P402, DOI 10.1046/j.1420-9101.1999.00039.x; GANGESTAD SW, EVOLUTION H IN PRESS; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Grant MD, 2010, BEHAV GENET, V40, P438, DOI 10.1007/s10519-010-9351-3; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Harden KP, 2007, BEHAV GENET, V37, P273, DOI 10.1007/s10519-006-9113-4; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Houle D, 2010, P NATL ACAD SCI USA, V107, P1793, DOI 10.1073/pnas.0906195106; Houlihan LM, 2009, GENES BRAIN BEHAV, V8, P238, DOI 10.1111/j.1601-183X.2008.00470.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Koenen KC, 2006, J ABNORM PSYCHOL, V115, P787, DOI 10.1037/0021-843X.115.4.787; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; Luciano M, 2010, INTELLIGENCE, V38, P304, DOI 10.1016/j.intell.2010.03.002; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; McCarthy M, 2006, LANCET NEUROL, V5, P907, DOI 10.1016/S1474-4422(06)70594-4; Miller G, 2000, Novartis Found Symp, V233, P260; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Oti M, 2008, TRENDS GENET, V24, P103, DOI 10.1016/j.tig.2007.12.005; Penke L, 2007, EUR J PERSONALITY, V21, P549, DOI 10.1002/per.629; Plomin R, 2004, J PERS SOC PSYCHOL, V86, P112, DOI 10.1037/0022-3514.86.1.112; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Prokosch MD, 2005, INTELLIGENCE, V33, P203, DOI 10.1016/j.intell.2004.07.007; *PSYCH CORP, 2002, WAIS 3 WECHSL AD INT; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Toulopoulou T, 2007, SCHIZOPHRENIA BULL, V33, P290; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; Tukey JW, 1977, EXPLORATORY DATA ANA; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; VANDONGEN S, EVOLUTION H IN PRESS; Waldron M, 2007, TWIN RES HUM GENET, V10, P440, DOI 10.1375/twin.10.3.440; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; YEO R, CURRENT ALZ IN PRESS; Yeo RA, 1999, SCHIZOPHR RES, V39, P197, DOI 10.1016/S0920-9964(99)00074-2; Yeo RA, 2007, CURR DIR PSYCHOL SCI, V16, P245, DOI 10.1111/j.1467-8721.2007.00513.x; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	73	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16339	10.1371/journal.pone.0016339	http://dx.doi.org/10.1371/journal.pone.0016339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298096	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800029
J	Qiu, JZ; Zhang, XR; Luo, MJ; Li, HG; Dong, J; Wang, JF; Leng, BF; Wang, XL; Feng, HH; Ren, WZ; Deng, XM				Qiu, Jiazhang; Zhang, Xiaoran; Luo, Mingjing; Li, Hongen; Dong, Jing; Wang, Jianfeng; Leng, Bingfeng; Wang, Xiaoliang; Feng, Haihua; Ren, Wenzhi; Deng, Xuming			Subinhibitory Concentrations of Perilla Oil Affect the Expression of Secreted Virulence Factor Genes in Staphylococcus aureus	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; ANTIBACTERIAL ACTIVITY	Background: The pathogenicity of staphylococcus aureus is dependent largely upon its ability to secrete a number of virulence factors, therefore, anti-virulence strategy to combat S. aureus-mediated infections is now gaining great interest. It is widely recognized that some plant essential oils could affect the production of staphylococcal exotoxins when used at subinhibitory concentrations. Perilla [Perilla frutescens (L.) Britton], a natural medicine found in eastern Asia, is primarily used as both a medicinal and culinary herb. Its essential oil (perilla oil) has been previously demonstrated to be active against S. aureus. However, there are no data on the influence of perilla oil on the production of S. aureus exotoxins. Methodology/Principal Findings: A broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of perilla oil against S. aureus strains. Hemolysis, tumour necrosis factor (TNF) release, Western blot, and real-time RT-PCR assays were performed to evaluate the effects of subinhibitory concentrations of perilla oil on exotoxins production in S. aureus. The data presented here show that perilla oil dose-dependently decreased the production of a-toxin, enterotoxins A and B (the major staphylococcal enterotoxins), and toxic shock syndrome toxin 1 (TSST-1) in both methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). Conclusions/Significance: The production of alpha-toxin, SEA, SEB, and TSST-1 in S. aureus was decreased by perilla oil. These data suggest that perilla oil may be useful for the treatment of S. aureus infections when used in combination with beta-lactam antibiotics, which can increase exotoxins production by S. aureus at subinhibitory concentrations. Furthermore, perilla oil could be rationally applied in food systems as a novel food preservative both to inhibit the growth of S. aureus and to repress the production of exotoxins, particularly staphylococcal enterotoxins.	[Qiu, Jiazhang; Luo, Mingjing; Li, Hongen; Dong, Jing; Wang, Jianfeng; Leng, Bingfeng; Wang, Xiaoliang; Feng, Haihua; Ren, Wenzhi; Deng, Xuming] Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130023, Peoples R China; [Zhang, Xiaoran] Jilin Univ, Coll Chem, Changchun 130023, Peoples R China	Jilin University; Jilin University	Qiu, JZ (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130023, Peoples R China.	rwz1964@163.com; dengxm@jlu.edu.cn			National Nature Science Foundation of China [30972212]; Chinese Postdoctoral Science Foundation [20090461034]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Nature Science Foundation of China (No. 30972212) and the Chinese Postdoctoral Science Foundation (No. 20090461034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Vical F, 2006, CHEMOTHERAPY, V52, P288, DOI 10.1159/000095960; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; CARSON CF, 1995, J ANTIMICROB CHEMOTH, V35, P421, DOI 10.1093/jac/35.3.421; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Cheung AL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1825, DOI 10.2741/cheung; Corpet DE, 2002, NUTR CANCER, V43, P1, DOI 10.1207/S15327914NC431_1; Derakhshan S, 2008, INT J ANTIMICROB AG, V32, P432, DOI 10.1016/j.ijantimicag.2008.05.009; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Ito M, 2008, J NAT MED, V62, P387, DOI 10.1007/s11418-008-0262-z; Jones TF, 2002, EMERG INFECT DIS, V8, P82, DOI 10.3201/eid0801.010174; Kalemba D, 2003, CURR MED CHEM, V10, P813, DOI 10.2174/0929867033457719; Koszczol C, 2006, J ANTIMICROB CHEMOTH, V58, P564, DOI 10.1093/jac/dkl291; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; O'Brien GJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-115; Okamoto M, 2000, INTERNAL MED, V39, P107, DOI 10.2169/internalmedicine.39.107; Okuyama H, 2007, LIPIDS, V42, P821, DOI 10.1007/s11745-007-3073-1; Qiu JZ, 2010, APPL ENVIRON MICROB, V76, P5846, DOI 10.1128/AEM.00704-10; Qiu JZ, 2010, FEMS MICROBIOL LETT, V307, P135, DOI 10.1111/j.1574-6968.2010.01973.x; Qiu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009736; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Saliba R, 2009, IMMUNOPHARM IMMUNOT, V31, P583, DOI 10.3109/08923970902838672; Sambanthamoorthy K, 2006, MICROBIOL-SGM, V152, P2559, DOI 10.1099/mic.0.29071-0; Senatore F, 2007, FITOTERAPIA, V78, P244, DOI 10.1016/j.fitote.2006.11.010; Smith-Palmer A, 2004, J MED MICROBIOL, V53, P1023, DOI 10.1099/jmm.0.45567-0; Smith-Palmer A, 2001, FOOD MICROBIOL, V18, P463, DOI 10.1006/fmic.2001.0415; Stewart CM, 2002, APPL ENVIRON MICROB, V68, P1864, DOI 10.1128/AEM.68.4.1864-1871.2002; Valero M, 2006, FOOD MICROBIOL, V23, P68, DOI 10.1016/j.fm.2005.01.016; WATANABE S, 1994, J NUTR, V124, P1566, DOI 10.1093/jn/124.9.1566; Yamada K, 2000, BIOFACTORS, V13, P167, DOI 10.1002/biof.5520130127; YAMAMOTO N, 1987, J LIPID RES, V28, P144	32	67	73	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16160	10.1371/journal.pone.0016160	http://dx.doi.org/10.1371/journal.pone.0016160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283822	Green Submitted, Green Published, gold			2022-12-27	WOS:000286520600026
J	Ma, FC; Zhang, HX; Zhai, Y; Huang, WF; Zhao, C; Ou, SQ; Zhou, H; Yuan, WZ; Wang, ZF; Wang, HX; Yue, W; Yu, LX; Li, PY; Xia, X; Cai, M; Zhang, Y; Cui, Y; He, FC; Ma, YL; Zhou, GQ				Ma, Fuchao; Zhang, Hongxing; Zhai, Yun; Huang, Wenfeng; Zhao, Chang; Ou, Shengqiu; Zhou, Hong; Yuan, Wenzhao; Wang, Zhifu; Wang, Hongxue; Yue, Wei; Yu, Lixia; Li, Peiyao; Xia, Xia; Cai, Mi; Zhang, Yang; Cui, Ying; He, Fuchu; Ma, Yilong; Zhou, Gangqiao			Functional Polymorphism-31C/G in the Promoter of BIRC5 Gene and Risk of Nasopharyngeal Carcinoma among Chinese	PLOS ONE			English	Article							HUMAN SURVIVIN GENE; SUSCEPTIBILITY; CANCER; ASSOCIATION; PATHWAYS; PROTEIN; REGION	Background: Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5, also called as survivin) is a member of the inhibitor of apoptosis protein (IAP) family, which plays an important role in the occurrence and progression of cancer. Recently, a polymorphism in the promoter of BIRC5, -31C/G (rs9904341), was shown to influence BIRC5 expression. Methods: We examined whether the -31C/G was related to the risk of developing nasopharyngeal carcinoma (NPC) in a case-control population from Guangxi province in southern China, which consists of 855 patients with NPC and 1036 controls. This polymorphism was genotyped by TaqMan assay. The genetic associations with the occurrence and progression of NPC were estimated by logistic regression. Results: We observed a statistically significant increased occurrence of NPC associated with the CC genotype (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.13-1.73; P = 0.0020) compared with the genotypes containing G allele (CG + GG genotype). However, no significant association was observed for the -31C/G with the severity of NPC (as measured by tumor-node-metastasis staging system). Conclusion: Our findings suggest that the functional polymorphism -31C/G in the promoter of BIRC5 gene may play a role in mediating the susceptibility to NPC among Chinese.	[Ma, Fuchao; Zhang, Hongxing; Zhai, Yun; Huang, Wenfeng; Wang, Zhifu; Wang, Hongxue; Yue, Wei; Yu, Lixia; Li, Peiyao; Xia, Xia; Cai, Mi; Zhang, Yang; He, Fuchu; Zhou, Gangqiao] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China; [Ma, Fuchao; Huang, Wenfeng; Zhao, Chang; Ou, Shengqiu; Zhou, Hong; Yuan, Wenzhao; Wang, Hongxue; Cui, Ying; Ma, Yilong] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Guangxi, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Academy of Military Medical Sciences - China; Guangxi Medical University; Fudan University	Ma, FC (corresponding author), Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China.	mayl74@yahoo.cn; zhougq114@gmail.com		Huang, Wenfeng/0000-0002-3194-4368	Chinese National Science Fund for Creative Research Groups Program [30621063]; Chinese National Natural Science Foundation [30872929, 30901707, 30900819, 30901231]; Chinese State Key Laboratory of Proteomics [SKLP-Y200808]; Beijing Science & Technology NOVA program [2006A54]	Chinese National Science Fund for Creative Research Groups Program(Science Fund for Creative Research Groups); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese State Key Laboratory of Proteomics; Beijing Science & Technology NOVA program	This study was supported by grants from Chinese National Science Fund for Creative Research Groups Program (No. 30621063), Chinese National Natural Science Foundation (No. 30872929, 30901707, 30900819 and 30901231), Chinese State Key Laboratory of Proteomics (No. SKLP-Y200808), and Beijing Science & Technology NOVA program (No. 2006A54). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1989, J CLIN EPIDEMIOL, V42, P659, DOI 10.1016/0895-4356(89)90009-7; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; [Anonymous], 1997, AJCC CANC STAGING MA; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Cheng Zheng-Jiang, 2008, Ai Zheng, V27, P258; Cho WC, 2010, CANC REPORT ASIAN PA, P284; Cho WCS, 2010, EXPERT REV MOL DIAGN, V10, P699, DOI [10.1586/erm.10.64, 10.1586/ERM.10.64]; Deng L, 2002, ACTA BIOCH BIOPH SIN, V34, P16; Gazouli M, 2009, INT J COLORECTAL DIS, V24, P145, DOI 10.1007/s00384-008-0601-2; Goldsmith DB, 2002, CLIN OTOLARYNGOL, V27, P61, DOI 10.1046/j.0307-7772.2001.00529.x; He Y, 2005, J MED GENET, V42, P172, DOI 10.1136/jmg.2004.022616; Jalbout M, 2003, CANCER LETT, V193, P75, DOI 10.1016/S0304-3835(02)00697-3; Jang JS, 2008, LUNG CANCER, V60, P31, DOI 10.1016/j.lungcan.2007.09.008; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li YH, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-1; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Nazar-Stewart V, 1999, CANCER EPIDEM BIOMAR, V8, P547; Nong LG, 2009, DNA CELL BIOL, V28, P507, DOI 10.1089/dna.2009.0912; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Shi W, 2006, INT J CANCER, V119, P2467, DOI 10.1002/ijc.22107; Tang FQ, 2005, EXP ONCOL, V27, P96; Wang YH, 2009, UROLOGY, V73, P670, DOI 10.1016/j.urology.2008.09.048; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Xu Y, 2004, DNA CELL BIOL, V23, P527, DOI 10.1089/dna.2004.23.527; Yang L, 2009, DIGEST DIS SCI, V54, P1021, DOI 10.1007/s10620-008-0441-5; Yip KW, 2006, CLIN CANCER RES, V12, P5726, DOI 10.1158/1078-0432.CCR-06-0571; Zhou B, 2009, CANCER LETT, V275, P72, DOI 10.1016/j.canlet.2008.10.002; Zhou G, 2007, HUM MUTAT, V28, P1091, DOI 10.1002/humu.20570; Zhou GQ, 2007, CLIN CANCER RES, V13, P2627, DOI 10.1158/1078-0432.CCR-06-2281	36	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16748	10.1371/journal.pone.0016748	http://dx.doi.org/10.1371/journal.pone.0016748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304814	Green Submitted, gold, Green Published			2022-12-27	WOS:000287036600021
J	Nurzaman, SG; Matsumoto, Y; Nakamura, Y; Shirai, K; Koizumi, S; Ishiguro, H				Nurzaman, Surya G.; Matsumoto, Yoshio; Nakamura, Yutaka; Shirai, Kazumichi; Koizumi, Satoshi; Ishiguro, Hiroshi			From Levy to Brownian: A Computational Model Based on Biological Fluctuation	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; MOVEMENT PATTERNS; BEHAVIOR; CHEMOTAXIS; EFFICIENCY; CONTEXT	Background: Theoretical studies predict that Levy walks maximizes the chance of encountering randomly distributed targets with a low density, but Brownian walks is favorable inside a patch of targets with high density. Recently, experimental data reports that some animals indeed show a Levy and Brownian walk movement patterns when forage for foods in areas with low and high density. This paper presents a simple, Gaussian-noise utilizing computational model that can realize such behavior. Methodology/Principal Findings: We extend Levy walks model of one of the simplest creature, Escherichia coli, based on biological fluctuation framework. We build a simulation of a simple, generic animal to observe whether Levy or Brownian walks will be performed properly depends on the target density, and investigate the emergent behavior in a commonly faced patchy environment where the density alternates. Conclusions/Significance: Based on the model, animal behavior of choosing Levy or Brownian walk movement patterns based on the target density is able to be generated, without changing the essence of the stochastic property in Escherichia coli physiological mechanism as explained by related researches. The emergent behavior and its benefits in a patchy environment are also discussed. The model provides a framework for further investigation on the role of internal noise in realizing adaptive and efficient foraging behavior.	[Nurzaman, Surya G.; Shirai, Kazumichi] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan; [Matsumoto, Yoshio] Natl Inst Adv Sci & Technol AIST, Tsukuba, Ibaraki, Japan; [Nakamura, Yutaka; Koizumi, Satoshi; Ishiguro, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 560, Japan	Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University	Nurzaman, SG (corresponding author), Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan.	surya.gn@irl.sys.es.osaka-u.ac.jp	Nurzaman, Surya G/G-9486-2017	Nurzaman, Surya G/0000-0002-8157-6495	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by "Special Coordination Funds for Promoting Science and Technology: Yuragi Project" of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PS, 1997, FRACTAL CHAOS ILLUST, P68; ADLER J, 1976, J SUPRAMOL STR CELL, V4, P305, DOI 10.1002/jss.400040302; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; CHAMBERS JM, 1976, J AM STAT ASSOC, V71, P340, DOI 10.2307/2285309; de Knegt HJ, 2007, BEHAV ECOL, V18, P1065, DOI 10.1093/beheco/arm080; Dees ND, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/044001; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Focardi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006587; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KHAN S, 1980, J MOL BIOL, V138, P599, DOI 10.1016/S0022-2836(80)80019-2; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Koyama Hideaki, 2008, SICE 2008 - 47th Annual Conference of the Society of Instrument and Control Engineers of Japan, P428, DOI 10.1109/SICE.2008.4654692; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Newman MEJ, 1999, MONTE CARLO METHODS, P60; Nurzaman SG, 2010, IEEE INT C INT ROBOT, P1927, DOI 10.1109/IROS.2010.5651671; Nurzaman SG, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P142, DOI 10.1109/IROS.2009.5353998; Reynolds AM, 2009, PHYSICA A, V388, P561, DOI 10.1016/j.physa.2008.11.007; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Schuster M, 2001, P NATL ACAD SCI USA, V98, P6003, DOI 10.1073/pnas.101571298; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Visser A, 2006, J MARINE SYSTEMS, V70, P287; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Webre DJ, 2003, CURR BIOL, V13, pR47, DOI 10.1016/S0960-9822(02)01424-0; Yanagida T, 2007, BIOSYSTEMS, V88, P228, DOI 10.1016/j.biosystems.2006.08.012	40	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16168	10.1371/journal.pone.0016168	http://dx.doi.org/10.1371/journal.pone.0016168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304911	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600006
J	Guo, YM; Barnett, AG; Yu, WW; Pan, XC; Ye, XF; Huang, CR; Tong, SL				Guo, Yuming; Barnett, Adrian G.; Yu, Weiwei; Pan, Xiaochuan; Ye, Xiaofang; Huang, Cunrui; Tong, Shilu			A Large Change in Temperature between Neighbouring Days Increases the Risk of Mortality	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; CASE-CROSSOVER ANALYSIS; UNITED-STATES; US CITIES; WEATHER; POPULATION; STROKE; VULNERABILITY; SCOTLAND; DISEASES	Background: Previous studies have found high temperatures increase the risk of mortality in summer. However, little is known about whether a sharp decrease or increase in temperature between neighbouring days has any effect on mortality. Method: Poisson regression models were used to estimate the association between temperature change and mortality in summer in Brisbane, Australia during 1996-2004 and Los Angeles, United States during 1987-2000. The temperature change was calculated as the current day's mean temperature minus the previous day's mean. Results: In Brisbane, a drop of more than 3 degrees C in temperature between days was associated with relative risks (RRs) of 1.157 (95% confidence interval (CI): 1.024, 1.307) for total non-external mortality (NEM), 1.186 (95%CI: 1.002, 1.405) for NEM in females, and 1.442 (95%CI: 1.099, 1.892) for people aged 65-74 years. An increase of more than 3 degrees C was associated with RRs of 1.353 (95%CI: 1.033, 1.772) for cardiovascular mortality and 1.667 (95%CI: 1.146, 2.425) for people aged <65 years. In Los Angeles, only a drop of more than 3 degrees C was significantly associated with RRs of 1.133 (95%CI: 1.053, 1.219) for total NEM, 1.252 (95%CI: 1.131, 1.386) for cardiovascular mortality, and 1.254 (95%CI: 1.135, 1.385) for people aged >= 75 years. In both cities, there were joint effects of temperature change and mean temperature on NEM. Conclusion: A significant change in temperature of more than 3 degrees C, whether positive or negative, has an adverse impact on mortality even after controlling for the current temperature.	[Guo, Yuming; Barnett, Adrian G.; Yu, Weiwei; Ye, Xiaofang; Huang, Cunrui; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Guo, Yuming; Barnett, Adrian G.; Yu, Weiwei; Ye, Xiaofang; Huang, Cunrui; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Pan, Xiaochuan] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Beijing 100871, Peoples R China	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Peking University	Guo, YM (corresponding author), Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	guoyuming@yahoo.cn; s.tong@qut.edu.au	Yu, Vivian/B-5837-2015; Barnett, Adrian/I-9850-2012; Huang, Cunrui/ABI-3312-2020; Huang, Cunrui/E-7253-2010; Guo, Yuming/I-8353-2018	Yu, Vivian/0000-0003-2452-8304; Barnett, Adrian/0000-0001-6339-0374; Guo, Yuming/0000-0002-1766-6592	Australian Research Council [DP0559655]; QUT Postgraduate Research Award (QUTPRA); NHMRC [553043]	Australian Research Council(Australian Research Council); QUT Postgraduate Research Award (QUTPRA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was partly funded by the Australian Research Council (DP0559655). YG is supported by the QUT Postgraduate Research Award (QUTPRA); ST is supported by a NHMRC Research Fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Ballester F, 1997, INT J EPIDEMIOL, V26, P551, DOI 10.1093/ije/26.3.551; Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Carder M, 2005, OCCUP ENVIRON MED, V62, P702, DOI 10.1136/oem.2004.016394; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Diaz J, 2002, INT J BIOMETEOROL, V46, P145, DOI 10.1007/s00484-002-0129-z; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; Faergeman Ole, 2008, Ugeskr Laeger, V170, P2667; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Intergovernmental Panel on Climate Change(IPCC), 2001, CLIM CHANG 2001 3 AS, V1; Ishigami A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-5; Kalkstein LS, 1997, ENVIRON HEALTH PERSP, V105, P84, DOI 10.1289/ehp.9710584; Keatinge W R, 2000, Int J Circumpolar Health, V59, P154; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Kilbourne EM, 1999, AM J PREV MED, V16, P359; Kyobutungi C, 2005, EUR J EPIDEMIOL, V20, P693, DOI 10.1007/s10654-005-0703-x; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; MCMICHAEL AJ, 1993, INT J EPIDEMIOL, V22, P1, DOI 10.1093/ije/22.1.1; Nakaji S, 2004, EUR J EPIDEMIOL, V19, P905, DOI 10.1007/s10654-004-4695-8; Plavcova E, 2010, INT J BIOMETEOROL; Ren CZ, 2006, ENVIRON HEALTH PERSP, V114, P1690, DOI 10.1289/ehp.9266; SAEZ M, 1995, INT J EPIDEMIOL, V24, P576, DOI 10.1093/ije/24.3.576; Schneider A, 2008, INT J BIOMETEOROL, V52, P535, DOI 10.1007/s00484-008-0144-9; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Stafoggia M, 2008, J EPIDEMIOL COMMUN H, V62, P209, DOI 10.1136/jech.2007.060715; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Vaneckova P, 2008, ENVIRON RES, V108, P361, DOI 10.1016/j.envres.2008.07.015; WHO, 2008, PROT HLTH CLIM CHANG; [WHO WMO UNEP], 1996, CLIM HLTH POT IMP CL	36	90	96	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16511	10.1371/journal.pone.0016511	http://dx.doi.org/10.1371/journal.pone.0016511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311772	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200019
J	Han, BA; Searle, CL; Blaustein, AR				Han, Barbara A.; Searle, Catherine L.; Blaustein, Andrew R.			Effects of an Infectious Fungus, Batrachochytrium dendrobatidis, on Amphibian Predator-Prey Interactions	PLOS ONE			English	Article							BUFO-BOREAS; CHYTRID FUNGUS; WIDESPREAD OCCURRENCE; SELECTIVE PREDATION; POPULATION DECLINES; EMERGING DISEASE; ALARM RESPONSE; CHYTRIDIOMYCOSIS; BEHAVIOR; RISK	The effects of parasites and pathogens on host behaviors may be particularly important in predator-prey contexts, since few animal behaviors are more crucial for ensuring immediate survival than the avoidance of lethal predators in nature. We examined the effects of an emerging fungal pathogen of amphibians, Batrachochytrium dendrobatidis, on anti-predator behaviors of tadpoles of four frog species. We also investigated whether amphibian predators consumed infected prey, and whether B. dendrobatidis caused differences in predation rates among prey in laboratory feeding trials. We found differences in anti-predator behaviors among larvae of four amphibian species, and show that infected tadpoles of one species (Anaxyrus boreas) were more active and sought refuge more frequently when exposed to predator chemical cues. Salamander predators consumed infected and uninfected tadpoles of three other prey species at similar rates in feeding trials, and predation risk among prey was unaffected by B. dendrobatidis. Collectively, our results show that even sub-lethal exposure to B. dendrobatidis can alter fundamental anti-predator behaviors in some amphibian prey species, and suggest the unexplored possibility that indiscriminate predation between infected and uninfected prey (i.e., non-selective predation) could increase the prevalence of this widely distributed pathogen in amphibian populations. Because one of the most prominent types of predators in many amphibian systems is salamanders, and because salamanders are susceptible to B. dendrobatidis, our work suggests the importance of considering host susceptibility and behavioral changes that could arise from infection in both predators and prey.	[Han, Barbara A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Searle, Catherine L.; Blaustein, Andrew R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	University System of Georgia; University of Georgia; Oregon State University	Han, BA (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	han@uga.edu	Han, Barbara A/H-9363-2015	Han, Barbara A/0000-0002-9948-3078; Searle, Catherine/0000-0002-6607-2299	National Science Foundation [DEB0213851, IBN9977063]	National Science Foundation(National Science Foundation (NSF))	Funding sources for this work include the National Science Foundation Postdoctoral Research Fellowship in Bioinformatics and the Budweiser Conservation Fellowship to BAH; and the National Science Foundation Integrated Research Challenges in Environmental Biology Program (DEB0213851 and IBN9977063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zyoud F, 2004, J PEST SCI, V77, P197, DOI 10.1007/s10340-004-0054-5; ANDERSON RM, 1980, SCIENCE, V210, P658, DOI 10.1126/science.210.4470.658; Bakker TCM, 1997, ECOLOGY, V78, P1098, DOI 10.1890/0012-9658(1997)078[1098:PICIBA]2.0.CO;2; Barber I, 1996, P ROY SOC B-BIOL SCI, V263, P1095, DOI 10.1098/rspb.1996.0161; Benard MF, 2006, ECOLOGY, V87, P340, DOI 10.1890/05-0381; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; CALEF GW, 1973, ECOLOGY, V54, P741, DOI 10.2307/1935670; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Cohen J., 1988, STAT POWER ANAL BEHA; Cullen JM, 1974, J ZOOL, V172, P549; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; Duellman WE, 1986, BIOL AMPHIBIANS, P241; Duffy MA, 2007, OECOLOGIA, V153, P453, DOI 10.1007/s00442-007-0742-y; DUPRE RK, 1985, COPEIA, P462, DOI 10.2307/1444859; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gilbert MA, 2003, J PARASITOL, V89, P658, DOI 10.1645/GE-82R; Gosner K. L., 1960, Herpetologica, V16, P183; Griffin AS, 2004, LEARN BEHAV, V32, P131; Han BA, 2008, BEHAV ECOL SOCIOBIOL, V63, P241, DOI 10.1007/s00265-008-0655-8; HEWS DK, 1985, BEHAV NEURAL BIOL, V43, P47, DOI 10.1016/S0163-1047(85)91482-7; HEWS DK, 1988, ANIM BEHAV, V36, P125, DOI 10.1016/S0003-3472(88)80255-0; Hoff KV, 1999, TADPOLES, P215; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Jones GA, 2005, CROP PROT, V24, P185, DOI 10.1016/j.cropro.2004.07.002; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martin J, 1999, BEHAV ECOL, V10, P487, DOI 10.1093/beheco/10.5.487; Mathis A, 2000, CAN J ZOOL, V78, P1646, DOI 10.1139/cjz-78-9-1646; OHARA RK, 1982, BEHAV ECOL SOCIOBIOL, V11, P43, DOI 10.1007/BF00297665; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Padgett-Flohr Gretchen E., 2005, Herpetological Review, V36, P50; Padgett-Flohr Gretchen E., 2007, Herpetological Review, V38, P176; Parris MJ, 2004, OECOLOGIA, V140, P626, DOI 10.1007/s00442-004-1631-2; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Parris MJ, 2006, CAN J ZOOL, V84, P58, DOI 10.1139/Z05-175; R.D.C. Team, 2010, R LANGUAGE ENV STAT; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Roy M, 2008, THEOR POPUL BIOL, V73, P319, DOI 10.1016/j.tpb.2007.12.008; Roy S, 2005, MATH METHOD APPL SCI, V28, P1257, DOI 10.1002/mma.607; SKELLY DK, 1990, ECOLOGY, V71, P2313, DOI 10.2307/1938642; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Therneau T, 2009, SURVIVAL SURVIVAL AN; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Watt PJ, 1997, ANIM BEHAV, V54, P865, DOI 10.1006/anbe.1996.0512; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Wildy EL, 1998, J HERPETOL, V32, P286, DOI 10.2307/1565312	60	17	18	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16675	10.1371/journal.pone.0016675	http://dx.doi.org/10.1371/journal.pone.0016675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311771	Green Published, gold			2022-12-27	WOS:000287036200030
J	Sudhaharan, T; Goh, WI; Sem, KP; Lim, KB; Bu, WY; Ahmed, S				Sudhaharan, Thankiah; Goh, Wah Ing; Sem, Kai Ping; Lim, Kim Buay; Bu, Wenyu; Ahmed, Sohail			Rho GTPase Cdc42 Is a Direct Interacting Partner of Adenomatous Polyposis Coli Protein and Can Alter Its Cellular Localization	PLOS ONE			English	Article							APC TUMOR-SUPPRESSOR; BETA-CATENIN; ACTIN-FILAMENTS; FILOPODIA; MEMBRANE; COMPLEX; CELLS; POLARIZATION; PROGRESSION; TRANSPORT	Adenomatous Polyposis Coli (APC) is a tumor suppressor gene product involved in colon cancer. APC is a large multidomain molecule of 2843 amino acid residues and connects cell-cell adhesion, the F-actin/microtubule cytoskeleton and the nucleus. Here we show that Cdc42 interacts directly with the first three armadillo repeats of APC by yeast two-hybrid screens. We confirm the Cdc42-APC interaction using pulldown assays in vitro and FRET assays in vivo. Interestingly, Cdc42 interacts with APC at leading edge sites where F-actin is enriched. In contrast, Cdc42 interacts with the truncated mutant APC(1-1638) in cellular puncta associated with the golgi-lysozome pathway in transfected CHO cells. In HCT116 and SW480 cells, Cdc42 induces the relocalization of endogenous APC and the mutant APC(1-1338) to the plasma membrane and cellular puncta, respectively. Taken together, these data indicate that the Cdc42-APC interaction induces localization of both APC and mutant APC and may thus play a direct role in the functions of these proteins.	[Sudhaharan, Thankiah; Goh, Wah Ing; Sem, Kai Ping; Lim, Kim Buay; Bu, Wenyu; Ahmed, Sohail] Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Sudhaharan, T (corresponding author), Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Goh, Wah Ing/0000-0001-6594-0640	Agency for Science, Technology and Research, Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MT, 2001, LARYNGOSCOPE, V111, P1285, DOI 10.1097/00005537-200107000-00027; Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Brocardo M, 2008, TRENDS CELL BIOL, V18, P587, DOI 10.1016/j.tcb.2008.09.002; DePina AS, 1999, MICROSC RES TECHNIQ, V47, P93, DOI 10.1002/(SICI)1097-0029(19991015)47:2<93::AID-JEMT2>3.0.CO;2-P; Dikovskaya D, 2001, TRENDS CELL BIOL, V11, P378, DOI 10.1016/S0962-8924(01)02069-4; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Heinen CD, 2002, GASTROENTEROLOGY, V123, P751, DOI 10.1053/gast.2002.35382; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Keely PJ, 2001, LANCET, V358, P1744, DOI 10.1016/S0140-6736(01)06840-4; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Senadheera D, 2001, INT J MOL MED, V8, P127; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tregidgo C, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937212; Wang B, 2005, AM J PHYSIOL-CELL PH, V288, pC1411, DOI 10.1152/ajpcell.00533.2004; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944	38	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16603	10.1371/journal.pone.0016603	http://dx.doi.org/10.1371/journal.pone.0016603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311754	Green Submitted, gold, Green Published			2022-12-27	WOS:000287036200022
J	Wald, DS; Morris, JK; Wald, NJ				Wald, David S.; Morris, Joan K.; Wald, Nicholas J.			Reconciling the Evidence on Serum Homocysteine and Ischaemic Heart Disease: A Meta-Analysis	PLOS ONE			English	Article							BETA-SYNTHASE DEFICIENCY; FOLIC-ACID SUPPLEMENTATION; TYPE-2 DIABETES-MELLITUS; PLATELETS IN-VITRO; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; VASCULAR-DISEASE; BLOOD-PLATELETS; HOMOCYSTINURIA; ACTIVATION	Background: Results from genetic epidemiological studies suggest that raised serum homocysteine is a cause of ischaemic heart disease, but the results of randomised trials suggest otherwise. We aimed to update meta-analyses on each type of study using the latest published data and test a hypothesis based on antiplatelet therapy use in the trials to explain the discrepancy. Methods and Findings: Meta-analyses of ischaemic heart disease using (i) 75 studies in which the prevalence of a mutation (C>T) in the MTHFR gene (which increases homocysteine) was determined in cases (22,068) and controls (23,618), and (ii) 14 randomised trials (39,597 participants) of homocysteine lowering and ischaemic heart disease events. The summary estimates from the two analyses were compared. Meta-analysis of the MTHFR studies showed a statistically significantly increased risk of ischaemic heart disease in TT compared with CC homozygotes; odds ratio 1.16 (1.04 to 1.29) for a 1.9 mu mol/L homocysteine difference (TT minus CC). Meta-analysis of randomised trials showed no significant reduction in IHD risk from folic acid; relative risk 1.00 (0.93 to 1.08), despite a reduction in homocysteine of 3.3 mu mol/L. There was a statistically significant difference in risk reduction between the 5 trials with the lowest prevalence of antiplatelet therapy (60% on average, usually aspirin), RR 0.93 (0.84 to 1.05) and the 5 trials with the highest prevalence (91% on average), RR 1.09 (1.00 to 1.19), p = 0.037 for the difference. Conclusion: Discordant results from MTHFR studies and randomised trials could be explained by aspirin reducing or negating the anti-platelet effect of lowering homocysteine. On this basis, folic acid would have a role in the primary prevention of ischaemic heart disease, when aspirin is not taken routinely, but not in secondary prevention, when it is routine.	[Wald, David S.; Morris, Joan K.; Wald, Nicholas J.] Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, London, England	University of London; Queen Mary University London	Wald, DS (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, London, England.	d.s.wald@qmul.ac.uk	Wald, Nicholas/AAY-2814-2021; Morris, Joan/AAT-9211-2020; Wald, Nicholas/AAY-8924-2021; Chernoff, Yury O/J-2833-2014	Morris, Joan/0000-0002-7164-612X; 				Alexandru N, 2008, J CELL MOL MED, V12, P2015, DOI 10.1111/j.1582-4934.2008.00200.x; Brattstrom L, 1998, CIRCULATION, V98, P2520, DOI 10.1161/01.CIR.98.23.2520; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; COPPOLA A, 2000, SEM THROMB HEM, V26; DAVIS JW, 1976, AM J DIS CHILD, V129, P1020; DIMINNO G, 1993, J CLIN INVEST, V92, P1400, DOI 10.1172/JCI116715; GRAEBER JE, 1982, PEDIATR RES, V16, P490, DOI 10.1203/00006450-198206000-00018; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; Leoncini G, 2006, J THROMB HAEMOST, V4, P209, DOI 10.1111/j.1538-7836.2005.01708.x; Leoncini G, 2003, EUR J CLIN INVEST, V33, P713, DOI 10.1046/j.1365-2362.2003.01203.x; Leoncini G, 2007, J CELL BIOCHEM, V100, P1255, DOI 10.1002/jcb.21123; Li JX, 2002, HEART VESSELS, V16, P46, DOI 10.1007/s380-002-8316-y; Luo FM, 2006, NUTRITION, V22, P69, DOI 10.1016/j.nut.2005.04.012; MCCULLY KS, 1987, RES COMMUN CHEM PATH, V56, P349; MCDONALD L, 1964, LANCET, V1, P745; Miller ER, 2010, AM J CARDIOL, V106, P517, DOI 10.1016/j.amjcard.2010.03.064; Mohan IV, 2008, CLIN APPL THROMB-HEM, V14, P8, DOI 10.1177/1076029607308390; MUDD SH, 1985, AM J HUM GENET, V37, P1; Mutus B, 2001, DIABETOLOGIA, V44, P979, DOI 10.1007/s001250100581; Olas B, 2008, PLATELETS, V19, P520, DOI 10.1080/09537100802308081; Riba R, 2004, ATHEROSCLEROSIS, V175, P69, DOI 10.1016/j.atherosclerosis.2004.02.008; Signorello MG, 2007, THROMB RES, V120, P607, DOI 10.1016/j.thromres.2006.11.008; Signorello MG, 2002, EUR J CLIN INVEST, V32, P279, DOI 10.1046/j.1365-2362.2002.00971.x; Spencer CGC, 2004, INT J CARDIOL, V94, P293, DOI 10.1016/j.ijcard.2003.06.002; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; Undas A, 2007, J THROMB HAEMOST, V5, P1070, DOI 10.1111/j.1538-7836.2007.02459.x; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VESTERQVIST O, 1984, PROSTAGLANDINS, V27, P627, DOI 10.1016/0090-6980(84)90098-4; Wald DS, 2006, BMJ-BRIT MED J, V333, P1114, DOI 10.1136/bmj.39000.486701.68; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Yap S, 1998, J INHERIT METAB DIS, V21, P738, DOI 10.1023/A:1005445132327	34	59	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16473	10.1371/journal.pone.0016473	http://dx.doi.org/10.1371/journal.pone.0016473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311765	Green Published, Green Submitted, gold			2022-12-27	WOS:000287036200015
J	Gu, R; Lu, W; Xie, J; Bai, JA; Xu, BA				Gu, Rong; Lu, Wen; Xie, Jun; Bai, Jian; Xu, Biao			Renalase Deficiency in Heart Failure Model of Rats-A Potential Mechanism Underlying Circulating Norepinephrine Accumulation	PLOS ONE			English	Article							SYMPATHETIC NERVOUS ACTIVITY; ANGIOTENSIN-II; CARDIAC-FAILURE; BLOOD-PRESSURE; ANG-II; ARTERIAL; IMPAIRMENT; OXIDASE; ROLES	Background: Sympathetic overactivity and catecholamine accumulation are important characteristic findings in heart failure, which contribute to its pathophysiology. Here, we identify a potential mechanism underlying norepinephrine accumulation in a rat model of heart failure. Methodology/Principal Findings: Initially, we constructed a rat model of unilateral renal artery stenosis (n = 16) and found that the expression of renalase, a previously identified secreted amine oxidase, was markedly reduced in the ischemic compared to the non-ischemic kidney (protein: 0.295 +/- 0.085 versus 0.765 +/- 0.171, p<0.05). Subsequently, we utilized an isolated perfused rat kidney model to demonstrate that the clearance rate of norepinephrine decreased with reduction of perfusion flow. On the basis of these findings, we hypothesized the reduced renal blood supply which occurs in heart failure would result in impaired synthesis of renalase by the kidney and consequently reduced degradation of circulating norepinephrine. To verify this, we used a rat model of infarction-induced heart failure (n = 12 per group). In these rats, the flow velocity of renal artery, when measured at four weeks, is obviously lower in the operation group. Renal expression of renalase was reduced (protein: 0.476 +/- 0.043 for control, 0.248 +/- 0.029 for operation versus 0.636 +/- 0.151 for sham-operation) and this was associated with an increase in circulating norepinephrine (0.168 +/- 0.016 ng/mL for control, 0.203 +/- 0.019 ng/mL for operation versus 0.138 +/- 0.008 ng/mL for sham-operation). Conclusions/Significance: Renalase expression is influenced by renal blood flow and impaired synthesis of renalase by the kidney may represent a potential mechanism underlying circulating norepinephrine accumulation in heart failure.	[Gu, Rong; Lu, Wen; Xie, Jun; Bai, Jian; Xu, Biao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Peoples R China	Nanjing University	Gu, R (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Peoples R China.	xubiao@medmail.com.cn	xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242	National Natural Science Foundation of China [30170370]; Jiangsu Key Laboratory for Molecular Medicine, Nanjing University [2008]; Department of Health, Jiangsu Province of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine, Nanjing University(Nanjing University); Department of Health, Jiangsu Province of China	This work was supported by grants from the National Natural Science Foundation of China [Research Grant Number 30170370]; the Jiangsu Key Laboratory for Molecular Medicine, Nanjing University [Research Grant 2008]; and Department of Health, Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; DIBNERDUNLAP ME, 1989, CIRC RES, V65, P1526, DOI 10.1161/01.RES.65.6.1526; DIBONA GF, 1995, AM J PHYSIOL-REG I, V268, pR112, DOI 10.1152/ajpregu.1995.268.1.R112; DIBONA GF, 1995, AM J PHYSIOL-REG I, V269, pR1189, DOI 10.1152/ajpregu.1995.269.5.R1189; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Ghosh SS, 2009, PEDIATR NEPHROL, V24, P367, DOI 10.1007/s00467-008-0978-8; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Liang CS, 2007, ACTA PHARMACOL SIN, V28, P921, DOI 10.1111/j.1745-7254.2007.00585.x; Magri P, 1998, CIRCULATION, V98, P2849, DOI 10.1161/01.CIR.98.25.2849; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; MEREDITH IT, 1991, NEW ENGL J MED, V325, P618, DOI 10.1056/NEJM199108293250905; Mircoli L, 2002, CIRCULATION, V106, P866, DOI 10.1161/01.CIR.0000024981.48160.6D; Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7; REID IA, 1992, AM J PHYSIOL, V262, pE763, DOI 10.1152/ajpendo.1992.262.6.E763; Russo LM, 2006, AM J PHYSIOL-RENAL, V291, pF246, DOI 10.1152/ajprenal.00437.2005; Taft David R, 2004, Curr Drug Discov Technol, V1, P97, DOI 10.2174/1570163043484824; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4; Zucker IH, 2004, PROG BIOPHYS MOL BIO, V84, P217, DOI 10.1016/j.pbiomolbio.2003.11.010	23	63	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14633	10.1371/journal.pone.0014633	http://dx.doi.org/10.1371/journal.pone.0014633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297953	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300015
J	Rova, E; Bjorklund, M				Rova, Emma; Bjorklund, Mats			Can Preference for Oviposition Sites Initiate Reproductive Isolation in Callosobruchus maculatus?	PLOS ONE			English	Article							SYMPATRIC SPECIATION; SEED BEETLE; SEXUAL SELECTION; SANTA ROSALIA; HOST RACES; EVOLUTION; POPULATIONS; COLEOPTERA; BRUCHIDAE; SPECIALIZATION	Theory has identified a variety of evolutionary processes that may lead to speciation. Our study includes selection experiments using different host plants and test key predictions concerning models of speciation based on host plant choice, such as the evolution of host use (preference and performance) and assortative mating. This study shows that after only ten generations of selection on different resources/hosts in allopatry, strains of the seed beetle Callosobruchus maculatus develop new resource preferences and show resource-dependent assortative mating when given the possibility to choose mates and resources during secondary contact. The resulting reduced gene flow between the different strains remained for two generations after contact before being overrun by disassortative mating. We show that reduced gene flow can evolve in a population due to a link between host preference and assortative mating, although this result was not found in all lines. However, consistent with models of speciation, assortative mating alone is not sufficient to maintain reproductive isolation when individuals disperse freely between hosts. We conclude that the evolution of reproductive isolation in this system cannot proceed without selection against hybrids. Other possible factors facilitating the evolution of isolation would be longer periods of allopatry, the build up of local adaptation or reduced migration upon secondary contact.	[Rova, Emma; Bjorklund, Mats] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Rova, E (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	emma.rova@ebc.uu.se		Bjorklund, Mats/0000-0001-5436-6989	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council. The funders had no deal in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Coyne J.A., 2004, SPECIATION; Dobzhansky T., 1937; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; EADY PE, 1991, ECOL ENTOMOL, V16, P45, DOI 10.1111/j.1365-2311.1991.tb00191.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Forister ML, 2005, EVOLUTION, V59, P1149, DOI 10.1111/j.0014-3820.2005.tb01051.x; Fox CW, 2004, HEREDITY, V92, P170, DOI 10.1038/sj.hdy.6800383; Fox CW, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P159; FOX CW, 1993, EVOLUTION, V47, P166, DOI [10.2307/2410126, 10.1111/j.1558-5646.1993.tb01207.x]; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Fry JD, 2003, EVOLUTION, V57, P1735; Gavrilets S, 2004, FITNESS LANDSCAPES O; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; KILIAS G, 1980, EVOLUTION, V34, P730, DOI 10.1111/j.1558-5646.1980.tb04012.x; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Magalhaes S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-182; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Messina FJ, 2009, ANN ENTOMOL SOC AM, V102, P181, DOI 10.1603/008.102.0121; RICE WR, 1990, EVOLUTION, V44, P1140, DOI 10.1111/j.1558-5646.1990.tb05221.x; Servedio MR, 2009, HEREDITY, V102, P51, DOI 10.1038/hdy.2008.98; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; SOANS AB, 1974, AM NAT, V108, P117, DOI 10.1086/282889; UDOVIC D, 1980, AM NAT, V116, P621, DOI 10.1086/283654; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; WASSERMAN SS, 1981, EVOLUTION, V35, P605, DOI 10.1111/j.1558-5646.1981.tb04923.x; WEIR BS, 1996, GENETIC ANAL, V2	31	12	12	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14628	10.1371/journal.pone.0014628	http://dx.doi.org/10.1371/journal.pone.0014628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297947	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300010
J	Sandegren, L; Groenheit, R; Koivula, T; Ghebremichael, S; Advani, A; Castro, E; Pennhag, A; Hoffner, S; Mazurek, J; Pawlowski, A; Kan, B; Bruchfeld, J; Melefors, O; Kallenius, G				Sandegren, Linus; Groenheit, Ramona; Koivula, Tuija; Ghebremichael, Solomon; Advani, Abdolreza; Castro, Elsie; Pennhag, Alexandra; Hoffner, Sven; Mazurek, Jolanta; Pawlowski, Andrzej; Kan, Boris; Bruchfeld, Judith; Melefors, Ojar; Kallenius, Gunilla			Genomic Stability over 9 Years of an Isoniazid Resistant Mycobacterium tuberculosis Outbreak Strain in Sweden	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GYRASE MUTATIONS; STREPTOMYCIN RESISTANCE; EXTENSIVE TRANSMISSION; GENETIC POLYMORPHISMS; INSERTION SEQUENCES; CLINICAL-RELEVANCE; IS6110 INSERTION; BEIJING GENOTYPE; DRUG-RESISTANCE	In molecular epidemiological studies of drug resistant Mycobacterium tuberculosis (TB) in Sweden a large outbreak of an isoniazid resistant strain was identified, involving 115 patients, mainly from the Horn of Africa. During the outbreak period, the genomic pattern of the outbreak strain has stayed virtually unchanged with regard to drug resistance, IS6110 restriction fragment length polymorphism and spoligotyping patterns. Here we present the complete genome sequence analyses of the index isolate and two isolates sampled nine years after the index case as well as experimental data on the virulence of this outbreak strain. Even though the strain has been present in the community for nine years and passaged between patients at least five times in-between the isolates, we only found four single nucleotide polymorphisms in one of the later isolates and a small (4 amino acids) deletion in the other compared to the index isolate. In contrast to many other evolutionarily successful outbreak lineages (e. g. the Beijing lineage) this outbreak strain appears to be genetically very stable yet evolutionarily successful in a low endemic country such as Sweden. These findings further illustrate that the rate of genomic variation in TB can be highly strain dependent, something that can have important implications for epidemiological studies as well as development of resistance.	[Sandegren, Linus] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Groenheit, Ramona; Koivula, Tuija; Ghebremichael, Solomon; Advani, Abdolreza; Pennhag, Alexandra; Hoffner, Sven; Melefors, Ojar] Swedish Inst Infect Dis Control, Solna, Sweden; [Groenheit, Ramona; Hoffner, Sven; Mazurek, Jolanta; Melefors, Ojar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Koivula, Tuija; Castro, Elsie; Mazurek, Jolanta; Pawlowski, Andrzej] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Kan, Boris; Bruchfeld, Judith; Kallenius, Gunilla] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Solna, Sweden	Uppsala University; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Sandegren, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Linus.Sandegren@imbim.uu.se	Sandegren, Linus/K-4638-2013; Källenius, Gunilla/AGZ-3956-2022; Melefors, Öjar/N-6164-2015	Sandegren, Linus/0000-0001-7382-9782; Melefors, Öjar/0000-0003-4115-1190; Mazurek, Jolanta/0000-0001-5023-0398; Kallenius, Gunilla/0000-0002-8921-0551; Groenheit, Ramona/0000-0003-2696-437X; Pawlowski, Andrzej/0000-0003-4555-6048	Swedish Heart-Lung Foundation; Swedish Research Council; Swedish International Development Cooperation Agency	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency	This work was financed by Swedish Heart-Lung Foundation (www.hjart-lungfonden.se/); Swedish Research Council (www.vr.se/); Swedish International Development Cooperation Agency (www.sida.se/) (to GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Angeby KA, 2010, J ANTIMICROB CHEMOTH, V65, P946, DOI 10.1093/jac/dkq091; Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Beggs ML, 2000, J CLIN MICROBIOL, V38, P2923, DOI 10.1128/JCM.38.8.2923-2928.2000; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brossier F, 2006, J CLIN MICROBIOL, V44, P3659, DOI 10.1128/JCM.01054-06; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ghebremichael S, 2008, MICROBES INFECT, V10, P699, DOI 10.1016/j.micinf.2008.03.006; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Herrera-Leon L, 2005, ANTIMICROB AGENTS CH, V49, P144, DOI 10.1128/AAC.49.1.144-147.2005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Jenkins C, 2005, EMERG INFECT DIS, V11, P931; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kan B, 2008, INT J TUBERC LUNG D, V12, P199; Kato-Maeda M, 2001, GENOME RES, V11, P547, DOI 10.1101/gr.166401; Kiers A, 1997, INT J TUBERC LUNG D, V1, P239; Kim EY, 2010, J CLIN MICROBIOL, V48, P1422, DOI 10.1128/JCM.02210-09; Kocagoz T, 1996, ANTIMICROB AGENTS CH, V40, P1768, DOI 10.1128/AAC.40.8.1768; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Kong Y, 2005, J CLIN MICROBIOL, V43, P6048, DOI 10.1128/JCM.43.12.6048-6053.2005; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Lavender C, 2005, ANTIMICROB AGENTS CH, V49, P4068, DOI 10.1128/AAC.49.10.4068-4074.2005; Lillebaek T, 2004, INT J TUBERC LUNG D, V8, P1001; Marquina-Castillo B, 2009, IMMUNOLOGY, V128, P123, DOI 10.1111/j.1365-2567.2008.03004.x; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Nikolayevskyy VV, 2007, CLIN MICROBIOL INFEC, V13, P129, DOI 10.1111/j.1469-0691.2006.01583.x; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Park H, 2006, J CLIN MICROBIOL, V44, P1619, DOI 10.1128/JCM.44.5.1619-1624.2006; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Piatek AS, 2000, ANTIMICROB AGENTS CH, V44, P103, DOI 10.1128/AAC.44.1.103-110.2000; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rhee JT, 1999, J CLIN MICROBIOL, V37, P1764, DOI 10.1128/JCM.37.6.1764-1770.1999; Ruddy MC, 2004, THORAX, V59, P279, DOI 10.1136/thx.2003.010405; Ryoo SW, 2007, J MICROBIOL, V45, P268; Safi H, 2004, MOL MICROBIOL, V52, P999, DOI 10.1111/j.1365-2958.2004.04037.x; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Soto CY, 2004, J CLIN MICROBIOL, V42, P212, DOI 10.1128/JCM.42.1.212-219.2004; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; ten Bokum AMC, 2008, TRENDS MICROBIOL, V16, P436, DOI 10.1016/j.tim.2008.06.003; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Viana-Niero C, 2004, MICROBIOL-SGM, V150, P967, DOI 10.1099/mic.0.26778-0; Wall S, 1999, MICROBIOL-SGM, V145, P3169, DOI 10.1099/00221287-145-11-3169; Warren RM, 2002, J CLIN MICROBIOL, V40, P1277, DOI 10.1128/JCM.40.4.1277-1282.2002; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; *WHO, 2009, GLOB TUB CONTR SHORT; [WHO IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance], 2008, 4 WHOIUATLD GLOB PRO; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127; Yang ZH, 2005, AM J RESP CRIT CARE, V171, P1436, DOI 10.1164/rccm.200408-1147OC; Yeh RW, 1998, J INFECT DIS, V177, P1107, DOI 10.1086/517406; Yesilkaya H, 2005, J BACTERIOL, V187, P6726, DOI 10.1128/JB.187.19.6726-6732.2005; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375; 2006, MMWR MORB MORTAL WKL, V55, P301; 2006, EMERG INFECT DIS, V12, P736	79	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16647	10.1371/journal.pone.0016647	http://dx.doi.org/10.1371/journal.pone.0016647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304944	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300107
J	Sonawane, PJ; Sahu, BS; Sasi, BK; Geedi, P; Lenka, G; Mahapatra, NR				Sonawane, Parshuram J.; Sahu, Bhavani S.; Sasi, Binu K.; Geedi, Parimala; Lenka, Govinda; Mahapatra, Nitish R.			Functional Promoter Polymorphisms Govern Differential Expression of HMG-CoA Reductase Gene in Mouse Models of Essential Hypertension	PLOS ONE			English	Article							COENZYME-A REDUCTASE; ELEMENT-BINDING PROTEIN; CHROMOGRANIN-B GENE; C-FOS; TRANSCRIPTIONAL REGULATION; REAL-TIME; IN-VIVO; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; REGULATORY ELEMENTS; SIGNALING PATHWAY	3-Hydroxy-3-methylglutaryl-coenzyme A [HMG-CoA] reductase gene (Hmgcr) is a susceptibility gene for essential hypertension. Sequencing of the Hmgcr locus in genetically hypertensive BPH (blood pressure high), genetically hypotensive BPL (blood pressure low) and genetically normotensive BPN (blood pressure normal) mice yielded a number of single nucleotide polymorphisms (SNPs). BPH/BPL/BPN Hmgcr promoter-luciferase reporter constructs were generated and transfected into liver HepG2, ovarian CHO, kidney HEK-293 and neuronal N2A cells for functional characterization of the promoter SNPs. The BPH-Hmgcr promoter showed significantly less activity than the BPL-Hmgcr promoter under basal as well as nicotine/cholesterol-treated conditions. This finding was consistent with lower endogenous Hmgcr expression in liver and lower plasma cholesterol in BPH mice. Transfection experiments using 5'-promoter deletion constructs (strategically made to assess the functional significance of each promoter SNP) and computational analysis predicted lower binding affinities of transcription factors c-Fos, n-Myc and Max with the BPH-promoter as compared to the BPL-promoter. Corroboratively, the BPH promoter-luciferase reporter construct co-transfected with expression plasmids of these transcription factors displayed less pronounced augmentation of luciferase activity than the BPL construct, particularly at lower amounts of transcription factor plasmids. Electrophoretic mobility shift assays also showed diminished interactions of the BPH promoter with HepG2 nuclear proteins. Taken together, this study provides mechanistic basis for the differential Hmgcr expression in these mouse models of human essential hypertension and have implications for better understanding the role of this gene in regulation of blood pressure.	[Sonawane, Parshuram J.; Sahu, Bhavani S.; Sasi, Binu K.; Geedi, Parimala; Lenka, Govinda; Mahapatra, Nitish R.] Indian Inst Technol Madras, Dept Biotechnol, Cardiovasc Genet Lab, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Sonawane, PJ (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Cardiovasc Genet Lab, Madras, Tamil Nadu, India.	nmahapatra@iitm.ac.in	SASI, BINU K/B-3770-2008; SONAWANE, PARSHURAM/CAF-3202-2022; Mahapatra, Nitish R/D-4123-2014	SASI, BINU K/0000-0002-3325-9874; Mahapatra, Nitish R/0000-0002-0695-3510	Industrial Consultancy & Sponsored Research at IIT Madras; Council of Scientific & Industrial Research, Government of India	Industrial Consultancy & Sponsored Research at IIT Madras; Council of Scientific & Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from the Industrial Consultancy & Sponsored Research at IIT Madras and the Council of Scientific & Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEKANI AM, 1989, LIFE SCI, V44, P919, DOI 10.1016/0024-3205(89)90490-6; Auvinen M, 2003, INT J BIOCHEM CELL B, V35, P496, DOI 10.1016/S1357-2725(02)00305-9; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOCAN TMA, 1992, BIOCHIM BIOPHYS ACTA, V1123, P133, DOI 10.1016/0005-2760(92)90103-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; BUSCH SJ, 1990, J BIOL CHEM, V265, P22474; Chapman MJ, 2008, PHARMACOL THERAPEUT, V117, P354, DOI 10.1016/j.pharmthera.2007.10.004; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Chattopadhyay K, 2008, INDIAN J MED RES, V127, P571; Chen GP, 2008, ACTA PHARMACOL SIN, V29, P1181, DOI 10.1111/j.1745-7254.2008.00855.x; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; CRAIG WY, 1993, BIOCHIM BIOPHYS ACTA, V1165, P249, DOI 10.1016/0005-2760(93)90133-T; Dewar BJ, 2002, J PHARMACOL EXP THER, V301, P930, DOI 10.1124/jpet.301.3.930; Di Croce L, 1999, MOL ENDOCRINOL, V13, P1225, DOI 10.1210/me.13.8.1225; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Donnelly LA, 2008, PHARMACOGENET GENOM, V18, P1021, DOI 10.1097/FPC.0b013e3283106071; DONY C, 1987, NATURE, V328, P711, DOI 10.1038/328711a0; Engfelt WH, 1998, J LIPID RES, V39, P2182; Fielding CJ, 2001, BBA-MOL CELL BIOL L, V1533, P175, DOI 10.1016/S1388-1981(01)00162-7; Freitas RN, 2010, EUR J CARDIOV PREV R, V17, P89, DOI 10.1097/HJR.0b013e328330be77; Freitas RN, 2009, J AM SOC HYPERTENS, V3, P238, DOI 10.1016/j.jash.2009.05.001; Fries RS, 2004, HYPERTENSION, V43, P1301, DOI 10.1161/01.HYP.0000127708.96195.E6; Friese RS, 2005, AM J HYPERTENS, V18, P633, DOI 10.1016/j.amjhyper.2004.11.037; Friese RS, 2010, PHYSIOL GENOMICS, V40, P195, DOI 10.1152/physiolgenomics.00164.2009; Gauthier BR, 1998, BIOCHEM BIOPH RES CO, V247, P280, DOI 10.1006/bbrc.1998.8777; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HASHIMOTO K, 1989, ENDOCRINOLOGY, V125, P1161, DOI 10.1210/endo-125-3-1161; Hsu M, 2006, BIOCHEM BIOPH RES CO, V343, P738, DOI 10.1016/j.bbrc.2006.03.036; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Jarvis CM, 2007, J CARDIOVASC NURS, V22, P429, DOI 10.1097/01.JCN.0000297387.21626.88; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; JUREVICS HA, 1994, J LIPID RES, V35, P112; Karla N, 2004, J BIOL CHEM, V279, P25313, DOI 10.1074/jbc.M400932200; KATO K, 1990, MOL CELL BIOL, V10, P486, DOI 10.1128/MCB.10.2.486; LATHA MS, 1993, INDIAN J MED RES-B, V98, P44; Lemaire-Ewing S, 2009, CELL BIOL TOXICOL, V25, P127, DOI 10.1007/s10565-008-9063-0; Lim HH, 2001, J VASC RES, V38, P228, DOI 10.1159/000051051; Liu Q, 2007, FASEB J, V21, P61, DOI 10.1096/fj.06-5841com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSKEY KL, 1987, MOL CELL BIOL, V7, P1881, DOI 10.1128/MCB.7.5.1881; Mahapatra NR, 2006, J NEUROCHEM, V99, P119, DOI 10.1111/j.1471-4159.2006.04128.x; Mahapatra NR, 2000, ENDOCRINOLOGY, V141, P3668, DOI 10.1210/en.141.10.3668; Mahapatra NR, 2003, J BIOL CHEM, V278, P19986, DOI 10.1074/jbc.M207983200; Mayerhofer A, 2002, MICROSC RES TECHNIQ, V59, P503, DOI 10.1002/jemt.10228; Mayerhofer A, 2003, LIFE SCI, V72, P2039, DOI 10.1016/S0024-3205(03)00081-X; Medina MW, 2010, DISCOV MED, V9, P495; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; MIHYEON J, 2003, NEUROSCI RES COMMUN, V32, P11; Mule G, 2006, Minerva Cardioangiol, V54, P173; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; Ngo TT, 2002, J BIOL CHEM, V277, P33901, DOI 10.1074/jbc.M202135200; OSBORNE TF, 1991, J BIOL CHEM, V266, P13947; PARKER RA, 1990, J LIPID RES, V31, P1271; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; REYNOLDS GA, 1985, J BIOL CHEM, V260, P369; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schlager G, 1997, LAB ANIM SCI, V47, P288; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; SMITH JR, 1988, J BIOL CHEM, V263, P18480; Sweileh W, 2000, MOL BRAIN RES, V75, P293, DOI 10.1016/S0169-328X(99)00302-2; Tacer K, 2002, J LIPID RES, V43, P82; TAM SP, 1991, J BIOL CHEM, V266, P16764; Toyohara J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008961; Tsuneoka M, 1997, ONCOGENE, V14, P2301, DOI 10.1038/sj.onc.1201067; TURLEY SD, 1981, J LIPID RES, V22, P551; Valentine JD, 1996, ENDOCRINOLOGY, V137, P622, DOI 10.1210/en.137.2.622; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Walker BR, 1996, HYPERTENSION, V27, P190, DOI 10.1161/01.HYP.27.2.190; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; WENZEL A, 1991, EMBO J, V10, P3703, DOI 10.1002/j.1460-2075.1991.tb04938.x; Xu J, 2003, J PHARMACOL EXP THER, V307, P1148, DOI 10.1124/jpet.103.055178	82	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16661	10.1371/journal.pone.0016661	http://dx.doi.org/10.1371/journal.pone.0016661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304971	gold, Green Submitted, Green Published			2022-12-27	WOS:000286834300110
J	Kang, TH; Guibinga, GH; Friedmann, T				Kang, Tae Hyuk; Guibinga, Ghiabe-Henri; Friedmann, Theodore			HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene?	PLOS ONE			English	Article							LESCH-NYHAN-DISEASE; NEURAL STEM-CELLS; DOPAMINERGIC-NEURONS; PRIMARY CULTURES; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; ONTOLOGY; CATENIN; MODEL	We have used microarray-based methods of global gene expression together with quantitative PCR and Western blot analysis to identify dysregulation of genes and aberrant cellular processes in human fibroblasts and in SH-SY5Y neuroblastoma cells made HPRT-deficient by transduction with a retrovirus stably expressing an shRNA targeted against HPRT. Analysis of the microarray expression data by Gene ontology (GO) and Gene Set Enrichment Analysis (GSEA) as well as significant pathway analysis by GeneSpring GX10 and Panther Classification System reveal that HPRT deficiency is accompanied by aberrations in a variety of pathways known to regulate neurogenesis or to be implicated in neurodegenerative disease, including the canonical Wnt/beta-catenin and the Alzheimer's disease/presenilin signaling pathways. Dysregulation of the Wnt/beta-catenin pathway is confirmed by Western blot demonstration of cytosolic sequestration of beta-catenin during in vitro differentiation of the SH-SY5Y cells toward the neuronal phenotype. We also demonstrate that two key transcription factor genes known to be regulated by Wnt signaling and to be vital for the generation and function of dopaminergic neurons; i.e., Lmx1a and Engrailed 1, are down-regulated in the HPRT knockdown SH-SY5Y cells. In addition to the Wnt signaling aberration, we found that expression of presenilin-1 shows severely aberrant expression in HPRT-deficient SH-SY5Y cells, reflected by marked deficiency of the 23 kDa C-terminal fragment of presenilin-1 in knockdown cells. Western blot analysis of primary fibroblast cultures from two LND patients also shows dysregulated presenilin-1 expression, including aberrant proteolytic processing of presenilin-1. These demonstrations of dysregulated Wnt signaling and presenilin-1 expression together with impaired expression of dopaminergic transcription factors reveal broad pleitropic neuro-regulatory defects played by HPRT expression and suggest new directions for investigating mechanisms of aberrant neurogenesis and neuropathology in LND and potential new targets for restoration of effective signaling in this neuro-developmental defect.	[Kang, Tae Hyuk] Univ Calif San Diego, San Diego Sch Med, Dept Pediat, Ctr Neural Circuit & Behav, La Jolla, CA 92093 USA; Univ Calif San Diego, San Diego Sch Med, San Diego Rady Childrens Hosp, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Kang, TH (corresponding author), Univ Calif San Diego, San Diego Sch Med, Dept Pediat, Ctr Neural Circuit & Behav, La Jolla, CA 92093 USA.	tfriedmann@ucsd.edu	Pillay, Nischalan/F-9536-2012; Xie, Huangming/B-2260-2012		National Institutes of Health (NIH) [DK082840]; Lesch Nyhan Disease Children's Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lesch Nyhan Disease Children's Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies have been supported by National Institutes of Health (NIH) DK082840 and by the Lesch Nyhan Disease Children's Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boer P, 2001, NEUROSCI LETT, V303, P45, DOI 10.1016/S0304-3940(01)01716-5; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Castelo-Branco G, 2006, NEURODEGENER DIS, V3, P5, DOI 10.1159/000092086; Ceballos-Picot I, 2009, HUM MOL GENET, V18, P2317, DOI 10.1093/hmg/ddp164; Cristini S, 2010, HUM MOL GENET, V19, P1939, DOI 10.1093/hmg/ddq072; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; Ernst M, 1996, NEW ENGL J MED, V334, P1568, DOI 10.1056/NEJM199606133342403; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jinnah HA, 2006, BRAIN, V129, P1201, DOI 10.1093/brain/awl056; JINNAH HA, 2000, METABOLIC MOL BASES, P2537; Kiewe P, 2009, ANN HEMATOL, V88, P1177, DOI 10.1007/s00277-009-0751-5; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lewers JC, 2008, NEUROSCIENCE, V152, P761, DOI 10.1016/j.neuroscience.2007.10.065; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; LLOYD KG, 1981, NEW ENGL J MED, V305, P1106, DOI 10.1056/NEJM198111053051902; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Martorana A, 2009, NEUROPSYCHOPHARMACOL, V34, P2323, DOI 10.1038/npp.2009.60; MEREDITH JE, 2010, BIOCHEM BIOPH RES CO, V299, P744; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murayama M, 1998, FEBS LETT, V433, P73, DOI 10.1016/S0014-5793(98)00886-2; PAGE T, 1982, CLIN CHEM, V28, P1181; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Reeves S, 2010, NEUROBIOL DIS, V37, P477, DOI 10.1016/j.nbd.2009.11.005; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; ROSE SD, 2006, NATURE METHOD, DOI DOI 10.1038/NMETH919; Saito Y, 1999, NEUROPEDIATRICS, V30, P66, DOI 10.1055/s-2007-973462; Sanfilippo Antonio, 2009, International Journal of Computational Biology and Drug Design, V2, P221, DOI 10.1504/IJCBDD.2009.030114; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Small DH, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-7; Smith DW, 2007, METAB BRAIN DIS, V22, P39, DOI 10.1007/s11011-007-9044-7; Smith DW, 2000, MOL THER, V1, P486, DOI 10.1006/mthe.2000.0057; Song S, 2007, MOL THER, V15, P1432, DOI 10.1038/sj.mt.6300199; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; STROOPER BD, 2001, J CELL BIOL, V152, pF17; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S23; Uemura K, 2003, J NEUROSCI RES, V73, P166, DOI 10.1002/jnr.10641; Visser JE, 2002, DEV BRAIN RES, V133, P127, DOI 10.1016/S0165-3806(02)00280-8; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Wong DF, 1996, P NATL ACAD SCI USA, V93, P5539, DOI 10.1073/pnas.93.11.5539; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	48	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16572	10.1371/journal.pone.0016572	http://dx.doi.org/10.1371/journal.pone.0016572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305049	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100045
J	Mattiuzzo, M; Vargiu, G; Totta, P; Fiore, M; Ciferri, C; Musacchio, A; Degrassi, F				Mattiuzzo, Marta; Vargiu, Giulia; Totta, Pierangela; Fiore, Mario; Ciferri, Claudio; Musacchio, Andrea; Degrassi, Francesca			Abnormal Kinetochore-Generated Pulling Forces from Expressing a N-Terminally Modified Hec1	PLOS ONE			English	Article							SPINDLE-POLE ORGANIZATION; CULTURED-MAMMALIAN-CELLS; MICROTUBULE ATTACHMENT; NDC80 COMPLEX; CHROMOSOME CONGRESSION; MITOTIC PROGRESSION; CENP-E; FLUORESCENT PROTEIN; CANCER; CHECKPOINT	Background: Highly Expressed in Cancer protein 1 (Hec1) is a constituent of the Ndc80 complex, a kinetochore component that has been shown to have a fundamental role in stable kinetochore-microtubule attachment, chromosome alignment and spindle checkpoint activation at mitosis. HEC1 RNA is found up-regulated in several cancer cells, suggesting a role for HEC1 deregulation in cancer. In light of this, we have investigated the consequences of experimentally-driven Hec1 expression on mitosis and chromosome segregation in an inducible expression system from human cells. Methodology/Principal Findings: Overexpression of Hec1 could never be obtained in HeLa clones inducibly expressing C-terminally tagged Hec1 or untagged Hec1, suggesting that Hec1 cellular levels are tightly controlled. On the contrary, a chimeric protein with an EGFP tag fused to the Hec1 N-terminus accumulated in cells and disrupted mitotic division. EGFP-Hec1 cells underwent altered chromosome segregation within multipolar spindles that originated from centriole splitting. We found that EGFP-Hec1 assembled a mutant Ndc80 complex that was unable to rescue the mitotic phenotypes of Hec1 depletion. Kinetochores harboring EGFP-Hec1 formed persisting lateral microtubule-kinetochore interactions that recruited the plus-end depolymerase MCAK and the microtubule stabilizing protein HURP on K-fibers. In these conditions the plus-end kinesin CENP-E was preferentially retained at kinetochores. RNAi-mediated CENP-E depletion further demonstrated that CENP-E function was required for multipolar spindle formation in EGFP-Hec1 expressing cells. Conclusions/Significance: Our study suggests that modifications on Hec1 N-terminal tail can alter kinetochore-microtubule attachment stability and influence Ndc80 complex function independently from the intracellular levels of the protein. N-terminally modified Hec1 promotes spindle pole fragmentation by CENP-E-mediated plus-end directed kinetochore pulling forces that disrupt the fine balance of kinetochore-and centrosome-associated forces regulating spindle bipolarity. Overall, our findings support a model in which centrosome integrity is influenced by the pathways regulating kinetochore-microtubule attachment stability.	[Mattiuzzo, Marta; Vargiu, Giulia; Totta, Pierangela; Fiore, Mario; Degrassi, Francesca] Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy; [Mattiuzzo, Marta; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Ciferri, Claudio] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS European Institute of Oncology (IEO); University of California System; University of California Berkeley	Mattiuzzo, M (corresponding author), Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy.	f.degrassi@caspur.it	Totta, Pierangela/I-3251-2018	Totta, Pierangela/0000-0001-7826-4733; Musacchio, Andrea/0000-0003-2362-8784	Italian Association for Cancer Research (AIRC) [IG 4809]; Italian Ministry of Health	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research (AIRC, IG 4809) and the Italian Ministry of Health to F. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ferretti C, 2010, CELL CYCLE, V9, P4174, DOI 10.4161/cc.9.20.13457; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Harborth J, 2001, J CELL SCI, V114, P4557; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Huang Y, 2009, CELL CYCLE, V8, P2643, DOI 10.4161/cc.8.16.9366; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Kaneko N, 2009, BIOCHEM BIOPH RES CO, V390, P1235, DOI 10.1016/j.bbrc.2009.10.127; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Mao YH, 2010, CELL CYCLE, V9, P715, DOI 10.4161/cc.9.4.10763; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; PUCKEY FR, 2002, DEV CELL, V3, P351; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; TANAKA TU, 2008, CURR OPIN CELL BIOL, V19, P1; Tanenbaum ME, 2008, EMBO J, V27, P3235, DOI 10.1038/emboj.2008.242; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Torosantucci L, 2009, J CELL SCI, V122, P3455, DOI 10.1242/jcs.047944; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walczak CE, 2003, MOL CELL, V11, P286, DOI 10.1016/S1097-2765(03)00067-4; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003; Wu GK, 2009, MOL BIOL CELL, V20, P4686, DOI 10.1091/mbc.E08-11-1123; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	67	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16307	10.1371/journal.pone.0016307	http://dx.doi.org/10.1371/journal.pone.0016307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297979	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100022
J	Ramanathan, A; Savol, AJ; Langmead, CJ; Agarwal, PK; Chennubhotla, CS				Ramanathan, Arvind; Savol, Andrej J.; Langmead, Christopher J.; Agarwal, Pratul K.; Chennubhotla, Chakra S.			Discovering Conformational Sub-States Relevant to Protein Function	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY LANDSCAPE; INTRINSIC DYNAMICS; CIS/TRANS ISOMERIZATION; ATOMIC FLUCTUATIONS; FERROCYTOCHROME-C; FORCE-FIELD; T4 LYSOZYME; MOTIONS; ANHARMONICITY	Background: Internal motions enable proteins to explore a range of conformations, even in the vicinity of native state. The role of conformational fluctuations in the designated function of a protein is widely debated. Emerging evidence suggests that sub-groups within the range of conformations (or sub-states) contain properties that may be functionally relevant. However, low populations in these sub-states and the transient nature of conformational transitions between these sub-states present significant challenges for their identification and characterization. Methods and Findings: To overcome these challenges we have developed a new computational technique, quasi-anharmonic analysis (QAA). QAA utilizes higher-order statistics of protein motions to identify sub-states in the conformational landscape. Further, the focus on anharmonicity allows identification of conformational fluctuations that enable transitions between sub-states. QAA applied to equilibrium simulations of human ubiquitin and T4 lysozyme reveals functionally relevant sub-states and protein motions involved in molecular recognition. In combination with a reaction pathway sampling method, QAA characterizes conformational sub-states associated with cis/trans peptidyl-prolyl isomerization catalyzed by the enzyme cyclophilin A. In these three proteins, QAA allows identification of conformational sub-states, with critical structural and dynamical features relevant to protein function. Conclusions: Overall, QAA provides a novel framework to intuitively understand the biophysical basis of conformational diversity and its relevance to protein function.	[Ramanathan, Arvind; Agarwal, Pratul K.] Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA; [Ramanathan, Arvind; Agarwal, Pratul K.] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN USA; [Savol, Andrej J.; Chennubhotla, Chakra S.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Savol, Andrej J.] Carnegie Mellon Univ Univ Pittsburgh Ph D Program, Pittsburgh, PA USA; [Langmead, Christopher J.] Carnegie Mellon Univ, Sch Comp Sci, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Ramanathan, Arvind; Langmead, Christopher J.] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Ramanathan, A (corresponding author), Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA.	agarwalpk@ornl.gov; chakracs@pitt.edu	Ramanathan, Arvind/E-5388-2010	Agarwal, Pratul/0000-0002-3848-9492; Langmead, Christopher/0000-0001-7521-6736	National Institutes of Health [1RC2GM093307]; NIH [T32 EB009403]; HHMI-NIBIB Interfaces Initiative; ORNLs Laboratory Directed Research and Development (LDRD); U.S. Department of Energy [DEAC05-00OR22725]; NSF Teragrid;  [R01 GM086238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238, RC2GM093307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI-NIBIB Interfaces Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); ORNLs Laboratory Directed Research and Development (LDRD); U.S. Department of Energy(United States Department of Energy (DOE)); NSF Teragrid(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AR was supported by National Institutes of Health 1RC2GM093307 to CJL. AJS was a predoctoral trainee supported by NIH T32 training grant T32 EB009403 as part of the HHMI-NIBIB Interfaces Initiative. PKA acknowledges the support by ORNLs Laboratory Directed Research and Development (LDRD) funds and the computing time allocation from the National Center for Computational Sciences (BIP003). ORNL is managed by UT-Battelle, LLC for the U.S. Department of Energy under Contract No. DEAC05-00OR22725. CSC was partially supported by R01 GM086238 (PI: Bahar, Co-PI: Chennubhotla). CSC is grateful for the simulation time allocated via startup allocation grant on NSF Teragrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-2; Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Agarwal PK, 2004, BIOCHEMISTRY-US, V43, P10605, DOI 10.1021/bi0495228; Agarwal PK, 2004, PROTEINS, V56, P449, DOI 10.1002/prot.20135; Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Altis A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2746330; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amari S, 1996, ADV NEUR IN, V8, P757; Arora K, 2009, J AM CHEM SOC, V131, P5642, DOI 10.1021/ja9000135; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I., 2003, MATH COMPUTATIONAL B; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERWEGER CD, 1995, CHEM PHYS LETT, V232, P429, DOI 10.1016/0009-2614(94)01391-8; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bowers K.J., 2006, SCALABLE ALGORITHMS; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Cannon WR, 1998, J BIOL CHEM, V273, P26257, DOI 10.1074/jbc.273.41.26257; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chen Y, 2003, J PHYS CHEM B, V107, P7947, DOI 10.1021/jp022406z; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113; FAURE P, 1994, NAT STRUCT BIOL, V1, P124, DOI 10.1038/nsb0294-124; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Ferguson AL, 2010, P NATL ACAD SCI USA, V107, P13597, DOI 10.1073/pnas.1003293107; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Golub GH., 2013, MATRIX COMPUTATIONS; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hastie T., 2009, UNSUPERVISED LEARNIN; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hub JS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000480; ICHIYE T, 1987, PROTEINS, V2, P236, DOI 10.1002/prot.340020308; ICHIYE T, 1988, BIOCHEMISTRY-US, V27, P3487, DOI 10.1021/bi00409a054; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KAMATH G, 2010, BIOCHEMISTR IN PRESS; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kong YF, 2007, STRUCTURE, V15, P611, DOI 10.1016/j.str.2007.04.002; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Lange OF, 2006, J PHYS CHEM B, V110, P22842, DOI 10.1021/jp062548j; Leitner D. M., 2010, PROTEINS ENERGY HEAT; Maisuradze GG, 2007, PROTEINS, V67, P569, DOI 10.1002/prot.21344; MAO B, 1982, BIOPOLYMERS, V21, P1979, DOI 10.1002/bip.360211005; Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668; Materese CK, 2008, P NATL ACAD SCI USA, V105, P10659, DOI 10.1073/pnas.0801850105; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; McLachlan G. J., 1988, MIXTURE MODELS INFER, V84; Moritsugu K, 2000, PHYS REV LETT, V85, P3970, DOI 10.1103/PhysRevLett.85.3970; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Nabney I.T., 2003, NETLAB ALGORITHMS PA; NORTHRUP SH, 1981, J MOL BIOL, V153, P1087, DOI 10.1016/0022-2836(81)90469-1; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petsko GA, 2000, CURR OPIN CHEM BIOL, V4, P89, DOI 10.1016/S1367-5931(99)00057-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST CB, 1986, J AM CHEM SOC, V108, P1317, DOI 10.1021/ja00266a044; POST CB, 1986, J MOL BIOL, V190, P455, DOI 10.1016/0022-2836(86)90015-X; Ramanathan A, 2009, J PHYS CHEM B, V113, P16669, DOI 10.1021/jp9077213; SCHRODER GF, 2004, THESIS U GOTTINGEN; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Shehu A, 2009, PROTEINS, V76, P837, DOI 10.1002/prot.22390; Shirts MR, 2001, PHYS REV LETT, V86, P4983, DOI 10.1103/PhysRevLett.86.4983; Stamati H, 2010, PROTEINS, V78, P223, DOI 10.1002/prot.22526; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X	82	53	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e15827	10.1371/journal.pone.0015827	http://dx.doi.org/10.1371/journal.pone.0015827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297978	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000286664100010
J	Temperton, B; Gilbert, JA; Quinn, JP; McGrath, JW				Temperton, Ben; Gilbert, Jack A.; Quinn, John P.; McGrath, John W.			Novel Analysis of Oceanic Surface Water Metagenomes Suggests Importance of Polyphosphate Metabolism in Oligotrophic Environments	PLOS ONE			English	Article							PHOSPHATE ACQUISITION GENES; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; MARINE-BACTERIA; GENOME SEQUENCE; FORCE DRIVES; PHOSPHORUS; KINASE; DATABASE; TRANSPORT	Polyphosphate is a ubiquitous linear homopolymer of phosphate residues linked by high-energy bonds similar to those found in ATP. It has been associated with many processes including pathogenicity, DNA uptake and multiple stress responses across all domains. Bacteria have also been shown to use polyphosphate as a way to store phosphate when transferred from phosphate-limited to phosphate-rich media - a process exploited in wastewater treatment and other environmental contaminant remediation. Despite this, there has, to date, been little research into the role of polyphosphate in the survival of marine bacterioplankton in oligotrophic environments. The three main proteins involved in polyphosphate metabolism, Ppk1, Ppk2 and Ppx are multi-domain and have differential inter-domain and inter-gene conservation, making unbiased analysis of relative abundance in metagenomic datasets difficult. This paper describes the development of a novel Isofunctional Homolog Annotation Tool (IHAT) to detect homologs of genes with a broad range of conservation without bias of traditional expect-value cutoffs. IHAT analysis of the Global Ocean Sampling (GOS) dataset revealed that genes associated with polyphosphate metabolism are more abundant in environments where available phosphate is limited, suggesting an important role for polyphosphate metabolism in marine oligotrophs.	[Temperton, Ben; Quinn, John P.; McGrath, John W.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Temperton, Ben] Plymouth Marine Lab, Plymouth, Devon, England	Queens University Belfast; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Plymouth Marine Laboratory	Temperton, B (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	btemperton@gmail.com	Temperton, Ben/AAE-2785-2021; Gilbert, Jack/AAF-3270-2019	Temperton, Ben/0000-0002-3667-8302	Northern Ireland Department of Education and Learning	Northern Ireland Department of Education and Learning	This work was supported by the Northern Ireland Department of Education and Learning Programme for Government Studentship (www.delni.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; Beszteri B, 2010, ISME J, V4, P1075, DOI 10.1038/ismej.2010.29; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Crawley M. J, 2002, STAT COMPUTING INTRO; Dyhrman ST, 2007, OCEANOGRAPHY, V20, P110, DOI 10.5670/oceanog.2007.54; Eddy Sean R, 2009, Genome Inform, V23, P205; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P111, DOI 10.1111/j.1462-2920.2008.01745.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gorley C.K., 2006, GETTING STARTED PRIM; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; HAROLD FM, 1964, J GEN MICROBIOL, V35, P81, DOI 10.1099/00221287-35-1-81; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jensen R.A., 2001, GENOME BIOL, V2, P1002, DOI DOI 10.3201/eid1412.080591; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lindsey JK, 1999, J ROY STAT SOC C-APP, V48, P553, DOI 10.1111/1467-9876.00171; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Malekzadeh F, 2002, WORLD J MICROB BIOT, V18, P295, DOI 10.1023/A:1015215718810; MALONEY PC, 1974, P NATL ACAD SCI USA, V71, P3896, DOI 10.1073/pnas.71.10.3896; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; McGrath JW, 2003, ADV APPL MICROBIOL, V52, P75, DOI 10.1016/S0065-2164(03)01003-7; McMahon KD, 2002, APPL ENVIRON MICROB, V68, P4971, DOI 10.1128/AEM.68.10.4971-4978.2002; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; Miyake T, 1999, DNA Res, V6, P103; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Nagata T, 2006, APPL MICROBIOL BIOT, V72, P777, DOI 10.1007/s00253-006-0336-3; Nahalka J, 2009, ORG BIOMOL CHEM, V7, P1778, DOI 10.1039/b822549b; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Oksanen J., 2007, R PACKAGE VERSION, V1, P8; Orchard ED, 2010, LIMNOL OCEANOGR, V55, P2161, DOI 10.4319/lo.2010.55.5.2161; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; Pinney JW, 2005, NUCLEIC ACIDS RES, V33, P1399, DOI 10.1093/nar/gki285; Quinn JP, 2007, ENVIRON MICROBIOL, V9, P2392, DOI 10.1111/j.1462-2920.2007.01397.x; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Shiba T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P315; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tetu SG, 2009, ISME J, V3, P835, DOI 10.1038/ismej.2009.31; Thomas S, 2010, ISME J, V4, P459, DOI 10.1038/ismej.2009.129; Trelstad PL, 1999, APPL ENVIRON MICROB, V65, P3780; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; White AE, 2009, P NATL ACAD SCI USA, V106, P21013, DOI 10.1073/pnas.0912475107; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	70	41	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16499	10.1371/journal.pone.0016499	http://dx.doi.org/10.1371/journal.pone.0016499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305044	gold, Green Submitted, Green Published			2022-12-27	WOS:000286664100039
J	Bjorkman, C; Kindvall, O; Hoglund, S; Lilja, A; Barring, L; Eklund, K				Bjorkman, Christer; Kindvall, Oskar; Hoglund, Solveig; Lilja, Anna; Barring, Lars; Eklund, Karin			High Temperature Triggers Latent Variation among Individuals: Oviposition Rate and Probability for Outbreaks	PLOS ONE			English	Article							EPIRRITA-AUTUMNATA LEPIDOPTERA; LIFE-HISTORY TRAITS; CLIMATE-CHANGE; CHITTY HYPOTHESIS; COUPLED MODEL; UNCERTAINTIES; CIRCULATION; SENSITIVITY; RESOLUTION; EVOLUTION	Background: It is anticipated that extreme population events, such as extinctions and outbreaks, will become more frequent as a consequence of climate change. To evaluate the increased probability of such events, it is crucial to understand the mechanisms involved. Variation between individuals in their response to climatic factors is an important consideration, especially if microevolution is expected to change the composition of populations. Methodology/Principal Findings: Here we present data of a willow leaf beetle species, showing high variation among individuals in oviposition rate at a high temperature (20 degrees C). It is particularly noteworthy that not all individuals responded to changes in temperature; individuals laying few eggs at 20 degrees C continued to do so when transferred to 12 degrees C, whereas individuals that laid many eggs at 20 degrees C reduced their oviposition and laid the same number of eggs as the others when transferred to 12 degrees C. When transferred back to 20 degrees C most individuals reverted to their original oviposition rate. Thus, high variation among individuals was only observed at the higher temperature. Using a simple population model and based on regional climate change scenarios we show that the probability of outbreaks increases if there is a realistic increase in the number of warm summers. The probability of outbreaks also increased with increasing heritability of the ability to respond to increased temperature. Conclusions/Significance: If climate becomes warmer and there is latent variation among individuals in their temperature response, the probability for outbreaks may increase. However, the likelihood for microevolution to play a role may be low. This conclusion is based on the fact that it has been difficult to show that microevolution affect the probability for extinctions. Our results highlight the urge for cautiousness when predicting the future concerning probabilities for extreme population events.	[Bjorkman, Christer; Hoglund, Solveig; Eklund, Karin] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Kindvall, Oskar] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden; [Lilja, Anna; Barring, Lars] Swedish Meteorol & Hydrol Inst, Rossby Ctr, Norrkoping, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish Meteorological & Hydrological Institute	Bjorkman, C (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	christer.bjorkman@slu.se			Mistra Future Forests [FOR 2008/019]; Formas [217-2005-1326]; Swedish Energy Agency [30599-1]; Mistra-SWECIA [FOR 2006/160]	Mistra Future Forests; Formas(Swedish Research Council Formas); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Mistra-SWECIA	Funding for this work was provided by the following: 1. Dnr FOR 2008/019 (Mistra Future Forests) - http://www.mistra.org/mistraenglish/research.4.39aa239f11a8dd8de6b80004117.html. 2. Dnr 217-2005-1326 (Formas) - http://www.formas.se/default_529.aspx. 3. Proj.nr. 30599-1 (Swedish Energy Agency) http://www. energimyndigheten.se/en/. 4. Dnr FOR 2006/160 (Mistra-SWECIA) - http://www.mistra.org/mistraenglish/research.4.39aa239f11a8dd8de6b80004117.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewartha H.G., 1954, DISTRIBUTION ABUNDAN, P782; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Berggren A, 2009, OIKOS, V118, P1121, DOI 10.1111/j.1600-0706.2009.17558.x; Berryman A.A., 1987, P3; Bjorkman C, 2006, AGR FOREST ENTOMOL, V8, P97, DOI 10.1111/j.1461-9555.2006.00288.x; Bjorkman C, 2000, POPUL ECOL, V42, P91, DOI 10.1007/s101440050013; Bjorkman C, 2004, ECOL APPL, V14, P1624, DOI 10.1890/03-5341; Bjorkman C., 2000, Agricultural and Forest Entomology, V2, P131, DOI 10.1046/j.1461-9563.2000.00058.x; BLECK R, 1992, J PHYS OCEANOGR, V22, P1486, DOI 10.1175/1520-0485(1992)022<1486:SDTTIA>2.0.CO;2; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BOONSTRA R, 1987, EVOLUTION, V41, P929, DOI 10.1111/j.1558-5646.1987.tb05868.x; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Chu Y.-I., 1986, P77; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Dalin P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005487; Deque M, 2007, CLIMATIC CHANGE, V81, P53, DOI 10.1007/s10584-006-9228-x; DEQUE M, 1994, CLIM DYNAM, V10, P249, DOI 10.1007/BF00208992; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fleming RA, 1998, ENVIRON MONIT ASSESS, V49, P235, DOI 10.1023/A:1005818108382; Gibelin AL, 2003, CLIM DYNAM, V20, P327, DOI 10.1007/s00382-002-0277-1; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Holopainen JK, 2004, CAN J FOREST RES, V34, P94, DOI [10.1139/x03-203, 10.1139/X03-203]; Hourdin F, 2006, CLIM DYNAM, V27, P787, DOI 10.1007/s00382-006-0158-0; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; KENDALL DA, 1996, BM40048714REP ETSU H, P44; Kjellstrom E., 2005, 140 YEAR SIMULATION; Kjellstrom E, 2011, TELLUS A, V63, P24, DOI 10.1111/j.1600-0870.2010.00475.x; KREBS CJ, 1978, CAN J ZOOL, V56, P2463, DOI 10.1139/z78-335; Larsson S, 2000, OIKOS, V89, P440, DOI 10.1034/j.1600-0706.2000.890303.x; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; MAISNER N, 1974, FORSTSCHADLINGE EURO, V2, P202; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; NILSSEN A, 1990, ENTOMOL EXP APPL, V57, P39, DOI 10.1007/BF00349594; OHGUSHI T, 1995, POPULATION DYNAMICS, P251; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Peterson NA, 1996, ENVIRON ENTOMOL, V25, P147, DOI 10.1093/ee/25.1.147; Rall BC, 2010, GLOBAL CHANGE BIOL, V16, P2145, DOI 10.1111/j.1365-2486.2009.02124.x; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Roff Derek A., 1992; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Roy M, 2003, BIOCONTROL, V48, P57, DOI 10.1023/A:1021289832664; RUOHOMAKI K, 1992, ECOL ENTOMOL, V17, P69, DOI 10.1111/j.1365-2311.1992.tb01041.x; Samuelsson P, 2011, TELLUS A, V63, P4, DOI 10.1111/j.1600-0870.2010.00478.x; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; *SMHI, 1999, WEATH WAT; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tenow O, 1999, J APPL ECOL, V36, P111, DOI 10.1046/j.1365-2664.1999.00385.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; WATT WB, 1992, P NATL ACAD SCI USA, V89, P10608, DOI 10.1073/pnas.89.22.10608; WILLIAMS DW, 1995, ENVIRON ENTOMOL, V24, P1, DOI 10.1093/ee/24.1.1; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	60	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16590	10.1371/journal.pone.0016590	http://dx.doi.org/10.1371/journal.pone.0016590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304605	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900078
J	Kawashita, E; Tsuji, D; Toyoshima, M; Kanno, Y; Matsuno, H; Itoh, K				Kawashita, Eri; Tsuji, Daisuke; Toyoshima, Masahiro; Kanno, Yosuke; Matsuno, Hiroyuki; Itoh, Kohji			Prostaglandin E2 Reverses Aberrant Production of an Inflammatory Chemokine by Microglia from Sandhoff Disease Model Mice through the cAMP-PKA Pathway	PLOS ONE			English	Article							MOUSE MODELS; TAY-SACHS; EPAC; PROTEIN-1-ALPHA; RECEPTOR; NEURODEGENERATION; PATHOGENESIS; EXPRESSION; CELLS; RAP1	Background: Sandhoff disease (SD) is a neurodegenerative lysosomal beta-hexosaminidase (Hex) deficiency involving excessive accumulation of undegraded substrates, including terminal GlcNAc-oligosaccharides and GM2 ganglioside. Microglia-mediated neuroinflammation contributes to the pathogenesis and progression of SD. Our previous study demonstrated that MIP-1 alpha, a putative pathogenic factor for SD, is up-regulated in microglial cells derived from SD model mice (SD-Mg) through activation of Akt and JNK. Methodology/Principal Findings: In this study, we first demonstrated that prostaglandin E2 (PGE2), which is one of the lipid mediators derived from arachidonic acid and is known to suppress activation of microglia, reduced the aberrant MIP-1 alpha production by SD-Mg to the same level as by WT-Mg. PGE2 also attenuated the activation of Akt and JNK. The inhibition of MIP-1 alpha production and the activation of Akt and JNK occurred through the EP2 and 4/cAMP/PKA signaling pathway in the murine microglia derived from SD model mice. Conclusions/Significance: We propose that PGE2 plays a role as a negative regulator of MIP-1 alpha production in the pathogenesis of SD, and that PGE2-EP2 and 4/cAMP/PKA signaling could be a target pathway for therapy for SD.	[Kawashita, Eri; Tsuji, Daisuke; Toyoshima, Masahiro; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Res, Dept Med Biotechnol, Tokushima 770, Japan; [Kawashita, Eri; Kanno, Yosuke; Matsuno, Hiroyuki] Doshisha Womens Collage Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pathol Biochem, Kyoto, Japan; [Tsuji, Daisuke; Itoh, Kohji] Natl Inst Biomed Innovat NIBIO, Osaka, Japan	Tokushima University	Kawashita, E (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Res, Dept Med Biotechnol, Tokushima 770, Japan.	kitoh@ph.tokushima-u.ac.jp	Tsuji, Daisuke/F-7085-2013	Tsuji, Daisuke/0000-0002-1528-7820	National Institute of Biomedical Innovation (NIBIO, Osaka, Japan); Grants-in-Aid for Scientific Research [22790318] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO, Osaka, Japan)(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funding supporting this work is the Program for Promotion of Fundamental Studied Health Sciences of the National Institute of Biomedical Innovation (NIBIO, Osaka, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Caggiano AO, 1999, J NEUROCHEM, V72, P565, DOI 10.1046/j.1471-4159.1999.0720565.x; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Jing H, 2004, J BIOL CHEM, V279, P55176, DOI 10.1074/jbc.M409816200; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Kawashita E, 2009, J NEUROCHEM, V109, P1215, DOI 10.1111/j.1471-4159.2009.06041.x; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Li J, 2008, NEUROSCI LETT, V438, P210, DOI 10.1016/j.neulet.2008.04.054; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Matsuoka K, 2010, MOL THER, V18, P1519, DOI 10.1038/mt.2010.113; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tsuji D, 2005, J NEUROCHEM, V92, P1497, DOI 10.1111/j.1471-4159.2005.02986.x; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wortmann SB, 2009, J INHERIT M IN PRESS; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101	32	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16269	10.1371/journal.pone.0016269	http://dx.doi.org/10.1371/journal.pone.0016269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298000	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900027
J	Leppiniemi, J; Maatta, JAE; Hammaren, H; Soikkeli, M; Laitaoja, M; Janis, J; Kulomaa, MS; Hytonen, VP				Leppiniemi, Jenni; Maatta, Juha A. E.; Hammaren, Henrik; Soikkeli, Mikko; Laitaoja, Mikko; Janis, Janne; Kulomaa, Markku S.; Hytonen, Vesa P.			Bifunctional Avidin with Covalently Modifiable Ligand Binding Site	PLOS ONE			English	Article							CIRCULARLY PERMUTED AVIDINS; BIOTIN-BINDING; CHICKEN AVIDIN; CRYSTAL-STRUCTURE; QUATERNARY STRUCTURE; HIGH-AFFINITY; CHAIN AVIDIN; STREPTAVIDIN; PROTEIN; COMPLEX	The extensive use of avidin and streptavidin in life sciences originates from the extraordinary tight biotin-binding affinity of these tetrameric proteins. Numerous studies have been performed to modify the biotin-binding affinity of (strept) avidin to improve the existing applications. Even so, (strept) avidin greatly favours its natural ligand, biotin. Here we engineered the biotin-binding pocket of avidin with a single point mutation S16C and thus introduced a chemically active thiol group, which could be covalently coupled with thiol-reactive molecules. This approach was applied to the previously reported bivalent dual chain avidin by modifying one binding site while preserving the other one intact. Maleimide was then coupled to the modified binding site resulting in a decrease in biotin affinity. Furthermore, we showed that this thiol could be covalently coupled to other maleimide derivatives, for instance fluorescent labels, allowing intratetrameric FRET. The bifunctional avidins described here provide improved and novel tools for applications such as the biofunctionalization of surfaces.	[Leppiniemi, Jenni; Maatta, Juha A. E.; Hammaren, Henrik; Soikkeli, Mikko; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Leppiniemi, Jenni; Maatta, Juha A. E.; Hammaren, Henrik; Soikkeli, Mikko; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Laitaoja, Mikko; Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Eastern Finland	Leppiniemi, J (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Leppiniemi, Jenni/A-6641-2016; Hytonen, Vesa P./E-8855-2013; Jänis, Janne/B-7326-2014; Kulomaa, Markku S/C-9063-2014; Leppiniemi, Jenni/S-6262-2019; Määttä, Juha/A-6629-2016	Leppiniemi, Jenni/0000-0002-7225-1648; Hytonen, Vesa P./0000-0002-9357-1480; Leppiniemi, Jenni/0000-0002-7225-1648; Määttä, Juha/0000-0003-3885-6149; Laitaoja, Mikko/0000-0003-4516-8627; Hammaren, Henrik/0000-0002-8534-2530	Tampere Graduate Program in Biomedicine and Biotechnology; Academy of Finland [SA 121236, SA 115976]; Finnish Funding Agency for Technology and Innovation [TEKES 40055/08]	Tampere Graduate Program in Biomedicine and Biotechnology; Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by Tampere Graduate Program in Biomedicine and Biotechnology, the Academy of Finland [SA 121236, SA 115976] and the Finnish Funding Agency for Technology and Innovation [TEKES 40055/08]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; Aslan FM, 2005, P NATL ACAD SCI USA, V102, P8507, DOI 10.1073/pnas.0503112102; BAYER EA, 1995, BBA-GENE STRUCT EXPR, V1263, P60, DOI 10.1016/0167-4781(95)00077-T; Dixon RW, 2002, J ORG CHEM, V67, P1827, DOI 10.1021/jo991846s; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Freitag S, 1999, P NATL ACAD SCI USA, V96, P8384, DOI 10.1073/pnas.96.15.8384; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Gruber HJ, 1998, BBA-GEN SUBJECTS, V1381, P203, DOI 10.1016/S0304-4165(98)00029-4; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Hyre DE, 2000, PROTEIN SCI, V9, P878, DOI 10.1110/ps.9.5.878; Hytonen VP, 2006, J MOL BIOL, V359, P1352, DOI 10.1016/j.jmb.2006.04.044; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; Kada G, 1999, BBA-GEN SUBJECTS, V1427, P33, DOI 10.1016/S0304-4165(98)00178-0; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Kopetzki E, 2002, Patent, Patent No. [US6391571 (B1), 6391571]; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Marttila AT, 2003, BIOCHEM J, V369, P249, DOI 10.1042/BJ20020886; Morag E, 1996, BIOCHEM J, V316, P193, DOI 10.1042/bj3160193; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Reznik GO, 1998, P NATL ACAD SCI USA, V95, P13525, DOI 10.1073/pnas.95.23.13525; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5	31	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16576	10.1371/journal.pone.0016576	http://dx.doi.org/10.1371/journal.pone.0016576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305032	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900076
J	Saathoff, AJ; Sarath, G; Chow, EK; Dien, BS; Tobias, CM				Saathoff, Aaron J.; Sarath, Gautam; Chow, Elaine K.; Dien, Bruce S.; Tobias, Christian M.			Downregulation of Cinnamyl-Alcohol Dehydrogenase in Switchgrass by RNA Silencing Results in Enhanced Glucose Release after Cellulase Treatment	PLOS ONE			English	Article							CELL-WALL COMPOSITION; BROWN-MIDRIB MUTANTS; REDUCED LIGNIN; PLANT DEVELOPMENT; PANICUM-VIRGATUM; SATIVA L.; SORGHUM; INHIBITION; ENERGY; TRANSFORMATION	Cinnamyl alcohol dehydrogenase (CAD) catalyzes the last step in monolignol biosynthesis and genetic evidence indicates CAD deficiency in grasses both decreases overall lignin, alters lignin structure and increases enzymatic recovery of sugars. To ascertain the effect of CAD downregulation in switchgrass, RNA mediated silencing of CAD was induced through Agrobacterium mediated transformation of cv. "Alamo'' with an inverted repeat construct containing a fragment derived from the coding sequence of PviCAD2. The resulting primary transformants accumulated less CAD RNA transcript and protein than control transformants and were demonstrated to be stably transformed with between 1 and 5 copies of the TDNA. CAD activity against coniferaldehyde, and sinapaldehyde in stems of silenced lines was significantly reduced as was overall lignin and cutin. Glucose release from ground samples pretreated with ammonium hydroxide and digested with cellulases was greater than in control transformants. When stained with the lignin and cutin specific stain phloroglucinol-HCl the staining intensity of one line indicated greater incorporation of hydroxycinnamyl aldehydes in the lignin.	[Saathoff, Aaron J.; Sarath, Gautam] ARS, Grain Forage & Bioenergy Res Unit, USDA, Lincoln, NE 68508 USA; [Dien, Bruce S.] ARS, Bioenergy Res Unit, USDA, Peoria, IL USA; [Chow, Elaine K.; Tobias, Christian M.] ARS, Genom & Gene Discovery Res Unit, USDA, Albany, CA 94710 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Saathoff, AJ (corresponding author), ARS, Grain Forage & Bioenergy Res Unit, USDA, Lincoln, NE 68508 USA.	christian.tobias@ars.usda.gov	Tobias, Christian/B-6602-2009	Tobias, Christian/0000-0002-7881-750X; Dien, Bruce/0000-0003-3863-6664	Office of Science (BER), U.S. Department of Energy [DE-AI02-09ER64829]; USDA Agricultural Research Service [307, 5325-21000-017-00, 5440-21000-028-00]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Aaron J. Saathoff was supported in part by the Office of Science (BER), U.S. Department of Energy grant number DE-AI02-09ER64829. This work was supported by the USDA Agricultural Research Service National Program 307 (Bioenergy) involving CRIS numbers: 5325-21000-017-00 and 5440-21000-028-00. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Baucher M, 1999, PLANT MOL BIOL, V39, P437, DOI 10.1023/A:1006182925584; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; BUCHOLTZ DL, 1980, J AGR FOOD CHEM, V28, P1239, DOI 10.1021/jf60232a045; CARVER TLW, 1994, PHYSIOL MOL PLANT P, V44, P261, DOI 10.1016/S0885-5765(05)80029-3; Chabannes M, 2001, PLANT J, V28, P257, DOI 10.1046/j.1365-313X.2001.01140.x; Chen L, 2003, PLANT BIOTECHNOL J, V1, P437, DOI 10.1046/j.1467-7652.2003.00040.x; Corredor DY, 2009, APPL BIOCHEM BIOTECH, V158, P164, DOI 10.1007/s12010-008-8340-y; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Du FY, 2010, APPL BIOCHEM BIOTECH, V161, P313, DOI 10.1007/s12010-009-8796-4; Funnell DL, 2006, PLANT DIS, V90, P331, DOI 10.1094/PD-90-0331; Graham RL, 2000, BIOMASS BIOENERG, V18, P309, DOI 10.1016/S0961-9534(99)00098-7; HAWKINS SW, 1994, PLANT PHYSIOL, V104, P75, DOI 10.1104/pp.104.1.75; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horser C, 2002, GENET ENG P, V24, P239; Jacobsen J, 2006, METH MOL B, V343, P171; JUNG HJG, 1992, J SCI FOOD AGR, V59, P169, DOI 10.1002/jsfa.2740590206; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson S, 2000, APPL BIOCHEM BIOTECH, V84-6, P617, DOI 10.1385/ABAB:84-86:1-9:617; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Li XJ, 2009, PLANT MOL BIOL, V69, P685, DOI 10.1007/s11103-008-9448-8; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592; McLaughlin SB, 2006, ADV AGRON, V90, P267, DOI 10.1016/S0065-2113(06)90007-8; McLaughlin SB, 2002, ENVIRON SCI TECHNOL, V36, P2122, DOI 10.1021/es010963d; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; MOERSCHBACHER BM, 1990, PLANT PHYSIOL, V93, P465, DOI 10.1104/pp.93.2.465; Monti A, 2009, EUR J AGRON, V31, P77, DOI 10.1016/j.eja.2009.04.001; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Onnerud H, 2002, PLANT CELL, V14, P1953, DOI 10.1105/tpc.001487; Palmer NA, 2008, PLANTA, V229, P115, DOI 10.1007/s00425-008-0814-1; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Pedersen JF, 2005, CROP SCI, V45, P812, DOI 10.2135/cropsci2004.0155; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; PILLONEL C, 1991, PLANTA, V185, P538, DOI 10.1007/BF00202964; Ralph J, 2001, PHYTOCHEMISTRY, V57, P993, DOI 10.1016/S0031-9422(01)00109-1; Saathoff AJ, 2010, BIOENERG RE IN PRESS; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Saballos A, 2008, BIOENERG RES, V1, P193, DOI 10.1007/s12155-008-9025-7; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sarath G, 2008, J IND MICROBIOL BIOT, V35, P343, DOI 10.1007/s10295-007-0296-3; Sarath G, 2007, BIORESOURCE TECHNOL, V98, P2985, DOI 10.1016/j.biortech.2006.10.020; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Sattler SE, 2010, J AGR FOOD CHEM, V58, P3611, DOI 10.1021/jf903784j; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; Smeets EMW, 2009, RENEW SUST ENERG REV, V13, P1230, DOI 10.1016/j.rser.2008.09.006; Somleva MN, 2008, PLANT BIOTECHNOL J, V6, P663, DOI 10.1111/j.1467-7652.2008.00350.x; Somleva MN, 2002, CROP SCI, V42, P2080, DOI 10.2135/cropsci2002.2080; Tobias CM, 2005, PLANTA, V220, P678, DOI 10.1007/s00425-004-1385-4; Vermerris W, 2002, HEREDITY, V88, P450, DOI 10.1038/sj.hdy.6800078; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel KP, 2011, RSC ENERGY ENVIRON S, P341; Vogel KP, 1999, CROP SCI, V39, P276, DOI 10.2135/cropsci1999.0011183X003900010042x; WYRAMBIK D, 1975, EUR J BIOCHEM, V59, P9, DOI 10.1111/j.1432-1033.1975.tb02418.x; Yahiaoui N, 1998, PLANTA, V204, P8, DOI 10.1007/s004250050224; Zhang KW, 2006, PLANT PHYSIOL, V140, P972, DOI 10.1104/pp.105.073007	62	124	129	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16416	10.1371/journal.pone.0016416	http://dx.doi.org/10.1371/journal.pone.0016416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298014	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900047
J	Schneider, SA; Schrader, C; Wagner, AE; Boesch-Saadatmandi, C; Liebig, J; Rimbach, G; Roeder, T				Schneider, Sebastian A.; Schrader, Charlotte; Wagner, Anika E.; Boesch-Saadatmandi, Christine; Liebig, Juergen; Rimbach, Gerald; Roeder, Thomas			Stress Resistance and Longevity Are Not Directly Linked to Levels of Enzymatic Antioxidants in the Ponerine Ant Harpegnathos saltator	PLOS ONE			English	Article							HONEY-BEE LONGEVITY; LIFE-SPAN; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; SOCIAL INSECTS; DROSOPHILA; WORKERS; GLUTATHIONE; EXPRESSION	Background: The molecular mechanisms of variations in individual longevity are not well understood, even though longevity can be increased substantially by means of diverse experimental manipulations. One of the factors supposed to be involved in the increase of longevity is a higher stress resistance. To test this hypothesis in a natural system, eusocial insects such as bees or ants are ideally suited. In contrast to most other eusocial insects, ponerine ants show a peculiar life history that comprises the possibility to switch during adult life from a normal worker to a reproductive gamergate, therewith increasing their life expectancy significantly. Results: We show that increased resistance against major stressors, such as reactive oxygen species and infection accompanies the switch from a life-history trait with normal lifespan to one with a longer life expectancy. A short period of social isolation was sufficient to enhance stress resistance of workers from the ponerine ant species Harpegnathos saltator significantly. All ant groups with increased stress resistances (reproducing gamergates and socially isolated workers) have lower catalase activities and glutathione levels than normal workers. Therewith, these ants resemble the characteristics of the youngest ants in the colony. Conclusions: Social insects with their specific life history including a switch from normal workers to reproducing gamergates during adult life are well suited for ageing research. The regulation of stress resistance in gamergates seemed to be modified compared to foraging workers in an economic way. Interestingly, a switch towards more stress resistant animals can also be induced by a brief period of social isolation, which may already be associated with a shift to a reproductive trajectory. In Harpegnathos saltator, stress resistances are differently and potentially more economically regulated in reproductive individuals, highlighting the significance of reproduction for an increase in longevity in social insects. As already shown for other organisms with a long lifespan, this trait is not directly coupled to higher levels of enzymatic and non-enzymatic antioxidants.	[Schneider, Sebastian A.; Roeder, Thomas] Univ Kiel, Dept Zoophysiol 2, Kiel, Germany; [Schrader, Charlotte; Wagner, Anika E.; Boesch-Saadatmandi, Christine; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [Liebig, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Liebig, Juergen] Arizona State Univ, Ctr Social Dynam & Complex, Tempe, AZ USA	University of Kiel; University of Kiel; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Schneider, SA (corresponding author), Univ Kiel, Dept Zoophysiol 2, Kiel, Germany.	troeder@zoologie.uni-kiel.de	Wagner, Anika/AAE-3579-2019; Roeder, Thomas/B-9016-2011; Rimbach, Gerald/A-7178-2011	Wagner, Anika/0000-0003-3047-7128; Roeder, Thomas/0000-0002-3489-3834; Rimbach, Gerald/0000-0001-7888-4684; Bosch, Christine/0000-0001-6705-5709	German Federal Ministry of Education and Research; University of Kiel	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Kiel	This work was supported by the Deutsche Forschungsgemeinschaft as part of the Cluster of Excellence: Inflammation at Interfaces, project "Vision Epifood", funded by the German Federal Ministry of Education and Research as well as by a stipend to SAS from the University of Kiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Corona M, 2005, MECH AGEING DEV, V126, P1230, DOI 10.1016/j.mad.2005.07.004; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Habig W H, 1981, Methods Enzymol, V77, P398; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hartmann A, 2003, EVOLUTION, V57, P2424, DOI 10.1111/j.0014-3820.2003.tb00254.x; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; HOLLDOBLER B, 1991, ANTS; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; Kaeberlein M, 2007, CURR GENOMICS, V8, P73, DOI 10.2174/138920207780368196; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Liebig J, 1998, NATURWISSENSCHAFTEN, V85, P133, DOI 10.1007/s001140050470; Liebig J, 2004, ECOL ENTOMOL, V29, P203, DOI 10.1111/j.1365-2311.2004.00583.x; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Parker JD, 2004, P NATL ACAD SCI USA, V101, P3486, DOI 10.1073/pnas.0400222101; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; PEETERS C, 1995, P NATL ACAD SCI USA, V92, P10977, DOI 10.1073/pnas.92.24.10977; Peeters C, 2000, INSECT SOC, V47, P325, DOI 10.1007/PL00001724; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Rueppell O, 2005, INSECT SOC, V52, P282, DOI 10.1007/s00040-005-0804-2; Salmon AB, 2009, FASEB J, V23, P2317, DOI 10.1096/fj.08-122523; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Tsuji K, 1996, NATURWISSENSCHAFTEN, V83, P577; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001	53	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14601	10.1371/journal.pone.0014601	http://dx.doi.org/10.1371/journal.pone.0014601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298046	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900005
J	Maher, LA; Stock, JT; Finney, S; Heywood, JJN; Miracle, PT; Banning, EB				Maher, Lisa A.; Stock, Jay T.; Finney, Sarah; Heywood, James J. N.; Miracle, Preston T.; Banning, Edward B.			A Unique Human-Fox Burial from a Pre-Natufian Cemetery in the Levant (Jordan)	PLOS ONE			English	Article							SOUTHERN LEVANT; ANCIENT DNA; DOGS; DOMESTICATION; EVOLUTION; ORIGIN; OCHRE	New human burials from northern Jordan provide important insights into the appearance of cemeteries and the nature of human-animal relationships within mortuary contexts during the Epipalaeolithic period (c. 23,000-11,600 cal BP) in the Levant, reinforcing a socio-ideological relationship that goes beyond predator-prey. Previous work suggests that archaeological features indicative of social complexity occur suddenly during the latest Epipalaeolithic phase, the Natufian (c. 14,500-11,600 cal BP). These features include sedentism, cemeteries, architecture, food production, including animal domestication, and burials with elaborate mortuary treatments. Our findings from the pre-Natufian (Middle Epipalaeolithic) cemetery of 'Uyun al-Hammam demonstrate that joint human-animal mortuary practices appear earlier in the Epipalaeolithic. We describe the earliest human-fox burial in the Near East, where the remains of dogs have been found associated with human burials at a number of Natufian sites. This is the first time that a fox has been documented in association with human interments pre-dating the Natufian and with a particular suite of grave goods. Analysis of the human and animal bones and their associated artefacts provides critical data on the nature and timing of these newly-developing relationships between people and animals prior to the appearance of domesticated dogs in the Natufian.	[Maher, Lisa A.; Stock, Jay T.] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Finney, Sarah] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Heywood, James J. N.] Univ Cambridge, Dept Paediat, Cambridge, England; [Miracle, Preston T.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; [Banning, Edward B.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Toronto	Maher, LA (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England.	l.maher@human-evol.cam.ac.uk	Banning, Edward B./B-1948-2008; Stock, Jay T/B-6453-2011; Heywood, James/A-9785-2016	Banning, Edward B./0000-0002-4281-7639; Stock, Jay T/0000-0003-0147-8631; Heywood, James/0000-0002-2499-3663	Social Sciences and Humanities Research Council of Canada [410-2007-1269]; National Geographic Society Committee for Research and Exploration [8495-08]; Arts and Humanities Research Council [AH/E009484/1]; AHRC [AH/E009484/1] Funding Source: UKRI; Natural Environment Research Council [NER/M/S/2003/00069] Funding Source: researchfish	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); National Geographic Society Committee for Research and Exploration(National Geographic Society); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research is funded by a Social Sciences and Humanities Research Council of Canada Research Grant to L. A. Maher and E. B. Banning (410-2007-1269; http://www.sshrc-crsh.gc.ca/), a National Geographic Society Committee for Research and Exploration Fieldwork Grant to L. A. Maher (8495-08; http://www.nationalgeographic.com/field/grants-programs/cre-fund.html), and an Arts and Humanities Research Council Research Grant to J. T. Stock (AH/E009484/1; http://www.ahrc.ac.uk/Pages/default.aspx). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburg B, 1973, PALEORIENT, V1, P201, DOI [10.3406/paleo.1973.4165, DOI 10.3406/PALEO.1973.4165]; Balter M, 2010, SCIENCE, V329, P1465, DOI 10.1126/science.329.5998.1465; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Belfer-Cohen A., 1988, PALEORIENT, V14, P297, DOI DOI 10.3406/PALE0.1988.4476; Belfer-Cohen A., 1995, ARCHAEOLOGY DEATH AN, P9; BELFERCOHEN A, 1991, ANNU REV ANTHROPOL, V20, P167, DOI 10.1146/annurev.an.20.100191.001123; Buck C. E., 1999, INTERNET ARCHAEOLOGY, V7; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC; Byrd BF, 2005, J ARCHAEOL RES, V13, P231, DOI 10.1007/s10814-005-3107-2; BYRD BF, 1995, J ANTHROPOL ARCHAEOL, V14, P251, DOI 10.1006/jaar.1995.1014; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Clutton-Brock Juliet, 1995, P7; Crockford S., 2000, DOGS TIME ARCHAEOLOG, V889; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Edwards P., 2002, PALEORIENT, V28, P103, DOI DOI 10.3406/paleo.2002.4741; Garrard A., 2003, B ARCHEOLOGIE ARCHIT, V7, P7; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Goring-Morris A.N., 2005, ARCHAEOLOGICAL PERSP, P89; Goring-Morris A. Nigel, 2002, MAGIC PRACTICES RITU, P67; Goring-Morris AN., 2009, TRANSITIONS PREHISTO, P185; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Grosman L, 2008, P NATL ACAD SCI USA, V105, P17665, DOI 10.1073/pnas.0806030105; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; HILL A, 1979, PALEOBIOLOGY, V5, P261, DOI 10.1017/S0094837300006552; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; KAUFMAN D, 1987, ANTHROPOLOGIE, V91, P335; Kuijt I, 2002, J WORLD PREHIST, V16, P361, DOI 10.1023/A:1022973114090; Kuijt I, 1996, J ANTHROPOL ARCHAEOL, V15, P313, DOI 10.1006/jaar.1996.0012; Kuijt I., 2000, LIFE NEOLITHIC FARMI, P19, DOI DOI 10.1007/0-306-47166-3_2; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; MAHER L, PRELIMINARY IN PRESS; Maher L, 2002, PALEORIENT, V27, P5; MAHER L, 2001, GEOARCHAEOLOGICAL SU, P61; MAHER L, 2005, ANN DEP ANTIQUITIES, V49, P101; Maher LA, 2007, ANN DEP ANTIQUITIES, V51, P263; Morey DF, 2006, J ARCHAEOL SCI, V33, P158, DOI 10.1016/j.jas.2005.07.009; Muheisen M., 1988, BRIT ARCHAEOLOGICAL, Vvol. 396, P353; Nadel D., 1994, PALEORIENT, V20, P113, DOI DOI 10.3406/paleo.1994.4605; O'Farrell V., 1995, THE DOMESTIC DOG; Peters Joris, 2004, Anthropozoologica, V39, P179; RICHTER R, 2011, CAMB ARCHAE IN PRESS; Richter T, 2010, ANTIQUITY, V84, P321, DOI 10.1017/S0003598X00066606; Richter T, 2007, ANN DEP ANTIQUITIES, V51, P313; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stock JT, 2005, AM J PHYS ANTHROPOL, V128, P453, DOI 10.1002/ajpa.20163; Tchernov E, 1997, J ARCHAEOL SCI, V24, P65, DOI 10.1006/jasc.1995.0096; VALLA F, 1998, ARCHEOLOGIA, V348, P36; Valla Francois R., 2002, B CTR RECHERCHE FRAN, V10, P17; Verhoeven M, 2004, J WORLD PREHIST, V18, P179, DOI 10.1007/s10963-004-4361-9; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; VONHOLDT BM, 2010, NATURE, V10, P1; Weinstein-Evron, 2009, FARMING, V2009, P1, DOI [10.3828/bfarm.2009.1.3, DOI 10.3828/BFARM.2009.1.3]; WRESCHNER EE, 1980, CURR ANTHROPOL, V21, P631, DOI 10.1086/202541	54	54	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15815	10.1371/journal.pone.0015815	http://dx.doi.org/10.1371/journal.pone.0015815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298094	Green Published, gold			2022-12-27	WOS:000286662800013
J	Barroso, H; Borrego, P; Bartolo, I; Marcelino, JM; Familia, C; Quintas, A; Taveira, N				Barroso, Helena; Borrego, Pedro; Bartolo, Ines; Marcelino, Jose Maria; Familia, Carlos; Quintas, Alexandre; Taveira, Nuno			Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; AUTOLOGOUS NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; SWISS-MODEL; MOLECULAR EPIDEMIOLOGY; CORECEPTOR USAGE; SITE VARIATION; SUBTYPE-G; GLYCOPROTEIN; SEQUENCE	Background: Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutralizing antibodies, control viral replication and survive as elite controllers. The identification of the molecular, structural and evolutionary footprints underlying these very distinct immunological and clinical outcomes may lead to the development of new strategies for the prevention and treatment of HIV infection. Methodology/Principal Findings: We performed a side-by-side molecular, evolutionary and structural comparison of the C2, V3 and C3 envelope regions from HIV-1 and HIV-2. These regions contain major antigenic targets and are important for receptor binding. In HIV-2, these regions also have immune modulatory properties. We found that these regions are significantly more variable in HIV-1 than in HIV-2. Within each virus, C3 is the most entropic region followed by either C2 (HIV-2) or V3 (HIV-1). The C3 region is well exposed in the HIV-2 envelope and is under strong diversifying selection suggesting that, like in HIV-1, it may harbour neutralizing epitopes. Notably, however, extreme diversification of C2 and C3 seems to be deleterious for HIV-2 and prevent its transmission. Computer modelling simulations showed that in HIV-2 the V3 loop is much less exposed than C2 and C3 and has a retractile conformation due to a physical interaction with both C2 and C3. The concealed and conserved nature of V3 in the HIV-2 is consistent with its lack of immunodominancy in vivo and with its role in preventing immune activation. In contrast, HIV-1 had an extended and accessible V3 loop that is consistent with its immunodominant and neutralizing nature. Conclusions/Significance: We identify significant structural and functional constrains to the diversification and evolution of C2, V3 and C3 in the HIV-2 envelope but not in HIV-1. These studies highlight fundamental differences in the biology and infection of HIV-1 and HIV-2 and in their mode of interaction with the human immune system and may inform new vaccine and therapeutic interventions against these viruses.	[Barroso, Helena; Borrego, Pedro; Bartolo, Ines; Taveira, Nuno] Fac Farm Lisboa, Ctr Patogenese Mol, URIA, Lisbon, Portugal; [Barroso, Helena; Bartolo, Ines; Familia, Carlos; Quintas, Alexandre; Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, CiiEM, Caparica, Portugal; [Marcelino, Jose Maria] Inst Higiene & Med Trop, Unidade Tecnol Proteinas & Anticorpos Monoclonais, Lisbon, Portugal; [Taveira, Nuno] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa	Barroso, H (corresponding author), Fac Farm Lisboa, Ctr Patogenese Mol, URIA, Lisbon, Portugal.	ntaveira@ff.ul.pt	Marcelino, José Maria/N-4047-2019; Familia, Carlos/A-4535-2013; Quintas, Alexandre/J-6436-2012; iMed.ULisboa, EEPHIV/B-4222-2014; Borrego, Pedro/H-6968-2013; Bártolo, Inês/A-7477-2014; Taveira, Nuno C/A-6252-2014; Marcelino, Jose/B-3374-2008	Marcelino, José Maria/0000-0002-4597-1535; Familia, Carlos/0000-0001-5059-2487; Quintas, Alexandre/0000-0002-5188-0453; Borrego, Pedro/0000-0002-1949-9484; Bártolo, Inês/0000-0002-2022-8921; Taveira, Nuno C/0000-0003-0176-5585; Marcelino, Jose/0000-0002-4597-1535; Barroso, Helena/0000-0003-4098-5433	Fundo para a Ciencia e Tecnologia, Portugal [PTDCSAU-FCF6767/2006]; European Union; Fundo para a Ciencia e Tecnologia	Fundo para a Ciencia e Tecnologia, Portugal; European Union(European Commission); Fundo para a Ciencia e Tecnologia	This work was supported by projects PTDCSAU-FCF6767/2006 from Fundo para a Ciencia e Tecnologia, Portugal and by Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union. PB and IB are supported by PhD grants from Fundo para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes R, 2003, J CLIN MICROBIOL, V41, P3361, DOI 10.1128/JCM.41.7.3361-3367.2003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barroso Helena, 2005, Infection Genetics and Evolution, V5, P239, DOI 10.1016/j.meegid.2004.07.008; Berry N, 1998, J Hum Virol, V1, P457; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; BIOVIA Discovery Studio, 2008, DISCOVERYSTUDIO 21 I; BJORLING E, 1993, VIROLOGY, V193, P528, DOI 10.1006/viro.1993.1160; BJORLING E, 1991, P NATL ACAD SCI USA, V88, P6082, DOI 10.1073/pnas.88.14.6082; BJORLING E, 1994, J IMMUNOL, V152, P1952; Blaak H, 2006, VIROLOGY, V353, P144, DOI 10.1016/j.virol.2006.05.029; Borrego P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-78; Canducci F, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-4; Cavaleiro R, 2000, AIDS, V14, P2679, DOI 10.1097/00002030-200012010-00007; Cavaleiro R, 2007, EUR J IMMUNOL, V37, P3435, DOI 10.1002/eji.200737511; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; DOUAGI I, 2009, J VIROL; Drylewicz J, 2008, AIDS, V22, P457, DOI 10.1097/QAD.0b013e3282f4ddfc; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; Garrity RR, 1997, J IMMUNOL, V159, P279; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GERSTEIN M, 1992, ACTA CRYSTALLOGR A, V48, P271, DOI 10.1107/S0108767391012680; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; HUANG ML, 1991, J VIROL, V65, P5073, DOI 10.1128/JVI.65.9.5073-5079.1991; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Isaka Y, 1999, VIROLOGY, V264, P237, DOI 10.1006/viro.1999.0006; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim YB, 2003, VIROLOGY, V305, P124, DOI 10.1006/viro.2002.1727; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEITNER T, 1995, VIROLOGY, V209, P136, DOI 10.1006/viro.1995.1237; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Lemey P, 2006, AIDS REV, V8, P125; Liang BH, 2007, BIOCHEM CELL BIOL, V85, P259, DOI 10.1139/O06-143; MacNeil A, 2007, J VIROL, V81, P5325, DOI 10.1128/JVI.02625-06; Marcelino JM, 2006, J CLIN MICROBIOL, V44, P607, DOI 10.1128/JCM.44.2.607-611.2006; Marcelino JM, 2010, J VIROL, V84, P12429, DOI 10.1128/JVI.01102-10; Marcelino JM, 2008, AIDS, V22, P2257, DOI 10.1097/QAD.0b013e3283155546; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MATSUSHITA S, 1995, J VIROL, V69, P3333, DOI 10.1128/JVI.69.6.3333-3340.1995; McKnight A, 1996, J VIROL, V70, P4598, DOI 10.1128/JVI.70.7.4598-4606.1996; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Morner A, 1999, VIRUS RES, V59, P49, DOI 10.1016/S0168-1702(98)00133-6; Mota-Miranda A, 2001, AIDS, V15, P2460, DOI 10.1097/00002030-200112070-00018; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinter A, 2007, CURR HIV RES, V5, P542, DOI 10.2174/157016207782418470; Plantier JC, 2001, J CLIN MICROBIOL, V39, P3803, DOI 10.1128/JCM.39.10.3803-3807.2001; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D., 2003, CURRENT PROTOCOLS BI; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Qin LZ, 2003, VIROLOGY, V308, P225, DOI [10.1016/S0042-6822(02)00088-0, 10.1016/S0042-3822(02)00088-0]; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez SK, 2007, J VIROL, V81, P5331, DOI 10.1128/JVI.02789-06; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rowland-Jones S, 2006, FUTURE MICROBIOL, V1, P427, DOI 10.2217/17460913.1.4.427; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387; Shi Y, 2005, J GEN VIROL, V86, P3385, DOI 10.1099/vir.0.81259-0; Skar H, 2010, J VIROL, V84, P7412, DOI 10.1128/JVI.02548-09; Skott P, 1999, VIRAL IMMUNOL, V12, P79, DOI 10.1089/vim.1999.12.79; Soares R, 2006, J VIROL, V80, P12425, DOI 10.1128/JVI.01557-06; Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; TRAINCARD F, 1994, AIDS RES HUM RETROV, V10, P1659, DOI 10.1089/aid.1994.10.1659; Valadas E, 2009, CLIN INFECT DIS, V48, P1166, DOI 10.1086/597504; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yamaguchi J, 2000, AIDS RES HUM RETROV, V16, P925; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	101	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14548	10.1371/journal.pone.0014548	http://dx.doi.org/10.1371/journal.pone.0014548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283793	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200004
J	Mestre, O; Luo, T; Dos Vultos, T; Kremer, K; Murray, A; Namouchi, A; Jackson, C; Rauzier, J; Bifani, P; Warren, R; Rasolofo, V; Mei, JA; Gao, QA; Gicquel, B				Mestre, Olga; Luo, Tao; Dos Vultos, Tiago; Kremer, Kristin; Murray, Alan; Namouchi, Amine; Jackson, Celine; Rauzier, Jean; Bifani, Pablo; Warren, Rob; Rasolofo, Voahangy; Mei, Jian; Gao, Qian; Gicquel, Brigitte			Phylogeny of Mycobacterium tuberculosis Beijing Strains Constructed from Polymorphisms in Genes Involved in DNA Replication, Recombination and Repair	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISMS; GLOBAL DISSEMINATION; GENOMIC DELETIONS; EVOLUTION; LINEAGE; FAMILY; GENOTYPE	Background: The Beijing family is a successful group of M. tuberculosis strains, often associated with drug resistance and widely distributed throughout the world. Polymorphic genetic markers have been used to type particular M. tuberculosis strains. We recently identified a group of polymorphic DNA repair replication and recombination (3R) genes. It was shown that evolution of M. tuberculosis complex strains can be studied using 3R SNPs and a high-resolution tool for strain discrimination was developed. Here we investigated the genetic diversity and propose a phylogeny for Beijing strains by analyzing polymorphisms in 3R genes. Methodology/Principal Findings: A group of 3R genes was sequenced in a collection of Beijing strains from different geographic origins. Sequence analysis and comparison with the ones of non-Beijing strains identified several SNPs. These SNPs were used to type a larger collection of Beijing strains and allowed identification of 26 different sequence types for which a phylogeny was constructed. Phylogenetic relationships established by sequence types were in agreement with evolutionary pathways suggested by other genetic markers, such as Large Sequence Polymorphisms (LSPs). A recent Beijing genotype (Bmyc10), which included 60% of strains from distinct parts of the world, appeared to be predominant. Conclusions/Significance: We found SNPs in 3R genes associated with the Beijing family, which enabled discrimination of different groups and the proposal of a phylogeny. The Beijing family can be divided into different groups characterized by particular genetic polymorphisms that may reflect pathogenic features. These SNPs are new, potential genetic markers that may contribute to better understand the success of the Beijing family.	[Mestre, Olga; Dos Vultos, Tiago; Murray, Alan; Namouchi, Amine; Jackson, Celine; Rauzier, Jean; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Luo, Tao; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Kremer, Kristin] Natl Inst Publ Hlth & Environm, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [Murray, Alan] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Bifani, Pablo] Sci Inst Publ Hlth, Brussels, Belgium; [Warren, Rob] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, NRF Ctr Excellence Biomed TB Research, Cape Town, South Africa; [Rasolofo, Voahangy] Inst Pasteur Madagascar, Unite TB & Mycobacteries, Antananarivo, Madagascar; [Mei, Jian] Shanghai Municipal CDC, Dept TB Control, Shanghai, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Fudan University; Netherlands National Institute for Public Health & the Environment; Massey University; Stellenbosch University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Mestre, O (corresponding author), Inst Pasteur, Unite Genet Mycobacterienne, Paris, France.	brigitte.gicquel@pasteur.fr	, 罗涛/AHA-1191-2022; Mestre, Olga/D-7418-2013	Warren, Robin/0000-0001-5741-7358; Mestre, Olga/0000-0002-0993-2248; Bifani, Pablo/0000-0001-9651-6439	European Commission [LSHP-CT-2006-037919, 200973]; Key Project of Chinese National Programs [2008ZX10003-010]	European Commission(European CommissionEuropean Commission Joint Research Centre); Key Project of Chinese National Programs	This work is part of the TB-ADAPT (LSHP-CT-2006-037919) and TB-VIR (Grant agreement nu 200973) projects supported by the European Commission under the Health Cooperation Work Programme of the 6th and 7th Framework Programme, respectively. This work was also supported by the Key Project of Chinese National Programs (2008ZX10003-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2006, EMERG INFECT DIS, P736; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gutacker MM, 2002, GENETICS, V162, P1533; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Moreland NJ, 2009, BIOCHEMISTRY-US, V48, P699, DOI 10.1021/bi8009554; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Rindi L, 2009, INFECT GENET EVOL, V9, P48, DOI 10.1016/j.meegid.2008.09.006; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x; 2008, WHO REPORT 2008 GLOB	21	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16020	10.1371/journal.pone.0016020	http://dx.doi.org/10.1371/journal.pone.0016020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283803	Green Published, gold			2022-12-27	WOS:000286522200023
J	Dong, JA; Yan, D; Chen, SY				Dong, Jian; Yan, Dong; Chen, Shao-yu			Stabilization of Nrf2 Protein by D3T Provides Protection against Ethanol-Induced Apoptosis in PC12 Cells	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; NEURAL CREST CELLS; TRANSCRIPTION FACTOR NRF2; INDUCED OXIDATIVE STRESS; ANTIOXIDANT RESPONSE ELEMENT; CUL3-BASED E3 LIGASE; SIGNALING PATHWAY; IN-VIVO; PROTEASOMAL DEGRADATION; MOUSE EMBRYOS	Previous studies have demonstrated that maternal ethanol exposure induces a moderate increase in Nrf2 protein expression in mouse embryos. Pretreatment with the Nrf2 inducer, 3H-1, 2-dithiole-3-thione (D3T), significantly increases the Nrf2 protein levels and prevents apoptosis in ethanol-exposed embryos. The present study, using PC12 cells, was designed to determine whether increased Nrf2 stability is a mechanism by which D3T enhances Nrf2 activation and subsequent antioxidant protection. Ethanol and D3T treatment resulted in a significant accumulation of Nrf2 protein in PC 12 cells. CHX chase analysis has shown that ethanol treatment delayed the degradation of Nrf2 protein in PC12 cells. A significantly greater decrease in Nrf2 protein degradation was observed in the cells treated with D3T alone or with both ethanol and D3T. In addition, D3T treatment significantly reduced ethanol-induced apoptosis. These results demonstrate that the stabilization of Nrf2 protein by D3T confers protection against ethanol-induced apoptosis.	[Dong, Jian; Yan, Dong] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA; [Chen, Shao-yu] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Peoria	Dong, JA (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA.	sychen@uic.edu			NIH from the National Institute on Alcohol Abuse and Alcoholism [AA017446, AA013908, AA11605]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017446, K01AA013908, P60AA011605, P50AA011605] Funding Source: NIH RePORTER	NIH from the National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by NIH grants AA017446, AA013908, and AA11605 from the National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Burd L, 2004, AM J MED GENET C, V127C, P1, DOI 10.1002/ajmg.c.30009; Burton NC, 2006, NEUROTOXICOLOGY, V27, P1094, DOI 10.1016/j.neuro.2006.07.019; Cao ZX, 2006, EXP BIOL MED, V231, P1353, DOI 10.1177/153537020623100809; CARTWRIGHT MM, 1995, ALCOHOL CLIN EXP RES, V19, P378, DOI 10.1111/j.1530-0277.1995.tb01519.x; Chen SY, 2000, J PHARMACOL EXP THER, V294, P134; Chen SY, 2004, FASEB J, V18, P1234, DOI 10.1096/fj.03-0850fje; Chen SY, 2001, FASEB J, V15, P1649, DOI 10.1096/fj.00-0862fje; Chen SY, 1996, ALCOHOL CLIN EXP RES, V20, P1071, DOI 10.1111/j.1530-0277.1996.tb01948.x; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Danilov CA, 2009, GLIA, V57, P645, DOI 10.1002/glia.20793; DE A, 1994, J BIOL CHEM, V269, P26697; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Dong J, 2008, ANTIOXID REDOX SIGN, V10, P2023, DOI 10.1089/ars.2007.2019; Dong J, 2010, TOXICOL LETT, V193, P94, DOI 10.1016/j.toxlet.2009.12.012; Dunty WC, 2001, ALCOHOL CLIN EXP RES, V25, P1523, DOI 10.1111/j.1530-0277.2001.tb02156.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Gong PF, 2006, J BIOL CHEM, V281, P14573, DOI 10.1074/jbc.M600613200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; He XQ, 2007, TOXICOL SCI, V98, P298, DOI 10.1093/toxsci/kfm081; Henderson George I., 1999, Frontiers in Bioscience, V4, pd541, DOI 10.2741/Henderson; Huang Y, 2006, PHYSIOL GENOMICS, V24, P144, DOI 10.1152/physiolgenomics.00258.2005; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Knorr-Wittmann C, 2005, FREE RADICAL BIO MED, V39, P1438, DOI 10.1016/j.freeradbiomed.2005.07.003; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Koh K, 2009, BIOCHEM BIOPH RES CO, V380, P449, DOI 10.1016/j.bbrc.2009.01.082; Korashy HM, 2006, DRUG METAB DISPOS, V34, P152, DOI 10.1124/dmd.105.005397; KOTCH LE, 1992, AM J MED GENET, V44, P168, DOI 10.1002/ajmg.1320440210; KOTCH LE, 1995, TERATOLOGY, V52, P128, DOI 10.1002/tera.1420520304; Kotlo KU, 2003, ONCOGENE, V22, P797, DOI 10.1038/sj.onc.1206077; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Luo J, 1999, ALCOHOL CLIN EXP RES, V23, P644, DOI 10.1111/j.1530-0277.1999.tb04166.x; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Munday R, 2004, CARCINOGENESIS, V25, P1721, DOI 10.1093/carcin/bgh162; NAPPER RMA, 1995, J COMP NEUROL, V362, P283, DOI 10.1002/cne.903620210; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oberdoerster J, 1998, J PHARMACOL EXP THER, V287, P359; Otieno MA, 2000, FREE RADICAL BIO MED, V28, P944, DOI 10.1016/S0891-5849(00)00175-1; PANTAZIS NJ, 1992, ALCOHOL, V9, P171, DOI 10.1016/0741-8329(92)90048-F; Ramachandran V, 2003, J NEUROSCI RES, V74, P577, DOI 10.1002/jnr.10767; Smith SM, 1997, ALCOHOL HEALTH RES W, V21, P287; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Teng L, 2006, ADV EXP MED BIOL, V589, P206; Tran TD, 2005, ALCOHOL CLIN EXP RES, V29, P117, DOI 10.1097/01.ALC.0000150004.53870.E1; WEST JR, 1994, METAB BRAIN DIS, V9, P291, DOI 10.1007/BF02098878; Yan D, 2010, BIOCHEM PHARMACOL, V80, P144, DOI 10.1016/j.bcp.2010.03.004; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang JD, 2009, BIOCHEM BIOPH RES CO, V386, P750, DOI 10.1016/j.bbrc.2009.06.129	58	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16845	10.1371/journal.pone.0016845	http://dx.doi.org/10.1371/journal.pone.0016845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304811	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600033
J	Akyurek, EG; Abedian-Amiri, A; Ostermeier, SM				Akyurek, Elkan G.; Abedian-Amiri, Ali; Ostermeier, Sonja M.			Content-Specific Working Memory Modulation of the Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; TEMPORAL ATTENTION; CAPACITY; CONSOLIDATION; DIFFICULTY; MODEL; TIME; TASK	Three experiments were conducted to investigate the effects of working memory content on temporal attention in a rapid serial visual presentation attentional blink paradigm. It was shown that categorical similarity between working memory content and the target stimuli pertaining to the attentional task (both digits) increased attentional blink magnitude compared to a condition in which this similarity was absent (colors and digits, respectively). This effect was only observed when the items in working memory were not presented as conjunctions of the involved categories (i.e., colored digits). This suggested that storage and retrieval from working memory was at least preferentially conjunctive in this case. It was furthermore shown that the content of working memory enhanced the identification rate of the second target, by means of repetition priming, when inter-target lag was short and the attentional blink was in effect. The results are incompatible with theories of temporal attention that assume working memory has no causal role in the attentional blink and support theories that do.	[Akyurek, Elkan G.; Abedian-Amiri, Ali; Ostermeier, Sonja M.] Univ Groningen, Groningen, Netherlands	University of Groningen	Akyurek, EG (corresponding author), Univ Groningen, Groningen, Netherlands.	e.g.akyurek@rug.nl		Akyurek, Elkan/0000-0001-9111-5847				Akyurek EG, 2007, MEM COGNITION, V35, P621, DOI 10.3758/BF03193300; Akyurek EG, 2010, PSYCHOPHYSIOLOGY, V47, P1134, DOI 10.1111/j.1469-8986.2010.01033.x; Akyurek EG, 2005, MEM COGNITION, V33, P654, DOI 10.3758/BF03195332; Akyurek EG, 2007, PERCEPT PSYCHOPHYS, V69, P1152, DOI 10.3758/BF03193952; Akyurek EG, 2006, EUR J COGN PSYCHOL, V18, P520, DOI 10.1080/09541440500423160; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P1, DOI 10.1007/s00426-008-0200-4; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Colzato LS, 2007, PSYCHON B REV, V14, P1051, DOI 10.3758/BF03193090; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; Hommel B, 2005, Q J EXP PSYCHOL-A, V58, P1415, DOI 10.1080/02724980443000647; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Jolicoeur P, 1999, J EXP PSYCHOL HUMAN, V25, P1097, DOI 10.1037/0096-1523.25.4.1097; Koelewijn T, 2008, PERCEPT PSYCHOPHYS, V70, P658, DOI 10.3758/PP.70.4.658; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; Nieuwenstein MR, 2009, J EXP PSYCHOL HUMAN, V35, P159, DOI 10.1037/0096-1523.35.1.159; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, J EXP PSYCH IN PRESS; Ouimet C, 2007, VIS COGN, V15, P290, DOI 10.1080/13506280600693741; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Visser TAW, 1999, PSYCHOL BULL, V125, P458, DOI 10.1037/0033-2909.125.4.458; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	32	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16696	10.1371/journal.pone.0016696	http://dx.doi.org/10.1371/journal.pone.0016696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	717IF	21311753	Green Submitted, gold, Green Published			2022-12-27	WOS:000287036200033
J	Echtermeyer, C; Costa, LD; Rodrigues, FA; Kaiser, M				Echtermeyer, Christoph; Costa, Luciano da Fontoura; Rodrigues, Francisco A.; Kaiser, Marcus			Automatic Network Fingerprinting through Single-Node Motifs	PLOS ONE			English	Article							COMPLEX NETWORKS; ROBUSTNESS; LETHALITY; INTERNET; MODEL	Complex networks have been characterised by their specific connectivity patterns (network motifs), but their building blocks can also be identified and described by node-motifs-a combination of local network features. One technique to identify single node-motifs has been presented by Costa et al. (L. D. F. Costa, F. A. Rodrigues, C. C. Hilgetag, and M. Kaiser, Europhys. Lett., 87, 1, 2009). Here, we first suggest improvements to the method including how its parameters can be determined automatically. Such automatic routines make high-throughput studies of many networks feasible. Second, the new routines are validated in different network-series. Third, we provide an example of how the method can be used to analyse network time-series. In conclusion, we provide a robust method for systematically discovering and classifying characteristic nodes of a network. In contrast to classical motif analysis, our approach can identify individual components (here: nodes) that are specific to a network. Such special nodes, as hubs before, might be found to play critical roles in real-world networks.	[Echtermeyer, Christoph; Kaiser, Marcus] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Costa, Luciano da Fontoura] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Rodrigues, Francisco A.] Univ Sao Paulo, Dept Matemat Aplicada & Estat, Inst Ciencia & Tecnol Polimeros, Inst Ciencias Matemat & Computacao, Sao Carlos, SP, Brazil; [Kaiser, Marcus] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kaiser, Marcus] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea	Newcastle University - UK; Universidade de Sao Paulo; Universidade de Sao Paulo; Newcastle University - UK; Seoul National University (SNU)	Echtermeyer, C (corresponding author), Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.kaiser@newcastle.ac.uk	da F. Costa, Luciano/H-5475-2011; Rodrigues, Francisco A./E-4418-2011; Kaiser, Marcus/A-7166-2008	da F. Costa, Luciano/0000-0001-5203-4366; Rodrigues, Francisco A./0000-0002-0145-5571; Kaiser, Marcus/0000-0002-4654-3110	Engineering and Physical Sciences Research Council (EPSRC) [EP/G03950X/1, EP/E002331/1]; Ministry of Education, Science and Technology [R32-10142]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301303/06-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/00587-5]; FAPESP [2007/50633-9]; EPSRC [EP/E002331/1, EP/G03950X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E002331/1, EP/G03950X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Marcus Kaiser and Christoph Echtermeyer were supported by the Engineering and Physical Sciences Research Council (EPSRC) (EP/G03950X/1), the CARMEN e-science project (http://www.carmen.org.uk) funded by EPSRC (EP/E002331/1), and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R32-10142). Luciano da F. Costa is grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (301303/06-1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (05/00587-5) for financial support. Francisco A. Rodrigues is grateful to FAPESP (2007/50633-9) for sponsorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BORDINO I, 2008, 8 INT C DAT MIN ICDM; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Costa LD, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18008; Costa LD, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/48001; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; DUDA RO, 2001, PATTERN CLASSIFICATI; Eaton J.W., 2002, GNU OCTAVE MANUAL; Estrada E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016103; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; GROENING M, 2005, SIMPSONS UNCENSORED; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; GUARE J, 1994, 6 DEGREES SEPARATION; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson R., 2007, APPL MULTIVARIATE ST; Kaiser M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/110; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kaiser M, 2007, PHILOS T R SOC A, V365, P3033, DOI 10.1098/rsta.2007.0007; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kochen Manfred, 1989, SMALL WORLD; Kuramochi M, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P313, DOI 10.1109/ICDM.2001.989534; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; MacKay D. J. C., 2003, INFORM THEORY INFERE; MAHALANOBIS PC, 1936, P NAT I SCI INDIA, V2, P49; Meloni S, 2009, P NATL ACAD SCI USA, V106, P16897, DOI 10.1073/pnas.0907121106; Middendorf M, 2005, P NATL ACAD SCI USA, V102, P3192, DOI 10.1073/pnas.0409515102; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ozik J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026108; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Ramasco JJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036122; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Ribeiro Pedro, 2009, Proceedings of the 2009 5th IEEE International Conference on e-Science (e-Science 2009), P80, DOI 10.1109/e-Science.2009.20; Rodrigues FA, 2009, MOL BIOSYST, V5, P385, DOI 10.1039/b815702m; Saavedra S, 2008, P NATL ACAD SCI USA, V105, P16466, DOI 10.1073/pnas.0804740105; Schnettler S, 2009, SOC NETWORKS, V31, P165, DOI 10.1016/j.socnet.2008.12.004; SEIDMAN SB, 1983, NETWORK STRUCTURE MI, V5; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Wang J, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/123023; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	69	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15765	10.1371/journal.pone.0015765	http://dx.doi.org/10.1371/journal.pone.0015765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297963	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300025
J	Hejblum, G; Setbon, M; Temime, L; Lesieur, S; Valleron, AJ				Hejblum, Gilles; Setbon, Michel; Temime, Laura; Lesieur, Sophie; Valleron, Alain-Jacques			Modelers' Perception of Mathematical Modeling in Epidemiology: A Web-Based Survey	PLOS ONE			English	Article								Background: Mathematical modeling in epidemiology (MME) is being used increasingly. However, there are many uncertainties in terms of definitions, uses and quality features of MME. Methodology/Principal Findings: To delineate the current status of these models, a 10-item questionnaire on MME was devised. Proposed via an anonymous internet-based survey, the questionnaire was completed by 189 scientists who had published in the domain of MME. A small minority (18%) of respondents claimed to have in mind a concise definition of MME. Some techniques were identified by the researchers as characterizing MME (e. g. Markov models), while others-at the same level of sophistication in terms of mathematics-were not (e. g. Cox regression). The researchers' opinions were also contrasted about the potential applications of MME, perceived as higly relevant for providing insight into complex mechanisms and less relevant for identifying causal factors. The quality criteria were those of good science and were not related to the size and the nature of the public health problems addressed. Conclusions/Significance: This study shows that perceptions on the nature, uses and quality criteria of MME are contrasted, even among the very community of published authors in this domain. Nevertheless, MME is an emerging discipline in epidemiology and this study underlines that it is associated with specific areas of application and methods. The development of this discipline is likely to deserve a framework providing recommendations and guidance at various steps of the studies, from design to report.	[Hejblum, Gilles; Lesieur, Sophie; Valleron, Alain-Jacques] INSERM, U707, Paris, France; [Hejblum, Gilles; Lesieur, Sophie; Valleron, Alain-Jacques] UPMC Univ Paris 06, Fac Med Pierre & Marie Curie, UMR S 707, Paris, France; [Hejblum, Gilles; Valleron, Alain-Jacques] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Setbon, Michel] CNRS, UMR 6123, Aix En Provence, France; [Setbon, Michel] Univ Mediterranee, Lab Econ & Sociol Travail, Aix En Provence, France; [Temime, Laura] CNAM, Chaire Hyg & Securite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Hejblum, G (corresponding author), INSERM, U707, Paris, France.	gilles.hejblum@inserm.fr	Temime, Laura/G-7010-2011; Hejblum, Gilles/N-6337-2017	Hejblum, Gilles/0000-0003-0127-1964; Temime, Laura/0000-0002-8850-5403	Centre National de la Recherche Scientifique-Institut National de Sante et de la Recherche Medicale-Mission Recherche de la Direction Regionale de la Recherche, des Etudes, de l'Evaluation et des Statistiques	Centre National de la Recherche Scientifique-Institut National de Sante et de la Recherche Medicale-Mission Recherche de la Direction Regionale de la Recherche, des Etudes, de l'Evaluation et des Statistiques(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a grant from the program "Sciences Biomedicales, Sante et Societe" of the Centre National de la Recherche Scientifique-Institut National de Sante et de la Recherche Medicale-Mission Recherche de la Direction Regionale de la Recherche, des Etudes, de l'Evaluation et des Statistiques. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chubb MC, 2010, EUR J EPIDEMIOL, V25, P13, DOI 10.1007/s10654-009-9397-9; Custer B, 2005, ANN INTERN MED, V143, P486, DOI 10.7326/0003-4819-143-7-200510040-00007; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; HOLLANDER M, 1999, NONPARAMETRIC STAT M, P295; KALBFLEISCH JD, 1989, TRANSFUSION, V29, P672, DOI 10.1046/j.1537-2995.1989.29890020437.x; KEELING MJ, 2008, INTRO MODELING INFEC, P1; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; R Core Team, 2018, R LANG ENV STAT COMP; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16531	10.1371/journal.pone.0016531	http://dx.doi.org/10.1371/journal.pone.0016531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304976	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300079
J	Juyal, G; Prasad, P; Senapati, S; Midha, V; Sood, A; Amre, D; Juyal, RC; Thelma, BK				Juyal, Garima; Prasad, Pushplata; Senapati, Sabyasachi; Midha, Vandana; Sood, Ajit; Amre, Devendra; Juyal, Ramesh C.; Thelma, B. K.			An Investigation of Genome-Wide Studies Reported Susceptibility Loci for Ulcerative Colitis Shows Limited Replication in North Indians	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; JAPANESE PATIENTS; RISK LOCI; ASSOCIATION; IL23R; ATG16L1; POPULATION; MULTIPLE; GENE	Genome-Wide Association studies (GWAS) of both Crohn's Disease (CD) and Ulcerative Colitis (UC) have unearthed over 40 risk conferring variants. Recently, a meta-analysis on UC revealed several loci, most of which were either previously associated with UC or CD susceptibility in populations of European origin. In this study, we attempted to replicate these findings in an ethnically distinct north Indian UC cohort. 648 UC cases and 850 controls were genotyped using Infinium Human 660W-quad. Out of 59 meta-analysis index SNPs, six were not in the SNP array used in the study. Of the remaining 53 SNPs, four were found monomorphic. Association (p<0.05) at 25 SNPs was observed, of which 15 were CD specific. Only five SNPs namely rs2395185 (HLA-DRA), rs3024505 (IL10), rs6426833 (RNF186), rs3763313 (BTNL2) and rs2066843 (NOD2) retained significance after Bonferroni correction. These results (i) reveal limited replication of Caucasian based meta-analysis results; (ii) reiterate overlapping molecular mechanism(s) in UC and CD; (iii) indicate differences in genetic architecture between populations; and (iv) suggest that resources such as HapMap need to be extended to cover diverse ethnic populations. They also suggest a systematic GWAS in this terrain may be insightful for identifying population specific IBD risk conferring loci and thus enable cross-ethnicity fine mapping of disease loci.	[Juyal, Garima; Prasad, Pushplata; Senapati, Sabyasachi; Thelma, B. K.] Univ Delhi, Dept Genet, New Delhi, India; [Midha, Vandana; Sood, Ajit] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India; [Amre, Devendra] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Amre, Devendra] Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Juyal, Ramesh C.] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; Dayanand Medical College & Hospital; Universite de Montreal; Universite de Montreal; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Juyal, G (corresponding author), Univ Delhi, Dept Genet, South Campus, New Delhi, India.	thelmabk@gmail.com	Singh, Pushplata/ABH-9083-2020; AMRE, DEVENDRA K/D-4988-2015	Singh, Pushplata/0000-0002-4273-6898; Senapati, Sabyasachi/0000-0002-9448-7432; Thelma, B.K/0000-0002-2154-5443; juyal, garima/0000-0002-3857-9578	Dept. of Biotechnology, New Delhi, India [BT/01/COE/07/UDSC]	Dept. of Biotechnology, New Delhi, India	Research grant #BT/01/COE/07/UDSC from Dept. of Biotechnology, New Delhi, India is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Buning C, 2007, ALIMENT PHARM THERAP, V26, P1025, DOI 10.1111/j.1365-2036.2007.03446.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen B, 2009, J GENET, V88, P191, DOI 10.1007/s12041-009-0027-9; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Juyal G, 2007, ALIMENT PHARM THER, V26, P1325, DOI 10.1111/j.1365-2036.2007.03524.x; Kakuta Y, 2006, GUT, V55, P1527, DOI 10.1136/gut.2006.100297; Madsen KL, 2000, GASTROENTEROLOGY, V118, pA817, DOI 10.1016/S0016-5085(00)85409-8; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rajkumar R, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-23; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Yang SK, 2009, INFLAMM BOWEL DIS, V15, P1385, DOI 10.1002/ibd.20921; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	32	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16565	10.1371/journal.pone.0016565	http://dx.doi.org/10.1371/journal.pone.0016565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304977	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300087
J	Liu, YB; Mei, C; Koh, J; Sun, LH; Ji, LH				Liu, Yanbin; Mei, Chong; Koh, John; Sun, Longhua; Ji, Lianghui			Tartronate Semialdehyde Reductase Defines a Novel Rate-Limiting Step in Assimilation and Bioconversion of Glycerol in Ustilago maydis	PLOS ONE			English	Article							GENE-CLUSTER; ESCHERICHIA-COLI; CARBON SOURCE; METABOLISM; DIFFERENTIATION; TRANSFORMATION; TRANSCRIPTION; BIOSYNTHESIS; MUTANTS; PATHWAY	Background: Glycerol is a by-product of biodiesel production. Currently, it has limited applications with low bioconversion efficiency to most metabolites reported. This is partly attributed to the poor knowledge on the glycerol metabolic pathway in bacteria and fungi. Methodology/Principal Findings: We have established a fast screening method for identification of genes that improve glycerol utilization in Ustilago maydis. This was done by comparing the growth rates of T-DNA tagged mutant colonies on solid medium using glycerol as the sole carbon source. We present a detailed characterization of one of the mutants, GUM1, which contains a T-DNA element inserted into the promoter region of UM02592 locus (MIPS Ustilago maydis database, MUMDB), leading to enhanced and constitutive expression of its mRNA. We have demonstrated that um02592 encodes a functional tartronate semialdehyde reductase (Tsr1), which showed dual specificity to cofactors NAD(+) and NADP(+) and strong substrate specificity and enantioselectivity for (D)-glycerate. Improved glycerol assimilation in GUM1 was associated with elevated expression of tsr1 mRNA and this could be phenocopied by over-expression of the gene. Glycolipid accumulation was reduced by 45.2% in the knockout mutant whereas introduction of an extra copy of tsr1 driven by the glyceraldehyde phosphate dehydrogenase promoter increased it by 40.4%. Conclusions/Significance: Our results demonstrate that tartronate semialdehyde reductase (TSR) plays an important role in glycerol assimilation in U. maydis and defines a novel target in genetic engineering for improved conversion of glycerol to higher value products. Our results add significant depth to the understanding of the glycerol metabolic pathway in fungi. We have demonstrated, for the first time, a biological role of a eukaryotic TSR.	[Liu, Yanbin; Mei, Chong; Koh, John; Sun, Longhua; Ji, Lianghui] Natl Univ Singapore, Biomat & Biocatalysts Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Liu, YB (corresponding author), Natl Univ Singapore, Biomat & Biocatalysts Grp, Temasek Life Sci Lab, 1 Res Link, Singapore 117548, Singapore.	jilh@tll.org.sg		Ji, Lianghui/0000-0001-9030-3731	Singapore Economic Development Board; Temasek Trust	Singapore Economic Development Board(Singapore Economic Development Board); Temasek Trust	This work was funded by the Singapore Economic Development Board (http://www.edb.gov.sg) and Temasek Trust (http://www.temasekholdings.com.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD N, 1995, BIOCHEM BIOPH RES CO, V208, P895, DOI 10.1006/bbrc.1995.1419; BOLKER M, 1995, MOL GEN GENET, V248, P547, DOI 10.1007/BF02423450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006; COURTRIGHT JB, 1975, J BACTERIOL, V124, P497, DOI 10.1128/JB.124.1.497-502.1975; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; GOTTO AM, 1961, BIOCHEM J, V81, P273, DOI 10.1042/bj0810273; HAWES JW, 1995, BIOCHEMISTRY-US, V34, P4231, DOI 10.1021/bi00013a012; Heimel K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001035; Hewald S, 2005, APPL ENVIRON MICROB, V71, P3033, DOI 10.1128/AEM.71.6.3033-3040.2005; Hewald S, 2006, APPL ENVIRON MICROB, V72, P5469, DOI 10.1128/AEM.00506-06; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Inoh Y, 2004, J CONTROL RELEASE, V94, P423, DOI 10.1016/j.jconrel.2003.10.020; Isoda H, 1997, BIOSCI BIOTECH BIOCH, V61, P609, DOI 10.1271/bbb.61.609; Ji LH, 2010, FUNGAL GENET BIOL, V47, P279, DOI 10.1016/j.fgb.2010.01.002; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; KOHN LD, 1968, J BIOL CHEM, V243, P2465; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; NORTH MJ, 1973, FEBS LETT, V35, P67, DOI 10.1016/0014-5793(73)80578-2; OCHMAN H, 1988, GENETICS, V120, P621; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Teichmann B, 2007, MOL MICROBIOL, V66, P525, DOI 10.1111/j.1365-2958.2007.05941.x; Teichmann B, 2010, APPL ENVIRON MICROB, V76, P2633, DOI 10.1128/AEM.02211-09; Thompson JC, 2006, APPL ENG AGRIC, V22, P261; TOM GD, 1978, ARCH MICROBIOL, V117, P259, DOI 10.1007/BF00738544; VIRCA GD, 1990, BIOTECHNIQUES, V8, P370; VISWANATHREDDY M, 1977, MOL GEN GENET, V153, P29, DOI 10.1007/BF01035993; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yu KO, 2010, BIORESOURCE TECHNOL, V101, P4157, DOI 10.1016/j.biortech.2010.01.066; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhao XX, 1999, CANCER RES, V59, P482	36	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16438	10.1371/journal.pone.0016438	http://dx.doi.org/10.1371/journal.pone.0016438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305026	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300064
J	Southwell, AL; Bugg, CW; Kaltenbach, LS; Dunn, D; Butland, S; Weiss, A; Paganetti, P; Lo, DC; Patterson, PH				Southwell, Amber L.; Bugg, Charles W.; Kaltenbach, Linda S.; Dunn, Denise; Butland, Stefanie; Weiss, Andreas; Paganetti, Paolo; Lo, Donald C.; Patterson, Paul H.			Perturbation with Intrabodies Reveals That Calpain Cleavage Is Required for Degradation of Huntingtin Exon 1	PLOS ONE			English	Article							MUTANT HUNTINGTIN; DISEASE; TOXICITY; AGGREGATION; PROTEOLYSIS; FRAGMENTS; GENE; PATHOLOGY; MODULATE; PROTEIN	Background: Proteolytic processing of mutant huntingtin (mHtt), the protein that causes Huntington's disease (HD), is critical for mHtt toxicity and disease progression. mHtt contains several caspase and calpain cleavage sites that generate N-terminal fragments that are more toxic than full-length mHtt. Further processing is then required for the degradation of these fragments, which in turn, reduces toxicity. This unknown, secondary degradative process represents a promising therapeutic target for HD. Methodology/Principal Findings: We have used intrabodies, intracellularly expressed antibody fragments, to gain insight into the mechanism of mutant huntingtin exon 1 (mHDx-1) clearance. Happ1, an intrabody recognizing the proline-rich region of mHDx-1, reduces the level of soluble mHDx-1 by increasing clearance. While proteasome and macroautophagy inhibitors reduce turnover of mHDx-1, Happ1 is still able to reduce mHDx-1 under these conditions, indicating Happ1-accelerated mHDx-1 clearance does not rely on these processes. In contrast, a calpain inhibitor or an inhibitor of lysosomal pH block Happ1-mediated acceleration of mHDx-1 clearance. These results suggest that mHDx-1 is cleaved by calpain, likely followed by lysosomal degradation and this process regulates the turnover rate of mHDx-1. Sequence analysis identifies amino acid (AA) 15 as a potential calpain cleavage site. Calpain cleavage of recombinant mHDx-1 in vitro yields fragments of sizes corresponding to this prediction. Moreover, when the site is blocked by binding of another intrabody, V(L)12.3, turnover of soluble mHDx-1 in living cells is blocked. Conclusions/Significance: These results indicate that calpain-mediated removal of the 15 N-terminal AAs is required for the degradation of mHDx-1, a finding that may have therapeutic implications.	[Southwell, Amber L.; Butland, Stefanie] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Southwell, Amber L.; Bugg, Charles W.; Patterson, Paul H.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kaltenbach, Linda S.; Dunn, Denise; Lo, Donald C.] Duke Univ, Med Ctr, Dept Neurobiol, Ctr Drug Discovery, Durham, NC 27710 USA; [Weiss, Andreas; Paganetti, Paolo] Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci Discovery, Basel, Switzerland	Child & Family Research Institute; University of British Columbia; California Institute of Technology; Duke University; Novartis	Southwell, AL (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	php@caltech.edu	Paganetti, Paolo/AAF-8039-2020	Butland, Stefanie/0000-0002-5427-8951; Southwell, Amber/0000-0002-6353-5008; Paganetti, Paolo/0000-0003-1896-6324	Hereditary Disease Foundation; NINDS [5RO1NS055298]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055298] Funding Source: NIH RePORTER	Hereditary Disease Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Hereditary Disease Foundation (www.hdfoundation.org) and the NINDS 5RO1NS055298 (www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kaltenbach LS, 2010, J BIOMOL SCREEN, V15, P806, DOI 10.1177/1087057110373392; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Majumder P, 2007, CELL MOL NEUROBIOL, V27, P1127, DOI 10.1007/s10571-007-9220-7; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Qin ZH, 2004, ACTA PHARMACOL SIN, V25, P1243; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SOUTHWELL AL, 2010, REV NEUROSC IN PRESS; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; THAKUR AK, 2009, NAT STRUCT MOL BIOL; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Warby SC, 2009, MOL CELL NEUROSCI, V40, P121, DOI 10.1016/j.mcn.2008.09.007; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001	33	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16676	10.1371/journal.pone.0016676	http://dx.doi.org/10.1371/journal.pone.0016676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304966	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000286834300119
J	Spingath, EY; Kang, HS; Plummer, T; Blake, DT				Spingath, Elsie Y.; Kang, Hyun Sug; Plummer, Thane; Blake, David T.			Different Neuroplasticity for Task Targets and Distractors	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; PRIMARY SOMATOSENSORY CORTEX; CORTICAL MAP REORGANIZATION; MIDDLE TEMPORAL AREA; ADULT OWL MONKEYS; NUCLEUS BASALIS; DEPENDENT PLASTICITY; DISCRIMINATION TASK; HAND REPRESENTATION; TACTILE STIMULATION	Adult learning-induced sensory cortex plasticity results in enhanced action potential rates in neurons that have the most relevant information for the task, or those that respond strongly to one sensory stimulus but weakly to its comparison stimulus. Current theories suggest this plasticity is caused when target stimulus evoked activity is enhanced by reward signals from neuromodulatory nuclei. Prior work has found evidence suggestive of nonselective enhancement of neural responses, and suppression of responses to task distractors, but the differences in these effects between detection and discrimination have not been directly tested. Using cortical implants, we defined physiological responses in macaque somatosensory cortex during serial, matched, detection and discrimination tasks. Nonselective increases in neural responsiveness were observed during detection learning. Suppression of responses to task distractors was observed during discrimination learning, and this suppression was specific to cortical locations that sampled responses to the task distractor before learning. Changes in receptive field size were measured as the area of skin that had a significant response to a constant magnitude stimulus, and these areal changes paralleled changes in responsiveness. From before detection learning until after discrimination learning, the enduring changes were selective suppression of cortical locations responsive to task distractors, and nonselective enhancement of responsiveness at cortical locations selective for target and control skin sites. A comparison of observations in prior studies with the observed plasticity effects suggests that the non-selective response enhancement and selective suppression suffice to explain known plasticity phenomena in simple spatial tasks. This work suggests that differential responsiveness to task targets and distractors in primary sensory cortex for a simple spatial detection and discrimination task arise from nonselective increases in response over a broad cortical locus that includes the representation of the task target, and selective suppression of responses to the task distractor within this locus.	[Spingath, Elsie Y.; Kang, Hyun Sug; Plummer, Thane; Blake, David T.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Spingath, Elsie Y.; Kang, Hyun Sug] Med Coll Georgia, Grad Program Neurosci, Augusta, GA 30912 USA; [Plummer, Thane; Blake, David T.] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Spingath, EY (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	dblake@mcg.edu			NIH [5R01NS055173]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work funded by NIH grant 5R01NS055173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Blake David T., 2005, P279, DOI 10.1016/B978-012088382-0/50023-2; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Blake DT, 2005, J NEUROPHYSIOL, V94, P2239, DOI 10.1152/jn.00172.2005; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CARPENTERHYLAND E, 2010, P NAT ACAD SCI US; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Green DM, 1966, SIGNAL DETECTION THE; Harris JA, 2001, J NEUROSCI, V21, P1056, DOI 10.1523/JNEUROSCI.21-03-01056.2001; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; JOHANSSON R, 1978, J PHYSL; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Killebrew JH, 2007, J NEUROSCI METH, V161, P62, DOI 10.1016/j.jneumeth.2006.10.012; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; MERZENICH MM, 1978, J COMP NEUROL, V181, P41, DOI 10.1002/cne.901810104; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; Pei YC, 2009, J NEUROPHYSIOL, V102, P1843, DOI 10.1152/jn.00235.2009; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Porro CA, 1996, J NEUROSCI, V16, P7688; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; RICHARDSON RT, 1986, BRAIN RES, V399, P364, DOI 10.1016/0006-8993(86)91529-5; RICHARDSON RT, 1990, J NEUROSCI, V10, P2528; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SEGUELA P, 1990, NEUROSCIENCE, V35, P249, DOI 10.1016/0306-4522(90)90079-J; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Uka T, 2003, J NEUROSCI, V23, P3515; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15342	10.1371/journal.pone.0015342	http://dx.doi.org/10.1371/journal.pone.0015342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297962	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300022
J	Xiang, XR; Phung, Y; Feng, MQ; Nagashima, K; Zhang, JL; Broaddus, VC; Hassan, R; FitzGerald, D; Ho, M				Xiang, Xinran; Phung, Yen; Feng, Mingqian; Nagashima, Kunio; Zhang, Jingli; Broaddus, V. Courtney; Hassan, Raffit; FitzGerald, David; Ho, Mitchell			The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy	PLOS ONE			English	Article							E-CADHERIN; MALIGNANT MESOTHELIOMA; MULTICELLULAR SPHEROIDS; APOPTOTIC RESISTANCE; SOLID TUMORS; LUNG-CANCER; CELL-LINES; TAXOL; ADENOCARCINOMA; CHEMOTHERAPY	Background: Tumor microenvironments present significant barriers to penetration by antibodies and immunoconjugates. Tumor microenvironments, however, are difficult to study in vitro. Cells cultured as monolayers exhibit less resistance to therapy than those grown in vivo and an alternative research model more representative of the in vivo tumor is more desirable. SS1P is an immunotoxin composed of the Fv portion of a mesothelin-specific antibody fused to a bacterial toxin that is presently undergoing clinical trials in mesothelioma. Methodology/Principal Findings: Here, we examined how the tumor microenvironment affects the penetration and killing activity of SS1P in a new three-dimensional (3D) spheroid model cultured in vitro using the human mesothelioma cell line (NCI-H226) and two primary cell lines isolated from the ascites of malignant mesothelioma patients. Mesothelioma cells grown as monolayers or as spheroids expressed comparable levels of mesothelin; however, spheroids were at least 100 times less affected by SS1P. To understand this disparity in cytotoxicity, we made fluorescence-labeled SS1P molecules and used confocal microscopy to examine the time course of SS1P penetration within spheroids. The penetration was limited after 4 hours. Interestingly, we found a significant increase in the number of tight junctions in the core area of spheroids by electron microscopy. Expression of E-Cadherin, a protein involved in the assembly and sealing of tight junctions and highly expressed in malignant mesothelioma, was found significantly increased in spheroids as compared to monolayers. Moreover, we found that siRNA silencing and antibody inhibition targeting E-Cadherin could enhance SS1P immunotoxin therapy in vitro. Conclusion/Significance: This work is one of the first to investigate immunotoxins in 3D tumor spheroids in vitro. This initial description of an in vitro tumor model may offer a simple and more representative model of in vivo tumors and will allow for further investigations of the microenvironmental effects on drug penetration and tumor cell killing. We believe that the methods developed here may apply to the studies of other tumor-targeting antibodies and immunoconjugates in vitro.	[Xiang, Xinran; Phung, Yen; Feng, Mingqian; Zhang, Jingli; Hassan, Raffit; FitzGerald, David; Ho, Mitchell] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nagashima, Kunio] Sci Applicat Int Corp Frederick Inc, Frederick, MD USA; [Broaddus, V. Courtney] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of California System; University of California San Francisco	Xiang, XR (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	homi@mail.nih.gov	Ho, Mitchell/F-5059-2015	Ho, Mitchell/0000-0002-9152-5405; Xiang, Xinran/0000-0001-6422-436X	National Institutes of Health (NIH); National Cancer Institute (NCI); Center for Cancer Research; Mesothelioma Applied Research Foundation; NCI, NIH [HHSN26120080001E]; NATIONAL CANCER INSTITUTE [ZIABC010816, ZIABC010891] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mesothelioma Applied Research Foundation; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research, in part by the NCI Director's Intramural Innovation Award for Principal Investigators (MH), in part by a Mesothelioma Applied Research Foundation Grant in Honor of Craig Kozicki (MH), and in part with federal funds from the NCI, NIH, under contract HHSN26120080001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Contreras RG, 2002, PFLUG ARCH EUR J PHY, V444, P467, DOI 10.1007/s00424-002-0827-8; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Daubriac J, 2009, CELL DEATH DIFFER, V16, P1146, DOI 10.1038/cdd.2009.32; Decker T, 2004, BLOOD, V103, P2718, DOI 10.1182/blood-2003-04-1317; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Green SK, 2004, MOL CANCER THER, V3, P149; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hassan R, 2007, CLIN CANCER RES, V13, P7166, DOI 10.1158/1078-0432.CCR-07-1592; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; Kitazume H, 2000, CANCER CYTOPATHOL, V90, P55, DOI 10.1002/(SICI)1097-0142(20000225)90:1<55::AID-CNCR8>3.0.CO;2-P; LECHNER JF, 1985, P NATL ACAD SCI USA, V82, P3884, DOI 10.1073/pnas.82.11.3884; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Marchevsky AM, 2008, ARCH PATHOL LAB MED, V132, P397, DOI 10.1043/1543-2165(2008)132[397:AOITTD]2.0.CO;2; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Oury TD, 1998, HUM PATHOL, V29, P1382, DOI 10.1016/S0046-8177(98)90006-5; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Simsir A, 1999, DIAGN CYTOPATHOL, V20, P125, DOI 10.1002/(SICI)1097-0339(199903)20:3<125::AID-DC3>3.0.CO;2-V; Steele JPC, 2005, LUNG CANCER, V49, pS49, DOI 10.1016/j.lungcan.2005.03.009; Wang YH, 2002, CANCER RES, V62, P6434; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Yaziji H, 2006, MODERN PATHOL, V19, P514, DOI 10.1038/modpathol.3800534; Zhang YJ, 2008, CLIN CANCER RES, V14, P7981, DOI 10.1158/1078-0432.CCR-08-0324; Zhang YJ, 2007, P NATL ACAD SCI USA, V104, P17099, DOI 10.1073/pnas.0708101104; Zhang YJ, 2006, CLIN CANCER RES, V12, P4695, DOI 10.1158/1078-0432.CCR-06-0346; Zhang YJ, 2010, CANCER RES, V70, P1082, DOI 10.1158/0008-5472.CAN-09-2405	35	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14640	10.1371/journal.pone.0014640	http://dx.doi.org/10.1371/journal.pone.0014640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305058	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300021
J	Chen, JA; Guo, SX; Liu, PG				Chen, Juan; Guo, Shun-Xing; Liu, Pei-Gui			Species Recognition and Cryptic Species in the Tuber indicum Complex	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CHINESE TRUFFLES; SP-NOV; PSEUDOHIMALAYENSE; PSEUDOEXCAVATUM; SPAIN	Morphological delimitation of Asian black truffles, including Tuber himalayense, T. indicum, T. sinense, T. pseudohimalayense, T. formosanum and T. pseudoexcavatum, has remained problematic and even phylogenetic analyses have been controversial. In this study, we combined five years of field investigation in China with morphological study and DNA sequences analyses (ITS, LSU and beta-tubulin) of 131 Tuber specimens to show that T. pseudohimalayense and T. pseudoexcavatum are the same species. T. formosanum is a separate species based on its host plants and geographic distribution, combined with minor morphological difference from T. indicum. T. sinense should be treated as a synonym of T. indicum. Our results demonstrate that the present T. indicum, a single described morphological species, should include at least two separate phylogenetic species. These findings are of high importance for truffle taxonomy and reveal and preserve the richness of truffle diversity.	[Chen, Juan; Liu, Pei-Gui] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Chen, Juan; Guo, Shun-Xing] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100037, Peoples R China; [Chen, Juan; Guo, Shun-Xing] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, JA (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	pgliu@mail.kib.ac.cn	Chen, Juan/AEX-8536-2022		National Science Foundation of China [30470011, 30770007, 30900004]; National Science Foundation of China; Yunnan Province Government [U0836604]; Yunnan Program of Innovation [2009AC013]; Key Laboratory of Biodiversity and Biogeography; Kunming Institute of Botany; Chinese Academy of Sciences [0806361121, KSCX2-YW-G-025]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Government; Yunnan Program of Innovation; Key Laboratory of Biodiversity and Biogeography; Kunming Institute of Botany; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was financed by the National Science Foundation of China (No.30470011, 30770007 and 30900004), the Joint Founds of the National Science Foundation of China and Yunnan Province Government (No.U0836604), Yunnan Program of Innovation to strong provinces by Science & Technology (No. 2009AC013) and Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences (No. 0806361121), as well as the Knowledge Innovation Program of the Chinese Academy of Sciences (No.KSCX2-YW-G-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceruti A., 2003, SPECIE EUROPEE GENER; CHEN J, 2007, THESIS CHINESE ACAD; Chen J, 2007, MYCOLOGIA, V99, P475, DOI 10.3852/mycologia.99.3.475; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HOLMGREN PK, 2007, INDEX HERBARIORUM; HU HT, 1992, J EXPT FOREST NATL T, V6, P79; Liu B, 1989, J SHANXI U NAT SCI E, V12, P215; MABRU D, 2004, INT J FOOD MICROBIOL, V33, P230; Manjon JL, 2009, MYCOTAXON, V110, P399, DOI 10.5248/110.399; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; Moncalvo JM, 2000, SYST BIOL, V49, P278, DOI 10.1093/sysbio/49.2.278; Moreno G, 1997, MYCOTAXON, V63, P217; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NYLANDER JAA, 2002, MODELTEST; Paolocci F, 1997, FEMS MICROBIOL LETT, V153, P255, DOI 10.1111/j.1574-6968.1997.tb12582.x; PEGLER DN, 1993, BRIT TRUFFLES REVISI; RIOUSSET L, 2001, TRUFFES EUROPE CHINE; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roux C, 1999, FEMS MICROBIOL LETT, V180, P147, DOI 10.1111/j.1574-6968.1999.tb08789.x; Rubini A, 2007, NEW PHYTOL, V174, P256, DOI 10.1111/j.1469-8137.2007.01976.x; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRAPPE JM, 1979, MYCOTAXON, V9, P297; Wang Y, 1998, CRYPTOGAMIE MYCOL, V19, P113; Wang YJ, 2006, MYCOL RES, V110, P1034, DOI 10.1016/j.mycres.2006.06.013; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; ZHANG BC, 1988, T BRIT MYCOL SOC, V91, P593, DOI 10.1016/S0007-1536(88)80032-9; Zhang LF, 2005, FEMS MICROBIOL LETT, V245, P85, DOI 10.1016/j.femsle.2005.02.028	31	44	55	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14625	10.1371/journal.pone.0014625	http://dx.doi.org/10.1371/journal.pone.0014625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297969	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100009
J	Kim, J; Hwangbo, J; Wong, PKY				Kim, Jeesun; Hwangbo, Jeon; Wong, Paul K. Y.			p38 MAPK-Mediated Bmi-1 Down-Regulation and Defective Proliferation in ATM-Deficient Neural Stem Cells Can Be Restored by Akt Activation	PLOS ONE			English	Article							SELF-RENEWAL; OXIDATIVE STRESS; PROTEIN-KINASE; CHROMATIN-ASSOCIATION; PURKINJE NEURONS; EXPRESSION; GROWTH; SURVIVAL; CYCLE	A-T (ataxia telangiectasia) is a genetic disease caused by a mutation in the Atm (A-T mutated) gene that leads to neurodegeneration. Despite an increase in the numbers of studies in this area in recent years, the mechanisms underlying neurodegeneration in human A-T are still poorly understood. Previous studies demonstrated that neural stem cells (NSCs) isolated from the subventricular zone (SVZ) of Atm(-/-) mouse brains show defective self-renewal and proliferation, which is accompanied by activation of chronic p38 mitogen-activated protein kinase (MAPK) and a lower level of the polycomb protein Bmi-1. However, the mechanism underlying Bmi-1 down-regulation and its relevance to defective proliferation in Atm(-/-) NSCs remained unclear. Here, we show that over-expression of Bmi-1 increases self-renewal and proliferation of Atm(-/-) NSCs to normal, indicating that defective proliferation in Atm(-/-) NSCs is a consequence of down-regulation of Bmi-1. We also demonstrate that epidermal growth factor (EGF)-induced Akt phosphorylation renders Bmi-1 resistant to the proteasomal degradation, leading to its stabilization and accumulation in the nucleus. However, inhibition of the Akt-dependent Bmi-1 stabilizing process by p38 MAPK signaling reduces the levels of Bmi-1. Treatment of the Atm(-/-) NSCs with a specific p38 MAPK inhibitor SB203580 extended Bmi-1 posttranscriptional turnover and H2A ubiquitination in Atm(-/-) SCs. Our observations demonstrate the molecular basis underlying the impairment of self-renewal and proliferation in Atm(-/-) SCs through the p38 MAPK-Akt-Bmi-1-p21 signaling pathway.	[Kim, Jeesun; Wong, Paul K. Y.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Hwangbo, Jeon] Kyung Hee Univ, Dept Genet Engn, Suwon, South Korea; [Hwangbo, Jeon] Kyung Hee Univ, Grad Sch Biotechnol, Suwon, South Korea	University of Texas System; UTMD Anderson Cancer Center; Kyung Hee University; Kyung Hee University	Kim, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.	pkwong@mdanderson.org			MD Anderson Cancer Center; Longevity Foundation in Austin, Texas; A-T Children's Project in Deerfield Beach, Florida	MD Anderson Cancer Center; Longevity Foundation in Austin, Texas; A-T Children's Project in Deerfield Beach, Florida	This work was supported by fellowship from the Odyssey Program of MD Anderson Cancer Center, and by funds from the Longevity Foundation (formally, A-T Foundation) in Austin, Texas and A-T Children's Project in Deerfield Beach, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DM, 2000, GENE DEV, V15, P554; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bhattacharyya J, 2009, ANN HEMATOL, V88, P333, DOI 10.1007/s00277-008-0603-8; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Chen P, 2003, J NEUROSCI, V23, P11453; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Kim J, 2009, J BIOL CHEM, V284, P14396, DOI 10.1074/jbc.M808116200; Lee B, 2006, FEBS LETT, V580, P5177, DOI 10.1016/j.febslet.2006.08.064; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li JX, 2006, J NEUROSCI, V26, P7839, DOI 10.1523/JNEUROSCI.1624-06.2006; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wong P. K., 2010, NEURODEGENERATION TH, P1; Yang SR, 2006, STEM CELLS, V24, P292, DOI 10.1634/stemcells.2005-0221; Zuluaga S, 2007, CELL SIGNAL, V19, P62, DOI 10.1016/j.cellsig.2006.05.032	36	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16615	10.1371/journal.pone.0016615	http://dx.doi.org/10.1371/journal.pone.0016615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305053	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100050
J	Adel-Patient, K; Guimaraes, VD; Paris, A; Drumare, MF; Ah-Leung, S; Lamourette, P; Nevers, MC; Canlet, C; Molina, J; Bernard, H; Creminon, C; Wal, JM				Adel-Patient, Karine; Guimaraes, Valeria D.; Paris, Alain; Drumare, Marie-Francoise; Ah-Leung, Sandrine; Lamourette, Patricia; Nevers, Marie-Claire; Canlet, Cecile; Molina, Jerome; Bernard, Herve; Creminon, Christophe; Wal, Jean-Michel			Immunological and Metabolomic Impacts of Administration of Cry1Ab Protein and MON 810 Maize in Mouse	PLOS ONE			English	Article							BETA-LACTOGLOBULIN; IMMUNE-RESPONSE; BALB/C MICE; MONOCLONAL-ANTIBODIES; ANIMAL-MODELS; IGE; ALLERGENICITY; ALLERGY; IMMUNOASSAYS; CHALLENGE	We have investigated the immunological and metabolomic impacts of Cry1Ab administration to mice, either as a purified protein or as the Cry1Ab-expressing genetically modified (GM) MON810 maize. Humoral and cellular specific immune responses induced in BALB/cJ mice after intra-gastric (i.g.) or intra-peritoneal (i.p.) administration of purified Cry1Ab were analyzed and compared with those induced by proteins of various immunogenic and allergic potencies. Possible unintended effects of the genetic modification on the pattern of expression of maize natural allergens were studied using IgE-immunoblot and sera from maize-allergic patients. Mice were experimentally sensitized (i.g. or i.p. route) with protein extracts from GM or non-GM maize, and then anti-maize proteins and anti-Cry1Ab-induced immune responses were analyzed. In parallel, longitudinal metabolomic studies were performed on the urine of mice treated via the i.g. route. Weak immune responses were observed after i.g. administration of the different proteins. Using the i.p. route, a clear Th2 response was observed with the known allergenic proteins, whereas a mixed Th1/Th2 immune response was observed with immunogenic protein not known to be allergenic and with Cry1Ab. This then reflects protein immunogenicity in the BALB/c Th2-biased mouse strain rather than allergenicity. No difference in natural maize allergen profiles was evidenced between MON810 and its non-GM comparator. Immune responses against maize proteins were quantitatively equivalent in mice treated with MON810 vs the non-GM counterpart and no anti-Cry1Ab-specific immune response was detected in mice that received MON810. Metabolomic studies showed a slight "cultivar'' effect, which represented less than 1% of the initial metabolic information. Our results confirm the immunogenicity of purified Cry1Ab without evidence of allergenic potential. Immunological and metabolomic studies revealed slight differences in mouse metabolic profiles after i.g. administration of MON810 vs its non-GM counterpart, but no significant unintended effect of the genetic modification on immune responses was seen.	[Adel-Patient, Karine; Guimaraes, Valeria D.; Drumare, Marie-Francoise; Ah-Leung, Sandrine; Bernard, Herve; Wal, Jean-Michel] INRA, UR496, Unite Immuno Allergie Alimentaire, Jouy En Josas, France; [Paris, Alain] INRA, UR1204, Paris, France; [Lamourette, Patricia; Nevers, Marie-Claire; Creminon, Christophe] CEA, iBiTeCS, Lab Etude & Rech Immunoanalyse, Gif Sur Yvette, France; [Canlet, Cecile; Molina, Jerome] INRA, UMR1089, F-31931 Toulouse, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Adel-Patient, K (corresponding author), INRA, UR496, Unite Immuno Allergie Alimentaire, Jouy En Josas, France.	Karine.Adel-Patient@cea.fr	Paris, Alain/AAW-6157-2020		French Ministry of Research and Technology	French Ministry of Research and Technology	The authors thank the French Ministry of Research and Technology for financial support (ANR "Impact des OGM''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2005, ALLERGY, V60, P658, DOI 10.1111/j.1398-9995.2005.00767.x; Adel-Patient K, 2003, CLIN EXP ALLERGY, V33, P376, DOI 10.1046/j.1365-2222.2003.01613.x; Adel-Patient K, 2000, J IMMUNOL METHODS, V235, P21, DOI 10.1016/S0022-1759(99)00210-0; Batista R, 2005, J ALLERGY CLIN IMMUN, V116, P403, DOI 10.1016/j.jaci.2005.04.014; Bernard H, 2003, ALLERGY, V58, P1285, DOI 10.1046/j.1398-9995.2003.00300.x; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Codex Alimentarius Commission, 2003, AL 03 34 JOINT FAO W, P47; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Dearman RJ, 2009, CLIN EXP ALLERGY, V39, P458, DOI 10.1111/j.1365-2222.2008.03194.x; Dearman RJ, 2007, METHODS, V41, P91, DOI 10.1016/j.ymeth.2006.07.008; Dearman RJ, 2001, TOXICOLOGY, V167, P217, DOI 10.1016/S0300-483X(01)00462-0; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Dumas ME, 2002, ANAL CHEM, V74, P2261, DOI 10.1021/ac0156870; EFSA Panel on Genetically Modified Organisms (GMO), 2010, SCI OP ASS ALL GM PL, P1700; Eiwegger T, 2006, CLIN EXP ALLERGY, V36, P1281, DOI 10.1111/j.1365-2222.2006.02565.x; Eum SY, 1995, P NATL ACAD SCI USA, V92, P12290, DOI 10.1073/pnas.92.26.12290; FAO/WHO, 2001, EV ALL GEN MOD FOODS; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343; GRASSI J, 1988, ANAL BIOCHEM, V168, P436, DOI 10.1016/0003-2697(88)90341-7; Guerrero GG, 2004, MOL IMMUNOL, V41, P1177, DOI 10.1016/j.molimm.2004.06.026; Guimaraes V, 2010, J AGR FOOD CHEM, V58, P3222, DOI 10.1021/jf903189j; Hefle SL, 1996, CRIT REV FOOD SCI, V36, pS69, DOI 10.1080/10408399609527760; HOFTE H, 1986, EUR J BIOCHEM, V161, P273, DOI 10.1111/j.1432-1033.1986.tb10443.x; HOLT PG, 1981, INT ARCH ALLER A IMM, V65, P42, DOI 10.1159/000232736; Hourihane JO, 1998, ALLERGY, V53, P84, DOI 10.1111/j.1398-9995.1998.tb04971.x; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Kim JH, 2009, FOOD SCI BIOTECHNOL, V18, P1273; Kim T., 2003, REGULATORY FRAMEWORK, V527, P1; Kimber I, 2003, ENVIRON HEALTH PERSP, V111, P1125; Konig A, 2004, FOOD CHEM TOXICOL, V42, P1047, DOI 10.1016/j.fct.2004.02.019; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; LECADET MM, 1967, CR ACAD SCI D NAT, V265, P1543; MARCELLETTI JF, 1992, CELL IMMUNOL, V143, P405, DOI 10.1016/0008-8749(92)90036-O; Moreno-Fierros L, 2000, MICROBES INFECT, V2, P885, DOI 10.1016/S1286-4579(00)00398-1; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakajima O, 2007, REGUL TOXICOL PHARM, V47, P90, DOI 10.1016/j.yrtph.2006.08.003; Negroni L, 1998, J IMMUNOL METHODS, V220, P25, DOI 10.1016/S0022-1759(98)00150-1; PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Stickler M, 2003, ENVIRON HEALTH PERSP, V111, P251, DOI 10.1289/ehp.5707; TAYLOR WA, 1980, IMMUNOLOGY, V39, P583; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vazquez-Padron RI, 2000, BRAZ J MED BIOL RES, V33, P147, DOI 10.1590/S0100-879X2000000200002	45	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16346	10.1371/journal.pone.0016346	http://dx.doi.org/10.1371/journal.pone.0016346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298004	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900037
J	Malmsten, M; Kasetty, G; Pasupuleti, M; Alenfall, J; Schmidtchen, A				Malmsten, Martin; Kasetty, Gopinath; Pasupuleti, Mukesh; Alenfall, Jan; Schmidtchen, Artur			Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP	PLOS ONE			English	Article							HEPARIN-BINDING PEPTIDES; ANTIBACTERIAL PEPTIDES; HOST-DEFENSE; PSEUDOMONAS-AERUGINOSA; BACTERIAL PATHOGENS; INNATE IMMUNITY; DESIGN; POLYPEPTIDES; INFECTIONS; RESISTANCE	Background: Antimicrobial peptides (AMPs) are receiving increasing attention due to resistance development against conventional antibiotics. Pseudomonas aeruginosa and Staphylococcus aureus are two major pathogens involved in an array of infections such as ocular infections, cystic fibrosis, wound and post-surgery infections, and sepsis. The goal of the study was to design novel AMPs against these pathogens. Methodology and Principal Findings: Antibacterial activity was determined by radial diffusion, viable count, and minimal inhibitory concentration assays, while toxicity was evaluated by hemolysis and effects on human epithelial cells. Liposome and fluorescence studies provided mechanistic information. Protease sensitivity was evaluated after subjection to human leukocyte elastase, staphylococcal aureolysin and V8 proteinase, as well as P. aeruginosa elastase. Highly active peptides were evaluated in ex vivo skin infection models. C-terminal end-tagging by W and F amino acid residues increased antimicrobial potency of the peptide sequences GRRPRPRPRP and RRPRPRPRP, derived from proline arginine-rich and leucine-rich repeat protein (PRELP). The optimized peptides were antimicrobial against a range of Gram-positive S. aureus and Gram-negative P. aeruginosa clinical isolates, also in the presence of human plasma and blood. Simultaneously, they showed low toxicity against mammalian cells. Particularly W-tagged peptides displayed stability against P. aeruginosa elastase, and S. aureus V8 proteinase and aureolysin, and the peptide RRPRPRPRPWWWW-NH2 was effective against various "superbugs'' including vancomycin-resistant enterococci, multi-drug resistant P. aeruginosa, and methicillin-resistant S. aureus, as well as demonstrated efficiency in an ex vivo skin wound model of S. aureus and P. aeruginosa infection. Conclusions/Significance: Hydrophobic C-terminal end-tagging of the cationic sequence RRPRPRPRP generates highly selective AMPs with potent activity against multiresistant bacteria and efficiency in ex vivo wound infection models. A precise "tuning'' of toxicity and proteolytic stability may be achieved by changing tag-length and adding W-or F-amino acid tags.	[Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Kasetty, Gopinath; Pasupuleti, Mukesh; Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Alenfall, Jan] Dermagen AB, Lund, Sweden	Uppsala University; Lund University	Malmsten, M (corresponding author), Uppsala Univ, Dept Pharm, Uppsala, Sweden.	artur.schmidtchen@med.lu.se	Pasupuleti, Mukesh/AAF-4066-2020; Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAD-9977-2020; Schmidtchen, Artur/F-9507-2015	Pasupuleti, Mukesh/0000-0001-6337-6257; 	Swedish Research Council [521-2009-3378, 7480, 621-2003-4022]; Royal Physiographic Society in Lund; Welander-Finsen Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; Marianne and Marcus Wallenberg Foundation; DermaGen AB; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Welander-Finsen Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; Marianne and Marcus Wallenberg Foundation; DermaGen AB; Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (projects 521-2009-3378, 7480, and 621-2003-4022), the Royal Physiographic Society in Lund, the Welander-Finsen, Crafoord, Osterlund, and Kock Foundations, Marianne and Marcus Wallenberg Foundation, DermaGen AB, and the Swedish Government Funds for Clinical Research (ALF). Dermagen AB (JA) provided data concerning MIC analyses of multi-resistant bacterial isolates (Table 2) and approved the manuscript before submission. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt;74::AID-BIP70&gt;3.0.CO;2-S; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Fritsche TR, 2008, J ANTIMICROB CHEMOTH, V61, P1092, DOI 10.1093/jac/dkn074; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Kunz AN, 2010, CHEMOTHERAPY, V56, P492, DOI 10.1159/000321018; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li X, 2006, BBA-BIOMEMBRANES, V1758, P1203, DOI 10.1016/j.bbamem.2006.03.032; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Marr AK, 2006, CURR OPIN PHARM; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; McDonnell G, 1999, J MICROBIOL METH, V35, P31, DOI 10.1016/S0167-7012(98)00094-3; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; Pasupuleti M, 2009, BBA-GEN SUBJECTS, V1790, P800, DOI 10.1016/j.bbagen.2009.03.029; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Sajjan US, 2001, ANTIMICROB AGENTS CH, V45, P3437, DOI 10.1128/AAC.45.12.3437-3444.2001; Schmidtchen A, 2003, MICROB PATHOGENESIS, V34, P47, DOI 10.1016/S0882-4010(02)00197-3; Schmidtchen A, 2009, J BIOL CHEM, V284, P17584, DOI 10.1074/jbc.M109.011650; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Vermeulen H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005486.pub2; Werthen M, 2004, J ANTIMICROB CHEMOTH, V54, P772, DOI 10.1093/jac/dkh407; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; ZELEZETSKY I, 2006, J BIOL CHEM; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	68	61	64	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16400	10.1371/journal.pone.0016400	http://dx.doi.org/10.1371/journal.pone.0016400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298015	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900046
J	Pope, WH; Jacobs-Sera, D; Russell, DA; Peebles, CL; Al-Atrache, Z; Alcoser, TA; Alexander, LM; Alfano, MB; Alford, ST; Amy, NE; Anderson, MD; Anderson, AG; Ang, AAS; Ares, M; Barber, AJ; Barker, LP; Barrett, JM; Barshop, WD; Bauerle, CM; Bayles, IM; Belfield, KL; Best, AA; Borjon, A; Bowman, CA; Boyer, CA; Bradley, KW; Bradley, VA; Broadway, LN; Budwal, K; Busby, KN; Campbell, IW; Campbell, AM; Carey, A; Caruso, SM; Chew, RD; Cockburn, CL; Cohen, LB; Corajod, JM; Cresawn, SG; Davis, KR; Deng, LS; Denver, DR; Dixon, BR; Ekram, S; Elgin, SCR; Engelsen, AE; English, BEV; Erb, ML; Estrada, C; Filliger, LZ; Findley, AM; Forbes, L; Forsyth, MH; Fox, TM; Fritz, MJ; Garcia, R; George, ZD; Georges, AE; Gissendanner, CR; Goff, S; Goldstein, R; Gordon, KC; Green, RD; Guerra, SL; Guiney-Olsen, KR; Guiza, BG; Haghighat, L; Hagopian, GV; Harmon, CJ; Harmson, JS; Hartzog, GA; Harvey, SE; He, SP; He, KJ; Healy, KE; Higinbotham, ER; Hildebrandt, EN; Ho, JH; Hogan, GM; Hohenstein, VG; Holz, NA; Huang, VJ; Hufford, EL; Hynes, PM; Jackson, AS; Jansen, EC; Jarvik, J; Jasinto, PG; Jordan, TC; Kasza, T; Katelyn, MA; Kelsey, JS; Kerrigan, LA; Khaw, D; Kim, J; Knutter, JZ; Ko, CC; Larkin, GV; Laroche, JR; Latif, A; Leuba, KD; Leuba, SI; Lewis, LO; Loesser-Casey, KE; Long, CA; Lopez, AJ; Lowery, N; Lu, TQ; Mac, V; Masters, IR; McCloud, JJ; McDonough, MJ; Medenbach, AJ; Menon, A; Miller, R; Morgan, BK; Ng, PC; Nguyen, E; Nguyen, KT; Nguyen, ET; Nicholson, KM; Parnell, LA; Peirce, CE; Perz, AM; Peterson, LJ; Pferdehirt, RE; Philip, SV; Pogliano, K; Pogliano, J; Polley, T; Puopolo, EJ; Rabinowitz, HS; Resiss, MJ; Rhyan, CN; Robinson, YM; Rodriguez, LL; Rose, AC; Rubin, JD; Ruby, JA; Saha, MS; Sandoz, JW; Savitskaya, J; Schipper, DJ; Schnitzler, CE; Schott, AR; Segal, JB; Shaffer, CD; Sheldon, KE; Shepard, EM; Shepardson, JW; Shroff, MK; Simmons, JM; Simms, EF; Simpson, BM; Sinclair, KM; Sjoholm, RL; Slette, IJ; Spaulding, BC; Straub, CL; Stukey, J; Sughrue, T; Tang, TY; Tatyana, LM; Taylor, SB; Taylor, BJ; Temple, LM; Thompson, JV; Tokarz, MP; Trapani, SE; Troum, AP; Tsay, J; Tubbs, AT; Walton, JM; Wang, DH; Wang, HN; Warner, JR; Weisser, EG; Wendler, SC; Weston-Hafer, KA; Whelan, HM; Williamson, KE; Willis, AN; Wirtshafter, HS; Wong, TW; Wu, PL; Yang, YJ; Yee, BC; Zaidins, DA; Zhang, B; Zuniga, MY; Hendrix, RW; Hatfull, GF				Pope, Welkin H.; Jacobs-Sera, Deborah; Russell, Daniel A.; Peebles, Craig L.; Al-Atrache, Zein; Alcoser, Turi A.; Alexander, Lisa M.; Alfano, Matthew B.; Alford, Samantha T.; Amy, Nichols E.; Anderson, Marie D.; Anderson, Alexander G.; Ang, Andrew A. S.; Ares, Manuel, Jr.; Barber, Amanda J.; Barker, Lucia P.; Barrett, Jonathan M.; Barshop, William D.; Bauerle, Cynthia M.; Bayles, Ian M.; Belfield, Katherine L.; Best, Aaron A.; Borjon, Agustin, Jr.; Bowman, Charles A.; Boyer, Christine A.; Bradley, Kevin W.; Bradley, Victoria A.; Broadway, Lauren N.; Budwal, Keshav; Busby, Kayla N.; Campbell, Ian W.; Campbell, Anne M.; Carey, Alyssa; Caruso, Steven M.; Chew, Rebekah D.; Cockburn, Chelsea L.; Cohen, Lianne B.; Corajod, Jeffrey M.; Cresawn, Steven G.; Davis, Kimberly R.; Deng, Lisa; Denver, Dee R.; Dixon, Breyon R.; Ekram, Sahrish; Elgin, Sarah C. R.; Engelsen, Angela E.; English, Belle E. V.; Erb, Marcella L.; Estrada, Crystal; Filliger, Laura Z.; Findley, Ann M.; Forbes, Lauren; Forsyth, Mark H.; Fox, Tyler M.; Fritz, Melissa J.; Garcia, Roberto; George, Zindzi D.; Georges, Anne E.; Gissendanner, Christopher R.; Goff, Shannon; Goldstein, Rebecca; Gordon, Kobie C.; Green, Russell D.; Guerra, Stephanie L.; Guiney-Olsen, Krysta R.; Guiza, Bridget G.; Haghighat, Leila; Hagopian, Garrett V.; Harmon, Catherine J.; Harmson, Jeremy S.; Hartzog, Grant A.; Harvey, Samuel E.; He, Siping; He, Kevin J.; Healy, Kaitlin E.; Higinbotham, Ellen R.; Hildebrandt, Erin N.; Ho, Jason H.; Hogan, Gina M.; Hohenstein, Victoria G.; Holz, Nathan A.; Huang, Vincent J.; Hufford, Ericka L.; Hynes, Peter M.; Jackson, Arrykka S.; Jansen, Erica C.; Jarvik, Jonathan; Jasinto, Paul G.; Jordan, Tuajuanda C.; Kasza, Tomas; Katelyn, Murray A.; Kelsey, Jessica S.; Kerrigan, Larisa A.; Khaw, Daryl; Kim, Junghee; Knutter, Justin Z.; Ko, Ching-Chung; Larkin, Gail V.; Laroche, Jennifer R.; Latif, Asma; Leuba, Kohana D.; Leuba, Sequoia I.; Lewis, Lynn O.; Loesser-Casey, Kathryn E.; Long, Courtney A.; Lopez, A. Javier; Lowery, Nicholas; Lu, Tina Q.; Mac, Victor; Masters, Isaac R.; McCloud, Jazmyn J.; McDonough, Molly J.; Medenbach, Andrew J.; Menon, Anjali; Miller, Rachel; Morgan, Brandon K.; Ng, Patrick C.; Nguyen, Elvis; Nguyen, Katrina T.; Nguyen, Emilie T.; Nicholson, Kaylee M.; Parnell, Lindsay A.; Peirce, Caitlin E.; Perz, Allison M.; Peterson, Luke J.; Pferdehirt, Rachel E.; Philip, Seegren V.; Pogliano, Kit; Pogliano, Joe; Polley, Tamsen; Puopolo, Erica J.; Rabinowitz, Hannah S.; Resiss, Michael J.; Rhyan, Corwin N.; Robinson, Yetta M.; Rodriguez, Lauren L.; Rose, Andrew C.; Rubin, Jeffrey D.; Ruby, Jessica A.; Saha, Margaret S.; Sandoz, James W.; Savitskaya, Judith; Schipper, Dale J.; Schnitzler, Christine E.; Schott, Amanda R.; Segal, J. Bradley; Shaffer, Christopher D.; Sheldon, Kathryn E.; Shepard, Erica M.; Shepardson, Jonathan W.; Shroff, Madav K.; Simmons, Jessica M.; Simms, Erika F.; Simpson, Brandy M.; Sinclair, Kathryn M.; Sjoholm, Robert L.; Slette, Ingrid J.; Spaulding, Blaire C.; Straub, Clark L.; Stukey, Joseph; Sughrue, Trevor; Tang, Tin-Yun; Tatyana, Lyons M.; Taylor, Stephen B.; Taylor, Barbara J.; Temple, Louise M.; Thompson, Jasper V.; Tokarz, Michael P.; Trapani, Stephanie E.; Troum, Alexander P.; Tsay, Jonathan; Tubbs, Anthony T.; Walton, Jillian M.; Wang, Danielle H.; Wang, Hannah; Warner, John R.; Weisser, Emilie G.; Wendler, Samantha C.; Weston-Hafer, Kathleen A.; Whelan, Hilary M.; Williamson, Kurt E.; Willis, Angelica N.; Wirtshafter, Hannah S.; Wong, Theresa W.; Wu, Phillip; Yang, Yun Jeong; Yee, Brandon C.; Zaidins, David A.; Zhang, Bo; Zuniga, Melina Y.; Hendrix, Roger W.; Hatfull, Graham F.			Expanding the Diversity of Mycobacteriophages: Insights into Genome Architecture and Evolution	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHAGE GENOMICS; TMRNA GENES; BACTERIOPHAGES; VIRUSES; TRANSFORMATION; TUBERCULOSIS; RECOGNITION; INTEGRATION; SEQUENCES	Mycobacteriophages are viruses that infect mycobacterial hosts such as Mycobacterium smegmatis and Mycobacterium tuberculosis. All mycobacteriophages characterized to date are dsDNA tailed phages, and have either siphoviral or myoviral morphotypes. However, their genetic diversity is considerable, and although sixty-two genomes have been sequenced and comparatively analyzed, these likely represent only a small portion of the diversity of the mycobacteriophage population at large. Here we report the isolation, sequencing and comparative genomic analysis of 18 new mycobacteriophages isolated from geographically distinct locations within the United States. Although no clear correlation between location and genome type can be discerned, these genomes expand our knowledge of mycobacteriophage diversity and enhance our understanding of the roles of mobile elements in viral evolution. Expansion of the number of mycobacteriophages grouped within Cluster A provides insights into the basis of immune specificity in these temperate phages, and we also describe a novel example of apparent immunity theft. The isolation and genomic analysis of bacteriophages by freshman college students provides an example of an authentic research experience for novice scientists.	[Al-Atrache, Zein; Alcoser, Turi A.; Alexander, Lisa M.; Bayles, Ian M.; Budwal, Keshav; Campbell, Ian W.; Cohen, Lianne B.; English, Belle E. V.; Filliger, Laura Z.; Fox, Tyler M.; Guerra, Stephanie L.; He, Siping; Healy, Kaitlin E.; Jarvik, Jonathan; Jasinto, Paul G.; Lopez, A. Javier; Medenbach, Andrew J.; Pferdehirt, Rachel E.; Resiss, Michael J.; Savitskaya, Judith; Sheldon, Kathryn E.; Shroff, Madav K.; Thompson, Jasper V.; Wirtshafter, Hannah S.; Zaidins, David A.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Forsyth, Mark H.; Gordon, Kobie C.; Harvey, Samuel E.; Jackson, Arrykka S.; McDonough, Molly J.; Perz, Allison M.; Saha, Margaret S.; Walton, Jillian M.; Whelan, Hilary M.; Williamson, Kurt E.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Barber, Amanda J.; Best, Aaron A.; Chew, Rebekah D.; Corajod, Jeffrey M.; Georges, Anne E.; Harmon, Catherine J.; Hildebrandt, Erin N.; Jansen, Erica C.; Knutter, Justin Z.; Laroche, Jennifer R.; Long, Courtney A.; Peirce, Caitlin E.; Peterson, Luke J.; Rose, Andrew C.; Schipper, Dale J.; Simmons, Jessica M.; Sjoholm, Robert L.; Slette, Ingrid J.; Stukey, Joseph; Willis, Angelica N.] Hope Coll, A Paul Schaap Sci Ctr, Dept Biol, Holland, MI 49423 USA; [Barker, Lucia P.; Bradley, Kevin W.; Jordan, Tuajuanda C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Amy, Nichols E.; Barrett, Jonathan M.; Bradley, Victoria A.; Cockburn, Chelsea L.; Cresawn, Steven G.; Green, Russell D.; Katelyn, Murray A.; Masters, Isaac R.; Philip, Seegren V.; Schott, Amanda R.; Sinclair, Kathryn M.; Tatyana, Lyons M.; Taylor, Stephen B.; Temple, Louise M.; Trapani, Stephanie E.; Troum, Alexander P.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Carey, Alyssa; Denver, Dee R.; Forbes, Lauren; Garcia, Roberto; Goff, Shannon; Khaw, Daryl; Kim, Junghee; Lowery, Nicholas; Menon, Anjali; Miller, Rachel; Nguyen, Elvis; Polley, Tamsen; Puopolo, Erica J.; Schnitzler, Christine E.; Shepardson, Jonathan W.; Taylor, Barbara J.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Anderson, Marie D.; Bauerle, Cynthia M.; Dixon, Breyon R.; George, Zindzi D.; McCloud, Jazmyn J.; Parnell, Lindsay A.; Robinson, Yetta M.; Spaulding, Blaire C.; Zuniga, Melina Y.] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Ang, Andrew A. S.; Busby, Kayla N.; Ekram, Sahrish; Erb, Marcella L.; Estrada, Crystal; Guiza, Bridget G.; Haghighat, Leila; He, Kevin J.; Ho, Jason H.; Lu, Tina Q.; Nguyen, Katrina T.; Nguyen, Emilie T.; Pogliano, Kit; Pogliano, Joe; Segal, J. Bradley; Tang, Tin-Yun; Tsay, Jonathan; Wang, Danielle H.; Wang, Hannah; Wong, Theresa W.; Wu, Phillip; Yang, Yun Jeong] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ares, Manuel, Jr.; Borjon, Agustin, Jr.; Davis, Kimberly R.; Hagopian, Garrett V.; Hartzog, Grant A.; Holz, Nathan A.; Kasza, Tomas; Mac, Victor; Nicholson, Kaylee M.; Rodriguez, Lauren L.; Rubin, Jeffrey D.; Ruby, Jessica A.; Shepard, Erica M.; Straub, Clark L.; Sughrue, Trevor; Yee, Brandon C.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Broadway, Lauren N.; Engelsen, Angela E.; Findley, Ann M.; Gissendanner, Christopher R.; Harmson, Jeremy S.; Hogan, Gina M.; Hufford, Ericka L.; Morgan, Brandon K.; Warner, John R.] NE Louisiana Univ, Dept Biol, Monroe, LA 71209 USA; [Al-Atrache, Zein; Alfano, Matthew B.; Belfield, Katherine L.; Boyer, Christine A.; Campbell, Anne M.; Guiney-Olsen, Krysta R.; Higinbotham, Ellen R.; Kerrigan, Larisa A.; Larkin, Gail V.; Latif, Asma; Lewis, Lynn O.; Loesser-Casey, Kathryn E.; Simpson, Brandy M.; Tokarz, Michael P.; Wendler, Samantha C.] Univ Mary Washington, Dept Biol Sci, Fredericksburg, VA USA; [Caruso, Steven M.; Goldstein, Rebecca; Kelsey, Jessica S.; Sandoz, James W.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21201 USA; [Pope, Welkin H.; Jacobs-Sera, Deborah; Russell, Daniel A.; Peebles, Craig L.; Bowman, Charles A.; Fritz, Melissa J.; Hohenstein, Victoria G.; Ko, Ching-Chung; Leuba, Kohana D.; Leuba, Sequoia I.; Hendrix, Roger W.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Alford, Samantha T.; Anderson, Alexander G.; Barshop, William D.; Deng, Lisa; Elgin, Sarah C. R.; Huang, Vincent J.; Hynes, Peter M.; Ng, Patrick C.; Rabinowitz, Hannah S.; Rhyan, Corwin N.; Shaffer, Christopher D.; Simms, Erika F.; Tubbs, Anthony T.; Weisser, Emilie G.; Weston-Hafer, Kathleen A.; Zhang, Bo] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Carnegie Mellon University; William & Mary; Hope College; Howard Hughes Medical Institute; James Madison University; Oregon State University; Spelman College; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; University of Louisiana System; University of Louisiana Monroe; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Pope, WH (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	gfh@pitt.edu	Slette, Ingrid J/AAL-8634-2020; Schnitzler, Christine/G-8733-2013; Caruso, Steven M/AAF-2169-2020	Slette, Ingrid J/0000-0002-7707-3246; Caruso, Steven M/0000-0001-9166-9137; Wirtshafter, Hannah/0000-0003-4684-7074; Rubin, Jeffrey/0000-0001-9168-4361; Tubbs, Anthony/0000-0002-5605-8231; Yuen, Lisa/0000-0002-3900-416X; Jansen, Erica/0000-0002-3364-3729; Barshop, William/0000-0001-9517-2339; Tang, Tin-Yun/0000-0003-2030-9518; Belfield, Katherine/0000-0001-5893-0882; Leuba, Sequoia/0000-0002-6585-2824; Schnitzler, Christine/0000-0002-5001-6524; Forsyth, Mark/0000-0001-8653-6508; Busby, Kayla/0000-0002-3360-9707; Lin, Hilary/0000-0002-3006-9741; Saha, Margaret/0000-0003-0096-2667; Elgin, Sarah C. R./0000-0002-5176-2510; Pogliano, Kit/0000-0002-7868-3345; Holland, Laura/0000-0002-5726-0087; Seegren, Philip/0000-0002-7153-4670; Vallespir Lowery, Nick/0000-0001-7887-4179; Ko, Ching-Chung/0000-0002-8950-7128	National Institutes of Health [GM51975]; Howard Hughes Medical Institute; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0821202] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Institutes of Health Grant GM51975; Howard Hughes Medical Institute. The University of Pittsburgh was supported through a Professor's grant from HHMI. The Science Education Alliance (SEA) program at HHMI also supported the 12 participating institutions in offering a research-based course for freshman undergraduates. HHMI participated in course design and implementation, and designed tools for data analysis.	Bandhu A, 2010, BIOCHEMISTRY-US, V49, P4235, DOI 10.1021/bi9020956; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brown KL, 1997, EMBO J, V16, P5914, DOI 10.1093/emboj/16.19.5914; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Calendar R., 2006, BACTERIOPHAGES; Caruso SM, 2009, CBE-LIFE SCI EDUC, V8, P278, DOI 10.1187/cbe.09-07-0052; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Derbyshire V, 1998, P NATL ACAD SCI USA, V95, P1356, DOI 10.1073/pnas.95.4.1356; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; Fraser JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/j.jmb.2006.03.043; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hanauer DI, 2009, MENTOR ACAD IND, V2, P1, DOI 10.1007/978-0-387-89649-6_1; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hatfull G. F., 2006, BACTERIOPHAGES, P602; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Henry M, 2010, GENE, V453, P9, DOI 10.1016/j.gene.2009.12.007; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Jain S, 2000, MOL MICROBIOL, V38, P971, DOI 10.1046/j.1365-2958.2000.02184.x; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kumar V, 2008, TUBERCULOSIS, V88, P616, DOI 10.1016/j.tube.2008.02.007; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martinsohn JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000065; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Perler FB, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540500531739; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; SOLOFF BL, 1978, J VIROL, V25, P253, DOI 10.1128/JVI.25.1.253-262.1978; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sulakvelidze Andrew M. Kropinski Alexander, 2007, V394, P133, DOI 10.1007/978-1-59745-512-1_9; Summer EJ, 2007, CURR OPIN MICROBIOL, V10, P410, DOI 10.1016/j.mib.2007.05.016; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006	53	102	107	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16329	10.1371/journal.pone.0016329	http://dx.doi.org/10.1371/journal.pone.0016329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298013	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000286663900036
J	Staats, HF; Fielhauer, JR; Thompson, AL; Tripp, AA; Sobel, AE; Maddaloni, M; Abraham, SN; Pascual, DW				Staats, Herman F.; Fielhauer, Jeffrey R.; Thompson, Afton L.; Tripp, Alice A.; Sobel, Ashley E.; Maddaloni, Massimo; Abraham, Soman N.; Pascual, David W.			Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NASAL LYMPHOID-TISSUE; BOTULINUM NEUROTOXIN; PROTECTIVE ANTIGEN; INFLUENZA VACCINE; CHOLERA-TOXIN; INTRANASAL IMMUNIZATION; MONOCLONAL-ANTIBODIES; SYSTEMIC IMMUNITY; BELLS-PALSY	Background: We previously reported that the immunogenicity of Hc beta tre, a botulinum neurotoxin A (BoNT/A) immunogen, was enhanced by fusion to an epithelial cell binding domain, Ad2F, when nasally delivered to mice with cholera toxin (CT). This study was performed to determine if Ad2F would enhance the nasal immunogenicity of Hc beta tre in rabbits, an animal model with a nasal cavity anatomy similar to humans. Since CT is not safe for human use, we also tested the adjuvant activity of compound 48/80 (C48/80), a mast cell activating compound previously determined to safely exhibit nasal adjuvant activity in mice. Methods: New Zealand White or Dutch Belted rabbits were nasally immunized with Hc beta tre or Hc beta tre-Ad2F alone or combined with CT or C48/80, and serum samples were tested for the presence of Hc beta tre-specific binding (ELISA) or BoNT/A neutralizing antibodies. Results: Hc beta tre-Ad2F nasally administered with CT induced serum anti-Hc beta tre IgG ELISA and BoNT/A neutralizing antibody titers greater than those induced by Hc beta tre + CT. C48/80 provided significant nasal adjuvant activity and induced BoNT/A-neutralizing antibodies similar to those induced by CT. Conclusions: Ad2F enhanced the nasal immunogenicity of Hc beta tre, and the mast cell activator C48/80 was an effective adjuvant for nasal immunization in rabbits, an animal model with a nasal cavity anatomy similar to that in humans.	[Staats, Herman F.; Fielhauer, Jeffrey R.; Thompson, Afton L.; Tripp, Alice A.; Sobel, Ashley E.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Staats, Herman F.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Staats, Herman F.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; [Maddaloni, Massimo; Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Duke University; Duke University; Duke University; Duke University; Montana State University System; Montana State University Bozeman	Staats, HF (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	herman.staats@duke.edu	Pascual, David/AAC-2248-2022	Staats, Herman/0000-0003-1039-1087	NIH [R01 AI064879, R21 AI059591, R01 AI078938]; Rocky Mountain Research Center of Excellence, NIH [U54 AI06537]; Montana Agricultural Station; U.S. Department of Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078938, R01AI064879, R21AI059591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Research Center of Excellence, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana Agricultural Station; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01 AI064879, R21 AI059591, R01 AI078938, and Rocky Mountain Research Center of Excellence, NIH U54 AI06537, and in part by Montana Agricultural Station and U.S. Department of Agriculture Formula Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 1997, VACCINE, V15, P307, DOI 10.1016/S0264-410X(96)00175-2; Allegranzi B, 2007, J HOSP INFECT, V65, P115, DOI 10.1016/S0195-6701(07)60027-9; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2005, INFECT IMMUN, V73, P6998, DOI 10.1128/IAI.73.10.6998-7005.2005; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; Boyaka PN, 2000, AM J PATHOL, V157, P2023, DOI 10.1016/S0002-9440(10)64841-9; Boyaka PN, 2003, J IMMUNOL, V170, P5636, DOI 10.4049/jimmunol.170.11.5636; Bradney CP, 2002, J VIROL, V76, P517, DOI 10.1128/JVI.76.2.517-524.2002; Brandtzaeg P, 2003, INT J PEDIATR OTORHI, V67, pS69, DOI 10.1016/j.ijporl.2003.08.018; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Casteleyn C, 2010, VET IMMUNOL IMMUNOP, V133, P212, DOI 10.1016/j.vetimm.2009.08.011; Chen D, 2002, AIDS RES HUM RETROV, V18, P715, DOI 10.1089/088922202760072348; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; Coucke D, 2009, VACCINE, V27, P1279, DOI 10.1016/j.vaccine.2008.12.013; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; Debertin AS, 2003, CLIN EXP IMMUNOL, V134, P503, DOI 10.1111/j.1365-2249.2003.02311.x; Egan MA, 2004, VACCINE, V22, P3774, DOI 10.1016/j.vaccine.2004.03.011; Ginalski K, 2000, FEBS LETT, V482, P119, DOI 10.1016/S0014-5793(00)01954-2; Gwinn WM, 2010, VACCINE, V28, P6901, DOI 10.1016/j.vaccine.2010.08.006; GWINN WM, 2010, VACCINE; Harris SL, 2003, INFECT IMMUN, V71, P275, DOI 10.1128/IAI.71.1.275-286.2003; HEIMSCH RC, 1970, P SOC EXP BIOL MED, V135, P151; Huang J, 2007, HUM VACCINES, V3, P90, DOI 10.4161/hv.3.3.4011; Jodar L, 2001, VACCINE, V19, P1594, DOI 10.1016/S0264-410X(00)00358-3; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kleinstreuer C, 2008, ANNU REV BIOMED ENG, V10, P195, DOI 10.1146/annurev.bioeng.10.061807.160544; Kobayashi R, 2005, J IMMUNOL, V174, P2190, DOI 10.4049/jimmunol.174.4.2190; KRIEGLSTEIN KG, 1994, J PROTEIN CHEM, V13, P49, DOI 10.1007/BF01891992; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Maddaloni M, 2006, J IMMUNOL, V177, P5524, DOI 10.4049/jimmunol.177.8.5524; Mallory RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013755; MARINARO M, 1995, J IMMUNOL, V155, P4621; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; McCloskey N, 1997, J IMMUNOL METHODS, V205, P67, DOI 10.1016/S0022-1759(97)00059-8; McGowen AL, 2009, VACCINE, V27, P3544, DOI 10.1016/j.vaccine.2009.03.069; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Millner VS, 2010, SOUTH MED J, V103, P993, DOI 10.1097/SMJ.0b013e3181eda3d5; MORO PL, 2010, AM J OBSTET GYNECOLO; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Newman SP, 2004, CRIT REV THER DRUG, V21, P21, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.20; Nir Y, 2003, AM J TROP MED HYG, V68, P341, DOI 10.4269/ajtmh.2003.68.341; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]; Nordone SK, 2006, AIDS RES HUM RETROV, V22, P558, DOI 10.1089/aid.2006.22.558; Olszewska W, 2000, VIROLOGY, V272, P98, DOI 10.1006/viro.2000.0285; Reid S, 2009, INT J STD AIDS, V20, P295, DOI 10.1258/ijsa.2008.008441; RUSNAK JM, 2009, HUM VACCIN, V5; SCHLESINGER Y, 1992, JAMA-J AM MED ASSOC, V267, P1489, DOI 10.1001/jama.267.11.1489; Schoggins JW, 2005, J VIROL, V79, P11627, DOI 10.1128/JVI.79.18.11627-11637.2005; Simecka JW, 2000, INFECT IMMUN, V68, P672, DOI 10.1128/IAI.68.2.672-679.2000; SINGH BR, 1989, TOXICON, V27, P403, DOI 10.1016/0041-0101(89)90202-X; Smith LA, 2007, CRIT REV IMMUNOL, V27, P303, DOI 10.1615/CritRevImmunol.v27.i4.20; Smith LA, 2009, VACCINE, V27, pD33, DOI 10.1016/j.vaccine.2009.08.059; SNIDER DP, 1994, J IMMUNOL, V153, P647; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Staats HF, 1996, J IMMUNOL, V157, P462; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; *WHO, 2002, 231 WHO; Wu HY, 1997, SCAND J IMMUNOL, V46, P506, DOI 10.1046/j.1365-3083.1997.d01-159.x; Wu HY, 1997, IMMUNOL RES, V16, P187, DOI 10.1007/BF02786362; Zuercher AW, 2002, EUR J IMMUNOL, V32, P3191, DOI 10.1002/1521-4141(200211)32:11<3191::AID-IMMU3191>3.0.CO;2-0	67	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16532	10.1371/journal.pone.0016532	http://dx.doi.org/10.1371/journal.pone.0016532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304600	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900064
J	Wang, DV; Tsien, JZ				Wang, Dong V.; Tsien, Joe Z.			Conjunctive Processing of Locomotor Signals by the Ventral Tegmental Area Neuronal Population	PLOS ONE			English	Article							GABA-CONTAINING NEURONS; DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; REWARD; ENCODE; TRANSMISSION; PROJECTIONS; ADDICTION; MOVEMENT; BEHAVIOR	The ventral tegmental area (VTA) plays an essential role in reward and motivation. How the dopamine (DA) and non-DA neurons in the VTA engage in motivation-based locomotor behaviors is not well understood. We recorded activity of putative DA and non-DA neurons simultaneously in the VTA of awake mice engaged in motivated voluntary movements such as wheel running. Our results revealed that VTA non-DA neurons exhibited significant rhythmic activity that was correlated with the animal's running rhythms. Activity of putative DA neurons also correlated with the movement behavior, but to a lesser degree. More importantly, putative DA neurons exhibited significant burst activation at both onset and offset of voluntary movements. These findings suggest that VTA DA and non-DA neurons conjunctively process locomotor-related motivational signals that are associated with movement initiation, maintenance and termination.	[Wang, Dong V.] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE & STCSM, Shanghai 200062, Peoples R China; [Wang, Dong V.; Tsien, Joe Z.] Georgia Hlth Sci Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University	Wang, DV (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE & STCSM, Shanghai 200062, Peoples R China.	jtsien@mcg.edu			NIMH [MH060236]; NIA [AG024022, AG034663, AG025918]; Georgia Research Alliance;  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034663, R01AG024022, R01AG025918] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from NIMH (MH060236), NIA (AG024022, AG034663 and AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Belke TW, 2005, BEHAV PROCESS, V68, P165, DOI 10.1016/j.beproc.2004.12.006; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Cannon CM, 2003, J NEUROSCI, V23, P10827; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; GRACE AA, 1984, J NEUROSCI, V4, P2877; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; Lee RS, 2001, J NEUROSCI, V21, P1757; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Narayanan Nandakumar S., 2009, V489, P135, DOI 10.1007/978-1-59745-543-5_7; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Puryear CB, 2010, BEHAV NEUROSCI, V124, P234, DOI 10.1037/a0018865; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Steffensen SC, 2001, BRAIN RES, V906, P190, DOI 10.1016/S0006-8993(01)02581-1; Stobbs SH, 2004, J PHARMACOL EXP THER, V311, P282, DOI 10.1124/jpet.104.071860; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	44	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16528	10.1371/journal.pone.0016528	http://dx.doi.org/10.1371/journal.pone.0016528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304590	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900063
J	Deiuliis, J; Shah, Z; Shah, N; Needleman, B; Mikami, D; Narula, V; Perry, K; Hazey, J; Kampfrath, T; Kollengode, M; Sun, QH; Satoskar, AR; Lumeng, C; Moffatt-Bruce, S; Rajagopalan, S				Deiuliis, Jeffrey; Shah, Zubair; Shah, Nilay; Needleman, Bradley; Mikami, Dean; Narula, Vimal; Perry, Kyle; Hazey, Jeffrey; Kampfrath, Thomas; Kollengode, Madhukar; Sun, Qinghua; Satoskar, Abhay R.; Lumeng, Carey; Moffatt-Bruce, Susan; Rajagopalan, Sanjay			Visceral Adipose Inflammation in Obesity Is Associated with Critical Alterations in Tregulatory Cell Numbers	PLOS ONE			English	Article							REGULATORY T-CELLS; INSULIN-RESISTANCE; DENDRITIC CELLS; MACROPHAGE POLARIZATION; TISSUE INFLAMMATION; DISTINCT SUBSETS; MONOCYTE SUBSETS; BLOOD MONOCYTES; HOMING RECEPTOR; UP-REGULATION	Background: The development of insulin resistance (IR) in mouse models of obesity and type 2 diabetes mellitus (DM) is characterized by progressive accumulation of inflammatory macrophages and subpopulations of T cells in the visceral adipose. Regulatory T cells (Tregs) may play a critical role in modulating tissue inflammation via their interactions with both adaptive and innate immune mechanisms. We hypothesized that an imbalance in Tregs is a critical determinant of adipose inflammation and investigated the role of Tregs in IR/obesity through coordinated studies in mice and humans. Methods and Findings: Foxp3-green fluorescent protein (GFP) "knock-in'' mice were randomized to a high-fat diet intervention for a duration of 12 weeks to induce DIO/IR. Morbidly obese humans without overt type 2 DM (n = 13) and lean controls (n = 7) were recruited prospectively for assessment of visceral adipose inflammation. DIO resulted in increased CD3(+) CD4(+), and CD3(+) CD8(+) cells in visceral adipose with a striking decrease in visceral adipose Tregs. Treg numbers in visceral adipose inversely correlated with CD11b(+) CD11c(+) adipose tissue macrophages (ATMs). Splenic Treg numbers were increased with up-regulation of homing receptors CXCR3 and CCR7 and marker of activation CD44. In-vitro differentiation assays showed an inhibition of Treg differentiation in response to conditioned media from inflammatory macrophages. Human visceral adipose in morbid obesity was characterized by an increase in CD11c(+) ATMs and a decrease in foxp3 expression. Conclusions: Our experiments indicate that obesity in mice and humans results in adipose Treg depletion. These changes appear to occur via reduced local differentiation rather than impaired homing. Our findings implicate a role for Tregs as determinants of adipose inflammation.	[Deiuliis, Jeffrey; Shah, Zubair; Kampfrath, Thomas; Kollengode, Madhukar; Sun, Qinghua; Rajagopalan, Sanjay] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Shah, Nilay; Needleman, Bradley; Mikami, Dean; Narula, Vimal; Perry, Kyle; Hazey, Jeffrey; Moffatt-Bruce, Susan] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Satoskar, Abhay R.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Lumeng, Carey] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	Deiuliis, J (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	deiuliis.1@osu.edu	Sun, Qinghua/E-4167-2011; Perry, Kyle/E-3853-2011; Narula, Vimal/E-3736-2011; Mikami, MD, Dean/E-3676-2011; Satoskar, Abhay/AAB-7748-2019; Needleman, Bradley/E-3743-2011	Needleman, Bradley/0000-0002-9186-4028; Perry, Kyle/0000-0003-4391-3259; Lumeng, Carey/0000-0003-0303-6204; Moffatt-Bruce, Susan/0000-0002-0999-5505; Deiuliis, Jeffrey/0000-0002-5665-8894; Narula, Vimal/0000-0003-1261-2736	National Institute of Diabetes And Digestive And Kidney Diseases [F32DK083903]; NIEHS [R01, KO1, ES016588]; NIDDK [ES015146, R21, DK088522]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078851, R21DK088522, R01DK090262, F32DK083903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015146, K01ES016588] Funding Source: NIH RePORTER	National Institute of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was supported by Award Number F32DK083903 from the National Institute of Diabetes And Digestive And Kidney Diseases awarded to Dr. Deiuliis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Diabetes And Digestive And Kidney Diseases or the National Institutes of Health. Dr. Rajagopalan is supported by an R01 award from the NIEHS "Air Pollution and Vascular Mechanisms'' (ES015146) and R21 award NIDDK "T Regulatory Cells as Determinants of Inflammation in Adipose Tissue'' (DK088522) grants. Dr. Sun is supported by an NIEHS KO1 award "Air Pollution and Microvascular Dysfunction: Leukocyte Dependent NAD(P)H Oxidase" (ES016588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baaten BJ, IMMUNITY, V32, P104; Barbi J, 2009, FASEB J, V23, P3990, DOI 10.1096/fj.09-138057; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Chai JG, 2008, J IMMUNOL, V180, P858, DOI 10.4049/jimmunol.180.2.858; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DIAZ YR, J INFECT DIS, V202, P406; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Forster-Horvath C, 2001, EUR J IMMUNOL, V31, P600, DOI 10.1002/1521-4141(200102)31:2<600::AID-IMMU600>3.0.CO;2-8; FOX SB, 1994, CANCER RES, V54, P4539; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; ILAN Y, P NATL ACAD SCI US, V107, P9765; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tosello V, 2008, CLIN IMMUNOL, V126, P291, DOI 10.1016/j.clim.2007.11.008; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; WENTWORTH JM, 2010, PROINFLAMMATORY CD 1; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379	45	217	224	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16376	10.1371/journal.pone.0016376	http://dx.doi.org/10.1371/journal.pone.0016376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298111	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800033
J	Dulin, JN; Moore, ML; Gates, KW; Queen, JH; Grill, RJ				Dulin, Jennifer N.; Moore, Meredith L.; Gates, Kevin W.; Queen, Joanna H.; Grill, Raymond J.			Spinal Cord Injury Causes Sustained Disruption of the Blood-Testis Barrier in the Rat	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; TESTICULAR MAST-CELLS; EXOGENOUS TESTOSTERONE; SEMINIFEROUS TUBULES; TIGHT JUNCTIONS; SEMINAL PLASMA; SERTOLI-CELL; SPERMATOGENESIS; CYTOKINES	There is a high incidence of infertility in males following traumatic spinal cord injury (SCI). Quality of semen is frequently poor in these patients, but the pathophysiological mechanism(s) causing this are not known. Blood-testis barrier (BTB) integrity following SCI has not previously been examined. The objective of this study was to characterize the effects of spinal contusion injury on the BTB in the rat. 63 adult, male Sprague Dawley rats received SCI (n = 28), laminectomy only (n = 7) or served as uninjured, age-matched controls (n = 28). Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), BTB permeability to the vascular contrast agent gadopentate dimeglumine (Gd) was assessed at either 72 hours-, or 10 months post-SCI. DCE-MRI data revealed that BTB permeability to Gd was greater than controls at both 72 h and 10 mo post-SCI. Histological evaluation of testis tissue showed increased BTB permeability to immunoglobulin G at both 72 hours- and 10 months post-SCI, compared to age-matched sham-operated and uninjured controls. Tight junctional integrity within the seminiferous epithelium was assessed; at 72 hours post-SCI, decreased expression of the tight junction protein occludin was observed. Presence of inflammation in the testes was also examined. High expression of the proinflammatory cytokine interleukin-1 beta was detected in testis tissue. CD68(+) immune cell infiltrate and mast cells were also detected within the seminiferous epithelium of both acute and chronic SCI groups but not in controls. In addition, extensive germ cell apoptosis was observed at 72 h post-SCI. Based on these results, we conclude that SCI is followed by compromised BTB integrity by as early as 72 hours post-injury in rats and is accompanied by a substantial immune response within the testis. Furthermore, our results indicate that the BTB remains compromised and testis immune cell infiltration persists for months after the initial injury.	[Dulin, Jennifer N.; Queen, Joanna H.; Grill, Raymond J.] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Moore, Meredith L.; Gates, Kevin W.] Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Dulin, JN (corresponding author), Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA.	raymond.j.grill@uth.tmc.edu		Dulin, Jennifer/0000-0001-5767-4290	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS049409]; Paralyzed Veterans of America [2511]; Mission Connect; The Institute for Rehabilitation and Research (TIRR) Foundation; The Gillson-Longenbaugh Foundation; National Institutes of Health [T32, 5TL1RR024147]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049409] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Paralyzed Veterans of America; Mission Connect; The Institute for Rehabilitation and Research (TIRR) Foundation; The Gillson-Longenbaugh Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) R01NS049409, Paralyzed Veterans of America #2511, and Mission Connect, a project of The Institute for Rehabilitation and Research (TIRR) Foundation and The Gillson-Longenbaugh Foundation. JND is supported by the National Institutes of Health T32 training grant 5TL1RR024147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Apodaca G, 2003, AM J PHYSIOL-RENAL, V284, pF966, DOI 10.1152/ajprenal.00359.2002; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Basu S, 2004, J ANDROL, V25, P250; BERETTA G, 1987, Acta Europaea Fertilitatis, V18, P203; Brackett NL, 1998, J UROLOGY, V159, P844, DOI 10.1016/S0022-5347(01)63749-2; Brackett NL, 1996, PHYS THER, V76, P1221, DOI 10.1093/ptj/76.11.1221; Chow SH, 2000, NEUROENDOCRINOLOGY, V72, P37, DOI 10.1159/000054569; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; DeForge D, 2005, SPINAL CORD, V43, P693, DOI 10.1038/sj.sc.3101769; FARGHALI H, 1991, MAGNET RESON MED, V22, P81, DOI 10.1002/mrm.1910220109; Gerdprasert O, 2002, CELL TISSUE RES, V308, P277, DOI 10.1007/s00441-002-0547-6; Grill RJ, 2005, EXP NEUROL, V196, P1, DOI 10.1016/j.expneurol.2005.08.005; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Griswold M D, 1988, Int Rev Cytol, V110, P133; Hedger MP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1195; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Herrera JJ, 2010, J NEUROTRAUM, V27, P423, DOI 10.1089/neu.2009.0997; HIRSCH IH, 1990, ARCH ANDROLOGY, V25, P69, DOI 10.3109/01485019008987596; HIRSCH IH, 1992, UROLOGY, V39, P243, DOI 10.1016/0090-4295(92)90298-B; Huang HFS, 2004, J ANDROL, V25, P95; Huang HFS, 2004, J SPINAL CORD MED, V27, P55, DOI 10.1080/10790268.2004.11753731; Hussein MR, 2005, FERTIL STERIL, V83, P1447, DOI 10.1016/j.fertnstert.2004.11.062; JOHNSON AR, 1974, J PHARMACOL EXP THER, V189, P221; JONES WR, 1994, HUM REPROD, V9, P828, DOI 10.1093/oxfordjournals.humrep.a138603; Kashiwabara S, 2002, SCIENCE, V298, P1999, DOI 10.1126/science.1074632; Kim KN, 2004, INVEST RADIOL, V39, P445, DOI 10.1097/01.rli.0000129466.33263.8c; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007; Lui WY, 2009, J MOL ENDOCRINOL, V43, P43, DOI 10.1677/JME-08-0174; Luna JD, 1997, J NEUROSCI RES, V49, P268, DOI 10.1002/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A; LUSTIG L, 1982, J REPROD IMMUNOL, V4, P79, DOI 10.1016/0165-0378(82)90039-0; Lysiak Jeffrey J, 2004, Reprod Biol Endocrinol, V2, P9, DOI 10.1186/1477-7827-2-9; Lysiak JJ, 2003, BIOL REPROD, V69, P202, DOI 10.1095/biolreprod.102.013318; Lysiak JJ, 2001, BIOL REPROD, V65, P718, DOI 10.1095/biolreprod65.3.718; MALLIDIS C, 1994, LANCET, V343, P1072, DOI 10.1016/S0140-6736(94)90183-X; Meineke V, 2000, FERTIL STERIL, V74, P239, DOI 10.1016/S0015-0282(00)00626-9; Moffit JS, 2007, TOXICOL PATHOL, V35, P719, DOI 10.1080/01926230701481931; Moroi S, 1998, AM J PHYSIOL-CELL PH, V274, pC1708, DOI 10.1152/ajpcell.1998.274.6.C1708; Mruk DD, 2010, PHILOS T R SOC B, V365, P1621, DOI 10.1098/rstb.2010.0010; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Padron OF, 1997, FERTIL STERIL, V67, P1115, DOI 10.1016/S0015-0282(97)81448-3; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Saari T, 1996, J REPROD IMMUNOL, V31, P65, DOI 10.1016/0165-0378(96)00962-X; Sarkar O, 2008, BIOL REPROD, V78, P445, DOI 10.1095/biolreprod.107.064501; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Setchell BP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P771; Su LL, 2009, INT J BIOCHEM CELL B, V41, P2578, DOI 10.1016/j.biocel.2009.08.015; Theas MS, 2008, HUM REPROD, V23, P1865, DOI 10.1093/humrep/den240; Tung K S, 1991, Monogr Pathol, P308; TUNG KSK, 1977, TESTIS, P491; Wang SL, 2005, J ANDROL, V26, P592, DOI 10.2164/jandrol.04168; Wong CH, 2007, FASEB J, V21, P438, DOI 10.1096/fj.05-4144com; Yamanaka K, 2000, HUM REPROD, V15, P1543, DOI 10.1093/humrep/15.7.1543	61	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16456	10.1371/journal.pone.0016456	http://dx.doi.org/10.1371/journal.pone.0016456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298060	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800043
J	Jaenicke, S; Ander, C; Bekel, T; Bisdorf, R; Droge, M; Gartemann, KH; Junemann, S; Kaiser, O; Krause, L; Tille, F; Zakrzewski, M; Puhler, A; Schluter, A; Goesmann, A				Jaenicke, Sebastian; Ander, Christina; Bekel, Thomas; Bisdorf, Regina; Droege, Marcus; Gartemann, Karl-Heinz; Juenemann, Sebastian; Kaiser, Olaf; Krause, Lutz; Tille, Felix; Zakrzewski, Martha; Puehler, Alfred; Schlueter, Andreas; Goesmann, Alexander			Comparative and Joint Analysis of Two Metagenomic Datasets from a Biogas Fermenter Obtained by 454-Pyrosequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITY ANALYSIS; 16S RIBOSOMAL-RNA; SP-NOV.; METHANOGENIC ARCHAEA; GEN. NOV.; REACTOR; SEQUENCE; DIVERSITY; POPULATION; BACTERIUM	Biogas production from renewable resources is attracting increased attention as an alternative energy source due to the limited availability of traditional fossil fuels. Many countries are promoting the use of alternative energy sources for sustainable energy production. In this study, a metagenome from a production-scale biogas fermenter was analysed employing Roche's GS FLX Titanium technology and compared to a previous dataset obtained from the same community DNA sample that was sequenced on the GS FLX platform. Taxonomic profiling based on 16S rRNA-specific sequences and an Environmental Gene Tag (EGT) analysis employing CARMA demonstrated that both approaches benefit from the longer read lengths obtained on the Titanium platform. Results confirmed Clostridia as the most prevalent taxonomic class, whereas species of the order Methanomicrobiales are dominant among methanogenic Archaea. However, the analyses also identified additional taxa that were missed by the previous study, including members of the genera Streptococcus, Acetivibrio, Garciella, Tissierella, and Gelria, which might also play a role in the fermentation process leading to the formation of methane. Taking advantage of the CARMA feature to correlate taxonomic information of sequences with their assigned functions, it appeared that Firmicutes, followed by Bacteroidetes and Proteobacteria, dominate within the functional context of polysaccharide degradation whereas Methanomicrobiales represent the most abundant taxonomic group responsible for methane production. Clostridia is the most important class involved in the reductive CoA pathway (Wood-Ljungdahl pathway) that is characteristic for acetogenesis. Based on binning of 16S rRNA-specific sequences allocated to the dominant genus Methanoculleus, it could be shown that this genus is represented by several different species. Phylogenetic analysis of these sequences placed them in close proximity to the hydrogenotrophic methanogen Methanoculleus bourgensis. While rarefaction analyses still indicate incomplete coverage, examination of the GS FLX Titanium dataset resulted in the identification of additional genera and functional elements, providing a far more complete coverage of the community involved in anaerobic fermentative pathways leading to methane formation.	[Jaenicke, Sebastian; Puehler, Alfred; Schlueter, Andreas] Univ Bielefeld, Ctr Biotechnol CeBiTec, Inst Genome Res & Syst Biol, Bielefeld, Germany; [Droege, Marcus; Kaiser, Olaf] Roche Diagnost GmbH, Penzberg, Germany; [Gartemann, Karl-Heinz] Univ Bielefeld, Dept Genetechnol Microbiol, Bielefeld, Germany; [Juenemann, Sebastian] Univ Hosp Munster, Dept Periodontol, Munster, Germany; [Krause, Lutz] Queensland Inst Med Res, Div Genet & Populat Hlth, Herston, Qld 4006, Australia	University of Bielefeld; Roche Holding; University of Bielefeld; University of Munster; QIMR Berghofer Medical Research Institute	Jaenicke, S (corresponding author), Univ Bielefeld, Ctr Biotechnol CeBiTec, Inst Genome Res & Syst Biol, Bielefeld, Germany.	agoesman@CeBiTec.Uni-Bielefeld.DE	Krause, Lutz/M-7305-2015; Krause, Lutz/G-6283-2013; Gartemann, Karl-Heinz/I-5065-2012	Krause, Lutz/0000-0003-3806-0845; Krause, Lutz/0000-0003-3806-0845; Gartemann, Karl-Heinz/0000-0002-4886-1294; Puhler, Alfred/0000-0003-4723-2960; Goesmann, Alexander/0000-0002-7086-2568; Schluter, Andreas/0000-0003-4830-310X; Junemann, Sebastian/0000-0002-3714-0328; Zakrzewski, Martha/0000-0003-1436-5070	Bundesministerium fur Bildung und Forschung (BMBF) [0313704, 0313805A, 0313801N]; European Commission [KBBE-222625]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	T. Bekel acknowledges financial support from the Bundesministerium fur Bildung und Forschung (BMBF), SysMAP project (grant 0313704). S. Jaenicke acknowledges financial support by the BMBF grant 0313805A 'GenoMik-Plus'. S. Junemann was supported by the BMBF PathoGeno-Mik Plus project 0313801N. The METAEXPLORE grant of the European Commission (KBBE-222625) is gratefully acknowledged. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M. Droge and O. Kaiser are employees of Roche Diagnostics GmbH; sequencing of the obtained DNA sample was funded by Roche Diagnostics GmbH.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005797; Bae JW, 2004, INT J SYST EVOL MICR, V54, P947, DOI 10.1099/ijs.0.63068-0; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BLAUT M, 1994, ANTON LEEUW INT J G, V66, P187, DOI 10.1007/BF00871639; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Cirne DG, 2007, J APPL MICROBIOL, V103, P516, DOI 10.1111/j.1365-2672.2006.03270.x; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dollhopf SL, 2001, APPL MICROBIOL BIOT, V56, P531, DOI 10.1007/s002530100612; Drake HL, 2002, ANTON LEEUW INT J G, V81, P203, DOI 10.1023/A:1020514617738; Drake HL, 1997, BIOFACTORS, V6, P13, DOI 10.1002/biof.5520060103; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang HHP, 2002, APPL MICROBIOL BIOT, V58, P112; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez AS, 2000, APPL ENVIRON MICROB, V66, P4058, DOI 10.1128/AEM.66.9.4058-4067.2000; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Hansen KH, 1999, APPL ENVIRON MICROB, V65, P4767; Juottonen H, 2006, RES MICROBIOL, V157, P914, DOI 10.1016/j.resmic.2006.08.006; Kaster KM, 2006, APPL MICROBIOL BIOT, V72, P1308, DOI 10.1007/s00253-006-0412-8; Kim W, 2010, BIORESOURCE TECHNOL, V101, pS17, DOI 10.1016/j.biortech.2009.03.029; Kirby BM, 2006, INT J SYST EVOL MICR, V56, P1097, DOI 10.1099/ijs.0.63951-0; Klocke M, 2008, SYST APPL MICROBIOL, V31, P190, DOI 10.1016/j.syapm.2008.02.003; Klocke M, 2007, SYST APPL MICROBIOL, V30, P139, DOI 10.1016/j.syapm.2006.03.007; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Kutner M., 2005, APPL LINEAR STAT MOD; LADAPO J, 1990, P NATL ACAD SCI USA, V87, P5598, DOI 10.1073/pnas.87.15.5598; Lee YJ, 2006, INT J SYST EVOL MICR, V56, P2089, DOI 10.1099/ijs.0.64040-0; Li TL, 2009, ENVIRON MICROBIOL, V11, P889, DOI 10.1111/j.1462-2920.2008.01810.x; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Miranda-Tello E, 2003, INT J SYST EVOL MICR, V53, P1509, DOI 10.1099/ijs.0.02662-0; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Myint M, 2007, WATER RES, V41, P323, DOI 10.1016/j.watres.2006.10.026; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Noach I, 2010, J MOL BIOL, V399, P294, DOI 10.1016/j.jmb.2010.04.013; Pearson W R, 2000, Methods Mol Biol, V132, P185; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Plugge CM, 2002, INT J SYST EVOL MICR, V52, P401, DOI 10.1099/00207713-52-2-401; POBEHEIM H, 2010, CHEMOSPHERE; R Core Team, 2018, R LANG ENV STAT COMP; Rastogi G, 2008, BIORESOURCE TECHNOL, V99, P5317, DOI 10.1016/j.biortech.2007.11.024; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; Sasaki K, 2007, APPL MICROBIOL BIOT, V75, P941, DOI 10.1007/s00253-007-0888-x; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Schnurer A, 1999, FEMS MICROBIOL ECOL, V29, P249; Shah HN, 2009, ANAEROBE, V15, P179, DOI 10.1016/j.anaerobe.2009.08.003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shigematsu T, 2006, APPL MICROBIOL BIOT, V72, P401, DOI 10.1007/s00253-005-0275-4; Shin HS, 2005, BIODEGRADATION, V16, P33, DOI 10.1007/s10531-004-0377-9; Sousa DZ, 2009, FEMS MICROBIOL ECOL, V68, P257, DOI 10.1111/j.1574-6941.2009.00680.x; Tang YQ, 2005, J BIOSCI BIOENG, V99, P150, DOI 10.1263/jbb.99.150; Tang YQ, 2004, WATER RES, V38, P2537, DOI 10.1016/j.watres.2004.03.012; Tang YQ, 2007, J BIOSCI BIOENG, V104, P281, DOI 10.1263/jbb.104.281; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiland P, 2003, APPL BIOCHEM BIOTECH, V109, P263, DOI 10.1385/ABAB:109:1-3:263; Weiss A, 2008, APPL MICROBIOL BIOT, V81, P163, DOI 10.1007/s00253-008-1717-6; Yadvika, 2004, BIORESOURCE TECHNOL, V95, P1, DOI 10.1016/j.biortech.2004.02.010; Zhilina TN, 2004, ARCH MICROBIOL, V182, P244, DOI 10.1007/s00203-004-0722-0; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	74	193	205	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14519	10.1371/journal.pone.0014519	http://dx.doi.org/10.1371/journal.pone.0014519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297863	gold, Green Published, Green Submitted			2022-12-27	WOS:000286662800001
J	Naor, A; Lazary, R; Barzel, A; Papke, RT; Gophna, U				Naor, Adit; Lazary, Rona; Barzel, Adi; Papke, R. Thane; Gophna, Uri			In Vivo Characterization of the Homing Endonuclease within the polB Gene in the Halophilic Archaeon Haloferax volcanii	PLOS ONE			English	Article							RECOMBINATION	Inteins are parasitic genetic elements, analogous to introns that excise themselves at the protein level by self-splicing, allowing the formation of functional non-disrupted proteins. Many inteins contain a homing endonuclease (HEN) gene, and rely on its activity for horizontal propagation. In the halophilic archaeon, Haloferax volcanii, the gene encoding DNA polymerase B (polB) contains an intein with an annotated but uncharacterized HEN. Here we examine the activity of the polB HEN in vivo, within its natural archaeal host. We show that this HEN is highly active, and able to insert the intein into both a chromosomal target and an extra-chromosomal plasmid target, by gene conversion. We also demonstrate that the frequency of its incorporation depends on the length of the flanking homologous sequences around the target site, reflecting its dependence on the homologous recombination machinery. Although several evolutionary models predict that the presence of an intein involves a change in the fitness of the host organism, our results show that a strain deleted for the intein sequence shows no significant changes in growth rate compared to the wild type.	[Naor, Adit; Lazary, Rona; Barzel, Adi; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Papke, R. Thane] Univ Connecticut, Dept Mol Cell Biol, Storrs, CT USA	Tel Aviv University; University of Connecticut	Naor, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	urigo@tauex.tau.ac.il	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652; Papke, Robertson/0000-0003-1371-2341	Biational Science Foundation (BSF) [2007043]; James S. McDonnell Foundation; Israeli Ministry of Health; National Science Foundation [DEB-0919290, DEB-0830024]; University of Connecticut Research Foundation; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	Biational Science Foundation (BSF)(US-Israel Binational Science Foundation); James S. McDonnell Foundation; Israeli Ministry of Health; National Science Foundation(National Science Foundation (NSF)); University of Connecticut Research Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the Biational Science Foundation (BSF) grant number 2007043. UG is supported by the James S. McDonnell Foundation and the Israeli Ministry of Health. RTP acknowledges National Science Foundation awards DEB-0919290, DEB-0830024 and the University of Connecticut Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 1995, P NATL ACAD SCI USA, V92, P12285, DOI 10.1073/pnas.92.26.12285; Agmon N, 2009, NUCLEIC ACIDS RES, V37, P5081, DOI 10.1093/nar/gkp495; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Gogarten JP, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-94; Kurokawa S, 2005, FEBS J, V272, P2487, DOI 10.1111/j.1742-4658.2005.04669.x; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Miyake T, 2003, J BIOL CHEM, V278, P39632, DOI 10.1074/jbc.M302084200; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063	18	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15833	10.1371/journal.pone.0015833	http://dx.doi.org/10.1371/journal.pone.0015833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283796	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200015
J	Escobar, PR; Gernandt, DS; Pinero, D; Garcillan, PP				Rosas Escobar, Patricia; Gernandt, David S.; Pinero, Daniel; Garcillan, Pedro P.			Plastid DNA Diversity Is Higher in the Island Endemic Guadalupe Cypress than in the Continental Tecate Cypress	PLOS ONE			English	Article							GENETIC DIVERSITY; PERIPHERAL-POPULATIONS; CHLOROPLAST; CUPRESSACEAE; CONSEQUENCES; DIVERGENCE; CALIFORNIA; RARE; MITOCHONDRIAL; POLYMORPHISM	Background: Callitropsis guadalupensis (Guadalupe cypress) is endemic to Guadalupe Island, Mexico, where it is the dominant species of the only forest. The species has suffered declining numbers following the introduction of goats to the island over 150 years ago. Callitropsis guadalupensis is closely related to Callitropsis forbesii (Tecate cypress), distributed in small isolated populations in mainland Baja California and southern California. The objective of the present study was to compare the genetic diversity of the island endemic to the continental species. Methodology/Principal Findings: We measured genetic diversity in Callitropsis guadalupensis (n = 54) from Guadalupe Island and in Callitropsis forbesii (n = 100) from five populations in mainland Baja California. The plastid DNA trnS-trnG spacer and the trnL-trnF region were chosen for characterization. Thirty-four haplotypes were observed, of which six were shared between both species. One of these haplotypes was also shared with three other species, Callitropsis lusitanica, Callitropsis montana, and Callitropsis stephensonii. Haplotype diversity (h) and nucleotide diversity (pi) were significantly higher for Callitropsis guadalupensis (h = 0.698, pi = 0.00071) than for Callitropsis forbesii (h = 0.337, pi = 0.00024). Conclusions/Significance: Callitropsis guadalupensis shows no evidence of a founder effect or of a genetic bottleneck, and can be added to a growing list of insular species with higher genetic diversity than their mainland relatives.	[Rosas Escobar, Patricia] Univ Autonoma Baja California, Fac Ciencias, Ensenada, Baja California, Mexico; [Rosas Escobar, Patricia] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Gernandt, David S.] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City 04510, DF, Mexico; [Pinero, Daniel] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Garcillan, Pedro P.] Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico	Universidad Autonoma de Baja California; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Escobar, PR (corresponding author), Univ Autonoma Baja California, Fac Ciencias, Ensenada, Baja California, Mexico.	dgernandt@ibiologia.unam.mx		Pinero, Daniel/0000-0002-2509-2445	Secretaria de Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia, Mexico [2004-C01-122]	Secretaria de Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia, Mexico	This study was supported by the Secretaria de Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia (2004-C01-122), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RP, 2009, PHYTOLOGIA, V91, P160; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AXELROD DI, 1958, BOT REV, V24, P433, DOI 10.1007/BF02872570; Cheng YP, 2005, MOL ECOL, V14, P2075, DOI 10.1111/j.1365-294X.2005.02567.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Gouvenain RC, 2006, SOUTHWEST NAT, V51, P447, DOI 10.1894/0038-4909(2006)51[447:ABFRIA]2.0.CO;2; Delgado P, 1999, AM J BOT, V86, P669, DOI 10.2307/2656576; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Dunn AT, 1987, CONSERVATION MANAGEM, P367; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ENGEL CG, 1961, AAPG BULL, V45, P1799; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Farjon A., 1999, CONIFERS STATUS SURV; Farjon A, 2005, MONOGRAPH CUPRESSACE; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Furches MS, 2009, CONSERV GENET, V10, P115, DOI 10.1007/s10592-008-9531-3; Garcillan P.P., 2009, P 7 CAL ISL S I WILD, P177; Gernandt DS, 2009, SYST BOT, V34, P481, DOI 10.1600/036364409789271290; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamrick J. L., 1996, P281; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Helenurm K, 2005, ANN BOT-LONDON, V95, P1221, DOI 10.1093/aob/mci135; Helenurm K, 2001, J HERED, V92, P427, DOI 10.1093/jhered/92.5.427; Hoelzel AR, 2002, J EVOLUTION BIOL, V15, P567, DOI 10.1046/j.1420-9101.2002.00419.x; HONG YP, 1993, MOL PHYLOGENET EVOL, V2, P322, DOI 10.1006/mpev.1993.1031; Huang SF, 2004, J BIOGEOGR, V31, P1251, DOI 10.1111/j.1365-2699.2004.01082.x; Huang SSF, 2002, MOL ECOL, V11, P2349, DOI 10.1046/j.1365-294X.2002.01624.x; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hwang SY, 2003, MOL ECOL, V12, P2689, DOI 10.1046/j.1365-294X.2003.01935.x; *IUCN, 2006, 2006 IUCN RED LIST T; Jaramillo-Correa JP, 2008, MOL ECOL, V17, P2476, DOI 10.1111/j.1365-294X.2008.03762.x; Junak S., 2005, ISLA GUADALUPE RESTA, P83; KAHRU A, 2005, J EVOLUTION BIOL, V19, P167; Kondo T, 1998, BREEDING SCI, V48, P177; Lammi A, 1999, CONSERV BIOL, V13, P1069, DOI 10.1046/j.1523-1739.1999.98278.x; LEDIG FT, 1983, EVOLUTION, V37, P79, DOI 10.1111/j.1558-5646.1983.tb05515.x; Ledig FT, 2002, CONSERV GENET, V3, P113, DOI 10.1023/A:1015297621884; LESICA P, 1992, CONSERV BIOL, V6, P135, DOI 10.1046/j.1523-1739.1992.610135.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liston A, 2007, MOL ECOL, V16, P3926, DOI 10.1111/j.1365-294X.2007.03461.x; Little DP, 2006, SYST BOT, V31, P461, DOI 10.1600/036364406778388638; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Moran R., 1996, MEMOIRS CALIFORNIA A, V19; Muller Kai, 2005, Appl Bioinformatics, V4, P65; NEALE DB, 1991, CAN J FOREST RES, V21, P717, DOI 10.1139/x91-100; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; Nei M., 1987, MOL EVOLUTIONARY GEN; Oberbauer T., 2005, P 6 CAL ISL S, P143; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rasmussen KK, 2008, CONSERV GENET, V9, P1533, DOI 10.1007/s10592-007-9492-y; Rehfeldt GE, 1997, AM J BOT, V84, P190, DOI 10.2307/2446080; *SEMARNAT, 2002, NOM059ECOL2001 SEMAR; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SPENGER C, 1985, FREMONTIA, V13, P8; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TSUMURA Y, 1993, CAN J FOREST RES, V23, P859, DOI 10.1139/x93-112; Vogl RJ., 1977, TERRESTRIAL VEGETATI, P295; Wang DL, 2004, BIOCHEM SYST ECOL, V32, P797, DOI 10.1016/j.bse.2003.12.003; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zedler PH, 1981, FOREST SUCCESSION CO, P406; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x	75	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16133	10.1371/journal.pone.0016133	http://dx.doi.org/10.1371/journal.pone.0016133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283771	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200028
J	Smith, AL; Friedman, DB; Yu, HP; Carnahan, RH; Reynolds, AB				Smith, Andrew L.; Friedman, David B.; Yu, Huapeng; Carnahan, Robert H.; Reynolds, Albert B.			ReCLIP (Reversible Cross-Link Immuno-Precipitation): An Efficient Method for Interrogation of Labile Protein Complexes	PLOS ONE			English	Article							P120 CATENIN; BETA(1) INTEGRINS; EPITHELIAL-CELLS; IDENTIFICATION; ADHESION; CD98; PHOSPHORYLATION; P120-CATENIN; P120(CTN); RECEPTOR	The difficulty of maintaining intact protein complexes while minimizing non-specific background remains a significant limitation in proteomic studies. Labile interactions, such as the interaction between p120-catenin and the E-cadherin complex, are particularly challenging. Using the cadherin complex as a model-system, we have developed a procedure for efficient recovery of otherwise labile protein-protein interactions. We have named the procedure "ReCLIP'' (Reversible Cross-Link Immuno-Precipitation) to reflect the primary elements of the method. Using cell-permeable, thiol-cleavable crosslinkers, normally labile interactions (i.e. p120 and E-cadherin) are stabilized in situ prior to isolation. After immunoprecipitation, crosslinked binding partners are selectively released and all other components of the procedure (i.e. beads, antibody, and p120 itself) are discarded. The end result is extremely efficient recovery with exceptionally low background. ReCLIP therefore appears to provide an excellent alternative to currently available affinity-purification approaches, particularly for studies of labile complexes.	[Smith, Andrew L.; Yu, Huapeng; Carnahan, Robert H.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37240 USA; [Friedman, David B.] Vanderbilt Univ, Dept Biochem, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Smith, AL (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37240 USA.	al.reynolds@vanderbilt.edu	Carnahan, Robert H/N-7429-2013	Carnahan, Robert H/0000-0001-5230-1532; Yu, Huapeng/0000-0002-6669-7459	National Institutes of Health [RO1 CA55724, RO1 CA111947]; Vanderbilt GI SPORE [50 CA95103]; Vanderbilt Cancer Center [P30-CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485, P50CA095103, R01CA055724, R01CA111947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt GI SPORE; Vanderbilt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health Grants RO1 CA55724 and RO1 CA111947 to A.B. Reynolds, Vanderbilt GI SPORE (50 CA95103) to R.J. Coffey, and the Vanderbilt Cancer Center Support grant (P30-CA068485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Baldwin MA, 2004, MOL CELL PROTEOMICS, V3, P1, DOI 10.1074/mcp.R300012-MCP200; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; CAMERON CM, 1985, BIOCHIM BIOPHYS ACTA, V841, P254, DOI 10.1016/0304-4165(85)90066-2; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Casula S, 2009, BLOOD CELL MOL DIS, V42, P233, DOI 10.1016/j.bcmd.2009.01.021; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; GUMBINER BM, 1993, J CELL SCI, P155; HAYNES BF, 1981, J IMMUNOL, V126, P1409; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Kim SM, 2008, EXP MOL MED, V40, P261, DOI 10.3858/emm.2008.40.3.261; KISS A, 2008, MOL BIOL CELL; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Nesvizhskii AI, 2006, MOL CELL PROTEOMICS, V5, P652, DOI 10.1074/mcp.M500319-MCP200; Nguyen HTT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003895; Norvell SM, 1998, J CELL SCI, V111, P1305; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; Studdert CA, 2007, METHOD ENZYMOL, V423, P414, DOI 10.1016/S0076-6879(07)23019-8; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; Vretou E, 2008, MICROB PATHOGENESIS, V45, P265, DOI 10.1016/j.micpath.2008.06.007; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Xia XB, 2006, EXP CELL RES, V312, P3336, DOI 10.1016/j.yexcr.2006.07.007; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020	44	49	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16206	10.1371/journal.pone.0016206	http://dx.doi.org/10.1371/journal.pone.0016206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283770	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522200037
J	Maniere, X; Lebois, F; Matic, I; Ladoux, B; Di Meglio, JM; Hersen, P				Maniere, Xavier; Lebois, Felix; Matic, Ivan; Ladoux, Benoit; Di Meglio, Jean-Marc; Hersen, Pascal			Running Worms: C. elegans Self-Sorting by Electrotaxis	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MOVEMENT; SYSTEM; TARGET	The nematode C. elegans displays complex dynamical behaviors that are commonly used to identify relevant phenotypes. Although its maintenance is straightforward, sorting large populations of worms when looking for a behavioral phenotype is difficult, time consuming and hardly quantitative when done manually. Interestingly, when submitted to a moderate electric field, worms move steadily along straight trajectories. Here, we report an inexpensive method to measure worms crawling velocities and sort them within a few minutes by taking advantage of their electrotactic skills. This method allows to quantitatively measure the effect of mutations and aging on worm's crawling velocity. We also show that worms with different locomotory phenotypes can be spatially sorted, fast worms traveling away from slow ones. Group of nematodes with comparable locomotory fitness could then be isolated for further analysis. C. elegans is a growing model for neurodegenerative diseases and using electrotaxis for self-sorting can improve the high-throughput search of therapeutic bio-molecules.	[Maniere, Xavier; Matic, Ivan] Univ Paris 05, U1001, Lab TaMaRa, Paris, France; [Maniere, Xavier; Matic, Ivan] INSERM, Paris, France; [Lebois, Felix; Ladoux, Benoit; Di Meglio, Jean-Marc; Hersen, Pascal] Univ Paris Diderot, UMR7057, Lab Mat & Syst Complexes, Paris, France; [Lebois, Felix; Ladoux, Benoit; Di Meglio, Jean-Marc; Hersen, Pascal] CNRS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Maniere, X (corresponding author), Univ Paris 05, U1001, Lab TaMaRa, Paris, France.	pascal.hersen@univ-paris-diderot.fr	Di Meglio, Jean-Marc/E-7897-2012; Hersen, Pascal/D-6405-2012	Di Meglio, Jean-Marc/0000-0003-0446-4550; Hersen, Pascal/0000-0003-2379-4280; Ladoux, Benoit/0000-0003-2086-1556	NIH National Center for Research Resources (NCRR); Laboratoire Servier; ANR [ANR-06-BLAN-0406/AGING, ANR JCh-DiSiP]	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Laboratoire Servier; ANR(French National Research Agency (ANR))	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). X. M. is supported by a PhD fellowship from the Laboratoire Servier. The ANR program is gratefully acknowledged for its financial support (ANR-06-BLAN-0406/AGING to I. M. and ANR JCh-DiSiP to P. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; DUHON SA, 1995, J GERONTOL A-BIOL, V50, pB254, DOI 10.1093/gerona/50A.5.B254; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gieseler K, 2002, NEUROMUSCULAR DISORD, V12, P371, DOI 10.1016/S0960-8966(01)00330-3; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; HOSONO R, 1980, EXP GERONTOL, V15, P285, DOI 10.1016/0531-5565(80)90032-7; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rasband W.S., 1997, IMAGE J; Rezai P, 2010, LAB CHIP, V10, P220, DOI 10.1039/b917486a; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Saeki S, 2001, J EXP BIOL, V204, P1757; SUKUL NC, 1978, J NEMATOL, V10, P314; Suzuki Y, 2002, GENETICS, V162, P1631; *WORMB, C EL RES COMM, DOI DOI 10.1895/WORMBOOK.1.130.1	23	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16637	10.1371/journal.pone.0016637	http://dx.doi.org/10.1371/journal.pone.0016637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326598	Green Published, gold, Green Submitted			2022-12-27	WOS:000287037000015
J	Larue, BL; Padilla, PA				LaRue, Bobby L.; Padilla, Pamela A.			Environmental and Genetic Preconditioning for Long-Term Anoxia Responses Requires AMPK in Caenorhabditis elegans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ISCHEMIA-REPERFUSION INJURY; C-ELEGANS; LIFE-SPAN; SUSPENDED ANIMATION; OXIDATIVE STRESS; HYPOXIA; OXYGEN; METABOLISM; SURVIVAL	Background: Preconditioning environments or therapeutics, to suppress the cellular damage associated with severe oxygen deprivation, is of interest to our understanding of diseases associated with oxygen deprivation. Wildtype C. elegans exposed to anoxia enter into a state of suspended animation in which energy-requiring processes reversibly arrest. C. elegans at all developmental stages survive 24-hours of anoxia exposure however, the ability of adult hermaphrodites to survive three days of anoxia significantly decreases. Mutations in the insulin-like signaling receptor (daf-2) and LIN-12/Notch (glp-1) lead to an enhanced long-term anoxia survival phenotype. Methodology/Principal Findings: In this study we show that the combined growth environment of 25 degrees C and a diet of HT115 E. coli will precondition adult hermaphrodites to survive long-term anoxia; many of these survivors have normal movement after anoxia treatment. Animals fed the drug metformin, which induces a dietary-restriction like state in animals and activates AMPK in mammalian cell culture, have a higher survival rate when exposed to long-term anoxia. Mutations in genes encoding components of AMPK (aak-2, aakb-1, aakb-2, aakg-2) suppress the environmentally and genetically induced long-term anoxia survival phenotype. We further determine that there is a correlation between the animals that survive long-term anoxia and increased levels of carminic acid staining, which is a fluorescent dye that incorporates in with carbohydrates such as glycogen. Conclusions/Significance: We conclude that small changes in growth conditions such as increased temperature and food source can influence the physiology of the animal thus affecting the responses to stress such as anoxia. Furthermore, this supports the idea that metformin should be further investigated as a therapeutic tool for treatment of oxygen-deprived tissues. Finally, the capacity for an animal to survive long bouts of severe oxygen deprivation is likely dependent on specific subunits of the heterotrimeric protein AMPK and energy stores such as carbohydrates.	[LaRue, Bobby L.; Padilla, Pamela A.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Larue, BL (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	ppadilla@unt.edu			National Science Foundation [0747391]; Division Of Integrative Organismal Systems [0747391] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (NSF CAREER 0747391) to P. A. Padilla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Chan K, 2010, MOL BIOL CELL, V21, P2161, DOI 10.1091/mbc.E09-07-0614; COOPER AF, 1970, J NEMATOL, V2, P305; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Fuson AL, 2003, J EXP BIOL, V206, P4139, DOI 10.1242/jeb.00654; Gems D, 1998, GENETICS, V150, P129; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; Hajeri VA, 2010, MOL BIOL CELL, V21, P712, DOI 10.1091/mbc.E09-09-0787; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; HOCHACHKA PW, 1986, INTENS CARE MED, V12, P127; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hochachka PW, 2000, ADV EXP MED BIOL, V475, P311; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Kaeberlein M, 2009, CELL CYCLE, V8, P2324, DOI 10.4161/cc.8.15.9126; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanatous SB, 2009, AM J PHYSIOL-CELL PH, V296, pC393, DOI 10.1152/ajpcell.00428.2008; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Liu D, 2009, INT J BIOCHEM CELL B, V41, P2315, DOI 10.1016/j.biocel.2009.05.021; LUTZ PL, 1992, ANNU REV PHYSIOL, V54, P601, DOI 10.1146/annurev.physiol.54.1.601; Mabon ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007937; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; MARSHALL PN, 1974, STAIN TECHNOL, V49, P19, DOI 10.3109/10520297409116931; McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x; Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008; MENDENHALL AR, 2006, GENETICS; Menger MD, 2007, TRANSPL P, V39, P485, DOI 10.1016/j.transproceed.2007.01.022; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; MURRY CE, 1990, CIRC RES, V66, P913, DOI 10.1161/01.RES.66.4.913; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Farrell PH, 2001, J CLIN INVEST, V107, P671, DOI 10.1172/JCI12562; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Padilla PA, 2001, P NATL ACAD SCI USA, V12, P12; Paiva MA, 2010, CARDIOVASC DRUG THER, V24, P25, DOI 10.1007/s10557-010-6222-3; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pignataro G, 2009, FEBS J, V276, P46, DOI 10.1111/j.1742-4658.2008.06769.x; Podrabsky JE, 2007, J EXP BIOL, V210, P2253, DOI 10.1242/jeb.005116; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; Powers SK, 2007, MED SCI SPORT EXER, V39, P1529, DOI 10.1249/mss.0b013e3180d099c1; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Shao ZY, 2009, GENETICS, V183, P821, DOI 10.1534/genetics.109.107284; Shen C, 2003, ANN NY ACAD SCI, V995, P191, DOI 10.1111/j.1749-6632.2003.tb03222.x; SULSTON JE, 1974, GENETICS, V77, P95; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Yang X, 2010, CARDIOVASC DRUGS THE; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	73	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16790	10.1371/journal.pone.0016790	http://dx.doi.org/10.1371/journal.pone.0016790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304820	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600024
J	Ray, KC; Bell, KM; Yan, JB; Gu, GQ; Chung, CH; Washington, MK; Means, AL				Ray, Kevin C.; Bell, Kayla M.; Yan, Jingbo; Gu, Guoqiang; Chung, Christine H.; Washington, M. Kay; Means, Anna L.			Epithelial Tissues Have Varying Degrees of Susceptibility to Kras(G12D)-Initiated Tumorigenesis in a Mouse Model	PLOS ONE			English	Article							PANCREATIC INTRAEPITHELIAL NEOPLASIA; ONCOGENIC K-RAS; DUCTAL ADENOCARCINOMA; TUMOR PROGRESSION; HUMAN CANCERS; ADULT MICE; EXPRESSION; CELLS; KRAS; PROLIFERATION	Activating mutations in the Kras gene are commonly found in some but not all epithelial cancers. In order to understand the susceptibility of different epithelial tissues to Kras-induced tumorigenesis, we introduced one of the most common Kras mutations, Kras(G12D), broadly in epithelial tissues. We used a mouse model in which the G12D mutation is placed in the endogenous Kras locus controlled by inducible, Cre-mediated recombination in tissues expressing cytokeratin 19 including the oral cavity, GI tract, lungs, and ducts of the liver, kidney, and the pancreas. Introduction of the Kras(G12D) mutation in adult mouse tissues led to neoplastic changes in some but not all of these tissues. Notably, many hyperplasias, metaplasias and adenomas were observed in the oral cavity, stomach, colon and lungs, suggesting that exposure to products of the outside environment promotes Kras(G12D)-initiated tumorigenesis. However, environmental exposure did not consistently correlate with tumor formation, such as in the small intestine, suggesting that there are also intrinsic differences in susceptibility to Kras activation. The pancreas developed small numbers of mucinous metaplasias with characteristics of early stage pancreatic intraepithelial neoplasms (PanINs), supporting the hypothesis that pancreatic ducts have the potential to give rise pancreatic cancer.	[Ray, Kevin C.; Bell, Kayla M.; Means, Anna L.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Yan, Jingbo; Gu, Guoqiang; Means, Anna L.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Chung, Christine H.] Johns Hopkins Univ Sch Med, Dept Oncol, Baltimore, MD USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Johns Hopkins University; Vanderbilt University	Ray, KC (corresponding author), Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA.	anna.means@vanderbilt.edu			NIH [R21CA123061, P50CA095103, R01DK065949, P30DK058404]; NATIONAL CANCER INSTITUTE [P50CA095103, R21CA123061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065949, P30DK058404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R21CA123061 (ALM), P50CA095103 (ALM and MKW), R01DK065949 (GG) and P30DK058404 (MKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Blaine SA, 2010, DEVELOPMENT; Caulin C, 2004, CANCER RES, V64, P5054, DOI 10.1158/0008-5472.CAN-04-1488; CHESA PG, 1987, P NATL ACAD SCI USA, V84, P3234, DOI 10.1073/pnas.84.10.3234; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Coffey RJ, 2007, J CLIN INVEST, V117, P70, DOI 10.1172/JCI30491; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; Ellis CA, 2000, CELL SIGNAL, V12, P425, DOI 10.1016/S0898-6568(00)00084-X; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; FURTH ME, 1987, ONCOGENE, V1, P47; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Hashimoto Y, 2010, CARCINOGENESIS, V31, P777, DOI 10.1093/carcin/bgq013; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karanjawala ZE, 2008, AM J SURG PATHOL, V32, P188, DOI 10.1097/PAS.0b013e31815701f3; Lea IA, 2007, CARCINOGENESIS, V28, P1851, DOI 10.1093/carcin/bgm176; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Luttges J, 1999, VIRCHOWS ARCH, V435, P461, DOI 10.1007/s004280050428; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Mita H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-198; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nakajima M, 1998, PATHOL INT, V48, P944; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Schlage WK, 1998, TOXICOL PATHOL, V26, P324, DOI 10.1177/019262339802600307; Sheu JJC, 2009, CANCER RES, V69, P2568, DOI 10.1158/0008-5472.CAN-08-3199; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	45	86	88	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16786	10.1371/journal.pone.0016786	http://dx.doi.org/10.1371/journal.pone.0016786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311774	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200040
J	Dros, J; Maarsingh, OR; van der Windt, DAWM; Oort, FJ; ter Riet, G; de Rooij, SEJA; Schellevis, FG; van der Horst, HE; van Weert, HCPM				Dros, Jacquelien; Maarsingh, Otto R.; van der Windt, Danielle A. W. M.; Oort, Frans J.; ter Riet, Gerben; de Rooij, Sophia E. J. A.; Schellevis, Francois G.; van der Horst, Henriette E.; van Weert, Henk C. P. M.			Profiling Dizziness in Older Primary Care Patients: An Empirical Study	PLOS ONE			English	Article							PERSISTENT DIZZINESS; MULTIPLE IMPUTATION; GENERAL-PRACTICE; PREVALENCE; COMMUNITY; SYMPTOMS; UPDATE	Background: The diagnostic approach to dizzy, older patients is not straightforward as many organ systems can be involved and evidence for diagnostic strategies is lacking. A first differentiation in diagnostic subtypes or profiles may guide the diagnostic process of dizziness and can serve as a classification system in future research. In the literature this has been done, but based on pathophysiological reasoning only. Objective: To establish a classification of diagnostic profiles of dizziness based on empirical data. Design: Cross-sectional study. Participants and Setting: 417 consecutive patients of 65 years and older presenting with dizziness to 45 primary care physicians in the Netherlands from July 2006 to January 2008. Methods: We performed tests, including patient history, and physical and additional examination, previously selected by an international expert panel and based on an earlier systematic review. We used the results of these tests in a principal component analysis for exploration, data-reduction and finally differentiation into diagnostic dizziness profiles. Results: Demographic data and the results of the tests yielded 221 variables, of which 49 contributed to the classification of dizziness into six diagnostic profiles, that may be named as follows: "frailty'', "psychological'', "cardiovascular'', "presyncope'', "non-specific dizziness'' and "ENT''. These explained 32% of the variance. Conclusions: Empirically identified components classify dizziness into six profiles. This classification takes into account the heterogeneity and multicausality of dizziness and may serve as starting point for research on diagnostic strategies and can be a first step in an evidence based diagnostic approach of dizzy older patients.	[Dros, Jacquelien; ter Riet, Gerben; van Weert, Henk C. P. M.] Univ Amsterdam, Acad Med Ctr, Dept Family Med, NL-1105 AZ Amsterdam, Netherlands; [Maarsingh, Otto R.; van der Windt, Danielle A. W. M.; Schellevis, Francois G.; van der Horst, Henriette E.] Vrije Univ Amsterdam Med Ctr, Dept Family Med, Amsterdam, Netherlands; [Maarsingh, Otto R.; van der Windt, Danielle A. W. M.; Schellevis, Francois G.; van der Horst, Henriette E.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van der Windt, Danielle A. W. M.] Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele, Staffs, England; [Oort, Frans J.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands; [de Rooij, Sophia E. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Med Sect, NL-1105 AZ Amsterdam, Netherlands; [Schellevis, Francois G.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Keele University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research	Dros, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Family Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.dros@amc.uva.nl	Maarsingh, Otto/AAD-1553-2022; Maarsingh, Otto R/C-9100-2012; Riet, Gerben ter/A-6943-2011	Riet, Gerben ter/0000-0002-2231-7637; Oort, Frans/0000-0003-1823-7105; Maarsingh, Otto/0000-0002-3747-9217	Netherlands Organisation for Health Research and Development (ZonMw) [4200.0018]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 4200.0018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branch W., APPROACH PATIENT DIZ; Brignole M, 2004, EUROPACE, V6, P467, DOI 10.1016/j.eupc.2004.08.008; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; COLLEDGE NR, 1994, AGE AGEING, V23, P117, DOI 10.1093/ageing/23.2.117; DRACHMAN DA, 1972, NEUROLOGY, V22, P323, DOI 10.1212/WNL.22.4.323; Dros J, 2010, CAN MED ASSOC J, V182, pE621, DOI 10.1503/cmaj.080910; Fife TD, 2000, NEUROLOGY, V55, P1431, DOI 10.1212/WNL.55.10.1431; Hanley K, 2002, BRIT J GEN PRACT, V52, P809; Hoffman RM, 1999, AM J MED, V107, P468, DOI 10.1016/S0002-9343(99)00260-0; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Laupacis A, 2007, ANN INTERN MED, V147, P273, DOI 10.7326/0003-4819-147-4-200708210-00180; Maarsingh OR, 2010, ANN FAM MED, V8, P196, DOI 10.1370/afm.1116; Maarsingh OR, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-2; Maarsingh OR, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-12; MADLONKAY DJ, 1985, J FAM PRACTICE, V21, P109; Nazareth I, 2006, J PSYCHOSOM RES, V60, P395, DOI 10.1016/j.jpsychores.2005.07.011; Newman-Toker DE, 2007, MAYO CLIN PROC, V82, P1329, DOI 10.4065/82.11.1329; *NIH CLIN EXC, CLIN KNOWL SUMM; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Sloane P D, 1994, J Am Board Fam Pract, V7, P1; Sloane PD, 2001, ANN INTERN MED, V134, P823, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00005; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; VANDERLINDEN MW, 2004, 2 DUTCH NATL SURVEY; Vereeck L, 2006, B-ENT, V2, P75; Verheij AAA, 2002, HUISARTS WET, V45, P601; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16481	10.1371/journal.pone.0016481	http://dx.doi.org/10.1371/journal.pone.0016481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304984	Green Published, Green Accepted, gold			2022-12-27	WOS:000286834300069
J	Kawano-Yamashita, E; Koyanagi, M; Shichida, Y; Oishi, T; Tamotsu, S; Terakita, A				Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Shichida, Yoshinori; Oishi, Tadashi; Tamotsu, Satoshi; Terakita, Akihisa			Beta-Arrestin Functionally Regulates the Non-Bleaching Pigment Parapinopsin in Lamprey Pineal	PLOS ONE			English	Article							RECEPTOR KINASES; PHOTORECEPTOR CELLS; LAMPETRA-JAPONICA; RIVER LAMPREY; S-ANTIGEN; PROTEIN; RHODOPSIN; ORGAN; ENDOCYTOSIS; APOPTOSIS	The light response of vertebrate visual cells is achieved by light-sensing proteins such as opsin-based pigments as well as signal transduction proteins, including visual arrestin. Previous studies have indicated that the pineal pigment parapinopsin has evolutionally and physiologically important characteristics. Parapinopsin is phylogenetically related to vertebrate visual pigments. However, unlike the photoproduct of the visual pigment rhodopsin, which is unstable, dissociating from its chromophore and bleaching, the parapinopsin photoproduct is stable and does not release its chromophore. Here, we investigated arrestin, which regulates parapinopsin signaling, in the lamprey pineal organ, where parapinopsin and rhodopsin are localized to distinct photoreceptor cells. We found that beta-arrestin, which binds to stimulated G protein-coupled receptors (GPCRs) other than opsin-based pigments, was localized to parapinopsin-containing cells. This result stands in contrast to the localization of visual arrestin in rhodopsin-containing cells. Beta-arrestin bound to cultured cell membranes containing parapinopsin light-dependently and translocated to the outer segments of pineal parapinopsin-containing cells, suggesting that beta-arrestin binds to parapinopsin to arrest parapinopsin signaling. Interestingly, beta-arrestin colocalized with parapinopsin in the granules of the parapinopsin-expressing cell bodies under light illumination. Because beta-arrestin, which is a mediator of clathrin-mediated GPCR internalization, also served as a mediator of parapinopsin internalization in cultured cells, these results suggest that the granules were generated light-dependently by beta-arrestin-mediated internalization of parapinopsins from the outer segments. Therefore, our findings imply that beta-arrestin-mediated internalization is responsible for eliminating the stable photoproduct and restoring cell conditions to the original dark state. Taken together with a previous finding that the bleaching pigment evolved from a non-bleaching pigment, vertebrate visual arrestin may have evolved from a "beta-like'' arrestin by losing its clathrin-binding domain and its function as an internalization mediator. Such changes would have followed the evolution of vertebrate visual pigments, which generate unstable photoproducts that independently decay by chromophore dissociation.	[Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 558, Japan; [Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan; [Oishi, Tadashi] Nara Saho Coll, Nara, Japan; [Tamotsu, Satoshi] Nara Womens Univ, Grad Sch Humanities & Sci, Nara 630, Japan	Osaka Metropolitan University; Kyoto University; Nara Womens University	Kawano-Yamashita, E (corresponding author), Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 558, Japan.	terakita@sci.osaka-cu.ac.jp		Terakita, Akihisa/0000-0002-8379-8913; Koyanagi, Mitsumasa/0000-0002-7741-918X	Japanese Ministry of Education, Science, Sports, and Culture; Yamada Science Foundation; Naito Foundation; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [22687005] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (to A.T. and M.K.), the Yamada Science Foundation (to A.T.) and the Naito Foundation (to A.T. and M.K.). E.K-Y. is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Blackshaw S, 1997, J NEUROSCI, V17, P8083; COLLIN JP, 1986, NEUROSCIENCE, V19, P657, DOI 10.1016/0306-4522(86)90288-5; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawano E, 2006, ZOOL SCI, V23, P277, DOI 10.2108/zsj.23.277; Kawano-Yamashita E, 2007, J EXP BIOL, V210, P3821, DOI 10.1242/jeb.007161; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Nakagawa M, 2002, EUR J BIOCHEM, V269, P5112, DOI 10.1046/j.1432-1033.2002.03240.x; Orem NR, 2006, J CELL SCI, V119, P3141, DOI 10.1242/jcs.03052; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMEJIMA M, 1989, CELL TISSUE RES, V258, P219; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Shichida Y, 2003, PHOTOCH PHOTOBIO SCI, V2, P1237, DOI 10.1039/b300434a; TAMOTSU S, 1990, CELL TISSUE RES, V262, P205, DOI 10.1007/BF00309875; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsukamoto H, 2010, PHOTOCH PHOTOBIO SCI, V9, P1435, DOI 10.1039/c0pp00168f; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	30	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16402	10.1371/journal.pone.0016402	http://dx.doi.org/10.1371/journal.pone.0016402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305016	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300061
J	Lappano, R; Recchia, AG; De Francesco, EM; Angelone, T; Cerra, MC; Picard, D; Maggiolini, M				Lappano, Rosamaria; Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Angelone, Tommaso; Cerra, Maria Carmela; Picard, Didier; Maggiolini, Marcello			The Cholesterol Metabolite 25-Hydroxycholesterol Activates Estrogen Receptor alpha-Mediated Signaling in Cancer Cells and in Cardiomyocytes	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SMOOTH-MUSCLE-CELLS; BREAST-CANCER; OVARIAN-CANCER; LEYDIG-CELLS; IN-VITRO; TESTICULAR MACROPHAGES; INDUCED APOPTOSIS; LIPID-METABOLISM	Background: The hydroxylated derivatives of cholesterol, such as the oxysterols, play important roles in lipid metabolism. In particular, 25-hydroxycholesterol (25HC) has been implicated in a variety of metabolic events including cholesterol homeostasis and atherosclerosis. 25HC is detectable in human plasma after ingestion of a meal rich in oxysterols and following a dietary cholesterol challenge. In addition, the levels of oxysterols, including 25HC, have been found to be elevated in hypercholesterolemic serum. Methodology/Principal Findings: Here, we demonstrate that the estrogen receptor (ER) alpha mediates gene expression changes and growth responses induced by 25HC in breast and ovarian cancer cells. Moreover, 25HC exhibits the ER alpha-dependent ability like 17 beta-estradiol (E2) to inhibit the up-regulation of HIF-1 alpha and connective tissue growth factor by hypoxic conditions in cardiomyocytes and rat heart preparations and to prevent the hypoxia-induced apoptosis. Conclusions/Significance: The estrogen action exerted by 25HC may be considered as an additional factor involved in the progression of breast and ovarian tumors. Moreover, the estrogen-like activity of 25HC elicited in the cardiovascular system may play a role against hypoxic environments.	[Lappano, Rosamaria; Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Cerra, Maria Carmela; Maggiolini, Marcello] Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy; [Angelone, Tommaso] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; [Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland	University of Calabria; University of Calabria; University of Geneva	Lappano, R (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy.	marcellomaggiolini@yahoo.it	Recchia, Anna Grazia/ABA-5228-2020; Maggiolini, Marcello/Z-4729-2019; Angelone, Tommaso/AAM-1230-2020; Lappano, Rosamaria/Z-4857-2019	Angelone, Tommaso/0000-0001-7797-7862; Recchia, Anna Grazia/0000-0001-5748-2002; Maggiolini, Marcello/0000-0002-7485-854X; Cerra, Maria Carmela/0000-0002-2091-928X; Lappano, Rosamaria/0000-0002-9374-9701	Associazione Italiana per la Ricerca sul Cancro (AIRC) [8925/2009]; Ministero dell'Universita e Ricerca Scientifica e Tecnologica (MIUR)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e Ricerca Scientifica e Tecnologica (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, project n. 8925/2009) (http://www.airc.it/) and Ministero dell'Universita e Ricerca Scientifica e Tecnologica (MIUR) (http://www.istruzione.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Burkard I, 2007, ATHEROSCLEROSIS, V194, P71, DOI 10.1016/j.atherosclerosis.2006.09.026; Cerra MC, 2006, BASIC RES CARDIOL, V101, P43, DOI 10.1007/s00395-005-0547-2; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Chen JX, 2009, NEUROSCI BULL, V25, P67, DOI 10.1007/s12264-009-1215-6; Chen JJ, 2002, BIOL REPROD, V66, P1336, DOI 10.1095/biolreprod66.5.1336; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Cho J, 2006, J STEROID BIOCHEM, V100, P18, DOI 10.1016/j.jsbmb.2006.03.002; Choi YK, 2008, FREE RADICAL RES, V42, P544, DOI 10.1080/10715760802146062; Cicha I, 2006, CLIN HEMORHEOL MICRO, V35, P203; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dai S, 2003, INT J RADIAT ONCOL, V55, P1027, DOI 10.1016/S0360-3016(02)04507-8; Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; DuSell CD, 2008, TRENDS PHARMACOL SCI, V29, P510, DOI 10.1016/j.tips.2008.07.003; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Fabian CJ, 2005, J CLIN ONCOL, V23, P1644, DOI 10.1200/JCO.2005.11.005; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; Flototto T, 2001, HORM METAB RES, V33, P451, DOI 10.1055/s-2001-16936; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Furberg AS, 2004, J NATL CANCER I, V96, P1152, DOI 10.1093/jnci/djh216; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gerstner B, 2009, J NEUROSCI RES, V87, P2078, DOI 10.1002/jnr.22023; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Higgins DF, 2003, KIDNEY INT, V64, P2079, DOI 10.1046/j.1523-1755.2003.00306.x; Hishikawa K, 1999, CIRCULATION, V100, P2108, DOI 10.1161/01.CIR.100.20.2108; HODIS HN, 1992, ATHEROSCLEROSIS, V96, P125, DOI 10.1016/0021-9150(92)90059-P; Hong KH, 2006, CLIN EXP IMMUNOL, V146, P362, DOI 10.1111/j.1365-2249.2006.03199.x; Hua KQ, 2009, ONCOL REP, V21, P893, DOI 10.3892/or_00000300; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Jeanes HL, 2008, J ENDOCRINOL, V197, P493, DOI 10.1677/JOE-08-0071; JOHNSON KA, 1994, J LIPID RES, V35, P2241; KANDUTSCH AA, 1974, J BIOL CHEM, V249, P6057; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Kazi AA, 2007, ENDOCRINOLOGY, V148, P2363, DOI 10.1210/en.2006-1394; Kim Jin Kyung, 2006, Nucl Recept Signal, V4, pe013; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kondo S, 2002, CARCINOGENESIS, V23, P769, DOI 10.1093/carcin/23.5.769; Krick S, 2005, AM J RESP CELL MOL, V32, P395, DOI 10.1165/rcmb.2004-0314OC; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lappano R, 2009, MOL NUTR FOOD RES, V53, P845, DOI 10.1002/mnfr.200800331; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Lemaire-Ewing S, 2009, CELL BIOL TOXICOL, V25, P127, DOI 10.1007/s10565-008-9063-0; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Ling SH, 2006, CLIN SCI, V111, P107, DOI 10.1042/CS20050084; Lukyanenko YO, 2001, BIOL REPROD, V64, P790, DOI 10.1095/biolreprod64.3.790; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008; Maggiolini M, 2001, MOL PHARMACOL, V60, P595; Malhotra R, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-9; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; NGUYEN VP, 2010, J ANGIOGENES RES, V11, P2; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; Oemar BS, 1997, CIRCULATION, V95, P831; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Peters K, 2001, J MATER SCI-MATER M, V12, P955, DOI 10.1023/A:1012852814570; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P301, DOI 10.1080/10937400701876095; Santagati S, 1997, MOL ENDOCRINOL, V11, P938, DOI 10.1210/me.11.7.938; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Sharma I, 2010, FERTIL STERIL, V94, P63, DOI 10.1016/j.fertnstert.2009.01.141; Shimo T, 2001, ONCOLOGY-BASEL, V61, P315, DOI 10.1159/000055339; Sovershaev MA, 2006, AM J PHYSIOL-HEART C, V291, pH1554, DOI 10.1152/ajpheart.01171.2005; Stoll BA, 2002, INT J OBESITY, V26, P747, DOI 10.1038/sj.ijo.0801998; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Travert C, 2006, REPROD TOXICOL, V22, P564, DOI 10.1016/j.reprotox.2006.05.006; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Velazquez E, 2006, NEUROPHARMACOLOGY, V51, P229, DOI 10.1016/j.neuropharm.2006.03.017; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Xie D, 2001, CANCER RES, V61, P8917; Yi JM, 2009, BIOCHEM BIOPH RES CO, V378, P842, DOI 10.1016/j.bbrc.2008.11.142; Yokoyama S, 1999, INT J ONCOL, V15, P565; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8; Zhao LQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-24; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010	92	79	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16631	10.1371/journal.pone.0016631	http://dx.doi.org/10.1371/journal.pone.0016631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304949	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300103
J	Schwartz, S; Oren, R; Ast, G				Schwartz, Schraga; Oren, Ram; Ast, Gil			Detection and Removal of Biases in the Analysis of Next-Generation Sequencing Reads	PLOS ONE			English	Article							RNA-POLYMERASE; CHIP-SEQ; ACTIVE PROMOTERS; NONCODING RNAS; HUMAN GENOME; CHROMATIN; BIOGENESIS; GENES; EXONS; TRANSCRIPTION	Since the emergence of next-generation sequencing (NGS) technologies, great effort has been put into the development of tools for analysis of the short reads. In parallel, knowledge is increasing regarding biases inherent in these technologies. Here we discuss four different biases we encountered while analyzing various Illumina datasets. These biases are due to both biological and statistical effects that in particular affect comparisons between different genomic regions. Specifically, we encountered biases pertaining to the distributions of nucleotides across sequencing cycles, to mappability, to contamination of pre-mRNA with mRNA, and to non-uniform hydrolysis of RNA. Most of these biases are not specific to one analyzed dataset, but are present across a variety of datasets and within a variety of genomic contexts. Importantly, some of these biases correlated in a highly significant manner with biological features, including transcript length, gene expression levels, conservation levels, and exon-intron architecture, misleadingly increasing the credibility of results due to them. We also demonstrate the relevance of these biases in the context of analyzing an NGS dataset mapping transcriptionally engaged RNA polymerase II (RNAPII) in the context of exon-intron architecture, and show that elimination of these biases is crucial for avoiding erroneous interpretation of the data. Collectively, our results highlight several important pitfalls, challenges and approaches in the analysis of NGS reads.	[Schwartz, Schraga; Oren, Ram; Ast, Gil] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Schwartz, S (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	schragas@post.tau.ac.il		Schwartz, Schraga/0000-0002-3671-9709	Israel Science Foundation [ISF 61/09]; Joint Germany-Israeli Research Program [ca-139]; Deutsche-Israel Project [DIP MI-1317]; Israel Cancer Association; Israel Cancer Research Foundation (ICRF)	Israel Science Foundation(Israel Science Foundation); Joint Germany-Israeli Research Program; Deutsche-Israel Project; Israel Cancer Association; Israel Cancer Research Foundation (ICRF)	S.S. is a fellow of the Edmond J. Safra bioinformatics program at Tel Aviv University. This work was supported by grants from the Israel Science Foundation (ISF 61/09), the Joint Germany-Israeli Research Program (ca-139), the Deutsche-Israel Project (DIP MI-1317), the Israel Cancer Association, and the Israel Cancer Research Foundation (ICRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; CHEN W, NUCL ACIDS RES, V38, P2788; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; GAULTON KJ, NAT GENET, V42, P255; Gilad Y, 2009, TRENDS GENET, V25, P463, DOI 10.1016/j.tig.2009.09.003; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hansen KD, NUCL ACIDS RES, V38, pe131; HEAP GA, HUM MOL GENET, V19, P122; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kiss T, 2006, MOL CELL, V23, P775, DOI 10.1016/j.molcel.2006.08.023; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; KUNARSO G, NAT GENET, V42, P631; LAURENT L, GENOME RES, V20, P320; LI B, BIOINFORMATICS, V26, P493; LI J, GENOME BIOL, V11, pR50; LICATALOSI DD, NAT REV GENET, V11, P75; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; METZKER ML, NAT REV GENET, V11, P31; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Philippe N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp492; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; WANG C, BMC BIOINFORMATICS, V11, P81; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhu LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-47	59	68	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16685	10.1371/journal.pone.0016685	http://dx.doi.org/10.1371/journal.pone.0016685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304912	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300121
J	Belsham, GJ; Jamal, SM; Tjornehoj, K; Botner, A				Belsham, Graham J.; Jamal, Syed M.; Tjornehoj, Kirsten; Botner, Anette			Rescue of Foot-and-Mouth Disease Viruses That Are Pathogenic for Cattle from Preserved Viral RNA Samples	PLOS ONE			English	Article							RT-PCR; REPLICATION; DIAGNOSIS; ASSAY	Background: Foot and mouth disease is an economically important disease of cloven-hoofed animals including cattle, sheep and pigs. It is caused by a picornavirus, foot-and-mouth disease virus (FMDV), which has a positive sense RNA genome which, when introduced into cells, can initiate virus replication. Principal Findings: A system has been developed to rescue infectious FMDV from RNA preparations generated from clinical samples obtained under experimental conditions and then applied to samples collected in the "field". Clinical samples from suspect cases of foot-and-mouth disease (FMD) were obtained from within Pakistan and Afghanistan. The samples were treated to preserve the RNA and then transported to National Veterinary Institute, Lindholm, Denmark. Following RNA extraction, FMDV RNA was quantified by real-time RT-PCR and samples containing significant levels of FMDV RNA were introduced into susceptible cells using electroporation. Progeny viruses were amplified in primary bovine thyroid cells and characterized using antigen ELISA and also by RT-PCR plus sequencing. FMD viruses of three different serotypes and multiple lineages have been successfully rescued from the RNA samples. Two of the rescued viruses (of serotype O and Asia 1) were inoculated into bull calves under high containment conditions. Acute clinical disease was observed in each case which spread rapidly from the inoculated calves to in-contact animals. Thus the rescued viruses were highly pathogenic. The availability of the rescued viruses enabled serotyping by antigen ELISA and facilitated genome sequencing. Conclusions: The procedure described here should improve the characterization of FMDVs circulating in countries where the disease is endemic and thus enhance disease control globally.	[Belsham, Graham J.; Jamal, Syed M.; Tjornehoj, Kirsten; Botner, Anette] Tech Univ Denmark, Natl Vet Inst, Lindholm, Kalvehave, Denmark; [Jamal, Syed M.] Natl Vet Lab, Islamabad, Pakistan; [Jamal, Syed M.] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan	Technical University of Denmark; Quaid I Azam University	Belsham, GJ (corresponding author), Tech Univ Denmark, Natl Vet Inst, Lindholm, Kalvehave, Denmark.	grbe@vet.dtu.dk	Belsham, Graham/J-3132-2019; Jamal, Syed M./H-5394-2011; Belsham, Graham J./H-8589-2019	Belsham, Graham/0000-0003-1187-4873; Jamal, Syed M./0000-0002-0768-4471; Belsham, Graham J./0000-0003-1187-4873	EuFMD [LoA PR 40134]	EuFMD	The work by SMJ was supported by funds from the EuFMD (LoA PR 40134). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Belsham GJ, 2005, CURR TOP MICROBIOL, V288, P43; BELSHAM GJ, 1988, J GEN VIROL, V69, P265, DOI 10.1099/0022-1317-69-2-265; Belsham GJ, 2008, J GEN VIROL, V89, P485, DOI 10.1099/vir.0.83385-0; Brehm KE, 2009, J CLIN MICROBIOL, V47, P3156, DOI 10.1128/JCM.00510-09; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Have P, 1983, P SESS RES GROUP STA, P44; Hofmann MA, 2000, J VIROL METHODS, V87, P29, DOI 10.1016/S0166-0934(00)00154-3; Nayak A, 2006, J VIROL, V80, P9865, DOI 10.1128/JVI.00561-06; *OIE, FOOT AND MOUTH DIS M; Reed LJ, 1938, AM J HYG, V27, P493, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A118408; Reid SM, 2003, J VIROL METHODS, V107, P129, DOI 10.1016/S0166-0934(02)00210-0; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	19	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14621	10.1371/journal.pone.0014621	http://dx.doi.org/10.1371/journal.pone.0014621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21298025	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100006
J	Cortes-Campos, C; Elizondo, R; Llanos, P; Uranga, RM; Nualart, F; Garcia, MA				Cortes-Campos, Christian; Elizondo, Roberto; Llanos, Paula; Maria Uranga, Romina; Nualart, Francisco; Angeles Garcia, Maria			MCT Expression and Lactate Influx/Efflux in Tanycytes Involved in Glia-Neuron Metabolic Interaction	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT2; XENOPUS-LAEVIS OOCYTES; LACTIC-ACID EFFLUX; MOUSE-BRAIN; HYPOTHALAMIC NEURONS; CONFOCAL MICROSCOPY; SENSING NEURONS; ARCUATE NUCLEUS; SKELETAL-MUSCLE; CDNA CLONING	Metabolic interaction via lactate between glial cells and neurons has been proposed as one of the mechanisms involved in hypothalamic glucosensing. We have postulated that hypothalamic glial cells, also known as tanycytes, produce lactate by glycolytic metabolism of glucose. Transfer of lactate to neighboring neurons stimulates ATP synthesis and thus contributes to their activation. Because destruction of third ventricle (III-V) tanycytes is sufficient to alter blood glucose levels and food intake in rats, it is hypothesized that tanycytes are involved in the hypothalamic glucose sensing mechanism. Here, we demonstrate the presence and function of monocarboxylate transporters (MCTs) in tanycytes. Specifically, MCT1 and MCT4 expression as well as their distribution were analyzed in Sprague Dawley rat brain, and we demonstrate that both transporters are expressed in tanycytes. Using primary tanycyte cultures, kinetic analyses and sensitivity to inhibitors were undertaken to confirm that MCT1 and MCT4 were functional for lactate influx. Additionally, physiological concentrations of glucose induced lactate efflux in cultured tanycytes, which was inhibited by classical MCT inhibitors. Because the expression of both MCT1 and MCT4 has been linked to lactate efflux, we propose that tanycytes participate in glucose sensing based on a metabolic interaction with neurons of the arcuate nucleus, which are stimulated by lactate released from MCT1 and MCT4-expressing tanycytes.	[Cortes-Campos, Christian; Elizondo, Roberto; Llanos, Paula; Angeles Garcia, Maria] Univ Concepcion, Lab Biol Celular, Dept Biol Celular, Concepcion, Chile; [Nualart, Francisco] Univ Concepcion, Lab Neurobiol & Celulas Madre, Dept Biol Celular, Concepcion, Chile; [Maria Uranga, Romina] Univ Nacl Sur, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Maria Uranga, Romina] Consejo Nacl Invest Cient & Tecn, Bahia Blanca, Buenos Aires, Argentina	Universidad de Concepcion; Universidad de Concepcion; National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cortes-Campos, C (corresponding author), Univ Concepcion, Lab Biol Celular, Dept Biol Celular, Concepcion, Chile.	mgarcia@udec.cl	Garcia-Robles, Maria/F-4900-2014; Uranga, Romina M/A-7660-2011; Cortes Campos, Christian/Q-4096-2016; Nualart, Francisco/AAB-9342-2021	Cortes Campos, Christian/0000-0002-2532-9035; Garcia-Robles, Maria/0000-0001-8482-0361; Uranga, Romina Maria/0000-0002-8113-4646; Llanos Fuentes, Paula Lorena/0000-0002-4388-4737; Elizondo, Roberto/0000-0001-9790-0002	FONDECYT [1100705]; Ring of Research PBCT [ACT-02]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ring of Research PBCT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT)	This work was supported by FONDECYT grant 1100705 (to MAG) and Ring of Research PBCT ACT-02 (to FN and MAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; AKMAYEV IG, 1977, CELL TISSUE RES, V180, P263; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Borg MA, 2003, DIABETES, V52, P663, DOI 10.2337/diabetes.52.3.663; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; CHAUVET N, 1995, J NEUROSCI RES, V41, P129, DOI 10.1002/jnr.490410115; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; FLAMENTDURAND J, 1985, INT REV CYTOL, V96, P121, DOI 10.1016/S0074-7696(08)60596-3; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gabrion JB, 1998, MICROSC RES TECHNIQ, V41, P124, DOI 10.1002/(SICI)1097-0029(19980415)41:2<124::AID-JEMT3>3.0.CO;2-U; GARCIA CK, 1994, GENOMICS, V23, P500, DOI 10.1006/geno.1994.1532; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Garcia MD, 2003, J NEUROCHEM, V86, P709, DOI 10.1046/j.1471-4159.2003.01892.x; Garcia MDA, 2001, J CELL BIOCHEM, V80, P491; Garcia MDL, 2005, GLIA, V50, P32, DOI 10.1002/glia.20133; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Gerhart DZ, 1998, GLIA, V22, P272; Gonzalez JA, 2009, J PHYSIOL-LONDON, V587, P41, DOI 10.1113/jphysiol.2008.163410; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; Lam CKL, 2008, AM J PHYSIOL-ENDOC M, V295, pE491, DOI 10.1152/ajpendo.90481.2008; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Leino RL, 1999, DEV BRAIN RES, V113, P47, DOI 10.1016/S0165-3806(98)00188-6; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; MANDERS EMM, 1992, J CELL SCI, V103, P857; Millan C, 2010, ASN NEURO, V2, P135, DOI 10.1042/AN20090059; Muroya S, 1999, NEUROSCI LETT, V264, P113, DOI 10.1016/S0304-3940(99)00185-8; Nualart FJ, 2003, J BIOL CHEM, V278, P10128, DOI 10.1074/jbc.M210686200; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Rafiki A, 2003, NEUROSCIENCE, V122, P677, DOI 10.1016/j.neuroscience.2003.08.040; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Sanders NM, 2004, DIABETES, V53, P1230, DOI 10.2337/diabetes.53.5.1230; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763	49	63	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16411	10.1371/journal.pone.0016411	http://dx.doi.org/10.1371/journal.pone.0016411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297988	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100029
J	Jun, AS; Cope, L; Speck, C; Feng, XJ; Lee, SW; Meng, HA; Hamad, A; Chakravarti, S				Jun, Albert S.; Cope, Leslie; Speck, Caroline; Feng, Xiaojun; Lee, Seakwoo; Meng, Huan; Hamad, Abdel; Chakravarti, Shukti			Subnormal Cytokine Profile in the Tear Fluid of Keratoconus Patients	PLOS ONE			English	Article							COLONIC SUBEPITHELIAL MYOFIBROBLASTS; INFLAMMATORY MOLECULES; T-CELLS; FIBROBLASTS; INTERLEUKIN-17; EYE; ACTIVATION; EXPRESSION; HISTORY; DISEASE	Keratoconus, historically viewed as a non-inflammatory disease, is an ectatic corneal disorder associated with progressive thinning of the corneal stroma. Recently, a few inflammatory mediators have been reported to be elevated in the tear fluid of keratoconus patients. Consequently, we investigated a wide range of inflammation regulating cytokines in the tears and sera of keratoconus and control subjects. Interleukin (IL)-1 beta, IL-4, IL-6, IL-10, IL-12, IL-13, IL-17, interferon (IFN)-gamma, chemokine C-C motif ligand 5 (CCL5) and tumor necrosis factor (TNF)-alpha were tested in tear samples and sera of keratoconus and control individuals by multiplex immuno-bead assays. Selected cytokines were further tested by standard ELISA on pooled tear samples. All cytokines in the sera were generally low, with no significant changes between keratoconus and control subjects. However, in tear fluids, clear differences were detected between the two groups. These differences include increased IL-6, and decreased IL-12, TNF-alpha, IFN-gamma, IL-4, IL-13 and CCL5 in keratoconus compared to control tear fluids. The decreases in IL-12, TNF-alpha and CCL5 were statistically significant, while the IL-13 decrease was statistically significant in the severe keratoconus group only. IL-17 could not be detected by multiplex immuno-bead assay, but showed an increase in keratoconus by conventional ELISA on a limited number of pooled tear samples. Our findings confirm increased IL-6, but dispute earlier reports of increased TNF-alpha, and suggest a cytokine imbalance in keratoconus disrupting corneal homeostasis. Moreover, an increase in IL-17 suggests tissue degenerative processes at work, contributing to the thinning and weakening of the corneal connective tissue in keratoconus.	[Jun, Albert S.; Meng, Huan; Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cope, Leslie] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Speck, Caroline] Johns Hopkins Sch Arts & Sci, Dept Psychol & Brain Sci, Baltimore, MD USA; [Feng, Xiaojun; Lee, Seakwoo; Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Hamad, Abdel] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Jun, AS (corresponding author), Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	schakra1@jhmi.edu	Feng, Xiaojun/K-4365-2012	Mills, Huan/0000-0002-8740-2074	Wilmer Openshaw Keratoconus Fund; National Eye Institute [EY11654]; Research to Prevent Blindness Dolly Green Special Scholar Award; NATIONAL EYE INSTITUTE [R56EY011654, R01EY011654] Funding Source: NIH RePORTER	Wilmer Openshaw Keratoconus Fund; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Dolly Green Special Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Wilmer Openshaw Keratoconus Fund, National Eye Institute grant EY11654 (SC), and Research to Prevent Blindness Dolly Green Special Scholar Award (ASJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoudjehane L, 2008, LAB INVEST, V88, P973, DOI 10.1038/labinvest.2008.61; Awasthi A, 2008, J CLIN IMMUNOL, V28, P660, DOI 10.1007/s10875-008-9239-7; Bamba S, 2003, J GASTROENTEROL, V38, P548, DOI 10.1007/s00535-002-1101-8; Bhogal R, 2008, INT REV IMMUNOL, V27, P472, DOI 10.1080/08830180802430974; CARRENO E, 2010, ACTA OPHTHALMOL; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Cristina Kenney M, 2003, Cont Lens Anterior Eye, V26, P139; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; FABRE EJ, 1991, CURR EYE RES, V10, P585, DOI 10.3109/02713689109013850; FINI ME, 1992, CURR EYE RES, V11, P849, DOI 10.3109/02713689209033483; FUKUCHI T, 1994, ARCH OPHTHALMOL-CHIC, V112, P1368, DOI 10.1001/archopht.1994.01090220118033; GALIN MA, 1958, AM J OPHTHALMOL, V45, P904, DOI 10.1016/0002-9394(58)90403-3; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jimenez JO, 1997, OPTOMETRY VISION SCI, V74, P147, DOI 10.1097/00006324-199703000-00025; Katsifis GE, 2007, CLIN REV ALLERG IMMU, V32, P252, DOI 10.1007/s12016-007-8011-8; KEMP EG, 1982, BRIT J OPHTHALMOL, V66, P717, DOI 10.1136/bjo.66.11.717; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Lema I, 2008, CORNEA, V27, P758, DOI 10.1097/ICO.0b013e31816a3591; Lema I, 2010, MOL VIS, V16, P2055; Leonardi A, 2006, CLIN EXP ALLERGY, V36, P777, DOI 10.1111/j.1365-2222.2006.02499.x; Li SM, 2008, OPTOMETRY VISION SCI, V85, P653, DOI 10.1097/OPX.0b013e3181824e20; Long Q, 2006, J REFRACT SURG, V22, P708, DOI 10.3928/1081-597X-20060901-13; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Pannebaker C, 2010, MOL VIS, V16, P1949; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Qiu Z, 2009, IMMUNOBIOLOGY, V214, P835, DOI 10.1016/j.imbio.2009.06.007; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; RAHI A, 1977, BRIT J OPHTHALMOL, V61, P761, DOI 10.1136/bjo.61.12.761; Rifas L, 2003, ARTHRITIS RHEUM-US, V48, P993, DOI 10.1002/art.10872; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Sylvester J, 2004, CELL SIGNAL, V16, P469, DOI 10.1016/j.cellsig.2003.09.008; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Yagi Y, 2007, J GASTROENTEROL, V42, P746, DOI 10.1007/s00535-007-2091-3; YUE BYJT, 1984, P SOC EXP BIOL MED, V175, P336; ZHENG X, 2010, INVEST OPHTHALMOL VI	41	129	130	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16437	10.1371/journal.pone.0016437	http://dx.doi.org/10.1371/journal.pone.0016437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298010	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900049
J	Qi, MS; Wang, DP; Bradley, CA; Zhao, YF				Qi, Mingsheng; Wang, Dongping; Bradley, Carl A.; Zhao, Youfu			Genome Sequence Analyses of Pseudomonas savastanoi pv. glycinea and Subtractive Hybridization-Based Comparative Genomics with Nine Pseudomonads	PLOS ONE			English	Article							SECRETION SYSTEM EFFECTORS; PPT23A PLASMID FAMILY; AVIRULENCE GENES; BACTERIAL-BLIGHT; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; NUCLEOTIDE-SEQUENCE; INNATE IMMUNITY; SYRINGAE B728A; TOMATO DC3000	Bacterial blight, caused by Pseudomonas savastanoi pv. glycinea (Psg), is a common disease of soybean. In an effort to compare a current field isolate with one isolated in the early 1960s, the genomes of two Psg strains, race 4 and B076, were sequenced using 454 pyrosequencing. The genomes of both Psg strains share more than 4,900 highly conserved genes, indicating very low genetic diversity between Psg genomes. Though conserved, genome rearrangements and recombination events occur commonly within the two Psg genomes. When compared to each other, 437 and 163 specific genes were identified in B076 and race 4, respectively. Most specific genes are plasmid-borne, indicating that acquisition and maintenance of plasmids may represent a major mechanism to change the genetic composition of the genome and even acquire new virulence factors. Type three secretion gene clusters of Psg strains are near identical with that of P. savastanoi pv. phaseolicola (Pph) strain 1448A and they shared 20 common effector genes. Furthermore, the coronatine biosynthetic cluster is present on a large plasmid in strain B076, but not in race 4. In silico subtractive hybridization-based comparative genomic analyses with nine sequenced phytopathogenic pseudomonads identified dozens of specific islands (SIs), and revealed that the genomes of Psg strains are more similar to those belonging to the same genomospecies such as Pph 1448A than to other phytopathogenic pseudomonads. The number of highly conserved genes (core genome) among them decreased dramatically when more genomes were included in the subtraction, suggesting the diversification of pseudomonads, and further indicating the genome heterogeneity among pseudomonads. However, the number of specific genes did not change significantly, suggesting these genes are indeed specific in Psg genomes. These results reinforce the idea of a species complex of P. syringae and support the reclassification of P. syringae into different species.	[Qi, Mingsheng; Wang, Dongping; Bradley, Carl A.; Zhao, Youfu] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Qi, MS (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	zhao888@illinois.edu	Qi, Mingsheng/G-8755-2013; Wang, Dongping/L-2124-2013	Bradley, Carl/0000-0002-8334-0750; Qi, Mingsheng/0000-0003-2448-1227	United States Department of Agriculture-National Institute of Food and Agriculture; Soybean Disease Biotechnology Center [ILLU-483-623, 483-612]; Illinois Soybean Association	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Soybean Disease Biotechnology Center; Illinois Soybean Association	This work was partially supported by United States Department of Agriculture-National Institute of Food and Agriculture special grant, Soybean Disease Biotechnology Center ILLU-483-623 and 483-612, and the Illinois Soybean Association. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Chaidez FJ, 2003, PLASMID, V49, P106, DOI 10.1016/S0147-619X(02)00155-5; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Ashfield T, 1998, THEOR APPL GENET, V96, P1013, DOI 10.1007/s001220050833; Ashfield T, 2004, PLANT CELL, V16, P309, DOI 10.1105/tpc.016725; Ashfield T, 2003, MOL PLANT MICROBE IN, V16, P817, DOI 10.1094/MPMI.2003.16.9.817; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; CROSS J. E., 1966, PLANT DB REPORT, V50, P557; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FETT WF, 1981, CAN J BOT, V59, P283, DOI 10.1139/b81-040; Gacesa P, 1998, MICROBIOL-SGM, V144, P1133, DOI 10.1099/00221287-144-5-1133; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; HETTWER U, 1995, J BACTERIOL, V177, P2834, DOI 10.1128/jb.177.10.2834-2839.1995; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Keith LW, 1997, MOL PLANT MICROBE IN, V10, P416, DOI 10.1094/MPMI.1997.10.3.416; KINSCHERF TG, 1991, J BACTERIOL, V173, P4124, DOI 10.1128/jb.173.13.4124-4132.1991; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lindeberg M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Ma ZH, 2007, APPL ENVIRON MICROB, V73, P1287, DOI 10.1128/AEM.01923-06; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Mellgren EM, 2009, J BACTERIOL, V191, P3132, DOI 10.1128/JB.01570-08; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mole BM, 2007, TRENDS MICROBIOL, V15, P363, DOI 10.1016/j.tim.2007.06.005; Morgan RL, 2010, MOL MICROBIOL, V76, P437, DOI 10.1111/j.1365-2958.2010.07107.x; NAGAHAMA K, 1994, MICROBIOL-UK, V140, P2309, DOI 10.1099/13500872-140-9-2309; NAGAHAMA K, 1991, J GEN MICROBIOL, V137, P2281, DOI 10.1099/00221287-137-10-2281; NAPOLI C, 1987, J BACTERIOL, V169, P572, DOI 10.1128/jb.169.2.572-578.1987; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Ong LE, 2006, MOL MICROBIOL, V60, P951, DOI 10.1111/j.1365-2958.2006.05162.x; Palleroni N., 1984, BERGEYS MANUAL SYSTE, VVolume 1, P141; PARK EW, 1986, PLANT DIS, V70, P214, DOI 10.1094/PD-70-214; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Penaloza-Vazquez A, 2004, MICROBIOL-SGM, V150, P2727, DOI 10.1099/mic.0.27199-0; Perez-Martinez I, 2008, J BACTERIOL, V190, P625, DOI 10.1128/JB.01067-07; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Prom LK, 1997, PLANT DIS, V81, P541, DOI 10.1094/PDIS.1997.81.5.541; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Rohde BH, 1999, J BACTERIOL, V181, P814, DOI 10.1128/JB.181.3.814-822.1999; Rohmer L, 2003, MOL MICROBIOL, V47, P1545, DOI 10.1046/j.1365-2958.2003.03402.x; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sato M, 1997, PHYTOPATHOLOGY, V87, P1192, DOI 10.1094/PHYTO.1997.87.12.1192; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schenk A, 2006, J BACTERIOL, V188, P8013, DOI 10.1128/JB.01160-06; Shao YC, 2010, NUCLEIC ACIDS RES, V38, pW194, DOI 10.1093/nar/gkq326; Siegel SP, 2008, PHYTOPATHOLOGY, V98, pS146; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; STASKAWICZ BJ, 1984, P NATL ACAD SCI-BIOL, V81, P6024, DOI 10.1073/pnas.81.19.6024; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Sundin GW, 2004, MOL GENET GENOMICS, V270, P462, DOI 10.1007/s00438-003-0945-9; TAMAKI S, 1988, J BACTERIOL, V170, P4846, DOI 10.1128/jb.170.10.4846-4854.1988; TAMAKI SJ, 1991, J BACTERIOL, V173, P301, DOI 10.1128/jb.173.1.301-307.1991; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Vinatzer Boris A, 2007, Methods Mol Biol, V354, P19; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Wrather JA, 2009, PLANT HLTH PROG, DOI [10.1094/PHP-2009-0401-01-RS, DOI 10.1094/PHP-2009-0401-01-RS]; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Young J. M., 1996, Review of Plant Pathology, V75, P721; Yu J, 1999, MOL MICROBIOL, V33, P712, DOI 10.1046/j.1365-2958.1999.01516.x; Zhao YF, 2005, J BACTERIOL, V187, P2113, DOI 10.1128/JB.187.6.2113-2126.2005; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zhou HB, 2009, MOL PLANT MICROBE IN, V22, P176, DOI 10.1094/MPMI-22-2-0176	89	46	49	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16451	10.1371/journal.pone.0016451	http://dx.doi.org/10.1371/journal.pone.0016451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304594	Green Submitted, Green Published, gold			2022-12-27	WOS:000286663900051
J	Zhong, L; Wang, DQ; Gan, XN; Yang, T; He, SP				Zhong, Lei; Wang, Dengqiang; Gan, Xiaoni; Yang, Tong; He, Shunping			Parallel Expansions of Sox Transcription Factor Group B Predating the Diversifications of the Arthropods and Jawed Vertebrates	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE FAMILY; MOLECULAR PHYLOGENY; DIVERGENCE TIMES; DOMAIN PROTEINS; ORIGIN; EXPRESSION; EVOLUTION; DICHAETE; DUPLICATION	Group B of the Sox transcription factor family is crucial in embryo development in the insects and vertebrates. Sox group B, unlike the other Sox groups, has an unusually enlarged functional repertoire in insects, but the timing and mechanism of the expansion of this group were unclear. We collected and analyzed data for Sox group B from 36 species of 12 phyla representing the major metazoan clades, with an emphasis on arthropods, to reconstruct the evolutionary history of SoxB in bilaterians and to date the expansion of Sox group B in insects. We found that the genome of the bilaterian last common ancestor probably contained one SoxB1 and one SoxB2 gene only and that tandem duplications of SoxB2 occurred before the arthropod diversification but after the arthropod-nematode divergence, resulting in the basal repertoire of Sox group B in diverse arthropod lineages. The arthropod Sox group B repertoire expanded differently from the vertebrate repertoire, which resulted from genome duplications. The parallel increases in the Sox group B repertoires of the arthropods and vertebrates are consistent with the parallel increases in the complexity and diversification of these two important organismal groups.	[Zhong, Lei; Wang, Dengqiang; Gan, Xiaoni; Yang, Tong; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Zhong, Lei; Wang, Dengqiang; Gan, Xiaoni] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhong, L (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.	clad@ihb.ac.cn			National Natural Science Foundation of China [30530120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant No. 30530120 from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; [Anonymous], 2007, TREE LIFE WEB PROJEC; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; Chipman AD, 2010, BIOESSAYS, V32, P60, DOI 10.1002/bies.200900130; Cremazy F, 2001, MECH DEVELOP, V109, P371, DOI 10.1016/S0925-4773(01)00529-9; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gabriel WN, 2007, DEV GENES EVOL, V217, P421, DOI 10.1007/s00427-007-0152-5; Galay-Burgos M, 2004, COMP BIOCHEM PHYS B, V137, P279, DOI 10.1016/j.cbpc.2003.12.002; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Graves JAM, 2002, TRENDS GENET, V18, P259, DOI 10.1016/S0168-9525(02)02666-5; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Hedges S. Blair, 2009, P383; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jager M, 2006, MOL PHYLOGENET EVOL, V39, P468, DOI 10.1016/j.ympev.2005.12.005; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kamachi Y, 1999, MOL CELL BIOL, V19, P107; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koopman P, 2004, GENE, V328, P177, DOI 10.1016/j.gene.2003.12.008; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Kuroiwa A, 2002, CYTOGENET GENOME RES, V98, P189, DOI 10.1159/000069803; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Leveugle M, 2004, J MOL EVOL, V58, P168, DOI 10.1007/s00239-003-2538-y; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; McKimmie C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-26; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Meulemans D, 2007, INT J BIOL SCI, V3, P356; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Ohno S, 1999, CELL MOL LIFE SCI, V55, P824, DOI 10.1007/s000180050336; Ohno S., 1970, P1; Overton PM, 2007, DEVELOPMENT, V134, P2807, DOI 10.1242/dev.02878; Overton PM, 2002, DEVELOPMENT, V129, P4219; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Phochanukul N, 2010, INT J BIOCHEM CELL B, V42, P453, DOI 10.1016/j.biocel.2009.06.013; Pioro HL, 2006, DEV GENES EVOL, V216, P417, DOI 10.1007/s00427-006-0078-3; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Russell SRH, 1996, DEVELOPMENT, V122, P3669; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sanchez-Soriano N, 2000, DEV BIOL, V220, P307, DOI 10.1006/dbio.2000.9648; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shinzato C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-311; Soriano NS, 1998, DEVELOPMENT, V125, P3989; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Taguchi S, 2002, ZOOL SCI, V19, P57, DOI 10.2108/zsj.19.57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Weiss J, 2003, MOL CELL BIOL, V23, P8084, DOI 10.1128/MCB.23.22.8084-8091.2003; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wilson MJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-120; Yang Tong, 2007, Acta Zootaxonomica Sinica, V32, P890; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	69	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16570	10.1371/journal.pone.0016570	http://dx.doi.org/10.1371/journal.pone.0016570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305035	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900075
J	Dzialak, MR; Harju, SM; Osborn, RG; Wondzell, JJ; Hayden-Wing, LD; Winstead, JB; Webb, SL				Dzialak, Matthew R.; Harju, Seth M.; Osborn, Robert G.; Wondzell, John J.; Hayden-Wing, Larry D.; Winstead, Jeffrey B.; Webb, Stephen L.			Prioritizing Conservation of Ungulate Calving Resources in Multiple-Use Landscapes	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; WINTER HABITAT SELECTION; PREDATION RISK; FUNCTIONAL-RESPONSES; GROUP-SIZE; MULE DEER; ELK; DISTURBANCE; STRATEGIES; MOVEMENTS	Background: Conserving animal populations in places where human activity is increasing is an ongoing challenge in many parts of the world. We investigated how human activity interacted with maternal status and individual variation in behavior to affect reliability of spatially-explicit models intended to guide conservation of critical ungulate calving resources. We studied Rocky Mountain elk (Cervus elaphus) that occupy a region where 2900 natural gas wells have been drilled. Methodology/Principal Findings: We present novel applications of generalized additive modeling to predict maternal status based on movement, and of random-effects resource selection models to provide population and individual-based inference on the effects of maternal status and human activity. We used a 2x2 factorial design (treatment vs. control) that included elk that were either parturient or non-parturient and in areas either with or without industrial development. Generalized additive models predicted maternal status (parturiency) correctly 93% of the time based on movement. Human activity played a larger role than maternal status in shaping resource use; elk showed strong spatiotemporal patterns of selection or avoidance and marked individual variation in developed areas, but no such pattern in undeveloped areas. This difference had direct consequences for landscape-level conservation planning. When relative probability of use was calculated across the study area, there was disparity throughout 72-88% of the landscape in terms of where conservation intervention should be prioritized depending on whether models were based on behavior in developed areas or undeveloped areas. Model validation showed that models based on behavior in developed areas had poor predictive accuracy, whereas the model based on behavior in undeveloped areas had high predictive accuracy. Conclusions/Significance: By directly testing for differences between developed and undeveloped areas, and by modeling resource selection in a random-effects framework that provided individual-based inference, we conclude that: 1) amplified selection or avoidance behavior and individual variation, as responses to increasing human activity, complicate conservation planning in multiple-use landscapes, and 2) resource selection behavior in places where human activity is predictable or less dynamic may provide a more reliable basis from which to prioritize conservation action.	[Dzialak, Matthew R.; Harju, Seth M.; Osborn, Robert G.; Wondzell, John J.; Hayden-Wing, Larry D.; Winstead, Jeffrey B.; Webb, Stephen L.] Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA		Dzialak, MR (corresponding author), Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA.	matt@haydenwing.com	Webb, Stephen L./B-6473-2009	Webb, Stephen L./0000-0001-6034-5164	Pioneer Natural Resources Company; Hayden-Wing Associates, LLC	Pioneer Natural Resources Company; Hayden-Wing Associates, LLC	Pioneer Natural Resources Company funded this work. Hayden-Wing Associates, LLC provided in-kind contributions including travel costs associated with dissemination of this work, and materials associated with data collection and analysis including radio-telemetry equipment, GPS devices, and statistical analysis software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, J WILDLIFE MANAGE, V69, P298, DOI 10.2193/0022-541X(2005)069&lt;0298:SSRSBR&gt;2.0.CO;2; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; BECK N, 1997, GETTING MEAN RIGHT G; Bernardo J, 1996, AM ZOOL, V36, P83; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bowyer RT, 1999, J MAMMAL, V80, P1070, DOI 10.2307/1383161; Bowyer RT, 1998, J MAMMAL, V79, P415, DOI 10.2307/1382972; CAMERON RD, 1992, ARCTIC, V45, P338; CLUTTONBROCK TH, 1975, BEHAVIOUR, V55, P287, DOI 10.1163/156853975X00506; Cowie G. M., 1985, Proceedings of a Deer Course for Veterinarians, Ashburton, July 1985., P143; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Edge W. D., 1991, P ELK VULN S MONT ST, P132; EDGE WD, 1985, J WILDLIFE MANAGE, V49, P926, DOI 10.2307/3801372; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Fortin D, 2008, J APPL ECOL, V45, P1392, DOI 10.1111/j.1365-2664.2008.01542.x; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Franke A, 2006, ECOL MODEL, V197, P237, DOI 10.1016/j.ecolmodel.2006.02.043; Friar J. L., 2008, J APPL ECOL, V45, P1504; Frid A, 2002, CONSERV ECOL, V6; Geist Valerius, 2002, P389; GILLESPIE RG, 1987, ECOLOGY, V68, P887, DOI 10.2307/1938360; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; HEMBORG HT, 1998, COLORADO GEOLOGICAL, V33; Hudson Robert J., 2002, P199; JOHNSON DE, 1951, J WILDLIFE MANAGE, V15, P396, DOI 10.2307/3796583; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; Kittle AM, 2008, OECOLOGIA, V157, P163, DOI 10.1007/s00442-008-1051-9; Long RA, 2009, WILDLIFE BIOL, V15, P288, DOI 10.2981/09-003; Manly B.F.J., 2002, RESOURCE SELECTION A; Manor R, 2003, ECOL APPL, V13, P1830, DOI 10.1890/01-5354; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; MORRISON JR, 1995, WILDLIFE SOC B, V23, P481; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Noyes JH, 1997, WILDLIFE SOC B, V25, P695; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; Poole KG, 2007, J MAMMAL, V88, P139, DOI 10.1644/06-MAMM-A-127R1.1; Potvin MJ, 2005, J WILDLIFE MANAGE, V69, P1660, DOI 10.2193/0022-541X(2005)69[1660:MAHAFW]2.0.CO;2; QUIMBY DON C., 1957, JOUR WILDLIFE MANAGEMENT, V21, P435, DOI 10.2307/3796676; Rowland MM, 2000, J WILDLIFE MANAGE, V64, P672, DOI 10.2307/3802737; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Singer FJ, 1997, J WILDLIFE MANAGE, V61, P12, DOI 10.2307/3802410; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P404, DOI 10.2193/0022-541X(2006)70[404:ABREDM]2.0.CO;2; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; Vander Wal E., 2009, J WILDLIFE MANAGE, V73, P1189; Vitt A., 2007, TRINCHERA DATA ANAL; Vore JM, 2001, WILDLIFE SOC B, V29, P720; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1; Winter AG, 2006, ICES J MAR SCI, V63, P1118, DOI 10.1016/j.icesjms.2006.03.014; Yuan LL, 2004, FRESHWATER BIOL, V49, P662, DOI 10.1111/j.1365-2427.2004.01206.x	64	38	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14597	10.1371/journal.pone.0014597	http://dx.doi.org/10.1371/journal.pone.0014597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297866	Green Submitted, Green Published, gold			2022-12-27	WOS:000286662800008
J	Tzur, A; Moore, JK; Jorgensen, P; Shapiro, HM; Kirschner, MW				Tzur, Amit; Moore, Jodene K.; Jorgensen, Paul; Shapiro, Howard M.; Kirschner, Marc W.			Optimizing Optical Flow Cytometry for Cell Volume-Based Sorting and Analysis	PLOS ONE			English	Article							GROWTH; SIZE; YEAST; CYCLE	Cell size is a defining characteristic central to cell function and ultimately to tissue architecture. The ability to sort cell subpopulations of different sizes would facilitate investigation at genomic and proteomic levels of mechanisms by which cells attain and maintain their size. Currently available cell sorters, however, cannot directly measure cell volume electronically, and it would therefore be desirable to know which of the optical measurements that can be made in such instruments provide the best estimate of volume. We investigated several different light scattering and fluorescence measurements in several different cell lines, sorting cell fractions from the high and low end of distributions, and measuring volume electronically to determine which sorting strategy yielded the best separated volume distributions. Since we found that different optical measurements were optimal for different cell lines, we suggest that following this procedure will enable other investigators to optimize their own cell sorters for volume-based separation of the cell types with which they work.	[Tzur, Amit; Moore, Jodene K.; Jorgensen, Paul; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Tzur, Amit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci & Adv Mat, Ramat Gan, Israel; [Tzur, Amit] Bar Ilan Univ, Nanotechnol Inst, Ramat Gan, Israel; [Jorgensen, Paul] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Shapiro, Howard M.] Ctr Microbial Cytometry & Howard M Shapiro, W Newton, MA USA	Harvard University; Harvard Medical School; Bar Ilan University; Bar Ilan University; University of Toronto	Tzur, A (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu			NIH [RO1 GM02875]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH; RO1 GM02875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER RS, 1952, NATURE, V169, P200, DOI 10.1038/169200a0; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Givan A. L., 2001, FLOW CYTOMETRY 1 PRI; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Hoffman RA, 2009, CURR PROTOC CYTOM; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; MULLANEY PF, 1969, REV SCI INSTRUM, V40, P1029, DOI 10.1063/1.1684143; NAKAZAKI M, 1983, J CHEM SOC CHEM COMM, P787, DOI 10.1039/c39830000787; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; STEEN HB, 1980, CYTOMETRY, V1, P26, DOI 10.1002/cyto.990010107; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; van Munster EB, 2002, CYTOMETRY, V47, P192, DOI 10.1002/cyto.10064; Watson JV, 1991, INTRO FLOW CYTOMETRY	19	124	131	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16053	10.1371/journal.pone.0016053	http://dx.doi.org/10.1371/journal.pone.0016053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283800	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200025
J	Choileain, SN; Weyand, NJ; Neumann, C; Thomas, J; So, M; Astier, AL				Choileain, Siobhan Ni; Weyand, Nathan J.; Neumann, Christian; Thomas, Joelle; So, Magdalene; Astier, Anne L.			The Dynamic Processing of CD46 Intracellular Domains Provides a Molecular Rheostat for T Cell Activation	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; EXPRESSION; CTLA-4; SIGNAL; MCP; PHOSPHORYLATION; COSTIMULATION; INDUCTION	Background: Adequate termination of an immune response is as important as the induction of an appropriate response. CD46, a regulator of complement activity, promotes T cell activation and differentiation towards a regulatory Tr1 phenotype. This Tr1 differentiation pathway is defective in patients with MS, asthma and rheumatoid arthritis, underlying its importance in controlling T cell function and the need to understand its regulatory mechanisms. CD46 has two cytoplasmic tails, Cyt1 and Cyt2, derived from alternative splicing, which are co-expressed in all nucleated human cells. The regulation of their expression and precise functions in regulating human T cell activation has not been fully elucidated. Methodology/Principal Findings: Here, we first report the novel role of CD46 in terminating T cell activation. Second, we demonstrate that its functions as an activator and inhibitor of T cell responses are mediated through the temporal processing of its cytoplasmic tails. Cyt1 processing is required to turn T cell activation on, while processing of Cyt2 switches T cell activation off, as demonstrated by proliferation, CD25 expression and cytokine secretion. Both tails require processing by Presenilin/gamma Secretase (P/gamma S) to exert these functions. This was confirmed by expressing wild-type Cyt1 and Cyt2 tails and uncleavable mutant tails in primary T cells. The role of CD46 tails was also demonstrated with T cells expressing CD19 ectodomain-CD46 C-Terminal Fragment (CTF) fusions, which allowed specific triggering of each tail individually. Conclusions/Significance: We conclude that CD46 acts as a molecular rheostat to control human T cell activation through the regulation of processing of its cytoplasmic tails.	[Choileain, Siobhan Ni; Neumann, Christian; Astier, Anne L.] Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Choileain, Siobhan Ni; Neumann, Christian; Astier, Anne L.] Univ Edinburgh, Queens Med Res Inst, Ctr Multiple Sclerosis Res, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Weyand, Nathan J.; So, Magdalene] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Weyand, Nathan J.; So, Magdalene] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Thomas, Joelle] Univ Lyon 1, CNRS, UMR5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France	University of Edinburgh; University of Edinburgh; University of Arizona; University of Arizona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Choileain, SN (corresponding author), Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	a.astier@ed.ac.uk	So, Magdalene/ABB-8918-2020; Astier, Anne L/A-1641-2008	Astier, Anne L/0000-0002-0144-3431; So, Magdalene/0000-0001-8301-0674; Thomas, Joelle/0000-0002-0461-6131	Multiple Sclerosis Society [859/07]	Multiple Sclerosis Society(National Multiple Sclerosis Society)	These studies were supported by a research grant to ALA from the Multiple Sclerosis Society (859/07) (www.mssociety.org.uk.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2007, J NEUROIMMUNOL, V191, P70, DOI 10.1016/j.jneuroim.2007.09.018; Astier AL, 2008, IMMUNOLOGY, V124, P149, DOI 10.1111/j.1365-2567.2008.02821.x; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cobbold SP, 2010, IMMUNOL REV, V236, P203, DOI 10.1111/j.1600-065X.2010.00913.x; Cole DS, 2006, MOL IMMUNOL, V43, P1953, DOI 10.1016/j.molimm.2005.11.015; Crimeen-Irwin B, 2003, J BIOL CHEM, V278, P46927, DOI 10.1074/jbc.M308261200; Ferber IA, 1996, J IMMUNOL, V156, P5; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; Hedrick SM, 2010, IMMUNOL REV, V236, P41, DOI 10.1111/j.1600-065X.2010.00918.x; JOHNSTONE RW, 1993, MOL IMMUNOL, V30, P1231, DOI 10.1016/0161-5890(93)90038-D; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; LUBLIN DM, 1988, J EXP MED, V168, P181, DOI 10.1084/jem.168.1.181; Ma AL, 2009, INT IMMUNOPHARMACOL, V9, P599, DOI 10.1016/j.intimp.2009.01.034; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Marrack P, 2010, IMMUNOL REV, V236, P5, DOI 10.1111/j.1600-065X.2010.00928.x; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; Meiffren G, 2006, J IMMUNOL, V177, P4957, DOI 10.4049/jimmunol.177.8.4957; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Oliaro J, 2006, P NATL ACAD SCI USA, V103, P18685, DOI 10.1073/pnas.0602458103; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; RUSSELL SM, 1992, TRANSPLANT P, V24, P2329; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Seya T, 1999, INT J BIOCHEM CELL B, V31, P1255, DOI 10.1016/S1357-2725(99)00092-8; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Tiroch K, 2002, J IMMUNOL, V168, P3275, DOI 10.4049/jimmunol.168.7.3275; Vaknin-Dembinsky A, 2008, J NEUROIMMUNOL, V195, P140, DOI 10.1016/j.jneuroim.2008.01.002; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; Weyand NJ, 2010, J IMMUNOL, V184, P694, DOI 10.4049/jimmunol.0900522; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Xu YQ, 2010, J ASTHMA, V47, P367, DOI 10.3109/02770903.2010.481340; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780	41	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16287	10.1371/journal.pone.0016287	http://dx.doi.org/10.1371/journal.pone.0016287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283821	Green Submitted, Green Published, gold			2022-12-27	WOS:000286520600038
J	Bo, M; Bertolino, M; Borghini, M; Castellano, M; Harriague, AC; Di Camillo, CG; Gasparini, G; Misic, C; Povero, P; Pusceddu, A; Schroeder, K; Bavestrello, G				Bo, Marzia; Bertolino, Marco; Borghini, Mireno; Castellano, Michela; Harriague, Anabella Covazzi; Di Camillo, Cristina Gioia; Gasparini, GianPietro; Misic, Cristina; Povero, Paolo; Pusceddu, Antonio; Schroeder, Katrin; Bavestrello, Giorgio			Characteristics of the Mesophotic Megabenthic Assemblages of the Vercelli Seamount (North Tyrrhenian Sea)	PLOS ONE			English	Article							COMMUNITIES; ECOLOGY; KELP; FAUNA; ENDEMISM; PACIFIC; IMPACTS; BIOLOGY; BIOTA; FOOD	The biodiversity of the megabenthic assemblages of the mesophotic zone of a Tyrrhenian seamount (Vercelli Seamount) is described using Remotely Operated Vehicle (ROV) video imaging from 100 m depth to the top of the mount around 61 m depth. This pinnacle hosts a rich coralligenous community characterized by three different assemblages: (i) the top shows a dense covering of the kelp Laminaria rodriguezii; (ii) the southern side biocoenosis is mainly dominated by the octocorals Paramuricea clavata and Eunicella cavolinii; while (iii) the northern side of the seamount assemblage is colonized by active filter-feeding organisms such as sponges (sometimes covering 100% of the surface) with numerous colonies of the ascidian Diazona violacea, and the polychaete Sabella pavonina. This study highlights, also for a Mediterranean seamount, the potential role of an isolated rocky peak penetrating the euphotic zone, to work as an aggregating structure, hosting abundant benthic communities dominated by suspension feeders, whose distribution may vary in accordance to the geomorphology of the area and the different local hydrodynamic conditions.	[Bo, Marzia; Bertolino, Marco; Di Camillo, Cristina Gioia; Pusceddu, Antonio; Bavestrello, Giorgio] Univ Politecn Marche, Ancona, Italy; [Castellano, Michela; Harriague, Anabella Covazzi; Misic, Cristina; Povero, Paolo] Univ Genoa, Genoa, Italy; [Borghini, Mireno; Gasparini, GianPietro; Schroeder, Katrin] CNR, ISMRA, Sez La Spezia, Pozzuolo Di Lerici, Italy	Marche Polytechnic University; University of Genoa; Consiglio Nazionale delle Ricerche (CNR)	Bo, M (corresponding author), Univ Politecn Marche, Ancona, Italy.	m.bo@univpm.it	Galparsoro, Ibon/B-8386-2009; Di Camillo, Cristina/AAI-5960-2021; Schroeder, Katrin/C-7490-2009; CNR, Ismar/P-1247-2014	Galparsoro, Ibon/0000-0002-5031-525X; Schroeder, Katrin/0000-0001-7991-9121; Bo, Marzia/0000-0001-8400-6722; COVAZZI HARRIAGUE, Sandra Anabella/0000-0003-0378-5395; Di Camillo, Cristina/0000-0002-4031-8158; MISIC, CRISTINA/0000-0002-2577-1800; CNR, Ismar/0000-0001-5351-1486; Castellano, Michela/0000-0001-6101-0112; BERTOLINO, Marco/0000-0003-3233-303X	Italian Ministry of Research and Instruction; Global Census of Marine Life on Seamounts (CenSeam, New Zealand)	Italian Ministry of Research and Instruction; Global Census of Marine Life on Seamounts (CenSeam, New Zealand)	This work was undertaken within the PRIN (Progetti di Rilevante Interesse Nazionale) project Tyrrhenian Seamounts ecosystems: an Integrated Study (TySEc) financed by the Italian Ministry of Research and Instruction and by the Global Census of Marine Life on Seamounts (CenSeam, New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R., 2009, P 1 MED S CONS COR O, P147; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2002, MEDATLAS; ARTALE V, 1994, J GEOPHYS RES-OCEANS, V99, P14127, DOI 10.1029/94JC00284; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Barberi F., 1978, INITIAL REPORTS DEEP, V42, P509, DOI 10.2973/ dsdp.proc.42-1.118.1978; Barberi M, 1989, MEM SOC GEOL ITAL, V36, P41; BEDFORD AP, 1984, ESTUAR COAST SHELF S, V18, P97, DOI 10.1016/0272-7714(84)90009-X; Bernardino AF, 2010, DEEP-SEA RES PT I, V57, P708, DOI 10.1016/j.dsr.2010.03.004; BERRILL NJ, 1948, J MAR BIOL ASSOC UK, V27, P389, DOI 10.1017/S0025315400025443; BERRISFORD C D, 1969, Transactions of the Royal Society of South Africa, V38, P387; BIRKELAND C, 1971, Northwest Science, V45, P193; BLANC J, 1967, ANN I OCEANOGR PARIS, V45, P257; Blanc JJ, 1964, ANN I OCEANOGR PARIS, V4, P219; Bo M, 2011, ITAL J ZOOL, V78, P231, DOI 10.1080/11250001003652619; Bo M, 2009, MAR ECOL PROG SER, V397, P53, DOI 10.3354/meps08185; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; Budillon G, 2009, DEEP-SEA RES PT II, V56, P713, DOI 10.1016/j.dsr2.2008.07.027; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Cecere E, 1988, OEBALIA, V14, P43; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Duggins DO, 1997, MAR BIOL, V128, P489, DOI 10.1007/s002270050115; Fava F., 2007, Biologia Marina Mediterranea, V14, P180; Galil Bella, 1998, Senckenbergiana Maritima, V28, P111; Gallignani P, 1973, GIOR GEO, V2, P1; Genesseaux M, 1986, CR HEBD ACAD SCI, V302, P785; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GENIN A, 1992, DEEP-SEA RES, V39, P293, DOI 10.1016/0198-0149(92)90110-F; Genin Amatzia, 2007, Fish and Aquatic Resources Series, V12, P85; Giaccone G, 1967, NOVA THALASSIA, V3, P1; Giaccone Giuseppe, 1997, Lagascalia, V19, P129; Hall-Spencer J, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P135; Harmelin Jean-Georges, 1995, Marine Life, V4, P5; KENSLEY B, 1980, Annals of the South African Museum, V83, P13; Kitchingman A., 2007, SEAMOUNTS ECOLOGY FI, V12, P26, DOI DOI 10.1002/9780470691953.CH2; Koslow JA, 1997, AM SCI, V85, P168; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; LUNING K, 1982, SYNTHETIC DEGRADATIV, P47; Massuti E, 2005, SCI MAR, V69, P167, DOI 10.3989/scimar.2005.69n1167; Matsumoto AK, 2005, ERLANGEN EARTH CONF, P345, DOI 10.1007/3-540-27673-4_17; Matsumoto AK, 2010, MAR ECOL PROG SER, V399, P81, DOI 10.3354/meps08392; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; McDaniel N., 2003, BIOL OBSERVATIONS BO; Mistri M, 1996, ITAL J ZOOL, V63, P221, DOI 10.1080/11250009609356137; Nair R, 1994, P 10 S IT ASS LIMN O, P65; Norderhaug KM, 2003, MAR ECOL PROG SER, V255, P135, DOI 10.3354/meps255135; OCEANA, 2005, FOND ERMENEGILDO ZEG, V72, DOI [10.1016/0038-092X(86)90130-1, DOI 10.1016/0038-092X(86)90130-1]; Panetta P., 1985, Oebalia, V11, P767; Parin NV, 1997, ADV MAR BIOL, V32, P145; PARKER T, 1994, BIOL BULL-US, V187, P336, DOI 10.2307/1542290; PERRONE A, 1985, J MOLLUS STUD, V51, P102, DOI 10.1093/oxfordjournals.mollus.a065878; Piepenburg D, 2004, ARCH FISH MAR RES, V51, P55; RAYMORE PA, 1982, PAC SCI, V36, P15; Robin C, 1986, CR HEBD ACAD SCI, V303, P1165; Rogers A.D., 2007, SEAMOUNTS ECOLOGY FI, P3343; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Sara M., 1987, NATO ASI Series Series G Ecological Sciences, V13, P205; Schaal G, 2010, J SEA RES, V63, P24, DOI 10.1016/j.seares.2009.09.002; Strusi A., 1985, Oebalia, V11, P379; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Tzetlin AB, 2007, HYDROBIOLOGIA, V355, P91; UCHUPI E, 1989, DEEP-SEA RES, V36, P1443, DOI 10.1016/0198-0149(89)90094-0; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; UNEP, 2003, WHIT COR COMM CAN SE; VARNAVAS SP, 1988, MAR GEOL, V81, P205, DOI 10.1016/0025-3227(88)90027-8; Vetrano A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005680; Wilson RR, 1987, GEOPHYS MONOGR SER, P355, DOI DOI 10.1029/GM043P0355; Zhuleva EV, 1988, OCEANOL, V27, P808	77	106	107	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16357	10.1371/journal.pone.0016357	http://dx.doi.org/10.1371/journal.pone.0016357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304906	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600007
J	Chi, RP; Snyder, AW				Chi, Richard P.; Snyder, Allan W.			Facilitate Insight by Non-Invasive Brain Stimulation	PLOS ONE			English	Article							TRANSCRANIAL DC STIMULATION; EXCITABILITY CHANGES; MOTOR CORTEX; LESIONS; PEOPLE; SKILLS; PLASTICITY; HEMISPHERE; HANDEDNESS; RESPONSES	Our experiences can blind us. Once we have learned to solve problems by one method, we often have difficulties in generating solutions involving a different kind of insight. Yet there is evidence that people with brain lesions are sometimes more resistant to this so-called mental set effect. This inspired us to investigate whether the mental set effect can be reduced by non-invasive brain stimulation. 60 healthy right-handed participants were asked to take an insight problem solving task while receiving transcranial direct current stimulation (tDCS) to the anterior temporal lobes (ATL). Only 20% of participants solved an insight problem with sham stimulation (control), whereas 3 times as many participants did so (p = 0.011) with cathodal stimulation (decreased excitability) of the left ATL together with anodal stimulation (increased excitability) of the right ATL. We found hemispheric differences in that a stimulation montage involving the opposite polarities did not facilitate performance. Our findings are consistent with the theory that inhibition to the left ATL can lead to a cognitive style that is less influenced by mental templates and that the right ATL may be associated with insight or novel meaning. Further studies including neurophysiological imaging are needed to elucidate the specific mechanisms leading to the enhancement.	[Chi, Richard P.; Snyder, Allan W.] Univ Sydney, Ctr Mind, Sydney, NSW 2006, Australia	University of Sydney	Chi, RP (corresponding author), Univ Sydney, Ctr Mind, Sydney, NSW 2006, Australia.	allan@centreforthemind.com						Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Bell V, 2007, CORTEX, V43, P551, DOI 10.1016/S0010-9452(08)70249-1; Bilalic M, 2010, CURR DIR PSYCHOL SCI, V19, P111, DOI 10.1177/0963721410363571; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V43, P623, DOI 10.1037/0022-3514.43.3.623; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Chaumon M, 2009, BRAIN RES, V1285, P77, DOI 10.1016/j.brainres.2009.05.087; Christman SD, 2008, LATERALITY, V13, P403, DOI 10.1080/13576500802079646; Christman SD, 2007, INT J EAT DISORDER, V40, P247, DOI 10.1002/eat.20357; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gainotti G, 2007, NEUROPSYCHOLOGIA, V45, P1591, DOI 10.1016/j.neuropsychologia.2006.12.013; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gilovich T., 1991, WE KNOW WHAT ISNT SO; GOLDBERG E, 1994, J NEUROPSYCH CLIN N, V6, P371; Goldberg E., 2001, EXECUTIVE BRAIN FRON; GREGORY RL, 1980, PHILOS T ROY SOC B, V290, P181, DOI 10.1098/rstb.1980.0090; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Kinsbourne M, 1977, Adv Neurol, V18, P41; Kounios J, 2009, CURR DIR PSYCHOL SCI, V18, P210, DOI 10.1111/j.1467-8721.2009.01638.x; Kuhn T., 1970, STRUCTURE SCI REVOLU; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Madhavan S, 2010, BRAIN STIMUL, V3, P42, DOI 10.1016/j.brs.2009.06.005; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Maynard J., 1936, GEN THEORY EMPLOYMEN; Mendez MF, 2004, MED HYPOTHESES, V63, P1, DOI 10.1016/j.mehy.2004.03.002; Miller BL, 1998, NEUROLOGY, V51, P978, DOI 10.1212/WNL.51.4.978; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Mummery CJ, 2000, ANN NEUROL, V47, P36; Nitsche MA, 2006, EUR J NEUROSCI, V23, P1651, DOI 10.1111/j.1460-9568.2006.04676.x; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Ollinger M, 2008, EXP PSYCHOL, V55, P269, DOI 10.1027/1618-3169.55.4.269; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2006, PROG BRAIN RES, V157, P315, DOI 10.1016/S0079-6123(06)57019-0; Pobric G, 2008, J COGNITIVE NEUROSCI, V20, P170, DOI 10.1162/jocn.2008.20005; Ramachandran V.S., 1998, PHANTOMS BRAIN HUMAN; RAUSCH R, 1977, NEUROPSYCHOLOGIA, V15, P385, DOI 10.1016/0028-3932(77)90090-2; Reverberi C, 2005, BRAIN, V128, P2882, DOI 10.1093/brain/awh577; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Sadleir RJ, 2010, NEUROIMAGE, V51, P1310, DOI 10.1016/j.neuroimage.2010.03.052; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Snyder A, 2006, PERCEPTION, V35, P837, DOI 10.1068/p5539; Snyder Allan, 2004, Journal of Integrative Neuroscience, V3, P31, DOI 10.1142/S0219635204000361; Snyder A, 2009, PHILOS T R SOC B, V364, P1399, DOI 10.1098/rstb.2008.0290; Snyder Allan W, 2003, J Integr Neurosci, V2, P149, DOI 10.1142/S0219635203000287; Snyder AW, 1999, P ROY SOC B-BIOL SCI, V266, P587, DOI 10.1098/rspb.1999.0676; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Tetlock PE, 2005, EXPERT POLITICAL JUDGMENT: HOW GOOD IS IT, HOW CAN WE KNOW, P1; Treffert DA, 2009, PHILOS T R SOC B, V364, P1351, DOI 10.1098/rstb.2008.0326; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Wolford G, 2000, J NEUROSCI, V20, part. no.; Young RL, 2004, NEUROCASE, V10, P215, DOI 10.1080/13554790490495140	60	95	103	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16655	10.1371/journal.pone.0016655	http://dx.doi.org/10.1371/journal.pone.0016655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311746	gold, Green Published			2022-12-27	WOS:000287036200029
J	Nexo, BA; Christensen, T; Frederiksen, J; Moller-Larsen, A; Oturai, AB; Villesen, P; Hansen, B; Nissen, KK; Laska, MJ; Petersen, TS; Bonnesen, S; Hedemand, A; Wu, TT; Wang, XJ; Zhang, XQ; Brudek, T; Maric, R; Sondergaard, HB; Sellebjerg, F; Brusgaard, K; Kjeldbjerg, AL; Rasmussen, HB; Nielsen, AL; Nyegaard, M; Petersen, T; Borglum, AD; Pedersen, FS				Nexo, Bjorn A.; Christensen, Tove; Frederiksen, Jette; Moller-Larsen, Anne; Oturai, Annette B.; Villesen, Palle; Hansen, Bettina; Nissen, Kari K.; Laska, Magdalena J.; Petersen, Trine S.; Bonnesen, Sandra; Hedemand, Anne; Wu, Tingting; Wang, Xinjie; Zhang, Xiuqing; Brudek, Tomasz; Maric, Romana; Sondergaard, Helle B.; Sellebjerg, Finn; Brusgaard, Klaus; Kjeldbjerg, Anders L.; Rasmussen, Henrik B.; Nielsen, Anders L.; Nyegaard, Mette; Petersen, Thor; Borglum, Anders D.; Pedersen, Finn S.			The Etiology of Multiple Sclerosis: Genetic Evidence for the Involvement of the Human Endogenous Retrovirus HERV-Fc1	PLOS ONE			English	Article							VIRUS; ASSOCIATION; INFECTION	We have investigated the role of human endogenous retroviruses in multiple sclerosis by analyzing the DNA of patients and controls in 4 cohorts for associations between multiple sclerosis and polymorphisms near viral restriction genes or near endogenous retroviral loci with one or more intact or almost-intact genes. We found that SNPs in the gene TRIM5 were inversely correlated with disease. Conversely, SNPs around one retroviral locus, HERV-Fc1, showed a highly significant association with disease. The latter association was limited to a narrow region that contains no other known genes. We conclude that HERV-Fc1 and TRIM5 play a role in the etiology of multiple sclerosis. If these results are confirmed, they point to new modes of treatment for multiple sclerosis.	[Nexo, Bjorn A.; Hansen, Bettina; Nissen, Kari K.; Laska, Magdalena J.; Petersen, Trine S.; Bonnesen, Sandra; Hedemand, Anne; Nielsen, Anders L.; Nyegaard, Mette; Borglum, Anders D.] Univ Aarhus, Dept Human Genet, Aarhus C, Denmark; [Christensen, Tove; Moller-Larsen, Anne; Brudek, Tomasz; Maric, Romana] Univ Aarhus, Dept Med Microbiol, Aarhus C, Denmark; [Frederiksen, Jette] Glostrup Cty Hosp, Dept Neurol, Glostrup, Denmark; [Oturai, Annette B.; Sondergaard, Helle B.; Sellebjerg, Finn] Copenhagen Univ Hosp, Danish Multiple Sclerosis Res Ctr, Dept Neurol, Copenhagen, Denmark; [Villesen, Palle] Univ Aarhus, Bioinformat Res Ctr, Aarhus C, Denmark; [Laska, Magdalena J.] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Wu, Tingting; Wang, Xinjie; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Peoples R China; [Brusgaard, Klaus] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Kjeldbjerg, Anders L.; Pedersen, Finn S.] Univ Aarhus, Dept Mol Biol, Aarhus C, Denmark; [Rasmussen, Henrik B.] Psychiat Ctr Sct Hans, Res Inst Biol Psychiat, Roskilde, Denmark	Aarhus University; Aarhus University; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; Beijing Genomics Institute (BGI); University of Southern Denmark; Odense University Hospital; Aarhus University	Nexo, BA (corresponding author), Univ Aarhus, Dept Human Genet, Aarhus C, Denmark.	nexo@humgen.au.dk	Nyegaard, Mette/G-4443-2012; Nyegaard, Mette/M-3379-2019; Nielsen, Anders Lade L/Q-9604-2016; Brusgaard, Klaus/AGE-8988-2022	Nyegaard, Mette/0000-0003-4973-8543; Nyegaard, Mette/0000-0003-4973-8543; Nielsen, Anders Lade L/0000-0003-4372-9961; frederiksen, jette/0000-0003-1661-7438; Laska, Magdalena Janina/0000-0001-5188-3446; Borglum, Anders/0000-0001-8627-7219; Petersen, Thor/0000-0001-5633-2600; Brusgaard, Klaus/0000-0002-2096-4988; Brudek, Tomasz/0000-0001-5453-1817; Villesen, Palle/0000-0001-7589-8781; Sellebjerg, Finn/0000-0002-1333-9623; Christensen, Tove/0000-0003-3977-6677; Sondergaard, Helle Bach/0000-0001-9435-0658	The Lundbeck Foundation; The Danish Multiple Sclerosis Society; Warwara Larsens Fond; The NovoNordisk Foundation; The Villum Kann Rasmussen Foundation	The Lundbeck Foundation(Lundbeckfonden); The Danish Multiple Sclerosis Society; Warwara Larsens Fond; The NovoNordisk Foundation(Novo Nordisk Foundation); The Villum Kann Rasmussen Foundation(Villum Fonden)	This work was supported by The Lundbeck Foundation, The Danish Multiple Sclerosis Society, Warwara Larsens Fond, The NovoNordisk Foundation and The Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; CHATTOPADHYAY SK, 1975, P NATL ACAD SCI USA, V72, P906, DOI 10.1073/pnas.72.3.906; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; CLEMENTS JE, 1988, ANNU REV IMMUNOL, V6, P139, DOI 10.1146/annurev.iy.06.040188.001035; GARDNER MB, 1993, GENETICA, V91, P199, DOI 10.1007/BF01435998; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hansen T, 2005, MULT SCLER J, V11, P504, DOI 10.1191/1352458505ms1220oa; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Pepin M, 1998, VET RES, V29, P341; PINCUS T, 1971, J EXP MED, V133, P1234, DOI 10.1084/jem.133.6.1234; ROWE WP, 1972, J EXP MED, V136, P1272, DOI 10.1084/jem.136.5.1272; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076	17	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16652	10.1371/journal.pone.0016652	http://dx.doi.org/10.1371/journal.pone.0016652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311761	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200028
J	Sutherland, TD; Church, JS; Hu, XA; Huson, MG; Kaplan, DL; Weisman, S				Sutherland, Tara D.; Church, Jeffrey S.; Hu, Xiao; Huson, Mickey G.; Kaplan, David L.; Weisman, Sarah			Single Honeybee Silk Protein Mimics Properties of Multi-Protein Silk	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; SIMILLIMA-XANTHOPTERA CAMERON; ALPHA-KERATIN FIBERS; COILED-COIL; STRUCTURAL-CHARACTERIZATION; FIBROUS PROTEINS; SPECTROSCOPY; BETA; TRANSITION; COMPLEXES	Honeybee silk is composed of four fibrous proteins that, unlike other silks, are readily synthesized at full-length and high yield. The four silk genes have been conserved for over 150 million years in all investigated bee, ant and hornet species, implying a distinct functional role for each protein. However, the amino acid composition and molecular architecture of the proteins are similar, suggesting functional redundancy. In this study we compare materials generated from a single honeybee silk protein to materials containing all four recombinant proteins or to natural honeybee silk. We analyse solution conformation by dynamic light scattering and circular dichroism, solid state structure by Fourier Transform Infrared spectroscopy and Raman spectroscopy, and fiber tensile properties by stress-strain analysis. The results demonstrate that fibers artificially generated from a single recombinant silk protein can reproduce the structural and mechanical properties of the natural silk. The importance of the four protein complex found in natural silk may lie in biological silk storage or hierarchical self-assembly. The finding that the functional properties of the mature material can be achieved with a single protein greatly simplifies the route to production for artificial honeybee silk.	[Sutherland, Tara D.; Weisman, Sarah] Entomol Commonwealth Sci & Res Org CSIRO, Canberra, ACT, Australia; [Church, Jeffrey S.; Huson, Mickey G.] Mat Sci & Engn CSIRO, Geelong, Vic, Australia; [Hu, Xiao; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Tufts University	Sutherland, TD (corresponding author), Entomol Commonwealth Sci & Res Org CSIRO, Canberra, ACT, Australia.	Tara.Sutherland@csiro.au	Huson, Mickey/K-2474-2012; Hu, Xiao/F-2403-2012; Weisman, Sarah/B-5091-2009; Sutherland, Tara/B-5635-2009	Huson, Mickey/0000-0003-1859-7805; Hu, Xiao/0000-0002-2579-2820; Sutherland, Tara/0000-0001-5211-4593	CSIRO, Australia; United States Air Force Office of Scientific Research	CSIRO, Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was funded by CSIRO, Australia and the United States Air Force Office of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, INSECT SOC; ASTBURY W. T., 1933, PHILOS TRANS ROY SOC LONDON, VA232, P333; ATKINS EDT, 1967, J MOL BIOL, V24, P139, DOI 10.1016/0022-2836(67)90099-X; Colthup N. B., 1990, INTRO INFRARED RAMAN, P216; Damaschun G, 1998, BIOCHEMISTRY-MOSCOW+, V63, P259; Feughelman M., 1997, MECH PROPERTIES STRU, P16; Flower N. E., 1967, Journal of the Royal Microscopical Society, V86, P297; Frushour B.G., 1975, ADV INFRARED RAMAN S, V1, P35; Heimburg T, 1999, BIOCHEMISTRY-US, V38, P12727, DOI 10.1021/bi983079h; HEPBURN HR, 1979, INSECT BIOCHEM, V9, P69, DOI 10.1016/0020-1790(79)90028-3; HEPBURN HR, 1988, APIDOLOGIE, V19, P25, DOI 10.1051/apido:19880102; Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d; Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109; ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017; Kameda T, 2005, Z NATURFORSCH C, V60, P906; Kameda T, 2009, INT J BIOL MACROMOL, V44, P64, DOI 10.1016/j.ijbiomac.2008.10.004; Kameda T, 2010, BIOMACROMOLECULES, V11, P1009, DOI 10.1021/bm901472a; Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749; Li XC, 2010, J STRUCT BIOL, V170, P313, DOI 10.1016/j.jsb.2010.01.016; MATTICE WL, 1976, BIOCHEMISTRY-US, V15, P4264, DOI 10.1021/bi00664a020; Meng FG, 2001, BIOCHIMIE, V83, P953, DOI 10.1016/S0300-9084(01)01340-2; PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5; Peng XN, 2004, ACTA CHIM SINICA, V62, P2127; Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x; REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161; Rudall K.M., 1962, COMP BIOCHEM PHYSIOL, V4, P397; Rusconi F, 2001, ANAL BIOCHEM, V295, P31, DOI 10.1006/abio.2001.5164; Sezutsu H, 2007, BIOSCI BIOTECH BIOCH, V71, P2725, DOI 10.1271/bbb.70326; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; Sutherland TD, 2007, MOL BIOL EVOL, V24, P2424, DOI 10.1093/molbev/msm171; Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519; Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021; Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5; WORTMANN FJ, 1994, TEXT RES J, V64, P737, DOI 10.1177/004051759406401206; YOUNG CY, 1978, J PHYS CHEM-US, V82, P1375, DOI 10.1021/j100501a011; Zhang K, 2010, P NATL ACAD SCI USA, V107, P9502, DOI 10.1073/pnas.0912066107; ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365	39	47	51	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16489	10.1371/journal.pone.0016489	http://dx.doi.org/10.1371/journal.pone.0016489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311767	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036200018
J	Ha, JW; Schwahn, AB; Downard, KM				Ha, Ji-won; Schwahn, Alexander B.; Downard, Kevin M.			Proteotyping to Establish Gene Origin within Reassortant Influenza Viruses	PLOS ONE			English	Article							H1N1 INFLUENZA; MASS; ANTIGENICITY; EVOLUTION; VACCINE	The application of a rapid and direct proteotyping approach with which to identify the gene origin of viral antigens in a reassortant influenza strain is demonstrated. The reassortant strain, constructed for a vaccine against type A 2009 H1N1 pandemic influenza, contains genes derived from a wild-type pandemic strain (A/California/7/2009) and an egg adapted high-growth strain (denoted NYMC X-157) derived from an earlier A/Puerto Rico/8/34 strain. The proteotyping approach employs modern proteomics methods and high resolution mass spectrometry to correctly establish that the genes of the surface antigens, hemagglutinin and neuraminidase, are derived from the A/California/7/2009 strain while those for nucleoprotein and matrix protein M1 antigens are derived from the NYMC X-157 strain. This is achieved for both gel-separated antigens and those from a whole vaccine digest. Furthermore, signature peptides detected in the mass spectra of the digested antigens enable the engineered reassortant strain to be identified as a type A virus of the H1N1 subtype in accord with earlier studies. The results demonstrate that proteotyping approach provides a more direct and rapid approach over RT-PCR with which to characterize reassortant strains of the influenza virus at the molecular protein level. Given that these strains pose the greatest risk to human and animal health and have been responsible for all human pandemics of the 20th and 21st centuries, there is a vital need for the origins and evolutionary history of these strains to be rapidly established.	[Ha, Ji-won; Schwahn, Alexander B.; Downard, Kevin M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Ha, JW (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	k.downard@sydney.edu.au	Ha, Ji Won/AAB-7949-2019	Downard, Kevin/0000-0003-0904-4141	Australian Research Council [DP1010101702, DP0770619]; Australian Research Council Linkage Infrastructure Equipment Facility (LIEF) [LE0668439]; University of Sydney	Australian Research Council(Australian Research Council); Australian Research Council Linkage Infrastructure Equipment Facility (LIEF)(Australian Research Council); University of Sydney(University of Sydney)	This research was supported by Australian Research Council Discovery Project grants (DP1010101702 and DP0770619) awarded to K. M. Downard. A. B. Schwahn was supported by an Australian Research Council Discovery Project grant (DP0770619) awarded to K. M. Downard. The FT-ICR mass spectrometer used in these investigations was purchased with funds provided by an Australian Research Council Linkage Infrastructure Equipment Facility (LIEF) grant (LE0668439) and the University of Sydney. The PanVax H1N1 vaccine was kindly donated by CSL Biotherapies, CSL Limited, Melbourne, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Kiselar JG, 1999, BIOCHEMISTRY-US, V38, P14185, DOI 10.1021/bi991609j; KISO M, 2010, PLOS PATHOGENS, V6; Lee EY, 2010, J VIROL METHODS, V165, P133, DOI 10.1016/j.jviromet.2009.10.022; Morrissey B, 2006, PROTEOMICS, V6, P2034, DOI 10.1002/pmic.200500642; Morrissey B, 2007, J VIROL METHODS, V145, P106, DOI 10.1016/j.jviromet.2007.05.015; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Pramanik BN, 2002, PROTEIN SCI, V11, P2676, DOI 10.1110/ps.0213702; Sakamoto S, 1996, J VIROL METHODS, V56, P161, DOI 10.1016/0166-0934(95)01909-X; SCHWAHN AB, 2010, J VIROL MET IN PRESS; Schwahn AB, 2010, EUR J MASS SPECTROM, V16, P321, DOI 10.1255/ejms.1056; Schwahn AB, 2010, ANAL CHEM, V82, P4584, DOI 10.1021/ac100594j; Schwahn AB, 2010, J VIROL METHODS, V165, P178, DOI 10.1016/j.jviromet.2010.01.015; Schwahn AB, 2009, ANALYST, V134, P2253, DOI 10.1039/b912234f; Schwahn AB, 2009, ANAL CHEM, V81, P3500, DOI 10.1021/ac900026f; Schwahn AB, 2009, J IMMUNOASS IMMUNOCH, V30, P245, DOI 10.1080/15321810903084350; Shu LP, 1996, EUR J EPIDEMIOL, V12, P63, DOI 10.1007/BF00144430; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182	25	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15771	10.1371/journal.pone.0015771	http://dx.doi.org/10.1371/journal.pone.0015771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305059	gold, Green Submitted, Green Published			2022-12-27	WOS:000286834300026
J	Huang, YC; Wu, YR; Tseng, MY; Chen, YC; Hsieh, SY; Chen, CM				Huang, Yen-Chu; Wu, Yih-Ru; Tseng, Mu-Yun; Chen, Yi-Chun; Hsieh, Sen-Yung; Chen, Chiung-Mei			Increased Prothrombin, Apolipoprotein A-IV, and Haptoglobin in the Cerebrospinal Fluid of Patients with Huntington's Disease	PLOS ONE			English	Article							INDUCED MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; THROMBIN; BRAIN; EXPRESSION; NEURODEGENERATION; BLOOD; PARTICIPATION; ASTROCYTES; RECEPTORS	Huntington's disease (HD) is a progressive neurodegenerative disease caused by an unstable CAG trinucleotide repeat expansion. The need for biomarkers of onset and progression in HD is imperative, since currently reliable outcome measures are lacking. We used two-dimensional electrophoresis and mass spectrometry to analyze the proteome profiles in cerebrospinal fluid (CSF) of 6 pairs of HD patients and controls. Prothrombin, apolipoprotein A-IV (Apo A-IV) and haptoglobin were elevated in CSF of the HD patients in comparison with the controls. We used western blot as a semi-quantified measurement for prothrombin and Apo A-IV, as well as enzyme linked immunosorbent assay (ELISA) for measurement of haptoglobin, in 9 HD patients and 9 controls. The albumin quotient (Qalb), a marker of blood-brain barrier (BBB) function, was not different between the HD patients and the controls. The ratios of CSF prothrombin/albumin (prothrombin/Alb) and Apo A-IV/albumin (Apo A-IV/Alb), and haptoglobin level were significantly elevated in HD. The ratio of CSF prothrombin/Alb significantly correlated with the disease severity assessed by Unified Huntington's Disease Rating Scale (UHDRS). The results implicate that increased CSF prothrombin, Apo A-IV, and haptoglobin may be involved in pathogenesis of HD and may serve as potential biomarkers for HD.	[Huang, Yen-Chu; Wu, Yih-Ru; Tseng, Mu-Yun; Chen, Yi-Chun; Chen, Chiung-Mei] Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurol, Coll Med, Taipei, Taiwan; [Hsieh, Sen-Yung] Chang Gung Mem Hosp, Clin Prote Ctr, Taipei 10591, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurol, Coll Med, Taipei, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020; Huang, Yenchu/AAO-1140-2020		Academia Sinica, Republic of China [23-4b]; Chang Gung Memorial Hospital, Taipei, Republic of China [CMRPG 38138]; National Science Council [NSC 94-3112-P-001-010-Y]; Academia Sinica	Academia Sinica, Republic of China(Academia Sinica - Taiwan); Chang Gung Memorial Hospital, Taipei, Republic of China(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica, Republic of China (23-4b, http://www.sinica.edu.tw/) and by Chang Gung Memorial Hospital, Taipei, Republic of China (CMRPG 38138, http://www.cgmh.org.tw/). MALDI-TOF MS/MS analyses were performed by the Core Facilities for Proteomics Research located at the Institute of Biological Chemistry, Academia Sinica, supported by a National Science Council grant (NSC 94-3112-P-001-010-Y, http://web1.nsc.gov.tw/) and the Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AN, 2008, BRAIN, V131, P381, DOI 10.1093/brain/awm312; Arai T, 2006, J NEUROPATH EXP NEUR, V65, P19, DOI 10.1097/01.jnen.0000196133.74087.cb; Bai SM, 2010, MOL BIOL REP, V37, P1619, DOI 10.1007/s11033-009-9574-7; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bjorkqvist M, 2007, MOVEMENT DISORD, V22, P1952, DOI 10.1002/mds.21447; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Chang KH, 2007, PROTEOM CLIN APPL, V1, P467, DOI 10.1002/prca.200600949; Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Choi SH, 2003, NEUROBIOL DIS, V14, P181, DOI 10.1016/S0969-9961(03)00085-8; Choi SH, 2003, J NEUROSCI, V23, P5877; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P245, DOI 10.1016/j.parkreldis.2008.05.012; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Fang QJ, 2009, MOL CELL PROTEOMICS, V8, P451, DOI 10.1074/mcp.M800231-MCP200; FUJIMOTO K, 1993, J CLIN INVEST, V91, P1830, DOI 10.1172/JCI116395; Hsiao HY, 2010, MOL NEUROBIOL, V41, P248, DOI 10.1007/s12035-009-8097-5; Jeitner TM, 2008, J NEUROCHEM, V106, P37, DOI 10.1111/j.1471-4159.2008.05350.x; Jeitner TM, 2001, J NEUROCHEM, V79, P1109, DOI 10.1046/j.1471-4159.2001.00673.x; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Li X, 2006, ACTA NEUROCHIR, V148, P859, DOI 10.1007/s00701-006-0787-4; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Montine TJ, 1999, NEUROLOGY, V52, P1104, DOI 10.1212/WNL.52.5.1104; Nemes Z, 2001, NEUROBIOL AGING, V22, P403, DOI 10.1016/S0197-4580(01)00224-X; PANTONI L, 1995, ACTA NEUROL SCAND, V91, P225; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Sarvari M, 2002, DRUG DEVELOP RES, V56, P458, DOI 10.1002/ddr.10098; Shen L, 2008, PHYSIOL BEHAV, V95, P161, DOI 10.1016/j.physbeh.2008.05.022; Shen L, 2007, ENDOCRINOLOGY, V148, P2681, DOI 10.1210/en.2006-1596; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; TANEDA H, 1994, J BIOCHEM-TOKYO, V116, P589, DOI 10.1093/oxfordjournals.jbchem.a124565; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Tso P, 2001, ANNU REV NUTR, V21, P231, DOI 10.1146/annurev.nutr.21.1.231; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Won SY, 2009, J NEUROIMMUNOL, V214, P83, DOI 10.1016/j.jneuroim.2009.07.005; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	47	36	38	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15809	10.1371/journal.pone.0015809	http://dx.doi.org/10.1371/journal.pone.0015809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297956	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300027
J	Tabach, Y; Kogan-Sakin, I; Buganim, Y; Solomon, H; Goldfinger, N; Hovland, R; Ke, XS; Oyan, AM; Kalland, KH; Rotter, V; Domany, E				Tabach, Yuval; Kogan-Sakin, Ira; Buganim, Yosef; Solomon, Hilla; Goldfinger, Naomi; Hovland, Randi; Ke, Xi-Song; Oyan, Anne M.; Kalland, Karl-H.; Rotter, Varda; Domany, Eytan			Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; GENE-EXPRESSION; PROSTATIC ADENOCARCINOMAS; FREQUENT AMPLIFICATION; ANEUPLOIDY; INSTABILITY; PROGRESSION; VISUALIZATION; CHEMOTHERAPY	Duplication of chromosomal arm 20q occurs in prostate, cervical, colon, gastric, bladder, melanoma, pancreas and breast cancer, suggesting that 20q amplification may play a causal role in tumorigenesis. According to an alternative view, chromosomal imbalance is mainly a common side effect of cancer progression. To test whether a specific genomic aberration might serve as a cancer initiating event, we established an in vitro system that models the evolutionary process of early stages of prostate tumor formation; normal prostate cells were immortalized by the over-expression of human telomerase catalytic subunit hTERT, and cultured for 650 days till several transformation hallmarks were observed. Gene expression patterns were measured and chromosomal aberrations were monitored by spectral karyotype analysis at different times. Several chromosomal aberrations, in particular duplication of chromosomal arm 20q, occurred early in the process and were fixed in the cell populations, while other aberrations became extinct shortly after their appearance. A wide range of bioinformatic tools, applied to our data and to data from several cancer databases, revealed that spontaneous 20q amplification can promote cancer initiation. Our computational model suggests that 20q amplification induced deregulation of several specific cancer-related pathways including the MAPK pathway, the p53 pathway and Polycomb group factors. In addition, activation of Myc, AML, B-Catenin and the ETS family transcription factors was identified as an important step in cancer development driven by 20q amplification. Finally we identified 13 "cancer initiating genes", located on 20q13, which were significantly over-expressed in many tumors, with expression levels correlated with tumor grade and outcome suggesting that these genes induce the malignant process upon 20q amplification.	[Tabach, Yuval; Domany, Eytan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Tabach, Yuval; Kogan-Sakin, Ira; Buganim, Yosef; Solomon, Hilla; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Hovland, Randi] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Hovland, Randi] Univ Bergen, Dept Biomed, Bergen, Norway; [Ke, Xi-Song; Oyan, Anne M.; Kalland, Karl-H.] Univ Bergen, Gade Inst, Bergen, Norway; [Ke, Xi-Song; Oyan, Anne M.; Kalland, Karl-H.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway	Weizmann Institute of Science; Weizmann Institute of Science; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Tabach, Y (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02115 USA.	eytan.domany@weizmann.ac.il	Kalland, Karl-Henning/B-9445-2017; DOMANY, EYTAN/K-1560-2012; Tabach, Yuval/Q-8488-2019	Kalland, Karl-Henning/0000-0003-4486-2334; 	Leir Charitable Foundation; EC; Center for Women's Health Research	Leir Charitable Foundation; EC(European CommissionEuropean Commission Joint Research Centre); Center for Women's Health Research	This research was supported by a grant from the Leir Charitable Foundation and by EC FP6 funding. Partial funding was provided by the Center for Women's Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers JC, 2001, AM J PATHOL, V158, P399, DOI 10.1016/S0002-9440(10)63983-1; Barks JH, 1997, GENE CHROMOSOME CANC, V19, P278, DOI 10.1002/(SICI)1098-2264(199708)19:4<278::AID-GCC11>3.3.CO;2-9; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Brookman-Amissah N, 2005, PROSTATE CANCER P D, V8, P335, DOI 10.1038/sj.pcan.4500826; Buganim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009657; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duesberg P, 2005, SCIENCE, V307, P41; Duesberg P, 2004, IUBMB LIFE, V56, P65, DOI 10.1080/15216540410001667902; Fauth C, 2004, GENE CHROMOSOME CANC, V40, P298, DOI 10.1002/gcc.20051; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Huret JL, 2003, NUCLEIC ACIDS RES, V31, P272, DOI 10.1093/nar/gkg126; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishiguro R, 2003, ANTICANCER RES, V23, P5213; Jarrard DF, 1999, CANCER RES, V59, P2957; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karhu R, 2006, GENE CHROMOSOME CANC, V45, P721, DOI 10.1002/gcc.20337; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; KOGANSAKIN I, 2010, CELL DEATH DIFFER; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; Kyomoto R, 1997, INT J CANCER, V74, P576, DOI 10.1002/(SICI)1097-0215(19971219)74:6<576::AID-IJC3>3.0.CO;2-R; Lai LA, 2007, GENE CHROMOSOME CANC, V46, P532, DOI 10.1002/gcc.20435; Lengauer C, 2004, NAT GENET, V36, P1144, DOI 10.1038/ng1104-1144; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Milyavsky M, 2003, CANCER RES, V63, P7147; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nakopoulou L, 2002, CANCER GENET CYTOGEN, V134, P127, DOI 10.1016/S0165-4608(01)00614-8; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Palmberg C, 2000, J UROLOGY, V164, P1992, DOI 10.1016/S0022-5347(05)66935-2; Postma C, 2007, CELL ONCOL, V29, P73; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; van Dekken H, 2004, GENE CHROMOSOME CANC, V39, P249, DOI 10.1002/gcc.20001; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wullich B, 2004, CANCER GENET CYTOGEN, V154, P119, DOI 10.1016/j.cancergencyto.2004.01.005	56	61	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14632	10.1371/journal.pone.0014632	http://dx.doi.org/10.1371/journal.pone.0014632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297939	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300014
J	Taylor, SM; Messina, JP; Hand, CC; Juliano, JJ; Muwonga, J; Tshefu, AK; Atua, B; Emch, M; Meshnick, SR				Taylor, Steve M.; Messina, Jane P.; Hand, Carla C.; Juliano, Jonathan J.; Muwonga, Jeremie; Tshefu, Antoinette K.; Atua, Benjamin; Emch, Michael; Meshnick, Steven R.			Molecular Malaria Epidemiology: Mapping and Burden Estimates for the Democratic Republic of the Congo, 2007	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; INFECTIONS; MORBIDITY; MORTALITY; CARRIAGE; CHILDREN; FULANI; AREA; AGE	Background: Epidemiologic data on malaria are scant in many high-burden countries including the Democratic Republic of the Congo (DRC), which suffers the second-highest global burden of malaria. Malaria control efforts in regions with challenging infrastructure require reproducible and efficient surveillance. We employed new high-throughput molecular testing to characterize the state of malaria control in the DRC and estimate childhood mortality attributable to excess malaria transmission. Methods and Findings: The Demographic and Health Survey was a cross-sectional, population-based cluster household survey of adults aged 15-59 years in 2007 employing structured questionnaires and dried blood spot collection. Parasitemia was detected by real-time PCR, and survey responses measured adoption of malaria control measures and under-5 health indices. The response rate was 99% at the household level, and 8,886 households were surveyed in 300 clusters; from 8,838 respondents molecular results were available. The overall prevalence of parasitemia was 33.5% (95% confidence interval [C.I.] 32-34.9); P. falciparum was the most prevalent species, either as monoinfection (90.4%; 95% C.I. 88.8-92.1) or combined with P. malariae (4.9%; 95% C.I. 3.7-5.9) or P. ovale (0.6%; 95% C.I. 0.1-0.9). Only 7.7% (95% CI 6.8-8.6) of households with children under 5 owned an insecticide-treated bednet (ITN), and only 6.8% (95% CI 6.1-7.5) of under-fives slept under an ITN the preceding night. The overall under-5 mortality rate was 147 deaths per 1,000 live births (95% C.I. 141153) and between clusters was associated with increased P. falciparum prevalence; based on the population attributable fraction, 26,488 yearly under-5 deaths were attributable to excess malaria transmission. Conclusions: Adult P. falciparum prevalence is substantial in the DRC and is associated with under-5 mortality. Molecular testing offers a new, generalizable, and efficient approach to characterizing malaria endemicity in underserved countries.	[Taylor, Steve M.; Hand, Carla C.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Taylor, Steve M.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA; [Messina, Jane P.; Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Messina, Jane P.; Emch, Michael] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Juliano, Jonathan J.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Muwonga, Jeremie] Lab Natl Reference SIDA, Kinshasa, DEM REP CONGO; [Muwonga, Jeremie] IST LNRS, Kinshasa, DEM REP CONGO; [Tshefu, Antoinette K.] Univ Kinshasa, Ecole Sante Publ, Fac Med, Kinshasa, DEM REP CONGO; [Atua, Benjamin] PNLP, Kinshasa, DEM REP CONGO	University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Universite de Kinshasa	Taylor, SM (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	stevemyertaylor@gmail.com		Cerami, Carla/0000-0002-7634-0955	UNC Gillings School of Global Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	UNC Gillings School of Global Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by a Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health (to SRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alker AP, 2008, TROP MED INT HEALTH, V13, P1384, DOI 10.1111/j.1365-3156.2008.02150.x; [Anonymous], 2008, WORLD MAL REP 2008; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Conrad Joseph, 1999, HEART DARKNESS; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; DUREN A N, 1951, Ann Soc Belg Med Trop (1920), V31, P129; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; JIMA D, MALAR J, V9, P58; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Marques PX, 2005, INT J BIOL SCI, V1, P96; Messina JP, 2010, SOC SCI MED, V71, P1428, DOI 10.1016/j.socscimed.2010.07.025; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; RAJARATNAM JK, PLOS MED, V7; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Reyburn H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2066; RIEDEL N, MALAR J, V9, P37; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Roux AVD, 2005, J INFECT DIS, V191, pS25, DOI 10.1086/425288; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; SNOW RW, 1995, PARASITOL TODAY, V11, P188, DOI 10.1016/0169-4758(95)80156-1; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Sullivan D, 2010, EPIDEMIOL REV, V32, P175, DOI 10.1093/epirev/mxq013; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; Vafa M, 2007, MICROBES INFECT, V9, P1043, DOI 10.1016/j.micinf.2007.04.011; Zwetyenga J, 1999, T ROY SOC TROP MED H, V93, P375, DOI 10.1016/S0035-9203(99)90122-0	40	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16420	10.1371/journal.pone.0016420	http://dx.doi.org/10.1371/journal.pone.0016420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305011	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300063
J	Yan, LQ; Della Coletta, L; Powell, KL; Shen, JJ; Thames, H; Aldaz, CM; MacLeod, MC				Yan, Leqin; Della Coletta, Luis; Powell, K. Leslie; Shen, Jianjun; Thames, Howard; Aldaz, C. Marcelo; MacLeod, Michael C.			Activation of the Canonical Wnt/beta-Catenin Pathway in ATF3-Induced Mammary Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ATF3; STRESS-INDUCIBLE GENE; BETA-CATENIN; BREAST-CANCER; SIGNALING PATHWAY; INDUCED APOPTOSIS; CYCLIN D1; C-JUN; COLORECTAL-CANCER; EPITHELIAL-CELLS	Female transgenic mice that constitutively overexpress the transcription factor ATF3 in the basal epithelium of the mammary gland develop mammary carcinomas with high frequency, but only if allowed to mate and raise pups early in life. This transgenic mouse model system reproduces some features of human breast cancer in that about 20% of human breast tumor specimens exhibit overexpression of ATF3 in the tumor cells. The ATF3-induced mouse tumors are phenotypically similar to mammary tumors induced by overexpression of activating Wnt/beta-catenin pathway genes. We now show that the Wnt/beta-catenin pathway is indeed activated in ATF3-induced tumors. beta-catenin is transcriptionally up-regulated in the tumors, and high levels of nuclear beta-catenin are seen in tumor cells. A reporter gene for Wnt/beta-catenin pathway activity, TOPGAL, is up-regulated in the tumors and several downstream targets of Wnt signaling, including Ccnd1, Jun, Axin2 and Dkk4, are also expressed at higher levels in ATF3-induced tumors compared to mammary glands of transgenic females. Several positive-acting ligands for this pathway, including Wnt3, Wnt3a, Wnt7b, and Wnt5a, are significantly overexpressed in tumor tissue, and mRNA for Wnt3 is about 5-fold more abundant in transgenic mammary tissue than in non-transgenic mammary tissue. Two known transcriptional targets of ATF3, Snai1 and Snai2, are also overexpressed in the tumors, and Snail and Slug proteins are found to be located primarily in the nuclei of tumor cells. In vitro knockdown of Atf3 expression results in significant decreases in expression of Wnt7b, Tcf7, Snai2 and Jun, suggesting that these genes may be direct transcriptional targets of ATF3 protein. By chromatin immunoprecipitation analysis, both ATF3 and JUN proteins appear to bind to a particular subclass of AP-1 sites upstream of the transcriptional start sites of each of these genes.	[Yan, Leqin; Della Coletta, Luis; Powell, K. Leslie; Shen, Jianjun; Aldaz, C. Marcelo; MacLeod, Michael C.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Thames, Howard] Univ Texas MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yan, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.	mcmacleod@mdanderson.org	Aldaz, C. Marcelo/E-7868-2011	Aldaz, C. Marcelo/0000-0002-2453-2939	 [R01 CA116620];  [P30 CA016672];  [P30 ES007784]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA116620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01 CA116620 (MCM) and by Center grants P30 CA016672 and P30 ES007784. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Bertolo C, 2008, AM J CLIN PATHOL, V130, P414, DOI 10.1309/J3QV9763DYPV338D; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Hai T, 1999, GENE EXPRESSION, V7, P321; Hamdi M, 2008, DNA REPAIR, V7, P487, DOI 10.1016/j.dnarep.2007.12.004; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin Z, 2001, BRIT J CANCER, V85, P69, DOI 10.1054/bjoc.2001.1853; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Perez S, 2001, ONCOGENE, V20, P1135, DOI 10.1038/sj.onc.1204200; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SMEAL T, 1994, EMBO J, V13, P6006, DOI 10.1002/j.1460-2075.1994.tb06946.x; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Virmani AK, 2001, CLIN CANCER RES, V7, P1998; Wang AJ, 2007, MOL CARCINOGEN, V46, P476, DOI 10.1002/mc.20298; Wang A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-46; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	58	45	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16515	10.1371/journal.pone.0016515	http://dx.doi.org/10.1371/journal.pone.0016515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304988	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300075
J	Smits, M; Mir, SE; Nilsson, RJA; van der Stoop, PM; Niers, JM; Marquez, VE; Cloos, J; Breakefield, XO; Krichevsky, AM; Noske, DP; Tannous, BA; Wurdinger, T				Smits, Michiel; Mir, Shahryar E.; Nilsson, R. Jonas A.; van der Stoop, Petra M.; Niers, Johanna M.; Marquez, Victor E.; Cloos, Jacqueline; Breakefield, Xandra O.; Krichevsky, Anna M.; Noske, David P.; Tannous, Bakhos A.; Wuerdinger, Thomas			Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; GROUP PROTEIN EZH2; GENE-EXPRESSION; TUMOR-GROWTH; ANGIOGENESIS; CANCER; MICRORNAS; COMPLEX; OVEREXPRESSION	Angiogenesis is a balanced process controlled by pro-and anti-angiogenic molecules of which the regulation is not fully understood. Besides classical gene regulation, miRNAs have emerged as post-transcriptional regulators of angiogenesis. Furthermore, epigenetic changes caused by histone-modifying enzymes were shown to modulate angiogenesis as well. However, a possible interplay between miRNAs and histone-modulating enzymes during angiogenesis has not been described. Here we show that VEGF-mediated down-regulation of miR-101 caused pro-angiogenic effects. We found that the pro-angiogenic effects are partly mediated through reduced repression by miR-101 of the histone-methyltransferase EZH2, a member of the Polycomb group family, thereby increasing methylation of histone H3 at lysine 27 and transcriptome alterations. In vitro, the sprouting and migratory properties of primary endothelial cell cultures were reduced by inhibiting EZH2 through up-regulation of miR-101, siRNA-mediated knockdown of EZH2, or treatment with 3-Deazaneplanocin-A (DZNep), a small molecule inhibitor of EZH2 methyltransferase activity. In addition, we found that systemic DZNep administration reduced the number of blood vessels in a subcutaneous glioblastoma mouse model, without showing adverse toxicities. Altogether, by identifying a pro-angiogenic VEGF/miR-101/EZH2 axis in endothelial cells we provide evidence for a functional link between growth factor-mediated signaling, post-transcriptional silencing, and histone-methylation in the angiogenesis process. Inhibition of EZH2 may prove therapeutic in diseases in which aberrant vascularization plays a role.	[Smits, Michiel; Mir, Shahryar E.; Nilsson, R. Jonas A.; van der Stoop, Petra M.; Niers, Johanna M.; Cloos, Jacqueline; Noske, David P.; Wuerdinger, Thomas] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp,Dept Neurosurg, Amsterdam, Netherlands; [Smits, Michiel; Mir, Shahryar E.; Nilsson, R. Jonas A.; van der Stoop, Petra M.; Niers, Johanna M.; Cloos, Jacqueline; Noske, David P.; Wuerdinger, Thomas] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp,Dept Pediat Oncol Hematol, Amsterdam, Netherlands; [Niers, Johanna M.; Breakefield, Xandra O.; Tannous, Bakhos A.; Wuerdinger, Thomas] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Mol Neurogenet Unit, Boston, MA USA; [Niers, Johanna M.; Breakefield, Xandra O.; Tannous, Bakhos A.; Wuerdinger, Thomas] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Mol Neurogenet Unit, Boston, MA USA; [Niers, Johanna M.; Breakefield, Xandra O.; Tannous, Bakhos A.; Wuerdinger, Thomas] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Marquez, Victor E.] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Krichevsky, Anna M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Smits, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp,Dept Neurosurg, Amsterdam, Netherlands.	t.wurdinger@vumc.nl	Wurdinger, Thomas/AAA-5645-2022; Nilsson, Jonas/AAS-7101-2020; Marquez, Victor/AAP-3549-2021	Nilsson, Jonas/0000-0002-1933-1104; Cloos, Jacqueline/0000-0001-9150-8026; Noske, David/0000-0001-5992-4468; Krichevsky, Anna/0000-0002-5080-5507	Dutch Cancer Society/KWF; Lions Cancer Research Foundation; Umea University, Sweden; Stichting Translational Research CCA/VU University Medical Center; Swedish Research Counsil; National Cancer Institute (NCI) [CA069246, CA86355]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [P50CA086355, P01CA069246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064983] Funding Source: NIH RePORTER	Dutch Cancer Society/KWF(KWF Kankerbestrijding); Lions Cancer Research Foundation; Umea University, Sweden; Stichting Translational Research CCA/VU University Medical Center; Swedish Research Counsil; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Dutch Cancer Society/KWF (S. E. M.), Lions Cancer Research Foundation, Umea University, Sweden; Stichting Translational Research CCA/VU University Medical Center; Swedish Research Counsil (R.J.A.N.), National Cancer Institute (NCI) CA069246 and CA86355 (X.O.B.), and the American Brain Tumor Association (T. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Burdach S, 2009, CELL CYCLE, V8, P1991, DOI 10.4161/cc.8.13.8929; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heusschen R, 2010, BBA-REV CANCER, V1805, P87, DOI 10.1016/j.bbcan.2009.09.005; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Miebach S, 2006, J NEURO-ONCOL, V76, P39, DOI 10.1007/s11060-005-3674-6; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Raaphorst FM, 2003, NEOPLASIA, V5, P481, DOI 10.1016/S1476-5586(03)80032-5; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Wurdinger T, 2009, CELL ADHES MIGR, V3, P230, DOI 10.4161/cam.3.2.7910; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177	50	79	83	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16282	10.1371/journal.pone.0016282	http://dx.doi.org/10.1371/journal.pone.0016282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297974	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100018
J	Du, LY; Leung, VHC; Zhang, XJ; Zhou, J; Chen, M; He, W; Zhang, HY; Chan, CCS; Poon, VKM; Zhao, GY; Sun, SH; Cai, LF; Zhou, YS; Zheng, BJ; Jiang, S				Du, Lanying; Leung, Virtual Ho-Chuen; Zhang, Xiujuan; Zhou, Jie; Chen, Min; He, Wu; Zhang, Hai-Ying; Chan, Chris C. S.; Poon, Vincent Kwok-Man; Zhao, Guangyu; Sun, Shihui; Cai, Lifeng; Zhou, Yusen; Zheng, Bo-Jian; Jiang, Shibo			A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; POTENT NEUTRALIZING ANTIBODIES; INFLUENZA-A VIRUS; AVIAN INFLUENZA; IMMUNE-RESPONSES; SWINE FLU; PROTEIN; HEMAGGLUTININ; IMMUNOGENICITY; INFECTION	Development of effective vaccines to prevent influenza, particularly highly pathogenic avian influenza (HPAI) caused by influenza A virus (IAV) subtype H5N1, is a challenging goal. In this study, we designed and constructed two recombinant influenza vaccine candidates by fusing hemagglutinin 1 (HA1) fragment of A/Anhui/1/2005(H5N1) to either Fc of human IgG (HA1-Fc) or foldon plus Fc (HA1-Fdc), and evaluated their immune responses and cross-protection against divergent strains of H5N1 virus. Results showed that these two recombinant vaccines induced strong immune responses in the vaccinated mice, which specifically reacted with HA1 proteins and an inactivated heterologous H5N1 virus. Both proteins were able to cross-neutralize infections by one homologous strain (clade 2.3) and four heterologous strains belonging to clades 0, 1, and 2.2 of H5N1 pseudoviruses as well as three heterologous strains (clades 0, 1, and 2.3.4) of H5N1 live virus. Importantly, immunization with these two vaccine candidates, especially HA1-Fdc, provided complete cross-clade protection against high-dose lethal challenge of different strains of H5N1 virus covering clade 0, 1, and 2.3.4 in the tested mouse model. This study suggests that the recombinant fusion proteins, particularly HA1-Fdc, could be developed into an efficacious universal H5N1 influenza vaccine, providing cross-protection against infections by divergent strains of highly pathogenic H5N1 virus.	[Du, Lanying; Zhang, Xiujuan; He, Wu; Cai, Lifeng; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Leung, Virtual Ho-Chuen; Zhou, Jie; Chen, Min; Zhang, Hai-Ying; Chan, Chris C. S.; Poon, Vincent Kwok-Man; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Zhao, Guangyu; Sun, Shihui; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOE MOH, Shanghai 200032, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China	New York Blood Center; University of Hong Kong; Beijing Institute of Microbiology & Epidemiology; Fudan University; Fudan University	Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	bzheng@hkucc.hku.hk; sjiang@nybloodcenter.org	Zhou, Jie/E-9839-2010; Zhang, Xiujuan/AAG-9780-2020; Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; ZHOU, Jie/0000-0002-2948-3873; Poon, Vincent kwok-man/0000-0002-7737-8912	New York Blood Center [NYB000068]; Research Fund for the Control of Infectious Diseases; Health, Welfare and Food Bureau of the Hong Kong SAR Government; National 973 Basic Research Program of China [2005CB523001]	New York Blood Center; Research Fund for the Control of Infectious Diseases; Health, Welfare and Food Bureau of the Hong Kong SAR Government; National 973 Basic Research Program of China(National Basic Research Program of China)	This study was supported by an intramural fund of the New York Blood Center (NYB000068), by the Research Fund for the Control of Infectious Diseases, the Health, Welfare and Food Bureau of the Hong Kong SAR Government, and by the National 973 Basic Research Program of China (2005CB523001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Du CL, 2008, APPL MICROBIOL BIOT, V79, P195, DOI 10.1007/s00253-008-1427-0; Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948; Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031; Du LY, 2010, BIOCHEM BIOPH RES CO, V397, P580, DOI 10.1016/j.bbrc.2010.05.161; Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018; Du LY, 2009, BIOCHEM BIOPH RES CO, V384, P486, DOI 10.1016/j.bbrc.2009.05.003; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Holman DH, 2008, VACCINE, V26, P2627, DOI 10.1016/j.vaccine.2008.02.053; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Martyn JC, 2009, ARCH VIROL, V154, P1129, DOI 10.1007/s00705-009-0423-8; Nayak B, 2010, J VIROL, V84, P2408, DOI 10.1128/JVI.02135-09; Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Qi Z, 2010, BIOCHEM BIOPH RES CO, V398, P506, DOI 10.1016/j.bbrc.2010.06.109; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Szecsi J, 2009, J INFECT DIS, V200, P181, DOI 10.1086/599840; Tao P, 2009, VIRAL IMMUNOL, V22, P273, DOI 10.1089/vim.2009.0017; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Xie QM, 2009, POULTRY SCI, V88, P1608, DOI 10.3382/ps.2009-00092; Zhang SL, 2008, J VIROL METHODS, V154, P99, DOI 10.1016/j.jviromet.2008.08.016; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; 2009, MMWR MORB MORTAL WKL, V58, P585	47	34	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16555	10.1371/journal.pone.0016555	http://dx.doi.org/10.1371/journal.pone.0016555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304591	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900070
J	Gautam, US; Chauhan, S; Tyagi, JS				Gautam, Uma Shankar; Chauhan, Santosh; Tyagi, Jaya Sivaswami			Determinants Outside the DevR C-Terminal Domain Are Essential for Cooperativity and Robust Activation of Dormancy Genes in Mycobacterium tuberculosis	PLOS ONE			English	Article							DNA-BINDING DOMAIN; RESPONSE REGULATOR; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; HYPOXIC RESPONSE; 2-COMPONENT SYSTEM; BACILLUS-SUBTILIS; PHOSPHORYLATION; PROTEIN	Background: DevR (also called as DosR) is a two-domain response regulator of the NarL subfamily that controls dormancy adaptation of Mycobacterium tuberculosis (M. tb). In response to inducing signals such as hypoxia and ascorbic acid, the N-terminal receiver domain of DevR (DevR(N)) is phosphorylated at Asp54. This results in DevR binding to DNA via its C-terminal domain (DevR(C)) and subsequent induction of the DevR regulon. The mechanism of phosphorylation-mediated activation is not known. The present study was designed to understand the role of the N- and C-terminal domains of DevR in DevR regulon genes activation. Methodology/Principal Findings: Towards deciphering the activation mechanism of DevR, we compared the DNA binding properties of DevR(C) and DevR and correlated the findings with their ability to activate gene expression. We show that isolated DevR(C) can interact with DNA, but only with the high affinity site of a representative target promoter. Therefore, one role of DevR(N) is to mask the intrinsic DNA binding function of DevR(C). However, unlike phosphorylated DevR, isolated DevR(C) does not interact with the adjacent low affinity binding site suggesting that a second role of DevR(N) is in cooperative binding to the secondary site. Transcriptional analysis shows that consistent with unmasking of its DNA binding property, DevR(C) supports the aerobic induction, albeit feebly, of DevR regulon genes but is unable to sustain gene activation during hypoxia. Conclusions/Significance: DevR is a unique response regulator that employs a dual activation mechanism including relief of inhibition and cooperative interaction with binding sites. Importantly, both these functions reside outside the C-terminal domain. DevR(N) is also essential for stabilizing DevR and sustaining autoregulation under hypoxia. Hence, both domains of DevR are required for robust transcription activation.	[Gautam, Uma Shankar; Chauhan, Santosh; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Gautam, US (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	jstyagi@aiims.ac.in	Chauhan, Santosh/K-3031-2019; Uma S Gautam, MSc/H-3474-2019; GAUTAM, UMA/AAI-1531-2021	Chauhan, Santosh/0000-0001-9167-5107; Uma S Gautam, MSc/0000-0003-0326-6325; 	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by a grant from the Department of Biotechnology, Government of India to JST. JST is thankful to the Department of Biotechnology, Government of India for a Tata Innovation Fellowship. USG and SC are thankful to the Council for Scientific and Industrial Research (CSIR) for Senior Research Associateship (Scientist's Pool Scheme) and Research Associateship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2009, J BACTERIOL, V191, P6075, DOI 10.1128/JB.00310-09; DARE S, 1994, NUCLEIC ACIDS RES, V22, P1555; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; De Majumdar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009448; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; GALINIER A, 1994, J BIOL CHEM, V269, P23784; Grange JM, 1992, TUBERCLE LUNG DIS, P73249; GRIMSLEY JK, 1994, J BIOL CHEM, V269, P16977; Gupta RK, 2009, J MED CHEM, V52, P6324, DOI 10.1021/jm900358q; HARLOCKER SL, 1995, J BIOL CHEM, V270, P26849, DOI 10.1074/jbc.270.45.26849; Hoch JA, 1995, 2 COMPONENT SIGNAL T; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; KAHN D, 1991, MOL MICROBIOL, V5, P987, DOI 10.1111/j.1365-2958.1991.tb00774.x; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leoni L, 2003, BIOCHEM BIOPH RES CO, V303, P926, DOI 10.1016/S0006-291X(03)00450-9; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; NAKASHIMA K, 1991, J BIOL CHEM, V266, P10775; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; PORTER SC, 1993, GENE DEV, V7, P2258, DOI 10.1101/gad.7.11.2258; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Saini DK, 2005, J BIOMOL SCREEN, V10, P215, DOI 10.1177/1087057104272090; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; STEAD WW, 1967, AM REV RESPIR DIS, V95, P729; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WEISS V, 1992, P NATL ACAD SCI USA, V89, P5088, DOI 10.1073/pnas.89.11.5088; Wickstrum JR, 2007, J BACTERIOL, V189, P4984, DOI 10.1128/JB.00530-07; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029	46	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16500	10.1371/journal.pone.0016500	http://dx.doi.org/10.1371/journal.pone.0016500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304599	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900058
J	Castillo-Olivares, J; Calvo-Pinilla, E; Casanova, I; Bachanek-Bankowska, K; Chiam, R; Maan, S; Nieto, JM; Ortego, J; Mertens, PPC				Castillo-Olivares, Javier; Calvo-Pinilla, Eva; Casanova, Isabel; Bachanek-Bankowska, Katarzyna; Chiam, Rachael; Maan, Sushila; Maria Nieto, Jose; Ortego, Javier; Mertens, Peter Paul Clement			A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR -/- Mouse Model	PLOS ONE			English	Article							BLUETONGUE-VIRUS; HORSESICKNESS AHS; IMMUNIZATION; LETHAL; MICE	African horse sickness (AHS) is a lethal viral disease of equids, which is transmitted by Culicoides midges that become infected after biting a viraemic host. The use of live attenuated vaccines has been vital for the control of this disease in endemic regions. However, there are safety concerns over their use in non-endemic countries. Research efforts over the last two decades have therefore focused on developing alternative vaccines based on recombinant baculovirus or live viral vectors expressing structural components of the AHS virion. However, ethical and financial considerations, relating to the use of infected horses in high biosecurity installations, have made progress very slow. We have therefore assessed the potential of an experimental mouse-model for AHSV infection for vaccine and immunology research. We initially characterised AHSV infection in this model, then tested the protective efficacy of a recombinant vaccine based on modified vaccinia Ankara expressing AHS-4 VP2 (MVA-VP2).	[Castillo-Olivares, Javier; Bachanek-Bankowska, Katarzyna; Maan, Sushila; Mertens, Peter Paul Clement] Inst Anim Hlth, Surrey, England; [Calvo-Pinilla, Eva; Casanova, Isabel; Maria Nieto, Jose; Ortego, Javier] CISA, Madrid, Spain; [Chiam, Rachael] Wellcome Trust Sanger Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Wellcome Trust Sanger Institute	Castillo-Olivares, J (corresponding author), Inst Anim Hlth, Surrey, England.	javier.castillo-olivares@bbsrc.ac.uk	ortego, javier/K-6020-2014; Castillo-Olivares, Javier/L-5337-2014; Ortego, Javier/M-6810-2019; CALVO-PINILLA, EVA/L-5348-2014; Castillo-Olivares, Javier/AAA-8837-2019; Castillo-Olivares, Javier/AAA-7603-2019	ortego, javier/0000-0002-4275-7277; Castillo-Olivares, Javier/0000-0003-3453-8557; Ortego, Javier/0000-0002-4275-7277; CALVO-PINILLA, EVA/0000-0002-4667-4081; Castillo-Olivares, Javier/0000-0003-3453-8557; Mertens, Peter/0000-0002-3438-3738	BBSRC; Department for the Environment Food and Rural Affairs (DEFRA) [SE4109]; EPIZONE; Biotechnology and Biological Sciences Research Council [BBS/B/00654] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for the Environment Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); EPIZONE; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC (IAH-ISPG grant) and the Department for the Environment Food and Rural Affairs (DEFRA), grant number: SE4109. Additional funds were obtained from EPIZONE through their short-term mission project programme. Kasia Bankowska is recipient of a BBSRC funded doctoral Training Award (DTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; BURRAGE TG, 1993, VIROLOGY, V196, P799, DOI 10.1006/viro.1993.1537; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Chiam R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005997; Coetzer J. A. W., 2004, Infectious diseases of livestock. Volume Two, P1231; Guthrie AJ, 2009, VACCINE, V27, P4434, DOI 10.1016/j.vaccine.2009.05.044; HOUSE C, 1992, ANN NY ACAD SCI, V653, P228, DOI 10.1111/j.1749-6632.1992.tb19651.x; Howell P. G., 1960, Journal of the South African Veterinary Medical Association, V31, P329; JAMESON P, 1978, INFECT IMMUN, V20, P321, DOI 10.1128/IAI.20.1.321-323.1978; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Martinez-Torrecuadrada JL, 1999, VIROLOGY, V257, P449, DOI 10.1006/viro.1999.9680; MartinezTorrecuadrada JL, 1996, J GEN VIROL, V77, P1211, DOI 10.1099/0022-1317-77-6-1211; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MONTILLA RD, 1967, B OFF INT EPIZOOT, V68, P705; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; O'Hara RS, 1998, ARCH VIROL, P259; Rafyi A., 1961, Bulletin de l'Office International des Epizooties, V56, P216; RANZ AI, 1992, VET MICROBIOL, V33, P143, DOI 10.1016/0378-1135(92)90042-R; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; Roy P, 1998, ARCH VIROL, P177; Roy P, 1996, J GEN VIROL, V77, P2053, DOI 10.1099/0022-1317-77-9-2053; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Scanlen M, 2002, VACCINE, V20, P1079, DOI 10.1016/S0264-410X(01)00445-5; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; StoneMarschat MA, 1996, VIROLOGY, V220, P219, DOI 10.1006/viro.1996.0304; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VANDIJK AA, 1998, AFRICAN HORSE SICKNE; von Teichman BF, 2008, VACCINE, V26, P5014, DOI 10.1016/j.vaccine.2008.07.037; WadeEvans AM, 1997, J GEN VIROL, V78, P1611, DOI 10.1099/0022-1317-78-7-1611; ZINKERNAGEL RM, 1993, IMMUNOL REV, V133, P199, DOI 10.1111/j.1600-065X.1993.tb01517.x	31	49	49	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16503	10.1371/journal.pone.0016503	http://dx.doi.org/10.1371/journal.pone.0016503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298069	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800050
J	Psifidi, A; Dovas, C; Banos, G				Psifidi, Androniki; Dovas, Chrysostomos; Banos, Georgios			Novel Quantitative Real-Time LCR for the Sensitive Detection of SNP Frequencies in Pooled DNA: Method Development, Evaluation and Application	PLOS ONE			English	Article							LIGASE CHAIN-REACTION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ALLELE FREQUENCY; PRIMER EXTENSION; QUANTIFICATION; PCR; ASSAY; POLYMERASE; EVAGREEN; SAMPLES	Background: Single nucleotide polymorphisms (SNP) have proven to be powerful genetic markers for genetic applications in medicine, life science and agriculture. A variety of methods exist for SNP detection but few can quantify SNP frequencies when the mutated DNA molecules correspond to a small fraction of the wild-type DNA. Furthermore, there is no generally accepted gold standard for SNP quantification, and, in general, currently applied methods give inconsistent results in selected cohorts. In the present study we sought to develop a novel method for accurate detection and quantification of SNP in DNA pooled samples. Methods: The development and evaluation of a novel Ligase Chain Reaction (LCR) protocol that uses a DNA-specific fluorescent dye to allow quantitative real-time analysis is described. Different reaction components and thermocycling parameters affecting the efficiency and specificity of LCR were examined. Several protocols, including gap-LCR modifications, were evaluated using plasmid standard and genomic DNA pools. A protocol of choice was identified and applied for the quantification of a polymorphism at codon 136 of the ovine PRNP gene that is associated with susceptibility to a transmissible spongiform encephalopathy in sheep. Conclusions: The real-time LCR protocol developed in the present study showed high sensitivity, accuracy, reproducibility and a wide dynamic range of SNP quantification in different DNA pools. The limits of detection and quantification of SNP frequencies were 0.085% and 0.35%, respectively. Significance: The proposed real-time LCR protocol is applicable when sensitive detection and accurate quantification of low copy number mutations in DNA pools is needed. Examples include oncogenes and tumour suppressor genes, infectious diseases, pathogenic bacteria, fungal species, viral mutants, drug resistance resulting from point mutations, and genetically modified organisms in food.	[Psifidi, Androniki; Banos, Georgios] Aristotle Univ Thessaloniki, Fac Vet Med, Dept Anim Prod, GR-54006 Thessaloniki, Greece; [Dovas, Chrysostomos] Aristotle Univ Thessaloniki, Fac Vet Med, Lab Microbiol & Infect Dis, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Psifidi, A (corresponding author), Aristotle Univ Thessaloniki, Fac Vet Med, Dept Anim Prod, GR-54006 Thessaloniki, Greece.	dovas@vet.auth.gr	Dovas, Chrysostomos/AAF-9663-2019	Dovas, Chrysostomos/0000-0003-2947-1765; Banos, Georgios/0000-0002-7674-858X	European Commission [030278, FPC-2004-SMW-COLL]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by the Sixth Framework Program of the European Commission, project RISKSCRA, grant number: 030278, FPC-2004-SMW-COLL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1995, NUCLEIC ACIDS RES, V23, P675, DOI 10.1093/nar/23.4.675; Bagnato A, 2008, J DAIRY SCI, V91, P767, DOI 10.3168/jds.2007-0507; BIRKENMEYER L, 1992, J CLIN MICROBIOL, V30, P3089, DOI 10.1128/JCM.30.12.3089-3094.1992; Borodina TA, 2004, ANAL BIOCHEM, V333, P309, DOI 10.1016/j.ab.2004.05.032; Buitkamp J, 2004, ARCH TIERZUCHT, V47, P15, DOI 10.5194/aab-47-15-2004; CAO W, 2004, TRENDS BIOTECHNOL, V22; de Noronha C M, 1992, PCR Methods Appl, V2, P131; Di Giusto DA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh036; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Dovas CI, 2010, APPL ENVIRON MICROB, V76, P2165, DOI 10.1128/AEM.01929-09; Gruber JD, 2002, HUM GENET, V110, P395, DOI 10.1007/s00439-002-0722-6; Gut IG, 2001, HUM MUTAT, V17, P475; Harden SV, 2004, CLIN CANCER RES, V10, P2379, DOI 10.1158/1078-0432.CCR-03-0405; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Ihrig J, 2006, ANAL BIOCHEM, V359, P265, DOI 10.1016/j.ab.2006.07.043; Inczedy J., 1998, COMPEDIUM ANAL NOMEN; KNOW PY, 2001, ANNU REV GENOM HUM G, V2, P235; Luhken G, 2004, ARCH VIROL, V149, P1571, DOI 10.1007/s00705-004-0303-1; Macgregor S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl136; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Marshall R L, 1994, PCR Methods Appl, V4, P80; Mattarucchi E, 2005, J BIOCHEM MOL BIOL, V38, P555; Mhlanga MM, 2001, METHODS, V25, P463, DOI 10.1006/meth.2001.1269; Norton N, 2004, ANN MED, V36, P146, DOI 10.1080/07853890310021724; PSIFIDI A, 2010, ANIMAL GENE IN PRESS; Psifidi A, 2010, MOL CELL PROBE, V24, P93, DOI 10.1016/j.mcp.2009.11.001; Schwarz G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh020; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Tapp I, 2000, BIOTECHNIQUES, V28, P732, DOI 10.2144/00284rr02; Tian F, 2008, CLIN CHEM LAB MED, V46, P486, DOI 10.1515/CCLM.2008.098; Tooley PW, 2002, CAN J PLANT PATHOL, V24, P294; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang WJ, 2006, ANAL BIOCHEM, V356, P303, DOI 10.1016/j.ab.2006.05.027; WIEDMANN M, 1994, PCR METH APPL, V3, pS51; Yu AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-143; Zhou GH, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.19.e93	36	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14560	10.1371/journal.pone.0014560	http://dx.doi.org/10.1371/journal.pone.0014560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283808	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600006
J	Lee, JP; Bae, JB; Yang, SH; Cha, RH; Seong, EY; Park, YJ; Ha, J; Park, MH; Paik, JH; Kim, YS				Lee, Jung Pyo; Bae, Jong Bin; Yang, Seung Hee; Cha, Ran-hui; Seong, Eun Young; Park, Yang Jin; Ha, Jongwon; Park, Myoung Hee; Paik, Jin Ho; Kim, Yon Su			Genetic Predisposition of Donors Affects the Allograft Outcome in Kidney Transplantation; Polymorphisms of Stromal-Derived Factor-1 and CXC Receptor 4	PLOS ONE			English	Article							PROGENITOR-CELL RECRUITMENT; CXCL12-G801A POLYMORPHISM; CHEMOKINE RECEPTORS; SDF-1; EXPRESSION; REJECTION; INJURY; LIVER; IMPACT; CANCER	Genetic interaction between donor and recipient may dictate the impending responses after transplantation. In this study, we evaluated the role of the genetic predispositions of stromal-derived factor-1 (SDF1) [rs1801157 (G>A)] and CXC receptor 4 (CXCR4) [rs2228014 (C>T)] on renal allograft outcomes. A total of 335 pairs of recipients and donors were enrolled. Biopsy-proven acute rejection (BPAR) and long-term graft survival were traced. Despite similar allele frequencies between donors and recipients, minor allele of SDF1 rs1801157 (GA+AA) from donor, not from recipients, has a protective effect on the development of BPAR compared to wild type donor (GG) (P = 0.005). Adjustment for multiple covariates did not affect this result (odds ratio 0.39, 95% C.I 0.20-0.76, P = 0.006). CXCR4 rs2228014 polymorphisms from donor or recipient did not affect the incidence of acute rejection. SDF1 was differentially expressed in renal tubular epithelium with acute rejection according to genetic variations of donor rs1801157 showing higher expressions in the grafts from GG donors. Contrary to the development of BPAR, the presence of minor allele rs1801157 A, especially homozygocity, predisposed poor graft survival (P = 0.001). This association was significant after adjusting for several risk factors (hazard ratio 3.01; 95% C.I = 1.19-7.60; P = 0.020). The allelic variation of recipients, however, was not associated with graft loss. A donor-derived genetic polymorphism of SDF1 has influenced the graft outcome. Thus, the genetic predisposition of donor should be carefully considered in transplantation.	[Lee, Jung Pyo; Yang, Seung Hee; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Cha, Ran-hui] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Seong, Eun Young] Pusan Natl Univ, Sch Med, Dept Internal Med, Pusan, South Korea; [Park, Yang Jin; Ha, Jongwon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Park, Myoung Hee] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Park, Myoung Hee] Seoul Natl Univ, Clin Res Inst, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Pusan National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, JP (corresponding author), Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea.	yonsukim@snu.ac.kr	Ha, Jong Won/E-3893-2012; Park, Myoung Hee/J-5483-2012; Kim, Yon Su/J-2743-2012		Ministry of Health and Welfare, Republic of Korea [03-PJ10-PG13-GD01-0002]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Health 21 R&D project. Ministry of Health and Welfare, Republic of Korea (03-PJ10-PG13-GD01-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Cha RH, 2009, NEPHROL DIAL TRANSPL, V24, P2919, DOI 10.1093/ndt/gfp317; Chang SC, 2009, ANN SURG ONCOL, V16, P2323, DOI 10.1245/s10434-009-0501-x; Ghilardi G, 2008, CYTOKINE, V41, P24, DOI 10.1016/j.cyto.2007.10.007; Goddard S, 2001, TRANSPLANTATION, V72, P1957, DOI 10.1097/00007890-200112270-00016; Halloran PF, 2001, AM J PATHOL, V158, P215, DOI 10.1016/S0002-9440(10)63960-0; Hirata H, 2007, CLIN CANCER RES, V13, P5056, DOI 10.1158/1078-0432.CCR-07-0859; Hoffmann U, 2006, CLIN TRANSPLANT, V20, P712, DOI 10.1111/j.1399-0012.2006.00540.x; Khademi B, 2008, PATHOL ONCOL RES, V14, P45, DOI 10.1007/s12253-008-9007-2; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kucia M, 2004, J MOL HISTOL, V35, P233; NAUMANN U, PLOS ONE, V5, pE9175; Neusser MA, 2010, KIDNEY INT, V77, P801, DOI 10.1038/ki.2010.6; Ponziani V, 2008, LEUKEMIA, V22, P669, DOI 10.1038/sj.leu.2404938; Rabin RL, 1999, J IMMUNOL, V162, P3840; Schroppel B, 2002, AM J TRANSPLANT, V2, P640, DOI 10.1034/j.1600-6143.2002.20709.x; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xiao QZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004061; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	23	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16710	10.1371/journal.pone.0016710	http://dx.doi.org/10.1371/journal.pone.0016710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304904	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036600016
J	Wang, GZ; Luo, HY; Meng, K; Wang, YR; Huang, HQ; Shi, PJ; Pan, X; Yang, PL; Diao, QY; Zhang, HF; Yao, B				Wang, Guozeng; Luo, Huiying; Meng, Kun; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Pan, Xia; Yang, Peilong; Diao, Qiyu; Zhang, Hongfu; Yao, Bin			High Genetic Diversity and Different Distributions of Glycosyl Hydrolase Family 10 and 11 Xylanases in the Goat Rumen	PLOS ONE			English	Article							BACTERIAL COMMUNITY; LIGNIN REMOVAL; DIRECT CLONING; EXPRESSION; PROTEIN; METAGENOMICS; MULTIPLICITY; SPECIFICITY; STRAINS; PROGRAM	Background: The rumen harbors a complex microbial ecosystem for efficient hydrolysis of plant polysaccharides which are the main constituent of the diet. Xylanase is crucial for hemicellulose hydrolysis and plays an important role in the plant cell wall degradation. Xylanases of ruminal strains were widely studied, but few studies have focused on their diversity in rumen microenvironment. Methodology/Principal Findings: We explored the genetic diversity of xylanases belonging to two major glycosyl hydrolase families (GH 10 and 11) in goat rumen contents by analyzing the amplicons generated with two degenerate primer sets. Fifty-two distinct GH 10 and 35 GH 11 xylanase gene fragments (similarity <95%) were retrieved, and most had low identities with known sequences. Based on phylogenetic analysis, all GH 10 xylanase sequences fell into seven clusters, and 88.5% of them were related to xylanases from Bacteroidetes. Five clusters of GH 11 xylanase sequences were identified. Of these, 85.7% were related to xylanases from Firmicutes, and 14.3% were related to those of rumen fungi. Two full-length xylanase genes (one for each family) were directly cloned and expressed in Escherichia coli. Both the recombinant enzymes showed substantial xylanase activity, and were purified and characterized. Combined with the results of sheep rumen, Bacteroidetes and Firmicutes are the two major phyla of xylan-degrading microorganisms in rumen, which is distinct from the representatives of other environments such as soil and termite hindgut, suggesting that xylan-degrading microorganisms are environment specific. Conclusion/Significance: The numerous new xylanase genes suggested the functional diversity of xylanase in the rumen microenvironment which may have great potential applications in industry and agriculture. The phylogenetic diversity and different distributions of xylanase genes will help us understand their roles in plant cell wall degradation in the rumen microenvironment.	[Wang, Guozeng; Luo, Huiying; Meng, Kun; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Pan, Xia; Yang, Peilong; Diao, Qiyu; Yao, Bin] Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China; [Zhang, Hongfu] Chinese Acad Agr Sci, State Key Lab Anim Nutr, Inst Anim Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Wang, GZ (corresponding author), Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China.	yaobin@caas-bio.net.cn		Wang, Guozeng/0000-0001-6547-0490	Key Program of Transgenic Plant Breeding [2008ZX08011-005]; Earmarked Fund for Modern Agro-industry Technology Research System [NYCYTX-42-G2-05]; Agricultural Science and Technology Conversion Funds [2008GB23260388]	Key Program of Transgenic Plant Breeding; Earmarked Fund for Modern Agro-industry Technology Research System; Agricultural Science and Technology Conversion Funds	This work was supported by the Key Program of Transgenic Plant Breeding (2008ZX08011-005), the Earmarked Fund for Modern Agro-industry Technology Research System (NYCYTX-42-G2-05), and the Agricultural Science and Technology Conversion Funds (grant 2008GB23260388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Bunzel M, 2003, ERNAHRUNGS UMSCHAU, V50, P469; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Dalrymple BP, 1999, APPL ENVIRON MICROB, V65, P3660; de Segura BG, 1998, FEMS MICROBIOL LETT, V164, P47, DOI 10.1111/j.1574-6968.1998.tb13066.x; Dehority BA, 2000, APPL ENVIRON MICROB, V66, P2921, DOI 10.1128/AEM.66.7.2921-2927.2000; Dick LK, 2005, APPL ENVIRON MICROB, V71, P3184, DOI 10.1128/AEM.71.6.3184-3191.2005; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 1997, BBA-PROTEIN STRUCT M, V1337, P161, DOI 10.1016/S0167-4838(96)00213-0; FLINT HJ, 1994, CURR MICROBIOL, V29, P139, DOI 10.1007/BF01570754; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; GASPARIC A, 1995, APPL ENVIRON MICROB, V61, P2958, DOI 10.1128/AEM.61.8.2958-2964.1995; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; Hayashi H, 2005, CAN J MICROBIOL, V51, P251, DOI 10.1139/W04-136; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Huang HQ, 2010, APPL MICROBIOL BIOT, V87, P1141, DOI 10.1007/s00253-010-2613-4; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; KOPECNY J, 1988, FOLIA MICROBIOL, V33, P208, DOI 10.1007/BF02925906; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Leser TD, 2000, APPL ENVIRON MICROB, V66, P3290, DOI 10.1128/AEM.66.8.3290-3296.2000; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JR, 2005, FEMS MICROBIOL LETT, V251, P233, DOI 10.1016/j.femsle.2005.08.008; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morrison M, 2010, MICROB ECOL, V59, P212, DOI 10.1007/s00248-009-9562-4; Ohgren K, 2007, BIORESOURCE TECHNOL, V98, P2503, DOI 10.1016/j.biortech.2006.09.003; Qi M, 2008, APPL ENVIRON MICROB, V74, P987, DOI 10.1128/AEM.02514-07; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shi PJ, 2008, LETT APPL MICROBIOL, V46, P132, DOI 10.1111/j.1472-765X.2007.02274.x; Singh B, 2008, ANAEROBE, V14, P138, DOI 10.1016/j.anaerobe.2008.03.002; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Wouters J, 2001, ACTA CRYSTALLOGR D, V57, P1813, DOI 10.1107/S0907444901015153; Yang B, 2004, BIOTECHNOL BIOENG, V86, P88, DOI 10.1002/bit.20043	48	18	22	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16731	10.1371/journal.pone.0016731	http://dx.doi.org/10.1371/journal.pone.0016731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304822	Green Submitted, Green Published, gold			2022-12-27	WOS:000287036600018
J	Yamamoto, M; Kondo, E; Takeuchi, M; Harashima, A; Otani, T; Tsuji-Takayama, K; Yamasaki, F; Kumon, H; Kibata, M; Nakamura, S				Yamamoto, Mayuko; Kondo, Eisaku; Takeuchi, Makoto; Harashima, Akira; Otani, Takeshi; Tsuji-Takayama, Kazue; Yamasaki, Fumiyuki; Kumon, Hiromi; Kibata, Masayoshi; Nakamura, Shuji			miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3; UMBILICAL-CORD BLOOD; T-CELL LINES; OXIDATIVE STRESS; FOXP3 EXPRESSION; MESSENGER-RNA; TARGET GENES; REG-CELLS; MICRORNAS; ACTIVATION	MicroRNAs (miRNAs) play important roles in regulating post-transcriptional gene repression in a variety of immunological processes. In particular, much attention has been focused on their roles in regulatory T (Treg) cells which are crucial for maintaining peripheral tolerance and controlling T cell responses. Recently, we established a novel type of human Treg cell line, termed HOZOT, multifunctional cells exhibiting a CD4(+) CD8(+) phenotype. In this study, we performed miRNA profiling to identify signature miRNAs of HOZOT, and therein identified miR-155. Although miR-155 has also been characterized as a signature miRNA for FOXP3(+) natural Treg (nTreg) cells, it was expressed quite differently in HOZOT cells. Under both stimulatory and non-stimulatory conditions, miR-155 expression remained at low levels in HOZOT, while its expression in nTreg and conventional T cells remarkably increased after stimulation. We next searched candidate target genes of miR-155 through bioinformatics, and identified FOXO3a, a negative regulator of Akt signaling, as a miR-155 target gene. Further studies by gain-and loss-of-function experiments supported a role for miR-155 in the regulation of FOXO3a protein expression in conventional T and HOZOT cells.	[Yamamoto, Mayuko; Takeuchi, Makoto; Harashima, Akira; Otani, Takeshi; Tsuji-Takayama, Kazue; Kibata, Masayoshi; Nakamura, Shuji] Hayashibara Biochem Labs Inc, Res Ctr, Inst Cell Biol, Okayama, Japan; [Kondo, Eisaku] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan; [Kondo, Eisaku] Aichi Canc Ctr Res Inst, Div Oncol Pathol, Nagoya, Aichi, Japan; [Yamasaki, Fumiyuki] Kurashiki Med Ctr, Kurashiki, Okayama, Japan; [Kumon, Hiromi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama, Japan	Hayashibara Biochemical Laboratories, Inc.; Okayama University; Aichi Cancer Center; Okayama University	Yamamoto, M (corresponding author), Hayashibara Biochem Labs Inc, Res Ctr, Inst Cell Biol, Okayama, Japan.	m_yamamoto@hayashibara.co.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [50019]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by a grant from the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)'s FY2006 "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" (project; 50019) Scheme in Japan (http://okayama-u.net/medic/icont/english/mainpage/programe.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Harashima A, 2002, BLOOD, V100, P4440, DOI 10.1182/blood-2002-03-0864; Harashima A, 2009, MOL IMMUNOL, V46, P3310, DOI 10.1016/j.molimm.2009.07.023; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakamura S, 2007, EXP HEMATOL, V35, P287, DOI 10.1016/j.exphem.2006.10.011; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sugimoto A, 2009, EXP HEMATOL, V37, P1454, DOI 10.1016/j.exphem.2009.10.002; Suzuki M, 2009, EXP HEMATOL, V37, P92, DOI 10.1016/j.exphem.2008.09.010; Tait ED, 2009, NAT IMMUNOL, V10, P457, DOI 10.1038/ni0509-457; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Tsuji-Takayama K, 2008, EXP HEMATOL, V36, P181, DOI 10.1016/j.exphem.2007.09.010; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Yamamoto M, 2008, LEUKEMIA RES, V32, P651, DOI 10.1016/j.leukres.2007.08.020; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	44	44	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16841	10.1371/journal.pone.0016841	http://dx.doi.org/10.1371/journal.pone.0016841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304824	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600031
J	Hoye, BJ; Buttemer, WA				Hoye, Bethany J.; Buttemer, William A.			Inexplicable Inefficiency of Avian Molt? Insights from an Opportunistically Breeding Arid-Zone Species, Lichenostomus penicillatus	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; FEMALE PIED FLYCATCHERS; BASAL METABOLIC-RATE; TRADE-OFF; REPRODUCTIVE SUCCESS; PASSER-DOMESTICUS; BODY-COMPOSITION; SEASONAL-CHANGES; IMMUNE FUNCTION; PARENTAL CARE	The majority of bird species studied to date have molt schedules that are not concurrent with other energy demanding life history stages, an outcome assumed to arise from energetic trade-offs. Empirical studies reveal that molt is one of the most energetically demanding and perplexingly inefficient growth processes measured. Furthermore, small birds, which have the highest mass-specific basal metabolic rates (BMRm), have the highest costs of molt per gram of feathers produced. However, many small passerines, including white-plumed honeyeaters (WPHE; Lichenostomus penicillatus), breed in response to resource availability at any time of year, and do so without interrupting their annual molt. We examined the energetic cost of molt in WPHE by quantifying weekly changes in minimum resting metabolic rate (RMRmin) during a natural-molt period in 7 wild-caught birds. We also measured the energetic cost of feather replacement in a second group of WPHEs that we forced to replace an additional 25% of their plumage at the start of their natural molt period. Energy expenditure during natural molt revealed an energy conversion efficiency of just 6.9% (+/- 0.57) close to values reported for similar-sized birds from more predictable north-temperate environments. Maximum increases in RMRmin during the molt of WPHE, at 82% (+/- 5.59) above individual pre-molt levels, were some of the highest yet reported. Yet RMRmin maxima during molt were not coincident with the peak period of feather replacement in naturally molting or plucked birds. Given the tight relationship between molt efficiency and mass-specific metabolic rate in all species studied to date, regardless of life-history pattern (Efficiency (%) = 35.720.10(-0.494BMRm); r(2) = 0.944; p = <0.0001), there appears to be concomitant physiological costs entrained in the molt period that is not directly due to feather replacement. Despite these high total expenditures, the protracted molt period of WPHE significantly reduces these added costs on a daily basis.	[Hoye, Bethany J.; Buttemer, William A.] Univ Wollongong, Inst Conservat Biol, Sch Biol Sci, Wollongong, NSW, Australia; [Hoye, Bethany J.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Buttemer, William A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia	University of Wollongong; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Hoye, BJ (corresponding author), Univ Wollongong, Inst Conservat Biol, Sch Biol Sci, Wollongong, NSW, Australia.	b.hoye@nioo.knaw.nl	Buttemer, William A/F-9573-2019; Hoye, Bethany J/A-4486-2010; Bond, Alexander L/A-3786-2010	Buttemer, William A/0000-0003-3176-4452; Hoye, Bethany J/0000-0001-9502-5582; 	Australian Research Council [DP0453021]; Institute for Conservation Biology at the University of Wollongong	Australian Research Council(Australian Research Council); Institute for Conservation Biology at the University of Wollongong	The Australian Research Council (DP0453021) and the Institute for Conservation Biology at the University of Wollongong contributed funds for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alodan MA, 1999, POULTRY SCI, V78, P171, DOI 10.1093/ps/78.2.171; Astheimer LB, 2002, EMU, V102, P19, DOI 10.1071/MU01031; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; Bourgeon S, 2007, ECOSCIENCE, V14, P519, DOI 10.2980/1195-6860(2007)14[519:HAILIK]2.0.CO;2; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; BUTTEMER WA, 1991, J COMP PHYSIOL B, V161, P427; Buttemer WA, 2003, J COMP PHYSIOL B, V173, P223, DOI 10.1007/s00360-003-0326-z; Buttemer WA, 2000, J AVIAN BIOL, V31, P479, DOI 10.1034/j.1600-048X.2000.310407.x; Chapman A, 1995, TROP ZOOL, V8, P227, DOI 10.1080/03946975.1995.10539283; CHILGREN JD, 1977, AUK, V94, P677, DOI 10.2307/4085264; CHILGREN JD, 1977, AUK, V94, P169; CRAIG A, 1983, IBIS, V125, P346, DOI 10.1111/j.1474-919X.1983.tb03120.x; Dawson A, 2003, IBIS, V145, pE69, DOI 10.1046/j.1474-919X.2003.00161.x; DEGRAW WA, 1985, COMP BIOCHEM PHYS A, V81, P889, DOI 10.1016/0300-9629(85)90925-9; DIETZ MW, 1992, PHYSIOL ZOOL, V65, P1217, DOI 10.1086/physzool.65.6.30158276; FARNER DS, 1960, ANAT REC, V137, P354; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Freed LA, 2005, CONDOR, V107, P753, DOI 10.1650/7820.1; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hahn TP, 1998, ECOLOGY, V79, P2365, DOI 10.1890/0012-9658(1998)079[2365:RSIAOB]2.0.CO;2; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Hemborg C, 1999, ANN ZOOL FENN, V36, P1; Hemborg C, 2001, OECOLOGIA, V129, P206, DOI 10.1007/s004420100710; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; KEAST A, 1968, J ZOOL, V155, P185; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Macdonald BCT, 2000, RANGELAND J, V22, P5, DOI 10.1071/RJ0000005; Martin LB, 2005, CAN J ZOOL, V83, P780, DOI 10.1139/Z05-062; Murphy Mary E., 1996, P158; MURPHY ME, 1995, COMP BIOCHEM PHYS A, V111, P385, DOI 10.1016/0300-9629(95)00039-A; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; Nava MP, 2001, CAN J ZOOL, V79, P145, DOI 10.1139/cjz-79-1-145; Newton I, 2005, IBIS, V147, P667, DOI 10.1111/j.1474-919X.2005.00439.x; NEWTON I, 1968, CONDOR, V70, P323, DOI 10.2307/1365926; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Pap PL, 2010, ARDEA, V98, P105, DOI 10.5253/078.098.0113; Portugal SJ, 2007, J EXP BIOL, V210, P1391, DOI 10.1242/jeb.004598; Ricklefs RE, 2000, CONDOR, V102, P9, DOI 10.1650/0010-5422(2000)102[0009:DDEOAT]2.0.CO;2; Sanz JJ, 1997, J AVIAN BIOL, V28, P157, DOI 10.2307/3677309; SCHIELTZ PC, 1995, COMP BIOCHEM PHYS A, V112, P265, DOI 10.1016/0300-9629(95)00097-6; Schmidt-Nielsen K, 1979, ANIMAL PHYSL; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Silverin B, 1999, J AVIAN BIOL, V30, P255, DOI 10.2307/3677351; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; Svensson E, 1997, BEHAV ECOL, V8, P92, DOI 10.1093/beheco/8.1.92; WARD P, 1968, IBIS, V110, P203, DOI 10.1111/j.1474-919X.1968.tb00443.x; WIJANDTS H, 1984, ARDEA, V72, P1; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; YOUNG VR, 1992, ENERGY METABOLISM, P439; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; [No title captured]	57	37	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16230	10.1371/journal.pone.0016230	http://dx.doi.org/10.1371/journal.pone.0016230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311594	Green Published, gold			2022-12-27	WOS:000287036200009
J	Laidre, ME				Laidre, Mark E.			Meaningful Gesture in Monkeys? Investigating whether Mandrills Create Social Culture	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; WILD CHIMPANZEES; ANIMAL CULTURES; CAPTIVE CHIMPANZEES; CUSTOM; IMITATION; SPHINX; COMMUNICATION; TRANSMISSION; CONVENTIONS	Background: Human societies exhibit a rich array of gestures with cultural origins. Often these gestures are found exclusively in local populations, where their meaning has been crafted by a community into a shared convention. In nonhuman primates like African monkeys, little evidence exists for such culturally-conventionalized gestures. Methodology/Principal Findings: Here I report a striking gesture unique to a single community of mandrills (Mandrillus sphinx) among nineteen studied across North America, Africa, and Europe. The gesture was found within a community of 23 mandrills where individuals old and young, female and male covered their eyes with their hands for periods which could exceed 30 min, often while simultaneously raising their elbow prominently into the air. This 'Eye covering' gesture has been performed within the community for a decade, enduring deaths, removals, and births, and it persists into the present. Differential responses to Eye covering versus controls suggested that the gesture might have a locally-respected meaning, potentially functioning over a distance to inhibit interruptions as a 'do not disturb' sign operates. Conclusions/Significance: The creation of this gesture by monkeys suggests that the ability to cultivate shared meanings using novel manual acts may be distributed more broadly beyond the human species. Although logistically difficult with primates, the translocation of gesturers between communities remains critical to experimentally establishing the possible cultural origin and transmission of nonhuman gestures.	[Laidre, Mark E.] Princeton Univ, Dept Ecol & Evolut Biol, Inst Neurosci, Princeton, NJ 08544 USA	Princeton University	Laidre, ME (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	mlaidre@berkeley.edu			Animal Behavior Society; Princeton University Graduate School Centennial Fellowship in the Sciences and Engineering; National Science Foundation	Animal Behavior Society; Princeton University Graduate School Centennial Fellowship in the Sciences and Engineering; National Science Foundation(National Science Foundation (NSF))	Support was derived from an Animal Behavior Society grant, a Princeton University Graduate School Centennial Fellowship in the Sciences and Engineering, and a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KA, 2002, J ZOOL, V258, P131, DOI 10.1017/S0952836902001267; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bonner JohnT., 1980, EVOLUTION CULTURE AN; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Byrne R., 2006, INT J PSYCHOL PSYCHO, V6, P215; Byrne RW, 2004, TRENDS COGN SCI, V8, P341, DOI 10.1016/j.tics.2004.06.002; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; Call J., 2007, GESTURAL COMMUNICATI; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Dawkins R., 1978, P282; de Waal F., 2001, APE SUSHI MASTER CUL; De Waal FBM, 2003, ANN NY ACAD SCI, V1000, P7, DOI 10.1196/annals.1280.003; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; DeWaal FBM, 1997, AM J PRIMATOL, V43, P339, DOI 10.1002/(SICI)1098-2345(1997)43:4<339::AID-AJP5>3.0.CO;2-Y; DEWAAL FBM, 1993, CHILD DEV, V64, P897, DOI 10.2307/1131225; Durham WH., 1991, COEVOLUTION GENES CU; Eibl-Eibesfeldt I., 1972, NONVERBAL COMMUNICAT, P297; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kroeber A. L., 1952, CULTURE CRITICAL REV; Krutzen M, 2007, TRENDS ECOL EVOL, V22, P6, DOI 10.1016/j.tree.2006.10.011; Kuczaj Stan A. II, 2006, Aquatic Mammals, V32, P413, DOI 10.1578/AM.32.4.2006.413; Kummer Hans, 1995, QUEST SACRED BABOON; Laidre ME, 2008, ANIM COGN, V11, P179, DOI 10.1007/s10071-007-0121-4; Laidre ME, 2009, J COMP PSYCHOL, V123, P34, DOI 10.1037/a0013129; Laidre ME, 2005, BEHAVIOUR, V142, P455, DOI 10.1163/1568539054012038; Laidre ME, 2005, ETHOLOGY, V111, P143, DOI 10.1111/j.1439-0310.2004.01051.x; Laland K., 2009, QUESTION ANIMAL CULT, P1; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Liebal Katja, 2007, GESTURAL COMMUNICATI; Liebal Katja, 2006, GESTURE, V6, P1, DOI [10.1075/gest.6.1.02lie, DOI 10.1075/GEST.6.1.02LIE]; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mc Grew WC, 2001, CURR ANTHROPOL, V42, P148, DOI 10.1086/318441; McGrew W., 2009, QUESTION ANIMAL CULT, P41; MCGREW WC, 1978, MAN, V13, P234, DOI 10.2307/2800247; McGrew William, 2004, CULTURED CHIMPANZEE; Nakamura M, 2000, PRIMATES, V41, P237, DOI 10.1007/BF02557594; NISHIDA T, 1980, J HUM EVOL, V9, P117, DOI 10.1016/0047-2484(80)90068-8; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Pika S, 2006, CURR BIOL, V16, pR191, DOI 10.1016/j.cub.2006.02.037; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Richerson PJ., 2005, NOT GENES ALONE CULT; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Sapolsky RM, 2006, CURR ANTHROPOL, V47, P641, DOI 10.1086/504162; Smith W.J., 1977, BEHAV COMMUNICATING; Smuts B, 2002, COGNITIVE ANIMAL, P301; Tanaka I, 1998, ANIM BEHAV, V56, P1229, DOI 10.1006/anbe.1998.0891; Tomasello M, 2002, COGNITIVE ANIMAL, P293; Tomasello M., 1997, EVOLUTION COMMUNICAT, V1, P223, DOI [DOI 10.1075/EOC.1.2.04TOM, 10.1075/eoc.1.2.04tom]; Topal J, 2006, ANIM COGN, V9, P355, DOI 10.1007/s10071-006-0051-6; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069	59	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e14610	10.1371/journal.pone.0014610	http://dx.doi.org/10.1371/journal.pone.0014610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311591	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200001
J	Gilbert, ER; Cox, CM; Williams, PM; McElroy, AP; Dalloul, RA; Ray, WK; Barri, A; Emmerson, DA; Wong, EA; Webb, KE				Gilbert, Elizabeth R.; Cox, Chasity M.; Williams, Patricia M.; McElroy, Audrey P.; Dalloul, Rami A.; Ray, W. Keith; Barri, Adriana; Emmerson, Derek A.; Wong, Eric A.; Webb, Kenneth E., Jr.			Eimeria Species and Genetic Background Influence the Serum Protein Profile of Broilers with Coccidiosis	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; AVIAN COCCIDIOSIS; VACCINATION STRATEGIES; ANTIVIRAL ACTIVITY; TENELLA; OVOTRANSFERRIN; INHIBITORS; IMMUNITY; ACERVULINA; EXPRESSION	Background: Coccidiosis is an intestinal disease caused by protozoal parasites of the genus Eimeria. Despite the advent of anti-coccidial drugs and vaccines, the disease continues to result in substantial annual economic losses to the poultry industry. There is still much unknown about the host response to infection and to date there are no reports of protein profiles in the blood of Eimeria-infected animals. The objective of this study was to evaluate the serum proteome of two genetic lines of broiler chickens after infection with one of three species of Eimeria. Methodology/Principal Findings: Birds from lines A and B were either not infected or inoculated with sporulated oocysts from one of the three Eimeria strains at 15 d post-hatch. At 21 d (6 d post-infection), whole blood was collected and lesion scoring was performed. Serum was harvested and used for 2-dimensional gel electrophoresis. A total of 1,266 spots were quantitatively assessed by densitometry. Protein spots showing a significant effect of coccidia strain and/or broiler genetic line on density at P<0.05-0.01 (250 spots), P<0.01-0.001 (248 spots), and P<0.001 (314 spots) were excised and analyzed by matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry. Proteins were identified in 172 spots. A total of 46 different proteins were identified. Of the spots with a corresponding protein identification, 57 showed a main effect of coccidia infection and/or 2-way interaction of coccidia infectionxbroiler genetic line at P<0.001. Conclusions/Significance: Several of the metabolic enzymes identified in this study are potential candidates for early diagnostic markers of E. acervulina infection including malate dehydrogenase 2, NADH dehydrogenase 1 alpha subcomplex 9, and an ATP synthase. These proteins were detected only in Line A birds that were inoculated with E. acervulina. Results from this study provide a basic framework for future research aimed at uncovering the complex biochemical mechanisms involved in host response to Eimeria infection and in identifying molecular targets for diagnostic screening and development of alternative preventative and therapeutic methods.	[Gilbert, Elizabeth R.; Cox, Chasity M.; Williams, Patricia M.; McElroy, Audrey P.; Dalloul, Rami A.; Barri, Adriana; Wong, Eric A.; Webb, Kenneth E., Jr.] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Ray, W. Keith] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Emmerson, Derek A.] Aviagen, Huntsville, AL USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Gilbert, ER (corresponding author), Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	webbk@vt.edu		Dalloul, Rami/0000-0003-4690-9220	KEW [231908]	KEW	Funding for this research came from unrestricted funds accumulated by KEW over time in return for his having performed amino acid analyses for various investigators (Fund # 231908). Only the authors of the current manuscript had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other individual or agency was involved.	ADAMS JH, 1988, INT J PARASITOL, V18, P683, DOI 10.1016/0020-7519(88)90104-X; Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Cornelissen JBWJ, 2009, VET PARASITOL, V162, P58, DOI 10.1016/j.vetpar.2009.02.001; Dalloul RA, 2005, AVIAN DIS, V49, P1, DOI 10.1637/7306-11150R; Dalloul RA, 2007, MOL IMMUNOL, V44, P558, DOI 10.1016/j.molimm.2006.02.004; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; Fetterer RH, 2007, J PARASITOL, V93, P333, DOI 10.1645/GE-824R1.1; Fetterer RH, 2008, J PARASITOL, V94, P1269, DOI 10.1645/GE-1559.1; FULLER AL, 1990, J PARASITOL, V76, P464, DOI 10.2307/3282822; Georgieva NV, 2006, VET J, V172, P488, DOI 10.1016/j.tvjl.2005.07.016; GIAMBRONE JJ, 1981, POULTRY SCI, V60, P2612, DOI 10.3382/ps.0602612; Giansanti F, 2005, BIOCHEM BIOPH RES CO, V331, P69, DOI 10.1016/j.bbrc.2005.03.125; Giansanti F, 2002, BIOCHEM CELL BIOL, V80, P125, DOI 10.1139/o01-208; Giansanti F, 2007, BIOCHEM CELL BIOL, V85, P150, DOI 10.1139/O06-210; Gilbert ER, 2007, POULTRY SCI, V86, P1739, DOI 10.1093/ps/86.8.1739; Gilbert ER, 2010, J PROTEOME RES, V9, P4628, DOI 10.1021/pr1003533; Granjeaud S, 1999, IMMUNOGENETICS, V49, P964, DOI 10.1007/s002510050580; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Huang SY, 2006, PROTEOMICS, V6, P2217, DOI 10.1002/pmic.200500410; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kim DK, 2009, POULTRY SCI, V88, P1565, DOI 10.3382/ps.2009-00012; Kurokawa H, 1999, J BIOL CHEM, V274, P28445, DOI 10.1074/jbc.274.40.28445; LAURSEN I, 1989, SCAND J IMMUNOL, V30, P529, DOI 10.1111/j.1365-3083.1989.tb02460.x; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; LILLEHOJ HS, 1987, INFECT IMMUN, V55, P1616, DOI 10.1128/IAI.55.7.1616-1621.1987; Lillehoj HS, 1996, CLIN MICROBIOL REV, V9, P349, DOI 10.1128/CMR.9.3.349; Lillehoj HS, 2000, AVIAN DIS, V44, P408, DOI 10.2307/1592556; Loeffen JLCM, 1998, BIOCHEM BIOPH RES CO, V253, P415, DOI 10.1006/bbrc.1998.9786; MAVROIDIS M, 1995, J IMMUNOL, V154, P2164; Meilinger M, 1999, J BIOL CHEM, V274, P38091, DOI 10.1074/jbc.274.53.38091; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; OLSON ST, 2010, BIOCHIMIE; PETERS T, 1987, CLIN CHEM, V33, P1317; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; RICHARDS MP, 1988, BIOL TRACE ELEM RES, V17, P207, DOI 10.1007/BF02795457; Saxena I, 1997, CELL MOL LIFE SCI, V53, P13, DOI 10.1007/PL00000575; STROUT RG, 1994, J PARASITOL, V80, P946, DOI 10.2307/3283444; TURK DE, 1986, POULTRY SCI, V65, P2098, DOI 10.3382/ps.0652098; Weinberg RB, 2000, J LIPID RES, V41, P1410; ZHIRNOV OP, 1982, ARCH VIROL, V73, P263, DOI 10.1007/BF01318080	47	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14636	10.1371/journal.pone.0014636	http://dx.doi.org/10.1371/journal.pone.0014636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297942	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300018
J	Jay, F; Francois, O; Blum, MGB				Jay, Flora; Francois, Olivier; Blum, Michael G. B.			Predictions of Native American Population Structure Using Linguistic Covariates in a Hidden Regression Framework	PLOS ONE			English	Article							GENETIC-STRUCTURE; HISTORICAL LINGUISTICS; BAYESIAN-ANALYSIS; DIFFERENTIATION; DIVERSITY; GEOGRAPHY; LANGUAGE; HAPLOTYPE; MICROSATELLITES; RECONSTRUCTION	Background: The mainland of the Americas is home to a remarkable diversity of languages, and the relationships between genes and languages have attracted considerable attention in the past. Here we investigate to which extent geography and languages can predict the genetic structure of Native American populations. Methodology/Principal Findings: Our approach is based on a Bayesian latent cluster regression model in which cluster membership is explained by geographic and linguistic covariates. After correcting for geographic effects, we find that the inclusion of linguistic information improves the prediction of individual membership to genetic clusters. We further compare the predictive power of Greenberg's and The Ethnologue classifications of Amerindian languages. We report that The Ethnologue classification provides a better genetic proxy than Greenberg's classification at the stock and at the group levels. Although high predictive values can be achieved from The Ethnologue classification, we nevertheless emphasize that Choco, Chibchan and Tupi linguistic families do not exhibit a univocal correspondence with genetic clusters. Conclusions/Significance: The Bayesian latent class regression model described here is efficient at predicting population genetic structure using geographic and linguistic information in Native American populations.	[Jay, Flora] Univ Grenoble 1, Grenoble, France; Fac Med, Ctr Natl Rech Sci, Lab Tech Ingn Med & Complexite, Equipe Biol Computat & Math, La Tronche, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Jay, F (corresponding author), Univ Grenoble 1, Grenoble, France.	olivier.francois@imag.fr	Francois, Olivier/AAQ-3137-2020; Francois, Olivier/A-6051-2012; Blum, Michael/F-9978-2010	Francois, Olivier/0000-0003-2402-2442; Francois, Olivier/0000-0003-2402-2442; Blum, Michael/0000-0003-4174-7373; jay, flora/0000-0001-5884-4730	Institute of Complex Systems IXXI	Institute of Complex Systems IXXI	OF received external fundings from the Institute of Complex Systems IXXI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Ayub Q, 2003, AM J PHYS ANTHROPOL, V122, P259, DOI 10.1002/ajpa.10234; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Bandeen-Roche K, 1997, J AM STAT ASSOC, V92, P1375, DOI 10.2307/2965407; BARRANTES R, 1990, AM J HUM GENET, V46, P63; Belle EMS, 2007, AM J PHYS ANTHROPOL, V133, P1137, DOI 10.1002/ajpa.20622; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; CAMPBELL L, 2006, ENCY LANGUAGE LINGUI, P324; Campbell Lyle, 1997, AM INDIAN LANGUAGES; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1975, THEOR POPUL BIOL, V8, P127, DOI 10.1016/0040-5809(75)90029-5; CHAKRABORTY R, 1976, SOC BIOL, V23, P73, DOI 10.1080/19485565.1976.9988205; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chung H, 2006, J R STAT SOC A STAT, V169, P723, DOI 10.1111/j.1467-985X.2006.00419.x; COLONNA V, 2010, HUM HERED IN PRESS; Corander J, 2003, GENETICS, V163, P367; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Dawson KJ, 2001, GENET RES, V78, P59, DOI 10.1017/S001667230100502X; DESARBO WS, 1988, J CLASSIF, V5, P249, DOI 10.1007/BF01897167; Dugoujon JM, 2004, AM J PHYS ANTHROPOL, V125, P175, DOI 10.1002/ajpa.10405; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; EXCOFFIER L, 1991, HUM BIOL, V63, P273; Fisher R. A., 1915, BIOMETRIKA, P507, DOI DOI 10.2307/2331838; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hastie T., 2009, UNSUPERVISED LEARNIN; Heggarty P, 2010, PHILOS T R SOC B, V365, P3829, DOI 10.1098/rstb.2010.0099; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; Hunley K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000239; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; LEWIN R, 1988, SCIENCE, V242, P1632, DOI 10.1126/science.242.4886.1632; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; MANTEL N, 1967, CANCER RES, V27, P209; Melton PE, 2007, AM J PHYS ANTHROPOL, V133, P753, DOI 10.1002/ajpa.20581; MURILLO F, 1977, AM J PHYS ANTHROPOL, V46, P45, DOI 10.1002/ajpa.1330460107; NOELLI F, 2008, HDB S AM ARCHAEOLOGY, P400; Noelli FS, 1998, ANTIQUITY, V72, P648, DOI 10.1017/S0003598X00087068; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Premo LS, 2009, P NATL ACAD SCI USA, V106, P33, DOI 10.1073/pnas.0809194105; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ripley B. D., 1996, PATTERN RECOGNITION; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; SALZANO FM, 1977, AM J PHYS ANTHROPOL, V42, P337; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Smyth P, 2000, STAT COMPUT, V10, P63, DOI 10.1023/A:1008940618127; SPIELMAN RS, 1974, SCIENCE, V184, P637, DOI 10.1126/science.184.4137.637; Spuhler J, 1972, ASSESSMENT POPULATIO, P73; Spuhler J. N., 1979, 1ST AM ORIGINS AFFIN, P135; SUITS DB, 1957, J AM STAT ASSOC, V52, P548, DOI 10.2307/2281705; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WITKOWSKI SR, 1981, AM ANTHROPOL, V83, P905, DOI 10.1525/aa.1981.83.4.02a00150	65	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16227	10.1371/journal.pone.0016227	http://dx.doi.org/10.1371/journal.pone.0016227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21305006	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300043
J	Novota, P; Zinocker, S; Norden, J; Wang, XN; Sviland, L; Opitz, L; Salinas-Riester, G; Rolstad, B; Dickinson, AM; Walter, L; Dressel, R				Novota, Peter; Zinocker, Severin; Norden, Jean; Wang, Xiao Nong; Sviland, Lisbet; Opitz, Lennart; Salinas-Riester, Gabriela; Rolstad, Bent; Dickinson, Anne M.; Walter, Lutz; Dressel, Ralf			Expression Profiling of Major Histocompatibility and Natural Killer Complex Genes Reveals Candidates for Controlling Risk of Graft versus Host Disease	PLOS ONE			English	Article							INFLAMMATORY FACTOR-I; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; SKIN-EXPLANT MODEL; RAT; MHC; POLYMORPHISMS; PROTEIN; IDENTIFICATION; SEQUENCE	Background: The major histocompatibility complex (MHC) is the most important genomic region that contributes to the risk of graft versus host disease (GVHD) after haematopoietic stem cell transplantation. Matching of MHC class I and II genes is essential for the success of transplantation. However, the MHC contains additional genes that also contribute to the risk of developing acute GVHD. It is difficult to identify these genes by genetic association studies alone due to linkage disequilibrium in this region. Therefore, we aimed to identify MHC genes and other genes involved in the pathophysiology of GVHD by mRNA expression profiling. Methodology/Principal Findings: To reduce the complexity of the task, we used genetically well-defined rat inbred strains and a rat skin explant assay, an in-vitro-model of the graft versus host reaction (GVHR), to analyze the expression of MHC, natural killer complex (NKC), and other genes in cutaneous GVHR. We observed a statistically significant and strong up or down regulation of 11 MHC, 6 NKC, and 168 genes encoded in other genomic regions, i.e. 4.9%, 14.0%, and 2.6% of the tested genes respectively. The regulation of 7 selected MHC and 3 NKC genes was confirmed by quantitative real-time PCR and in independent skin explant assays. In addition, similar regulations of most of the selected genes were observed in GVHD-affected skin lesions of transplanted rats and in human skin explant assays. Conclusions/Significance: We identified rat and human MHC and NKC genes that are regulated during GVHR in skin explant assays and could therefore serve as biomarkers for GVHD. Several of the respective human genes, including HLA-DMB, C2, AIF1, SPR1, UBD, and OLR1, are polymorphic. These candidates may therefore contribute to the genetic risk of GVHD in patients.	[Novota, Peter; Dressel, Ralf] Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Zinocker, Severin; Rolstad, Bent] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Norden, Jean; Wang, Xiao Nong; Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sviland, Lisbet] Univ Bergen, Dept Pathol, Haukeland Sykehus, Sect Pathol,Gades Inst, Bergen, Norway; [Opitz, Lennart; Salinas-Riester, Gabriela] Univ Gottingen, Transcriptome Anal Lab, Gottingen, Germany; [Walter, Lutz] German Primate Ctr, Dept Primate Genet, Gottingen, Germany	University of Gottingen; University of Oslo; Newcastle University - UK; University of Bergen; Haukeland University Hospital; University of Gottingen; Deutsches Primatenzentrum (DPZ)	Novota, P (corresponding author), Inst Rheumatol, Dept Mol Biol & Immunogenet, Slupi 4, Prague 12850 2, Czech Republic.	rdresse@gwdg.de	Walter, Lutz/I-2606-2017; Dressel, Ralf/R-7065-2016; Zinöcker, Severin/G-9026-2011	Walter, Lutz/0000-0001-9408-3131; Dressel, Ralf/0000-0002-1651-1214; Zinöcker, Severin/0000-0003-1730-0125	European Union [MRTN-CT-2004-512253]; Research Council of Norway [ES420977]; Norwegian Cancer Society [41978271522-PR-2006-0467]	European Union(European Commission); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This study was supported by the grant MRTN-CT-2004-512253 (TRANS-NET) from the European Union to A. M. D, B. R., and R. D. and by grant ES420977 from the Research Council of Norway and a grant #41978271522-PR-2006-0467 from the Norwegian Cancer Society to B. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun JA, 1997, BONE MARROW TRANSPL, V19, P1023, DOI 10.1038/sj.bmt.1700788; AGUADO B, 1995, GENOMICS, V25, P650, DOI 10.1016/0888-7543(95)80007-9; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aly TA, 2008, DIABETES, V57, P770, DOI 10.2337/db07-0900; Arora M, 2009, J CLIN ONCOL, V27, P1644, DOI 10.1200/JCO.2008.18.7740; Autieri MV, 2002, CIRCULATION, V106, P2218, DOI 10.1161/01.CIR.0000035652.71915.00; BAKER KS, 1995, BONE MARROW TRANSPL, V15, P595; Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buzzeo MP, 2008, CELL TRANSPLANT, V17, P489, DOI 10.3727/096368908785096042; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chen Q, 2003, CIRCULATION, V107, P3146, DOI 10.1161/01.CIR.0000074207.85796.36; Curry JL, 2003, ARCH PATHOL LAB MED, V127, P289; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Dickinson AM, 2008, INT J IMMUNOGENET, V35, P375, DOI 10.1111/j.1744-313X.2008.00790.x; Dickinson AM, 2004, BRIT J HAEMATOL, V127, P479, DOI 10.1111/j.1365-2141.2004.05216.x; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; DICKINSON AM, 1988, BONE MARROW TRANSPL, V3, P323; Dickinson AM, 2001, HUM IMMUNOL, V62, P1266, DOI 10.1016/S0198-8859(01)00324-X; Dickinson Anne M., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000488; Dressel R, 2001, IMMUNOL REV, V184, P82, DOI 10.1034/j.1600-065x.2001.1840108.x; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Gunther E, 2001, IMMUNOGENETICS, V53, P520, DOI 10.1007/s002510100361; Hahn T, 2008, J CLIN ONCOL, V26, P5728, DOI 10.1200/JCO.2008.17.6545; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Holm SJ, 2003, EXP DERMATOL, V12, P435, DOI 10.1034/j.1600-0625.2003.00048.x; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Hu HZ, 1999, IMMUNOLOGY, V98, P379, DOI 10.1046/j.1365-2567.1999.00881.x; Hurt P, 2004, GENOME RES, V14, P631, DOI 10.1101/gr.1987704; Ichiba T, 2003, BLOOD, V102, P763, DOI 10.1182/blood-2002-09-2748; Ioannidu S, 2001, J IMMUNOL, V166, P3957, DOI 10.4049/jimmunol.166.6.3957; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; KLEMPNAUER J, 1989, IMMUNOGENETICS, V30, P81, DOI 10.1007/BF02421535; KLEMPNAUER J, 1983, TRANSPL P, V15, P1308; Kraft JR, 2000, J EXP MED, V192, P613, DOI 10.1084/jem.192.5.613; Kveberg L, 2010, J LEUKOCYTE BIOL, V88, P87, DOI 10.1189/jlb.0110039; Lambert JC, 2003, J MED GENET, V40, P424, DOI 10.1136/jmg.40.6.424; LANDGREBE J, 2004, IN SILICO BIOL, V4, P461; Lau P, 2000, IMMUNOGENETICS, V51, P148, DOI 10.1007/s002510050023; Leong LYW, 1999, J IMMUNOL, V162, P743; LERNER KG, 1974, TRANSPLANT P, V6, P367; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malkki M, 2007, BIOL BLOOD MARROW TR, V13, P986, DOI 10.1016/j.bbmt.2007.05.007; Mallya M, 2002, GENOMICS, V80, P113, DOI 10.1006/geno.2002.6794; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Morel J, 2003, J RHEUMATOL, V30, P1485; Mulcahy H, 2006, IMMUNOGENETICS, V57, P893, DOI 10.1007/s00251-005-0057-2; Naper C, 1999, EUR J IMMUNOL, V29, P2046, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;2046::AID-IMMU2046&gt;3.0.CO;2-Z; Naper C, 2005, J IMMUNOL, V174, P2702, DOI 10.4049/jimmunol.174.5.2702; Novota P, 2008, TRANSPLANTATION, V85, P1809, DOI 10.1097/TP.0b013e31817753f7; Oh SJ, 2008, BONE MARROW TRANSPL, V41, P1047, DOI 10.1038/bmt.2008.37; Pawlik A, 2008, TISSUE ANTIGENS, V72, P171, DOI 10.1111/j.1399-0039.2008.01086.x; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Rollinger-Holzinger I, 2000, J IMMUNOL, V164, P3169, DOI 10.4049/jimmunol.164.6.3169; SALGAR SK, 1995, IMMUNOGENETICS, V42, P244, DOI 10.1007/BF00176441; Schilling D, 2001, ONCOGENE, V20, P7992, DOI 10.1038/sj.onc.1204965; Shen L, 2006, J BIOL CHEM, V281, P15304, DOI 10.1074/jbc.M600054200; Socie G, 2004, BLOOD, V103, P50, DOI 10.1182/blood-2003-03-0909; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Sugerman PB, 2004, AM J PATHOL, V164, P2189, DOI 10.1016/S0002-9440(10)63776-5; Sviland L, 2001, HUM IMMUNOL, V62, P1277, DOI 10.1016/S0198-8859(01)00318-4; Takahashi N, 2008, EXP HEMATOL, V36, P1760, DOI 10.1016/j.exphem.2008.07.007; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Utans U, 1996, TRANSPLANTATION, V61, P1387, DOI 10.1097/00007890-199605150-00018; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velardi A, 2008, SEMIN IMMUNOPATHOL, V30, P489, DOI 10.1007/s00281-008-0136-1; Vohra RS, 2006, TRENDS CARDIOVAS MED, V16, P60, DOI 10.1016/j.tcm.2005.12.001; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yakoub-Agha I, 2006, J CLIN ONCOL, V24, P5695, DOI 10.1200/JCO.2006.08.0952; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	79	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16582	10.1371/journal.pone.0016582	http://dx.doi.org/10.1371/journal.pone.0016582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305040	gold, Green Published, Green Submitted			2022-12-27	WOS:000286664100046
J	Chatterjee, N; Rollins, J; Mahowald, AP; Bazinet, C				Chatterjee, Nabanita; Rollins, Janet; Mahowald, Anthony P.; Bazinet, Christopher			Neurotransmitter Transporter-Like: A Male Germline-specific SLC6 Transporter Required for Drosophila Spermiogenesis	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; BETA-TUBULIN; NEURONAL EXCITABILITY; SEROTONIN TRANSPORTER; AXONEMAL TUBULIN; GENETIC-ANALYSIS; ALPHA-TUBULIN; MELANOGASTER; SPERMATOGENESIS; MUTATIONS	The SLC6 class of membrane transporters, known primarily as neurotransmitter transporters, is increasingly appreciated for its roles in nutritional uptake of amino acids and other developmentally specific functions. A Drosophila SLC6 gene, Neurotransmitter transporter-like (Ntl), is expressed only in the male germline. Mobilization of a transposon inserted near the 39 end of the Ntl coding region yields male-sterile mutants defining a single complementation group. Germline transformation with Ntl cDNAs under control of male germline-specific control elements restores Ntl/Ntl homozygotes to normal fertility, indicating that Ntl is required only in the germ cells. In mutant males, sperm morphogenesis appears normal, with elongated, individualized and coiled spermiogenic cysts accumulating at the base of the testes. However, no sperm are transferred to the seminal vesicle. The level of polyglycylation of Ntl mutant sperm tubulin appears to be significantly lower than that of wild type controls. Glycine transporters are the most closely related SLC6 transporters to Ntl, suggesting that Ntl functions as a glycine transporter in developing sperm, where augmentation of the cytosolic pool of glycine may be required for the polyglycylation of the massive amounts of tubulin in the fly's giant sperm. The male-sterile phenotype of Ntl mutants may provide a powerful genetic system for studying the function of an SLC6 transporter family in a model organism.	[Chatterjee, Nabanita; Rollins, Janet; Bazinet, Christopher] St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA; [Mahowald, Anthony P.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Saint John's University; University of Chicago	Chatterjee, N (corresponding author), St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA.	bazinetc@stjohns.edu			National Institutes of Health (NIH) [HD043885, R15HD043885]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD043885] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) grant HD043885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Eric Kubli for encouraging us to study this gene. Anti poly-G was generously provided by Martin Gorovsky. Thanks also to Ming Guo for pTMR vector and S. Goto and Karen Hales for the tubulin-GFP-expressing flies. We thank colleagues Paromita Gupta, Roshni Ghosh, Maurice Kernan, Rachel Zufferey, Sergio Bibis, and Julie Brill for critical comments and discussion. Critical reagents and information were provided by FLYBASE, the Bloomington Drosophila Stock Center, and the Drosophila Genome Disruption Project. This work was funded in part by NIH Grant R15HD043885 to C. B.	Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Baker JD, 2004, DEVELOPMENT, V131, P3411, DOI 10.1242/dev.01229; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BIGLER D, 1994, NACHWEIS NEUROTRANSM; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Boudko DY, 2005, P NATL ACAD SCI USA, V102, P1360, DOI 10.1073/pnas.0405183101; Bre MH, 1996, J CELL SCI, V109, P727; BRESSAC C, 1995, EUR J CELL BIOL, V67, P346; Broer S, 2006, NEUROCHEM INT, V48, P559, DOI 10.1016/j.neuint.2005.11.021; Bulinski JC, 2009, DEV CELL, V16, P773, DOI 10.1016/j.devcel.2009.06.003; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; DEMCHYSHYN LL, 1994, P NATL ACAD SCI USA, V91, P5158, DOI 10.1073/pnas.91.11.5158; DORIG R, 1991, ANAL DROSOPHILA GENC; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Gavin BA, 2007, PLOS GENET, V3, P2358, DOI 10.1371/journal.pgen.0030206; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guo JH, 2005, CYTOGENET GENOME RES, V111, P107, DOI 10.1159/000086378; Hafen E., 1997, NATURE, V389, P559; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoyle HD, 2008, CELL MOTIL CYTOSKEL, V65, P295, DOI 10.1002/cm.20261; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Johnson K, 1999, DEV BIOL, V212, P440, DOI 10.1006/dbio.1999.9351; KALTSCHMIDT B, 1991, EUR J CELL BIOL, V54, P110; KEMPHUES KJ, 1982, CELL, V31, P655, DOI 10.1016/0092-8674(82)90321-X; LIFSCHYTZ E, 1987, INT REV CYTOL, V109, P211, DOI 10.1016/S0074-7696(08)61723-4; LIFSCHYTZ E, 1977, CHROMOSOMA, V64, P371, DOI 10.1007/BF00294944; Masson J, 1999, PHARMACOL REV, V51, P439; MATTHEWS KA, 1994, DROSOPHILA MELANGOST, P13; Miller MM, 2008, INSECT BIOCHEM MOLEC, V38, P923, DOI 10.1016/j.ibmb.2008.07.005; Nerusheva OO, 2009, CELL BIOL INT, V33, P586, DOI 10.1016/j.cellbi.2009.02.009; Noguchi T, 2008, MOL BIOL CELL, V19, P2363, DOI 10.1091/mbc.E07-08-0840; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Richards S, 1996, GENETICS, V142, P1215; Riparbelli MG, 2007, DEV BIOL, V303, P108, DOI 10.1016/j.ydbio.2006.10.038; ROBERTSON HM, 1988, GENETICS, V118, P461; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Santel A, 1998, J CELL SCI, V111, P3299; Soehnge H, 1996, P NATL ACAD SCI USA, V93, P13262, DOI 10.1073/pnas.93.23.13262; STERN M, 1992, J NEUROGENET, V8, P157, DOI 10.3109/01677069209083445; Tan Y, 2010, NEURON, V67, P810, DOI 10.1016/j.neuron.2010.08.020; Texada MJ, 2008, J CELL SCI, V121, P1926, DOI 10.1242/jcs.026559; Thimgan MS, 2006, J EXP BIOL, V209, P3383, DOI 10.1242/jeb.02328; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZHANG P, 1993, GENETICS, V133, P361; Zhang YQ, 2004, DEV BIOL, V270, P290, DOI 10.1016/j.ydbio.2004.02.010	65	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16275	10.1371/journal.pone.0016275	http://dx.doi.org/10.1371/journal.pone.0016275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298005	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900028
J	Tyralla, K; Adamczak, M; Benz, K; Campean, V; Gross, ML; Hilgers, KF; Ritz, E; Amann, K				Tyralla, Karin; Adamczak, Marcin; Benz, Kerstin; Campean, Valentina; Gross, Marie-Luise; Hilgers, Karl F.; Ritz, Eberhard; Amann, Kerstin			High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CHRONIC-RENAL-FAILURE; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; INTERSTITIAL FIBROSIS; HEMODIALYSIS-PATIENTS; HEART-FAILURE; RATS; BRADYKININ	Aims: Patients with renal failure develop cardiovascular alterations which contribute to the higher rate of cardiac death. Blockade of the renin angiotensin system ameliorates the development of such changes. It is unclear, however, to what extent ACE-inhibitors can also reverse existing cardiovascular alterations. Therefore, we investigated the effect of high dose enalapril treatment on these alterations. Methods: Male Sprague Dawley rats underwent subtotal nephrectomy (SNX, n = 34) or sham operation (sham, n = 39). Eight weeks after surgery, rats were sacrificed or allocated to treatment with either high-dose enalapril, combination of furosemide/dihydralazine or solvent for 4 weeks. Heart and aorta were evaluated using morphometry, stereological techniques and TaqMan PCR. Results: After 8 and 12 weeks systolic blood pressure, albumin excretion, and left ventricular weight were significantly higher in untreated SNX compared to sham. Twelve weeks after SNX a significantly higher volume density of cardiac interstitial tissue (2.57 +/- 0.43% in SNX vs 1.50 +/- 0.43% in sham, p < 0.05) and a significantly lower capillary length density (4532 +/- 355 mm/mm(3) in SNX vs 50236624 mm/mm(3) in sham, p < 0.05) were found. Treatment of SNX with enalapril from week 8-12 significantly improved myocardial fibrosis (1.63 +/- 0.25%, p < 0.05), but not capillary reduction (3908 +/- 486 mm/mm(3)) or increased intercapillary distance. In contrast, alternative antihypertensive treatment showed no such effect. Significantly increased media thickness together with decreased vascular smooth muscles cell number and a disarray of elastic fibres were found in the aorta of SNX animals compared to sham. Both antihypertensive treatments failed to cause complete regression of these alterations. Conclusions: The study indicates that high dose ACE-I treatment causes partial, but not complete, reversal of cardiovascular changes in SNX.	[Tyralla, Karin; Benz, Kerstin; Campean, Valentina; Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany; [Adamczak, Marcin; Gross, Marie-Luise] Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany; [Adamczak, Marcin] Silesian Univ Sch Med, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland; [Hilgers, Karl F.] Univ Erlangen Nurnberg, Dept Internal Med Nephrol, Erlangen, Germany; [Ritz, Eberhard] Heidelberg Univ, Dept Internal Med, D-6900 Heidelberg, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Medical University Silesia; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg	Tyralla, K (corresponding author), Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany.	kerstin.amann@uk-erlangen.de		Adamczak, Marcin/0000-0002-0804-1718	IZKF Erlangen [A11]	IZKF Erlangen	Parts of the study were sponsored by a grant from the IZKF Erlangen (project A11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2003, J AM SOC NEPHROL, V14, P2833, DOI 10.1097/01.ASN.0000095248.91994.D3; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; AMANN K, 1995, NEPHROL DIAL TRANSPL, V10, P2043; Amann K, 1997, AM J KIDNEY DIS, V30, P382, DOI 10.1016/S0272-6386(97)90283-3; Amann K, 2003, KIDNEY INT, V63, P1708, DOI 10.1046/j.1523-1755.2003.00927.x; Amann K, 2002, KIDNEY INT, V62, P877, DOI 10.1046/j.1523-1755.2002.00518.x; AMANN K, 1995, AM J HYPERTENS, V8, P409, DOI 10.1016/0895-7061(94)00248-A; Amann K, 1997, Adv Ren Replace Ther, V4, P212; Amann K, 2000, KIDNEY INT, V58, P153, DOI 10.1046/j.1523-1755.2000.00163.x; Amann K, 2000, J AM SOC NEPHROL, V11, P1702, DOI 10.1681/ASN.V1191702; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; Amann K, 2001, J CLIN BAS CARDIOL, V4, P109; Cannella G, 1997, AM J KIDNEY DIS, V30, P659, DOI 10.1016/S0272-6386(97)90490-X; Clerk A, 1996, BIOCHEM J, V317, P109, DOI 10.1042/bj3170109; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Eckardt KU, 2009, J AM SOC NEPHROL, V20, P2651, DOI 10.1681/ASN.2009060631; Fernandez-Juarez G, 2006, J AM SOC NEPHROL, V17, pS250, DOI 10.1681/ASN.2006080922; GOHLKE P, 1993, AM J CARDIOL, V72, pE2; Gonzalez A, 2002, J MOL CELL CARDIOL, V34, P1585, DOI 10.1006/jmcc.2002.2081; Gretz N, 1988, Contrib Nephrol, V60, P46; GRIFFIN KA, 1994, J AM SOC NEPHROL, V4, P2023; Hampl H, 2005, AM J NEPHROL, V25, P211, DOI 10.1159/000085881; Hartner Andrea, 2005, BMC Nephrol, V6, P6, DOI 10.1186/1471-2369-6-6; Hui AY, 2006, LIVER INT, V26, P125, DOI 10.1111/j.1478-3231.2005.01202.x; IKOMA M, 1991, KIDNEY INT, V40, P195, DOI 10.1038/ki.1991.200; Imai C, 2005, CLIN EXP HYPERTENS, V27, P59, DOI 10.1081/CEH-200044262; JACKSON B, 1988, AM J HYPERTENS, V1, P298, DOI 10.1093/ajh/1.3.298; KAKINUMA Y, 1992, KIDNEY INT, V42, P46, DOI 10.1038/ki.1992.259; KUNCZERA M, 1991, J HYPERTENS, V9, P41; Li YW, 2007, J CARD FAIL, V13, P155, DOI 10.1016/j.cardfail.2006.11.005; LONDON GM, 1990, KIDNEY INT, V37, P137, DOI 10.1038/ki.1990.19; MALL G, 1990, NEPHROL DIAL TRANSPL, V5, P39, DOI 10.1093/ndt/5.1.39; MALL G, 1988, KIDNEY INT, V33, P804, DOI 10.1038/ki.1988.71; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; MINSHALL RD, 1995, CIRC RES, V76, P773, DOI 10.1161/01.RES.76.5.773; Ozkahya M, 1998, NEPHROL DIAL TRANSPL, V13, P1489, DOI 10.1093/ndt/13.6.1489; RAMBAUSEK M, 1985, KIDNEY INT, V28, P775, DOI 10.1038/ki.1985.197; Ritz E, 1997, Adv Nephrol Necker Hosp, V27, P85; Ritz E, 2009, KIDNEY INT, V75, P771, DOI 10.1038/ki.2009.35; Ruiz V, 2003, AM J PHYSIOL-LUNG C, V285, pL1026, DOI 10.1152/ajplung.00183.2003; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Siedlecki AM, 2009, KIDNEY INT, V75, P800, DOI 10.1038/ki.2008.690; SUZUKI H, 1995, AM J NEPHROL, V15, P129, DOI 10.1159/000168817; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Toz H, 1999, KIDNEY INT, V56, P350; WEIZ MR, 2007, CLIN THER, V9, P1803; Wolf G, 1996, HYPERTENSION, V27, P897, DOI 10.1161/01.HYP.27.4.897; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	49	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15287	10.1371/journal.pone.0015287	http://dx.doi.org/10.1371/journal.pone.0015287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298056	gold, Green Submitted, Green Published			2022-12-27	WOS:000286663900014
J	Williams-Guillen, K; Perfecto, I				Williams-Guillen, Kimberly; Perfecto, Ivette			Ensemble Composition and Activity Levels of Insectivorous Bats in Response to Management Intensification in Coffee Agroforestry Systems	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; FOREST FRAGMENTS; ECHOLOCATION; DIVERSITY; PHYLLOSTOMIDAE; IDENTIFICATION; COMPLETENESS; COMMUNITIES; CHIROPTERA; INDICATORS	Shade coffee plantations have received attention for their role in biodiversity conservation. Bats are among the most diverse mammalian taxa in these systems; however, previous studies of bats in coffee plantations have focused on the largely herbivorous leaf-nosed bats (Phyllostomidae). In contrast, we have virtually no information on how ensembles of aerial insectivorous bats - nearly half the Neotropical bat species - change in response to habitat modification. To evaluate the effects of agroecosystem management on insectivorous bats, we studied their diversity and activity in southern Chiapas, Mexico, a landscape dominated by coffee agroforestry. We used acoustic monitoring and live captures to characterize the insectivorous bat ensemble in forest fragments and coffee plantations differing in the structural and taxonomic complexity of shade trees. We captured bats of 12 non-phyllostomid species; acoustic monitoring revealed the presence of at least 12 more species of aerial insectivores. Richness of forest bats was the same across all land-use types; in contrast, species richness of open-space bats increased in low shade, intensively managed coffee plantations. Conversely, only forest bats demonstrated significant differences in ensemble structure (as measured by similarity indices) across land-use types. Both overall activity and feeding activity of forest bats declined significantly with increasing management intensity, while the overall activity, but not feeding activity, of open-space bats increased. We conclude that diverse shade coffee plantations in our study area serve as valuable foraging and commuting habitat for aerial insectivorous bats, and several species also commute through or forage in low shade coffee monocultures.	[Williams-Guillen, Kimberly; Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Williams-Guillen, K (corresponding author), Univ Washington, Bothell, WA USA.	kimwg@uw.edu			National Science Foundation [DBI-0610473]; Bat Conservation International	National Science Foundation(National Science Foundation (NSF)); Bat Conservation International	Funding provided by National Science Foundation (DBI-0610473 to KWG) and Bat Conservation International (www.batcon.org). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Colwell RK, 2013, ESTIMATES STAT ESTIM; Corben C., 2004, BAT ECHOLOCATION RES, P95; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Cruz-Lara Laura E., 2004, Acta Zool. Mex, V20, P63; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Estrada A, 2002, BIOL CONSERV, V103, P237, DOI 10.1016/S0006-3207(01)00135-5; Estrada A., 2004, ANIMAL BIODIVERSITY, V27, P1; Estrada-Villegas S, 2010, BIOL CONSERV, V143, P597, DOI 10.1016/j.biocon.2009.11.009; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; FENTON MB, 1992, BIOTROPICA, V24, P440, DOI 10.2307/2388615; Fenton MB, 2000, ACTA CHIROPTEROL, V2, P215; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Estrada CG, 2006, BIOL CONSERV, V132, P351, DOI 10.1016/j.biocon.2006.04.027; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Jung K, 2010, J MAMMAL, V91, P144, DOI [10.1644/08-MAMM-A-313R.1, 10.1644/08-MAMM-A-313R.1.]; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kelm DH, 2008, CONSERV BIOL, V22, P733, DOI 10.1111/j.1523-1739.2008.00925.x; KUNZ TH, 1996, MEASURING MONITORING, P122; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; MacSwiney MC, 2008, J APPL ECOL, V45, P1364, DOI 10.1111/j.1365-2664.2008.01531.x; MacSwiney MC, 2007, BIOL CONSERV, V136, P499, DOI 10.1016/j.biocon.2006.12.021; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Miller BW, 2001, ACTA CHIROPTEROL, V3, P93; MILLER BW, 2003, COMMUNITY ECOLOGY NO; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; O'Farrell MJ, 1999, BIOTROPICA, V31, P507, DOI 10.1111/j.1744-7429.1999.tb00394.x; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; Perfecto I, 2003, ADV AGROECOL, P159; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Reid F. A., 2009, FIELD GUIDE MAMMALS; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rydell J, 2002, J ZOOL, V257, P27, DOI 10.1017/S0952836902000626; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; Somarriba Eduardo, 2004, P198; Struebig MJ, 2008, BIOL CONSERV, V141, P2112, DOI 10.1016/j.biocon.2008.06.009; Wickramasinghe LP, 2003, J APPL ECOL, V40, P984, DOI 10.1111/j.1365-2664.2003.00856.x; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Williams-Guillen K, 2010, BIOTROPICA, V42, P605, DOI 10.1111/j.1744-7429.2010.00626.x; Willig Michael R., 1996, P399; Wilson Don E., 1996, P613	50	37	44	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16502	10.1371/journal.pone.0016502	http://dx.doi.org/10.1371/journal.pone.0016502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298059	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800049
J	Boivin, A; Hanot, M; Malesys, C; Maalouf, M; Rousson, R; Rodriguez-Lafrasse, C; Ardail, D				Boivin, Anthony; Hanot, Maite; Malesys, Celine; Maalouf, Mira; Rousson, Robert; Rodriguez-Lafrasse, Claire; Ardail, Dominique			Transient Alteration of Cellular Redox Buffering before Irradiation Triggers Apoptosis in Head and Neck Carcinoma Stem and Non-Stem Cells	PLOS ONE			English	Article							L-BUTHIONINE-SULFOXIMINE; HUMAN-TUMOR-CELLS; CANCER-CELLS; OXIDATIVE STRESS; GLUTATHIONE DEPLETION; RADIATION RESPONSE; REACTIVE OXYGEN; BREAST-CANCER; IN-VITRO; PHASE-I	Background: Head and neck squamous cell carcinoma (HNSCC) is an aggressive and recurrent malignancy owing to intrinsic radioresistance and lack of induction of apoptosis. The major focus of this work was to design a transient glutathione depleting strategy during the course of irradiation of HNSCC in order to overcome their radioresistance associated with redox adaptation. Methodology/Principal Findings: Treatment of SQ20B cells with dimethylfumarate (DMF), a GSH-depleting agent, and L-Buthionine sulfoximine (BSO), an inhibitor of GSH biosynthesis 4 h before a 10 Gy irradiation led to the lowering of the endogenous GSH content to less than 10% of that in control cells and to the triggering of radiation-induced apoptotic cell death. The sequence of biochemical events after GSH depletion and irradiation included ASK-1 followed by JNK activation which resulted in the triggering of the intrinsic apoptotic pathway through Bax translocation to mitochondria. Conclusions: This transient GSH depletion also triggered radiation-induced cell death in SQ20B stem cells, a key event to overcome locoregional recurrence of HNSCC. Finally, our in vivo data highlight the relevance for further clinical trials of endogenous redox modulation to enhance the cytotoxic effects of radiotherapy.	[Boivin, Anthony; Hanot, Maite; Malesys, Celine; Maalouf, Mira; Rodriguez-Lafrasse, Claire; Ardail, Dominique] Univ Lyon 1, F-69365 Lyon, France; [Boivin, Anthony; Hanot, Maite; Malesys, Celine; Maalouf, Mira; Rodriguez-Lafrasse, Claire; Ardail, Dominique] Fac Med Lyon Sud, Lab Radiobiol Cellulaire & Mol, EA 3738, Oullins, France; [Rousson, Robert; Rodriguez-Lafrasse, Claire; Ardail, Dominique] Hosp Civils Lyon, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Boivin, A (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	Dominique.ardail@univ-lyon1.fr	Rodriguez-Lafrasse, Claire/G-7741-2018		Ligue Contre le Cancer (Comite de l'Ain); Espace de Traitement Oncologique par Ions Legers a dimension Europeenne (ETOILE)	Ligue Contre le Cancer (Comite de l'Ain); Espace de Traitement Oncologique par Ions Legers a dimension Europeenne (ETOILE)	This work was supported by the Ligue Contre le Cancer (Comite de l'Ain) and Espace de Traitement Oncologique par Ions Legers a dimension Europeenne (ETOILE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Alphonse G, 2002, INT J RADIAT BIOL, V78, P821, DOI 10.1080/09553000210153943; Andringa KK, 2006, CANCER RES, V66, P1605, DOI 10.1158/0008-5472.CAN-05-3462; Bailey HH, 1997, J NATL CANCER I, V89, P1789, DOI 10.1093/jnci/89.23.1789; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Biaglow JE, 2003, RADIAT RES, V159, P484, DOI 10.1667/0033-7587(2003)159[0484:RROCDA]2.0.CO;2; Bionda C, 2007, FREE RADICAL BIO MED, V43, P681, DOI 10.1016/j.freeradbiomed.2007.04.031; Castro B, 2002, ANTI-CANCER DRUG, V13, P281, DOI 10.1097/00001813-200203000-00010; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chin D, 2006, EXPERT REV ANTICANC, V6, P1111, DOI 10.1586/14737140.6.7.1111; DETHLEFSEN LA, 1988, RADIAT RES, V114, P215, DOI 10.2307/3577219; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; GIGANTE M, 2003, AM J CLIN ONCOL-CANC, V26, P73; Graziano A, 2008, J CELL BIOCHEM, V103, P408, DOI 10.1002/jcb.21436; Gu B, 2005, ANTI-CANCER DRUG, V16, P167, DOI 10.1097/00001813-200502000-00008; Inci E, 2003, TOHOKU J EXP MED, V200, P17, DOI 10.1620/tjem.200.17; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; LEHNERT S, 1990, RADIAT RES, V124, P208, DOI 10.2307/3577868; LEUNG SW, 1993, CANCER-AM CANCER SOC, V71, P2276, DOI 10.1002/1097-0142(19930401)71:7<2276::AID-CNCR2820710718>3.0.CO;2-7; Lewis-Wambi JS, 2009, J STEROID BIOCHEM, V114, P33, DOI 10.1016/j.jsbmb.2008.12.016; Li LY, 2003, RADIAT RES, V160, P617, DOI 10.1667/RR3076; LIPPITZ BE, 1990, NEUROSURGERY, V26, P255, DOI 10.1227/00006123-199002000-00012; Lo Russo L, 2009, CURR OPIN INVEST DR, V10, P1325; Maalouf M, 2009, INT J RADIAT ONCOL, V74, P200, DOI 10.1016/j.ijrobp.2009.01.012; Maeda H, 2004, CELL DEATH DIFFER, V11, P737, DOI 10.1038/sj.cdd.4401389; Magwere T, 2008, EUR J CANCER, V44, P2276, DOI 10.1016/j.ejca.2008.06.008; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Mazeron R, 2009, ORAL ONCOL, V45, P402, DOI 10.1016/j.oraloncology.2009.01.010; Mirkovic N, 1997, ONCOGENE, V15, P1461, DOI 10.1038/sj.onc.1201310; MIURA M, 1991, RADIAT RES, V126, P229, DOI 10.2307/3577823; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Nelson KC, 1999, INVEST OPHTH VIS SCI, V40, P1927; Odom RY, 2009, NUTR CANCER, V61, P332, DOI 10.1080/01635580802549982; ODwyer PJ, 1996, J CLIN ONCOL, V14, P249, DOI 10.1200/JCO.1996.14.1.249; ORTA T, 1995, INT J RADIAT BIOL, V68, P413, DOI 10.1080/09553009514551371; Palomares T, 1999, MELANOMA RES, V9, P233, DOI 10.1097/00008390-199906000-00004; Palomares T, 2009, ANTICANCER RES, V29, P3957; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; SCHWARTZ JL, 1988, INT J RADIAT ONCOL, V15, P907, DOI 10.1016/0360-3016(88)90125-3; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thomas SM, 2009, HUM GENE THER, V20, P1565, DOI 10.1089/hum.2009.163; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vahrmeijer AL, 1999, CANCER CHEMOTH PHARM, V44, P111, DOI 10.1007/s002800050954; Wick W, 2002, INT J ONCOL, V21, P213; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8	63	47	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14558	10.1371/journal.pone.0014558	http://dx.doi.org/10.1371/journal.pone.0014558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283807	Green Submitted, gold, Green Published			2022-12-27	WOS:000286520600005
J	Siegers, GM; Felizardo, TC; Mathieson, AM; Kosaka, Y; Wang, XH; Medin, JA; Keating, A				Siegers, Gabrielle M.; Felizardo, Tania C.; Mathieson, A. Mark; Kosaka, Yoko; Wang, Xing-Hua; Medin, Jeffrey A.; Keating, Armand			Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE INHIBITOR THERAPY; TYROSINE KINASE; ADOPTIVE IMMUNOTHERAPY; PERIPHERAL-BLOOD; IN-VITRO; LENTIVIRAL VECTORS; DASATINIB THERAPY; EFFECTOR-CELLS; KILLER-CELLS	Gamma delta T cells (GDTc) lyse a variety of hematological and solid tumour cells in vitro and in vivo, and are thus promising candidates for cellular immunotherapy. We have developed a protocol to expand human GDTc in vitro, yielding highly cytotoxic Vgamma9/Vdelta2 CD27/CD45RA double negative effector memory cells. These cells express CD16, CD45RO, CD56, CD95 and NKG2D. Flow cytometric, clonogenic, and chromium release assays confirmed their specific cytotoxicity against Ph+ cell lines in vitro. We have generated a fluorescent and bioluminescent Ph+ cell line, EM-2eGFPluc, and established a novel xenogeneic leukemia model. Intravenous injection of EM-2eGFPluc into NOD. Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice resulted in significant dose-dependent bone marrow engraftment; lower levels engrafted in blood, lung, liver and spleen. In vitro-expanded human GDTc injected intraperitoneally were found at higher levels in blood and organs compared to those injected intravenously; GDTc survived at least 33 days post-injection. In therapy experiments, we documented decreased bone marrow leukemia burden in mice treated with GDTc. Live GDTc were found in spleen and bone marrow at endpoint, suggesting the potential usefulness of this therapy.	[Siegers, Gabrielle M.; Mathieson, A. Mark; Kosaka, Yoko; Wang, Xing-Hua; Keating, Armand] Univ Hlth Network, Princess Margaret Hosp, Cell Therapy Program, Toronto, ON, Canada; [Felizardo, Tania C.; Medin, Jeffrey A.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Siegers, GM (corresponding author), Univ Hlth Network, Princess Margaret Hosp, Cell Therapy Program, Toronto, ON, Canada.	gsiegers@imaging.robarts.ca	Siegers, Gabrielle M/M-2042-2017	Siegers, Gabrielle M/0000-0003-2154-0279	Orsino Cell Therapy Fund	Orsino Cell Therapy Fund	This work was supported by the Orsino Cell Therapy Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331; Aswald JM, 2006, CYTOM PART B-CLIN CY, V70B, P379, DOI 10.1002/cyto.b.20115; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Bocchia M, 2005, LANCET, V365, P657; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; BRAAKMAN E, 1991, INT IMMUNOL, V3, P691, DOI 10.1093/intimm/3.7.691; D'Asaro M, 2010, J IMMUNOL, V184, P3260, DOI 10.4049/jimmunol.0903454; Deininger Michael W, 2008, Hematology Am Soc Hematol Educ Program, P419, DOI 10.1182/asheducation-2008.1.419; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dokouhaki P, 2010, CANCER LETT, V297, P126, DOI 10.1016/j.canlet.2010.05.005; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; ENSSLIN AS, 1991, JNCI-J NATL CANCER I, V83, P1564, DOI 10.1093/jnci/83.21.1564; Espinosa E, 2001, J BIOL CHEM, V276, P18337, DOI 10.1074/jbc.M100495200; Freedman MS, 1997, J NEUROIMMUNOL, V74, P135, DOI 10.1016/S0165-5728(96)00217-2; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Kabelitz D, 2004, J IMMUNOL, V173, P6767, DOI 10.4049/jimmunol.173.11.6767; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Keating A, 1983, S MOL CELL BIOL UCLA, P513; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; Kobayashi H, 2010, ANTICANCER RES, V30, P575; Kreutzman A, 2010, BLOOD, V116, P772, DOI 10.1182/blood-2009-12-256800; Kunzmann V, 2000, BLOOD, V96, P384; Lamb L S Jr, 1996, J Hematother, V5, P503, DOI 10.1089/scd.1.1996.5.503; Lamb LS, 2005, BIOL BLOOD MARROW TR, V11, P161, DOI 10.1016/j.bbmt.2004.11.015; Lamb LS, 2001, BONE MARROW TRANSPL, V27, P601, DOI 10.1038/sj.bmt.1702830; MCCOY JL, 1973, NATL CANCER I MONOGR, P59; Mustjoki S, 2010, LEUKEMIA, V24, P219, DOI 10.1038/leu.2009.190; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Poccia F, 1996, J IMMUNOL, V157, P449; Roelofs AJ, 2009, BRIT J HAEMATOL, V144, P245, DOI 10.1111/j.1365-2141.2008.07435.x; Rohon P, 2010, EUR J HAEMATOL, V85, P387, DOI 10.1111/j.1600-0609.2010.01501.x; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Salot S, 2009, J IMMUNOL METHODS, V347, P12, DOI 10.1016/j.jim.2009.05.006; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Viey E, 2008, J IMMUNOTHER, V31, P313, DOI 10.1097/CJI.0b013e3181609988; VOLLENWEIDER I, 1993, CANCER IMMUNOL IMMUN, V36, P331, DOI 10.1007/BF01741172; WRIGHT A, 1989, J EXP MED, V169, P1557, DOI 10.1084/jem.169.5.1557; Yoshimitsu M, 2004, P NATL ACAD SCI USA, V101, P16909, DOI 10.1073/pnas.0407572101; Zheng BJ, 2001, INT J CANCER, V92, P421, DOI 10.1002/ijc.1198	47	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16700	10.1371/journal.pone.0016700	http://dx.doi.org/10.1371/journal.pone.0016700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304898	gold, Green Submitted, Green Published			2022-12-27	WOS:000287036600015
J	Masson, O; Prebois, C; Derocq, D; Meulle, A; Dray, C; Daviaud, D; Quilliot, D; Valet, P; Muller, C; Liaudet-Coopman, E				Masson, Olivier; Prebois, Christine; Derocq, Danielle; Meulle, Aline; Dray, Cedric; Daviaud, Danielle; Quilliot, Didier; Valet, Philippe; Muller, Catherine; Liaudet-Coopman, Emmanuelle			Cathepsin-D, a Key Protease in Breast Cancer, Is Up-Regulated in Obese Mouse and Human Adipose Tissue, and Controls Adipogenesis	PLOS ONE			English	Article							GENE-EXPRESSION; PROCATHEPSIN-D; GROWTH-FACTORS; IN-VIVO; CELLS; METASTASIS; ADIPOCYTES; TUMOR; DIFFERENTIATION; PROLIFERATION	The aspartic protease cathepsin-D (cath-D) is overexpressed by human epithelial breast cancer cells and is closely correlated with poor prognosis in breast cancer. The adipocyte is one of the most prominent cell types in the tumor-microenvironment of breast cancer, and clinical studies have shown that obesity increases the incidence of breast cancer. Here, we provide the first evidence that cath-D expression is up-regulated in adipose tissue from obese human beings, as well as in adipocytes from the obese C57BI6/J mouse. Cath-D expression is also increased during human and mouse adipocyte differentiation. We show that cath-D silencing in 3T3-F442A murine preadipocytes leads to lipid-depleted cells after adipogenesis induction, and inhibits of the expression of PPAR gamma, HSL and aP2 adipocyte differentiation markers. Altogether, our findings demonstrate the key role of cath-D in the control of adipogenesis, and suggest that cath-D may be a novel target in obesity.	[Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] Inst Rech Cancerol Montpellier, IRCM, Montpellier, France; [Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] INSERM, U896, Montpellier, France; [Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] Univ Montpellier 1, Montpellier, France; [Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] CRLC Val Aurelle Paul Lamarque, Montpellier, France; [Meulle, Aline; Dray, Cedric; Daviaud, Danielle; Valet, Philippe] Univ Toulouse, UPS, Inst Med Mol Rangueil, Toulouse, France; [Meulle, Aline; Muller, Catherine] CNRS, Inst Pharmacol & Struct Biol, UMR 5089, Toulouse, France; [Dray, Cedric; Daviaud, Danielle; Valet, Philippe] Fac Med Toulouse, INSERM, U858, F-31073 Toulouse, France; [Quilliot, Didier] CHU Nancy, Serv Diabetol Malad Metabol & Nutr, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy	Masson, O (corresponding author), Inst Rech Cancerol Montpellier, IRCM, Montpellier, France.	e.liaudet@valdorel.fnclcc.fr	Meulle, Aline/M-6370-2014; Liaudet-Coopman, Emmanuelle/N-4744-2017; Valet, Philippe/N-7472-2017; MULLER, Catherine/M-2185-2018; MULLER, Catherine/E-2060-2011; dray, cedric/N-7440-2017; Quillot, Didier/ABB-5326-2021	Liaudet-Coopman, Emmanuelle/0000-0001-9313-9690; Valet, Philippe/0000-0001-6520-7393; DRAY, Cedric/0000-0002-4712-791X	'Institut National de la Sante et de la Recherche Medicale; University of Montpellier I; Canceropole Grand Sud-Ouest; Institut National du Cancer [PL2006_035]	'Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier I; Canceropole Grand Sud-Ouest; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by the 'Institut National de la Sante et de la Recherche Medicale', the University of Montpellier I, the Canceropole Grand Sud-Ouest and the Institut National du Cancer (INCA grants PL2006_035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Bour S, 2007, BIOCHIMIE, V89, P916, DOI 10.1016/j.biochi.2007.02.013; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; CAPONY F, 1987, J CELL BIOL, V104, P253, DOI 10.1083/jcb.104.2.253; CAPONY F, 1989, CANCER RES, V49, P3904; CAVAILLES V, 1988, NUCLEIC ACIDS RES, V16, P1903, DOI 10.1093/nar/16.5.1903; CAVAILLES V, 1989, MOL ENDOCRINOL, V3, P552, DOI 10.1210/mend-3-3-552; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Ferrandina G, 1997, BRIT J CANCER, V76, P661, DOI 10.1038/bjc.1997.442; Foekens JA, 1999, BRIT J CANCER, V79, P300, DOI 10.1038/sj.bjc.6990048; FUSEK M, 1994, BIOCHEM J, V303, P775, DOI 10.1042/bj3030775; GARCIA M, 1990, ONCOGENE, V5, P1809; Gesta S, 2003, HORM METAB RES, V35, P158, DOI 10.1055/s-2003-39070; Glondu M, 2001, ONCOGENE, V20, P6920, DOI 10.1038/sj.onc.1204843; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Iyengar Puneeth, 2003, Pediatr Diabetes, V4, P32, DOI 10.1034/j.1399-5448.2003.00029.x; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078; LIAUDET E, 1994, ONCOGENE, V9, P1145; LIAUDET E, 1995, CELL GROWTH DIFFER, V6, P1045; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; MAQUOI N, 2002, P NATL ACAD SCI USA, V99, P15345; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P515, DOI 10.1139/Y02-067; MUTKA AL, 2009, J NEUROCHEM; NAOUR N, J CLIN ENDOCRINOL ME, V95, P1861; Nicotra G, 2010, CANCER BIOMARK, V7, P47, DOI 10.3233/CBM-2010-0143; Ohri SS, 2008, INT J ONCOL, V32, P491; Prawitt J, 2008, EXP CELL RES, V314, P814, DOI 10.1016/j.yexcr.2007.11.011; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rochefort H, 1999, APMIS, V107, P86, DOI 10.1111/j.1699-0463.1999.tb01530.x; ROCHEFORT H, 1992, EUR J CANCER, V28A, P1780, DOI 10.1016/0959-8049(92)90003-K; Rodriguez J, 2005, INT J BIOL MARKER, V20, P103, DOI 10.1177/172460080502000204; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Vashishta A, 2007, INT J ONCOL, V30, P1223; Vashishta Aruna, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P385; WESTLEY B, 1980, CELL, V20, P353, DOI 10.1016/0092-8674(80)90621-2; Westley BR, 1999, BRIT J CANCER, V79, P189, DOI 10.1038/sj.bjc.6690032; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623; Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486; Zhou H, 2009, ACTA BIOCH BIOPH SIN, V41, P910, DOI 10.1093/abbs/gmp085	52	45	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16452	10.1371/journal.pone.0016452	http://dx.doi.org/10.1371/journal.pone.0016452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311773	gold, Green Submitted, Green Published			2022-12-27	WOS:000287036200014
J	Cai, X; Wang, R; Filloux, A; Waksman, G; Meng, GY				Cai, Xun; Wang, Rui; Filloux, Alain; Waksman, Gabriel; Meng, Guoyu			Structural and Functional Characterization of Pseudomonas aeruginosa CupB Chaperones	PLOS ONE			English	Article							PROTEIN SECRETION; USHER; BIOFILM; INFECTIONS; BIOGENESIS; PARAMETERS; COMPLEX	Pseudomonas aeruginosa, an important human pathogen, is estimated to be responsible for,10% of nosocomial infections worldwide. The pathogenesis of P. aeruginosa starts from its colonization in the damaged tissue or medical devices (e. g. catheters, prothesis and implanted heart valve etc.) facilitated by several extracellular adhesive factors including fimbrial pili. Several clusters containing fimbrial genes have been previously identified on the P. aeruginosa chromosome and named cup [1]. The assembly of the CupB pili is thought to be coordinated by two chaperones, CupB2 and CupB4. However, due to the lack of structural and biochemical data, their chaperone activities remain speculative. In this study, we report the 2.5 A crystal structure of P. aeruginosa CupB2. Based on the structure, we further tested the binding specificity of CupB2 and CupB4 towards CupB1 (the presumed major pilus subunit) and CupB6 (the putative adhesin) using limited trypsin digestion and strep-tactin pull-down assay. The structural and biochemical data suggest that CupB2 and CupB4 might play different, but not redundant, roles in CupB secretion. CupB2 is likely to be the chaperone of CupB1, and CupB4 could be the chaperone of CupB4:CupB5:CupB6, in which the interaction of CupB4 and CupB6 might be mediated via CupB5.	[Cai, Xun; Meng, Guoyu] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, Sch Med,State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Wang, Rui; Waksman, Gabriel] UCL Birkbeck, Inst Struct & Mol Biol, London, England; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London, England	Chinese Academy of Sciences; Shanghai Jiao Tong University; University of London; Birkbeck University London; University College London; Imperial College London	Cai, X (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, Sch Med,State Key Lab Med Genom, Shanghai 200030, Peoples R China.	a.filloux@imperial.ac.uk; guoyumeng@shsmu.edu.cn		Meng (meng), Guoyu (guo yu)/0000-0001-7904-2382	Shanghai Institute of Higher Learning; National Natural Science Foundation of China [31070645, 30871105]; Wellcome Trust, the United Kingdom [08087]; BBSRC [BB/I018484/1] Funding Source: UKRI; MRC [G0800002] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I018484/1] Funding Source: researchfish; Medical Research Council [G0800002] Funding Source: researchfish	Shanghai Institute of Higher Learning; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wellcome Trust, the United Kingdom(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by "The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institute of Higher Learning" (to GM), the research grants 31070645 and 30871105 of the National Natural Science Foundation of China (to GM and XC) and a research grant 08087 from the Wellcome Trust, the United Kingdom (to GM and GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bann JG, 2004, P NATL ACAD SCI USA, V101, P17389, DOI 10.1073/pnas.0408072101; BODEY GP, 1983, REV INFECT DIS, V5, P279; Chorell E, 2010, J MED CHEM, V53, P5690, DOI 10.1021/jm100470t; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Filloux A, 2003, M S-MED SCI, V19, P77, DOI 10.1051/medsci/200319177; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Geme JWS, 2009, TRENDS MICROBIOL, V17, P355, DOI 10.1016/j.tim.2009.06.002; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hodak H, 2007, RES MICROBIOL, V158, P631, DOI 10.1016/j.resmic.2007.08.001; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; KUEHN MJ, 1993, SCIENCE, V262, P1234, DOI 10.1126/science.7901913; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Sauer FG, 2000, CURR OPIN STRUC BIOL, V10, P548, DOI 10.1016/S0959-440X(00)00129-9; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; Veesenmeyer JL, 2009, CRIT CARE MED, V37, P1777, DOI 10.1097/CCM.0b013e31819ff137; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zavialov A, 2007, FEMS MICROBIOL REV, V31, P478, DOI 10.1111/j.1574-6976.2007.00075.x; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	35	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16583	10.1371/journal.pone.0016583	http://dx.doi.org/10.1371/journal.pone.0016583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304995	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000286834300092
J	Ghavami, S; Mutawe, MM; Sharma, P; Yeganeh, B; McNeill, KD; Klonisch, T; Unruh, H; Kashani, HH; Schaafsma, D; Los, M; Halayko, AJ				Ghavami, Saeid; Mutawe, Mark M.; Sharma, Pawan; Yeganeh, Behzad; McNeill, Karol D.; Klonisch, Thomas; Unruh, Helmut; Kashani, Hessam H.; Schaafsma, Dedmer; Los, Marek; Halayko, Andrew J.			Mevalonate Cascade Regulation of Airway Mesenchymal Cell Autophagy and Apoptosis: A Dual Role for p53	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; MITOCHONDRIAL PERMEABILITY TRANSITION; COENZYME-A REDUCTASE; SMOOTH-MUSCLE-CELLS; CANCER-CELLS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; INDUCE APOPTOSIS; MAMMALIAN-CELLS; DEATH	Statins inhibit the proximal steps of cholesterol biosynthesis, and are linked to health benefits in various conditions, including cancer and lung disease. We have previously investigated apoptotic pathways triggered by statins in airway mesenchymal cells, and identified reduced prenylation of small GTPases as a primary effector mechanism leading to p53-mediated cell death. Here, we extend our studies of statin-induced cell death by assessing endpoints of both apoptosis and autophagy, and investigating their interplay and coincident regulation. Using primary cultured human airway smooth muscle (HASM) and human airway fibroblasts (HAF), autophagy, and autophagosome formation and flux were assessed by transmission electron microscopy, cytochemistry (lysosome number and co-localization with LC3) and immunoblotting (LC3 lipidation and Atg 12-5 complex formation). Chemical inhibition of autophagy increased simvastatin-induced caspase activation and cell death. Similarly, Atg5 silencing with shRNA, thus preventing Atg5-12 complex formation, increased proapoptotic effects of simvastatin. Simvastatin concomitantly increased p53-dependent expression of p53 up-regulated modulator of apoptosis (PUMA), NOXA, and damage-regulated autophagy modulator (DRAM). Notably both mevalonate cascade inhibition-induced autophagy and apoptosis were p53 dependent: simvastatin increased nuclear p53 accumulation, and both cyclic pifithrin-alpha and p53 shRNAi partially inhibited NOXA, PUMA expression and caspase-3/7 cleavage (apoptosis) and DRAM expression, Atg5-12 complex formation, LC3 lipidation, and autophagosome formation (autophagy). Furthermore, the autophagy response is induced rapidly, significantly delaying apoptosis, suggesting the existence of a temporally coordinated p53 regulation network. These findings are relevant for the development of statin-based therapeutic approaches in obstructive airway disease.	[Ghavami, Saeid; Mutawe, Mark M.; Sharma, Pawan; Yeganeh, Behzad; McNeill, Karol D.; Kashani, Hessam H.; Schaafsma, Dedmer; Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Ghavami, Saeid; Sharma, Pawan; Yeganeh, Behzad; Kashani, Hessam H.; Halayko, Andrew J.] Univ Manitoba, Natl Training Program Allergy & Asthma, Winnipeg, MB, Canada; [Klonisch, Thomas] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Unruh, Helmut; Halayko, Andrew J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Ghavami, Saeid; Mutawe, Mark M.; Sharma, Pawan; Yeganeh, Behzad; McNeill, Karol D.; Kashani, Hessam H.; Schaafsma, Dedmer; Halayko, Andrew J.] Manitoba Inst Child Hlth, Biol Breathing Grp, Winnipeg, MB, Canada; [Los, Marek] Linkoping Univ, Integrat Regenerat Med Ctr IGEN, Dept Clin & Expt Med, Linkoping, Sweden	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Linkoping University	Ghavami, S (corresponding author), Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada.	ahalayk@cc.umanitoba.ca	Ghavami, Saeid/Q-8918-2016; Kashani, Hessam H./S-7968-2017; Ghavami, Saeid/GLT-0606-2022; Sharma, Pawan/D-4314-2016; Klonisch, Thomas/W-9923-2019	Kashani, Hessam H./0000-0003-2581-1769; Ghavami, Saeid/0000-0001-5948-508X; Sharma, Pawan/0000-0002-2904-2306; Halayko, Andrew/0000-0002-7865-4552; Yeganeh, Behzad/0000-0002-2315-7620; Los, Marek/0000-0001-9518-1411; Schaafsma, Dedmer/0000-0003-0898-7973	Canadian Institutes of Health Research (CIHR); GlaxoSmithKline Collaborative Innovation Research Fund; Manitoba Institute of Child Health (MICH); Canada Foundation for Innovation; Parker B Francis Fellowship in Pulmonary Research; Manitoba Health Research Council; CIHR; Natural Sciences and Engineering Research Council of Canada (NSERC); DFG Deutsche Krebshilfe [SFB 773, GRK 1302]; Landesstiftung BW [P-PS-ASII/11]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline Collaborative Innovation Research Fund(GlaxoSmithKline); Manitoba Institute of Child Health (MICH); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Parker B Francis Fellowship in Pulmonary Research; Manitoba Health Research Council; CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); DFG Deutsche Krebshilfe; Landesstiftung BW	This work was supported by grants from the Canadian Institutes of Health Research (CIHR), GlaxoSmithKline Collaborative Innovation Research Fund, Manitoba Institute of Child Health (MICH), and Canada Foundation for Innovation. SG is supported by a Parker B Francis Fellowship in Pulmonary Research. DS is supported by a CIHR Postdoctoral Fellowship. PS is supported by the Manitoba Health Research Council, MICH and CIHR. TK acknowledges the support by the Natural Sciences and Engineering Research Council of Canada (NSERC). ML thankfully acknowledges the support from DFG (SFB 773, GRK 1302) Deutsche Krebshilfe, and Landesstiftung BW (P-PS-ASII/11). AJH holds a Canada Research Chair in Airway Cell and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Araki M, 2008, BIOCHEM BIOPH RES CO, V367, P462, DOI 10.1016/j.bbrc.2007.12.166; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Blanco-Colio LM, 2002, ATHEROSCLEROSIS, V161, P17, DOI 10.1016/S0021-9150(01)00613-X; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Ghavami S, 2008, J CELL MOL MED, V12, P1005, DOI 10.1111/j.1582-4934.2008.00129.x; Ghavami Saeid, 2005, P323, DOI 10.1007/0-387-23695-3_15; Ghavami S, 2010, BBA-MOL CELL RES, V1803, P452, DOI 10.1016/j.bbamcr.2009.12.005; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490; Harhaji L, 2007, EUR J PHARMACOL, V568, P89, DOI 10.1016/j.ejphar.2007.04.041; Horiguchi A, 2004, CLIN CANCER RES, V10, P8648, DOI 10.1158/1078-0432.CCR-04-1568; Hsieh CH, 2008, TOXICOL SCI, V102, P150, DOI 10.1093/toxsci/kfm298; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; JONES KD, 1994, BIOCHEM BIOPH RES CO, V205, P1681, DOI 10.1006/bbrc.1994.2861; Kaneta S, 2003, ATHEROSCLEROSIS, V170, P237, DOI 10.1016/S0021-9150(03)00301-0; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nishida M, 1999, BIOCHEM BIOPH RES CO, V262, P350, DOI 10.1006/bbrc.1999.1218; PEREZSALA D, 1995, J BIOL CHEM, V270, P6235, DOI 10.1074/jbc.270.11.6235; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Rosenfeldt MT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001306; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	57	77	79	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16523	10.1371/journal.pone.0016523	http://dx.doi.org/10.1371/journal.pone.0016523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304979	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300076
J	Mayer, ML; Sheridan, JA; Blohmke, CJ; Turvey, SE; Hancock, REW				Mayer, Matthew L.; Sheridan, Jared A.; Blohmke, Christoph J.; Turvey, Stuart E.; Hancock, Robert E. W.			The Pseudomonas aeruginosa Autoinducer 3O-C12 Homoserine Lactone Provokes Hyperinflammatory Responses from Cystic Fibrosis Airway Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; QUORUM-SENSING MOLECULE; TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE-EXPRESSION; IL-8 PRODUCTION; N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; ANTIINFLAMMATORY TARGET; LUNG INFECTION; IN-VIVO; ACTIVATION	The discovery of novel antiinflammatory targets to treat inflammation in the cystic fibrosis (CF) lung stands to benefit patient populations suffering with this disease. The Pseudomonas aeruginosa quorum sensing autoinducer N-3oxododecanoyl homoserine lactone (3O-C12) is an important bacterial virulence factor that has been reported to induce proinflammatory cytokine production from a variety of cell types. The goal of this study was to examine the ability of 3O-C12 to induce proinflammatory cytokine production in normal and CF bronchial epithelial cells, and better understand the cellular mechanisms by which this cytokine induction occurs. 3O-C12 was found to induce higher levels of IL-6 production in the CF cell lines IB3-1 and CuFi, compared to their corresponding control cell lines C38 and NuLi. Systems biology and network analysis revealed a high predominance of over-represented innate immune pathways bridged together by calcium-dependant transcription factors governing the transcriptional responses of A549 airway cells to stimulation with 3O-C12. Using calcium-flux assays, 3O-C12 was found to induce larger and more sustained increases in intracellular calcium in IB3-1 cells compared to C38, and blocking this calcium flux with BAPTA-AM reduced the production of IL-6 by IB3-1 to the levels produced by C38. These data suggest that 3O-C12 induces proinflammatory cytokine production in airway epithelial cells in a calcium-dependent manner, and that dysregulated calcium storage or signalling in CF cells results in an increased production of proinflammatory cytokines.	[Mayer, Matthew L.; Sheridan, Jared A.; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Mayer, Matthew L.; Sheridan, Jared A.; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Blohmke, Christoph J.; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 1M9, Canada; [Blohmke, Christoph J.; Turvey, Stuart E.] BC Childrens Hosp, Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Mayer, ML (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	bob@cmdr.ubc.ca	Hancock, Robert E. W./E-1145-2013; Turvey, Stuart/HGV-1191-2022	Hancock, Robert E. W./0000-0001-5989-8503; Turvey, Stuart/0000-0003-1599-1065	Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation; Canadian Institutes for Health Research (CIHR); Grand Challenges in Global Health Initiative; Genome BC for the Pathogenomics of Innate Immunity; Michael Smith Foundation; Canadian Cystic Fibrosis Foundation; British Columbia Lung Association; CIHR Team in Mutagenesis and Infectious Diseases	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Grand Challenges in Global Health Initiative; Genome BC for the Pathogenomics of Innate Immunity; Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Cystic Fibrosis Foundation; British Columbia Lung Association; CIHR Team in Mutagenesis and Infectious Diseases(Canadian Institutes of Health Research (CIHR))	The lab of REWH receives funding from the Foundation for the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Canadian Institutes for Health Research (CIHR) for two separate program grants from the Grand Challenges in Global Health Initiative and Genome BC for the Pathogenomics of Innate Immunity research program grant. M.L.M. holds a CIHR M.D./Ph.D. studentship and a Michael Smith Foundation for Health Research trainee award. C.J.B. was supported by the Canadian Cystic Fibrosis Foundation. S.E.T. holds a Career Development Award from the Canadian Child Health Clinician Scientist Program (a CIHR Strategic Training Program) and is funded by operating grants from the Canadian Cystic Fibrosis Foundation, British Columbia Lung Association, and the CIHR Team in Mutagenesis and Infectious Diseases. R.E.W.H. is a Canada Research Chair in Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2009, J AM CHEM SOC, V131, P10610, DOI 10.1021/ja903292v; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Bjarnsholt T, 2010, NAT PROTOC, V5, P282, DOI 10.1038/nprot.2009.205; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Blohmke CJ, 2010, J IMMUNOL, V185, P7731, DOI 10.4049/jimmunol.1001513; Boontham P, 2008, CLIN SCI, V115, P343, DOI 10.1042/CS20080018; Borgatti M, 2007, BIOCHEM BIOPH RES CO, V357, P977, DOI 10.1016/j.bbrc.2007.04.081; Bryan A, 2010, MICROBES INFECT, V12, P1042, DOI 10.1016/j.micinf.2010.07.006; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Delgado MA, 2006, INFECT IMMUN, V74, P2975, DOI 10.1128/IAI.74.5.2975-2984.2006; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916; Hartman G, 1998, LANCET, V351, P848, DOI 10.1016/S0140-6736(05)70282-8; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ierano T, 2010, INNATE IMMUN-LONDON, V16, P354, DOI 10.1177/1753425909347400; Imamura Y, 2005, J MED MICROBIOL, V54, P515, DOI 10.1099/jmm.0.46004-0; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Levy H, 2009, PEDIATR PULM, V44, P580, DOI 10.1002/ppul.21026; Li HT, 2009, MED MICROBIOL IMMUN, V198, P113, DOI 10.1007/s00430-009-0111-z; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; Miyairi S, 2006, J MED MICROBIOL, V55, P1381, DOI 10.1099/jmm.0.46658-0; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Mookherjee N, 2009, MOL BIOSYST, V5, P483, DOI 10.1039/b813787k; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; Ornatowski W, 2007, J CLIN INVEST, V117, P3489, DOI 10.1172/JCI31499; Palfreyman RW, 1997, INFECT IMMUN, V65, P617, DOI 10.1128/IAI.65.2.617-622.1997; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Schwarzer C, 2010, J BIOL CHEM, V285, P34850, DOI 10.1074/jbc.M110.167668; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith RS, 2002, J IMMUNOL, V169, P2636, DOI 10.4049/jimmunol.169.5.2636; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Tabary O, 2006, CELL SIGNAL, V18, P652, DOI 10.1016/j.cellsig.2005.06.004; Tan K, 2008, GENOMICS, V91, P219, DOI 10.1016/j.ygeno.2007.11.005; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Vikstrom E, 2010, EUR J CELL BIOL, V89, P584, DOI 10.1016/j.ejcb.2010.03.002; Wu H, 2004, J ANTIMICROB CHEMOTH, V53, P1054, DOI 10.1093/jac/dkh223; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhu H, 2008, EYE CONTACT LENS, V34, P179, DOI 10.1097/ICL.0b013e318159afde; Zimmermann S, 2006, INFECT IMMUN, V74, P5687, DOI 10.1128/IAI.01940-05	58	51	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16246	10.1371/journal.pone.0016246	http://dx.doi.org/10.1371/journal.pone.0016246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305014	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300044
J	Ott, CE; Grunhagen, J; Jager, M; Horbelt, D; Schwill, S; Kallenbach, K; Guo, G; Manke, T; Knaus, P; Mundlos, S; Robinson, PN				Ott, Claus Eric; Gruenhagen, Johannes; Jaeger, Marten; Horbelt, Daniel; Schwill, Simon; Kallenbach, Klaus; Guo, Gao; Manke, Thomas; Knaus, Petra; Mundlos, Stefan; Robinson, Peter N.			MicroRNAs Differentially Expressed in Postnatal Aortic Development Downregulate Elastin via 3 ' UTR and Coding-Sequence Binding Sites	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA; FIBER FORMATION; MARKED LONGEVITY; D-ASPARTATE; TGF-BETA; PROTEIN; TRANSCRIPTION; TARGETS; COLLAGEN	Elastin production is characteristically turned off during the maturation of elastin-rich organs such as the aorta. MicroRNAs (miRNAs) are small regulatory RNAs that down-regulate target mRNAs by binding to miRNA regulatory elements (MREs) typically located in the 3' UTR. Here we show a striking up-regulation of miR-29 and miR-15 family miRNAs during murine aortic development with commensurate down-regulation of targets including elastin and other extracellular matrix (ECM) genes. There were a total of 14 MREs for miR-29 in the coding sequences (CDS) and 3' UTR of elastin, which was highly significant, and up to 22 miR-29 MREs were found in the CDS of multiple ECM genes including several collagens. This overrepresentation was conserved throughout mammalian evolution. Luciferase reporter assays showed synergistic effects of miR-29 and miR-15 family miRNAs on 3' UTR and coding-sequence elastin constructs. Our results demonstrate that multiple miR-29 and miR-15 family MREs are characteristic for some ECM genes and suggest that miR-29 and miR-15 family miRNAs are involved in the down-regulation of elastin in the adult aorta.	[Ott, Claus Eric; Gruenhagen, Johannes; Jaeger, Marten; Guo, Gao; Mundlos, Stefan; Robinson, Peter N.] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Jaeger, Marten; Mundlos, Stefan; Robinson, Peter N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Horbelt, Daniel; Knaus, Petra] Free Univ Berlin, Inst Biochem, D-1000 Berlin, Germany; [Schwill, Simon; Kallenbach, Klaus] Univ Heidelberg Hosp, Dept Cardiac Surg, Heidelberg, Germany; [Manke, Thomas; Mundlos, Stefan; Robinson, Peter N.] Max Planck Inst Mol Genet, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Ruprecht Karls University Heidelberg; Max Planck Society	Ott, CE (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	peter.robinson@charite.de	Manke, Thomas/L-9075-2019; Ott, Claus E/G-1936-2011; Mundlos, Stefan/ABH-9585-2020; Ott, Claus/U-8226-2019	Ott, Claus E/0000-0003-3627-3791; Ott, Claus/0000-0003-3627-3791; Robinson, Peter/0000-0002-0736-9199; Mundlos, Stefan/0000-0002-9788-3166	National Marfan Foundation; European Commission (FAD) [HEALTH-F2-2008-200647]; Deutsche Forschungsgemeinschaft [DFG SFB 760]; Sonnenfeld Fellowship	National Marfan Foundation; European Commission (FAD)(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld Fellowship	This work was supported by grants from the National Marfan Foundation, the European Commission (FAD; HEALTH-F2-2008-200647), and the Deutsche Forschungsgemeinschaft (DFG SFB 760). D.H. is supported by a Sonnenfeld Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booms P, 2006, J MOL CELL CARDIOL, V40, P234, DOI 10.1016/j.yjmcc.2005.11.009; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; DEGROOT ACG, 2006, TRENDS CARDIOVAS MED, V16, P1; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Jawien J, 2008, J PHYSIOL PHARMACOL, V59, P239; JOHNSON DJ, 1995, CIRC RES, V77, P1107, DOI 10.1161/01.RES.77.6.1107; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Ketting RF, 2009, DEV CELL, V16, P487, DOI 10.1016/j.devcel.2009.03.014; Kielty CM, 2002, J CELL SCI, V115, P2817; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Kuang PP, 2002, AM J PHYSIOL-CELL PH, V283, pC58, DOI 10.1152/ajpcell.00314.2001; Kucich U, 1997, AM J RESP CELL MOL, V17, P10, DOI 10.1165/ajrcmb.17.1.2816; Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lei J, 1998, AM J PHYSIOL-RENAL, V274, pF252, DOI 10.1152/ajprenal.1998.274.2.F252; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Neumann C, 2008, INVEST OPHTH VIS SCI, V49, P1464, DOI 10.1167/iovs.07-1053; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pierce RA, 2006, AM J PHYSIOL-LUNG C, V291, pL391, DOI 10.1152/ajplung.00441.2004; POWELL JT, 1992, ATHEROSCLEROSIS, V97, P201, DOI 10.1016/0021-9150(92)90132-Z; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Ritz-Timme S, 2003, BRIT J DERMATOL, V149, P951, DOI 10.1111/j.1365-2133.2003.05618.x; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Sysa P, 2009, DNA CELL BIOL, V28, P425, DOI 10.1089/dna.2009.0884; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	68	89	93	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16250	10.1371/journal.pone.0016250	http://dx.doi.org/10.1371/journal.pone.0016250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305018	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300045
J	Bonadies, N; Foster, SD; Chan, WI; Kvinlaug, BT; Spensberger, D; Dawson, MA; Spooncer, E; Whetton, AD; Bannister, AJ; Huntly, BJ; Gottgens, B				Bonadies, Nicolas; Foster, Samuel D.; Chan, Wai-In; Kvinlaug, Brynn T.; Spensberger, Dominik; Dawson, Mark A.; Spooncer, Elaine; Whetton, Anthony D.; Bannister, Andrew J.; Huntly, Brian J.; Goettgens, Berthold			Genome-Wide Analysis of Transcriptional Reprogramming in Mouse Models of Acute Myeloid Leukaemia	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; MLL; GATA-2; TRANSFORMATION; DIFFERENTIATION; PROGENITOR; REGULATORS; CANCER; BLOOD	Acute leukaemias are commonly caused by mutations that corrupt the transcriptional circuitry of haematopoietic stem/progenitor cells. However, the mechanisms underlying large-scale transcriptional reprogramming remain largely unknown. Here we investigated transcriptional reprogramming at genome-scale in mouse retroviral transplant models of acute myeloid leukaemia (AML) using both gene-expression profiling and ChIP-sequencing. We identified several thousand candidate regulatory regions with altered levels of histone acetylation that were characterised by differential distribution of consensus motifs for key haematopoietic transcription factors including Gata2, Gfi1 and Sfpi1/Pu.1. In particular, downregulation of Gata2 expression was mirrored by abundant GATA motifs in regions of reduced histone acetylation suggesting an important role in leukaemogenic transcriptional reprogramming. Forced re-expression of Gata2 was not compatible with sustained growth of leukaemic cells thus suggesting a previously unrecognised role for Gata2 in downregulation during the development of AML. Additionally, large scale human AML datasets revealed significantly higher expression of GATA2 in CD34+ cells from healthy controls compared with AML blast cells. The integrated genome-scale analysis applied in this study represents a valuable and widely applicable approach to study the transcriptional control of both normal and aberrant haematopoiesis and to identify critical factors responsible for transcriptional reprogramming in human cancer.	[Bonadies, Nicolas; Foster, Samuel D.; Chan, Wai-In; Kvinlaug, Brynn T.; Spensberger, Dominik; Dawson, Mark A.; Huntly, Brian J.; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Bannister, Andrew J.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Bannister, Andrew J.] Univ Cambridge, Dept Pathol, Cambridge, England; [Spooncer, Elaine; Whetton, Anthony D.] Univ Manchester, Sch Canc & Imaging Sci, Manchester, Lancs, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Manchester	Bonadies, N (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England.	bg200@cam.ac.uk	Foster, Samantha Michelle/GQI-0807-2022; Dawson, Mark A/B-9317-2017; Bonadies, Nicolas/F-2388-2017; huntly, brian/E-6725-2014	Dawson, Mark A/0000-0002-5464-5029; Bonadies, Nicolas/0000-0001-8761-2066; Gottgens, Berthold/0000-0001-6302-5705; WHETTON, ANTHONY D/0000-0002-1098-3878; Bannister, Andrew/0000-0002-6312-4436; Spensberger, Dominik/0000-0002-9798-2949; huntly, brian/0000-0003-0312-161X; Foster, Samuel/0000-0001-5375-7080	Leukemia & Lymphoma Research; Leukemia & Lymphoma Society; Cambridge Cancer Centre; Cancer Research UK; Medical Research Council; Roche Research Foundation; Huggenberger-Bischoff Stiftung zur Krebsforschung; Newton Trust; MRC [G116/187, G0800784] Funding Source: UKRI; Medical Research Council [G116/187, G0800784, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	Leukemia & Lymphoma Research; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Cambridge Cancer Centre; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Roche Research Foundation; Huggenberger-Bischoff Stiftung zur Krebsforschung; Newton Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by grants from Leukemia & Lymphoma Research, Newton Trust, Leukemia & Lymphoma Society, Cambridge Cancer Centre, Cancer Research UK, Medical Research Council and fellowships to N.B. from the Roche Research Foundation and Huggenberger-Bischoff Stiftung zur Krebsforschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala RM, 2009, AM J HEMATOL, V84, P79, DOI 10.1002/ajh.21332; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; FOSTER SD, 2009, MOL BIOSYST; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Heuser M, 2005, HAEMATOLOGICA, V90, P1484; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Katsumoto T, 2008, CANCER SCI, V99, P1523, DOI 10.1111/j.1349-7006.2008.00865.x; Kennedy JA, 2008, LEUKEMIA, V22, P2029, DOI 10.1038/leu.2008.206; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; MARTENS JH, CANC CELL, V17, P173; Melnick AM, 2005, J CLIN ONCOL, V23, P3957, DOI 10.1200/JCO.2005.14.498; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pimanda JE, 2008, BLOOD, V112, P4512, DOI 10.1182/blood-2008-05-157560; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Romer KA, 2007, NUCLEIC ACIDS RES, V35, pW217, DOI 10.1093/nar/gkm376; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; Stam RW, 2006, LEUKEMIA, V20, P264, DOI 10.1038/sj.leu.2404074; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Tonelli R, 2006, LEUKEMIA, V20, P1307, DOI 10.1038/sj.leu.2404221; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; VISVADER J, 1993, BLOOD, V82, P1493; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105	66	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16330	10.1371/journal.pone.0016330	http://dx.doi.org/10.1371/journal.pone.0016330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297973	Green Submitted, Green Published, gold			2022-12-27	WOS:000286664100023
J	Burns, KEA; Adhikari, NKJ; Slutsky, AS; Guyatt, GH; Villar, J; Zhang, HB; Zhou, Q; Cook, DJ; Stewart, TE; Meade, MO				Burns, Karen E. A.; Adhikari, Neill K. J.; Slutsky, Arthur S.; Guyatt, Gordon H.; Villar, Jesus; Zhang, Haibo; Zhou, Qi; Cook, Deborah J.; Stewart, Thomas E.; Meade, Maureen O.			Pressure and Volume Limited Ventilation for the Ventilatory Management of Patients with Acute Lung Injury: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RESPIRATORY-DISTRESS-SYNDROME; COMPUTERIZED DECISION-SUPPORT; END-EXPIRATORY PRESSURE; MECHANICAL VENTILATION; PERMISSIVE HYPERCAPNIA; CLINICAL-TRIALS; MORTALITY; STRATEGY; SCORE; SEVERITY	Background: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life threatening clinical conditions seen in critically ill patients with diverse underlying illnesses. Lung injury may be perpetuated by ventilation strategies that do not limit lung volumes and airway pressures. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing pressure and volume-limited (PVL) ventilation strategies with more traditional mechanical ventilation in adults with ALI and ARDS. Methods and Findings: We searched Medline, EMBASE, HEALTHSTAR and CENTRAL, related articles on PubMed (TM), conference proceedings and bibliographies of identified articles for randomized trials comparing PVL ventilation with traditional approaches to ventilation in critically ill adults with ALI and ARDS. Two reviewers independently selected trials, assessed trial quality, and abstracted data. We identified ten trials (n = 1,749) meeting study inclusion criteria. Tidal volumes achieved in control groups were at the lower end of the traditional range of 10-15 mL/kg. We found a clinically important but borderline statistically significant reduction in hospital mortality with PVL [relative risk (RR) 0.84; 95% CI 0.70, 1.00; p = 0.05]. This reduction in risk was attenuated (RR 0.90; 95% CI 0.74, 1.09, p = 0.27) in a sensitivity analysis which excluded 2 trials that combined PVL with open-lung strategies and stopped early for benefit. We found no effect of PVL on barotrauma; however, use of paralytic agents increased significantly with PVL (RR 1.37; 95% CI, 1.04, 1.82; p = 0.03). Conclusions: This systematic review suggests that PVL strategies for mechanical ventilation in ALI and ARDS reduce mortality and are associated with increased use of paralytic agents.	[Burns, Karen E. A.; Adhikari, Neill K. J.; Slutsky, Arthur S.; Zhang, Haibo; Stewart, Thomas E.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Burns, Karen E. A.; Slutsky, Arthur S.; Villar, Jesus; Zhang, Haibo] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Burns, Karen E. A.; Slutsky, Arthur S.; Villar, Jesus; Zhang, Haibo] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Adhikari, Neill K. J.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Adhikari, Neill K. J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Guyatt, Gordon H.; Zhou, Qi; Cook, Deborah J.; Meade, Maureen O.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Villar, Jesus] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Villar, Jesus] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Burns, KEA (corresponding author), Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada.	burnsk@smh.ca	Slutsky, Arthur/M-3325-2019; Villar, Jesús/R-4526-2019; Zhou, Qi/GSM-9583-2022	Villar, Jesús/0000-0001-5687-3562; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Dr. Burns holds a Clinician Scientist Award with the Canadian Institutes of Health Research. No funding was received to conduct the systematic review and meta-analysis.	AMATO MBP, 1995, AM J RESP CRIT CARE, V152, P1835, DOI 10.1164/ajrccm.152.6.8520744; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], COCHRANE DATABASE SY; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BALK R, 1983, MED CLIN N AM, V67, P685, DOI 10.1016/S0025-7125(16)31197-X; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Carvalho CRR, 1997, AM J RESP CRIT CARE, V156, P1458, DOI 10.1164/ajrccm.156.5.9604081; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; East TD, 1999, J AM MED INFORM ASSN, P251; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Esteban A, 2000, CHEST, V117, P1690, DOI 10.1378/chest.117.6.1690; FEIHL F, 1994, AM J RESP CRIT CARE, V150, P1722, DOI 10.1164/ajrccm.150.6.7952641; Gainnier M, 2004, CRIT CARE MED, V32, P113, DOI 10.1097/01.CCM.0000104114.72614.BC; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; GELLER NL, 1987, BIOMETRICS, V43, P213, DOI 10.2307/2531962; GREENFIELD LJ, 1964, ANESTHESIOLOGY, V25, P312, DOI 10.1097/00000542-196405000-00009; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; HICKLING KG, 1994, CRIT CARE MED, V22, P1568, DOI 10.1097/00003246-199422100-00011; HICKLING KG, 1990, INTENS CARE MED, V16, P372, DOI 10.1007/BF01735174; HICKLING KG, 1988, INTENS CARE MED, V14, P617; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kallet R H, 2001, Respir Care, V46, P1024; KLEINBAUM DG, 1988, APPL REGRESSION ANAL, P512; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; KOLOBOW T, 1987, AM REV RESPIR DIS, V135, P312; LEE PC, 1990, CHEST, V97, P430, DOI 10.1378/chest.97.2.430; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Long Yun, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P549; MARINI JJ, 1994, CHEST, V105, pS109, DOI 10.1378/chest.105.3_Supplement.109S; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McKinley BA, 2001, J TRAUMA, V50, P415, DOI 10.1097/00005373-200103000-00004; Meade M O, 1995, Clin Intensive Care, V6, P166, DOI 10.1080/714028896; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Moran JL, 2005, INTENS CARE MED, V31, P227, DOI 10.1007/s00134-004-2506-z; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; NIU T, 2000, CHINESE CRIT CARE ME, V12, P36; Orme J, 2003, AM J RESP CRIT CARE, V167, P690, DOI 10.1164/rccm.200206-542OC; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Phoenix SI, 2009, ANESTHESIOLOGY, V110, P1098, DOI 10.1097/ALN.0b013e31819fae06; POCOCK SJ, 1990, STAT MED, V9, P657, DOI 10.1002/sim.4780090612; Qin Zhi-qiang, 2003, Zhonghua Yi Xue Za Zhi, V83, P224; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; RAPPAPORT SH, 1994, CRIT CARE MED, V22, P22, DOI 10.1097/00003246-199401000-00009; SLUTSKY AS, 1993, CHEST, V104, P1833, DOI 10.1378/chest.104.6.1833; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; SUN JJ, 2009, CHIN CRIT CARE MED, V21, P209; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Wang Xiao-zhi, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P44; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; WU G, 1998, B HUNAN MED U, V23, P57	59	65	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14623	10.1371/journal.pone.0014623	http://dx.doi.org/10.1371/journal.pone.0014623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21298026	Green Submitted, gold, Green Published			2022-12-27	WOS:000286664100008
J	Dixon, BP; Henry, J; Siroky, BJ; Chu, A; Groen, PA; Bissler, JJ				Dixon, Bradley P.; Henry, Jeff; Siroky, Brian J.; Chu, Albert; Groen, Pamela A.; Bissler, John J.			Cell Cycle Control and DNA Damage Response of Conditionally Immortalized Urothelial Cells	PLOS ONE			English	Article							EPITHELIAL-CELLS; BARRIER FUNCTION; URINARY-BLADDER; TRANSGENIC MICE; HIGH NACL; IN-VIVO; EXPRESSION; CULTURE; LINES; ESTABLISHMENT	Background: Children with complex urogenital anomalies often require bladder reconstruction. Gastrointestinal tissues used in bladder augmentations exhibit a greatly increased risk of malignancy, and the bladder microenvironment may play a role in this carcinogenesis. Investigating the influences of the bladder microenvironment on gastrointestinal and urothelial cell cycle checkpoint activation and DNA damage response has been limited by the lack of an appropriate well-differentiated urothelial cell line system. Methodology/Principal Findings: To meet this need, we have developed a well-differentiated conditionally immortalized urothelial cell line by isolating it from the H-2K(b)-tsA58 transgenic mouse. These cells express a thermosensitive SV40 large T antigen that can be deactivated by adjustment of cell culture conditions, allowing the cell line to regain normal control of the cell cycle. The isolated urothelial cell line demonstrates a polygonal, dome-shaped morphology, expresses cytokeratin 18, and exhibits well-developed tight junctions. Adaptation of the urothelial cell line to hyperosmolal culture conditions induces expression of both cytokeratin 20 and uroplakin II, markers of a superficial urothelial cell or "umbrella cell.'' This cell line can be maintained indefinitely in culture under permissive conditions but when cultured under non-permissive conditions, large T antigen expression is reduced substantially, leading to increased p53 activity and reduced cellular proliferation. Conclusions/Significance: This new model of urothelial cells, along with gastrointestinal cell lines previously derived from the H-2K(b)-tsA58 transgenic mouse, will be useful for studying the potential mechanisms of carcinogenesis of the augmented bladder.	[Dixon, Bradley P.; Henry, Jeff; Siroky, Brian J.; Chu, Albert; Bissler, John J.] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH USA; [Groen, Pamela A.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dixon, BP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH USA.	john.bissler@cchmc.org		Dixon, Bradley/0000-0003-3704-0922; Bissler, John/0000-0001-9685-9183	Kidney Foundation of Greater Cincinnati; William Cooper Procter Pediatric Research Award; National Institutes of Health [K12 HD028827, R01 DK061458]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061458] Funding Source: NIH RePORTER	Kidney Foundation of Greater Cincinnati; William Cooper Procter Pediatric Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work described herein was funded by a Kidney Foundation of Greater Cincinnati Research Award, the William Cooper Procter Pediatric Research Award, and an institutional allocation of funding from a Child Health Research Career Development Award from the National Institutes of Health (K12 HD028827) to BPD, and grant funding from the National Institutes of Health (R01 DK061458) to JJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Boffetta P, 2008, SCAND J UROL NEPHROL, V42, P45, DOI 10.1080/03008880802283664; Boyle P, 2008, WORLD CANC REPORT 20; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chapman EJ, 2008, MOL CANCER RES, V6, P1154, DOI 10.1158/1541-7786.MCR-07-2168; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Dixon BP, 2009, MUTAT RES-FUND MOL M, V670, P88, DOI 10.1016/j.mrfmmm.2009.07.010; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Dmitrieva NI, 2003, AM J PHYSIOL-RENAL, V285, pF266, DOI 10.1152/ajprenal.00060.2003; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; FILMER RB, 1990, J UROLOGY, V143, P671, DOI 10.1016/S0022-5347(17)40055-3; Han XL, 2007, CHINESE MED J-PEKING, V120, P405; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Husmann DA, 2009, THER ADV UROL, V1, P5, DOI 10.1177/1756287209104163; Ivil KD, 2007, UROLOGY, V70, P905, DOI 10.1016/j.urology.2007.06.1121; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kiltie AE, 2010, CURR OPIN GENET DEV, V20, P218, DOI 10.1016/j.gde.2010.01.002; King LE, 2010, VIROLOGY, V406, P95, DOI 10.1016/j.virol.2010.06.033; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; Koizumi M, 2005, SURGERY, V138, P125, DOI 10.1016/j.surg.2005.06.008; Kotoh S, 1997, J UROLOGY, V157, P1054, DOI 10.1016/S0022-5347(01)65140-1; Kreft ME, 2005, FOLIA BIOL-PRAGUE, V51, P126; Kreft ME, 2002, CELL BIOL INT, V26, P63, DOI 10.1006/cbir.2001.0829; Kwon ED, 1996, AM J PHYSIOL-RENAL, V271, pF230, DOI 10.1152/ajprenal.1996.271.1.F230; Langley RR, 2009, INT J ONCOL, V35, P665, DOI 10.3892/ijo_00000378; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; LUCAS SB, 1982, E AFR MED J, V59, P345; MOLL R, 1988, AM J PATHOL, V132, P123; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; National Cancer Institute, SEER STAT FACT SHEET; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Ricceri F, 2010, DNA REPAIR, V9, P191, DOI 10.1016/j.dnarep.2009.12.002; RIGBY CC, 1970, BRIT J CANCER, V24, P746, DOI 10.1038/bjc.1970.89; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Tyagi S, 2006, J UROLOGY, V176, P1673, DOI 10.1016/j.juro.2006.06.088; Veys CA, 2004, OCCUP MED-OXFORD, V54, P322, DOI 10.1093/occmed/kqh010; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; WU XR, 1994, J BIOL CHEM, V269, P13716; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16595	10.1371/journal.pone.0016595	http://dx.doi.org/10.1371/journal.pone.0016595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305048	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100047
J	Baird, AM; Gray, SG; O'Byrne, KJ				Baird, Anne-Marie; Gray, Steven G.; O'Byrne, Kenneth J.			Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DUFFY ANTIGEN RECEPTOR; GROWTH-FACTOR; TUMOR-GROWTH; OXIDATIVE STRESS; MELANOMA GROWTH; BREAST-CANCER; INTERLEUKIN-8; ANGIOGENESIS; EXPRESSION; CARCINOMA	Background: Angiogenesis may play a role in the pathogenesis of Non-Small Cell Lung cancer (NSCLC). The CXC (ELR+) chemokine family are powerful promoters of the angiogenic response. Methods: The expression of the CXC (ELR+) family members (CXCL1-3/GRO alpha-gamma, CXCL8/IL-8, CXCR1/2) was examined in a series of resected fresh frozen NSCLC tumours. Additionally, the expression and epigenetic regulation of these chemokines was examined in normal bronchial epithelial and NSCLC cell lines. Results: Overall, expression of the chemokine ligands (CXCL1, 2, 8) and their receptors (CXCR1/2) were down regulated in tumour samples compared with normal, with the exception of CXCL3. CXCL8 and CXCR1/2 were found to be epigenetically regulated by histone post-translational modifications. Recombinant CXCL8 did not stimulate cell growth in either a normal bronchial epithelial or a squamous carcinoma cell line (SKMES-1). However, an increase was observed at 72 hours post treatment in an adenocarcinoma cell line. Conclusions: CXC (ELR+) chemokines are dysregulated in NSCLC. The balance of these chemokines may be critical in the tumour microenvironment and requires further elucidation. It remains to be seen if epigenetic targeting of these pathways is a viable therapeutic option in lung cancer treatment.	[Baird, Anne-Marie; Gray, Steven G.; O'Byrne, Kenneth J.] Trinity Coll Dublin, Inst Mol Med, Thorac Oncol Res Grp, Dublin, Ireland; [O'Byrne, Kenneth J.] St James Hosp, HOPE Directorate, Dublin 8, Ireland	Trinity College Dublin; Trinity College Dublin	Baird, AM (corresponding author), Trinity Coll Dublin, Inst Mol Med, Thorac Oncol Res Grp, Dublin, Ireland.	kobyrne@stjames.ie	Gray, Steven G./I-3081-2019	Gray, Steven G./0000-0002-5850-6392; Baird, Anne-Marie/0000-0001-7501-1159; O'Byrne, Kenneth/0000-0002-6754-5633	Pfizer	Pfizer(Pfizer)	This work was supported by an unrestricted educational grant from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2009, CANCER RES, V69, P2167, DOI 10.1158/0008-5472.CAN-08-3772; Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Addison CL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-28; Anderson IC, 2000, CANCER RES, V60, P269; Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Arenberg D, 2006, J THORAC ONCOL, V1, P287, DOI 10.1097/01243894-200605000-00003; Atanackovic D, 2008, TUMOR BIOL, V29, P93, DOI 10.1159/000135689; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Colasante A, 1997, AM J RESP CRIT CARE, V156, P968, DOI 10.1164/ajrccm.156.3.9701122; Gabellini C, 2009, EUR J CANCER, V45, P2618, DOI 10.1016/j.ejca.2009.07.007; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Heller G, 2010, CANCER METAST REV, V29, P95, DOI 10.1007/s10555-010-9203-x; Horton LW, 2007, CANCER RES, V67, P9791, DOI 10.1158/0008-5472.CAN-07-0246; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Lawless MW, 2009, J CELL MOL MED, V13, P2800, DOI 10.1111/j.1582-4934.2009.00845.x; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Makki MS, 2008, NUCLEIC ACIDS RES, V36, P4067, DOI 10.1093/nar/gkn356; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; O'Byrne KJ, 2000, EUR J CANCER, V36, P151, DOI 10.1016/S0959-8049(99)00241-5; Ohri CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-172; Orditura M, 2002, J INTERF CYTOK RES, V22, P1129, DOI 10.1089/10799900260442557; Owen JD, 1997, INT J CANCER, V73, P94, DOI 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Seike M, 2007, JNCI-J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Singh S, 2009, CANCER RES, V69, P411, DOI 10.1158/0008-5472.CAN-08-3378; Slettenaar VIF, 2006, ADV DRUG DELIVER REV, V58, P962, DOI 10.1016/j.addr.2006.03.012; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; Strieter RM, 2004, ANN NY ACAD SCI, V1028, P351, DOI 10.1196/annals.1322.041; Wang JY, 1996, J INTERF CYTOK RES, V16, P53, DOI 10.1089/jir.1996.16.53; Wente MN, 2006, CANCER LETT, V241, P221, DOI 10.1016/j.canlet.2005.10.041; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Wislez M, 2004, INFLAMM RES, V53, P4, DOI 10.1007/s00011-003-1215-3; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Zhou Q, 2009, BREAST CANCER RES TR, V117, P443, DOI 10.1007/s10549-008-0148-5; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	47	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14593	10.1371/journal.pone.0014593	http://dx.doi.org/10.1371/journal.pone.0014593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298036	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900002
J	Gatta, V; Drago, D; Fincati, K; Valenti, MT; Carbonare, LD; Sensi, SL; Zatta, P				Gatta, Valentina; Drago, Denise; Fincati, Karina; Valenti, Maria Teresa; Carbonare, Luca Dalle; Sensi, Stefano L.; Zatta, Paolo			Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, beta(1-42)-Amyloid or the beta(1-42)-Amyloid Aluminum Complex	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; LONG-TERM POTENTIATION; ESTROGEN-RECEPTOR-ALPHA; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; TRANSCRIPTION FACTORS; INTRACELLULAR DOMAIN; CALCIUM HOMEOSTASIS	Background: A typical pathological feature of Alzheimer's disease (AD) is the appearance in the brain of senile plaques made up of beta-amyloid (A beta) and neurofibrillary tangles. AD is also associated with an abnormal accumulation of some metal ions, and we have recently shown that one of these, aluminum (Al), plays a relevant role in affecting A beta aggregation and neurotoxicity. Methodology: In this study, employing a microarray analysis of 35,129 genes, we investigated the effects induced by the exposure to the A beta(1-42)-Al (A beta-Al) complex on the gene expression profile of the neuronal-like cell line, SH-SY5Y. Principal Findings: The microarray assay indicated that, compared to A beta or Al alone, exposure to A beta-Al complex produced selective changes in gene expression. Some of the genes selectively over or underexpressed are directly related to AD. A further evaluation performed with Ingenuity Pathway analysis revealed that these genes are nodes of networks and pathways that are involved in the modulation of Ca2+ homeostasis as well as in the regulation of glutamatergic transmission and synaptic plasticity. Conclusions and Significance: A beta-Al appears to be largely involved in the molecular machinery that regulates neuronal as well as synaptic dysfunction and loss. A beta-Al seems critical in modulating key AD-related pathways such as glutamatergic transmission, Ca2+ homeostasis, oxidative stress, inflammation, and neuronal apoptosis.	[Gatta, Valentina] Univ G DAnnunzio, Dept Biomed Sci, Chieti Pescara, Italy; [Gatta, Valentina] Ctr Excellence Aging CeSI, Funct Genet Unit, Chieti, Italy; [Drago, Denise; Zatta, Paolo] Univ Padua, CNR Inst Biomed Technol, Dept Biol, Metalloprot Unit, Padua, Italy; [Fincati, Karina] Assoc Univ Padua, Venice, Italy; [Valenti, Maria Teresa; Carbonare, Luca Dalle] Univ Verona, Dept Biomed & Surg Sci, I-37100 Verona, Italy; [Sensi, Stefano L.] Mol Neurol Unit CeSI, Chieti, Italy; [Sensi, Stefano L.] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Sensi, Stefano L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Padua; University of Padua; University of Verona; G d'Annunzio University of Chieti-Pescara; University of California System; University of California Irvine	Gatta, V (corresponding author), Univ G DAnnunzio, Dept Biomed Sci, Chieti Pescara, Italy.	ssensi@uci.edu; zatta@bio.unipd.it	Drago, Denise/K-8551-2016; Valenti, Maria Teresa/F-4712-2011; Carbonare, Luca Dalle/E-5720-2011; Sensi, Stefano L./O-1335-2019; Gatta, Valentina/G-5765-2014; Sensi, Stefano L./J-3164-2016	Drago, Denise/0000-0003-1363-5518; Sensi, Stefano L./0000-0002-0710-2574; Sensi, Stefano L./0000-0002-0710-2574; Valenti, Maria Teresa/0000-0003-1166-8033; GATTA, Valentina/0000-0002-9999-5823	Italian Ministry of Research and University [GNEO3PX83]	Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Italian Ministry of Research and University "Fondo per gli Investimenti della Ricerca di Base (FIRB GNEO3PX83; PZ and SLS) and Progetti Ricerca di Interesse Nazionale (PRIN 2006; PRIN 2008 SLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerz L, 2007, J BIOL CHEM, V282, P10203, DOI 10.1074/jbc.M611183200; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Alexandrov PN, 2005, J ALZHEIMERS DIS, V8, P117; Aliev G, 2009, NEUROTOX RES, V16, P293, DOI 10.1007/s12640-009-9066-5; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Aronica E, 1998, NEUROSCIENCE, V82, P979; Aulia S, 2006, BIOCHEM BIOPH RES CO, V339, P1, DOI 10.1016/j.bbrc.2005.10.059; Balsinde J, 1999, J BIOL CHEM, V274, P25967, DOI 10.1074/jbc.274.37.25967; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; BATAILLE N, 1994, BIOCHEM BIOPH RES CO, V203, P1477, DOI 10.1006/bbrc.1994.2351; Bayer TA, 1997, ACTA NEUROPATHOL, V94, P519, DOI 10.1007/s004010050745; Bazan NG, 2002, PROSTAG OTH LIPID M, V68-9, P197, DOI 10.1016/S0090-6980(02)00031-X; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bernardini S, 2005, CLIN CHEM, V51, P944, DOI 10.1373/clinchem.2004.045955; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Canzoniero LMT, 2004, NEUROBIOL DIS, V15, P520, DOI 10.1016/j.nbd.2003.10.013; Carrasquillo MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008764; Carrasquillo MM, 2010, ARCH NEUROL; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Citri A, 2009, EUR J NEUROSCI, V30, P1443, DOI 10.1111/j.1460-9568.2009.06950.x; Cuello AC, 2010, NEURODEGENER DIS, V7, P96, DOI 10.1159/000285514; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Drago D, 2008, REJUV RES, V11, P861, DOI 10.1089/rej.2008.0761; Drago D, 2008, INT J BIOCHEM CELL B, V40, P731, DOI 10.1016/j.biocel.2007.10.014; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Francis YI, 2007, NEUROSCI LETT, V413, P137, DOI 10.1016/j.neulet.2006.11.036; Fu HJ, 2009, EUR J PHARMACOL, V623, P14, DOI 10.1016/j.ejphar.2009.09.013; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Guo Q, 1999, J NEUROSCI RES, V56, P457, DOI 10.1002/(SICI)1097-4547(19990601)56:5<457::AID-JNR2>3.0.CO;2-P; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; House E, 2004, J ALZHEIMERS DIS, V6, P291; Hwang EM, 2006, BIOCHEM BIOPH RES CO, V349, P654, DOI 10.1016/j.bbrc.2006.08.077; Ishunina TA, 2010, NEUROBIOL AGING; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Liang KW, 2010, J BIOL CHEM, V285, P935, DOI 10.1074/jbc.M109.051664; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Liu GJ, 2006, J STRUCT BIOL, V155, P45, DOI 10.1016/j.jsb.2005.12.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562; Lukiw WJ, 1998, J MOL NEUROSCI, V11, P67, DOI 10.1385/JMN:11:1:67; Lukiw WJ, 2005, J INORG BIOCHEM, V99, P1895, DOI 10.1016/j.jinorgbio.2005.04.021; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Pascale A, 2007, PHARMACOL RES, V55, P560, DOI 10.1016/j.phrs.2007.04.013; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Porrello E, 2006, EUR J NEUROL, V13, P639, DOI 10.1111/j.1468-1331.2006.01333.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Richartz-Salzburger E, 2007, J PSYCHIATR RES, V41, P174, DOI 10.1016/j.jpsychires.2006.01.010; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Savaskan E, 2001, BRAIN RES, V908, P113, DOI 10.1016/S0006-8993(01)02610-5; Schaeffer EL, 2009, PSYCHOPHARMACOLOGY, V202, P37, DOI 10.1007/s00213-008-1351-0; Schupf N, 2008, DEMENT GERIATR COGN, V25, P476, DOI 10.1159/000126495; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sheng M, 2000, J CELL SCI, V113, P1851; Spalletta G, 2007, AM J GERIAT PSYCHIAT, V15, P879, DOI 10.1097/JGP.0b013e3180547076; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Vukic V, 2009, NEUROBIOL DIS, V34, P95, DOI 10.1016/j.nbd.2008.12.007; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Weihl CC, 1999, J NEUROCHEM, V73, P31, DOI 10.1046/j.1471-4159.1999.0730031.x; Wu FB, 2009, AGEING RES REV, V8, P147, DOI 10.1016/j.arr.2009.03.002; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	109	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15965	10.1371/journal.pone.0015965	http://dx.doi.org/10.1371/journal.pone.0015965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298039	gold, Green Published			2022-12-27	WOS:000286663900019
J	Niehof, M; Borlak, J				Niehof, Monika; Borlak, Juergen			HNF4alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Hypertension	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; NUCLEAR FACTOR; II RECEPTORS; A TREATMENT; EXPRESSION; NEPHROTOXICITY; MECHANISM; GENE; ENDOTHELIN-1; MODULATION	Induction of tolerance against grafted organs is achieved by the immunosuppressive agent cyclosporine, a prominent member of the calcineurin inhibitors. Unfortunately, its lifetime use is associated with hypertension and nephrotoxicity. Several mechanism for cyclosporine induced hypertension have been proposed, i.e. activation of the sympathetic nervous system, endothelin-mediated systemic vasoconstriction, impaired vasodilatation secondary to reduction in prostaglandin and nitric oxide, altered cytosolic calcium translocation, and activation of the renin-angiotensin system (RAS). In this regard the molecular basis for undue RAS activation and an increased signaling of the vasoactive oligopeptide angiotensin II (AngII) remain elusive. Notably, angiotensinogen (AGT) is the precursor of AngII and transcriptional regulation of AGT is controlled by the hepatic nuclear factor HNF4alpha. To better understand the molecular events associated with cyclosporine induced hypertension, we investigated the effect of cyclosporine on HNF4alpha expression and activity and searched for novel HNF4alpha target genes among members of the RAS cascade. Using bioinformatic algorithm and EMSA bandshift assays we identified angiotensin II receptor type 1 (AGTR1), angiotensin I converting enzyme (ACE), and angiotensin I converting enzyme 2 (ACE2) as genes targeted by HNF4alpha. Notably, cyclosporine represses HNF4alpha gene and protein expression and its DNA-binding activity at consensus sequences to AGT, AGTR1, ACE, and ACE2. Consequently, the gene expression of AGT, AGTR1, and ACE2 was significantly reduced as evidenced by quantitative real-time RT-PCR. While RAS is composed of a sophisticated interplay between multiple factors we propose a decrease of ACE2 to enforce AngII signaling via AGTR1 to ultimately result in vasoconstriction and hypertension. Taken collectively we demonstrate cyclosporine to repress HNF4alpha activity through calcineurin inhibitor mediated inhibition of nuclear factor of activation of T-cells (NFAT) which in turn represses HNF4alpha that leads to a disturbed balance of RAS.	[Niehof, Monika; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Ctr Mol Med & Med Biotechnol, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany	Fraunhofer Gesellschaft; Hannover Medical School	Niehof, M (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Ctr Mol Med & Med Biotechnol, Hannover, Germany.	borlak@item.fraunhofer.de			Lower Saxony Ministry of Culture and Science; Volkswagen Foundation, Germany [25A.5-7251-99-3/00]	Lower Saxony Ministry of Culture and Science; Volkswagen Foundation, Germany(Volkswagen)	This work was supported by a grant of the Lower Saxony Ministry of Culture and Science and the Volkswagen Foundation, Germany, to J.B. (grant number: 25A.5-7251-99-3/00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2009, TOXICOL SCI, V112, P507, DOI 10.1093/toxsci/kfp216; Avdonin PV, 1999, KIDNEY INT, V55, P2407, DOI 10.1046/j.1523-1755.1999.00481.x; Bai JPF, 2010, PHARMACOTHERAPY, V30, P195, DOI 10.1592/phco.30.2.195; BANTLE JP, 1987, AM J MED, V83, P59, DOI 10.1016/0002-9343(87)90497-9; Bartholomeusz B, 1998, J HUM HYPERTENS, V12, P839, DOI 10.1038/sj.jhh.1000709; Batlle D, 2008, CURR OPIN NEPHROL HY, V17, P250, DOI 10.1097/MNH.0b013e3282f945c2; Borlak J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004662; Busauschina A, 2004, TRANSPL P, V36, p229S, DOI 10.1016/j.transproceed.2004.01.021; CARRIER M, 1991, AM J PHYSIOL, V261, pH1791, DOI 10.1152/ajpheart.1991.261.6.H1791; Cauduro RL, 2005, CLIN TRANSPLANT, V19, P470, DOI 10.1111/j.1399-0012.2005.00357.x; CLOZEL JP, 1993, J HYPERTENS, V11, P75, DOI 10.1097/00004872-199301000-00011; Curnow KM, 1996, CLIN EXP PHARMACOL P, V23, pS67, DOI 10.1111/j.1440-1681.1996.tb02816.x; EDWARDS BD, 1994, CLIN NEPHROL, V41, P350; Elton TS, 2003, TRENDS ENDOCRIN MET, V14, P66, DOI 10.1016/S1043-2760(02)00038-3; ERMAN A, 1990, J PHARM PHARMACOL, V42, P525, DOI 10.1111/j.2042-7158.1990.tb06614.x; Grobecker H. F., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS94, DOI 10.1111/j.1440-1681.1995.tb02984.x; Heinze G, 2006, J AM SOC NEPHROL, V17, P889, DOI 10.1681/ASN.2005090955; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; IWAI J, 1993, EUR J PHARM-ENVIRON, V248, P341; Jamaluddin M, 2000, MOL ENDOCRINOL, V14, P99, DOI 10.1210/me.14.1.99; JULIEN J, 1993, TRANSPLANTATION, V56, P885, DOI 10.1097/00007890-199310000-00022; Keidar S, 2007, CARDIOVASC RES, V73, P463, DOI 10.1016/j.cardiores.2006.09.006; Kel A, 2004, MOL PHARMACOL, V66, P1557, DOI 10.1124/mol.104.001677; Lassila M, 2002, CURR DRUG METAB, V3, P61, DOI 10.2174/1389200023337964; Letizia C, 1995, INT J CLIN PHARM RES, V15, P209; Li C, 2004, YONSEI MED J, V45, P1004, DOI 10.3349/ymj.2004.45.6.1004; LUKE RG, 1991, AM J HYPERTENS, V4, P468, DOI 10.1093/ajh/4.5.468; MASON J, 1991, KIDNEY INT, V39, pS28; MASON J, 1990, PEDIATR NEPHROL, V4, P554, DOI 10.1007/BF00869843; MORGAN BJ, 1991, HYPERTENSION, V18, P458, DOI 10.1161/01.HYP.18.4.458; Moser Marvin, 2007, J Clin Hypertens (Greenwich), V9, P9; MYERS BD, 1988, KIDNEY INT, V33, P590, DOI 10.1038/ki.1988.38; Niehof M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-68; Nishiyama A, 2003, HYPERTENSION, V42, P754, DOI 10.1161/01.HYP.0000085195.38870.44; Oudit GY, 2003, TRENDS CARDIOVAS MED, V13, P93, DOI 10.1016/S1050-1738(02)00233-5; PICHLER RH, 1995, J AM SOC NEPHROL, V6, P1186; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Ramirez C, 2000, EXP NEPHROL, V8, P161; REGITZZAGROSEK V, 1995, J CARDIOVASC PHARM, V26, P66, DOI 10.1097/00005344-199507000-00011; REGO A, 1991, J PHARMACOL EXP THER, V259, P905; RICHER C, 1984, BRIT J CLIN PHARMACO, V17, P243, DOI 10.1111/j.1365-2125.1984.tb02338.x; Robert N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007893.pub2; ROLLS KA, 1994, CLIN EXP PHARMACOL P, V21, P227, DOI 10.1111/j.1440-1681.1994.tb02502.x; Shang MH, 2008, CHINESE MED J-PEKING, V121, P983, DOI 10.1097/00029330-200806010-00005; SHEHATA M, 1995, EXP NEPHROL, V3, P173; Shimamoto Y, 2004, J BIOL CHEM, V279, P7770, DOI 10.1074/jbc.M310577200; Singer DRJ, 1996, J HUM HYPERTENS, V10, P395; TRESHAM JJ, 1990, TRANSPLANTATION, V49, P144, DOI 10.1097/00007890-199001000-00032; TRONC F, 1991, ANN CHIR, V45, P827; Varagic J, 2002, J MOL CELL CARDIOL, V34, P1435, DOI 10.1006/jmcc.2002.2075; Ventura HO, 1997, CURR OPIN CARDIOL, V12, P375, DOI 10.1097/00001573-199707000-00005; WOLF G, 1995, TRANSPLANTATION, V60, P237, DOI 10.1097/00007890-199508000-00005; Wu Mai-Szu, 2007, Chang Gung Med J, V30, P7; Yanai K, 1999, J BIOL CHEM, V274, P34605, DOI 10.1074/jbc.274.49.34605; YOUNG BA, 1995, KIDNEY INT, V48, P439, DOI 10.1038/ki.1995.312	57	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16319	10.1371/journal.pone.0016319	http://dx.doi.org/10.1371/journal.pone.0016319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298017	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900033
J	Ramos, E; Torre, EA; Bushey, AM; Gurudatta, BV; Corces, VG				Ramos, Edward; Torre, Eduardo A.; Bushey, Ashley M.; Gurudatta, B. V.; Corces, Victor G.			DNA Topoisomerase II Modulates Insulator Function in Drosophila	PLOS ONE			English	Article							CHROMATIN INSULATOR; NUCLEAR-ORGANIZATION; GENOME ORGANIZATION; GYPSY INSULATOR; GENE-REGULATION; 3 DIMENSIONS; CTCF; PROTEINS; MELANOGASTER; TRANSCRIPTION	Insulators are DNA sequences thought to be important for the establishment and maintenance of cell-type specific nuclear architecture. In Drosophila there are several classes of insulators that appear to have unique roles in gene expression. The mechanisms involved in determining and regulating the specific roles of these insulator classes are not understood. Here we report that DNA Topoisomerase II modulates the activity of the Su(Hw) insulator. Downregulation of Topo II by RNAi or mutations in the Top2 gene result in disruption of Su(Hw) insulator function. This effect is mediated by the Mod(mdg4)2.2 protein, which is a unique component of the Su(Hw) insulator complex. Co-immunoprecipitation and yeast two-hybrid experiments show that Topo II and Mod(mdg4) 2.2 proteins directly interact. In addition, mutations in Top2 cause a slight decrease of Mod(mdg4) 2.2 transcript but have a dramatic effect on Mod(mdg4) 2.2 protein levels. In the presence of proteasome inhibitors, normal levels of Mod(mdg4) 2.2 protein and its binding to polytene chromosomes are restored. Thus, Topo II is required to prevent Mod(mdg4) 2.2 degradation and, consequently, to stabilize Su(Hw) insulator-mediated chromatin organization.	[Ramos, Edward; Torre, Eduardo A.; Bushey, Ashley M.; Gurudatta, B. V.; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Bushey, Ashley M.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Emory University; Johns Hopkins University	Ramos, E (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vcorces@emory.edu		Wood, Ashley/0000-0002-8713-601X; Corces, Victor/0000-0001-5140-4337	National Institutes of Health [GM35463, CA133106]; NATIONAL CANCER INSTITUTE [K01CA133106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. Public Health Service Awards to VC (GM35463) and ER (CA133106) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bartova E, 2008, J HISTOCHEM CYTOCHEM, V56, P711, DOI 10.1369/jhc.2008.951251; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Feng JM, 2008, CANC BIOL THER, V7; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Golovnin A, 2008, EMBO REP, V9, P440, DOI 10.1038/embor.2008.32; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; HOOVER KK, 1993, GENETICS, V135, P507; HOOVER KK, 1992, GENETICS, V132, P691; JACKSON DA, 1992, CELL BIOL INT REP, V16, P687, DOI 10.1016/S0309-1651(05)80013-X; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Nabirochkin S, 1998, J BIOL CHEM, V273, P2473, DOI 10.1074/jbc.273.4.2473; NEGRE N, PLOS GENET, V6; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; PETERSEN NS, 1994, GENETICS, V136, P173; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; von Metzler I, 2009, EXP CELL RES, V315, P2471, DOI 10.1016/j.yexcr.2009.04.019; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8	53	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16562	10.1371/journal.pone.0016562	http://dx.doi.org/10.1371/journal.pone.0016562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304601	Green Published, gold			2022-12-27	WOS:000286663900072
J	Wang, W; Li, JM				Wang, Wei; Li, Jinming			Identification of Natural Bispecific Antibodies against Cyclic Citrullinated Peptide and Immunoglobulin G in Rheumatoid Arthritis	PLOS ONE			English	Article							HUMAN IGG4; SUBCLASS DISTRIBUTION; ANTI-CCP; AUTOANTIBODIES	Background: Previous studies indicate that natural bispecific antibodies can be readily produced in vivo when the body is simultaneously stimulated with 2 distinct antigens. Patients with rheumatoid arthritis (RA) usually exhibit persistent immune responses to various autoantigens, raising the possibility that natural bispecific antibodies against 2 distinct autoantigens might exist. Methodology/Principal Findings: We identified the presence of natural bispecific antibodies against cyclic citrullinated peptide (CCP) and immunoglobulin G (IgG) in RA patients' sera by means of a double-antigen sandwich enzyme-linked immunosorbent assay (ELISA). The spontaneous emergence of bispecific antibodies was confirmed by mixing different proportions of 1 anti-CCP-positive serum and 1 rheumatoid factor (RF)-positive serum in vitro. Among the tested samples, positive correlations were found between the presence of bispecific antibodies and both IgG4 anti-CCP antibodies and IgG4 RF (r = 0.507, p < 0.001 and r = 0.249, p = 0.044, respectively), suggesting that the IgG4 subclass is associated with this phenomenon. Furthermore, bispecific antibodies were selectively generated when several anti-CCP- and RF-positive sera were mixed pairwise, indicating that factors other than the monospecific antibody titers may also contribute to the production of the natural bispecific antibodies. Conclusions/Significance: We successfully identified the presence of natural bispecific antibodies. Our results suggest that these antibodies originate from anti-CCP and RF in the sera of RA patients. The natural occurrence of bispecific antibodies in human diseases may provide new insights for a better understanding of the diseases. Further investigations are needed to elucidate their precise generation mechanisms and explore their clinical significance in disease development and progression in a larger study population.	[Wang, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100037, Peoples R China; [Wang, Wei; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital	Wang, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100037, Peoples R China.	ljm63hn@yahoo.com.cn						Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Attar SM, 2009, SAUDI MED J, V30, P446; AVRAMEAS S, 1971, IMMUNOCHEMISTRY, V8, P1175, DOI 10.1016/0019-2791(71)90395-8; Chapuy-Regaud S, 2005, CLIN EXP IMMUNOL, V139, P542, DOI 10.1111/j.1365-2249.2004.02708.x; COHEN PL, 1987, J IMMUNOL, V139, P1466; Engelmann R, 2008, RHEUMATOLOGY, V47, P1489, DOI 10.1093/rheumatology/ken336; Ferri S, 1988, Scand J Rheumatol Suppl, V75, P223; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Lee Ashley Nicole, 2008, Clin Lab Sci, V21, P15; Lopez-Hoyos M, 2004, RHEUMATOLOGY, V43, P655, DOI 10.1093/rheumatology/keh143; Ortona E, 2008, AUTOIMMUN REV, V7, P579, DOI 10.1016/j.autrev.2008.06.001; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Selby C, 1999, ANN CLIN BIOCHEM, V36, P704, DOI 10.1177/000456329903600603; STONE R, 1987, J CLIN PATHOL, V40, P107, DOI 10.1136/jcp.40.1.107; TANIMOTO K, 1976, ANN RHEUM DIS, V35, P240, DOI 10.1136/ard.35.3.240; Wang W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010879	21	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16527	10.1371/journal.pone.0016527	http://dx.doi.org/10.1371/journal.pone.0016527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304585	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900062
J	Wesolowski, LG; Delaney, KP; Lampe, MA; Nesheim, SR				Wesolowski, Laura G.; Delaney, Kevin P.; Lampe, Margaret A.; Nesheim, Steven R.			False-Positive Human Immunodeficiency Virus Enzyme Immunoassay Results in Pregnant Women	PLOS ONE			English	Article							WESTERN BLOTS; INDETERMINATE; TESTS; RISK; DELIVERY; ADULTS; LABOR; CARE	Objective: Examine whether false-positive HIV enzyme immunoassay (EIA) test results occur more frequently among pregnant women than among women who are not pregnant and men (others). Design: To obtain a large number of pregnant women and others tested for HIV, we identified specimens tested at a national laboratory using Genetic Systems HIV-1/HIV-2 Plus O EIA from July 2007 to June 2008. Methods: Specimens with EIA repeatedly reactive and Western blot-negative or indeterminate results were considered EIA false-positive. We compared the false-positive rate among uninfected pregnant women and others, adjusting for HIV prevalence. Among all reactive EIAs, we evaluated the proportion of false-positives, positive predictive value (PPV), and Western blot bands among indeterminates, by pregnancy status. Results: HIV prevalence was 0.06% among 921,438 pregnant women and 1.34% among 1,103,961 others. The false-positive rate was lower for pregnant women than others (0.14% vs. 0.21%, odds ratio 0.65 [95% confidence interval 0.61, 0.70]). Pregnant women with reactive EIAs were more likely than others (p < 0.01) to have Western blot-negative (52.9% vs. 9.8%) and indeterminate results (17.0% vs. 3.7%) and lower PPV (30% vs. 87%). The p24 band was detected more often among pregnant women (p < 0.01). Conclusions: False-positive HIV EIA results were rare and occurred less frequently among pregnant women than others. Pregnant women with reactive EIAs were more likely to have negative and indeterminate Western blot results due to lower HIV prevalence and higher p24 reactivity, respectively. Indeterminate results may complicate clinical management during pregnancy. Alternative methods are needed to rule out infection in persons with reactive EIAs from low prevalence populations.	[Wesolowski, Laura G.; Delaney, Kevin P.; Lampe, Margaret A.; Nesheim, Steven R.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Wesolowski, LG (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	lig7@cdc.gov	Delaney, Kevin/HHS-1060-2022		Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this project was provided by the Centers for Disease Control and Prevention (CDC). CDC staff designed the analysis, decided to publish the data, and prepared the manuscript. The study was based on existing laboratory data collected at a commercial laboratory.	American College of Obstetrics and Gynecology Committee on Obstetric Practice, 2008, Obstet Gynecol, V112, P739, DOI 10.1097/AOG.0b013e318188d29c; Anderson JE, 2006, MATERN CHILD HLTH J, V10, P413, DOI 10.1007/s10995-006-0120-0; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 1999, Pediatrics, V104, P128; [Anonymous], HIV TEST ALG STAT RE; [Anonymous], RETROVIRAL TESTING Q; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; CELUM CL, 1991, J INFECT DIS, V164, P656, DOI 10.1093/infdis/164.4.656; CELUM CL, 1994, ARCH INTERN MED, V154, P1129, DOI 10.1001/archinte.154.10.1129; Doran TI, 2000, ARCH FAM MED, V9, P924, DOI 10.1001/archfami.9.9.924; Garcia T, 2009, J MED MICROBIOL, V58, P1529, DOI 10.1099/jmm.0.008599-0; Greenland S., 1998, MODERN EPIDEMIOLOGY, P343; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Havens PL, 2008, PEDIATRICS, V122, P1127, DOI 10.1542/peds.2008-2175; JACKSON JB, 1995, TRANSFUSION, V35, P98, DOI 10.1046/j.1537-2995.1995.35295125746.x; Jamieson DJ, 2007, AM J OBSTET GYNECOL, V197, pS72, DOI 10.1016/j.ajog.2007.03.067; Laperche S, 2003, TRANSFUSION, V43, P1428, DOI 10.1046/j.1537-2995.2003.00541.x; MIDTHUN K, 1990, J INFECT DIS, V162, P1379, DOI 10.1093/infdis/162.6.1379; Owen SM, 2008, J CLIN MICROBIOL, V46, P1588, DOI 10.1128/JCM.02196-07; *PUBL HLTH SERV TA, 2009, PUBL HLTH SERV TASK; Rahangdale L, 2007, JAIDS-J ACQ IMM DEF, V46, P376, DOI 10.1097/QAI.0b013e3181576888; Rich JD, 1998, J ACQ IMMUN DEF SYND, V17, P376, DOI 10.1097/00042560-199804010-00013; Wesolowski LG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001524	23	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16538	10.1371/journal.pone.0016538	http://dx.doi.org/10.1371/journal.pone.0016538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304592	gold, Green Published			2022-12-27	WOS:000286663900065
J	Manera, V; Becchio, C; Schouten, B; Bara, BG; Verfaillie, K				Manera, Valeria; Becchio, Cristina; Schouten, Ben; Bara, Bruno G.; Verfaillie, Karl			Communicative Interactions Improve Visual Detection of Biological Motion	PLOS ONE			English	Article							POINT-LIGHT DISPLAYS; STIMULUS SET; JOINT ACTION; PERCEPTION; BODY; EMOTION; INTENTIONS; MECHANISMS; ATTENTION; MOVEMENT	Background: In the context of interacting activities requiring close-body contact such as fighting or dancing, the actions of one agent can be used to predict the actions of the second agent [1]. In the present study, we investigated whether interpersonal predictive coding extends to interactive activities - such as communicative interactions - in which no physical contingency is implied between the movements of the interacting individuals. Methodology/Principal Findings: Participants observed point-light displays of two agents (A and B) performing separate actions. In the communicative condition, the action performed by agent B responded to a communicative gesture performed by agent A. In the individual condition, agent A's communicative action was substituted with a non-communicative action. Using a simultaneous masking detection task, we demonstrate that observing the communicative gesture performed by agent A enhanced visual discrimination of agent B. Conclusions/Significance: Our finding complements and extends previous evidence for interpersonal predictive coding, suggesting that the communicative gestures of one agent can serve as a predictor for the expected actions of the respondent, even if no physical contact between agents is implied.	[Manera, Valeria; Becchio, Cristina; Bara, Bruno G.] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Manera, Valeria; Schouten, Ben; Verfaillie, Karl] Katholieke Univ Leuven, Dept Psychol, Expt Psychol Lab, Louvain, Belgium	University of Turin; KU Leuven	Manera, V (corresponding author), Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy.	valeria.manera@unito.it	Manera, Valeria/H-7551-2012; Manera, Valeria/O-3498-2016	Manera, Valeria/0000-0003-4490-4485; Becchio, Cristina/0000-0002-6845-0521	Regione Piemonte; bando Scienze Umane e Sociali [4/2006]; Research Foundation Flanders (FWO) [FWO G.0621.07]	Regione Piemonte(Regione Piemonte); bando Scienze Umane e Sociali; Research Foundation Flanders (FWO)(FWO)	This research was supported by a grant from the Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006, and by a grant from the Research Foundation Flanders (FWO), FWO G.0621.07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Bara B.G., 2010, COGNITIVE PRAGMATICS; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gervais WM, 2010, ATTEN PERCEPT PSYCHO, V72, P1437, DOI 10.3758/APP.72.6.1437; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Hietanen JK, 2002, PSYCHOL RES-PSYCH FO, V66, P174, DOI 10.1007/s00426-002-0091-8; Langton SRH, 2000, J EXP PSYCHOL HUMAN, V26, P747, DOI 10.1037//0096-1523.26.2.747; Macmillan NA, 2005, DETECTION THEORY USE; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Mundy P, 2007, CURR DIR PSYCHOL SCI, V16, P269, DOI 10.1111/j.1467-8721.2007.00518.x; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; RUNESON S, 1983, J EXP PSYCHOL GEN, V112, P585, DOI 10.1037/0096-3445.112.4.585; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838	30	60	61	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14594	10.1371/journal.pone.0014594	http://dx.doi.org/10.1371/journal.pone.0014594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21297865	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800006
J	Stielow, B; Bratek, Z; Orczan, AKI; Rudnoy, S; Hensel, G; Hoffmann, P; Klenk, HP; Goker, M				Stielow, Benjamin; Bratek, Zoltan; Orczan, Akos Kund I.; Rudnoy, Szabolcs; Hensel, Gunnar; Hoffmann, Peter; Klenk, Hans-Peter; Goeker, Markus			Species Delimitation in Taxonomically Difficult Fungi: The Case of Hymenogaster	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; MOLECULAR PHYLOGENETICS; DNA TAXONOMY; DIVERSITY; CORTINARIUS; AGARICALES; UNITS; BIODIVERSITY; SEQUENCES; TAXA	Background: False truffles are ecologically important as mycorrhizal partners of trees and evolutionarily highly interesting as the result of a shift from epigeous mushroom-like to underground fruiting bodies. Since its first description by Vittadini in 1831, inappropriate species concepts in the highly diverse false truffle genus Hymenogaster has led to continued confusion, caused by a large variety of prevailing taxonomical opinions. Methodology: In this study, we reconsidered the species delimitations in Hymenogaster based on a comprehensive collection of Central European taxa comprising more than 140 fruiting bodies from 20 years of field work. The ITS rDNA sequence dataset was subjected to phylogenetic analysis as well as clustering optimization using OPTSIL software. Conclusions: Among distinct species concepts from the literature used to create reference partitions for clustering optimization, the broadest concept resulted in the highest agreement with the ITS data. Our results indicate a highly variable morphology of H. citrinus and H. griseus, most likely linked to environmental influences on the phenology (maturity, habitat, soil type and growing season). In particular, taxa described in the 19(th) century frequently appear as conspecific. Conversely, H. niveus appears as species complex comprising seven cryptic species with almost identical macro-and micromorphology. H. intermedius and H. huthii are described as novel species, each of which with a distinct morphology intermediate between two species complexes. A revised taxonomy for one of the most taxonomically difficult genera of Basidiomycetes is proposed, including an updated identification key. The (semi-)automated selection among species concepts used here is of importance for the revision of taxonomically problematic organism groups in general.	[Stielow, Benjamin; Hoffmann, Peter; Klenk, Hans-Peter; Goeker, Markus] DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany; [Bratek, Zoltan; Orczan, Akos Kund I.; Rudnoy, Szabolcs] ELTE Univ, Dept Plant Physiol & Mol Plant Biol, Budapest, Hungary; [Hensel, Gunnar] Fungarium Gunnar Hensel, Merseburg, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Eotvos Lorand University	Stielow, B (corresponding author), DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany.	markus.goeker@dsmz.de	Bratek, Zoltan/AAG-3027-2020; Göker, Markus/AAX-6258-2021; Bratek, Zoltan/AGZ-4630-2022; Rudnóy, Szabolcs/C-5005-2012	Bratek, Zoltan/0000-0001-6953-5132; Göker, Markus/0000-0002-5144-6200; Bratek, Zoltan/0000-0001-6953-5132; Rudnóy, Szabolcs/0000-0002-2726-1687	Anyos Jedlik Programme; National Technology Programme	Anyos Jedlik Programme; National Technology Programme	ZB's work was supported by a project under the Anyos Jedlik Programme entitled MIKOQUAL and by the project under the National Technology Programme entitled QUTAOMEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; BEATON G, 1985, Kew Bulletin, V40, P167, DOI 10.2307/4108493; Berkeley MJ., 1844, ANN MAG NAT HIST, V13, P340, DOI [10.1080/03745484409442617, DOI 10.1080/03745484409442617]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; BOUGHER NL, 1993, MYCOLOGIA, V85, P273, DOI 10.2307/3760462; Bougher NL, 2001, AUST SYST BOT, V14, P439, DOI 10.1071/SB00002; Boyle H, 2006, MYCOL RES, V110, P369, DOI 10.1016/j.mycres.2005.11.015; BRENNER DJ, 1973, INT J SYST BACTERIOL, V23, P298, DOI 10.1099/00207713-23-4-298; CASTELLANO M A, 1990, Australian Systematic Botany, V3, P653, DOI 10.1071/SB9900653; CASTELLANO MA, 1994, PLANT SOIL, V159, P37, DOI 10.1007/BF00000093; CORDA ACJ, 1842, ICONES FUNGORUM ANLE; Crous PW, 2004, STUD MYCOL, P19; CUNNINGHAM G. H., 1934, PROC LINNEAN SOC N S WALES, V59, P156; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DODGE CARROLL W., 1934, ANN MISSOURI BOT GARDEN, V21, P625, DOI 10.2307/2394189; Doolittle WF, 2009, COLD SH Q B, V74, P197, DOI 10.1101/sqb.2009.74.002; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; FISCHER E, 1933, NAT PFL A, V7, P72; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FOGEL R, 1985, MYCOLOGIA, V77, P72, DOI 10.2307/3793250; FOGEL R, 1985, MYCOLOGIA, V77, P732, DOI 10.2307/3793282; FRANCIS AA, 2003, AUSTRALASIAN MYCOLOG, V21, P81; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Froslev TG, 2007, MOL PHYLOGENET EVOL, V44, P217, DOI 10.1016/j.ympev.2006.11.013; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2003, MYCOLOGIA, V95, P1155, DOI 10.2307/3761917; Goker M, 2010, EVOL BIOINFORM, V6, P97; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; GROSS G, 1980, MYCOTAXON, V93, P241; HAWKER LE, 1954, PHILOS T R SOC B, V237, P429, DOI 10.1098/rstb.1954.0002; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; HESSE R, 1890, HYPOGAEEN DEUTSCHLAN, V2; Hosaka K, 2006, MYCOLOGIA, V98, P949, DOI 10.3852/mycologia.98.6.949; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Julich W, 1984, NICHTBLATTERPILZE GA; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lange M, 1956, DAN BOT ARK, V16, P1; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Massee G, 1891, GREVILLEA, V19, P94; MASSEE G, 1898, KEW B MISCELLANEOUS, V138, P124; MASSEE GE, 1901, KEW B MISC INFORM, V175, P158; MASSEE GE, 1899, KEW B MISC INFORM, V153, P180; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; McNeill J., 2006, V146, P1; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Montecchi A, 2000, FUNGI IPOGEI EUROPA; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; PEGLER DN, 1993, BRIT TRUFFLES REVISI; Peintner U, 2004, MYCOLOGIA, V96, P1042, DOI 10.2307/3762088; Peintner U, 2001, AM J BOT, V88, P2168, DOI 10.2307/3558378; Pilat A, 1958, FLORA CSR GASTEROMYC; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SMITH AH, 1966, MYCOLOGIA, V58, P100, DOI 10.2307/3756992; SOEHNER E, 1962, MONOGRAPHISCHE STUDI; Sokal RR, 1963, PRINCIPLES NUMERICAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stielow B, 2010, MYCOL PROG, V9, P195, DOI 10.1007/s11557-009-0625-1; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAMM H, 2010, MYCOLOGICAL IN PRESS, DOI DOI 10.1007/S11557-010-0659-4; Tindall BJ, 2008, INT J SYST EVOL MICR, V58, P1987, DOI 10.1099/ijs.0.2008/006155-0; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; TULASNE LR, 1843, HIST MONOGRAPHIE CHA; Vittadini C., 1831, MONOGRAPHIA TUBERACE; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Wubet T, 2006, MYCOL RES, V110, P1059, DOI 10.1016/j.mycres.2006.04.005	81	26	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15614	10.1371/journal.pone.0015614	http://dx.doi.org/10.1371/journal.pone.0015614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21311589	Green Submitted, gold, Green Published			2022-12-27	WOS:000286661400009
J	Matsunoshita, Y; Ijiri, K; Ishidou, Y; Nagano, S; Yamamoto, T; Nagao, H; Komiya, S; Setoguchi, T				Matsunoshita, Yukihiro; Ijiri, Kosei; Ishidou, Yasuhiro; Nagano, Satoshi; Yamamoto, Takuya; Nagao, Hiroko; Komiya, Setsuro; Setoguchi, Takao			Suppression of Osteosarcoma Cell Invasion by Chemotherapy Is Mediated by Urokinase Plasminogen Activator Activity via Up-Regulation of EGR1	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; EARLY GROWTH RESPONSE-1; NONMETASTATIC OSTEOSARCOMA; NEOADJUVANT CHEMOTHERAPY; MULTIDRUG-RESISTANCE; CANINE OSTEOSARCOMA; 27-YEAR EXPERIENCE; TUMOR-SUPPRESSOR; RECEPTOR GENE; EXPRESSION	Background: The cellular and molecular mechanisms of tumour response following chemotherapy are largely unknown. We found that low dose anti-tumour agents up-regulate early growth response 1 (EGR1) expression. EGR1 is a member of the immediate-early gene group of transcription factors which modulate transcription of multiple genes involved in cell proliferation, differentiation, and development. It has been reported that EGR1 act as either tumour promoting factor or suppressor. We therefore examined the expression and function of EGR1 in osteosarcoma. Methods: We investigated the expression of EGR1 in human osteosarcoma cell lines and biopsy specimens. We next examined the expression of EGR1 following anti-tumour agents treatment. To examine the function of EGR1 in osteosarcoma, we assessed the tumour growth and invasion in vitro and in vivo. Results: Real-time PCR revealed that EGR1 was down-regulated both in osteosarcoma cell lines and osteosarcoma patients' biopsy specimens. In addition, EGR1 was up-regulated both in osteosarcoma patient' specimens and osteosarcoma cell lines following anti-tumour agent treatment. Although forced expression of EGR1 did not prevent osteosarcoma growth, forced expression of EGR1 prevented osteosarcoma cell invasion in vitro. In addition, forced expression of EGR1 promoted down-regulation of urokinase plasminogen activator, urokinase receptor, and urokinase plasminogen activity. Xenograft mice models showed that forced expression of EGR1 prevents osteosarcoma cell migration into blood vessels. Conclusions: These findings suggest that although chemotherapy could not prevent osteosarcoma growth in chemotherapy-resistant patients, it did prevent osteosarcoma cell invasion by down-regulation of urokinase plasminogen activity via up-regulation of EGR1 during chemotherapy periods.	[Matsunoshita, Yukihiro; Ijiri, Kosei; Nagano, Satoshi; Yamamoto, Takuya; Nagao, Hiroko; Komiya, Setsuro; Setoguchi, Takao] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 890, Japan; [Ishidou, Yasuhiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Matsunoshita, Y (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 890, Japan.	setoro@m2.kufm.kagoshima-u.ac.jp		Nagano, Satoshi/0000-0003-2015-1730	Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer [18390419, 19591725, 20591786, 21591919, 21591920, 22591663]	Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer	This work was supported by Grants-in-Aid for Scientific Research (B) 18390419, (C) 19591725, (C) 20591786, (C) 21591919, (C) 21591920, and (C) 22591663 (KAKENHI), and a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer (http://www.jsps.go.jp/j-grantsinaid/index.html, http://ganjoho.ncc.go.jp/pro/taigan/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bacci G, 2005, EUR J CANCER, V41, P2836, DOI 10.1016/j.ejca.2005.08.026; Bacci G, 2007, J SURG ONCOL, V96, P118, DOI 10.1002/jso.20628; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Dass CR, 2005, CLIN EXP METASTAS, V22, P643, DOI 10.1007/s10585-006-9004-3; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; de Bock CE, 2005, FEBS J, V272, P3572, DOI 10.1111/j.1742-4658.2005.04778.x; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Goorin AM, 2003, J CLIN ONCOL, V21, P1574, DOI 10.1200/JCO.2003.08.165; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HAMILTON JW, 1994, ANN NY ACAD SCI, V726, P343, DOI 10.1111/j.1749-6632.1994.tb52846.x; Henley DB, 2009, EXPERT OPIN PHARMACO, V10, P1657, DOI 10.1517/14656560903044982; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; HOTTA T, 1992, ACTA PATHOL JAPON, V42, P595; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; HUANG RP, 1995, CANCER RES, V55, P5054; Ihnat MA, 1997, CLIN CANCER RES, V3, P1339; Iwamoto Y, 2009, J ORTHOP SCI, V14, P397, DOI 10.1007/s00776-009-1347-6; KARIKO K, 1993, CANCER RES, V53, P3109; Kim J, 2006, CANCER RES, V66, P784, DOI 10.1158/0008-5472.CAN-05-1316; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483; Lengyel E, 1996, J BIOL CHEM, V271, P23176, DOI 10.1074/jbc.271.38.23176; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199; Liu XY, 2009, MOL BIOL CELL, V20, P2174, DOI 10.1091/mbc.E08-10-0994; MacEwen EG, 2004, J CELL BIOCHEM, V92, P77, DOI 10.1002/jcb.20046; MacEwen EG, 2003, CLIN EXP METASTAS, V20, P421; Mahalingam D, 2010, BRIT J CANCER, V102, P754, DOI 10.1038/sj.bjc.6605545; Mahalingam D, 2009, CURR DRUG TARGETS, V10, P937, DOI 10.2174/138945009789577990; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Mirabello L, 2009, INT J CANCER, V125, P229, DOI 10.1002/ijc.24320; Patel SJ, 2002, AM J CLIN ONCOL-CANC, V25, P489, DOI 10.1097/00000421-200210000-00014; Quinones A, 2003, LIFE SCI, V72, P2975, DOI 10.1016/S0024-3205(03)00230-3; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Santiago FS, 1999, AM J PATHOL, V154, P937, DOI 10.1016/S0002-9440(10)65341-2; Sasaki H, 2010, ONCOL REP, V23, P677, DOI 10.3892/or_00000684; Schwachtgen JL, 1998, J CLIN INVEST, V101, P2540, DOI 10.1172/JCI1404; SHINGU T, 1994, J BIOL CHEM, V269, P32551; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Su L, 2010, ONCOGENE, V29, P4352, DOI 10.1038/onc.2010.204; Ta H, 2009, CANCER METAST REV, V28, P247, DOI 10.1007/s10555-009-9186-7; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Wittig JC, 2002, AM FAM PHYSICIAN, V65, P1123; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16234	10.1371/journal.pone.0016234	http://dx.doi.org/10.1371/journal.pone.0016234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283769	Green Published, gold, Green Submitted			2022-12-27	WOS:000286522200041
J	Johnson, W; Kyvik, KO; Skytthe, A; Deary, IJ; Sorensen, TIA				Johnson, Wendy; Kyvik, Kirsten Ohm; Skytthe, Axel; Deary, Ian J.; Sorensen, Thorkild I. A.			Education Modifies Genetic and Environmental Influences on BMI	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL HEALTH; OBESITY; WEIGHT; TWIN; MODELS; INTELLIGENCE; VARIANCE; HEIGHT; SEX	Obesity is more common among the less educated, suggesting education-related environmental triggers. Such triggers may act differently dependent on genetic and environmental predisposition to obesity. In a Danish Twin Registry survey, 21,522 twins of same-sex pairs provided zygosity, height, weight, and education data. Body mass index (BMI = kg weight/m height(2)) was used to measure degree of obesity. We used quantitative genetic modeling to examine how genetic and shared and nonshared environmental variance in BMI differed by level of education and to estimate how genetic and shared and nonshared environmental correlations between education and BMI differed by level of education, analyzing women and men separately. Correlations between education and BMI were -.13 in women, -.15 in men. High BMI's were less frequent among well-educated participants, generating less variance. In women, this was due to restriction of all forms of variance, overall by a factor of about 2. In men, genetic variance did not vary with education, but results for shared and nonshared environmental variance were similar to those for women. The contributions of the shared environment to the correlations between education and BMI were substantial among the well-educated, suggesting importance of familial environmental influences common to high education and lower BMI. Family influence was particularly important in linking high education and lower levels of obesity.	[Johnson, Wendy; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Johnson, Wendy] Univ Minnesota, Dept Psychol, St Paul, MN USA; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Reg Hlth Serv Res, Odense, Denmark; [Kyvik, Kirsten Ohm; Skytthe, Axel] Univ So Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark; [Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	University of Edinburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Southern Denmark; University of Southern Denmark; University of Copenhagen	Johnson, W (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	wendy.johnson@ed.ac.uk	Skytthe, Axel E/G-4820-2019; Deary, Ian J/C-6297-2009; Kyvik, Kirsten O/K-5680-2016	Skytthe, Axel E/0000-0002-8629-4913; Deary, Ian J/0000-0002-1733-263X; Kyvik, Kirsten O/0000-0003-2981-0245	Biotechnology and Biological Sciences Research Council [R40547]; Engineering and Physical Sciences Research Council [R40547]; Economic and Social Research Council [R40547]; Medical Research Council, Lifelong Health and Wellbeing Initiative [R40547, G0700704]; University of Edinburgh [SC005336]; MRC [G0700704] Funding Source: UKRI; Medical Research Council [G0700704B, G0700704] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council, Lifelong Health and Wellbeing Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Research Councils of the United Kingdom [#R40547 to W. J.]: the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, and the Medical Research Council [G0700704 to the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology] as part of the Lifelong Health and Wellbeing Initiative; and the University of Edinburgh, a charitable body, registered in Scotland with registration number SC005336. The questionnaire to the participants of the Danish Twin Registry was funded by the participating researchers. This study was part of the activity of the Danish Obesity Research Centre (DanORC; see www.danorc.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N.E., 1999, SOCIOECONOMIC STATUS; Akaike H, 1973, B INT STAT I, V50, P277; Andreasen CH, 2009, NUTRITION, V25, P998, DOI 10.1016/j.nut.2009.06.001; CAREY G, 1994, J ABNORM PSYCHOL, V103, P32, DOI 10.1037/0021-843X.103.1.32; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/136905203322296610; CHRISTIKAS NA, NEW ENG J MED, V357, P350; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Crosnoe R, 2007, SOCIOL EDUC, V80, P241, DOI 10.1177/003804070708000303; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; FERNANDEZ JR, 2008, PHYSL BEH, V94, P94; Finch CE, 2007, BIOL HUMAN LONGEVITY; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Jain A, 2001, PEDIATRICS, V107, P1138, DOI 10.1542/peds.107.5.1138; Jain RB, 2010, INT J OBESITY, V34, P1655, DOI 10.1038/ijo.2010.80; JALKANEN L, 1987, SCAND J SOC MED, V15, P191, DOI 10.1177/140349488701500311; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; Johnson W, 2005, BEHAV GENET, V35, P579, DOI 10.1007/s10519-005-3598-0; Johnson W, 2005, J PERS SOC PSYCHOL, V88, P165, DOI 10.1037/0022-3514.88.1.165; Johnson W, 2010, INT J EPIDEMIOL, V39, P406, DOI 10.1093/ije/dyp314; Johnson W, 2009, INTELLIGENCE, V37, P466, DOI 10.1016/j.intell.2009.05.006; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Neale M. C, 2003, MX STAT MODELING, V6th; Plomin R., 2007, BEHAV GENETICS; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rathouz PJ, 2008, BEHAV GENET, V38, P301, DOI 10.1007/s10519-008-9193-4; Skytthe A, 2002, TWIN RES, V5, P352; SORENSEN TIA, 1985, J BIOSOC SCI, V17, P379; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; TEASDALE TW, 1992, HUM BIOL, V64, P99; Turkheimer E, 2000, CURR DIR PSYCHOL SCI, V9, P160, DOI 10.1111/1467-8721.00084; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Wilson ME, 2008, PHYSIOL BEHAV, V94, P586, DOI 10.1016/j.physbeh.2008.03.019	37	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16290	10.1371/journal.pone.0016290	http://dx.doi.org/10.1371/journal.pone.0016290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OH	21283825	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600039
J	Sserwanga, A; Harris, JC; Kigozi, R; Menon, M; Bukirwa, H; Gasasira, A; Kakeeto, S; Kizito, F; Quinto, E; Rubahika, D; Nasr, S; Filler, S; Kamya, MR; Dorsey, G				Sserwanga, Asadu; Harris, Jamal C.; Kigozi, Ruth; Menon, Manoj; Bukirwa, Hasifa; Gasasira, Anne; Kakeeto, Stella; Kizito, Fred; Quinto, Ebony; Rubahika, Denis; Nasr, Sussann; Filler, Scott; Kamya, Moses R.; Dorsey, Grant			Improved Malaria Case Management through the Implementation of a Health Facility-Based Sentinel Site Surveillance System in Uganda	PLOS ONE			English	Article							COMBINATION THERAPY; COST-EFFECTIVENESS; MICROSCOPY; TRANSMISSION; TANZANIA; AFRICA; ZAMBIA; KENYA; ERA	Background: Heath facility-based sentinel site surveillance has been proposed as a means of monitoring trends in malaria morbidity but may also provide an opportunity to improve malaria case management. Here we described the impact of a sentinel site malaria surveillance system on promoting laboratory testing and rational antimalarial drug use. Methodology/Principal Findings: Sentinel site malaria surveillance was established at six health facilities in Uganda between September 2006 and January 2007. Data were collected from all patients presenting to the outpatient departments including demographics, laboratory results, diagnoses, and treatments prescribed. Between the start of surveillance and March 2010, a total 424,701 patients were seen of which 229,375 (54%) were suspected of having malaria. Comparing the first three months with the last three months of surveillance, the proportion of patients with suspected malaria who underwent diagnostic testing increased from 39% to 97% (p<0.001). The proportion of patients with an appropriate decision to prescribe antimalarial therapy (positive test result prescribed, negative test result not prescribed) increased from 64% to 95% (p<0.001). The proportion of patients appropriately prescribed antimalarial therapy who were prescribed the recommended first-line regimen artemether-lumefantrine increased from 48% to 69% (p<0.001). Conclusions/Significance: The establishment of a sentinel site malaria surveillance system in Uganda achieved almost universal utilization of diagnostic testing in patients with suspected malaria and appropriate decisions to prescribed antimalarial based on test results. Less success was achieved in promoting prescribing practice for the recommended first-line therapy. This system could provide a model for improving malaria case management in other health facilities in Africa.	[Sserwanga, Asadu; Kigozi, Ruth; Bukirwa, Hasifa; Gasasira, Anne; Kakeeto, Stella; Kizito, Fred] Uganda Malaria Surveillance Project, Kampala, Uganda; [Harris, Jamal C.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Menon, Manoj; Nasr, Sussann; Filler, Scott] Ctr Dis Control & Prevent, Atlanta, GA USA; [Quinto, Ebony; Rubahika, Denis] Uganda Minist Hlth, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Makerere University; University of California System; University of California San Francisco	Sserwanga, A (corresponding author), Uganda Malaria Surveillance Project, Kampala, Uganda.	gdorsey@medsfgh.ucsf.edu			President's Malaria Initiative; Centers for Disease Control and Prevention [U50/CCU925122]; National Institute of Mental Health [T32MH019105]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105] Funding Source: NIH RePORTER	President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study received financial support from the President's Malaria Initiative through a cooperative agreement with the Centers for Disease Control and Prevention (U50/CCU925122). JH was supported in part by an Institutional Research Training Grant (T32MH019105) from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funding agencies had no role in the design and conduct of the study; collection, management, and analysis of the data. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. Members of the Centers for Disease Control and Prevention (MM, SN, and SF) were involved in the preparation, review, and approval of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2008, WORLD MAL REP 2008; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Breman JG, 2007, AM J TROP MED HYG, V77, P36; BRYCE J, 1994, B WORLD HEALTH ORGAN, V72, P371; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Kamya MR, 2002, TROP MED INT HEALTH, V7, P1031, DOI 10.1046/j.1365-3156.2002.00974.x; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Reyburn H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-4; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; WHO, 2010, GUID TREATM MAL, V2nd; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	19	56	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16316	10.1371/journal.pone.0016316	http://dx.doi.org/10.1371/journal.pone.0016316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283815	Green Published, Green Submitted, gold			2022-12-27	WOS:000286520600040
J	Darpolor, MM; Molthen, RC; Schmainda, KM				Darpolor, Moses M.; Molthen, Robert C.; Schmainda, Kathleen M.			Multimodality Imaging of Abnormal Vascular Perfusion and Morphology in Preclinical 9L Gliosarcoma Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUSCEPTIBILITY CONTRAST MRI; BLOOD-VOLUME MAPS; IONIZING-RADIATION; IN-VIVO; PERMEABILITY FACTOR; DEXAMETHASONE; ANGIOGENESIS; TUMORS; AGENT	Background: This study demonstrates that a dynamic susceptibility contrast-magnetic resonance imaging (DSC-MRI) perfusion parameter may indicate vascular abnormality in a brain tumor model and reflects an effect of dexamethasone treatment. In addition, X-ray computed tomography (CT) measurements of vascular tortuosity and tissue markers of vascular morphology were performed to investigate the underpinnings of tumor response to dexamethasone. Methodology/Principal Findings: One cohort of Fisher 344 rats (N = 13), inoculated intracerebrally with 9L gliosarcoma cells, was treated with dexamethasone (i.p. 3 mg/kg/day) for five consecutive days, and another cohort (N = 11) was treated with equal volume of saline. Longitudinal DSC-MRI studies were performed at the first (baseline), third and fifth day of treatments. Relative cerebral blood volume (rCBV) was significantly reduced on the third day of dexamethasone treatment (0.65 +/-.13) as compared to the fifth day during treatment (1.26 +/-.19, p<0.05). In saline treated rats, relative CBV gradually increased during treatment (0.89 +/-.13, 1.00 +/-.21, 1.13 +/-.23) with no significant difference on the third day of treatment (p>0.05). In separate serial studies, microfocal X-ray CT of ex vivo brain specimens (N = 9) and immunohistochemistry for endothelial cell marker anti-CD31 (N = 8) were performed. Vascular morphology of ex vivo rat brains from micro-CT analysis showed hypervascular characteristics in tumors, and both vessel density (41.32 +/- 2.34 branches/mm(3), p<0.001) and vessel tortuosity (p<0.05) were significantly reduced in tumors of rats treated with dexamethasone compared to saline (74.29 +/- 3.51 branches/mm(3)). The vascular architecture of rat brain tissue was examined with anti-CD31 antibody, and dexamethasone treated tumor regions showed reduced vessel area (16.45 +/- 1.36 mu m(2)) as compared to saline treated tumor regions (30.83 +/- 4.31 mu m(2), p<0.001) and non-tumor regions (22.80 +/- 1.11 mu m(2), p<0.01). Conclusions/Significance: Increased vascular density and tortuosity are culprit to abnormal perfusion, which is transiently reduced during dexamethasone treatment.	[Darpolor, Moses M.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Molthen, Robert C.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Darpolor, Moses M.; Schmainda, Kathleen M.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Schmainda, Kathleen M.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA	Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Darpolor, MM (corresponding author), Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA.	kathleen@mcw.edu	Darpolor, Moses/AAJ-8016-2020; Molthen, Robert/A-3757-2008	Darpolor, Moses/0000-0002-5172-8101; Schmainda, Kathleen/0000-0001-6402-2602	NIH/NCI [R01 CA082500]; Marquette University; NATIONAL CANCER INSTITUTE [R01CA082500] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marquette University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by NIH/NCI R01 CA082500 and GAANN grant (Marquette University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Baish JW, 2000, CANCER RES, V60, P3683; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bello L, 2001, CANCER RES, V61, P7501; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Gorski DH, 1999, CANCER RES, V59, P3374; Gorski DH, 1998, CANCER RES, V58, P5686; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Johnson RH, 1998, PHYS MED BIOL, V43, P929, DOI 10.1088/0031-9155/43/4/020; Kadambi A, 2001, CANCER RES, V61, P2404; Karau KL, 2001, AM J PHYSIOL-HEART C, V281, pH2747, DOI 10.1152/ajpheart.2001.281.6.H2747; Lee CG, 2000, CANCER RES, V60, P5565; Machein MR, 1999, NEUROPATH APPL NEURO, V25, P104; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Moffat BA, 2006, CLIN CANCER RES, V12, P1525, DOI 10.1158/1078-0432.CCR-05-1408; Molthen RC, 2004, J APPL PHYSIOL, V97, P2372, DOI 10.1152/japplphysiol.00454.2004; Pathak AP, 2001, MAGNET RESON MED, V46, P735, DOI 10.1002/mrm.1252; Portnow J, 2002, NEURO-ONCOLOGY, V4, P22, DOI 10.1093/neuonc/4.1.22; Quarles CC, 2007, MAGN RESON MED, V57, P680, DOI 10.1002/mrm.21193; Quarles CC, 2005, TECHNOL CANCER RES T, V4, P245, DOI 10.1177/153303460500400303; Quarles CC, 2005, MAGN RESON MED, V53, P1307, DOI 10.1002/mrm.20497; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; ROBB RA, 1989, IEEE T MED IMAGING, V8, P217, DOI 10.1109/42.34710; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Shalinsky DR, 1999, CLIN CANCER RES, V5, P1905; SHEN T, 1993, MAGN RESON MED, V29, P599, DOI 10.1002/mrm.1910290504; Wolff JEA, 1997, KLIN PADIATR, V209, P275, DOI 10.1055/s-2008-1043962; WOLFF JEA, 1993, BRAIN RES, V604, P79, DOI 10.1016/0006-8993(93)90354-P; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16621	10.1371/journal.pone.0016621	http://dx.doi.org/10.1371/journal.pone.0016621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305001	gold, Green Submitted, Green Published			2022-12-27	WOS:000286834300100
J	Gazzin, S; Berengeno, AL; Strazielle, N; Fazzari, F; Raseni, A; Ostrow, JD; Wennberg, R; Ghersi-Egea, JF; Tiribelli, C				Gazzin, Silvia; Berengeno, Andrea Lorena; Strazielle, Nathalie; Fazzari, Francesco; Raseni, Alan; Ostrow, J. Donald; Wennberg, Richard; Ghersi-Egea, Jean-Francois; Tiribelli, Claudio			Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; OXIDATIVE STRESS; CHOROID-PLEXUS; UNCONJUGATED BILIRUBIN; CEREBELLAR HYPOPLASIA; ENDOTHELIAL-CELLS; DIFFERENTIAL EXPRESSION; INCREASED SENSITIVITY; DRUG-METABOLISM	Accumulation of unconjugated bilirubin (UCB) in the brain causes bilirubin encephalopathy. Pgp (ABCb1) and Mrp1 (ABCc1), highly expressed in the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB) respectively, may modulate the accumulation of UCB in brain. We examined the effect of prolonged exposure to elevated concentrations of UCB on expression of the two transporters in homozygous, jaundiced (jj) Gunn rats compared to heterozygous, not jaundiced (Jj) littermates at different developmental stages (2, 9, 17 and 60 days after birth). BBB Pgp protein expression was low in both jj and Jj pups at 9 days (about 16-27% of adult values), despite the up-regulation in jj animals (2 and 1.3 fold higher than age matched Jj animals at P9 and P17-P60, respectively); Mrp1 protein expression was barely detectable. Conversely, at the BCSFB Mrp1 protein expression was rather high (60-70% of the adult values) in both jj and Jj at P2, but was markedly (50%) down-regulated in jj pups starting at P9, particularly in the 4(th) ventricle choroid plexuses: Pgp was almost undetectable. The Mrp1 protein down regulation was accompanied by a modest up-regulation of mRNA, suggesting a translational rather than a transcriptional inhibition. In vitro exposure of choroid plexus epithelial cells obtained from normal rats to UCB, also resulted in a down-regulation of Mrp1 protein. These data suggest that down-regulation of Mrp1 protein at the BSCFB, resulting from a direct effect of UCB on epithelial cells, may impact the Mrp1-mediated neuroprotective functions of the blood-cerebrospinal fluid barrier and actually potentiate UCB neurotoxicity.	[Gazzin, Silvia; Berengeno, Andrea Lorena; Fazzari, Francesco; Tiribelli, Claudio] Ctr Fegato, Basovizza Trieste, Italy; [Strazielle, Nathalie] Univ Lyon 1, Fac Med Laennec, Brain I INSERM U842, F-69365 Lyon, France; [Raseni, Alan] SC Lab Anal Clin IRCCS Burlo Garofolo, Trieste, Italy; [Ostrow, J. Donald] Univ Washington, Sch Med, Div Gastroenterol Hepatol, Seattle, WA USA; [Ostrow, J. Donald] VA Puget Sound Hlth Care System, Seattle Div, Seattle, WA USA; [Wennberg, Richard] Univ Washington, Sch Med, Div Neonatol, Seattle, WA USA; [Ghersi-Egea, Jean-Francois] Univ Lyon 1, INSERM U842, Fac Med Laennec, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; IRCCS Burlo Garofolo; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gazzin, S (corresponding author), Ctr Fegato, Basovizza Trieste, Italy.	silvia.gazzin@csf.units.it	; Tiribelli, Claudio/A-4716-2014	Ghersi-Egea, Jean-Francois/0000-0002-0181-4909; Tiribelli, Claudio/0000-0001-6596-7595	Fondo Regionale FVG [legge 23/00]; Telethon [GGP05062]; Italian Liver Foundation; Italian Ministry of Foreign Affairs, Rome, Italy	Fondo Regionale FVG; Telethon(Fondazione Telethon); Italian Liver Foundation; Italian Ministry of Foreign Affairs, Rome, Italy	This work was supported in part by a grant from the Fondo Regionale FVG (legge 23/00) and in part from a Telethon grant number GGP05062. The reimaging costs were covered by an in house grant from the Italian Liver Foundation. ALB was supported by a PhD fellowship from the Italian Ministry of Foreign Affairs, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSMA PJ, 1993, GASTROENTEROLOGY, V105, P216, DOI 10.1016/0016-5085(93)90029-C; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brito MA, 2008, NEUROBIOL DIS, V29, P30, DOI 10.1016/j.nbd.2007.07.023; Cannon C, 2006, BIOL NEONATE, V90, P40, DOI 10.1159/000091843; Cesaratto L, 2007, J MOL MED, V85, P1099, DOI 10.1007/s00109-007-0204-3; CHOWDHURY JR, 1993, ADV VET SCI COMP MED, V37, P149; CHOWDHURY JR, 1991, J BIOL CHEM, V266, P18294; COLE SPC, 1994, CANCER RES, V54, P5902; Conlee JW, 1997, ACTA NEUROPATHOL, V93, P450, DOI 10.1007/s004010050639; Corich L, 2009, BIOCHEM J, V417, P305, DOI 10.1042/BJ20080918; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; DIAMOND I, 1966, J CLIN INVEST, V45, P678, DOI 10.1172/JCI105383; EHRLICH P, 1883, CENTR KLIN MED, V4, P721; Elferink MGL, 2004, AM J PHYSIOL-GASTR L, V287, pG1008, DOI 10.1152/ajpgi.00071.2004; Felix RA, 2002, J NEUROCHEM, V80, P64, DOI 10.1046/j.0022-3042.2001.00660.x; Fernetti C, 2001, BIOCHEM BIOPH RES CO, V288, P1064, DOI 10.1006/bbrc.2001.5885; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Ghersi-Egea JF, 2009, CURR PHARM DESIGN, V15, P2893, DOI 10.2174/138161209789058147; Ghersi-Egea JF, 2001, MICROSC RES TECHNIQ, V52, P83, DOI 10.1002/1097-0029(20010101)52:1<83::AID-JEMT10>3.0.CO;2-N; GHERSIEGEA JF, 1994, J NEUROCHEM, V62, P1089; GhersiEgea JF, 1995, TOXICOL LETT, V82-3, P645, DOI 10.1016/0378-4274(95)03510-9; Gourley G R, 1997, Adv Pediatr, V44, P173; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Hong H, 2006, J NEUROCHEM, V98, P1465, DOI 10.1111/j.1471-4159.2006.03993.x; IYANAGI T, 1989, J BIOL CHEM, V264, P21302; Jedlitschky G, 1996, CANCER RES, V56, P988; JETTE L, 1995, BIOCHEM PHARMACOL, V50, P1701, DOI 10.1016/0006-2952(95)02073-X; JOHNSON JA, 1993, BIOCHEM J, V291, P453, DOI 10.1042/bj2910453; Jones BR, 2005, MOL PHARMACOL, V68, P701, DOI 10.1124/mol.105.013144; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kaplan M, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e47; KEINO H, 1986, PEDIATR NEUROSCI, V12, P145, DOI 10.1159/000120237; Lawrenson JG, 1999, ANAT EMBRYOL, V199, P29, DOI 10.1007/s004290050206; LEIER I, 1994, J BIOL CHEM, V269, P27807; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Lippoldt A, 2000, NEUROREPORT, V11, P1427, DOI 10.1097/00001756-200005150-00015; Lorico A, 1997, CANCER RES, V57, P5238; Matsuoka Y, 1999, J NEUROBIOL, V39, P383, DOI 10.1002/(SICI)1097-4695(19990605)39:3<383::AID-NEU5>3.0.CO;2-4; Mediavilla MG, 1999, FEBS LETT, V463, P143, DOI 10.1016/S0014-5793(99)01606-3; NAG S, 2003, METH MOLEC MED, V89, pR5; Ostrow JD, 2004, TRENDS MOL MED, V10, P65, DOI 10.1016/j.molmed.2003.12.003; Ostrow JD, 2003, EUR J CLIN INVEST, V33, P988, DOI 10.1046/j.1365-2362.2003.01261.x; OSTROW JD, 1994, J LIPID RES, V35, P1715; OSTROW JD, 1987, BILE PIGMENTS JAUNDI; Rigato L, 2004, BIOCHEM J, V383, P335, DOI 10.1042/BJ20040599; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; SAWASAKI Y, 1976, J NEUROCHEM, V27, P577, DOI 10.1111/j.1471-4159.1976.tb12285.x; SCHMID R, 1958, J CLIN INVEST, V37, P1123, DOI 10.1172/JCI103702; Shapiro SM, 2002, PEDIATR RES, V52, P844, DOI 10.1203/01.PDR.0000036880.02060.EE; Shapiro SM, 2006, CLIN PERINATOL, V33, P387, DOI 10.1016/j.clp.2006.03.010; Strazielle N, 1999, J NEUROSCI, V19, P6275; Strazielle N, 2003, AIDS, V17, P1473, DOI 10.1097/00002030-200307040-00008; Sugiyama D, 2003, PHARM RES-DORDR, V20, P1394, DOI 10.1023/A:1025749925541; TAKAHASHI M, 1984, J BIOCHEM-TOKYO, V96, P1705, DOI 10.1093/oxfordjournals.jbchem.a135003; Tell G, 2009, CURR PHARM DESIGN, V15, P2908, DOI 10.2174/138161209789058174; Tsai CE, 2002, BIOL NEONATE, V81, P58, DOI 10.1159/000047185; Virgintino D, 2008, J NEUROPATH EXP NEUR, V67, P50, DOI 10.1097/nen.0b013e31815f65d9; Watchko J F, 2001, J Perinatol, V21 Suppl 1, pS43, DOI 10.1038/sj.jp.7210633; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395; Wennberg RP, 2000, CELL MOL NEUROBIOL, V20, P97, DOI 10.1023/A:1006900111744; Wijnholds J, 2000, J CLIN INVEST, V105, P279, DOI 10.1172/JCI8267; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275	65	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16165	10.1371/journal.pone.0016165	http://dx.doi.org/10.1371/journal.pone.0016165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297965	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300038
J	Gotzek, D; Robertson, HM; Wurm, Y; Shoemaker, D				Gotzek, Dietrich; Robertson, Hugh M.; Wurm, Yannick; Shoemaker, DeWayne			Odorant Binding Proteins of the Red Imported Fire Ant, Solenopsis invicta: An Example of the Problems Facing the Analysis of Widely Divergent Proteins	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; AMINO-ACID SITES; CHEMOSENSORY PROTEINS; GENOME ANNOTATION; GROUP HYMENOPTERA; GENE FAMILY; EVOLUTION; INFERENCE; ACCURACY	We describe the odorant binding proteins (OBPs) of the red imported fire ant, Solenopsis invicta, obtained from analyses of an EST library and separate 454 sequencing runs of two normalized cDNA libraries. We identified a total of 18 putative functional OBPs in this ant. A third of the fire ant OBPs are orthologs to honey bee OBPs. Another third of the OBPs belong to a lineage-specific expansion, which is a common feature of insect OBP evolution. Like other OBPs, the different fire ant OBPs share little sequence similarity (similar to 20%), rendering evolutionary analyses difficult. We discuss the resulting problems with sequence alignment, phylogenetic analysis, and tests of selection. As previously suggested, our results underscore the importance for careful exploration of the sensitivity to the effects of alignment methods for data comprising widely divergent sequences.	[Gotzek, Dietrich; Wurm, Yannick] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Shoemaker, DeWayne] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	University of Lausanne; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Gotzek, D (corresponding author), Natl Museum Nat Hist, Dept Entomol, Smithsonian Inst, Washington, DC 20560 USA.	gotzekd@si.edu	Wurm, Yannick/A-9525-2009	Wurm, Yannick/0000-0002-3140-2809; Shoemaker, DeWayne/0000-0003-3659-8393	USDA-AFRI	USDA-AFRI(United States Department of Agriculture (USDA))	Part of this study was funded by USDA-AFRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Boussau B, 2010, TRENDS ECOL EVOL, V25, P224, DOI 10.1016/j.tree.2009.09.007; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2003, BIOINFORMATICS, V19, P1404, DOI 10.1093/bioinformatics/btg158; Felsenstein J., 2004, INFERRING PHYLOGENIE; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fletcher W, 2010, MOL BIOL EVOL, V27, P2257, DOI 10.1093/molbev/msq115; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Gotzek D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007713; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guntur KVP, 2004, ARCH INSECT BIOCHEM, V57, P101, DOI 10.1002/arch.20019; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Higgins D, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P68; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Krieger MJB, 2005, MOL BIOL EVOL, V22, P2090, DOI 10.1093/molbev/msi203; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003762; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Martin W, 2007, TRENDS GENET, V23, P478, DOI 10.1016/j.tig.2007.08.007; Morgenstern B, 2003, BIOINFORMATICS, V19, P425, DOI 10.1093/bioinformatics/btf882; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Morrison DA, 2009, SYST BIOL, V58, P150, DOI 10.1093/sysbio/syp009; Nielsen R, 1998, GENETICS, V148, P929; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Opperdoes FR, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P313; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pitts JP, 2005, ZOOL SCR, V34, P493, DOI 10.1111/j.1463-6409.2005.00203.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rambaut A., 2007, TRACER V1 5; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross KG, 1997, GENETICS, V145, P961; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Smith CD, 2010, MOL ECOL, V19, P31, DOI 10.1111/j.1365-294X.2009.04438.x; STEEL MA, 1993, NATURE, V364, P440, DOI 10.1038/364440a0; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r9; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x	72	36	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16289	10.1371/journal.pone.0016289	http://dx.doi.org/10.1371/journal.pone.0016289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305009	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300047
J	Nicolle, A; Hansson, LA; Brodersen, J; Nilsson, PA; Bronmark, C				Nicolle, Alice; Hansson, Lars-Anders; Brodersen, Jakob; Nilsson, P. Anders; Bronmark, Christer			Interactions between Predation and Resources Shape Zooplankton Population Dynamics	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; CLIMATE-DRIVEN CHANGES; BOTTOM-UP; TOP-DOWN; FISH PREDATION; PLANKTON DYNAMICS; RUTILUS-RUTILUS; TROPHIC INTERACTIONS; NUTRIENT ENRICHMENT; FOOD LIMITATION	Identifying the relative importance of predation and resources in population dynamics has a long tradition in ecology, while interactions between them have been studied less intensively. In order to disentangle the effects of predation by juvenile fish, algal resource availability and their interactive effects on zooplankton population dynamics, we conducted an enclosure experiment where zooplankton were exposed to a gradient of predation of roach (Rutilus rutilus) at different algal concentrations. We show that zooplankton populations collapse under high predation pressure irrespective of resource availability, confirming that juvenile fish are able to severely reduce zooplankton prey when occurring in high densities. At lower predation pressure, however, the effect of predation depended on algal resource availability since high algal resource supply buffered against predation. Hence, we suggest that interactions between mass-hatching of fish, and the strong fluctuations in algal resources in spring have the potential to regulate zooplankton population dynamics. In a broader perspective, increasing spring temperatures due to global warming will most likely affect the timing of these processes and have consequences for the spring and summer zooplankton dynamics.	[Nicolle, Alice; Hansson, Lars-Anders; Brodersen, Jakob; Nilsson, P. Anders; Bronmark, Christer] Lund Univ, Inst Ecol Limnol, Lund, Sweden	Lund University	Nicolle, A (corresponding author), Lund Univ, Inst Ecol Limnol, Lund, Sweden.	Alice.nicolle@limnol.lu.se	Hansson, Lars-Anders/HCI-2735-2022; Nilsson, Anders/H-6836-2014	Nilsson, Anders/0000-0002-3541-9835; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR); Royal Physiographic Society in Lund	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Royal Physiographic Society in Lund	The study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS; www.formas.se), the Swedish Research Council (VR; www.vr.se) and the Royal Physiographic Society in Lund (www.fysiografen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attayde JL, 2001, LIMNOL OCEANOGR, V46, P1001, DOI 10.4319/lo.2001.46.5.1001; BLINDOW I, 1993, FRESHWATER BIOL, V30, P159, DOI 10.1111/j.1365-2427.1993.tb00796.x; Brett MT, 1997, SCIENCE, V275, P384, DOI 10.1126/science.275.5298.384; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brodersen J, 2008, OIKOS, V117, P40, DOI 10.1111/j.2007.0030-1299.16118.x; CARPENTER SR, 1991, COMPARATIVE ANALYSES OF ECOSYSTEMS, P67; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; CRYER M, 1986, LIMNOL OCEANOGR, V31, P1022, DOI 10.4319/lo.1986.31.5.1022; DURBIN J, 1971, BIOMETRIKA, V58, P1; Ferreira V, 2006, OECOLOGIA, V149, P718, DOI 10.1007/s00442-006-0478-0; Garibaldi LA, 2010, OIKOS, V119, P337, DOI 10.1111/j.1600-0706.2009.17862.x; GEORGE DG, 1985, NATURE, V316, P536, DOI 10.1038/316536a0; George DG, 2004, FRESHWATER BIOL, V49, P760, DOI 10.1111/j.1365-2427.2004.01223.x; Gerten D, 2000, LIMNOL OCEANOGR, V45, P1058, DOI 10.4319/lo.2000.45.5.1058; Gillet C, 2006, J FISH BIOL, V69, P518, DOI 10.1111/j.1095-8649.2006.01123.x; GLIWICZ ZM, 1981, HYDROBIOLOGIA, V80, P205, DOI 10.1007/BF00018359; Gliwicz ZM, 2002, FRESHWATER BIOL, V47, P2296; Gliwicz ZM, 1989, PLANKTON ECOLOGY SUC, P253; GOLDSPINK CR, 1979, J FISH BIOL, V15, P473, DOI 10.1111/j.1095-8649.1979.tb03632.x; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Hamback PA, 2007, OIKOS, V116, P1995, DOI 10.1111/j.2007.0030-1299.15800.x; HANSSON LA, 1992, ECOLOGY, V73, P241, DOI 10.2307/1938735; Hansson LA, 2004, FRESHWATER BIOL, V49, P1538, DOI 10.1111/j.1365-2427.2004.01291.x; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; HUNTER MD, 1992, ECOLOGY, V73, P724; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Lacroix G., 1991, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V48, P53; LAMPERT W, 1986, LIMNOL OCEANOGR, V31, P478, DOI 10.4319/lo.1986.31.3.0478; LAMPERT W, 1988, PROC INT ASSOC THE 2, V23, P713, DOI DOI 10.1080/03680770.1987.11899698; Lappalainen J, 2007, J FISH BIOL, V70, P441, DOI 10.1111/j.1095-8649.2007.01315.x; LAUDE U, 2002, VERTEILUNG ERNAHRUNG; LUECKE C, 1990, LIMNOL OCEANOGR, V35, P1718, DOI 10.4319/lo.1990.35.8.1718; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Mehner T, 1999, ENVIRON BIOL FISH, V56, P169, DOI 10.1023/A:1007532720226; MILLS EL, 1983, T AM FISH SOC, V112, P154, DOI 10.1577/1548-8659(1983)112<154:IODPOP>2.0.CO;2; Moss B, 2004, FRESHWATER BIOL, V49, P1633, DOI 10.1111/j.1365-2427.2004.01304.x; MullerNavarra DC, 1997, GLOB CHANGE BIOL, V3, P429, DOI 10.1046/j.1365-2486.1997.00080.x; Noges P, 2005, BOREAL ENVIRON RES, V10, P45; Osenberg Craig W., 1996, P134; Perrow M. R., 1999, Hydrobiologia, P85; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PTOVIN C, 2001, DESIGN ANAL ECOLOGIC, P63; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; SARNELLE O, 1992, ECOLOGY, V73, P551, DOI 10.2307/1940761; Scheffer M, 1997, OIKOS, V80, P519, DOI 10.2307/3546625; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; Skov C, 2008, ECOL FRESHW FISH, V17, P406, DOI 10.1111/j.1600-0633.2008.00291.x; Sosa-Cordero E, 1998, J EXP MAR BIOL ECOL, V229, P1, DOI 10.1016/S0022-0981(98)00037-9; Straile D, 2000, GLOBAL CHANGE BIOL, V6, P663, DOI 10.1046/j.1365-2486.2000.00350.x; Straile D, 2000, OECOLOGIA, V122, P44, DOI 10.1007/PL00008834; THRELKELD ST, 1979, ECOLOGY, V60, P165, DOI 10.2307/1936478; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; URABE J, 1991, FRESHWATER BIOL, V25, P1, DOI 10.1111/j.1365-2427.1991.tb00467.x; Vakkilainen K, 2004, FRESHWATER BIOL, V49, P1619, DOI 10.1111/j.1365-2427.2004.01300.x; VANNI MJ, 1986, ECOLOGY, V67, P337, DOI 10.2307/1938577; Wagner A, 2004, ARCH HYDROBIOL, V160, P1, DOI 10.1127/0003-9136/2004/0160-0001; Wahlstrom E, 1999, CAN J FISH AQUAT SCI, V56, P1865, DOI 10.1139/cjfas-56-10-1865; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; WU L, 1994, J GREAT LAKES RES, V20, P537, DOI 10.1016/S0380-1330(94)71170-9	67	30	30	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16534	10.1371/journal.pone.0016534	http://dx.doi.org/10.1371/journal.pone.0016534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304980	Green Submitted, Green Published, gold			2022-12-27	WOS:000286834300080
J	Garbacki, N; Di Valentin, E; Huynh-Thu, VA; Geurts, P; Irrthum, A; Crahay, C; Arnould, T; Deroanne, C; Piette, J; Cataldo, D; Colige, A				Garbacki, Nancy; Di Valentin, Emmanuel; Huynh-Thu, Van Anh; Geurts, Pierre; Irrthum, Alexandre; Crahay, Celine; Arnould, Thierry; Deroanne, Christophe; Piette, Jacques; Cataldo, Didier; Colige, Alain			MicroRNAs Profiling in Murine Models of Acute and Chronic Asthma: A Relationship with mRNAs Targets	PLOS ONE			English	Article							LUNG-CANCER; MATRIX METALLOPROTEINASES; LYMPHOCYTIC-LEUKEMIA; AIRWAY INFLAMMATION; EXPRESSION PROFILES; CARDIAC DEVELOPMENT; CELL-PROLIFERATION; ANDROGEN RECEPTOR; GENE-EXPRESSION; SMOOTH-MUSCLE	Background: miRNAs are now recognized as key regulator elements in gene expression. Although they have been associated with a number of human diseases, their implication in acute and chronic asthma and their association with lung remodelling have never been thoroughly investigated. Methodology/Principal Findings: In order to establish a miRNAs expression profile in lung tissue, mice were sensitized and challenged with ovalbumin mimicking acute, intermediate and chronic human asthma. Levels of lung miRNAs were profiled by microarray and in silico analyses were performed to identify potential mRNA targets and to point out signalling pathways and biological processes regulated by miRNA-dependent mechanisms. Fifty-eight, 66 and 75 miRNAs were found to be significantly modulated at short-, intermediate- and long-term challenge, respectively. Inverse correlation with the expression of potential mRNA targets identified mmu-miR-146b, -223, -29b, -29c, -483, -574-5p, -672 and -690 as the best candidates for an active implication in asthma pathogenesis. A functional validation assay was performed by cotransfecting in human lung fibroblasts (WI26) synthetic miRNAs and engineered expression constructs containing the coding sequence of luciferase upstream of the 3'UTR of various potential mRNA targets. The bioinformatics analysis identified miRNA-linked regulation of several signalling pathways, as matrix metalloproteinases, inflammatory response and TGF-beta signalling, and biological processes, including apoptosis and inflammation. Conclusions/Significance: This study highlights that specific miRNAs are likely to be involved in asthma disease and could represent a valuable resource both for biological makers identification and for unveiling mechanisms underlying the pathogenesis of asthma.	[Garbacki, Nancy; Deroanne, Christophe; Colige, Alain] Univ Liege, GIGA Res, Lab Connect Tissues Biol, Liege, Belgium; [Di Valentin, Emmanuel; Piette, Jacques] Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium; [Crahay, Celine; Cataldo, Didier] Univ Liege, GIGA Res, Lab Biol Tumours & Dev, Liege, Belgium; [Arnould, Thierry] Univ Namur, Lab Biochem & Cell Biol, Namur, Belgium	University of Liege; University of Liege; University of Liege; University of Namur	Garbacki, N (corresponding author), Univ Liege, GIGA Res, Lab Connect Tissues Biol, Liege, Belgium.	acolige@ulg.ac.be	Cataldo, Didier/GPG-3453-2022	Di Valentin, Emmanuel/0000-0002-5287-7950; Cataldo, Didier/0000-0002-3079-7941	Walloon Region Government [DGO6]; Fonds National de la Recherche Scientifique (FNRS, Brussels, Belgium); Fondation Leon Fredericq (University of Liege); CHU (Liege, Belgium); Action de Recherches Concertees; Communaute Francaise de Belgique; European Union; Interuniversity Attraction Poles Programme- Belgian Science Policy (Brussels, Belgium); IAP6/18 program (Brussels, Belgium)	Walloon Region Government; Fonds National de la Recherche Scientifique (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation Leon Fredericq (University of Liege)(University of Liege); CHU (Liege, Belgium); Action de Recherches Concertees; Communaute Francaise de Belgique(Australian Research Council); European Union(European Commission); Interuniversity Attraction Poles Programme- Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); IAP6/18 program (Brussels, Belgium)	This work was supported by grants of the Walloon Region Government (DGO6), the Fonds National de la Recherche Scientifique (FNRS, Brussels, Belgium), the Fondation Leon Fredericq (University of Liege), the CHU (Liege, Belgium), Action de Recherches Concertees, Communaute Francaise de Belgique and European Union (FP6 and FP-7), the Interuniversity Attraction Poles Programme- Belgian Science Policy (Brussels, Belgium). Emmanuel Di Valentin is a postdoctoral fellow supported by the IAP6/18 program (Brussels, Belgium). The integrity of RNA extracts was analyzed with the help of Benoit Hennuy (GenoTranscriptomics Platform, GIGA, University of Liege). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BARNES PJ, 2002, ASTHMA COPD BASIC ME, P780; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Di Valentin E, 2009, AM J PHYSIOL-LUNG C, V296, pL185, DOI 10.1152/ajplung.90367.2008; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabry Ben, 2007, Drug Discov Today Dis Models, V4, P131, DOI 10.1016/j.ddmod.2007.12.003; Foell J, 2003, J CLIN INVEST, V111, P1505, DOI 10.1172/JCI200317662; FOLKS JL, 1984, HDB STATISTICS, V4, P113, DOI DOI 10.1016/S0169-7161(84)04008-6; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gosens R, 2004, EUR J PHARMACOL, V494, P73, DOI 10.1016/j.ejphar.2004.04.035; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gueders MM, 2008, BIOCHEM PHARMACOL, V75, P514, DOI 10.1016/j.bcp.2007.09.012; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Hennessy Erica, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000781; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izuhara Kenji, 2006, Allergol Int, V55, P361, DOI 10.2332/allergolint.55.361; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; MEEKER TC, 1990, BLOOD, V76, P285; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nal B, 2002, GENOMICS, V79, P77, DOI 10.1006/geno.2001.6682; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Nishioku T, 2002, J BIOL CHEM, V277, P4816, DOI 10.1074/jbc.M108382200; Noma T, 2002, J ASTHMA, V39, P591, DOI 10.1081/JAS-120014923; Noverstern N, 2008, AM J RESP CELL MOL, V38, P324, DOI 10.1165/rcmb.2007-0151OC; Ohta K, 2001, INT ARCH ALLERGY IMM, V124, P259, DOI 10.1159/000053727; OPAZO SA, 2004, AM J PHYSIOL-CELL PH, V286, pC433; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Park SG, 2008, INT ARCH ALLERGY IMM, V146, P44, DOI 10.1159/000112502; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pennings JLA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002596; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rolph MS, 2006, PHARMACOL THERAPEUT, V109, P284, DOI 10.1016/j.pharmthera.2005.08.009; Saotome A, 2003, RESP MED, V97, P688, DOI 10.1053/rmed.2003.1502; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Shin SM, 2007, J LEUKOCYTE BIOL, V81, P1455, DOI 10.1189/jlb.1006619; Southam DS, 2008, AM J RESP CRIT CARE, V178, P1115, DOI 10.1164/rccm.200801-084OC; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Van Hove CL, 2009, INT ARCH ALLERGY IMM, V149, P195, DOI 10.1159/000199715; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang J, 2009, CARDIOLOGY, V113, P81, DOI 10.1159/000172616; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang Y, 2008, CLIN GENET, V74, P307, DOI 10.1111/j.1399-0004.2008.01075.x; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011; Yamashita N, 2005, CELL IMMUNOL, V235, P85, DOI 10.1016/j.cellimm.2005.07.006; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	126	117	128	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16509	10.1371/journal.pone.0016509	http://dx.doi.org/10.1371/journal.pone.0016509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305051	Green Submitted, gold, Green Published			2022-12-27	WOS:000286664100040
J	Lindgren, AG; Natsuhara, K; Tian, E; Vincent, JJ; Li, XM; Jiao, J; Wu, H; Banerjee, U; Clark, AT				Lindgren, Anne G.; Natsuhara, Kyle; Tian, E.; Vincent, John J.; Li, Xinmin; Jiao, Jing; Wu, Hong; Banerjee, Utpal; Clark, Amander T.			Loss of Pten Causes Tumor Initiation Following Differentiation of Murine Pluripotent Stem Cells Due to Failed Repression of Nanog	PLOS ONE			English	Article							IN-VITRO; TERATOMA FORMATION; GERM-CELLS; CULTURE ADAPTATION; MOUSE; SURVIVAL; TRANSPLANTATION; PROGRESSION; AKT; EXPRESSION	Pluripotent stem cells (PSCs) hold significant promise in regenerative medicine due to their unlimited capacity for self-renewal and potential to differentiate into every cell type in the body. One major barrier to the use of PSCs is their potential risk for tumor initiation following differentiation and transplantation in vivo. In the current study we sought to evaluate the role of the tumor suppressor Pten in murine PSC neoplastic progression. Using eight functional assays that have previously been used to indicate PSC adaptation or transformation, Pten null embryonic stem cells (ESCs) failed to rate as significant in five of them. Instead, our data demonstrate that the loss of Pten causes the emergence of a small number of aggressive, teratoma-initiating embryonic carcinoma cells (ECCs) during differentiation in vitro, while the remaining 90-95% of differentiated cells are non-tumorigenic. Furthermore, our data show that the mechanism by which Pten null ECCs emerge in vitro and cause tumors in vivo is through increased survival and self-renewal, due to failed repression of the transcription factor Nanog.	[Lindgren, Anne G.; Natsuhara, Kyle; Tian, E.; Vincent, John J.; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vincent, John J.; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Li, Xinmin; Wu, Hong; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Jiao, Jing; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Lindgren, Anne G.; Vincent, John J.; Wu, Hong; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lindgren, AG (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu	Jiao, Jing/F-5354-2015	Natsuhara, Kyle/0000-0001-7682-1751	NIH/NICHD [R01, 1R01HD058047-01]; NIH/NIGMS [P01 P01GM081621]; Fuller Foundation; University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; California Institute for Regenerative Medicine [TG2-01169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fuller Foundation; University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: NIH/NICHD R01, 1R01HD058047-01, NIH/NIGMS P01 P01GM081621, Fuller Foundation, University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (http://www.stemcell.ucla.edu/), and California Institute for Regenerative Medicine Training grants TG2-01169 (http://www.cirm.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Conway AE, 2009, STEM CELLS, V27, P18, DOI 10.1634/stemcells.2008-0529; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; Harrison NJ, 2009, STEM CELLS, V27, P1057, DOI 10.1002/stem.41; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Ishii T, 2007, STEM CELLS, V25, P3252, DOI 10.1634/stemcells.2007-0199; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lee MH, 2007, STEM CELLS, V25, P1654, DOI 10.1634/stemcells.2006-0753; Mandal S, 2010, STEM CELLS; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Rajpert-de Meyts E, 2003, APMIS, V111, P267, DOI 10.1034/j.1600-0463.2003.11101301.x; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; West JA, 2006, NAT PROTOC, V1, P2026, DOI 10.1038/nprot.2006.303; Yang S, 2010, CELL PROLIFERAT, V43, P195, DOI 10.1111/j.1365-2184.2010.00669.x; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Young JC, 2010, BIOL REPROD, V82, P390, DOI 10.1095/biolreprod.109.078493	38	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16478	10.1371/journal.pone.0016478	http://dx.doi.org/10.1371/journal.pone.0016478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304588	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900055
J	Guenaga, J; Dosenovic, P; Ofek, G; Baker, D; Schief, WR; Kwong, PD; Hedestam, GBK; Wyatt, RT				Guenaga, Javier; Dosenovic, Pia; Ofek, Gilad; Baker, David; Schief, William R.; Kwong, Peter D.; Hedestam, Gunilla B. Karlsson; Wyatt, Richard T.			Heterologous Epitope-Scaffold Prime:Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; V3-SPECIFIC ANTIBODIES; STRUCTURAL ELEMENTS; GP120 GLYCOPROTEIN; ENVELOPE PROTEIN; IMMUNOGENICITY; BROAD; IMMUNIZATION; INDUCTION	The HIV-1 envelope glycoproteins (Env) gp120 and gp41 mediate entry and are the targets for neutralizing antibodies. Within gp41, a continuous epitope defined by the broadly neutralizing antibody 2F5, is one of the few conserved sites accessible to antibodies on the functional HIV Env spike. Recently, as an initial attempt at structure-guided design, we transplanted the 2F5 epitope onto several non-HIV acceptor scaffold proteins that we termed epitope scaffolds (ES). As immunogens, these ES proteins elicited antibodies with exquisite binding specificity matching that of the 2F5 antibody. These novel 2F5 epitope scaffolds presented us with the opportunity to test heterologous prime: boost immunization strategies to selectively boost antibody responses against the engrafted gp41 2F5 epitope. Such strategies might be employed to target conserved but poorly immunogenic sites on the HIV-1 Env, and, more generally, other structurally defined pathogen targets. Here, we assessed ES prime: boosting by measuring epitope specific serum antibody titers by ELISA and B cell responses by ELISpot analysis using both free 2F5 peptide and an unrelated ES protein as probes. We found that the heterologous ES prime: boosting immunization regimen elicits cross-reactive humoral responses to the structurally constrained 2F5 epitope target, and that incorporating a promiscuous T cell helper epitope in the immunogens resulted in higher antibody titers against the 2F5 graft, but did not result in virus neutralization. Interestingly, two epitope scaffolds (ES1 and ES2), which did not elicit a detectable 2F5 epitope-specific response on their own, boosted such responses when primed with the ES5. Together, these results indicate that heterologous ES prime: boost immunization regimens effectively focus the humoral immune response on the structurally defined and immunogen-conserved HIV-1 2F5 epitope.	[Guenaga, Javier; Ofek, Gilad; Kwong, Peter D.; Wyatt, Richard T.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Dosenovic, Pia; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Baker, David; Schief, William R.] Univ Washington, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; Karolinska Institutet; University of Washington; University of Washington Seattle	Guenaga, J (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA USA.	wyatt@scripps.edu	Dosenovic, Pia/S-6894-2018; Schief, William/ABF-3645-2020; Hedestam, Gunilla Karlsson/AAN-9616-2021; Baker, David/K-8941-2012	Dosenovic, Pia/0000-0002-0426-4586; Schief, William/0000-0002-1120-0150; Baker, David/0000-0001-7896-6217	National Institutes of Health; Bill and Melinda Gates Foundation, International AIDS Vaccine Initiative; Swedish Research Council [K2008-56X-20666-01-3]; Karolinska Institutet; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation, International AIDS Vaccine Initiative(Bill & Melinda Gates Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health intramural funds, The Bill and Melinda Gates Foundation (www.gatesfoundation.org) International AIDS Vaccine Initiative (www.iavi.org), The Swedish Research Council (project No. K2008-56X-20666-01-3), and a Karolinska Institutet doctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CHENGMAYER C, 1988, P NATL ACAD SCI USA, V85, P2815, DOI 10.1073/pnas.85.8.2815; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Dosenovic P, 2009, J IMMUNOL, V183, P3373, DOI 10.4049/jimmunol.0900407; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; GILDEN RV, 1963, IMMUNOLOGY, V6, P30; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; Hoffman TL, 1999, MOL MEMBR BIOL, V16, P57, DOI 10.1080/096876899294760; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kusov YY, 2007, ANTIVIR RES, V73, P101, DOI 10.1016/j.antiviral.2006.08.003; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; OFEK G, 2010, P NATL ACAD SCI US; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Rademeyer C, 2007, VIROLOGY, V368, P172, DOI 10.1016/j.virol.2007.06.013; RAJEWSKY K, 1969, J EXP MED, V129, P1131, DOI 10.1084/jem.129.6.1131; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang HT, 2004, J VIROL, V78, P8342, DOI 10.1128/jvi.78.15.8342-8348.2004	55	69	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16074	10.1371/journal.pone.0016074	http://dx.doi.org/10.1371/journal.pone.0016074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297864	gold, Green Submitted, Green Published			2022-12-27	WOS:000286662800016
J	Kuhn, S; Gallinat, J; Brass, M				Kuehn, Simone; Gallinat, Juergen; Brass, Marcel			"Keep Calm and Carry On'': Structural Correlates of Expressive Suppression of Emotions	PLOS ONE			English	Article							NEGATIVE EMOTION; INHIBITION; PHYSIOLOGY; STOP	There is a growing appreciation that individuals differ systematically in their use of particular emotion regulation strategies. Our aim was to examine the structural correlates of the habitual use of expressive suppression of emotions. Based on our previous research on the voluntary suppression of actions we expected this response-focused emotion regulation strategy to be associated with increased grey matter volume in the dorsomedial prefrontal cortex (dmPFC). On high-resolution MRI scans of 42 college-aged healthy adults we computed optimized voxel-based-morphometry (VBM) to explore the correlation between grey matter volume and inter-individual differences in the tendency to suppress the expression of emotions assessed by means of the Emotion Regulation Questionnaire (Gross & John, 2003). We found a positive correlation between the habitual use of expressive suppression as an emotion regulation strategy and grey matter volume in the dmPFC. No other brain area showed a significant positive or negative correlation with the Emotion Regulation Questionnaire scores. The association between the suppression of expression of emotions and volume in the dmPFC supports the behavioural stability and biological foundation of the concept of this particular emotion regulation strategy within an age-homogenous sample of adults.	[Kuehn, Simone; Brass, Marcel] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Kuehn, Simone; Brass, Marcel] Univ Ghent, Ghent Inst Funct & Metab Imaging, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium; [Kuehn, Simone; Gallinat, Juergen] Charite, Clin Psychiat & Psychotherapy, St Hedwig Krankenhaus, D-13353 Berlin, Germany	Ghent University; Ghent University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuhn, S (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	simone.kuhn@ugent.be	Brass, Marcel/J-7082-2012; Kuehn, Simone/P-6145-2014	Brass, Marcel/0000-0002-3364-4019; Kuhn, Simone/0000-0001-6823-7969	AstraZeneca; Eli Lilly Co; Janssen-Cilag; Bristol-Myers Squibb	AstraZeneca(AstraZeneca); Eli Lilly Co(Eli Lilly); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb)	JG has received research funding from AstraZeneca, Eli Lilly & Co, Janssen-Cilag, Bristol-Myers Squibb and speaker fees from AstraZeneca, Janssen-Cilag, and Bristol-Myers Squibb. The authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Brass M, 2007, J NEUROSCI, V27, P9141, DOI 10.1523/JNEUROSCI.0924-07.2007; Brody AL, 2007, BIOL PSYCHIAT, V62, P642, DOI 10.1016/j.biopsych.2006.10.026; Campbell-Meiklejohn DK, 2008, BIOL PSYCHIAT, V63, P293, DOI 10.1016/j.biopsych.2007.05.014; Carver CS, 1981, ATTENTION SELF CONTR; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Gaser C, 2003, J NEUROSCI, V23, P9240; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Kuhn S, 2009, HUM BRAIN MAPP, V30, P2834, DOI 10.1002/hbm.20711; LAZARUS RS, 1964, J ABNORM SOC PSYCH, V69, P195, DOI 10.1037/h0044635; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; MEISSNER WW, 1981, INTERNALIZATION PSYC; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons T., 1967, SOCIOL THEOR; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Schmidt-Wilcke T, 2010, NEUROIMAGE, V51, P1234, DOI 10.1016/j.neuroimage.2010.03.042; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf	32	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16569	10.1371/journal.pone.0016569	http://dx.doi.org/10.1371/journal.pone.0016569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298057	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800056
J	Noymer, A; Penner, AM; Saperstein, A				Noymer, Andrew; Penner, Andrew M.; Saperstein, Aliya			Cause of Death Affects Racial Classification on Death Certificates	PLOS ONE			English	Article							RACE	Recent research suggests racial classification is responsive to social stereotypes, but how this affects racial classification in national vital statistics is unknown. This study examines whether cause of death influences racial classification on death certificates. We analyze the racial classifications from a nationally representative sample of death certificates and subsequent interviews with the decedents' next of kin and find notable discrepancies between the two racial classifications by cause of death. Cirrhosis decedents are more likely to be recorded as American Indian on their death certificates, and homicide victims are more likely to be recorded as Black; these results remain net of controls for followback survey racial classification, indicating that the relationship we reveal is not simply a restatement of the fact that these causes of death are more prevalent among certain groups. Our findings suggest that seemingly non-racial characteristics, such as cause of death, affect how people are racially perceived by others and thus shape U.S. official statistics.	[Noymer, Andrew; Penner, Andrew M.] Univ Calif Irvine, Dept Sociol, Irvine, CA 92717 USA; [Noymer, Andrew] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA USA; [Noymer, Andrew] Int Inst Appl Syst Anal, Hlth & Global Change Project, A-2361 Laxenburg, Austria; [Saperstein, Aliya] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; International Institute for Applied Systems Analysis (IIASA); University of Oregon	Noymer, A (corresponding author), Univ Calif Irvine, Dept Sociol, Irvine, CA 92717 USA.	noymer@uci.edu	Saperstein, Aliya/E-8403-2013; Penner, Andrew/A-5128-2010	Saperstein, Aliya/0000-0002-6429-1172				[Anonymous], 2006, POSTMORTEM MED EXAMI; ARIAS E, 2008, VITAL HLTH STAT, V2, P1; *CDCP, 1981, HLTH DAT INT MORT UN; Davis F. James, 2001, WHO IS BLACK ONE NAT; HAHN RA, 1992, JAMA-J AM MED ASSOC, V267, P259, DOI 10.1001/jama.267.2.259; *NAT CTR HLTH STAT, 1998, PUBL US DAT FIL DOC; Penner AM, 2008, P NATL ACAD SCI USA, V105, P19628, DOI 10.1073/pnas.0805762105; Thoroughman DA, 2002, AM J EPIDEMIOL, V155, P1137, DOI 10.1093/aje/155.12.1137	8	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15812	10.1371/journal.pone.0015812	http://dx.doi.org/10.1371/journal.pone.0015812			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298093	Green Accepted, Green Published, gold			2022-12-27	WOS:000286662800012
J	Reynolds, MM; Bogomolnaya, L; Guo, JB; Aldrich, L; Bokhari, D; Santiviago, CA; McClelland, M; Andrews-Polymenis, H				Reynolds, M. Megan; Bogomolnaya, Lydia; Guo, Jinbai; Aldrich, Lindsay; Bokhari, Danial; Santiviago, Carlos A.; McClelland, Michael; Andrews-Polymenis, Helene			Abrogation of the Twin Arginine Transport System in Salmonella enterica Serovar Typhimurium Leads to Colonization Defects during Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSLOCATION PATHWAY; SIGNAL PEPTIDE; MOLECULAR CHARACTERIZATION; PROTEIN TRANSLOCATION; PUTATIVE COMPONENTS; SWARMING MOTILITY; VIRULENCE FACTORS; FLIR PROTEINS; TAT	TatC (STM3975) is a highly conserved component of the Twin Arginine Transport (Tat) systems that is required for transport of folded proteins across the inner membrane in gram-negative bacteria. We previously identified a Delta tatC mutant as defective in competitive infections with wild type ATCC14028 during systemic infection of Salmonella-susceptible BALB/c mice. Here we confirm these results and show that the Delta tatC mutant is internalized poorly by cultured J774-A.1 mouse macrophages a phenotype that may be related to the systemic infection defect. This mutant is also defective for short-term intestinal and systemic colonization after oral infection of BALB/c mice and is shed in reduced numbers in feces from orally infected Salmonella-resistant (CBA/J) mice. We show that the Delta tatC mutant is highly sensitive to bile acids perhaps resulting in the defect in intestinal infection that we observe. Finally, the Delta tatC mutant has an unusual combination of motility phenotypes in Salmonella; it is severely defective for swimming motility but is able to swarm well. The Delta tatC mutant has a lower amount of flagellin on the bacterial surface during swimming motility but normal levels under swarming conditions.	[Reynolds, M. Megan; Bogomolnaya, Lydia; Guo, Jinbai; Aldrich, Lindsay; Bokhari, Danial; Andrews-Polymenis, Helene] Texas A&M Univ Syst, Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA; [Santiviago, Carlos A.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Coll Hlth Sci, Irvine, CA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Universidad de Chile; University of California System; University of California Irvine	Reynolds, MM (corresponding author), Texas A&M Univ Syst, Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA.	handrews@medicine.tamhsc.edu	Santiviago, Carlos/N-9991-2018; McClelland, Michael/A-8583-2011	Santiviago, Carlos/0000-0002-7043-7908; Bogomolnaya, Lydia/0000-0001-7041-1815; McClelland, Michael/0000-0003-1788-9347	National Institutes of Health [AI075093, AI052237, AI073971, AI083964, AI039557, AI077645, AI083646]; USDA [2009-03579]; DOD [IS-4267-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077645, R01AI052237, R21AI083964, R01AI075093, R01AI073971, R21AI039557, R01AI039557, R01AI083646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); DOD(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HAP is supported by National Institutes of Health grants AI083964, AI083646, AI077645, AI075093, and USDA grant 2009-03579. MM is supported by NIH grants AI052237, AI073971, AI075093, AI083964, AI039557, AI077645, AI083646, and DOD grant IS-4267-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Allen SCH, 2002, J BIOL CHEM, V277, P10362, DOI 10.1074/jbc.M109135200; Barrett CML, 2005, FEBS J, V272, P2261, DOI 10.1111/j.1742-4658.2005.04654.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BENJAMIN WH, 1990, J IMMUNOL, V144, P3143; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BOGOMOLNAYA LM, 2008, FORM VARIATION O12 A; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Chen L, 2009, ARCH MICROBIOL, V191, P163, DOI 10.1007/s00203-008-0440-0; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GuardPetter J, 1997, FEMS MICROBIOL LETT, V149, P173, DOI 10.1016/S0378-1097(97)00071-2; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; HORMAECHE CE, 1989, RES IMMUNOL, V140, P791, DOI 10.1016/0923-2494(89)90034-5; Ize B, 2004, J BIOL CHEM, V279, P47543, DOI 10.1074/jbc.M406910200; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Maniatis T, 1989, MOL CLONING; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Mickael CS, 2010, INFECT IMMUN, V78, P3493, DOI 10.1128/IAI.00090-10; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ohnishi K, 1997, J BACTERIOL, V179, P6092, DOI 10.1128/jb.179.19.6092-6099.1997; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Pradel N, 2003, BIOCHEM BIOPH RES CO, V306, P786, DOI 10.1016/S0006-291X(03)01043-X; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Ramos-Morales F, 2003, J BACTERIOL, V185, P5328, DOI 10.1128/JB.185.17.5328-5332.2003; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	54	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15800	10.1371/journal.pone.0015800	http://dx.doi.org/10.1371/journal.pone.0015800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298091	Green Published, gold			2022-12-27	WOS:000286662800011
J	Plaisant, M; Giorgetti-Peraldi, S; Gabrielson, M; Loubat, A; Dani, C; Peraldi, P				Plaisant, Magali; Giorgetti-Peraldi, Sophie; Gabrielson, Marike; Loubat, Agnes; Dani, Christian; Peraldi, Pascal			Inhibition of Hedgehog Signaling Decreases Proliferation and Clonogenicity of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; IN-VITRO; SELF-RENEWAL; DIFFERENTIATION; ACTIVATION; MECHANISMS; GROWTH; EXPRESSION; GLI2; SUPPRESSION	Human mesenchymal stem cells (hMSC) have the ability to differentiate into osteoblasts, adipocytes and chondrocytes. We have previously shown that hMSC were endowed with a basal level of Hedgehog signaling that decreased after differentiation of these cells. Since hMSC differentiation is associated with growth-arrest we investigated the function of Hh signaling on cell proliferation. Here, we show that inhibition of Hh signaling, using the classical inhibitor cyclopamine, or a siRNA directed against Gli-2, leads to a decrease in hMSC proliferation. This phenomenon is not linked to apoptosis but to a block of the cells in the G0/G1 phases of the cell cycle. At the molecular level, it is associated with an increase in the active form of pRB, and a decrease in cyclin A expression and MAP kinase phosphorylation. Inhibition of Hh signaling is also associated with a decrease in the ability of the cells to form clones. By contrast, inhibition of Hh signaling during hMSC proliferation does not affect their ability to differentiate. This study demonstrates that hMSC are endowed with a basal Hedgehog signaling activity that is necessary for efficient proliferation and clonogenicity of hMSC. This observation unravels an unexpected new function for Hedgehog signaling in the regulation of human mesenchymal stem cells and highlights the critical function of this morphogen in hMSC biology.	[Plaisant, Magali; Gabrielson, Marike; Dani, Christian; Peraldi, Pascal] CNRS, UMR6543, Inst Biol Dev & Canc, Fac Med, F-06034 Nice, France; [Plaisant, Magali; Giorgetti-Peraldi, Sophie; Gabrielson, Marike; Loubat, Agnes; Dani, Christian; Peraldi, Pascal] Univ Nice Sophia Antipolis, IFR50, Fac Med, Nice, France; [Giorgetti-Peraldi, Sophie] INSERM, U895, Team Cellular & Mol Physiopathol Obes & Diabet, Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Plaisant, M (corresponding author), CNRS, UMR6543, Inst Biol Dev & Canc, Fac Med, F-06034 Nice, France.		DANI, Christian/G-3639-2014; Peraldi, Pascal/O-4592-2016	DANI, Christian/0000-0003-3228-0230; Peraldi, Pascal/0000-0003-0205-9252; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618; Gabrielson, Marike/0000-0002-3171-1556	Agence National de la Recherche HYP-INSRES-HH [ANR09-GENO-036]; CNRS; Agence Nationale de la Recherche	Agence National de la Recherche HYP-INSRES-HH(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the "Agence National de la Recherche HYP-INSRES-HH grant ANR09-GENO-036" and the CNRS. MP is supported by the "Agence Nationale de la Recherche." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elabd C, 2007, BIOCHEM BIOPH RES CO, V361, P342, DOI 10.1016/j.bbrc.2007.06.180; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013	40	39	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16798	10.1371/journal.pone.0016798	http://dx.doi.org/10.1371/journal.pone.0016798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304817	gold, Green Published, Green Submitted			2022-12-27	WOS:000287036600025
J	Bernini, F; Ebranati, E; De Maddalena, C; Shkjezi, R; Milazzo, L; Lo Presti, A; Ciccozzi, M; Galli, M; Zehender, G				Bernini, Flavia; Ebranati, Erika; De Maddalena, Chiara; Shkjezi, Renata; Milazzo, Laura; Lo Presti, Alessandra; Ciccozzi, Massimo; Galli, Massimo; Zehender, Gianguglielmo			Within-Host Dynamics of the Hepatitis C Virus Quasispecies Population in HIV-1/HCV Coinfected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; AMINO-ACID SITES; HYPERVARIABLE REGION; NEUTRALIZING ANTIBODIES; SCAVENGER RECEPTOR; SEQUENCE VARIATION; EVOLUTIONARY DYNAMICS; POSITIVE SELECTION	HIV/HCV coinfected individuals under highly active antiretroviral therapy (HAART) represent an interesting model for the investigation of the role played by the immune system in driving the evolution of the HCV quasispecies. We prospectively studied the intra-host evolution of the HCV heterogeneity in 8 coinfected subjects, selected from a cohort of 32 patients initiating HAART: 5 immunological responders (group A) and 3 immunological non-responders (group B), and in two HCV singly infected controls not assuming drugs (group C). For all these subjects at least two serial samples obtained at the first observation (before HAART) and more than 1 year later, underwent clonal sequence analysis of partial E1/E2 sequences, encompassing the whole HVR1. Evolutionary rates, dated phylogenies and population dynamics were co-estimated by using a Bayesian Markov Chain Monte Carlo approach, and site specific selection pressures were estimated by maximum likelihood-based methods. The intra-host evolutionary rates of HCV quasispecies was 10 times higher in subjects treated with HAART than in controls without immunodeficiency (1.9 and 2.3x10(-3) sub/site/month in group A and B and 0.29x10(-3) sub/site/month in group C individuals). The within-host Bayesian Skyline plot analysis showed an exponential growth of the quasispecies populations in immunological responders, coinciding with a peak in CD4 cell counts. On the contrary, quasispecies population remained constant in group B and in group C controls. A significant positive selection pressure was detected in a half of the patients under HAART and in none of the group C controls. Several sites under significant positive selection were described, mainly included in the HVR1. Our data indicate that different forces, in addition to the selection pressure, drive an exceptionally fast evolution of HCV during HAART immune restoration. We hypothesize that an important role is played by the enlargement of the viral replicative space.	[Bernini, Flavia; Ebranati, Erika; De Maddalena, Chiara; Shkjezi, Renata; Milazzo, Laura; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy; [Lo Presti, Alessandra; Ciccozzi, Massimo] Inst Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy	University of Milan; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Bernini, F (corresponding author), Univ Milan, Dept Clin Sci L Sacco, Milan, Italy.	gianguglielmo.zehender@unimi.it	Ciccozzi, Massimo/AAC-3271-2022; Lo Presti, Alessandra/K-1451-2016; CICCOZZI, MASSIMO/C-6484-2016; GALLI, MASSIMO/L-7282-2017	Ciccozzi, Massimo/0000-0003-3866-9239; Lo Presti, Alessandra/0000-0001-7611-5021; CICCOZZI, MASSIMO/0000-0003-3866-9239; GALLI, MASSIMO/0000-0001-8887-6215				ABE K, 1992, J GEN VIROL, V73, P2725, DOI 10.1099/0022-1317-73-10-2725; Allain JP, 2000, J VIROL, V74, P2541, DOI 10.1128/JVI.74.6.2541-2549.2000; Babik JM, 2003, J VIROL, V77, P1940, DOI 10.1128/JVI.77.3.1940-1950.2003; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Blackard JT, 2004, J INFECT DIS, V189, P1472, DOI 10.1086/382959; Booth JCL, 1998, HEPATOLOGY, V27, P223, DOI 10.1002/hep.510270134; Brown RJP, 2005, J GEN VIROL, V86, P1931, DOI 10.1099/vir.0.80957-0; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; Christie JML, 1999, HEPATOLOGY, V30, P1037, DOI 10.1002/hep.510300403; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; Cuevas JM, 2009, INFECT GENET EVOL, V9, P860, DOI 10.1016/j.meegid.2009.05.007; Curran R, 2002, J GEN VIROL, V83, P11, DOI 10.1099/0022-1317-83-1-11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Duffy M, 2002, VIROLOGY, V301, P354, DOI 10.1006/viro.2002.1597; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; KATO N, 1992, BIOCHEM BIOPH RES CO, V189, P119, DOI 10.1016/0006-291X(92)91533-V; Kingman JFC, 2000, GENETICS, V156, P1461; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Laskus T, 1998, J INFECT DIS, V178, P1189, DOI 10.1086/515682; Laskus T, 2007, HEPATOLOGY, V46, P359, DOI 10.1002/hep.21715; Marine-Barjoan E, 2004, AIDS, V18, P2163, DOI 10.1097/00002030-200411050-00008; McAllister J, 1998, J VIROL, V72, P4893, DOI 10.1128/JVI.72.6.4893-4905.1998; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2000, GENETICS, V155, P1429; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salemi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008153; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Sheridan I, 2004, J VIROL, V78, P3447, DOI 10.1128/JVI.78.7.3447-3454.2004; Shuhart MC, 2006, J INFECT DIS, V193, P1211, DOI 10.1086/502974; Smith DB, 1999, J VIRAL HEPATITIS, V6, P41, DOI 10.1046/j.1365-2893.1999.00010.x; Solmone M, 2006, ANTIVIR THER, V11, P87; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyoda H, 1997, J HEPATOL, V26, P975, DOI 10.1016/S0168-8278(97)80105-5; Valdez H, 2001, CLIN INFECT DIS, V32, P1487, DOI 10.1086/320164; Vento S, 1998, AIDS, V12, P116; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zehender G, 2005, J VIROL, V79, P9145, DOI 10.1128/JVI.79.14.9145-9156.2005; Zehender G, 1997, J INFECT DIS, V176, P1209, DOI 10.1086/514114; Zeisel MB, 2007, WORLD J GASTROENTERO, V13, P4824, DOI 10.3748/wjg.v13.i36.4824	57	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16551	10.1371/journal.pone.0016551	http://dx.doi.org/10.1371/journal.pone.0016551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304985	Green Published, gold			2022-12-27	WOS:000286834300084
J	Borth, N; Litsche, K; Franke, C; Sachse, K; Saluz, HP; Hanel, F				Borth, Nicole; Litsche, Katrin; Franke, Claudia; Sachse, Konrad; Saluz, Hans Peter; Haenel, Frank			Functional Interaction between Type III-Secreted Protein IncA of Chlamydophila psittaci and Human G3BP1	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; INCLUSION MEMBRANE; STRESS GRANULES; BINDING-PROTEIN; HOST-CELLS; C-MYC; APOPTOSIS; CYCLE; DEGRADATION; REQUIRES	Chlamydophila (Cp.) psittaci, the causative agent of psittacosis in birds and humans, is the most important zoonotic pathogen of the family Chlamydiaceae. These obligate intracellular bacteria are distinguished by a unique biphasic developmental cycle, which includes proliferation in a membrane-bound compartment termed inclusion. All Chlamydiaceae spp. possess a coding capacity for core components of a Type III secretion apparatus, which mediates specific delivery of anti-host effector proteins either into the chlamydial inclusion membrane or into the cytoplasm of target eukaryotic cells. Here we describe the interaction between Type III-secreted protein IncA of Cp. psittaci and host protein G3BP1 in a yeast two-hybrid system. In GST-pull down and co-immunoprecipitation experiments both in vitro and in vivo interaction between full-length IncA and G3BP1 were shown. Using fluorescence microscopy, the localization of G3BP1 near the inclusion membrane of Cp. psittaci-infected Hep-2 cells was demonstrated. Notably, infection of Hep-2 cells with Cp. psittaci and overexpression of IncA in HEK293 cells led to a decrease in c-Myc protein concentration. This effect could be ascribed to the interaction between IncA and G3BP1 since overexpression of an IncA mutant construct disabled to interact with G3BP1 failed to reduce c-Myc concentration. We hypothesize that lowering the host cell c-Myc protein concentration may be part of a strategy employed by Cp. psittaci to avoid apoptosis and scale down host cell proliferation.	[Borth, Nicole; Litsche, Katrin; Franke, Claudia; Saluz, Hans Peter; Haenel, Frank] Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoell Inst, Dept Cell & Mol Biol, Jena, Germany; [Saluz, Hans Peter] Univ Jena, Jena, Germany; [Sachse, Konrad] Inst Mol Pathogenesis, Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Borth, N (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoell Inst, Dept Cell & Mol Biol, Jena, Germany.	frank.haenel@hki-jena.de	Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786	German Federal Ministry of Education and Research (BMBF) [01 KI 0724]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (BMBF), grant 01 KI 0724 to H. P. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsara ZR, 2006, INFECT IMMUN, V74, P5602, DOI 10.1128/IAI.00266-06; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Beeckman DSA, 2008, VET RES, V39, DOI 10.1051/vetres:2008002; BETTS HJ, 2008, CURR OPIN MICROBIOL, V11, P1; Bohme L, 2009, MICROBES INFECT, V11, P1063, DOI 10.1016/j.micinf.2009.08.014; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; HOROSCHAK KD, 1978, INFECT IMMUN, V19, P281, DOI 10.1128/IAI.19.1.281-286.1978; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pantchev A., 2009, COMP IMMUNO IN PRESS; Parker F, 1996, MOL CELL BIOL, V16, P2561; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Schneider S, 1999, NAT BIOTECHNOL, V17, P170, DOI 10.1038/6172; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Szeredi L, 2005, VET RES COMMUN, V29, P37, DOI 10.1007/s11259-005-0835-1; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WOLF K, 2009, CELL MICROB IN PRESS; Wollmann Y, 2007, J CELL BIOCHEM, V102, P171, DOI 10.1002/jcb.21292; Ying Songmin, 2007, Curr Immunol Rev, V3, P31, DOI 10.2174/157339507779802179; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	42	13	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16692	10.1371/journal.pone.0016692	http://dx.doi.org/10.1371/journal.pone.0016692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304914	Green Published, gold, Green Submitted			2022-12-27	WOS:000286834300122
J	Loukovitis, D; Sarropoulou, E; Tsigenopoulos, CS; Batargias, C; Magoulas, A; Apostolidis, AP; Chatziplis, D; Kotoulas, G				Loukovitis, Dimitrios; Sarropoulou, Elena; Tsigenopoulos, Costas S.; Batargias, Costas; Magoulas, Antonios; Apostolidis, Apostolos P.; Chatziplis, Dimitrios; Kotoulas, Georgios			Quantitative Trait Loci Involved in Sex Determination and Body Growth in the Gilthead Sea Bream (Sparus aurata L.) through Targeted Genome Scan	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; OVARIAN AROMATASE; BINARY TRAITS; DIFFERENTIATION; FISH; QTL; EXPRESSION; REGRESSION; SEABREAM; BASS	Among vertebrates, teleost fish exhibit a considerably wide range of sex determination patterns that may be influenced by extrinsic parameters. However even for model fish species like the zebrafish Danio rerio the precise mechanisms involved in primary sex determination have not been studied extensively. The zebrafish, a gonochoristic species, is lacking discernible sex chromosomes and the sex of juvenile fish is difficult to determine. Sequential protandrous hermaphrodite species provide distinct determination of the gender and allow studying the sex determination process by looking at the mechanism of sex reversal. This is the first attempt to understand the genetic basis of phenotypic variation for sex determination and body weight in a sequential protandrous hermaphrodite species, the gilthead sea bream (Sparus aurata). This work demonstrates a fast and efficient strategy for Quantitative Trait Loci (QTL) detection in the gilthead sea bream, a non-model but target hermaphrodite fish species. Therefore a comparative mapping approach was performed to query syntenies against two other Perciformes, the European sea bass (Dicentrarchus labrax), a gonochoristic species and the Asian sea bass (Lates calcarifer) a protandrous hermaphrodite. In this manner two significant QTLs, one QTL affecting both body weight and sex and one QTL affecting sex, were detected on the same linkage group. The co-segregation of the two QTLs provides a genomic base to the observed genetic correlation between these two traits in sea bream as well as in other teleosts. The identification of QTLs linked to sex reversal and growth, will contribute significantly to a better understanding of the complex nature of sex determination in S. aurata where most individuals reverse to the female sex at the age of two years through development and maturation of the ovarian portion of the gonad and regression of the testicular area. [Genomic sequences reported in this manuscript have been submitted to GenBank under accession numbers HQ021443-HQ021749.]	[Loukovitis, Dimitrios; Chatziplis, Dimitrios] Alexander Technol Inst Thessaloniki, Sch Agr Technol, Dept Anim Prod, Sindos, Greece; [Sarropoulou, Elena; Tsigenopoulos, Costas S.; Magoulas, Antonios; Kotoulas, Georgios] Hellen Ctr Marine Res, Inst Marine Biol & Genet, Iraklion, Crete, Greece; [Batargias, Costas] Inst Educ Technol, Sch Agr Technol, Dept Fisheries & Aquaculture, Mesolongion, Greece; [Loukovitis, Dimitrios; Apostolidis, Apostolos P.] Aristotle Univ Thessaloniki, Fac Agr, Dept Anim Prod, Lab Ichthyol & Fisheries, GR-54006 Thessaloniki, Greece	Hellenic Centre for Marine Research; Western Greece University of Applied Sciences (TEI of Western Greece); Aristotle University of Thessaloniki	Loukovitis, D (corresponding author), Alexander Technol Inst Thessaloniki, Sch Agr Technol, Dept Anim Prod, Sindos, Greece.	sarris@her.hcmr.gr	Tsigenopoulos, Costas/R-9467-2019; Apostolidis, Apostolos P/P-6122-2014; Batargias, Costas/AAJ-9614-2020; Kotoulas, Georgios/AAM-7938-2020	Tsigenopoulos, Costas/0000-0003-0615-7941; Batargias, Costas/0000-0002-8846-8518; LOUKOVITIS, DIMITRIOS/0000-0002-4845-5747; Apostolidis, Apostolos/0000-0001-7941-1790; Kotoulas, Georgios/0000-0002-4667-8533	EU; Hellenic Centre for Marine Research; Alexander Technological Institute of Thessaloniki; AQUAGENOME	EU(European Commission); Hellenic Centre for Marine Research; Alexander Technological Institute of Thessaloniki; AQUAGENOME	The authors would like to acknowledge the EU FP5 BRIDGEMAP project, Hellenic Centre for Marine Research and Alexander Technological Institute of Thessaloniki as well as AQUAGENOME for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, OFFICIAL J EUROPEAN, VL358, P1; Batargias C, 1998, THESIS U CRETE; BECAK W, 1983, DIFFERENTIATION, V23, pS3; Brown R.C., 2003, THESIS U STIRLING; Brown RC, 2005, AQUACULTURE, V247, P219, DOI 10.1016/j.aquaculture.2005.02.002; BrusleSicard S, 1997, J FISH BIOL, V50, P1094, DOI 10.1006/jfbi.1996.0382; CATAUDELLA S, 1980, GENETICA, V54, P155, DOI 10.1007/BF00055985; Chatziplis D, 2007, AQUACULTURE, V272, pS172, DOI 10.1016/j.aquaculture.2007.08.022; CHURCHILL GA, 1994, GENETICS, V138, P963; de Koning DJ, 2001, J ANIM SCI, V79, P616; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Duchesne P, 2002, MOL ECOL NOTES, V2, P191, DOI 10.1046/j.1471-8286.2002.00164.x; Franch R, 2006, GENETICS, V174, P851, DOI 10.1534/genetics.106.059014; Fuller RC, 1998, P ROY SOC B-BIOL SCI, V265, P2365, DOI 10.1098/rspb.1998.0585; GREEN P, 1990, CRIMAP VERSION 2 4; Guiguen Y, 1999, MOL REPROD DEV, V54, P154, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;154::AID-MRD7&gt;3.0.CO;2-5; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Kadarmideen HN, 2001, J ANIM BREED GENET, V118, P297, DOI 10.1046/j.1439-0388.2001.00301.x; Kadarmideen HN, 2000, GENET RES, V76, P305, DOI 10.1017/S001667230000481X; KADMON D, 1985, PROSTATE, V6, P343, DOI 10.1002/pros.2990060403; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Kolbehdari D, 2005, GENET SEL EVOL, V37, P601, DOI 10.1051/gse:2005021; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kwon JY, 2001, MOL REPROD DEV, V59, P359, DOI 10.1002/mrd.1042; Lee BY, 2004, HEREDITY, V92, P543, DOI 10.1038/sj.hdy.6800453; Lee BY, 2003, ANIM GENET, V34, P379, DOI 10.1046/j.1365-2052.2003.01035.x; Liarte S, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-20; Martyniuk CJ, 2003, J FISH BIOL, V63, P746, DOI 10.1046/j.1095-8649.2003.00188.x; Massault C, 2010, ANIM GENET, V41, P337, DOI 10.1111/j.1365-2052.2009.02010.x; MASSAULT C, 2010, ANIMAL GENETICS, DOI DOI 10.1111/J.1365-2052.2010.02110; Massault C, 2008, AQUACULTURE, V285, P23, DOI 10.1016/j.aquaculture.2008.06.040; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Meiri I, 2002, J EXP ZOOL, V292, P555, DOI 10.1002/jez.10072; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moghadam HK, 2007, MOL GENET GENOMICS, V277, P647, DOI 10.1007/s00438-007-0215-3; MOORE R, 1979, AUST J MAR FRESH RES, V30, P803, DOI 10.1071/MF9790803; Oldfield RG, 2005, FISH FISH, V6, P93, DOI 10.1111/j.1467-2979.2005.00184.x; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; Sarropoulou E, 2008, MAR BIOTECHNOL, V10, P227, DOI 10.1007/s10126-007-9066-5; Sarropoulou E, 2005, PHYSIOL GENOMICS, V23, P182, DOI 10.1152/physiolgenomics.00139.2005; Sarropoulou E, 2005, AQUACULTURE, V243, P69, DOI 10.1016/j.aquaculture.2004.10.012; Sarropoulou E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-44; Seaton G, 2006, P 8 WORLD C GEN APPL; Senger F, 2006, GENOMICS, V87, P793, DOI 10.1016/j.ygeno.2005.11.019; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Vandeputte M, 2007, GENETICS, V176, P1049, DOI 10.1534/genetics.107.072140; Wang CM, 2008, ANIM GENET, V39, P34, DOI 10.1111/j.1365-2052.2007.01672.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wong TT, 2006, BIOL REPROD, V74, P857, DOI 10.1095/biolreprod.105.045351; ZOHAR Y, 1978, ANN BIOL ANIM BIOCH, V18, P877, DOI 10.1051/rnd:19780519; ZOHAR Y, 1995, BROODSTOCK MANAGEMEN, P94; J FISH BIOL, V68, P1; 1998, ANIMAL BEHAV, V55, P251	56	59	61	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16599	10.1371/journal.pone.0016599	http://dx.doi.org/10.1371/journal.pone.0016599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304996	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300096
J	Johnson, TR; Johnson, CN; Corbett, KS; Edwards, GC; Graham, BS				Johnson, Teresa R.; Johnson, Christina N.; Corbett, Kizzmekia S.; Edwards, Gretchen C.; Graham, Barney S.			Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus	PLOS ONE			English	Article							INTERFERON-PRODUCING CELLS; ALLERGIC AIRWAY DISEASE; CD4 T-CELLS; VIRAL-INFECTION; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; EPITHELIAL-CELLS; ADAPTIVE IMMUNITY; INFLUENZA-VIRUS	Respiratory syncytial virus (RSV) causes recurrent infections throughout life. Vaccine development may depend upon understanding the molecular basis for induction of ineffective immunity. Because dendritic cells (DCs) are critically involved in early responses to infection, their interaction with RSV may determine the immunological outcome of RSV infection. Therefore, we investigated the ability of RSV to infect and activate primary mDCs and pDCs using recombinant RSV expressing green fluorescent protein (GFP). At a multiplicity of infection of 5, initial studies demonstrated similar to 6.8% of mDC1 and similar to 0.9% pDCs were infected. We extended these studies to include CD1c(-)CD141(+) mDC2, finding mDC2 infected at similar frequencies as mDC1. Both infected and uninfected cells upregulated phenotypic markers of maturation. Divalent cations were required for infection and maturation, but maturation did not require viral replication. There is evidence that attachment and entry/replication processes exert distinct effects on DC activation. Cell-specific patterns of RSV-induced maturation and cytokine production were detected in mDC1, mDC2, and pDC. We also demonstrate for the first time that RSV induces significant TIMP-2 production in all DC subsets. Defining the influence of RSV on the function of selected DC subsets may improve the likelihood of achieving protective vaccine-induced immunity.	[Johnson, Teresa R.; Johnson, Christina N.; Corbett, Kizzmekia S.; Edwards, Gretchen C.; Graham, Barney S.] NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, Natl Inst Hlth Bethesda, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Johnson, TR (corresponding author), NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, Natl Inst Hlth Bethesda, 9000 Rockville Pike, Bethesda, MD 20892 USA.	teresaj@nih.gov	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853	NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DM, 2005, MOL IMMUNOL, V42, P547, DOI 10.1016/j.molimm.2004.07.040; AUCELIO JG, 1984, NEUROPEPTIDES, V5, P141, DOI 10.1016/0143-4179(84)90047-7; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bartz H, 2003, IMMUNOLOGY, V109, P49, DOI 10.1046/j.1365-2567.2003.01629.x; Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x; Bhardwaj N, 1997, J EXP MED, V186, P795, DOI 10.1084/jem.186.6.795; Bont L, 2002, PEDIATR RES, V52, P363, DOI [10.1203/01.PDR.0000028458.76706.C7, 10.1203/00006450-200209000-00009]; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; Chi B, 2006, J VIROL, V80, P5032, DOI 10.1128/JVI.80.10.5032-5040.2006; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Ebihara T, 2007, INT IMMUNOL, V19, P1145, DOI 10.1093/intimm/dxm073; Elliott MB, 2007, J MED VIROL, V79, P447, DOI 10.1002/jmv.20830; EVONIUK G, 1989, MOL PHARMACOL, V35, P695; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Gersuk G, 2005, J IMMUNOL METHODS, V299, P99, DOI 10.1016/j.jim.2005.01.018; Ghildyal R, 1999, J INFECT DIS, V180, P2009, DOI 10.1086/315134; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Gill MA, 2008, J INFECT DIS, V198, P1667, DOI 10.1086/593018; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grayson MH, 2007, J MOL MED, V85, P1057, DOI 10.1007/s00109-007-0212-3; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hickling TP, 1999, EUR J IMMUNOL, V29, P3478, DOI 10.1002/(SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.0.CO;2-W; Hirose H, 2008, INT ARCH ALLERGY IMM, V146, P149, DOI 10.1159/000113518; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Krishnan S, 2003, J INFECT DIS, V188, P433, DOI 10.1086/376530; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Looney RJ, 2002, J INFECT DIS, V185, P682, DOI 10.1086/339008; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Martinez FD, 2003, PEDIATR INFECT DIS J, V22, pS76, DOI 10.1097/00006454-200302001-00011; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; MURPHY BR, 1986, J CLIN MICROBIOL, V23, P1009, DOI 10.1128/JCM.23.6.1009-1014.1986; Ono K, 2007, IMMUNOL RES, V38, P319, DOI 10.1007/s12026-007-0011-5; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; PRESTON FM, 1992, J INFECT DIS, V165, P819, DOI 10.1093/infdis/165.5.819; Rate A, 2009, J IMMUNOL, V182, P72, DOI 10.4049/jimmunol.182.1.72; ROBERTS NJ, 1982, INFECT IMMUN, V35, P1142, DOI 10.1128/IAI.35.3.1142-1146.1982; Rothoeft T, 2007, CLIN EXP IMMUNOL, V150, P263, DOI 10.1111/j.1365-2249.2007.03497.x; Schauer U, 2004, CLIN EXP IMMUNOL, V138, P102, DOI 10.1111/j.1365-2249.2004.02582.x; Schauer U, 2002, EUR RESPIR J, V20, P1277, DOI 10.1183/09031936.02.00019902; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; SHAHRABADI MS, 1988, J CLIN MICROBIOL, V26, P139, DOI 10.1128/JCM.26.1.139-141.1988; Shingai M, 2008, INT IMMUNOL, V20, P1169, DOI 10.1093/intimm/dxn074; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Silver E, 2009, PEDIAT ALLERG IMM-UK, V20, P471, DOI 10.1111/j.1399-3038.2008.00818.x; Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; van Tongeren J, 2008, ALLERGY, V63, P1124, DOI 10.1111/j.1398-9995.2008.01791.x; Vanhooren A, 2002, BIOCHEMISTRY-US, V41, P11035, DOI 10.1021/bi0258851; Vass I, 1996, BIOCHEMISTRY-US, V35, P8964, DOI 10.1021/bi9530595; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; WELLIVER RC, 1984, J IMMUNOL, V133, P1925; Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009	79	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16458	10.1371/journal.pone.0016458	http://dx.doi.org/10.1371/journal.pone.0016458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297989	Green Published, Green Submitted, gold			2022-12-27	WOS:000286664100033
J	Mueller, EE; Eder, W; Ebner, S; Schwaiger, E; Santic, D; Kreindl, T; Stanger, O; Paulweber, B; Iglseder, B; Oberkofler, H; Maier, R; Mayr, JA; Krempler, F; Weitgasser, R; Patsch, W; Sperl, W; Kofler, B				Mueller, Edith E.; Eder, Waltraud; Ebner, Sabine; Schwaiger, Eva; Santic, Danijela; Kreindl, Tanja; Stanger, Olaf; Paulweber, Bernhard; Iglseder, Bernhard; Oberkofler, Hannes; Maier, Richard; Mayr, Johannes A.; Krempler, Franz; Weitgasser, Raimund; Patsch, Wolfgang; Sperl, Wolfgang; Kofler, Barbara			The Mitochondrial T16189C Polymorphism Is Associated with Coronary Artery Disease in Middle European Populations	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; DNA VARIANT; INSULIN-RESISTANCE; OXIDATIVE STRESS; C VARIANT; 16189 T; SUSCEPTIBILITY; INFARCTION; THINNESS	Background: The pivotal role of mitochondria in energy production and free radical generation suggests that the mitochondrial genome could have an important influence on the expression of multifactorial age related diseases. Substitution of T to C at nucleotide position 16189 in the hypervariable D-loop of the control region (CR) of mitochondrial DNA (mtDNA) has attracted research interest because of its suspected association with various multifactorial diseases. The aim of the present study was to compare the frequency of this polymorphism in the CR of mtDNA in patients with coronary artery disease (CAD, n = 482) and type 2 diabetes mellitus (T2DM, n = 505) from two study centers, with healthy individuals (n = 1481) of Middle European descent in Austria. Methodology and Principal Findings: CR polymorphisms and the nine major European haplogroups were identified by DNA sequencing and primer extension analysis, respectively. Frequencies and Odds Ratios for the association between cases and controls were calculated. Compared to healthy controls, the prevalence of T16189C was significantly higher in patients with CAD (11.8% vs 21.6%), as well as in patients with T2DM (11.8% vs 19.4%). The association of CAD, but not the one of T2DM, with T16189C remained highly significant after correction for age, sex and body mass index (BMI) and was independent of the two study centers. Conclusions and Significance: Our results show for the first time a significant association of T16189C with CAD in a Middle European population. As reported in other studies, in patients with T2DM an association with T16189C in individuals of European decent remains questionable.	[Mueller, Edith E.; Eder, Waltraud; Ebner, Sabine; Schwaiger, Eva; Santic, Danijela; Kreindl, Tanja; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Stanger, Olaf] Paracelsus Med Univ, Dept Cardiac Surg, Salzburg, Austria; [Paulweber, Bernhard; Weitgasser, Raimund] Paracelsus Med Univ, Dept Internal Med, Salzburg, Austria; [Iglseder, Bernhard] Paracelsus Med Univ, Dept Geriatr, Salzburg, Austria; [Oberkofler, Hannes; Patsch, Wolfgang] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria; [Maier, Richard] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Krempler, Franz] Hosp Hallein, Dept Internal Med, Hallein, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Graz	Mueller, EE (corresponding author), Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.	b.kofler@salk.at		Kofler, Barbara/0000-0002-1198-4776; Iglseder, Bernhard/0000-0002-6132-8670; Mayr, Johannes/0000-0001-6970-336X	Medizinische Forschungsgesellschaft Salzburg; Kamillo-Eisner Stiftung	Medizinische Forschungsgesellschaft Salzburg; Kamillo-Eisner Stiftung	The project was supported by the "Medizinische Forschungsgesellschaft Salzburg" and by a grant from the "Kamillo-Eisner Stiftung" (www.kamillo-eisner-stiftung.ch/) to B. Paulweber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2010, GENET TEST MOL BIOMA, V14, P43, DOI 10.1089/gtmb.2009.0095; Bhat A, 2007, HUM GENET, V120, P821, DOI 10.1007/s00439-006-0272-4; Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Das S, 2007, J CLIN ENDOCR METAB, V92, P3219, DOI 10.1210/jc.2007-0702; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Gill-Randall R, 2001, DIABETIC MED, V18, P413, DOI 10.1046/j.1464-5491.2001.00477.x; Harrison D, 2003, AM J CARDIOL, V91, p7A; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Kim JH, 2002, DIABETIC MED, V19, P681, DOI 10.1046/j.1464-5491.2002.00747.x; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377; Lin TK, 2005, ANN NY ACAD SCI, V1042, P64, DOI 10.1196/annals.1338.007; Liou CW, 2007, J CLIN ENDOCR METAB, V92, P235, DOI 10.1210/jc.2006-0653; Liou CW, 2004, ANN NY ACAD SCI, V1011, P317, DOI 10.1196/annals.1293.031; Livesey KJ, 2004, J MED GENET, V41, P6, DOI 10.1136/jmg.2003.008805; Maassen JA, 2006, BIOCHEM SOC T, V34, P819, DOI 10.1042/BST0340819; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; Momiyama Y, 2003, BIOCHEM BIOPH RES CO, V312, P858, DOI 10.1016/j.bbrc.2003.10.195; MORTEN K, 2003, DIABETIC MED, V13, pP13; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Parker E, 2005, AM J PHYSIOL-ENDOC M, V289, pE1110, DOI 10.1152/ajpendo.00600.2004; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001; Tsutsui Hiroyuki, 2008, Circ J, V72 Suppl A, pA31, DOI 10.1253/circj.CJ-08-0014; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang Pei-Wen, 2009, Rev Diabet Stud, V6, P237, DOI 10.1900/RDS.2009.6.237; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Weng SW, 2005, J CLIN ENDOCR METAB, V90, P5037, DOI 10.1210/jc.2005-0227; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086	39	45	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16455	10.1371/journal.pone.0016455	http://dx.doi.org/10.1371/journal.pone.0016455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298061	Green Submitted, Green Published, gold			2022-12-27	WOS:000286662800042
J	Ridsdale, R; Na, CL; Xu, Y; Greis, KD; Weaver, T				Ridsdale, Ross; Na, Cheng-Lun; Xu, Yan; Greis, Kenneth D.; Weaver, Timothy			Comparative Proteomic Analysis of Lung Lamellar Bodies and Lysosome-Related Organelles	PLOS ONE			English	Article							PULMONARY SURFACTANT; RESPIRATORY-FAILURE; BODY DEGENERATION; MOUSE MODEL; RAT LUNG; RECEPTOR; ABCA3; PHOSPHOLIPIDS; LOCALIZATION; HOMEOSTASIS	Pulmonary surfactant is a complex mixture of lipids and proteins that is essential for postnatal function. Surfactant is synthesized in alveolar type II cells and stored as multi-bilayer membranes in a specialized secretory lysosome-related organelle (LRO), known as the lamellar body (LB), prior to secretion into the alveolar airspaces. Few LB proteins have been identified and the mechanisms regulating formation and trafficking of this organelle are poorly understood. Lamellar bodies were isolated from rat lungs, separated into limiting membrane and core populations, fractionated by SDS-PAGE and proteins identified by nanoLC-tandem mass spectrometry. In total 562 proteins were identified, significantly extending a previous study that identified 44 proteins in rat lung LB. The lung LB proteome reflects the dynamic interaction of this organelle with the biosynthetic, secretory and endocytic pathways of the type II epithelial cell. Comparison with other LRO proteomes indicated that 60% of LB proteins were detected in one or more of 8 other proteomes, confirming classification of the LB as a LRO. Remarkably the LB shared 37.8% of its proteins with the melanosome but only 9.9% with lamellar bodies from the skin. Of the 229 proteins not detected in other LRO proteomes, a subset of 34 proteins was enriched in lung relative to other tissues. Proteins with lipid-related functions comprised a significant proportion of the LB unique subset, consistent with the major function of this organelle in the organization, storage and secretion of surfactant lipid. The lung LB proteome will facilitate identification of molecular pathways involved in LB biogenesis, surfactant homeostasis and disease pathogenesis.	[Ridsdale, Ross; Na, Cheng-Lun; Xu, Yan; Weaver, Timothy] Univ Cincinnati, Med Ctr, Div Pulm Biol, Coll Med,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA; [Ridsdale, Ross; Na, Cheng-Lun; Xu, Yan; Weaver, Timothy] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Greis, Kenneth D.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Ridsdale, R (corresponding author), Univ Cincinnati, Med Ctr, Div Pulm Biol, Coll Med,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA.	tim.weaver@cchmc.org		Greis, Kenneth/0000-0002-5316-3351; , Yan/0000-0003-2025-027X	National Heart Lung and Blood Institute [R37HL56285]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL056285] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by a grant from the National Heart Lung and Blood Institute (R37HL56285) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; BARR F, 1998, AM J PHYSIOL, V18, pL404; Benjamini Y, 2001, ANN STAT, V29, P1165; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Conkright JJ, 2010, AM J RESP CELL MOL, V42, P181, DOI 10.1165/rcmb.2009-0058OC; Dessinioti C, 2009, EXP DERMATOL, V18, P741, DOI 10.1111/j.1600-0625.2009.00896.x; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Getz GS, 2004, CURR OPIN LIPIDOL, V15, P261, DOI 10.1097/00041433-200406000-00005; GIL J, 1973, J CELL BIOL, V58, P152, DOI 10.1083/jcb.58.1.152; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Guttentag SH, 2005, AM J RESP CELL MOL, V33, P14, DOI 10.1165/rcmb.2004-0293OC; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hu ZZ, 2007, INT J MASS SPECTROM, V259, P147, DOI 10.1016/j.ijms.2006.09.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikegami M, 1998, BBA-MOL BASIS DIS, V1408, P218, DOI 10.1016/S0925-4439(98)00069-6; Jarrold B, 2005, ELECTROPHORESIS, V26, P2269, DOI 10.1002/elps.200410367; JOBE A, 1981, BIOCHIM BIOPHYS ACTA, V666, P47, DOI 10.1016/0005-2760(81)90089-8; Katsuoka F, 1997, BIOCHEM BIOPH RES CO, V238, P512, DOI 10.1006/bbrc.1997.7263; Krishnasamy S, 1997, BIOCHEM BIOPH RES CO, V235, P180, DOI 10.1006/bbrc.1997.6719; Krishnasamy S, 1998, AM J PHYSIOL-LUNG C, V275, pL969, DOI 10.1152/ajplung.1998.275.5.L969; Lyerla TA, 2003, AM J PHYSIOL-LUNG C, V285, pL643, DOI 10.1152/ajplung.00024.2003; Matsumura Y, 2007, FEBS LETT, V581, P3139, DOI 10.1016/j.febslet.2007.05.078; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; McEwan DG, 2010, CELL, V141, P564, DOI 10.1016/j.cell.2010.04.030; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Osanai K, 2010, AM J PHYSIOL-LUNG C, V298, pL243, DOI 10.1152/ajplung.00242.2009; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Raymond AA, 2008, MOL CELL PROTEOMICS, V7, P2151, DOI 10.1074/mcp.M700334-MCP200; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Smejkal GB, 2007, ANAL BIOCHEM, V363, P309, DOI 10.1016/j.ab.2007.01.033; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; Tang XY, 2005, PATHOL INT, V55, P137, DOI 10.1111/j.1440-1827.2005.01811.x; TSILIBARY EC, 1983, J HISTOCHEM CYTOCHEM, V31, P1289, DOI 10.1177/31.11.6684669; Tsuruoka S, 2002, BIOCHEM BIOPH RES CO, V298, P41, DOI 10.1016/S0006-291X(02)02389-6; van Weeren L, 2004, AM J RESP CELL MOL, V30, P288, DOI 10.1165/rcmb.2003-0264OC; Wakaumi M, 2005, CLIN EXP PHARMACOL P, V32, P1034, DOI 10.1111/j.1440-1681.2005.04301.x; Wang PC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-34; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Xu Y, 2009, AM J PHYSIOL-LUNG C, V297, pL286, DOI 10.1152/ajplung.00094.2009; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	49	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16482	10.1371/journal.pone.0016482	http://dx.doi.org/10.1371/journal.pone.0016482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298062	gold, Green Submitted, Green Published			2022-12-27	WOS:000286662800047
J	Taylor, SH; Al-Youha, S; Van Agtmael, T; Lu, YH; Wong, J; McGrouther, DA; Kadler, KE				Taylor, Susan H.; Al-Youha, Sarah; Van Agtmael, Tom; Lu, Yinhui; Wong, Jason; McGrouther, Duncan A.; Kadler, Karl E.			Tendon Is Covered by a Basement Membrane Epithelium That Is Required for Cell Retention and the Prevention of Adhesion Formation	PLOS ONE			English	Article							COLLAGEN-IV; JUNCTIONS; SHEATHS; MUTATIONS; DISEASE	The ability of tendons to glide smoothly during muscle contraction is impaired after injury by fibrous adhesions that form between the damaged tendon surface and surrounding tissues. To understand how adhesions form we incubated excised tendons in fibrin gels (to mimic the homeostatic environment at the injury site) and assessed cell migration. We noticed cells exiting the tendon from only the cut ends. Furthermore, treatment of the tendon with trypsin resulted in cell extravagation from the shaft of the tendons. Electron microscopy and immunolocalisation studies showed that the tendons are covered by a novel cell layer in which a collagen type IV/laminin basement membrane (BM) overlies a keratinised epithelium. PCR and western blot analyses confirmed the expression of laminin beta 1 in surface cells, only. To evaluate the cell retentive properties of the BM in vivo we examined the tendons of the Col4a1(+/Svc) mouse that is heterozygous for a G-to-A transition in the Col4a1 gene that produces a G1064D substitution in the alpha 1(IV) chain of collagen IV. The flexor tendons had a discontinuous BM, developed fibrous adhesions with overlying tissues, and were acellular at sites of adhesion formation. In further experiments, tenotomy of wild-type mice resulted in expression of laminin throughout the adhesion. In conclusion, we show the existence of a novel tendon BM-epithelium that is required to prevent adhesion formation. The Col4a1(+/Svc) mouse is an effective animal model for studying adhesion formation because of the presence of a structurally-defective collagen type IV-containing BM.	[Taylor, Susan H.; Al-Youha, Sarah; Lu, Yinhui; Kadler, Karl E.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Al-Youha, Sarah; Wong, Jason; McGrouther, Duncan A.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Van Agtmael, Tom] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Manchester; University of Manchester; University of Glasgow	Taylor, SH (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	karl.kadler@manchester.ac.uk	Wong, Jason/AAQ-9239-2020; KADLER, KARL/ABI-2403-2020; Zeef, Leo/D-6922-2011	Wong, Jason/0000-0003-2592-3226; KADLER, KARL/0000-0003-4977-4683; Taylor, Susan/0000-0001-9554-055X; Van Agtmael, Tom/0000-0003-4282-449X	The Wellcome Trust [076939/Z/05/Z]; The Medical Research Council [G0601268]; Kuwaiti Ministry of Higher Education [aa08961]; MRC [G0601268] Funding Source: UKRI; Medical Research Council [G0601268] Funding Source: researchfish; National Institute for Health Research [CL-2006-06-004] Funding Source: researchfish	The Wellcome Trust(Wellcome TrustEuropean Commission); The Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kuwaiti Ministry of Higher Education; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Wellcome Trust (076939/Z/05/Z) to KEK and The Medical Research Council (G0601268) to TVA. SA-Y was funded by a grant (aa08961) from the Kuwaiti Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpay Z, 2008, SEMIN REPROD MED, V26, P313, DOI 10.1055/s-0028-1082389; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BANES AJ, 1988, J ORTHOP RES, V6, P83, DOI 10.1002/jor.1100060111; BECKSTEAD JH, 1995, J HISTOCHEM CYTOCHEM, V43, P345, DOI 10.1177/43.3.7868864; BECKSTEAD JH, 1994, J HISTOCHEM CYTOCHEM, V42, P1127, DOI 10.1177/42.8.8027531; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; DUANCE VC, 1977, FEBS LETT, V79, P248, DOI 10.1016/0014-5793(77)80797-7; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; GUIZZARDI S, 1987, BASIC APPL HISTOCHEM, V31, P177; HUMPHRIES SM, 2008, J BIOL CHEM; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; McNeilly CM, 1996, J ANAT, V189, P593; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; POTENZA AD, 1963, J BONE JOINT SURG AM, V45, P1217, DOI 10.2106/00004623-196345060-00009; Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07; RISBERG B, 1997, EUR J SURG S, V577, P32; Schwarzbauer J, 1999, CURR BIOL, V9, pR242, DOI 10.1016/S0960-9822(99)80153-5; STROCCHI R, 1985, J ANAT, V140, P57; Thaung C, 2002, HUM MOL GENET, V11, P755, DOI 10.1093/hmg/11.7.755; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; Wong JKF, 2006, J HAND SURG-BRIT EUR, V31B, P358, DOI 10.1016/j.jhsb.2006.03.162; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380	29	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16337	10.1371/journal.pone.0016337	http://dx.doi.org/10.1371/journal.pone.0016337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298098	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000286662800028
J	Xia, JQ; Sedransk, N; Feng, XD				Xia, Jessie Q.; Sedransk, Nell; Feng, Xingdong			Variance Component Analysis of a Multi-Site Study for the Reproducibility of Multiple Reaction Monitoring Measurements of Peptides in Human Plasma	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROTEOMICS	Background: In the Addona et al. paper (Nature Biotechnology 2009), a large-scale multi-site study was performed to quantify Multiple Reaction Monitoring (MRM) measurements of proteins spiked in human plasma. The unlabeled signature peptides derived from the seven target proteins were measured at nine different concentration levels, and their isotopic counterparts were served as the internal standards. Methodology/Principal Findings: In this paper, the sources of variation are analyzed by decomposing the variance into parts attributable to specific experimental factors: technical replicates, sites, peptides, transitions within each peptide, and higher-order interaction terms based on carefully built mixed effects models. The factors of peptides and transitions are shown to be major contributors to the variance of the measurements considering heavy (isotopic) peptides alone. For the light ((12)C) peptides alone, in addition to these factors, the factor of study*peptide also contributes significantly to the variance of the measurements. Heterogeneous peptide component models as well as influence analysis identify the outlier peptides in the study, which are then excluded from the analysis. Using a log-log scale transformation and subtracting the heavy/isotopic peptide [internal standard] measurement from the peptide measurements (i.e., taking the logarithm of the peak area ratio in the original scale establishes that), the MRM measurements are overall consistent across laboratories following the same standard operating procedures, and the variance components related to sites, transitions and higher-order interaction terms involving sites have greatly reduced impact. Thus the heavy peptides have been effective in reducing apparent inter-site variability. In addition, the estimates of intercepts and slopes of the calibration curves are calculated for the sub-studies. Conclusions/Significance: The MRM measurements are overall consistent across laboratories following the same standard operating procedures, and heavy peptides can be used as an effective internal standard for reducing apparent inter-site variability. Mixed effects modeling is a valuable tool in mass spectrometry-based proteomics research.	[Xia, Jessie Q.; Sedransk, Nell; Feng, Xingdong] Natl Inst Stat Sci, Res Triangle Pk, NC USA; [Xia, Jessie Q.; Feng, Xingdong] Duke Univ, Dept Stat, Durham, NC USA	Duke University	Xia, JQ (corresponding author), Natl Inst Stat Sci, Res Triangle Pk, NC USA.	xq8@niss.org			National Cancer Institute [29XS081]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by a subcontract (29XS081) from the National Cancer Institute. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Diamandis EP, 2004, MOL CELL PROTEOMICS, V3, P367, DOI 10.1074/mcp.R400007-MCP200; Eckel-Passow JE, 2009, BIOSTATISTICS, V10, P481, DOI 10.1093/biostatistics/kxp006; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Mercier C, 2009, J PROTEOMICS, V72, P974, DOI 10.1016/j.jprot.2009.05.005; Sprinthall R.C., 2011, BASIC STAT ANAL; Wang JS, 2008, ECOTOXICOLOGY, V17, P213, DOI 10.1007/s10646-007-0187-4	10	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14590	10.1371/journal.pone.0014590	http://dx.doi.org/10.1371/journal.pone.0014590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298095	Green Published, Green Submitted, gold			2022-12-27	WOS:000286662800003
J	Lopez-Bao, JV; Gonzalez-Varo, JP				Lopez-Bao, Jose V.; Gonzalez-Varo, Juan P.			Frugivory and Spatial Patterns of Seed Deposition by Carnivorous Mammals in Anthropogenic Landscapes: A Multi-Scale Approach	PLOS ONE			English	Article							DISPERSAL PATTERNS; AVIAN FRUGIVORES; FRUIT CONSUMPTION; RESOURCE TRACKING; NORTHERN SPAIN; SCENT-MARKING; HABITAT; BIRDS; POPULATION; MANAGEMENT	Background: Knowledge about how frugivory and seed deposition are spatially distributed is valuable to understand the role of dispersers on the structure and dynamics of plant populations. This may be particularly important within anthropogenic areas, where either the patchy distribution of wild plants or the presence of cultivated fleshy-fruits may influence plant-disperser interactions. Methodology/Principal Findings: We investigated frugivory and spatial patterns of seed deposition by carnivorous mammals in anthropogenic landscapes considering two spatial scales: 'landscape' (similar to 10 km(2)) and 'habitat type' (similar to 1-2 km(2)). We sampled carnivore faeces and plant abundance at three contrasting habitats (chestnut woods, mosaics and scrublands), each replicated within three different landscapes. Sixty-five percent of faeces collected (n = 1077) contained seeds, among which wild and cultivated seeds appeared in similar proportions (58% and 53%) despite that cultivated fruiting plants were much less abundant. Seed deposition was spatially structured among both spatial scales being different between fruit types. Whereas the most important source of spatial variation in deposition of wild seeds was the landscape scale, it was the habitat scale for cultivated seeds. At the habitat scale, seeds of wild species were mostly deposited within mosaics while seeds of cultivated species were within chestnut woods and scrublands. Spatial concordance between seed deposition and plant abundance was found only for wild species. Conclusions/Significance: Spatial patterns of seed deposition by carnivores differed between fruit types and seemed to be modulated by the fleshy-fruited plant assemblages and the behaviour of dispersers. Our results suggest that a strong preference for cultivated fruits by carnivores may influence their spatial foraging behaviour and lower their dispersal services to wild species. However, the high amount of seeds removed within and between habitats suggests that carnivores must play an important role - often overlooked - as 'restorers' and 'habitat shapers' in anthropogenic areas.	[Lopez-Bao, Jose V.] Estac Biol Donana, Dept Conservat Biol, E-41013 Seville, Spain; [Gonzalez-Varo, Juan P.] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Sevilla	Lopez-Bao, JV (corresponding author), Estac Biol Donana, Dept Conservat Biol, E-41013 Seville, Spain.	jvlb@ebd.csic.es	González-Varo, Juan P./E-6395-2011	González-Varo, Juan P./0000-0003-1439-6475; Lopez-Bao, Jose Vicente/0000-0001-9213-998X	Conselleria de Educacion Xunta de Galicia [05RFO 20001 PR]	Conselleria de Educacion Xunta de Galicia(Xunta de Galicia)	This research was funded by the project PGIDIT 05RFO 20001 PR (Conselleria de Educacion Xunta de Galicia) coordinated by the Grupo Biologia Evolutiva de Plantas (Universidad de Santiago de Compostela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger J, 2002, AM MIDL NAT, V147, P352, DOI 10.1674/0003-0031(2002)147[0352:AABBUA]2.0.CO;2; BAS S, 1978, CONTRIBUCION ESTUDIO, V1; Bermejo T, 2000, FOLIA ZOOL, V49, P89; Cavallini P, 1996, ETHOL ECOL EVOL, V8, P323; DEBUSSCHE M, 1989, OIKOS, V56, P327, DOI 10.2307/3565617; Fedriani JM, 2010, ECOGRAPHY, V33, P545, DOI 10.1111/j.1600-0587.2009.06052.x; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Garcia D, 2004, ECOGRAPHY, V27, P187, DOI 10.1111/j.0906-7590.2004.03751.x; Garcia D, 2009, J ECOL, V97, P217, DOI 10.1111/j.1365-2745.2008.01470.x; Gonzalez-Varo JP, 2008, LANDSCAPE ECOL, V23, P79, DOI 10.1007/s10980-007-9166-7; Gonzalez-Varo JP, 2010, ECOGRAPHY, V33, P185, DOI 10.1111/j.1600-0587.2009.06021.x; GORMAN ML, 1990, REV SUISSE ZOOL, V97, P3, DOI 10.5962/bhl.part.79722; Guitian J, 2008, OIKOS, V117, P265, DOI 10.1111/j.2007.0030-1299.16316.x; Guitian J, 2010, ACTA OECOL, V36, P242, DOI 10.1016/j.actao.2010.01.005; Guix J.C., 2001, ORSIS, V16, P145; Hernandez A, 2008, POL J ECOL, V56, P127; Herrera Carlos M., 2002, P185; HERRERA CM, 1995, ANNU REV ECOL SYST, V26, P705, DOI 10.1146/annurev.es.26.110195.003421; HERRERA CM, 1989, OIKOS, V55, P250, DOI 10.2307/3565429; Herrmann Mathias, 1994, P122; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Hutchings MR, 2000, MAMMAL REV, V30, P157, DOI 10.1046/j.1365-2907.2000.00065.x; IZHAKI I, 1991, J ECOL, V79, P575, DOI 10.2307/2260654; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kimura K, 2001, J TROP ECOL, V17, P833, DOI 10.1017/S0266467401001626; Koike S, 2008, J FOREST RES-JPN, V13, P215, DOI 10.1007/s10310-008-0069-5; Kollmann Johannes, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P29, DOI 10.1078/1433-8319-00003; Kuiters AT, 2003, FOREST ECOL MANAG, V181, P239, DOI 10.1016/S0378-1127(03)00136-1; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Martinez I, 2008, ECOSCIENCE, V15, P189, DOI 10.2980/15-2-3096; Matias L, 2010, RESTOR ECOL, V18, P619, DOI 10.1111/j.1526-100X.2008.00475.x; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; Mortelliti A, 2008, LANDSCAPE ECOL, V23, P285, DOI 10.1007/s10980-007-9182-7; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; R Core Team, 2018, R LANG ENV STAT COMP; RODRIGUEZ A, 1992, J ZOOL, V227, P347, DOI 10.1111/j.1469-7998.1992.tb04833.x; Rosalino LM, 2004, CAN J ZOOL, V82, P1493, DOI 10.1139/Z04-130; Rosalino LM, 2009, MAMMAL REV, V39, P67, DOI 10.1111/j.1365-2907.2008.00134.x; Rumbao IM, 2008, ARDEOLA, V55, P221; Schaumann F, 2002, FLORA, V197, P370, DOI 10.1078/0367-2530-00053; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Verdu M, 1998, J VEG SCI, V9, P713, DOI 10.2307/3237289; WILLSON MF, 1993, OIKOS, V67, P159, DOI 10.2307/3545106; Wright S. J., 2007, Seed dispersal: theory and its application in a changing world, P599, DOI 10.1079/9781845931650.0599; Zalewski A, 2004, ECOSCIENCE, V11, P113, DOI 10.1080/11956860.2004.11682815; Zhou YB, 2008, FOREST ECOL MANAG, V255, P1595, DOI 10.1016/j.foreco.2007.11.018	50	54	55	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14569	10.1371/journal.pone.0014569	http://dx.doi.org/10.1371/journal.pone.0014569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21297861	Green Published, gold			2022-12-27	WOS:000286522300007
J	Cohen, CR; Brown, J; Moscicki, AB; Bukusi, EA; Paull, JRA; Price, CF; Shiboski, S				Cohen, Craig R.; Brown, Joelle; Moscicki, Anna-Barbara; Bukusi, Elizabeth A.; Paull, Jeremy R. A.; Price, Clare F.; Shiboski, Stephen			A Phase I Randomized Placebo Controlled Trial of the Safety of 3% SPL7013 Gel (VivaGel (R)) in Healthy Young Women Administered Twice Daily for 14 Days	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TOPICAL MICROBICIDES; VAGINAL MICROBICIDE; ACCEPTABILITY; DENDRIMERS; BUFFERGEL	Objective: To assess the safety of VivaGel (R) used vaginally twice daily for 14 days among healthy, sexually-abstinent women, aged 18-24 years in the USA and Kenya. Design: Randomized placebo controlled trial. Methods: Participants were randomized 2: 1, VivaGel to placebo. Safety was assessed by comparing genitourinary (GU) adverse events (AEs), colposcopy findings, vaginal lactobacilli and laboratory abnormalities by arm. Results: Fifty-four women were enrolled; 35 in the VivaGel arm and 19 in the placebo arm. Twenty-six (74%) and 10 (53%) women reported taking all doses of VivaGel and placebo, respectively. No grade 3 or 4 AEs, or serious AEs occurred. Twenty-five (71%) participants in the VivaGel arm compared to 10 (53%) participants in the placebo arm had at least one grade 1 or 2 GU AE associated with product use (RR = 1.4, 95% CI 0.8-2.2). All seven grade 2 GU AEs associated with product use occurred among four women in the VivaGel arm. Vulvar and cervical erythema, cervical lesions, symptomatic BV, urinary frequency and metrorrhagia were more common in the VivaGel arm than the placebo arm. Twenty-nine (83%) participants in the VivaGel arm had a colposcopic finding compared to 10 (53%) participants in the placebo arm (RR = 1.6, 95% CI = 1.0-2.5). Two women in the VivaGel arm prematurely discontinued product use themselves due to a reported GU AE. Persistence of H2O2-producing and non-producing lactobacilli did not differ by study arm. Conclusions: GU AEs and colposcopic findings consistent with mild epithelial irritation and inflammation occurred more commonly among women in the VivaGel arm. This trial is registered at www.ClinicalTrials.gov(NCT00331032).	[Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Brown, Joelle] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Moscicki, Anna-Barbara] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Paull, Jeremy R. A.; Price, Clare F.] Starpharma Pty Ltd, Melbourne, Vic, Australia; [Shiboski, Stephen] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco	Cohen, CR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	ccohen@globalhealth.ucsf.edu	Moscicki, Anna-Barbara/AAP-3806-2021	Paull, Jeremy/0000-0002-9981-421X	STI Clinical Trials Group [NIAID-DMID HHSN266200400074C]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	STI Clinical Trials Group; NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the STI Clinical Trials Group (NIAID-DMID HHSN266200400074C). In addition, this study was supported by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH. Information on NCRR is available at http://www.ncrr.nih.gov/. Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp. The National Institutes of Health (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballagh SA, 2002, CONTRACEPTION, V66, P369, DOI 10.1016/S0010-7824(02)00433-X; Bourne N, 2003, CLIN MICROBIOL INFEC, V9, P816, DOI 10.1046/j.1469-0691.2003.00659.x; Chen MP, 2007, SEX TRANSM DIS, V34, P557, DOI 10.1097/01.olq.0000258487.38309.b9; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; *CONRAD WHO, 2004, MAN STAND COLP EV VA; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gong E, 2005, ANTIVIR RES, V68, P139, DOI 10.1016/j.antiviral.2005.08.004; Gong YH, 2002, ANTIVIR RES, V55, P319, DOI 10.1016/S0166-3542(02)00054-2; Hoffman IF, 2004, AIDS, V18, P2191, DOI 10.1097/00002030-200411050-00012; Malonza IM, 2005, AIDS, V19, P2157, DOI 10.1097/01.aids.0000194797.59046.8f; Mauck C, 2001, AIDS, V15, P857, DOI 10.1097/00002030-200105040-00006; Mauck CK, 2004, CONTRACEPTION, V70, P233, DOI 10.1016/j.contraception.2004.04.010; Mayer KH, 2001, CLIN INFECT DIS, V32, P476, DOI 10.1086/318496; MCGOWAN I, 2010, PHASE 1 STUDY SAFETY; Melendez JH, 2007, SEX TRANSM DIS, V34, P617, DOI 10.1097/01.olq.0000258336.65285.31; National AIDS and STI Control Programme, 2008, KEN AIDS IND SURV 20; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Loughlin J, 2010, SEX TRANSM DIS, V37, P100, DOI 10.1097/OLQ.0b013e3181bc0aac; Patton DL, 2006, ANTIMICROB AGENTS CH, V50, P1696, DOI 10.1128/AAC.50.5.1696-1700.2006; Schwartz JL, 2006, CONTRACEPTION, V74, P133, DOI 10.1016/j.contraception.2006.02.008; UNAIDS, 2008, REP GLOB AIDS EP; van de Wijgert J, 2001, J ACQ IMMUN DEF SYND, V26, P21, DOI 10.1097/00126334-200101010-00003; van de Wijgert JHHM, 2008, CONTRACEPTION, V77, P122, DOI 10.1016/j.contraception.2007.10.006; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012; Witvrouw M, 2000, MOL PHARMACOL, V58, P1100, DOI 10.1124/mol.58.5.1100	26	48	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16258	10.1371/journal.pone.0016258	http://dx.doi.org/10.1371/journal.pone.0016258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21311578	gold, Green Submitted, Green Published			2022-12-27	WOS:000286522200044
J	Aziz, A; Harrop, SP; Bishop, NE				Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.			Characterization of the Deleted in Autism 1 Protein Family: Implications for Studying Cognitive Disorders	PLOS ONE			English	Article							COMPARATIVE GENOMICS; SEQUENCE DIVERGENCE; SPECTRUM DISORDERS; VERTEBRATE GENOME; GENE DUPLICATION; AMPHIOXUS GENOME; NERVOUS-SYSTEM; MODEL ORGANISM; ANIMAL-MODELS; GOLGI PROTEIN	Autism spectrum disorders (ASDs) are a group of commonly occurring, highly-heritable developmental disabilities. Human genes c3orf58 or Deleted In Autism-1 (DIA1) and cXorf36 or Deleted in Autism-1 Related (DIA1R) are implicated in ASD and mental retardation. Both gene products encode signal peptides for targeting to the secretory pathway. As evolutionary medicine has emerged as a key tool for understanding increasing numbers of human diseases, we have used an evolutionary approach to study DIA1 and DIA1R. We found DIA1 conserved from cnidarians to humans, indicating DIA1 evolution coincided with the development of the first primitive synapses. Nematodes lack a DIA1 homologue, indicating Caenorhabditis elegans is not suitable for studying all aspects of ASD etiology, while zebrafish encode two DIA1 paralogues. By contrast to DIA1, DIA1R was found exclusively in vertebrates, with an origin coinciding with the whole-genome duplication events occurring early in the vertebrate lineage, and the evolution of the more complex vertebrate nervous system. Strikingly, DIA1R was present in schooling fish but absent in fish that have adopted a more solitary lifestyle. An additional DIA1-related gene we named DIA1-Like (DIA1L), lacks a signal peptide and is restricted to the genomes of the echinoderm Strongylocentrotus purpuratus and cephalochordate Branchiostoma floridae. Evidence for remarkable DIA1L gene expansion was found in B. floridae. Amino acid alignments of DIA1 family gene products revealed a potential Golgi-retention motif and a number of conserved motifs with unknown function. Furthermore, a glycine and three cysteine residues were absolutely conserved in all DIA1-family proteins, indicating a critical role in protein structure and/or function. We have therefore identified a new metazoan protein family, the DIA1-family, and understanding the biological roles of DIA1-family members will have implications for our understanding of autism and mental retardation.	[Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.] La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia	La Trobe University	Aziz, A (corresponding author), La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia.	N.Bishop@latrobe.edu.au			La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	NEB and SPH were supported by La Trobe University and AA by La Trobe University, the Malaysian Ministry of Higher Education, and the Islamic Science University of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; AZIZ A, 2010, PLOS ONE IN PRESS; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Best J D, 2008, Neuropsychiatr Dis Treat, V4, P567; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; D'Aniello S, 2008, MOL BIOL EVOL, V25, P1841, DOI 10.1093/molbev/msn132; D'Elia D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S1; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Eisen GE, 2009, DEV BIOL, V335, P78, DOI 10.1016/j.ydbio.2009.08.024; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Flint J, 2008, CURR OPIN GENET DEV, V18, P235, DOI 10.1016/j.gde.2008.07.002; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fontanillas E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-95; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Froschauer A, 2006, CURR GENOMICS, V7, P43, DOI 10.2174/138920206776389766; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Gerlach Daniel, 2007, In Silico Biology, V7, P151; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grimmelikhuijzen C.J.P., 1995, Experientia Supplementum (Basel), V72, P7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halanych KM, 2001, AM ZOOL, V41, P629, DOI 10.1668/0003-1569(2001)041[0629:ABROMP]2.0.CO;2; Hardham AR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-63; Harper RA, 1996, TRENDS BIOCHEM SCI, V21, P150, DOI 10.1016/S0968-0004(96)80170-8; Hoegg S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-317; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holland LZ, 2008, BRAIN BEHAV EVOLUT, V72, P91, DOI 10.1159/000151470; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; Holland LZ, 2003, BIOESSAYS, V25, P529, DOI 10.1002/bies.10302; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufton AL, 2008, GENOME RES, V18, P1582, DOI 10.1101/gr.080119.108; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; KABASHI E, 2010, BIOCH BIOPH IN PRESS; Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kawano T, 1997, BIOSCI BIOTECH BIOCH, V61, P927, DOI 10.1271/bbb.61.927; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Kurosawa G, 1999, BIOCHEM BIOPH RES CO, V260, P66, DOI 10.1006/bbrc.1999.0834; Laviola G, 2009, NEUROSCI BIOBEHAV R, V33, P560, DOI 10.1016/j.neubiorev.2008.09.006; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Losh M, 2008, J NEUROPATH EXP NEUR, V67, P829, DOI 10.1097/NEN.0b013e318184482d; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miller G, 2009, SCIENCE, V325, P24, DOI 10.1126/science.325_24; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Mitreva M, 2005, TRENDS GENET, V21, P573, DOI 10.1016/j.tig.2005.08.003; Morris JA, 2009, PROG BRAIN RES, V179, P97, DOI 10.1016/S0079-6123(09)17911-6; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590; NELSON J S, 1976, P416; Nesselhut J, 2001, FEBS LETT, V509, P469, DOI 10.1016/S0014-5793(01)03187-8; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Paxton J.R., 1998, ENCY FISHES; Permanyer J, 2006, INT J BIOL SCI, V2, P48; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qian WF, 2009, GENOME BIOL EVOL, V1, P198, DOI 10.1093/gbe/evp021; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Rosso L, 2008, PLOS BIOL, V6, P1281, DOI 10.1371/journal.pbio.0060140; Rupp B, 1996, ANAT EMBRYOL, V194, P187; Rutter M, 2000, J ABNORM CHILD PSYCH, V28, P3, DOI 10.1023/A:1005113900068; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2009, CEREBELLUM, V8, P312, DOI 10.1007/s12311-009-0097-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh N, 2006, GENOME DYN, V2, P198, DOI 10.1159/000095105; Sawa A, 2009, PROG BRAIN RES, V179, pVII, DOI 10.1016/S0079-6123(09)17919-0; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schioth HB, 2005, ANN NY ACAD SCI, V1040, P460, DOI 10.1196/annals.1327.090; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Takatalo MS, 2009, J DENT RES, V88, P534, DOI 10.1177/0022034509338452; Takatalo M, 2008, DEV DYNAM, V237, P2243, DOI 10.1002/dvdy.21646; Takatalo MS, 2006, PROTEOMICS, V6, P3502, DOI 10.1002/pmic.200500516; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taniai H, 2008, AM J MED GENET B, V147B, P844, DOI 10.1002/ajmg.b.30740; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tordjman S, 2007, BEHAV GENET, V37, P61, DOI 10.1007/s10519-006-9120-5; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; VANEGAS H, 1983, BRAIN RES REV, V6, P117, DOI 10.1016/0165-0173(83)90036-X; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; Wang YF, 2000, J MOL EVOL, V51, P88, DOI 10.1007/s002390010069; WARING R, 2001, SULPHATION AUTISM WH; WARING R, 2001, Patent No. 2001077681; Weiss LA, 2009, EXPERT REV MOL DIAGN, V9, P795, DOI 10.1586/ERM.09.59; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wilkins MR, 1999, METH MOL B, V112, P531; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P641; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; WULLIMANN MF, 1991, J COMP NEUROL, V312, P415, DOI 10.1002/cne.903120309; Xue HG, 2005, NEUROSCI LETT, V390, P104, DOI 10.1016/j.neulet.2005.08.007; Yoshihara Motojiro, 2001, Functional and Integrative Genomics, V1, P235, DOI 10.1007/s101420000029; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	170	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14547	10.1371/journal.pone.0014547	http://dx.doi.org/10.1371/journal.pone.0014547			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283809	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600002
J	Mazumder, S; Maji, M; Das, A; Ali, N				Mazumder, Saumyabrata; Maji, Mithun; Das, Amrita; Ali, Nahid			Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice	PLOS ONE			English	Article							CONFERS PROTECTIVE IMMUNITY; PRIME-BOOST VACCINATION; EXPERIMENTAL VISCERAL LEISHMANIASIS; DNA VACCINE; GENETIC IMMUNIZATION; CATIONIC LIPOSOMES; CELLULAR-IMMUNITY; ANTIGEN PROTECTS; INTERFERON-GAMMA; MAJOR INFECTION	Background: Visceral leishmaniasis (VL) caused by an intracellular protozoan parasite Leishmania, is fatal in the absence of treatment. At present there are no effective vaccines against any form of leishmaniasis. Here, we evaluate the potency, efficacy and durability of DNA/DNA, DNA-prime/Protein-boost, and Protein/Protein based vaccination against VL in a susceptible murine model. Methods and Findings: To compare the potency, efficacy, and durability of DNA, protein and heterologous prime-boost (HPB) vaccination against Leishmania donovani, major surface glycoprotein gp63 was cloned into mammalian expression vector pcDNA3.1 for DNA based vaccines. We demonstrated that gp63 DNA based vaccination induced immune responses and conferred protection against challenge infection. However, vaccination with HPB approach showed comparatively enhanced cellular and humoral responses than other regimens and elicited early mixed Th1/Th2 responses before infection. Moreover, challenge with parasites induced polarized Th1 responses with enhanced IFN-gamma, IL-12, nitric oxide, IgG2a/IgG1 ratio and reduced IL-4 and IL-10 responses compared to other vaccination strategies. Although, vaccination with gp63 DNA either alone or mixed with CpG- ODN or heterologously prime-boosting with CpG- ODN showed comparable levels of protection at short-term protection study, DNA-prime/Protein-boost in presence of CpG significantly reduced hepatic and splenic parasite load by 10(7) fold and 10(10) fold respectively, in long-term study. The extent of protection, obtained in this study has till now not been achieved in long-term protection through HPB approach in susceptible BALB/c model against VL. Interestingly, the HPB regimen also showed marked reduction in the footpad swelling of BALB/c mice against Leishmania major infection. Conclusion/Significance: HPB approach based on gp63 in association with CpG, resulted in robust cellular and humoral responses correlating with durable protection against L. donovani challenge till twelve weeks post-vaccination. These results emphasize the potential of DNA-prime/Protein-boost vaccination over DNA/DNA and Protein/Protein based vaccination in maintaining long-term immunity against intracellular pathogen like Leishmania.	[Mazumder, Saumyabrata; Maji, Mithun; Das, Amrita; Ali, Nahid] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Mazumder, S (corresponding author), Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India.	nali@iicb.res.in	Maji, Mithun/D-3734-2012; bhattacharyya, Anirban/F-6067-2015		Department of Science and Technology - Government of India; Council of Scientific and Industrial Research - Government of India	Department of Science and Technology - Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research - Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful for the financial support of the Department of Science and Technology - Government of India and for the Council of Scientific and Industrial Research - Government of India for providing a Senior Research Fellowship to Saumyabrata Mazumder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin F, 1997, INFECT IMMUN, V65, P2371, DOI 10.1128/IAI.65.6.2371-2377.1997; Aguilar-Be I, 2005, INFECT IMMUN, V73, P812, DOI 10.1128/IAI.73.2.812-819.2005; Ahmed SB, 2004, VACCINE, V22, P1631, DOI 10.1016/j.vaccine.2003.10.046; Banerjee A, 2008, J IMMUNOL, V181, P1386, DOI 10.4049/jimmunol.181.2.1386; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhaumik S, 2009, VACCINE, V27, P1306, DOI 10.1016/j.vaccine.2008.12.053; Bhowmick S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005820; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001; COLOMERGOULD V, 1985, J EXP MED, V162, P902, DOI 10.1084/jem.162.3.902; COX GJM, 1993, J VIROL, V67, P5664, DOI 10.1128/JVI.67.9.5664-5667.1993; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dumonteil E, 2003, VACCINE, V21, P2161, DOI 10.1016/S0264-410X(02)00769-7; Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;669::AID-IMMU669&gt;3.0.CO;2-N; Gonzalo RM, 2002, VACCINE, V20, P1226, DOI 10.1016/S0264-410X(01)00427-3; Gurunathan S, 2000, CURR OPIN IMMUNOL, V12, P442, DOI 10.1016/S0952-7915(00)00118-7; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; HALDAR JP, 1983, INFECT IMMUN, V42, P702, DOI 10.1128/IAI.42.2.702-707.1983; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HOWARD JG, 1984, PHILOS T R SOC B, V307, P87, DOI 10.1098/rstb.1984.0111; KEMP M, 1993, INFECT IMMUN, V61, P1069, DOI 10.1128/IAI.61.3.1069-1073.1993; Klinman DM, 1997, J IMMUNOL, V158, P3635; Kojima Y, 2002, VACCINE, V20, P2857, DOI 10.1016/S0264-410X(02)00238-4; Lange UG, 2004, INFECT IMMUN, V72, P4924, DOI 10.1128/IAI.72.8.4924-4928.2004; LEPAY DA, 1983, J EXP MED, V157, P1562, DOI 10.1084/jem.157.5.1562; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Mazumdar T, 2004, VACCINE, V22, P1162, DOI 10.1016/j.vaccine.2003.09.030; Mendez S, 2001, J IMMUNOL, V166, P5122, DOI 10.4049/jimmunol.166.8.5122; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; MURRAY HW, 1987, J IMMUNOL, V138, P2290; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; Rafati S, 2006, VACCINE, V24, P3290, DOI 10.1016/j.vaccine.2006.01.030; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Rhee EG, 2002, J EXP MED, V195, P1565, DOI 10.1084/jem.20020147; Roy MJ, 2000, VACCINE, V19, P764, DOI 10.1016/S0264-410X(00)00302-9; Sachdeva R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007880; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Sedegah M, 2002, INFECT IMMUN, V70, P3493, DOI 10.1128/IAI.70.7.3493-3499.2002; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Sundar S, 2002, CLIN INFECT DIS, V35, P581, DOI 10.1086/342057; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Walker PS, 1998, HUM GENE THER, V9, P1899, DOI 10.1089/hum.1998.9.13-1899; Wang QM, 2004, VACCINE, V22, P3622, DOI 10.1016/j.vaccine.2004.03.029; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; XU D, 1994, VACCINE, V12, P1534, DOI 10.1016/0264-410X(94)90079-5; XU D, 1995, IMMUNOLOGY, V84, P173; Yi AK, 1998, J IMMUNOL, V160, P5898	60	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e14644	10.1371/journal.pone.0014644	http://dx.doi.org/10.1371/journal.pone.0014644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311597	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200002
J	Lalor, MK; Floyd, S; Gorak-Stolinska, P; Weir, RE; Blitz, R; Branson, K; Fine, PE; Dockrell, HM				Lalor, Maeve K.; Floyd, Sian; Gorak-Stolinska, Patricia; Weir, Rosemary E.; Blitz, Rose; Branson, Keith; Fine, Paul E.; Dockrell, Hazel M.			BCG Vaccination: A Role for Vitamin D?	PLOS ONE			English	Article							D DEFICIENCY; PULMONARY TUBERCULOSIS; CHILDHOOD SURVIVAL; GUINEA-BISSAU; IMMUNITY; HEALTH; MYCOBACTERIA; IMMUNIZATION; CATHELICIDIN; METAANALYSIS	Background: BCG vaccination is administered in infancy in most countries with the aim of providing protection against tuberculosis. There is increasing interest in the role of vitamin D in immunity to tuberculosis. This study objective was to determine if there was an association between circulating 25(OH) D concentrations and BCG vaccination status and cytokine responses following BCG vaccination in infants. Methods: Blood samples were collected from UK infants who were vaccinated with BCG at 3 (n = 47) and 12 (n = 37) months post BCG vaccination. These two time-points are denoted as time-point 1 and time-point 2. Two blood samples were also collected from age-matched unvaccinated infants (n = 32 and 28 respectively), as a control group. Plasma vitamin D concentrations (25(OH) D) were measured by radio-immunoassay. The cytokine IFN gamma was measured in supernatants from diluted whole blood stimulated with M. tuberculosis (M.tb) PPD for 6 days. Results: 58% of infants had some level of hypovitaminosis (25(OH) D <30ng/ml) at time-point 1, and this increased to 97% 9 months later. BCG vaccinated infants were almost 6 times (CI: 1.8-18.6) more likely to have sufficient vitamin D concentrations than unvaccinated infants at time-point 1, and the association remained strong after controlling for season of blood collection, ethnic group and sex. Among vaccinees, there was also a strong inverse association between IFN gamma response to M.tb PPD and vitamin D concentration, with infants with higher vitamin D concentrations having lower IFN gamma responses. Conclusions: Vitamin D may play an immuno-regulatory role following BCG vaccination. The increased vitamin D concentrations in BCG vaccinated infants could have important implications: vitamin D may play a role in immunity induced by BCG vaccination and may contribute to non-specific effects observed following BCG vaccination.	[Lalor, Maeve K.; Gorak-Stolinska, Patricia; Weir, Rosemary E.; Blitz, Rose; Dockrell, Hazel M.] Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1E 7HT, England; [Floyd, Sian; Branson, Keith; Fine, Paul E.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Publ Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lalor, MK (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	maeve_lalor@yahoo.com		Dockrell, Hazel/0000-0003-1869-9107	Wellcome Trust [063558/Z/01/B]; Bill & Melinda Gates Foundation [37772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082575] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Wellcome Trust (grant number 063558/Z/01/B) and by grant 37772 from the Bill & Melinda Gates Foundation through the Grand Challenges in Global Health Initiative. http://www.grandchallenges.org/Pages/Default.aspx and wellcometrust.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; Cantorna MT, 2008, MOL ASPECTS MED, V29, P369, DOI 10.1016/j.mam.2008.04.004; Elliott AM, 1999, LANCET, V354, P1000, DOI 10.1016/S0140-6736(99)03290-0; Enioutina EY, 2009, J IMMUNOL, V182, P4296, DOI 10.4049/jimmunol.0804344; Fine PEM, 2007, TROP MED INT HEALTH, V12, P1, DOI 10.1111/j.1365-3156.2006.01794.x; Friis H, 2008, J NUTR, V138, P2474, DOI 10.3945/jn.108.094979; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; MATSUOKA LY, 1995, J LAB CLIN MED, V126, P452; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Rousseau MC, 2008, PEDIAT ALLERG IMM-UK, V19, P438, DOI 10.1111/j.1399-3038.2007.00669.x; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; van Etten E, 2008, NUTR REV, V66, pS125, DOI 10.1111/j.1753-4887.2008.00096.x; Velilla PA, 2006, CLIN IMMUNOL, V121, P251, DOI 10.1016/j.clim.2006.08.010; Vidal M, 2002, MOL CELL BIOL, V22, P2777, DOI 10.1128/MCB.22.8.2777-2787.2002; VONESSEN MR, NAT IMMUNOL, V11, P344; Wagner CL, 2008, BREASTFEED MED, V3, P239, DOI 10.1089/bfm.2008.9984; Weir RE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-9; Wejse C, 2007, AM J CLIN NUTR, V86, P1376, DOI 10.1093/ajcn/86.5.1376; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; *WHO, 2007, IMM SURV ASS MON REP; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df	40	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16709	10.1371/journal.pone.0016709	http://dx.doi.org/10.1371/journal.pone.0016709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304967	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000286834300126
J	Okaty, BW; Sugino, K; Nelson, SB				Okaty, Benjamin W.; Sugino, Ken; Nelson, Sacha B.			A Quantitative Comparison of Cell-Type-Specific Microarray Gene Expression Profiling Methods in the Mouse Brain	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; SACCHAROMYCES-CEREVISIAE; NEURONS; RNA; OLIGODENDROCYTES; TRANSLATION; ASTROCYTES; MATURATION; REGIONS; CORTEX	Expression profiling of restricted neural populations using microarrays can facilitate neuronal classification and provide insight into the molecular bases of cellular phenotypes. Due to the formidable heterogeneity of intermixed cell types that make up the brain, isolating cell types prior to microarray processing poses steep technical challenges that have been met in various ways. These methodological differences have the potential to distort cell-type-specific gene expression profiles insofar as they may insufficiently filter out contaminating mRNAs or induce aberrant cellular responses not normally present in vivo. Thus we have compared the repeatability, susceptibility to contamination from off-target cell-types, and evidence for stress-responsive gene expression of five different purification methods - Laser Capture Microdissection (LCM), Translating Ribosome Affinity Purification (TRAP), Immunopanning (PAN), Fluorescence Activated Cell Sorting (FACS), and manual sorting of fluorescently labeled cells (Manual). We found that all methods obtained comparably high levels of repeatability, however, data from LCM and TRAP showed significantly higher levels of contamination than the other methods. While PAN samples showed higher activation of apoptosis-related, stress-related and immediate early genes, samples from FACS and Manual studies, which also require dissociated cells, did not. Given that TRAP targets actively translated mRNAs, whereas other methods target all transcribed mRNAs, observed differences may also reflect translational regulation.	[Okaty, Benjamin W.; Sugino, Ken; Nelson, Sacha B.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Brandeis University	Okaty, BW (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	nelson@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599	National Institute of Neurological Disorders and Stroke (NINDS); National Institute of Mental Health (NIMH); Simons Foundation	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation	This work was supported by funding from the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH) and the Simons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bahn S, 2001, J CHEM NEUROANAT, V22, P79, DOI 10.1016/S0891-0618(01)00099-0; Bernard R, 2009, J NEUROSCI METH, V178, P46, DOI 10.1016/j.jneumeth.2008.11.012; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Dougherty JD, 2010, NUCL ACIDS RES; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Ordway GA, 2009, J NEUROSCI RES, V87, P2430, DOI 10.1002/jnr.22078; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Rong YQ, 2004, MOL BRAIN RES, V132, P128, DOI 10.1016/j.molbrainres.2004.10.015; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Sanchez A, 2008, P NATL ACAD SCI USA, V105, P5081, DOI 10.1073/pnas.0707904105; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46	31	86	89	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16493	10.1371/journal.pone.0016493	http://dx.doi.org/10.1371/journal.pone.0016493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304595	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900056
J	Chen, EYT; Garnica, M; Wang, YC; Chen, CS; Chin, WC				Chen, Eric Y. T.; Garnica, Maria; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun			Mucin Secretion Induced by Titanium Dioxide Nanoparticles	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; PROTEIN-KINASE-C; AIR-POLLUTION; OXIDATIVE STRESS; GENE-EXPRESSION; GOBLET CELLS; CA2+; CALCIUM; PARTICLES; ULTRAFINE	Nanoparticle (NP) exposure has been closely associated with the exacerbation and pathophysiology of many respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. Mucus hypersecretion and accumulation in the airway are major clinical manifestations commonly found in these diseases. Among a broad spectrum of NPs, titanium dioxide (TiO2), one of the PM10 components, is widely utilized in the nanoindustry for manufacturing and processing of various commercial products. Although TiO2 NPs have been shown to induce cellular nanotoxicity and emphysema-like symptoms, whether TiO2 NPs can directly induce mucus secretion from airway cells is currently unknown. Herein, we showed that TiO2 NPs (<75 nm) can directly stimulate mucin secretion from human bronchial ChaGo-K1 epithelial cells via a Ca2+ signaling mediated pathway. The amount of mucin secreted was quantified with enzyme-linked lectin assay (ELLA). The corresponding changes in cytosolic Ca2+ concentration were monitored with Rhod-2, a fluorescent Ca2+ dye. We found that TiO2 NP-evoked mucin secretion was a function of increasing intracellular Ca2+ concentration resulting from an extracellular Ca2+ influx via membrane Ca2+ channels and cytosolic ER Ca2+ release. The calcium-induced calcium release (CICR) mechanism played a major role in further amplifying the intracellular Ca2+ signal and in sustaining a cytosolic Ca2+ increase. This study provides a potential mechanistic link between airborne NPs and the pathoetiology of pulmonary diseases involving mucus hypersecretion.	[Chen, Eric Y. T.; Garnica, Maria; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun] Univ Calif Merced, Merced, CA 95344 USA	University of California System; University of California Merced	Chen, EYT (corresponding author), Univ Calif Merced, Merced, CA 95344 USA.	wchin2@ucmerced.edu	Chin, Wei-Chun/A-6068-2008	Chin, Wei-Chun/0000-0003-4881-9085	NIH [1R15HL095039]; NSF [CBET-0932404]; UC CITRIS Program; UC Merced Center of Excellence on Health Disparities, National Center on Minority Health and Health Disparities [1P20MD005049-01]; UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD005049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL095039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UC CITRIS Program; UC Merced Center of Excellence on Health Disparities, National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from NIH (1R15HL095039), NSF (CBET-0932404) and the UC CITRIS Program. CSC was supported by UC Merced Center of Excellence on Health Disparities (1P20MD005049-01 from the National Center on Minority Health and Health Disparities). EYTC was supported by GRC summer fellowship from UC Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Ahn MH, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-34; Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; Ashby MC, 2002, J CELL BIOL, V158, P283, DOI 10.1083/jcb.200112025; Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Barlow PG, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-11; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Boezen M, 1998, AM J RESP CRIT CARE, V158, P1848, DOI 10.1164/ajrccm.158.6.9804072; BOULTON CL, 1991, EUR J NEUROSCI, V3, P992, DOI 10.1111/j.1460-9568.1991.tb00035.x; Brown DM, 2007, TOXICOL LETT, V168, P1, DOI 10.1016/j.toxlet.2006.10.016; Brown DM, 2007, AM J PHYSIOL-LUNG C, V292, pL1444, DOI 10.1152/ajplung.00162.2006; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Card JW, 2008, AM J PHYSIOL-LUNG C, V295, pL400, DOI 10.1152/ajplung.00041.2008; Chen E, 2008, J EXP NANOSCI, V3, P171, DOI 10.1080/17458080802412430; Chen EYT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015434; CHEN EY, 2010, AM J PHYSL LUNG CELL; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; DAHIYA R, 1993, CANCER RES, V53, P1437; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; EDWARDS DA, 1995, J CONTROL RELEASE, V34, P211, DOI 10.1016/0168-3659(94)00132-E; GARABRANT DH, 1987, SCAND J WORK ENV HEA, V13, P47, DOI 10.5271/sjweh.2087; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Hyun JS, 2008, TOXICOL LETT, V182, P24, DOI 10.1016/j.toxlet.2008.08.003; Johnston HJ, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-33; Kawasaki S, 2001, AM J RESP CELL MOL, V24, P419, DOI 10.1165/ajrcmb.24.4.4085; Kelly CV, 2008, J PHYS CHEM B, V112, P9346, DOI 10.1021/jp8013783; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mogami H, 2003, J BIOL CHEM, V278, P9896, DOI 10.1074/jbc.M210653200; Nguyen T, 2001, J PHYSIOL-LONDON, V531, P131, DOI 10.1111/j.1469-7793.2001.0131j.x; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; PETERSEN CCH, 1991, EMBO J, V10, P527, DOI 10.1002/j.1460-2075.1991.tb07979.x; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rogers DF, 2007, RESP CARE, V52, P1134; Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197; Sethi S, 2004, CURR OPIN INFECT DIS, V17, P113, DOI 10.1097/00001432-200404000-00008; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Stone V, 2000, EUR RESPIR J, V15, P297, DOI 10.1034/j.1399-3003.2000.15b13.x; Stone V, 2000, AM J RESP CRIT CARE, V162, pS44, DOI 10.1164/ajrccm.162.supplement_1.maic-12; Stone V, 2007, IEEE T NANOBIOSCI, V6, P331, DOI 10.1109/TNB.2007.909005; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Zhang AP, 2004, WORLD J GASTROENTERO, V10, P3191; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899	50	55	56	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16198	10.1371/journal.pone.0016198	http://dx.doi.org/10.1371/journal.pone.0016198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283816	Green Submitted, gold, Green Published			2022-12-27	WOS:000286520600028
J	Normand, JM; Giannopoulos, E; Spanlang, B; Slater, M				Normand, Jean-Marie; Giannopoulos, Elias; Spanlang, Bernhard; Slater, Mel			Multisensory Stimulation Can Induce an Illusion of Larger Belly Size in Immersive Virtual Reality	PLOS ONE			English	Article							RUBBER HAND ILLUSION; BODY; SUM; ONLINE; TOUCH; FEEL	Background: Body change illusions have been of great interest in recent years for the understanding of how the brain represents the body. Appropriate multisensory stimulation can induce an illusion of ownership over a rubber or virtual arm, simple types of out-of-the-body experiences, and even ownership with respect to an alternate whole body. Here we use immersive virtual reality to investigate whether the illusion of a dramatic increase in belly size can be induced in males through (a) first person perspective position (b) synchronous visual-motor correlation between real and virtual arm movements, and (c) self-induced synchronous visual-tactile stimulation in the stomach area. Methodology: Twenty two participants entered into a virtual reality (VR) delivered through a stereo head-tracked wide field-of-view head-mounted display. They saw from a first person perspective a virtual body substituting their own that had an inflated belly. For four minutes they repeatedly prodded their real belly with a rod that had a virtual counterpart that they saw in the VR. There was a synchronous condition where their prodding movements were synchronous with what they felt and saw and an asynchronous condition where this was not the case. The experiment was repeated twice for each participant in counter-balanced order. Responses were measured by questionnaire, and also a comparison of before and after self-estimates of belly size produced by direct visual manipulation of the virtual body seen from the first person perspective. Conclusions: The results show that first person perspective of a virtual body that substitutes for the own body in virtual reality, together with synchronous multisensory stimulation can temporarily produce changes in body representation towards the larger belly size. This was demonstrated by (a) questionnaire results, (b) the difference between the self-estimated belly size, judged from a first person perspective, after and before the experimental manipulation, and (c) significant positive correlations between these two measures. We discuss this result in the general context of body ownership illusions, and suggest applications including treatment for body size distortion illnesses.	[Normand, Jean-Marie; Giannopoulos, Elias; Spanlang, Bernhard; Slater, Mel] Univ Barcelona, Fac Psicol, EVENT Lab, Barcelona, Spain; [Slater, Mel] ICREA, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England	University of Barcelona; ICREA; University of London; University College London	Normand, JM (corresponding author), Univ Barcelona, Fac Psicol, EVENT Lab, Barcelona, Spain.	melslater@ub.edu	Slater, Mel/M-5210-2014	Slater, Mel/0000-0002-6223-0050; Spanlang, Bernhard/0000-0002-9659-635X; Normand, Jean-Marie/0000-0003-0557-4356	European Union; European Research Council; ICREA Funding Source: Custom	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	The work was funded under the European Union FET project IMMERSENCE cordis.europa.eu/ist/fet/pr-sy.htm. There was also funding from the European Research Council project TRAVERSE. The ERC web page is erc.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Carruthers G, 2008, CONSCIOUS COGN, V17, P1321, DOI 10.1016/j.concog.2008.07.008; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Fox J, 2009, PRESENCE-TELEOP VIRT, V18, P294, DOI 10.1162/pres.18.4.294; Gillies M, 2010, PRESENCE-VIRTUAL AUG, V19, P95, DOI 10.1162/pres.19.2.95; Gonzalez-Franco M, 2010, P IEEE VIRT REAL ANN, P111, DOI 10.1109/VR.2010.5444805; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Holmes NP, 2006, PERCEPT PSYCHOPHYS, V68, P685, DOI 10.3758/BF03208768; Holmes NP, 2007, BEHAV BRAIN SCI, V30, P211, DOI 10.1017/S0140525X07001501; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; KAMMERS M, EXPT BRAIN RES, V202, P203; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; Perpina C, 2003, EUR EAT DISORD REV, V11, P261, DOI 10.1002/erv.520; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Tecchia F, 2010, PRESENCE-VIRTUAL AUG, V19, P302, DOI 10.1162/PRES_a_00002; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2008, CONSCIOUS COGN, V17, P1317, DOI 10.1016/j.concog.2008.06.012; Yuan Y, 2010, P IEEE VIRT REAL ANN, P95, DOI 10.1109/VR.2010.5444807	34	145	146	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16128	10.1371/journal.pone.0016128	http://dx.doi.org/10.1371/journal.pone.0016128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OH	21283823	Green Published, gold, Green Submitted			2022-12-27	WOS:000286520600024
J	Reetz, K; Kleinman, A; Klein, C; Lencer, R; Zuehlke, C; Brockmann, K; Rolfs, A; Binkofski, F				Reetz, Kathrin; Kleinman, Alexandra; Klein, Christine; Lencer, Rebekka; Zuehlke, Christine; Brockmann, Kathrin; Rolfs, Arndt; Binkofski, Ferdinand			CAG Repeats Determine Brain Atrophy in Spinocerebellar Ataxia 17: A VBM Study	PLOS ONE			English	Article							HUNTINGTONS-DISEASE-LIKE; TATA-BINDING PROTEIN; TRINUCLEOTIDE REPEAT; SCA17; PHENOTYPE; POLYGLUTAMINE; DEMENTIA; SPECTRUM; MUTATION; FEATURES	Background: Abnormal repeat length has been associated with an earlier age of onset and more severe disease progression in the rare neurodegenerative disorder spinocerebellar ataxia 17 (SCA17). Methodology/Principal Findings: To determine whether specific structural brain degeneration and rate of disease progression in SCA17 might be associated with the CAG repeat size, observer-independent voxel-based morphometry was applied to high-resolution magnetic resonance images of 16 patients with SCA17 and 16 age-matched healthy controls. The main finding contrasting SCA17 patients with healthy controls demonstrated atrophy in the cerebellum bilaterally. Multiple regression analyses with available genetic data and also post-hoc correlations revealed an inverse relationship again with cerebellar atrophy. Moreover, we found an inverse relationship between the CAG repeat length and rate of disease progression. Conclusions: Our results highlight the fundamental role of the cerebellum in this neurodegenerative disease and support the genotype-phenotype relationship in SCA17 patients. Genetic factors may determine individual susceptibility to neurodegeneration and rate of disease progression.	[Reetz, Kathrin; Kleinman, Alexandra] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Reetz, Kathrin; Kleinman, Alexandra] Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany; [Reetz, Kathrin; Kleinman, Alexandra] Julich Aachen Res Alliance JARA Translat Brain Me, Aachen, Germany; [Klein, Christine] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Klein, Christine] Med Univ Lubeck, Schilling Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Lencer, Rebekka] Med Univ Lubeck, Dept Psychiat & Psychotherapy, D-23538 Lubeck, Germany; [Zuehlke, Christine] Med Univ Lubeck, Inst Human Genet, D-23538 Lubeck, Germany; [Brockmann, Kathrin; Rolfs, Arndt] Univ Rostock, Fac Med, Albrecht Kossel Inst Neuroregenerat, Rostock, Germany; [Binkofski, Ferdinand] Rhein Westfal TH Aachen, Div Cognit Neurol, Aachen, Germany	RWTH Aachen University; Helmholtz Association; Research Center Julich; University of Lubeck; University of Lubeck; University of Lubeck; University of Lubeck; University of Rostock; RWTH Aachen University	Reetz, K (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.	fbinkofski@ukaachen.de	Binkofski, Ferdinand/S-6997-2017; Lencer, Rebekka/A-4994-2009; Reetz, Kathrin/H-9510-2012; Klein, Christine/AGK-8003-2022	Binkofski, Ferdinand/0000-0002-6750-943X; Lencer, Rebekka/0000-0003-4032-7297; Reetz, Kathrin/0000-0002-9730-9228; Klein, Christine/0000-0003-2102-3431	DFG Translational Brain Research in Psychiatry and Neurology [DFG ZUK32/1]	DFG Translational Brain Research in Psychiatry and Neurology	KR was funded by the DFG Translational Brain Research in Psychiatry and Neurology (DFG ZUK32/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bauer P, 2004, J MED GENET, V41, P230, DOI 10.1136/jmg.2003.015602; Bech S, 2010, PARKINSONISM RELAT D, V16, P12, DOI 10.1016/j.parkreldis.2009.06.006; Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314; Craig K, 2005, J NEUROL SCI, V239, P105, DOI 10.1016/j.jns.2005.08.009; De Michele G, 2003, NEUROL SCI, V24, P166, DOI 10.1007/s10072-003-0112-4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HELSINKI WMA, 2000, JAMA-J AM MED ASSOC, V284, P3043; Klockgether T, 1998, BRAIN, V121, P1687, DOI 10.1093/brain/121.9.1687; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Netravathi M, 2009, J NEUROL SCI, V277, P83, DOI 10.1016/j.jns.2008.10.016; Onodera O, 1998, ANN NEUROL, V43, P288, DOI 10.1002/ana.410430305; Reetz K, 2010, CEREBELLUM, V9, P210, DOI 10.1007/s12311-009-0150-4; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Schulz JB, 2010, NEUROIMAGE, V49, P158, DOI 10.1016/j.neuroimage.2009.07.027; Stevanin G, 2000, EUR J HUM GENET, V8, P4, DOI 10.1038/sj.ejhg.5200403; Stevanin G, 2008, CEREBELLUM, V7, P170, DOI 10.1007/s12311-008-0016-1; Toyoshima Y, 2004, ANN NEUROL, V55, P281, DOI 10.1002/ana.10824; ZUHLKE C, 2007, CEREBELLUM, P1	23	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15125	10.1371/journal.pone.0015125	http://dx.doi.org/10.1371/journal.pone.0015125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21311576	Green Published, gold			2022-12-27	WOS:000286520600008
J	Pollock, CB; Yin, YZ; Yuan, HY; Zeng, XA; King, S; Li, X; Kopelovich, L; Albanese, C; Glazer, RI				Pollock, Claire B.; Yin, Yuzhi; Yuan, Hongyan; Zeng, Xiao; King, Sruthi; Li, Xin; Kopelovich, Levy; Albanese, Chris; Glazer, Robert I.			PPAR delta Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ATP CITRATE LYASE; RECEPTOR-DELTA; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; GROWTH-FACTOR; PDK1; PHOSPHORYLATION	Peroxisome proliferator-activated receptor delta (PPAR delta) is a transcription factor that is associated with metabolic gene regulation and inflammation. It has been implicated in tumor promotion and in the regulation of 3-phosphoinositide-dependent kinase-1 (PDK1). PDK1 is a key regulator of the AGC protein kinase family, which includes the proto-oncogene AKT/PKB implicated in several malignancies, including breast cancer. To assess the role of PDK1 in mammary tumorigenesis and its interaction with PPAR delta, transgenic mice were generated in which PDK1 was expressed in mammary epithelium under the control of the MMTV enhancer/promoter region. Transgene expression increased pT308AKT and pS9GSK3 beta, but did not alter phosphorylation of mTOR, 4EBP1, ribosomal protein S6 and PKC alpha. The transgenic mammary gland also expressed higher levels of PPAR delta and a gene expression profile resembling wild-type mice maintained on a diet containing the PPAR delta agonist, GW501516. Both wild-type and transgenic mice treated with GW501516 exhibited accelerated rates of tumor formation that were more pronounced in transgenic animals. GW501516 treatment was accompanied by a distinct metabolic gene expression and metabolomic signature that was not present in untreated animals. GW501516-treated transgenic mice expressed higher levels of fatty acid and phospholipid metabolites than treated wild-type mice, suggesting the involvement of PDK1 in enhancing PPAR delta-driven energy metabolism. These results reveal that PPAR delta activation elicits a distinct metabolic and metabolomic profile in tumors that is in part related to PDK1 and AKT signaling.	[Pollock, Claire B.; Yin, Yuzhi; Yuan, Hongyan; Zeng, Xiao; Albanese, Chris; Glazer, Robert I.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Pollock, Claire B.; Yin, Yuzhi; Yuan, Hongyan; Zeng, Xiao; Albanese, Chris; Glazer, Robert I.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [King, Sruthi] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA; [Li, Xin] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA; [Kopelovich, Levy] NCI, Chemoprevent Agent Dev & Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pollock, CB (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA.	glazerr@georgetown.edu			National Institutes of Health, Bethesda, MD [R01 CA111482, N01 CN43309]; National Cancer Institute [1P30-CA-51008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA111482] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01 CA111482 and contract N01 CN43309 from the National Institutes of Health, Bethesda, MD. This investigation was conducted using the Animal Research, Histopathology and Tissue, Genomics and Epigenomics, Preclinical Imaging, and Proteomics and Metabolomics Shared Resources supported in part by Cancer Center Support Grant 1P30-CA-51008 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; Behbod F, 2006, STEM CELLS, V24, P1065, DOI 10.1634/stemcells.2005-0375; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Genini D, 2007, J BIOL CHEM, V282, P11776, DOI 10.1074/jbc.M609149200; Ghosh M, 2009, PROSTAG OTH LIPID M, V88, P97, DOI 10.1016/j.prostaglandins.2008.11.004; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Glazer RI, 2008, PPAR RES, V2008, DOI 10.1155/2008/247379; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Han SW, 2009, AM J RESP CELL MOL, V40, P325, DOI 10.1165/rcmb.2008-0197OC; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Jaeckel EC, 2001, ARCH OTOLARYNGOL, V127, P1253, DOI 10.1001/archotol.127.10.1253; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Knutsen HK, 2005, ANTICANCER RES, V25, P3781; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Li YP, 2008, BIOCHEM BIOPH RES CO, V369, P1034, DOI 10.1016/j.bbrc.2008.02.147; Liang K, 2006, MOL PHARMACOL, V70, P1045, DOI 10.1124/mol.106.023333; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Liu Y, 2009, MOL CANCER RES, V7, P944, DOI 10.1158/1541-7786.MCR-08-0368; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEDCHENKO TV, 2008, AM J RESP CELL MOL B; POLLOCK CB, 2010, PPAR RES IN PRESS; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; SCHMIDT M, 2009, J CANC RES CLIN ONCO; Sedlakova I, 2008, EUR J GYNAECOL ONCOL, V29, P511; Shao JY, 2002, CANCER RES, V62, P3282; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Suchanek KM, 2002, INT J BIOCHEM CELL B, V34, P1051, DOI 10.1016/S1357-2725(02)00025-0; Tian XJ, 2002, EMBO J, V21, P1327, DOI 10.1093/emboj/21.6.1327; Tong BJ, 2000, NEOPLASIA, V2, P483, DOI 10.1038/sj.neo.7900119; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Xie ZH, 2003, CANCER RES, V63, P5370; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yin Y, 2005, MOL CARCINOGEN, V44, P42, DOI 10.1002/mc.20119; Yin YZ, 2009, CANCER RES, V69, P687, DOI 10.1158/0008-5472.CAN-08-2446; Yin YZ, 2006, MOL ENDOCRINOL, V20, P268, DOI 10.1210/me.2005-0197; Yin YZ, 2005, CANCER RES, V65, P3950, DOI 10.1158/0008-5472.CAN-04-3990; Zeng X, 2002, CANCER RES, V62, P3538	61	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16215	10.1371/journal.pone.0016215	http://dx.doi.org/10.1371/journal.pone.0016215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21297860	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000033
J	Birbrair, A; Wang, ZM; Messi, ML; Enikolopov, GN; Delbono, O				Birbrair, Alexander; Wang, Zhong-Min; Messi, Maria Laura; Enikolopov, Grigori N.; Delbono, Osvaldo			Nestin-GFP Transgene Reveals Neural Precursor Cells in Adult Skeletal Muscle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; SATELLITE CELLS; BETA-TUBULIN; SPINAL-CORD; DIFFERENTIATION; NEUROGENESIS; MULTIPOTENT; EXPRESSION	Background: Therapy for neural lesions or degenerative diseases relies mainly on finding transplantable active precursor cells. Identifying them in peripheral tissues accessible for biopsy, outside the central nervous system, would circumvent the serious immunological and ethical concerns impeding cell therapy. Methodology/Principal Findings: In this study, we isolated neural progenitor cells in cultured adult skeletal muscle from transgenic mice in which nestin regulatory elements control GFP expression. These cells also expressed the early neural marker Tuj1 and light and heavy neurofilament but not S100 beta, indicating that they express typical neural but not Schwann cell markers. GFP+/Tuj1+ cells were also negative for the endothelial and pericyte markers CD31 and alpha-smooth muscle actin, respectively. We established their a) functional response to glutamate in patch-clamp recordings; b) interstitial mesenchymal origin; c) replicative capacity; and d) the environment necessary for their survival after fluorescence-activated cell sorting. Conclusions/Significance: We propose that the decline in nestin-GFP expression in muscle progenitor cells and its persistence in neural precursor cells in muscle cultures provide an invaluable tool for isolating a population of predifferentiated neural cells with therapeutic potential.	[Birbrair, Alexander; Wang, Zhong-Min; Messi, Maria Laura; Delbono, Osvaldo] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Gerontol, Winston Salem, NC 27106 USA; [Birbrair, Alexander; Delbono, Osvaldo] Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27103 USA; [Enikolopov, Grigori N.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Cold Spring Harbor Laboratory	Birbrair, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Gerontol, Winston Salem, NC 27106 USA.	odelbono@wfubmc.edu	Birbrair, Alexander/H-2497-2012; Enikolopov, Grigori/P-5731-2019	Birbrair, Alexander/0000-0003-1015-2561; Enikolopov, Grigori/0000-0001-8178-8917	National Institutes of Health/National Institute on Aging [AG13934, AG033385, AG15820]; Muscular Dystrophy Association (MDA) [33149]; Wake Forest University Claude D. Pepper Older Americans Independence Center [P30-AG21332]; National Institutes of Mental Health; Ira Hazan Fund	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Wake Forest University Claude D. Pepper Older Americans Independence Center; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ira Hazan Fund	The present study was supported by grants to Osvaldo Delbono from the National Institutes of Health/National Institute on Aging (AG13934, AG033385, and AG15820), the Muscular Dystrophy Association (MDA #33149), and the Wake Forest University Claude D. Pepper Older Americans Independence Center (P30-AG21332) and by the National Institutes of Mental Health and Ira Hazan Fund to Grigori N. Enikolopov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2008, CLIN PHARMACOL THER, V83, P386, DOI 10.1038/sj.clpt.6100384; Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Arsic N, 2008, EXP CELL RES, V314, P1266, DOI 10.1016/j.yexcr.2008.01.009; Bachstetter AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010496; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Mazzer PYCN, 2008, J NEUROSCI METH, V173, P249, DOI 10.1016/j.jneumeth.2008.06.019; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Carlson BM, 2001, J GERONTOL A-BIOL, V56, pB224, DOI 10.1093/gerona/56.5.B224; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gingras M, 2007, J CELL PHYSIOL, V210, P498, DOI 10.1002/jcp.20889; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOSHI HC, 1989, J CELL BIOL, V109, P663, DOI 10.1083/jcb.109.2.663; Katsetos CD, 2000, ARCH PATHOL LAB MED, V124, P535; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; LEE MK, 1990, P NATL ACAD SCI USA, V87, P7195, DOI 10.1073/pnas.87.18.7195; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lepski G, 2010, EXP CELL RES, V316, P216, DOI 10.1016/j.yexcr.2009.08.006; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Li WW, 1998, J NEUROSCI, V18, P8853; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LUNN JS, 2010, PLEOTROPHIC EFFECTS; Luo KX, 2003, J BONE JOINT SURG AM, V85A, P39, DOI 10.2106/00004623-200300003-00008; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pekcec A, 2006, NEUROREPORT, V17, P571, DOI 10.1097/00001756-200604240-00003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rao MS, 1999, ANAT RECORD, V257, P137; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Salgado Antonio J, 2006, Curr Stem Cell Res Ther, V1, P345; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022; Schultz SS, 2006, WOUND REPAIR REGEN, V14, P224, DOI 10.1111/j.1743-6109.2006.00114.x; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Silva AT, 2008, BRAIN RES, V1218, P47, DOI 10.1016/j.brainres.2008.04.051; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zavan B, 2007, EUR J HISTOCHEM, V51, P1; Zipori Dov, 2006, Curr Stem Cell Res Ther, V1, P95, DOI 10.2174/157488806775269133	66	66	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16816	10.1371/journal.pone.0016816	http://dx.doi.org/10.1371/journal.pone.0016816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304812	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287036600028
J	Li, HY; Daculsi, R; Grellier, M; Bareille, R; Bourget, C; Remy, M; Amedee, J				Li, Haiyan; Daculsi, Richard; Grellier, Maritie; Bareille, Reine; Bourget, Chantal; Remy, Murielle; Amedee, Joelle			The Role of Vascular Actors in Two Dimensional Dialogue of Human Bone Marrow Stromal Cell and Endothelial Cell for Inducing Self-Assembled Network	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR-INDUCED ANGIOGENESIS; IN-VITRO; VE-CADHERIN; UROKINASE RECEPTOR; FIBRIN MATRICES; CAPILLARY-LIKE; HUMAN OSTEOPROGENITORS; INVITRO ANGIOGENESIS; TUBE FORMATION	Angiogenesis is very important for vascularized tissue engineering. In this study, we found that a two-dimensional co-culture of human bone marrow stromal cell (HBMSC) and human umbical vein endothelial cell (HUVEC) is able to stimulate the migration of co-cultured HUVEC and induce self-assembled network formation. During this process, expression of vascular endothelial growth factor (VEGF(165)) was upregulated in co-cultured HBMSC. Meanwhile, VEGF(165)-receptor2 (KDR) and urokinase-type plasminogen activator (uPA) were upregulated in co-cultured HUVEC. Functional studies show that neutralization of VEGF(165) blocked the migration and the rearrangement of the cells and downregulated the expression of uPA and its receptor. Blocking of vascular endothelial-cadherin (VE-cad) did not affect the migration of co-cultured HUVEC but suppressed the self-assembled network formation. In conclusion, co-cultures upregulated the expression of VEGF(165) in co-cultured HBMSC; VEGF(165) then activated uPA in co-cultured HUVEC, which might be responsible for initiating the migration and the self-assembled network formation with the participation of VE-cad. All of these results indicated that only the direct contact of HBMSC and HUVEC and their respective dialogue are sufficient to stimulate secretion of soluble factors and to activate molecules that are critical for self-assembled network formation which show a great application potential for vascularization in tissue engineering.	[Li, Haiyan; Daculsi, Richard; Bareille, Reine; Bourget, Chantal; Remy, Murielle; Amedee, Joelle] INSERM, U577, Bordeaux, France; [Li, Haiyan; Daculsi, Richard; Bareille, Reine; Bourget, Chantal; Remy, Murielle; Amedee, Joelle] Univ Bordeaux 2, F-33076 Bordeaux, France; [Grellier, Maritie] Univ Porto, IPATIMUP Inst Patol Imunol Mol, P-4100 Oporto, Portugal	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universidade do Porto	Li, HY (corresponding author), INSERM, U577, Bordeaux, France.	haiyan.li@inserm.fr	AMEDEE, Joelle VILAMITJANA/F-3369-2013	Li, Haiyan/0000-0002-7423-2715	L'Agence Nationale de la Recherche [ANR 06-PNANO-022-06, ANR 07-ITOV-TECSAN 011-01]	L'Agence Nationale de la Recherche(French National Research Agency (ANR))	The work was funded by L'Agence Nationale de la Recherche, grant numbers ANR 06-PNANO-022-06 and ANR 07-ITOV-TECSAN 011-01. http://www.agence-nationale-recherche.fr/Accueil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844; BISCHOFF J, 1995, TRENDS CELL BIOL, V5, P69, DOI 10.1016/S0962-8924(00)88949-7; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398; BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Caveda L, 1996, J CLIN INVEST, V98, P886, DOI 10.1172/JCI118870; COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; DENNIS PA, 1990, J CELL PHYSIOL, V144, P84, DOI 10.1002/jcp.1041440112; Deroanne CF, 1997, CANCER RES, V57, P5590; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Finkenzeller G, 2006, TISSUE ENG, V12, P2889, DOI 10.1089/ten.2006.12.2889; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOURNIER N, 1992, CELL BIOL INT REP, V16, P1251, DOI 10.1016/S0309-1651(06)80042-1; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018; Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025; Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342; Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x; Hurley JR, 2010, AM J PHYSIOL-CELL PH, V299, pC444, DOI 10.1152/ajpcell.00572.2009; JAFFE EA, 1980, TRANSPL P, V12, P49; KANZAWA S, 1993, ANN PLAS SURG, V30, P244, DOI 10.1097/00000637-199303000-00008; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Kyriakidou K, 2008, J BIOACT COMPAT POL, V23, P227, DOI 10.1177/0883911508091905; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Li HY, 2010, AM J PHYSIOL-CELL PH, V299, pC422, DOI 10.1152/ajpcell.00562.2009; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Mandriota SJ, 1997, J CELL SCI, V110, P2293; Martin T A, 1999, Angiogenesis, V3, P69, DOI 10.1023/A:1009004212357; Martin TA, 2001, EUR J CLIN INVEST, V31, P931, DOI 10.1046/j.1365-2362.2001.00914.x; MONTESANO R, 1993, J CELL SCI, V105, P1013; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; NEHLS V, 1995, HISTOCHEM CELL BIOL, V104, P459, DOI 10.1007/BF01464336; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Prager GW, 2004, CIRC RES, V94, P1562, DOI 10.1161/01.RES.0000131498.36194.6b; Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685; Silvestri I, 2002, INT J CANCER, V102, P562, DOI 10.1002/ijc.10744; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Terman BI, 1996, CANCER METAST REV, V15, P159, DOI 10.1007/BF00437468; Tille JC, 2002, EXP CELL RES, V280, P179, DOI 10.1006/excr.2002.5635; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; Velazquez OC, 2002, FASEB J, V16, P1316, DOI 10.1096/fj.01-1011fje; Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2; Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001; Wright TJ, 2002, EXP CELL RES, V280, P159, DOI 10.1006/excr.2002.5636; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047	61	42	46	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16767	10.1371/journal.pone.0016767	http://dx.doi.org/10.1371/journal.pone.0016767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304816	Green Submitted, gold, Green Published			2022-12-27	WOS:000287036600023
J	Li, Q; Ke, F; Zhang, WW; Shen, XY; Xu, QN; Wang, H; Yu, XZ; Leng, QB; Wang, HL				Li, Qun; Ke, Fang; Zhang, Weiwei; Shen, Xiaoyan; Xu, Qiannan; Wang, Hong; Yu, Xue-Zhong; Leng, Qibin; Wang, Honglin			Plasmin Plays an Essential Role in Amplification of Psoriasiform Skin Inflammation in Mice	PLOS ONE			English	Article							ANNEXIN-II; EXPRESSION; ACTIVATOR; MACROPHAGES; CYTOKINE; IL-23	Background: Although increased levels of plasminogen activators have been found in psoriatic lesions, the role of plasmin converted from plasminogen by plasminogen activators in pathogenesis of psoriasis has not been investigated. Methodology/Principal Findings: Here we examined the contribution of plasmin to amplification of inflammation in patients with psoriasis. We found that plasminogen was diminished, but that the amount and activity of its converted product plasmin were markedly increased in psoriasis. Moreover, annexin II, a receptor for plasmin was dramatically increased in both dermis and epidermis in psoriasis. Plasmin at sites of inflammation was pro-inflammatory, eliciting production of inflammatory factors, including CC chemokine ligand 20 (CCL20) and interleukin-23 (IL-23), that was mediated by the nuclear factor-kappaB (NF-kappa B) signaling pathway and that had an essential role in the recruitment and activation of pathogenic C-C chemokine receptor type 6 (CCR6)(+) T cells. Moreover, intradermal injection of plasmin or plasmin together with recombinant monocyte/macrophage chemotactic protein-1 (MCP-1) resulted in induction of psoriasiform skin inflammation around the injection sites with several aspects of human psoriasis in mice. Conclusions/Significance: Plasmin converted from plasminogen by plasminogen activators plays an essential role in amplification of psoriasiform skin inflammation in mice, and targeting plasmin receptor - annexin II - may harbor therapeutic potential for the treatment of human psoriasis.	[Li, Qun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Vasc Biol Lab,Dept Hypertens,Shanghai Ruijin Hosp, Shanghai 200030, Peoples R China; [Li, Qun] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai 200030, Peoples R China; [Li, Qun] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ke, Fang; Zhang, Weiwei; Xu, Qiannan; Wang, Hong; Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Shen, Xiaoyan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, Shanghai 200030, Peoples R China; [Yu, Xue-Zhong] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Leng, Qibin] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; H Lee Moffitt Cancer Center & Research Institute; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Li, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Vasc Biol Lab,Dept Hypertens,Shanghai Ruijin Hosp, Shanghai 200030, Peoples R China.	honglin_wang@shsmu.edu.cn	WANG, Honglin/AAJ-2708-2020	WANG, Honglin/0000-0001-6302-6927; Yu, Xue-Zhong/0000-0002-1751-2884	National Natural Science Foundation of China [30972787]; Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality [09140902600]; Shanghai Municipal Education Commission [J50208, J50207]; Shanghai Pujiang Program [10PJ407300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This research is supported by a grant from the National Natural Science Foundation of China (No: 30972787), by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, by the Science and Technology Commission of Shanghai Municipality (No.: 09140902600), and by the Leading Academic Discipline Project of the Shanghai Municipal Education Commission (No: J50208 and No: J50207). Supported by Shanghai Pujiang Program (No: 10PJ407300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATACSORGO Z, 1995, J INVEST DERMATOL, V105, pS89, DOI 10.1111/1523-1747.ep12316121; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Clark RA, 2006, J CLIN INVEST, V116, P2084, DOI 10.1172/JCI29441; FRAKI JE, 1982, SCIENCE, V215, P685, DOI 10.1126/science.7036342; GISSLER HM, 1993, BRIT J DERMATOL, V128, P612, DOI 10.1111/j.1365-2133.1993.tb00254.x; Gong Y, 2001, J BIOL CHEM, V276, P19078, DOI 10.1074/jbc.M101387200; Hajjar KA, 1997, ANN NY ACAD SCI, V811, P337, DOI 10.1111/j.1749-6632.1997.tb52013.x; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Herren T, 2001, BLOOD, V97, P1070, DOI 10.1182/blood.V97.4.1070; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; JENSEN PJ, 1988, J INVEST DERMATOL, V90, P777, DOI 10.1111/1523-1747.ep12461494; JENSEN PJ, 1990, J INVEST DERMATOL, V95, pS13, DOI 10.1111/1523-1747.ep12505666; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Karimi-Busheri F, 2002, J CELL BIOCHEM, V86, P737, DOI 10.1002/jcb.10256; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; Longstaff C, 1999, BLOOD, V93, P3839, DOI 10.1182/blood.V93.11.3839.411k08_3839_3846; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; SPIERS EM, 1994, J INVEST DERMATOL, V102, P333, DOI 10.1111/1523-1747.ep12371792; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Wang HL, 2009, J IMMUNOL, V183, P4755, DOI 10.4049/jimmunol.0900521; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zibert JR, 2010, J INVEST DERMATOL, V130, P150, DOI 10.1038/jid.2009.206	33	21	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16483	10.1371/journal.pone.0016483	http://dx.doi.org/10.1371/journal.pone.0016483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311769	Green Published, gold, Green Submitted			2022-12-27	WOS:000287036200016
J	Ghumra, A; Khunrae, P; Ataide, R; Raza, A; Rogerson, SJ; Higgins, MK; Rowe, JA				Ghumra, Ashfaq; Khunrae, Pongsak; Ataide, Ricardo; Raza, Ahmed; Rogerson, Stephen J.; Higgins, Matthew K.; Rowe, J. Alexandra			Immunisation with Recombinant PfEMP1 Domains Elicits Functional Rosette-Inhibiting and Phagocytosis-Inducing Antibodies to Plasmodium falciparum	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; SEVERE MALARIA; IN-VITRO; PARASITIZED ERYTHROCYTES; CODON OPTIMIZATION; ESCHERICHIA-COLI; CEREBRAL MALARIA; STRUCTURAL BASIS	Background: Rosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes. PfEMP1 is a possible target for a vaccine to induce antibodies to inhibit rosetting and prevent severe malaria. Methodology/Findings: We examined the vaccine potential of the six extracellular domains of a rosette-mediating PfEMP1 variant (ITvar9/R29var1 from the R29 parasite strain) by immunizing rabbits with recombinant proteins expressed in E. coli. Antibodies raised to each domain were tested for surface fluorescence with live infected erythrocytes, rosette inhibition and phagocytosis-induction. Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes down to low concentrations (0.02-1.56 mu g/ml of total IgG). Antibodies to all PfEMP1 domains except for the second Duffy-Binding-Like region inhibited rosetting (50% inhibitory concentration 0.04-4 mu g/ml) and were able to opsonize and induce phagocytosis of infected erythrocytes at low concentrations (1.56-6.25 mu g/ml). Antibodies to the N-terminal region (NTS-DBL1 alpha) were the most effective in all assays. All antibodies were specific for the R29 parasite strain, and showed no functional activity against five other rosetting strains. Conclusions/Significance: These results are encouraging for vaccine development as they show that potent antibodies can be generated to recombinant PfEMP1 domains that will inhibit rosetting and induce phagocytosis of infected erythrocytes. However, further work is needed on rosetting mechanisms and cross-reactivity in field isolates to define a set of PfEMP1 variants that could induce functional antibodies against a broad range of P. falciparum rosetting parasites.	[Ghumra, Ashfaq; Raza, Ahmed; Rowe, J. Alexandra] Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Khunrae, Pongsak; Higgins, Matthew K.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ataide, Ricardo; Rogerson, Stephen J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Ataide, Ricardo] Univ Porto, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal	University of Edinburgh; University of Cambridge; University of Melbourne; Universidade do Porto	Ghumra, A (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Alex.Rowe@ed.ac.uk	Ataide, Ricardo/B-7307-2017	Ataide, Ricardo/0000-0002-1014-0432; Rogerson, Stephen/0000-0003-4287-1982; Rowe, Alexandra/0000-0002-7702-1892; Higgins, Matthew/0000-0002-2870-1955	Wellcome Trust [084226]; Royal Society; Royal Thai Government; National Health and Medical Research Council of Australia; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/32985/2006]	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Royal Thai Government; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	JAR, AG and AR are supported by the Wellcome Trust (http://www.wellcome.ac.uk/) via a Senior Research Fellowship in Basic Biomedical Science to JAR, grant no 084226. MKH is a Royal Society University Research Fellow (http://royalsociety.org/) and this work was supported by grants from the Royal Society and the Wellcome Trust. PK was funded by a scholarship from the Royal Thai Government. SJR is supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) and RA is supported by Fundacao para a Ciencia e Tecnologia, Portugal (http://alfa.fct.mctes.pt/), reference SFRH/BD/32985/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; CELADA A, 1983, J PARASITOL, V69, P49, DOI 10.2307/3281273; CELADA A, 1982, CLIN EXP IMMUNOL, V47, P635; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2004, VACCINE, V22, P2701, DOI 10.1016/j.vaccine.2004.02.015; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Corrigan RA, 2010, PARASITE IMMUNOL, V32, P512, DOI 10.1111/j.1365-3024.2010.01225.x; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; Deans AM, 2006, EXP PARASITOL, V112, P269, DOI 10.1016/j.exppara.2005.11.007; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Ghumra A, 2008, J IMMUNOL, V181, P1988, DOI 10.4049/jimmunol.181.3.1988; HANDUNNETTI SM, 1992, AM J TROP MED HYG, V46, P371, DOI 10.4269/ajtmh.1992.46.371; Higgins MK, 2008, ACTA CRYSTALLOGR F, V64, P221, DOI 10.1107/S1744309108004211; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Joergensen LM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-100; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KAUL DK, 1991, BLOOD, V78, P812; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyriacou HM, 2007, ANTIMICROB AGENTS CH, V51, P1321, DOI 10.1128/AAC.01216-06; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; Mota MM, 1998, INFECT IMMUN, V66, P4080; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oguariri RM, 2003, PARASITOL RES, V90, P467, DOI 10.1007/s00436-003-0884-8; RINGWALD P, 1993, INFECT IMMUN, V61, P5198, DOI 10.1128/IAI.61.12.5198-5204.1993; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 2002, AM J TROP MED HYG, V66, P458, DOI 10.4269/ajtmh.2002.66.458; Rowe JA, 1998, MOL BIOCHEM PARASIT, V92, P177, DOI 10.1016/S0166-6851(97)00237-5; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Russell C, 2005, MOL BIOCHEM PARASIT, V144, P109, DOI 10.1016/j.molbiopara.2005.06.009; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Singh AP, 2002, MOL BIOCHEM PARASIT, V121, P21, DOI 10.1016/S0166-6851(02)00017-8; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003; Zhou ZY, 2004, PROTEIN EXPRES PURIF, V34, P87, DOI 10.1016/j.pep.2003.11.006	64	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16414	10.1371/journal.pone.0016414	http://dx.doi.org/10.1371/journal.pone.0016414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305024	gold, Green Published			2022-12-27	WOS:000286834300062
J	Oiki, S; Iwamoto, M; Sumikama, T				Oiki, Shigetoshi; Iwamoto, Masayuki; Sumikama, Takashi			Cycle Flux Algebra for Ion and Water Flux through the KcsA Channel Single-File Pore Links Microscopic Trajectories and Macroscopic Observables	PLOS ONE			English	Article							STREAMING POTENTIAL MEASUREMENTS; POTASSIUM CHANNELS; K+ CHANNEL; SELECTIVITY FILTER; CONDUCTION; PERMEATION; GRAMICIDIN; MECHANISM; TRANSPORT; DYNAMICS	In narrow pore ion channels, ions and water molecules diffuse in a single-file manner and cannot pass each other. Under such constraints, ion and water fluxes are coupled, leading to experimentally observable phenomena such as the streaming potential. Analysis of this coupled flux would provide unprecedented insights into the mechanismof permeation. In this study, ion and water permeation through the KcsA potassium channel was the focus, for which an eight-state discrete-state Markov model has been proposed based on the crystal structure, exhibiting four ion-binding sites. Random transitions on the model lead to the generation of the net flux. Here we introduced the concept of cycle flux to derive exact solutions of experimental observables from the permeation model. There are multiple cyclic paths on the model, and random transitions complete the cycles. The rate of cycle completion is called the cycle flux. The net flux is generated by a combination of cyclic paths with their own cycle flux. T.L. Hill developed a graphical method of exact solutions for the cycle flux. This method was extended to calculate one-way cycle fluxes of the KcsA channel. By assigning the stoichiometric numbers for ion and water transfer to each cycle, we established a method to calculate the water-ion coupling ratio (CRw-i) through cycle flux algebra. These calculations predicted that CRw-i would increase at low potassium concentrations. One envisions an intuitive picture of permeation as random transitions among cyclic paths, and the relative contributions of the cycle fluxes afford experimental observables.	[Oiki, Shigetoshi; Iwamoto, Masayuki; Sumikama, Takashi] Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 910, Japan	University of Fukui	Oiki, S (corresponding author), Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 910, Japan.	oiki-fki@umin.ac.jp	Sumikama, Takashi/I-6527-2019	Sumikama, Takashi/0000-0003-3696-5720; Oiki, Shigetoshi/0000-0002-8438-6750; Iwamoto, Masayuki/0000-0001-9505-2652				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; ANDERSEN OS, 1989, METHOD ENZYMOL, V171, P62; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g; Domene C, 2008, J AM CHEM SOC, V130, P3389, DOI 10.1021/ja075164v; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Finkelstein A., 1987, WATER MOVEMENT LIPID; Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106; Heckmann K, 1972, Biomembranes, V3, P127; HILL TL, 1988, P NATL ACAD SCI USA, V85, P2879, DOI 10.1073/pnas.85.9.2879; HILL TL, 1975, P NATL ACAD SCI USA, V72, P1291, DOI 10.1073/pnas.72.4.1291; Hill TL, 2004, FREE ENERGY TRANSDUC; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HLADKY SB, 1984, CURR TOP MEMBR TRANS, V21, P327; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Ismailov II, 1997, P NATL ACAD SCI USA, V94, P7651, DOI 10.1073/pnas.94.14.7651; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Katchalsky A., 1965, NONEQUILIBRIUM THERM; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; LEVITT DG, 1978, BIOCHIM BIOPHYS ACTA, V512, P436, DOI 10.1016/0005-2736(78)90266-3; MILLER C, 1982, BIOPHYS J, V38, P227, DOI 10.1016/S0006-3495(82)84552-9; Miller C, 1999, J GEN PHYSIOL, V113, P783, DOI 10.1085/jgp.113.6.783; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Oiki S, 2010, J GEN PHYSIOL, V136, P363, DOI 10.1085/jgp.201010504; ROSENBERG PA, 1978, J GEN PHYSIOL, V72, P327, DOI 10.1085/jgp.72.3.327; SCHULZ SG, 1980, BASIC PRINCIPLES MEM; Skiena S, 1990, IMPLEMENTING DISCRET; Sumikama T, 2006, J PHYS CHEM B, V110, P20671, DOI 10.1021/jp062547r; Swope WC, 2004, J PHYS CHEM B, V108, P6582, DOI 10.1021/jp037422q; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16578	10.1371/journal.pone.0016578	http://dx.doi.org/10.1371/journal.pone.0016578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304994	gold, Green Published, Green Submitted			2022-12-27	WOS:000286834300090
J	Hua, ZH; Zou, C; Shiu, SH; Vierstra, RD				Hua, Zhihua; Zou, Cheng; Shiu, Shin-Han; Vierstra, Richard D.			Phylogenetic Comparison of F-Box (FBX) Gene Superfamily within the Plant Kingdom Reveals Divergent Evolutionary Histories Indicative of Genomic Drift	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; LINEAGE-SPECIFIC EXPANSION; UBIQUITIN-LIGASE; ARABIDOPSIS-THALIANA; MAXIMUM-LIKELIHOOD; LARGE-SCALE; PROTEIN; FAMILY; COMPLEX; DUPLICATION	The emergence of multigene families has been hypothesized as a major contributor to the evolution of complex traits and speciation. To help understand how such multigene families arose and diverged during plant evolution, we examined the phylogenetic relationships of F-Box (FBX) genes, one of the largest and most polymorphic superfamilies known in the plant kingdom. FBX proteins comprise the target recognition subunit of SCF-type ubiquitin-protein ligases, where they individually recruit specific substrates for ubiquitylation. Through the extensive analysis of 10,811 FBX loci from 18 plant species, ranging from the alga Chlamydomonas reinhardtii to numerous monocots and eudicots, we discovered strikingly diverse evolutionary histories. The number of FBX loci varies widely and appears independent of the growth habit and life cycle of land plants, with a little as 198 predicted for Carica papaya to as many as 1350 predicted for Arabidopsis lyrata. This number differs substantially even among closely related species, with evidence for extensive gains/losses. Despite this extraordinary inter-species variation, one subset of FBX genes was conserved among most species examined. Together with evidence of strong purifying selection and expression, the ligases synthesized from these conserved loci likely direct essential ubiquitylation events. Another subset was much more lineage specific, showed more relaxed purifying selection, and was enriched in loci with little or no evidence of expression, suggesting that they either control more limited, species-specific processes or arose from genomic drift and thus may provide reservoirs for evolutionary innovation. Numerous FBX loci were also predicted to be pseudogenes with their numbers tightly correlated with the total number of FBX genes in each species. Taken together, it appears that the FBX superfamily has independently undergone substantial birth/death in many plant lineages, with its size and rapid evolution potentially reflecting a central role for ubiquitylation in driving plant fitness.	[Hua, Zhihua; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Zou, Cheng; Shiu, Shin-Han] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	University of Wisconsin System; University of Wisconsin Madison; Michigan State University	Hua, ZH (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	vierstra@wisc.edu	Shiu, Shin-Han/R-6117-2016; Hua, Zhihua/AAD-1146-2021; Hua, Zhihua/B-8835-2012	Shiu, Shin-Han/0000-0001-6470-235X; zou, cheng/0000-0001-9325-9465	National Science Foundation [MCB-0115870]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Arabidopsis 2010 Program (MCB-0115870) to R.D.V and S.-H. Shiu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; HUA Z, 2011, ANN REV PLA IN PRESS; Hua ZH, 2007, PLANT CELL, V19, P3593, DOI 10.1105/tpc.107.055426; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kong HZ, 2004, MOL BIOL EVOL, V21, P117, DOI 10.1093/molbev/msh001; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li W.-H., 1983, P14; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thibaud-Nissen F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-317; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; van Dongen S.M., 2000, GRAPH CLUSTERING FLO, P169; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zou C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000581; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	66	90	98	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16219	10.1371/journal.pone.0016219	http://dx.doi.org/10.1371/journal.pone.0016219			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297981	Green Published, gold, Green Submitted			2022-12-27	WOS:000286664100015
J	Mahmud, SM; Franco, EL; Turner, D; Platt, RW; Beck, P; Skarsgard, D; Tonita, J; Sharpe, C; Aprikian, AG				Mahmud, Salaheddin M.; Franco, Eduardo L.; Turner, Donna; Platt, Robert W.; Beck, Patricia; Skarsgard, David; Tonita, Jon; Sharpe, Colin; Aprikian, Armen G.			Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study	PLOS ONE			English	Article							ASPIRIN USE; BREAST-CANCER; CYCLOOXYGENASE-2; SASKATCHEWAN; PREVENTION; COHORT; INHIBITION; AGENTS	Background: Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) could prevent prostate cancer, epidemiological studies have so far reported conflicting results. Most studies were limited by lack of information on dosage and duration of use of the different classes of NSAIDs. Methods: We conducted a nested case-control study using data from Saskatchewan Prescription Drug Plan (SPDP) and Cancer Registry to examine the effects of dose and duration of use of five classes of NSAIDs on prostate cancer risk. Cases (N = 9,007) were men aged >= 40 years diagnosed with prostatic carcinoma between 1985 and 2000, and were matched to four controls on age and duration of SPDP membership. Detailed histories of exposure to prescription NSAIDs and other drugs were obtained from the SPDP. Results: Any use of propionates (e. g., ibuprofen, naproxen) was associated with a modest reduction in prostate cancer risk (Odds ratio = 0.90; 95% CI 0.84-0.95), whereas use of other NSAIDs was not. In particular, we did not observe the hypothesized inverse association with aspirin use (1.01; 0.95-1.07). There was no clear evidence of dose-response or duration-response relationships for any of the examined NSAID classes. Conclusions: Our findings suggest modest benefits of at least some NSAIDs in reducing prostate cancer risk.	[Mahmud, Salaheddin M.; Franco, Eduardo L.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Mahmud, Salaheddin M.; Aprikian, Armen G.] McGill Univ, Dept Urol Surg, Montreal, PQ, Canada; [Mahmud, Salaheddin M.; Turner, Donna] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Franco, Eduardo L.; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Beck, Patricia] Saskatchewan Minist Hlth, Populat Hlth Branch, Regina, SK, Canada; [Skarsgard, David] Univ Calgary, Div Radiat Oncol, Calgary, AB, Canada; [Skarsgard, David] Tom Baker Canc Clin, Calgary, AB, Canada; [Tonita, Jon] Saskatchewan Canc Agcy, Populat Hlth Div, Regina, SK, Canada	McGill University; McGill University; University of Manitoba; McGill University; University of Calgary; Tom Baker Cancer Clinic; University of Calgary	Mahmud, SM (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.	Salah.mahmud@gmail.com	; Franco, Eduardo/C-6445-2014	Platt, Robert/0000-0002-5981-8443; Franco, Eduardo/0000-0002-4409-8084; Mahmud, Salaheddin/0000-0002-6574-0574	United States Department of Defense [W81XWH-04-1-0175]; CancerCare Manitoba Foundation; FRSQ	United States Department of Defense(United States Department of Defense); CancerCare Manitoba Foundation; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by the United States Department of Defense Prostate Cancer Research Program [W81XWH-04-1-0175]. SMM is the recipient of the Mona and Allen Copp Award from the CancerCare Manitoba Foundation. RWP is a chercheur-boursier of the Fonds de Recherche en Sante du Quebec (FRSQ) and is a member of the Research Institute of the McGill University Health Centre, which is supported in part by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosetti C, 2006, EUR J CANCER PREV, V15, P43, DOI 10.1097/01.cej.0000180665.04335.de; CHAUDRY AA, 1994, INT J CANCER, V57, P176, DOI 10.1002/ijc.2910570208; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Downey W, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P295; Frolich JC, 1997, TRENDS PHARMACOL SCI, V18, P30, DOI 10.1016/S0165-6147(96)01017-6; Godley PA, 1999, J CLIN EPIDEMIOL, V52, P129, DOI 10.1016/S0895-4356(98)00152-8; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Habel LA, 2002, CANCER CAUSE CONTROL, V13, P427, DOI 10.1023/A:1015788502099; Harris RE, 2005, ONCOL REP, V13, P559; Hsu AL, 2000, J BIOL CHEM, V275, P11397, DOI 10.1074/jbc.275.15.11397; Irani J, 2002, J UROLOGY, V168, P1985, DOI 10.1016/S0022-5347(05)64277-2; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Jafari S, 2009, CUAJ-CAN UROL ASSOC, V3, P323; Khuder SA, 2001, BRIT J CANCER, V84, P1188, DOI 10.1054/bjoc.2000.1709; Kirschenbaum A, 2001, UROLOGY, V58, P127, DOI 10.1016/S0090-4295(01)01255-9; Leitzmann MF, 2002, CANCER EPIDEM BIOMAR, V11, P1108; Lipworth Loren, 2004, Am J Ther, V11, P156, DOI 10.1097/00045391-200405000-00002; Lix L, 2006, DEFINING VALIDATING; MACLURE M, 1992, AM J EPIDEMIOL, V135, P96; Mahmud S, 2004, BRIT J CANCER, V90, P93, DOI 10.1038/sj.bjc.6601416; Mahmud SM, 2010, INT J CANCER, V127, P1680, DOI 10.1002/ijc.25186; Mahmud SM, 2006, EUR J CANCER PREV, V15, P158, DOI 10.1097/01.cej.0000197451.02604.25; Mahmud SM, 2007, INT J CANC PREV, V3, P39; Narayanan BA, 2006, MOL CANCER THER, V5, P1117, DOI 10.1158/1535-7163.MCT-05-0520; Norrish AE, 1998, INT J CANCER, V77, P511; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; Perron L, 2003, INT J CANCER, V106, P409, DOI 10.1002/ijc.11250; Platz EA, 2007, CANCER EPIDEM BIOMAR, V16, P2175, DOI 10.1158/1055-9965.EPI-07-0777; RISCH HA, 1994, AM J EPIDEMIOL, V139, P670, DOI 10.1093/oxfordjournals.aje.a117057; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Rothman K., 1998, MODERN EPIDEMIOLOGY; ROTHMAN KJ, 1981, AM J EPIDEMIOL, V114, P253, DOI 10.1093/oxfordjournals.aje.a113189; Sabichi AL, 2004, SEMIN ONCOL, V31, P36, DOI 10.1053/j.seminoncol.2004.03.044; Salas M, 1999, AM J EPIDEMIOL, V149, P981; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Skarsgard D, 2000, CANCER CAUSE CONTROL, V11, P79, DOI 10.1023/A:1008965617078; *STAT CAN, 2008, AB POP PROF; Stock DC, 2008, PROSTATE, V68, P1655, DOI 10.1002/pros.20834; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; TONITA JM, 2008, CHANGES CASE MIX TRE; Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wechter WJ, 2000, CANCER RES, V60, P2203; Weiss NS, 2003, AM J EPIDEMIOL, V157, P957, DOI 10.1093/aje/kwg062; *WHO COLL CTR DRUG, 2002, ATC IND DDDS	47	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16412	10.1371/journal.pone.0016412	http://dx.doi.org/10.1371/journal.pone.0016412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297996	Green Submitted, Green Published, gold			2022-12-27	WOS:000286664100030
J	Chaparro-Garcia, A; Wilkinson, RC; Gimenez-Ibanez, S; Findlay, K; Coffey, MD; Zipfel, C; Rathjen, JP; Kamoun, S; Schornack, S				Chaparro-Garcia, Angela; Wilkinson, Rachael C.; Gimenez-Ibanez, Selena; Findlay, Kim; Coffey, Michael D.; Zipfel, Cyril; Rathjen, John P.; Kamoun, Sophien; Schornack, Sebastian			The Receptor-Like Kinase SERK3/BAK1 Is Required for Basal Resistance against the Late Blight Pathogen Phytophthora infestans in Nicotiana benthamiana	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; INF1-INDUCED CELL-DEATH; INNATE IMMUNITY; EFFECTOR AVR3A; PLANT IMMUNITY; ELICITOR PROTEIN; GENE; ARABIDOPSIS; ACTIVATION; TOMATO	Background: The filamentous oomycete plant pathogen Phytophthora infestans causes late blight, an economically important disease, on members of the nightshade family (Solanaceae), such as the crop plants potato and tomato. The related plant Nicotiana benthamiana is a model system to study plant-pathogen interactions, and the susceptibility of N. benthamiana to Phytophthora species varies from susceptible to resistant. Little is known about the extent to which plant basal immunity, mediated by membrane receptors that recognise conserved pathogen-associated molecular patterns (PAMPs), contributes to P. infestans resistance. Principal Findings: We found that different species of Phytophthora have varying degrees of virulence on N. benthamiana ranging from avirulence (incompatible interaction) to moderate virulence through to full aggressiveness. The leucine-rich repeat receptor-like kinase (LRR-RLK) BAK1/SERK3 is a major modulator of PAMP-triggered immunity (PTI) in Arabidopsis thaliana and N. benthamiana. We cloned two NbSerk3 homologs, NbSerk3A and NbSerk3B, from N. benthamiana based on sequence similarity to the A. thaliana gene. N. benthamiana plants silenced for NbSerk3 showed markedly enhanced susceptibility to P. infestans infection but were not altered in resistance to Phytophthora mirabilis, a sister species of P. infestans that specializes on a different host plant. Furthermore, silencing of NbSerk3 reduced the cell death response triggered by the INF1, a secreted P. infestans protein with features of PAMPs. Conclusions/Significance: We demonstrated that N. benthamiana NbSERK3 significantly contributes to resistance to P. infestans and regulates the immune responses triggered by the P. infestans PAMP protein INF1. In the future, the identification of novel surface receptors that associate with NbSERK3A and/or NbSERK3B should lead to the identification of new receptors that mediate recognition of oomycete PAMPs, such as INF1.	[Chaparro-Garcia, Angela; Wilkinson, Rachael C.; Gimenez-Ibanez, Selena; Zipfel, Cyril; Rathjen, John P.; Kamoun, Sophien; Schornack, Sebastian] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England; [Coffey, Michael D.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California Riverside	Chaparro-Garcia, A (corresponding author), John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England.	sophien.kamoun@tsl.ac.uk; sebastian.schornack@tsl.ac.uk	ZIPFEL, CYRIL B/D-7103-2011; Schornack, Sebastian/AAE-4897-2020; Kamoun, Sophien/B-3529-2009; Schornack, Sebastian/A-3650-2011; ZIPFEL, CYRIL/ABD-5076-2021; rathjen, john p/C-9327-2009; Gimenez-Ibanez, Selena/B-1172-2017	ZIPFEL, CYRIL B/0000-0003-4935-8583; Schornack, Sebastian/0000-0002-7836-5881; Kamoun, Sophien/0000-0002-0290-0315; Schornack, Sebastian/0000-0002-7836-5881; ZIPFEL, CYRIL/0000-0003-4935-8583; rathjen, john p/0000-0003-4073-8088; Gimenez-Ibanez, Selena/0000-0002-5453-8565; Findlay, Kim/0000-0002-1556-0532; Wilkinson, Rachael/0000-0002-0749-108X	Gatsby Charitable Foundation; BBSRC; Nuffield Foundation; German Research Foundation (DFG);  [SCHO1347/1-1]	Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nuffield Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); 	This work was supported by the Gatsby Charitable Foundation, BBSRC, Nuffield Foundation and the German Research Foundation (DFG). SS was supported by a personal research fellowship (SCHO1347/1-1). JPR is an Australian Research Council Future Fellow (FT0992129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; BAR M, 2010, PLANT J; Becktell MC, 2006, PLANT DIS, V90, P24, DOI 10.1094/PD-90-0024; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bos JIB, 2009, MOL PLANT MICROBE IN, V22, P269, DOI 10.1094/MPMI-22-3-0269; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; KAMOUN S, 1993, MOL PLANT MICROBE IN, V6, P573, DOI 10.1094/MPMI-6-573; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P1028, DOI 10.1094/MPMI.1997.10.8.1028; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; Kanzaki H, 2008, PLANTA, V228, P977, DOI 10.1007/s00425-008-0797-y; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Peart JR, 2002, PLANT J, V29, P569, DOI 10.1046/j.1365-313X.2002.029005569.x; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; SCHORNACK S, 2010, P NATL ACAD SCI US; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Tanaka S, 2009, PLANT CELL, V21, P2517, DOI 10.1105/tpc.109.068023; Torres GA, 2010, PLANT DIS, V94, P1163, DOI 10.1094/PDIS-94-9-1163A; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van West P, 1998, FUNGAL GENET BIOL, V23, P126, DOI 10.1006/fgbi.1998.1036; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; WELLS B, 1985, MICRON MICROSC ACTA, V16, P49, DOI 10.1016/0739-6260(85)90031-0; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	48	123	130	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16608	10.1371/journal.pone.0016608	http://dx.doi.org/10.1371/journal.pone.0016608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304602	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900080
J	Filenko, NA; Kolar, C; West, JT; Smith, SA; Hassan, YI; Borgstahl, GEO; Zempleni, J; Lyubchenko, YL				Filenko, Nina A.; Kolar, Carol; West, John T.; Smith, S. Abbie; Hassan, Yousef I.; Borgstahl, Gloria E. O.; Zempleni, Janos; Lyubchenko, Yuri L.			The Role of Histone H4 Biotinylation in the Structure of Nucleosomes	PLOS ONE			English	Article							PROTEIN-DNA COMPLEXES; HOLOCARBOXYLASE SYNTHETASE; DROSOPHILA-MELANOGASTER; RECOMBINANT HISTONES; ENERGY-TRANSFER; CORE PARTICLE; BIOTIN; CELLS; TRANSCRIPTION; ACETYLATION	Background: Post-translational modifications of histones play important roles in regulating nucleosome structure and gene transcription. It has been shown that biotinylation of histone H4 at lysine-12 in histone H4 (K12Bio-H4) is associated with repression of a number of genes. We hypothesized that biotinylation modifies the physical structure of nucleosomes, and that biotin-induced conformational changes contribute to gene silencing associated with histone biotinylation. Methodology/Principal Findings: To test this hypothesis we used atomic force microscopy to directly analyze structures of nucleosomes formed with biotin-modified and non-modified H4. The analysis of the AFM images revealed a 13% increase in the length of DNA wrapped around the histone core in nucleosomes with biotinylated H4. This statistically significant (p<0.001) difference between native and biotinylated nucleosomes corresponds to adding approximately 20 bp to the classical 147 bp length of nucleosomal DNA. Conclusions/Significance: The increase in nucleosomal DNA length is predicted to stabilize the association of DNA with histones and therefore to prevent nucleosomes from unwrapping. This provides a mechanistic explanation for the gene silencing associated with K12Bio-H4. The proposed single-molecule AFM approach will be instrumental for studying the effects of various epigenetic modifications of nucleosomes, in addition to biotinylation.	[Filenko, Nina A.; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Kolar, Carol; Borgstahl, Gloria E. O.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Hassan, Yousef I.; Zempleni, Janos] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA; [West, John T.; Smith, S. Abbie] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Oklahoma System; University of Oklahoma Health Sciences Center	Filenko, NA (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu	Borgstahl, Gloria/AAZ-4114-2020		National Science Foundation [EPS-0701892]; Nebraska Research Initiative; University of Nebraska Agricultural Research Division; National Institutes of Health [DK063945, DK077816, DK082476]; National Cancer Institute Eppley Cancer Center Support Grant [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082476, R01DK063945, R01DK077816] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Nebraska Research Initiative; University of Nebraska Agricultural Research Division; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Eppley Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Science Foundation-Experimental Program to Stimulate Competitive Research EPS-0701892. Additional support was provided by Nebraska Research Initiative (to YLL), the University of Nebraska Agricultural Research Division (Hatch Act), and National Institutes of Health grants DK063945, DK077816, and DK082476 (all to JZ) and National Cancer Institute Eppley Cancer Center Support Grant [P30CA036727] (to GEOB and YLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao B, J NUTR BIOCH; Bussiek M, 2006, BIOCHEMISTRY-US, V45, P10838, DOI 10.1021/bi060807p; Camporeale G, 2004, EUR J BIOCHEM, V271, P2257, DOI 10.1111/j.1432-1033.2004.04167.x; Camporeale G, 2007, J NUTR BIOCHEM, V18, P760, DOI 10.1016/j.jnutbio.2006.12.014; Camporeale G, 2006, J NUTR, V136, P2735, DOI 10.1093/jn/136.11.2735; Chew YC, 2008, J NUTR, V138, P2316, DOI 10.3945/jn.108.098673; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; Ghosh, 2009, THESIS U NEBRASKA LI; Gralla M, 2008, J NUTR BIOCHEM, V19, P400, DOI 10.1016/j.jnutbio.2007.06.002; HYMES J, 1995, BIOCHEM MOL MED, V56, P76, DOI 10.1006/bmme.1995.1059; Kobza K, 2005, FEBS J, V272, P4249, DOI 10.1111/j.1742-4658.2005.04839.x; Kobza K, 2008, BMB REP, V41, P310, DOI 10.5483/BMBRep.2008.41.4.310; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Osley MA, 2006, RES PRO CEL, V41, P47, DOI 10.1007/006; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Shlyakhtenko LS, 2009, BIOCHEMISTRY-US, V48, P7842, DOI 10.1021/bi900977t; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stanley JS, 2001, EUR J BIOCHEM, V268, P5424, DOI 10.1046/j.0014-2956.2001.02481.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki Y, 2010, ULTRAMICROSCOPY, V110, P682, DOI 10.1016/j.ultramic.2010.02.032; Takechi R, 2008, J NUTR, V138, P680, DOI 10.1093/jn/138.4.680; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Toth K, 2006, BIOCHEMISTRY-US, V45, P1591, DOI 10.1021/bi052110u; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Wijeratne SSK, 2010, J NUTR BIOCHEM, V21, P310, DOI 10.1016/j.jnutbio.2009.01.010; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	34	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16299	10.1371/journal.pone.0016299	http://dx.doi.org/10.1371/journal.pone.0016299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298003	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900030
J	Paixao-Cortes, VR; Meyer, D; Pereira, TV; Mazieres, S; Elion, J; Krishnamoorthy, R; Zago, MA; Silva, WA; Salzano, FM; Bortolini, MC				Paixao-Cortes, Vanessa R.; Meyer, Diogo; Pereira, Tiago V.; Mazieres, Stephane; Elion, Jacques; Krishnamoorthy, Rajagopal; Zago, Marco A.; Silva, Wilson A., Jr.; Salzano, Francisco M.; Bortolini, Maria Catira			Genetic Variation among Major Human Geographic Groups Supports a Peculiar Evolutionary Trend in PAX9	PLOS ONE			English	Article							POSITIVE SELECTION; NATURAL-SELECTION; POPULATION DIFFERENTIATION; MUTATION; POLYMORPHISM; REVEALS; HISTORY; MODELS; MOLAR	A total of 172 persons from nine South Amerindian, three African and one Eskimo populations were studied in relation to the Paired box gene 9 (PAX9) exon 3 (138 base pairs) as well as its 5' and 3' flanking intronic segments (232 bp and 220 bp, respectively) and integrated with the information available for the same genetic region from individuals of different geographical origins. Nine mutations were scored in exon 3 and six in its flanking regions; four of them are new South American tribe-specific singletons. Exon3 nucleotide diversity is several orders of magnitude higher than its intronic regions. Additionally, a set of variants in the PAX9 and 101 other genes related with dentition can define at least some dental morphological differences between Sub-Saharan Africans and non-Africans, probably associated with adaptations after the modern human exodus from Africa. Exon 3 of PAX9 could be a good molecular example of how evolvability works.	[Paixao-Cortes, Vanessa R.; Salzano, Francisco M.; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Meyer, Diogo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Pereira, Tiago V.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Mazieres, Stephane] CNRS, Lab Anthropobiol, FRE2960, Toulouse, France; [Mazieres, Stephane] Fac Med, CS80011, Marseille, France; [Elion, Jacques; Krishnamoorthy, Rajagopal] Univ Paris Diderot, Hop Robert Debre, Insern, UMR 763, Paris, France; [Zago, Marco A.] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, Brazil; [Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Universidade de Sao Paulo	Paixao-Cortes, VR (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	maria.bortolini@ufrgs.br	Silva Jr, Wilson Araújo/E-9487-2011; Paixão-Côrtes, Vanessa R/H-3564-2011; Mazières, Stéphane/R-2061-2019; ZAGO, MARCO A/E-9442-2017; Elion, Jacques/A-1048-2014; Salzano, Francisco M/L-7916-2015; Meyer, Diogo/A-1868-2008; Mazieres, Stephane/G-1702-2010	Silva Jr, Wilson Araújo/0000-0001-9364-2886; Paixão-Côrtes, Vanessa R/0000-0003-2677-0903; Elion, Jacques/0000-0002-8407-1783; Mazieres, Stephane/0000-0003-1266-4659	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Institutos do Milenio and Programa de Apoio a Nucleos de Excelencia Programs; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul; Inserm-FAPESP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institutos do Milenio and Programa de Apoio a Nucleos de Excelencia Programs; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Inserm-FAPESP	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Institutos do Milenio and Programa de Apoio a Nucleos de Excelencia Programs, Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, and Inserm-FAPESP 2010-2011 Joint Projects Agreement, Brazil and France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Alonso S, 2001, P NATL ACAD SCI USA, V98, P864, DOI 10.1073/pnas.011244998; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CHAGULA WK, 1960, AM J PHYS ANTHROPOL, V18, P77, DOI 10.1002/ajpa.1330180202; Cheng F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-221; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; FU YX, 1993, GENETICS, V133, P693; Gomez-Valdes J, 2005, THESIS ESCUELA NACL; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Harris EE, 2006, YEARB PHYS ANTHROPOL, V49, P89, DOI 10.1002/ajpa.20518; Haydenblit R, 1996, AM J PHYS ANTHROPOL, V100, P225; Hetzer-Egger C, 2000, BBA-GENE STRUCT EXPR, V1492, P517, DOI 10.1016/S0167-4781(00)00130-5; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; Hughes DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001686; IRISH JD, 1993, THESIS ARIZONA STATE; Kula Katherine, 2008, World J Orthod, V9, pe55; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Paixao-Cortes VR, 2010, ARCH ORAL B IN PRESS; Pan YC, 2008, EUR J ORAL SCI, V116, P98, DOI 10.1111/j.1600-0722.2007.00517.x; Pereira TV, 2006, P NATL ACAD SCI USA, V103, P5676, DOI 10.1073/pnas.0509562103; Peters H, 1998, EUR J ORAL SCI, V106, P38, DOI 10.1111/j.1600-0722.1998.tb02151.x; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; ROGERS J, 1995, AM J PHYS ANTHROPOL, V98, P216, DOI 10.1002/ajpa.1330980212; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozkovcova E, 2004, Prague Med Rep, V105, P391; Rozkovcova E, 2004, Prague Med Rep, V105, P35; Rozkovcova E, 1999, Sb Lek, V100, P71; Santagati F, 2003, GENETICS, V165, P235; Santos-Lopes SS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000557; Silvestri AR, 2003, J AM DENT ASSOC, V134, P450, DOI 10.14219/jada.archive.2003.0194; Stelzer G, 2009, OMICS, V13, P477, DOI 10.1089/omi.2009.0069; Sutter R, 2005, ANDEAN, V7; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TRIMMELL JB, 2004, THESIS U MISSOURI KA; TURNER CG, 1987, AM J PHYS ANTHROPOL, V73, P305, DOI 10.1002/ajpa.1330730304; TURNER CG, 1986, NATL GEOGR RES, V2, P37; TURNER CG, 1981, SCIENCE, V212, P1053, DOI 10.1126/science.7015507; Urban G., 1998, HIST INDIOS BRASIL, P87; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wooding S, 2004, HUM GENET, V115, P221, DOI 10.1007/s00439-004-1130-x; Wu DD, 2010, HUM MOL GENET, V19, P2341, DOI 10.1093/hmg/ddq107; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yang ZH, 2000, GENETICS, V155, P431	56	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15656	10.1371/journal.pone.0015656	http://dx.doi.org/10.1371/journal.pone.0015656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JV	21298044	Green Published, gold, Green Submitted			2022-12-27	WOS:000286663900016
J	Beisner, BA; Jackson, ME; Cameron, AN; McCowan, B				Beisner, Brianne A.; Jackson, Megan E.; Cameron, Ashley N.; McCowan, Brenda			Detecting Instability in Animal Social Networks: Genetic Fragmentation Is Associated with Social Instability in Rhesus Macaques	PLOS ONE			English	Article							MATRILINEAL OVERTHROWS; KIN BIAS; RANK; AGGRESSION; BEHAVIOR; ROBUSTNESS; MECHANISMS; EVOLUTION; MONKEYS; KINSHIP	The persistence of biological systems requires evolved mechanisms which promote stability. Cohesive primate social groups are one example of stable biological systems, which persist in spite of regular conflict. We suggest that genetic relatedness and its associated kinship structure are a potential source of stability in primate social groups as kinship structure is an important organizing principle in many animal societies. We investigated the effect of average genetic relatedness per matrilineal family on the stability of matrilineal grooming and agonistic interactions in 48 matrilines from seven captive groups of rhesus macaques. Matrilines with low average genetic relatedness show increased family-level instability such as: more sub-grouping in their matrilineal groom network, more frequent fighting with kin, and higher rates of wounding. Family-level instability in multiple matrilines within a group is further associated with group-level instability such as increased wounding. Stability appears to arise from the presence of clear matrilineal structure in the rhesus macaque group hierarchy, which is derived from cohesion among kin in their affiliative and agonistic interactions with each other. We conclude that genetic relatedness and kinship structure are an important source of group stability in animal societies, particularly when dominance and/or affilative interactions are typically governed by kinship.	[Beisner, Brianne A.; Jackson, Megan E.; Cameron, Ashley N.; McCowan, Brenda] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Beisner, Brianne A.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [McCowan, Brenda] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis	Beisner, BA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	bab42@psu.edu			NIH [R24 RR024396, PR51 RR000169]; IACUC [11843]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR024396, P51RR000169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IACUC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by NIH grants #R24 RR024396 and #PR51 RR000169, and conducted under IACUC protocol #11843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; BEISNER BA, 2010, AM J PRIMAT IN PRESS; Berman CM, 1999, ANIM BEHAV, V58, P883, DOI 10.1006/anbe.1999.1221; BERNSTEIN IS, 1985, AM J PRIMATOL, V8, P37, DOI 10.1002/ajp.1350080105; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Borgatti S., 2002, UCINET WINDOWS SOFTW; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CHAPAIS B, 1985, Primates, V26, P407, DOI 10.1007/BF02382456; CHAPAIS B, 1988, ANIM BEHAV, V36, P1025, DOI 10.1016/S0003-3472(88)80062-9; CHAPAIS B, 1994, ANIM BEHAV, V48, P1335, DOI 10.1006/anbe.1994.1370; CHAPAIS B, 1988, BEHAVIOUR, V104, P41, DOI 10.1163/156853988X00593; Chapais Bernard, 1992, P29; CHENEY DL, 1977, BEHAV ECOL SOCIOBIOL, V2, P303, DOI 10.1007/BF00299742; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Datta S. B., 1992, P61; DAZEY J, 1977, AM J PHYS ANTHROPOL, V46, P73, DOI 10.1002/ajpa.1330460110; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DITTUS WPJ, 1988, ANIM BEHAV, V36, P1626, DOI 10.1016/S0003-3472(88)80104-0; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P273, DOI 10.1007/BF02734142; EHARDT CL, 1986, INT J PRIMATOL, V7, P157, DOI 10.1007/BF02692316; EMLEN ST, 1994, TRENDS ECOL EVOL, V9, P282, DOI 10.1016/0169-5347(94)90030-2; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; GOUZOULES H, 1980, Primates, V21, P262, DOI 10.1007/BF02374039; GOUZOULES S, 1984, YEARB PHYS ANTHROPOL, V27, P99; Gustafsson M, 2009, IET SYST BIOL, V3, P219, DOI 10.1049/iet-syb.2008.0112; Gygax L, 1997, PRIMATES, V38, P149, DOI 10.1007/BF02382005; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HORROCKS J, 1983, ANIM BEHAV, V31, P772, DOI 10.1016/S0003-3472(83)80234-6; KAPLAN JR, 1978, AM J PHYS ANTHROPOL, V49, P241, DOI 10.1002/ajpa.1330490212; Krakauer David C., 2006, P183; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; MISSAKIAN E A, 1972, Primates, V13, P169, DOI 10.1007/BF01840878; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; NEWSON R, 1999, STATA TECHN B, V50, P27; Oates-O'Brien RS, 2010, J AM ASSOC LAB ANIM, V49, P196; Packer C., 1986, P429; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; PONS P, 2005, ARXIVPHYSICS0512106V; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers WH., 1993, STATA TECHNICAL B RE, V13, P19; Rubenstein D.I., 1986, P282; Sade D.S., 1967, P99; SADE DS, 1969, AM J PHYS ANTHROPOL, V31, P261; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Thierry B, 2004, WURZBURG, P267; Voelkl B, 2009, BIOL LETTERS, V5, P462, DOI 10.1098/rsbl.2009.0204; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; Widdig A, 2006, BEHAV ECOL SOCIOBIOL, V61, P205, DOI 10.1007/s00265-006-0251-8; Wolf JBW, 2007, ANIM BEHAV, V74, P1293, DOI 10.1016/j.anbehav.2007.02.024; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	59	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16365	10.1371/journal.pone.0016365	http://dx.doi.org/10.1371/journal.pone.0016365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298105	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800031
J	Kanaly, CW; Ding, D; Mehta, AI; Waller, AF; Crocker, I; Desjardins, A; Reardon, DA; Friedman, AH; Bigner, DD; Sampson, JH				Kanaly, Charles W.; Ding, Dale; Mehta, Ankit I.; Waller, Anthony F.; Crocker, Ian; Desjardins, Annick; Reardon, David A.; Friedman, Allan H.; Bigner, Darell D.; Sampson, John H.			A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; FUNCTIONAL DIFFUSION MAP; PROGRESSION-FREE SURVIVAL; MALIGNANT GLIOMA; CONCOMITANT RADIOCHEMOTHERAPY; IMAGING BIOMARKER; SOLID TUMORS; END-POINT; PHASE-II; CRITERIA	Current radiographic response criteria for brain tumors have difficulty describing changes surrounding postoperative resection cavities. Volumetric techniques may offer improved assessment, however usually are time-consuming, subjective and require expert opinion and specialized magnetic resonance imaging (MRI) sequences. We describe the application of a novel volumetric software algorithm that is nearly fully automated and uses standard T1 pre- and post-contrast MRI sequences. T1-weighted pre- and post-contrast images are automatically fused and normalized. The tumor region of interest is grossly outlined by the user. An atlas of the nasal mucosa is automatically detected and used to normalize levels of enhancement. The volume of enhancing tumor is then automatically calculated. We tested the ability of our method to calculate enhancing tumor volume with resection cavity collapse and when the enhancing tumor is obscured by subacute blood in a resection cavity. To determine variability in results, we compared narrowly-defined tumor regions with tumor regions that include adjacent meningeal enhancement and also compared different contrast enhancement threshold levels used for the automatic calculation of enhancing tumor volume. Our method quantified enhancing tumor volume despite resection cavity collapse. It detected tumor volume increase in the midst of blood products that incorrectly caused decreased measurements by other techniques. Similar trends in volume changes across scans were seen with inclusion or exclusion of meningeal enhancement and despite different automated thresholds for tissue enhancement. Our approach appears to overcome many of the challenges with response assessment of enhancing brain tumors and warrants further examination and validation.	[Kanaly, Charles W.; Mehta, Ankit I.; Reardon, David A.; Friedman, Allan H.; Sampson, John H.] Duke Univ, Med Ctr, Div Neurosurg, Dept Surg, Durham, NC 27710 USA; [Ding, Dale] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA; [Waller, Anthony F.; Crocker, Ian] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Desjardins, Annick] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Bigner, Darell D.; Sampson, John H.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; University of Virginia; Emory University; Duke University; Duke University	Kanaly, CW (corresponding author), Duke Univ, Med Ctr, Div Neurosurg, Dept Surg, Durham, NC 27710 USA.	john.sampson@duke.edu	Ding, Dale/AAN-3583-2020	Sampson, John/0000-0002-0104-7658	National Institutes of Health [5R25-NS065731-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS065731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health Grant 5R25-NS065731-02 (A.I.M., J.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthnarayan S, 2008, J NEURO-ONCOL, V88, P339, DOI 10.1007/s11060-008-9573-x; Ballman KV, 2007, NEURO-ONCOLOGY, V9, P29, DOI 10.1215/15228517-2006-025; Brandes AA, 2008, NEURO-ONCOLOGY, V10, P361, DOI 10.1215/15228517-2008-008; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Burri RJ, 2008, INT J RADIAT ONCOL, V71, P682, DOI 10.1016/j.ijrobp.2007.10.055; Clark MC, 1998, IEEE T MED IMAGING, V17, P187, DOI 10.1109/42.700731; Clarke LP, 1998, MAGN RESON IMAGING, V16, P271, DOI 10.1016/S0730-725X(97)00302-0; de Wit MCY, 2004, NEUROLOGY, V63, P535, DOI 10.1212/01.WNL.0000133398.11870.9A; Dempsey MF, 2005, AM J NEURORADIOL, V26, P770; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Erdi YE, 1997, CANCER, V80, P2505, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.3.CO;2-B; Fischer U, 1999, RADIOLOGY, V213, P881, DOI 10.1148/radiology.213.3.r99dc01881; Fraioli F, 2006, RADIOL MED, V111, P365, DOI 10.1007/s11547-006-0035-2; Galanis E, 2006, NEURO-ONCOLOGY, V8, P156, DOI 10.1215/15228517-2005-005; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Gonzalez J, 2007, INT J RADIAT ONCOL, V67, P323, DOI 10.1016/j.ijrobp.2006.10.010; Grant R, 1997, NEUROLOGY, V48, P1336, DOI 10.1212/WNL.48.5.1336; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Hormigo A, 2007, CANCER CELL, V11, P6, DOI 10.1016/j.ccr.2006.12.008; Jaffe CC, 2006, J CLIN ONCOL, V24, P3245, DOI 10.1200/JCO.2006.06.5599; LAI R, 2010, INTERIM DATA ACT 3 P; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; Letteboer MMJ, 2004, ACAD RADIOL, V11, P1125, DOI 10.1016/j.acra.2004.05.020; Lorenzon M, 2009, EUR J RADIOL, V71, P82, DOI 10.1016/j.ejrad.2008.03.021; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Marten K, 2006, EUR RADIOL, V16, P781, DOI 10.1007/s00330-005-0036-x; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Pope WB, 2006, NEUROLOGY, V66, P1258, DOI 10.1212/01.wnl.0000208958.29600.87; Ross BD, 2003, MOL CANCER THER, V2, P581; Schwartz LH, 2000, J CLIN ONCOL, V18, P2179, DOI 10.1200/JCO.2000.18.10.2179; Shah GD, 2006, NEURO-ONCOLOGY, V8, P38, DOI 10.1215/S1522851705000529; Sohaib SA, 2000, BRIT J RADIOL, V73, P1178, DOI 10.1259/bjr.73.875.11144795; Sorensen AG, 2008, NAT CLIN PRACT ONCOL, V5, P634, DOI 10.1038/ncponc1204; Sorensen AG, 2001, J CLIN ONCOL, V19, P551, DOI 10.1200/JCO.2001.19.2.551; Suzuki C, 2008, RADIOGRAPHICS, V28, P329, DOI 10.1148/rg.282075068; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tran LN, 2004, ACAD RADIOL, V11, P1355, DOI 10.1016/j.acra.2004.09.004; van den Bent MJ, 2009, J CLIN ONCOL, V27, P2905, DOI 10.1200/JCO.2009.22.4998; Warren KE, 2001, J NATL CANCER I, V93, P1401, DOI 10.1093/jnci/93.18.1401; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	42	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16031	10.1371/journal.pone.0016031	http://dx.doi.org/10.1371/journal.pone.0016031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298088	gold, Green Published, Green Submitted			2022-12-27	WOS:000286662800015
J	Russ, PK; Pino, CJ; Williams, CS; Bader, DM; Haselton, FR; Chang, MS				Russ, Patricia K.; Pino, Christopher J.; Williams, Christopher S.; Bader, David M.; Haselton, Frederick R.; Chang, Min S.			Bves Modulates Tight Junction Associated Signaling	PLOS ONE			English	Article							CONTAINING GENE FAMILY; SKELETAL-MUSCLE; EXPRESSION; INHIBITION; INTEGRITY; INTERACTS; MOVEMENT; BARRIER; HEART; ZO-1	Blood vessel epicardial substance (Bves) is a transmembrane adhesion protein that regulates tight junction (TJ) formation in a variety of epithelia. The role of TJs within epithelium extends beyond the mechanical properties. They have been shown to play a direct role in regulation of RhoA and ZONAB/DbpA, a y-box transcription factor. We hypothesize that Bves can modulate RhoA activation and ZONAB/DbpA activity through its regulatory effect on TJ formation. Immortalized human corneal epithelial (HCE) cells were stably transfected with Flag-tagged full length chicken Bves (w-Bves) or C-terminus truncated Bves (t-Bves). We found that stably transfected w-Bves and t-Bves were interacting with endogenous human Bves. However, interaction with t-Bves appeared to disrupt cell membrane localization of endogenous Bves and interaction with ZO-1. w-Bves cells exhibited increased TJ function reflected by increased trans-epithelial electrical resistance, while t-Bves cells lost TJ protein immunolocalization at cell-cell contacts and exhibited decreased trans-epithelial electrical resistance. In parental HCE and w-Bves cells ZONAB/DbpA and GEF-H1 were seen at cell borders in the same pattern as ZO-1. However, expression of t-Bves led to decreased membrane localization of both ZONAB/DbpA and GEF-H1. t-Bves cells had increased RhoA activity, as indicated by a significant 30% increase in FRET activity compared to parental HCE cells. ZONAB/DbpA transcriptional activity, assessed using a luciferase reporter probe, was increased in t-Bves cells. These studies demonstrate that Bves expression and localization can regulate RhoA and ZONAB/DbpA activity.	[Russ, Patricia K.; Pino, Christopher J.; Haselton, Frederick R.; Chang, Min S.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Haselton, Frederick R.; Chang, Min S.] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, Nashville, TN USA; [Williams, Christopher S.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA; [Bader, David M.] Vanderbilt Univ, Dept Cardiovasc Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Russ, PK (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	patricia.k.russ@vanderbilt.edu	Williams, Christopher/W-3524-2019	Williams, Christopher/0000-0002-1541-579X; Pino, Christopher/0000-0003-4063-9215	NIH [EY 13593, EY 13451, HL 07751]; Vanderbilt University; NATIONAL EYE INSTITUTE [R01EY013451, R01EY017185] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751, R01HL079050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was sponsored in part by NIH grants EY 13593, EY 13451, HL 07751, and by a Vanderbilt University discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Andree B, 2002, MOL CELL BIOL, V22, P1504, DOI 10.1128/MCB.22.5.1504-1512.2002; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 1998, J CELL SCI, V111, P541; Brand T, 2005, CELL BIOCHEM BIOPHYS, V43, P95, DOI 10.1385/CBB:43:1:095; Chusainow J, 2005, RNA, V11, P1201, DOI 10.1261/rna.7277705; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Hager HA, 2009, HISTOL HISTOPATHOL, V24, P777, DOI 10.14670/HH-24.777; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Kavanagh E, 2006, J CELL SCI, V119, P5098, DOI 10.1242/jcs.03297; Kawaguchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002261; Knight RF, 2003, J BIOL CHEM, V278, P32872, DOI 10.1074/jbc.M301961200; Matter K, 1999, INT REV CYTOL, V186, P117; Oshima T, 2001, MICROVASC RES, V61, P130, DOI 10.1006/mvre.2000.2288; Osler ME, 2006, DEV DYNAM, V235, P586, DOI 10.1002/dvdy.20688; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Osler ME, 2004, DEV DYNAM, V229, P658, DOI 10.1002/dvdy.10490; Reese DE, 1999, MAMM GENOME, V10, P913, DOI 10.1007/s003359901113; Ripley AN, 2006, P NATL ACAD SCI USA, V103, P614, DOI 10.1073/pnas.0506095103; Ripley AN, 2004, INVEST OPHTH VIS SCI, V45, P2475, DOI 10.1167/iovs.04-0013; Russ PK, 2010, INVEST OPHTH VIS SCI, V51, P223, DOI 10.1167/iovs.09-3539; Smith TK, 2008, P NATL ACAD SCI USA, V105, P8298, DOI 10.1073/pnas.0802345105; TSAPARA A, 2010, MOL BIOL CELL; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vasavada TK, 2004, J HISTOCHEM CYTOCHEM, V52, P371, DOI 10.1177/002215540405200308; Wada AM, 2001, DEVELOPMENT, V128, P2085	29	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14563	10.1371/journal.pone.0014563	http://dx.doi.org/10.1371/journal.pone.0014563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283798	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522200006
J	Park, BS; Jin, SH; Park, JJ; Park, JW; Namgoong, IS; Kim, YI; Lee, BJ; Kim, JG				Park, Byong Seo; Jin, Sung Ho; Park, Joong Jean; Park, Jeong Woo; Namgoong, Il Seong; Kim, Young Il; Lee, Byung Ju; Kim, Jae Geun			Visfatin Induces Sickness Responses in the Brain	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; INSULIN-RESISTANCE; INFLAMMATION; ANOREXIA; BEHAVIOR; OBESITY; ADIPOCYTOKINE; HYPOTHALAMUS; MECHANISMS; APPETITE	Background/Objective: Visfatin, also known as nicotiamide phosphoribosyltransferase or pre-B cell colony enhancing factor, is a pro-inflammatory cytokine whose serum level is increased in sepsis and cancer as well as in obesity. Here we report a pro-inflammatory role of visfatin in the brain, to mediate sickness responses including anorexia, hyperthermia and hypoactivity. Methodology: Rats were intracerebroventricularly (ICV) injected with visfatin, and changes in food intake, body weight, body temperature and locomotor activity were monitored. Real-time PCR was applied to determine the expressions of proinflammatory cytokines, proopiomelanocortin (POMC) and prostaglandin-synthesizing enzymes in their brain. To determine the roles of cyclooxygenase (COX) and melanocortin in the visfatin action, rats were ICV-injected with visfatin with or without SHU9119, a melanocortin receptor antagonist, or indomethacin, a COX inhibitor, and their sickness behaviors were evaluated. Principal Findings: Administration of visfatin decreased food intake, body weight and locomotor activity and increased body temperature. Visfatin evoked significant increases in the levels of pro-inflammatory cytokines, prostaglandin-synthesizing enzymes and POMC, an anorexigenic neuropeptide. Indomethacin attenuated the effects of visfatin on hyperthermia and hypoactivity, but not anorexia. Further, SHU9119 blocked visfatin-induced anorexia but did not affect hyperthermia or hypoactivity. Conclusions: Visfatin induced sickness responses via regulation of COX and the melanocortin pathway in the brain.	[Park, Byong Seo; Jin, Sung Ho; Park, Jeong Woo; Lee, Byung Ju; Kim, Jae Geun] Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea; [Park, Jeong Woo; Lee, Byung Ju; Kim, Jae Geun] Univ Ulsan, Biomed Res Ctr, Coll Med, Ulsan 680749, South Korea; [Park, Joong Jean] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Namgoong, Il Seong; Kim, Young Il] Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea	University of Ulsan; University of Ulsan; Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Ulsan University Hospital	Park, BS (corresponding author), Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea.	bjlee@ulsan.ac.kr; jg-kim@mail.ulsan.ac.kr		NAM-GOONG, IL SEONG/0000-0002-0492-0467; Park, Byong Seo/0000-0001-6463-9645; Park, Joong-Jean/0000-0002-4534-3002	National Research Foundation (NRF) of Korea [BRL 2009-0087350]; Brain Research Center [2009K001268]; Ministry of Education, Science and Technology (MEST) [2009-0076067]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Brain Research Center; Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	B.J.L. was supported by the National Research Foundation (NRF) of Korea Grant (BRL 2009-0087350) and by Research Grant (2009K001268) from the Brain Research Center of the 21st Century Frontier Research Program. J.G.K. was supported by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science and Technology (MEST; 2009-0076067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2007, BRAIN BEHAV IMMUN, V21, P147, DOI 10.1016/j.bbi.2006.08.002; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Carrero JJ, 2010, NEPHROL DIAL TRANSPL, V25, P901, DOI 10.1093/ndt/gfp587; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Johnson PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE650, DOI 10.1152/ajpendo.00388.2001; Kim JG, 2006, BIOCHEM BIOPH RES CO, V349, P969, DOI 10.1016/j.bbrc.2006.08.147; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Laviano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1000, DOI 10.1152/ajpendo.90252.2008; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Mercader J, 2008, HORM METAB RES, V40, P467, DOI 10.1055/s-2008-1065324; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Oki K, 2007, CLIN ENDOCRINOL, V67, P796, DOI 10.1111/j.1365-2265.2007.02966.x; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P3165, DOI 10.1210/jc.2006-0361; Pecchi E, 2009, PHYSIOL BEHAV, V97, P279, DOI 10.1016/j.physbeh.2009.02.040; Reyes TM, 2002, J NEUROSCI, V22, P5091, DOI 10.1523/JNEUROSCI.22-12-05091.2002; Rorato R, 2009, EXP PHYSIOL, V94, P371, DOI 10.1113/expphysiol.2008.045435; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Shimizu H, 2007, J ENDOCRINOL, V193, P1, DOI 10.1677/JOE-06-0144; Skinner GW, 2009, PHYSIOL BEHAV, V96, P421, DOI 10.1016/j.physbeh.2008.11.004; Sun G, 2007, AM J CLIN NUTR, V85, P399, DOI 10.1093/ajcn/85.2.399; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002	29	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15981	10.1371/journal.pone.0015981	http://dx.doi.org/10.1371/journal.pone.0015981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283791	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200020
J	Bai, XD; Mamidala, P; Rajarapu, SP; Jones, SC; Mittapalli, O				Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna P.; Jones, Susan C.; Mittapalli, Omprakash			Transcriptomics of the Bed Bug (Cimex lectularius)	PLOS ONE			English	Article							ARTHROPOD CUTICULAR PROTEINS; EXPRESSED SEQUENCE TAGS; PUBLIC-HEALTH PROBLEM; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; HEMIPTERA-CIMICIDAE; WOLBACHIA; GENES; EVOLUTION; DATABASE	Background: Bed bugs (Cimex lectularius) are blood-feeding insects poised to become one of the major pests in households throughout the United States. Resistance of C. lectularius to insecticides/pesticides is one factor thought to be involved in its sudden resurgence. Despite its high-impact status, scant knowledge exists at the genomic level for C. lectularius. Hence, we subjected the C. lectularius transcriptome to 454 pyrosequencing in order to identify potential genes involved in pesticide resistance. Methodology and Principal Findings: Using 454 pyrosequencing, we obtained a total of 216,419 reads with 79,596,412 bp, which were assembled into 35,646 expressed sequence tags (3902 contigs and 31744 singletons). Nearly 85.9% of the C. lectularius sequences showed similarity to insect sequences, but 44.8% of the deduced proteins of C. lectularius did not show similarity with sequences in the GenBank non-redundant database. KEGG analysis revealed putative members of several detoxification pathways involved in pesticide resistance. Lamprin domains, Protein Kinase domains, Protein Tyrosine Kinase domains and cytochrome P450 domains were among the top Pfam domains predicted for the C. lectularius sequences. An initial assessment of putative defense genes, including a cytochrome P450 and a glutathione-S-transferase (GST), revealed high transcript levels for the cytochrome P450 (CYP9) in pesticide-exposed versus pesticide-susceptible C. lectularius populations. A significant number of single nucleotide polymorphisms (296) and microsatellite loci (370) were predicted in the C. lectularius sequences. Furthermore, 59 putative sequences of Wolbachia were retrieved from the database. Conclusions: To our knowledge this is the first study to elucidate the genetic makeup of C. lectularius. This pyrosequencing effort provides clues to the identification of potential detoxification genes involved in pesticide resistance of C. lectularius and lays the foundation for future functional genomics studies.	[Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna P.; Mittapalli, Omprakash] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Jones, Susan C.] Ohio State Univ, Dept Entomol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bai, XD (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	mittapalli.1@osu.edu	Rajarapu, Swapna Priya/H-3514-2019	Mamidala, Praveen/0000-0001-8587-0635	State and Federal funds	State and Federal funds	This research was supported by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Naser M, 2006, PARASITOL RES, V98, P550, DOI 10.1007/s00436-005-0076-9; Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson AL, 2008, J ENVIRON HEALTH, V70, P24; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Barbehenn RV, 2002, J CHEM ECOL, V28, P1329, DOI 10.1023/A:1016288201110; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Boase C., 2001, Pesticide Outlook, V12, P159, DOI 10.1039/b106301b; Bochicchio B, 2001, MATRIX BIOL, V20, P243, DOI 10.1016/S0945-053X(01)00139-1; COGILL P, 2008, CURR PROTOC BIOINFOR, V2; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Gangloff-Kaufmann J., 2006, American Entomologist, V52, P105; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Goddard J., 2010, INFECT DIS ARTHROPOD, P177; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HAMODRAKAS SJ, 1988, PROTEIN ENG, V2, P201, DOI 10.1093/protein/2.3.201; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P102, DOI 10.1016/j.pestbp.2006.09.006; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lee IY, 2008, KOREAN J PARASITOL, V46, P269, DOI 10.3347/kjp.2008.46.4.269; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Maier D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-74; McNeil GP, 2001, GENETICS, V159, P229; Mittapalli O, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2001; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Myamba J, 2002, MED VET ENTOMOL, V16, P448, DOI 10.1046/j.1365-2915.2002.00389.x; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; Olafson PU, 2010, ARCH INSECT BIOCHEM, V74, P179, DOI 10.1002/arch.20372; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Potter M. F., 2005, Pest Control Technology, V33, P82; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Reinhardt K, 2009, MED VET ENTOMOL, V23, P163, DOI 10.1111/j.1365-2915.2008.00793.x; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Rendahl KG, 1996, J NEUROSCI, V16, P1511; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1111/j.1365-3032.1997.tb01182.x; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robson P, 2000, MOL BIOL EVOL, V17, P1739, DOI 10.1093/oxfordjournals.molbev.a026272; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Rose RL, 1997, INSECT BIOCHEM MOLEC, V27, P605, DOI 10.1016/S0965-1748(97)00036-2; Rossi L, 2010, J ENVIRON HEALTH, V72, P34; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Scarupa MD, 2006, J ALLERGY CLIN IMMUN, V117, P1508, DOI 10.1016/j.jaci.2006.03.034; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Stanewsky R, 1996, GENETICS, V143, P259; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Stibich AS, 2001, DERMATOLOGY, V202, P193, DOI 10.1159/000051635; Stucki A, 2008, NEW ENGL J MED, V359, P1047, DOI 10.1056/NEJMicm060268; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Ter Poorten MC, 2005, PEDIATR DERMATOL, V22, P183, DOI 10.1111/j.1525-1470.2005.22301.x; THURSTON MI, 2005, MSATFINDER DETECTION; TOMITA T, 1995, INSECT BIOCHEM MOLEC, V25, P275, DOI 10.1016/0965-1748(94)00066-Q; Usinger R., 1966, MONOGRAPH CIMICIDAE, V7; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; WERREN JH, 1995, P ROY SOC LOND B BIO, V265, P1447; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	94	123	139	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16336	10.1371/journal.pone.0016336	http://dx.doi.org/10.1371/journal.pone.0016336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283830	gold, Green Published, Green Submitted			2022-12-27	WOS:000286520600041
J	Handel, AE; Williamson, AJ; Disanto, G; Dobson, R; Giovannoni, G; Ramagopalan, SV				Handel, Adam E.; Williamson, Alexander J.; Disanto, Giulio; Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.			Smoking and Multiple Sclerosis: An Updated Meta-Analysis	PLOS ONE			English	Article							LIFE-STYLE FACTORS; CIGARETTE-SMOKING; RHEUMATOID-ARTHRITIS; ORAL-CONTRACEPTIVES; RISK-FACTOR; PROGRESSION; EXPOSURE; DISEASE; MS; EPIDEMIOLOGY	Background: Multiple sclerosis (MS) is a leading cause of disability in young adults. Susceptibility to MS is determined by environmental exposure on the background of genetic risk factors. A previous meta-analysis suggested that smoking was an important risk factor for MS but many other studies have been published since then. Methods/Principal Findings: We performed a Medline search to identify articles published that investigated MS risk following cigarette smoking. A total of 14 articles were included in this study. This represented data on 3,052 cases and 457,619 controls. We analysed these studies in both a conservative (limiting our analysis to only those where smoking behaviour was described prior to disease onset) and non-conservative manner. Our results show that smoking is associated with MS susceptibility (conservative: risk ratio (RR) 1.48, 95% confidence interval (CI) 1.35-1.63, p<10(-15); non-conservative: RR 1.52, 95% CI 1.39-1.66, p<10(-19)). We also analysed 4 studies reporting risk of secondary progression in MS and found that this fell just short of statistical significance with considerable heterogeneity (RR 1.88, 95% CI 0.98-3.61, p = 0.06). Discussion: Our results demonstrate that cigarette smoking is important in determining MS susceptibility but the effect on the progression of disease is less certain. Further work is needed to understand the mechanism behind this association and how smoking integrates with other established risk factors.	[Handel, Adam E.; Disanto, Giulio; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Handel, Adam E.; Disanto, Giulio; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Williamson, Alexander J.] Univ Oxford, Dept Phys & Theoret Chem, Oxford, England; [Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of London; Queen Mary University London	Handel, AE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	g.giovannoni@qmul.ac.uk; sreeramr@well.ox.ac.uk	Handel, Adam/F-2489-2011	Ebers, George/0000-0003-4771-4177; McKeating, Jane/0000-0002-7229-5886; Handel, Adam/0000-0001-8385-6346	Wellcome Trust [075491/Z/04]; Medical Research Council [G0801976]; MRC [G0801976] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust [GRANT NUMBER 075491/Z/04] and Medical Research Council [GRANT NUMBER G0801976]. SVR is a Goodger Scholar at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOVSKY A, 1965, ARCH NEUROL-CHICAGO, V13, P183, DOI 10.1001/archneur.1965.00470020073010; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Carlens C, 2010, AM J RESP CRIT CARE, V181, P1217, DOI 10.1164/rccm.200909-1338OC; CLAYTON D, 1993, STAT MODELS EPIDEMIO, pR8; Dahl J, 2007, EUR J NEUROL, V14, P1113, DOI 10.1111/j.1468-1331.2007.01913.x; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Fowles Jeff, 2006, N Z Med J, V119, pU1931; Frutos-Alegria MT, 2002, REV NEUROLOGIA, V34, P813, DOI 10.33588/rn.3409.2001502; Frutos-Alegria MT, 2002, REV NEUROLOGIA, V34, P1013, DOI 10.33588/rn.3411.2001503; Fusby JS, 2010, INHAL TOXICOL, V22, P785, DOI 10.3109/08958378.2010.483258; George J, 1997, SCAND J IMMUNOL, V45, P1, DOI 10.1046/j.1365-3083.1997.d01-366.x; Ghadirian T, 2001, CAN J PUBLIC HEALTH, V92, P281, DOI 10.1007/BF03404961; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; HANDEL AE, 2010, EUR J NEUROL; Hawkes CH, 2007, MULT SCLER J, V13, P610, DOI 10.1177/1352458506073501; Healy BC, 2009, ARCH NEUROL-CHICAGO, V66, P858, DOI 10.1001/archneurol.2009.122; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jafari N, 2009, MULT SCLER J, V15, P1363, DOI 10.1177/1352458509345907; Koch M, 2007, NEUROLOGY, V69, P1515, DOI 10.1212/01.wnl.0000277658.78381.db; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Mack WP, 1999, OPHTHAL PLAST RECONS, V15, P260, DOI 10.1097/00002341-199907000-00007; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; Munger KL, 2003, EPIDEMIOLOGY, V14, P141, DOI 10.1097/00001648-200303000-00006; Nortvedt MW, 2005, NEUROL SCI, V26, P334, DOI 10.1007/s10072-005-0498-2; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Pekmezovic T, 2006, NEUROEPIDEMIOLOGY, V27, P212, DOI 10.1159/000096853; da Silva KRP, 2009, ARQ NEURO-PSIQUIAT, V67, P229, DOI 10.1590/S0004-282X2009000200011; PITTAS F, 2009, J NEUROL; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; Regal AR, 2009, NEUROLOGIA, V24, P177; Russo C, 2008, J NEUROL, V255, P64, DOI 10.1007/s00415-007-0668-7; Scolding N, 1998, LANCET, V352, P340, DOI 10.1016/S0140-6736(05)60463-1; SENECALQUEVILLON M, 1986, MUTAT RES, V161, P65, DOI 10.1016/0027-5107(86)90100-4; Simon KC, 2010, NEUROLOGY, V74, P1365, DOI 10.1212/WNL.0b013e3181dad57e; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Sundstrom P, 2008, MULT SCLER J, V14, P1031, DOI 10.1177/1352458508093615; Sundstrom P, 2008, EUR J NEUROL, V15, P579, DOI 10.1111/j.1468-1331.2008.02122.x; Thorogood M, 1998, BRIT J OBSTET GYNAEC, V105, P1296, DOI 10.1111/j.1471-0528.1998.tb10008.x; Tremlett H, 2008, NEUROEPIDEMIOLOGY, V31, P271, DOI 10.1159/000166602; Turner AP, 2007, ARCH PHYS MED REHAB, V88, P1394, DOI 10.1016/j.apmr.2007.08.003; VILLARDMACKINTOSH L, 1993, CONTRACEPTION, V47, P161, DOI 10.1016/0010-7824(93)90088-O	52	176	177	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16149	10.1371/journal.pone.0016149	http://dx.doi.org/10.1371/journal.pone.0016149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249154	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000022
J	Zhao, YH; Calon, F; Julien, C; Winkler, JW; Petasis, NA; Lukiw, WJ; Bazan, NG				Zhao, Yuhai; Calon, Frederic; Julien, Carl; Winkler, Jeremy W.; Petasis, Nicos A.; Lukiw, Walter J.; Bazan, Nicolas G.			Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPAR gamma-Mediated Mechanisms in Alzheimer's Disease Models	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; AMYLOID-PRECURSOR-PROTEIN; HUMAN BRAIN-CELLS; POLYUNSATURATED FATTY-ACID; PIGMENT EPITHELIAL-CELLS; STRESS-INDUCED APOPTOSIS; OXIDATIVE STRESS; A-BETA; IN-VITRO; SIGNALING PATHWAY	Neuroprotectin D1 (NPD1) is a stereoselective mediator derived from the omega-3 essential fatty acid docosahexaenoic acid (DHA) with potent inflammatory resolving and neuroprotective bioactivity. NPD1 reduces A beta 42 peptide release from aging human brain cells and is severely depleted in Alzheimer's disease (AD) brain. Here we further characterize the mechanism of NPD1's neurogenic actions using 3xTg-AD mouse models and human neuronal-glial (HNG) cells in primary culture, either challenged with A beta 42 oligomeric peptide, or transfected with beta amyloid precursor protein (beta APP)(sw) (Swedish double mutation APP695(sw), K595N-M596L). We also show that NPD1 downregulates A beta 42-triggered expression of the pro-inflammatory enzyme cyclooxygenase-2 (COX-2) and of B-94 (a TNF-alpha-inducible pro-inflammatory element) and apoptosis in HNG cells. Moreover, NPD1 suppresses A beta 42 peptide shedding by down-regulating beta-secretase-1 (BACE1) while activating the alpha-secretase ADAM10 and up-regulating sAPP alpha, thus shifting the cleavage of beta APP holoenzyme from an amyloidogenic into the non-amyloidogenic pathway. Use of the thiazolidinedione peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist rosiglitazone, the irreversible PPAR gamma antagonist GW9662, and overexpressing PPAR gamma suggests that the NPD1-mediated down-regulation of BACE1 and A beta 42 peptide release is PPAR gamma-dependent. In conclusion, NPD1 bioactivity potently down regulates inflammatory signaling, amyloidogenic APP cleavage and apoptosis, underscoring the potential of this lipid mediator to rescue human brain cells in early stages of neurodegenerations.	[Zhao, Yuhai; Lukiw, Walter J.; Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA; [Calon, Frederic; Julien, Carl] Ctr Hosp Univ Laval Res Ctr CHUL, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ, Canada; [Winkler, Jeremy W.; Petasis, Nicos A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Laval University; University of Southern California	Zhao, YH (corresponding author), Univ Texas Hlth Sci Ctr, Houston, TX USA.	wlukiw@lsuhsc.edu; nbazan@lsuhsc.edu	Winkler, Jeremy/C-3198-2008; Petasis, Nicos/B-3162-2009; Bazan, Nicolas/AAN-4121-2020; Calon, Frederic/AAF-4390-2020; Julien, Carl/AAU-5309-2021	Petasis, Nicos/0000-0002-8864-4446; Bazan, Nicolas/0000-0002-9243-5444; Calon, Frederic/0000-0002-4203-0887	National Institutes of Health, National Center for Research Resource [P20 RR016816]; Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038834] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, National Center for Research Resource grant (P20 RR016816), the Edward G. Schlieder Educational Foundation, and the Eye, Ear, Nose & Throat Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Antony R, 2010, J BIOL CHEM, V285, P18301, DOI 10.1074/jbc.M109.095232; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; Avramovich Y, 2002, J BIOL CHEM, V277, P31466, DOI 10.1074/jbc.M201308200; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; d'Abramo C, 2005, BIOCHEM J, V391, P693, DOI 10.1042/BJ20050560; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Galasko D, 2010, BIOMARK MED, V4, P27, DOI 10.2217/BMM.09.89; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2010, NAT MED, V16, P1201, DOI 10.1038/nm.2223; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Henke BR, 2004, PROGR MED CHEM, V42, P1, DOI 10.1016/S0079-6468(04)42001-3; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jang JH, 2005, FREE RADICAL BIO MED, V38, P1604, DOI 10.1016/j.freeradbiomed.2005.02.023; JULIEN C, 2008, NEUROBIOL AGING, V159, P296; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Ma QL, 2007, J NEUROSCI, V27, P14299, DOI 10.1523/JNEUROSCI.3593-07.2007; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marion-Letellier R, 2008, AM J CLIN NUTR, V87, P939, DOI 10.1093/ajcn/87.4.939; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCLACHLAN DRC, 1988, MOL BRAIN RES, V3, P255, DOI 10.1016/0169-328X(88)90048-4; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Roberts LJ, 2005, BRAIN PATHOL, V15, P143; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sahlin C, 2007, EUR J NEUROSCI, V26, P882, DOI 10.1111/j.1460-9568.2007.05719.x; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shie FS, 2009, CURR MED CHEM, V16, P643, DOI 10.2174/092986709787458399; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yamamoto K, 2005, BIOORG MED CHEM LETT, V15, P517, DOI 10.1016/j.bmcl.2004.11.053; Yang HQ, 2007, EUR J NEUROSCI, V26, P381, DOI 10.1111/j.1460-9568.2007.05648.x; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com; Zhao YH, 2007, NEUROREPORT, V18, P1187, DOI 10.1097/WNR.0b013e32821c56c4	68	195	206	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15816	10.1371/journal.pone.0015816	http://dx.doi.org/10.1371/journal.pone.0015816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246057	Green Submitted, gold, Green Published			2022-12-27	WOS:000286511200016
J	Liu, Y; McNevin, JP; Holte, S; McElrath, MJ; Mullins, JI				Liu, Yi; McNevin, John P.; Holte, Sarah; McElrath, M. Juliana; Mullins, James I.			Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; ESCAPE; CELLS; VIREMIA; SELECTION; ANTIGEN; REPLICATION; VARIANTS; EPITOPES	Improved understanding of the dynamics of host immune responses and viral evolution is critical for effective HIV-1 vaccine design. We comprehensively analyzed Cytotoxic T-lymphocyte (CTL)-viral epitope dynamics in an antiretroviral therapy-naive subject over the first four years of HIV-1 infection. We found that CTL responses developed sequentially and required constant antigenic stimulation for maintenance. CTL responses exerting strong selective pressure emerged early and led to rapid escape, proliferated rapidly and were predominant during acute/early infection. Although CTL responses to a few persistent epitopes developed over the first two months of infection, they proliferated slowly. As CTL epitopes were replaced by mutational variants, the corresponding responses immediately declined, most rapidly in the cases of strongly selected epitopes. CTL recognition of epitope variants, via cross-reactivity and de novo responses, was common throughout the period of study. Our data demonstrate that HIV-specific CTL responses, especially in the critical acute/early stage, were focused on regions that are prone to escape. Failure of CTL responses to strongly target functional or structurally critical regions of the virus, as well as the sequential cascade of CTL responses, followed closely by viral escape and decline of the corresponding responses, likely contribute to a lack of sustainable viral suppression. Focusing early and rapidly proliferating CTL on persistent epitopes may be essential for durable viral control in HIV-1 infection.	[Liu, Yi; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [McElrath, M. Juliana; Mullins, James I.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [McNevin, John P.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Liu, Y (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu		mcnevin, john paul/0000-0002-9893-9256; Li, Yong/0000-0003-2651-8791	United States Public Health Service [P01 AI57005, R01 AI055343]; University of Washington Center for AIDS Research Computational Biology Core [P30 AI27757];  [M01-RR-00037]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, R01AI055343, P30AI027757] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Washington Center for AIDS Research Computational Biology Core; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the United States Public Health Service to JIM (P01 AI57005), to SH (R01 AI055343) and the University of Washington Center for AIDS Research Computational Biology Core (P30 AI27757), and by grant M01-RR-00037 for leukapheresis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buseyne F, 2001, INT IMMUNOL, V13, P941, DOI 10.1093/intimm/13.7.941; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Fujiwara M, 2008, J VIROL, V82, P138, DOI 10.1128/JVI.01452-07; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Jamieson BD, 2003, J IMMUNOL, V171, P5372, DOI 10.4049/jimmunol.171.10.5372; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LEITNER TF, 2006, HIV SEQUENCE COMPEND; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Liu Y, 2009, J INFECT DIS, V200, P1825, DOI 10.1086/648401; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Streeck H, 2006, J INFECT DIS, V194, P734, DOI 10.1086/503811; Tomiyama H, 2000, EUR J IMMUNOL, V30, P2521, DOI 10.1002/1521-4141(200009)30:9<2521::AID-IMMU2521>3.0.CO;2-Q; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Welsh RM, 2001, J EXP MED, V193, pF19, DOI 10.1084/jem.193.5.F19; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101	34	121	129	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15639	10.1371/journal.pone.0015639	http://dx.doi.org/10.1371/journal.pone.0015639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283794	Green Published, Green Submitted, gold			2022-12-27	WOS:000286522200010
J	Johnson, CL; Runge, JA; Curtis, KA; Durbin, EG; Hare, JA; Incze, LS; Link, JS; Melvin, GD; O'Brien, TD; Van Guelpen, L				Johnson, Catherine L.; Runge, Jeffrey A.; Curtis, K. Alexandra; Durbin, Edward G.; Hare, Jonathan A.; Incze, Lewis S.; Link, Jason S.; Melvin, Gary D.; O'Brien, Todd D.; Van Guelpen, Lou			Biodiversity and Ecosystem Function in the Gulf of Maine: Pattern and Role of Zooplankton and Pelagic Nekton	PLOS ONE			English	Review							CONTINENTAL-SHELF ECOSYSTEM; NORTHWEST ATLANTIC-OCEAN; HERRING CLUPEA-HARENGUS; LONGFIN INSHORE SQUID; LARGE-SCALE PATTERNS; GEORGES-BANK; CALANUS-FINMARCHICUS; PREDATION MORTALITY; MARINE ECOSYSTEM; LOLIGO-PEALEII	This paper forms part of a broader overview of biodiversity of marine life in the Gulf of Maine area (GoMA), facilitated by the GoMA Census of Marine Life program. It synthesizes current data on species diversity of zooplankton and pelagic nekton, including compilation of observed species and descriptions of seasonal, regional and cross-shelf diversity patterns. Zooplankton diversity in the GoMA is characterized by spatial differences in community composition among the neritic environment, the coastal shelf, and deep offshore waters. Copepod diversity increased with depth on the Scotian Shelf. On the coastal shelf of the western Gulf of Maine, the number of higher-level taxonomic groups declined with distance from shore, reflecting more nearshore meroplankton. Copepod diversity increased in late summer, and interdecadal diversity shifts were observed, including a period of higher diversity in the 1990s. Changes in species diversity were greatest on interannual scales, intermediate on seasonal scales, and smallest across regions, in contrast to abundance patterns, suggesting that zooplankton diversity may be a more sensitive indicator of ecosystem response to interannual climate variation than zooplankton abundance. Local factors such as bathymetry, proximity of the coast, and advection probably drive zooplankton and pelagic nekton diversity patterns in the GoMA, while ocean-basin-scale diversity patterns probably contribute to the increase in diversity at the Scotian Shelf break, a zone of mixing between the cold-temperate community of the shelf and the warm-water community offshore. Pressing research needs include establishment of a comprehensive system for observing change in zooplankton and pelagic nekton diversity, enhanced observations of "underknown'' but important functional components of the ecosystem, population and metapopulation studies, and development of analytical modeling tools to enhance understanding of diversity patterns and drivers. Ultimately, sustained observations and modeling analysis of biodiversity must be effectively communicated to managers and incorporated into ecosystem approaches for management of GoMA living marine resources.	[Johnson, Catherine L.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Runge, Jeffrey A.] Univ Maine, Sch Marine Sci, Portland, ME USA; [Runge, Jeffrey A.] Gulf Maine Res Inst, Portland, ME USA; [Curtis, K. Alexandra] Acadia Univ, Acadia Ctr Estuarine Res, Wolfville, NS B0P 1X0, Canada; [Durbin, Edward G.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Hare, Jonathan A.] NOAA, Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Narragansett, RI 02882 USA; [Incze, Lewis S.] Univ So Maine, Aquat Syst Grp, Portland, ME 04103 USA; [Link, Jason S.] Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Melvin, Gary D.] Fisheries & Oceans Canada, St Andrews Biol Stn, St Andrews, NB, Canada; [O'Brien, Todd D.] Natl Marine Fisheries Serv, Marine Ecosyst Div, Off Sci Technol, Silver Spring, MD USA; [Van Guelpen, Lou] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; University of Maine System; University of Maine Orono; Gulf of Maine Research Institute; Acadia University; University of Rhode Island; National Oceanic Atmospheric Admin (NOAA) - USA; University of Maine System; University of Southern Maine; National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada; National Oceanic Atmospheric Admin (NOAA) - USA	Johnson, CL (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	Catherine.Johnson@dfo-mpo.gc.ca		Johnson, Catherine/0000-0001-5291-3141; Curtis, Katherine Alexandra/0000-0001-7284-944X; Gray, Nicola M/0000-0001-8497-394X; Link, Jason/0000-0003-2740-7161	Alfred P. Sloan Foundation; National Science Foundation [OCE-0815336, 0733907, OISE-0502252]; Fisheries and Oceans Canada's Ecosystem Research Initiative in the Gulf of Maine	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Fisheries and Oceans Canada's Ecosystem Research Initiative in the Gulf of Maine	This work was supported by the Alfred P. Sloan Foundation through the Gulf of Maine Area Program of the Census of Marine Life (grant to L. Incze), by the National Science Foundation under awards OCE-0815336 and 0733907 to J. Runge and OISE-0502252 to C. Johnson, and by Fisheries and Oceans Canada's Ecosystem Research Initiative in the Gulf of Maine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA F, 1999, 9906 NE FISH SCI CTR; Angel MV, 1997, MARINE BIODIVERSITY-BOOK, P35, DOI 10.1017/CBO9780511752360.004; Auster PJ, 2009, MAR ECOL PROG SER, V382, P163, DOI 10.3354/meps07962; Azarovitz T.R., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P62; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; BIGELOW HB, 1926, B US BUREAU FISHER 2, V40; Bonnet D, 2005, PROG OCEANOGR, V65, P1, DOI 10.1016/j.pocean.2005.02.002; BRADFORD J M, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P159; Brodziak JKT, 2002, NE FISHERY SCI CTR R, P245; Bucklin A, 1996, DEEP-SEA RES PT II, V43, P1665, DOI 10.1016/S0967-0645(96)00059-8; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ICLARM C P, V26, P14; CHURCHILL J, FISH OCEANO IN PRESS; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; COWEN RK, 1993, B MAR SCI, V53, P567; COX J, 1979, ESTUAR COAST MAR SCI, V9, P509, DOI 10.1016/0302-3524(79)90076-8; Cushing D.H., 1982, CLIMATE FISHERIES; DABORN GR, 1984, CAN TECH REP FISH AQ, V1256, P135; Darbyson E, 2003, J FISH BIOL, V63, P1235, DOI 10.1046/j.1095-8649.2003.00247.x; Davis C.S., 1987, P256; Dawe EG, 2007, FISH OCEANOGR, V16, P303, DOI 10.1111/j.1365-2419.2007.00431.x; deYoung B, 2004, SCIENCE, V304, P1463, DOI 10.1126/science.1094858; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; DFO, 2003, STAT E SCOT SHELF EC; Duffy JE, 2006, MAR ECOL PROG SER, V311, P179, DOI 10.3354/meps311179; Durbin E, 2007, PROG OCEANOGR, V72, P249, DOI 10.1016/j.pocean.2007.01.008; Durbin EG, 2006, DEEP-SEA RES PT II, V53, P2537, DOI 10.1016/j.dsr2.2006.08.017; Durbin EG, 2003, MAR ECOL PROG SER, V254, P81, DOI 10.3354/meps254081; Ecosystem Assessment Program (EAP), 2009, 0911 EAP US DEP COMM; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Edwards SF, 2004, ECOL ECON, V49, P317, DOI 10.1016/j.ecolecon.2004.04.002; EVSEENKO SA, 1982, J NW ATL FISH SCI, P127; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FROST BW, 1989, CAN J ZOOL, V67, P525, DOI 10.1139/z89-077; Fulton EA, 2004, ECOL MODEL, V174, P267, DOI 10.1016/j.ecolmodel.2003.09.027; Garrison LP, 2010, ICES J MAR SCI, V67, P856, DOI 10.1093/icesjms/fsq005; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Gosselin F, 2006, J THEOR BIOL, V242, P591, DOI 10.1016/j.jtbi.2006.04.017; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Grabe SA, 1996, J PLANKTON RES, V18, P881, DOI 10.1093/plankt/18.6.881; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; HAMNER WM, 1975, LIMNOL OCEANOGR, V20, P907, DOI 10.4319/lo.1975.20.6.0907; Hare JA, 2001, FISH OCEANOGR, V10, P164, DOI 10.1046/j.1365-2419.2001.00168.x; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; HOPKINS T L, 1981, Journal of Plankton Research, V3, P645, DOI 10.1093/plankt/3.4.645; HOYSGAARD S, 2009, GROUPWISE COMPUTATIO; Hunsicker ME, 2008, CAN J FISH AQUAT SCI, V65, P2524, DOI 10.1139/F08-154; Hunsicker ME, 2006, CAN J FISH AQUAT SCI, V63, P754, DOI 10.1139/f05-258; Huret M, 2007, MAR ECOL PROG SER, V347, P261, DOI 10.3354/meps06983; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Incze L, 2010, FISH OCEANOGR, V19, P1, DOI 10.1111/j.1365-2419.2009.00522.x; Ji RB, 2009, MAR ECOL PROG SER, V384, P187, DOI 10.3354/meps08032; Johnson CL, 2008, ICES J MAR SCI, V65, P339, DOI 10.1093/icesjms/fsm171; JOHNSON CL, ADV ECOSYST IN PRESS; Johnson WS, 2005, ZOOPLANKTON ATLANTIC; Jumars PA, 2007, OCEANOGR MAR BIOL, V45, P89, DOI 10.1201/9781420050943.ch3; Kane J, 1997, FISH B-NOAA, V95, P85; Kane J, 2008, J PLANKTON RES, V30, P619, DOI 10.1093/plankt/fbn026; Kane J, 2007, ICES J MAR SCI, V64, P909, DOI 10.1093/icesjms/fsm066; Kane J, 2009, J PLANKTON RES, V31, P249, DOI 10.1093/plankt/fbn119; Kelly NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013832; Kindt R., 2005, WORLD; Kirby RR, 2008, LIMNOL OCEANOGR, V53, P1805, DOI 10.4319/lo.2008.53.5.1805; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LANGE AMT, 1980, MAR FISH REV, V42, P23; LEGARE JEH, 1960, J FISH RES BOARD CAN, V17, P409, DOI 10.1139/f60-030; LEGARE JEH, 1961, ZOOPLANKTON PASSAMAQ; Lemon J., 2009, PLOTRIX VARIOUS PLOT; LI WKW, PLOS ONE UNPUB; Lindley JA, 1997, J CRUSTACEAN BIOL, V17, P569, DOI 10.2307/1549361; Link J, 2002, MAR ECOL PROG SER, V230, P1, DOI 10.3354/meps230001; Link J., 2008, J NW ATLANTIC FISHER, V39, P83, DOI DOI 10.2960/J.V39.M582; Link J, 2008, J MARINE SYST, V74, P453, DOI 10.1016/j.jmarsys.2008.03.007; Link J, 2009, ECOL MODEL, V220, P351, DOI 10.1016/j.ecolmodel.2008.10.009; Link JS, 2007, ECOL APPL, V17, P2037, DOI 10.1890/06-1154.1; Link JS, 2006, MAR ECOL PROG SER, V320, P153, DOI 10.3354/meps320153; Link JS, 2009, N AM J FISH MANAGE, V29, P1567, DOI 10.1577/M08-233.1; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; LINK JS, FULTON EA NEUS ATLAN; Link JS, 2006, US DEP COMMERCE NE F, P166; LONGHURST AR, 1985, DEEP-SEA RES, V32, P1535, DOI 10.1016/0198-0149(85)90102-5; Mackas DL, 2010, J MARINE SYST, V79, P286, DOI 10.1016/j.jmarsys.2008.11.030; Mackas DL, 2004, DEEP-SEA RES PT II, V51, P875, DOI 10.1016/j.dsr2.2004.05.011; MACY WK, 1982, BIOL BULL, V162, P28, DOI 10.2307/1540967; Madin LP, 1996, DEEP-SEA RES PT II, V43, P1823, DOI 10.1016/S0967-0645(96)00038-0; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manning CA, 2005, MAR ECOL PROG SER, V292, P233, DOI 10.3354/meps292233; Marcus NH, 1996, HYDROBIOLOGIA, V320, P141, DOI 10.1007/BF00016815; Mauchline J., 1998, ADV MARINE BIOL, V33; May R.M., 1975, P81; Mitchell M. R., 2002, ATLANTIC ZONAL MONIT; Moore J. A., 2003, Journal of Northwest Atlantic Fishery Science, V31, P363; Moore JA, 2003, NORTHEAST NAT, V10, P159, DOI 10.1656/1092-6194(2003)010[0159:AALODF]2.0.CO;2; MORGAN S, 1995, ECOLOGY MARINE INVER; Morgan Steven G., 1995, P157; Mountain D.G., 2004, J NW ATL FISH SCI, V34, P101; Moustahfid H, 2009, ICES J MAR SCI, V66, P445, DOI 10.1093/icesjms/fsn217; Moustahfid H, 2009, N AM J FISH MANAGE, V29, P1555, DOI 10.1577/M08-221.1; NEFC, 1988, NMFSFNEC52 NOAA; *NEFSC, 2007, 0716 NE FISH SCI CTR, P13; *NEFSC, 2006, 42 NE REG STOCK AS B; NICOL S, 1984, MAR ECOL PROG SER, V18, P241, DOI 10.3354/meps018241; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Overholtz WJ, 2008, N AM J FISH MANAGE, V28, P247, DOI 10.1577/M06-267.1; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz WJ, 2002, FISH B-NOAA, V100, P593; Overholtz WJ, 2002, FISH RES, V57, P237, DOI 10.1016/S0165-7836(01)00359-9; PERCY JA, 1997, BAY FUND ISS SCI OV; Perry RI, 2004, ICES J MAR SCI, V61, P445, DOI 10.1016/j.icesjms.2004.03.022; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Pershing AJ, 2009, MAR ECOL PROG SER, V378, P227, DOI 10.3354/meps07828; Pershing AJ, 2009, MAR ECOL PROG SER, V378, P245, DOI 10.3354/meps07829; Pierrot-Bults AC, 1997, MARINE BIODIVERSITY-BOOK, P69, DOI 10.1017/CBO9780511752360.005; PODRAZHANSKAYA SG, 2009, NW ATLANTIC FISHERIE, V19, P79; Quattrini AM, 2005, FISH OCEANOGR, V14, P413, DOI 10.1111/j.1365-2419.2005.00344.x; R Core Team, 2020, R LANG ENV STAT COMP; RAMP SR, 1985, J PHYS OCEANOGR, V15, P1790, DOI 10.1175/1520-0485(1985)015<1790:TDFTTN>2.0.CO;2; Razouls C., 2020, DIVERSITY GEOGRAPHIC; Record NR, 2010, J PLANKTON RES, V32, P1675, DOI 10.1093/plankt/fbq050; Richardson DE, 2010, ICES J MAR SCI, V67, P617, DOI 10.1093/icesjms/fsp276; ROGERS CA, 1976, IMPACT AUTUMN WINTER, P76; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Royle J. A., 2008, HIERARCHICAL MODELIN; RUNGE J, 2010, PROG OCEANO IN PRESS; RUNGE J, 2005, GLOBAL COASTAL OCEAN, V13; RUNGE JA, ADV ECOSYST IN PRESS; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; SAMEOTO D, 1993, CAN J FISH AQUAT SCI, V50, P334, DOI 10.1139/f93-039; SAMEOTO DD, 1992, CAN J FISH AQUAT SCI, V49, P857, DOI 10.1139/f92-096; Saumweber WJ, 2006, DEEP-SEA RES PT II, V53, P2597, DOI 10.1016/j.dsr2.2006.08.003; SCHNEPPENHEIM R, 1986, POLAR BIOL, V6, P215, DOI 10.1007/BF00443398; SHERMAN K, 1983, FISH B-NOAA, V81, P855; SHERMAN K, 1968, SEASONAL AREAL DISTR, P1; SINCLAIR M, 1988, MARINE POPULATIONS A; SMITH PC, 1983, J PHYS OCEANOGR, V13, P1034, DOI 10.1175/1520-0485(1983)013<1034:TMASCO>2.0.CO;2; Staudinger MD, 2006, FISH B-NOAA, V104, P605; Steele JH, 2007, PROG OCEANOGR, V74, P423, DOI 10.1016/j.pocean.2007.05.003; Steele John H., 2008, GLOBEC International Newsletter, V14, P3; Stevick PT, 2008, MAR ECOL PROG SER, V363, P15, DOI 10.3354/meps07475; Townsend D.W., 2006, SEA, V14A, P119; TOWNSEND DW, 1984, MAR ECOL PROG SER, V15, P79, DOI 10.3354/meps015079; TREMBLAY MJ, 1983, CAN J FISH AQUAT SCI, V40, P598, DOI 10.1139/f83-079; TURNER JT, 1994, HYDROBIOLOGIA, V293, P405; TURNER JT, 1981, J BIOGEOGR, V8, P369, DOI 10.2307/2844757; Tyrrell MC, 2008, ICES J MAR SCI, V65, P1689, DOI 10.1093/icesjms/fsn185; UCHUPI E, 1968, US GEOL SURV PROF C, V529, pC1; VARPE O, ECOLOGY IN PRESS; Vidjak O, 2009, ACTA ADRIAT, V50, P45; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Weisse T, 2002, ESTUAR COAST SHELF S, V54, P423, DOI 10.1006/ecss.2000.0656; WIGLEY RL, 1971, FISH BULL NATL OC AT, V69, P717; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189	164	90	94	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16491	10.1371/journal.pone.0016491	http://dx.doi.org/10.1371/journal.pone.0016491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304990	Green Submitted, gold, Green Published			2022-12-27	WOS:000286834300071
J	Lee, DH; Steffes, MW; Sjodin, A; Jones, RS; Needham, LL; Jacobs, DR				Lee, Duk-Hee; Steffes, Michael W.; Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.; Jacobs, David R., Jr.			Low Dose Organochlorine Pesticides and Polychlorinated Biphenyls Predict Obesity, Dyslipidemia, and Insulin Resistance among People Free of Diabetes	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; ENDOCRINE-DISRUPTING CHEMICALS; SERUM CONCENTRATIONS; NONDIABETIC ADULTS; NATIONAL-HEALTH; ASSOCIATION; MECHANISMS	Background: There is emerging evidence that background exposure to persistent organic pollutants (POPs) are important in the development of conditions predisposing to diabetes as well as of type 2 diabetes itself. We recently reported that low dose POPs predicted incident type 2 diabetes in a nested case-control study. The current study examined if low dose POPs predicted future adiposity, dyslipidemia, and insulin resistance among controls without diabetes in that study. Methodology/Principal Findings: The 90 controls were diabetes-free during 20 years follow-up. They were a stratified random sample, enriched with overweight and obese persons. POPs measured in 1987-88 (year 2) sera included 8 organochlorine (OC) pesticides, 22 polychlorinated biphenyls (PCBs), and 1 polybrominated biphenyl (PBB). Body mass index (BMI), triglycerides, HDL-cholesterol, LDL-cholesterol, and homeostasis model assessment value for insulin resistance (HOMA-IR) were study outcomes at 2005-06 (year 20). The evolution of study outcomes during 18 years by categories of serum concentrations of POPs at year 2 was evaluated by adjusting for the baseline values of outcomes plus potential confounders. Parallel to prediction of type 2 diabetes, many statistically significant associations of POPs with dysmetabolic conditions appeared at low dose, forming inverted U-shaped dose-response relations. Among OC pesticides, p,p'-DDE most consistently predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 after adjusting for baseline values. Oxychlordane, trans-nonachlor, and hexachlorobenzene also significantly predicted higher triglycerides. Persistent PCBs with >= 7 chlorides predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 with similar dose-response curves. Conclusions/Significance: Simultaneous exposure to various POPs in the general population may contribute to development of obesity, dyslipidemia, and insulin resistance, common precursors of type 2 diabetes and cardiovascular diseases. Although obesity is a primary cause of these metabolic abnormalities, POPs exposure may contribute to excess adiposity and other features of dysmetabolism.	[Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea; [Steffes, Michael W.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.] Ctr Dis Control & Prevent, Organ Analyt Toxicol Branch OAT, DLS, NCEH, Atlanta, GA USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Kyungpook National University; University of Minnesota System; University of Minnesota Twin Cities; Centers for Disease Control & Prevention - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Lee, DH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea.	jacob004@umn.edu	Needham, Larry/E-4930-2011; Sjodin, Andreas/F-2464-2010	Jacobs, David/0000-0002-7232-0543; Palsson, Bernhard/0000-0003-2357-6785	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center) [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095]; YALTA [R01-HL-53560]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048049, N01HC095095, N01HC048047, N01HC048050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL053560, R01HL048050, R01HL048049, R01HL048048] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); YALTA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Heart, Lung, and Blood Institute contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers), N01-HC-95095 (CARDIA Coordinating Center), and grant R01-HL-53560 (YALTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Daston GP, 2003, TOXICOL SCI, V74, P245, DOI 10.1093/toxsci/kfg105; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karmaus W, 2009, OCCUP ENVIRON MED, V66, P143, DOI 10.1136/oem.2008.041921; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; LEE DH, 2010, LOW DOSE PERSISTENT; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lopez MCC, 2003, ENVIRON INT, V28, P751, DOI 10.1016/S0160-4120(02)00120-4; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; OBANA H, 1987, ENVIRON RES, V42, P500, DOI 10.1016/S0013-9351(87)80217-7; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640; Sjodin A, 2004, ANAL CHEM, V76, P1921, DOI 10.1021/ac030381; Szapary PO, 2004, AM HEART J, V148, P211, DOI 10.1016/j.ahj.2004.03.037; Turyk M, 2009, ENVIRON HEALTH PERSP, V117, P1076, DOI 10.1289/ehp.0800281; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494	23	276	299	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15977	10.1371/journal.pone.0015977	http://dx.doi.org/10.1371/journal.pone.0015977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	22028828	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800014
